[
  {
    "kegg_id": "D00714",
    "name_en": "Thiopental sodium (JP18/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Pentothal (TN)"
    ],
    "formula": "C11H17N2O2S. Na",
    "efficacy": "Anesthetic (intravenous), Anticonvulsant",
    "target": "GABR [HSA:2554 2555 2556 2557 2558 2559 2560 2561 2562 2563 2564 2565 2566 2567 2568 55879] [KO:K05175 K05181 K05184 K05185 K05186 K05189 K05192]\nPATHWAY   hsa04080(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879)  Neuroactive ligand-receptor interaction\nhsa04727(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879)  GABAergic synapse",
    "metabolism": "",
    "therapeutic_category": "1115",
    "atc_code": "N01AF03",
    "drug_class": [
      "Neuropsychiatric agent",
      "Barbiturate sedative-hypnotics",
      "GABA-A receptor agonist",
      "Anesthetics",
      "General anesthetics",
      "Barbiturate anesthetics"
    ],
    "cyp_enzymes": [],
    "search_name": "Thiopental sodium"
  },
  {
    "kegg_id": "D00713",
    "name_en": "Thiamylal sodium (JP18)",
    "name_ja": "",
    "names_alt": [
      "Surital (TN)"
    ],
    "formula": "C12H17N2O2S. Na",
    "efficacy": "Anesthetic (intravenous)",
    "target": "GABR [HSA:2554 2555 2556 2557 2558 2559 2560 2561 2562 2563 2564 2565 2566 2567 2568 55879] [KO:K05175 K05181 K05184 K05185 K05186 K05189 K05192]\nPATHWAY   hsa04080(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879)  Neuroactive ligand-receptor interaction\nhsa04727(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879)  GABAergic synapse",
    "metabolism": "",
    "therapeutic_category": "1115",
    "atc_code": "",
    "drug_class": [
      "Neuropsychiatric agent",
      "Barbiturate sedative-hypnotics",
      "GABA-A receptor agonist",
      "Anesthetics",
      "General anesthetics",
      "Barbiturate anesthetics"
    ],
    "cyp_enzymes": [],
    "search_name": "Thiamylal sodium"
  },
  {
    "kegg_id": "D00102",
    "name_en": "Nitrous oxide (JP18/USP)",
    "name_ja": "",
    "names_alt": [],
    "formula": "N2O",
    "efficacy": "Anesthetic (inhalation)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "1116",
    "atc_code": "N01AX13",
    "drug_class": [
      "Neuropsychiatric agent",
      "Anesthetics",
      "General anesthetics",
      "Inhalational anaesthetics"
    ],
    "cyp_enzymes": [],
    "search_name": "Nitrous oxide"
  },
  {
    "kegg_id": "D00545",
    "name_en": "Isoflurane (JP18/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Forane (TN)"
    ],
    "formula": "C3H2ClF5O",
    "efficacy": "Anesthetic (inhalation)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "1119",
    "atc_code": "N01AB06",
    "drug_class": [
      "Neuropsychiatric agent",
      "Anesthetics",
      "General anesthetics",
      "Inhalational anaesthetics",
      "Halogenated hydrocarbons"
    ],
    "cyp_enzymes": [],
    "search_name": "Isoflurane"
  },
  {
    "kegg_id": "D00546",
    "name_en": "Desflurane (JAN/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Suprane (TN)"
    ],
    "formula": "C3H2F6O",
    "efficacy": "Anesthetic (inhalation)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "1119",
    "atc_code": "N01AB07",
    "drug_class": [
      "Neuropsychiatric agent",
      "Anesthetics",
      "General anesthetics",
      "Inhalational anaesthetics",
      "Halogenated hydrocarbons"
    ],
    "cyp_enzymes": [],
    "search_name": "Desflurane"
  },
  {
    "kegg_id": "D00547",
    "name_en": "Sevoflurane (JP18/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Ultane (TN)"
    ],
    "formula": "C4H3F7O",
    "efficacy": "Anesthetic (inhalation)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "1119",
    "atc_code": "N01AB08",
    "drug_class": [
      "Neuropsychiatric agent",
      "Anesthetics",
      "General anesthetics",
      "Inhalational anaesthetics",
      "Halogenated hydrocarbons"
    ],
    "cyp_enzymes": [],
    "search_name": "Sevoflurane"
  },
  {
    "kegg_id": "D00711",
    "name_en": "Ketamine hydrochloride (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Ketalar (TN)"
    ],
    "formula": "C13H16ClNO. HCl",
    "efficacy": "Anesthetic (intravenous), NMDA receptor antagonist",
    "target": "GRIN (NMDAR) [HSA:2902 2903 2904 2905 2906] [KO:K05208 K05209 K05210 K05211 K05212]\nPATHWAY   hsa04020(2902+2903+2905+2906)  Calcium signaling pathway\nhsa04080(2902+2903+2904+2905+2906)  Neuroactive ligand-receptor interaction\nhsa04724(2902+2903+2904+2905+2906)  Glutamatergic synapse",
    "metabolism": "",
    "therapeutic_category": "1119",
    "atc_code": "N01AX03",
    "drug_class": [
      "Neuropsychiatric agent",
      "Anesthetics",
      "General anesthetics",
      "NMDA receptor antagonist"
    ],
    "cyp_enzymes": [],
    "search_name": "Ketamine hydrochloride"
  },
  {
    "kegg_id": "D00549",
    "name_en": "Propofol (JAN/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Diprivan (TN)"
    ],
    "formula": "C12H18O",
    "efficacy": "Anesthetic (intravenous), GABA-A receptor agonist",
    "target": "GABR [HSA:2554 2555 2556 2557 2558 2559 2560 2561 2562 2563 2564 2565 2566 2567 2568 55879] [KO:K05175 K05181 K05184 K05185 K05186 K05189 K05192]\nPATHWAY   hsa04080(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879)  Neuroactive ligand-receptor interaction\nhsa04727(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879)  GABAergic synapse",
    "metabolism": "",
    "therapeutic_category": "1119",
    "atc_code": "N01AX10",
    "drug_class": [
      "Neuropsychiatric agent",
      "GABA-A receptor agonist",
      "Anesthetics",
      "General anesthetics"
    ],
    "cyp_enzymes": [],
    "search_name": "Propofol"
  },
  {
    "kegg_id": "D00308",
    "name_en": "Droperidol (JP18/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Droleptan (TN)",
      "Inapsine (TN)"
    ],
    "formula": "C22H22FN3O2",
    "efficacy": "Anesthetic (intravenous), Anti-emetic, Antipsychotic",
    "target": "ADRA1 [HSA:148 147 146] [KO:K04135 K04136 K04137]\nDRD2 [HSA:1813] [KO:K04145]\nPATHWAY   hsa04080(146+147+148+1813)  Neuroactive ligand-receptor interaction\nhsa04728(1813)  Dopaminergic synapse",
    "metabolism": "",
    "therapeutic_category": "1119",
    "atc_code": "N05AD08",
    "drug_class": [
      "Neuropsychiatric agent",
      "Dopamine antagonist",
      "Dopamine D2-receptor antagonist",
      "Antipsychotic agent",
      "Butyrophenone derivative"
    ],
    "cyp_enzymes": [],
    "search_name": "Droperidol"
  },
  {
    "kegg_id": "D10194",
    "name_en": "Remimazolam besylate (USAN)",
    "name_ja": "",
    "names_alt": [
      "Remimazolam besilate (JAN)",
      "Anerem (TN)",
      "Byfavo (TN)"
    ],
    "formula": "C21H19BrN4O2. C6H6O3S",
    "efficacy": "Anesthetic (intravenous), Sedative",
    "target": "GABR [HSA:2554 2555 2556 2557 2558 2559 2560 2561 2562 2563 2564 2565 2566 2567 2568 55879] [KO:K05175 K05181 K05184 K05185 K05186 K05189 K05192]\nPATHWAY   hsa04080(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879)  Neuroactive ligand-receptor interaction\nhsa04727(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879)  GABAergic synapse",
    "metabolism": "",
    "therapeutic_category": "1119",
    "atc_code": "N05CD14",
    "drug_class": [
      "Neuropsychiatric agent",
      "GABA-A receptor agonist"
    ],
    "cyp_enzymes": [],
    "search_name": "Remimazolam besylate"
  },
  {
    "kegg_id": "D00265",
    "name_en": "Chloral hydrate (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Noctec (TN)"
    ],
    "formula": "C2H3Cl3O2",
    "efficacy": "Antianxiety, Sedative-hypnotic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "1123",
    "atc_code": "N05CC01",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Chloral hydrate"
  },
  {
    "kegg_id": "D00388",
    "name_en": "Triclofos sodium (JP18/USAN)",
    "name_ja": "",
    "names_alt": [
      "Tricloryl (TN)"
    ],
    "formula": "C2H3Cl3O4P. Na",
    "efficacy": "Sedative-hypnotic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "1123",
    "atc_code": "N05CM07",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Triclofos sodium"
  },
  {
    "kegg_id": "D00293",
    "name_en": "Diazepam (JP18/USP/INN)",
    "name_ja": "ジアゼパム",
    "names_alt": [
      "Diastat (TN)",
      "Valium (TN)"
    ],
    "formula": "C16H13ClN2O",
    "efficacy": "Antianxiety, Antiepileptic, Minor tranquilizer, Sedative-hypnotic\nDISEASE   Anxiety disorders [DS:H01662]",
    "target": "GABR [HSA:2554 2555 2556 2557 2558 2559 2560 2561 2562 2563 2564 2565 2566 2567 2568 55879] [KO:K05175 K05181 K05184 K05185 K05186 K05189 K05192]\nPATHWAY   hsa04080(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879)  Neuroactive ligand-receptor interaction\nhsa04727(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879)  GABAergic synapse",
    "metabolism": "Enzyme: CYP2C19 [HSA:1557], CYP3A4 [HSA:1576]",
    "therapeutic_category": "1124",
    "atc_code": "N05BA01",
    "drug_class": [
      "Neuropsychiatric agent",
      "Benzodiazepine sedative-hypnotics",
      "GABA-A receptor agonist",
      "Anxiolytics, benzodiazepine derivatives",
      "Antiepileptic agent",
      "Metabolizing enzyme substrate",
      "CYP2C19 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C19",
      "CYP3A4"
    ],
    "search_name": "Diazepam"
  },
  {
    "kegg_id": "D00267",
    "name_en": "Chlordiazepoxide (JP18/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Libritabs (TN)"
    ],
    "formula": "C16H14ClN3O",
    "efficacy": "Antianxiety, Minor tranquilizer, Sedative-hypnotic",
    "target": "GABR [HSA:2554 2555 2556 2557 2558 2559 2560 2561 2562 2563 2564 2565 2566 2567 2568 55879] [KO:K05175 K05181 K05184 K05185 K05186 K05189 K05192]\nPATHWAY   hsa04080(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879)  Neuroactive ligand-receptor interaction\nhsa04727(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879)  GABAergic synapse",
    "metabolism": "",
    "therapeutic_category": "1124",
    "atc_code": "N05BA02",
    "drug_class": [
      "Neuropsychiatric agent",
      "GABA-A receptor agonist",
      "Anxiolytics, benzodiazepine derivatives"
    ],
    "cyp_enzymes": [],
    "search_name": "Chlordiazepoxide"
  },
  {
    "kegg_id": "D01292",
    "name_en": "Medazepam (JP18/INN)",
    "name_ja": "",
    "names_alt": [
      "Pamnace (TN)"
    ],
    "formula": "C16H15ClN2",
    "efficacy": "Antianxiety",
    "target": "GABR [HSA:2554 2555 2556 2557 2558 2559 2560 2561 2562 2563 2564 2565 2566 2567 2568 55879] [KO:K05175 K05181 K05184 K05185 K05186 K05189 K05192]\nPATHWAY   hsa04080(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879)  Neuroactive ligand-receptor interaction\nhsa04727(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879)  GABAergic synapse",
    "metabolism": "",
    "therapeutic_category": "1124",
    "atc_code": "N05BA03",
    "drug_class": [
      "Neuropsychiatric agent",
      "GABA-A receptor agonist",
      "Anxiolytics, benzodiazepine derivatives"
    ],
    "cyp_enzymes": [],
    "search_name": "Medazepam"
  },
  {
    "kegg_id": "D00694",
    "name_en": "Clorazepate dipotassium (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Tranxene (TN)"
    ],
    "formula": "C16H10ClN2O3. KOH. K",
    "efficacy": "Antianxiety, Minor tranquilizer\nDISEASE   Anxiety disorders [DS:H01662]",
    "target": "GABR [HSA:2554 2555 2556 2557 2558 2559 2560 2561 2562 2563 2564 2565 2566 2567 2568 55879] [KO:K05175 K05181 K05184 K05185 K05186 K05189 K05192]\nPATHWAY   hsa04080(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879)  Neuroactive ligand-receptor interaction\nhsa04727(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879)  GABAergic synapse",
    "metabolism": "",
    "therapeutic_category": "1124",
    "atc_code": "N05BA05",
    "drug_class": [
      "Neuropsychiatric agent",
      "Anxiolytics, benzodiazepine derivatives"
    ],
    "cyp_enzymes": [],
    "search_name": "Clorazepate dipotassium"
  },
  {
    "kegg_id": "D00365",
    "name_en": "Lorazepam (JP18/USP/INN)",
    "name_ja": "ロラゼパム",
    "names_alt": [
      "Ativan (TN)"
    ],
    "formula": "C15H10Cl2N2O2",
    "efficacy": "Antianxiety, Anticonvulsant, Minor tranquilizer",
    "target": "GABR [HSA:2554 2555 2556 2557 2558 2559 2560 2561 2562 2563 2564 2565 2566 2567 2568 55879] [KO:K05175 K05181 K05184 K05185 K05186 K05189 K05192]\nPATHWAY   hsa04080(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879)  Neuroactive ligand-receptor interaction\nhsa04727(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879)  GABAergic synapse",
    "metabolism": "Enzyme: UGT2B7 [HSA:7364], UGT2B15 [HSA:7366]",
    "therapeutic_category": "1124",
    "atc_code": "N05BA06",
    "drug_class": [
      "Neuropsychiatric agent",
      "GABA-A receptor agonist",
      "Anxiolytics, benzodiazepine derivatives",
      "Antiepileptic agent",
      "Metabolizing enzyme substrate",
      "UGT substrate",
      "UGT2B7 substrate",
      "UGT2B15 substrate"
    ],
    "cyp_enzymes": [],
    "search_name": "Lorazepam"
  },
  {
    "kegg_id": "D01245",
    "name_en": "Bromazepam (JP18/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Lectopam (TN)"
    ],
    "formula": "C14H10BrN3O",
    "efficacy": "Antianxiety, Minor tranquilizer, Sedative-hypnotic",
    "target": "GABR [HSA:2554 2555 2556 2557 2558 2559 2560 2561 2562 2563 2564 2565 2566 2567 2568 55879] [KO:K05175 K05181 K05184 K05185 K05186 K05189 K05192]\nPATHWAY   hsa04080(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879)  Neuroactive ligand-receptor interaction\nhsa04727(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879)  GABAergic synapse",
    "metabolism": "",
    "therapeutic_category": "1124",
    "atc_code": "N05BA08",
    "drug_class": [
      "Neuropsychiatric agent",
      "GABA-A receptor agonist",
      "Anxiolytics, benzodiazepine derivatives"
    ],
    "cyp_enzymes": [],
    "search_name": "Bromazepam"
  },
  {
    "kegg_id": "D00225",
    "name_en": "Alprazolam (JP18/USP/INN)",
    "name_ja": "アルプラゾラム",
    "names_alt": [
      "Xanax (TN)"
    ],
    "formula": "C17H13ClN4",
    "efficacy": "Antianxiety, Minor tranquilizer, Sedative-hypnotic\nDISEASE   Generalized anxiety disorder [DS:H01662]\nPanic disorder [DS:H01664]",
    "target": "GABR [HSA:2554 2555 2556 2557 2558 2559 2560 2561 2562 2563 2564 2565 2566 2567 2568 55879] [KO:K05175 K05181 K05184 K05185 K05186 K05189 K05192]\nPATHWAY   hsa04080(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879)  Neuroactive ligand-receptor interaction\nhsa04727(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879)  GABAergic synapse",
    "metabolism": "Enzyme: CYP3A [HSA:1576 1577 1551]",
    "therapeutic_category": "1124",
    "atc_code": "N05BA12",
    "drug_class": [
      "Neuropsychiatric agent",
      "GABA-A receptor agonist",
      "Anxiolytics, benzodiazepine derivatives",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A"
    ],
    "search_name": "Alprazolam"
  },
  {
    "kegg_id": "D01293",
    "name_en": "Ethyl loflazepate (JP18/INN)",
    "name_ja": "",
    "names_alt": [
      "Meilax (TN)"
    ],
    "formula": "C18H14ClFN2O3",
    "efficacy": "Antianxiety",
    "target": "GABR [HSA:2554 2555 2556 2557 2558 2559 2560 2561 2562 2563 2564 2565 2566 2567 2568 55879] [KO:K05175 K05181 K05184 K05185 K05186 K05189 K05192]\nPATHWAY   hsa04080(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879)  Neuroactive ligand-receptor interaction\nhsa04727(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879)  GABAergic synapse",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "1124",
    "atc_code": "N05BA18",
    "drug_class": [
      "Neuropsychiatric agent",
      "GABA-A receptor agonist",
      "Anxiolytics, benzodiazepine derivatives",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Ethyl loflazepate"
  },
  {
    "kegg_id": "D01268",
    "name_en": "Cloxazolam (JP18/INN)",
    "name_ja": "",
    "names_alt": [
      "Sepazon (TN)"
    ],
    "formula": "C17H14Cl2N2O2",
    "efficacy": "Antianxiety, Minor tranquilizer, Sedative-hypnotic",
    "target": "GABR [HSA:2554 2555 2556 2557 2558 2559 2560 2561 2562 2563 2564 2565 2566 2567 2568 55879] [KO:K05175 K05181 K05184 K05185 K05186 K05189 K05192]\nPATHWAY   hsa04080(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879)  Neuroactive ligand-receptor interaction\nhsa04727(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879)  GABAergic synapse",
    "metabolism": "",
    "therapeutic_category": "1124",
    "atc_code": "N05BA22",
    "drug_class": [
      "Neuropsychiatric agent",
      "GABA-A receptor agonist",
      "Anxiolytics, benzodiazepine derivatives"
    ],
    "cyp_enzymes": [],
    "search_name": "Cloxazolam"
  },
  {
    "kegg_id": "D01254",
    "name_en": "Tofisopam (JP18/INN)",
    "name_ja": "",
    "names_alt": [
      "Emandaxin (TN)"
    ],
    "formula": "C22H26N2O4",
    "efficacy": "Antianxiety, Sedative-hypnotic",
    "target": "GABR [HSA:2554 2555 2556 2557 2558 2559 2560 2561 2562 2563 2564 2565 2566 2567 2568 55879] [KO:K05175 K05181 K05184 K05185 K05186 K05189 K05192]\nPATHWAY   hsa04080(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879)  Neuroactive ligand-receptor interaction\nhsa04727(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879)  GABAergic synapse",
    "metabolism": "",
    "therapeutic_category": "1124",
    "atc_code": "N05BA23",
    "drug_class": [
      "Neuropsychiatric agent",
      "GABA-A receptor agonist",
      "Anxiolytics, benzodiazepine derivatives"
    ],
    "cyp_enzymes": [],
    "search_name": "Tofisopam"
  },
  {
    "kegg_id": "D01316",
    "name_en": "Mexazolam (JAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Melex (TN)"
    ],
    "formula": "C18H16Cl2N2O2",
    "efficacy": "Antianxiety",
    "target": "GABR [HSA:2554 2555 2556 2557 2558 2559 2560 2561 2562 2563 2564 2565 2566 2567 2568 55879] [KO:K05175 K05181 K05184 K05185 K05186 K05189 K05192]\nPATHWAY   hsa04080(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879)  Neuroactive ligand-receptor interaction\nhsa04727(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879)  GABAergic synapse",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "1124",
    "atc_code": "N05BA25",
    "drug_class": [
      "Neuropsychiatric agent",
      "Benzodiazepine sedative-hypnotics",
      "GABA-A receptor agonist",
      "Anxiolytics, benzodiazepine derivatives",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Mexazolam"
  },
  {
    "kegg_id": "D01408",
    "name_en": "Flurazepam hydrochloride (JP18)",
    "name_ja": "",
    "names_alt": [
      "Flurazepam monohydrochloride",
      "Dalmate (TN)"
    ],
    "formula": "C21H23ClFN3O. HCl",
    "efficacy": "Sedative-hypnotic",
    "target": "GABR [HSA:2554 2555 2556 2557 2558 2559 2560 2561 2562 2563 2564 2565 2566 2567 2568 55879] [KO:K05175 K05181 K05184 K05185 K05186 K05189 K05192]\nPATHWAY   hsa04080(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879)  Neuroactive ligand-receptor interaction\nhsa04727(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879)  GABAergic synapse",
    "metabolism": "",
    "therapeutic_category": "1124",
    "atc_code": "N05CD01",
    "drug_class": [
      "Neuropsychiatric agent",
      "Benzodiazepine sedative-hypnotics",
      "Hypnotic",
      "GABA-A receptor agonist"
    ],
    "cyp_enzymes": [],
    "search_name": "Flurazepam hydrochloride"
  },
  {
    "kegg_id": "D00531",
    "name_en": "Nitrazepam (JP18/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Benzalin (TN)",
      "Nitrazepam (TN)"
    ],
    "formula": "C15H11N3O3",
    "efficacy": "Anticonvulsant, Sedative-hypnotic",
    "target": "GABR [HSA:2554 2555 2556 2557 2558 2559 2560 2561 2562 2563 2564 2565 2566 2567 2568 55879] [KO:K05175 K05181 K05184 K05185 K05186 K05189 K05192]\nPATHWAY   hsa04080(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879)  Neuroactive ligand-receptor interaction\nhsa04727(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879)  GABAergic synapse",
    "metabolism": "",
    "therapeutic_category": "1124",
    "atc_code": "N05CD02",
    "drug_class": [
      "Neuropsychiatric agent",
      "Benzodiazepine sedative-hypnotics",
      "Hypnotic",
      "GABA-A receptor agonist",
      "Antiepileptic agent",
      "Benzodiazepine derivative, antiepileptic"
    ],
    "cyp_enzymes": [],
    "search_name": "Nitrazepam"
  },
  {
    "kegg_id": "D01230",
    "name_en": "Flunitrazepam (JP18/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Rohypnol (TN)"
    ],
    "formula": "C16H12FN3O3",
    "efficacy": "Anesthetic (intravenous), Sedative-hypnotic",
    "target": "GABR [HSA:2554 2555 2556 2557 2558 2559 2560 2561 2562 2563 2564 2565 2566 2567 2568 55879] [KO:K05175 K05181 K05184 K05185 K05186 K05189 K05192]\nPATHWAY   hsa04080(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879)  Neuroactive ligand-receptor interaction\nhsa04727(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879)  GABAergic synapse",
    "metabolism": "",
    "therapeutic_category": "1124",
    "atc_code": "N05CD03",
    "drug_class": [
      "Neuropsychiatric agent",
      "Benzodiazepine sedative-hypnotics",
      "Hypnotic",
      "GABA-A receptor agonist"
    ],
    "cyp_enzymes": [],
    "search_name": "Flunitrazepam"
  },
  {
    "kegg_id": "D00311",
    "name_en": "Estazolam (JP18/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "ProSom (TN)"
    ],
    "formula": "C16H11ClN4",
    "efficacy": "Sedative-hypnotic\nDISEASE   Insomnia [DS:H01609]",
    "target": "GABR [HSA:2554 2555 2556 2557 2558 2559 2560 2561 2562 2563 2564 2565 2566 2567 2568 55879] [KO:K05175 K05181 K05184 K05185 K05186 K05189 K05192]\nPATHWAY   hsa04080(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879)  Neuroactive ligand-receptor interaction\nhsa04727(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879)  GABAergic synapse",
    "metabolism": "Enzyme: CYP3A [HSA:1576 1577 1551]",
    "therapeutic_category": "1124",
    "atc_code": "N05CD04",
    "drug_class": [
      "Neuropsychiatric agent",
      "Benzodiazepine sedative-hypnotics",
      "Hypnotic",
      "GABA-A receptor agonist",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A"
    ],
    "search_name": "Estazolam"
  },
  {
    "kegg_id": "D00387",
    "name_en": "Triazolam (JP18/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Halcion (TN)"
    ],
    "formula": "C17H12Cl2N4",
    "efficacy": "Sedative-hypnotic\nDISEASE   Insomnia [DS:H01609]",
    "target": "GABR [HSA:2554 2555 2556 2557 2558 2559 2560 2561 2562 2563 2564 2565 2566 2567 2568 55879] [KO:K05175 K05181 K05184 K05185 K05186 K05189 K05192]\nPATHWAY   hsa04080(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879)  Neuroactive ligand-receptor interaction\nhsa04727(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879)  GABAergic synapse",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "1124",
    "atc_code": "N05CD05",
    "drug_class": [
      "Neuropsychiatric agent",
      "Benzodiazepine sedative-hypnotics",
      "Hypnotic",
      "GABA-A receptor agonist",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Triazolam"
  },
  {
    "kegg_id": "D01657",
    "name_en": "Lormetazepam (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Loramet (TN)"
    ],
    "formula": "C16H12Cl2N2O2",
    "efficacy": "Sedative-hypnotic",
    "target": "GABR [HSA:2554 2555 2556 2557 2558 2559 2560 2561 2562 2563 2564 2565 2566 2567 2568 55879] [KO:K05175 K05181 K05184 K05185 K05186 K05189 K05192]\nPATHWAY   hsa04080(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879)  Neuroactive ligand-receptor interaction\nhsa04727(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879)  GABAergic synapse",
    "metabolism": "",
    "therapeutic_category": "1124",
    "atc_code": "N05CD06",
    "drug_class": [
      "Neuropsychiatric agent",
      "Benzodiazepine sedative-hypnotics",
      "Hypnotic",
      "GABA-A receptor agonist"
    ],
    "cyp_enzymes": [],
    "search_name": "Lormetazepam"
  },
  {
    "kegg_id": "D00550",
    "name_en": "Midazolam (JAN/USP/INN)",
    "name_ja": "ミダゾラム",
    "names_alt": [
      "Dormicum (TN)",
      "Buccolam (TN)",
      "Nayzilam (TN)"
    ],
    "formula": "C18H13ClFN3",
    "efficacy": "Anesthetic (intravenous), Anticonvulsant, Sedative-hypnotic",
    "target": "GABR [HSA:2554 2555 2556 2557 2558 2559 2560 2561 2562 2563 2564 2565 2566 2567 2568 55879] [KO:K05175 K05181 K05184 K05185 K05186 K05189 K05192]\nPATHWAY   hsa04080(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879)  Neuroactive ligand-receptor interaction\nhsa04727(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879)  GABAergic synapse",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "1124",
    "atc_code": "N05CD08",
    "drug_class": [
      "Neuropsychiatric agent",
      "Benzodiazepine sedative-hypnotics",
      "GABA-A receptor agonist",
      "Antiepileptic agent",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Midazolam"
  },
  {
    "kegg_id": "D01744",
    "name_en": "Brotizolam (JP18/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Lendormin (TN)"
    ],
    "formula": "C15H10BrClN4S",
    "efficacy": "Sedative-hypnotic",
    "target": "GABR [HSA:2554 2555 2556 2557 2558 2559 2560 2561 2562 2563 2564 2565 2566 2567 2568 55879] [KO:K05175 K05181 K05184 K05185 K05186 K05189 K05192]\nPATHWAY   hsa04080(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879)  Neuroactive ligand-receptor interaction\nhsa04727(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879)  GABAergic synapse",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "1124",
    "atc_code": "N05CD09",
    "drug_class": [
      "Neuropsychiatric agent",
      "Benzodiazepine sedative-hypnotics",
      "Hypnotic",
      "GABA-A receptor agonist",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Brotizolam"
  },
  {
    "kegg_id": "D00457",
    "name_en": "Quazepam (JAN/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Doral (TN)"
    ],
    "formula": "C17H11ClF4N2S",
    "efficacy": "Sedative-hypnotic\nDISEASE   Insomnia [DS:H01609]",
    "target": "GABR [HSA:2554 2555 2556 2557 2558 2559 2560 2561 2562 2563 2564 2565 2566 2567 2568 55879] [KO:K05175 K05181 K05184 K05185 K05186 K05189 K05192]\nPATHWAY   hsa04080(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879)  Neuroactive ligand-receptor interaction\nhsa04727(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879)  GABAergic synapse",
    "metabolism": "Enzyme: CYP2C9 [HSA:1559], CYP3A4 [HSA:1576]",
    "therapeutic_category": "1124",
    "atc_code": "N05CD10",
    "drug_class": [
      "Neuropsychiatric agent",
      "Benzodiazepine sedative-hypnotics",
      "Hypnotic",
      "GABA-A receptor agonist",
      "Metabolizing enzyme substrate",
      "CYP2C9 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C9",
      "CYP3A4"
    ],
    "search_name": "Quazepam"
  },
  {
    "kegg_id": "D01278",
    "name_en": "Oxazolam (JP18/INN)",
    "name_ja": "",
    "names_alt": [
      "Serenal (TN)"
    ],
    "formula": "C18H17ClN2O2",
    "efficacy": "Antianxiety, Minor tranquilizer, Sedative-hypnotic",
    "target": "GABR [HSA:2554 2555 2556 2557 2558 2559 2560 2561 2562 2563 2564 2565 2566 2567 2568 55879] [KO:K05175 K05181 K05184 K05185 K05186 K05189 K05192]\nPATHWAY   hsa04080(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879)  Neuroactive ligand-receptor interaction\nhsa04727(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879)  GABAergic synapse",
    "metabolism": "",
    "therapeutic_category": "1124",
    "atc_code": "",
    "drug_class": [
      "Neuropsychiatric agent",
      "GABA-A receptor agonist",
      "Anxiolytics, benzodiazepine derivatives"
    ],
    "cyp_enzymes": [],
    "search_name": "Oxazolam"
  },
  {
    "kegg_id": "D01286",
    "name_en": "Flutazolam (JAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Coreminal (TN)"
    ],
    "formula": "C19H18ClFN2O3",
    "efficacy": "Antianxiety, Sedative-hypnotic",
    "target": "GABR [HSA:2554 2555 2556 2557 2558 2559 2560 2561 2562 2563 2564 2565 2566 2567 2568 55879] [KO:K05175 K05181 K05184 K05185 K05186 K05189 K05192]\nPATHWAY   hsa04080(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879)  Neuroactive ligand-receptor interaction\nhsa04727(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879)  GABAergic synapse",
    "metabolism": "",
    "therapeutic_category": "1124",
    "atc_code": "",
    "drug_class": [
      "Neuropsychiatric agent",
      "Benzodiazepine sedative-hypnotics",
      "GABA-A receptor agonist",
      "Anxiolytics, benzodiazepine derivatives"
    ],
    "cyp_enzymes": [],
    "search_name": "Flutazolam"
  },
  {
    "kegg_id": "D01758",
    "name_en": "Haloxazolam (JP18/INN)",
    "name_ja": "",
    "names_alt": [
      "Somelin (TN)"
    ],
    "formula": "C17H14BrFN2O2",
    "efficacy": "Sedative-hypnotic",
    "target": "GABR [HSA:2554 2555 2556 2557 2558 2559 2560 2561 2562 2563 2564 2565 2566 2567 2568 55879] [KO:K05175 K05181 K05184 K05185 K05186 K05189 K05192]\nPATHWAY   hsa04080(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879)  Neuroactive ligand-receptor interaction\nhsa04727(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879)  GABAergic synapse",
    "metabolism": "",
    "therapeutic_category": "1124",
    "atc_code": "",
    "drug_class": [
      "Neuropsychiatric agent",
      "Benzodiazepine sedative-hypnotics",
      "Hypnotic",
      "GABA-A receptor agonist"
    ],
    "cyp_enzymes": [],
    "search_name": "Haloxazolam"
  },
  {
    "kegg_id": "D00506",
    "name_en": "Phenobarbital (JP18/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Luminal (TN)"
    ],
    "formula": "C12H12N2O3",
    "efficacy": "Antianxiety, Anticonvulsant, Sedative-hypnotic",
    "target": "GABR [HSA:2554 2555 2556 2557 2558 2559 2560 2561 2562 2563 2564 2565 2566 2567 2568 55879] [KO:K05175 K05181 K05184 K05185 K05186 K05189 K05192]\nPATHWAY   hsa04080(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879)  Neuroactive ligand-receptor interaction\nhsa04727(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879)  GABAergic synapse",
    "metabolism": "",
    "therapeutic_category": "1125",
    "atc_code": "N03AA02",
    "drug_class": [
      "Neuropsychiatric agent",
      "GABA-A receptor agonist",
      "Antiepileptic agent",
      "Barbiturate antiepileptic",
      "Metabolizing enzyme inducer",
      "CYP1A2 inducer",
      "CYP2B6 inducer",
      "CYP2C9 inducer",
      "CYP3A/CYP3A4 inducer"
    ],
    "cyp_enzymes": [],
    "search_name": "Phenobarbital"
  },
  {
    "kegg_id": "D00701",
    "name_en": "Phenobarbital sodium (JAN/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Luminal sodium (TN)"
    ],
    "formula": "C12H11N2O3. Na",
    "efficacy": "Antianxiety, Anticonvulsant, Sedative-hypnotic\nDISEASE   Anxiety-tension states [DS:H01662]\nHyperthyroidism [DS:H01645]\nInsomnia [DS:H01609]",
    "target": "GABR [HSA:2554 2555 2556 2557 2558 2559 2560 2561 2562 2563 2564 2565 2566 2567 2568 55879] [KO:K05175 K05181 K05184 K05185 K05186 K05189 K05192]\nPATHWAY   hsa04080(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879)  Neuroactive ligand-receptor interaction\nhsa04727(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879)  GABAergic synapse",
    "metabolism": "",
    "therapeutic_category": "1125",
    "atc_code": "N03AA02",
    "drug_class": [
      "Neuropsychiatric agent",
      "GABA-A receptor agonist",
      "Antiepileptic agent",
      "Barbiturate antiepileptic",
      "Metabolizing enzyme inducer",
      "CYP1A2 inducer",
      "CYP2B6 inducer",
      "CYP2C9 inducer",
      "CYP3A/CYP3A4 inducer"
    ],
    "cyp_enzymes": [],
    "search_name": "Phenobarbital sodium"
  },
  {
    "kegg_id": "D02253",
    "name_en": "Pentobarbital calcium (JP18)",
    "name_ja": "",
    "names_alt": [
      "Ravona (TN)"
    ],
    "formula": "(C11H17N2O3)2. Ca",
    "efficacy": "Sedative-hypnotic",
    "target": "GABR [HSA:2554 2555 2556 2557 2558 2559 2560 2561 2562 2563 2564 2565 2566 2567 2568 55879] [KO:K05175 K05181 K05184 K05185 K05186 K05189 K05192]\nPATHWAY   hsa04080(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879)  Neuroactive ligand-receptor interaction\nhsa04727(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879)  GABAergic synapse",
    "metabolism": "",
    "therapeutic_category": "1125",
    "atc_code": "N05CA01",
    "drug_class": [
      "Neuropsychiatric agent",
      "Barbiturate sedative-hypnotics",
      "GABA-A receptor agonist"
    ],
    "cyp_enzymes": [],
    "search_name": "Pentobarbital calcium"
  },
  {
    "kegg_id": "D01731",
    "name_en": "Potassium bromide (JP18/USP)",
    "name_ja": "",
    "names_alt": [],
    "formula": "Br. K",
    "efficacy": "Anticonvulsant, Sedative-hypnotic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "1126",
    "atc_code": "",
    "drug_class": [
      "Neuropsychiatric agent",
      "Antiepileptic agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Potassium bromide"
  },
  {
    "kegg_id": "D02055",
    "name_en": "Sodium bromide (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "Br. Na",
    "efficacy": "Anticonvulsant, Sedative-hypnotic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "1126",
    "atc_code": "",
    "drug_class": [
      "Neuropsychiatric agent",
      "Antiepileptic agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Sodium bromide"
  },
  {
    "kegg_id": "D01372",
    "name_en": "Zopiclone (JP18/INN)",
    "name_ja": "",
    "names_alt": [
      "Amoban (TN)"
    ],
    "formula": "C17H17ClN6O3",
    "efficacy": "Sedative-hypnotic",
    "target": "GABR [HSA:2554 2555 2556 2557 2558 2559 2560 2561 2562 2563 2564 2565 2566 2567 2568 55879] [KO:K05175 K05181 K05184 K05185 K05186 K05189 K05192]\nPATHWAY   hsa04080(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879)  Neuroactive ligand-receptor interaction\nhsa04727(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879)  GABAergic synapse",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]; CYP2C8 [HSA:1558]",
    "therapeutic_category": "1129",
    "atc_code": "N05CF01",
    "drug_class": [
      "Neuropsychiatric agent",
      "Non-benzodiazepine sedative-hypnotics",
      "Hypnotic",
      "GABA-A receptor agonist",
      "Metabolizing enzyme substrate",
      "CYP2C8 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C8",
      "CYP3A4"
    ],
    "search_name": "Zopiclone"
  },
  {
    "kegg_id": "D00706",
    "name_en": "Zolpidem tartrate (JP18/USP)",
    "name_ja": "ゾルピデム",
    "names_alt": [
      "Ambien (TN)",
      "Intermezzo (TN)"
    ],
    "formula": "(C19H21N3O)2. C4H6O6",
    "efficacy": "Sedative-hypnotic\nDISEASE   Insomnia [DS:H01609]",
    "target": "GABR [HSA:2554 2555 2556 2557 2558 2559 2560 2561 2562 2563 2564 2565 2566 2567 2568 55879] [KO:K05175 K05181 K05184 K05185 K05186 K05189 K05192]\nPATHWAY   hsa04080(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879)  Neuroactive ligand-receptor interaction\nhsa04727(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879)  GABAergic synapse",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]; CYP2C9 [HSA:1559], CYP1A2 [HSA:1544]",
    "therapeutic_category": "1129",
    "atc_code": "N05CF02",
    "drug_class": [
      "Neuropsychiatric agent",
      "Non-benzodiazepine sedative-hypnotics",
      "Hypnotic",
      "GABA-A receptor agonist",
      "Metabolizing enzyme substrate",
      "CYP1A2 substrate",
      "CYP2C9 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C9",
      "CYP3A4",
      "CYP1A2"
    ],
    "search_name": "Zolpidem tartrate"
  },
  {
    "kegg_id": "D02624",
    "name_en": "Eszopiclone (JAN/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Estorra (TN)",
      "Lunesta (TN)"
    ],
    "formula": "C17H17ClN6O3",
    "efficacy": "Sedative-hypnotic\nDISEASE   Insomnia [DS:H01609]",
    "target": "GABR [HSA:2554 2555 2556 2557 2558 2559 2560 2561 2562 2563 2564 2565 2566 2567 2568 55879] [KO:K05175 K05181 K05184 K05185 K05186 K05189 K05192]\nPATHWAY   hsa04080(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879)  Neuroactive ligand-receptor interaction\nhsa04727(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879)  GABAergic synapse",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]; CYP2E1 [HSA:1571]",
    "therapeutic_category": "1129",
    "atc_code": "N05CF04",
    "drug_class": [
      "Neuropsychiatric agent",
      "Non-benzodiazepine sedative-hypnotics",
      "Hypnotic",
      "GABA-A receptor agonist",
      "Metabolizing enzyme substrate",
      "CYP2E1 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP2E1",
      "CYP3A4"
    ],
    "search_name": "Eszopiclone"
  },
  {
    "kegg_id": "D01205",
    "name_en": "Dexmedetomidine hydrochloride (JAN/USP)",
    "name_ja": "",
    "names_alt": [
      "Igalmi (TN)",
      "Precedex (TN)"
    ],
    "formula": "C13H16N2. HCl",
    "efficacy": "Sedative-hypnotic, Tranquilizer, alpha2-Adrenergic receptor agonist\nDISEASE   Schizophrenia [DS:H01649]\nBipolar I or II disorder [DS:H01653]",
    "target": "ADRA2 [HSA:150 151 152] [KO:K04138 K04139 K04140]\nPATHWAY   hsa04080(150+151+152)  Neuroactive ligand-receptor interaction",
    "metabolism": "Enzyme: CYP2A6 [HSA:1548]; CYP1A2 [HSA:1544], CYP2E1 [HSA:1571], CYP2D6 [HSA:1565], CYP2C19 [HSA:1557]",
    "therapeutic_category": "1129",
    "atc_code": "N05CM18",
    "drug_class": [
      "Cardiovascular agent",
      "Adrenergic receptor agonist",
      "alpha-Adrenergic receptor agonist",
      "alpha2-Adrenergic receptor agonist",
      "Metabolizing enzyme substrate",
      "CYP1A2 substrate",
      "CYP2A6 substrate",
      "CYP2C19 substrate",
      "CYP2D6 substrate",
      "CYP2E1 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C19",
      "CYP1A2",
      "CYP2A6",
      "CYP2D6",
      "CYP2E1"
    ],
    "search_name": "Dexmedetomidine hydrochloride"
  },
  {
    "kegg_id": "D01221",
    "name_en": "gamma Oryzanol (JAN)",
    "name_ja": "",
    "names_alt": [
      "Hi-Z (TN)"
    ],
    "formula": "C40H58O4",
    "efficacy": "Antianxiety, Antihyperlipidemic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "1129",
    "atc_code": "",
    "drug_class": [
      "Hypolipidemic agent",
      "Hypolipidemic agent"
    ],
    "cyp_enzymes": [],
    "search_name": "gamma Oryzanol"
  },
  {
    "kegg_id": "D01564",
    "name_en": "Rilmazafone hydrochloride hydrate (JP18)",
    "name_ja": "",
    "names_alt": [
      "Rilmazafone hydrochloride dihydrate",
      "Rilmazafone hydrochloride",
      "Rhythmy (TN)"
    ],
    "formula": "C21H20Cl2N6O3. 2H2O. HCl",
    "efficacy": "Sedative-hypnotic",
    "target": "GABR [HSA:2554 2555 2556 2557 2558 2559 2560 2561 2562 2563 2564 2565 2566 2567 2568 55879] [KO:K05175 K05181 K05184 K05185 K05186 K05189 K05192]\nPATHWAY   hsa04080(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879)  Neuroactive ligand-receptor interaction\nhsa04727(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879)  GABAergic synapse",
    "metabolism": "Enzyme: CES [HSA:1066 8824 23491 221223], CYP3A4 [HSA:1576]",
    "therapeutic_category": "1129",
    "atc_code": "",
    "drug_class": [
      "Neuropsychiatric agent",
      "Benzodiazepine sedative-hypnotics",
      "Hypnotic",
      "GABA-A receptor agonist",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "CES substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Rilmazafone hydrochloride hydrate"
  },
  {
    "kegg_id": "D01992",
    "name_en": "Tandospirone citrate (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "SM 3997",
      "Sediel (TN)"
    ],
    "formula": "C21H29N5O2. C6H8O7",
    "efficacy": "Antianxiety, Serotonin 5-HT1A receptor agonist",
    "target": "HTR1A [HSA:3350] [KO:K04153]\nPATHWAY   hsa04080(3350)  Neuroactive ligand-receptor interaction\nhsa04726(3350)  Serotonergic synapse",
    "metabolism": "",
    "therapeutic_category": "1129",
    "atc_code": "",
    "drug_class": [
      "Neuropsychiatric agent",
      "5-HT1A-receptor agonist"
    ],
    "cyp_enzymes": [],
    "search_name": "Tandospirone citrate"
  },
  {
    "kegg_id": "D01409",
    "name_en": "Acetylpheneturide (JAN)",
    "name_ja": "",
    "names_alt": [
      "Crampol (TN)"
    ],
    "formula": "C13H16N2O3",
    "efficacy": "Anticonvulsant, Antiepileptic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "1131",
    "atc_code": "",
    "drug_class": [
      "Neuropsychiatric agent",
      "Antiepileptic agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Acetylpheneturide"
  },
  {
    "kegg_id": "D00708",
    "name_en": "Ethotoin (JAN/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Accenon (TN)",
      "Peganone (TN)"
    ],
    "formula": "C11H12N2O2",
    "efficacy": "Antiepileptic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "1132",
    "atc_code": "N03AB01",
    "drug_class": [
      "Neuropsychiatric agent",
      "Antiepileptic agent",
      "Hydantoin antiepileptic"
    ],
    "cyp_enzymes": [],
    "search_name": "Ethotoin"
  },
  {
    "kegg_id": "D00512",
    "name_en": "Phenytoin (JP18/USP/INN)",
    "name_ja": "フェニトイン",
    "names_alt": [
      "Dilantin (TN)"
    ],
    "formula": "C15H12N2O2",
    "efficacy": "Antiepileptic",
    "target": "SCN1A [HSA:6323] [KO:K04833]\nSCN2A [HSA:6326] [KO:K04834]\nSCN3A [HSA:6328] [KO:K04836]\nSCN4A [HSA:6329] [KO:K04837]\nSCN5A [HSA:6331] [KO:K04838]\nSCN8A [HSA:6334] [KO:K04840]\nSCN9A [HSA:6335] [KO:K04841]\nSCN10A [HSA:6336] [KO:K04842]\nSCN11A [HSA:11280] [KO:K04843]\nPATHWAY   hsa04728(6323)  Dopaminergic synapse",
    "metabolism": "Enzyme: CYP2C9 [HSA:1559]; CYP2C19 [HSA:1557]",
    "therapeutic_category": "1132",
    "atc_code": "N03AB02",
    "drug_class": [
      "Neuropsychiatric agent",
      "Antiepileptic agent",
      "Hydantoin antiepileptic",
      "Metabolizing enzyme substrate",
      "CYP2C9 substrate",
      "CYP2C19 substrate",
      "Metabolizing enzyme inducer",
      "CYP2B6 inducer",
      "CYP3A/CYP3A4 inducer",
      "Transporter inducer",
      "ABCB1 inducer"
    ],
    "cyp_enzymes": [
      "CYP2C9",
      "CYP2C19"
    ],
    "search_name": "Phenytoin"
  },
  {
    "kegg_id": "D02103",
    "name_en": "Phenytoin sodium (USP)",
    "name_ja": "フェニトイン",
    "names_alt": [
      "Phenytoin sodium for injection (JP18)",
      "Aleviatin (TN)",
      "Dilantin (TN)"
    ],
    "formula": "C15H11N2O2. Na",
    "efficacy": "Antiepileptic",
    "target": "SCN1A [HSA:6323] [KO:K04833]\nSCN2A [HSA:6326] [KO:K04834]\nSCN3A [HSA:6328] [KO:K04836]\nSCN4A [HSA:6329] [KO:K04837]\nSCN5A [HSA:6331] [KO:K04838]\nSCN8A [HSA:6334] [KO:K04840]\nSCN9A [HSA:6335] [KO:K04841]\nSCN10A [HSA:6336] [KO:K04842]\nSCN11A [HSA:11280] [KO:K04843]\nPATHWAY   hsa04728(6323)  Dopaminergic synapse",
    "metabolism": "Enzyme: CYP2C9 [HSA:1559]; CYP2C19 [HSA:1557]",
    "therapeutic_category": "1132",
    "atc_code": "N03AB02",
    "drug_class": [
      "Neuropsychiatric agent",
      "Antiepileptic agent",
      "Hydantoin antiepileptic",
      "Metabolizing enzyme substrate",
      "CYP2C9 substrate",
      "CYP2C19 substrate",
      "Metabolizing enzyme inducer",
      "CYP2B6 inducer",
      "CYP3A/CYP3A4 inducer",
      "Transporter inducer",
      "ABCB1 inducer"
    ],
    "cyp_enzymes": [
      "CYP2C9",
      "CYP2C19"
    ],
    "search_name": "Phenytoin sodium"
  },
  {
    "kegg_id": "D07595",
    "name_en": "Fosphenytoin sodium hydrate (JAN)",
    "name_ja": "",
    "names_alt": [
      "Fostoin (TN)"
    ],
    "formula": "C16H13N2O6P. 7H2O. 2Na",
    "efficacy": "Anticonvulsant",
    "target": "SCN1A [HSA:6323] [KO:K04833]\nSCN2A [HSA:6326] [KO:K04834]\nSCN3A [HSA:6328] [KO:K04836]\nSCN4A [HSA:6329] [KO:K04837]\nSCN5A [HSA:6331] [KO:K04838]\nSCN8A [HSA:6334] [KO:K04840]\nSCN9A [HSA:6335] [KO:K04841]\nSCN10A [HSA:6336] [KO:K04842]\nSCN11A [HSA:11280] [KO:K04843]\nPATHWAY   hsa04728(6323)  Dopaminergic synapse",
    "metabolism": "Enzyme: CYP2C9 [HSA:1559]; CYP2C19 [HSA:1557]",
    "therapeutic_category": "1132",
    "atc_code": "N03AB05",
    "drug_class": [
      "Neuropsychiatric agent",
      "Antiepileptic agent",
      "Hydantoin antiepileptic",
      "Metabolizing enzyme substrate",
      "CYP2C9 substrate",
      "CYP2C19 substrate",
      "Metabolizing enzyme inducer",
      "CYP2B6 inducer",
      "CYP3A/CYP3A4 inducer",
      "CYP3A4 inducer",
      "Transporter inducer",
      "ABCB1 inducer"
    ],
    "cyp_enzymes": [
      "CYP2C9",
      "CYP2C19"
    ],
    "search_name": "Fosphenytoin sodium hydrate"
  },
  {
    "kegg_id": "D00392",
    "name_en": "Trimethadione (JP18/INN)",
    "name_ja": "",
    "names_alt": [
      "Tridione (TN)"
    ],
    "formula": "C6H9NO3",
    "efficacy": "Antiepileptic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "1133",
    "atc_code": "N03AC02",
    "drug_class": [
      "Neuropsychiatric agent",
      "Antiepileptic agent",
      "Oxazolidine antiepileptic"
    ],
    "cyp_enzymes": [],
    "search_name": "Trimethadione"
  },
  {
    "kegg_id": "D00474",
    "name_en": "Primidone (JP18/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Mysoline (TN)"
    ],
    "formula": "C12H14N2O2",
    "efficacy": "Antiepileptic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "1135",
    "atc_code": "N03AA03",
    "drug_class": [
      "Neuropsychiatric agent",
      "Antiepileptic agent",
      "Barbiturate antiepileptic"
    ],
    "cyp_enzymes": [],
    "search_name": "Primidone"
  },
  {
    "kegg_id": "D01787",
    "name_en": "Sulthiame (USAN)",
    "name_ja": "",
    "names_alt": [
      "Sultiame (JP18)",
      "Ospolot (TN)"
    ],
    "formula": "C10H14N2O4S2",
    "efficacy": "Antiepileptic, Carbonic anhydrase inhibitor",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "1137",
    "atc_code": "N03AX03",
    "drug_class": [
      "Neuropsychiatric agent",
      "Antiepileptic agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Sulthiame"
  },
  {
    "kegg_id": "D04148",
    "name_en": "Fenfluramine hydrochloride (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Fintepla (TN)",
      "Pondimin (TN)"
    ],
    "formula": "C12H16F3N. HCl",
    "efficacy": "Antiepileptic, Appetite suppressant\nDISEASE   Dravet syndrome [DS:H01818]\nLennox-Gastaut syndrome [DS:H01813]",
    "target": "SLC6A4 (HTT) [HSA:6532] [KO:K05037]\nHTR1D [HSA:3352] [KO:K04153]\nHTR2A [HSA:3356] [KO:K04157]\nHTR2C [HSA:3358] [KO:K04157]\nSIGMAR1 [HSA:10280] [KO:K20719]\nPATHWAY   hsa04080(3352+3356+3358)  Neuroactive ligand-receptor interaction\nhsa04726(3352+3356+3358+6532)  Serotonergic synapse\nhsa05022(10280)  Pathways of neurodegeneration - multiple diseases",
    "metabolism": "Enzyme: CYP1A2 [HSA:1544], CYP2B6 [HSA:1555], CYP2D6 [HSA:1565]; CYP2C9 [HSA:1559], CYP2C19 [HSA:1557], CYP3A4 [HSA:1576], CYP3A5 [HSA:1577]",
    "therapeutic_category": "1139",
    "atc_code": "A08AA02",
    "drug_class": [
      "Gastrointestinal agent",
      "Anoretic",
      "Phenethylamine anorexic",
      "Metabolizing enzyme substrate",
      "CYP1A2 substrate",
      "CYP2B6 substrate",
      "CYP2C9 substrate",
      "CYP2C19 substrate",
      "CYP2D6 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "CYP3A5 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C19",
      "CYP2B6",
      "CYP1A2",
      "CYP3A4",
      "CYP3A5",
      "CYP2C9",
      "CYP2D6"
    ],
    "search_name": "Fenfluramine hydrochloride"
  },
  {
    "kegg_id": "D00332",
    "name_en": "Gabapentin (JAN/USP/INN)",
    "name_ja": "ガバペンチン",
    "names_alt": [
      "Neurontin (TN)",
      "Gralise (TN)"
    ],
    "formula": "C9H17NO2",
    "efficacy": "Anticonvulsant, Antiepileptic\nDISEASE   Postherpetic neuralgia [DS:H01624]",
    "target": "CACNA2D [HSA:781 9254 55799 93589] [KO:K04858 K04859 K04860 K04861]\nSLC6A1 (GAT1) [HSA:6529] [KO:K05034]\nPATHWAY   hsa04010(55799+781+9254+93589)  MAPK signaling pathway\nhsa04727(6529)  GABAergic synapse",
    "metabolism": "",
    "therapeutic_category": "1139",
    "atc_code": "N02BF01",
    "drug_class": [
      "Neuropsychiatric agent",
      "Antiepileptic agent",
      "GABA mimetic antiepileptic",
      "Calcium channel alpha-2 delta blocker"
    ],
    "cyp_enzymes": [],
    "search_name": "Gabapentin"
  },
  {
    "kegg_id": "D07583",
    "name_en": "Phenytoin and phenobarbital",
    "name_ja": "フェニトイン",
    "names_alt": [
      "Aleviatin with phenobarbital (TN)"
    ],
    "formula": "",
    "efficacy": "Antiepileptic",
    "target": "",
    "metabolism": "Enzyme: CYP2C9 [HSA:1559]; CYP2C19 [HSA:1557]",
    "therapeutic_category": "1139",
    "atc_code": "N03AB52",
    "drug_class": [
      "Neuropsychiatric agent",
      "Antiepileptic agent",
      "Metabolizing enzyme substrate",
      "CYP2C9 substrate",
      "CYP2C19 substrate",
      "Metabolizing enzyme inducer",
      "CYP2B6 inducer",
      "CYP3A/CYP3A4 inducer",
      "Transporter inducer",
      "ABCB1 inducer"
    ],
    "cyp_enzymes": [
      "CYP2C9",
      "CYP2C19"
    ],
    "search_name": "Phenytoin and phenobarbital"
  },
  {
    "kegg_id": "D00539",
    "name_en": "Ethosuximide (JP18/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Zarontin (TN)"
    ],
    "formula": "C7H11NO2",
    "efficacy": "Antiepileptic",
    "target": "CACNA1-T [HSA:8911 8912 8913] [KO:K04856 K04855 K04854]\nPATHWAY   hsa04010(8911+8912+8913)  MAPK signaling pathway\nhsa04020(8911+8912+8913)  Calcium signaling pathway",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "1139",
    "atc_code": "N03AD01",
    "drug_class": [
      "Cardiovascular agent",
      "Calcium channel blocker",
      "Calcium channel T type blocker",
      "Neuropsychiatric agent",
      "Antiepileptic agent",
      "Succinimide antiepileptic",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Ethosuximide"
  },
  {
    "kegg_id": "D00280",
    "name_en": "Clonazepam (JP18/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Klonopin (TN)"
    ],
    "formula": "C15H10ClN3O3",
    "efficacy": "Anticonvulsant, Antiepileptic\nDISEASE   Lennox-Gastaut syndrome [DS:H01813]\nPanic disorder [DS:H01664]",
    "target": "GABR [HSA:2554 2555 2556 2557 2558 2559 2560 2561 2562 2563 2564 2565 2566 2567 2568 55879] [KO:K05175 K05181 K05184 K05185 K05186 K05189 K05192]\nPATHWAY   hsa04080(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879)  Neuroactive ligand-receptor interaction\nhsa04727(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879)  GABAergic synapse",
    "metabolism": "",
    "therapeutic_category": "1139",
    "atc_code": "N03AE01",
    "drug_class": [
      "Neuropsychiatric agent",
      "GABA-A receptor agonist",
      "Antiepileptic agent",
      "Benzodiazepine derivative, antiepileptic"
    ],
    "cyp_enzymes": [],
    "search_name": "Clonazepam"
  },
  {
    "kegg_id": "D00252",
    "name_en": "Carbamazepine (JP18/USP/INN)",
    "name_ja": "カルバマゼピン",
    "names_alt": [
      "Equetro (TN)",
      "Tegretol (TN)"
    ],
    "formula": "C15H12N2O",
    "efficacy": "Analgesic, Antiepileptic\nDISEASE   Trigeminal neuralgia [DS:H01638]",
    "target": "SCN1A [HSA:6323] [KO:K04833]\nSCN2A [HSA:6326] [KO:K04834]\nSCN3A [HSA:6328] [KO:K04836]\nSCN4A [HSA:6329] [KO:K04837]\nSCN5A [HSA:6331] [KO:K04838]\nSCN8A [HSA:6334] [KO:K04840]\nSCN9A [HSA:6335] [KO:K04841]\nSCN10A [HSA:6336] [KO:K04842]\nSCN11A [HSA:11280] [KO:K04843]\nPATHWAY   hsa04728(6323)  Dopaminergic synapse",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "1139",
    "atc_code": "N03AF01",
    "drug_class": [
      "Neuropsychiatric agent",
      "Antiepileptic agent",
      "Carboxamide antiepileptic",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "Metabolizing enzyme inducer",
      "CYP3A/CYP3A4 inducer",
      "CYP3A4 inducer",
      "Transporter inducer",
      "ABCB1 inducer"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Carbamazepine"
  },
  {
    "kegg_id": "D05775",
    "name_en": "Rufinamide (JAN/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Banzel (TN)"
    ],
    "formula": "C10H8F2N4O",
    "efficacy": "Antiepileptic\nDISEASE   Lennox-Gastaut syndrome [DS:H01813]",
    "target": "SCN1A [HSA:6323] [KO:K04833]\nSCN2A [HSA:6326] [KO:K04834]\nSCN3A [HSA:6328] [KO:K04836]\nSCN4A [HSA:6329] [KO:K04837]\nSCN5A [HSA:6331] [KO:K04838]\nSCN8A [HSA:6334] [KO:K04840]\nSCN9A [HSA:6335] [KO:K04841]\nSCN10A [HSA:6336] [KO:K04842]\nSCN11A [HSA:11280] [KO:K04843]\nPATHWAY   hsa04728(6323)  Dopaminergic synapse",
    "metabolism": "Enzyme: CES [HSA:1066 8824 23491 221223]",
    "therapeutic_category": "1139",
    "atc_code": "N03AF03",
    "drug_class": [
      "Neuropsychiatric agent",
      "Antiepileptic agent",
      "Carboxamide antiepileptic",
      "Metabolizing enzyme substrate",
      "CES substrate"
    ],
    "cyp_enzymes": [],
    "search_name": "Rufinamide"
  },
  {
    "kegg_id": "D00710",
    "name_en": "Valproate sodium (USAN)",
    "name_ja": "",
    "names_alt": [
      "Sodium valproate (JP18)",
      "Depakene (TN)",
      "Selenica (TN)"
    ],
    "formula": "C8H15O2. Na",
    "efficacy": "Anticonvulsant, Antimanic, Antimigraine, Antiepileptic",
    "target": "ABAT [HSA:18] [KO:K13524]\nSSADH [HSA:7915] [KO:K00139]\nGAD [HSA:2571 2572] [KO:K01580]\nCACNA1-T [HSA:8911 8912 8913] [KO:K04856 K04855 K04854]\nPATHWAY   hsa04020(8911+8912+8913)  Calcium signaling pathway\nhsa04727(18+2571+2572)  GABAergic synapse",
    "metabolism": "",
    "therapeutic_category": "1139",
    "atc_code": "N03AG01",
    "drug_class": [
      "Cardiovascular agent",
      "Calcium channel blocker",
      "Calcium channel T type blocker",
      "Neuropsychiatric agent",
      "Antiepileptic agent",
      "Fatty acid antiepileptic"
    ],
    "cyp_enzymes": [],
    "search_name": "Valproate sodium"
  },
  {
    "kegg_id": "D00535",
    "name_en": "Vigabatrin (JAN/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Sabril (TN)"
    ],
    "formula": "C6H11NO2",
    "efficacy": "Anticonvulsant, Antiepileptic\nDISEASE   Infantile spasms [DS:H01460]",
    "target": "ABAT [HSA:18] [KO:K13524]\nPATHWAY   hsa04727(18)  GABAergic synapse",
    "metabolism": "",
    "therapeutic_category": "1139",
    "atc_code": "N03AG04",
    "drug_class": [
      "Neuropsychiatric agent",
      "Antiepileptic agent",
      "GABA mimetic antiepileptic"
    ],
    "cyp_enzymes": [],
    "search_name": "Vigabatrin"
  },
  {
    "kegg_id": "D00354",
    "name_en": "Lamotrigine (JAN/USP/INN)",
    "name_ja": "ラモトリギン",
    "names_alt": [
      "Lamictal (TN)"
    ],
    "formula": "C9H7Cl2N5",
    "efficacy": "Anti-bipolar disorder, Anticonvulsant, Antiepileptic\nDISEASE   Lennox-Gastaut syndrome [DS:H01813]\nBipolar disorder [DS:H01653]",
    "target": "SCN1A [HSA:6323] [KO:K04833]\nSCN2A [HSA:6326] [KO:K04834]\nSCN3A [HSA:6328] [KO:K04836]\nSCN4A [HSA:6329] [KO:K04837]\nSCN5A [HSA:6331] [KO:K04838]\nSCN8A [HSA:6334] [KO:K04840]\nSCN9A [HSA:6335] [KO:K04841]\nSCN10A [HSA:6336] [KO:K04842]\nSCN11A [HSA:11280] [KO:K04843]\nPATHWAY   hsa04728(6323)  Dopaminergic synapse",
    "metabolism": "Enzyme: UGT1A4 [HSA:54657]",
    "therapeutic_category": "1139",
    "atc_code": "N03AX09",
    "drug_class": [
      "Neuropsychiatric agent",
      "Antiepileptic agent",
      "Metabolizing enzyme substrate",
      "UGT substrate",
      "UGT1A4 substrate"
    ],
    "cyp_enzymes": [],
    "search_name": "Lamotrigine"
  },
  {
    "kegg_id": "D00537",
    "name_en": "Topiramate (JAN/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Topamax (TN)",
      "Trokendi xr (TN)"
    ],
    "formula": "C12H21NO8S",
    "efficacy": "Anticonvulsant, Antiepileptic, Antimigraine, AMPA receptor antagonist\nDISEASE   Lennox-Gastaut syndrome [DS:H01813]",
    "target": "GRIA [HSA:2890 2891 2892 2893] [KO:K05197 K05198 K05199 K05200]\nGRIK [HSA:2897 2898 2899 2900 2901] [KO:K05201 K05202 K05203 K05204 K05205]\nCACNA1-L [HSA:775 776 778 779] [KO:K04850 K04851 K04853 K04857]\nSCN1A [HSA:6323] [KO:K04833]\nSCN2A [HSA:6326] [KO:K04834]\nSCN3A [HSA:6328] [KO:K04836]\nSCN4A [HSA:6329] [KO:K04837]\nSCN5A [HSA:6331] [KO:K04838]\nSCN8A [HSA:6334] [KO:K04840]\nSCN9A [HSA:6335] [KO:K04841]\nSCN10A [HSA:6336] [KO:K04842]\nSCN11A [HSA:11280] [KO:K04843]\nGABR [HSA:2554 2555 2556 2557 2558 2559 2560 2561 2562 2563 2564 2565 2566 2567 2568 55879] [KO:K05175 K05181 K05184 K05185 K05186 K05189 K05192]\nCA2 [HSA:760] [KO:K18245]\nCA4 [HSA:762] [KO:K18246]\nPATHWAY   hsa04020(775+776+778+779)  Calcium signaling pathway\nhsa04080(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+2890+2891+2892+2893+2897+2898+2899+2900+2901+55879)  Neuroactive ligand-receptor interaction\nhsa04724(2890+2891+2892+2893+2897+2898+2899+2900+2901+775+776)  Glutamatergic synapse\nhsa04727(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879+775+776+778+779)  GABAergic synapse",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "1139",
    "atc_code": "N03AX11",
    "drug_class": [
      "Cardiovascular agent",
      "Calcium channel blocker",
      "Calcium channel L type blocker",
      "Neuropsychiatric agent",
      "Antiepileptic agent",
      "AMPA receptor antagonist",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Topiramate"
  },
  {
    "kegg_id": "D00709",
    "name_en": "Levetiracetam (JAN/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Keppra (TN)",
      "E keppra (TN)"
    ],
    "formula": "C8H14N2O2",
    "efficacy": "Antiepileptic\nDISEASE   Juvenile myoclonic epilepsy [DS:H00808]",
    "target": "SV2A [HSA:9900] [KO:K06258]\nPATHWAY   hsa04512(9900)  ECM-receptor interaction",
    "metabolism": "",
    "therapeutic_category": "1139",
    "atc_code": "N03AX14",
    "drug_class": [
      "Neuropsychiatric agent",
      "Antiepileptic agent",
      "Piracetam antiepileptic"
    ],
    "cyp_enzymes": [],
    "search_name": "Levetiracetam"
  },
  {
    "kegg_id": "D00538",
    "name_en": "Zonisamide (JP18/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Excegran (TN)"
    ],
    "formula": "C8H8N2O3S",
    "efficacy": "Anticonvulsant, Antiepileptic",
    "target": "SCN1A [HSA:6323] [KO:K04833]\nSCN2A [HSA:6326] [KO:K04834]\nSCN3A [HSA:6328] [KO:K04836]\nSCN4A [HSA:6329] [KO:K04837]\nSCN5A [HSA:6331] [KO:K04838]\nSCN8A [HSA:6334] [KO:K04840]\nSCN9A [HSA:6335] [KO:K04841]\nSCN10A [HSA:6336] [KO:K04842]\nSCN11A [HSA:11280] [KO:K04843]\nCACNA1-T [HSA:8911 8912 8913] [KO:K04856 K04855 K04854]\nPATHWAY   hsa04010(8911+8912+8913)  MAPK signaling pathway\nhsa04020(8911+8912+8913)  Calcium signaling pathway\nhsa04728(6323)  Dopaminergic synapse",
    "metabolism": "Enzyme: CYP3A [HSA:1576 1577 1551]",
    "therapeutic_category": "1139",
    "atc_code": "N03AX15",
    "drug_class": [
      "Cardiovascular agent",
      "Calcium channel blocker",
      "Calcium channel T type blocker",
      "Neuropsychiatric agent",
      "Antiepileptic agent",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A"
    ],
    "search_name": "Zonisamide"
  },
  {
    "kegg_id": "D05928",
    "name_en": "Stiripentol (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Diacomit (TN)"
    ],
    "formula": "C14H18O3",
    "efficacy": "Anticonvulsant, Antiepileptic\nDISEASE   Dravet syndrome [DS:H01818]",
    "target": "",
    "metabolism": "Enzyme: CYP1A2 [HSA:1544], CYP2C19 [HSA:1557], CYP3A4 [HSA:1576]",
    "therapeutic_category": "1139",
    "atc_code": "N03AX17",
    "drug_class": [
      "Neuropsychiatric agent",
      "Antiepileptic agent",
      "Metabolizing enzyme substrate",
      "CYP1A2 substrate",
      "CYP2C19 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "Metabolizing enzyme inhibitor",
      "CYP1A2 inhibitor",
      "CYP2C9 inhibitor",
      "CYP2C19 inhibitor",
      "CYP2D6 inhibitor",
      "CYP3A/CYP3A4 inhibitor",
      "CYP3A4 inhibitor"
    ],
    "cyp_enzymes": [
      "CYP3A4",
      "CYP2C19",
      "CYP1A2"
    ],
    "search_name": "Stiripentol"
  },
  {
    "kegg_id": "D07299",
    "name_en": "Lacosamide (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Erlosamide",
      "Vimpat (TN)"
    ],
    "formula": "C13H18N2O3",
    "efficacy": "Antiepileptic, Pain relief (neuropathic)",
    "target": "SCN3A [HSA:6328] [KO:K04836]\nSCN9A [HSA:6335] [KO:K04841]\nSCN10A [HSA:6336] [KO:K04842]",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576], CYP2C9 [HSA:1559], CYP2C19 [HSA:1557]",
    "therapeutic_category": "1139",
    "atc_code": "N03AX18",
    "drug_class": [
      "Neuropsychiatric agent",
      "Antiepileptic agent",
      "Metabolizing enzyme substrate",
      "CYP2C9 substrate",
      "CYP2C19 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "Metabolizing enzyme inhibitor",
      "CYP2C19 inhibitor"
    ],
    "cyp_enzymes": [
      "CYP2C19",
      "CYP2C9",
      "CYP3A4"
    ],
    "search_name": "Lacosamide"
  },
  {
    "kegg_id": "D10780",
    "name_en": "Perampanel hydrate (JAN)",
    "name_ja": "",
    "names_alt": [
      "Fycompa (TN)"
    ],
    "formula": "(C23H15N3O)4. 3H2O",
    "efficacy": "Antiepileptic, AMPA receptor antagonist",
    "target": "GRIA [HSA:2890 2891 2892 2893] [KO:K05197 K05198 K05199 K05200]\nPATHWAY   hsa04080(2890+2891+2892+2893)  Neuroactive ligand-receptor interaction\nhsa04724(2890+2891+2892+2893)  Glutamatergic synapse\nhsa04728(2890+2891+2892+2893)  Dopaminergic synapse",
    "metabolism": "Enzyme: CYP3A [HSA:1576 1577 1551]",
    "therapeutic_category": "1139",
    "atc_code": "N03AX22",
    "drug_class": [
      "Neuropsychiatric agent",
      "Antiepileptic agent",
      "AMPA receptor antagonist",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A"
    ],
    "search_name": "Perampanel hydrate"
  },
  {
    "kegg_id": "D08879",
    "name_en": "Brivaracetam (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Briviact (TN)"
    ],
    "formula": "C11H20N2O2",
    "efficacy": "Anticonvulsant, Pain relief",
    "target": "SV2A [HSA:9900] [KO:K06258]\nPATHWAY   hsa04512(9900)  ECM-receptor interaction",
    "metabolism": "Enzyme: CYP2C19 [HSA:1557]",
    "therapeutic_category": "1139",
    "atc_code": "N03AX23",
    "drug_class": [
      "Neuropsychiatric agent",
      "Antiepileptic agent",
      "Piracetam antiepileptic",
      "Metabolizing enzyme substrate",
      "CYP2C19 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C19"
    ],
    "search_name": "Brivaracetam"
  },
  {
    "kegg_id": "D01253",
    "name_en": "Clobazam (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Mystan (TN)",
      "Onfi (TN)"
    ],
    "formula": "C16H13ClN2O2",
    "efficacy": "Anticonvulsant, Minor tranquilizer\nDISEASE   Lennox-Gastaut syndrome [DS:H01813]",
    "target": "GABR [HSA:2554 2555 2556 2557 2558 2559 2560 2561 2562 2563 2564 2565 2566 2567 2568 55879] [KO:K05175 K05181 K05184 K05185 K05186 K05189 K05192]\nPATHWAY   hsa04080(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879)  Neuroactive ligand-receptor interaction\nhsa04727(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879)  GABAergic synapse",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576], CYP2C19 [HSA:1557]",
    "therapeutic_category": "1139",
    "atc_code": "N05BA09",
    "drug_class": [
      "Neuropsychiatric agent",
      "GABA-A receptor agonist",
      "Anxiolytics, benzodiazepine derivatives",
      "Antiepileptic agent",
      "Benzodiazepine derivative, antiepileptic",
      "Metabolizing enzyme substrate",
      "CYP2C19 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C19",
      "CYP3A4"
    ],
    "search_name": "Clobazam"
  },
  {
    "kegg_id": "D00151",
    "name_en": "Mefenamic acid (JP18/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Ponstel (TN)"
    ],
    "formula": "C15H15NO2",
    "efficacy": "Analgesic, Anti-inflammatory, Antipyretic, COX inhibitor",
    "target": "PTGS1 (COX1) [HSA:5742] [KO:K00509]\nPTGS2 (COX2) [HSA:5743] [KO:K11987]\nPATHWAY   hsa00590(5742+5743)  Arachidonic acid metabolism",
    "metabolism": "Enzyme: CYP2C9 [HSA:1559]",
    "therapeutic_category": "1141",
    "atc_code": "M01AG01",
    "drug_class": [
      "Anti-inflammatory",
      "Nonsteroidal anti-inflammatory drug (NSAID)",
      "Anti-inflammatory drug, fenamic acid derivatives",
      "Metabolizing enzyme substrate",
      "CYP2C9 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C9"
    ],
    "search_name": "Mefenamic acid"
  },
  {
    "kegg_id": "D00217",
    "name_en": "Acetaminophen (JP18/USP)",
    "name_ja": "アセトアミノフェン",
    "names_alt": [
      "Paracetamol (INN)",
      "Tylenol (TN)"
    ],
    "formula": "C8H9NO2",
    "efficacy": "Analgesic, Antipyretic",
    "target": "PTGS1 (COX1) [HSA:5742] [KO:K00509]\nPTGS2 (COX2) [HSA:5743] [KO:K11987]\nPATHWAY   hsa00590(5742+5743)  Arachidonic acid metabolism",
    "metabolism": "",
    "therapeutic_category": "1141",
    "atc_code": "N02BE01",
    "drug_class": [
      "Anti-inflammatory",
      "Anilide derivative, anti-inflammatory"
    ],
    "cyp_enzymes": [],
    "search_name": "Acetaminophen"
  },
  {
    "kegg_id": "D00109",
    "name_en": "Aspirin (JP18/USP)",
    "name_ja": "アスピリン",
    "names_alt": [
      "Aspalon (JAN)",
      "Acetylsalicylic acid",
      "Easprin (TN)",
      "Durlaza (TN)"
    ],
    "formula": "C9H8O4",
    "efficacy": "Analgesic, Anti-inflammatory, Antipyretic, Antirheumatic, Antiplatelet, COX inhibitor\nDISEASE   Myocardial infarction [DS:H01730]\nUnstable angina pectoris [DS:H01632]\nChronic stable angina [DS:H01632]",
    "target": "PTGS1 (COX1) [HSA:5742] [KO:K00509]\nPTGS2 (COX2) [HSA:5743] [KO:K11987]\nPATHWAY   hsa00590(5742+5743)  Arachidonic acid metabolism\nhsa04611(5742)  Platelet activation",
    "metabolism": "",
    "therapeutic_category": "1143",
    "atc_code": "A01AD05",
    "drug_class": [
      "Blood modifier agent",
      "Antithrombotic agent",
      "Antiplatelet agent",
      "Anti-inflammatory",
      "Nonsteroidal anti-inflammatory drug (NSAID)",
      "Anti-inflammatory drug, salicylic acid derivatives"
    ],
    "cyp_enzymes": [],
    "search_name": "Aspirin"
  },
  {
    "kegg_id": "D00566",
    "name_en": "Sodium salicylate (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Salsonin (TN)"
    ],
    "formula": "C7H5O3. Na",
    "efficacy": "Analgesic, Anti-inflammatory, COX inhibitor",
    "target": "PTGS1 (COX1) [HSA:5742] [KO:K00509]\nPTGS2 (COX2) [HSA:5743] [KO:K11987]\nPATHWAY   hsa00590(5742+5743)  Arachidonic acid metabolism",
    "metabolism": "",
    "therapeutic_category": "1143",
    "atc_code": "N02BA04",
    "drug_class": [
      "Anti-inflammatory",
      "Nonsteroidal anti-inflammatory drug (NSAID)",
      "Anti-inflammatory drug, salicylic acid derivatives"
    ],
    "cyp_enzymes": [],
    "search_name": "Sodium salicylate"
  },
  {
    "kegg_id": "D01466",
    "name_en": "Ethenzamide (JP18/INN)",
    "name_ja": "",
    "names_alt": [],
    "formula": "C9H11NO2",
    "efficacy": "Analgesic, Antipyretic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "1143",
    "atc_code": "N02BA07",
    "drug_class": [
      "Anti-inflammatory",
      "Nonsteroidal anti-inflammatory drug (NSAID)",
      "Anti-inflammatory drug, salicylic acid derivatives"
    ],
    "cyp_enzymes": [],
    "search_name": "Ethenzamide"
  },
  {
    "kegg_id": "D04022",
    "name_en": "Sodium salicylate, dibucaine hydrocholoride and calcium bromide",
    "name_ja": "",
    "names_alt": [
      "Neo vitacain (TN)"
    ],
    "formula": "",
    "efficacy": "Pain relief",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "1143",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Sodium salicylate, dibucaine hydrocholoride and calcium bromide"
  },
  {
    "kegg_id": "D00141",
    "name_en": "Indomethacin (USP)",
    "name_ja": "インドメタシン",
    "names_alt": [
      "Indometacin (JP18/INN)",
      "Aconip (TN)",
      "Indocin (TN)"
    ],
    "formula": "C19H16ClNO4",
    "efficacy": "Analgesic, Anti-inflammatory, Antipyretic, COX inhibitor\nDISEASE   Rheumatoid arthritis [DS:H00630]\nAnkylosing spondylitis [DS:H01674]\nAcute gouty arthritis [DS:H01532]",
    "target": "PTGS1 (COX1) [HSA:5742] [KO:K00509]\nPTGS2 (COX2) [HSA:5743] [KO:K11987]\nPATHWAY   hsa00590(5742+5743)  Arachidonic acid metabolism",
    "metabolism": "",
    "therapeutic_category": "1145",
    "atc_code": "C01EB03",
    "drug_class": [
      "Anti-inflammatory",
      "Nonsteroidal anti-inflammatory drug (NSAID)",
      "Anti-inflammatory drug, acetic acid derivatives",
      "Anti-inflammatory drug, indoleacetic acid derivative"
    ],
    "cyp_enzymes": [],
    "search_name": "Indomethacin"
  },
  {
    "kegg_id": "D01565",
    "name_en": "Indometacin farnesil (JAN)",
    "name_ja": "",
    "names_alt": [
      "Infree (TN)"
    ],
    "formula": "C34H40ClNO4",
    "efficacy": "Analgesic, Anti-inflammatory, COX inhibitor",
    "target": "PTGS1 (COX1) [HSA:5742] [KO:K00509]\nPTGS2 (COX2) [HSA:5743] [KO:K11987]\nPATHWAY   hsa00590(5742+5743)  Arachidonic acid metabolism",
    "metabolism": "",
    "therapeutic_category": "1145",
    "atc_code": "C01EB03",
    "drug_class": [
      "Anti-inflammatory",
      "Nonsteroidal anti-inflammatory drug (NSAID)",
      "Anti-inflammatory drug, acetic acid derivatives",
      "Anti-inflammatory drug, indoleacetic acid derivative"
    ],
    "cyp_enzymes": [],
    "search_name": "Indometacin farnesil"
  },
  {
    "kegg_id": "D01582",
    "name_en": "Acemetacin (JP18/INN)",
    "name_ja": "",
    "names_alt": [
      "Rantudil (TN)"
    ],
    "formula": "C21H18ClNO6",
    "efficacy": "Analgesic, Anti-inflammatory, Antipyretic, COX inhibitor",
    "target": "PTGS1 (COX1) [HSA:5742] [KO:K00509]\nPTGS2 (COX2) [HSA:5743] [KO:K11987]\nPATHWAY   hsa00590(5742+5743)  Arachidonic acid metabolism",
    "metabolism": "",
    "therapeutic_category": "1145",
    "atc_code": "M01AB11",
    "drug_class": [
      "Anti-inflammatory",
      "Nonsteroidal anti-inflammatory drug (NSAID)",
      "Anti-inflammatory drug, acetic acid derivatives",
      "Anti-inflammatory drug, indoleacetic acid derivative"
    ],
    "cyp_enzymes": [],
    "search_name": "Acemetacin"
  },
  {
    "kegg_id": "D00904",
    "name_en": "Diclofenac sodium (JP18/USP)",
    "name_ja": "ジクロフェナク",
    "names_alt": [
      "Solaraze (TN)",
      "Voltaren (TN)"
    ],
    "formula": "C14H10Cl2NO2. Na",
    "efficacy": "Analgesic, Anti-inflammatory, Antipyretic, COX inhibitor",
    "target": "PTGS1 (COX1) [HSA:5742] [KO:K00509]\nPTGS2 (COX2) [HSA:5743] [KO:K11987]\nPATHWAY   hsa00590(5742+5743)  Arachidonic acid metabolism",
    "metabolism": "Enzyme: CYP2C9 [HSA:1559]",
    "therapeutic_category": "1147",
    "atc_code": "D11AX18",
    "drug_class": [
      "Anti-inflammatory",
      "Nonsteroidal anti-inflammatory drug (NSAID)",
      "Anti-inflammatory drug, acetic acid derivatives",
      "Anti-inflammatory drug, phenylacetic acid derivative",
      "Metabolizing enzyme substrate",
      "CYP2C9 substrate",
      "Transporter inhibitor",
      "SLC22A8 inhibitor"
    ],
    "cyp_enzymes": [
      "CYP2C9"
    ],
    "search_name": "Diclofenac sodium"
  },
  {
    "kegg_id": "D01341",
    "name_en": "Tiaramide hydrochloride (JP18/USAN)",
    "name_ja": "",
    "names_alt": [
      "Solantal (TN)"
    ],
    "formula": "C15H18ClN3O3S. HCl",
    "efficacy": "Analgesic, Anti-inflammatory, Antiasthmatic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "1148",
    "atc_code": "",
    "drug_class": [
      "Anti-inflammatory",
      "Nonsteroidal anti-inflammatory drug (NSAID)"
    ],
    "cyp_enzymes": [],
    "search_name": "Tiaramide hydrochloride"
  },
  {
    "kegg_id": "D00126",
    "name_en": "Ibuprofen (JP18/USP/INN)",
    "name_ja": "イブプロフェン",
    "names_alt": [
      "Advil (TN)",
      "Motrin (TN)"
    ],
    "formula": "C13H18O2",
    "efficacy": "Analgesic, Anti-inflammatory, Antipyretic, COX inhibitor",
    "target": "PTGS1 (COX1) [HSA:5742] [KO:K00509]\nPTGS2 (COX2) [HSA:5743] [KO:K11987]\nPATHWAY   hsa00590(5742+5743)  Arachidonic acid metabolism",
    "metabolism": "Enzyme: CYP2C9 [HSA:1559]",
    "therapeutic_category": "1149",
    "atc_code": "C01EB16",
    "drug_class": [
      "Anti-inflammatory",
      "Nonsteroidal anti-inflammatory drug (NSAID)",
      "Anti-inflammatory drug, propionic acid derivative",
      "Metabolizing enzyme substrate",
      "CYP2C9 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C9"
    ],
    "search_name": "Ibuprofen"
  },
  {
    "kegg_id": "D00118",
    "name_en": "Naproxen (JP18/USP/INN)",
    "name_ja": "ナプロキセン",
    "names_alt": [
      "Naprosyn (TN)"
    ],
    "formula": "C14H14O3",
    "efficacy": "Analgesic, Anti-inflammatory, Antipyretic, COX inhibitor\nDISEASE   Rheumatoid arthritis [DS:H00630]\nAnkylosing spondylitis [DS:H01674]\nPolyarticular juvenile idiopathic arthritis [DS:H01672]\nAcute gout [DS:H01532]",
    "target": "PTGS1 (COX1) [HSA:5742] [KO:K00509]\nPTGS2 (COX2) [HSA:5743] [KO:K11987]\nPATHWAY   hsa00590(5742+5743)  Arachidonic acid metabolism",
    "metabolism": "",
    "therapeutic_category": "1149",
    "atc_code": "G02CC02",
    "drug_class": [
      "Anti-inflammatory",
      "Nonsteroidal anti-inflammatory drug (NSAID)",
      "Anti-inflammatory drug, propionic acid derivative"
    ],
    "cyp_enzymes": [],
    "search_name": "Naproxen"
  },
  {
    "kegg_id": "D00567",
    "name_en": "Celecoxib (JP18/USP/INN)",
    "name_ja": "セレコキシブ",
    "names_alt": [
      "Celebrex (TN)",
      "Onsenal (TN)"
    ],
    "formula": "C17H14F3N3O2S",
    "efficacy": "Analgesic, Anti-inflammatory, COX-2 inhibitor\nDISEASE   Rheumatoid arthritis [DS:H00630]\nJuvenile rheumatoid arthritis [DS:H01672]\nAnkylosing spondylitis [DS:H01674]",
    "target": "PTGS2 (COX2) [HSA:5743] [KO:K11987]\nPATHWAY   hsa00590(5743)  Arachidonic acid metabolism",
    "metabolism": "Enzyme: CYP2C9 [HSA:1559]",
    "therapeutic_category": "1149",
    "atc_code": "L01XX33",
    "drug_class": [
      "Anti-inflammatory",
      "Nonsteroidal anti-inflammatory drug (NSAID)",
      "Selective COX2 inhibitor",
      "Anti-inflammatory drug, coxibs",
      "Metabolizing enzyme substrate",
      "CYP2C9 substrate",
      "Metabolizing enzyme inhibitor",
      "CYP2D6 inhibitor"
    ],
    "cyp_enzymes": [
      "CYP2C9"
    ],
    "search_name": "Celecoxib"
  },
  {
    "kegg_id": "D00315",
    "name_en": "Etodolac (JP18/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Lodine (TN)"
    ],
    "formula": "C17H21NO3",
    "efficacy": "Analgesic, Anti-inflammatory, COX-2 inhibitor",
    "target": "PTGS2 (COX2) [HSA:5743] [KO:K11987]\nPATHWAY   hsa00590(5743)  Arachidonic acid metabolism",
    "metabolism": "",
    "therapeutic_category": "1149",
    "atc_code": "M01AB08",
    "drug_class": [
      "Anti-inflammatory",
      "Nonsteroidal anti-inflammatory drug (NSAID)",
      "Anti-inflammatory drug, acetic acid derivatives",
      "Selective COX2 inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Etodolac"
  },
  {
    "kegg_id": "D00127",
    "name_en": "Piroxicam (JP18/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Feldene (TN)"
    ],
    "formula": "C15H13N3O4S",
    "efficacy": "Analgesic, Anti-inflammatory, Antirheumatic, COX inhibitor\nDISEASE   Rheumatoid arthritis [DS:H00630]",
    "target": "PTGS1 (COX1) [HSA:5742] [KO:K00509]\nPTGS2 (COX2) [HSA:5743] [KO:K11987]\nPATHWAY   hsa00590(5742+5743)  Arachidonic acid metabolism",
    "metabolism": "Enzyme: CYP2C9 [HSA:1559]",
    "therapeutic_category": "1149",
    "atc_code": "M01AC01",
    "drug_class": [
      "Anti-inflammatory",
      "Nonsteroidal anti-inflammatory drug (NSAID)",
      "Anti-inflammatory drug, oxicams",
      "Metabolizing enzyme substrate",
      "CYP2C9 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C9"
    ],
    "search_name": "Piroxicam"
  },
  {
    "kegg_id": "D01866",
    "name_en": "Lornoxicam (JP18/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Lorcam (TN)"
    ],
    "formula": "C13H10ClN3O4S2",
    "efficacy": "Analgesic, Anti-inflammatory, COX-2 inhibitor",
    "target": "PTGS2 (COX2) [HSA:5743] [KO:K11987]\nPTGS1 (COX1) [HSA:5742] [KO:K00509]\nPATHWAY   hsa00590(5742+5743)  Arachidonic acid metabolism",
    "metabolism": "Enzyme: CYP2C9 [HSA:1559]",
    "therapeutic_category": "1149",
    "atc_code": "M01AC05",
    "drug_class": [
      "Anti-inflammatory",
      "Nonsteroidal anti-inflammatory drug (NSAID)",
      "Anti-inflammatory drug, oxicams",
      "Selective COX2 inhibitor",
      "Metabolizing enzyme substrate",
      "CYP2C9 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C9"
    ],
    "search_name": "Lornoxicam"
  },
  {
    "kegg_id": "D00969",
    "name_en": "Meloxicam (JAN/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Mobic (TN)"
    ],
    "formula": "C14H13N3O4S2",
    "efficacy": "Analgesic, Anti-inflammatory, COX-2 inhibitor",
    "target": "PTGS2 (COX2) [HSA:5743] [KO:K11987]\nPATHWAY   hsa00590(5743)  Arachidonic acid metabolism",
    "metabolism": "Enzyme: CYP2C9 [HSA:1559]; CYP3A4 [HSA:1576]",
    "therapeutic_category": "1149",
    "atc_code": "M01AC06",
    "drug_class": [
      "Anti-inflammatory",
      "Nonsteroidal anti-inflammatory drug (NSAID)",
      "Anti-inflammatory drug, oxicams",
      "Selective COX2 inhibitor",
      "Metabolizing enzyme substrate",
      "CYP2C9 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C9",
      "CYP3A4"
    ],
    "search_name": "Meloxicam"
  },
  {
    "kegg_id": "D00132",
    "name_en": "Ketoprofen (JP18/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Orudis (TN)"
    ],
    "formula": "C16H14O3",
    "efficacy": "Analgesic, Anti-inflammatory, Antipyretic, COX inhibitor",
    "target": "PTGS1 (COX1) [HSA:5742] [KO:K00509]\nPTGS2 (COX2) [HSA:5743] [KO:K11987]\nPATHWAY   hsa00590(5742+5743)  Arachidonic acid metabolism",
    "metabolism": "",
    "therapeutic_category": "1149",
    "atc_code": "M01AE03",
    "drug_class": [
      "Anti-inflammatory",
      "Nonsteroidal anti-inflammatory drug (NSAID)",
      "Anti-inflammatory drug, propionic acid derivative",
      "Transporter inhibitor",
      "SLC22A7 inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Ketoprofen"
  },
  {
    "kegg_id": "D00330",
    "name_en": "Flurbiprofen (JP18/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Ansaid (TN)"
    ],
    "formula": "C15H13FO2",
    "efficacy": "Analgesic, Anti-inflammatory, COX inhibitor\nDISEASE   Rheumatoid arthritis [DS:H00630]",
    "target": "PTGS1 (COX1) [HSA:5742] [KO:K00509]\nPTGS2 (COX2) [HSA:5743] [KO:K11987]\nPATHWAY   hsa00590(5742+5743)  Arachidonic acid metabolism",
    "metabolism": "Enzyme: CYP2C9 [HSA:1559]",
    "therapeutic_category": "1149",
    "atc_code": "M01AE09",
    "drug_class": [
      "Anti-inflammatory",
      "Nonsteroidal anti-inflammatory drug (NSAID)",
      "Anti-inflammatory drug, propionic acid derivative",
      "Metabolizing enzyme substrate",
      "CYP2C9 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C9"
    ],
    "search_name": "Flurbiprofen"
  },
  {
    "kegg_id": "D01475",
    "name_en": "Flurbiprofen axetil (JAN)",
    "name_ja": "",
    "names_alt": [
      "FP 83",
      "Ropion (TN)"
    ],
    "formula": "C19H19FO4",
    "efficacy": "Analgesic, COX inhibitor",
    "target": "PTGS1 (COX1) [HSA:5742] [KO:K00509]\nPTGS2 (COX2) [HSA:5743] [KO:K11987]\nPATHWAY   hsa00590(5742+5743)  Arachidonic acid metabolism",
    "metabolism": "Enzyme: CYP2C9 [HSA:1559]",
    "therapeutic_category": "1149",
    "atc_code": "M01AE09",
    "drug_class": [
      "Anti-inflammatory",
      "Nonsteroidal anti-inflammatory drug (NSAID)",
      "Anti-inflammatory drug, propionic acid derivative",
      "Metabolizing enzyme substrate",
      "CYP2C9 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C9"
    ],
    "search_name": "Flurbiprofen axetil"
  },
  {
    "kegg_id": "D00463",
    "name_en": "Oxaprozin (JP18/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Daypro (TN)"
    ],
    "formula": "C18H15NO3",
    "efficacy": "Analgesic, Anti-inflammatory, COX inhibitor\nDISEASE   Rheumatoid arthritis [DS:H00630]\nJuvenile rheumatoid arthritis [DS:H01672]",
    "target": "PTGS1 (COX1) [HSA:5742] [KO:K00509]\nPTGS2 (COX2) [HSA:5743] [KO:K11987]\nPATHWAY   hsa00590(5742+5743)  Arachidonic acid metabolism",
    "metabolism": "",
    "therapeutic_category": "1149",
    "atc_code": "M01AE12",
    "drug_class": [
      "Anti-inflammatory",
      "Nonsteroidal anti-inflammatory drug (NSAID)",
      "Anti-inflammatory drug, propionic acid derivative"
    ],
    "cyp_enzymes": [],
    "search_name": "Oxaprozin"
  },
  {
    "kegg_id": "D01709",
    "name_en": "Loxoprofen sodium hydrate (JP18)",
    "name_ja": "ロキソプロフェン",
    "names_alt": [
      "Lorfenamin (TN)",
      "Loxonin (TN)"
    ],
    "formula": "C15H17O3. 2H2O. Na",
    "efficacy": "Analgesic, Anti-inflammatory, Antipyretic, COX inhibitor",
    "target": "PTGS2 (COX2) [HSA:5743] [KO:K11987]\nPTGS1 (COX1) [HSA:5742] [KO:K00509]\nPATHWAY   hsa00590(5742+5743)  Arachidonic acid metabolism",
    "metabolism": "",
    "therapeutic_category": "1149",
    "atc_code": "M01AE19",
    "drug_class": [
      "Anti-inflammatory",
      "Nonsteroidal anti-inflammatory drug (NSAID)",
      "Anti-inflammatory drug, propionic acid derivative"
    ],
    "cyp_enzymes": [],
    "search_name": "Loxoprofen sodium hydrate"
  },
  {
    "kegg_id": "D00425",
    "name_en": "Nabumetone (JP18/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Relafen (TN)"
    ],
    "formula": "C15H16O2",
    "efficacy": "Analgesic, Anti-inflammatory, COX inhibitor",
    "target": "PTGS2 (COX2) [HSA:5743] [KO:K11987]\nPTGS1 (COX1) [HSA:5742] [KO:K00509]\nPATHWAY   hsa00590(5742+5743)  Arachidonic acid metabolism",
    "metabolism": "",
    "therapeutic_category": "1149",
    "atc_code": "M01AX01",
    "drug_class": [
      "Anti-inflammatory",
      "Nonsteroidal anti-inflammatory drug (NSAID)",
      "Selective COX2 inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Nabumetone"
  },
  {
    "kegg_id": "D00498",
    "name_en": "Pentazocine (JP18/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Fortral (TN)"
    ],
    "formula": "C19H27NO",
    "efficacy": "Analgesic, Opioid receptor agonist/antagonist",
    "target": "OPRK1 [HSA:4986] [KO:K04214]\nOPRM1 [HSA:4988] [KO:K04215]\nPATHWAY   hsa04080(4986+4988)  Neuroactive ligand-receptor interaction",
    "metabolism": "",
    "therapeutic_category": "1149",
    "atc_code": "N02AD01",
    "drug_class": [
      "Neuropsychiatric agent",
      "Opioid receptor agonist",
      "Analgesic",
      "Opioid analgesics"
    ],
    "cyp_enzymes": [],
    "search_name": "Pentazocine"
  },
  {
    "kegg_id": "D02227",
    "name_en": "Pentazocine hydrochloride (JAN/USP)",
    "name_ja": "",
    "names_alt": [
      "Sosegon (TN)",
      "Talacen (TN)"
    ],
    "formula": "C19H27NO. HCl",
    "efficacy": "Analgesic, Opioid receptor agonist/antagonist",
    "target": "OPRK1 [HSA:4986] [KO:K04214]\nOPRM1 [HSA:4988] [KO:K04215]\nPATHWAY   hsa04080(4986+4988)  Neuroactive ligand-receptor interaction",
    "metabolism": "",
    "therapeutic_category": "1149",
    "atc_code": "N02AD01",
    "drug_class": [
      "Neuropsychiatric agent",
      "Opioid receptor agonist",
      "Analgesic",
      "Opioid analgesics"
    ],
    "cyp_enzymes": [],
    "search_name": "Pentazocine hydrochloride"
  },
  {
    "kegg_id": "D00836",
    "name_en": "Buprenorphine hydrochloride (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Buprenex (TN)"
    ],
    "formula": "C29H41NO4. HCl",
    "efficacy": "Analgesic, Opioid receptor agonist/antagonist",
    "target": "OPRK1 [HSA:4986] [KO:K04214]\nOPRM1 [HSA:4988] [KO:K04215]\nPATHWAY   hsa04080(4986+4988)  Neuroactive ligand-receptor interaction",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "1149",
    "atc_code": "N02AE01",
    "drug_class": [
      "Analgesic",
      "Opioid analgesics",
      "Opioid receptor antagonist",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Buprenorphine hydrochloride"
  },
  {
    "kegg_id": "D07132",
    "name_en": "Buprenorphine (JAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Temgesic (TN)"
    ],
    "formula": "C29H41NO4",
    "efficacy": "Analgesic, Opioid receptor agonist/antagonist",
    "target": "OPRK1 [HSA:4986] [KO:K04214]\nOPRM1 [HSA:4988] [KO:K04215]\nPATHWAY   hsa04080(4986+4988)  Neuroactive ligand-receptor interaction",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "1149",
    "atc_code": "N02AE01",
    "drug_class": [
      "Analgesic",
      "Opioid analgesics",
      "Opioid receptor antagonist",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Buprenorphine"
  },
  {
    "kegg_id": "D09999",
    "name_en": "Tramadol hydrochloride and acetaminophen",
    "name_ja": "トラマドール",
    "names_alt": [
      "Tramcet (TN)"
    ],
    "formula": "",
    "efficacy": "Pain relief",
    "target": "",
    "metabolism": "Enzyme: CYP2D6 [HSA:1565], CYP3A4 [HSA:1576]",
    "therapeutic_category": "1149",
    "atc_code": "N02AJ13",
    "drug_class": [
      "Analgesic",
      "Opioid analgesics",
      "Metabolizing enzyme substrate",
      "CYP2D6 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4",
      "CYP2D6"
    ],
    "search_name": "Tramadol hydrochloride and acetaminophen"
  },
  {
    "kegg_id": "D01355",
    "name_en": "Tramadol hydrochloride (JP18/USP)",
    "name_ja": "トラマドール",
    "names_alt": [
      "Ultram (TN)"
    ],
    "formula": "C16H25NO2. HCl",
    "efficacy": "Analgesic, Opioid receptor agonist",
    "target": "OPRM1 [HSA:4988] [KO:K04215]\nPATHWAY   hsa04080(4988)  Neuroactive ligand-receptor interaction",
    "metabolism": "Enzyme: CYP2D6 [HSA:1565], CYP3A4 [HSA:1576]",
    "therapeutic_category": "1149",
    "atc_code": "N02AX02",
    "drug_class": [
      "Neuropsychiatric agent",
      "Opioid receptor agonist",
      "mu-Opioid receptor agonist",
      "Analgesic",
      "Opioid analgesics",
      "Metabolizing enzyme substrate",
      "CYP2D6 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4",
      "CYP2D6"
    ],
    "search_name": "Tramadol hydrochloride"
  },
  {
    "kegg_id": "D03976",
    "name_en": "Isopropylantipyrine, allyl isopropyl acetyl urea, acetaminophen and anhydrous caffeine",
    "name_ja": "",
    "names_alt": [
      "SG (TN)"
    ],
    "formula": "",
    "efficacy": "Analgesic, Antipyretic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "1149",
    "atc_code": "N02BB54",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Isopropylantipyrine, allyl isopropyl acetyl urea, acetaminophen and anhydrous caffeine"
  },
  {
    "kegg_id": "D07585",
    "name_en": "Isopropylantipyrine, ergotamine tartrate and anhydrous caffeine",
    "name_ja": "",
    "names_alt": [
      "Cleamine A (TN)"
    ],
    "formula": "",
    "efficacy": "Antimigraine",
    "target": "",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "1149",
    "atc_code": "N02CA52",
    "drug_class": [
      "Neuropsychiatric agent",
      "Ergot alkaloid",
      "Antimigraine, ergot alkaloid",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Isopropylantipyrine, ergotamine tartrate and anhydrous caffeine"
  },
  {
    "kegg_id": "D01902",
    "name_en": "Fonazine mesylate (USAN)",
    "name_ja": "",
    "names_alt": [
      "Dimetotiazine mesilate (JAN)",
      "Banistyl (TN)"
    ],
    "formula": "C19H25N3O2S2. CH4SO3",
    "efficacy": "Antimigraine, Serotonin receptor antagonist, H1 receptor antagonist",
    "target": "HTR2 [HSA:3356 3357 3358] [KO:K04157]\nHRH1 [HSA:3269] [KO:K04149]\nPATHWAY   hsa04020(3269+3356+3357+3358)  Calcium signaling pathway\nhsa04080(3269+3356+3357+3358)  Neuroactive ligand-receptor interaction",
    "metabolism": "",
    "therapeutic_category": "1149",
    "atc_code": "N02CX05",
    "drug_class": [
      "Anti-allergic agent",
      "Histamine receptor antagonist",
      "Histamine receptor H1 antagonist"
    ],
    "cyp_enzymes": [],
    "search_name": "Fonazine mesylate"
  },
  {
    "kegg_id": "D01395",
    "name_en": "Actarit (JAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Orcl (TN)"
    ],
    "formula": "C10H11NO3",
    "efficacy": "Anti-inflammatory, Antirheumatic, Immunomodulator",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "1149",
    "atc_code": "",
    "drug_class": [
      "Anti-inflammatory",
      "Disease modifying anti-rheumatic drug (DMARD)"
    ],
    "cyp_enzymes": [],
    "search_name": "Actarit"
  },
  {
    "kegg_id": "D01547",
    "name_en": "Zaltoprofen (JP18/INN)",
    "name_ja": "",
    "names_alt": [
      "CN 100",
      "Peon (TN)"
    ],
    "formula": "C17H14O3S",
    "efficacy": "Analgesic, Anti-inflammatory, COX-2 inhibitor",
    "target": "PTGS2 (COX2) [HSA:5743] [KO:K11987]\nPTGS1 (COX1) [HSA:5742] [KO:K00509]\nPATHWAY   hsa00590(5742+5743)  Arachidonic acid metabolism",
    "metabolism": "",
    "therapeutic_category": "1149",
    "atc_code": "",
    "drug_class": [
      "Anti-inflammatory",
      "Nonsteroidal anti-inflammatory drug (NSAID)",
      "Anti-inflammatory drug, propionic acid derivative",
      "Selective COX2 inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Zaltoprofen"
  },
  {
    "kegg_id": "D01661",
    "name_en": "Bucolome (JAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Paramidin (TN)"
    ],
    "formula": "C14H22N2O3",
    "efficacy": "Anti-inflammatory",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "1149",
    "atc_code": "",
    "drug_class": [
      "Anti-inflammatory",
      "Nonsteroidal anti-inflammatory drug (NSAID)"
    ],
    "cyp_enzymes": [],
    "search_name": "Bucolome"
  },
  {
    "kegg_id": "D04011",
    "name_en": "Chondroitin sulfate sodium and sodium salicylate",
    "name_ja": "",
    "names_alt": [
      "Kashowadol (TN)"
    ],
    "formula": "",
    "efficacy": "Analgesic, Anti-inflammatory",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "1149",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Chondroitin sulfate sodium and sodium salicylate"
  },
  {
    "kegg_id": "D07611",
    "name_en": "Simetride and anhydrous caffeine",
    "name_ja": "",
    "names_alt": [
      "Kyorin AP2 (TN)"
    ],
    "formula": "",
    "efficacy": "Analgesic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "1149",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Simetride and anhydrous caffeine"
  },
  {
    "kegg_id": "D07630",
    "name_en": "Neurotropin (JAN)",
    "name_ja": "",
    "names_alt": [
      "An extract from inflammatory rabbit skin inoculated by vaccinia virus"
    ],
    "formula": "",
    "efficacy": "Anti-inflammatory, Antipruritic, Pain relief",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "1149",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Neurotropin"
  },
  {
    "kegg_id": "D02242",
    "name_en": "Methamphetamine hydrochloride (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Desoxyn (TN)"
    ],
    "formula": "C10H15N. HCl",
    "efficacy": "Psychostimulant, Stimulant (central)\nDISEASE   Attention deficit disorder with hyperactivity [DS:H01895]",
    "target": "SLC6A3 (DAT1) [HSA:6531] [KO:K05036]\nSLC6A2 (NAT1) [HSA:6530] [KO:K05035]\nSLC6A4 (HTT) [HSA:6532] [KO:K05037]\nSLC18A2 (VMAT2) [HSA:6571] [KO:K08155]\nSLC18A1 (VMAT1) [HSA:6570] [KO:K08155]\nPATHWAY   hsa04721(6530+6531+6532+6570+6571)  Synaptic vesicle cycle\nhsa04726(6532+6570+6571)  Serotonergic synapse\nhsa04728(6531+6570+6571)  Dopaminergic synapse\nhsa05031(6531+6570+6571)  Amphetamine addiction",
    "metabolism": "Enzyme: CYP2D6 [HSA:1565]",
    "therapeutic_category": "1151",
    "atc_code": "N06BA03",
    "drug_class": [
      "Neuropsychiatric agent",
      "Agents for narcolepsy",
      "Metabolizing enzyme substrate",
      "CYP2D6 substrate"
    ],
    "cyp_enzymes": [
      "CYP2D6"
    ],
    "search_name": "Methamphetamine hydrochloride"
  },
  {
    "kegg_id": "D00777",
    "name_en": "Amantadine hydrochloride (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Symmetrel (TN)",
      "Gocovri (TN)",
      "Osmolex er (TN)"
    ],
    "formula": "C10H17N. HCl",
    "efficacy": "Antiviral, M2 protein inhibitor, Antiparkinsonian, Dopamine secretagogue\nDISEASE   Influenza A infection [DS:H00398]\nParkinson disease/syndrome [DS:H00057 H01600]",
    "target": "Influenza A virus M2 [KO:K19394]\nGRIN (NMDAR) [HSA:2902 2903 2904 2905 2906] [KO:K05208 K05209 K05210 K05211 K05212]\nPATHWAY   hsa04080(2902+2903+2904+2905+2906)  Neuroactive ligand-receptor interaction\nhsa04724(2902+2903+2904+2905+2906)  Glutamatergic synapse\nhsa04728(2903+2904)  Dopaminergic synapse\nko03230(K19394)  Viral genome structure\nko05164(K19394)  Influenza A",
    "metabolism": "Transporter: SLC22A2 [HSA:6582]",
    "therapeutic_category": "1161",
    "atc_code": "N04BB01",
    "drug_class": [
      "Antiviral",
      "Anti-influenza virus agent",
      "Viral uncoating inhibitor",
      "Neuropsychiatric agent",
      "NMDA receptor antagonist",
      "Antiparkinson agent",
      "Transporter substrate",
      "SLC22A2 substrate"
    ],
    "cyp_enzymes": [],
    "search_name": "Amantadine hydrochloride"
  },
  {
    "kegg_id": "D02246",
    "name_en": "Biperiden hydrochloride (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Tasmolin (TN)"
    ],
    "formula": "C21H29NO. HCl",
    "efficacy": "Antiparkinsonian, Muscarinic acetylcholine receptor antagonist\nDISEASE   Parkinsonism [DS:H01600]",
    "target": "CHRM [HSA:1128 1129 1131 1132 1133] [KO:K04129 K04130 K04131 K04132 K04133]\nPATHWAY   hsa04080(1128+1129+1131+1132+1133)  Neuroactive ligand-receptor interaction\nhsa04725(1128+1129+1131+1132+1133)  Cholinergic synapse",
    "metabolism": "",
    "therapeutic_category": "1162",
    "atc_code": "N04AA02",
    "drug_class": [
      "Neuropsychiatric agent",
      "Muscarinic cholinergic receptor antagonist",
      "Anticholinergic antiparkinson agent",
      "Antiparkinson agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Biperiden hydrochloride"
  },
  {
    "kegg_id": "D02247",
    "name_en": "Biperiden lactate (JAN/USP)",
    "name_ja": "",
    "names_alt": [
      "Tasmolin (TN)"
    ],
    "formula": "C21H29NO. C3H6O3",
    "efficacy": "Antiparkinsonian, Muscarinic acetylcholine receptor antagonist\nDISEASE   Parkinsonism [DS:H01600]",
    "target": "CHRM [HSA:1128 1129 1131 1132 1133] [KO:K04129 K04130 K04131 K04132 K04133]\nPATHWAY   hsa04080(1128+1129+1131+1132+1133)  Neuroactive ligand-receptor interaction\nhsa04725(1128+1129+1131+1132+1133)  Cholinergic synapse",
    "metabolism": "",
    "therapeutic_category": "1162",
    "atc_code": "N04AA02",
    "drug_class": [
      "Neuropsychiatric agent",
      "Muscarinic cholinergic receptor antagonist",
      "Anticholinergic antiparkinson agent",
      "Antiparkinson agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Biperiden lactate"
  },
  {
    "kegg_id": "D00059",
    "name_en": "Levodopa (JP18/USP/INN)",
    "name_ja": "レボドパ",
    "names_alt": [
      "Dopar (TN)"
    ],
    "formula": "C9H11NO4",
    "efficacy": "Antiparkinsonian\nDISEASE   Parkinson disease [DS:H00057]\nParkinsonism [DS:H01600]",
    "target": "DRD [HSA:1812 1813 1814 1815 1816] [KO:K04144 K04145 K04146 K04147 K05840]\nPATHWAY   hsa04020(1812+1816)  Calcium signaling pathway\nhsa04080(1812+1813+1814+1815+1816)  Neuroactive ligand-receptor interaction\nhsa04728(1812+1813+1814+1815+1816)  Dopaminergic synapse\nhsa05012(1812+1813)  Parkinson disease",
    "metabolism": "",
    "therapeutic_category": "1164",
    "atc_code": "N04BA01",
    "drug_class": [
      "Neuropsychiatric agent",
      "Dopamine agonist",
      "Antiparkinson agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Levodopa"
  },
  {
    "kegg_id": "D01277",
    "name_en": "Droxidopa (JP18/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Dops (TN)",
      "Northera (TN)"
    ],
    "formula": "C9H11NO5",
    "efficacy": "Antiparkinsonian, Replenisher (noradrenalin)\nDISEASE   Parkinson disease [DS:H00057]\nMultiple system atrophy [DS:H01614]\nDopamine beta-hydroxylase deficiency [DS:H01005]",
    "target": "ADRA1 [HSA:148 147 146] [KO:K04135 K04136 K04137]\nADRA2 [HSA:150 151 152] [KO:K04138 K04139 K04140]\nADRB [HSA:153 154 155] [KO:K04141 K04142 K04143]\nPATHWAY   hsa04080(146+147+148+150+151+152+153+154+155)  Neuroactive ligand-receptor interaction\nhsa04261(146+147+148+153+154)  Adrenergic signaling in cardiomyocytes",
    "metabolism": "",
    "therapeutic_category": "1169",
    "atc_code": "C01CA27",
    "drug_class": [
      "Neuropsychiatric agent",
      "Antiparkinson agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Droxidopa"
  },
  {
    "kegg_id": "D03290",
    "name_en": "Promethazine methylenedisalicylate (JAN)",
    "name_ja": "",
    "names_alt": [
      "Pyrethia (TN)"
    ],
    "formula": "(C17H20N2S)2. C15H12O6",
    "efficacy": "Antiallergic, Antiparkinsonian, H1 receptor antagonist",
    "target": "HRH1 [HSA:3269] [KO:K04149]\nPATHWAY   hsa04020(3269)  Calcium signaling pathway\nhsa04080(3269)  Neuroactive ligand-receptor interaction\nhsa04750(3269)  Inflammatory mediator regulation of TRP channels",
    "metabolism": "Enzyme: CYP2D6 [HSA:1565]",
    "therapeutic_category": "1169",
    "atc_code": "D04AA10",
    "drug_class": [
      "Anti-allergic agent",
      "Histamine receptor antagonist",
      "Histamine receptor H1 antagonist",
      "Metabolizing enzyme substrate",
      "CYP2D6 substrate"
    ],
    "cyp_enzymes": [
      "CYP2D6"
    ],
    "search_name": "Promethazine methylenedisalicylate"
  },
  {
    "kegg_id": "D00780",
    "name_en": "Bromocriptine mesylate (USP)",
    "name_ja": "",
    "names_alt": [
      "Bromocriptine mesilate (JP18)",
      "Parlodel (TN)"
    ],
    "formula": "C32H40BrN5O5. CH4SO3",
    "efficacy": "Antiparkinsonian, Dopamine D2 receptor agonist, Prolactin inhibitor\nDISEASE   Hyperprolactinemia [DS:H01388]\nAcromegaly [DS:H01483]\nParkinson disease [DS:H00057]",
    "target": "DRD2 [HSA:1813] [KO:K04145]\nPRL [HSA:5617] [KO:K05439]\nPATHWAY   hsa04080(1813+5617)  Neuroactive ligand-receptor interaction\nhsa04728(1813)  Dopaminergic synapse\nhsa04917(5617)  Prolactin signaling pathway\nhsa05012(1813)  Parkinson disease\nNETWORK   nt06325  Hormone/cytokine signaling",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "1169",
    "atc_code": "G02CB01",
    "drug_class": [
      "Neuropsychiatric agent",
      "Dopamine agonist",
      "Dopamine D2-receptor agonist",
      "Ergot alkaloid",
      "Antiparkinson agent",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "Metabolizing enzyme inhibitor",
      "CYP3A/CYP3A4 inhibitor",
      "CYP3A4 inhibitor"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Bromocriptine mesylate"
  },
  {
    "kegg_id": "D00987",
    "name_en": "Cabergoline (JP18/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Cabaser (TN)",
      "Dostinex (TN)"
    ],
    "formula": "C26H37N5O2",
    "efficacy": "Antiparkinsonian, Antidyskinetic, Dopamine D2 receptor agonist, Prolactin inhibitor\nDISEASE   Hyperprolactinemic [DS:H01388]",
    "target": "DRD2 [HSA:1813] [KO:K04145]\nPRL [HSA:5617] [KO:K05439]\nPATHWAY   hsa04080(1813+5617)  Neuroactive ligand-receptor interaction\nhsa04728(1813)  Dopaminergic synapse\nhsa04917(5617)  Prolactin signaling pathway\nhsa05012(1813)  Parkinson disease\nNETWORK   nt06325  Hormone/cytokine signaling",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "1169",
    "atc_code": "G02CB03",
    "drug_class": [
      "Neuropsychiatric agent",
      "Dopamine agonist",
      "Dopamine D2-receptor agonist",
      "Ergot alkaloid",
      "Antiparkinson agent",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Cabergoline"
  },
  {
    "kegg_id": "D02004",
    "name_en": "Apomorphine hydrochloride (USP)",
    "name_ja": "",
    "names_alt": [
      "Apomorphine hydrochloride hydrate (JAN)",
      "Apokyn (TN)",
      "Ixense (TN)",
      "Uprima (TN)"
    ],
    "formula": "(C17H17NO2)2. 2HCl. H2O",
    "efficacy": "Antiparkinsonian, Emetic, Dopamine receptor agonist\nDISEASE   Parkinson disease [DS:H00057]",
    "target": "DRD1 [HSA:1812] [KO:K04144]\nDRD2 [HSA:1813] [KO:K04145]\nPATHWAY   hsa04080(1812+1813)  Neuroactive ligand-receptor interaction\nhsa04728(1812+1813)  Dopaminergic synapse\nhsa05012(1812+1813)  Parkinson disease",
    "metabolism": "",
    "therapeutic_category": "1169",
    "atc_code": "G04BE07",
    "drug_class": [
      "Neuropsychiatric agent",
      "Dopamine agonist",
      "Antiparkinson agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Apomorphine hydrochloride"
  },
  {
    "kegg_id": "D00787",
    "name_en": "Trihexyphenidyl hydrochloride (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Artane (TN)"
    ],
    "formula": "C20H31NO. HCl",
    "efficacy": "Antiparkinsonian, Muscarinic acetylcholine receptor antagonist\nDISEASE   Parkinsonism [DS:H01600]",
    "target": "CHRM [HSA:1128 1129 1131 1132 1133] [KO:K04129 K04130 K04131 K04132 K04133]\nPATHWAY   hsa04080(1128+1129+1131+1132+1133)  Neuroactive ligand-receptor interaction\nhsa04725(1128+1129+1131+1132+1133)  Cholinergic synapse",
    "metabolism": "",
    "therapeutic_category": "1169",
    "atc_code": "N04AA01",
    "drug_class": [
      "Neuropsychiatric agent",
      "Muscarinic cholinergic receptor antagonist",
      "Anticholinergic antiparkinson agent",
      "Antiparkinson agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Trihexyphenidyl hydrochloride"
  },
  {
    "kegg_id": "D00253",
    "name_en": "Carbidopa hydrate and levodopa",
    "name_ja": "",
    "names_alt": [
      "Parcopa (TN)",
      "Sinemet (TN)"
    ],
    "formula": "",
    "efficacy": "Antiparkinsonian\nDISEASE   Parkinson disease [DS:H00057]\nParkinsonism [DS:H01600]",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "1169",
    "atc_code": "N04BA02",
    "drug_class": [
      "Neuropsychiatric agent",
      "Antiparkinson agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Carbidopa hydrate and levodopa"
  },
  {
    "kegg_id": "D02135",
    "name_en": "Levodopa and benserazide hydrochloride",
    "name_ja": "レボドパ",
    "names_alt": [
      "Madopar (TN)"
    ],
    "formula": "",
    "efficacy": "Antiparkinsonian",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "1169",
    "atc_code": "N04BA02",
    "drug_class": [
      "Neuropsychiatric agent",
      "Antiparkinson agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Levodopa and benserazide hydrochloride"
  },
  {
    "kegg_id": "D10293",
    "name_en": "Carbidopa, levodopa and entacapone",
    "name_ja": "",
    "names_alt": [
      "Stalevo (TN)"
    ],
    "formula": "",
    "efficacy": "Antiparkinsonian\nDISEASE   Parkinson disease [DS:H00057]",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "1169",
    "atc_code": "N04BA03",
    "drug_class": [
      "Neuropsychiatric agent",
      "Antiparkinson agent",
      "COMT inhibitor",
      "Metabolizing enzyme inhibitor",
      "CYP2C9 inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Carbidopa, levodopa and entacapone"
  },
  {
    "kegg_id": "D12494",
    "name_en": "Foslevodopa and foscarbidopa",
    "name_ja": "",
    "names_alt": [
      "Vyalev (TN)"
    ],
    "formula": "",
    "efficacy": "Antiparkinsonian",
    "target": "",
    "metabolism": "Enzyme: COMT [HSA:1312], DDC [HSA:1644]",
    "therapeutic_category": "1169",
    "atc_code": "N04BA07",
    "drug_class": [
      "Metabolizing enzyme substrate",
      "COMT substrate",
      "DDC substrate"
    ],
    "cyp_enzymes": [],
    "search_name": "Foslevodopa and foscarbidopa"
  },
  {
    "kegg_id": "D00502",
    "name_en": "Pergolide mesylate (USP)",
    "name_ja": "",
    "names_alt": [
      "Pergolide mesilate (JAN)",
      "Permax (TN)"
    ],
    "formula": "C19H26N2S. CH4SO3",
    "efficacy": "Antiparkinsonian, Dopamine receptor agonist",
    "target": "DRD1 [HSA:1812] [KO:K04144]\nDRD2 [HSA:1813] [KO:K04145]\nPATHWAY   hsa04080(1812+1813)  Neuroactive ligand-receptor interaction\nhsa04728(1812+1813)  Dopaminergic synapse\nhsa05012(1812+1813)  Parkinson disease",
    "metabolism": "",
    "therapeutic_category": "1169",
    "atc_code": "N04BC02",
    "drug_class": [
      "Neuropsychiatric agent",
      "Dopamine agonist",
      "Ergot alkaloid",
      "Antiparkinson agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Pergolide mesylate"
  },
  {
    "kegg_id": "D00784",
    "name_en": "Ropinirole hydrochloride (JAN/USP)",
    "name_ja": "",
    "names_alt": [
      "Requip (TN)"
    ],
    "formula": "C16H24N2O. HCl",
    "efficacy": "Antiparkinsonian, Dopamine receptor agonist\nDISEASE   Parkinson disease [DS:H00057]\nRestless legs syndrome [DS:H01597]",
    "target": "DRD2 [HSA:1813] [KO:K04145]\nDRD3 [HSA:1814] [KO:K04146]\nDRD4 [HSA:1815] [KO:K04147]\nPATHWAY   hsa04080(1813+1814+1815)  Neuroactive ligand-receptor interaction\nhsa04728(1813+1814+1815)  Dopaminergic synapse\nhsa05012(1813)  Parkinson disease",
    "metabolism": "Enzyme: CYP1A2 [HSA:1544]",
    "therapeutic_category": "1169",
    "atc_code": "N04BC04",
    "drug_class": [
      "Neuropsychiatric agent",
      "Dopamine agonist",
      "Dopamine D2-receptor agonist",
      "Antiparkinson agent",
      "Metabolizing enzyme substrate",
      "CYP1A2 substrate"
    ],
    "cyp_enzymes": [
      "CYP1A2"
    ],
    "search_name": "Ropinirole hydrochloride"
  },
  {
    "kegg_id": "D00559",
    "name_en": "Pramipexole dihydrochloride (USP)",
    "name_ja": "",
    "names_alt": [
      "Pramipexole hydrochloride hydrate (JAN)",
      "Pramipexole dihydrochloride monohydrate",
      "Mirapex (TN)"
    ],
    "formula": "C10H17N3S. 2HCl. H2O",
    "efficacy": "Antidepressant, Antiparkinsonian, Dopamine receptor agonist\nDISEASE   Parkinson disease [DS:H00057]\nRestless legs syndrome [DS:H01597]",
    "target": "DRD2 [HSA:1813] [KO:K04145]\nDRD3 [HSA:1814] [KO:K04146]\nDRD4 [HSA:1815] [KO:K04147]\nPATHWAY   hsa04080(1813+1814+1815)  Neuroactive ligand-receptor interaction\nhsa04728(1813+1814+1815)  Dopaminergic synapse\nhsa05012(1813)  Parkinson disease",
    "metabolism": "",
    "therapeutic_category": "1169",
    "atc_code": "N04BC05",
    "drug_class": [
      "Neuropsychiatric agent",
      "Dopamine agonist",
      "Antiparkinson agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Pramipexole dihydrochloride"
  },
  {
    "kegg_id": "D05768",
    "name_en": "Rotigotine (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Neupro (TN)"
    ],
    "formula": "C19H25NOS",
    "efficacy": "Antiparkinsonian, Dopamine D2 receptor agonist\nDISEASE   Parkinson disease [DS:H00057]\nRestless legs syndrome [DS:H01597]",
    "target": "DRD2 [HSA:1813] [KO:K04145]\nPATHWAY   hsa04080(1813)  Neuroactive ligand-receptor interaction\nhsa04728(1813)  Dopaminergic synapse\nhsa05012(1813)  Parkinson disease",
    "metabolism": "",
    "therapeutic_category": "1169",
    "atc_code": "N04BC09",
    "drug_class": [
      "Neuropsychiatric agent",
      "Dopamine agonist",
      "Dopamine D2-receptor agonist",
      "Antiparkinson agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Rotigotine"
  },
  {
    "kegg_id": "D00785",
    "name_en": "Selegiline hydrochloride (JAN/USP)",
    "name_ja": "",
    "names_alt": [
      "Eldepryl (TN)"
    ],
    "formula": "C13H17N. HCl",
    "efficacy": "Antiparkinsonian, Antidyskinetic, Monoamine oxidase B (MAO-B) inhibitor\nDISEASE   Parkinson disease [DS:H00057]",
    "target": "MAOB [HSA:4129] [KO:K00274]\nPATHWAY   hsa04726(4129)  Serotonergic synapse\nhsa04728(4129)  Dopaminergic synapse",
    "metabolism": "Enzyme: CYP2B6 [HSA:1555], CYP2D6 [HSA:1565], CYP3A4 [HSA:1576]; CYP2A6 [HSA:1548]",
    "therapeutic_category": "1169",
    "atc_code": "N04BD01",
    "drug_class": [
      "Neuropsychiatric agent",
      "MAO inhibitor",
      "Monoamine oxidase B inhibitor",
      "Antiparkinson agent",
      "Metabolizing enzyme substrate",
      "CYP2A6 substrate",
      "CYP2B6 substrate",
      "CYP2D6 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP2A6",
      "CYP3A4",
      "CYP2B6",
      "CYP2D6"
    ],
    "search_name": "Selegiline hydrochloride"
  },
  {
    "kegg_id": "D02562",
    "name_en": "Rasagiline mesylate (USAN)",
    "name_ja": "",
    "names_alt": [
      "Rasagiline mesilate (JAN)",
      "Azilect (TN)"
    ],
    "formula": "C12H13N. CH4SO3",
    "efficacy": "Antiparkinsonian, Monoamine oxidase B (MAO-B) inhibitor\nDISEASE   Parkinson's disease [DS:H00057]",
    "target": "MAOB [HSA:4129] [KO:K00274]\nPATHWAY   hsa04726(4129)  Serotonergic synapse\nhsa04728(4129)  Dopaminergic synapse",
    "metabolism": "Enzyme: CYP1A2 [HSA:1544]",
    "therapeutic_category": "1169",
    "atc_code": "N04BD02",
    "drug_class": [
      "Neuropsychiatric agent",
      "MAO inhibitor",
      "Monoamine oxidase B inhibitor",
      "Antiparkinson agent",
      "Metabolizing enzyme substrate",
      "CYP1A2 substrate"
    ],
    "cyp_enzymes": [
      "CYP1A2"
    ],
    "search_name": "Rasagiline mesylate"
  },
  {
    "kegg_id": "D10191",
    "name_en": "Safinamide mesylate (USAN)",
    "name_ja": "",
    "names_alt": [
      "Safinamide mesilate (JAN)",
      "Safinamide methanesulfonate",
      "Xadago (TN)",
      "Equfina (TN)"
    ],
    "formula": "C17H19FN2O2. CH4SO3",
    "efficacy": "Antiparkinsonian, Monoamine oxidase B (MAO-B) inhibitor\nDISEASE   Parkinson's disease [DS:H00057]",
    "target": "MAOB [HSA:4129] [KO:K00274]\nPATHWAY   hsa04726(4129)  Serotonergic synapse\nhsa04728(4129)  Dopaminergic synapse",
    "metabolism": "Enzyme: MAOA [HSA:4128]; CYP3A4 [HSA:1576]",
    "therapeutic_category": "1169",
    "atc_code": "N04BD03",
    "drug_class": [
      "Neuropsychiatric agent",
      "MAO inhibitor",
      "Monoamine oxidase B inhibitor",
      "Antiparkinson agent",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "MAO substrate",
      "MAOA substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Safinamide mesylate"
  },
  {
    "kegg_id": "D00781",
    "name_en": "Entacapone (JP18/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Comtan (TN)"
    ],
    "formula": "C14H15N3O5",
    "efficacy": "Antiparkinsonian, Antidyskinetic, COMT inhibitor\nDISEASE   Parkinson disease [DS:H00057]",
    "target": "COMT [HSA:1312] [KO:K00545]\nPATHWAY   hsa04728(1312)  Dopaminergic synapse",
    "metabolism": "",
    "therapeutic_category": "1169",
    "atc_code": "N04BX02",
    "drug_class": [
      "Neuropsychiatric agent",
      "Catechol O-methyltransferase inhibitor",
      "Antiparkinson agent",
      "COMT inhibitor",
      "Metabolizing enzyme inhibitor",
      "CYP2C9 inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Entacapone"
  },
  {
    "kegg_id": "D10825",
    "name_en": "Opicapone (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Ongentys (TN)"
    ],
    "formula": "C15H10Cl2N4O6",
    "efficacy": "Antiparkinsonian, COMT inhibitor\nDISEASE   Parkinson's disease [DS:H00057]",
    "target": "COMT [HSA:1312] [KO:K00545]\nPATHWAY   hsa04728(1312)  Dopaminergic synapse",
    "metabolism": "",
    "therapeutic_category": "1169",
    "atc_code": "N04BX04",
    "drug_class": [
      "Neuropsychiatric agent",
      "Antiparkinson agent",
      "COMT inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Opicapone"
  },
  {
    "kegg_id": "D04641",
    "name_en": "Istradefylline (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Nourianz (TN)",
      "Nouriast (TN)"
    ],
    "formula": "C20H24N4O4",
    "efficacy": "Antiparkinsonian, Adenosine A2A receptor antagonist\nDISEASE   Parkinson's disease [DS:H00057]",
    "target": "ADORA2A [HSA:135] [KO:K04266]\nPATHWAY   hsa04080(135)  Neuroactive ligand-receptor interaction\nhsa05012(135)  Parkinson disease",
    "metabolism": "Enzyme: CYP1A1 [HSA:1543], CYP3A4 [HSA:1576], CYP3A5 [HSA:1577]",
    "therapeutic_category": "1169",
    "atc_code": "N04CX01",
    "drug_class": [
      "Neuropsychiatric agent",
      "Antiparkinson agent",
      "Xantine-type antiparkinsonian agent",
      "Metabolizing enzyme substrate",
      "CYP1A1 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "CYP3A5 substrate",
      "Metabolizing enzyme inhibitor",
      "CYP3A/CYP3A4 inhibitor",
      "CYP3A4 inhibitor",
      "CYP3A5 inhibitor",
      "Transporter inhibitor",
      "ABCB1 inhibitor"
    ],
    "cyp_enzymes": [
      "CYP1A1",
      "CYP3A4",
      "CYP3A5"
    ],
    "search_name": "Istradefylline"
  },
  {
    "kegg_id": "D01231",
    "name_en": "Piroheptine hydrochloride (JAN)",
    "name_ja": "",
    "names_alt": [
      "Trimol (TN)"
    ],
    "formula": "C22H25N. HCl",
    "efficacy": "Antiparkinsonian, Muscarinic acetylcholine receptor antagonist",
    "target": "CHRM [HSA:1128 1129 1131 1132 1133] [KO:K04129 K04130 K04131 K04132 K04133]\nPATHWAY   hsa04080(1128+1129+1131+1132+1133)  Neuroactive ligand-receptor interaction\nhsa04725(1128+1129+1131+1132+1133)  Cholinergic synapse",
    "metabolism": "",
    "therapeutic_category": "1169",
    "atc_code": "",
    "drug_class": [
      "Neuropsychiatric agent",
      "Muscarinic cholinergic receptor antagonist",
      "Anticholinergic antiparkinson agent",
      "Antiparkinson agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Piroheptine hydrochloride"
  },
  {
    "kegg_id": "D00789",
    "name_en": "Chlorpromazine hydrochloride (JP18/USP)",
    "name_ja": "クロルプロマジン",
    "names_alt": [
      "Sonazine (TN)"
    ],
    "formula": "C17H19ClN2S. HCl",
    "efficacy": "Anti-emetic, Antipsychotic\nDISEASE   Schizophrenia [DS:H01649]\nAcute intermittent porphyria [DS:H00202 H01763]\nTetanus [DS:H00337]\nManic-depressive illness [DS:H01653]",
    "target": "HTR2 [HSA:3356 3357 3358] [KO:K04157]\nHRH1 [HSA:3269] [KO:K04149]\nADRA2 [HSA:150 151 152] [KO:K04138 K04139 K04140]\nDRD2 [HSA:1813] [KO:K04145]\nCHRM [HSA:1128 1129 1131 1132 1133] [KO:K04129 K04130 K04131 K04132 K04133]\nPATHWAY   hsa04080(1128+1129+1131+1132+1133+150+151+152+1813+3269+3356+3357+3358)  Neuroactive ligand-receptor interaction\nhsa04725(1128+1129+1131+1132+1133)  Cholinergic synapse\nhsa04726(3356+3357+3358)  Serotonergic synapse\nhsa04728(1813)  Dopaminergic synapse",
    "metabolism": "Enzyme: CYP2D6 [HSA:1565]",
    "therapeutic_category": "1171",
    "atc_code": "N05AA01",
    "drug_class": [
      "Cardiovascular agent",
      "Adrenergic receptor antagonist",
      "alpha-Adrenergic receptor antagonist",
      "alpha2-Adrenergic receptor antagonist",
      "Neuropsychiatric agent",
      "Dopamine antagonist",
      "Dopamine D2-receptor antagonist",
      "Muscarinic cholinergic receptor antagonist",
      "Antipsychotic agent",
      "Phenothiazine antipsychotics",
      "Anti-allergic agent",
      "Histamine receptor antagonist",
      "Histamine receptor H1 antagonist",
      "Metabolizing enzyme substrate",
      "CYP2D6 substrate",
      "Metabolizing enzyme inhibitor",
      "CYP2D6 inhibitor"
    ],
    "cyp_enzymes": [
      "CYP2D6"
    ],
    "search_name": "Chlorpromazine hydrochloride"
  },
  {
    "kegg_id": "D04034",
    "name_en": "Chlorpromazine phenolphthalinate (JAN)",
    "name_ja": "クロルプロマジン",
    "names_alt": [
      "Wintermin (TN)"
    ],
    "formula": "C20H16O4. C17H19ClN2S",
    "efficacy": "Antipsychotic",
    "target": "HTR2 [HSA:3356 3357 3358] [KO:K04157]\nHRH1 [HSA:3269] [KO:K04149]\nADRA2 [HSA:150 151 152] [KO:K04138 K04139 K04140]\nDRD2 [HSA:1813] [KO:K04145]\nCHRM [HSA:1128 1129 1131 1132 1133] [KO:K04129 K04130 K04131 K04132 K04133]\nPATHWAY   hsa04080(1128+1129+1131+1132+1133+150+151+152+1813+3269+3356+3357+3358)  Neuroactive ligand-receptor interaction\nhsa04725(1128+1129+1131+1132+1133)  Cholinergic synapse\nhsa04726(3356+3357+3358)  Serotonergic synapse\nhsa04728(1813)  Dopaminergic synapse",
    "metabolism": "Enzyme: CYP2D6 [HSA:1565]",
    "therapeutic_category": "1171",
    "atc_code": "N05AA01",
    "drug_class": [
      "Cardiovascular agent",
      "Adrenergic receptor antagonist",
      "alpha-Adrenergic receptor antagonist",
      "alpha2-Adrenergic receptor antagonist",
      "Neuropsychiatric agent",
      "Dopamine antagonist",
      "Dopamine D2-receptor antagonist",
      "Muscarinic cholinergic receptor antagonist",
      "Antipsychotic agent",
      "Phenothiazine antipsychotics",
      "Anti-allergic agent",
      "Histamine receptor antagonist",
      "Histamine receptor H1 antagonist",
      "Metabolizing enzyme substrate",
      "CYP2D6 substrate",
      "Metabolizing enzyme inhibitor",
      "CYP2D6 inhibitor"
    ],
    "cyp_enzymes": [
      "CYP2D6"
    ],
    "search_name": "Chlorpromazine phenolphthalinate"
  },
  {
    "kegg_id": "D01520",
    "name_en": "Levomepromazine hydrochloride (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Nozinan (TN)"
    ],
    "formula": "C19H24N2OS. HCl",
    "efficacy": "Analgesic, Antipsychotic",
    "target": "DRD2 [HSA:1813] [KO:K04145]\nPATHWAY   hsa04080(1813)  Neuroactive ligand-receptor interaction\nhsa04728(1813)  Dopaminergic synapse",
    "metabolism": "",
    "therapeutic_category": "1172",
    "atc_code": "N05AA02",
    "drug_class": [
      "Neuropsychiatric agent",
      "Dopamine antagonist",
      "Dopamine D2-receptor antagonist",
      "Antipsychotic agent",
      "Phenothiazine antipsychotics"
    ],
    "cyp_enzymes": [],
    "search_name": "Levomepromazine hydrochloride"
  },
  {
    "kegg_id": "D02248",
    "name_en": "Levomepromazine maleate (JP18/USAN)",
    "name_ja": "",
    "names_alt": [
      "Hirnamin (TN)"
    ],
    "formula": "C19H24N2OS. C4H4O4",
    "efficacy": "Analgesic, Antipsychotic",
    "target": "DRD2 [HSA:1813] [KO:K04145]\nPATHWAY   hsa04080(1813)  Neuroactive ligand-receptor interaction\nhsa04728(1813)  Dopaminergic synapse",
    "metabolism": "",
    "therapeutic_category": "1172",
    "atc_code": "N05AA02",
    "drug_class": [
      "Neuropsychiatric agent",
      "Dopamine antagonist",
      "Dopamine D2-receptor antagonist",
      "Antipsychotic agent",
      "Phenothiazine antipsychotics"
    ],
    "cyp_enzymes": [],
    "search_name": "Levomepromazine maleate"
  },
  {
    "kegg_id": "D00793",
    "name_en": "Fluphenazine decanoate (JAN/USP)",
    "name_ja": "",
    "names_alt": [
      "Prolixin decanoate (TN)"
    ],
    "formula": "C32H44F3N3O2S",
    "efficacy": "Antipsychotic, Dopamine D2 receptor antagonist\nDISEASE   Schizophrenics [DS:H01649]",
    "target": "DRD2 [HSA:1813] [KO:K04145]\nPATHWAY   hsa04080(1813)  Neuroactive ligand-receptor interaction\nhsa04728(1813)  Dopaminergic synapse",
    "metabolism": "Enzyme: CYP2D6 [HSA:1565]",
    "therapeutic_category": "1172",
    "atc_code": "N05AB02",
    "drug_class": [
      "Neuropsychiatric agent",
      "Dopamine antagonist",
      "Dopamine D2-receptor antagonist",
      "Antipsychotic agent",
      "Phenothiazine antipsychotics",
      "Metabolizing enzyme substrate",
      "CYP2D6 substrate"
    ],
    "cyp_enzymes": [
      "CYP2D6"
    ],
    "search_name": "Fluphenazine decanoate"
  },
  {
    "kegg_id": "D02163",
    "name_en": "Fluphenazine maleate (JAN)",
    "name_ja": "",
    "names_alt": [
      "Flumezin (TN)"
    ],
    "formula": "C22H26F3N3OS. C4H4O4",
    "efficacy": "Antipsychotic, Dopamine D2 receptor antagonist",
    "target": "DRD2 [HSA:1813] [KO:K04145]\nPATHWAY   hsa04080(1813)  Neuroactive ligand-receptor interaction\nhsa04728(1813)  Dopaminergic synapse",
    "metabolism": "Enzyme: CYP2D6 [HSA:1565]",
    "therapeutic_category": "1172",
    "atc_code": "N05AB02",
    "drug_class": [
      "Neuropsychiatric agent",
      "Dopamine antagonist",
      "Dopamine D2-receptor antagonist",
      "Antipsychotic agent",
      "Phenothiazine antipsychotics",
      "Metabolizing enzyme substrate",
      "CYP2D6 substrate"
    ],
    "cyp_enzymes": [
      "CYP2D6"
    ],
    "search_name": "Fluphenazine maleate"
  },
  {
    "kegg_id": "D00503",
    "name_en": "Perphenazine (JP18/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Trilafon (TN)"
    ],
    "formula": "C21H26ClN3OS",
    "efficacy": "Antipsychotic, Dopamine D2 receptor antagonist\nDISEASE   Schizophrenia [DS:H01649]",
    "target": "DRD2 [HSA:1813] [KO:K04145]\nPATHWAY   hsa04080(1813)  Neuroactive ligand-receptor interaction\nhsa04728(1813)  Dopaminergic synapse",
    "metabolism": "Enzyme: CYP2D6 [HSA:1565]",
    "therapeutic_category": "1172",
    "atc_code": "N05AB03",
    "drug_class": [
      "Neuropsychiatric agent",
      "Dopamine antagonist",
      "Dopamine D2-receptor antagonist",
      "Antipsychotic agent",
      "Phenothiazine antipsychotics",
      "Metabolizing enzyme substrate",
      "CYP2D6 substrate"
    ],
    "cyp_enzymes": [
      "CYP2D6"
    ],
    "search_name": "Perphenazine"
  },
  {
    "kegg_id": "D02037",
    "name_en": "Perphenazine maleate (JP18)",
    "name_ja": "",
    "names_alt": [
      "PZC (TN)"
    ],
    "formula": "C21H26ClN3OS. (C4H4O4)2",
    "efficacy": "Antipsychotic, Dopamine D2 receptor antagonist",
    "target": "DRD2 [HSA:1813] [KO:K04145]\nPATHWAY   hsa04080(1813)  Neuroactive ligand-receptor interaction\nhsa04728(1813)  Dopaminergic synapse",
    "metabolism": "Enzyme: CYP2D6 [HSA:1565]",
    "therapeutic_category": "1172",
    "atc_code": "N05AB03",
    "drug_class": [
      "Neuropsychiatric agent",
      "Dopamine antagonist",
      "Dopamine D2-receptor antagonist",
      "Antipsychotic agent",
      "Phenothiazine antipsychotics",
      "Metabolizing enzyme substrate",
      "CYP2D6 substrate"
    ],
    "cyp_enzymes": [
      "CYP2D6"
    ],
    "search_name": "Perphenazine maleate"
  },
  {
    "kegg_id": "D04038",
    "name_en": "Perphenazine fendizoate (JAN)",
    "name_ja": "",
    "names_alt": [
      "PZC (TN)"
    ],
    "formula": "(C20H14O4)2. C21H26ClN3OS",
    "efficacy": "Antipsychotic, Dopamine D2 receptor antagonist",
    "target": "DRD2 [HSA:1813] [KO:K04145]\nPATHWAY   hsa04080(1813)  Neuroactive ligand-receptor interaction\nhsa04728(1813)  Dopaminergic synapse",
    "metabolism": "Enzyme: CYP2D6 [HSA:1565]",
    "therapeutic_category": "1172",
    "atc_code": "N05AB03",
    "drug_class": [
      "Neuropsychiatric agent",
      "Dopamine antagonist",
      "Dopamine D2-receptor antagonist",
      "Antipsychotic agent",
      "Phenothiazine antipsychotics",
      "Metabolizing enzyme substrate",
      "CYP2D6 substrate"
    ],
    "cyp_enzymes": [
      "CYP2D6"
    ],
    "search_name": "Perphenazine fendizoate"
  },
  {
    "kegg_id": "D04965",
    "name_en": "Perphenazine hydrochloride",
    "name_ja": "",
    "names_alt": [
      "Perphenazine dihydrochloride",
      "PZC (TN)"
    ],
    "formula": "C21H26ClN3OS. 2HCl",
    "efficacy": "Antipsychotic, Dopamine D2 receptor antagonist",
    "target": "DRD2 [HSA:1813] [KO:K04145]\nPATHWAY   hsa04080(1813)  Neuroactive ligand-receptor interaction\nhsa04728(1813)  Dopaminergic synapse",
    "metabolism": "Enzyme: CYP2D6 [HSA:1565]",
    "therapeutic_category": "1172",
    "atc_code": "N05AB03",
    "drug_class": [
      "Neuropsychiatric agent",
      "Dopamine antagonist",
      "Dopamine D2-receptor antagonist",
      "Antipsychotic agent",
      "Phenothiazine antipsychotics",
      "Metabolizing enzyme substrate",
      "CYP2D6 substrate"
    ],
    "cyp_enzymes": [
      "CYP2D6"
    ],
    "search_name": "Perphenazine hydrochloride"
  },
  {
    "kegg_id": "D00479",
    "name_en": "Prochlorperazine maleate (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Compazine (TN)"
    ],
    "formula": "C20H24ClN3S. (C4H4O4)2",
    "efficacy": "Antipsychotic, Anti-emetic, Dopamine D2 receptor antagonist\nDISEASE   Schizophrenia [DS:H01649]",
    "target": "DRD2 [HSA:1813] [KO:K04145]\nPATHWAY   hsa04080(1813)  Neuroactive ligand-receptor interaction\nhsa04728(1813)  Dopaminergic synapse",
    "metabolism": "",
    "therapeutic_category": "1172",
    "atc_code": "N05AB04",
    "drug_class": [
      "Neuropsychiatric agent",
      "Dopamine antagonist",
      "Dopamine D2-receptor antagonist",
      "Antipsychotic agent",
      "Phenothiazine antipsychotics"
    ],
    "cyp_enzymes": [],
    "search_name": "Prochlorperazine maleate"
  },
  {
    "kegg_id": "D02022",
    "name_en": "Prochlorperazine mesilate (JAN)",
    "name_ja": "",
    "names_alt": [
      "Prochlorperazine dimethanesulfonate",
      "Novamin (TN)"
    ],
    "formula": "C20H24ClN3S. (CH4SO3)2",
    "efficacy": "Antipsychotic, Dopamine D2 receptor antagonist",
    "target": "DRD2 [HSA:1813] [KO:K04145]\nPATHWAY   hsa04080(1813)  Neuroactive ligand-receptor interaction\nhsa04728(1813)  Dopaminergic synapse",
    "metabolism": "",
    "therapeutic_category": "1172",
    "atc_code": "N05AB04",
    "drug_class": [
      "Neuropsychiatric agent",
      "Dopamine antagonist",
      "Dopamine D2-receptor antagonist",
      "Antipsychotic agent",
      "Phenothiazine antipsychotics"
    ],
    "cyp_enzymes": [],
    "search_name": "Prochlorperazine mesilate"
  },
  {
    "kegg_id": "D01485",
    "name_en": "Propericiazine (JAN)",
    "name_ja": "",
    "names_alt": [
      "Periciazine",
      "Neuleptil (TN)"
    ],
    "formula": "C21H23N3OS",
    "efficacy": "Antipsychotic, Dopamine D2 receptor antagonist",
    "target": "DRD2 [HSA:1813] [KO:K04145]\nADRA1 [HSA:148 147 146] [KO:K04135 K04136 K04137]\nHTR2 [HSA:3356 3357 3358] [KO:K04157]\nPATHWAY   hsa04080(146+147+148+1813+3356+3357+3358)  Neuroactive ligand-receptor interaction\nhsa04726(3356+3357+3358)  Serotonergic synapse\nhsa04728(1813)  Dopaminergic synapse",
    "metabolism": "",
    "therapeutic_category": "1172",
    "atc_code": "N05AC01",
    "drug_class": [
      "Neuropsychiatric agent",
      "Dopamine antagonist",
      "Dopamine D2-receptor antagonist",
      "Antipsychotic agent",
      "Phenothiazine antipsychotics"
    ],
    "cyp_enzymes": [],
    "search_name": "Propericiazine"
  },
  {
    "kegg_id": "D00815",
    "name_en": "Imipramine hydrochloride (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Tofranil (TN)"
    ],
    "formula": "C19H24N2. HCl",
    "efficacy": "Antidepressant, Serotonin-noradrenaline reuptake inhibitor (SNRI)\nDISEASE   Depression [DS:H01646]",
    "target": "SLC6A4 (HTT) [HSA:6532] [KO:K05037]\nSLC6A2 (NAT1) [HSA:6530] [KO:K05035]\nPATHWAY   hsa04721(6530+6532)  Synaptic vesicle cycle\nhsa04726(6532)  Serotonergic synapse",
    "metabolism": "Enzyme: CYP2D6 [HSA:1565]; CYP1A2 [HSA:1544], CYP3A4 [HSA:1576], CYP2C19 [HSA:1557]",
    "therapeutic_category": "1174",
    "atc_code": "N06AA02",
    "drug_class": [
      "Neuropsychiatric agent",
      "Non-selective monoamine reuptake inhibitor",
      "Tricyclic antidepressant",
      "Metabolizing enzyme substrate",
      "CYP1A2 substrate",
      "CYP2C19 substrate",
      "CYP2D6 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C19",
      "CYP3A4",
      "CYP1A2",
      "CYP2D6"
    ],
    "search_name": "Imipramine hydrochloride"
  },
  {
    "kegg_id": "D00811",
    "name_en": "Clomipramine hydrochloride (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Anafranil (TN)"
    ],
    "formula": "C19H23ClN2. HCl",
    "efficacy": "Antidepressant, Serotonin-noradrenaline reuptake inhibitor (SNRI)\nDISEASE   Obsessive-compulsive disorder [DS:H01450]",
    "target": "SLC6A4 (HTT) [HSA:6532] [KO:K05037]\nSLC6A2 (NAT1) [HSA:6530] [KO:K05035]\nPATHWAY   hsa04721(6530+6532)  Synaptic vesicle cycle\nhsa04726(6532)  Serotonergic synapse",
    "metabolism": "Enzyme: CYP2D6 [HSA:1565]; CYP1A2 [HSA:1544], CYP3A4 [HSA:1576], CYP2C19 [HSA:1557]",
    "therapeutic_category": "1174",
    "atc_code": "N06AA04",
    "drug_class": [
      "Neuropsychiatric agent",
      "Non-selective monoamine reuptake inhibitor",
      "Tricyclic antidepressant",
      "Metabolizing enzyme substrate",
      "CYP1A2 substrate",
      "CYP2C19 substrate",
      "CYP2D6 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C19",
      "CYP3A4",
      "CYP1A2",
      "CYP2D6"
    ],
    "search_name": "Clomipramine hydrochloride"
  },
  {
    "kegg_id": "D02408",
    "name_en": "Trimipramine maleate (JAN/USP)",
    "name_ja": "",
    "names_alt": [
      "Surmontil (TN)"
    ],
    "formula": "C20H26N2. C4H4O4",
    "efficacy": "Antidepressant, Serotonin-noradrenaline reuptake inhibitor (SNRI)\nDISEASE   Depression [DS:H01646]",
    "target": "SLC6A2 (NAT1) [HSA:6530] [KO:K05035]\nSLC6A4 (HTT) [HSA:6532] [KO:K05037]\nPATHWAY   hsa04721(6530+6532)  Synaptic vesicle cycle\nhsa04726(6532)  Serotonergic synapse",
    "metabolism": "",
    "therapeutic_category": "1174",
    "atc_code": "N06AA06",
    "drug_class": [
      "Neuropsychiatric agent",
      "Non-selective monoamine reuptake inhibitor",
      "Tricyclic antidepressant"
    ],
    "cyp_enzymes": [],
    "search_name": "Trimipramine maleate"
  },
  {
    "kegg_id": "D00606",
    "name_en": "Guanfacine hydrochloride (JAN/USP)",
    "name_ja": "",
    "names_alt": [
      "Intuniv (TN)",
      "Tenex (TN)"
    ],
    "formula": "C9H9Cl2N3O. HCl",
    "efficacy": "Antihypertensive, alpha2-Adrenergic receptor agonist\nDISEASE   Attention deficit hyperactivity disorder [DS:H01895]\nHypertension [DS:H01633]",
    "target": "ADRA2A [HSA:150] [KO:K04138]\nPATHWAY   hsa04022(150)  cGMP-PKG signaling pathway\nhsa04080(150)  Neuroactive ligand-receptor interaction",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576], CYP3A5 [HSA:1577]",
    "therapeutic_category": "1179",
    "atc_code": "C02AC02",
    "drug_class": [
      "Cardiovascular agent",
      "Centrally-acting antiadrenergic",
      "Adrenergic receptor agonist",
      "alpha-Adrenergic receptor agonist",
      "alpha2-Adrenergic receptor agonist",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "CYP3A5 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4",
      "CYP3A5"
    ],
    "search_name": "Guanfacine hydrochloride"
  },
  {
    "kegg_id": "D00136",
    "name_en": "Haloperidol (JP18/USP/INN)",
    "name_ja": "ハロペリドール",
    "names_alt": [
      "Haldol (TN)"
    ],
    "formula": "C21H23ClFNO2",
    "efficacy": "Antipsychotic, Antidyskinetic, Neuroleptic, Dopamine D2 receptor antagonist\nDISEASE   Tourette’s disorder [DS:H00862]",
    "target": "DRD2 [HSA:1813] [KO:K04145]\nPATHWAY   hsa04080(1813)  Neuroactive ligand-receptor interaction\nhsa04728(1813)  Dopaminergic synapse",
    "metabolism": "Enzyme: CYP2D6 [HSA:1565], CYP3A4 [HSA:1576]",
    "therapeutic_category": "1179",
    "atc_code": "N05AD01",
    "drug_class": [
      "Neuropsychiatric agent",
      "Dopamine antagonist",
      "Dopamine D2-receptor antagonist",
      "Antipsychotic agent",
      "Butyrophenone derivative",
      "Metabolizing enzyme substrate",
      "CYP2D6 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4",
      "CYP2D6"
    ],
    "search_name": "Haloperidol"
  },
  {
    "kegg_id": "D01898",
    "name_en": "Haloperidol decanoate (JAN/USP)",
    "name_ja": "ハロペリドール",
    "names_alt": [
      "Halomonth (TN)"
    ],
    "formula": "C31H41ClFNO3",
    "efficacy": "Antipsychotic, Neuroleptic, Dopamine D2 receptor antagonist\nDISEASE   Schizophrenia [DS:H01649]",
    "target": "DRD2 [HSA:1813] [KO:K04145]\nPATHWAY   hsa04080(1813)  Neuroactive ligand-receptor interaction\nhsa04728(1813)  Dopaminergic synapse",
    "metabolism": "Enzyme: CYP2D6 [HSA:1565], CYP3A4 [HSA:1576]",
    "therapeutic_category": "1179",
    "atc_code": "N05AD01",
    "drug_class": [
      "Neuropsychiatric agent",
      "Dopamine antagonist",
      "Dopamine D2-receptor antagonist",
      "Antipsychotic agent",
      "Butyrophenone derivative",
      "Metabolizing enzyme substrate",
      "CYP2D6 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4",
      "CYP2D6"
    ],
    "search_name": "Haloperidol decanoate"
  },
  {
    "kegg_id": "D01482",
    "name_en": "Pipamperone hydrochloride (JAN)",
    "name_ja": "",
    "names_alt": [],
    "formula": "C21H30FN3O2. 2HCl",
    "efficacy": "Antipsychotic, Dopamine D2 receptor antagonist",
    "target": "DRD2 [HSA:1813] [KO:K04145]\nPATHWAY   hsa04080(1813)  Neuroactive ligand-receptor interaction\nhsa04728(1813)  Dopaminergic synapse",
    "metabolism": "",
    "therapeutic_category": "1179",
    "atc_code": "N05AD05",
    "drug_class": [
      "Neuropsychiatric agent",
      "Dopamine antagonist",
      "Dopamine D2-receptor antagonist",
      "Antipsychotic agent",
      "Butyrophenone derivative"
    ],
    "cyp_enzymes": [],
    "search_name": "Pipamperone hydrochloride"
  },
  {
    "kegg_id": "D01101",
    "name_en": "Bromperidol (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Impromen (TN)"
    ],
    "formula": "C21H23BrFNO2",
    "efficacy": "Antipsychotic, Dopamine D2 receptor antagonist",
    "target": "DRD2 [HSA:1813] [KO:K04145]\nPATHWAY   hsa04080(1813)  Neuroactive ligand-receptor interaction\nhsa04728(1813)  Dopaminergic synapse",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "1179",
    "atc_code": "N05AD06",
    "drug_class": [
      "Neuropsychiatric agent",
      "Dopamine antagonist",
      "Dopamine D2-receptor antagonist",
      "Antipsychotic agent",
      "Butyrophenone derivative",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Bromperidol"
  },
  {
    "kegg_id": "D04820",
    "name_en": "Lurasidone hydrochloride (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "SM 13496",
      "Latuda (TN)"
    ],
    "formula": "C28H36N4O2S. HCl",
    "efficacy": "Antipsychotic, Serotonin receptor antagonist, Dopamine D2 receptor antagonist\nDISEASE   Schizophrenia [DS:H01649]\nBipolar I disorder [DS:H01653]",
    "target": "DRD2 [HSA:1813] [KO:K04145]\nHTR2A [HSA:3356] [KO:K04157]\nPATHWAY   hsa04080(1813+3356)  Neuroactive ligand-receptor interaction\nhsa04726(3356)  Serotonergic synapse\nhsa04728(1813)  Dopaminergic synapse",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "1179",
    "atc_code": "N05AE05",
    "drug_class": [
      "Neuropsychiatric agent",
      "5-HT1A-receptor agonist",
      "Dopamine agonist",
      "Dopamine D2-receptor agonist",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Lurasidone hydrochloride"
  },
  {
    "kegg_id": "D00283",
    "name_en": "Clozapine (JAN/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Clozaril (TN)"
    ],
    "formula": "C18H19ClN4",
    "efficacy": "Antipsychotic\nDISEASE   Treatment-resistant schizophrenia [DS:H01649]",
    "target": "HTR2A [HSA:3356] [KO:K04157]\nHTR2C [HSA:3358] [KO:K04157]\nHTR3 [HSA:3359 9177 170572 200909 285242] [KO:K04819]\nADRA2 [HSA:150 151 152] [KO:K04138 K04139 K04140]\nDRD4 [HSA:1815] [KO:K04147]\nPATHWAY   hsa04080(150+151+152+1815+3356+3358)  Neuroactive ligand-receptor interaction\nhsa04726(170572+200909+285242+3356+3358+3359+9177)  Serotonergic synapse\nhsa04728(1815)  Dopaminergic synapse",
    "metabolism": "Enzyme: CYP1A2 [HSA:1544], CYP3A4 [HSA:1576]",
    "therapeutic_category": "1179",
    "atc_code": "N05AH02",
    "drug_class": [
      "Neuropsychiatric agent",
      "Dopamine antagonist",
      "Dopamine D4-receptor antagonist",
      "Antipsychotic agent",
      "Atypical antipsychotic",
      "Metabolizing enzyme substrate",
      "CYP1A2 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4",
      "CYP1A2"
    ],
    "search_name": "Clozapine"
  },
  {
    "kegg_id": "D00454",
    "name_en": "Olanzapine (JAN/USP/INN)",
    "name_ja": "オランザピン",
    "names_alt": [
      "Zyprexa (TN)"
    ],
    "formula": "C17H20N4S",
    "efficacy": "Antipsychotic\nDISEASE   Schizophrenia [DS:H01649]\nBipolar I disorder, manic or mixed episodes [DS:H01653]",
    "target": "HTR2 [HSA:3356 3357 3358] [KO:K04157]\nHTR6 [HSA:3362] [KO:K04162]\nHRH1 [HSA:3269] [KO:K04149]\nADRA1 [HSA:148 147 146] [KO:K04135 K04136 K04137]\nDRD2 [HSA:1813] [KO:K04145]\nDRD3 [HSA:1814] [KO:K04146]\nDRD4 [HSA:1815] [KO:K04147]\nPATHWAY   hsa04080(146+147+148+1813+1814+1815+3269+3356+3357+3358+3362)  Neuroactive ligand-receptor interaction\nhsa04726(3356+3357+3358+3362)  Serotonergic synapse\nhsa04728(1813+1814+1815)  Dopaminergic synapse",
    "metabolism": "Enzyme: CYP1A2 [HSA:1544]; CYP2D6 [HSA:1565]",
    "therapeutic_category": "1179",
    "atc_code": "N05AH03",
    "drug_class": [
      "Cardiovascular agent",
      "Adrenergic receptor antagonist",
      "alpha-Adrenergic receptor antagonist",
      "alpha1-Adrenergic receptor antagonist",
      "Neuropsychiatric agent",
      "Dopamine antagonist",
      "Antipsychotic agent",
      "Atypical antipsychotic",
      "Anti-allergic agent",
      "Histamine receptor antagonist",
      "Histamine receptor H1 antagonist",
      "Metabolizing enzyme substrate",
      "CYP1A2 substrate",
      "CYP2D6 substrate"
    ],
    "cyp_enzymes": [
      "CYP1A2",
      "CYP2D6"
    ],
    "search_name": "Olanzapine"
  },
  {
    "kegg_id": "D00458",
    "name_en": "Quetiapine fumarate (JP18/USP)",
    "name_ja": "クエチアピン",
    "names_alt": [
      "Seroquel (TN)"
    ],
    "formula": "(C21H25N3O2S)2. C4H4O4",
    "efficacy": "Antipsychotic\nDISEASE   Schizophrenia [DS:H01649]\nBipolar disorder [DS:H01653]",
    "target": "HTR2A [HSA:3356] [KO:K04157]\nDRD2 [HSA:1813] [KO:K04145]\nPATHWAY   hsa04080(1813+3356)  Neuroactive ligand-receptor interaction\nhsa04726(3356)  Serotonergic synapse\nhsa04728(1813)  Dopaminergic synapse",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "1179",
    "atc_code": "N05AH04",
    "drug_class": [
      "Neuropsychiatric agent",
      "Dopamine antagonist",
      "Dopamine D2-receptor antagonist",
      "Antipsychotic agent",
      "Atypical antipsychotic",
      "Anti-allergic agent",
      "Histamine receptor antagonist",
      "Histamine receptor H1 antagonist",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Quetiapine fumarate"
  },
  {
    "kegg_id": "D02995",
    "name_en": "Asenapine maleate (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Saphris (TN)"
    ],
    "formula": "C17H16ClNO. C4H4O4",
    "efficacy": "Antipsychotic\nDISEASE   Schizophrenia [DS:H01649]\nBipolar I disorder [DS:H01653]",
    "target": "HTR1A [HSA:3350] [KO:K04153]\nHTR2A [HSA:3356] [KO:K04157]\nHTR2C [HSA:3358] [KO:K04157]\nHTR6 [HSA:3362] [KO:K04162]\nHTR7 [HSA:3363] [KO:K04163]\nDRD2 [HSA:1813] [KO:K04145]\nPATHWAY   hsa04080(1813+3350+3356+3358+3362+3363)  Neuroactive ligand-receptor interaction\nhsa04726(3350+3356+3358+3362+3363)  Serotonergic synapse\nhsa04728(1813)  Dopaminergic synapse",
    "metabolism": "Enzyme: CYP1A2 [HSA:1544]",
    "therapeutic_category": "1179",
    "atc_code": "N05AH05",
    "drug_class": [
      "Neuropsychiatric agent",
      "Dopamine antagonist",
      "Dopamine D2-receptor antagonist",
      "Metabolizing enzyme substrate",
      "CYP1A2 substrate",
      "Metabolizing enzyme inhibitor",
      "CYP2D6 inhibitor"
    ],
    "cyp_enzymes": [
      "CYP1A2"
    ],
    "search_name": "Asenapine maleate"
  },
  {
    "kegg_id": "D01226",
    "name_en": "Sulpiride (JP18/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Dogmatyl (TN)"
    ],
    "formula": "C15H23N3O4S",
    "efficacy": "Antidepressant, Antipsychotic, Anti-ulcerative, Dopamine receptor antagonist",
    "target": "DRD2 [HSA:1813] [KO:K04145]\nPATHWAY   hsa04080(1813)  Neuroactive ligand-receptor interaction\nhsa04728(1813)  Dopaminergic synapse",
    "metabolism": "",
    "therapeutic_category": "1179",
    "atc_code": "N05AL01",
    "drug_class": [
      "Neuropsychiatric agent",
      "Dopamine antagonist",
      "Dopamine D2-receptor antagonist",
      "Antipsychotic agent",
      "Benzamide antipsychotic"
    ],
    "cyp_enzymes": [],
    "search_name": "Sulpiride"
  },
  {
    "kegg_id": "D02208",
    "name_en": "Sultopride hydrochloride (JAN)",
    "name_ja": "",
    "names_alt": [
      "Sultopride monohydrochloride",
      "Barnetil (TN)"
    ],
    "formula": "C17H26N2O4S. HCl",
    "efficacy": "Antipsychotic, Neuroleptic, Dopamine D2 receptor antagonist",
    "target": "DRD2 [HSA:1813] [KO:K04145]\nPATHWAY   hsa04080(1813)  Neuroactive ligand-receptor interaction\nhsa04728(1813)  Dopaminergic synapse",
    "metabolism": "",
    "therapeutic_category": "1179",
    "atc_code": "N05AL02",
    "drug_class": [
      "Neuropsychiatric agent",
      "Dopamine antagonist",
      "Dopamine D2-receptor antagonist",
      "Antipsychotic agent",
      "Benzamide antipsychotic"
    ],
    "cyp_enzymes": [],
    "search_name": "Sultopride hydrochloride"
  },
  {
    "kegg_id": "D01522",
    "name_en": "Tiapride hydrochloride (JP18)",
    "name_ja": "",
    "names_alt": [
      "Gramalil (TN)"
    ],
    "formula": "C15H24N2O4S. HCl",
    "efficacy": "Antidyskinetic, Neuroleptic, Dopamine D2 receptor antagonist",
    "target": "DRD2 [HSA:1813] [KO:K04145]\nPATHWAY   hsa04080(1813)  Neuroactive ligand-receptor interaction\nhsa04728(1813)  Dopaminergic synapse",
    "metabolism": "",
    "therapeutic_category": "1179",
    "atc_code": "N05AL03",
    "drug_class": [
      "Neuropsychiatric agent",
      "Dopamine antagonist",
      "Dopamine D2-receptor antagonist",
      "Antipsychotic agent",
      "Benzamide antipsychotic"
    ],
    "cyp_enzymes": [],
    "search_name": "Tiapride hydrochloride"
  },
  {
    "kegg_id": "D00801",
    "name_en": "Lithium carbonate (JP18/USP)",
    "name_ja": "炭酸リチウム",
    "names_alt": [
      "Eskalith (TN)",
      "Lithobid (TN)"
    ],
    "formula": "CO3. 2Li",
    "efficacy": "Antimanic\nDISEASE   Bipolar disorder, manic episodes [DS:H01653]",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "1179",
    "atc_code": "N05AN01",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Lithium carbonate"
  },
  {
    "kegg_id": "D00426",
    "name_en": "Risperidone (JP18/USP/INN)",
    "name_ja": "リスペリドン",
    "names_alt": [
      "Risperdal (TN)"
    ],
    "formula": "C23H27FN4O2",
    "efficacy": "Antipsychotic, Neuroleptic\nDISEASE   Schizophrenia [DS:H01649]\nBipolar mania [DS:H01653]",
    "target": "DRD2 [HSA:1813] [KO:K04145]\nHTR2A [HSA:3356] [KO:K04157]\nPATHWAY   hsa04080(1813+3356)  Neuroactive ligand-receptor interaction\nhsa04726(3356)  Serotonergic synapse\nhsa04728(1813)  Dopaminergic synapse",
    "metabolism": "Enzyme: CYP2D6 [HSA:1565], CYP3A4 [HSA:1576]",
    "therapeutic_category": "1179",
    "atc_code": "N05AX08",
    "drug_class": [
      "Neuropsychiatric agent",
      "Dopamine antagonist",
      "Dopamine D2-receptor antagonist",
      "Serotonin-dopamine antagonist (SDA)",
      "Antipsychotic agent",
      "Atypical antipsychotic",
      "Metabolizing enzyme substrate",
      "CYP2D6 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4",
      "CYP2D6"
    ],
    "search_name": "Risperidone"
  },
  {
    "kegg_id": "D01548",
    "name_en": "Mosapramine hydrochloride (JAN)",
    "name_ja": "",
    "names_alt": [
      "Cremin (TN)"
    ],
    "formula": "C28H35ClN4O. 2HCl",
    "efficacy": "Antipsychotic",
    "target": "DRD2 [HSA:1813] [KO:K04145]\nHTR2A [HSA:3356] [KO:K04157]\nPATHWAY   hsa04080(1813+3356)  Neuroactive ligand-receptor interaction\nhsa04728(1813)  Dopaminergic synapse",
    "metabolism": "",
    "therapeutic_category": "1179",
    "atc_code": "N05AX10",
    "drug_class": [
      "Neuropsychiatric agent",
      "Dopamine antagonist",
      "Dopamine D2-receptor antagonist",
      "Antipsychotic agent",
      "Iminobenzyl antipsychotic"
    ],
    "cyp_enzymes": [],
    "search_name": "Mosapramine hydrochloride"
  },
  {
    "kegg_id": "D01321",
    "name_en": "Zotepine (JAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Setous (TN)"
    ],
    "formula": "C18H18ClNOS",
    "efficacy": "Antipsychotic, Dopamine D2 receptor antagonist, Serotonin receptor antagonist",
    "target": "DRD2 [HSA:1813] [KO:K04145]\nHTR1 [HSA:3350 3351 3352 3354 3355] [KO:K04153]\nPATHWAY   hsa04080(1813+3350+3351+3352+3354+3355)  Neuroactive ligand-receptor interaction\nhsa04726(3350+3351+3352+3354+3355)  Serotonergic synapse\nhsa04728(1813)  Dopaminergic synapse",
    "metabolism": "",
    "therapeutic_category": "1179",
    "atc_code": "N05AX11",
    "drug_class": [
      "Neuropsychiatric agent",
      "Dopamine antagonist",
      "Dopamine D2-receptor antagonist",
      "Serotonin-dopamine antagonist (SDA)"
    ],
    "cyp_enzymes": [],
    "search_name": "Zotepine"
  },
  {
    "kegg_id": "D01164",
    "name_en": "Aripiprazole (JP18/USP/INN)",
    "name_ja": "アリピプラゾール",
    "names_alt": [
      "Abilify (TN)"
    ],
    "formula": "C23H27Cl2N3O2",
    "efficacy": "Antipsychotic, Dopamine receptor partial agonist, Serotonin receptor agonist/antagonist\nDISEASE   Schizophrenia [DS:H01649]\nBipolar I disorder [DS:H01653]\nMajor depressive disorder [DS:H01646]",
    "target": "DRD2 [HSA:1813] [KO:K04145]\nDRD3 [HSA:1814] [KO:K04146]\nHTR1A [HSA:3350] [KO:K04153]\nHTR2A [HSA:3356] [KO:K04157]\nPATHWAY   hsa04080(1813+1814+3350+3356)  Neuroactive ligand-receptor interaction\nhsa04726(3350+3356)  Serotonergic synapse\nhsa04728(1813+1814)  Dopaminergic synapse",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576], CYP2D6 [HSA:1565]",
    "therapeutic_category": "1179",
    "atc_code": "N05AX12",
    "drug_class": [
      "Neuropsychiatric agent",
      "Antipsychotic agent",
      "Atypical antipsychotic",
      "Metabolizing enzyme substrate",
      "CYP2D6 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4",
      "CYP2D6"
    ],
    "search_name": "Aripiprazole"
  },
  {
    "kegg_id": "D10516",
    "name_en": "Aripiprazole hydrate (JAN)",
    "name_ja": "アリピプラゾール",
    "names_alt": [
      "Aripiprazole monohydrate",
      "Abilify maintena (TN)"
    ],
    "formula": "C23H27Cl2N3O2. H2O",
    "efficacy": "Antipsychotic, Dopamine receptor partial agonist, Serotonin receptor agonist/antagonist\nDISEASE   Schizophrenia [DS:H01649]\nBipolar I disorder [DS:H01653]",
    "target": "DRD2 [HSA:1813] [KO:K04145]\nDRD3 [HSA:1814] [KO:K04146]\nHTR1A [HSA:3350] [KO:K04153]\nHTR2A [HSA:3356] [KO:K04157]\nPATHWAY   hsa04080(1813+1814+3350+3356)  Neuroactive ligand-receptor interaction\nhsa04726(3350+3356)  Serotonergic synapse\nhsa04728(1813+1814)  Dopaminergic synapse",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576], CYP2D6 [HSA:1565]",
    "therapeutic_category": "1179",
    "atc_code": "N05AX12",
    "drug_class": [
      "Neuropsychiatric agent",
      "Antipsychotic agent",
      "Atypical antipsychotic",
      "Metabolizing enzyme substrate",
      "CYP2D6 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4",
      "CYP2D6"
    ],
    "search_name": "Aripiprazole hydrate"
  },
  {
    "kegg_id": "D05339",
    "name_en": "Paliperidone (JAN/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Invega (TN)"
    ],
    "formula": "C23H27FN4O3",
    "efficacy": "Antipsychotic, Serotonin receptor antagonist, Dopamine D2 receptor antagonist\nDISEASE   Schizophrenia [DS:H01649]",
    "target": "HTR2A [HSA:3356] [KO:K04157]\nDRD2 [HSA:1813] [KO:K04145]\nPATHWAY   hsa04080(1813+3356)  Neuroactive ligand-receptor interaction\nhsa04726(3356)  Serotonergic synapse\nhsa04728(1813)  Dopaminergic synapse",
    "metabolism": "",
    "therapeutic_category": "1179",
    "atc_code": "N05AX13",
    "drug_class": [
      "Neuropsychiatric agent",
      "Dopamine antagonist",
      "Dopamine D2-receptor antagonist",
      "Serotonin-dopamine antagonist (SDA)",
      "Antipsychotic agent",
      "Atypical antipsychotic"
    ],
    "cyp_enzymes": [],
    "search_name": "Paliperidone"
  },
  {
    "kegg_id": "D05340",
    "name_en": "Paliperidone palmitate (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Xeplion (TN)",
      "Trevicta (TN)",
      "Invega sustenna (TN)",
      "Invega trinza (TN)"
    ],
    "formula": "C39H57FN4O4",
    "efficacy": "Antipsychotic, Serotonin receptor antagonist, Dopamine D2 receptor antagonist\nDISEASE   Schizophrenia [DS:H01649]",
    "target": "HTR2A [HSA:3356] [KO:K04157]\nDRD2 [HSA:1813] [KO:K04145]\nPATHWAY   hsa04080(1813+3356)  Neuroactive ligand-receptor interaction\nhsa04726(3356)  Serotonergic synapse\nhsa04728(1813)  Dopaminergic synapse",
    "metabolism": "",
    "therapeutic_category": "1179",
    "atc_code": "N05AX13",
    "drug_class": [
      "Neuropsychiatric agent",
      "Dopamine antagonist",
      "Dopamine D2-receptor antagonist",
      "Serotonin-dopamine antagonist (SDA)",
      "Antipsychotic agent",
      "Atypical antipsychotic"
    ],
    "cyp_enzymes": [],
    "search_name": "Paliperidone palmitate"
  },
  {
    "kegg_id": "D10309",
    "name_en": "Brexpiprazole (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Rexulti (TN)"
    ],
    "formula": "C25H27N3O2S",
    "efficacy": "Antipsychotic\nDISEASE   Major depressive disorder [DS:H01646]\nSchizophrenia [DS:H01649]",
    "target": "DRD2 [HSA:1813] [KO:K04145]\nHTR1A [HSA:3350] [KO:K04153]\nHTR2A [HSA:3356] [KO:K04157]\nPATHWAY   hsa04080(1813+3350+3356)  Neuroactive ligand-receptor interaction\nhsa04726(3350+3356)  Serotonergic synapse\nhsa04728(1813)  Dopaminergic synapse",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576], CYP2D6 [HSA:1565]",
    "therapeutic_category": "1179",
    "atc_code": "N05AX16",
    "drug_class": [
      "Neuropsychiatric agent",
      "5-HT1A-receptor agonist",
      "Metabolizing enzyme substrate",
      "CYP2D6 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4",
      "CYP2D6"
    ],
    "search_name": "Brexpiprazole"
  },
  {
    "kegg_id": "D01514",
    "name_en": "Etizolam (JP18/INN)",
    "name_ja": "",
    "names_alt": [
      "Sedekopan (TN)"
    ],
    "formula": "C17H15ClN4S",
    "efficacy": "Antianxiety, Minor tranquilizer, Sedative-hypnotic",
    "target": "GABR [HSA:2554 2555 2556 2557 2558 2559 2560 2561 2562 2563 2564 2565 2566 2567 2568 55879] [KO:K05175 K05181 K05184 K05185 K05186 K05189 K05192]\nPATHWAY   hsa04080(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879)  Neuroactive ligand-receptor interaction\nhsa04727(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879)  GABAergic synapse",
    "metabolism": "Enzyme: CYP2C9 [HSA:1559], CYP3A4 [HSA:1576]",
    "therapeutic_category": "1179",
    "atc_code": "N05BA19",
    "drug_class": [
      "Neuropsychiatric agent",
      "Hypnotic",
      "GABA-A receptor agonist",
      "Anxiolytics, benzodiazepine derivatives",
      "Metabolizing enzyme substrate",
      "CYP2C9 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C9",
      "CYP3A4"
    ],
    "search_name": "Etizolam"
  },
  {
    "kegg_id": "D01328",
    "name_en": "Clotiazepam (JP18/INN)",
    "name_ja": "",
    "names_alt": [
      "Rize (TN)"
    ],
    "formula": "C16H15ClN2OS",
    "efficacy": "Antianxiety, Sedative-hypnotic",
    "target": "GABR [HSA:2554 2555 2556 2557 2558 2559 2560 2561 2562 2563 2564 2565 2566 2567 2568 55879] [KO:K05175 K05181 K05184 K05185 K05186 K05189 K05192]\nPATHWAY   hsa04080(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879)  Neuroactive ligand-receptor interaction\nhsa04727(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879)  GABAergic synapse",
    "metabolism": "",
    "therapeutic_category": "1179",
    "atc_code": "N05BA21",
    "drug_class": [
      "Neuropsychiatric agent",
      "GABA-A receptor agonist",
      "Anxiolytics, benzodiazepine derivatives"
    ],
    "cyp_enzymes": [],
    "search_name": "Clotiazepam"
  },
  {
    "kegg_id": "D00672",
    "name_en": "Hydroxyzine hydrochloride (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Hydroxyzine dihydrochloride",
      "Atarax (TN)",
      "Vistaril (TN)"
    ],
    "formula": "C21H27ClN2O2. 2HCl",
    "efficacy": "Antianxiety, Minor tranquilizer, H1 receptor antagonist\nDISEASE   Atopic dermatitis [DS:H01358]\nContact dermatitis [DS:H01357]",
    "target": "HRH1 [HSA:3269] [KO:K04149]\nPATHWAY   hsa04020(3269)  Calcium signaling pathway\nhsa04080(3269)  Neuroactive ligand-receptor interaction",
    "metabolism": "",
    "therapeutic_category": "1179",
    "atc_code": "N05BB01",
    "drug_class": [
      "Anti-allergic agent",
      "Histamine receptor antagonist",
      "Histamine receptor H1 antagonist"
    ],
    "cyp_enzymes": [],
    "search_name": "Hydroxyzine hydrochloride"
  },
  {
    "kegg_id": "D01096",
    "name_en": "Hydroxyzine pamoate (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Atarax-P (TN)",
      "Vistaril pamoate (TN)"
    ],
    "formula": "C23H16O6. C21H27ClN2O2",
    "efficacy": "Antianxiety, Minor tranquilizer, H1 receptor antagonist\nDISEASE   Atopic dermatitis [DS:H01358]\nContact dermatitis [DS:H01357]",
    "target": "HRH1 [HSA:3269] [KO:K04149]\nPATHWAY   hsa04020(3269)  Calcium signaling pathway\nhsa04080(3269)  Neuroactive ligand-receptor interaction",
    "metabolism": "",
    "therapeutic_category": "1179",
    "atc_code": "N05BB01",
    "drug_class": [
      "Anti-allergic agent",
      "Histamine receptor antagonist",
      "Histamine receptor H1 antagonist",
      "Dermatological agent",
      "Atopic dermatitis agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Hydroxyzine pamoate"
  },
  {
    "kegg_id": "D00809",
    "name_en": "Amitriptyline hydrochloride (JP18/USP)",
    "name_ja": "アミトリプチリン",
    "names_alt": [
      "Elavil (TN)"
    ],
    "formula": "C20H23N. HCl",
    "efficacy": "Antidepressant\nDISEASE   Depression [DS:H01646]",
    "target": "SLC6A4 (HTT) [HSA:6532] [KO:K05037]\nSLC6A2 (NAT1) [HSA:6530] [KO:K05035]\nPATHWAY   hsa04721(6530+6532)  Synaptic vesicle cycle\nhsa04726(6532)  Serotonergic synapse",
    "metabolism": "Enzyme: CYP2D6 [HSA:1565]; CYP1A2 [HSA:1544], CYP3A4 [HSA:1576], CYP2C19 [HSA:1557]",
    "therapeutic_category": "1179",
    "atc_code": "N06AA09",
    "drug_class": [
      "Neuropsychiatric agent",
      "Non-selective monoamine reuptake inhibitor",
      "Tricyclic antidepressant",
      "Metabolizing enzyme substrate",
      "CYP1A2 substrate",
      "CYP2C19 substrate",
      "CYP2D6 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C19",
      "CYP3A4",
      "CYP1A2",
      "CYP2D6"
    ],
    "search_name": "Amitriptyline hydrochloride"
  },
  {
    "kegg_id": "D00816",
    "name_en": "Nortriptyline hydrochloride (JP18/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Pamelor (TN)"
    ],
    "formula": "C19H21N. HCl",
    "efficacy": "Antidepressant, Serotonin-noradrenaline reuptake inhibitor (SNRI)\nDISEASE   Depression [DS:H01646]",
    "target": "SLC6A4 (HTT) [HSA:6532] [KO:K05037]\nSLC6A2 (NAT1) [HSA:6530] [KO:K05035]\nPATHWAY   hsa04721(6530+6532)  Synaptic vesicle cycle\nhsa04726(6532)  Serotonergic synapse",
    "metabolism": "Enzyme: CYP2D6 [HSA:1565]",
    "therapeutic_category": "1179",
    "atc_code": "N06AA10",
    "drug_class": [
      "Neuropsychiatric agent",
      "Non-selective monoamine reuptake inhibitor",
      "Tricyclic antidepressant",
      "Metabolizing enzyme substrate",
      "CYP2D6 substrate"
    ],
    "cyp_enzymes": [
      "CYP2D6"
    ],
    "search_name": "Nortriptyline hydrochloride"
  },
  {
    "kegg_id": "D01546",
    "name_en": "Dothiepin hydrochloride (USAN)",
    "name_ja": "",
    "names_alt": [
      "Dosulepin hydrochloride (JAN)",
      "Prothiaden (TN)"
    ],
    "formula": "C19H21NS. HCl",
    "efficacy": "Antidepressant",
    "target": "SLC6A4 (HTT) [HSA:6532] [KO:K05037]\nSLC6A2 (NAT1) [HSA:6530] [KO:K05035]\nPATHWAY   hsa04721(6530+6532)  Synaptic vesicle cycle\nhsa04726(6532)  Serotonergic synapse",
    "metabolism": "Enzyme: CYP2D6 [HSA:1565]",
    "therapeutic_category": "1179",
    "atc_code": "N06AA16",
    "drug_class": [
      "Neuropsychiatric agent",
      "Non-selective monoamine reuptake inhibitor",
      "Tricyclic antidepressant",
      "Metabolizing enzyme substrate",
      "CYP2D6 substrate"
    ],
    "cyp_enzymes": [
      "CYP2D6"
    ],
    "search_name": "Dothiepin hydrochloride"
  },
  {
    "kegg_id": "D00228",
    "name_en": "Amoxapine (JP18/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Asendin (TN)"
    ],
    "formula": "C17H16ClN3O",
    "efficacy": "Antidepressant, Serotonin-noradrenaline reuptake inhibitor (SNRI)\nDISEASE   Depression [DS:H01646]",
    "target": "SLC6A4 (HTT) [HSA:6532] [KO:K05037]\nSLC6A2 (NAT1) [HSA:6530] [KO:K05035]\nPATHWAY   hsa04721(6530+6532)  Synaptic vesicle cycle\nhsa04726(6532)  Serotonergic synapse",
    "metabolism": "Enzyme: CYP2D6 [HSA:1565]",
    "therapeutic_category": "1179",
    "atc_code": "N06AA17",
    "drug_class": [
      "Neuropsychiatric agent",
      "Non-selective monoamine reuptake inhibitor",
      "Tricyclic antidepressant",
      "Metabolizing enzyme substrate",
      "CYP2D6 substrate"
    ],
    "cyp_enzymes": [
      "CYP2D6"
    ],
    "search_name": "Amoxapine"
  },
  {
    "kegg_id": "D00818",
    "name_en": "Maprotiline hydrochloride (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Ludiomil (TN)"
    ],
    "formula": "C20H23N. HCl",
    "efficacy": "Antidepressant, Selective noradrenaline reuptake inhibitor (NRI)\nDISEASE   Major depressive disorder [DS:H01646]",
    "target": "SLC6A2 (NAT1) [HSA:6530] [KO:K05035]\nPATHWAY   hsa04721(6530)  Synaptic vesicle cycle",
    "metabolism": "Enzyme: CYP2D6 [HSA:1565]",
    "therapeutic_category": "1179",
    "atc_code": "N06AA21",
    "drug_class": [
      "Neuropsychiatric agent",
      "Non-selective monoamine reuptake inhibitor",
      "Tetracyclic antidepressant",
      "Metabolizing enzyme substrate",
      "CYP2D6 substrate"
    ],
    "cyp_enzymes": [
      "CYP2D6"
    ],
    "search_name": "Maprotiline hydrochloride"
  },
  {
    "kegg_id": "D02260",
    "name_en": "Paroxetine hydrochloride hemihydrate (USP)",
    "name_ja": "パロキセチン",
    "names_alt": [
      "Paroxetine hydrochloride hydrate (JP18)",
      "Paxil (TN)"
    ],
    "formula": "(C19H20FNO3. HCl)2. H2O",
    "efficacy": "Antidepressant, Selective serotonin reuptake inhibitor (SSRI)\nDISEASE   Major depressive disorder [DS:H01646]\nPanic disorder [DS:H01664]\nSocial anxiety disorder [DS:H01670]",
    "target": "SLC6A4 (HTT) [HSA:6532] [KO:K05037]\nPATHWAY   hsa04726(6532)  Serotonergic synapse",
    "metabolism": "Enzyme: CYP2D6 [HSA:1565]",
    "therapeutic_category": "1179",
    "atc_code": "N06AB05",
    "drug_class": [
      "Neuropsychiatric agent",
      "Selective serotonin reuptake inhibitor (SSRI)",
      "Metabolizing enzyme substrate",
      "CYP2D6 substrate",
      "Metabolizing enzyme inhibitor",
      "CYP2D6 inhibitor"
    ],
    "cyp_enzymes": [
      "CYP2D6"
    ],
    "search_name": "Paroxetine hydrochloride hemihydrate"
  },
  {
    "kegg_id": "D00825",
    "name_en": "Sertraline hydrochloride (JAN/USP)",
    "name_ja": "セルトラリン",
    "names_alt": [
      "Zoloft (TN)"
    ],
    "formula": "C17H17Cl2N. HCl",
    "efficacy": "Antidepressant, Selective serotonin reuptake inhibitor (SSRI)\nDISEASE   Major depressive disorder [DS:H01646]\nObsessive-compulsive disorder [DS:H01450]\nPanic disorder [DS:H01664]\nSocial anxiety disorder [DS:H01670]",
    "target": "SLC6A4 (HTT) [HSA:6532] [KO:K05037]\nPATHWAY   hsa04726(6532)  Serotonergic synapse",
    "metabolism": "Enzyme: CYP2C19 [HSA:1557], CYP2C9 [HSA:1559], CYP2B6 [HSA:1555], CYP3A4 [HSA:1576]",
    "therapeutic_category": "1179",
    "atc_code": "N06AB06",
    "drug_class": [
      "Neuropsychiatric agent",
      "Selective serotonin reuptake inhibitor (SSRI)",
      "Metabolizing enzyme substrate",
      "CYP2B6 substrate",
      "CYP2C9 substrate",
      "CYP2C19 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4",
      "CYP2C9",
      "CYP2C19",
      "CYP2B6"
    ],
    "search_name": "Sertraline hydrochloride"
  },
  {
    "kegg_id": "D00824",
    "name_en": "Fluvoxamine maleate (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Luvox (TN)"
    ],
    "formula": "C15H21F3N2O2. C4H4O4",
    "efficacy": "Antidepressant, Selective serotonin reuptake inhibitor (SSRI)\nDISEASE   Obsessive compulsive disorder [DS:H01450]",
    "target": "SLC6A4 (HTT) [HSA:6532] [KO:K05037]\nPATHWAY   hsa04726(6532)  Serotonergic synapse",
    "metabolism": "Enzyme: CYP2D6 [HSA:1565]",
    "therapeutic_category": "1179",
    "atc_code": "N06AB08",
    "drug_class": [
      "Neuropsychiatric agent",
      "Selective serotonin reuptake inhibitor (SSRI)",
      "Metabolizing enzyme substrate",
      "CYP2D6 substrate",
      "Metabolizing enzyme inhibitor",
      "CYP1A2 inhibitor",
      "CYP2C9 inhibitor",
      "CYP2C19 inhibitor",
      "CYP2D6 inhibitor",
      "CYP3A/CYP3A4 inhibitor",
      "CYP3A4 inhibitor"
    ],
    "cyp_enzymes": [
      "CYP2D6"
    ],
    "search_name": "Fluvoxamine maleate"
  },
  {
    "kegg_id": "D02567",
    "name_en": "Escitalopram oxalate (JAN/USP)",
    "name_ja": "エスシタロプラム",
    "names_alt": [
      "Lexapro (TN)"
    ],
    "formula": "C20H21FN2O. C2H2O4",
    "efficacy": "Antidepressant, Selective serotonin reuptake inhibitor (SSRI)\nDISEASE   Major depressive disorder [DS:H01646]\nGeneralized anxiety disorder [DS:H01662]",
    "target": "SLC6A4 (HTT) [HSA:6532] [KO:K05037]\nPATHWAY   hsa04726(6532)  Serotonergic synapse",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576], CYP2C19 [HSA:1557], CYP2D6 [HSA:1565]; MAO [HSA:4128 4129], AOX1 [HSA:316]",
    "therapeutic_category": "1179",
    "atc_code": "N06AB10",
    "drug_class": [
      "Neuropsychiatric agent",
      "Selective serotonin reuptake inhibitor (SSRI)",
      "Metabolizing enzyme substrate",
      "CYP2C19 substrate",
      "CYP2D6 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "AOX1 substrate",
      "MAO substrate",
      "Metabolizing enzyme inhibitor",
      "CYP2D6 inhibitor"
    ],
    "cyp_enzymes": [
      "CYP2C19",
      "CYP3A4",
      "CYP2D6"
    ],
    "search_name": "Escitalopram oxalate"
  },
  {
    "kegg_id": "D01358",
    "name_en": "Mianserin hydrochloride (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Tetramide (TN)"
    ],
    "formula": "C18H20N2. HCl",
    "efficacy": "Antidepressant",
    "target": "ADRA2 [HSA:150 151 152] [KO:K04138 K04139 K04140]\nHTR2A [HSA:3356] [KO:K04157]\nHTR2C [HSA:3358] [KO:K04157]\nHTR3 [HSA:3359 9177 170572 200909 285242] [KO:K04819]\nHRH1 [HSA:3269] [KO:K04149]\nPATHWAY   hsa04080(150+151+152+3269+3356+3358)  Neuroactive ligand-receptor interaction\nhsa04726(170572+200909+285242+3356+3358+3359+9177)  Serotonergic synapse",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576], CYP1A2 [HSA:1544], CYP2D6 [HSA:1565]",
    "therapeutic_category": "1179",
    "atc_code": "N06AX03",
    "drug_class": [
      "Cardiovascular agent",
      "Adrenergic receptor antagonist",
      "alpha-Adrenergic receptor antagonist",
      "alpha2-Adrenergic receptor antagonist",
      "Neuropsychiatric agent",
      "Tetracyclic antidepressant",
      "Metabolizing enzyme substrate",
      "CYP1A2 substrate",
      "CYP2D6 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4",
      "CYP1A2",
      "CYP2D6"
    ],
    "search_name": "Mianserin hydrochloride"
  },
  {
    "kegg_id": "D00820",
    "name_en": "Trazodone hydrochloride (JAN/USP)",
    "name_ja": "",
    "names_alt": [
      "Desyrel (TN)"
    ],
    "formula": "C19H22ClN5O. HCl",
    "efficacy": "Antidepressant, Serotonin antagonist and reuptake inhibitor (SARI)\nDISEASE   Major depressive disorder [DS:H01646]",
    "target": "SLC6A4 (HTT) [HSA:6532] [KO:K05037]\nHTR2 [HSA:3356 3357 3358] [KO:K04157]\nPATHWAY   hsa04080(3356+3357+3358)  Neuroactive ligand-receptor interaction\nhsa04726(3356+3357+3358+6532)  Serotonergic synapse",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576], CYP2D6 [HSA:1565]",
    "therapeutic_category": "1179",
    "atc_code": "N06AX05",
    "drug_class": [
      "Neuropsychiatric agent",
      "Serotonin antagonist and reuptake inhibitor (SARI)",
      "Metabolizing enzyme substrate",
      "CYP2D6 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4",
      "CYP2D6"
    ],
    "search_name": "Trazodone hydrochloride"
  },
  {
    "kegg_id": "D00563",
    "name_en": "Mirtazapine (JAN/USP/INN)",
    "name_ja": "ミルタザピン",
    "names_alt": [
      "Remeron (TN)",
      "Reflex (TN)"
    ],
    "formula": "C17H19N3",
    "efficacy": "Antidepressant, Serotonin receptor antagonist\nDISEASE   Major depressive disorder [DS:H01646]",
    "target": "HTR2 [HSA:3356 3357 3358] [KO:K04157]\nHTR3 [HSA:3359 9177 170572 200909 285242] [KO:K04819]\nADRA2 [HSA:150 151 152] [KO:K04138 K04139 K04140]\nPATHWAY   hsa04080(150+151+152+3356+3357+3358)  Neuroactive ligand-receptor interaction\nhsa04726(170572+200909+285242+3356+3357+3358+3359+9177)  Serotonergic synapse",
    "metabolism": "Enzyme: CYP1A2 [HSA:1544], CYP2D6 [HSA:1565], CYP3A4 [HSA:1576]",
    "therapeutic_category": "1179",
    "atc_code": "N06AX11",
    "drug_class": [
      "Cardiovascular agent",
      "Adrenergic receptor antagonist",
      "alpha-Adrenergic receptor antagonist",
      "alpha2-Adrenergic receptor antagonist",
      "Neuropsychiatric agent",
      "Tetracyclic antidepressant",
      "Noradrenergic and specific serotonergic antidepressant (NaSSA)",
      "Gastrointestinal agent",
      "5-HT3-receptor antagonist",
      "Metabolizing enzyme substrate",
      "CYP1A2 substrate",
      "CYP2D6 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4",
      "CYP1A2",
      "CYP2D6"
    ],
    "search_name": "Mirtazapine"
  },
  {
    "kegg_id": "D00821",
    "name_en": "Venlafaxine hydrochloride (JAN/USP)",
    "name_ja": "",
    "names_alt": [
      "Effexor (TN)"
    ],
    "formula": "C17H27NO2. HCl",
    "efficacy": "Antidepressant, Serotonin-noradrenaline reuptake inhibitor (SNRI)\nDISEASE   Major depressive disorder [DS:H01646]\nGeneralized anxiety disorder [DS:H01662]\nSocial anxiety disorder [DS:H01670]\nPanic disorder [DS:H01664]",
    "target": "SLC6A4 (HTT) [HSA:6532] [KO:K05037]\nSLC6A2 (NAT1) [HSA:6530] [KO:K05035]\nPATHWAY   hsa04721(6530+6532)  Synaptic vesicle cycle\nhsa04726(6532)  Serotonergic synapse",
    "metabolism": "Enzyme: CYP2D6 [HSA:1565]; CYP3A4 [HSA:1576]",
    "therapeutic_category": "1179",
    "atc_code": "N06AX16",
    "drug_class": [
      "Neuropsychiatric agent",
      "Serotonin and norepinephrine reuptake inhibitor (SNRI)",
      "Metabolizing enzyme substrate",
      "CYP2D6 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4",
      "CYP2D6"
    ],
    "search_name": "Venlafaxine hydrochloride"
  },
  {
    "kegg_id": "D01107",
    "name_en": "Milnacipran hydrochloride (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Savella (TN)",
      "Toledomin (TN)"
    ],
    "formula": "C15H22N2O. HCl",
    "efficacy": "Antidepressant, Serotonin-noradrenaline reuptake inhibitor (SNRI)",
    "target": "SLC6A4 (HTT) [HSA:6532] [KO:K05037]\nSLC6A2 (NAT1) [HSA:6530] [KO:K05035]\nPATHWAY   hsa04721(6530+6532)  Synaptic vesicle cycle\nhsa04726(6532)  Serotonergic synapse",
    "metabolism": "",
    "therapeutic_category": "1179",
    "atc_code": "N06AX17",
    "drug_class": [
      "Neuropsychiatric agent",
      "Serotonin and norepinephrine reuptake inhibitor (SNRI)"
    ],
    "cyp_enzymes": [],
    "search_name": "Milnacipran hydrochloride"
  },
  {
    "kegg_id": "D01179",
    "name_en": "Duloxetine hydrochloride (JAN/USP)",
    "name_ja": "デュロキセチン",
    "names_alt": [
      "Cymbalta (TN)",
      "Yentreve (TN)"
    ],
    "formula": "C18H19NOS. HCl",
    "efficacy": "Antidepressant, Serotonin-noradrenaline reuptake inhibitor (SNRI)\nDISEASE   Major depressive disorder [DS:H01646]\nGeneralized anxiety disorder [DS:H01662]\nDiabetic peripheral neuropathic pain [DS:H01459]\nFibromyalgia [DS:H01636]",
    "target": "SLC6A4 (HTT) [HSA:6532] [KO:K05037]\nSLC6A2 (NAT1) [HSA:6530] [KO:K05035]\nPATHWAY   hsa04721(6530+6532)  Synaptic vesicle cycle\nhsa04726(6532)  Serotonergic synapse",
    "metabolism": "Enzyme: CYP1A2 [HSA:1544]; CYP2D6 [HSA:1565]",
    "therapeutic_category": "1179",
    "atc_code": "N06AX21",
    "drug_class": [
      "Neuropsychiatric agent",
      "Serotonin and norepinephrine reuptake inhibitor (SNRI)",
      "Metabolizing enzyme substrate",
      "CYP1A2 substrate",
      "CYP2D6 substrate",
      "Metabolizing enzyme inhibitor",
      "CYP2D6 inhibitor"
    ],
    "cyp_enzymes": [
      "CYP1A2",
      "CYP2D6"
    ],
    "search_name": "Duloxetine hydrochloride"
  },
  {
    "kegg_id": "D10185",
    "name_en": "Vortioxetine hydrobromide (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Brintellix (TN)",
      "Trintellix (TN)"
    ],
    "formula": "C18H22N2S. HBr",
    "efficacy": "Antidepressant, Antianxiety, Serotonin reuptake inhibitor, Serotonin receptor antagonist/agonist\nDISEASE   Major depressive disorder [DS:H01646]",
    "target": "SLC6A4 (HTT) [HSA:6532] [KO:K05037]\nHTR3 [HSA:3359 9177 170572 200909 285242] [KO:K04819]\nHTR1A [HSA:3350] [KO:K04153]\nPATHWAY   hsa04080(3350)  Neuroactive ligand-receptor interaction\nhsa04726(170572+200909+285242+3350+3359+6532+9177)  Serotonergic synapse",
    "metabolism": "Enzyme: CYP2D6 [HSA:1565]; CYP3A4 [HSA:1576], CYP3A5 [HSA:1577], CYP2C19 [HSA:1557], CYP2C9 [HSA:1559], CYP2A6 [HSA:1548], CYP2C8 [HSA:1558], CYP2B6 [HSA:1555]",
    "therapeutic_category": "1179",
    "atc_code": "N06AX26",
    "drug_class": [
      "Neuropsychiatric agent",
      "5-HT1A-receptor agonist",
      "Gastrointestinal agent",
      "5-HT3-receptor antagonist",
      "Metabolizing enzyme substrate",
      "CYP2A6 substrate",
      "CYP2B6 substrate",
      "CYP2C8 substrate",
      "CYP2C9 substrate",
      "CYP2C19 substrate",
      "CYP2D6 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "CYP3A5 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C19",
      "CYP3A4",
      "CYP3A5",
      "CYP2A6",
      "CYP2B6",
      "CYP2C9",
      "CYP2D6",
      "CYP2C8"
    ],
    "search_name": "Vortioxetine hydrobromide"
  },
  {
    "kegg_id": "D11793",
    "name_en": "Zuranolone (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Zurzuvae (TN)"
    ],
    "formula": "C25H35N3O2",
    "efficacy": "Antidepressant, Antiepileptic",
    "target": "GABR [HSA:2554 2555 2556 2557 2558 2559 2560 2561 2562 2563 2564 2565 2566 2567 2568 55879] [KO:K05175 K05181 K05184 K05185 K05186 K05189 K05192]\nPATHWAY   hsa04080(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879)  Neuroactive ligand-receptor interaction\nhsa04082(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879)  Neuroactive ligand signaling\nhsa04726(2560+2561+2562)  Serotonergic synapse\nhsa04727(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879)  GABAergic synapse",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "1179",
    "atc_code": "N06AX31",
    "drug_class": [
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Zuranolone"
  },
  {
    "kegg_id": "D01296",
    "name_en": "Methylphenidate hydrochloride (JAN/USP)",
    "name_ja": "",
    "names_alt": [
      "Concerta (TN)",
      "Metadate (TN)",
      "Quillivant xr (TN)",
      "Ritalin (TN)"
    ],
    "formula": "C14H19NO2. HCl",
    "efficacy": "Stimulant (central)\nDISEASE   Attention deficit hyperactivity disorder [DS:H01895]\nNarcolepsy [DS:H01293]",
    "target": "SLC6A3 (DAT1) [HSA:6531] [KO:K05036]\nSLC6A2 (NAT1) [HSA:6530] [KO:K05035]\nPATHWAY   hsa04721(6530+6531)  Synaptic vesicle cycle\nhsa04728(6531)  Dopaminergic synapse",
    "metabolism": "",
    "therapeutic_category": "1179",
    "atc_code": "N06BA04",
    "drug_class": [
      "Neuropsychiatric agent",
      "Agents for narcolepsy"
    ],
    "cyp_enzymes": [],
    "search_name": "Methylphenidate hydrochloride"
  },
  {
    "kegg_id": "D00744",
    "name_en": "Pemoline (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Cylert (TN)"
    ],
    "formula": "C9H8N2O2",
    "efficacy": "Antidepressant, Sedative-hypnotic, Stimulant (central)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "1179",
    "atc_code": "N06BA05",
    "drug_class": [
      "Neuropsychiatric agent",
      "Agents for narcolepsy"
    ],
    "cyp_enzymes": [],
    "search_name": "Pemoline"
  },
  {
    "kegg_id": "D01832",
    "name_en": "Modafinil (JAN/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Provigil (TN)"
    ],
    "formula": "C15H15NO2S",
    "efficacy": "Stimulant (central)\nDISEASE   Narcolepsy [DS:H01293]",
    "target": "",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "1179",
    "atc_code": "N06BA07",
    "drug_class": [
      "Neuropsychiatric agent",
      "Agents for narcolepsy",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "Metabolizing enzyme inhibitor",
      "CYP2C9 inhibitor",
      "CYP2C19 inhibitor",
      "Metabolizing enzyme inducer",
      "CYP1A2 inducer",
      "CYP2B6 inducer",
      "CYP3A/CYP3A4 inducer",
      "CYP3A4 inducer"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Modafinil"
  },
  {
    "kegg_id": "D02574",
    "name_en": "Atomoxetine hydrochloride (JAN/USP)",
    "name_ja": "",
    "names_alt": [
      "Tomoxetine hydrochloride",
      "Strattera (TN)"
    ],
    "formula": "C17H21NO. HCl",
    "efficacy": "Stimulant (central), Selective noradrenaline reuptake inhibitor (NRI)\nDISEASE   Attention-deficit/hyperactivity disorder [DS:H01895]",
    "target": "SLC6A2 (NAT1) [HSA:6530] [KO:K05035]\nPATHWAY   hsa04721(6530)  Synaptic vesicle cycle",
    "metabolism": "Enzyme: CYP2D6 [HSA:1565]",
    "therapeutic_category": "1179",
    "atc_code": "N06BA09",
    "drug_class": [
      "Neuropsychiatric agent",
      "Selective norepinephrine reuptake inhibitor (NRI)",
      "Metabolizing enzyme substrate",
      "CYP2D6 substrate"
    ],
    "cyp_enzymes": [
      "CYP2D6"
    ],
    "search_name": "Atomoxetine hydrochloride"
  },
  {
    "kegg_id": "D04747",
    "name_en": "Lisdexamfetamine dimesylate (USAN)",
    "name_ja": "",
    "names_alt": [
      "Lisdexamfetamine mesilate (JAN)",
      "Vyvanse (TN)",
      "Elvanse (TN)"
    ],
    "formula": "C15H25N3O. (CH4SO3)2",
    "efficacy": "Stimulant (central)\nDISEASE   Attention deficit hyperactivity disorder [DS:H01895]\nBinge eating disorder [DS:H01703]",
    "target": "SLC6A2 (NAT1) [HSA:6530] [KO:K05035]\nSLC6A3 (DAT1) [HSA:6531] [KO:K05036]\nPATHWAY   hsa04721(6530+6531)  Synaptic vesicle cycle\nhsa04728(6531)  Dopaminergic synapse",
    "metabolism": "",
    "therapeutic_category": "1179",
    "atc_code": "N06BA12",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Lisdexamfetamine dimesylate"
  },
  {
    "kegg_id": "D01051",
    "name_en": "Spiperone (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Spiropitan (TN)"
    ],
    "formula": "C23H26FN3O2",
    "efficacy": "Antipsychotic, Dopamine D2 receptor antagonist",
    "target": "DRD2 [HSA:1813] [KO:K04145]\nPATHWAY   hsa04080(1813)  Neuroactive ligand-receptor interaction\nhsa04728(1813)  Dopaminergic synapse",
    "metabolism": "",
    "therapeutic_category": "1179",
    "atc_code": "",
    "drug_class": [
      "Neuropsychiatric agent",
      "Dopamine antagonist",
      "Dopamine D2-receptor antagonist",
      "Antipsychotic agent",
      "Butyrophenone derivative"
    ],
    "cyp_enzymes": [],
    "search_name": "Spiperone"
  },
  {
    "kegg_id": "D01176",
    "name_en": "Blonanserin (JAN/INN)",
    "name_ja": "",
    "names_alt": [
      "AD 5423"
    ],
    "formula": "C23H30FN3",
    "efficacy": "Antipsychotic",
    "target": "HTR2A [HSA:3356] [KO:K04157]\nDRD2 [HSA:1813] [KO:K04145]\nDRD3 [HSA:1814] [KO:K04146]\nPATHWAY   hsa04080(1813+1814+3356)  Neuroactive ligand-receptor interaction\nhsa04726(3356)  Serotonergic synapse\nhsa04728(1813+1814)  Dopaminergic synapse",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "1179",
    "atc_code": "",
    "drug_class": [
      "Neuropsychiatric agent",
      "Dopamine antagonist",
      "Antipsychotic agent",
      "Atypical antipsychotic",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Blonanserin"
  },
  {
    "kegg_id": "D01468",
    "name_en": "Nemonapride (JAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Emilace (TN)"
    ],
    "formula": "C21H26ClN3O2",
    "efficacy": "Antipsychotic, Dopamine receptor antagonist",
    "target": "DRD2 [HSA:1813] [KO:K04145]\nPATHWAY   hsa04080(1813)  Neuroactive ligand-receptor interaction\nhsa04728(1813)  Dopaminergic synapse",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "1179",
    "atc_code": "",
    "drug_class": [
      "Neuropsychiatric agent",
      "Dopamine antagonist",
      "Dopamine D2-receptor antagonist",
      "Antipsychotic agent",
      "Benzamide antipsychotic",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Nemonapride"
  },
  {
    "kegg_id": "D02034",
    "name_en": "Setiptiline maleate (JAN)",
    "name_ja": "",
    "names_alt": [
      "Tecipul (TN)"
    ],
    "formula": "C19H19N. C4H4O4",
    "efficacy": "Antidepressant, alpha2-Adrenergic receptor antagonist",
    "target": "ADRA2 [HSA:150 151 152] [KO:K04138 K04139 K04140]\nPATHWAY   hsa04080(150+151+152)  Neuroactive ligand-receptor interaction",
    "metabolism": "",
    "therapeutic_category": "1179",
    "atc_code": "",
    "drug_class": [
      "Cardiovascular agent",
      "Adrenergic receptor antagonist",
      "alpha-Adrenergic receptor antagonist",
      "alpha2-Adrenergic receptor antagonist",
      "Neuropsychiatric agent",
      "Tetracyclic antidepressant",
      "Noradrenergic and specific serotonergic antidepressant (NaSSA)"
    ],
    "cyp_enzymes": [],
    "search_name": "Setiptiline maleate"
  },
  {
    "kegg_id": "D02035",
    "name_en": "Timiperone (JAN)",
    "name_ja": "",
    "names_alt": [
      "Tolopelon (TN)"
    ],
    "formula": "C22H24FN3OS",
    "efficacy": "Antipsychotic, Dopamine D2 receptor antagonist",
    "target": "DRD2 [HSA:1813] [KO:K04145]\nPATHWAY   hsa04080(1813)  Neuroactive ligand-receptor interaction\nhsa04540(1813)  Gap junction",
    "metabolism": "",
    "therapeutic_category": "1179",
    "atc_code": "",
    "drug_class": [
      "Neuropsychiatric agent",
      "Dopamine antagonist",
      "Dopamine D2-receptor antagonist",
      "Antipsychotic agent",
      "Butyrophenone derivative"
    ],
    "cyp_enzymes": [],
    "search_name": "Timiperone"
  },
  {
    "kegg_id": "D02371",
    "name_en": "Clocapramine hydrochloride hydrate (JP18)",
    "name_ja": "",
    "names_alt": [
      "Clofekton (TN)"
    ],
    "formula": "C28H37ClN4O. 2HCl. H2O",
    "efficacy": "Antipsychotic, Neuroleptic, Dopamine D2 receptor antagonist",
    "target": "DRD2 [HSA:1813] [KO:K04145]\nPATHWAY   hsa04080(1813)  Neuroactive ligand-receptor interaction\nhsa04540(1813)  Gap junction",
    "metabolism": "",
    "therapeutic_category": "1179",
    "atc_code": "",
    "drug_class": [
      "Neuropsychiatric agent",
      "Dopamine antagonist",
      "Dopamine D2-receptor antagonist",
      "Antipsychotic agent",
      "Iminobenzyl antipsychotic"
    ],
    "cyp_enzymes": [],
    "search_name": "Clocapramine hydrochloride hydrate"
  },
  {
    "kegg_id": "D02372",
    "name_en": "Perospirone hydrochloride hydrate (JAN)",
    "name_ja": "",
    "names_alt": [
      "Lullan (TN)"
    ],
    "formula": "C23H30N4O2S. 2H2O. HCl",
    "efficacy": "Antipsychotic, Serotonin receptor antagonist, Dopamine D2 receptor antagonist",
    "target": "HTR2A [HSA:3356] [KO:K04157]\nDRD2 [HSA:1813] [KO:K04145]\nPATHWAY   hsa04020(3356)  Calcium signaling pathway\nhsa04080(1813+3356)  Neuroactive ligand-receptor interaction\nhsa04540(1813+3356)  Gap junction",
    "metabolism": "",
    "therapeutic_category": "1179",
    "atc_code": "",
    "drug_class": [
      "Neuropsychiatric agent",
      "Dopamine antagonist",
      "Dopamine D2-receptor antagonist",
      "Antipsychotic agent",
      "Atypical antipsychotic"
    ],
    "cyp_enzymes": [],
    "search_name": "Perospirone hydrochloride hydrate"
  },
  {
    "kegg_id": "D04044",
    "name_en": "Chlorpheniramine maleate, acetaminophen, salicylamide and anhydrous caffeine",
    "name_ja": "",
    "names_alt": [
      "LL (TN)"
    ],
    "formula": "",
    "efficacy": "Cold remedy",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "1180",
    "atc_code": "N02BA55",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Chlorpheniramine maleate, acetaminophen, salicylamide and anhydrous caffeine"
  },
  {
    "kegg_id": "D04046",
    "name_en": "Salicylamide, acetaminophen, anhydrous caffeine and promethazine methylenedisalicylate",
    "name_ja": "",
    "names_alt": [
      "PL (TN)"
    ],
    "formula": "",
    "efficacy": "Cold remedy",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "1180",
    "atc_code": "N02BA55",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Salicylamide, acetaminophen, anhydrous caffeine and promethazine methylenedisalicylate"
  },
  {
    "kegg_id": "D00367",
    "name_en": "Mazindol (JAN/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Sanorex (TN)"
    ],
    "formula": "C16H13ClN2O",
    "efficacy": "Appetite suppressant",
    "target": "SLC6A2 (NAT1) [HSA:6530] [KO:K05035]\nSLC6A3 (DAT1) [HSA:6531] [KO:K05036]\nSLC6A4 (HTT) [HSA:6532] [KO:K05037]\nPATHWAY   hsa04721(6530+6531+6532)  Synaptic vesicle cycle\nhsa04726(6532)  Serotonergic synapse\nhsa04728(6531)  Dopaminergic synapse",
    "metabolism": "",
    "therapeutic_category": "1190",
    "atc_code": "A08AA05",
    "drug_class": [
      "Gastrointestinal agent",
      "Anoretic"
    ],
    "cyp_enzymes": [],
    "search_name": "Mazindol"
  },
  {
    "kegg_id": "D03246",
    "name_en": "Mecobalamin (JP18/USAN)",
    "name_ja": "",
    "names_alt": [
      "Adestolmin (TN)"
    ],
    "formula": "C62H88N13O14P. Co. CH3",
    "efficacy": "Hematinic, Peripheral neuropathy agent, Supplement (vitamin B12)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "1190",
    "atc_code": "B03BA05",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Mecobalamin"
  },
  {
    "kegg_id": "D09314",
    "name_en": "Ofatumumab (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Ofatumumab (genetical recombination) (JAN)",
      "Arzerra (TN)",
      "Kesimpta (TN)"
    ],
    "formula": "C6480H10022N1742O2020S44",
    "efficacy": "Antineoplastic, Anti-CD20 antibody\nDISEASE   Chronic lymphocytic leukemia [DS:H00005]\nMultiple sclerosis [DS:H01490]\nTYPE      Monoclonal antibody",
    "target": "CD20 [HSA:931] [KO:K06466]\nPATHWAY   hsa04640(931)  Hematopoietic cell lineage",
    "metabolism": "",
    "therapeutic_category": "1190",
    "atc_code": "L01FA02",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Ofatumumab"
  },
  {
    "kegg_id": "D06886",
    "name_en": "Natalizumab (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Natalizumab (genetical recombination) (JAN)",
      "Natalizumab-sztn",
      "Tysabri (TN)",
      "Tyruko (TN)"
    ],
    "formula": "",
    "efficacy": "Immunosuppressant, Anti-integrin alpha 4 antibody\nDISEASE   Multiple sclerosis [DS:H01490]\nCrohn's disease [DS:H00286]\nTYPE      Monoclonal antibody",
    "target": "ITGA4 (CD49D) [HSA:3676] [KO:K06483]\nPATHWAY   hsa04512(3676)  ECM-receptor interaction\nhsa04670(3676)  Leukocyte transendothelial migration",
    "metabolism": "",
    "therapeutic_category": "1190",
    "atc_code": "L04AG03",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Natalizumab"
  },
  {
    "kegg_id": "D03846",
    "name_en": "Dimethyl fumarate (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Tecfidera (TN)"
    ],
    "formula": "C6H8O4",
    "efficacy": "Immunomodulator\nDISEASE   Multiple sclerosis [DS:H01490]",
    "target": "KEAP1 [HSA:9817] [KO:K10456]",
    "metabolism": "",
    "therapeutic_category": "1190",
    "atc_code": "L04AX07",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Dimethyl fumarate"
  },
  {
    "kegg_id": "D10791",
    "name_en": "Nusinersen sodium (JAN)",
    "name_ja": "",
    "names_alt": [
      "Spinraza (TN)"
    ],
    "formula": "C234H323N61O128P17S17.17Na",
    "efficacy": "Translation inhibitor\nDISEASE   Spinal muscular atrophy [DS:H00455]\nTYPE      Antisense oligonucleotide",
    "target": "SMN2 [HSA:6607] [KO:K13129] (pre-mRNA intron7)",
    "metabolism": "",
    "therapeutic_category": "1190",
    "atc_code": "M09AX07",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Nusinersen sodium"
  },
  {
    "kegg_id": "D11406",
    "name_en": "Risdiplam (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Evrysdi (TN)"
    ],
    "formula": "C22H23N7O",
    "efficacy": "Protein modulator\nDISEASE   Spinal muscular atrophy [DS:H00455]",
    "target": "SMN2 [HSA:6607] [KO:K13129]\nPATHWAY   hsa03013(6607)  Nucleocytoplasmic transport",
    "metabolism": "Enzyme: FMO1 [HSA:2326], FMO3 [HSA:2328], CYP1A1 [HSA:1543], CYP2J2 [HSA:1573], CYP3A4 [HSA:1576], CYP3A7 [HSA:1551]",
    "therapeutic_category": "1190",
    "atc_code": "M09AX10",
    "drug_class": [
      "Metabolizing enzyme substrate",
      "CYP1A1 substrate",
      "CYP2J2 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "CYP3A7 substrate",
      "FMO substrate",
      "FMO1 substrate",
      "FMO3 substrate"
    ],
    "cyp_enzymes": [
      "CYP1A1",
      "CYP3A7",
      "CYP3A4",
      "CYP2J2"
    ],
    "search_name": "Risdiplam"
  },
  {
    "kegg_id": "D09539",
    "name_en": "Gabapentin enacarbil (JAN/USAN/INN)",
    "name_ja": "ガバペンチン",
    "names_alt": [
      "Horizant (TN)"
    ],
    "formula": "C16H27NO6",
    "efficacy": "Anticonvulsant\nDISEASE   Restless legs syndrome [DS:H01597]\nPostherpetic neuralgia [DS:H01624]",
    "target": "CACNA2D [HSA:781 9254 55799 93589] [KO:K04858 K04859 K04860 K04861]\nSLC6A1 (GAT1) [HSA:6529] [KO:K05034]\nPATHWAY   hsa04010(55799+781+9254+93589)  MAPK signaling pathway\nhsa04727(6529)  GABAergic synapse",
    "metabolism": "",
    "therapeutic_category": "1190",
    "atc_code": "N02BF01",
    "drug_class": [
      "Neuropsychiatric agent",
      "Antiepileptic agent",
      "GABA mimetic antiepileptic",
      "Calcium channel alpha-2 delta blocker"
    ],
    "cyp_enzymes": [],
    "search_name": "Gabapentin enacarbil"
  },
  {
    "kegg_id": "D02716",
    "name_en": "Pregabalin (JAN/USAN/INN)",
    "name_ja": "プレガバリン",
    "names_alt": [
      "Lyrica (TN)"
    ],
    "formula": "C8H17NO2",
    "efficacy": "Anticonvulsant, Pain relief\nDISEASE   Diabetic peripheral neuropathy [DS:H01459]\nPostherpetic neuralgia [DS:H01624]\nFibromyalgia [DS:H01636]",
    "target": "CACNA2D [HSA:781 9254 55799 93589] [KO:K04858 K04859 K04860 K04861]\nPATHWAY   hsa04010(55799+781+9254+93589)  MAPK signaling pathway",
    "metabolism": "",
    "therapeutic_category": "1190",
    "atc_code": "N02BF02",
    "drug_class": [
      "Neuropsychiatric agent",
      "Antiepileptic agent",
      "GABA mimetic antiepileptic",
      "Calcium channel alpha-2 delta blocker"
    ],
    "cyp_enzymes": [],
    "search_name": "Pregabalin"
  },
  {
    "kegg_id": "D10790",
    "name_en": "Mirogabalin besylate (USAN)",
    "name_ja": "",
    "names_alt": [
      "Mirogabalin besilate (JAN)"
    ],
    "formula": "C12H19NO2. C6H6O3S",
    "efficacy": "Pain relief",
    "target": "CACNA2D1 [HSA:781] [KO:K04858]\nCACNA2D2 [HSA:9254] [KO:K04859]\nPATHWAY   hsa04010(781+9254)  MAPK signaling pathway",
    "metabolism": "",
    "therapeutic_category": "1190",
    "atc_code": "N02BF03",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Mirogabalin besylate"
  },
  {
    "kegg_id": "D10424",
    "name_en": "Lasmiditan succinate (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "lasmiditan hemisuccinate",
      "Reyvow (TN)"
    ],
    "formula": "(C19H18F3N3O2)2. C4H6O4",
    "efficacy": "Antimigraine, Hydroxytryptamine receptor agonist",
    "target": "HTR1F [HSA:3355] [KO:K04153]\nPATHWAY   hsa04080(3355)  Neuroactive ligand-receptor interaction\nhsa04726(3355)  Serotonergic synapse",
    "metabolism": "",
    "therapeutic_category": "1190",
    "atc_code": "N02CC08",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Lasmiditan succinate"
  },
  {
    "kegg_id": "D10928",
    "name_en": "Erenumab (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Erenumab (genetical recombination) (JAN)",
      "Erenumab-aooe",
      "Aimovig (TN)"
    ],
    "formula": "",
    "efficacy": "Antimigraine, Anti-calcitonin receptor-like receptor antibody\nTYPE      Monoclonal antibody",
    "target": "CALCRL [HSA:10203] [KO:K04577]\nPATHWAY   hsa04080(10203)  Neuroactive ligand-receptor interaction\nhsa04270(10203)  Vascular smooth muscle contraction",
    "metabolism": "",
    "therapeutic_category": "1190",
    "atc_code": "N02CD01",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Erenumab"
  },
  {
    "kegg_id": "D10936",
    "name_en": "Galcanezumab (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Galcanezumab (genetical recombination) (JAN)",
      "Galcanezumab-gnlm",
      "Emgality (TN)"
    ],
    "formula": "",
    "efficacy": "Analgesic, Antimigraine, Anti-calcitonin gene related peptide (GCRP) antibody\nTYPE      Monoclonal antibody",
    "target": "CALCA (CGRP) [HSA:796] [KO:K12332]",
    "metabolism": "",
    "therapeutic_category": "1190",
    "atc_code": "N02CD02",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Galcanezumab"
  },
  {
    "kegg_id": "D11055",
    "name_en": "Fremanezumab (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Fremanezumab (genetical recombination) (JAN)",
      "Fremanezumab-vfrm",
      "Ajovy (TN)"
    ],
    "formula": "C6470H9952N1716O2016S46",
    "efficacy": "Antimigraine, Anti-calcitonin gene related peptide (GCRP) antibody\nTYPE      Monoclonal antibody",
    "target": "CALCA (CGRP) [HSA:796] [KO:K12332]\nPATHWAY   hsa04080(796)  Neuroactive ligand-receptor interaction",
    "metabolism": "",
    "therapeutic_category": "1190",
    "atc_code": "N02CD03",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Fremanezumab"
  },
  {
    "kegg_id": "D10663",
    "name_en": "Rimegepant sulfate (USAN)",
    "name_ja": "",
    "names_alt": [
      "Rimegepant sulfate hydrate (JAN)",
      "Nurtec odt (TN)",
      "Vydura (TN)"
    ],
    "formula": "(C28H28F2N6O3)2. H2SO4. 3H2O",
    "efficacy": "Antimigraine, Calcitonin receptor-like receptor antagonist",
    "target": "CALCRL [HSA:10203] [KO:K04577]\nPATHWAY   hsa04080(10203)  Neuroactive ligand-receptor interaction",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]; CYP2C9 [HSA:1559]",
    "therapeutic_category": "1190",
    "atc_code": "N02CD06",
    "drug_class": [
      "Metabolizing enzyme substrate",
      "CYP2C9 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C9",
      "CYP3A4"
    ],
    "search_name": "Rimegepant sulfate"
  },
  {
    "kegg_id": "D08170",
    "name_en": "Melatonin (JAN)",
    "name_ja": "",
    "names_alt": [
      "Melatonina (TN)",
      "Melatobel (TN)"
    ],
    "formula": "C13H16N2O2",
    "efficacy": "Anticonvulsant, Cerebroprotective, Sedative-hypnotic, Melatonin receptor agonist",
    "target": "MTNR1 [HSA:4543 4544] [KO:K04285 K04286]\nPATHWAY   hsa04080(4543+4544)  Neuroactive ligand-receptor interaction\nhsa04713(4543+4544)  Circadian entrainment",
    "metabolism": "Enzyme: CYP1A2 [HSA:1544]",
    "therapeutic_category": "1190",
    "atc_code": "N05CH01",
    "drug_class": [
      "Neuropsychiatric agent",
      "Melatonin receptor agonist",
      "Metabolizing enzyme substrate",
      "CYP1A2 substrate"
    ],
    "cyp_enzymes": [
      "CYP1A2"
    ],
    "search_name": "Melatonin"
  },
  {
    "kegg_id": "D02689",
    "name_en": "Ramelteon (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Rozerem (TN)"
    ],
    "formula": "C16H21NO2",
    "efficacy": "Hypnotic, Melatonin receptor agonist\nDISEASE   Insomnia [DS:H01609]",
    "target": "MTNR1 [HSA:4543 4544] [KO:K04285 K04286]\nPATHWAY   hsa04080(4543+4544)  Neuroactive ligand-receptor interaction\nhsa04713(4543+4544)  Circadian entrainment",
    "metabolism": "Enzyme: CYP1A2 [HSA:1544]",
    "therapeutic_category": "1190",
    "atc_code": "N05CH02",
    "drug_class": [
      "Neuropsychiatric agent",
      "Melatonin receptor agonist",
      "Hypnotic",
      "Metabolizing enzyme substrate",
      "CYP1A2 substrate"
    ],
    "cyp_enzymes": [
      "CYP1A2"
    ],
    "search_name": "Ramelteon"
  },
  {
    "kegg_id": "D10082",
    "name_en": "Suvorexant (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "MK-4305",
      "Belsomra (TN)"
    ],
    "formula": "C23H23ClN6O2",
    "efficacy": "Hypnotic, Orexin receptor antagonist\nDISEASE   Insomnia [DS:H01609]",
    "target": "HCRTR [HSA:3061 3062] [KO:K04238 K04239]\nPATHWAY   hsa04080(3061+3062)  Neuroactive ligand-receptor interaction",
    "metabolism": "Enzyme: CYP3A [HSA:1576 1577 1551]; CYP2C19 [HSA:1557]",
    "therapeutic_category": "1190",
    "atc_code": "N05CJ01",
    "drug_class": [
      "Neuropsychiatric agent",
      "Orexin receptor antagonist",
      "Hypnotic",
      "Metabolizing enzyme substrate",
      "CYP2C19 substrate",
      "CYP3A/CYP3A4 substrate",
      "Transporter inhibitor",
      "ABCB1 inhibitor"
    ],
    "cyp_enzymes": [
      "CYP3A",
      "CYP2C19"
    ],
    "search_name": "Suvorexant"
  },
  {
    "kegg_id": "D11022",
    "name_en": "Lemborexant (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Dayvigo (TN)"
    ],
    "formula": "C22H20F2N4O2",
    "efficacy": "Hypnotic, Orexin receptor antagonist\nDISEASE   Insomnia [DS:H01609]",
    "target": "HCRTR [HSA:3061 3062] [KO:K04238 K04239]\nPATHWAY   hsa04080(3061+3062)  Neuroactive ligand-receptor interaction",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]; CYP3A5 [HSA:1577]",
    "therapeutic_category": "1190",
    "atc_code": "N05CJ02",
    "drug_class": [
      "Neuropsychiatric agent",
      "Orexin receptor antagonist",
      "Hypnotic",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "CYP3A5 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4",
      "CYP3A5"
    ],
    "search_name": "Lemborexant"
  },
  {
    "kegg_id": "D11887",
    "name_en": "Daridorexant hydrochloride (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Quviviq (TN)"
    ],
    "formula": "C23H23ClN6O2. HCl",
    "efficacy": "Hypnotic, Orexin receptor antagonist\nDISEASE   Insomnia [DS:H01609]",
    "target": "HCRTR [HSA:3061 3062] [KO:K04238 K04239]\nPATHWAY   hsa04080(3061+3062)  Neuroactive ligand-receptor interaction",
    "metabolism": "Enzyme: CYP3A [HSA:1576 1577 1551]",
    "therapeutic_category": "1190",
    "atc_code": "N05CJ03",
    "drug_class": [
      "Neuropsychiatric agent",
      "Orexin receptor antagonist",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A"
    ],
    "search_name": "Daridorexant hydrochloride"
  },
  {
    "kegg_id": "D01914",
    "name_en": "Piracetam (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Myocalm (TN)"
    ],
    "formula": "C6H10N2O2",
    "efficacy": "Anticonvulsant, Nootropic",
    "target": "SV2A [HSA:9900] [KO:K06258]\nPATHWAY   hsa04512(9900)  ECM-receptor interaction",
    "metabolism": "",
    "therapeutic_category": "1190",
    "atc_code": "N06BX03",
    "drug_class": [
      "Neuropsychiatric agent",
      "Racetam derivative, nootropic"
    ],
    "cyp_enzymes": [],
    "search_name": "Piracetam"
  },
  {
    "kegg_id": "D00057",
    "name_en": "Citicoline (JP18/INN)",
    "name_ja": "",
    "names_alt": [
      "Nicholin (TN)"
    ],
    "formula": "C14H26N4O11P2",
    "efficacy": "Nootropic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "1190",
    "atc_code": "N06BX06",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Citicoline"
  },
  {
    "kegg_id": "D00670",
    "name_en": "Donepezil hydrochloride (JP18/USP)",
    "name_ja": "ドネペジル",
    "names_alt": [
      "Aricept (TN)"
    ],
    "formula": "C24H29NO3. HCl",
    "efficacy": "Dementia therapeutic agent, Acetylcholinesterase inhibitor\nDISEASE   Dementia of the Alzheimer's type [DS:H00056]",
    "target": "ACHE [HSA:43] [KO:K01049]\nPATHWAY   hsa00564(43)  Glycerophospholipid metabolism\nhsa04725(43)  Cholinergic synapse",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]; CYP2D6 [HSA:1565]",
    "therapeutic_category": "1190",
    "atc_code": "N06DA02",
    "drug_class": [
      "Neuropsychiatric agent",
      "Cholinesterase inhibitor",
      "Acetylcholinesterase inhibitor",
      "Antidementia agent",
      "Metabolizing enzyme substrate",
      "CYP2D6 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4",
      "CYP2D6"
    ],
    "search_name": "Donepezil hydrochloride"
  },
  {
    "kegg_id": "D07869",
    "name_en": "Donepezil (JAN/INN)",
    "name_ja": "ドネペジル",
    "names_alt": [
      "Donaz (TN)",
      "Allydone (TN)"
    ],
    "formula": "C24H29NO3",
    "efficacy": "Dementia therapeutic agent, Acetylcholinesterase inhibitor",
    "target": "ACHE [HSA:43] [KO:K01049]\nPATHWAY   hsa00564(43)  Glycerophospholipid metabolism\nhsa04725(43)  Cholinergic synapse",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]; CYP2D6 [HSA:1565]",
    "therapeutic_category": "1190",
    "atc_code": "N06DA02",
    "drug_class": [
      "Neuropsychiatric agent",
      "Cholinesterase inhibitor",
      "Acetylcholinesterase inhibitor",
      "Antidementia agent",
      "Metabolizing enzyme substrate",
      "CYP2D6 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4",
      "CYP2D6"
    ],
    "search_name": "Donepezil"
  },
  {
    "kegg_id": "D03822",
    "name_en": "Rivastigmine (JAN/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Exelon (TN)",
      "Prometax (TN)"
    ],
    "formula": "C14H22N2O2",
    "efficacy": "Dementia therapeutic agent, Acetylcholinesterase inhibitor\nDISEASE   Alzheimer's disease [DS:H00056]",
    "target": "ACHE [HSA:43] [KO:K01049]\nBCHE [HSA:590] [KO:K01050]\nPATHWAY   hsa00564(43)  Glycerophospholipid metabolism\nhsa04725(43)  Cholinergic synapse",
    "metabolism": "",
    "therapeutic_category": "1190",
    "atc_code": "N06DA03",
    "drug_class": [
      "Neuropsychiatric agent",
      "Cholinesterase inhibitor",
      "Acetylcholinesterase inhibitor",
      "Butyrylcholinesterase inhibitor",
      "Antidementia agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Rivastigmine"
  },
  {
    "kegg_id": "D02173",
    "name_en": "Galantamine hydrobromide (JAN/USP)",
    "name_ja": "",
    "names_alt": [
      "Razadyne (TN)",
      "Reminyl (TN)"
    ],
    "formula": "C17H21NO3. HBr",
    "efficacy": "Dementia therapeutic agent, Acetylcholinesterase inhibitor\nDISEASE   Dementia of the Alzheimer's type [DS:H00056]",
    "target": "ACHE [HSA:43] [KO:K01049]\nPATHWAY   hsa00564(43)  Glycerophospholipid metabolism\nhsa04725(43)  Cholinergic synapse",
    "metabolism": "Enzyme: CYP2D6 [HSA:1565], CYP3A4 [HSA:1576]",
    "therapeutic_category": "1190",
    "atc_code": "N06DA04",
    "drug_class": [
      "Neuropsychiatric agent",
      "Cholinesterase inhibitor",
      "Acetylcholinesterase inhibitor",
      "Antidementia agent",
      "Metabolizing enzyme substrate",
      "CYP2D6 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4",
      "CYP2D6"
    ],
    "search_name": "Galantamine hydrobromide"
  },
  {
    "kegg_id": "D04905",
    "name_en": "Memantine hydrochloride (JAN/USP)",
    "name_ja": "",
    "names_alt": [
      "Namenda (TN)",
      "Memary (TN)"
    ],
    "formula": "C12H21N. HCl",
    "efficacy": "Dementia therapeutic agent, NMDA receptor antagonist\nDISEASE   Dementia of the Alzheimer's type [DS:H00056]",
    "target": "GRIN (NMDAR) [HSA:2902 2903 2904 2905 2906] [KO:K05208 K05209 K05210 K05211 K05212]\nPATHWAY   hsa04080(2902+2903+2904+2905+2906)  Neuroactive ligand-receptor interaction\nhsa04724(2902+2903+2904+2905+2906)  Glutamatergic synapse\nhsa05010(2902+2903+2904+2905+2906)  Alzheimer disease",
    "metabolism": "Transporter: SLC22A2 [HSA:6582]",
    "therapeutic_category": "1190",
    "atc_code": "N06DX01",
    "drug_class": [
      "Neuropsychiatric agent",
      "NMDA receptor antagonist",
      "Antidementia agent",
      "Transporter substrate",
      "SLC22A2 substrate"
    ],
    "cyp_enzymes": [],
    "search_name": "Memantine hydrochloride"
  },
  {
    "kegg_id": "D11678",
    "name_en": "Lecanemab (USAN)",
    "name_ja": "",
    "names_alt": [
      "Lecanemab (genetical recombination) (JAN)",
      "Lecanemab-irmb",
      "Leqembi (TN)"
    ],
    "formula": "C6544H10088N1744O2032S46",
    "efficacy": "Dementia therapeutic agent\nDISEASE   Alzheimer's disease [DS:H00056]\nTYPE      Monoclonal antibody",
    "target": "Amyloid beta [CPD:C16514 C16515] [HSA:351] [KO:K04520]\nPATHWAY   hsa04726(351)  Serotonergic synapse\nhsa05010(351)  Alzheimer disease\nNETWORK   nt06460  Alzheimer disease",
    "metabolism": "",
    "therapeutic_category": "1190",
    "atc_code": "N06DX04",
    "drug_class": [
      "Neuropsychiatric agent",
      "Antidementia agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Lecanemab"
  },
  {
    "kegg_id": "D11500",
    "name_en": "Donanemab (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Donanemab (genetical recombination) (JAN)",
      "Donanemab-azbt",
      "Kisunla (TN)"
    ],
    "formula": "C6452H10038N1708O2013S42",
    "efficacy": "Dementia therapeutic agent\nDISEASE   Alzheimer's disease [DS:H00056]\nTYPE      Monoclonal antibody",
    "target": "Amyloid beta [CPD:C16514 C16515]\nNETWORK   nt06460  Alzheimer disease",
    "metabolism": "",
    "therapeutic_category": "1190",
    "atc_code": "N06DX05",
    "drug_class": [
      "Neuropsychiatric agent",
      "Antidementia agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Donanemab"
  },
  {
    "kegg_id": "D02780",
    "name_en": "Acamprosate calcium (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Campral (TN)",
      "Regtect (TN)"
    ],
    "formula": "(C5H10NO4S)2. Ca",
    "efficacy": "Antialcohol dependence, NMDA receptor antagonist\nDISEASE   Alcohol dependence [DS:H01611]",
    "target": "GRIN (NMDAR) [HSA:2902 2903 2904 2905 2906] [KO:K05208 K05209 K05210 K05211 K05212]\nPATHWAY   hsa04080(2902+2903+2904+2905+2906)  Neuroactive ligand-receptor interaction\nhsa04724(2902+2903+2904+2905+2906)  Glutamatergic synapse\nhsa04728(2903+2904)  Dopaminergic synapse\nhsa05034(2902+2903+2904+2905+2906)  Alcoholism",
    "metabolism": "",
    "therapeutic_category": "1190",
    "atc_code": "N07BB03",
    "drug_class": [
      "Neuropsychiatric agent",
      "NMDA receptor antagonist"
    ],
    "cyp_enzymes": [],
    "search_name": "Acamprosate calcium"
  },
  {
    "kegg_id": "D10812",
    "name_en": "Nalmefene hydrochloride hydrate (JAN)",
    "name_ja": "",
    "names_alt": [
      "Nalmefene hydrochloride dihydrate",
      "Selincro (TN)"
    ],
    "formula": "C21H25NO3. HCl. 2H2O",
    "efficacy": "Antialcohol dependence, Narcotic antagonist, Opioid receptor partial agonist/antagonist",
    "target": "OPRK1 [HSA:4986] [KO:K04214]\nOPRM1 [HSA:4988] [KO:K04215]\nOPRD1 [HSA:4985] [KO:K04213]\nPATHWAY   hsa04080(4985+4986+4988)  Neuroactive ligand-receptor interaction\nhsa05032(4988)  Morphine addiction",
    "metabolism": "",
    "therapeutic_category": "1190",
    "atc_code": "N07BB05",
    "drug_class": [
      "Analgesic",
      "Opioid receptor antagonist",
      "Opioid receptor agonist/antagonist"
    ],
    "cyp_enzymes": [],
    "search_name": "Nalmefene hydrochloride hydrate"
  },
  {
    "kegg_id": "D00775",
    "name_en": "Riluzole (JAN/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Rilutek (TN)"
    ],
    "formula": "C8H5F3N2OS",
    "efficacy": "Nerve cells protectant\nDISEASE   Amyotrophic lateral sclerosis [DS:H00058]",
    "target": "GRIN (NMDAR) [HSA:2902 2903 2904 2905 2906] [KO:K05208 K05209 K05210 K05211 K05212]\nGRIA [HSA:2890 2891 2892 2893] [KO:K05197 K05198 K05199 K05200]\nGRIK [HSA:2897 2898 2899 2900 2901] [KO:K05201 K05202 K05203 K05204 K05205]\nPATHWAY   hsa04080(2890+2891+2892+2893+2897+2898+2899+2900+2901+2902+2903+2904+2905+2906)  Neuroactive ligand-receptor interaction\nhsa04724(2890+2891+2892+2893+2897+2898+2899+2900+2901+2902+2903+2904+2905+2906)  Glutamatergic synapse\nhsa04728(2890+2891+2892+2893+2903+2904)  Dopaminergic synapse\nhsa05014(2890+2891+2902+2903+2904+2905+2906)  Amyotrophic lateral sclerosis",
    "metabolism": "Enzyme: CYP1A2 [HSA:1544]",
    "therapeutic_category": "1190",
    "atc_code": "N07XX02",
    "drug_class": [
      "Metabolizing enzyme substrate",
      "CYP1A2 substrate"
    ],
    "cyp_enzymes": [
      "CYP1A2"
    ],
    "search_name": "Riluzole"
  },
  {
    "kegg_id": "D08575",
    "name_en": "Tetrabenazine (JAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Nitoman (TN)",
      "Xenazine (TN)"
    ],
    "formula": "C19H27NO3",
    "efficacy": "Neuroleptic, Vesicular monoamine transporter inhibitor\nDISEASE   Huntington's disease [DS:H00059]",
    "target": "SLC18A2 (VMAT2) [HSA:6571] [KO:K08155]\nPATHWAY   hsa04721(6571)  Synaptic vesicle cycle\nhsa04726(6571)  Serotonergic synapse\nhsa04728(6571)  Dopaminergic synapse",
    "metabolism": "Enzyme: CYP2D6 [HSA:1565]; CYP3A4 [HSA:1576], CYP1A2 [HSA:1544], CBR [HSA:873 874]",
    "therapeutic_category": "1190",
    "atc_code": "N07XX06",
    "drug_class": [
      "Metabolizing enzyme substrate",
      "CYP1A2 substrate",
      "CYP2D6 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "CBR substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4",
      "CYP1A2",
      "CYP2D6"
    ],
    "search_name": "Tetrabenazine"
  },
  {
    "kegg_id": "D10999",
    "name_en": "Valbenazine tosylate (USAN)",
    "name_ja": "",
    "names_alt": [
      "Valbenazine tosilate (JAN)",
      "Valbenazine ditosylate",
      "Ingrezza (TN)",
      "Dysval (TN)"
    ],
    "formula": "C24H38N2O4. (C7H8O3S)2",
    "efficacy": "Neuroleptic, Vesicular monoamine transporter 2 inhibitor",
    "target": "SLC18A2 (VMAT2) [HSA:6571] [KO:K08155]\nPATHWAY   hsa04721(6571)  Synaptic vesicle cycle\nhsa04726(6571)  Serotonergic synapse\nhsa04728(6571)  Dopaminergic synapse",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576], CYP3A5 [HSA:1577]; CYP2D6 [HSA:1565]",
    "therapeutic_category": "1190",
    "atc_code": "N07XX13",
    "drug_class": [
      "Metabolizing enzyme substrate",
      "CYP2D6 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "CYP3A5 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4",
      "CYP3A5",
      "CYP2D6"
    ],
    "search_name": "Valbenazine tosylate"
  },
  {
    "kegg_id": "D01552",
    "name_en": "Edaravone (USAN/JP18/INN)",
    "name_ja": "",
    "names_alt": [
      "Radicava (TN)",
      "Radicut (TN)"
    ],
    "formula": "C10H10N2O",
    "efficacy": "Cerebroprotective\nDISEASE   Amyotrophic lateral sclerosis [DS:H00058]",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "1190",
    "atc_code": "N07XX14",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Edaravone"
  },
  {
    "kegg_id": "D11811",
    "name_en": "Tofersen (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "BIIB067",
      "Qalsody (TN)"
    ],
    "formula": "C230H317N72O123P19S15",
    "efficacy": "Translation inhibitor\nDISEASE   Amyotrophic lateral sclerosis (SOD1 mutated) [DS:H00058]\nTYPE      Antisense oligonucleotide",
    "target": "SOD1* [HSA_VAR:6647v1] [HSA:6647] [KO:K04565] (mRNA)\nPATHWAY   hsa04146(6647)  Peroxisome\nhsa04213(6647)  Longevity regulating pathway - multiple species\nhsa05014(6647)  Amyotrophic lateral sclerosis\nhsa05022(6647)  Pathways of neurodegeneration - multiple diseases\nNETWORK   nt06464  Amyotrophic lateral sclerosis",
    "metabolism": "",
    "therapeutic_category": "1190",
    "atc_code": "N07XX22",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Tofersen"
  },
  {
    "kegg_id": "D06405",
    "name_en": "Nalfurafine hydrochloride (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Remitch (TN)"
    ],
    "formula": "C28H32N2O5. HCl",
    "efficacy": "Antipruritic, kappa-Opioid receptor agonist",
    "target": "OPRK1 [HSA:4986] [KO:K04214]\nPATHWAY   hsa04080(4986)  Neuroactive ligand-receptor interaction",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "1190",
    "atc_code": "V03AX02",
    "drug_class": [
      "Neuropsychiatric agent",
      "Opioid receptor agonist",
      "kappa-Opioid receptor agonist",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Nalfurafine hydrochloride"
  },
  {
    "kegg_id": "D02007",
    "name_en": "Protirelin tartrate hydrate (JP18)",
    "name_ja": "",
    "names_alt": [
      "Hirtonin (TN)"
    ],
    "formula": "C16H22N6O4. C4H6O6. H2O",
    "efficacy": "Thyrotropin-releasing hormone receptor agonist",
    "target": "TRHR [HSA:7201] [KO:K04282]\nPATHWAY   hsa04020(7201)  Calcium signaling pathway\nhsa04080(7201)  Neuroactive ligand-receptor interaction",
    "metabolism": "",
    "therapeutic_category": "1190",
    "atc_code": "V04CJ02",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Protirelin tartrate hydrate"
  },
  {
    "kegg_id": "D00047",
    "name_en": "Taurine (JP18/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Aminoethylsulfonic acid (JAN)"
    ],
    "formula": "C2H7NO3S",
    "efficacy": "Liver function improving agent",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "1190",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Taurine"
  },
  {
    "kegg_id": "D01925",
    "name_en": "Taltirelin hydrate (JP18)",
    "name_ja": "",
    "names_alt": [
      "Ceredist (TN)"
    ],
    "formula": "C17H23N7O5. 4H2O",
    "efficacy": "Thyrotropin-releasing hormone receptor agonist",
    "target": "TRHR [HSA:7201] [KO:K04282]\nPATHWAY   hsa04020(7201)  Calcium signaling pathway\nhsa04080(7201)  Neuroactive ligand-receptor interaction",
    "metabolism": "",
    "therapeutic_category": "1190",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Taltirelin hydrate"
  },
  {
    "kegg_id": "D12611",
    "name_en": "Vornorexant hydrate (JAN)",
    "name_ja": "",
    "names_alt": [],
    "formula": "(C23H22FN7O2)4. H2O",
    "efficacy": "Hypnotic, Orexin receptor antagonist",
    "target": "HCRTR [HSA:3061 3062] [KO:K04238 K04239]\nPATHWAY   hsa04080(3061+3062)  Neuroactive ligand-receptor interaction",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "1190",
    "atc_code": "",
    "drug_class": [
      "Neuropsychiatric agent",
      "Orexin receptor antagonist",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Vornorexant hydrate"
  },
  {
    "kegg_id": "D00740",
    "name_en": "Procaine hydrochloride (JP18/USP)",
    "name_ja": "プロカイン",
    "names_alt": [
      "Novocain (TN)"
    ],
    "formula": "C13H20N2O2. HCl",
    "efficacy": "Anesthetic (local)",
    "target": "SCN1A [HSA:6323] [KO:K04833]\nSCN2A [HSA:6326] [KO:K04834]\nSCN3A [HSA:6328] [KO:K04836]\nSCN4A [HSA:6329] [KO:K04837]\nSCN5A [HSA:6331] [KO:K04838]\nSCN8A [HSA:6334] [KO:K04840]\nSCN9A [HSA:6335] [KO:K04841]\nSCN10A [HSA:6336] [KO:K04842]\nSCN11A [HSA:11280] [KO:K04843]\nPATHWAY   hsa04728(6323)  Dopaminergic synapse",
    "metabolism": "",
    "therapeutic_category": "1211",
    "atc_code": "C05AD05",
    "drug_class": [
      "Neuropsychiatric agent",
      "Anesthetics",
      "Local anesthetic",
      "Esterified local anesthetic"
    ],
    "cyp_enzymes": [],
    "search_name": "Procaine hydrochloride"
  },
  {
    "kegg_id": "D00358",
    "name_en": "Lidocaine (JP18/USP/INN)",
    "name_ja": "リドカイン",
    "names_alt": [
      "Dentipatch (TN)",
      "Xylocaine (TN)"
    ],
    "formula": "C14H22N2O",
    "efficacy": "Anesthetic (topical), Antiarrhythmic, Sodium channel blocker",
    "target": "SCN1A [HSA:6323] [KO:K04833]\nSCN2A [HSA:6326] [KO:K04834]\nSCN3A [HSA:6328] [KO:K04836]\nSCN4A [HSA:6329] [KO:K04837]\nSCN5A [HSA:6331] [KO:K04838]\nSCN8A [HSA:6334] [KO:K04840]\nSCN9A [HSA:6335] [KO:K04841]\nSCN10A [HSA:6336] [KO:K04842]\nSCN11A [HSA:11280] [KO:K04843]\nPATHWAY   hsa04261(6331)  Adrenergic signaling in cardiomyocytes\nhsa04728(6323)  Dopaminergic synapse",
    "metabolism": "Enzyme: CYP1A2 [HSA:1544], CYP3A4 [HSA:1576]",
    "therapeutic_category": "1214",
    "atc_code": "C01BB01",
    "drug_class": [
      "Cardiovascular agent",
      "Antiarrhythmics",
      "Class I antiarrhythmic agent",
      "Class Ib antiarrhythmic agent",
      "Neuropsychiatric agent",
      "Anesthetics",
      "Local anesthetic",
      "Amide type local anesthetic",
      "Metabolizing enzyme substrate",
      "CYP1A2 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4",
      "CYP1A2"
    ],
    "search_name": "Lidocaine"
  },
  {
    "kegg_id": "D02086",
    "name_en": "Lidocaine hydrochloride (JAN/USP)",
    "name_ja": "リドカイン",
    "names_alt": [
      "Dalcaine (TN)",
      "Xylocaine (TN)"
    ],
    "formula": "C14H22N2O. HCl",
    "efficacy": "Anesthetic (local), Antiarrhythmic, Sodium channel blocker",
    "target": "SCN1A [HSA:6323] [KO:K04833]\nSCN2A [HSA:6326] [KO:K04834]\nSCN3A [HSA:6328] [KO:K04836]\nSCN4A [HSA:6329] [KO:K04837]\nSCN5A [HSA:6331] [KO:K04838]\nSCN8A [HSA:6334] [KO:K04840]\nSCN9A [HSA:6335] [KO:K04841]\nSCN10A [HSA:6336] [KO:K04842]\nSCN11A [HSA:11280] [KO:K04843]\nPATHWAY   hsa04261(6331)  Adrenergic signaling in cardiomyocytes\nhsa04728(6323)  Dopaminergic synapse",
    "metabolism": "Enzyme: CYP1A2 [HSA:1544], CYP3A4 [HSA:1576]",
    "therapeutic_category": "1214",
    "atc_code": "C01BB01",
    "drug_class": [
      "Cardiovascular agent",
      "Antiarrhythmics",
      "Class I antiarrhythmic agent",
      "Class Ib antiarrhythmic agent",
      "Neuropsychiatric agent",
      "Anesthetics",
      "Local anesthetic",
      "Amide type local anesthetic",
      "Metabolizing enzyme substrate",
      "CYP1A2 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4",
      "CYP1A2"
    ],
    "search_name": "Lidocaine hydrochloride"
  },
  {
    "kegg_id": "D08127",
    "name_en": "Lidocaine hydrochloride monohydrate",
    "name_ja": "リドカイン",
    "names_alt": [
      "Lidocaine (TN)",
      "Zingo (TN)"
    ],
    "formula": "C14H22N2O. HCl. H2O",
    "efficacy": "Anesthetic (topical), Antiarrhythmic, Sodium channel blocker",
    "target": "SCN1A [HSA:6323] [KO:K04833]\nSCN2A [HSA:6326] [KO:K04834]\nSCN3A [HSA:6328] [KO:K04836]\nSCN4A [HSA:6329] [KO:K04837]\nSCN5A [HSA:6331] [KO:K04838]\nSCN8A [HSA:6334] [KO:K04840]\nSCN9A [HSA:6335] [KO:K04841]\nSCN10A [HSA:6336] [KO:K04842]\nSCN11A [HSA:11280] [KO:K04843]\nPATHWAY   hsa04261(6331)  Adrenergic signaling in cardiomyocytes\nhsa04728(6323)  Dopaminergic synapse",
    "metabolism": "Enzyme: CYP1A2 [HSA:1544], CYP3A4 [HSA:1576]",
    "therapeutic_category": "1214",
    "atc_code": "C01BB01",
    "drug_class": [
      "Cardiovascular agent",
      "Antiarrhythmics",
      "Class I antiarrhythmic agent",
      "Class Ib antiarrhythmic agent",
      "Neuropsychiatric agent",
      "Anesthetics",
      "Local anesthetic",
      "Amide type local anesthetic",
      "Metabolizing enzyme substrate",
      "CYP1A2 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4",
      "CYP1A2"
    ],
    "search_name": "Lidocaine hydrochloride monohydrate"
  },
  {
    "kegg_id": "D01450",
    "name_en": "Bupivacaine hydrochloride (USP)",
    "name_ja": "",
    "names_alt": [
      "Bupivacaine hydrochloride hydrate (JP18)",
      "Marcaine (TN)"
    ],
    "formula": "C18H28N2O. HCl. H2O",
    "efficacy": "Anesthetic (local)",
    "target": "SCN1A [HSA:6323] [KO:K04833]\nSCN2A [HSA:6326] [KO:K04834]\nSCN3A [HSA:6328] [KO:K04836]\nSCN4A [HSA:6329] [KO:K04837]\nSCN5A [HSA:6331] [KO:K04838]\nSCN8A [HSA:6334] [KO:K04840]\nSCN9A [HSA:6335] [KO:K04841]\nSCN10A [HSA:6336] [KO:K04842]\nSCN11A [HSA:11280] [KO:K04843]\nPATHWAY   hsa04728(6323)  Dopaminergic synapse",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "1214",
    "atc_code": "N01BB01",
    "drug_class": [
      "Neuropsychiatric agent",
      "Anesthetics",
      "Local anesthetic",
      "Amide type local anesthetic",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Bupivacaine hydrochloride"
  },
  {
    "kegg_id": "D00738",
    "name_en": "Mepivacaine hydrochloride (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Carbocaine (TN)",
      "Polocaine (TN)",
      "Scandonest plain (TN)"
    ],
    "formula": "C15H22N2O. HCl",
    "efficacy": "Anesthetic (local)",
    "target": "SCN1A [HSA:6323] [KO:K04833]\nSCN2A [HSA:6326] [KO:K04834]\nSCN3A [HSA:6328] [KO:K04836]\nSCN4A [HSA:6329] [KO:K04837]\nSCN5A [HSA:6331] [KO:K04838]\nSCN8A [HSA:6334] [KO:K04840]\nSCN9A [HSA:6335] [KO:K04841]\nSCN10A [HSA:6336] [KO:K04842]\nSCN11A [HSA:11280] [KO:K04843]\nPATHWAY   hsa04728(6323)  Dopaminergic synapse",
    "metabolism": "",
    "therapeutic_category": "1214",
    "atc_code": "N01BB03",
    "drug_class": [
      "Neuropsychiatric agent",
      "Anesthetics",
      "Local anesthetic",
      "Amide type local anesthetic"
    ],
    "cyp_enzymes": [],
    "search_name": "Mepivacaine hydrochloride"
  },
  {
    "kegg_id": "D04048",
    "name_en": "Ropivacaine hydrochloride (USP)",
    "name_ja": "",
    "names_alt": [
      "Ropivacaine hydrochloride hydrate (JAN)",
      "Anapeine (TN)"
    ],
    "formula": "C17H26N2O. HCl. H2O",
    "efficacy": "Anesthetic (local)",
    "target": "SCN1A [HSA:6323] [KO:K04833]\nSCN2A [HSA:6326] [KO:K04834]\nSCN3A [HSA:6328] [KO:K04836]\nSCN4A [HSA:6329] [KO:K04837]\nSCN5A [HSA:6331] [KO:K04838]\nSCN8A [HSA:6334] [KO:K04840]\nSCN9A [HSA:6335] [KO:K04841]\nSCN10A [HSA:6336] [KO:K04842]\nSCN11A [HSA:11280] [KO:K04843]\nPATHWAY   hsa04728(6323)  Dopaminergic synapse",
    "metabolism": "Enzyme: CYP1A2 [HSA:1544], CYP3A4 [HSA:1576]",
    "therapeutic_category": "1214",
    "atc_code": "N01BB09",
    "drug_class": [
      "Neuropsychiatric agent",
      "Anesthetics",
      "Local anesthetic",
      "Amide type local anesthetic",
      "Metabolizing enzyme substrate",
      "CYP1A2 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4",
      "CYP1A2"
    ],
    "search_name": "Ropivacaine hydrochloride"
  },
  {
    "kegg_id": "D01287",
    "name_en": "Levobupivacaine hydrochloride (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Chirocaine (TN)"
    ],
    "formula": "C18H28N2O. HCl",
    "efficacy": "Anesthetic (local), Analgesic",
    "target": "SCN1A [HSA:6323] [KO:K04833]\nSCN2A [HSA:6326] [KO:K04834]\nSCN3A [HSA:6328] [KO:K04836]\nSCN4A [HSA:6329] [KO:K04837]\nSCN5A [HSA:6331] [KO:K04838]\nSCN8A [HSA:6334] [KO:K04840]\nSCN9A [HSA:6335] [KO:K04841]\nSCN10A [HSA:6336] [KO:K04842]\nSCN11A [HSA:11280] [KO:K04843]\nPATHWAY   hsa04728(6323)  Dopaminergic synapse",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576], CYP1A2 [HSA:1544]",
    "therapeutic_category": "1214",
    "atc_code": "N01BB10",
    "drug_class": [
      "Neuropsychiatric agent",
      "Anesthetics",
      "Local anesthetic",
      "Amide type local anesthetic",
      "Metabolizing enzyme substrate",
      "CYP1A2 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4",
      "CYP1A2"
    ],
    "search_name": "Levobupivacaine hydrochloride"
  },
  {
    "kegg_id": "D04052",
    "name_en": "Epinephrine and lidocaine hydrochloride",
    "name_ja": "エピネフリン",
    "names_alt": [
      "Adrenaline and lidocaine hydrochloride",
      "Xylocaine (TN)"
    ],
    "formula": "",
    "efficacy": "Anesthetic (local)",
    "target": "",
    "metabolism": "Enzyme: CYP1A2 [HSA:1544], CYP3A4 [HSA:1576]",
    "therapeutic_category": "1214",
    "atc_code": "",
    "drug_class": [
      "Metabolizing enzyme substrate",
      "CYP1A2 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4",
      "CYP1A2"
    ],
    "search_name": "Epinephrine and lidocaine hydrochloride"
  },
  {
    "kegg_id": "D01152",
    "name_en": "Oxethazaine (JP18/USAN)",
    "name_ja": "",
    "names_alt": [
      "Oxetacaine (INN)",
      "Strocain (TN)"
    ],
    "formula": "C28H41N3O3",
    "efficacy": "Anesthetic (local), Anti-ulcerative",
    "target": "SCN1A [HSA:6323] [KO:K04833]\nSCN2A [HSA:6326] [KO:K04834]\nSCN3A [HSA:6328] [KO:K04836]\nSCN4A [HSA:6329] [KO:K04837]\nSCN5A [HSA:6331] [KO:K04838]\nSCN8A [HSA:6334] [KO:K04840]\nSCN9A [HSA:6335] [KO:K04841]\nSCN10A [HSA:6336] [KO:K04842]\nSCN11A [HSA:11280] [KO:K04843]\nPATHWAY   hsa04728(6323)  Dopaminergic synapse",
    "metabolism": "",
    "therapeutic_category": "1219",
    "atc_code": "C05AD06",
    "drug_class": [
      "Neuropsychiatric agent",
      "Anesthetics",
      "Local anesthetic",
      "Amide type local anesthetic",
      "Gastrointestinal agent",
      "Agents for peptic ulcer"
    ],
    "cyp_enzymes": [],
    "search_name": "Oxethazaine"
  },
  {
    "kegg_id": "D02740",
    "name_en": "Lidocaine and prilocaine",
    "name_ja": "リドカイン",
    "names_alt": [
      "Lidocaine and propitocaine",
      "Emla (TN)",
      "Oraqix (TN)"
    ],
    "formula": "",
    "efficacy": "Anesthetic (topical)",
    "target": "",
    "metabolism": "Enzyme: CYP1A2 [HSA:1544], CYP3A4 [HSA:1576]",
    "therapeutic_category": "1219",
    "atc_code": "N01BB52",
    "drug_class": [
      "Metabolizing enzyme substrate",
      "CYP1A2 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4",
      "CYP1A2"
    ],
    "search_name": "Lidocaine and prilocaine"
  },
  {
    "kegg_id": "D02275",
    "name_en": "Suxamethonium chloride hydrate (JP18)",
    "name_ja": "",
    "names_alt": [
      "Suxamethonium chloride dihydrate",
      "Succin (TN)"
    ],
    "formula": "C14H30N2O4. 2H2O. 2Cl",
    "efficacy": "Muscle relaxant",
    "target": "CHRN (muscle type) [HSA:1134 1140 1144 1145 1146] [KO:K04803 K04812 K04816 K04817 K04818]\nPATHWAY   hsa04080(1134+1140+1144+1145+1146)  Neuroactive ligand-receptor interaction",
    "metabolism": "",
    "therapeutic_category": "1224",
    "atc_code": "M03AB01",
    "drug_class": [
      "Musculo-skeletal system agent",
      "Muscle relaxant",
      "Peripherally-acting muscle relaxant",
      "Quaternary ammonium compound type muscle relaxant"
    ],
    "cyp_enzymes": [],
    "search_name": "Suxamethonium chloride hydrate"
  },
  {
    "kegg_id": "D00402",
    "name_en": "Methocarbamol (JAN/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Delaxin (TN)",
      "Robaxin (TN)"
    ],
    "formula": "C11H15NO5",
    "efficacy": "Skeletal muscle relaxant",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "1225",
    "atc_code": "M03BA03",
    "drug_class": [
      "Musculo-skeletal system agent",
      "Muscle relaxant",
      "Centrally acting muscle relaxant",
      "Carbamate muscle relaxant"
    ],
    "cyp_enzymes": [],
    "search_name": "Methocarbamol"
  },
  {
    "kegg_id": "D00770",
    "name_en": "Chlorphenesin carbamate (JP18/USAN)",
    "name_ja": "",
    "names_alt": [
      "Maolate (TN)"
    ],
    "formula": "C10H12ClNO4",
    "efficacy": "Skeletal muscle relaxant",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "1225",
    "atc_code": "",
    "drug_class": [
      "Musculo-skeletal system agent",
      "Muscle relaxant",
      "Centrally acting muscle relaxant",
      "Carbamate muscle relaxant"
    ],
    "cyp_enzymes": [],
    "search_name": "Chlorphenesin carbamate"
  },
  {
    "kegg_id": "D00765",
    "name_en": "Rocuronium bromide (JAN/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Zemuron (TN)"
    ],
    "formula": "C32H53N2O4. Br",
    "efficacy": "Skeletal muscle relaxant, Neuromuscular blocking agent, Muscarinic acetylcholine receptor antagonist",
    "target": "CHRN (neuronal type) [HSA:1135 1136 1137 1138 8973 1139 55584 57053 1141 1142 1143] [KO:K04804 K04805 K04806 K04807 K04808 K04809 K04810 K04811 K04813 K04814 K04815]\nCHRM [HSA:1128 1129 1131 1132 1133] [KO:K04129 K04130 K04131 K04132 K04133]\nPATHWAY   hsa04080(1128+1129+1131+1132+1133+1135+1136+1137+1138+1139+1141+1142+1143+55584+57053+8973)  Neuroactive ligand-receptor interaction\nhsa04725(1128+1129+1131+1132+1133+1136+1137+1139+1141+1143+8973)  Cholinergic synapse",
    "metabolism": "",
    "therapeutic_category": "1229",
    "atc_code": "M03AC09",
    "drug_class": [
      "Musculo-skeletal system agent",
      "Muscle relaxant",
      "Peripherally-acting muscle relaxant",
      "Nondepolarizing neuromuscular blocking agent",
      "Quaternary ammonium compound type muscle relaxant"
    ],
    "cyp_enzymes": [],
    "search_name": "Rocuronium bromide"
  },
  {
    "kegg_id": "D00783",
    "name_en": "Botulinum toxin type A (JAN)",
    "name_ja": "",
    "names_alt": [
      "Botox (TN)",
      "Dysport (TN)"
    ],
    "formula": "",
    "efficacy": "Skeletal muscle relaxant, Neuromuscular blocking agent\nDISEASE   Cervical dystonia [DS:H01608]",
    "target": "SNAP25 [HSA:6616] [KO:K18211]\nPATHWAY   hsa04721(6616)  Synaptic vesicle cycle",
    "metabolism": "",
    "therapeutic_category": "1229",
    "atc_code": "M03AX01",
    "drug_class": [
      "Musculo-skeletal system agent",
      "Muscle relaxant",
      "Peripherally-acting muscle relaxant",
      "Nondepolarizing neuromuscular blocking agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Botulinum toxin type A"
  },
  {
    "kegg_id": "D10012",
    "name_en": "Incobotulinumtoxin A (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Onaclostox",
      "Xeomin (TN)"
    ],
    "formula": "C2286H3500N578O666S9. C4422H6863N1151O1329S23",
    "efficacy": "Skeletal muscle relaxant, SNAP25 protein inhibitor\nDISEASE   Cervical dystonia [DS:H01608]",
    "target": "SNAP25 [HSA:6616] [KO:K18211]\nPATHWAY   hsa04721(6616)  Synaptic vesicle cycle",
    "metabolism": "",
    "therapeutic_category": "1229",
    "atc_code": "M03AX01",
    "drug_class": [
      "Musculo-skeletal system agent",
      "Muscle relaxant",
      "Peripherally-acting muscle relaxant",
      "Nondepolarizing neuromuscular blocking agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Incobotulinumtoxin A"
  },
  {
    "kegg_id": "D02064",
    "name_en": "Pridinol mesilate (JAN)",
    "name_ja": "",
    "names_alt": [
      "Pridinol methanesulfonate",
      "Konlax (TN)"
    ],
    "formula": "C20H25NO. CH4SO3",
    "efficacy": "Antispasmodic, Muscle relaxant, Muscarinic acetylcholine receptor antagonist",
    "target": "CHRM [HSA:1128 1129 1131 1132 1133] [KO:K04129 K04130 K04131 K04132 K04133]\nPATHWAY   hsa04080(1128+1129+1131+1132+1133)  Neuroactive ligand-receptor interaction\nhsa04725(1128+1129+1131+1132+1133)  Cholinergic synapse",
    "metabolism": "",
    "therapeutic_category": "1229",
    "atc_code": "M03BX03",
    "drug_class": [
      "Musculo-skeletal system agent",
      "Muscle relaxant",
      "Centrally acting muscle relaxant"
    ],
    "cyp_enzymes": [],
    "search_name": "Pridinol mesilate"
  },
  {
    "kegg_id": "D02274",
    "name_en": "Dantrolene sodium (USP)",
    "name_ja": "",
    "names_alt": [
      "Dantrolene sodium hydrate (JP18)",
      "Dantrium (TN)",
      "Ryanodex (TN)"
    ],
    "formula": "(C14H9N4O5. Na)2. 7H2O",
    "efficacy": "Skeletal muscle relaxant\nDISEASE   Cerebral palsy [DS:H01097]\nMultiple sclerosis [DS:H01490]",
    "target": "",
    "metabolism": "Enzyme: CYP1A1 [HSA:1543], CYP1A2 [HSA:1544], CYP3A [HSA:1576 1577 1551]",
    "therapeutic_category": "1229",
    "atc_code": "M03CA01",
    "drug_class": [
      "Musculo-skeletal system agent",
      "Muscle relaxant",
      "Metabolizing enzyme substrate",
      "CYP1A1 substrate",
      "CYP1A2 substrate",
      "CYP3A/CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP1A1",
      "CYP3A",
      "CYP1A2"
    ],
    "search_name": "Dantrolene sodium"
  },
  {
    "kegg_id": "D00481",
    "name_en": "Propantheline bromide (JP18/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Pro-banthine (TN)"
    ],
    "formula": "C23H30NO3. Br",
    "efficacy": "Antispasmodic, Muscarinic acetylcholine receptor antagonist\nDISEASE   Peptic ulcer [DS:H01634]",
    "target": "CHRM [HSA:1128 1129 1131 1132 1133] [KO:K04129 K04130 K04131 K04132 K04133]\nPATHWAY   hsa04020(1128+1129+1131+1133)  Calcium signaling pathway\nhsa04024(1128+1129)  cAMP signaling pathway\nhsa04080(1128+1129+1131+1132+1133)  Neuroactive ligand-receptor interaction\nhsa04725(1128+1129+1131+1132+1133)  Cholinergic synapse\nhsa04971(1131)  Gastric acid secretion",
    "metabolism": "",
    "therapeutic_category": "1231",
    "atc_code": "A03AB05",
    "drug_class": [
      "Neuropsychiatric agent",
      "Muscarinic cholinergic receptor antagonist",
      "Gastrointestinal agent",
      "Agents for peptic ulcer"
    ],
    "cyp_enzymes": [],
    "search_name": "Propantheline bromide"
  },
  {
    "kegg_id": "D00720",
    "name_en": "Mepenzolate bromide (JP18/INN)",
    "name_ja": "",
    "names_alt": [
      "Cantil (TN)"
    ],
    "formula": "C21H26NO3. Br",
    "efficacy": "Antispasmodic, Anti-ulcerative, Muscarinic acetylcholine receptor antagonist",
    "target": "CHRM [HSA:1128 1129 1131 1132 1133] [KO:K04129 K04130 K04131 K04132 K04133]\nPATHWAY   hsa04020(1128+1129+1131+1133)  Calcium signaling pathway\nhsa04080(1128+1129+1131+1132+1133)  Neuroactive ligand-receptor interaction\nhsa04725(1128+1129+1131+1132+1133)  Cholinergic synapse\nhsa04971(1131)  Gastric acid secretion",
    "metabolism": "",
    "therapeutic_category": "1231",
    "atc_code": "A03AB12",
    "drug_class": [
      "Neuropsychiatric agent",
      "Muscarinic cholinergic receptor antagonist"
    ],
    "cyp_enzymes": [],
    "search_name": "Mepenzolate bromide"
  },
  {
    "kegg_id": "D01228",
    "name_en": "Distigmine bromide (JP18/INN)",
    "name_ja": "",
    "names_alt": [
      "Ubretid (TN)"
    ],
    "formula": "C22H32N4O4. 2Br",
    "efficacy": "Acetylcholinesterase inhibitor",
    "target": "ACHE [HSA:43] [KO:K01049]\nPATHWAY   hsa00564(43)  Glycerophospholipid metabolism\nhsa04725(43)  Cholinergic synapse",
    "metabolism": "",
    "therapeutic_category": "1231",
    "atc_code": "N07AA03",
    "drug_class": [
      "Neuropsychiatric agent",
      "Cholinesterase inhibitor",
      "Acetylcholinesterase inhibitor",
      "Parasympathomimetic agent",
      "Ophthalmic agent",
      "Intraocular pressure lowering agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Distigmine bromide"
  },
  {
    "kegg_id": "D01001",
    "name_en": "Ambenonium chloride (JP18/INN)",
    "name_ja": "",
    "names_alt": [
      "Mytelase (TN)"
    ],
    "formula": "C28H42Cl2N4O2. 2Cl",
    "efficacy": "Acetylcholinesterase inhibitor",
    "target": "ACHE [HSA:43] [KO:K01049]\nPATHWAY   hsa00564(43)  Glycerophospholipid metabolism\nhsa04725(43)  Cholinergic synapse",
    "metabolism": "",
    "therapeutic_category": "1231",
    "atc_code": "N07AA30",
    "drug_class": [
      "Neuropsychiatric agent",
      "Cholinesterase inhibitor",
      "Acetylcholinesterase inhibitor",
      "Parasympathomimetic agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Ambenonium chloride"
  },
  {
    "kegg_id": "D01000",
    "name_en": "Bethanechol chloride (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Urecholine (TN)"
    ],
    "formula": "C7H17N2O2. Cl",
    "efficacy": "Prokinetic, Muscarinic acetylcholine receptor agonist",
    "target": "CHRM [HSA:1128 1129 1131 1132 1133] [KO:K04129 K04130 K04131 K04132 K04133]\nPATHWAY   hsa04080(1128+1129+1131+1132+1133)  Neuroactive ligand-receptor interaction\nhsa04725(1128+1129+1131+1132+1133)  Cholinergic synapse\nhsa04971(1131)  Gastric acid secretion",
    "metabolism": "",
    "therapeutic_category": "1231",
    "atc_code": "N07AB02",
    "drug_class": [
      "Neuropsychiatric agent",
      "Muscarinic cholinergic receptor agonist",
      "Parasympathomimetic agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Bethanechol chloride"
  },
  {
    "kegg_id": "D01875",
    "name_en": "Tiquizium bromide (JAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Thiaton (TN)"
    ],
    "formula": "C19H24NS2. Br",
    "efficacy": "Antispasmodic, Muscarinic acetylcholine receptor antagonist",
    "target": "CHRM3 [HSA:1131] [KO:K04131]\nPATHWAY   hsa04080(1131)  Neuroactive ligand-receptor interaction\nhsa04725(1131)  Cholinergic synapse\nhsa04971(1131)  Gastric acid secretion",
    "metabolism": "",
    "therapeutic_category": "1231",
    "atc_code": "",
    "drug_class": [
      "Neuropsychiatric agent",
      "Muscarinic cholinergic receptor antagonist",
      "Gastrointestinal agent",
      "Agents for peptic ulcer"
    ],
    "cyp_enzymes": [],
    "search_name": "Tiquizium bromide"
  },
  {
    "kegg_id": "D00999",
    "name_en": "Acetylcholine chloride (JP18/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Miochol (TN)"
    ],
    "formula": "C7H16NO2. Cl",
    "efficacy": "Miotic, Vasodilator (peripheral), Cholinergic receptor agonist",
    "target": "CHRM [HSA:1128 1129 1131 1132 1133] [KO:K04129 K04130 K04131 K04132 K04133]\nCHRN [HSA:1134 1135 1136 1137 1138 8973 1139 55584 57053 1140 1141 1142 1143 1144 1145 1146] [KO:K04803 K04804 K04805 K04806 K04807 K04808 K04809 K04810 K04811 K04812 K04813 K04814 K04815 K04816 K04817 K04818]\nPATHWAY   hsa04020(1128+1129+1131+1133+1139)  Calcium signaling pathway\nhsa04080(1128+1129+1131+1132+1133+1134+1135+1136+1137+1138+1139+1140+1141+1142+1143+1144+1145+1146+55584+57053+8973)  Neuroactive ligand-receptor interaction\nhsa04725(1128+1129+1131+1132+1133+1136+1137+1139+1141+1143+8973)  Cholinergic synapse\nhsa04970(1131)  Salivary secretion\nhsa04971(1131)  Gastric acid secretion",
    "metabolism": "Enzyme: ACHE [HSA:43]",
    "therapeutic_category": "1232",
    "atc_code": "S01EB09",
    "drug_class": [
      "Cardiovascular agent",
      "Nicotinic cholinergic receptor agonist",
      "Neuropsychiatric agent",
      "Muscarinic cholinergic receptor agonist",
      "Ophthalmic agent",
      "Intraocular pressure lowering agent",
      "Metabolizing enzyme substrate",
      "ACHE substrate"
    ],
    "cyp_enzymes": [],
    "search_name": "Acetylcholine chloride"
  },
  {
    "kegg_id": "D00995",
    "name_en": "Neostigmine bromide (JAN/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Vagostigmin (TN)"
    ],
    "formula": "C12H19N2O2. Br",
    "efficacy": "Parasympathomimetic, Acetylcholinesterase inhibitor",
    "target": "ACHE [HSA:43] [KO:K01049]\nPATHWAY   hsa00564(43)  Glycerophospholipid metabolism\nhsa04725(43)  Cholinergic synapse",
    "metabolism": "",
    "therapeutic_category": "1233",
    "atc_code": "N07AA01",
    "drug_class": [
      "Neuropsychiatric agent",
      "Cholinesterase inhibitor",
      "Acetylcholinesterase inhibitor",
      "Parasympathomimetic agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Neostigmine bromide"
  },
  {
    "kegg_id": "D00998",
    "name_en": "Neostigmine methylsulfate (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Bloxiverz (TN)",
      "Prostigmin (TN)"
    ],
    "formula": "C12H19N2O2. CH3SO4",
    "efficacy": "Parasympathomimetic, Acetylcholinesterase inhibitor",
    "target": "ACHE [HSA:43] [KO:K01049]\nPATHWAY   hsa00564(43)  Glycerophospholipid metabolism\nhsa04725(43)  Cholinergic synapse",
    "metabolism": "",
    "therapeutic_category": "1233",
    "atc_code": "N07AA01",
    "drug_class": [
      "Neuropsychiatric agent",
      "Cholinesterase inhibitor",
      "Acetylcholinesterase inhibitor",
      "Parasympathomimetic agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Neostigmine methylsulfate"
  },
  {
    "kegg_id": "D00487",
    "name_en": "Pyridostigmine bromide (JP18/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Mestinon (TN)"
    ],
    "formula": "C9H13N2O2. Br",
    "efficacy": "Acetylcholinesterase inhibitor\nDISEASE   Myasthenia gravis [DS:H01594]",
    "target": "ACHE [HSA:43] [KO:K01049]\nPATHWAY   hsa00564(43)  Glycerophospholipid metabolism\nhsa04725(43)  Cholinergic synapse",
    "metabolism": "",
    "therapeutic_category": "1233",
    "atc_code": "N07AA02",
    "drug_class": [
      "Neuropsychiatric agent",
      "Cholinesterase inhibitor",
      "Acetylcholinesterase inhibitor",
      "Parasympathomimetic agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Pyridostigmine bromide"
  },
  {
    "kegg_id": "D09186",
    "name_en": "Neostigmine methylsulfate and atropine sulfate",
    "name_ja": "",
    "names_alt": [
      "Atvagoreverse (TN)"
    ],
    "formula": "",
    "efficacy": "Muscle relaxant antagonist, Parasympathomimetic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "1233",
    "atc_code": "N07AA51",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Neostigmine methylsulfate and atropine sulfate"
  },
  {
    "kegg_id": "D02069",
    "name_en": "Atropine sulfate (JP18/USP)",
    "name_ja": "アトロピン",
    "names_alt": [
      "Ryjusea (TN)"
    ],
    "formula": "(C17H23NO3)2. H2SO4. H2O",
    "efficacy": "Antispasmodic, Mydriatic, Muscarinic acetylcholine receptor antagonist",
    "target": "CHRM [HSA:1128 1129 1131 1132 1133] [KO:K04129 K04130 K04131 K04132 K04133]\nPATHWAY   hsa04020(1128+1129+1131+1133)  Calcium signaling pathway\nhsa04080(1128+1129+1131+1132+1133)  Neuroactive ligand-receptor interaction\nhsa04725(1128+1129+1131+1132+1133)  Cholinergic synapse\nhsa04971(1131)  Gastric acid secretion",
    "metabolism": "",
    "therapeutic_category": "1242",
    "atc_code": "A03BA01",
    "drug_class": [
      "Neuropsychiatric agent",
      "Muscarinic cholinergic receptor antagonist"
    ],
    "cyp_enzymes": [],
    "search_name": "Atropine sulfate"
  },
  {
    "kegg_id": "D01451",
    "name_en": "Scopolamine butylbromide (JP18)",
    "name_ja": "",
    "names_alt": [
      "Butylscopolamine bromide",
      "Buscopan (TN)"
    ],
    "formula": "C21H30NO4. Br",
    "efficacy": "Antispasmodic, Muscarinic acetylcholine receptor antagonist",
    "target": "CHRM [HSA:1128 1129 1131 1132 1133] [KO:K04129 K04130 K04131 K04132 K04133]\nPATHWAY   hsa04020(1128+1129+1131+1133)  Calcium signaling pathway\nhsa04080(1128+1129+1131+1132+1133)  Neuroactive ligand-receptor interaction\nhsa04725(1128+1129+1131+1132+1133)  Cholinergic synapse\nhsa04971(1131)  Gastric acid secretion",
    "metabolism": "",
    "therapeutic_category": "1242",
    "atc_code": "A03BB01",
    "drug_class": [
      "Neuropsychiatric agent",
      "Muscarinic cholinergic receptor antagonist",
      "Gastrointestinal agent",
      "Agents for peptic ulcer"
    ],
    "cyp_enzymes": [],
    "search_name": "Scopolamine butylbromide"
  },
  {
    "kegg_id": "D02218",
    "name_en": "Papaverine hydrochloride (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Pavabid (TN)"
    ],
    "formula": "C20H21NO4. HCl",
    "efficacy": "Antispasmodic, Smooth muscle relaxant, Vasodilator, Phosphodiesterase inhibitor",
    "target": "PDE [HSA:10846 27115 50940 5136 5137 5138 5139 5140 5141 5142 5143 5144 5150 5151 5153 8622] [KO:K18438 K18436 K13298 K13755 K18283 K19021 K13296 K13293 K18437]\nPATHWAY   hsa04020(5136+5137+5153)  Calcium signaling pathway\nhsa04022(5138+5139+5140)  cGMP-PKG signaling pathway\nhsa04024(10846+5139+5140+5141+5142+5143+5144)  cAMP signaling pathway",
    "metabolism": "",
    "therapeutic_category": "1243",
    "atc_code": "A03AD01",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Papaverine hydrochloride"
  },
  {
    "kegg_id": "D01108",
    "name_en": "Magnesium sulfate (USP)",
    "name_ja": "",
    "names_alt": [
      "Magnesium sulfate hydrate (JP18)",
      "Magnesium sulfate heptahydrate",
      "Conclyte-Mg (TN)"
    ],
    "formula": "SO4. 7H2O. Mg",
    "efficacy": "Antiarrhythmic, Laxative, Replenisher (electrolyte)\nDISEASE   Hypomagnesemia [DS:H01210]",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "1244",
    "atc_code": "A06AD04",
    "drug_class": [
      "Gastrointestinal agent",
      "Laxative",
      "Magnesium containing preparation"
    ],
    "cyp_enzymes": [],
    "search_name": "Magnesium sulfate"
  },
  {
    "kegg_id": "D02019",
    "name_en": "Magnesium sulfate hydrate and glucose",
    "name_ja": "",
    "names_alt": [
      "Magnesol (TN)"
    ],
    "formula": "",
    "efficacy": "Antispasmodic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "1244",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Magnesium sulfate hydrate and glucose"
  },
  {
    "kegg_id": "D04062",
    "name_en": "Scopolia extract (JP18)",
    "name_ja": "",
    "names_alt": [
      "Scopolia extract powder (JP18)"
    ],
    "formula": "",
    "efficacy": "Antispasmodic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "1245",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Scopolia extract"
  },
  {
    "kegg_id": "D01165",
    "name_en": "Piperidolate hydrochloride (JAN)",
    "name_ja": "",
    "names_alt": [
      "Dactil (TN)"
    ],
    "formula": "C21H25NO2. HCl",
    "efficacy": "Antispasmodic, Muscarinic acetylcholine receptor antagonist",
    "target": "CHRM [HSA:1128 1129 1131 1132 1133] [KO:K04129 K04130 K04131 K04132 K04133]\nPATHWAY   hsa04020(1128+1129+1131+1133)  Calcium signaling pathway\nhsa04024(1128+1129)  cAMP signaling pathway\nhsa04080(1128+1129+1131+1132+1133)  Neuroactive ligand-receptor interaction\nhsa04725(1128+1129+1131+1132+1133)  Cholinergic synapse\nhsa04970(1131)  Salivary secretion\nhsa04971(1131)  Gastric acid secretion\nhsa04972(1131)  Pancreatic secretion",
    "metabolism": "",
    "therapeutic_category": "1249",
    "atc_code": "A03AA30",
    "drug_class": [
      "Neuropsychiatric agent",
      "Muscarinic cholinergic receptor antagonist",
      "Gastrointestinal agent",
      "Agents for peptic ulcer"
    ],
    "cyp_enzymes": [],
    "search_name": "Piperidolate hydrochloride"
  },
  {
    "kegg_id": "D02535",
    "name_en": "Timepidium bromide hydrate (JP18)",
    "name_ja": "",
    "names_alt": [
      "Sesden (TN)"
    ],
    "formula": "C17H22NOS2. Br. H2O",
    "efficacy": "Antispasmodic, Muscarinic acetylcholine receptor antagonist",
    "target": "CHRM [HSA:1128 1129 1131 1132 1133] [KO:K04129 K04130 K04131 K04132 K04133]\nPATHWAY   hsa04020(1128+1129+1131+1133)  Calcium signaling pathway\nhsa04024(1128+1129)  cAMP signaling pathway\nhsa04080(1128+1129+1131+1132+1133)  Neuroactive ligand-receptor interaction\nhsa04725(1128+1129+1131+1132+1133)  Cholinergic synapse\nhsa04970(1131)  Salivary secretion\nhsa04971(1131)  Gastric acid secretion\nhsa04972(1131)  Pancreatic secretion",
    "metabolism": "",
    "therapeutic_category": "1249",
    "atc_code": "A03AB19",
    "drug_class": [
      "Neuropsychiatric agent",
      "Muscarinic cholinergic receptor antagonist",
      "Gastrointestinal agent",
      "Agents for peptic ulcer"
    ],
    "cyp_enzymes": [],
    "search_name": "Timepidium bromide hydrate"
  },
  {
    "kegg_id": "D01748",
    "name_en": "Isoxsuprine hydrochloride (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Duvadilan (TN)"
    ],
    "formula": "C18H23NO3. HCl",
    "efficacy": "Vasodilator, beta2-Adrenergic receptor agonist\nDISEASE   Arteriosclerosis obliterans [DS:H01626]\nThromboangiitis obliterans; Buerger's disease [DS:H01625]\nRaynaud's disease [DS:H01620]",
    "target": "ADRB2 [HSA:154] [KO:K04142]\nPATHWAY   hsa04080(154)  Neuroactive ligand-receptor interaction\nhsa04261(154)  Adrenergic signaling in cardiomyocytes",
    "metabolism": "",
    "therapeutic_category": "1249",
    "atc_code": "C04AA01",
    "drug_class": [
      "Cardiovascular agent",
      "Adrenergic receptor agonist",
      "beta-Adrenergic receptor agonist",
      "beta2-Adrenergic receptor agonist"
    ],
    "cyp_enzymes": [],
    "search_name": "Isoxsuprine hydrochloride"
  },
  {
    "kegg_id": "D00241",
    "name_en": "Baclofen (JP18/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Kemstro (TN)",
      "Lioresal (TN)"
    ],
    "formula": "C10H12ClNO2",
    "efficacy": "Antispasmodic, Muscle relaxant, GABA-B receptor agonist\nDISEASE   Multiple sclerosis [DS:H01490]",
    "target": "GABBR [HSA:2550 9568] [KO:K04615]\nPATHWAY   hsa04024(2550+9568)  cAMP signaling pathway\nhsa04080(2550+9568)  Neuroactive ligand-receptor interaction\nhsa04727(2550+9568)  GABAergic synapse",
    "metabolism": "",
    "therapeutic_category": "1249",
    "atc_code": "M03BX01",
    "drug_class": [
      "Neuropsychiatric agent",
      "GABA-B receptor agonist",
      "Musculo-skeletal system agent",
      "Muscle relaxant",
      "Centrally acting muscle relaxant"
    ],
    "cyp_enzymes": [],
    "search_name": "Baclofen"
  },
  {
    "kegg_id": "D00776",
    "name_en": "Tizanidine hydrochloride (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Zanaflex (TN)"
    ],
    "formula": "C9H8ClN5S. HCl",
    "efficacy": "Antispasmodic, Muscle relaxant, alpha2-Adrenergic receptor agonist",
    "target": "ADRA2 [HSA:150 151 152] [KO:K04138 K04139 K04140]\nPATHWAY   hsa04080(150+151+152)  Neuroactive ligand-receptor interaction",
    "metabolism": "Enzyme: CYP1A2 [HSA:1544]",
    "therapeutic_category": "1249",
    "atc_code": "M03BX02",
    "drug_class": [
      "Cardiovascular agent",
      "Adrenergic receptor agonist",
      "alpha-Adrenergic receptor agonist",
      "alpha2-Adrenergic receptor agonist",
      "Musculo-skeletal system agent",
      "Muscle relaxant",
      "Centrally acting muscle relaxant",
      "Metabolizing enzyme substrate",
      "CYP1A2 substrate"
    ],
    "cyp_enzymes": [
      "CYP1A2"
    ],
    "search_name": "Tizanidine hydrochloride"
  },
  {
    "kegg_id": "D01671",
    "name_en": "Eperisone hydrochloride (JP18)",
    "name_ja": "",
    "names_alt": [
      "Epenard (TN)"
    ],
    "formula": "C17H25NO. HCl",
    "efficacy": "Antispasmodic, Muscle relaxant",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "1249",
    "atc_code": "M03BX09",
    "drug_class": [
      "Musculo-skeletal system agent",
      "Muscle relaxant",
      "Centrally acting muscle relaxant"
    ],
    "cyp_enzymes": [],
    "search_name": "Eperisone hydrochloride"
  },
  {
    "kegg_id": "D01259",
    "name_en": "Flopropione (JP18/INN)",
    "name_ja": "",
    "names_alt": [
      "Ephtanon (TN)"
    ],
    "formula": "C9H10O4",
    "efficacy": "Antispasmodic, Cathechol-O-methyltransferase (COMT) inhibitor",
    "target": "COMT [HSA:1312] [KO:K00545]\nPATHWAY   hsa00140(1312)  Steroid hormone biosynthesis\nhsa00350(1312)  Tyrosine metabolism\nhsa04728(1312)  Dopaminergic synapse",
    "metabolism": "",
    "therapeutic_category": "1249",
    "atc_code": "",
    "drug_class": [
      "Neuropsychiatric agent",
      "Catechol O-methyltransferase inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Flopropione"
  },
  {
    "kegg_id": "D01638",
    "name_en": "Afloqualone (JP18/INN)",
    "name_ja": "",
    "names_alt": [
      "Airomate (TN)"
    ],
    "formula": "C16H14FN3O",
    "efficacy": "Muscle relaxant",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "1249",
    "atc_code": "",
    "drug_class": [
      "Musculo-skeletal system agent",
      "Muscle relaxant",
      "Centrally acting muscle relaxant"
    ],
    "cyp_enzymes": [],
    "search_name": "Afloqualone"
  },
  {
    "kegg_id": "D10939",
    "name_en": "Glycopyrronium tosylate (USAN)",
    "name_ja": "",
    "names_alt": [
      "Glycopyrronium tosilate hydrate (JAN)",
      "Glycopyrronium tosylate monohydrate",
      "Qbrexza (TN)",
      "Rapifort (TN)"
    ],
    "formula": "C19H28NO3. C7H7O3S. H2O",
    "efficacy": "Muscarinic acetylcholine receptor antagonist",
    "target": "CHRM [HSA:1128 1129 1131 1132 1133] [KO:K04129 K04130 K04131 K04132 K04133]\nPATHWAY   hsa04080(1128+1129+1131+1132+1133)  Neuroactive ligand-receptor interaction\nhsa04725(1128+1129+1131+1132+1133)  Cholinergic synapse",
    "metabolism": "",
    "therapeutic_category": "1259",
    "atc_code": "D11AA01",
    "drug_class": [
      "Neuropsychiatric agent",
      "Muscarinic cholinergic receptor antagonist"
    ],
    "cyp_enzymes": [],
    "search_name": "Glycopyrronium tosylate"
  },
  {
    "kegg_id": "D10989",
    "name_en": "Sofpironium bromide (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Ecclock (TN)",
      "Sofdra (TN)"
    ],
    "formula": "C22H32NO5. Br",
    "efficacy": "Anhidrotic",
    "target": "CHRM3 [HSA:1131] [KO:K04131]\nPATHWAY   hsa04080(1131)  Neuroactive ligand-receptor interaction\nhsa04725(1131)  Cholinergic synapse",
    "metabolism": "Enzyme: CYP2D6 [HSA:1565], CYP3A4 [HSA:1576]",
    "therapeutic_category": "1259",
    "atc_code": "D11AA02",
    "drug_class": [
      "Neuropsychiatric agent",
      "Muscarinic cholinergic receptor antagonist",
      "Metabolizing enzyme substrate",
      "CYP2D6 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4",
      "CYP2D6"
    ],
    "search_name": "Sofpironium bromide"
  },
  {
    "kegg_id": "D00722",
    "name_en": "Oxybutynin chloride (USP)",
    "name_ja": "",
    "names_alt": [
      "Oxybutynin hydrochloride (JP18)",
      "Ditropan (TN)",
      "Gelnique (TN)"
    ],
    "formula": "C22H31NO3. HCl",
    "efficacy": "Antipollakisuria, Overactive bladder agent, Muscarinic acetylcholine receptor antagonist",
    "target": "CHRM [HSA:1128 1129 1131 1132 1133] [KO:K04129 K04130 K04131 K04132 K04133]\nPATHWAY   hsa04020(1128+1129+1131+1133)  Calcium signaling pathway\nhsa04080(1128+1129+1131+1132+1133)  Neuroactive ligand-receptor interaction\nhsa04725(1128+1129+1131+1132+1133)  Cholinergic synapse",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576], CYP3A5 [HSA:1577]",
    "therapeutic_category": "1259",
    "atc_code": "G04BD04",
    "drug_class": [
      "Neuropsychiatric agent",
      "Muscarinic cholinergic receptor antagonist",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "CYP3A5 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4",
      "CYP3A5"
    ],
    "search_name": "Oxybutynin chloride"
  },
  {
    "kegg_id": "D00754",
    "name_en": "Thalidomide (JAN/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Thalomid (TN)",
      "Thaled (TN)"
    ],
    "formula": "C13H10N2O4",
    "efficacy": "Antibiotic, Antineoplastic\nDISEASE   Multiple myeloma [DS:H00010]\nErythema nodosum leprosum [DS:H01473]",
    "target": "TNF (TNFA, TNFSF2) [HSA:7124] [KO:K03156]\nPATHWAY   hsa04060(7124)  Cytokine-cytokine receptor interaction\nhsa04064(7124)  NF-kappa B signaling pathway\nhsa04640(7124)  Hematopoietic cell lineage\nhsa04668(7124)  TNF signaling pathway",
    "metabolism": "",
    "therapeutic_category": "1290",
    "atc_code": "L04AX02",
    "drug_class": [
      "Antineoplastic",
      "Thalidomide derivative"
    ],
    "cyp_enzymes": [],
    "search_name": "Thalidomide"
  },
  {
    "kegg_id": "D10689",
    "name_en": "Amifampridine phosphate (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Firdapse (TN)"
    ],
    "formula": "C5H7N3. H3PO4",
    "efficacy": "Autoimmune disease treatment, Potassium channel blocker\nDISEASE   Lambert-Eaton myasthenic syndrome [DS:H01596]",
    "target": "KCNA [HSA:3736 3737 3738 3739 3741 3742 3743 3744] [KO:K04874 K04875 K04876 K04877 K04878 K04879 K04880 K04881]\nKCNB [HSA:3745 9312] [KO:K04885 K04886]\nKCNC [HSA:3746 3747 3748 3749] [KO:K04887 K04888 K04889 K04890]\nKCND [HSA:3750 3751 3752] [KO:K04891 K04892 K04893]",
    "metabolism": "Enzyme: NAT [HSA:9 10]",
    "therapeutic_category": "1290",
    "atc_code": "N07XX05",
    "drug_class": [
      "Metabolizing enzyme substrate",
      "NAT substrate"
    ],
    "cyp_enzymes": [],
    "search_name": "Amifampridine phosphate"
  },
  {
    "kegg_id": "D09674",
    "name_en": "Tafamidis meglumine (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Vyndaqel (TN)"
    ],
    "formula": "C14H7Cl2NO3. C7H17NO5",
    "efficacy": "Amyloidogenesis suppressant\nDISEASE   Hereditary transthyretin-mediated amyloidosis [DS:H00845]",
    "target": "TTR [HSA:7276] [KO:K20731]\nPATHWAY   hsa04918(7276)  Thyroid hormone synthesis",
    "metabolism": "",
    "therapeutic_category": "1290",
    "atc_code": "N07XX08",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Tafamidis meglumine"
  },
  {
    "kegg_id": "D10794",
    "name_en": "Patisiran sodium (JAN)",
    "name_ja": "",
    "names_alt": [
      "Onpattro (TN)"
    ],
    "formula": "C412H480N148O290P40.40Na",
    "efficacy": "Gene expression regulator, Prealbumin expression inhibitor\nDISEASE   Hereditary transthyretin-mediated amyloidosis [DS:H00845]\nTYPE      RNA interference (RNAi) drug",
    "target": "TTR [HSA:7276] [KO:K20731] (mRNA)\nPATHWAY   hsa04918(7276)  Thyroid hormone synthesis",
    "metabolism": "",
    "therapeutic_category": "1290",
    "atc_code": "N07XX12",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Patisiran sodium"
  },
  {
    "kegg_id": "D11916",
    "name_en": "Vutrisiran sodium (JAN)",
    "name_ja": "",
    "names_alt": [
      "Amvuttra (TN)"
    ],
    "formula": "C530H672F9N171O323P43S6.43Na",
    "efficacy": "Gene expression regulator\nDISEASE   Polyneuropathy of hereditary transthyretin-mediated amyloidosis [DS:H00845]\nTYPE      RNA interference (RNAi) drug",
    "target": "TTR [HSA:7276] [KO:K20731] (mRNA)\nPATHWAY   hsa04918(7276)  Thyroid hormone synthesis",
    "metabolism": "",
    "therapeutic_category": "1290",
    "atc_code": "N07XX18",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Vutrisiran sodium"
  },
  {
    "kegg_id": "D10890",
    "name_en": "Difelikefalin acetate (JAN)",
    "name_ja": "",
    "names_alt": [
      "Korsuva (TN)"
    ],
    "formula": "C36H53N7O6. (C2H4O2)x",
    "efficacy": "Analgesic, Antipruritic, Opioid receptor agonist",
    "target": "OPRK1 [HSA:4986] [KO:K04214]\nPATHWAY   hsa04080(4986)  Neuroactive ligand-receptor interaction",
    "metabolism": "",
    "therapeutic_category": "1290",
    "atc_code": "V03AX04",
    "drug_class": [
      "Neuropsychiatric agent",
      "Opioid receptor agonist",
      "kappa-Opioid receptor agonist"
    ],
    "cyp_enzymes": [],
    "search_name": "Difelikefalin acetate"
  },
  {
    "kegg_id": "D00511",
    "name_en": "Phenylephrine hydrochloride (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Neo-synephrine (TN)"
    ],
    "formula": "C9H13NO2. HCl",
    "efficacy": "Antihypotensive, Midriatic, Vasoconstrictor, alpha1-Adrenergic receptor agonist",
    "target": "ADRA1 [HSA:148 147 146] [KO:K04135 K04136 K04137]\nPATHWAY   hsa04020(146+147+148)  Calcium signaling pathway\nhsa04080(146+147+148)  Neuroactive ligand-receptor interaction\nhsa04261(146+147+148)  Adrenergic signaling in cardiomyocytes\nhsa04270(146+147+148)  Vascular smooth muscle contraction",
    "metabolism": "",
    "therapeutic_category": "1311",
    "atc_code": "C01CA06",
    "drug_class": [
      "Cardiovascular agent",
      "Cardiotonic",
      "Phenethylamine cardiotonic",
      "Adrenergic receptor agonist",
      "alpha-Adrenergic receptor agonist",
      "alpha1-Adrenergic receptor agonist"
    ],
    "cyp_enzymes": [],
    "search_name": "Phenylephrine hydrochloride"
  },
  {
    "kegg_id": "D01002",
    "name_en": "Cyclopentolate hydrochloride (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Cyclogyl (TN)"
    ],
    "formula": "C17H25NO3. HCl",
    "efficacy": "Mydriatic, Muscarinic acetylcholine receptor antagonist",
    "target": "CHRM [HSA:1128 1129 1131 1132 1133] [KO:K04129 K04130 K04131 K04132 K04133]\nPATHWAY   hsa04080(1128+1129+1131+1132+1133)  Neuroactive ligand-receptor interaction\nhsa04725(1128+1129+1131+1132+1133)  Cholinergic synapse",
    "metabolism": "",
    "therapeutic_category": "1311",
    "atc_code": "S01FA04",
    "drug_class": [
      "Neuropsychiatric agent",
      "Muscarinic cholinergic receptor antagonist"
    ],
    "cyp_enzymes": [],
    "search_name": "Cyclopentolate hydrochloride"
  },
  {
    "kegg_id": "D00397",
    "name_en": "Tropicamide (JP18/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Mydriacyl (TN)"
    ],
    "formula": "C17H20N2O2",
    "efficacy": "Mydriatic, Muscarinic acetylcholine receptor antagonist",
    "target": "CHRM [HSA:1128 1129 1131 1132 1133] [KO:K04129 K04130 K04131 K04132 K04133]\nPATHWAY   hsa04020(1128+1129+1131+1133)  Calcium signaling pathway\nhsa04080(1128+1129+1131+1132+1133)  Neuroactive ligand-receptor interaction\nhsa04725(1128+1129+1131+1132+1133)  Cholinergic synapse\nhsa04970(1131)  Salivary secretion\nhsa04971(1131)  Gastric acid secretion",
    "metabolism": "",
    "therapeutic_category": "1311",
    "atc_code": "S01FA06",
    "drug_class": [
      "Neuropsychiatric agent",
      "Muscarinic cholinergic receptor antagonist"
    ],
    "cyp_enzymes": [],
    "search_name": "Tropicamide"
  },
  {
    "kegg_id": "D02200",
    "name_en": "Pilocarpine hydrochloride (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Isopto carpine (TN)",
      "Pilopine HS (TN)",
      "Salagen (TN)",
      "Sanpilo (TN)"
    ],
    "formula": "C11H16N2O2. HCl",
    "efficacy": "Antiglaucoma, Miotic, Salivation accelaletor, Muscarinic acetylcholine receptor agonist\nDISEASE   Open-angle glaucoma [DS:H00612]\nSjogren's Syndrome [DS:H01502]",
    "target": "CHRM3 [HSA:1131] [KO:K04131]\nCHRM2 [HSA:1129] [KO:K04130]\nPATHWAY   hsa04080(1129+1131)  Neuroactive ligand-receptor interaction\nhsa04725(1129+1131)  Cholinergic synapse\nhsa04970(1131)  Salivary secretion",
    "metabolism": "Enzyme: CYP2A6 [HSA:1548]",
    "therapeutic_category": "1312",
    "atc_code": "N07AX01",
    "drug_class": [
      "Neuropsychiatric agent",
      "Muscarinic cholinergic receptor agonist",
      "Parasympathomimetic agent",
      "Ophthalmic agent",
      "Intraocular pressure lowering agent",
      "Metabolizing enzyme substrate",
      "CYP2A6 substrate"
    ],
    "cyp_enzymes": [
      "CYP2A6"
    ],
    "search_name": "Pilocarpine hydrochloride"
  },
  {
    "kegg_id": "D01768",
    "name_en": "Benoxinate hydrochloride (USP)",
    "name_ja": "",
    "names_alt": [
      "Oxybuprocaine hydrochloride (JP18)",
      "Benoxil (TN)"
    ],
    "formula": "C17H28N2O3. HCl",
    "efficacy": "Anesthetic (topical)",
    "target": "SCN1A [HSA:6323] [KO:K04833]\nSCN2A [HSA:6326] [KO:K04834]\nSCN3A [HSA:6328] [KO:K04836]\nSCN4A [HSA:6329] [KO:K04837]\nSCN5A [HSA:6331] [KO:K04838]\nSCN8A [HSA:6334] [KO:K04840]\nSCN9A [HSA:6335] [KO:K04841]\nSCN10A [HSA:6336] [KO:K04842]\nSCN11A [HSA:11280] [KO:K04843]\nPATHWAY   hsa04728(6323)  Dopaminergic synapse",
    "metabolism": "",
    "therapeutic_category": "1313",
    "atc_code": "D04AB03",
    "drug_class": [
      "Neuropsychiatric agent",
      "Anesthetics",
      "Local anesthetic"
    ],
    "cyp_enzymes": [],
    "search_name": "Benoxinate hydrochloride"
  },
  {
    "kegg_id": "D01089",
    "name_en": "Boric acid (JP18/NF)",
    "name_ja": "",
    "names_alt": [],
    "formula": "H3BO3",
    "efficacy": "Antiseptic (ophthalmic)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "1314",
    "atc_code": "S02AA03",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Boric acid"
  },
  {
    "kegg_id": "D00292",
    "name_en": "Dexamethasone (JP18/USP/INN)",
    "name_ja": "デキサメタゾン",
    "names_alt": [
      "Decadron (TN)",
      "Maxidex (TN)"
    ],
    "formula": "C22H29FO5",
    "efficacy": "Anti-inflammatory, Antipruritic, Glucocorticoid receptor agonist\nDISEASE   Diabetic macular edema [DS:H01651]\nAsthma [DS:H00079]\nAtopic dermatitis [DS:H01358]\nContact dermatitis [DS:H01357]\nAllergic rhinitis [DS:H01360]\nBullous dermatitis herpetiformis [DS:H01362]\nMycosis fungoides [DS:H01463]\nPemphigus [DS:H01648]\nErythema multiforme [DS:H01695]\nStevens-Johnson syndrome [DS:H01694]\nCongenital adrenal hyperplasia [DS:H00216]\nUlcerative colitis [DS:H01466]\nAcquired (autoimmune) hemolytic anemia [DS:H01585]\nCongenital (erythroid) hypoplastic anemia; Diamond-Blackfan anemia [DS:H00237]\nPure red cell aplasia [DS:H01586]\nMultiple sclerosis [DS:H01490]\nTemporal arteritis [DS:H01698]\nNephrotic syndrome [DS:H01657]\nPulmonary tuberculosis [DS:H00342]\nAcute gouty arthritis [DS:H01532]\nAnkylosing spondylitis [DS:H01674]\nPsoriatic arthritis [DS:H01507]\nRheumatoid arthritis [DS:H00630]\nJuvenile rheumatoid arthritis [DS:H01672]\nDermatomyositis and polymyositis [DS:H01604]\nSystemic lupus erythematosus [DS:H00080]",
    "target": "NR3C1 (GR) [HSA:2908] [KO:K05771]\nPATHWAY   hsa04080(2908)  Neuroactive ligand-receptor interaction",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "1315",
    "atc_code": "A01AC02",
    "drug_class": [
      "Anti-inflammatory",
      "Corticosteroid",
      "Glucocorticoid",
      "Dermatological agent",
      "Atopic dermatitis agent",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "Metabolizing enzyme inducer",
      "CYP3A/CYP3A4 inducer",
      "CYP3A4 inducer"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Dexamethasone"
  },
  {
    "kegg_id": "D00975",
    "name_en": "Dexamethasone sodium phosphate (JAN/USP)",
    "name_ja": "デキサメタゾン",
    "names_alt": [
      "Dalalone (TN)",
      "Maxidex (TN)"
    ],
    "formula": "C22H28FO8P. 2Na",
    "efficacy": "Anti-inflammatory, Glucocorticoid receptor agonist\nDISEASE   Primary or secondary adrenocortical insufficiency [DS:H01598]\nCongenital adrenal hyperplasia [DS:H00216]\nRheumatoid arthritis [DS:H00630]\nJuvenile rheumatoid arthritis [DS:H01672]\nAcute gouty arthritis [DS:H01532]\nPsoriatic arthritis [DS:H01507]\nAnkylosing spondylitis [DS:H01674]\nSystemic lupus erythematosus [DS:H00080]\nPemphigus [DS:H01648]\nSevere erythema multiforme [DS:H01695]\nStevens-Johnson syndrome [DS:H01694]\nSeborrheic dermatitis [DS:H01652]\nPsoriasis [DS:H01656]\nMycosis fungoides [DS:H01463]\nBronchial asthma [DS:H00079]\nContact dermatitis [DS:H01357]\nAtopic dermatitis [DS:H01358]\nSeasonal or perennial allergic rhinitis [DS:H01360]\nHerpes zoster ophthalmicus [DS:H00366]\nOptic neuritis [DS:H01717]\nUlcerative colitis [DS:H01466]\nPulmonary tuberculosis [DS:H00342]\nAcquired (autoimmune) hemolytic anemia [DS:H01585]\nNephrotic syndrome [DS:H01657]",
    "target": "NR3C1 (GR) [HSA:2908] [KO:K05771]\nPATHWAY   hsa04080(2908)  Neuroactive ligand-receptor interaction",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "1315",
    "atc_code": "A01AC02",
    "drug_class": [
      "Anti-inflammatory",
      "Corticosteroid",
      "Glucocorticoid",
      "Dermatological agent",
      "Atopic dermatitis agent",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "Metabolizing enzyme inducer",
      "CYP3A/CYP3A4 inducer",
      "CYP3A4 inducer"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Dexamethasone sodium phosphate"
  },
  {
    "kegg_id": "D01510",
    "name_en": "Dexamethasone metasulfobenzoate sodium (JAN)",
    "name_ja": "デキサメタゾン",
    "names_alt": [
      "Dexamethazone metasulfobenzoate sodium",
      "Dexapos",
      "Santeson (TN)"
    ],
    "formula": "C29H32FO9S. Na",
    "efficacy": "Anti-inflammatory, Glucocorticoid receptor agonist",
    "target": "NR3C1 (GR) [HSA:2908] [KO:K05771]\nPATHWAY   hsa04080(2908)  Neuroactive ligand-receptor interaction",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "1315",
    "atc_code": "A01AC02",
    "drug_class": [
      "Anti-inflammatory",
      "Corticosteroid",
      "Glucocorticoid",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "Metabolizing enzyme inducer",
      "CYP3A/CYP3A4 inducer",
      "CYP3A4 inducer"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Dexamethasone metasulfobenzoate sodium"
  },
  {
    "kegg_id": "D00980",
    "name_en": "Prednisolone acetate (JP18/USP/INN)",
    "name_ja": "プレドニゾロン",
    "names_alt": [
      "Econopred (TN)",
      "Pred forte (TN)"
    ],
    "formula": "C23H30O6",
    "efficacy": "Anti-inflammatory, Glucocorticoid receptor agonist",
    "target": "NR3C1 (GR) [HSA:2908] [KO:K05771]\nPATHWAY   hsa04080(2908)  Neuroactive ligand-receptor interaction",
    "metabolism": "",
    "therapeutic_category": "1315",
    "atc_code": "A01AC04",
    "drug_class": [
      "Anti-inflammatory",
      "Corticosteroid",
      "Glucocorticoid"
    ],
    "cyp_enzymes": [],
    "search_name": "Prednisolone acetate"
  },
  {
    "kegg_id": "D00972",
    "name_en": "Betamethasone sodium phosphate (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Celestone (TN)"
    ],
    "formula": "C22H28FO8P. 2Na",
    "efficacy": "Anti-inflammatory, Antirheumatic, Glucocorticoid receptor agonist",
    "target": "NR3C1 (GR) [HSA:2908] [KO:K05771]\nPATHWAY   hsa04080(2908)  Neuroactive ligand-receptor interaction",
    "metabolism": "",
    "therapeutic_category": "1315",
    "atc_code": "A07EA04",
    "drug_class": [
      "Anti-inflammatory",
      "Corticosteroid",
      "Glucocorticoid"
    ],
    "cyp_enzymes": [],
    "search_name": "Betamethasone sodium phosphate"
  },
  {
    "kegg_id": "D01367",
    "name_en": "Fluorometholone (JP18/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "NSC 33001",
      "Fluor-op (TN)",
      "Fml (TN)",
      "Oxylone (TN)"
    ],
    "formula": "C22H29FO4",
    "efficacy": "Anti-inflammatory, Glucocorticoid receptor agonist",
    "target": "NR3C1 (GR) [HSA:2908] [KO:K05771]\nPATHWAY   hsa04080(2908)  Neuroactive ligand-receptor interaction",
    "metabolism": "",
    "therapeutic_category": "1315",
    "atc_code": "C05AA06",
    "drug_class": [
      "Anti-inflammatory",
      "Corticosteroid",
      "Glucocorticoid"
    ],
    "cyp_enzymes": [],
    "search_name": "Fluorometholone"
  },
  {
    "kegg_id": "D01021",
    "name_en": "Naphazoline nitrate (JP18)",
    "name_ja": "",
    "names_alt": [
      "Privine (TN)"
    ],
    "formula": "C14H14N2. HNO3",
    "efficacy": "Vasoconstrictor, alpha1-Adrenergic receptor agonist",
    "target": "ADRA1 [HSA:148 147 146] [KO:K04135 K04136 K04137]\nPATHWAY   hsa04080(146+147+148)  Neuroactive ligand-receptor interaction\nhsa04270(146+147+148)  Vascular smooth muscle contraction",
    "metabolism": "",
    "therapeutic_category": "1316",
    "atc_code": "R01AA08",
    "drug_class": [
      "Cardiovascular agent",
      "Adrenergic receptor agonist",
      "alpha-Adrenergic receptor agonist",
      "alpha1-Adrenergic receptor agonist"
    ],
    "cyp_enzymes": [],
    "search_name": "Naphazoline nitrate"
  },
  {
    "kegg_id": "D00884",
    "name_en": "Natamycin (USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Pimaricin (JP18)",
      "Natacyn (TN)"
    ],
    "formula": "C33H47NO13",
    "efficacy": "Antibacterial, Antifungal",
    "target": "Ergosterol",
    "metabolism": "",
    "therapeutic_category": "1317",
    "atc_code": "A01AB10",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Natamycin"
  },
  {
    "kegg_id": "D00104",
    "name_en": "Chloramphenicol (JP18/USP/INN)",
    "name_ja": "クロラムフェニコール",
    "names_alt": [
      "Amphicol (TN)",
      "Chloromycetin (TN)",
      "Econochlor (TN)"
    ],
    "formula": "C11H12Cl2N2O5",
    "efficacy": "Antibacterial, Antirickettsial, Protein biosynthesis inhibitor",
    "target": "50S ribosomal subunit\nPATHWAY   ko03010(K01980)  Ribosome",
    "metabolism": "",
    "therapeutic_category": "1317",
    "atc_code": "D06AX02",
    "drug_class": [
      "Antibacterial",
      "Amphenicol type antibacterial",
      "Metabolizing enzyme inhibitor",
      "CYP2C19 inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Chloramphenicol"
  },
  {
    "kegg_id": "D01063",
    "name_en": "Gentamicin sulfate (JP18/USP)",
    "name_ja": "ゲンタマイシン",
    "names_alt": [
      "Garamycin (TN)",
      "Gentacin (TN)"
    ],
    "formula": "C19H37N5O7(R1)(R2). H2SO4",
    "efficacy": "Antibacterial, Protein biosynthesis inhibitor\nDISEASE   Bacterial endocarditis [DS:H00334]",
    "target": "30S ribosomal subunit\nPATHWAY   ko03010(K01977)  Ribosome",
    "metabolism": "",
    "therapeutic_category": "1317",
    "atc_code": "D06AX07",
    "drug_class": [
      "Antibacterial",
      "Aminoglycoside antibiotic"
    ],
    "cyp_enzymes": [],
    "search_name": "Gentamicin sulfate"
  },
  {
    "kegg_id": "D01739",
    "name_en": "Cefmenoxime hydrochloride (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Bestcall (TN)"
    ],
    "formula": "(C16H17N9O5S3)2. HCl",
    "efficacy": "Antibacterial, Cell wall biosynthesis inhibitor",
    "target": "penicillin binding protein\nPATHWAY   ko00550  Peptidoglycan biosynthesis",
    "metabolism": "",
    "therapeutic_category": "1317",
    "atc_code": "J01DD05",
    "drug_class": [
      "Antibacterial",
      "beta-Lactam antibiotic",
      "Cephalosporin skeleton group",
      "Cephem",
      "Third-generation cephalosporin",
      "Oxyimino beta-lactam"
    ],
    "cyp_enzymes": [],
    "search_name": "Cefmenoxime hydrochloride"
  },
  {
    "kegg_id": "D02134",
    "name_en": "Azithromycin hydrate (JP18)",
    "name_ja": "アジスロマイシン",
    "names_alt": [
      "Azithromycin dihydrate",
      "Zithromac (TN)",
      "Zmax (TN)",
      "Azimycin (TN)"
    ],
    "formula": "C38H72N2O12. 2H2O",
    "efficacy": "Antibacterial, Protein biosynthesis inhibitor\nDISEASE   Urethritis due to Chlamydia trachomatis [DS:H00347]\nDisseminated Mycobacterium avium complex (MAC) disease [DS:H01458]",
    "target": "50S ribosomal subunit\nPATHWAY   ko03010(K01980)  Ribosome",
    "metabolism": "Transporter: ABCB1 [HSA:5243]",
    "therapeutic_category": "1317",
    "atc_code": "J01FA10",
    "drug_class": [
      "Antibacterial",
      "Macrolide antibiotic",
      "15-Membered ring macrolide antibiotic",
      "Transporter substrate",
      "ABCB1 substrate",
      "Transporter inhibitor",
      "ABCB1 inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Azithromycin hydrate"
  },
  {
    "kegg_id": "D00063",
    "name_en": "Tobramycin (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Tobi (TN)",
      "Tobracin (TN)",
      "Tobrex (TN)",
      "Bethkis (TN)"
    ],
    "formula": "C18H37N5O9",
    "efficacy": "Antibacterial, Protein biosynthesis inhibitor\nDISEASE   Cystic fibrosis patients with Pseudomonas aeruginosa [DS:H00218]",
    "target": "50S ribosomal subunit\n30S ribosomal subunit\nPATHWAY   ko03010(K01977)  Ribosome",
    "metabolism": "",
    "therapeutic_category": "1317",
    "atc_code": "J01GB01",
    "drug_class": [
      "Antibacterial",
      "Aminoglycoside antibiotic"
    ],
    "cyp_enzymes": [],
    "search_name": "Tobramycin"
  },
  {
    "kegg_id": "D01753",
    "name_en": "Dibekacin sulfate (JP18)",
    "name_ja": "",
    "names_alt": [
      "Panimycin (TN)"
    ],
    "formula": "C18H37N5O8. xH2SO4",
    "efficacy": "Antibacterial, Protein biosynthesis inhibitor",
    "target": "30S ribosomal subunit\nPATHWAY   ko03010(K01977)  Ribosome",
    "metabolism": "",
    "therapeutic_category": "1317",
    "atc_code": "J01GB09",
    "drug_class": [
      "Antibacterial",
      "Aminoglycoside antibiotic"
    ],
    "cyp_enzymes": [],
    "search_name": "Dibekacin sulfate"
  },
  {
    "kegg_id": "D00208",
    "name_en": "Mitomycin (USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Mitomycin C (JP18)",
      "MMC",
      "Jelmyto (TN)",
      "Muamycin (TN)"
    ],
    "formula": "C15H18N4O5",
    "efficacy": "Antineoplastic\nDISEASE   Glaucoma [DS:H00612]\nUpper tract urothelial cancer [DS:H00022]\nAdenocarcinoma of the stomach or pancreas [DS:H00018 H00019]",
    "target": "DNA",
    "metabolism": "",
    "therapeutic_category": "1317",
    "atc_code": "L01DC03",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Mitomycin"
  },
  {
    "kegg_id": "D00983",
    "name_en": "Triamcinolone acetonide (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Azmacort (TN)",
      "Kenalog (TN)",
      "Nasacort (TN)"
    ],
    "formula": "C24H31FO6",
    "efficacy": "Antiasthmatic, Anti-inflammatory, Antirheumatic, Glucocorticoid receptor agonist\nDISEASE   Asthma [DS:H00079]\nAtopic dermatitis [DS:H01358]\nContact dermatitis [DS:H01357]\nPerennial or seasonal allergic rhinitis [DS:H01360]\nBullous dermatitis herpetiformis [DS:H01362]\nMycosis fungoides [DS:H01463]\nPemphigus [DS:H01648]\nErythema multiforme [DS:H01695]\nStevens-Johnson syndrome [DS:H01694]\nPrimary adrenocortical insufficiency [DS:H01598]\nCongenital adrenal hyperplasia [DS:H00216]\nUlcerative colitis [DS:H01466]\nAcquired (autoimmune) hemolytic anemia [DS:H01585]\nDiamond-Blackfan anemia [DS:H00237]\nPure red cell aplasia [DS:H01586]\nThrombocytopenia [DS:H00978]\nMultiple sclerosis [DS:H01490]\nTemporal arteritis [DS:H01698]\nNephrotic syndrome [DS:H01657]\nPulmonary tuberculosis [DS:H00342]\nAnkylosing spondylitis [DS:H01674]\nPsoriatic arthritis [DS:H01507]\nRheumatoid arthritis [DS:H00630]\nJuvenile rheumatoid arthritis [DS:H01672]\nDermatomyositis and polymyositis [DS:H01604]\nSystemic lupus erythematosus [DS:H00080]",
    "target": "NR3C1 (GR) [HSA:2908] [KO:K05771]\nPATHWAY   hsa04080(2908)  Neuroactive ligand-receptor interaction",
    "metabolism": "",
    "therapeutic_category": "1319",
    "atc_code": "A01AC01",
    "drug_class": [
      "Anti-inflammatory",
      "Corticosteroid",
      "Glucocorticoid",
      "Dermatological agent",
      "Atopic dermatitis agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Triamcinolone acetonide"
  },
  {
    "kegg_id": "D01121",
    "name_en": "Rebamipide (JP18/INN)",
    "name_ja": "",
    "names_alt": [
      "Mucosta (TN)"
    ],
    "formula": "C19H15ClN2O4",
    "efficacy": "Anti-ulcerative, Mucin production accelerator",
    "target": "",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "1319",
    "atc_code": "A02BX14",
    "drug_class": [
      "Gastrointestinal agent",
      "Agents for peptic ulcer",
      "Gastric mucosal protectant",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Rebamipide"
  },
  {
    "kegg_id": "D00526",
    "name_en": "Cromolyn sodium (USP)",
    "name_ja": "",
    "names_alt": [
      "Sodium cromoglicate (JP18)",
      "Gastrocrom (TN)",
      "Intal (TN)"
    ],
    "formula": "C23H14O11. 2Na",
    "efficacy": "Antiallergic, Antiasthmatic, Chemical mediator release inhibitor",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "1319",
    "atc_code": "A07EB01",
    "drug_class": [
      "Anti-allergic agent",
      "Mediator release inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Cromolyn sodium"
  },
  {
    "kegg_id": "D00166",
    "name_en": "Cyanocobalamin (JP18/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Cyomin (TN)",
      "Nascobal (TN)",
      "Rubramin PC (TN)"
    ],
    "formula": "C63H88CoN14O14P",
    "efficacy": "Anti-anemic, Hematopoietic, Supplement (vitamin B12)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "1319",
    "atc_code": "B03BA01",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Cyanocobalamin"
  },
  {
    "kegg_id": "D00603",
    "name_en": "Timolol maleate (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Blocadren (TN)",
      "Istalol (TN)",
      "Timoptic (TN)"
    ],
    "formula": "C13H24N4O3S. C4H4O4",
    "efficacy": "Antiglaucoma, beta-Adrenergic receptor antagonist\nDISEASE   Open-angle glaucoma [DS:H00612]",
    "target": "ADRB1 [HSA:153] [KO:K04141]\nADRB2 [HSA:154] [KO:K04142]\nPATHWAY   hsa04020(153+154)  Calcium signaling pathway\nhsa04022(153+154)  cGMP-PKG signaling pathway\nhsa04024(153+154)  cAMP signaling pathway\nhsa04080(153+154)  Neuroactive ligand-receptor interaction\nhsa04261(153+154)  Adrenergic signaling in cardiomyocytes",
    "metabolism": "Enzyme: CYP2D6 [HSA:1565]",
    "therapeutic_category": "1319",
    "atc_code": "C07AA06",
    "drug_class": [
      "Cardiovascular agent",
      "Adrenergic receptor antagonist",
      "beta-Adrenergic receptor antagonist (Beta blocker)",
      "Ophthalmic agent",
      "Intraocular pressure lowering agent",
      "Metabolizing enzyme substrate",
      "CYP2D6 substrate"
    ],
    "cyp_enzymes": [
      "CYP2D6"
    ],
    "search_name": "Timolol maleate"
  },
  {
    "kegg_id": "D00599",
    "name_en": "Carteolol hydrochloride (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Cartrol (TN)",
      "Ocupress (TN)"
    ],
    "formula": "C16H24N2O3. HCl",
    "efficacy": "Antiglaucoma, Antiarrhythmic, Antihypertensive, beta-Adrenergic receptor antagonist\nDISEASE   Chronic open-angle glaucoma [DS:H00612]",
    "target": "ADRB [HSA:153 154 155] [KO:K04141 K04142 K04143]\nPATHWAY   hsa04020(153+154+155)  Calcium signaling pathway\nhsa04022(153+154+155)  cGMP-PKG signaling pathway\nhsa04024(153+154)  cAMP signaling pathway\nhsa04080(153+154+155)  Neuroactive ligand-receptor interaction\nhsa04261(153+154)  Adrenergic signaling in cardiomyocytes\nhsa04540(153)  Gap junction",
    "metabolism": "Enzyme: CYP2D6 [HSA:1565]",
    "therapeutic_category": "1319",
    "atc_code": "C07AA15",
    "drug_class": [
      "Cardiovascular agent",
      "Adrenergic receptor antagonist",
      "beta-Adrenergic receptor antagonist (Beta blocker)",
      "Antiarrhythmics",
      "Class II antiarrhythmic agent",
      "Antihypertensive",
      "Ophthalmic agent",
      "Intraocular pressure lowering agent",
      "Metabolizing enzyme substrate",
      "CYP2D6 substrate"
    ],
    "cyp_enzymes": [
      "CYP2D6"
    ],
    "search_name": "Carteolol hydrochloride"
  },
  {
    "kegg_id": "D00598",
    "name_en": "Betaxolol hydrochloride (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Betoptic (TN)",
      "Kerlone (TN)"
    ],
    "formula": "C18H29NO3. HCl",
    "efficacy": "Antiglaucoma, Antihypertensive, Vasodilator, beta1-Adrenergic receptor antagonist\nDISEASE   Chronic open-angle glaucoma [DS:H00612]\nHypertension [DS:H01633]",
    "target": "ADRB1 [HSA:153] [KO:K04141]\nPATHWAY   hsa04020(153)  Calcium signaling pathway\nhsa04022(153)  cGMP-PKG signaling pathway\nhsa04024(153)  cAMP signaling pathway\nhsa04080(153)  Neuroactive ligand-receptor interaction\nhsa04261(153)  Adrenergic signaling in cardiomyocytes",
    "metabolism": "",
    "therapeutic_category": "1319",
    "atc_code": "C07AB05",
    "drug_class": [
      "Cardiovascular agent",
      "Adrenergic receptor antagonist",
      "beta-Adrenergic receptor antagonist (Beta blocker)",
      "beta1-Adrenergic receptor antagonist",
      "Antihypertensive",
      "Ophthalmic agent",
      "Intraocular pressure lowering agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Betaxolol hydrochloride"
  },
  {
    "kegg_id": "D03354",
    "name_en": "Hyaluronate sodium (USAN)",
    "name_ja": "",
    "names_alt": [
      "Purified sodium hyaluronate (JP18)",
      "Sodium hyaluronate (JAN)",
      "Legend (TN)"
    ],
    "formula": "(C14H20NO11. Na)n",
    "efficacy": "Joint function improving agent, Keratoconjunctival protection, Ophthalmic surgery adjunct",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "1319",
    "atc_code": "D03AX05",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Hyaluronate sodium"
  },
  {
    "kegg_id": "D00222",
    "name_en": "Acyclovir (USP)",
    "name_ja": "アシクロビル",
    "names_alt": [
      "Aciclovir (JP18/INN)",
      "Sitavig (TN)",
      "Zovirax (TN)"
    ],
    "formula": "C8H11N5O3",
    "efficacy": "Antiviral, DNA polymerase inhibitor\nDISEASE   Herpes simplex virus infection [DS:H00365]\nHerpes zoster infection [DS:H00366]\nChickenpox [DS:H00366]",
    "target": "Herpesvirus DNA polymerase [KO:K18964]\nPATHWAY   ko03240(K18964)  Viral replication",
    "metabolism": "Transporter: SLC22A1 [HSA:6580], SLC22A6 [HSA:9356], SLC22A8 [HSA:9376]",
    "therapeutic_category": "1319",
    "atc_code": "D06BB03",
    "drug_class": [
      "Antiviral",
      "Anti-herpesvirus agent",
      "Transporter substrate",
      "SLC22A1 substrate",
      "SLC22A6 substrate",
      "SLC22A8 substrate"
    ],
    "cyp_enzymes": [],
    "search_name": "Acyclovir"
  },
  {
    "kegg_id": "D04250",
    "name_en": "Fradiomycin sulfate and methylprednisolone",
    "name_ja": "",
    "names_alt": [
      "Neo medrol EE (TN)"
    ],
    "formula": "",
    "efficacy": "Antibacterial",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "1319",
    "atc_code": "D07CA02",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Fradiomycin sulfate and methylprednisolone"
  },
  {
    "kegg_id": "D01730",
    "name_en": "Silver nitrate (JP18/USP)",
    "name_ja": "",
    "names_alt": [],
    "formula": "Ag. NO3",
    "efficacy": "Disinfectant, Emollient",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "1319",
    "atc_code": "D08AL01",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Silver nitrate"
  },
  {
    "kegg_id": "D00107",
    "name_en": "Tacrolimus (USP/INN)",
    "name_ja": "タクロリムス",
    "names_alt": [
      "Tacrolimus hydrate (JP18)",
      "Prograf (TN)",
      "Protopic (TN)"
    ],
    "formula": "C44H69NO12. H2O",
    "efficacy": "Antiallergic, Immunosuppressant, Calcineurin inhibitor\nDISEASE   Organ rejection in kidney transplant [DS:H00083]\nOrgan rejection in liver transplant [DS:H00083]\nOrgan rejection in heart transplant [DS:H00083]\nAtopic dermatitis [DS:H01358]",
    "target": "PPP3C/PPP3R/CHP [HSA:5530 5532 5533 5534 5535 11261 63928] [KO:K04348 K06268 K17610 K17611]\nPATHWAY   hsa04010(5530+5532+5533+5534+5535)  MAPK signaling pathway\nhsa04218(5530+5532+5533+5534+5535)  Cellular senescence\nhsa04380(5530+5532+5533+5534+5535)  Osteoclast differentiation\nhsa04650(5530+5532+5533+5534+5535)  Natural killer cell mediated cytotoxicity\nhsa04658(5530+5532+5533+5534+5535)  Th1 and Th2 cell differentiation\nhsa04659(5530+5532+5533+5534+5535)  Th17 cell differentiation\nhsa04660(5530+5532+5533+5534+5535)  T cell receptor signaling pathway",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "1319",
    "atc_code": "D11AH01",
    "drug_class": [
      "Immunological agent",
      "Calcineurin inhibitor",
      "Anti-inflammatory",
      "Disease modifying anti-rheumatic drug (DMARD)",
      "Dermatological agent",
      "Atopic dermatitis agent",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Tacrolimus"
  },
  {
    "kegg_id": "D02076",
    "name_en": "Brimonidine tartrate (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Alphagan (TN)"
    ],
    "formula": "C11H10BrN5. C4H6O6",
    "efficacy": "Antiglaucoma, alpha-Adrenergic receptor agonist\nDISEASE   Open-angle glaucoma [DS:H00612]",
    "target": "ADRA2 [HSA:150 151 152] [KO:K04138 K04139 K04140]\nPATHWAY   hsa04080(150+151+152)  Neuroactive ligand-receptor interaction",
    "metabolism": "",
    "therapeutic_category": "1319",
    "atc_code": "D11AX21",
    "drug_class": [
      "Cardiovascular agent",
      "Adrenergic receptor agonist",
      "alpha-Adrenergic receptor agonist",
      "alpha2-Adrenergic receptor agonist",
      "Ophthalmic agent",
      "Intraocular pressure lowering agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Brimonidine tartrate"
  },
  {
    "kegg_id": "D01022",
    "name_en": "Oxymetazoline hydrochloride (JAN/USP)",
    "name_ja": "",
    "names_alt": [
      "Ocuclear (TN)",
      "Rhfade (TN)",
      "Upneeq (TN)"
    ],
    "formula": "C16H24N2O. HCl",
    "efficacy": "Muscle contraction agent, Vasoconstrictor, alpha1-Adrenergic receptor agonist",
    "target": "ADRA1A [HSA:148] [KO:K04135]\nPATHWAY   hsa04080(148)  Neuroactive ligand-receptor interaction\nhsa04270(148)  Vascular smooth muscle contraction",
    "metabolism": "",
    "therapeutic_category": "1319",
    "atc_code": "D11AX27",
    "drug_class": [
      "Cardiovascular agent",
      "Adrenergic receptor agonist",
      "alpha-Adrenergic receptor agonist",
      "alpha1-Adrenergic receptor agonist"
    ],
    "cyp_enzymes": [],
    "search_name": "Oxymetazoline hydrochloride"
  },
  {
    "kegg_id": "D00453",
    "name_en": "Ofloxacin (JP18/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Floxin (TN)"
    ],
    "formula": "C18H20FN3O4",
    "efficacy": "Antibacterial, Nucleic acid biosynthesis inhibitor",
    "target": "DNA gyrase [KO:K02469 K02470]\ntopoisomerase IV [KO:K02621 K02622]",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "1319",
    "atc_code": "J01MA01",
    "drug_class": [
      "Antibacterial",
      "Quinolone",
      "Fluoroquinolone",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Ofloxacin"
  },
  {
    "kegg_id": "D00210",
    "name_en": "Norfloxacin (JP18/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Noroxin (TN)"
    ],
    "formula": "C16H18FN3O3",
    "efficacy": "Antibacterial, Nucleic acid biosynthesis inhibitor",
    "target": "DNA gyrase [KO:K02469 K02470]",
    "metabolism": "Enzyme: CYP1A2 [HSA:1544]",
    "therapeutic_category": "1319",
    "atc_code": "J01MA06",
    "drug_class": [
      "Antibacterial",
      "Quinolone",
      "Fluoroquinolone",
      "Metabolizing enzyme substrate",
      "CYP1A2 substrate",
      "Metabolizing enzyme inhibitor",
      "CYP1A2 inhibitor",
      "CYP3A/CYP3A4 inhibitor"
    ],
    "cyp_enzymes": [
      "CYP1A2"
    ],
    "search_name": "Norfloxacin"
  },
  {
    "kegg_id": "D00873",
    "name_en": "Lomefloxacin hydrochloride (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Maxaquin (TN)"
    ],
    "formula": "C17H19F2N3O3. HCl",
    "efficacy": "Antibacterial, Nucleic acid biosynthesis inhibitor",
    "target": "DNA gyrase [KO:K02469 K02470]",
    "metabolism": "",
    "therapeutic_category": "1319",
    "atc_code": "J01MA07",
    "drug_class": [
      "Antibacterial",
      "Quinolone",
      "Fluoroquinolone"
    ],
    "cyp_enzymes": [],
    "search_name": "Lomefloxacin hydrochloride"
  },
  {
    "kegg_id": "D00588",
    "name_en": "Levofloxacin (USP)",
    "name_ja": "レボフロキサシン",
    "names_alt": [
      "Levofloxacin hydrate (JP18)",
      "Levofloxacin hemihydrate",
      "Iquix (TN)",
      "Levaquin (TN)",
      "Quixin (TN)"
    ],
    "formula": "(C18H20FN3O4)2. H2O",
    "efficacy": "Antibacterial, Nucleic acid biosynthesis inhibitor\nDISEASE   Inhalational anthrax [DS:H00328]\nPlague [DS:H00297]\nUncomplicated urinary tract infections [DS:H01176]",
    "target": "DNA gyrase [KO:K02469 K02470]\ntopoisomerase IV [KO:K02621 K02622]",
    "metabolism": "Transporter: SLCO1A2 [HSA:6579]",
    "therapeutic_category": "1319",
    "atc_code": "J01MA12",
    "drug_class": [
      "Antibacterial",
      "Quinolone",
      "Fluoroquinolone",
      "Antitubercular",
      "Transporter substrate",
      "SLCO1A2 substrate"
    ],
    "cyp_enzymes": [],
    "search_name": "Levofloxacin"
  },
  {
    "kegg_id": "D00874",
    "name_en": "Moxifloxacin hydrochloride (JAN/USP)",
    "name_ja": "",
    "names_alt": [
      "Avelox (TN)",
      "Vigamox (TN)"
    ],
    "formula": "C21H24FN3O4. HCl",
    "efficacy": "Antibacterial, Nucleic acid biosynthesis inhibitor\nDISEASE   Plague [DS:H00297]\nBacterial conjunctivitis [DS:H01366]",
    "target": "DNA gyrase [KO:K02469 K02470]\ntopoisomerase IV [KO:K02621 K02622]",
    "metabolism": "",
    "therapeutic_category": "1319",
    "atc_code": "J01MA14",
    "drug_class": [
      "Antibacterial",
      "Quinolone",
      "Fluoroquinolone"
    ],
    "cyp_enzymes": [],
    "search_name": "Moxifloxacin hydrochloride"
  },
  {
    "kegg_id": "D00589",
    "name_en": "Gatifloxacin (USAN)",
    "name_ja": "",
    "names_alt": [
      "Gatifloxacin hydrate (JP18)",
      "GFLX",
      "Gatiflo (TN)",
      "Tequin (TN)",
      "Zymar (TN)",
      "Zymaxid (TN)"
    ],
    "formula": "(C19H22FN3O4)2. 3H2O",
    "efficacy": "Antibacterial, Nucleic acid biosynthesis inhibitor\nDISEASE   Bacterial conjunctivitis [DS:H01366]",
    "target": "DNA gyrase [KO:K02469 K02470]\ntopoisomerase IV [KO:K02621 K02622]",
    "metabolism": "",
    "therapeutic_category": "1319",
    "atc_code": "J01MA16",
    "drug_class": [
      "Antibacterial",
      "Quinolone",
      "Fluoroquinolone"
    ],
    "cyp_enzymes": [],
    "search_name": "Gatifloxacin"
  },
  {
    "kegg_id": "D01996",
    "name_en": "Tosufloxacin tosylate hydrate (JP18)",
    "name_ja": "",
    "names_alt": [
      "Tosufloxacin tosilate",
      "Ozex (TN)",
      "Tosuxacin (TN)"
    ],
    "formula": "C19H15F3N4O3. C7H8O3S. H2O",
    "efficacy": "Antibacterial, Nucleic acid biosynthesis inhibitor",
    "target": "DNA gyrase [KO:K02469 K02470]\ntopoisomerase IV [KO:K02621 K02622]",
    "metabolism": "",
    "therapeutic_category": "1319",
    "atc_code": "J01MA22",
    "drug_class": [
      "Antibacterial",
      "Quinolone",
      "Fluoroquinolone"
    ],
    "cyp_enzymes": [],
    "search_name": "Tosufloxacin tosylate hydrate"
  },
  {
    "kegg_id": "D09574",
    "name_en": "Aflibercept (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Aflibercept (genetical recombination) (JAN)",
      "Aflibercept (genetical recombination) [Aflibercept biosimilar 1] (JAN)",
      "Aflibercept (genetical recombination) [Aflibercept biosimilar 2] (JAN)",
      "Aflibercept (genetical recombination) [Aflibercept biosimilar 3] (JAN)",
      "Ziv-aflibercept",
      "Aflibercept-mrbb",
      "Eylea (TN)",
      "Zaltrap (TN)",
      "Ahzantive (TN)"
    ],
    "formula": "C4318H6788N1164O1304S32",
    "efficacy": "Angiogenesis inhibitor\nDISEASE   Age-related macular degeneration [DS:H00821]\nMacular edema [DS:H01651]\nDiabetic macular edema [DS:H01651]\nDiabetic retinopathy [DS:H01457]\nColorectal cancer [DS:H00020]",
    "target": "VEGFA [HSA:7422] [KO:K05448]\nVEGFB [HSA:7423] [KO:K16858]\nPGF [HSA:5228] [KO:K16859]\nPATHWAY   hsa04370(7422)  VEGF signaling pathway\nhsa05200(5228+7422+7423)  Pathways in cancer",
    "metabolism": "",
    "therapeutic_category": "1319",
    "atc_code": "L01XX44",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Aflibercept"
  },
  {
    "kegg_id": "D00184",
    "name_en": "Cyclosporine (USP)",
    "name_ja": "シクロスポリン",
    "names_alt": [
      "Ciclosporin (JP18)",
      "Gengraf (TN)",
      "Neoral (TN)",
      "Restasis (TN)",
      "Sandimmune (TN)"
    ],
    "formula": "C62H111N11O12",
    "efficacy": "Immunosuppressant, Calcineurin inhibitor\nDISEASE   Keratoconjunctivitis sicca [DS:H01641]\nOrgan rejection in kidney, liver, and heart allogeneic transplants [DS:H00083]\nRheumatoid arthritis [DS:H00630]\nPsoriasis [DS:H01656]",
    "target": "PPP3C/PPP3R/CHP [HSA:5530 5532 5533 5534 5535 11261 63928] [KO:K04348 K06268 K17610 K17611]\nPATHWAY   hsa04010(5530+5532+5533+5534+5535)  MAPK signaling pathway\nhsa04218(5530+5532+5533+5534+5535)  Cellular senescence\nhsa04380(5530+5532+5533+5534+5535)  Osteoclast differentiation\nhsa04650(5530+5532+5533+5534+5535)  Natural killer cell mediated cytotoxicity\nhsa04658(5530+5532+5533+5534+5535)  Th1 and Th2 cell differentiation\nhsa04659(5530+5532+5533+5534+5535)  Th17 cell differentiation\nhsa04660(5530+5532+5533+5534+5535)  T cell receptor signaling pathway",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "1319",
    "atc_code": "L04AD01",
    "drug_class": [
      "Immunological agent",
      "Calcineurin inhibitor",
      "Dermatological agent",
      "Atopic dermatitis agent",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "Metabolizing enzyme inhibitor",
      "CYP3A/CYP3A4 inhibitor",
      "CYP3A4 inhibitor",
      "Transporter inhibitor",
      "ABCB1 inhibitor"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Cyclosporine"
  },
  {
    "kegg_id": "D04078",
    "name_en": "Chondroitin sulfate sodium (JAN)",
    "name_ja": "",
    "names_alt": [
      "Chondron (TN)"
    ],
    "formula": "(C14H20NO14S. Na)n",
    "efficacy": "Analgesic, Anti-inflammatory, Corneal protection",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "1319",
    "atc_code": "M01AX25",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Chondroitin sulfate sodium"
  },
  {
    "kegg_id": "D04114",
    "name_en": "Neostigmine methylsulfate and inorganic salt",
    "name_ja": "",
    "names_alt": [
      "Miopin (TN)"
    ],
    "formula": "",
    "efficacy": "Anti-accommondation disturbance, Acetylcholinesterase inhibitor",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "1319",
    "atc_code": "N07AA51",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Neostigmine methylsulfate and inorganic salt"
  },
  {
    "kegg_id": "D01717",
    "name_en": "Levocabastine hydrochloride (JAN/USP)",
    "name_ja": "",
    "names_alt": [
      "Livostin (TN)"
    ],
    "formula": "C26H29FN2O2. HCl",
    "efficacy": "Antiallergic, H1 receptor antagonist",
    "target": "HRH1 [HSA:3269] [KO:K04149]\nPATHWAY   hsa04020(3269)  Calcium signaling pathway\nhsa04080(3269)  Neuroactive ligand-receptor interaction",
    "metabolism": "",
    "therapeutic_category": "1319",
    "atc_code": "R01AC02",
    "drug_class": [
      "Anti-allergic agent",
      "Histamine receptor antagonist",
      "Histamine receptor H1 antagonist"
    ],
    "cyp_enzymes": [],
    "search_name": "Levocabastine hydrochloride"
  },
  {
    "kegg_id": "D01192",
    "name_en": "Olopatadine hydrochloride (JP18/USP)",
    "name_ja": "オロパタジン",
    "names_alt": [
      "Allelock (TN)",
      "Patanol (TN)",
      "Opatanol (TN)"
    ],
    "formula": "C21H23NO3. HCl",
    "efficacy": "Antiallergic, H1 receptor antagonist\nDISEASE   Seasonal allergic rhinitis [DS:H01360]",
    "target": "HRH1 [HSA:3269] [KO:K04149]\nPATHWAY   hsa04020(3269)  Calcium signaling pathway\nhsa04080(3269)  Neuroactive ligand-receptor interaction",
    "metabolism": "",
    "therapeutic_category": "1319",
    "atc_code": "R01AC08",
    "drug_class": [
      "Anti-allergic agent",
      "Histamine receptor antagonist",
      "Histamine receptor H1 antagonist",
      "Dermatological agent",
      "Atopic dermatitis agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Olopatadine hydrochloride"
  },
  {
    "kegg_id": "D01385",
    "name_en": "Ibudilast (JP18/INN)",
    "name_ja": "",
    "names_alt": [
      "Ketas (TN)"
    ],
    "formula": "C14H18N2O",
    "efficacy": "Antiallergic, Bronchodilator, Vasodilator, Phosphodiesterase inhibitor, Leukotriene receptor antagonist",
    "target": "PDE3 [HSA:5139 5140] [KO:K19021 K13296]\nPDE4 [HSA:5141 5142 5143 5144] [KO:K13293]\nCYSLTR1 [HSA:10800] [KO:K04322]\nPTGIR [HSA:5739] [KO:K04263]\nPATHWAY   hsa04022(5139+5140)  cGMP-PKG signaling pathway\nhsa04024(5139+5140+5141+5142+5143+5144)  cAMP signaling pathway\nhsa04080(10800+5739)  Neuroactive ligand-receptor interaction\nhsa04270(5739)  Vascular smooth muscle contraction",
    "metabolism": "",
    "therapeutic_category": "1319",
    "atc_code": "R03DC04",
    "drug_class": [
      "Cardiovascular agent",
      "Phosphodiesterase III inhibitor",
      "Anti-allergic agent",
      "Cysteinyl leukotriene receptor antagonist"
    ],
    "cyp_enzymes": [],
    "search_name": "Ibudilast"
  },
  {
    "kegg_id": "D01332",
    "name_en": "Ketotifen fumarate (JP18/USAN)",
    "name_ja": "",
    "names_alt": [
      "Zaditen (TN)"
    ],
    "formula": "C19H19NOS. C4H4O4",
    "efficacy": "Antiallergic, Antiasthmatic, H1 receptor antagonist",
    "target": "HRH1 [HSA:3269] [KO:K04149]\nPATHWAY   hsa04080(3269)  Neuroactive ligand-receptor interaction\nhsa04750(3269)  Inflammatory mediator regulation of TRP channels",
    "metabolism": "",
    "therapeutic_category": "1319",
    "atc_code": "R06AX17",
    "drug_class": [
      "Anti-allergic agent",
      "Histamine receptor antagonist",
      "Histamine receptor H1 antagonist"
    ],
    "cyp_enzymes": [],
    "search_name": "Ketotifen fumarate"
  },
  {
    "kegg_id": "D01713",
    "name_en": "Epinastine hydrochloride (JAN)",
    "name_ja": "",
    "names_alt": [
      "Alesion (TN)",
      "Elestat (TN)"
    ],
    "formula": "C16H15N3. HCl",
    "efficacy": "Antiallergic, H1 receptor antagonist",
    "target": "HRH1 [HSA:3269] [KO:K04149]\nPATHWAY   hsa04080(3269)  Neuroactive ligand-receptor interaction\nhsa04750(3269)  Inflammatory mediator regulation of TRP channels",
    "metabolism": "",
    "therapeutic_category": "1319",
    "atc_code": "R06AX24",
    "drug_class": [
      "Anti-allergic agent",
      "Histamine receptor antagonist",
      "Histamine receptor H1 antagonist",
      "Dermatological agent",
      "Atopic dermatitis agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Epinastine hydrochloride"
  },
  {
    "kegg_id": "D03243",
    "name_en": "Sodium borate (JP18/NF)",
    "name_ja": "",
    "names_alt": [
      "Sodium tetraborate decahydrate"
    ],
    "formula": "B4O7. 10H2O. 2Na",
    "efficacy": "Antiseptic (ophthalmic), Pharmaceutic aid (alkalizing)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "1319",
    "atc_code": "S01AX07",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Sodium borate"
  },
  {
    "kegg_id": "D01578",
    "name_en": "Pranoprofen (JP18/INN)",
    "name_ja": "",
    "names_alt": [
      "Elicapric (TN)"
    ],
    "formula": "C15H13NO3",
    "efficacy": "Analgesic, Anti-inflammatory, Antipyretic, COX inhibitor",
    "target": "PTGS1 (COX1) [HSA:5742] [KO:K00509]\nPTGS2 (COX2) [HSA:5743] [KO:K11987]\nPATHWAY   hsa00590(5742+5743)  Arachidonic acid metabolism",
    "metabolism": "",
    "therapeutic_category": "1319",
    "atc_code": "S01BC09",
    "drug_class": [
      "Anti-inflammatory",
      "Nonsteroidal anti-inflammatory drug (NSAID)",
      "Anti-inflammatory drug, propionic acid derivative"
    ],
    "cyp_enzymes": [],
    "search_name": "Pranoprofen"
  },
  {
    "kegg_id": "D05143",
    "name_en": "Nepafenac (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Nevanac (TN)"
    ],
    "formula": "C15H14N2O2",
    "efficacy": "Analgesic, Anti-inflammatory, COX inhibitor",
    "target": "PTGS1 (COX1) [HSA:5742] [KO:K00509]\nPTGS2 (COX2) [HSA:5743] [KO:K11987]\nPATHWAY   hsa00590(5742+5743)  Arachidonic acid metabolism",
    "metabolism": "",
    "therapeutic_category": "1319",
    "atc_code": "S01BC10",
    "drug_class": [
      "Anti-inflammatory",
      "Nonsteroidal anti-inflammatory drug (NSAID)",
      "Anti-inflammatory drug, acetic acid derivatives"
    ],
    "cyp_enzymes": [],
    "search_name": "Nepafenac"
  },
  {
    "kegg_id": "D03163",
    "name_en": "Bromfenac sodium (USAN)",
    "name_ja": "",
    "names_alt": [
      "Bromfenac sodium hydrate (JP18)",
      "Bromfenac sodium sesquihydrate",
      "Bromday (TN)",
      "Prolensa (TN)",
      "Xibrom (TN)",
      "Yellox (TN)"
    ],
    "formula": "(C15H11BrNO3)2. 2Na. 3H2O",
    "efficacy": "Analgesic, Anti-inflammatory (ophthalmic), COX inhibitor",
    "target": "PTGS1 (COX1) [HSA:5742] [KO:K00509]\nPTGS2 (COX2) [HSA:5743] [KO:K11987]\nPATHWAY   hsa00590(5742+5743)  Arachidonic acid metabolism",
    "metabolism": "",
    "therapeutic_category": "1319",
    "atc_code": "S01BC11",
    "drug_class": [
      "Anti-inflammatory",
      "Nonsteroidal anti-inflammatory drug (NSAID)",
      "Anti-inflammatory drug, acetic acid derivatives",
      "Anti-inflammatory drug, phenylacetic acid derivative"
    ],
    "cyp_enzymes": [],
    "search_name": "Bromfenac sodium"
  },
  {
    "kegg_id": "D04246",
    "name_en": "Fradiomycin sulfate and betamethasone sodium phosphate",
    "name_ja": "",
    "names_alt": [
      "Rinderon A (TN)"
    ],
    "formula": "",
    "efficacy": "Antibacterial, Anti-inflammatory",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "1319",
    "atc_code": "S01CA05",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Fradiomycin sulfate and betamethasone sodium phosphate"
  },
  {
    "kegg_id": "D01008",
    "name_en": "Apraclonidine hydrochloride (JAN/USP)",
    "name_ja": "",
    "names_alt": [
      "Iopidine (TN)"
    ],
    "formula": "C9H10Cl2N4. HCl",
    "efficacy": "Antihypertensive (intraocular), alpha2-Adrenergic receptor agonist",
    "target": "ADRA2 [HSA:150 151 152] [KO:K04138 K04139 K04140]\nPATHWAY   hsa04080(150+151+152)  Neuroactive ligand-receptor interaction",
    "metabolism": "",
    "therapeutic_category": "1319",
    "atc_code": "S01EA03",
    "drug_class": [
      "Cardiovascular agent",
      "Adrenergic receptor agonist",
      "alpha-Adrenergic receptor agonist",
      "alpha2-Adrenergic receptor agonist",
      "Ophthalmic agent",
      "Intraocular pressure lowering agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Apraclonidine hydrochloride"
  },
  {
    "kegg_id": "D12437",
    "name_en": "Ripasudil hydrochloride and brimonidine tartrate",
    "name_ja": "",
    "names_alt": [
      "Gla-alpha (TN)"
    ],
    "formula": "",
    "efficacy": "Antiglaucoma",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "1319",
    "atc_code": "S01EA55",
    "drug_class": [
      "Ophthalmic agent",
      "Intraocular pressure lowering agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Ripasudil hydrochloride and brimonidine tartrate"
  },
  {
    "kegg_id": "D00653",
    "name_en": "Dorzolamide hydrochloride (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Trusopt (TN)"
    ],
    "formula": "C10H16N2O4S3. HCl",
    "efficacy": "Antiglaucoma, Carbonic anhydrase inhibitor\nDISEASE   Open-angle glaucoma [DS:H00612]",
    "target": "CA [HSA:759 760 761 762 763 11238 765 766 767 768 771 377677 23632] [KO:K01672 K18245 K18246]\nPATHWAY   hsa04964(760+762)  Proximal tubule bicarbonate reclamation",
    "metabolism": "Enzyme: CYP2C9 [HSA:1559], CYP2C19 [HSA:1557], CYP3A4 [HSA:1576]",
    "therapeutic_category": "1319",
    "atc_code": "S01EC03",
    "drug_class": [
      "Cardiovascular agent",
      "Carbonic anhydrase inhibitor",
      "Ophthalmic agent",
      "Intraocular pressure lowering agent",
      "Metabolizing enzyme substrate",
      "CYP2C9 substrate",
      "CYP2C19 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C9",
      "CYP2C19",
      "CYP3A4"
    ],
    "search_name": "Dorzolamide hydrochloride"
  },
  {
    "kegg_id": "D00652",
    "name_en": "Brinzolamide (JAN/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Azopt (TN)"
    ],
    "formula": "C12H21N3O5S3",
    "efficacy": "Antiglaucoma, Carbonic anhydrase inhibitor\nDISEASE   Open-angle glaucoma [DS:H00612]",
    "target": "CA2 [HSA:760] [KO:K18245]\nPATHWAY   hsa04964(760)  Proximal tubule bicarbonate reclamation",
    "metabolism": "",
    "therapeutic_category": "1319",
    "atc_code": "S01EC04",
    "drug_class": [
      "Cardiovascular agent",
      "Carbonic anhydrase inhibitor",
      "Ophthalmic agent",
      "Intraocular pressure lowering agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Brinzolamide"
  },
  {
    "kegg_id": "D10854",
    "name_en": "Brinzolamide and brimonidine tartrate",
    "name_ja": "",
    "names_alt": [
      "Simbrinza (TN)",
      "Ailamide (TN)"
    ],
    "formula": "",
    "efficacy": "Antiglaucoma\nDISEASE   Open-angle glaucoma [DS:H00612]",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "1319",
    "atc_code": "S01EC54",
    "drug_class": [
      "Ophthalmic agent",
      "Intraocular pressure lowering agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Brinzolamide and brimonidine tartrate"
  },
  {
    "kegg_id": "D10512",
    "name_en": "Brinzolamide and timolol maleate",
    "name_ja": "",
    "names_alt": [
      "Azorga (TN)"
    ],
    "formula": "",
    "efficacy": "Antiglaucoma",
    "target": "",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576], CYP2D6 [HSA:1565]; CYP2A6 [HSA:1548], CYP2B6 [HSA:1555], CYP2C8 [HSA:1558], CYP2C9 [HSA:1559]",
    "therapeutic_category": "1319",
    "atc_code": "S01EC54",
    "drug_class": [
      "Ophthalmic agent",
      "Intraocular pressure lowering agent",
      "Combination of carbonic anhydrase inhibitor and beta blocker",
      "Metabolizing enzyme substrate",
      "CYP2A6 substrate",
      "CYP2B6 substrate",
      "CYP2C8 substrate",
      "CYP2C9 substrate",
      "CYP2D6 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4",
      "CYP2B6",
      "CYP2A6",
      "CYP2C9",
      "CYP2D6",
      "CYP2C8"
    ],
    "search_name": "Brinzolamide and timolol maleate"
  },
  {
    "kegg_id": "D01025",
    "name_en": "Levobunolol hydrochloride (JAN/USP)",
    "name_ja": "",
    "names_alt": [
      "Betagan (TN)"
    ],
    "formula": "C17H25NO3. HCl",
    "efficacy": "Antiglaucoma, alpha1/beta-Adrenergic receptor antagonist\nDISEASE   Open-angle glaucoma [DS:H00612]",
    "target": "ADRB [HSA:153 154 155] [KO:K04141 K04142 K04143]\nADRA1 [HSA:148 147 146] [KO:K04135 K04136 K04137]\nPATHWAY   hsa04020(146+147+148+153+154+155)  Calcium signaling pathway\nhsa04080(146+147+148+153+154+155)  Neuroactive ligand-receptor interaction",
    "metabolism": "",
    "therapeutic_category": "1319",
    "atc_code": "S01ED03",
    "drug_class": [
      "Cardiovascular agent",
      "Adrenergic receptor antagonist",
      "beta-Adrenergic receptor antagonist (Beta blocker)",
      "Ophthalmic agent",
      "Intraocular pressure lowering agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Levobunolol hydrochloride"
  },
  {
    "kegg_id": "D07505",
    "name_en": "Latanoprost and timolol maleate",
    "name_ja": "",
    "names_alt": [
      "Xalacom (TN)"
    ],
    "formula": "",
    "efficacy": "Antiglaucoma",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "1319",
    "atc_code": "S01ED51",
    "drug_class": [
      "Ophthalmic agent",
      "Intraocular pressure lowering agent",
      "Combination of prostaglandin derivative and beta blocker"
    ],
    "cyp_enzymes": [],
    "search_name": "Latanoprost and timolol maleate"
  },
  {
    "kegg_id": "D08493",
    "name_en": "Dorzolamide hydrochloride and timolol maleate (JP18)",
    "name_ja": "",
    "names_alt": [
      "Cosopt (TN)"
    ],
    "formula": "",
    "efficacy": "Antiglaucoma\nDISEASE   Open-angle glaucoma [DS:H00612]",
    "target": "",
    "metabolism": "Enzyme: CYP2C9 [HSA:1559], CYP2C19 [HSA:1557], CYP3A4 [HSA:1576], CYP2D6 [HSA:1565]",
    "therapeutic_category": "1319",
    "atc_code": "S01ED51",
    "drug_class": [
      "Ophthalmic agent",
      "Intraocular pressure lowering agent",
      "Combination of carbonic anhydrase inhibitor and beta blocker",
      "Metabolizing enzyme substrate",
      "CYP2C9 substrate",
      "CYP2C19 substrate",
      "CYP2D6 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C9",
      "CYP2C19",
      "CYP3A4",
      "CYP2D6"
    ],
    "search_name": "Dorzolamide hydrochloride and timolol maleate"
  },
  {
    "kegg_id": "D09815",
    "name_en": "Travoprost and timolol maleate",
    "name_ja": "",
    "names_alt": [
      "Duotrav (TN)"
    ],
    "formula": "",
    "efficacy": "Antiglaucoma",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "1319",
    "atc_code": "S01ED51",
    "drug_class": [
      "Ophthalmic agent",
      "Intraocular pressure lowering agent",
      "Combination of prostaglandin derivative and beta blocker"
    ],
    "cyp_enzymes": [],
    "search_name": "Travoprost and timolol maleate"
  },
  {
    "kegg_id": "D10298",
    "name_en": "Brimonidine tartrate and timolol maleate",
    "name_ja": "",
    "names_alt": [
      "Combigan (TN)",
      "Aibeta (TN)"
    ],
    "formula": "",
    "efficacy": "Antiglaucoma\nDISEASE   Glaucoma [DS:H00612]",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "1319",
    "atc_code": "S01ED51",
    "drug_class": [
      "Ophthalmic agent",
      "Intraocular pressure lowering agent",
      "Combination of carbonic anhydrase inhibitor and beta blocker"
    ],
    "cyp_enzymes": [],
    "search_name": "Brimonidine tartrate and timolol maleate"
  },
  {
    "kegg_id": "D10569",
    "name_en": "Tafluprost and timolol maleate",
    "name_ja": "",
    "names_alt": [
      "Tapcom (TN)"
    ],
    "formula": "",
    "efficacy": "Antiglaucoma",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "1319",
    "atc_code": "S01ED51",
    "drug_class": [
      "Ophthalmic agent",
      "Intraocular pressure lowering agent",
      "Combination of prostaglandin derivative and beta blocker"
    ],
    "cyp_enzymes": [],
    "search_name": "Tafluprost and timolol maleate"
  },
  {
    "kegg_id": "D10804",
    "name_en": "Carteolol and latanoprost",
    "name_ja": "",
    "names_alt": [
      "Mikeluna (TN)"
    ],
    "formula": "",
    "efficacy": "Antiglaucoma",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "1319",
    "atc_code": "S01ED55",
    "drug_class": [
      "Ophthalmic agent",
      "Intraocular pressure lowering agent",
      "Combination of prostaglandin derivative and beta blocker"
    ],
    "cyp_enzymes": [],
    "search_name": "Carteolol and latanoprost"
  },
  {
    "kegg_id": "D00356",
    "name_en": "Latanoprost (JAN/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Xalatan (TN)"
    ],
    "formula": "C26H40O5",
    "efficacy": "Antiglaucoma, Prostaglandin F receptor agonist\nDISEASE   Open-angle glaucoma [DS:H00612]",
    "target": "PTGFR [HSA:5737] [KO:K04262]\nPATHWAY   hsa04020(5737)  Calcium signaling pathway\nhsa04080(5737)  Neuroactive ligand-receptor interaction",
    "metabolism": "",
    "therapeutic_category": "1319",
    "atc_code": "S01EE01",
    "drug_class": [
      "Hormonal agent",
      "Prostaglandin derivative",
      "Prostaglandin F derivative",
      "Ophthalmic agent",
      "Intraocular pressure lowering agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Latanoprost"
  },
  {
    "kegg_id": "D01452",
    "name_en": "Isopropyl unoprostone (JAN)",
    "name_ja": "",
    "names_alt": [
      "Unoprostone isopropyl",
      "Rescula (TN)"
    ],
    "formula": "C25H44O5",
    "efficacy": "Antiglaucoma\nDISEASE   Open-angle glaucoma [DS:H00612]",
    "target": "PTGFR [HSA:5737] [KO:K04262]\nPATHWAY   hsa04020(5737)  Calcium signaling pathway\nhsa04080(5737)  Neuroactive ligand-receptor interaction",
    "metabolism": "",
    "therapeutic_category": "1319",
    "atc_code": "S01EE02",
    "drug_class": [
      "Hormonal agent",
      "Prostaglandin derivative",
      "Prostaglandin F derivative",
      "Ophthalmic agent",
      "Intraocular pressure lowering agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Isopropyl unoprostone"
  },
  {
    "kegg_id": "D02724",
    "name_en": "Bimatoprost (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Lumigan (TN)",
      "Latisse (TN)"
    ],
    "formula": "C25H37NO4",
    "efficacy": "Antiglaucoma, Eyelash growth stimulant\nDISEASE   Open angle glaucoma [DS:H00612]",
    "target": "PTGFR [HSA:5737] [KO:K04262]\nPATHWAY   hsa04020(5737)  Calcium signaling pathway\nhsa04080(5737)  Neuroactive ligand-receptor interaction",
    "metabolism": "",
    "therapeutic_category": "1319",
    "atc_code": "S01EE03",
    "drug_class": [
      "Hormonal agent",
      "Prostaglandin derivative",
      "Prostaglandin F derivative",
      "Ophthalmic agent",
      "Intraocular pressure lowering agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Bimatoprost"
  },
  {
    "kegg_id": "D01964",
    "name_en": "Travoprost (JAN/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Travatan (TN)"
    ],
    "formula": "C26H35F3O6",
    "efficacy": "Antiglaucoma, Prostaglandin F receptor agonist\nDISEASE   Open-angle glaucoma [DS:H00612]",
    "target": "PTGFR [HSA:5737] [KO:K04262]\nPATHWAY   hsa04020(5737)  Calcium signaling pathway\nhsa04080(5737)  Neuroactive ligand-receptor interaction",
    "metabolism": "",
    "therapeutic_category": "1319",
    "atc_code": "S01EE04",
    "drug_class": [
      "Hormonal agent",
      "Prostaglandin derivative",
      "Prostaglandin F derivative",
      "Ophthalmic agent",
      "Intraocular pressure lowering agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Travoprost"
  },
  {
    "kegg_id": "D06274",
    "name_en": "Tafluprost (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Zioptan (TN)"
    ],
    "formula": "C25H34F2O5",
    "efficacy": "Antiglaucoma, Prostaglandin F receptor agonist\nDISEASE   Open-angle glaucoma [DS:H00612]",
    "target": "PTGFR [HSA:5737] [KO:K04262]\nPATHWAY   hsa04020(5737)  Calcium signaling pathway\nhsa04080(5737)  Neuroactive ligand-receptor interaction",
    "metabolism": "",
    "therapeutic_category": "1319",
    "atc_code": "S01EE05",
    "drug_class": [
      "Hormonal agent",
      "Prostaglandin derivative",
      "Prostaglandin F derivative",
      "Ophthalmic agent",
      "Intraocular pressure lowering agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Tafluprost"
  },
  {
    "kegg_id": "D10966",
    "name_en": "Omidenepag isopropyl (JAN)",
    "name_ja": "",
    "names_alt": [
      "Eybelis (TN)",
      "Omlonti (TN)"
    ],
    "formula": "C26H28N6O4S",
    "efficacy": "Antiglaucoma, Prostaglandin E2 receptor agonist\nDISEASE   Open-angle glaucoma [DS:H00612]",
    "target": "PTGER2 [HSA:5732] [KO:K04259]\nPATHWAY   hsa04080(5732)  Neuroactive ligand-receptor interaction",
    "metabolism": "Enzyme: CES1 [HSA:1066]",
    "therapeutic_category": "1319",
    "atc_code": "S01EX06",
    "drug_class": [
      "Ophthalmic agent",
      "Intraocular pressure lowering agent",
      "Metabolizing enzyme substrate",
      "CES substrate",
      "CES1 substrate"
    ],
    "cyp_enzymes": [],
    "search_name": "Omidenepag isopropyl"
  },
  {
    "kegg_id": "D10463",
    "name_en": "Ripasudil hydrochloride hydrate (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Glanatec (TN)"
    ],
    "formula": "C15H18FN3O2S. HCl. 2H2O",
    "efficacy": "Antiglaucoma, Rho-associated kinase inhibitor",
    "target": "ROCK [HSA:6093 9475] [KO:K04514 K17388]\nPATHWAY   hsa04270(6093+9475)  Vascular smooth muscle contraction\nhsa04670(6093+9475)  Leukocyte transendothelial migration\nhsa04810(6093+9475)  Regulation of actin cytoskeleton",
    "metabolism": "",
    "therapeutic_category": "1319",
    "atc_code": "S01EX07",
    "drug_class": [
      "Ophthalmic agent",
      "Intraocular pressure lowering agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Ripasudil hydrochloride hydrate"
  },
  {
    "kegg_id": "D04081",
    "name_en": "Tropicamide and phenylephrine hydrochloride",
    "name_ja": "",
    "names_alt": [
      "Sandol P (TN)"
    ],
    "formula": "",
    "efficacy": "Mydriatic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "1319",
    "atc_code": "S01FA56",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Tropicamide and phenylephrine hydrochloride"
  },
  {
    "kegg_id": "D07632",
    "name_en": "Chondroitin sulfate sodium and sodium hyaluronate",
    "name_ja": "",
    "names_alt": [
      "Viscoat (TN)"
    ],
    "formula": "",
    "efficacy": "Ophthalmic surgery adjunct",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "1319",
    "atc_code": "S01KA51",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Chondroitin sulfate sodium and sodium hyaluronate"
  },
  {
    "kegg_id": "D01162",
    "name_en": "Verteporfin (JAN/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Visudyne (TN)"
    ],
    "formula": "(C41H42N4O8)m. (C41H42N4O8)n",
    "efficacy": "Antineoplastic, Photosensitizer\nDISEASE   Age-related macular degeneration [DS:H00821]",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "1319",
    "atc_code": "S01LA01",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Verteporfin"
  },
  {
    "kegg_id": "D05697",
    "name_en": "Ranibizumab (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Ranibizumab (genetical recombination) (JAN)",
      "Ranibizumab (genetical recombination) [Ranibizumab biosimilar 1] (JAN)",
      "Ranibizumab-nuna",
      "Ranibizumab-eqrn",
      "Byooviz (TN)",
      "Cimerli (TN)",
      "Lucentis (TN)",
      "Susvimo (TN)",
      "Ximluci (TN)"
    ],
    "formula": "C2158H3282N562O681S12",
    "efficacy": "Angiogenesis inhibitor, Anti-VEGF antibody\nDISEASE   Age-related macular degeneration [DS:H00821]\nMacular edema following retinal vein occlusion [DS:H01651]\nDiabetic macular edema [DS:H01651]\nDiabetic retinopathy [DS:H01457]\nTYPE      Monoclonal antibody",
    "target": "VEGFA [HSA:7422] [KO:K05448]\nPATHWAY   hsa04370(7422)  VEGF signaling pathway",
    "metabolism": "",
    "therapeutic_category": "1319",
    "atc_code": "S01LA04",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Ranibizumab"
  },
  {
    "kegg_id": "D11083",
    "name_en": "Brolucizumab (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Brolucizumab (genetical recombination) (JAN)",
      "Brolucizuab-dbll",
      "Beovu (TN)"
    ],
    "formula": "C1164H1768N310O372S8",
    "efficacy": "Age-related macular degeneration therapeutic agent, Anti-VEGF antibody\nDISEASE   Age-related macular degeneration [DS:H00821]\nTYPE      Monoclonal antibody",
    "target": "VEGFA [HSA:7422] [KO:K05448]\nPATHWAY   hsa04370(7422)  VEGF signaling pathway",
    "metabolism": "",
    "therapeutic_category": "1319",
    "atc_code": "S01LA06",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Brolucizumab"
  },
  {
    "kegg_id": "D11516",
    "name_en": "Faricimab (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Faricimab (genetical recombination) (JAN)",
      "Faricimab-svoa",
      "Vabysmo (TN)"
    ],
    "formula": "C6506H9968N1724O1026S45",
    "efficacy": "Angiogenesis inhibitor, Anti-angiopoietin 2 antibody, Anti-VEGF antibody\nDISEASE   Neovascular (wet) age-related macular degeneration [DS:H00821]\nDiabetic macular edema [DS:H01651]\nTYPE      Bispecific antibody",
    "target": "ANGPT2 [HSA:285] [KO:K05466]\nVEGFA [HSA:7422] [KO:K05448]",
    "metabolism": "",
    "therapeutic_category": "1319",
    "atc_code": "S01LA09",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Faricimab"
  },
  {
    "kegg_id": "D02706",
    "name_en": "Sodium gualenate hydrate (JAN)",
    "name_ja": "",
    "names_alt": [
      "Azulene sulfonate sodium hydrate",
      "Sodium guaiazulene sulfonate",
      "Azunol (TN)"
    ],
    "formula": "C15H17O3S. Na. H2O",
    "efficacy": "Anti-inflammatory, Anti-ulcerative",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "1319",
    "atc_code": "S01XA01",
    "drug_class": [
      "Anti-inflammatory",
      "Nonsteroidal anti-inflammatory drug (NSAID)",
      "Gastrointestinal agent",
      "Agents for peptic ulcer",
      "Gastric mucosal protectant"
    ],
    "cyp_enzymes": [],
    "search_name": "Sodium gualenate hydrate"
  },
  {
    "kegg_id": "D04113",
    "name_en": "Boric acid and Inorganic salt",
    "name_ja": "",
    "names_alt": [
      "Artificial tear mytear (TN)"
    ],
    "formula": "",
    "efficacy": "Artificial tear",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "1319",
    "atc_code": "S01XA20",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Boric acid and Inorganic salt"
  },
  {
    "kegg_id": "D03635",
    "name_en": "Cysteamine hydrochloride (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Mercaptamine hydrochloride",
      "Cystaran (TN)",
      "Cystadrops (TN)"
    ],
    "formula": "C2H7NS. HCl",
    "efficacy": "Anti-urolithic (cysteine calculi), Cystinosis treatment\nDISEASE   Cystinosis [DS:H00275]",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "1319",
    "atc_code": "S01XA21",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Cysteamine hydrochloride"
  },
  {
    "kegg_id": "D11748",
    "name_en": "Avacincaptad pegol sodium (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Izervay (TN)"
    ],
    "formula": "C395H453F21N142Na39O262P39. (C2H4O)2n",
    "efficacy": "Aging-related macular degeneration therapeutic agent\nDISEASE   Age-related macular degeneration, geographic atrophy [DS:H00821]\nTYPE      RNA aptamer",
    "target": "C5 [HSA:727] [KO:K03994]\nPATHWAY   hsa04080(727)  Neuroactive ligand-receptor interaction\nhsa04610(727)  Complement and coagulation cascades",
    "metabolism": "",
    "therapeutic_category": "1319",
    "atc_code": "S01XA32",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Avacincaptad pegol sodium"
  },
  {
    "kegg_id": "D03864",
    "name_en": "Diquafosol tetrasodium (USAN)",
    "name_ja": "",
    "names_alt": [
      "Diquafosol sodium (JAN)",
      "Ins 365"
    ],
    "formula": "C18H22N4Na4O23P4",
    "efficacy": "Corneal protection, P2Y2 receptor agonist",
    "target": "P2RY2 [HSA:5029] [KO:K04269]\nPATHWAY   hsa04080(5029)  Neuroactive ligand-receptor interaction",
    "metabolism": "",
    "therapeutic_category": "1319",
    "atc_code": "S01XA33",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Diquafosol tetrasodium"
  },
  {
    "kegg_id": "D00031",
    "name_en": "Oxiglutatione (JAN/INN)",
    "name_ja": "",
    "names_alt": [],
    "formula": "C20H32N6O12S2",
    "efficacy": "Ocular tissue perfusion and lavage",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "1319",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Oxiglutatione"
  },
  {
    "kegg_id": "D01031",
    "name_en": "Helenien (JAN)",
    "name_ja": "",
    "names_alt": [
      "Xantofyl palmitate (INN)",
      "Adaptinol (TN)"
    ],
    "formula": "C72H116O4",
    "efficacy": "Rhodopsin resynthesis stimulant",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "1319",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Helenien"
  },
  {
    "kegg_id": "D01088",
    "name_en": "Pemirolast potassium (JP18/USAN)",
    "name_ja": "",
    "names_alt": [
      "Alamast (TN)",
      "Alegysal (TN)",
      "Pemilaston (TN)"
    ],
    "formula": "C10H7N6O. K",
    "efficacy": "Antiallergic, Mediator release inhibitor",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "1319",
    "atc_code": "",
    "drug_class": [
      "Anti-allergic agent",
      "Mediator release inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Pemirolast potassium"
  },
  {
    "kegg_id": "D01100",
    "name_en": "Pirenoxine (JP18/INN)",
    "name_ja": "",
    "names_alt": [
      "Catalin-K (TN)"
    ],
    "formula": "C16H8N2O5",
    "efficacy": "Anticataract",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "1319",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Pirenoxine"
  },
  {
    "kegg_id": "D01691",
    "name_en": "Nipradilol (JAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Hypadil (TN)"
    ],
    "formula": "C15H22N2O6",
    "efficacy": "Antiglaucoma, Antihypertensive, Vasodilator, alpha1/beta-Adrenergic receptor antagonist",
    "target": "ADRB [HSA:153 154 155] [KO:K04141 K04142 K04143]\nADRA1 [HSA:148 147 146] [KO:K04135 K04136 K04137]\nPATHWAY   hsa04020(146+147+148+153+154+155)  Calcium signaling pathway\nhsa04022(146+147+148+153+154+155)  cGMP-PKG signaling pathway\nhsa04024(153+154)  cAMP signaling pathway\nhsa04080(146+147+148+153+154+155)  Neuroactive ligand-receptor interaction\nhsa04261(146+147+148+153+154)  Adrenergic signaling in cardiomyocytes\nhsa04270(146+147+148)  Vascular smooth muscle contraction",
    "metabolism": "",
    "therapeutic_category": "1319",
    "atc_code": "",
    "drug_class": [
      "Cardiovascular agent",
      "Adrenergic receptor antagonist",
      "alpha1 and beta-Adrenergic receptor antagonist",
      "Antihypertensive",
      "alpha1 and beta-Adrenergic receptor antagonist",
      "Ophthalmic agent",
      "Intraocular pressure lowering agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Nipradilol"
  },
  {
    "kegg_id": "D01887",
    "name_en": "Bunazosin hydrochloride (JP18)",
    "name_ja": "",
    "names_alt": [
      "Detantol (TN)"
    ],
    "formula": "C19H27N5O3. HCl",
    "efficacy": "Antiglaucoma, Antihypertensive, alpha1-Adrenergic receptor antagonist",
    "target": "ADRA1 [HSA:148 147 146] [KO:K04135 K04136 K04137]\nPATHWAY   hsa04020(146+147+148)  Calcium signaling pathway\nhsa04080(146+147+148)  Neuroactive ligand-receptor interaction\nhsa04270(146+147+148)  Vascular smooth muscle contraction\nhsa04970(146+147+148)  Salivary secretion",
    "metabolism": "",
    "therapeutic_category": "1319",
    "atc_code": "",
    "drug_class": [
      "Cardiovascular agent",
      "Adrenergic receptor antagonist",
      "alpha-Adrenergic receptor antagonist",
      "alpha1-Adrenergic receptor antagonist",
      "Antihypertensive",
      "Ophthalmic agent",
      "Intraocular pressure lowering agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Bunazosin hydrochloride"
  },
  {
    "kegg_id": "D02027",
    "name_en": "Tranilast (JP18/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Rizaben (TN)"
    ],
    "formula": "C18H17NO5",
    "efficacy": "Antiallergic, Antiasthmatic, Mediator release inhibitor",
    "target": "",
    "metabolism": "Enzyme: CYP2C9 [HSA:1559]",
    "therapeutic_category": "1319",
    "atc_code": "",
    "drug_class": [
      "Anti-allergic agent",
      "Mediator release inhibitor",
      "Dermatological agent",
      "Atopic dermatitis agent",
      "Metabolizing enzyme substrate",
      "CYP2C9 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C9"
    ],
    "search_name": "Tranilast"
  },
  {
    "kegg_id": "D03233",
    "name_en": "Acitazanolast hydrate (JAN)",
    "name_ja": "",
    "names_alt": [
      "Zepelin (TN)"
    ],
    "formula": "C9H7N5O3. H2O",
    "efficacy": "Antiallergic, Mediator release inhibitor",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "1319",
    "atc_code": "",
    "drug_class": [
      "Anti-allergic agent",
      "Mediator release inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Acitazanolast hydrate"
  },
  {
    "kegg_id": "D04099",
    "name_en": "Erythromycin lactobionate and colistin sodium methanesulfonate",
    "name_ja": "エリスロマイシン",
    "names_alt": [
      "Ecolicin (TN)"
    ],
    "formula": "",
    "efficacy": "Antibacterial (ophthalmic)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "1319",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Erythromycin lactobionate and colistin sodium methanesulfonate"
  },
  {
    "kegg_id": "D04106",
    "name_en": "Chloramphenicol and colistin sodium methanesulfonate (JP18)",
    "name_ja": "クロラムフェニコール",
    "names_alt": [
      "Colimy C (TN)"
    ],
    "formula": "",
    "efficacy": "Antibiotic (ophthalmic)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "1319",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Chloramphenicol and colistin sodium methanesulfonate"
  },
  {
    "kegg_id": "D04109",
    "name_en": "Glucose and inorganic salt",
    "name_ja": "ブドウ糖",
    "names_alt": [
      "Opeguard MA (TN)"
    ],
    "formula": "",
    "efficacy": "Ocular tissue perfusion and lavage",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "1319",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Glucose and inorganic salt"
  },
  {
    "kegg_id": "D04285",
    "name_en": "Concentrated glycerin and fructose",
    "name_ja": "",
    "names_alt": [
      "Glyceol (TN)"
    ],
    "formula": "",
    "efficacy": "Antihypertensive (intracranial, intraocular)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "1319",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Concentrated glycerin and fructose"
  },
  {
    "kegg_id": "D07703",
    "name_en": "Hydroxyethyl cellulose, boric acid, dibasic sodium phosphate, potassium chloride, sodium chloride and dried sodium carbonate",
    "name_ja": "",
    "names_alt": [
      "Scopisol (TN)"
    ],
    "formula": "",
    "efficacy": "Ophthalmic surgery adjunct",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "1319",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Hydroxyethyl cellulose, boric acid, dibasic sodium phosphate, potassium chloride, sodium chloride and dried sodium carbonate"
  },
  {
    "kegg_id": "D07709",
    "name_en": "Polyvinyl alcohol and iodine",
    "name_ja": "",
    "names_alt": [
      "PA iodo (TN)"
    ],
    "formula": "",
    "efficacy": "Antiseptic, Disinfectant",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "1319",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Polyvinyl alcohol and iodine"
  },
  {
    "kegg_id": "D12617",
    "name_en": "Sepetaprost (JAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Setaneo (TN0"
    ],
    "formula": "C26H36F2O6",
    "efficacy": "Antiglaucoma, Prostaglandin receptor agonist",
    "target": "PTGFR [HSA:5737] [KO:K04262]\nPTGER3 [HSA:5733] [KO:K04260]\nPATHWAY   hsa04080(5733+5737)  Neuroactive ligand-receptor interaction",
    "metabolism": "",
    "therapeutic_category": "1319",
    "atc_code": "",
    "drug_class": [
      "Hormonal agent",
      "Prostaglandin derivative",
      "Prostaglandin F derivative"
    ],
    "cyp_enzymes": [],
    "search_name": "Sepetaprost"
  },
  {
    "kegg_id": "D12841",
    "name_en": "Motugivatrep (JAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Avarept (TN)"
    ],
    "formula": "C22H20F3NO3",
    "efficacy": "Analgesic, Transient receptor potential (TRP) channel antagonist",
    "target": "TRPV1 [HSA:7442] [KO:K05222]\nPATHWAY   hsa04080(7442)  Neuroactive ligand-receptor interaction\nhsa04750(7442)  Inflammatory mediator regulation of TRP channels",
    "metabolism": "",
    "therapeutic_category": "1319",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Motugivatrep"
  },
  {
    "kegg_id": "D01347",
    "name_en": "Tramazoline hydrochloride (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Towk (TN)"
    ],
    "formula": "C13H17N3. HCl",
    "efficacy": "Vasoconstrictor, alpha-Adrenergic receptor agonist",
    "target": "ADRA1 [HSA:148 147 146] [KO:K04135 K04136 K04137]\nADRA2 [HSA:150 151 152] [KO:K04138 K04139 K04140]\nPATHWAY   hsa04020(146+147+148)  Calcium signaling pathway\nhsa04080(146+147+148+150+151+152)  Neuroactive ligand-receptor interaction\nhsa04270(146+147+148)  Vascular smooth muscle contraction",
    "metabolism": "",
    "therapeutic_category": "1324",
    "atc_code": "R01AA09",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Tramazoline hydrochloride"
  },
  {
    "kegg_id": "D02188",
    "name_en": "Fosfomycin sodium (JP18)",
    "name_ja": "",
    "names_alt": [
      "Fosmicin S (TN)"
    ],
    "formula": "C3H5O4P. 2Na",
    "efficacy": "Antibacterial, Cell wall biosynthesis inhibitor",
    "target": "UDP-N-acetylglucosamine 1-carboxyvinyltransferase [KO:K00790]\nPATHWAY   ko00550(K00790)  Peptidoglycan biosynthesis",
    "metabolism": "",
    "therapeutic_category": "1325",
    "atc_code": "J01XX01",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Fosfomycin sodium"
  },
  {
    "kegg_id": "D07073",
    "name_en": "Dexamethasone cipecilate (JAN/INN)",
    "name_ja": "デキサメタゾン",
    "names_alt": [],
    "formula": "C33H43FO7",
    "efficacy": "Antiallergic, Anti-inflammatory, Glucocorticoid receptor agonist",
    "target": "NR3C1 (GR) [HSA:2908] [KO:K05771]\nPATHWAY   hsa04080(2908)  Neuroactive ligand-receptor interaction",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "1329",
    "atc_code": "A01AC02",
    "drug_class": [
      "Anti-inflammatory",
      "Corticosteroid",
      "Glucocorticoid",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "Metabolizing enzyme inducer",
      "CYP3A/CYP3A4 inducer",
      "CYP3A4 inducer"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Dexamethasone cipecilate"
  },
  {
    "kegg_id": "D00305",
    "name_en": "Docusate sodium (USP)",
    "name_ja": "",
    "names_alt": [
      "Sodium dioctyl sulfosuccinate (INN)",
      "Dioctyl sodium sulfosuccinate (JAN)",
      "Colace (TN)"
    ],
    "formula": "C20H37O7S. Na",
    "efficacy": "Softener, Surfactant",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "1329",
    "atc_code": "A06AA02",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Docusate sodium"
  },
  {
    "kegg_id": "D00689",
    "name_en": "Beclomethasone dipropionate (USP)",
    "name_ja": "",
    "names_alt": [
      "Beclometasone dipropionate (JP18)",
      "Beclovent (TN)",
      "Qnasl (TN)",
      "Vanceril (TN)"
    ],
    "formula": "C28H37ClO7",
    "efficacy": "Antiasthmatic, Anti-inflammatory, Glucocorticoid receptor agonist\nDISEASE   Asthma [DS:H00079]\nAllergic rhinitis [DS:H01360]",
    "target": "NR3C1 (GR) [HSA:2908] [KO:K05771]\nPATHWAY   hsa04080(2908)  Neuroactive ligand-receptor interaction",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "1329",
    "atc_code": "A07EA07",
    "drug_class": [
      "Anti-inflammatory",
      "Corticosteroid",
      "Glucocorticoid",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Beclomethasone dipropionate"
  },
  {
    "kegg_id": "D03362",
    "name_en": "Trafermin (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Trafermin (genetical recombination) (JAN)",
      "Fiblast (TN)"
    ],
    "formula": "C764H1201N217O219S6",
    "efficacy": "Anti-ulcerative (skin), Periodontal guided tissue regeneraion agent, Stroke treatment",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "1329",
    "atc_code": "D03AX15",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Trafermin"
  },
  {
    "kegg_id": "D03325",
    "name_en": "Mometasone furoate hydrate (JAN)",
    "name_ja": "",
    "names_alt": [
      "Mometasone furoate monohydrate",
      "Nasonex (TN)"
    ],
    "formula": "C27H30Cl2O6. H2O",
    "efficacy": "Antiallergic, Anti-inflammatory, Glucocorticoid receptor agonist",
    "target": "NR3C1 (GR) [HSA:2908] [KO:K05771]\nPATHWAY   hsa04080(2908)  Neuroactive ligand-receptor interaction",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "1329",
    "atc_code": "D07AC13",
    "drug_class": [
      "Anti-inflammatory",
      "Corticosteroid",
      "Glucocorticoid",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Mometasone furoate hydrate"
  },
  {
    "kegg_id": "D06315",
    "name_en": "Fluticasone furoate (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Veramyst (TN)"
    ],
    "formula": "C27H29F3O6S",
    "efficacy": "Anti-inflammatory, Glucocorticoid receptor agonist\nDISEASE   Allergic rhinitis [DS:H01360]\nAsthma [DS:H00079]",
    "target": "NR3C1 (GR) [HSA:2908] [KO:K05771]\nPATHWAY   hsa04080(2908)  Neuroactive ligand-receptor interaction",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "1329",
    "atc_code": "D07AC17",
    "drug_class": [
      "Anti-inflammatory",
      "Corticosteroid",
      "Glucocorticoid",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Fluticasone furoate"
  },
  {
    "kegg_id": "D01708",
    "name_en": "Fluticasone propionate (JAN/USP)",
    "name_ja": "",
    "names_alt": [
      "Cutivate (TN)",
      "Flonase (TN)",
      "Flovent (TN)"
    ],
    "formula": "C25H31F3O5S",
    "efficacy": "Antiasthmatic, Anti-inflammatory, Glucocorticoid receptor agonist\nDISEASE   Asthma [DS:H00079]",
    "target": "NR3C1 (GR) [HSA:2908] [KO:K05771]\nPATHWAY   hsa04080(2908)  Neuroactive ligand-receptor interaction",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "1329",
    "atc_code": "D07AC17",
    "drug_class": [
      "Anti-inflammatory",
      "Corticosteroid",
      "Glucocorticoid",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Fluticasone propionate"
  },
  {
    "kegg_id": "D04251",
    "name_en": "Tetrahydrozoline hydrochloride and prednisolone",
    "name_ja": "",
    "names_alt": [
      "Cor tyzine (TN)"
    ],
    "formula": "",
    "efficacy": "Anti-inflammatory, Vasoconstrictor (nasal spray)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "1329",
    "atc_code": "R01AD52",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Tetrahydrozoline hydrochloride and prednisolone"
  },
  {
    "kegg_id": "D04252",
    "name_en": "Nicotinamide and papaverine hydrochloride",
    "name_ja": "",
    "names_alt": [
      "Stomin A (TN)"
    ],
    "formula": "",
    "efficacy": "Vasodilator",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "1329",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Nicotinamide and papaverine hydrochloride"
  },
  {
    "kegg_id": "D00520",
    "name_en": "Dimenhydrinate (JP18/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Dramamine (TN)"
    ],
    "formula": "C17H21NO. C7H7ClN4O2",
    "efficacy": "Anti-emetic, Antivertigo, H1 receptor antagonist",
    "target": "HRH1 [HSA:3269] [KO:K04149]\nPATHWAY   hsa04020(3269)  Calcium signaling pathway\nhsa04080(3269)  Neuroactive ligand-receptor interaction",
    "metabolism": "",
    "therapeutic_category": "1331",
    "atc_code": "R06AA11",
    "drug_class": [
      "Anti-allergic agent",
      "Histamine receptor antagonist",
      "Histamine receptor H1 antagonist",
      "Respiratory system agent",
      "Xanthine derivative"
    ],
    "cyp_enzymes": [],
    "search_name": "Dimenhydrinate"
  },
  {
    "kegg_id": "D01390",
    "name_en": "Isoproterenol hydrochloride (USP)",
    "name_ja": "",
    "names_alt": [
      "dl-Isoprenaline hydrochloride (JAN)",
      "Isuprel (TN)",
      "Proternol-S (TN)"
    ],
    "formula": "C11H17NO3. HCl",
    "efficacy": "Antivertigo, Cardiotonic, Bronchodilator, beta-Adrenergic receptor agonist",
    "target": "ADRB [HSA:153 154 155] [KO:K04141 K04142 K04143]\nPATHWAY   hsa04020(153+154+155)  Calcium signaling pathway\nhsa04080(153+154+155)  Neuroactive ligand-receptor interaction\nhsa04261(153+154)  Adrenergic signaling in cardiomyocytes",
    "metabolism": "Enzyme: COMT [HSA:1312]",
    "therapeutic_category": "1339",
    "atc_code": "C01CA02",
    "drug_class": [
      "Cardiovascular agent",
      "Cardiotonic",
      "Catecholamine cardiotonic",
      "Adrenergic receptor agonist",
      "beta-Adrenergic receptor agonist",
      "Catecholamine adrenergic receptor agonist",
      "Metabolizing enzyme substrate",
      "COMT substrate"
    ],
    "cyp_enzymes": [],
    "search_name": "Isoproterenol hydrochloride"
  },
  {
    "kegg_id": "D01445",
    "name_en": "Ifenprodil tartrate (JP18)",
    "name_ja": "",
    "names_alt": [
      "Cerocral (TN)"
    ],
    "formula": "(C21H27NO2)2. C4H6O6",
    "efficacy": "Vasodilator (peripheral), alpha-Adrenergic receptor antagonist",
    "target": "ADRA1 [HSA:148 147 146] [KO:K04135 K04136 K04137]\nPATHWAY   hsa04080(146+147+148)  Neuroactive ligand-receptor interaction\nhsa04270(146+147+148)  Vascular smooth muscle contraction",
    "metabolism": "",
    "therapeutic_category": "1339",
    "atc_code": "C04AX28",
    "drug_class": [
      "Cardiovascular agent",
      "Adrenergic receptor antagonist",
      "alpha-Adrenergic receptor antagonist",
      "alpha1-Adrenergic receptor antagonist",
      "Neuropsychiatric agent",
      "NMDA receptor antagonist"
    ],
    "cyp_enzymes": [],
    "search_name": "Ifenprodil tartrate"
  },
  {
    "kegg_id": "D01592",
    "name_en": "Betahistine mesilate (JP18)",
    "name_ja": "",
    "names_alt": [
      "Suzutolon (TN)"
    ],
    "formula": "(CH4SO3)2. C8H12N2",
    "efficacy": "Antivertigo, Vasodilator, Antihistaminic",
    "target": "HRH1 [HSA:3269] [KO:K04149]\nHRH3 [HSA:11255] [KO:K04151]\nPATHWAY   hsa04020(3269)  Calcium signaling pathway\nhsa04080(11255+3269)  Neuroactive ligand-receptor interaction",
    "metabolism": "",
    "therapeutic_category": "1339",
    "atc_code": "N07CA01",
    "drug_class": [
      "Anti-allergic agent",
      "Histamine receptor antagonist",
      "Histamine receptor H3 antagonist"
    ],
    "cyp_enzymes": [],
    "search_name": "Betahistine mesilate"
  },
  {
    "kegg_id": "D01318",
    "name_en": "Diphenidol hydrochloride (USAN)",
    "name_ja": "",
    "names_alt": [
      "Difenidol hydrochloride (JP18)",
      "Cephadol (TN)",
      "Vontrol (TN)"
    ],
    "formula": "C21H27NO. HCl",
    "efficacy": "Anti-emetic, Antivertigo",
    "target": "CHRM [HSA:1128 1129 1131 1132 1133] [KO:K04129 K04130 K04131 K04132 K04133]\nPATHWAY   hsa04080(1128+1129+1131+1132+1133)  Neuroactive ligand-receptor interaction\nhsa04725(1128+1129+1131+1132+1133)  Cholinergic synapse",
    "metabolism": "",
    "therapeutic_category": "1339",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Diphenidol hydrochloride"
  },
  {
    "kegg_id": "D04259",
    "name_en": "Diphenhydramine hydrochloride and diprophylline",
    "name_ja": "",
    "names_alt": [
      "Travelmin (TN)"
    ],
    "formula": "",
    "efficacy": "Antivertigo",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "1339",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Diphenhydramine hydrochloride and diprophylline"
  },
  {
    "kegg_id": "D04261",
    "name_en": "Diphenhydramine salicylate and diprophylline",
    "name_ja": "",
    "names_alt": [
      "Travelmin (TN)"
    ],
    "formula": "",
    "efficacy": "Antivertigo",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "1339",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Diphenhydramine salicylate and diprophylline"
  },
  {
    "kegg_id": "D09680",
    "name_en": "Teprotumumab (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Teprotumumab (genetical recombination) (JAN)",
      "Teprotumumab-trbw",
      "Tepezza (TN)"
    ],
    "formula": "C6476H10012N1748O2000S40",
    "efficacy": "Anti-inflammatory, Insulin-like growth factor 1 receptor antibody\nDISEASE   Thyroid eye disease [DS:H02402]\nTYPE      Monoclonal antibody",
    "target": "IGF1R (CD221) [HSA:3480] [KO:K05087]",
    "metabolism": "",
    "therapeutic_category": "1390",
    "atc_code": "L04AG13",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Teprotumumab"
  },
  {
    "kegg_id": "D00639",
    "name_en": "Mexiletine hydrochloride (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Mexitil (TN)"
    ],
    "formula": "C11H17NO. HCl",
    "efficacy": "Antiarrhythmic, Antihypertensive, Sodium channel blocker",
    "target": "SCN1A [HSA:6323] [KO:K04833]\nSCN2A [HSA:6326] [KO:K04834]\nSCN3A [HSA:6328] [KO:K04836]\nSCN4A [HSA:6329] [KO:K04837]\nSCN5A [HSA:6331] [KO:K04838]\nSCN8A [HSA:6334] [KO:K04840]\nSCN9A [HSA:6335] [KO:K04841]\nSCN10A [HSA:6336] [KO:K04842]\nSCN11A [HSA:11280] [KO:K04843]\nPATHWAY   hsa04261(6331)  Adrenergic signaling in cardiomyocytes\nhsa04728(6323)  Dopaminergic synapse",
    "metabolism": "Enzyme: CYP1A2 [HSA:1544], CYP2D6 [HSA:1565]",
    "therapeutic_category": "1900",
    "atc_code": "C01BB02",
    "drug_class": [
      "Cardiovascular agent",
      "Antiarrhythmics",
      "Class I antiarrhythmic agent",
      "Class Ib antiarrhythmic agent",
      "Metabolizing enzyme substrate",
      "CYP1A2 substrate",
      "CYP2D6 substrate"
    ],
    "cyp_enzymes": [
      "CYP1A2",
      "CYP2D6"
    ],
    "search_name": "Mexiletine hydrochloride"
  },
  {
    "kegg_id": "D11016",
    "name_en": "Aceneuramic acid (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Acenobel (TN)"
    ],
    "formula": "C11H19NO9",
    "efficacy": "Myopathy treatment",
    "target": "",
    "metabolism": "Enzyme: NPL [HSA:80896]",
    "therapeutic_category": "1900",
    "atc_code": "M09AX05",
    "drug_class": [
      "Metabolizing enzyme substrate",
      "NPL substrate"
    ],
    "cyp_enzymes": [],
    "search_name": "Aceneuramic acid"
  },
  {
    "kegg_id": "D11528",
    "name_en": "Viltolarsen (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Viltepso (TN)"
    ],
    "formula": "C244H381N113O88P20",
    "efficacy": "Translation inhibitor\nDISEASE   Duchenne muscular dystrophy (amenable to exon 53 skipping mutated) [DS:H01963]\nTYPE      Antisense oligonucleotide",
    "target": "DMD* [HSA_VAR:1756v1] [HSA:1756] [KO:K10366] (pre-mRNA exon53)\nPATHWAY   hsa04820(1756)  Cytoskeleton in muscle cells\nNETWORK   nt06539  Cytoskeleton in muscle cells",
    "metabolism": "",
    "therapeutic_category": "1900",
    "atc_code": "M09AX12",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Viltolarsen"
  },
  {
    "kegg_id": "D12633",
    "name_en": "Delandistrogene moxeparvovec (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Delandistrogene moxeparvovec-rokl",
      "Elevidys (TN)"
    ],
    "formula": "",
    "efficacy": "Nervous system disease agent\nDISEASE   Duchenne muscular dystrophy [DS:H01963]\nTYPE      Gene therapy product",
    "target": "DMD* [HSA_VAR:1756v1] [HSA:1756] [KO:K10366]",
    "metabolism": "",
    "therapeutic_category": "1900",
    "atc_code": "M09AX15",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Delandistrogene moxeparvovec"
  },
  {
    "kegg_id": "D00298",
    "name_en": "Digoxin (JP18/USP)",
    "name_ja": "ジゴキシン",
    "names_alt": [
      "Lanoxicaps (TN)",
      "Lanoxin (TN)"
    ],
    "formula": "C41H64O14",
    "efficacy": "Cardiotonic",
    "target": "ATP1A [HSA:476 477 478 480] [KO:K01539]\nPATHWAY   hsa04260(476+477+478+480)  Cardiac muscle contraction\nhsa04261(476+477+478+480)  Adrenergic signaling in cardiomyocytes",
    "metabolism": "Transporter: ABCB1 [HSA:5243]",
    "therapeutic_category": "2113",
    "atc_code": "C01AA05",
    "drug_class": [
      "Cardiovascular agent",
      "Cardiotonic",
      "Cardiac glycoside",
      "Digitalis cardiac glycoside",
      "Antiarrhythmics",
      "Transporter substrate",
      "ABCB1 substrate"
    ],
    "cyp_enzymes": [],
    "search_name": "Digoxin"
  },
  {
    "kegg_id": "D01240",
    "name_en": "Deslanoside (JP18/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Cedilanid-d (TN)"
    ],
    "formula": "C47H74O19",
    "efficacy": "Cardiotonic",
    "target": "ATP1A [HSA:476 477 478 480] [KO:K01539]\nPATHWAY   hsa04260(476+477+478+480)  Cardiac muscle contraction\nhsa04261(476+477+478+480)  Adrenergic signaling in cardiomyocytes",
    "metabolism": "",
    "therapeutic_category": "2113",
    "atc_code": "C01AA07",
    "drug_class": [
      "Cardiovascular agent",
      "Cardiotonic",
      "Cardiac glycoside",
      "Digitalis cardiac glycoside",
      "Antiarrhythmics"
    ],
    "cyp_enzymes": [],
    "search_name": "Deslanoside"
  },
  {
    "kegg_id": "D02587",
    "name_en": "Metildigoxin (JP18)",
    "name_ja": "",
    "names_alt": [
      "Lanirapid (TN)"
    ],
    "formula": "(C42H66O14)2. C3H6O",
    "efficacy": "Cardiotonic",
    "target": "ATP1A [HSA:476 477 478 480] [KO:K01539]\nPATHWAY   hsa04260(476+477+478+480)  Cardiac muscle contraction\nhsa04261(476+477+478+480)  Adrenergic signaling in cardiomyocytes",
    "metabolism": "Transporter: ABCB1 [HSA:5243]",
    "therapeutic_category": "2113",
    "atc_code": "C01AA08",
    "drug_class": [
      "Cardiovascular agent",
      "Cardiotonic",
      "Cardiac glycoside",
      "Digitalis cardiac glycoside",
      "Antiarrhythmics",
      "Transporter substrate",
      "ABCB1 substrate"
    ],
    "cyp_enzymes": [],
    "search_name": "Metildigoxin"
  },
  {
    "kegg_id": "D00528",
    "name_en": "Caffeine (USP)",
    "name_ja": "カフェイン",
    "names_alt": [
      "Anhydrous caffeine (JP18)",
      "Anhydrous caffeine (TN)",
      "Respia (TN)"
    ],
    "formula": "C8H10N4O2",
    "efficacy": "Stimulant (central), Adenosine receptor antagonist, Phosphodiesterase inhibitor",
    "target": "ADORA1 [HSA:134] [KO:K04265]\nADORA2A [HSA:135] [KO:K04266]\nPDE [HSA:5153 5138 5139 5140 5141 5142 5143 5144 8654] [KO:K13755 K18283 K19021 K13296 K13293 K13762]\nPATHWAY   hsa04020(135+5153)  Calcium signaling pathway\nhsa04024(134+135+5139+5140+5141+5142+5143+5144)  cAMP signaling pathway\nhsa04080(134+135)  Neuroactive ligand-receptor interaction\nhsa04270(135)  Vascular smooth muscle contraction",
    "metabolism": "Enzyme: CYP1A2 [HSA:1544]; CYP3A4 [HSA:1576], CYP2E1 [HSA:1571]",
    "therapeutic_category": "2115",
    "atc_code": "D11AX26",
    "drug_class": [
      "Respiratory system agent",
      "Xanthine derivative",
      "Xanthine-type central nervous system stimulant",
      "Metabolizing enzyme substrate",
      "CYP1A2 substrate",
      "CYP2E1 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP2E1",
      "CYP3A4",
      "CYP1A2"
    ],
    "search_name": "Caffeine"
  },
  {
    "kegg_id": "D01453",
    "name_en": "Caffeine hydrate (JP18)",
    "name_ja": "カフェイン",
    "names_alt": [
      "Caffeine monohydrate"
    ],
    "formula": "C8H10N4O2. H2O",
    "efficacy": "Stimulant (central), Adenosine receptor antagonist, Phosphodiesterase inhibitor",
    "target": "ADORA1 [HSA:134] [KO:K04265]\nADORA2A [HSA:135] [KO:K04266]\nPDE [HSA:5153 5138 5139 5140 5141 5142 5143 5144 8654] [KO:K13755 K18283 K19021 K13296 K13293 K13762]\nPATHWAY   hsa04020(135+5153)  Calcium signaling pathway\nhsa04024(134+135+5139+5140+5141+5142+5143+5144)  cAMP signaling pathway\nhsa04080(134+135)  Neuroactive ligand-receptor interaction\nhsa04270(135)  Vascular smooth muscle contraction",
    "metabolism": "Enzyme: CYP1A2 [HSA:1544]; CYP3A4 [HSA:1576], CYP2E1 [HSA:1571]",
    "therapeutic_category": "2115",
    "atc_code": "D11AX26",
    "drug_class": [
      "Respiratory system agent",
      "Xanthine derivative",
      "Xanthine-type central nervous system stimulant",
      "Metabolizing enzyme substrate",
      "CYP1A2 substrate",
      "CYP2E1 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP2E1",
      "CYP3A4",
      "CYP1A2"
    ],
    "search_name": "Caffeine hydrate"
  },
  {
    "kegg_id": "D00691",
    "name_en": "Dyphylline (USP)",
    "name_ja": "",
    "names_alt": [
      "Diprophylline (JAN/INN)",
      "Lufyllin (TN)"
    ],
    "formula": "C10H14N4O4",
    "efficacy": "Bronchodilator, Cardiotonic, Phosphodiesterase inhibitor",
    "target": "PDE [HSA:10846 27115 50940 5136 5137 5138 5139 5140 5141 5142 5143 5144 5150 5151 5153 8622] [KO:K18438 K18436 K13298 K13755 K18283 K19021 K13296 K13293 K18437]\nADORA1 [HSA:134] [KO:K04265]\nADORA2B [HSA:136] [KO:K04267]\nPATHWAY   hsa04024(10846+134+5139+5140+5141+5142+5143+5144)  cAMP signaling pathway\nhsa04080(134+136)  Neuroactive ligand-receptor interaction\nhsa04270(136)  Vascular smooth muscle contraction",
    "metabolism": "",
    "therapeutic_category": "2115",
    "atc_code": "R03DA01",
    "drug_class": [
      "Respiratory system agent",
      "Xanthine derivative",
      "Xanthine-type bronchodilator"
    ],
    "cyp_enzymes": [],
    "search_name": "Dyphylline"
  },
  {
    "kegg_id": "D05429",
    "name_en": "Aminophylline hydrate (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "(C7H8N4O2)2. C2H8N2. xH2O",
    "efficacy": "Bronchodilator, Cardiotonic, Phosphodiesterase inhibitor\nDISEASE   Asthma [DS:H00079]\nEmphysema [DS:H01714]",
    "target": "ADORA1 [HSA:134] [KO:K04265]\nADORA2B [HSA:136] [KO:K04267]\nPDE [HSA:10846 27115 50940 5136 5137 5138 5139 5140 5141 5142 5143 5144 5150 5151 5153 8622] [KO:K18438 K18436 K13298 K13755 K18283 K19021 K13296 K13293 K18437]\nPATHWAY   hsa04020(136+5136+5137+5153)  Calcium signaling pathway\nhsa04022(134+5138+5139+5140)  cGMP-PKG signaling pathway\nhsa04024(10846+134+5139+5140+5141+5142+5143+5144)  cAMP signaling pathway\nhsa04080(134+136)  Neuroactive ligand-receptor interaction\nhsa04270(136)  Vascular smooth muscle contraction",
    "metabolism": "Enzyme: CYP1A2 [HSA:1544]",
    "therapeutic_category": "2115",
    "atc_code": "R03DA05",
    "drug_class": [
      "Respiratory system agent",
      "Xanthine derivative",
      "Xanthine-type bronchodilator",
      "Metabolizing enzyme substrate",
      "CYP1A2 substrate"
    ],
    "cyp_enzymes": [
      "CYP1A2"
    ],
    "search_name": "Aminophylline hydrate"
  },
  {
    "kegg_id": "D02409",
    "name_en": "Caffeine and sodium benzoate (JP18)",
    "name_ja": "カフェイン",
    "names_alt": [
      "Sodium caffeine benzoate",
      "Annaca (TN)"
    ],
    "formula": "C8H10N4O2. C7H5O2. Na",
    "efficacy": "Stimulant (central)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2115",
    "atc_code": "V04CG30",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Caffeine and sodium benzoate"
  },
  {
    "kegg_id": "D01386",
    "name_en": "Ephedrine hydrochloride (JP18/USP)",
    "name_ja": "",
    "names_alt": [],
    "formula": "C10H15NO. HCl",
    "efficacy": "Antitussive, Bronchodilator, Adrenergic receptor agonist",
    "target": "ADRA1 [HSA:148 147 146] [KO:K04135 K04136 K04137]\nADRA2 [HSA:150 151 152] [KO:K04138 K04139 K04140]\nADRB [HSA:153 154 155] [KO:K04141 K04142 K04143]\nPATHWAY   hsa04020(146+147+148+153+154+155)  Calcium signaling pathway\nhsa04080(146+147+148+150+151+152+153+154+155)  Neuroactive ligand-receptor interaction\nhsa04261(146+147+148+153+154)  Adrenergic signaling in cardiomyocytes\nhsa04270(146+147+148)  Vascular smooth muscle contraction\nhsa04970(146+147+148+153+154+155)  Salivary secretion",
    "metabolism": "",
    "therapeutic_category": "2118",
    "atc_code": "C01CA26",
    "drug_class": [
      "Cardiovascular agent",
      "Cardiotonic",
      "Phenethylamine cardiotonic",
      "Adrenergic receptor agonist",
      "Respiratory system agent",
      "Ephedrine-containing preparation"
    ],
    "cyp_enzymes": [],
    "search_name": "Ephedrine hydrochloride"
  },
  {
    "kegg_id": "D01573",
    "name_en": "Etilefrine hydrochloride (JP18)",
    "name_ja": "",
    "names_alt": [
      "Effortil (TN)"
    ],
    "formula": "C10H15NO2. HCl",
    "efficacy": "Antihypotensive, Cardiotonic, Adrenergic receptor agonist",
    "target": "ADRA1 [HSA:148 147 146] [KO:K04135 K04136 K04137]\nADRA2 [HSA:150 151 152] [KO:K04138 K04139 K04140]\nADRB [HSA:153 154 155] [KO:K04141 K04142 K04143]\nPATHWAY   hsa04020(146+147+148+153+154+155)  Calcium signaling pathway\nhsa04022(146+147+148+150+151+152+153+154+155)  cGMP-PKG signaling pathway\nhsa04024(153+154)  cAMP signaling pathway\nhsa04080(146+147+148+150+151+152+153+154+155)  Neuroactive ligand-receptor interaction\nhsa04261(146+147+148+153+154)  Adrenergic signaling in cardiomyocytes\nhsa04270(146+147+148)  Vascular smooth muscle contraction",
    "metabolism": "",
    "therapeutic_category": "2119",
    "atc_code": "C01CA01",
    "drug_class": [
      "Cardiovascular agent",
      "Cardiotonic",
      "Phenethylamine cardiotonic"
    ],
    "cyp_enzymes": [],
    "search_name": "Etilefrine hydrochloride"
  },
  {
    "kegg_id": "D02150",
    "name_en": "l-Isoprenaline hydrochloride (JP18)",
    "name_ja": "",
    "names_alt": [
      "Proternol-L (TN)"
    ],
    "formula": "C11H17NO3. HCl",
    "efficacy": "Bronchodilator, Cardiotonic, beta-Adrenergic receptor agonist",
    "target": "ADRB [HSA:153 154 155] [KO:K04141 K04142 K04143]\nPATHWAY   hsa04020(153+154+155)  Calcium signaling pathway\nhsa04080(153+154+155)  Neuroactive ligand-receptor interaction\nhsa04261(153+154)  Adrenergic signaling in cardiomyocytes",
    "metabolism": "Enzyme: COMT [HSA:1312]",
    "therapeutic_category": "2119",
    "atc_code": "C01CA02",
    "drug_class": [
      "Cardiovascular agent",
      "Cardiotonic",
      "Catecholamine cardiotonic",
      "Adrenergic receptor agonist",
      "beta-Adrenergic receptor agonist",
      "Catecholamine adrenergic receptor agonist",
      "Metabolizing enzyme substrate",
      "COMT substrate"
    ],
    "cyp_enzymes": [],
    "search_name": "l-Isoprenaline hydrochloride"
  },
  {
    "kegg_id": "D00633",
    "name_en": "Dopamine hydrochloride (JP18/USP)",
    "name_ja": "ドパミン",
    "names_alt": [
      "Actopamin (TN)",
      "Intropin (TN)"
    ],
    "formula": "C8H11NO2. HCl",
    "efficacy": "Cardiotonic, Dopamine receptor agonist\nDISEASE   Myocardial infarction [DS:H01730]",
    "target": "DRD [HSA:1812 1813 1814 1815 1816] [KO:K04144 K04145 K04146 K04147 K05840]\nPATHWAY   hsa04020(1812+1816)  Calcium signaling pathway\nhsa04080(1812+1813+1814+1815+1816)  Neuroactive ligand-receptor interaction\nhsa04728(1812+1813+1814+1815+1816)  Dopaminergic synapse",
    "metabolism": "Enzyme: MAOB [HSA:4129], COMT [HSA:1312]\nTransporter: SLC22A2 [HSA:6582]",
    "therapeutic_category": "2119",
    "atc_code": "C01CA04",
    "drug_class": [
      "Cardiovascular agent",
      "Cardiotonic",
      "Catecholamine cardiotonic",
      "Neuropsychiatric agent",
      "Dopamine agonist",
      "Metabolizing enzyme substrate",
      "COMT substrate",
      "MAO substrate",
      "MAOB substrate",
      "Transporter substrate",
      "SLC22A2 substrate"
    ],
    "cyp_enzymes": [],
    "search_name": "Dopamine hydrochloride"
  },
  {
    "kegg_id": "D00632",
    "name_en": "Dobutamine hydrochloride (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Dobutrex (TN)"
    ],
    "formula": "C18H23NO3. HCl",
    "efficacy": "Cardiotonic, beta1-Adrenergic receptor agonist",
    "target": "ADRB1 [HSA:153] [KO:K04141]\nPATHWAY   hsa04020(153)  Calcium signaling pathway\nhsa04022(153)  cGMP-PKG signaling pathway\nhsa04024(153)  cAMP signaling pathway\nhsa04080(153)  Neuroactive ligand-receptor interaction\nhsa04261(153)  Adrenergic signaling in cardiomyocytes",
    "metabolism": "",
    "therapeutic_category": "2119",
    "atc_code": "C01CA07",
    "drug_class": [
      "Cardiovascular agent",
      "Cardiotonic",
      "Catecholamine cardiotonic",
      "Adrenergic receptor agonist",
      "beta-Adrenergic receptor agonist",
      "beta1-Adrenergic receptor agonist",
      "Catecholamine adrenergic receptor agonist"
    ],
    "cyp_enzymes": [],
    "search_name": "Dobutamine hydrochloride"
  },
  {
    "kegg_id": "D00417",
    "name_en": "Milrinone (JAN/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Milrila (TN)"
    ],
    "formula": "C12H9N3O",
    "efficacy": "Cardiotonic, Phosphodiesterase 3 inhibitor",
    "target": "PDE3 [HSA:5139 5140] [KO:K19021 K13296]\nPATHWAY   hsa00230(5139+5140)  Purine metabolism\nhsa04022(5139+5140)  cGMP-PKG signaling pathway\nhsa04024(5139+5140)  cAMP signaling pathway\nhsa04371(5140)  Apelin signaling pathway",
    "metabolism": "Enzyme: UGT [KO:K00699]",
    "therapeutic_category": "2119",
    "atc_code": "C01CE02",
    "drug_class": [
      "Cardiovascular agent",
      "Cardiotonic",
      "Amrinone type cardiotonic",
      "Phosphodiesterase III inhibitor",
      "Amrinone type cardiotonic",
      "Metabolizing enzyme substrate",
      "UGT substrate"
    ],
    "cyp_enzymes": [],
    "search_name": "Milrinone"
  },
  {
    "kegg_id": "D01238",
    "name_en": "Bucladesine sodium (JAN)",
    "name_ja": "",
    "names_alt": [
      "Actosin (TN)"
    ],
    "formula": "C18H23N5O8P. Na",
    "efficacy": "Anti-ulcerative (skin), Cardiotonic, Phosphodiesterase inhibitor",
    "target": "PDE [HSA:10846 27115 50940 5136 5137 5138 5139 5140 5141 5142 5143 5144 5150 5151 5153 8622] [KO:K18438 K18436 K13298 K13755 K18283 K19021 K13296 K13293 K18437]\nPATHWAY   hsa04020(5136+5137+5153)  Calcium signaling pathway\nhsa04022(5138+5139+5140)  cGMP-PKG signaling pathway\nhsa04024(10846+5139+5140+5141+5142+5143+5144)  cAMP signaling pathway\nhsa04371(5140)  Apelin signaling pathway\nhsa04910(5140)  Insulin signaling pathway\nhsa04922(5140)  Glucagon signaling pathway\nhsa04923(5140)  Regulation of lipolysis in adipocytes\nhsa04925(5138)  Aldosterone synthesis and secretion",
    "metabolism": "",
    "therapeutic_category": "2119",
    "atc_code": "C01CE04",
    "drug_class": [
      "Cardiovascular agent",
      "Cardiotonic"
    ],
    "cyp_enzymes": [],
    "search_name": "Bucladesine sodium"
  },
  {
    "kegg_id": "D01065",
    "name_en": "Ubidecarenone (JP18/INN)",
    "name_ja": "",
    "names_alt": [
      "Adelir (TN)"
    ],
    "formula": "C59H90O4",
    "efficacy": "Cardiotonic, Coenzyme, ATP production enhancer",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2119",
    "atc_code": "C01EB09",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Ubidecarenone"
  },
  {
    "kegg_id": "D01133",
    "name_en": "Pimobendan (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Acardi (TN)"
    ],
    "formula": "C19H18N4O2",
    "efficacy": "Cardiotonic, Phosphodiesterase inhibitor",
    "target": "PDE3 [HSA:5139 5140] [KO:K19021 K13296]\nPATHWAY   hsa04024(5139+5140)  cAMP signaling pathway\nhsa04371(5140)  Apelin signaling pathway",
    "metabolism": "",
    "therapeutic_category": "2119",
    "atc_code": "",
    "drug_class": [
      "Cardiovascular agent",
      "Cardiotonic",
      "Pimobendan type cardiotonic",
      "Phosphodiesterase III inhibitor",
      "Pimobendan type cardiotonic"
    ],
    "cyp_enzymes": [],
    "search_name": "Pimobendan"
  },
  {
    "kegg_id": "D01697",
    "name_en": "Colforsin daropate hydrochloride (JAN)",
    "name_ja": "",
    "names_alt": [
      "Nkh 477",
      "Adehl (TN)"
    ],
    "formula": "C27H43NO8. HCl",
    "efficacy": "Cardiotonic, Adenylate cyclase activator",
    "target": "ADCY [HSA:107 108 109 196883 111 112 113 114 115 55811] [KO:K08041 K08042 K08043 K08044 K08045 K08046 K08047 K08048 K08049 K11265]\nPATHWAY   hsa04020(107+108+109+113+114+115+196883)  Calcium signaling pathway\nhsa04024(107+108+109+111+112+113+114+115+196883+55811)  cAMP signaling pathway\nhsa04261(107+108+109+111+112+113+114+115+196883)  Adrenergic signaling in cardiomyocytes\nhsa04270(107+108+109+111+112+113+114+115+196883)  Vascular smooth muscle contraction\nhsa04371(107+108+109+111+112+113+114+115+196883+55811)  Apelin signaling pathway",
    "metabolism": "Enzyme: CYP3A [HSA:1576 1577 1551]",
    "therapeutic_category": "2119",
    "atc_code": "",
    "drug_class": [
      "Cardiovascular agent",
      "Cardiotonic",
      "Adenylate cyclase activator",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A"
    ],
    "search_name": "Colforsin daropate hydrochloride"
  },
  {
    "kegg_id": "D01903",
    "name_en": "Docarpamine (JAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Tanadopa (TN)"
    ],
    "formula": "C21H30N2O8S",
    "efficacy": "Cardiotonic, Dopamine D1 receptor agonist, beta1-Adrenergic receptor agonist",
    "target": "DRD1 [HSA:1812] [KO:K04144]\nADRB1 [HSA:153] [KO:K04141]\nPATHWAY   hsa04024(153+1812)  cAMP signaling pathway\nhsa04080(153+1812)  Neuroactive ligand-receptor interaction\nhsa04261(153)  Adrenergic signaling in cardiomyocytes\nhsa04728(1812)  Dopaminergic synapse",
    "metabolism": "",
    "therapeutic_category": "2119",
    "atc_code": "",
    "drug_class": [
      "Cardiovascular agent",
      "Cardiotonic",
      "Catecholamine cardiotonic"
    ],
    "cyp_enzymes": [],
    "search_name": "Docarpamine"
  },
  {
    "kegg_id": "D02042",
    "name_en": "Olprinone hydrochloride hydrate (JAN)",
    "name_ja": "",
    "names_alt": [
      "Coretec (TN)"
    ],
    "formula": "C14H10N4O. HCl. H2O",
    "efficacy": "Cardiotonic, Phosphodiesterase 3 inhibitor",
    "target": "PDE3 [HSA:5139 5140] [KO:K19021 K13296]\nPATHWAY   hsa00230(5139+5140)  Purine metabolism",
    "metabolism": "",
    "therapeutic_category": "2119",
    "atc_code": "",
    "drug_class": [
      "Cardiovascular agent",
      "Cardiotonic",
      "Amrinone type cardiotonic",
      "Phosphodiesterase III inhibitor",
      "Amrinone type cardiotonic"
    ],
    "cyp_enzymes": [],
    "search_name": "Olprinone hydrochloride hydrate"
  },
  {
    "kegg_id": "D02614",
    "name_en": "Denopamine (JAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Kalgut (TN)"
    ],
    "formula": "C18H23NO4",
    "efficacy": "Cardiotonic, beta1-Adrenergic receptor agonist",
    "target": "ADRB1 [HSA:153] [KO:K04141]\nPATHWAY   hsa04020(153)  Calcium signaling pathway\nhsa04080(153)  Neuroactive ligand-receptor interaction\nhsa04261(153)  Adrenergic signaling in cardiomyocytes\nhsa04970(153)  Salivary secretion",
    "metabolism": "",
    "therapeutic_category": "2119",
    "atc_code": "",
    "drug_class": [
      "Cardiovascular agent",
      "Cardiotonic",
      "Catecholamine cardiotonic",
      "Adrenergic receptor agonist",
      "beta-Adrenergic receptor agonist",
      "beta1-Adrenergic receptor agonist",
      "Catecholamine adrenergic receptor agonist"
    ],
    "cyp_enzymes": [],
    "search_name": "Denopamine"
  },
  {
    "kegg_id": "D00477",
    "name_en": "Procainamide hydrochloride (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Procan SR (TN)",
      "Procanbid (TN)",
      "Pronestyl (TN)"
    ],
    "formula": "C13H21N3O. HCl",
    "efficacy": "Antiarrhythmic, Sodium channel blocker",
    "target": "SCN1A [HSA:6323] [KO:K04833]\nSCN2A [HSA:6326] [KO:K04834]\nSCN3A [HSA:6328] [KO:K04836]\nSCN4A [HSA:6329] [KO:K04837]\nSCN5A [HSA:6331] [KO:K04838]\nSCN8A [HSA:6334] [KO:K04840]\nSCN9A [HSA:6335] [KO:K04841]\nSCN10A [HSA:6336] [KO:K04842]\nSCN11A [HSA:11280] [KO:K04843]\nPATHWAY   hsa04261(6331)  Adrenergic signaling in cardiomyocytes\nhsa04728(6323)  Dopaminergic synapse",
    "metabolism": "Enzyme: NAT [HSA:9 10]\nTransporter: SLC22A1 [HSA:6580], SLC22A2 [HSA:6582], SLC47A1 [HSA:55244], SLC47A2 [HSA:146802]",
    "therapeutic_category": "2121",
    "atc_code": "C01BA02",
    "drug_class": [
      "Cardiovascular agent",
      "Antiarrhythmics",
      "Class I antiarrhythmic agent",
      "Class Ia antiarrhythmic agent",
      "Metabolizing enzyme substrate",
      "NAT substrate",
      "Transporter substrate",
      "SLC22A1 substrate",
      "SLC22A2 substrate",
      "SLC47A1 substrate",
      "SLC47A2 substrate"
    ],
    "cyp_enzymes": [],
    "search_name": "Procainamide hydrochloride"
  },
  {
    "kegg_id": "D02272",
    "name_en": "Quinidine sulfate (USP)",
    "name_ja": "キニジン",
    "names_alt": [
      "Quinidine sulfate hydrate (JP18)",
      "Quinidex (TN)"
    ],
    "formula": "(C20H24N2O2)2. H2SO4. 2H2O",
    "efficacy": "Antiarrhythmic, Sodium channel blocker\nDISEASE   Atrial fibrillation [DS:H00731]",
    "target": "SCN1A [HSA:6323] [KO:K04833]\nSCN2A [HSA:6326] [KO:K04834]\nSCN3A [HSA:6328] [KO:K04836]\nSCN4A [HSA:6329] [KO:K04837]\nSCN5A [HSA:6331] [KO:K04838]\nSCN8A [HSA:6334] [KO:K04840]\nSCN9A [HSA:6335] [KO:K04841]\nSCN10A [HSA:6336] [KO:K04842]\nSCN11A [HSA:11280] [KO:K04843]\nPATHWAY   hsa04261(6331)  Adrenergic signaling in cardiomyocytes\nhsa04728(6323)  Dopaminergic synapse",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "2122",
    "atc_code": "C01BA01",
    "drug_class": [
      "Cardiovascular agent",
      "Antiarrhythmics",
      "Class I antiarrhythmic agent",
      "Class Ia antiarrhythmic agent",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Quinidine sulfate"
  },
  {
    "kegg_id": "D00483",
    "name_en": "Propranolol hydrochloride (JP18/USP)",
    "name_ja": "プロプラノロール",
    "names_alt": [
      "Inderal (TN)",
      "Innopran XL (TN)"
    ],
    "formula": "C16H21NO2. HCl",
    "efficacy": "Antiarrhythmic, Antihypertensive, Vasodilator, beta-Adrenergic receptor antagonist\nDISEASE   Hypertension [DS:H01633]\nAngina pectoris due to coronary atherosclerosis [DS:H01632]\nAtrial fibrillation [DS:H00731]\nMyocardial infarction [DS:H01730]\nEssential tremor [DS:H01577]\nInfantile hemangioma [DS:H01482]",
    "target": "ADRB [HSA:153 154 155] [KO:K04141 K04142 K04143]\nPATHWAY   hsa04080(153+154+155)  Neuroactive ligand-receptor interaction\nhsa04261(153+154)  Adrenergic signaling in cardiomyocytes",
    "metabolism": "Enzyme: CYP2D6 [HSA:1565], CYP1A2 [HSA:1544], CYP2C19 [HSA:1557]",
    "therapeutic_category": "2123",
    "atc_code": "C07AA05",
    "drug_class": [
      "Cardiovascular agent",
      "Adrenergic receptor antagonist",
      "beta-Adrenergic receptor antagonist (Beta blocker)",
      "Antiarrhythmics",
      "Class II antiarrhythmic agent",
      "Antihypertensive",
      "Metabolizing enzyme substrate",
      "CYP1A2 substrate",
      "CYP2C19 substrate",
      "CYP2D6 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C19",
      "CYP1A2",
      "CYP2D6"
    ],
    "search_name": "Propranolol hydrochloride"
  },
  {
    "kegg_id": "D00432",
    "name_en": "Nadolol (JP18/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Corgard (TN)"
    ],
    "formula": "C17H27NO4",
    "efficacy": "Antiarrhythmic, Antihypertensive, Vasodilator, beta-Adrenergic receptor antagonist\nDISEASE   Angina Pectoris [DS:H01632]\nHypertension [DS:H01633]",
    "target": "ADRB1 [HSA:153] [KO:K04141]\nADRB2 [HSA:154] [KO:K04142]\nPATHWAY   hsa04020(153+154)  Calcium signaling pathway\nhsa04022(153+154)  cGMP-PKG signaling pathway\nhsa04024(153+154)  cAMP signaling pathway\nhsa04080(153+154)  Neuroactive ligand-receptor interaction\nhsa04261(153+154)  Adrenergic signaling in cardiomyocytes",
    "metabolism": "",
    "therapeutic_category": "2123",
    "atc_code": "C07AA12",
    "drug_class": [
      "Cardiovascular agent",
      "Adrenergic receptor antagonist",
      "beta-Adrenergic receptor antagonist (Beta blocker)",
      "Antiarrhythmics",
      "Class II antiarrhythmic agent",
      "Antihypertensive"
    ],
    "cyp_enzymes": [],
    "search_name": "Nadolol"
  },
  {
    "kegg_id": "D00601",
    "name_en": "Metoprolol tartrate (JP18/USP)",
    "name_ja": "メトプロロール",
    "names_alt": [
      "Lopressor (TN)"
    ],
    "formula": "(C15H25NO3)2. C4H6O6",
    "efficacy": "Antiarrhythmic, Antihypertensive, Vasodilator, beta1-Adrenergic receptor antagonist\nDISEASE   Hypertension [DS:H01633]\nAngina pectoris [DS:H01632]\nMyocardial infarction [DS:H01730]",
    "target": "ADRB1 [HSA:153] [KO:K04141]\nPATHWAY   hsa04080(153)  Neuroactive ligand-receptor interaction\nhsa04261(153)  Adrenergic signaling in cardiomyocytes",
    "metabolism": "Enzyme: CYP2D6 [HSA:1565]",
    "therapeutic_category": "2123",
    "atc_code": "C07AB02",
    "drug_class": [
      "Cardiovascular agent",
      "Adrenergic receptor antagonist",
      "beta-Adrenergic receptor antagonist (Beta blocker)",
      "beta1-Adrenergic receptor antagonist",
      "Antiarrhythmics",
      "Class II antiarrhythmic agent",
      "Antihypertensive",
      "Metabolizing enzyme substrate",
      "CYP2D6 substrate"
    ],
    "cyp_enzymes": [
      "CYP2D6"
    ],
    "search_name": "Metoprolol tartrate"
  },
  {
    "kegg_id": "D00235",
    "name_en": "Atenolol (JP18/USP/INN)",
    "name_ja": "アテノロール",
    "names_alt": [
      "Tenormin (TN)"
    ],
    "formula": "C14H22N2O3",
    "efficacy": "Antiarrhythmic, Antihypertensive, Vasodilator, beta1-Adrenergic receptor antagonist\nDISEASE   Hypertension [DS:H01633]\nAngina pectoris due to coronary atherosclerosis [DS:H01632]\nAcute Myocardial Infarction [DS:H01730]",
    "target": "ADRB1 [HSA:153] [KO:K04141]\nPATHWAY   hsa04080(153)  Neuroactive ligand-receptor interaction\nhsa04261(153)  Adrenergic signaling in cardiomyocytes",
    "metabolism": "Enzyme: CYP2D6 [HSA:1565]",
    "therapeutic_category": "2123",
    "atc_code": "C07AB03",
    "drug_class": [
      "Cardiovascular agent",
      "Adrenergic receptor antagonist",
      "beta-Adrenergic receptor antagonist (Beta blocker)",
      "beta1-Adrenergic receptor antagonist",
      "Antiarrhythmics",
      "Class II antiarrhythmic agent",
      "Antihypertensive",
      "Metabolizing enzyme substrate",
      "CYP2D6 substrate"
    ],
    "cyp_enzymes": [
      "CYP2D6"
    ],
    "search_name": "Atenolol"
  },
  {
    "kegg_id": "D00634",
    "name_en": "Bisoprolol fumarate (JP18/USP)",
    "name_ja": "ビソプロロール",
    "names_alt": [
      "Zebeta (TN)"
    ],
    "formula": "(C18H31NO4)2. C4H4O4",
    "efficacy": "Antihypertensive, Vasodilator, beta1-Adrenergic receptor antagonist\nDISEASE   Hypertension [DS:H01633]",
    "target": "ADRB1 [HSA:153] [KO:K04141]\nPATHWAY   hsa04020(153)  Calcium signaling pathway\nhsa04022(153)  cGMP-PKG signaling pathway\nhsa04024(153)  cAMP signaling pathway\nhsa04080(153)  Neuroactive ligand-receptor interaction\nhsa04261(153)  Adrenergic signaling in cardiomyocytes\nhsa05414(153)  Dilated cardiomyopathy",
    "metabolism": "",
    "therapeutic_category": "2123",
    "atc_code": "C07AB07",
    "drug_class": [
      "Cardiovascular agent",
      "Adrenergic receptor antagonist",
      "beta-Adrenergic receptor antagonist (Beta blocker)",
      "beta1-Adrenergic receptor antagonist",
      "Antiarrhythmics",
      "Class II antiarrhythmic agent",
      "Antihypertensive"
    ],
    "cyp_enzymes": [],
    "search_name": "Bisoprolol fumarate"
  },
  {
    "kegg_id": "D00644",
    "name_en": "Esmolol hydrochloride (JAN/USP)",
    "name_ja": "",
    "names_alt": [
      "Brevibloc (TN)"
    ],
    "formula": "C16H25NO4. HCl",
    "efficacy": "Antiarrhythmic, beta1-Adrenergic receptor antagonist\nDISEASE   Hypertension [DS:H01633]",
    "target": "ADRB1 [HSA:153] [KO:K04141]\nPATHWAY   hsa04080(153)  Neuroactive ligand-receptor interaction\nhsa04261(153)  Adrenergic signaling in cardiomyocytes",
    "metabolism": "",
    "therapeutic_category": "2123",
    "atc_code": "C07AB09",
    "drug_class": [
      "Cardiovascular agent",
      "Adrenergic receptor antagonist",
      "beta-Adrenergic receptor antagonist (Beta blocker)",
      "beta1-Adrenergic receptor antagonist",
      "Antiarrhythmics",
      "Class II antiarrhythmic agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Esmolol hydrochloride"
  },
  {
    "kegg_id": "D01847",
    "name_en": "Landiolol hydrochloride (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "ONO 1101 hydrochloride",
      "Onoact (TN)",
      "Rapiblyk (TN)"
    ],
    "formula": "C25H39N3O8. HCl",
    "efficacy": "Antiarrhythmic, beta1-Adrenergic receptor antagonist\nDISEASE   Atrial fibrillation [DS:H00731]",
    "target": "ADRB1 [HSA:153] [KO:K04141]\nPATHWAY   hsa04080(153)  Neuroactive ligand-receptor interaction\nhsa04261(153)  Adrenergic signaling in cardiomyocytes",
    "metabolism": "",
    "therapeutic_category": "2123",
    "atc_code": "C07AB14",
    "drug_class": [
      "Cardiovascular agent",
      "Adrenergic receptor antagonist",
      "beta-Adrenergic receptor antagonist (Beta blocker)",
      "beta1-Adrenergic receptor antagonist",
      "Antiarrhythmics",
      "Class II antiarrhythmic agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Landiolol hydrochloride"
  },
  {
    "kegg_id": "D01830",
    "name_en": "Arotinolol hydrochloride (JP18)",
    "name_ja": "",
    "names_alt": [
      "Almarl (TN)"
    ],
    "formula": "C15H21N3O2S3. HCl",
    "efficacy": "Antiarrhythmic, Antihypertensive, Vasodilator, Adrenergic receptor antagonist",
    "target": "ADRA1 [HSA:148 147 146] [KO:K04135 K04136 K04137]\nADRB1 [HSA:153] [KO:K04141]\nADRB2 [HSA:154] [KO:K04142]\nPATHWAY   hsa04020(146+147+148+153+154)  Calcium signaling pathway\nhsa04022(146+147+148+153+154)  cGMP-PKG signaling pathway\nhsa04024(153+154)  cAMP signaling pathway\nhsa04080(146+147+148+153+154)  Neuroactive ligand-receptor interaction\nhsa04261(146+147+148+153+154)  Adrenergic signaling in cardiomyocytes\nhsa04270(146+147+148)  Vascular smooth muscle contraction",
    "metabolism": "",
    "therapeutic_category": "2123",
    "atc_code": "",
    "drug_class": [
      "Cardiovascular agent",
      "Adrenergic receptor antagonist",
      "alpha1 and beta-Adrenergic receptor antagonist",
      "Antiarrhythmics",
      "Class II antiarrhythmic agent",
      "Antihypertensive",
      "alpha1 and beta-Adrenergic receptor antagonist"
    ],
    "cyp_enzymes": [],
    "search_name": "Arotinolol hydrochloride"
  },
  {
    "kegg_id": "D00303",
    "name_en": "Disopyramide (JP18/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Rythmodan P (TN)"
    ],
    "formula": "C21H29N3O",
    "efficacy": "Antiarrhythmic, Sodium channel blocker",
    "target": "SCN1A [HSA:6323] [KO:K04833]\nSCN2A [HSA:6326] [KO:K04834]\nSCN3A [HSA:6328] [KO:K04836]\nSCN4A [HSA:6329] [KO:K04837]\nSCN5A [HSA:6331] [KO:K04838]\nSCN8A [HSA:6334] [KO:K04840]\nSCN9A [HSA:6335] [KO:K04841]\nSCN10A [HSA:6336] [KO:K04842]\nSCN11A [HSA:11280] [KO:K04843]\nPATHWAY   hsa04261(6331)  Adrenergic signaling in cardiomyocytes\nhsa04728(6323)  Dopaminergic synapse",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "2129",
    "atc_code": "C01BA03",
    "drug_class": [
      "Cardiovascular agent",
      "Antiarrhythmics",
      "Class I antiarrhythmic agent",
      "Class Ia antiarrhythmic agent",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Disopyramide"
  },
  {
    "kegg_id": "D00637",
    "name_en": "Disopyramide phosphate (JAN/USP)",
    "name_ja": "",
    "names_alt": [
      "Norpace (TN)"
    ],
    "formula": "C21H29N3O. H3PO4",
    "efficacy": "Antiarrhythmic, Sodium channel blocker",
    "target": "SCN1A [HSA:6323] [KO:K04833]\nSCN2A [HSA:6326] [KO:K04834]\nSCN3A [HSA:6328] [KO:K04836]\nSCN4A [HSA:6329] [KO:K04837]\nSCN5A [HSA:6331] [KO:K04838]\nSCN8A [HSA:6334] [KO:K04840]\nSCN9A [HSA:6335] [KO:K04841]\nSCN10A [HSA:6336] [KO:K04842]\nSCN11A [HSA:11280] [KO:K04843]\nPATHWAY   hsa04261(6331)  Adrenergic signaling in cardiomyocytes\nhsa04728(6323)  Dopaminergic synapse",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "2129",
    "atc_code": "C01BA03",
    "drug_class": [
      "Cardiovascular agent",
      "Antiarrhythmics",
      "Class I antiarrhythmic agent",
      "Class Ia antiarrhythmic agent",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Disopyramide phosphate"
  },
  {
    "kegg_id": "D01326",
    "name_en": "Aprindine hydrochloride (JP18/USAN)",
    "name_ja": "",
    "names_alt": [
      "Aspenon (TN)"
    ],
    "formula": "C22H30N2. HCl",
    "efficacy": "Antiarrhythmic, Sodium channel blocker",
    "target": "SCN1A [HSA:6323] [KO:K04833]\nSCN2A [HSA:6326] [KO:K04834]\nSCN3A [HSA:6328] [KO:K04836]\nSCN4A [HSA:6329] [KO:K04837]\nSCN5A [HSA:6331] [KO:K04838]\nSCN8A [HSA:6334] [KO:K04840]\nSCN9A [HSA:6335] [KO:K04841]\nSCN10A [HSA:6336] [KO:K04842]\nSCN11A [HSA:11280] [KO:K04843]\nPATHWAY   hsa04261(6331)  Adrenergic signaling in cardiomyocytes\nhsa04728(6323)  Dopaminergic synapse",
    "metabolism": "Enzyme: CYP2D6 [HSA:1565]",
    "therapeutic_category": "2129",
    "atc_code": "C01BB04",
    "drug_class": [
      "Cardiovascular agent",
      "Antiarrhythmics",
      "Class I antiarrhythmic agent",
      "Class Ib antiarrhythmic agent",
      "Metabolizing enzyme substrate",
      "CYP2D6 substrate"
    ],
    "cyp_enzymes": [
      "CYP2D6"
    ],
    "search_name": "Aprindine hydrochloride"
  },
  {
    "kegg_id": "D00640",
    "name_en": "Propafenone hydrochloride (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Rythmol (TN)"
    ],
    "formula": "C21H27NO3. HCl",
    "efficacy": "Antiarrhythmic, Sodium channel blocker",
    "target": "SCN1A [HSA:6323] [KO:K04833]\nSCN2A [HSA:6326] [KO:K04834]\nSCN3A [HSA:6328] [KO:K04836]\nSCN4A [HSA:6329] [KO:K04837]\nSCN5A [HSA:6331] [KO:K04838]\nSCN8A [HSA:6334] [KO:K04840]\nSCN9A [HSA:6335] [KO:K04841]\nSCN10A [HSA:6336] [KO:K04842]\nSCN11A [HSA:11280] [KO:K04843]\nPATHWAY   hsa04261(6331)  Adrenergic signaling in cardiomyocytes\nhsa04728(6323)  Dopaminergic synapse",
    "metabolism": "Enzyme: CYP2D6 [HSA:1565], CYP3A4 [HSA:1576], CYP1A2 [HSA:1544]",
    "therapeutic_category": "2129",
    "atc_code": "C01BC03",
    "drug_class": [
      "Cardiovascular agent",
      "Antiarrhythmics",
      "Class I antiarrhythmic agent",
      "Class Ic antiarrhythmic agent",
      "Metabolizing enzyme substrate",
      "CYP1A2 substrate",
      "CYP2D6 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4",
      "CYP1A2",
      "CYP2D6"
    ],
    "search_name": "Propafenone hydrochloride"
  },
  {
    "kegg_id": "D00638",
    "name_en": "Flecainide acetate (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Tambocor (TN)"
    ],
    "formula": "C17H20F6N2O3. C2H4O2",
    "efficacy": "Antiarrhythmic, Sodium channel blocker\nDISEASE   Atrial fibrillation/flutter [DS:H00731]",
    "target": "SCN1A [HSA:6323] [KO:K04833]\nSCN2A [HSA:6326] [KO:K04834]\nSCN3A [HSA:6328] [KO:K04836]\nSCN4A [HSA:6329] [KO:K04837]\nSCN5A [HSA:6331] [KO:K04838]\nSCN8A [HSA:6334] [KO:K04840]\nSCN9A [HSA:6335] [KO:K04841]\nSCN10A [HSA:6336] [KO:K04842]\nSCN11A [HSA:11280] [KO:K04843]\nPATHWAY   hsa04261(6331)  Adrenergic signaling in cardiomyocytes\nhsa04728(6323)  Dopaminergic synapse",
    "metabolism": "Enzyme: CYP2D6 [HSA:1565]",
    "therapeutic_category": "2129",
    "atc_code": "C01BC04",
    "drug_class": [
      "Cardiovascular agent",
      "Antiarrhythmics",
      "Class I antiarrhythmic agent",
      "Class Ic antiarrhythmic agent",
      "Metabolizing enzyme substrate",
      "CYP2D6 substrate"
    ],
    "cyp_enzymes": [
      "CYP2D6"
    ],
    "search_name": "Flecainide acetate"
  },
  {
    "kegg_id": "D00636",
    "name_en": "Amiodarone hydrochloride (JP18/USP)",
    "name_ja": "アミオダロン",
    "names_alt": [
      "Ancaron (TN)",
      "Cordarone (TN)",
      "Nexterone (TN)"
    ],
    "formula": "C25H29I2NO3. HCl",
    "efficacy": "Antiarrhythmic, Potassium channel blocker",
    "target": "KCND3 [HSA:3752] [KO:K04893]\nKCNH2 [HSA:3757] [KO:K04905]\nKCNQ1 [HSA:3784] [KO:K04926]\nKCNJ3 [HSA:3760] [KO:K04997]\nKCNJ5 [HSA:3762] [KO:K04999]\nKCNJ8 [HSA:3764] [KO:K05001]\nKCNJ11 [HSA:3767] [KO:K05004]\nKCNJ12 [HSA:3768] [KO:K05005]\nADRA1 [HSA:148 147 146] [KO:K04135 K04136 K04137]\nADRB1 [HSA:153] [KO:K04141]\nSCN1A [HSA:6323] [KO:K04833]\nSCN2A [HSA:6326] [KO:K04834]\nSCN3A [HSA:6328] [KO:K04836]\nSCN4A [HSA:6329] [KO:K04837]\nSCN5A [HSA:6331] [KO:K04838]\nSCN8A [HSA:6334] [KO:K04840]\nSCN9A [HSA:6335] [KO:K04841]\nSCN10A [HSA:6336] [KO:K04842]\nSCN11A [HSA:11280] [KO:K04843]\nPATHWAY   hsa04020(146+147+148+153)  Calcium signaling pathway\nhsa04022(146+147+148+153+3764)  cGMP-PKG signaling pathway\nhsa04024(153)  cAMP signaling pathway\nhsa04080(146+147+148+153)  Neuroactive ligand-receptor interaction\nhsa04261(146+147+148+153+3784+6331)  Adrenergic signaling in cardiomyocytes\nhsa04270(146+147+148)  Vascular smooth muscle contraction",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "2129",
    "atc_code": "C01BD01",
    "drug_class": [
      "Cardiovascular agent",
      "Adrenergic receptor agonist",
      "beta-Adrenergic receptor agonist",
      "beta1-Adrenergic receptor agonist",
      "Antiarrhythmics",
      "Class III antiarrhythmic agent",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Amiodarone hydrochloride"
  },
  {
    "kegg_id": "D01455",
    "name_en": "Cifenline succinate (USAN)",
    "name_ja": "",
    "names_alt": [
      "Cibenzoline succinate (JP18)",
      "Cibenol (TN)",
      "Cipralan (TN)"
    ],
    "formula": "C18H18N2. C4H6O4",
    "efficacy": "Antiarrhythmic, Sodium channel blocker",
    "target": "SCN1A [HSA:6323] [KO:K04833]\nSCN2A [HSA:6326] [KO:K04834]\nSCN3A [HSA:6328] [KO:K04836]\nSCN4A [HSA:6329] [KO:K04837]\nSCN5A [HSA:6331] [KO:K04838]\nSCN8A [HSA:6334] [KO:K04840]\nSCN9A [HSA:6335] [KO:K04841]\nSCN10A [HSA:6336] [KO:K04842]\nSCN11A [HSA:11280] [KO:K04843]\nPATHWAY   hsa04261(6331)  Adrenergic signaling in cardiomyocytes\nhsa04728(6323)  Dopaminergic synapse",
    "metabolism": "Enzyme: CYP2D6 [HSA:1565], CYP3A4 [HSA:1576]",
    "therapeutic_category": "2129",
    "atc_code": "C01BG07",
    "drug_class": [
      "Cardiovascular agent",
      "Antiarrhythmics",
      "Class I antiarrhythmic agent",
      "Class Ia antiarrhythmic agent",
      "Metabolizing enzyme substrate",
      "CYP2D6 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4",
      "CYP2D6"
    ],
    "search_name": "Cifenline succinate"
  },
  {
    "kegg_id": "D01026",
    "name_en": "Sotalol hydrochloride (JAN/USP)",
    "name_ja": "",
    "names_alt": [
      "Betapace (TN)",
      "Sorine (TN)"
    ],
    "formula": "C12H20N2O3S. HCl",
    "efficacy": "Antiarrhythmic, beta-Adrenergic receptor antagonist, Potassium channel blocker",
    "target": "ADRB1 [HSA:153] [KO:K04141]\nADRB2 [HSA:154] [KO:K04142]\nKCNH2 [HSA:3757] [KO:K04905]\nPATHWAY   hsa04020(153+154)  Calcium signaling pathway\nhsa04080(153+154)  Neuroactive ligand-receptor interaction\nhsa04261(153+154)  Adrenergic signaling in cardiomyocytes",
    "metabolism": "",
    "therapeutic_category": "2129",
    "atc_code": "C07AA07",
    "drug_class": [
      "Cardiovascular agent",
      "Adrenergic receptor antagonist",
      "beta-Adrenergic receptor antagonist (Beta blocker)",
      "Antiarrhythmics",
      "Class III antiarrhythmic agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Sotalol hydrochloride"
  },
  {
    "kegg_id": "D00619",
    "name_en": "Verapamil hydrochloride (JP18/USP)",
    "name_ja": "ベラパミル",
    "names_alt": [
      "Calan (TN)",
      "Covera-hs (TN)",
      "Vasolan (TN)",
      "Verelan (TN)"
    ],
    "formula": "C27H38N2O4. HCl",
    "efficacy": "Antiarrhythmic, Vasodilator, Calcium channel blocker\nDISEASE   Hypertension [DS:H01633]\nAngina [DS:H01632]\nAtrial flutter [DS:H00731]",
    "target": "CACNA1-L [HSA:775 776 778 779] [KO:K04850 K04851 K04853 K04857]\nPATHWAY   hsa04010(775+776+778+779)  MAPK signaling pathway\nhsa04020(775+776+778+779)  Calcium signaling pathway\nhsa04260(775+776+778+779)  Cardiac muscle contraction\nhsa04270(775+776+778+779)  Vascular smooth muscle contraction",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]\nTransporter: ABCB1 [HSA:5243]",
    "therapeutic_category": "2129",
    "atc_code": "C08DA01",
    "drug_class": [
      "Cardiovascular agent",
      "Calcium channel blocker",
      "Calcium channel L type blocker",
      "Antiarrhythmics",
      "Phenylalkylamine derivative",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "Metabolizing enzyme inhibitor",
      "CYP3A/CYP3A4 inhibitor",
      "CYP3A4 inhibitor",
      "Transporter substrate",
      "ABCB1 substrate",
      "Transporter inhibitor",
      "ABCB1 inhibitor"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Verapamil hydrochloride"
  },
  {
    "kegg_id": "D00631",
    "name_en": "Bepridil hydrochloride (USAN)",
    "name_ja": "",
    "names_alt": [
      "Bepridil hydrochloride hydrate (JAN)",
      "Vascor (TN)"
    ],
    "formula": "C24H34N2O. HCl. H2O",
    "efficacy": "Antiarrhythmic, Vasodilator (coronary), Calcium channel blocker, Sodium channel blocker, Potassium channel blocker",
    "target": "CACNA1-L [HSA:775 776 778 779] [KO:K04850 K04851 K04853 K04857]\nCACNA1-T [HSA:8911 8912 8913] [KO:K04856 K04855 K04854]\nKCNH2 [HSA:3757] [KO:K04905]\nKCNQ1 [HSA:3784] [KO:K04926]\nKCNA5 [HSA:3741] [KO:K04878]\nKCND3 [HSA:3752] [KO:K04893]\nKCNJ3 [HSA:3760] [KO:K04997]\nKCNJ5 [HSA:3762] [KO:K04999]\nKCNJ8 [HSA:3764] [KO:K05001]\nKCNJ11 [HSA:3767] [KO:K05004]\nKCNJ12 [HSA:3768] [KO:K05005]\nATP1A [HSA:476 477 478 480] [KO:K01539]\nPATHWAY   hsa04010(775+776+778+779+8911+8912+8913)  MAPK signaling pathway\nhsa04020(775+776+778+779+8911+8912+8913)  Calcium signaling pathway\nhsa04022(3764+476+477+478+480+775+776+778+779)  cGMP-PKG signaling pathway\nhsa04024(476+477+478+480+775+776+778+779)  cAMP signaling pathway\nhsa04260(476+477+478+480+775+776+778+779)  Cardiac muscle contraction\nhsa04270(775+776+778+779)  Vascular smooth muscle contraction",
    "metabolism": "Enzyme: CYP2D6 [HSA:1565], CYP2C9 [HSA:1559], CYP3A4 [HSA:1576]",
    "therapeutic_category": "2129",
    "atc_code": "C08EA02",
    "drug_class": [
      "Cardiovascular agent",
      "Calcium channel blocker",
      "Calcium channel L type blocker",
      "Antiarrhythmics",
      "Phenylalkylamine derivative",
      "Metabolizing enzyme substrate",
      "CYP2C9 substrate",
      "CYP2D6 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "Metabolizing enzyme inhibitor",
      "CYP2D6 inhibitor"
    ],
    "cyp_enzymes": [
      "CYP2C9",
      "CYP3A4",
      "CYP2D6"
    ],
    "search_name": "Bepridil hydrochloride"
  },
  {
    "kegg_id": "D01554",
    "name_en": "Pilsicainide hydrochloride hydrate (JP18)",
    "name_ja": "",
    "names_alt": [
      "Pilsicainide hydrochloride",
      "SUN 1165 (TN)",
      "Sunrythm (TN)"
    ],
    "formula": "(C17H24N2O. HCl)2. H2O",
    "efficacy": "Antiarrhythmic, Sodium channel blocker",
    "target": "SCN1A [HSA:6323] [KO:K04833]\nSCN2A [HSA:6326] [KO:K04834]\nSCN3A [HSA:6328] [KO:K04836]\nSCN4A [HSA:6329] [KO:K04837]\nSCN5A [HSA:6331] [KO:K04838]\nSCN8A [HSA:6334] [KO:K04840]\nSCN9A [HSA:6335] [KO:K04841]\nSCN10A [HSA:6336] [KO:K04842]\nSCN11A [HSA:11280] [KO:K04843]",
    "metabolism": "",
    "therapeutic_category": "2129",
    "atc_code": "",
    "drug_class": [
      "Cardiovascular agent",
      "Antiarrhythmics",
      "Class I antiarrhythmic agent",
      "Class Ic antiarrhythmic agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Pilsicainide hydrochloride hydrate"
  },
  {
    "kegg_id": "D01785",
    "name_en": "Pirmenol hydrochloride hydrate (JAN)",
    "name_ja": "",
    "names_alt": [],
    "formula": "C22H30N2O. HCl. H2O",
    "efficacy": "Antiarrhythmic, Sodium channel blocker",
    "target": "SCN1A [HSA:6323] [KO:K04833]\nSCN2A [HSA:6326] [KO:K04834]\nSCN3A [HSA:6328] [KO:K04836]\nSCN4A [HSA:6329] [KO:K04837]\nSCN5A [HSA:6331] [KO:K04838]\nSCN8A [HSA:6334] [KO:K04840]\nSCN9A [HSA:6335] [KO:K04841]\nSCN10A [HSA:6336] [KO:K04842]\nSCN11A [HSA:11280] [KO:K04843]\nPATHWAY   hsa04261(6331)  Adrenergic signaling in cardiomyocytes\nhsa04728(6323)  Dopaminergic synapse",
    "metabolism": "",
    "therapeutic_category": "2129",
    "atc_code": "",
    "drug_class": [
      "Cardiovascular agent",
      "Antiarrhythmics",
      "Class I antiarrhythmic agent",
      "Class Ia antiarrhythmic agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Pirmenol hydrochloride hydrate"
  },
  {
    "kegg_id": "D01856",
    "name_en": "Nifekalant hydrochloride (JAN)",
    "name_ja": "",
    "names_alt": [
      "MS 551",
      "Shinbit (TN)"
    ],
    "formula": "C19H27N5O5. HCl",
    "efficacy": "Antiarrhythmic, Potassium channel blocker",
    "target": "KCND3 [HSA:3752] [KO:K04893]\nKCNH2 [HSA:3757] [KO:K04905]\nKCNJ12 [HSA:3768] [KO:K05005]",
    "metabolism": "",
    "therapeutic_category": "2129",
    "atc_code": "",
    "drug_class": [
      "Cardiovascular agent",
      "Antiarrhythmics",
      "Class III antiarrhythmic agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Nifekalant hydrochloride"
  },
  {
    "kegg_id": "D00340",
    "name_en": "Hydrochlorothiazide (JP18/USP/INN)",
    "name_ja": "ヒドロクロロチアジド",
    "names_alt": [
      "Esidrix (TN)",
      "Microzide (TN)"
    ],
    "formula": "C7H8ClN3O4S2",
    "efficacy": "Antihypertensive, Diuretic, Na+-Cl- symport inhibitor\nDISEASE   Hypertension [DS:H01633]",
    "target": "SLC12A3 (TSC) [HSA:6559] [KO:K14426]",
    "metabolism": "",
    "therapeutic_category": "2132",
    "atc_code": "C03AA03",
    "drug_class": [
      "Cardiovascular agent",
      "Antihypertensive",
      "Thiazide diuretic",
      "Sulfonamide diuretic",
      "Thiazide diuretic"
    ],
    "cyp_enzymes": [],
    "search_name": "Hydrochlorothiazide"
  },
  {
    "kegg_id": "D00658",
    "name_en": "Trichlormethiazide (JP18/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Naqua (TN)"
    ],
    "formula": "C8H8Cl3N3O4S2",
    "efficacy": "Antihypertensive, Diuretic, Na+-Cl- symport inhibitor",
    "target": "SLC12A3 (TSC) [HSA:6559] [KO:K14426]\nSLC12A1 (NKCC2) [HSA:6557] [KO:K14425]",
    "metabolism": "",
    "therapeutic_category": "2132",
    "atc_code": "C03AA06",
    "drug_class": [
      "Cardiovascular agent",
      "Antihypertensive",
      "Thiazide diuretic",
      "Sulfonamide diuretic",
      "Thiazide diuretic"
    ],
    "cyp_enzymes": [],
    "search_name": "Trichlormethiazide"
  },
  {
    "kegg_id": "D00443",
    "name_en": "Spironolactone (JP18/USP/INN)",
    "name_ja": "スピロノラクトン",
    "names_alt": [
      "Aldactone (TN)"
    ],
    "formula": "C24H32O4S",
    "efficacy": "Antihypertensive, Diuretic, Aldosterone antagonist\nDISEASE   Primary hyperaldosteronism [DS:H01603]\nNephrotic syndrome [DS:H01657]\nEssential hypertension [DS:H01633]",
    "target": "NR3C2 (MR) [HSA:4306] [KO:K08555]\nPATHWAY   hsa04960(4306)  Aldosterone-regulated sodium reabsorption",
    "metabolism": "",
    "therapeutic_category": "2133",
    "atc_code": "C03DA01",
    "drug_class": [
      "Cardiovascular agent",
      "Antihypertensive",
      "Aldosterone antagonist",
      "Potassium-sparing diuretic"
    ],
    "cyp_enzymes": [],
    "search_name": "Spironolactone"
  },
  {
    "kegg_id": "D01943",
    "name_en": "Canrenoate potassium (USAN)",
    "name_ja": "",
    "names_alt": [
      "Potassium canrenoate (JP18)",
      "Soldactone (TN)"
    ],
    "formula": "C22H29O4. K",
    "efficacy": "Antihypertensive, Diuretic, Aldosterone antagonist",
    "target": "NR3C2 (MR) [HSA:4306] [KO:K08555]\nPATHWAY   hsa04960(4306)  Aldosterone-regulated sodium reabsorption",
    "metabolism": "",
    "therapeutic_category": "2133",
    "atc_code": "C03DA02",
    "drug_class": [
      "Cardiovascular agent",
      "Antihypertensive",
      "Aldosterone antagonist",
      "Potassium-sparing diuretic"
    ],
    "cyp_enzymes": [],
    "search_name": "Canrenoate potassium"
  },
  {
    "kegg_id": "D00386",
    "name_en": "Triamterene (JP18/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Dyrenium (TN)"
    ],
    "formula": "C12H11N7",
    "efficacy": "Diuretic, Aldosterone antagonist, Epithelial sodium channel blocker\nDISEASE   Nephrotic syndrome [DS:H01657]",
    "target": "SCNN1 [HSA:6337 6338 6340] [KO:K04824 K04825 K04827]\nNR3C2 (MR) [HSA:4306] [KO:K08555]\nPATHWAY   hsa04960(4306+6337+6338+6340)  Aldosterone-regulated sodium reabsorption",
    "metabolism": "",
    "therapeutic_category": "2133",
    "atc_code": "C03DB02",
    "drug_class": [
      "Cardiovascular agent",
      "Antihypertensive",
      "Potassium-sparing diuretic"
    ],
    "cyp_enzymes": [],
    "search_name": "Triamterene"
  },
  {
    "kegg_id": "D00218",
    "name_en": "Acetazolamide (JP18/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Diamox (TN)"
    ],
    "formula": "C4H6N4O3S2",
    "efficacy": "Antiglaucoma, Carbonic anhydrase inhibitor\nDISEASE   Chronic simple (open-angle) glaucoma [DS:H00612]",
    "target": "CA [HSA:759 760 761 762 763 11238 765 766 767 768 771 377677 23632] [KO:K01672 K18245 K18246]\nPATHWAY   hsa04964(760+762)  Proximal tubule bicarbonate reclamation",
    "metabolism": "",
    "therapeutic_category": "2134",
    "atc_code": "S01EC01",
    "drug_class": [
      "Cardiovascular agent",
      "Carbonic anhydrase inhibitor",
      "Ophthalmic agent",
      "Intraocular pressure lowering agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Acetazolamide"
  },
  {
    "kegg_id": "D01196",
    "name_en": "Acetazolamide sodium (JAN)",
    "name_ja": "",
    "names_alt": [
      "Diamox (TN)"
    ],
    "formula": "C4H5N4O3S2. Na",
    "efficacy": "Antiglaucoma, Carbonic anhydrase inhibitor\nDISEASE   Chronic simple (open-angle) glaucoma [DS:H00612]",
    "target": "CA [HSA:759 760 761 762 763 11238 765 766 767 768 771 377677 23632] [KO:K01672 K18245 K18246]\nPATHWAY   hsa04964(760+762)  Proximal tubule bicarbonate reclamation",
    "metabolism": "",
    "therapeutic_category": "2134",
    "atc_code": "S01EC01",
    "drug_class": [
      "Cardiovascular agent",
      "Carbonic anhydrase inhibitor",
      "Ophthalmic agent",
      "Intraocular pressure lowering agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Acetazolamide sodium"
  },
  {
    "kegg_id": "D01877",
    "name_en": "Mefruside (JP18/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Baycaron (TN)"
    ],
    "formula": "C13H19ClN2O5S2",
    "efficacy": "Antihypertensive, Diuretic, Na+-Cl- symport inhibitor",
    "target": "SLC12A3 (TSC) [HSA:6559] [KO:K14426]",
    "metabolism": "",
    "therapeutic_category": "2135",
    "atc_code": "C03BA05",
    "drug_class": [
      "Cardiovascular agent",
      "Antihypertensive",
      "Thiazide related diuretic",
      "Sulfonamide diuretic",
      "Thiazide related diuretic"
    ],
    "cyp_enzymes": [],
    "search_name": "Mefruside"
  },
  {
    "kegg_id": "D00331",
    "name_en": "Furosemide (JP18/USP/INN)",
    "name_ja": "フロセミド",
    "names_alt": [
      "Frusemide",
      "Lasix (TN)"
    ],
    "formula": "C12H11ClN2O5S",
    "efficacy": "Diuretic, Na-K-Cl cotransporter inhibitor\nDISEASE   Hypertension [DS:H01633]",
    "target": "SLC12A1 (NKCC2) [HSA:6557] [KO:K14425]\nSLC12A2 (NKCC1) [HSA:6558] [KO:K10951]",
    "metabolism": "Transporter: SLC22A6 [HSA:9356], SLC22A8 [HSA:9376], ABCC4 [HSA:10257]",
    "therapeutic_category": "2139",
    "atc_code": "C03CA01",
    "drug_class": [
      "Cardiovascular agent",
      "Sulfonamide diuretic",
      "Furosemide type diuretic",
      "Loop diuretic",
      "Furosemide type diuretic",
      "Transporter substrate",
      "ABCC4 substrate",
      "SLC22A6 substrate",
      "SLC22A8 substrate"
    ],
    "cyp_enzymes": [],
    "search_name": "Furosemide"
  },
  {
    "kegg_id": "D00382",
    "name_en": "Torsemide (USP)",
    "name_ja": "",
    "names_alt": [
      "Torasemide (JAN/INN)",
      "Demadex (TN)",
      "Luprac (TN)"
    ],
    "formula": "C16H20N4O3S",
    "efficacy": "Diuretic, Na-K-Cl cotransporter inhibitor\nDISEASE   Hypertension [DS:H01633]",
    "target": "SLC12A1 (NKCC2) [HSA:6557] [KO:K14425]\nSLC12A2 (NKCC1) [HSA:6558] [KO:K10951]",
    "metabolism": "Enzyme: CYP2C9 [HSA:1559], CYP2C8 [HSA:1558]",
    "therapeutic_category": "2139",
    "atc_code": "C03CA04",
    "drug_class": [
      "Cardiovascular agent",
      "Sulfonamide diuretic",
      "Furosemide type diuretic",
      "Loop diuretic",
      "Furosemide type diuretic",
      "Metabolizing enzyme substrate",
      "CYP2C8 substrate",
      "CYP2C9 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C9",
      "CYP2C8"
    ],
    "search_name": "Torsemide"
  },
  {
    "kegg_id": "D01213",
    "name_en": "Tolvaptan (JP18/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Samsca (TN)"
    ],
    "formula": "C26H25ClN2O3",
    "efficacy": "Diuretic, Vasopressin V2 receptor antagonist",
    "target": "AVPR2 [HSA:554] [KO:K04228]\nPATHWAY   hsa04080(554)  Neuroactive ligand-receptor interaction\nhsa04962(554)  Vasopressin-regulated water reabsorption",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]\nTransporter: ABCB1 [HSA:5243]",
    "therapeutic_category": "2139",
    "atc_code": "C03XA01",
    "drug_class": [
      "Cardiovascular agent",
      "Arginine vasopressin receptor 2 (AVPR2) antagonist",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "Transporter substrate",
      "ABCB1 substrate",
      "Transporter inhibitor",
      "ABCB1 inhibitor"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Tolvaptan"
  },
  {
    "kegg_id": "D11659",
    "name_en": "Tolvaptan sodium phosphate (JAN)",
    "name_ja": "",
    "names_alt": [
      "Samtasu (TN)"
    ],
    "formula": "C26H24ClN2O6P. 2Na",
    "efficacy": "Diuretic, Vasopressin V2 receptor antagonist",
    "target": "AVPR2 [HSA:554] [KO:K04228]\nPATHWAY   hsa04080(554)  Neuroactive ligand-receptor interaction\nhsa04962(554)  Vasopressin-regulated water reabsorption",
    "metabolism": "",
    "therapeutic_category": "2139",
    "atc_code": "C03XA01",
    "drug_class": [
      "Cardiovascular agent",
      "Arginine vasopressin receptor 2 (AVPR2) antagonist"
    ],
    "cyp_enzymes": [],
    "search_name": "Tolvaptan sodium phosphate"
  },
  {
    "kegg_id": "D00347",
    "name_en": "Isosorbide (JP18/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Ismotic (TN)",
      "Isobide (TN)"
    ],
    "formula": "C6H10O4",
    "efficacy": "Diuretic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2139",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Isosorbide"
  },
  {
    "kegg_id": "D01323",
    "name_en": "Azosemide (JP18/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Diart (TN)"
    ],
    "formula": "C12H11ClN6O2S2",
    "efficacy": "Diuretic, Na-K-Cl cotransporter inhibitor",
    "target": "SLC12A1 (NKCC2) [HSA:6557] [KO:K14425]\nSLC12A2 (NKCC1) [HSA:6558] [KO:K10951]\nPATHWAY   hsa04970(6558)  Salivary secretion\nhsa04972(6558)  Pancreatic secretion",
    "metabolism": "",
    "therapeutic_category": "2139",
    "atc_code": "",
    "drug_class": [
      "Cardiovascular agent",
      "Sulfonamide diuretic",
      "Furosemide type diuretic",
      "Loop diuretic",
      "Furosemide type diuretic"
    ],
    "cyp_enzymes": [],
    "search_name": "Azosemide"
  },
  {
    "kegg_id": "D01302",
    "name_en": "Hydralazine hydrochloride (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Apresoline (TN)"
    ],
    "formula": "C8H8N4. HCl",
    "efficacy": "Antihypertensive\nDISEASE   Essential hypertension [DS:H01633]",
    "target": "",
    "metabolism": "Enzyme: NAT [HSA:9 10]",
    "therapeutic_category": "2142",
    "atc_code": "C02DB02",
    "drug_class": [
      "Cardiovascular agent",
      "Antihypertensive",
      "Hydrazinophthalazine derivative",
      "Metabolizing enzyme substrate",
      "NAT substrate",
      "Metabolizing enzyme inhibitor",
      "CYP2D6 inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Hydralazine hydrochloride"
  },
  {
    "kegg_id": "D00251",
    "name_en": "Captopril (JP18/USP/INN)",
    "name_ja": "カプトプリル",
    "names_alt": [
      "Apopril (TN)",
      "Capoten (TN)"
    ],
    "formula": "C9H15NO3S",
    "efficacy": "Antihypertensive, Angiotensin-converting enzyme inhibitor\nDISEASE   Hypertension [DS:H01633]\nDiabetic Nephropathy [DS:H01456]",
    "target": "ACE (CD143) [HSA:1636] [KO:K01283]\nPATHWAY   hsa04614(1636)  Renin-angiotensin system",
    "metabolism": "",
    "therapeutic_category": "2144",
    "atc_code": "C09AA01",
    "drug_class": [
      "Cardiovascular agent",
      "Renin-angiotensin system inhibitor",
      "Angiotensin-converting enzyme inhibitor",
      "Antihypertensive",
      "Angiotensin-converting enzyme inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Captopril"
  },
  {
    "kegg_id": "D00621",
    "name_en": "Enalapril maleate (JP18/USP)",
    "name_ja": "エナラプリル",
    "names_alt": [
      "Renivace (TN)",
      "Vasotec (TN)"
    ],
    "formula": "C20H28N2O5. C4H4O4",
    "efficacy": "Antihypertensive, Vasodilator, Angiotensin-converting enzyme inhibitor\nDISEASE   Hypertension [DS:H01633]",
    "target": "ACE (CD143) [HSA:1636] [KO:K01283]\nPATHWAY   hsa04614(1636)  Renin-angiotensin system",
    "metabolism": "",
    "therapeutic_category": "2144",
    "atc_code": "C09AA02",
    "drug_class": [
      "Cardiovascular agent",
      "Renin-angiotensin system inhibitor",
      "Angiotensin-converting enzyme inhibitor",
      "Antihypertensive",
      "Angiotensin-converting enzyme inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Enalapril maleate"
  },
  {
    "kegg_id": "D00362",
    "name_en": "Lisinopril (USP)",
    "name_ja": "リシノプリル",
    "names_alt": [
      "Lisinopril hydrate (JP18)",
      "Lisinopril dihydrate",
      "Prinivil (TN)",
      "Zestril (TN)"
    ],
    "formula": "C21H31N3O5. 2H2O",
    "efficacy": "Antihypertensive, Angiotensin-converting enzyme inhibitor\nDISEASE   Hypertension [DS:H01633]",
    "target": "ACE (CD143) [HSA:1636] [KO:K01283]\nPATHWAY   hsa04614(1636)  Renin-angiotensin system",
    "metabolism": "",
    "therapeutic_category": "2144",
    "atc_code": "C09AA03",
    "drug_class": [
      "Cardiovascular agent",
      "Renin-angiotensin system inhibitor",
      "Angiotensin-converting enzyme inhibitor",
      "Antihypertensive",
      "Angiotensin-converting enzyme inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Lisinopril"
  },
  {
    "kegg_id": "D00624",
    "name_en": "Perindopril erbumine (JAN/USP)",
    "name_ja": "",
    "names_alt": [
      "Aceon (TN)"
    ],
    "formula": "C19H32N2O5. C4H11N",
    "efficacy": "Antihypertensive, Angiotensin-converting enzyme inhibitor\nDISEASE   Hypertension [DS:H01633]\nCoronary artery disease [DS:H01742]",
    "target": "ACE (CD143) [HSA:1636] [KO:K01283]\nPATHWAY   hsa04614(1636)  Renin-angiotensin system\nhsa04924(1636)  Renin secretion",
    "metabolism": "",
    "therapeutic_category": "2144",
    "atc_code": "C09AA04",
    "drug_class": [
      "Cardiovascular agent",
      "Renin-angiotensin system inhibitor",
      "Angiotensin-converting enzyme inhibitor",
      "Antihypertensive",
      "Angiotensin-converting enzyme inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Perindopril erbumine"
  },
  {
    "kegg_id": "D00383",
    "name_en": "Trandolapril (JAN/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Mavik (TN)"
    ],
    "formula": "C24H34N2O5",
    "efficacy": "Antihypertensive, Angiotensin-converting enzyme inhibitor\nDISEASE   Hypertension [DS:H01633]",
    "target": "ACE (CD143) [HSA:1636] [KO:K01283]\nPATHWAY   hsa04614(1636)  Renin-angiotensin system",
    "metabolism": "",
    "therapeutic_category": "2144",
    "atc_code": "C09AA10",
    "drug_class": [
      "Cardiovascular agent",
      "Renin-angiotensin system inhibitor",
      "Angiotensin-converting enzyme inhibitor",
      "Antihypertensive",
      "Angiotensin-converting enzyme inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Trandolapril"
  },
  {
    "kegg_id": "D01667",
    "name_en": "Delapril hydrochloride (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Adecut (TN)"
    ],
    "formula": "C26H32N2O5. HCl",
    "efficacy": "Antihypertensive, Angiotensin-converting enzyme inhibitor",
    "target": "ACE (CD143) [HSA:1636] [KO:K01283]\nPATHWAY   hsa04614(1636)  Renin-angiotensin system",
    "metabolism": "",
    "therapeutic_category": "2144",
    "atc_code": "C09AA12",
    "drug_class": [
      "Cardiovascular agent",
      "Renin-angiotensin system inhibitor",
      "Angiotensin-converting enzyme inhibitor",
      "Antihypertensive",
      "Angiotensin-converting enzyme inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Delapril hydrochloride"
  },
  {
    "kegg_id": "D01119",
    "name_en": "Temocapril hydrochloride (JP18/USAN)",
    "name_ja": "",
    "names_alt": [
      "Acecol (TN)"
    ],
    "formula": "C23H28N2O5S2. HCl",
    "efficacy": "Antihypertensive, Angiotensin-converting enzyme inhibitor",
    "target": "ACE (CD143) [HSA:1636] [KO:K01283]\nPATHWAY   hsa04614(1636)  Renin-angiotensin system",
    "metabolism": "",
    "therapeutic_category": "2144",
    "atc_code": "C09AA14",
    "drug_class": [
      "Cardiovascular agent",
      "Renin-angiotensin system inhibitor",
      "Angiotensin-converting enzyme inhibitor",
      "Antihypertensive",
      "Angiotensin-converting enzyme inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Temocapril hydrochloride"
  },
  {
    "kegg_id": "D01549",
    "name_en": "Imidapril hydrochloride (JP18)",
    "name_ja": "",
    "names_alt": [
      "Tanatril (TN)"
    ],
    "formula": "C20H27N3O6. HCl",
    "efficacy": "Antihypertensive, Angiotensin-converting enzyme inhibitor",
    "target": "ACE (CD143) [HSA:1636] [KO:K01283]\nPATHWAY   hsa04614(1636)  Renin-angiotensin system",
    "metabolism": "",
    "therapeutic_category": "2144",
    "atc_code": "C09AA16",
    "drug_class": [
      "Cardiovascular agent",
      "Renin-angiotensin system inhibitor",
      "Angiotensin-converting enzyme inhibitor",
      "Antihypertensive",
      "Angiotensin-converting enzyme inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Imidapril hydrochloride"
  },
  {
    "kegg_id": "D01900",
    "name_en": "Alacepril (JP18/INN)",
    "name_ja": "",
    "names_alt": [
      "Cetapril (TN)"
    ],
    "formula": "C20H26N2O5S",
    "efficacy": "Antihypertensive, Angiotensin-converting enzyme inhibitor",
    "target": "ACE (CD143) [HSA:1636] [KO:K01283]\nPATHWAY   hsa04614(1636)  Renin-angiotensin system",
    "metabolism": "",
    "therapeutic_category": "2144",
    "atc_code": "",
    "drug_class": [
      "Cardiovascular agent",
      "Renin-angiotensin system inhibitor",
      "Angiotensin-converting enzyme inhibitor",
      "Antihypertensive",
      "Angiotensin-converting enzyme inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Alacepril"
  },
  {
    "kegg_id": "D00405",
    "name_en": "Methyldopa (USP)",
    "name_ja": "",
    "names_alt": [
      "Methyldopa hydrate (JP18)",
      "Aldomet (TN)"
    ],
    "formula": "(C10H13NO4)2. 3H2O",
    "efficacy": "Antihypertensive, alpha2-Adrenergic receptor agonist\nDISEASE   Hypertension [DS:H01633]",
    "target": "ADRA2 [HSA:150 151 152] [KO:K04138 K04139 K04140]\nPATHWAY   hsa04022(150+151+152)  cGMP-PKG signaling pathway\nhsa04080(150+151+152)  Neuroactive ligand-receptor interaction",
    "metabolism": "",
    "therapeutic_category": "2145",
    "atc_code": "C02AB01",
    "drug_class": [
      "Cardiovascular agent",
      "Centrally-acting antiadrenergic",
      "Adrenergic receptor agonist",
      "alpha-Adrenergic receptor agonist",
      "alpha2-Adrenergic receptor agonist",
      "Catecholamine adrenergic receptor agonist",
      "Catecholamine synthesis inhibitors",
      "Antihypertensive"
    ],
    "cyp_enzymes": [],
    "search_name": "Methyldopa"
  },
  {
    "kegg_id": "D00515",
    "name_en": "Nitroglycerin (JP18/USP)",
    "name_ja": "ニトログリセリン",
    "names_alt": [
      "Glyceryl trinitrate",
      "Minitran (TN)",
      "Nitro-bid (TN)",
      "Nitro-dur (TN)",
      "Nitromist (TN)",
      "Transderm-nitro (TN)"
    ],
    "formula": "C3H5N3O9",
    "efficacy": "Antihypertensive, Vasodilator (coronary)\nDISEASE   Coronary artery disease [DS:H01742]\nAngina pectoris [DS:H01632]\nAcute myocardial infarction [DS:H01730]",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2149",
    "atc_code": "C01DA02",
    "drug_class": [
      "Cardiovascular agent",
      "Nitrovasodilator",
      "Antihypertensive"
    ],
    "cyp_enzymes": [],
    "search_name": "Nitroglycerin"
  },
  {
    "kegg_id": "D00604",
    "name_en": "Clonidine hydrochloride (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Nexiclon (TN)",
      "Kapvay (TN)",
      "Duraclon (TN)",
      "Catapres (TN)"
    ],
    "formula": "C9H9Cl2N3. HCl",
    "efficacy": "Antihypertensive, alpha2-Adrenergic receptor agonist\nDISEASE   Hypertension [DS:H01633]",
    "target": "ADRA2 [HSA:150 151 152] [KO:K04138 K04139 K04140]\nPATHWAY   hsa04022(150+151+152)  cGMP-PKG signaling pathway\nhsa04080(150+151+152)  Neuroactive ligand-receptor interaction",
    "metabolism": "",
    "therapeutic_category": "2149",
    "atc_code": "C02AC01",
    "drug_class": [
      "Cardiovascular agent",
      "Centrally-acting antiadrenergic",
      "Adrenergic receptor agonist",
      "alpha-Adrenergic receptor agonist",
      "alpha2-Adrenergic receptor agonist",
      "Antihypertensive"
    ],
    "cyp_enzymes": [],
    "search_name": "Clonidine hydrochloride"
  },
  {
    "kegg_id": "D00609",
    "name_en": "Prazosin hydrochloride (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Minipress (TN)"
    ],
    "formula": "C19H21N5O4. HCl",
    "efficacy": "Antihypertensive, alpha1-Adrenergic receptor antagonist\nDISEASE   Hypertension [DS:H01633]",
    "target": "ADRA1 [HSA:148 147 146] [KO:K04135 K04136 K04137]\nPATHWAY   hsa04080(146+147+148)  Neuroactive ligand-receptor interaction\nhsa04261(146+147+148)  Adrenergic signaling in cardiomyocytes\nhsa04270(146+147+148)  Vascular smooth muscle contraction",
    "metabolism": "",
    "therapeutic_category": "2149",
    "atc_code": "C02CA01",
    "drug_class": [
      "Cardiovascular agent",
      "Adrenergic receptor antagonist",
      "alpha-Adrenergic receptor antagonist",
      "alpha1-Adrenergic receptor antagonist",
      "Peripherally-acting antiadrenergic",
      "Antihypertensive",
      "Transporter inhibitor",
      "SLC22A3 inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Prazosin hydrochloride"
  },
  {
    "kegg_id": "D00608",
    "name_en": "Doxazosin mesylate (USP)",
    "name_ja": "",
    "names_alt": [
      "Doxazosin mesilate (JP18)",
      "Cardura (TN)"
    ],
    "formula": "C23H25N5O5. CH4SO3",
    "efficacy": "Antihypertensive, alpha1-Adrenergic receptor antagonist\nDISEASE   Hypertension [DS:H01633]",
    "target": "ADRA1 [HSA:148 147 146] [KO:K04135 K04136 K04137]\nPATHWAY   hsa04080(146+147+148)  Neuroactive ligand-receptor interaction\nhsa04261(146+147+148)  Adrenergic signaling in cardiomyocytes\nhsa04270(146+147+148)  Vascular smooth muscle contraction",
    "metabolism": "",
    "therapeutic_category": "2149",
    "atc_code": "C02CA04",
    "drug_class": [
      "Cardiovascular agent",
      "Adrenergic receptor antagonist",
      "alpha-Adrenergic receptor antagonist",
      "alpha1-Adrenergic receptor antagonist",
      "Peripherally-acting antiadrenergic",
      "Antihypertensive"
    ],
    "cyp_enzymes": [],
    "search_name": "Doxazosin mesylate"
  },
  {
    "kegg_id": "D01333",
    "name_en": "Urapidil (JP18/INN)",
    "name_ja": "",
    "names_alt": [
      "Ebrantil (TN)"
    ],
    "formula": "C20H29N5O3",
    "efficacy": "Antidysuria, Antihypertensive, alpha1-Adrenergic receptor antagonist",
    "target": "ADRA1 [HSA:148 147 146] [KO:K04135 K04136 K04137]\nPATHWAY   hsa04080(146+147+148)  Neuroactive ligand-receptor interaction\nhsa04261(146+147+148)  Adrenergic signaling in cardiomyocytes\nhsa04270(146+147+148)  Vascular smooth muscle contraction",
    "metabolism": "Enzyme: CYP2D6 [HSA:1565]",
    "therapeutic_category": "2149",
    "atc_code": "C02CA06",
    "drug_class": [
      "Cardiovascular agent",
      "Adrenergic receptor antagonist",
      "alpha-Adrenergic receptor antagonist",
      "alpha1-Adrenergic receptor antagonist",
      "Peripherally-acting antiadrenergic",
      "Antihypertensive",
      "Metabolizing enzyme substrate",
      "CYP2D6 substrate"
    ],
    "cyp_enzymes": [
      "CYP2D6"
    ],
    "search_name": "Urapidil"
  },
  {
    "kegg_id": "D00614",
    "name_en": "Sodium nitroprusside (USP)",
    "name_ja": "",
    "names_alt": [
      "Sodium nitroprusside hydrate (JAN)",
      "Nitropress (TN)"
    ],
    "formula": "C5FeN6O. 2Na. 2H2O",
    "efficacy": "Antihypertensive, Vascular smooth muscle relaxant\nDISEASE   Acute heart failure [DS:H01631]",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2149",
    "atc_code": "C02DD01",
    "drug_class": [
      "Cardiovascular agent",
      "Antihypertensive"
    ],
    "cyp_enzymes": [],
    "search_name": "Sodium nitroprusside"
  },
  {
    "kegg_id": "D00345",
    "name_en": "Indapamide (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Lozol (TN)",
      "Natrix (TN)"
    ],
    "formula": "C16H16ClN3O3S",
    "efficacy": "Antihypertensive, Diuretic, Na+-Cl- symport inhibitor\nDISEASE   Hypertension [DS:H01633]",
    "target": "SLC12A3 (TSC) [HSA:6559] [KO:K14426]",
    "metabolism": "",
    "therapeutic_category": "2149",
    "atc_code": "C03BA11",
    "drug_class": [
      "Cardiovascular agent",
      "Antihypertensive",
      "Thiazide related diuretic",
      "Sulfonamide diuretic",
      "Thiazide related diuretic"
    ],
    "cyp_enzymes": [],
    "search_name": "Indapamide"
  },
  {
    "kegg_id": "D01115",
    "name_en": "Eplerenone (JP18/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Inspra (TN)"
    ],
    "formula": "C24H30O6",
    "efficacy": "Antihypertensive, Aldosterone antagonist\nDISEASE   Hypertension [DS:H01633]",
    "target": "NR3C2 (MR) [HSA:4306] [KO:K08555]\nPATHWAY   hsa04960(4306)  Aldosterone-regulated sodium reabsorption",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "2149",
    "atc_code": "C03DA04",
    "drug_class": [
      "Cardiovascular agent",
      "Antihypertensive",
      "Aldosterone antagonist",
      "Potassium-sparing diuretic",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Eplerenone"
  },
  {
    "kegg_id": "D01369",
    "name_en": "Bevantolol hydrochloride (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Calvan (TN)",
      "Vantol (TN)"
    ],
    "formula": "C20H27NO4. HCl",
    "efficacy": "Antiarrhythmic, Antihypertensive, Vasodilator, alpha1 and beta1-Adrenergic receptor antagonist, Calcium channel blocker",
    "target": "ADRB1 [HSA:153] [KO:K04141]\nADRA1 [HSA:148 147 146] [KO:K04135 K04136 K04137]\nCACNA1-L [HSA:775 776 778 779] [KO:K04850 K04851 K04853 K04857]\nPATHWAY   hsa04020(146+147+148+153+775+776+778+779)  Calcium signaling pathway\nhsa04080(146+147+148+153)  Neuroactive ligand-receptor interaction\nhsa04260(775+776+778+779)  Cardiac muscle contraction\nhsa04261(146+147+148+153+775+776+778+779)  Adrenergic signaling in cardiomyocytes\nhsa04270(146+147+148+775+776+778+779)  Vascular smooth muscle contraction",
    "metabolism": "",
    "therapeutic_category": "2149",
    "atc_code": "C07AB06",
    "drug_class": [
      "Cardiovascular agent",
      "Adrenergic receptor antagonist",
      "alpha1 and beta-Adrenergic receptor antagonist",
      "Antihypertensive",
      "alpha1 and beta-Adrenergic receptor antagonist"
    ],
    "cyp_enzymes": [],
    "search_name": "Bevantolol hydrochloride"
  },
  {
    "kegg_id": "D02342",
    "name_en": "Bisoprolol (JAN/USAN/INN)",
    "name_ja": "ビソプロロール",
    "names_alt": [],
    "formula": "C18H31NO4",
    "efficacy": "Antihypertensive, beta1-Adrenergic receptor antagonist",
    "target": "ADRB1 [HSA:153] [KO:K04141]\nPATHWAY   hsa04020(153)  Calcium signaling pathway\nhsa04022(153)  cGMP-PKG signaling pathway\nhsa04024(153)  cAMP signaling pathway\nhsa04080(153)  Neuroactive ligand-receptor interaction\nhsa04261(153)  Adrenergic signaling in cardiomyocytes",
    "metabolism": "",
    "therapeutic_category": "2149",
    "atc_code": "C07AB07",
    "drug_class": [
      "Cardiovascular agent",
      "Adrenergic receptor antagonist",
      "beta-Adrenergic receptor antagonist (Beta blocker)",
      "beta1-Adrenergic receptor antagonist",
      "Antiarrhythmics",
      "Class II antiarrhythmic agent",
      "Antihypertensive"
    ],
    "cyp_enzymes": [],
    "search_name": "Bisoprolol"
  },
  {
    "kegg_id": "D01741",
    "name_en": "Celiprolol hydrochloride (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Selectol (TN)"
    ],
    "formula": "C20H33N3O4. HCl",
    "efficacy": "Antihypertensive, Vasodilator, beta1-Adrenergic receptor antagonist",
    "target": "ADRB1 [HSA:153] [KO:K04141]\nPATHWAY   hsa04080(153)  Neuroactive ligand-receptor interaction\nhsa04261(153)  Adrenergic signaling in cardiomyocytes",
    "metabolism": "",
    "therapeutic_category": "2149",
    "atc_code": "C07AB08",
    "drug_class": [
      "Cardiovascular agent",
      "Adrenergic receptor antagonist",
      "beta-Adrenergic receptor antagonist (Beta blocker)",
      "beta1-Adrenergic receptor antagonist",
      "Antihypertensive"
    ],
    "cyp_enzymes": [],
    "search_name": "Celiprolol hydrochloride"
  },
  {
    "kegg_id": "D00600",
    "name_en": "Labetalol hydrochloride (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Normodyne (TN)",
      "Trandate (TN)"
    ],
    "formula": "C19H24N2O3. HCl",
    "efficacy": "Antihypertensive, alpha1/beta-Adrenergic receptor antagonist\nDISEASE   Hypertension [DS:H01633]",
    "target": "ADRA1 [HSA:148 147 146] [KO:K04135 K04136 K04137]\nADRB1 [HSA:153] [KO:K04141]\nADRB2 [HSA:154] [KO:K04142]\nPATHWAY   hsa04020(146+147+148+153+154)  Calcium signaling pathway\nhsa04022(146+147+148+153+154)  cGMP-PKG signaling pathway\nhsa04024(153+154)  cAMP signaling pathway\nhsa04080(146+147+148+153+154)  Neuroactive ligand-receptor interaction\nhsa04261(146+147+148+153+154)  Adrenergic signaling in cardiomyocytes\nhsa04270(146+147+148)  Vascular smooth muscle contraction",
    "metabolism": "",
    "therapeutic_category": "2149",
    "atc_code": "C07AG01",
    "drug_class": [
      "Cardiovascular agent",
      "Adrenergic receptor antagonist",
      "alpha1 and beta-Adrenergic receptor antagonist",
      "Antihypertensive",
      "alpha1 and beta-Adrenergic receptor antagonist"
    ],
    "cyp_enzymes": [],
    "search_name": "Labetalol hydrochloride"
  },
  {
    "kegg_id": "D00255",
    "name_en": "Carvedilol (JP18/USP/INN)",
    "name_ja": "カルベジロール",
    "names_alt": [
      "Artist (TN)",
      "Coreg (TN)"
    ],
    "formula": "C24H26N2O4",
    "efficacy": "Antihypertensive, alpha1/beta-Adrenergic receptor antagonist\nDISEASE   Hypertension [DS:H01633]",
    "target": "ADRA1 [HSA:148 147 146] [KO:K04135 K04136 K04137]\nADRB1 [HSA:153] [KO:K04141]\nADRB2 [HSA:154] [KO:K04142]\nPATHWAY   hsa04020(146+147+148+153+154)  Calcium signaling pathway\nhsa04022(146+147+148+153+154)  cGMP-PKG signaling pathway\nhsa04024(153+154)  cAMP signaling pathway\nhsa04080(146+147+148+153+154)  Neuroactive ligand-receptor interaction\nhsa04261(146+147+148+153+154)  Adrenergic signaling in cardiomyocytes\nhsa04270(146+147+148)  Vascular smooth muscle contraction\nhsa05414(153)  Dilated cardiomyopathy",
    "metabolism": "Enzyme: CYP2D6 [HSA:1565], CYP2C9 [HSA:1559], CYP3A4 [HSA:1576], CYP1A2 [HSA:1544], CYP2E1 [HSA:1571]",
    "therapeutic_category": "2149",
    "atc_code": "C07AG02",
    "drug_class": [
      "Cardiovascular agent",
      "Adrenergic receptor antagonist",
      "alpha1 and beta-Adrenergic receptor antagonist",
      "Antihypertensive",
      "alpha1 and beta-Adrenergic receptor antagonist",
      "Metabolizing enzyme substrate",
      "CYP1A2 substrate",
      "CYP2C9 substrate",
      "CYP2D6 substrate",
      "CYP2E1 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "Transporter inhibitor",
      "ABCB1 inhibitor"
    ],
    "cyp_enzymes": [
      "CYP3A4",
      "CYP1A2",
      "CYP2C9",
      "CYP2D6",
      "CYP2E1"
    ],
    "search_name": "Carvedilol"
  },
  {
    "kegg_id": "D00319",
    "name_en": "Felodipine (JP18/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Plendil (TN)"
    ],
    "formula": "C18H19Cl2NO4",
    "efficacy": "Antihypertensive, Vasodilator, Calcium channel blocker\nDISEASE   Hypertension [DS:H01633]",
    "target": "CACNA1-L [HSA:775 776 778 779] [KO:K04850 K04851 K04853 K04857]\nPATHWAY   hsa04020(775+776+778+779)  Calcium signaling pathway\nhsa04260(775+776+778+779)  Cardiac muscle contraction\nhsa04261(775+776+778+779)  Adrenergic signaling in cardiomyocytes\nhsa04270(775+776+778+779)  Vascular smooth muscle contraction",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "2149",
    "atc_code": "C08CA02",
    "drug_class": [
      "Cardiovascular agent",
      "Calcium channel blocker",
      "Calcium channel L type blocker",
      "Antihypertensive",
      "Dihydropyridine calcium channel blocker",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Felodipine"
  },
  {
    "kegg_id": "D00617",
    "name_en": "Nicardipine hydrochloride (JP18/USAN)",
    "name_ja": "",
    "names_alt": [
      "Cardene (TN)"
    ],
    "formula": "C26H29N3O6. HCl",
    "efficacy": "Antihypertensive, Vasodilator, Calcium channel blocker\nDISEASE   Hypertension [DS:H01633]",
    "target": "CACNA1-L [HSA:775 776 778 779] [KO:K04850 K04851 K04853 K04857]\nPATHWAY   hsa04020(775+776+778+779)  Calcium signaling pathway\nhsa04260(775+776+778+779)  Cardiac muscle contraction\nhsa04261(775+776+778+779)  Adrenergic signaling in cardiomyocytes\nhsa04270(775+776+778+779)  Vascular smooth muscle contraction",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "2149",
    "atc_code": "C08CA04",
    "drug_class": [
      "Cardiovascular agent",
      "Calcium channel blocker",
      "Calcium channel L type blocker",
      "Antihypertensive",
      "Dihydropyridine calcium channel blocker",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Nicardipine hydrochloride"
  },
  {
    "kegg_id": "D01908",
    "name_en": "Nilvadipine (JP18/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Nivadil (TN)"
    ],
    "formula": "C19H19N3O6",
    "efficacy": "Antihypertensive, Calcium channel blocker",
    "target": "CACNA1-L [HSA:775 776 778 779] [KO:K04850 K04851 K04853 K04857]\nPATHWAY   hsa04020(775+776+778+779)  Calcium signaling pathway\nhsa04260(775+776+778+779)  Cardiac muscle contraction\nhsa04261(775+776+778+779)  Adrenergic signaling in cardiomyocytes\nhsa04270(775+776+778+779)  Vascular smooth muscle contraction",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "2149",
    "atc_code": "C08CA10",
    "drug_class": [
      "Cardiovascular agent",
      "Calcium channel blocker",
      "Calcium channel L type blocker",
      "Antihypertensive",
      "Dihydropyridine calcium channel blocker",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Nilvadipine"
  },
  {
    "kegg_id": "D01553",
    "name_en": "Manidipine hydrochloride (JP18)",
    "name_ja": "",
    "names_alt": [
      "Manidipine dihydrochloride",
      "Calslot (TN)"
    ],
    "formula": "C35H38N4O6. 2HCl",
    "efficacy": "Antihypertensive, Vasodilator, Calcium channel blocker",
    "target": "CACNA1-L [HSA:775 776 778 779] [KO:K04850 K04851 K04853 K04857]\nPATHWAY   hsa04020(775+776+778+779)  Calcium signaling pathway\nhsa04260(775+776+778+779)  Cardiac muscle contraction\nhsa04261(775+776+778+779)  Adrenergic signaling in cardiomyocytes\nhsa04270(775+776+778+779)  Vascular smooth muscle contraction",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "2149",
    "atc_code": "C08CA11",
    "drug_class": [
      "Cardiovascular agent",
      "Calcium channel blocker",
      "Calcium channel L type blocker",
      "Antihypertensive",
      "Dihydropyridine calcium channel blocker",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Manidipine hydrochloride"
  },
  {
    "kegg_id": "D01104",
    "name_en": "Barnidipine hydrochloride (JAN)",
    "name_ja": "",
    "names_alt": [
      "Hypoca (TN)"
    ],
    "formula": "C27H29N3O6. HCl",
    "efficacy": "Antihypertensive, Calcium channel blocker",
    "target": "CACNA1-L [HSA:775 776 778 779] [KO:K04850 K04851 K04853 K04857]\nPATHWAY   hsa04020(775+776+778+779)  Calcium signaling pathway\nhsa04260(775+776+778+779)  Cardiac muscle contraction\nhsa04261(775+776+778+779)  Adrenergic signaling in cardiomyocytes\nhsa04270(775+776+778+779)  Vascular smooth muscle contraction",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "2149",
    "atc_code": "C08CA12",
    "drug_class": [
      "Cardiovascular agent",
      "Calcium channel blocker",
      "Calcium channel L type blocker",
      "Antihypertensive",
      "Dihydropyridine calcium channel blocker",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Barnidipine hydrochloride"
  },
  {
    "kegg_id": "D01173",
    "name_en": "Cilnidipine (JP18/INN)",
    "name_ja": "",
    "names_alt": [
      "Atelec (TN)"
    ],
    "formula": "C27H28N2O7",
    "efficacy": "Antihypertensive, Calcium channel blocker",
    "target": "CACNA1-L [HSA:775 776 778 779] [KO:K04850 K04851 K04853 K04857]\nCACNA1B [HSA:774] [KO:K04849]\nPATHWAY   hsa04020(774+775+776+778+779)  Calcium signaling pathway\nhsa04260(775+776+778+779)  Cardiac muscle contraction\nhsa04261(775+776+778+779)  Adrenergic signaling in cardiomyocytes\nhsa04270(775+776+778+779)  Vascular smooth muscle contraction",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]; CYP2C19 [HSA:1557]",
    "therapeutic_category": "2149",
    "atc_code": "C08CA14",
    "drug_class": [
      "Cardiovascular agent",
      "Calcium channel blocker",
      "Calcium channel L type blocker",
      "Calcium channel N type blocker",
      "Antihypertensive",
      "Dihydropyridine calcium channel blocker",
      "Metabolizing enzyme substrate",
      "CYP2C19 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C19",
      "CYP3A4"
    ],
    "search_name": "Cilnidipine"
  },
  {
    "kegg_id": "D00357",
    "name_en": "Losartan potassium (JP18/USP)",
    "name_ja": "ロサルタン",
    "names_alt": [
      "Cozaar (TN)"
    ],
    "formula": "C22H22ClN6O. K",
    "efficacy": "Antihypertensive, Angiotensin II receptor antagonist\nDISEASE   Hypertension [DS:H01633]\nNephropathy in type 2 diabetic [DS:H01456]",
    "target": "AGTR1 [HSA:185] [KO:K04166]\nPATHWAY   hsa04080(185)  Neuroactive ligand-receptor interaction\nhsa04261(185)  Adrenergic signaling in cardiomyocytes\nhsa04270(185)  Vascular smooth muscle contraction\nhsa04614(185)  Renin-angiotensin system",
    "metabolism": "Enzyme: CYP2C9 [HSA:1559]",
    "therapeutic_category": "2149",
    "atc_code": "C09CA01",
    "drug_class": [
      "Cardiovascular agent",
      "Renin-angiotensin system inhibitor",
      "Angiotensin II receptor antagonist",
      "Antihypertensive",
      "Angiotensin II receptor antagonist",
      "Metabolizing enzyme substrate",
      "CYP2C9 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C9"
    ],
    "search_name": "Losartan potassium"
  },
  {
    "kegg_id": "D00400",
    "name_en": "Valsartan (JP18/USP/INN)",
    "name_ja": "バルサルタン",
    "names_alt": [
      "Diovan (TN)"
    ],
    "formula": "C24H29N5O3",
    "efficacy": "Antihypertensive, Angiotensin II receptor antagonist\nDISEASE   Hypertension [DS:H01633]",
    "target": "AGTR1 [HSA:185] [KO:K04166]\nPATHWAY   hsa04080(185)  Neuroactive ligand-receptor interaction\nhsa04261(185)  Adrenergic signaling in cardiomyocytes\nhsa04270(185)  Vascular smooth muscle contraction\nhsa04614(185)  Renin-angiotensin system",
    "metabolism": "Enzyme: CYP2C9 [HSA:1559]\nTransporter: SLCO1B1 [HSA:10599], SLCO1B3 [HSA:28234], ABCC2 [HSA:1244]",
    "therapeutic_category": "2149",
    "atc_code": "C09CA03",
    "drug_class": [
      "Cardiovascular agent",
      "Renin-angiotensin system inhibitor",
      "Angiotensin II receptor antagonist",
      "Antihypertensive",
      "Angiotensin II receptor antagonist",
      "Metabolizing enzyme substrate",
      "CYP2C9 substrate",
      "Transporter substrate",
      "ABCC2 substrate",
      "SLCO1B1 substrate",
      "SLCO1B3 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C9"
    ],
    "search_name": "Valsartan"
  },
  {
    "kegg_id": "D00523",
    "name_en": "Irbesartan (JP18/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Avapro (TN)"
    ],
    "formula": "C25H28N6O",
    "efficacy": "Antihypertensive, Angiotensin II receptor antagonist\nDISEASE   Hypertension [DS:H01633]\nNephropathy in type 2 diabetic [DS:H01456]",
    "target": "AGTR1 [HSA:185] [KO:K04166]\nPATHWAY   hsa04080(185)  Neuroactive ligand-receptor interaction\nhsa04261(185)  Adrenergic signaling in cardiomyocytes\nhsa04270(185)  Vascular smooth muscle contraction\nhsa04614(185)  Renin-angiotensin system",
    "metabolism": "Enzyme: CYP2C9 [HSA:1559]",
    "therapeutic_category": "2149",
    "atc_code": "C09CA04",
    "drug_class": [
      "Cardiovascular agent",
      "Renin-angiotensin system inhibitor",
      "Angiotensin II receptor antagonist",
      "Antihypertensive",
      "Angiotensin II receptor antagonist",
      "Metabolizing enzyme substrate",
      "CYP2C9 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C9"
    ],
    "search_name": "Irbesartan"
  },
  {
    "kegg_id": "D00626",
    "name_en": "Candesartan cilexetil (JP18/USP)",
    "name_ja": "カンデサルタン",
    "names_alt": [
      "Atacand (TN)"
    ],
    "formula": "C33H34N6O6",
    "efficacy": "Antihypertensive, Angiotensin II receptor antagonist\nDISEASE   Hypertension [DS:H01633]",
    "target": "AGTR1 [HSA:185] [KO:K04166]\nPATHWAY   hsa04080(185)  Neuroactive ligand-receptor interaction\nhsa04261(185)  Adrenergic signaling in cardiomyocytes\nhsa04270(185)  Vascular smooth muscle contraction\nhsa04614(185)  Renin-angiotensin system",
    "metabolism": "Enzyme: CES [HSA:1066 8824 23491 221223], CYP2C9 [HSA:1559]",
    "therapeutic_category": "2149",
    "atc_code": "C09CA06",
    "drug_class": [
      "Cardiovascular agent",
      "Renin-angiotensin system inhibitor",
      "Angiotensin II receptor antagonist",
      "Antihypertensive",
      "Angiotensin II receptor antagonist",
      "Metabolizing enzyme substrate",
      "CYP2C9 substrate",
      "CES substrate"
    ],
    "cyp_enzymes": [
      "CYP2C9"
    ],
    "search_name": "Candesartan cilexetil"
  },
  {
    "kegg_id": "D00627",
    "name_en": "Telmisartan (JP18/USP/INN)",
    "name_ja": "テルミサルタン",
    "names_alt": [
      "Micardis (TN)"
    ],
    "formula": "C33H30N4O2",
    "efficacy": "Antihypertensive, Angiotensin II receptor antagonist\nDISEASE   Hypertension [DS:H01633]",
    "target": "AGTR1 [HSA:185] [KO:K04166]\nPATHWAY   hsa04080(185)  Neuroactive ligand-receptor interaction\nhsa04261(185)  Adrenergic signaling in cardiomyocytes\nhsa04270(185)  Vascular smooth muscle contraction\nhsa04614(185)  Renin-angiotensin system",
    "metabolism": "Enzyme: UGT [KO:K00699]",
    "therapeutic_category": "2149",
    "atc_code": "C09CA07",
    "drug_class": [
      "Cardiovascular agent",
      "Renin-angiotensin system inhibitor",
      "Angiotensin II receptor antagonist",
      "Antihypertensive",
      "Angiotensin II receptor antagonist",
      "Metabolizing enzyme substrate",
      "UGT substrate"
    ],
    "cyp_enzymes": [],
    "search_name": "Telmisartan"
  },
  {
    "kegg_id": "D01204",
    "name_en": "Olmesartan medoxomil (JP18/USP)",
    "name_ja": "オルメサルタン",
    "names_alt": [
      "Benicar (TN)",
      "Olmetec (TN)"
    ],
    "formula": "C29H30N6O6",
    "efficacy": "Antihypertensive, Angiotensin II receptor antagonist\nDISEASE   Hypertension [DS:H01633]",
    "target": "AGTR1 [HSA:185] [KO:K04166]\nPATHWAY   hsa04080(185)  Neuroactive ligand-receptor interaction\nhsa04261(185)  Adrenergic signaling in cardiomyocytes\nhsa04270(185)  Vascular smooth muscle contraction\nhsa04614(185)  Renin-angiotensin system",
    "metabolism": "Transporter: ABCC2 [HSA:1244], ABCB1 [HSA:5243], ABCG2 [HSA:9429]",
    "therapeutic_category": "2149",
    "atc_code": "C09CA08",
    "drug_class": [
      "Cardiovascular agent",
      "Renin-angiotensin system inhibitor",
      "Angiotensin II receptor antagonist",
      "Antihypertensive",
      "Angiotensin II receptor antagonist",
      "Transporter substrate",
      "ABCB1 substrate",
      "ABCC2 substrate",
      "ABCG2 substrate"
    ],
    "cyp_enzymes": [],
    "search_name": "Olmesartan medoxomil"
  },
  {
    "kegg_id": "D07895",
    "name_en": "Losartan potassium and hydrochlorothiazide (JP18)",
    "name_ja": "ロサルタン",
    "names_alt": [
      "Hydrochlorothiazide and losartan potassium",
      "Hyzaar (TN)",
      "Losarhyd (TN)"
    ],
    "formula": "",
    "efficacy": "Antihypertensive\nDISEASE   Hypertension [DS:H01633]",
    "target": "",
    "metabolism": "Enzyme: CYP2C9 [HSA:1559]",
    "therapeutic_category": "2149",
    "atc_code": "C09DA01",
    "drug_class": [
      "Cardiovascular agent",
      "Renin-angiotensin system inhibitor",
      "Antihypertensive",
      "Metabolizing enzyme substrate",
      "CYP2C9 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C9"
    ],
    "search_name": "Losartan potassium and hydrochlorothiazide"
  },
  {
    "kegg_id": "D09197",
    "name_en": "Valsartan and hydrochlorothiazide (JP18)",
    "name_ja": "バルサルタン",
    "names_alt": [
      "Co-dio (TN)"
    ],
    "formula": "",
    "efficacy": "Antihypertensive\nDISEASE   Hypertension [DS:H01633]",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2149",
    "atc_code": "C09DA03",
    "drug_class": [
      "Cardiovascular agent",
      "Renin-angiotensin system inhibitor",
      "Antihypertensive"
    ],
    "cyp_enzymes": [],
    "search_name": "Valsartan and hydrochlorothiazide"
  },
  {
    "kegg_id": "D10480",
    "name_en": "Irbesartan and trichlormethiazide",
    "name_ja": "",
    "names_alt": [
      "Irtra (TN)"
    ],
    "formula": "",
    "efficacy": "Antihypertensive",
    "target": "",
    "metabolism": "Enzyme: CYP2C9 [HSA:1559], UGT [KO:K00699]",
    "therapeutic_category": "2149",
    "atc_code": "C09DA04",
    "drug_class": [
      "Cardiovascular agent",
      "Renin-angiotensin system inhibitor",
      "Antihypertensive",
      "Metabolizing enzyme substrate",
      "CYP2C9 substrate",
      "UGT substrate"
    ],
    "cyp_enzymes": [
      "CYP2C9"
    ],
    "search_name": "Irbesartan and trichlormethiazide"
  },
  {
    "kegg_id": "D09196",
    "name_en": "Candesartan cilexetil and hydrochlorothiazide (JP18)",
    "name_ja": "カンデサルタン",
    "names_alt": [
      "Ecard (TN)"
    ],
    "formula": "",
    "efficacy": "Antihypertensive\nDISEASE   Hypertension [DS:H01633]",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2149",
    "atc_code": "C09DA06",
    "drug_class": [
      "Cardiovascular agent",
      "Renin-angiotensin system inhibitor",
      "Antihypertensive"
    ],
    "cyp_enzymes": [],
    "search_name": "Candesartan cilexetil and hydrochlorothiazide"
  },
  {
    "kegg_id": "D09219",
    "name_en": "Telmisartan and hydrochlorothiazide (JP18)",
    "name_ja": "テルミサルタン",
    "names_alt": [
      "Micombi (TN)"
    ],
    "formula": "",
    "efficacy": "Antihypertensive\nDISEASE   Hypertension [DS:H01633]",
    "target": "",
    "metabolism": "Enzyme: UGT [KO:K00699]",
    "therapeutic_category": "2149",
    "atc_code": "C09DA07",
    "drug_class": [
      "Cardiovascular agent",
      "Renin-angiotensin system inhibitor",
      "Antihypertensive",
      "Metabolizing enzyme substrate",
      "UGT substrate"
    ],
    "cyp_enzymes": [],
    "search_name": "Telmisartan and hydrochlorothiazide"
  },
  {
    "kegg_id": "D09745",
    "name_en": "Valsartan and amlodipine besilate",
    "name_ja": "バルサルタン",
    "names_alt": [
      "Exforge (TN)"
    ],
    "formula": "",
    "efficacy": "Antihypertensive\nDISEASE   Hypertension [DS:H01633]",
    "target": "",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "2149",
    "atc_code": "C09DB01",
    "drug_class": [
      "Cardiovascular agent",
      "Renin-angiotensin system inhibitor",
      "Antihypertensive",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Valsartan and amlodipine besilate"
  },
  {
    "kegg_id": "D09743",
    "name_en": "Telmisartan and amlodipine besilate (JP18)",
    "name_ja": "テルミサルタン",
    "names_alt": [
      "Telmisartan and amlodipine besylate",
      "Micamlo (TN)",
      "Twynsta (TN)"
    ],
    "formula": "",
    "efficacy": "Antihypertensive\nDISEASE   Hypertension [DS:H01633]",
    "target": "",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576], UGT [KO:K00699]",
    "therapeutic_category": "2149",
    "atc_code": "C09DB04",
    "drug_class": [
      "Cardiovascular agent",
      "Renin-angiotensin system inhibitor",
      "Antihypertensive",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "UGT substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Telmisartan and amlodipine besilate"
  },
  {
    "kegg_id": "D10243",
    "name_en": "Irbesartan and amlodipine besilate (JP18)",
    "name_ja": "",
    "names_alt": [
      "Aimix (TN)"
    ],
    "formula": "",
    "efficacy": "Antihypertensive",
    "target": "",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "2149",
    "atc_code": "C09DB05",
    "drug_class": [
      "Cardiovascular agent",
      "Renin-angiotensin system inhibitor",
      "Antihypertensive",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Irbesartan and amlodipine besilate"
  },
  {
    "kegg_id": "D07569",
    "name_en": "Candesartan cilexetil and anmlodipine besylate (JP18)",
    "name_ja": "カンデサルタン",
    "names_alt": [
      "Unisia (TN)"
    ],
    "formula": "",
    "efficacy": "Antihypertensive",
    "target": "",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "2149",
    "atc_code": "C09DB07",
    "drug_class": [
      "Cardiovascular agent",
      "Renin-angiotensin system inhibitor",
      "Antihypertensive",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Candesartan cilexetil and anmlodipine besylate"
  },
  {
    "kegg_id": "D10226",
    "name_en": "Sacubitril valsartan sodium hydrate (JAN)",
    "name_ja": "",
    "names_alt": [
      "Sacubitril mixture with valsartan",
      "Entresto (TN)"
    ],
    "formula": "(C24H27N5O3. 2Na)2. (C24H28NO5. Na)2. 5H2O",
    "efficacy": "Antihypertensive",
    "target": "MME (CD10) [HSA:4311] [KO:K01389]\nAGTR1 [HSA:185] [KO:K04166]\nPATHWAY   hsa04614(185+4311)  Renin-angiotensin system",
    "metabolism": "",
    "therapeutic_category": "2149",
    "atc_code": "C09DX04",
    "drug_class": [
      "Cardiovascular agent",
      "Renin-angiotensin system inhibitor",
      "Antihypertensive"
    ],
    "cyp_enzymes": [],
    "search_name": "Sacubitril valsartan sodium hydrate"
  },
  {
    "kegg_id": "D10805",
    "name_en": "Telmisartan, amlodipine and hydrochlorothiazide",
    "name_ja": "テルミサルタン",
    "names_alt": [
      "Micatrio (TN)"
    ],
    "formula": "",
    "efficacy": "Antihypertensive",
    "target": "",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576], UGT [KO:K00699]",
    "therapeutic_category": "2149",
    "atc_code": "C09DX08",
    "drug_class": [
      "Cardiovascular agent",
      "Renin-angiotensin system inhibitor",
      "Antihypertensive",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "UGT substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Telmisartan, amlodipine and hydrochlorothiazide"
  },
  {
    "kegg_id": "D06412",
    "name_en": "Aliskiren fumarate (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Aliskiren hemifumarate",
      "Tekturna (TN)"
    ],
    "formula": "(C30H53N3O6)2. C4H4O4",
    "efficacy": "Antihypertensive, Renin inhibitor\nDISEASE   Hypertension [DS:H01633]",
    "target": "REN [HSA:5972] [KO:K01380]\nPATHWAY   hsa04614(5972)  Renin-angiotensin system",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]\nTransporter: ABCB1 [HSA:5243]",
    "therapeutic_category": "2149",
    "atc_code": "C09XA02",
    "drug_class": [
      "Cardiovascular agent",
      "Renin-angiotensin system inhibitor",
      "Renin inhibitor",
      "Antihypertensive",
      "Renin inhibitor",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "Transporter substrate",
      "ABCB1 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Aliskiren fumarate"
  },
  {
    "kegg_id": "D00610",
    "name_en": "Terazosin hydrochloride (USP)",
    "name_ja": "",
    "names_alt": [
      "Terazosin hydrochloride hydrate (JAN)",
      "Hytrin (TN)"
    ],
    "formula": "C19H25N5O4. 2H2O. HCl",
    "efficacy": "Antidysuria, Antihypertensive, alpha1-Adrenergic receptor antagonist",
    "target": "ADRA1 [HSA:148 147 146] [KO:K04135 K04136 K04137]\nPATHWAY   hsa04022(146+147+148)  cGMP-PKG signaling pathway\nhsa04080(146+147+148)  Neuroactive ligand-receptor interaction\nhsa04270(146+147+148)  Vascular smooth muscle contraction",
    "metabolism": "",
    "therapeutic_category": "2149",
    "atc_code": "G04CA03",
    "drug_class": [
      "Cardiovascular agent",
      "Adrenergic receptor antagonist",
      "alpha-Adrenergic receptor antagonist",
      "alpha1-Adrenergic receptor antagonist",
      "Antihypertensive"
    ],
    "cyp_enzymes": [],
    "search_name": "Terazosin hydrochloride"
  },
  {
    "kegg_id": "D00605",
    "name_en": "Guanabenz acetate (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Wytensin (TN)"
    ],
    "formula": "C8H8Cl2N4. C2H4O2",
    "efficacy": "Antihypertensive, alpha2-Adrenergic receptor agonist",
    "target": "ADRA2 [HSA:150 151 152] [KO:K04138 K04139 K04140]\nPATHWAY   hsa04080(150+151+152)  Neuroactive ligand-receptor interaction",
    "metabolism": "",
    "therapeutic_category": "2149",
    "atc_code": "",
    "drug_class": [
      "Cardiovascular agent",
      "Centrally-acting antiadrenergic",
      "Antihypertensive"
    ],
    "cyp_enzymes": [],
    "search_name": "Guanabenz acetate"
  },
  {
    "kegg_id": "D01145",
    "name_en": "Azelnidipine (JP18/INN)",
    "name_ja": "",
    "names_alt": [
      "Calblock (TN)"
    ],
    "formula": "C33H34N4O6",
    "efficacy": "Antihypertensive, Calcium channel blocker",
    "target": "CACNA1-L [HSA:775 776 778 779] [KO:K04850 K04851 K04853 K04857]\nPATHWAY   hsa04020(775+776+778+779)  Calcium signaling pathway\nhsa04260(775+776+778+779)  Cardiac muscle contraction\nhsa04261(775+776+778+779)  Adrenergic signaling in cardiomyocytes\nhsa04270(775+776+778+779)  Vascular smooth muscle contraction",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "2149",
    "atc_code": "",
    "drug_class": [
      "Cardiovascular agent",
      "Calcium channel blocker",
      "Calcium channel L type blocker",
      "Antihypertensive",
      "Dihydropyridine calcium channel blocker",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Azelnidipine"
  },
  {
    "kegg_id": "D01469",
    "name_en": "Amosulalol hydrochloride (JP18)",
    "name_ja": "",
    "names_alt": [
      "Lowgan (TN)"
    ],
    "formula": "C18H24N2O5S. HCl",
    "efficacy": "Antihypertansive, alpha1/beta-Adrenergic receptor antagonist",
    "target": "ADRA1 [HSA:148 147 146] [KO:K04135 K04136 K04137]\nADRB1 [HSA:153] [KO:K04141]\nADRB2 [HSA:154] [KO:K04142]\nPATHWAY   hsa04020(146+147+148+153+154)  Calcium signaling pathway\nhsa04022(146+147+148+153+154)  cGMP-PKG signaling pathway\nhsa04024(153+154)  cAMP signaling pathway\nhsa04080(146+147+148+153+154)  Neuroactive ligand-receptor interaction\nhsa04261(146+147+148+153+154)  Adrenergic signaling in cardiomyocytes\nhsa04270(146+147+148)  Vascular smooth muscle contraction",
    "metabolism": "",
    "therapeutic_category": "2149",
    "atc_code": "",
    "drug_class": [
      "Cardiovascular agent",
      "Adrenergic receptor antagonist",
      "alpha1 and beta-Adrenergic receptor antagonist",
      "Antihypertensive",
      "alpha1 and beta-Adrenergic receptor antagonist"
    ],
    "cyp_enzymes": [],
    "search_name": "Amosulalol hydrochloride"
  },
  {
    "kegg_id": "D01604",
    "name_en": "Efonidipine hydrochloride ethanolate (JAN)",
    "name_ja": "",
    "names_alt": [
      "Efonidipine hydrochloride ethanol",
      "Efonidipine hydrochloride",
      "NZ 105 ethanolate",
      "Landel (TN)"
    ],
    "formula": "C34H38N3O7P. C2H6O. HCl",
    "efficacy": "Antihypertensive, Vasodilator, Calcium channel blocker",
    "target": "CACNA1-L [HSA:775 776 778 779] [KO:K04850 K04851 K04853 K04857]\nPATHWAY   hsa04020(775+776+778+779)  Calcium signaling pathway\nhsa04260(775+776+778+779)  Cardiac muscle contraction\nhsa04261(775+776+778+779)  Adrenergic signaling in cardiomyocytes\nhsa04270(775+776+778+779)  Vascular smooth muscle contraction",
    "metabolism": "",
    "therapeutic_category": "2149",
    "atc_code": "",
    "drug_class": [
      "Cardiovascular agent",
      "Calcium channel blocker",
      "Calcium channel L type blocker",
      "Calcium channel T type blocker",
      "Antihypertensive",
      "Dihydropyridine calcium channel blocker"
    ],
    "cyp_enzymes": [],
    "search_name": "Efonidipine hydrochloride ethanolate"
  },
  {
    "kegg_id": "D08864",
    "name_en": "Azilsartan (JAN/USAN/INN)",
    "name_ja": "アジルサルタン",
    "names_alt": [
      "Azilva (TN)"
    ],
    "formula": "C25H20N4O5",
    "efficacy": "Antihypertensive, Angiotensin II receptor antagonist",
    "target": "AGTR1 [HSA:185] [KO:K04166]\nPATHWAY   hsa04020(185)  Calcium signaling pathway\nhsa04080(185)  Neuroactive ligand-receptor interaction\nhsa04270(185)  Vascular smooth muscle contraction\nhsa04614(185)  Renin-angiotensin system",
    "metabolism": "Enzyme: CYP2C9 [HSA:1559]",
    "therapeutic_category": "2149",
    "atc_code": "",
    "drug_class": [
      "Cardiovascular agent",
      "Renin-angiotensin system inhibitor",
      "Angiotensin II receptor antagonist",
      "Antihypertensive",
      "Angiotensin II receptor antagonist",
      "Metabolizing enzyme substrate",
      "CYP2C9 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C9"
    ],
    "search_name": "Azilsartan"
  },
  {
    "kegg_id": "D09594",
    "name_en": "Olmesartan medoxomil and azelnidipine",
    "name_ja": "オルメサルタン",
    "names_alt": [
      "Rezaltas (TN)"
    ],
    "formula": "",
    "efficacy": "Antihypertensive",
    "target": "",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "2149",
    "atc_code": "",
    "drug_class": [
      "Cardiovascular agent",
      "Renin-angiotensin system inhibitor",
      "Antihypertensive",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Olmesartan medoxomil and azelnidipine"
  },
  {
    "kegg_id": "D10524",
    "name_en": "Azilsartan and amlodipine besilate",
    "name_ja": "アジルサルタン",
    "names_alt": [
      "Zacras (TN)"
    ],
    "formula": "",
    "efficacy": "Antihypertensive",
    "target": "",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "2149",
    "atc_code": "",
    "drug_class": [
      "Cardiovascular agent",
      "Renin-angiotensin system inhibitor",
      "Antihypertensive",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Azilsartan and amlodipine besilate"
  },
  {
    "kegg_id": "D10525",
    "name_en": "Valsartan and cilnidipine",
    "name_ja": "バルサルタン",
    "names_alt": [
      "Atedio (TN)"
    ],
    "formula": "",
    "efficacy": "Antihypertensive",
    "target": "",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]; CYP2C19 [HSA:1557]",
    "therapeutic_category": "2149",
    "atc_code": "",
    "drug_class": [
      "Cardiovascular agent",
      "Renin-angiotensin system inhibitor",
      "Antihypertensive",
      "Metabolizing enzyme substrate",
      "CYP2C19 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C19",
      "CYP3A4"
    ],
    "search_name": "Valsartan and cilnidipine"
  },
  {
    "kegg_id": "D10892",
    "name_en": "Esaxerenone (JAN/INN)",
    "name_ja": "",
    "names_alt": [],
    "formula": "C22H21F3N2O4S",
    "efficacy": "Antihypertensive, Aldosterone antagonist",
    "target": "NR3C2 (MR) [HSA:4306] [KO:K08555]\nPATHWAY   hsa04960(4306)  Aldosterone-regulated sodium reabsorption",
    "metabolism": "Enzyme: CYP3A [HSA:1576 1577 1551]",
    "therapeutic_category": "2149",
    "atc_code": "",
    "drug_class": [
      "Cardiovascular agent",
      "Antihypertensive",
      "Aldosterone antagonist",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A"
    ],
    "search_name": "Esaxerenone"
  },
  {
    "kegg_id": "D01307",
    "name_en": "Midodrine hydrochloride (JAN/USP)",
    "name_ja": "",
    "names_alt": [
      "Pro-Amatine (TN)"
    ],
    "formula": "C12H18N2O4. HCl",
    "efficacy": "Antihypotensive, alpha1-Adrenergic receptor agonist",
    "target": "ADRA1 [HSA:148 147 146] [KO:K04135 K04136 K04137]\nPATHWAY   hsa04020(146+147+148)  Calcium signaling pathway\nhsa04080(146+147+148)  Neuroactive ligand-receptor interaction\nhsa04270(146+147+148)  Vascular smooth muscle contraction\nhsa04970(146+147+148)  Salivary secretion",
    "metabolism": "",
    "therapeutic_category": "2160",
    "atc_code": "C01CA17",
    "drug_class": [
      "Cardiovascular agent",
      "Cardiotonic",
      "Phenethylamine cardiotonic",
      "Adrenergic receptor agonist",
      "alpha-Adrenergic receptor agonist",
      "alpha1-Adrenergic receptor agonist",
      "Metabolizing enzyme inhibitor",
      "CYP2D6 inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Midodrine hydrochloride"
  },
  {
    "kegg_id": "D00451",
    "name_en": "Sumatriptan (JAN/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Imigran (TN)",
      "Imitrex (TN)"
    ],
    "formula": "C14H21N3O2S",
    "efficacy": "Antimigraine, Vasoconstrictor, Serotonin receptor agonist",
    "target": "HTR1B [HSA:3351] [KO:K04153]\nHTR1D [HSA:3352] [KO:K04153]\nPATHWAY   hsa04080(3351+3352)  Neuroactive ligand-receptor interaction\nhsa04726(3351+3352)  Serotonergic synapse",
    "metabolism": "Enzyme: MAOA [HSA:4128]",
    "therapeutic_category": "2160",
    "atc_code": "N02CC01",
    "drug_class": [
      "Analgesic",
      "5-HT1B-receptor agonist",
      "5-HT1D-receptor agonist",
      "5-HT1B/1D-receptor agonist",
      "Triptan",
      "Metabolizing enzyme substrate",
      "MAO substrate",
      "MAOA substrate"
    ],
    "cyp_enzymes": [],
    "search_name": "Sumatriptan"
  },
  {
    "kegg_id": "D00676",
    "name_en": "Sumatriptan succinate (JAN/USP)",
    "name_ja": "",
    "names_alt": [
      "Alsuma (TN)",
      "Imitrex (TN)",
      "Sumave dosepro (TN)",
      "Zecutity (TN)"
    ],
    "formula": "C14H21N3O2S. C4H6O4",
    "efficacy": "Antimigraine, Vasoconstrictor, Serotonin receptor agonist\nDISEASE   Cluster headache [DS:H01588]",
    "target": "HTR1B [HSA:3351] [KO:K04153]\nHTR1D [HSA:3352] [KO:K04153]\nPATHWAY   hsa04080(3351+3352)  Neuroactive ligand-receptor interaction\nhsa04726(3351+3352)  Serotonergic synapse",
    "metabolism": "Enzyme: MAOA [HSA:4128]",
    "therapeutic_category": "2160",
    "atc_code": "N02CC01",
    "drug_class": [
      "Analgesic",
      "5-HT1B-receptor agonist",
      "5-HT1D-receptor agonist",
      "5-HT1B/1D-receptor agonist",
      "Triptan",
      "Metabolizing enzyme substrate",
      "MAO substrate",
      "MAOA substrate"
    ],
    "cyp_enzymes": [],
    "search_name": "Sumatriptan succinate"
  },
  {
    "kegg_id": "D00674",
    "name_en": "Naratriptan hydrochloride (JAN/USP)",
    "name_ja": "",
    "names_alt": [
      "Amerge (TN)"
    ],
    "formula": "C17H25N3O2S. HCl",
    "efficacy": "Antimigraine, Vasoconstrictor, Serotonin receptor agonist",
    "target": "HTR1B [HSA:3351] [KO:K04153]\nHTR1D [HSA:3352] [KO:K04153]\nPATHWAY   hsa04080(3351+3352)  Neuroactive ligand-receptor interaction\nhsa04726(3351+3352)  Serotonergic synapse",
    "metabolism": "Enzyme: CYP1A2 [HSA:1544], CYP2C9 [HSA:1559], CYP2D6 [HSA:1565], CYP2E1 [HSA:1571], CYP3A4 [HSA:1576], CYP3A5 [HSA:1577]",
    "therapeutic_category": "2160",
    "atc_code": "N02CC02",
    "drug_class": [
      "Neuropsychiatric agent",
      "5-HT1A-receptor agonist",
      "Analgesic",
      "5-HT1B-receptor agonist",
      "5-HT1D-receptor agonist",
      "5-HT1B/1D-receptor agonist",
      "Triptan",
      "Metabolizing enzyme substrate",
      "CYP1A2 substrate",
      "CYP2C9 substrate",
      "CYP2D6 substrate",
      "CYP2E1 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "CYP3A5 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4",
      "CYP1A2",
      "CYP3A5",
      "CYP2C9",
      "CYP2D6",
      "CYP2E1"
    ],
    "search_name": "Naratriptan hydrochloride"
  },
  {
    "kegg_id": "D00415",
    "name_en": "Zolmitriptan (JAN/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Zomig (TN)"
    ],
    "formula": "C16H21N3O2",
    "efficacy": "Antimigraine, Vasoconstrictor, Serotonin receptor agonist",
    "target": "HTR1B [HSA:3351] [KO:K04153]\nHTR1D [HSA:3352] [KO:K04153]\nPATHWAY   hsa04080(3351+3352)  Neuroactive ligand-receptor interaction\nhsa04726(3351+3352)  Serotonergic synapse",
    "metabolism": "Enzyme: CYP1A2 [HSA:1544], MAOA [HSA:4128]",
    "therapeutic_category": "2160",
    "atc_code": "N02CC03",
    "drug_class": [
      "Analgesic",
      "5-HT1B-receptor agonist",
      "5-HT1D-receptor agonist",
      "5-HT1B/1D-receptor agonist",
      "Triptan",
      "Metabolizing enzyme substrate",
      "CYP1A2 substrate",
      "MAO substrate",
      "MAOA substrate"
    ],
    "cyp_enzymes": [
      "CYP1A2"
    ],
    "search_name": "Zolmitriptan"
  },
  {
    "kegg_id": "D00675",
    "name_en": "Rizatriptan benzoate (JAN/USP)",
    "name_ja": "",
    "names_alt": [
      "Maxalt (TN)"
    ],
    "formula": "C15H19N5. C7H6O2",
    "efficacy": "Antimigraine, Vasoconstrictor, Serotonin receptor agonist",
    "target": "HTR1B [HSA:3351] [KO:K04153]\nHTR1D [HSA:3352] [KO:K04153]\nPATHWAY   hsa04080(3351+3352)  Neuroactive ligand-receptor interaction\nhsa04726(3351+3352)  Serotonergic synapse",
    "metabolism": "",
    "therapeutic_category": "2160",
    "atc_code": "N02CC04",
    "drug_class": [
      "Analgesic",
      "5-HT1B-receptor agonist",
      "5-HT1D-receptor agonist",
      "5-HT1B/1D-receptor agonist",
      "Triptan"
    ],
    "cyp_enzymes": [],
    "search_name": "Rizatriptan benzoate"
  },
  {
    "kegg_id": "D01973",
    "name_en": "Eletriptan hydrobromide (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Relpax (TN)"
    ],
    "formula": "C22H26N2O2S. HBr",
    "efficacy": "Antimigraine, Vasoconstrictor, Serotonin receptor agonist",
    "target": "HTR1B [HSA:3351] [KO:K04153]\nHTR1D [HSA:3352] [KO:K04153]\nPATHWAY   hsa04080(3351+3352)  Neuroactive ligand-receptor interaction\nhsa04726(3351+3352)  Serotonergic synapse",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "2160",
    "atc_code": "N02CC06",
    "drug_class": [
      "Analgesic",
      "5-HT1B-receptor agonist",
      "5-HT1D-receptor agonist",
      "5-HT1B/1D-receptor agonist",
      "Triptan",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Eletriptan hydrobromide"
  },
  {
    "kegg_id": "D00302",
    "name_en": "Dipyridamole (JP18/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Persantine (TN)"
    ],
    "formula": "C24H40N8O4",
    "efficacy": "Vasodilator (coronary), Platelet aggregation inhibitor, Phosphodiesterase inhibitor",
    "target": "PDE5 [HSA:8654] [KO:K13762]\nPDE4A [HSA:5141] [KO:K13293]\nPATHWAY   hsa04022(8654)  cGMP-PKG signaling pathway\nhsa04024(5141)  cAMP signaling pathway",
    "metabolism": "",
    "therapeutic_category": "2171",
    "atc_code": "B01AC07",
    "drug_class": [
      "Cardiovascular agent",
      "Phosphodiesterase V inhibitor",
      "Blood modifier agent",
      "Antithrombotic agent",
      "Antiplatelet agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Dipyridamole"
  },
  {
    "kegg_id": "D00516",
    "name_en": "Isosorbide dinitrate (JP18/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Dilatrate-sr (TN)",
      "Isordil (TN)"
    ],
    "formula": "C6H8N2O8",
    "efficacy": "Vasodilator (coronary)\nDISEASE   Angina pectoris [DS:H01632]",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2171",
    "atc_code": "C01DA08",
    "drug_class": [
      "Cardiovascular agent",
      "Nitrovasodilator"
    ],
    "cyp_enzymes": [],
    "search_name": "Isosorbide dinitrate"
  },
  {
    "kegg_id": "D00630",
    "name_en": "Isosorbide mononitrate (JP18/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Imdur (TN)",
      "Ismo (TN)"
    ],
    "formula": "C6H9NO6",
    "efficacy": "Vasodilator (coronary)\nDISEASE   Angina pectoris [DS:H01632]",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2171",
    "atc_code": "C01DA14",
    "drug_class": [
      "Cardiovascular agent",
      "Nitrovasodilator"
    ],
    "cyp_enzymes": [],
    "search_name": "Isosorbide mononitrate"
  },
  {
    "kegg_id": "D02631",
    "name_en": "Dilazep dihydrochloride hydrate (JP18)",
    "name_ja": "",
    "names_alt": [
      "Dilazep dihydrochloride monohydrate",
      "Irutep (TN)"
    ],
    "formula": "C31H44N2O10. 2HCl. H2O",
    "efficacy": "Vasodilator (coronary)",
    "target": "SLC29A1 (ENT1) [HSA:2030] [KO:K15014]",
    "metabolism": "",
    "therapeutic_category": "2171",
    "atc_code": "C01DX10",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Dilazep dihydrochloride hydrate"
  },
  {
    "kegg_id": "D01220",
    "name_en": "Trapidil (JP18/INN)",
    "name_ja": "",
    "names_alt": [
      "Rocornal (TN)"
    ],
    "formula": "C10H15N5",
    "efficacy": "Vasodilator, Phosphodiesterase inhibitor",
    "target": "PDE [HSA:10846 27115 50940 5136 5137 5138 5139 5140 5141 5142 5143 5144 5150 5151 5153 8622] [KO:K18438 K18436 K13298 K13755 K18283 K19021 K13296 K13293 K18437]\nTBXAS1 (CYP5A1) [HSA:6916] [KO:K01832]\nPATHWAY   hsa04022(5138+5139+5140)  cGMP-PKG signaling pathway\nhsa04024(10846+5139+5140+5141+5142+5143+5144)  cAMP signaling pathway\nhsa04611(6916)  Platelet activation",
    "metabolism": "",
    "therapeutic_category": "2171",
    "atc_code": "C01DX11",
    "drug_class": [
      "Blood modifier agent",
      "Antithrombotic agent",
      "Antiplatelet agent",
      "Thromboxane A2 synthase inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Trapidil"
  },
  {
    "kegg_id": "D01810",
    "name_en": "Nicorandil (JP18/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Sigmart (TN)"
    ],
    "formula": "C8H9N3O4",
    "efficacy": "Vasodilator (coronary)",
    "target": "ABCC8(SUR1)/KCNJ11(KIR6.2) [HSA:6833 3767] [KO:K05032 K05004]\nABCC9(SUR2)/KCNJ11(KIR6.2) [HSA:10060 3767] [KO:K05033 K05004]\nGUCY1A [HSA:2977 2982] [KO:K12318]\nGUCY1B [HSA:2983] [KO:K12319]\nPATHWAY   hsa02010(10060+6833)  ABC transporters\nhsa04022(2977+2982+2983)  cGMP-PKG signaling pathway\nhsa04270(2977+2982+2983)  Vascular smooth muscle contraction",
    "metabolism": "",
    "therapeutic_category": "2171",
    "atc_code": "C01DX16",
    "drug_class": [
      "Cardiovascular agent",
      "ATP-sensitive potassium channel opener",
      "Nitrovasodilator",
      "Blood modifier agent",
      "Antithrombotic agent",
      "Antiplatelet agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Nicorandil"
  },
  {
    "kegg_id": "D01606",
    "name_en": "Trimetazidine hydrochloride (JP18)",
    "name_ja": "",
    "names_alt": [
      "Kyurinett (TN)"
    ],
    "formula": "C14H22N2O3. 2HCl",
    "efficacy": "Vasodilator (coronary)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2171",
    "atc_code": "C01EB15",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Trimetazidine hydrochloride"
  },
  {
    "kegg_id": "D00616",
    "name_en": "Diltiazem hydrochloride (JP18/USP)",
    "name_ja": "ジルチアゼム",
    "names_alt": [
      "Cardizem (TN)",
      "Cartia XT (TN)",
      "Dilacor XR (TN)",
      "Dilt-CD (TN)"
    ],
    "formula": "C22H26N2O4S. HCl",
    "efficacy": "Antiarrhythmic, Antihypertensive, Vasodilator (coronary), Calcium channel blocker\nDISEASE   Hypertension [DS:H01633]\nAngina [DS:H01632]",
    "target": "CACNA1-L [HSA:775 776 778 779] [KO:K04850 K04851 K04853 K04857]\nPATHWAY   hsa04024(775+776+778+779)  cAMP signaling pathway\nhsa04260(775+776+778+779)  Cardiac muscle contraction\nhsa04261(775+776+778+779)  Adrenergic signaling in cardiomyocytes\nhsa04270(775+776+778+779)  Vascular smooth muscle contraction",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "2171",
    "atc_code": "C05AE03",
    "drug_class": [
      "Cardiovascular agent",
      "Calcium channel blocker",
      "Calcium channel L type blocker",
      "Antiarrhythmics",
      "Antihypertensive",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Diltiazem hydrochloride"
  },
  {
    "kegg_id": "D00615",
    "name_en": "Amlodipine besylate (USP)",
    "name_ja": "アムロジピン",
    "names_alt": [
      "Amlodipine besilate (JP18)",
      "Norvasc (TN)"
    ],
    "formula": "C20H25ClN2O5. C6H6O3S",
    "efficacy": "Antihypertensive, Vasodilator, Calcium channel blocker\nDISEASE   Hypertension [DS:H01633]\nChronic stable angina [DS:H01632]\nVasospastic angina [DS:H01632]",
    "target": "CACNA1-L [HSA:775 776 778 779] [KO:K04850 K04851 K04853 K04857]\nPATHWAY   hsa04020(775+776+778+779)  Calcium signaling pathway\nhsa04260(775+776+778+779)  Cardiac muscle contraction\nhsa04261(775+776+778+779)  Adrenergic signaling in cardiomyocytes\nhsa04270(775+776+778+779)  Vascular smooth muscle contraction",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "2171",
    "atc_code": "C08CA01",
    "drug_class": [
      "Cardiovascular agent",
      "Calcium channel blocker",
      "Calcium channel L type blocker",
      "Antihypertensive",
      "Dihydropyridine calcium channel blocker",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Amlodipine besylate"
  },
  {
    "kegg_id": "D00437",
    "name_en": "Nifedipine (JP18/USP/INN)",
    "name_ja": "ニフェジピン",
    "names_alt": [
      "Adalat (TN)",
      "Afeditab CR (TN)",
      "Procardia (TN)"
    ],
    "formula": "C17H18N2O6",
    "efficacy": "Antihypertensive, Vasodilator, Calcium channel blocker\nDISEASE   Hypertension [DS:H01633]\nVasospastic angina [DS:H01632]\nChronic stable angina [DS:H01632]",
    "target": "CACNA1-L [HSA:775 776 778 779] [KO:K04850 K04851 K04853 K04857]\nPATHWAY   hsa04020(775+776+778+779)  Calcium signaling pathway\nhsa04260(775+776+778+779)  Cardiac muscle contraction\nhsa04261(775+776+778+779)  Adrenergic signaling in cardiomyocytes\nhsa04270(775+776+778+779)  Vascular smooth muscle contraction",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "2171",
    "atc_code": "C08CA05",
    "drug_class": [
      "Cardiovascular agent",
      "Calcium channel blocker",
      "Calcium channel L type blocker",
      "Antihypertensive",
      "Dihydropyridine calcium channel blocker",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Nifedipine"
  },
  {
    "kegg_id": "D00629",
    "name_en": "Nitrendipine (JP18/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Baypress (TN)"
    ],
    "formula": "C18H20N2O6",
    "efficacy": "Antihypertensive, Vasodilator, Calcium channel blocker",
    "target": "CACNA1-L [HSA:775 776 778 779] [KO:K04850 K04851 K04853 K04857]\nPATHWAY   hsa04020(775+776+778+779)  Calcium signaling pathway\nhsa04260(775+776+778+779)  Cardiac muscle contraction\nhsa04261(775+776+778+779)  Adrenergic signaling in cardiomyocytes\nhsa04270(775+776+778+779)  Vascular smooth muscle contraction",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "2171",
    "atc_code": "C08CA08",
    "drug_class": [
      "Cardiovascular agent",
      "Calcium channel blocker",
      "Calcium channel L type blocker",
      "Antihypertensive",
      "Dihydropyridine calcium channel blocker",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Nitrendipine"
  },
  {
    "kegg_id": "D01882",
    "name_en": "Hepronicate (JAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Megrin (TN)"
    ],
    "formula": "C28H31N3O6",
    "efficacy": "Vasodilator",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2172",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Hepronicate"
  },
  {
    "kegg_id": "D02045",
    "name_en": "Benidipine hydrochloride (JP18)",
    "name_ja": "",
    "names_alt": [
      "KW 3049",
      "Coniel (TN)"
    ],
    "formula": "C28H31N3O6. HCl",
    "efficacy": "Antihypertensive, Vasodilator, Calcium channel blocker",
    "target": "CACNA1-L [HSA:775 776 778 779] [KO:K04850 K04851 K04853 K04857]\nPATHWAY   hsa04020(775+776+778+779)  Calcium signaling pathway\nhsa04260(775+776+778+779)  Cardiac muscle contraction\nhsa04261(775+776+778+779)  Adrenergic signaling in cardiomyocytes\nhsa04270(775+776+778+779)  Vascular smooth muscle contraction",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "2179",
    "atc_code": "C08CA15",
    "drug_class": [
      "Cardiovascular agent",
      "Calcium channel blocker",
      "Calcium channel L type blocker",
      "Antihypertensive",
      "Dihydropyridine calcium channel blocker",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Benidipine hydrochloride"
  },
  {
    "kegg_id": "D00517",
    "name_en": "Amyl nitrite (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Aspiral (TN)",
      "Vaporole (TN)"
    ],
    "formula": "C5H11NO2",
    "efficacy": "Antidote (cyanide), Vasodilator, Guanylate cyclase activator\nDISEASE   Angina pectoris [DS:H01632]",
    "target": "GUCY1A [HSA:2977 2982] [KO:K12318]\nGUCY1B [HSA:2983] [KO:K12319]\nPATHWAY   hsa04270(2977+2982+2983)  Vascular smooth muscle contraction",
    "metabolism": "",
    "therapeutic_category": "2179",
    "atc_code": "V03AB22",
    "drug_class": [
      "Cardiovascular agent",
      "Nitrovasodilator"
    ],
    "cyp_enzymes": [],
    "search_name": "Amyl nitrite"
  },
  {
    "kegg_id": "D03328",
    "name_en": "Carperitide (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Carperitide (genetical recombination) (JAN)",
      "Hanp (TN)"
    ],
    "formula": "C127H203N45O39S3",
    "efficacy": "Vasodilator, Atrial natriuretic peptide receptor agonist",
    "target": "NPR1 [HSA:4881] [KO:K12323]\nPATHWAY   hsa04022(4881)  cGMP-PKG signaling pathway\nhsa04024(4881)  cAMP signaling pathway\nhsa04270(4881)  Vascular smooth muscle contraction",
    "metabolism": "",
    "therapeutic_category": "2179",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Carperitide"
  },
  {
    "kegg_id": "D00279",
    "name_en": "Clofibrate (JP18/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Atromid-S (TN)"
    ],
    "formula": "C12H15ClO3",
    "efficacy": "Antihyperlipidemic, Triglyceride synthesis inhibitor, Peroxisome proliferator-activated receptor (PPAR) alpha agonist",
    "target": "NR1C1 (PPARA) [HSA:5465] [KO:K07294]\nPATHWAY   hsa03320(5465)  PPAR signaling pathway\nhsa04920(5465)  Adipocytokine signaling pathway",
    "metabolism": "",
    "therapeutic_category": "2183",
    "atc_code": "C10AB01",
    "drug_class": [
      "Hypolipidemic agent",
      "Hypolipidemic agent",
      "PPAR alpha agonist",
      "Fibrate"
    ],
    "cyp_enzymes": [],
    "search_name": "Clofibrate"
  },
  {
    "kegg_id": "D01366",
    "name_en": "Bezafibrate (JP18/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Bezatol SR (TN)"
    ],
    "formula": "C19H20ClNO4",
    "efficacy": "Antihyperlipidemic, Triglyceride synthesis inhibitor, Peroxisome proliferator-activated receptor (PPAR) alpha agonist",
    "target": "NR1C1 (PPARA) [HSA:5465] [KO:K07294]\nPATHWAY   hsa03320(5465)  PPAR signaling pathway\nhsa04920(5465)  Adipocytokine signaling pathway",
    "metabolism": "",
    "therapeutic_category": "2183",
    "atc_code": "C10AB02",
    "drug_class": [
      "Hypolipidemic agent",
      "Hypolipidemic agent",
      "PPAR alpha agonist",
      "Fibrate"
    ],
    "cyp_enzymes": [],
    "search_name": "Bezafibrate"
  },
  {
    "kegg_id": "D00565",
    "name_en": "Fenofibrate (JP18/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Antara (TN)",
      "Lipantil (TN)",
      "Lipofen (TN)",
      "Tricor (TN)",
      "Triglide (TN)"
    ],
    "formula": "C20H21ClO4",
    "efficacy": "Antihyperlipidemic, Triglyceride synthesis inhibitor, Peroxisome proliferator-activated receptor (PPAR) alpha agonist\nDISEASE   Primary hypercholesterolemia or mixed dyslipidemia [DS:H01635]\nHypertriglyceridemia [DS:H01637]",
    "target": "NR1C1 (PPARA) [HSA:5465] [KO:K07294]\nPATHWAY   hsa03320(5465)  PPAR signaling pathway\nhsa04920(5465)  Adipocytokine signaling pathway",
    "metabolism": "Enzyme: UGT [KO:K00699]",
    "therapeutic_category": "2183",
    "atc_code": "C10AB05",
    "drug_class": [
      "Hypolipidemic agent",
      "Hypolipidemic agent",
      "PPAR alpha agonist",
      "Fibrate",
      "Metabolizing enzyme substrate",
      "UGT substrate"
    ],
    "cyp_enzymes": [],
    "search_name": "Fenofibrate"
  },
  {
    "kegg_id": "D10711",
    "name_en": "Pemafibrate (JAN)",
    "name_ja": "",
    "names_alt": [
      "Parmodia (TN)"
    ],
    "formula": "C28H30N2O6",
    "efficacy": "Antihyperlipidemic, Triglyceride synthesis inhibitor, Peroxisome proliferator-activated receptor (PPAR) alpha agonist",
    "target": "NR1C1 (PPARA) [HSA:5465] [KO:K07294]",
    "metabolism": "Enzyme: CYP3A [HSA:1576 1577 1551], CYP2C9 [HSA:1559], CYP2C8 [HSA:1558]\nTransporter: SLCO1B1 [HSA:10599], SLCO1B3 [HSA:28234]",
    "therapeutic_category": "2183",
    "atc_code": "C10AB12",
    "drug_class": [
      "Hypolipidemic agent",
      "Hypolipidemic agent",
      "PPAR alpha agonist",
      "Fibrate",
      "Metabolizing enzyme substrate",
      "CYP2C8 substrate",
      "CYP2C9 substrate",
      "CYP3A/CYP3A4 substrate",
      "Transporter substrate",
      "SLCO1B1 substrate",
      "SLCO1B3 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C9",
      "CYP2C8",
      "CYP3A"
    ],
    "search_name": "Pemafibrate"
  },
  {
    "kegg_id": "D04267",
    "name_en": "Polyenephosphatidyl choline (JAN)",
    "name_ja": "",
    "names_alt": [
      "EPL (TN)"
    ],
    "formula": "",
    "efficacy": "Antihyperlipidemic, Cholesterol catabolism enhancer",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2189",
    "atc_code": "A05BA10",
    "drug_class": [
      "Hypolipidemic agent",
      "Hypolipidemic agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Polyenephosphatidyl choline"
  },
  {
    "kegg_id": "D03343",
    "name_en": "Dextran sulfate sodium sulfur 5 (JP18)",
    "name_ja": "",
    "names_alt": [
      "Dextran sulfate sodium sulfur 18 (JP18)",
      "MDS (TN)"
    ],
    "formula": "",
    "efficacy": "Antidyslipidemia (hypertriglyceridemic), Lipoprotein lipase (LPL) activator",
    "target": "LPL [HSA:4023] [KO:K01059]\nLIPC [HSA:3990] [KO:K22283]\nPATHWAY   hsa00561(3990+4023)  Glycerolipid metabolism\nhsa03320(4023)  PPAR signaling pathway\nhsa04979(3990+4023)  Cholesterol metabolism",
    "metabolism": "",
    "therapeutic_category": "2189",
    "atc_code": "B05AA05",
    "drug_class": [
      "Hypolipidemic agent",
      "Hypolipidemic agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Dextran sulfate sodium sulfur 5"
  },
  {
    "kegg_id": "D00434",
    "name_en": "Simvastatin (JP18/USP/INN)",
    "name_ja": "シンバスタチン",
    "names_alt": [
      "MK-733",
      "Zocor (TN)"
    ],
    "formula": "C25H38O5",
    "efficacy": "Antihyperlipidemic, HMG-CoA reductase inhibitor\nDISEASE   Hyperlipidemia [DS:H01635]\nHeterozygous familial hypercholesterolemia [DS:H00155]",
    "target": "HMGCR [HSA:3156] [KO:K00021]\nPATHWAY   hsa00900(3156)  Terpenoid backbone biosynthesis",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]\nTransporter: SLCO1B1 [HSA:10599], ABCG2 [HSA:9429]",
    "therapeutic_category": "2189",
    "atc_code": "C10AA01",
    "drug_class": [
      "Hypolipidemic agent",
      "Hypolipidemic agent",
      "HMG-CoA reductase inhibitor",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "Transporter substrate",
      "ABCG2 substrate",
      "SLCO1B1 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Simvastatin"
  },
  {
    "kegg_id": "D00893",
    "name_en": "Pravastatin sodium (JP18/USP)",
    "name_ja": "プラバスタチン",
    "names_alt": [
      "CS-514",
      "Pravachol (TN)"
    ],
    "formula": "C23H35O7. Na",
    "efficacy": "Antihyperlipidemic, HMG-CoA reductase inhibitor\nDISEASE   Hyperlipidemia [DS:H01635 H00155]",
    "target": "HMGCR [HSA:3156] [KO:K00021]\nPATHWAY   hsa00900(3156)  Terpenoid backbone biosynthesis\nhsa04976(3156)  Bile secretion",
    "metabolism": "Transporter: ABCC2 [HSA:1244], SLCO1B1 [HSA:10599], SLCO2B1 [HSA:11309]",
    "therapeutic_category": "2189",
    "atc_code": "C10AA03",
    "drug_class": [
      "Hypolipidemic agent",
      "Hypolipidemic agent",
      "HMG-CoA reductase inhibitor",
      "Transporter substrate",
      "ABCC2 substrate",
      "SLCO1B1 substrate",
      "SLCO2B1 substrate"
    ],
    "cyp_enzymes": [],
    "search_name": "Pravastatin sodium"
  },
  {
    "kegg_id": "D00892",
    "name_en": "Fluvastatin sodium (JAN/USP)",
    "name_ja": "フルバスタチン",
    "names_alt": [
      "Lescol (TN)"
    ],
    "formula": "C24H25FNO4. Na",
    "efficacy": "Antihyperlipidemic, HMG-CoA reductase inhibitor\nDISEASE   Hypercholesterolemia (Heterozygous familial) [DS:H00155]\nMixed dyslipidemia [DS:H01635]",
    "target": "HMGCR [HSA:3156] [KO:K00021]\nPATHWAY   hsa00900(3156)  Terpenoid backbone biosynthesis",
    "metabolism": "Enzyme: CYP2C9 [HSA:1559], CYP3A4 [HSA:1576]\nTransporter: SLCO1B1 [HSA:10599]",
    "therapeutic_category": "2189",
    "atc_code": "C10AA04",
    "drug_class": [
      "Hypolipidemic agent",
      "Hypolipidemic agent",
      "HMG-CoA reductase inhibitor",
      "Metabolizing enzyme substrate",
      "CYP2C9 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "Metabolizing enzyme inhibitor",
      "CYP2C9 inhibitor",
      "Transporter substrate",
      "SLCO1B1 substrate",
      "Transporter inhibitor",
      "ABCB11 inhibitor"
    ],
    "cyp_enzymes": [
      "CYP2C9",
      "CYP3A4"
    ],
    "search_name": "Fluvastatin sodium"
  },
  {
    "kegg_id": "D02258",
    "name_en": "Atorvastatin calcium (USP)",
    "name_ja": "アトルバスタチン",
    "names_alt": [
      "Atorvastatin calcium hydrate (JP18)",
      "Atorvastatin calcium trihydrate",
      "Atorvaliq (TN)",
      "Lipitor (TN)"
    ],
    "formula": "(C33H34FN2O5)2. 3H2O. Ca",
    "efficacy": "Antihyperlipidemic, HMG-CoA reductase inhibitor\nDISEASE   Hyperlipidemia [DS:H01635]\nHypercholesterolemia [DS:H00155]\nMyocardial infarction [DS:H01730]\nAngina [DS:H01632]",
    "target": "HMGCR [HSA:3156] [KO:K00021]\nPATHWAY   hsa00900(3156)  Terpenoid backbone biosynthesis",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]\nTransporter: ABCB1 [HSA:5243], ABCG2 [HSA:9429], SLCO1B1 [HSA:10599], SLCO1B3 [HSA:28234]",
    "therapeutic_category": "2189",
    "atc_code": "C10AA05",
    "drug_class": [
      "Hypolipidemic agent",
      "Hypolipidemic agent",
      "HMG-CoA reductase inhibitor",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "Transporter substrate",
      "ABCB1 substrate",
      "ABCG2 substrate",
      "SLCO1B1 substrate",
      "SLCO1B3 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Atorvastatin calcium"
  },
  {
    "kegg_id": "D01915",
    "name_en": "Rosuvastatin calcium (JP18/USP)",
    "name_ja": "ロスバスタチン",
    "names_alt": [
      "ZD 4522",
      "Crestor (TN)"
    ],
    "formula": "(C22H27FN3O6S)2. Ca",
    "efficacy": "Antihyperlipidemic, HMG-CoA reductase inhibitor\nDISEASE   Hypertriglyceridemia [DS:H01637]\nPrimary dysbetalipoproteinemia; type III hyperlipoproteinemia [DS:H01637]\nHomozygous familial hypercholesterolemia [DS:H00155]",
    "target": "HMGCR [HSA:3156] [KO:K00021]\nPATHWAY   hsa00900(3156)  Terpenoid backbone biosynthesis",
    "metabolism": "Transporter: SLCO1B1 [HSA:10599], ABCG2 [HSA:9429]",
    "therapeutic_category": "2189",
    "atc_code": "C10AA07",
    "drug_class": [
      "Hypolipidemic agent",
      "Hypolipidemic agent",
      "HMG-CoA reductase inhibitor",
      "Transporter substrate",
      "ABCG2 substrate",
      "SLCO1B1 substrate"
    ],
    "cyp_enzymes": [],
    "search_name": "Rosuvastatin calcium"
  },
  {
    "kegg_id": "D10568",
    "name_en": "Pitavastatin calcium hydrate (JP18)",
    "name_ja": "ピタバスタチン",
    "names_alt": [
      "Pitabastatin calcium pentahydrate",
      "Livalo (TN)"
    ],
    "formula": "(C25H23FNO4)2. 5H2O. Ca",
    "efficacy": "Antihyperlipidemic, HMG-CoA reductase inhibitor",
    "target": "HMGCR [HSA:3156] [KO:K00021]\nPATHWAY   hsa00900(3156)  Terpenoid backbone biosynthesis",
    "metabolism": "Enzyme: CYP2C9 [HSA:1559]",
    "therapeutic_category": "2189",
    "atc_code": "C10AA08",
    "drug_class": [
      "Hypolipidemic agent",
      "Hypolipidemic agent",
      "HMG-CoA reductase inhibitor",
      "Metabolizing enzyme substrate",
      "CYP2C9 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C9"
    ],
    "search_name": "Pitavastatin calcium hydrate"
  },
  {
    "kegg_id": "D02690",
    "name_en": "Cholestyramine resin (USP)",
    "name_ja": "",
    "names_alt": [
      "Colestyramine (JAN/INN)",
      "Questran (TN)"
    ],
    "formula": "(C12H18N. Cl)n",
    "efficacy": "Antihyperlipidemic, Bile acid sequestrant, Remover (active metabolite of leflunomide)\nDISEASE   Hypercholesterolemia [DS:H01635]",
    "target": "Bile acid [CPD:C01558]",
    "metabolism": "",
    "therapeutic_category": "2189",
    "atc_code": "C10AC01",
    "drug_class": [
      "Hypolipidemic agent",
      "Hypolipidemic agent",
      "Bile acid sequestrant"
    ],
    "cyp_enzymes": [],
    "search_name": "Cholestyramine resin"
  },
  {
    "kegg_id": "D00476",
    "name_en": "Probucol (JP18/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Lorelco (TN)"
    ],
    "formula": "C31H48O2S2",
    "efficacy": "Antihyperlipidemic, Cholesterol catabolism enhancer",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2189",
    "atc_code": "C10AX02",
    "drug_class": [
      "Hypolipidemic agent",
      "Hypolipidemic agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Probucol"
  },
  {
    "kegg_id": "D05255",
    "name_en": "Omega-3-acid ethyl esters (USP)",
    "name_ja": "",
    "names_alt": [
      "Omacor (TN)"
    ],
    "formula": "",
    "efficacy": "Antihyperlipidemic, Triglyceride synthesis inhibitor, Lipoprotein lipase (LPL) activator, Cholesteryl ester transfer protein inhibitor\nDISEASE   Hypertriglyceridemia [DS:H01637]",
    "target": "LPL [HSA:4023] [KO:K01059]\nCETP [HSA:1071] [KO:K16835]\nPATHWAY   hsa00561(4023)  Glycerolipid metabolism\nhsa03320(4023)  PPAR signaling pathway\nhsa04979(1071+4023)  Cholesterol metabolism",
    "metabolism": "",
    "therapeutic_category": "2189",
    "atc_code": "C10AX06",
    "drug_class": [
      "Hypolipidemic agent",
      "Hypolipidemic agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Omega-3-acid ethyl esters"
  },
  {
    "kegg_id": "D01966",
    "name_en": "Ezetimibe (JAN/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Zetia (TN)"
    ],
    "formula": "C24H21F2NO3",
    "efficacy": "Antihyperlipidemic, Cholesterol absorption inhibitor\nDISEASE   Hyperlipidemia [DS:H01635]\nHomozygous familial hypercholesterolemia [DS:H00155]\nHomozygous sitosterolemia [DS:H00152]",
    "target": "NPC1L1 [HSA:29881] [KO:K14461]\nPATHWAY   hsa04975(29881)  Fat digestion and absorption",
    "metabolism": "Enzyme: UGT1A1 [HSA:54658], UGT1A3 [HSA:54659], UGT2B15 [HSA:7366]\nTransporter: ABCB1 [HSA:5243]",
    "therapeutic_category": "2189",
    "atc_code": "C10AX09",
    "drug_class": [
      "Hypolipidemic agent",
      "Hypolipidemic agent",
      "Metabolizing enzyme substrate",
      "UGT substrate",
      "UGT1A1 substrate",
      "UGT1A3 substrate",
      "UGT2B15 substrate",
      "Transporter substrate",
      "ABCB1 substrate"
    ],
    "cyp_enzymes": [],
    "search_name": "Ezetimibe"
  },
  {
    "kegg_id": "D09638",
    "name_en": "Lomitapide mesylate (USAN)",
    "name_ja": "",
    "names_alt": [
      "Lomitapide mesilate (JAN)",
      "Juxtapid (TN)",
      "Lojuxta (TN)"
    ],
    "formula": "C39H37F6N3O2. CH4SO3",
    "efficacy": "Antihyperlipidemic, Microsomal triglyceride transfer protein (MTTP) inhibitor\nDISEASE   Homozygous familial hypercholesterolemia [DS:H00155]",
    "target": "MTTP [HSA:4547] [KO:K14463]\nPATHWAY   hsa04975(4547)  Fat digestion and absorption",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "2189",
    "atc_code": "C10AX12",
    "drug_class": [
      "Hypolipidemic agent",
      "Hypolipidemic agent",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Lomitapide mesylate"
  },
  {
    "kegg_id": "D10557",
    "name_en": "Evolocumab (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Evolocumab (genetical recombination) (JAN)",
      "Repatha (TN)"
    ],
    "formula": "C6242H9648N1668O1996S56",
    "efficacy": "Antihyperlipidemic, Anti-PCSK9 antibody\nDISEASE   Primary hyperlipidemia [DS:H01635]\nHomozygous familial hypercholesterolemia [DS:H00155]\nHeterozygous familial hypercholesterolemia [DS:H00155]\nTYPE      Monoclonal antibody",
    "target": "PCSK9 [HSA:255738] [KO:K13050]\nPATHWAY   hsa04979(255738)  Cholesterol metabolism",
    "metabolism": "",
    "therapeutic_category": "2189",
    "atc_code": "C10AX13",
    "drug_class": [
      "Hypolipidemic agent",
      "Hypolipidemic agent",
      "Anti-PCSK9 antibody and siRNA"
    ],
    "cyp_enzymes": [],
    "search_name": "Evolocumab"
  },
  {
    "kegg_id": "D10691",
    "name_en": "Bempedoic acid (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Nexletol (TN)"
    ],
    "formula": "C19H36O5",
    "efficacy": "Antidyslipidemia\nDISEASE   Heterozygous familial hypercholesterolemia [DS:H00155]",
    "target": "ACLY (ACL) [HSA:47] [KO:K01648]\nPATHWAY   hsa00020(47)  Citrate cycle (TCA cycle)",
    "metabolism": "",
    "therapeutic_category": "2189",
    "atc_code": "C10AX15",
    "drug_class": [
      "Hypolipidemic agent",
      "Hypolipidemic agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Bempedoic acid"
  },
  {
    "kegg_id": "D12293",
    "name_en": "Inclisiran sodium (JAN)",
    "name_ja": "",
    "names_alt": [
      "Leqvio (TN)"
    ],
    "formula": "C529H664F12N176O316P43S6. 43Na",
    "efficacy": "Antihyperlipidemic, Translation inhibitor\nDISEASE   Heterozygous familial hypercholesterolemia [DS:H00155]\nAtherosclerotic cardiovascular disease [DS:H02505]\nTYPE      RNA interference (RNAi) drug",
    "target": "PCSK9 [HSA:255738] [KO:K13050] (mRNA)\nPATHWAY   hsa04979(255738)  Cholesterol metabolism",
    "metabolism": "",
    "therapeutic_category": "2189",
    "atc_code": "C10AX16",
    "drug_class": [
      "Hypolipidemic agent",
      "Hypolipidemic agent",
      "Anti-PCSK9 antibody and siRNA"
    ],
    "cyp_enzymes": [],
    "search_name": "Inclisiran sodium"
  },
  {
    "kegg_id": "D11753",
    "name_en": "Evinacumab (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Evinacumab (genetical recombination) (JAN)",
      "Evinacumab-dgnb",
      "Evkeeza (TN)"
    ],
    "formula": "C6480H9992N1716O2042S46",
    "efficacy": "Antihyperlipidemic, Anti-angiopietin like 3 antibody\nDISEASE   Homozygous familial hypercholesterolemia [DS:H00155]\nTYPE      Monoclonal antibody",
    "target": "ANGPTL3 [HSA:27329] [KO:K22288]\nPATHWAY   hsa04979(27329)  Cholesterol metabolism",
    "metabolism": "",
    "therapeutic_category": "2189",
    "atc_code": "C10AX17",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Evinacumab"
  },
  {
    "kegg_id": "D10385",
    "name_en": "Ezetimibe and atorvastatin",
    "name_ja": "",
    "names_alt": [
      "Atozet (TN)",
      "Liptruzet (TN)"
    ],
    "formula": "",
    "efficacy": "Antihyperlipidemic",
    "target": "",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "2189",
    "atc_code": "C10BA05",
    "drug_class": [
      "Hypolipidemic agent",
      "Hypolipidemic agent",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Ezetimibe and atorvastatin"
  },
  {
    "kegg_id": "D12438",
    "name_en": "Pitavastatin calcium and ezetimibe",
    "name_ja": "ピタバスタチン",
    "names_alt": [
      "Livazebe (TN)"
    ],
    "formula": "",
    "efficacy": "Antihyperlipidemic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2189",
    "atc_code": "C10BA13",
    "drug_class": [
      "Hypolipidemic agent",
      "Hypolipidemic agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Pitavastatin calcium and ezetimibe"
  },
  {
    "kegg_id": "D01934",
    "name_en": "Colestilan chloride (USAN)",
    "name_ja": "",
    "names_alt": [
      "Colestilan (INN)",
      "Colestimide (JP18)",
      "Cholebine (TN)"
    ],
    "formula": "(C7H13N2O. Cl)n",
    "efficacy": "Antihyperlipidemic, Bile acid sequestrant",
    "target": "Bile acid [CPD:C01558]",
    "metabolism": "",
    "therapeutic_category": "2189",
    "atc_code": "V03AE06",
    "drug_class": [
      "Hypolipidemic agent",
      "Hypolipidemic agent",
      "Bile acid sequestrant"
    ],
    "cyp_enzymes": [],
    "search_name": "Colestilan chloride"
  },
  {
    "kegg_id": "D01291",
    "name_en": "Nicomol (JP18/INN)",
    "name_ja": "",
    "names_alt": [
      "Cholexamin (TN)"
    ],
    "formula": "C34H32N4O9",
    "efficacy": "Antihyperlipidemic, Vasodilator",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2189",
    "atc_code": "",
    "drug_class": [
      "Hypolipidemic agent",
      "Hypolipidemic agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Nicomol"
  },
  {
    "kegg_id": "D01892",
    "name_en": "Icosapent ethyl (USAN)",
    "name_ja": "",
    "names_alt": [
      "Ethyl icosapentate (JP18)",
      "Epadel S (TN)",
      "Vascepa (TN)"
    ],
    "formula": "C22H34O2",
    "efficacy": "Antihyperlipidemic, Platelet aggregation inhibitor\nDISEASE   Hypertriglyceridemia [DS:H01637]",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2189",
    "atc_code": "",
    "drug_class": [
      "Hypolipidemic agent",
      "Hypolipidemic agent",
      "Blood modifier agent",
      "Antithrombotic agent",
      "Antiplatelet agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Icosapent ethyl"
  },
  {
    "kegg_id": "D04268",
    "name_en": "Elastase ES",
    "name_ja": "",
    "names_alt": [
      "Elaszym (TN)"
    ],
    "formula": "",
    "efficacy": "Antihyperlipidemic, Cholesterol catabolism enhancer, Lipoprotein lipase (LPL) activator, Lecithin-cholesterol acyltransferase (LCAT) activator",
    "target": "LPL [HSA:4023] [KO:K01059]\nLCAT [HSA:3931] [KO:K00650]\nPATHWAY   hsa00561(4023)  Glycerolipid metabolism\nhsa03320(4023)  PPAR signaling pathway\nhsa04979(3931+4023)  Cholesterol metabolism",
    "metabolism": "",
    "therapeutic_category": "2189",
    "atc_code": "",
    "drug_class": [
      "Hypolipidemic agent",
      "Hypolipidemic agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Elastase ES"
  },
  {
    "kegg_id": "D11520",
    "name_en": "Ezetimibe and rosuvastatin",
    "name_ja": "",
    "names_alt": [
      "Roszet (TN)",
      "Rosuzet (TN)"
    ],
    "formula": "",
    "efficacy": "Antihyperlipidemic\nDISEASE   Hyperlipidemia [DS:H01635]\nHomozygous familial hypercholesterolemia [DS:H00155]",
    "target": "",
    "metabolism": "Enzyme: UGT [KO:K00699]\nTransporter: SLCO1B1 [HSA:10599], ABCG2 [HSA:9429]",
    "therapeutic_category": "2189",
    "atc_code": "",
    "drug_class": [
      "Hypolipidemic agent",
      "Hypolipidemic agent",
      "Metabolizing enzyme substrate",
      "UGT substrate",
      "Transporter substrate",
      "ABCG2 substrate",
      "SLCO1B1 substrate"
    ],
    "cyp_enzymes": [],
    "search_name": "Ezetimibe and rosuvastatin"
  },
  {
    "kegg_id": "D00932",
    "name_en": "Calcium carbonate (USP)",
    "name_ja": "�ite酸カルシウム",
    "names_alt": [
      "Precipitated calcium carbonate (JP18)",
      "Cal-sup (TN)"
    ],
    "formula": "CO3. Ca",
    "efficacy": "Antacid, Antihyperphosphatemic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2190",
    "atc_code": "A02AC01",
    "drug_class": [
      "Gastrointestinal agent",
      "Agents for peptic ulcer",
      "Antacid",
      "Calcium"
    ],
    "cyp_enzymes": [],
    "search_name": "Calcium carbonate"
  },
  {
    "kegg_id": "D00062",
    "name_en": "Mannitol (USP)",
    "name_ja": "",
    "names_alt": [
      "D-Mannitol (JP18)",
      "Osmitrol (TN)",
      "Tobrex (TN)",
      "Bronchitol (TN)"
    ],
    "formula": "C6H14O6",
    "efficacy": "Antihypertensive (intracranial, intraocular), Diagnostic aid (renal function determination), Diuretic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2190",
    "atc_code": "A06AD16",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Mannitol"
  },
  {
    "kegg_id": "D11653",
    "name_en": "Tenapanor hydrochloride (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Ibsrela (TN)",
      "Phozevel (TN)",
      "Xphozah (TN)"
    ],
    "formula": "C50H66Cl4N8O10S2. 2HCl",
    "efficacy": "Constipation-related diseases agent, Sodium/hydrogen exchanger 3 inhibitor\nDISEASE   Irritable bowel syndrome with constipation [DS:H01615]",
    "target": "SLC9A3 (NHE3) [HSA:6550] [KO:K12040]\nPATHWAY   hsa04978(6550)  Mineral absorption",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576], CYP3A5 [HSA:1577]",
    "therapeutic_category": "2190",
    "atc_code": "A06AX08",
    "drug_class": [
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "CYP3A5 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4",
      "CYP3A5"
    ],
    "search_name": "Tenapanor hydrochloride"
  },
  {
    "kegg_id": "D09763",
    "name_en": "Dapagliflozin propanediol (USAN)",
    "name_ja": "",
    "names_alt": [
      "Dapagliflozin propylene glycolate hydrate (JAN)",
      "Dapagliflozin propandiol monohydrate",
      "Forxiga (TN)",
      "Farxiga (TN)"
    ],
    "formula": "C21H25ClO6. C3H8O2. H2O",
    "efficacy": "Antidiabetic, SGLT-2 inhibitor\nDISEASE   Type 2 diabetes mellitus [DS:H00409]",
    "target": "SLC5A2 (SGLT2) [HSA:6524] [KO:K14382]",
    "metabolism": "Enzyme: UGT1A9 [HSA:54600]",
    "therapeutic_category": "2190",
    "atc_code": "A10BK01",
    "drug_class": [
      "Antidiabetic agent",
      "Hypoglycemic agent",
      "SGLT2 inhibitor",
      "Metabolizing enzyme substrate",
      "UGT substrate",
      "UGT1A9 substrate"
    ],
    "cyp_enzymes": [],
    "search_name": "Dapagliflozin propanediol"
  },
  {
    "kegg_id": "D10459",
    "name_en": "Empagliflozin (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Jardiance (TN)"
    ],
    "formula": "C23H27ClO7",
    "efficacy": "Antidiabetic, SGLT-2 inhibitor\nDISEASE   Type 2 diabetes mellitus [DS:H00409]",
    "target": "SLC5A2 (SGLT2) [HSA:6524] [KO:K14382]",
    "metabolism": "Enzyme: UGT2B7 [HSA:7364], UGT1A3 [HSA:54659], UGT1A8 [HSA:54576], UGT1A9 [HSA:54600]\nTransporter: ABCB1 [HSA:5243], ABCG2 [HSA:9429]",
    "therapeutic_category": "2190",
    "atc_code": "A10BK03",
    "drug_class": [
      "Antidiabetic agent",
      "Hypoglycemic agent",
      "SGLT2 inhibitor",
      "Metabolizing enzyme substrate",
      "UGT substrate",
      "UGT1A3 substrate",
      "UGT1A8 substrate",
      "UGT1A9 substrate",
      "UGT2B7 substrate",
      "Transporter substrate",
      "ABCB1 substrate",
      "ABCG2 substrate"
    ],
    "cyp_enzymes": [],
    "search_name": "Empagliflozin"
  },
  {
    "kegg_id": "D01530",
    "name_en": "Tocopherol nicotinate (JP18)",
    "name_ja": "",
    "names_alt": [
      "dl-alpha-Tocopherol nicotinate",
      "Juvela nicotinate (TN)"
    ],
    "formula": "C35H53NO3",
    "efficacy": "Microcirculation sysutem activator, Supplement (vitamin E)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2190",
    "atc_code": "A11HA03",
    "drug_class": [
      "Hypolipidemic agent",
      "Hypolipidemic agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Tocopherol nicotinate"
  },
  {
    "kegg_id": "D01337",
    "name_en": "Epoprostenol sodium (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Flolan (TN)",
      "Veletri (TN)"
    ],
    "formula": "C20H31O5. Na",
    "efficacy": "Antihypertensive, Platelet aggregation inhibitor, Prostaglandin I2 receptor agonist\nDISEASE   Pulmonary arterial hypertension [DS:H01621]",
    "target": "PTGIR [HSA:5739] [KO:K04263]\nPATHWAY   hsa04080(5739)  Neuroactive ligand-receptor interaction\nhsa04270(5739)  Vascular smooth muscle contraction\nhsa04611(5739)  Platelet activation",
    "metabolism": "",
    "therapeutic_category": "2190",
    "atc_code": "B01AC09",
    "drug_class": [
      "Blood modifier agent",
      "Antithrombotic agent",
      "Antiplatelet agent",
      "Hormonal agent",
      "Prostaglandin derivative",
      "Prostacycline derivative"
    ],
    "cyp_enzymes": [],
    "search_name": "Epoprostenol sodium"
  },
  {
    "kegg_id": "D01551",
    "name_en": "Beraprost sodium (JP18/USAN)",
    "name_ja": "",
    "names_alt": [
      "Procylin (TN)"
    ],
    "formula": "C24H29O5. Na",
    "efficacy": "Antihypertensive, Platelet aggregation inhibitor, Prostaglandin I2 receptor agonist",
    "target": "PTGIR [HSA:5739] [KO:K04263]\nPATHWAY   hsa04080(5739)  Neuroactive ligand-receptor interaction\nhsa04270(5739)  Vascular smooth muscle contraction\nhsa04611(5739)  Platelet activation",
    "metabolism": "",
    "therapeutic_category": "2190",
    "atc_code": "B01AC19",
    "drug_class": [
      "Blood modifier agent",
      "Antithrombotic agent",
      "Antiplatelet agent",
      "Hormonal agent",
      "Prostaglandin derivative",
      "Prostacycline derivative"
    ],
    "cyp_enzymes": [],
    "search_name": "Beraprost sodium"
  },
  {
    "kegg_id": "D06213",
    "name_en": "Treprostinil (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Remodulin (TN)"
    ],
    "formula": "C23H34O5",
    "efficacy": "Anticoagulant, Antihypertensive, Vasodilator, Platelet aggregation inhibitor, Prostaglandin I2 receptor agonist\nDISEASE   Pulmonary arterial hypertension [DS:H01621]",
    "target": "PTGIR [HSA:5739] [KO:K04263]\nPATHWAY   hsa04080(5739)  Neuroactive ligand-receptor interaction\nhsa04270(5739)  Vascular smooth muscle contraction\nhsa04611(5739)  Platelet activation",
    "metabolism": "Enzyme: CYP2C8 [HSA:1558]",
    "therapeutic_category": "2190",
    "atc_code": "B01AC21",
    "drug_class": [
      "Blood modifier agent",
      "Antithrombotic agent",
      "Antiplatelet agent",
      "Hormonal agent",
      "Prostaglandin derivative",
      "Prostacycline derivative",
      "Metabolizing enzyme substrate",
      "CYP2C8 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C8"
    ],
    "search_name": "Treprostinil"
  },
  {
    "kegg_id": "D09994",
    "name_en": "Selexipag (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Uptravi (TN)"
    ],
    "formula": "C26H32N4O4S",
    "efficacy": "Antihypertensive, Vasodilator, Prostaglandin I2 receptor agonist\nDISEASE   Pulmonary arterial hypertension [DS:H01621]",
    "target": "PTGIR [HSA:5739] [KO:K04263]\nPATHWAY   hsa04080(5739)  Neuroactive ligand-receptor interaction\nhsa04270(5739)  Vascular smooth muscle contraction\nhsa04611(5739)  Platelet activation",
    "metabolism": "Enzyme: CYP2C8 [HSA:1558], CYP3A4 [HSA:1576], UGT1A3 [HSA:54659], UGT2B7 [HSA:7364]",
    "therapeutic_category": "2190",
    "atc_code": "B01AC27",
    "drug_class": [
      "Blood modifier agent",
      "Antithrombotic agent",
      "Antiplatelet agent",
      "Metabolizing enzyme substrate",
      "CYP2C8 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "UGT substrate",
      "UGT1A3 substrate",
      "UGT2B7 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C8",
      "CYP3A4"
    ],
    "search_name": "Selexipag"
  },
  {
    "kegg_id": "D02860",
    "name_en": "Limaprost alfadex (JP18)",
    "name_ja": "",
    "names_alt": [
      "Opalmon (TN)"
    ],
    "formula": "(C36H60O30)x. C22H36O5",
    "efficacy": "Platelet aggregation inhibitor, Vasodilator, Prostaglandin E1 receptor agonist",
    "target": "PTGER1 [HSA:5731] [KO:K04258]\nPATHWAY   hsa04020(5731)  Calcium signaling pathway\nhsa04080(5731)  Neuroactive ligand-receptor interaction",
    "metabolism": "",
    "therapeutic_category": "2190",
    "atc_code": "B01AC28",
    "drug_class": [
      "Blood modifier agent",
      "Antithrombotic agent",
      "Antiplatelet agent",
      "Hormonal agent",
      "Prostaglandin derivative",
      "Prostaglandin E1 derivative"
    ],
    "cyp_enzymes": [],
    "search_name": "Limaprost alfadex"
  },
  {
    "kegg_id": "D00181",
    "name_en": "Argatroban (USP)",
    "name_ja": "",
    "names_alt": [
      "Argatroban hydrate (JP18)",
      "Novastan (TN)"
    ],
    "formula": "C23H36N6O5S. H2O",
    "efficacy": "Anticoagulant, Thrombin inhibitor",
    "target": "F2a [CPD:C00752] [HSA:2147] [KO:K01313]\nPATHWAY   hsa04610(2147+C00752)  Complement and coagulation cascades\nhsa04611(2147)  Platelet activation\nNETWORK   nt06514  Coagulation cascade",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "2190",
    "atc_code": "B01AE03",
    "drug_class": [
      "Blood modifier agent",
      "Antithrombotic agent",
      "Thrombin inhibitor",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Argatroban"
  },
  {
    "kegg_id": "D04616",
    "name_en": "Iron sucrose (USP)",
    "name_ja": "",
    "names_alt": [
      "Ferric oxide, saccharated",
      "Sucroferric oxyhydroxide",
      "Venofer (TN)",
      "Velphoro (TN)"
    ],
    "formula": "",
    "efficacy": "Anti-anemic, Hematinic, Supplement (iron)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2190",
    "atc_code": "B03AB02",
    "drug_class": [
      "Blood modifier agent",
      "Iron preparation"
    ],
    "cyp_enzymes": [],
    "search_name": "Iron sucrose"
  },
  {
    "kegg_id": "D01304",
    "name_en": "Amezinium metilsulfate (JAN)",
    "name_ja": "",
    "names_alt": [
      "Risumic (TN)"
    ],
    "formula": "C11H12N3O. CH3SO4",
    "efficacy": "Antihypotensive, Noradrenaline reuptake inhibitor",
    "target": "SLC6A2 (NAT1) [HSA:6530] [KO:K05035]\nPATHWAY   hsa04721(6530)  Synaptic vesicle cycle",
    "metabolism": "",
    "therapeutic_category": "2190",
    "atc_code": "C01CA25",
    "drug_class": [
      "Cardiovascular agent",
      "Cardiotonic"
    ],
    "cyp_enzymes": [],
    "search_name": "Amezinium metilsulfate"
  },
  {
    "kegg_id": "D11051",
    "name_en": "Vericiguat (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Verquvo (TN)"
    ],
    "formula": "C19H16F2N8O2",
    "efficacy": "Vasodilator, Guanylate cyclase activator",
    "target": "GUCY1A [HSA:2977 2982] [KO:K12318]\nGUCY1B [HSA:2983] [KO:K12319]\nPATHWAY   hsa04270(2977+2982+2983)  Vascular smooth muscle contraction\nhsa04611(2977+2982+2983)  Platelet activation",
    "metabolism": "Enzyme: UGT1A9 [HSA:54600]; UGT1A1 [HSA:54658]",
    "therapeutic_category": "2190",
    "atc_code": "C01DX22",
    "drug_class": [
      "Cardiovascular agent",
      "Guanylate cyclase activator",
      "Metabolizing enzyme substrate",
      "UGT substrate",
      "UGT1A1 substrate",
      "UGT1A9 substrate"
    ],
    "cyp_enzymes": [],
    "search_name": "Vericiguat"
  },
  {
    "kegg_id": "D00180",
    "name_en": "Alprostadil (JP18/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Prostin VR pediatric (TN)",
      "Caverject (TN)",
      "Edex (TN)",
      "Muse (TN)"
    ],
    "formula": "C20H34O5",
    "efficacy": "Vasodilator, Prostaglandin E1 receptor agonist\nDISEASE   Pulmonary atresia [DS:H01802 H01803]\nTricuspid atresia [DS:H01785]\nTetralogy of Fallot [DS:H00549]",
    "target": "PTGER1 [HSA:5731] [KO:K04258]\nPATHWAY   hsa04020(5731)  Calcium signaling pathway\nhsa04080(5731)  Neuroactive ligand-receptor interaction",
    "metabolism": "",
    "therapeutic_category": "2190",
    "atc_code": "C01EA01",
    "drug_class": [
      "Hormonal agent",
      "Prostaglandin derivative",
      "Prostaglandin E1 derivative"
    ],
    "cyp_enzymes": [],
    "search_name": "Alprostadil"
  },
  {
    "kegg_id": "D02705",
    "name_en": "Alprostadil alfadex (JP18)",
    "name_ja": "",
    "names_alt": [
      "Tandetron (TN)",
      "Caverject (TN)"
    ],
    "formula": "(C36H60O30)x. C20H34O5",
    "efficacy": "Anti-ulcerative (skin), Vasodilator, Prostaglandin E1 receptor agonist",
    "target": "PTGER1 [HSA:5731] [KO:K04258]\nPATHWAY   hsa04020(5731)  Calcium signaling pathway\nhsa04080(5731)  Neuroactive ligand-receptor interaction",
    "metabolism": "",
    "therapeutic_category": "2190",
    "atc_code": "C01EA01",
    "drug_class": [
      "Hormonal agent",
      "Prostaglandin derivative",
      "Prostaglandin E1 derivative"
    ],
    "cyp_enzymes": [],
    "search_name": "Alprostadil alfadex"
  },
  {
    "kegg_id": "D02110",
    "name_en": "Indomethacin sodium (USP)",
    "name_ja": "インドメタシン",
    "names_alt": [
      "Indometacin sodium hydrate (JAN)",
      "Indomethacin sodium trihydrate",
      "Indometacin sodium",
      "Indocin I.V. (TN)"
    ],
    "formula": "C19H15ClNO4. 3H2O. Na",
    "efficacy": "Anti-inflammatory, Cardiovascular agent, COX inhibitor",
    "target": "PTGS1 (COX1) [HSA:5742] [KO:K00509]\nPTGS2 (COX2) [HSA:5743] [KO:K11987]\nPATHWAY   hsa00590(5742+5743)  Arachidonic acid metabolism",
    "metabolism": "",
    "therapeutic_category": "2190",
    "atc_code": "C01EB03",
    "drug_class": [
      "Anti-inflammatory",
      "Nonsteroidal anti-inflammatory drug (NSAID)",
      "Anti-inflammatory drug, acetic acid derivatives",
      "Anti-inflammatory drug, indoleacetic acid derivative"
    ],
    "cyp_enzymes": [],
    "search_name": "Indomethacin sodium"
  },
  {
    "kegg_id": "D06606",
    "name_en": "Ibuprofen lysine (USAN)",
    "name_ja": "イブプロフェン",
    "names_alt": [
      "Ibuprofen L-lysine (JAN)",
      "Solufenum",
      "Neoprofen (TN)"
    ],
    "formula": "C13H18O2. C6H14N2O2",
    "efficacy": "Anti-inflammatory, COX inhibitor\nDISEASE   Patent ductus arteriosus [DS:H01630]",
    "target": "PTGS1 (COX1) [HSA:5742] [KO:K00509]\nPTGS2 (COX2) [HSA:5743] [KO:K11987]\nPATHWAY   hsa00590(5742+5743)  Arachidonic acid metabolism",
    "metabolism": "Enzyme: CYP2C9 [HSA:1559]",
    "therapeutic_category": "2190",
    "atc_code": "C01EB16",
    "drug_class": [
      "Anti-inflammatory",
      "Nonsteroidal anti-inflammatory drug (NSAID)",
      "Anti-inflammatory drug, propionic acid derivative",
      "Metabolizing enzyme substrate",
      "CYP2C9 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C9"
    ],
    "search_name": "Ibuprofen lysine"
  },
  {
    "kegg_id": "D08095",
    "name_en": "Ivabradine hydrochloride (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Ivabrandine hydrochloride",
      "Corlanor (TN)",
      "Corlentor (TN)",
      "Coralan (TN)"
    ],
    "formula": "C27H36N2O5. HCl",
    "efficacy": "Cardiotonic, HCN channel blocker",
    "target": "HCN [HSA:348980 610 57657 10021] [KO:K04954 K04955 K04956 K04957]\nPATHWAY   hsa04024(10021+610)  cAMP signaling pathway",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "2190",
    "atc_code": "C01EB17",
    "drug_class": [
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Ivabradine hydrochloride"
  },
  {
    "kegg_id": "D12265",
    "name_en": "Mavacamten (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Camzyos (TN)"
    ],
    "formula": "C15H19N3O2",
    "efficacy": "beta-Cardiac myosin inhibitor\nDISEASE   Hypertrophic cardiomyopathy [DS:H00292]",
    "target": "MYH7 [HSA:4625] [KO:K17751]\nPATHWAY   hsa04022(4625)  cGMP-PKG signaling pathway\nhsa04260(4625)  Cardiac muscle contraction\nhsa04261(4625)  Adrenergic signaling in cardiomyocytes\nhsa05410(4625)  Hypertrophic cardiomyopathy",
    "metabolism": "Enzyme: CYP2C19 [HSA:1557]; CYP3A4 [HSA:1576], CYP2C9 [HSA:1559]",
    "therapeutic_category": "2190",
    "atc_code": "C01EB24",
    "drug_class": [
      "Metabolizing enzyme substrate",
      "CYP2C9 substrate",
      "CYP2C19 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C9",
      "CYP2C19",
      "CYP3A4"
    ],
    "search_name": "Mavacamten"
  },
  {
    "kegg_id": "D11973",
    "name_en": "Acoramidis hydrochloride (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Attruby (TN)",
      "Beyonttra (TN)"
    ],
    "formula": "C15H17FN2O3. HCl",
    "efficacy": "Amyloidogenesis suppressant\nDISEASE   Cardiomyopathy of transthyretin-mediated amyloidosis [DS:H00845]",
    "target": "TTR [HSA:7276] [KO:K20731]\nPATHWAY   hsa04918(7276)  Thyroid hormone synthesis",
    "metabolism": "Enzyme: UGT1A9 [HSA:54600], UGT1A1 [HSA:54658], UGT2B7 [HSA:7364]",
    "therapeutic_category": "2190",
    "atc_code": "C01EB25",
    "drug_class": [
      "Metabolizing enzyme substrate",
      "UGT substrate",
      "UGT1A1 substrate",
      "UGT1A9 substrate",
      "UGT2B7 substrate"
    ],
    "cyp_enzymes": [],
    "search_name": "Acoramidis hydrochloride"
  },
  {
    "kegg_id": "D00762",
    "name_en": "Metyrosine (USP)",
    "name_ja": "",
    "names_alt": [
      "Metirosine (JAN/INN)",
      "Demser (TN)"
    ],
    "formula": "C10H13NO3",
    "efficacy": "Antihypertensive, Tyrosine monooxygenase inhibitor",
    "target": "TH [HSA:7054] [KO:K00501]\nPATHWAY   hsa00350(7054)  Tyrosine metabolism",
    "metabolism": "",
    "therapeutic_category": "2190",
    "atc_code": "C02KB01",
    "drug_class": [
      "Cardiovascular agent",
      "Catecholamine synthesis inhibitors"
    ],
    "cyp_enzymes": [],
    "search_name": "Metyrosine"
  },
  {
    "kegg_id": "D01227",
    "name_en": "Bosentan (USAN)",
    "name_ja": "",
    "names_alt": [
      "Bosentan hydrate (JAN)",
      "Tracleer (TN)"
    ],
    "formula": "C27H29N5O6S. H2O",
    "efficacy": "Antihypertensive, Endothelin receptor antagonist\nDISEASE   Pulmonary arterial hypertension [DS:H01621]",
    "target": "EDNR [HSA:1909 1910] [KO:K04197 K04198]\nPATHWAY   hsa04080(1909+1910)  Neuroactive ligand-receptor interaction\nhsa04270(1909)  Vascular smooth muscle contraction",
    "metabolism": "Enzyme: CYP2C9 [HSA:1559], CYP3A4 [HSA:1576]",
    "therapeutic_category": "2190",
    "atc_code": "C02KX01",
    "drug_class": [
      "Cardiovascular agent",
      "Endothelin receptor antagonist",
      "Metabolizing enzyme substrate",
      "CYP2C9 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "Metabolizing enzyme inducer",
      "CYP2C9 inducer",
      "CYP3A/CYP3A4 inducer",
      "CYP3A4 inducer"
    ],
    "cyp_enzymes": [
      "CYP2C9",
      "CYP3A4"
    ],
    "search_name": "Bosentan"
  },
  {
    "kegg_id": "D07077",
    "name_en": "Ambrisentan (JAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Letairis (TN)",
      "Volibris (TN)"
    ],
    "formula": "C22H22N2O4",
    "efficacy": "Antihypertensive, Endothelin receptor type A antagonist\nDISEASE   Pulmonary arterial hypertension [DS:H01621]",
    "target": "EDNRA [HSA:1909] [KO:K04197]\nPATHWAY   hsa04080(1909)  Neuroactive ligand-receptor interaction\nhsa04270(1909)  Vascular smooth muscle contraction",
    "metabolism": "",
    "therapeutic_category": "2190",
    "atc_code": "C02KX02",
    "drug_class": [
      "Cardiovascular agent",
      "Endothelin receptor antagonist"
    ],
    "cyp_enzymes": [],
    "search_name": "Ambrisentan"
  },
  {
    "kegg_id": "D10135",
    "name_en": "Macitentan (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Opsumit (TN)"
    ],
    "formula": "C19H20Br2N6O4S",
    "efficacy": "Antihypertensive, Endothelin receptor antagonist\nDISEASE   Pulmonary arterial hypertension [DS:H01621]",
    "target": "EDNR [HSA:1909 1910] [KO:K04197 K04198]\nPATHWAY   hsa04080(1909+1910)  Neuroactive ligand-receptor interaction\nhsa04270(1909)  Vascular smooth muscle contraction",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "2190",
    "atc_code": "C02KX04",
    "drug_class": [
      "Cardiovascular agent",
      "Endothelin receptor antagonist",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Macitentan"
  },
  {
    "kegg_id": "D09572",
    "name_en": "Riociguat (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Adempas (TN)"
    ],
    "formula": "C20H19FN8O2",
    "efficacy": "Vasodilator, Guanylate cyclase activator\nDISEASE   Chronic-thromboembolic pulmonary hypertension [DS:H01622]\nPulmonary arterial hypertension [DS:H01621]",
    "target": "GUCY1A [HSA:2977 2982] [KO:K12318]\nGUCY1B [HSA:2983] [KO:K12319]\nPATHWAY   hsa04270(2977+2982+2983)  Vascular smooth muscle contraction\nhsa04611(2977+2982+2983)  Platelet activation",
    "metabolism": "Enzyme: CYP1A1 [HSA:1543], CYP2C8 [HSA:1558], CYP2J2 [HSA:1573], CYP3A [HSA:1576 1577 1551]\nTransporter: ABCB1 [HSA:5243], ABCG2 [HSA:9429]",
    "therapeutic_category": "2190",
    "atc_code": "C02KX05",
    "drug_class": [
      "Cardiovascular agent",
      "Guanylate cyclase activator",
      "Metabolizing enzyme substrate",
      "CYP1A1 substrate",
      "CYP2C8 substrate",
      "CYP2J2 substrate",
      "CYP3A/CYP3A4 substrate",
      "Transporter substrate",
      "ABCB1 substrate",
      "ABCG2 substrate"
    ],
    "cyp_enzymes": [
      "CYP1A1",
      "CYP2C8",
      "CYP3A",
      "CYP2J2"
    ],
    "search_name": "Riociguat"
  },
  {
    "kegg_id": "D09670",
    "name_en": "Sotatercept (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Sotatercept (genetical recombination) (JAN)",
      "sotatercept-csrk",
      "Winrevair (TN)",
      "Airwin (TN)"
    ],
    "formula": "C3448H5264N920O1058S42",
    "efficacy": "Anti-anemic, Bone anabolic, Activin signaling inhibitor\nDISEASE   Pulmonary arterial hypertension [DS:H01621]",
    "target": "ACVR2A [HSA:92] [KO:K04670]\nPATHWAY   hsa04060(92)  Cytokine-cytokine receptor interaction\nhsa04350(92)  TGF-beta signaling pathway\nhsa04550(92)  Signaling pathways regulating pluripotency of stem cells\nhsa05418(92)  Fluid shear stress and atherosclerosis",
    "metabolism": "",
    "therapeutic_category": "2190",
    "atc_code": "C02KX06",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Sotatercept"
  },
  {
    "kegg_id": "D12963",
    "name_en": "Macitentan and tadalafil",
    "name_ja": "",
    "names_alt": [
      "Opsynvi (TN)",
      "Yuvanci (TN)"
    ],
    "formula": "",
    "efficacy": "Antihypertensive\nDISEASE   Pulmonary arterial hypertension [DS:H01621]",
    "target": "",
    "metabolism": "Enzyme: CYP3A [HSA:1576 1577 1551]; CYP2C8 [HSA:1558], CYP2C9 [HSA:1559], CYP2C19 [HSA:1557]",
    "therapeutic_category": "2190",
    "atc_code": "C02KX54",
    "drug_class": [
      "Metabolizing enzyme substrate",
      "CYP2C8 substrate",
      "CYP2C9 substrate",
      "CYP2C19 substrate",
      "CYP3A/CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C9",
      "CYP2C8",
      "CYP3A",
      "CYP2C19"
    ],
    "search_name": "Macitentan and tadalafil"
  },
  {
    "kegg_id": "D10633",
    "name_en": "Finerenone (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Kerendia (TN)"
    ],
    "formula": "C21H22N4O3",
    "efficacy": "Diuretic, Aldosterone antagonist\nDISEASE   Chronic kidney disease associated with type 2 diabetes [DS:H01456]",
    "target": "NR3C2 (MR) [HSA:4306] [KO:K08555]\nPATHWAY   hsa04960(4306)  Aldosterone-regulated sodium reabsorption",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]; CYP2C8 [HSA:1558]",
    "therapeutic_category": "2190",
    "atc_code": "C03DA05",
    "drug_class": [
      "Cardiovascular agent",
      "Antihypertensive",
      "Aldosterone antagonist",
      "Potassium-sparing diuretic",
      "Metabolizing enzyme substrate",
      "CYP2C8 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C8",
      "CYP3A4"
    ],
    "search_name": "Finerenone"
  },
  {
    "kegg_id": "D00509",
    "name_en": "Phentolamine mesylate (USP)",
    "name_ja": "",
    "names_alt": [
      "Phentolamine mesilate (JAN/INN)",
      "Regitine (TN)"
    ],
    "formula": "C17H19N3O. CH4SO3",
    "efficacy": "Vasodilator, Diagnostic, alpha-Adrenergic receptor antagonist",
    "target": "ADRA1 [HSA:148 147 146] [KO:K04135 K04136 K04137]\nADRA2 [HSA:150 151 152] [KO:K04138 K04139 K04140]\nPATHWAY   hsa04080(146+147+148+150+151+152)  Neuroactive ligand-receptor interaction\nhsa04261(146+147+148)  Adrenergic signaling in cardiomyocytes\nhsa04270(146+147+148)  Vascular smooth muscle contraction",
    "metabolism": "",
    "therapeutic_category": "2190",
    "atc_code": "C04AB01",
    "drug_class": [
      "Cardiovascular agent",
      "Adrenergic receptor antagonist",
      "alpha-Adrenergic receptor antagonist",
      "Antihypertensive"
    ],
    "cyp_enzymes": [],
    "search_name": "Phentolamine mesylate"
  },
  {
    "kegg_id": "D01290",
    "name_en": "Nicergoline (JP18/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Sermion (TN)"
    ],
    "formula": "C24H26BrN3O3",
    "efficacy": "Nootropic, Vasodilator, alpha1-Adrenergic receptor antagonist",
    "target": "ADRA1 [HSA:148 147 146] [KO:K04135 K04136 K04137]\nPATHWAY   hsa04080(146+147+148)  Neuroactive ligand-receptor interaction\nhsa04270(146+147+148)  Vascular smooth muscle contraction",
    "metabolism": "",
    "therapeutic_category": "2190",
    "atc_code": "C04AE02",
    "drug_class": [
      "Cardiovascular agent",
      "Adrenergic receptor antagonist",
      "alpha-Adrenergic receptor antagonist",
      "alpha1-Adrenergic receptor antagonist",
      "Neuropsychiatric agent",
      "Ergot alkaloid",
      "Vasodilator, ergot alkaloid"
    ],
    "cyp_enzymes": [],
    "search_name": "Nicergoline"
  },
  {
    "kegg_id": "D03115",
    "name_en": "Fasudil hydrochloride hydrate (JAN)",
    "name_ja": "",
    "names_alt": [
      "Eril-S (TN)"
    ],
    "formula": "(C14H17N3O2S. HCl)2. H2O",
    "efficacy": "Vasodilator, Rho-associated kinase inhibitor",
    "target": "ROCK [HSA:6093 9475] [KO:K04514 K17388]\nPATHWAY   hsa04022(6093+9475)  cGMP-PKG signaling pathway\nhsa04270(6093+9475)  Vascular smooth muscle contraction\nhsa04810(6093+9475)  Regulation of actin cytoskeleton\nhsa04921(6093+9475)  Oxytocin signaling pathway",
    "metabolism": "",
    "therapeutic_category": "2190",
    "atc_code": "C04AX32",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Fasudil hydrochloride hydrate"
  },
  {
    "kegg_id": "D07682",
    "name_en": "Clazosentan sodium (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Pivlaz (TN)"
    ],
    "formula": "C25H21N9Na2O6S",
    "efficacy": "Vasodilator, Endothelin receptor type A antagonist",
    "target": "EDNRA [HSA:1909] [KO:K04197]\nPATHWAY   hsa04024(1909)  cAMP signaling pathway\nhsa04080(1909)  Neuroactive ligand-receptor interaction\nhsa04270(1909)  Vascular smooth muscle contraction\nhsa04924(1909)  Renin secretion",
    "metabolism": "",
    "therapeutic_category": "2190",
    "atc_code": "C04AX33",
    "drug_class": [
      "Cardiovascular agent",
      "Endothelin receptor antagonist"
    ],
    "cyp_enzymes": [],
    "search_name": "Clazosentan sodium"
  },
  {
    "kegg_id": "D08488",
    "name_en": "Amlodipine besilate and atorvastatin calcium",
    "name_ja": "アムロジピン",
    "names_alt": [
      "Caduet (TN)"
    ],
    "formula": "",
    "efficacy": "Antihyperlipidemic, Antihypertensive\nDISEASE   Hypertension [DS:H01633]\nCoronary artery disease [DS:H01742]\nChronic stable angina [DS:H01632]\nHyperlipidemia [DS:H01635]",
    "target": "",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "2190",
    "atc_code": "C10BX03",
    "drug_class": [
      "Hypolipidemic agent",
      "Hypolipidemic agent",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Amlodipine besilate and atorvastatin calcium"
  },
  {
    "kegg_id": "D02229",
    "name_en": "Sildenafil citrate (JAN/USP)",
    "name_ja": "",
    "names_alt": [
      "Revatio (TN)",
      "Viagra (TN)"
    ],
    "formula": "C22H30N6O4S. C6H8O7",
    "efficacy": "Vasodilator, Impotence therapy, Phosphodiesterase V inhibitor\nDISEASE   Pulmonary arterial hypertension [DS:H01621]",
    "target": "PDE5 [HSA:8654] [KO:K13762]\nPATHWAY   hsa04022(8654)  cGMP-PKG signaling pathway",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]; CYP2C9 [HSA:1559]",
    "therapeutic_category": "2190",
    "atc_code": "G04BE03",
    "drug_class": [
      "Cardiovascular agent",
      "Phosphodiesterase V inhibitor",
      "Metabolizing enzyme substrate",
      "CYP2C9 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C9",
      "CYP3A4"
    ],
    "search_name": "Sildenafil citrate"
  },
  {
    "kegg_id": "D02008",
    "name_en": "Tadalafil (JAN/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Adcirca (TN)",
      "Cialis (TN)",
      "Zalutia (TN)"
    ],
    "formula": "C22H19N3O4",
    "efficacy": "Antihypertensive, Impotence therapy, Phosphodiesterase V inhibitor\nDISEASE   Pulmonary arterial hypertension [DS:H01621]",
    "target": "PDE5 [HSA:8654] [KO:K13762]\nPATHWAY   hsa00230(8654)  Purine metabolism",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "2190",
    "atc_code": "G04BE08",
    "drug_class": [
      "Cardiovascular agent",
      "Phosphodiesterase V inhibitor",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Tadalafil"
  },
  {
    "kegg_id": "D00058",
    "name_en": "gamma-Aminobutyric acid (JAN)",
    "name_ja": "",
    "names_alt": [
      "Gammalon (TN)"
    ],
    "formula": "C4H9NO2",
    "efficacy": "Brain metabolism enhancer, Neurotransmitter",
    "target": "GABR [HSA:2554 2555 2556 2557 2558 2559 2560 2561 2562 2563 2564 2565 2566 2567 2568 55879] [KO:K05175 K05181 K05184 K05185 K05186 K05189 K05192]\nGABBR [HSA:2550 9568] [KO:K04615]\nPATHWAY   hsa04080(2550+2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879+9568)  Neuroactive ligand-receptor interaction\nhsa04727(2550+2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879+9568)  GABAergic synapse",
    "metabolism": "",
    "therapeutic_category": "2190",
    "atc_code": "N03AG03",
    "drug_class": [
      "Neuropsychiatric agent",
      "GABA-A receptor agonist",
      "GABA-B receptor agonist",
      "Antiepileptic agent",
      "GABA mimetic antiepileptic"
    ],
    "cyp_enzymes": [],
    "search_name": "gamma-Aminobutyric acid"
  },
  {
    "kegg_id": "D09673",
    "name_en": "Tafamidis (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Vyndamax (TN)",
      "Vynmac (TN)"
    ],
    "formula": "C14H7Cl2NO3",
    "efficacy": "Amyloidogenesis suppressant\nDISEASE   Hereditary transthyretin-mediated amyloidosis [DS:H00845]",
    "target": "TTR [HSA:7276] [KO:K20731]\nPATHWAY   hsa04918(7276)  Thyroid hormone synthesis",
    "metabolism": "",
    "therapeutic_category": "2190",
    "atc_code": "N07XX08",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Tafamidis"
  },
  {
    "kegg_id": "D00074",
    "name_en": "Nitric oxide (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "INOmax (TN)",
      "Ulspira (TN)"
    ],
    "formula": "NO",
    "efficacy": "Vasodilator (pulmonary)\nDISEASE   Pulmonary hypertension [DS:H01619 H01621]",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2190",
    "atc_code": "R07AX01",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Nitric oxide"
  },
  {
    "kegg_id": "D03263",
    "name_en": "Sodium polystyrene sulfonate (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Kayexalate (TN)",
      "Kionex (TN)"
    ],
    "formula": "(C8H7O3S. Na)n",
    "efficacy": "Antihyperkalemic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2190",
    "atc_code": "V03AE01",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Sodium polystyrene sulfonate"
  },
  {
    "kegg_id": "D03270",
    "name_en": "Calcium polystyrene sulfonate (JP18)",
    "name_ja": "",
    "names_alt": [
      "Argamate (TN)"
    ],
    "formula": "",
    "efficacy": "Antihyperkalemic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2190",
    "atc_code": "V03AE01",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Calcium polystyrene sulfonate"
  },
  {
    "kegg_id": "D01983",
    "name_en": "Sevelamer hydrochloride (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Renagel (TN)"
    ],
    "formula": "((C3H5ClO)mon. (C3H7N)mon)co. xHCl",
    "efficacy": "Antihyperphosphatemic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2190",
    "atc_code": "V03AE02",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Sevelamer hydrochloride"
  },
  {
    "kegg_id": "D04667",
    "name_en": "Lanthanum carbonate (USAN)",
    "name_ja": "",
    "names_alt": [
      "Lanthanum carbonate hydrate (JAN)",
      "Fosrenol (TN)"
    ],
    "formula": "2La. (CO3)3. nH2O",
    "efficacy": "Antihyperphosphatemic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2190",
    "atc_code": "V03AE03",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Lanthanum carbonate"
  },
  {
    "kegg_id": "D09993",
    "name_en": "Ferric citrate hydrate (JAN)",
    "name_ja": "",
    "names_alt": [
      "Ferric citrate trihydrate",
      "Riona (TN)"
    ],
    "formula": "C6H5O7. 3H2O. Fe",
    "efficacy": "Anti-anemic, Antihyperphosphatemic, Supplement (iron)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2190",
    "atc_code": "V03AE08",
    "drug_class": [
      "Blood modifier agent",
      "Iron preparation"
    ],
    "cyp_enzymes": [],
    "search_name": "Ferric citrate hydrate"
  },
  {
    "kegg_id": "D11037",
    "name_en": "Patiromer sorbitex calcium (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Veltassa (TN)"
    ],
    "formula": "[((C3H2FO2)2.Ca)x. (C8H14)z. (C10H10)y. (C6H14O6)w]n",
    "efficacy": "Antihyperkalemic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2190",
    "atc_code": "V03AE09",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Patiromer sorbitex calcium"
  },
  {
    "kegg_id": "D10727",
    "name_en": "Sodium zirconium cyclosilicate (USAN)",
    "name_ja": "",
    "names_alt": [
      "Sodium zirconium cyclosilicate hydrate (JAN)",
      "Lokelma (TN)"
    ],
    "formula": "ZrH4O6. 3H4SiO4. 2H2O. 2Na",
    "efficacy": "Antihyperkalemic, Potassium lowering agent",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2190",
    "atc_code": "V03AE10",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Sodium zirconium cyclosilicate"
  },
  {
    "kegg_id": "D01684",
    "name_en": "Ozagrel sodium (JP18)",
    "name_ja": "",
    "names_alt": [
      "Ozapen (TN)"
    ],
    "formula": "C13H11N2O2. Na",
    "efficacy": "Anticoagulant, Platelet aggregation inhibitor, Thromboxane A2 (TXA2) synthase inhibitor",
    "target": "TBXAS1 (CYP5A1) [HSA:6916] [KO:K01832]\nPATHWAY   hsa00590(6916)  Arachidonic acid metabolism\nhsa04611(6916)  Platelet activation",
    "metabolism": "",
    "therapeutic_category": "2190",
    "atc_code": "",
    "drug_class": [
      "Blood modifier agent",
      "Antithrombotic agent",
      "Antiplatelet agent",
      "Thromboxane A2 synthase inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Ozagrel sodium"
  },
  {
    "kegg_id": "D02633",
    "name_en": "Lomerizine hydrochloride (JAN)",
    "name_ja": "",
    "names_alt": [
      "Terranas (TN)"
    ],
    "formula": "C27H30F2N2O3. 2HCl",
    "efficacy": "Antimigraine, Vasoconstriction suppressant",
    "target": "CACNA1-T [HSA:8911 8912 8913] [KO:K04856 K04855 K04854]\nPATHWAY   hsa04020(8911+8912+8913)  Calcium signaling pathway",
    "metabolism": "",
    "therapeutic_category": "2190",
    "atc_code": "",
    "drug_class": [
      "Cardiovascular agent",
      "Calcium channel blocker"
    ],
    "cyp_enzymes": [],
    "search_name": "Lomerizine hydrochloride"
  },
  {
    "kegg_id": "D09586",
    "name_en": "Bixalomer (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [],
    "formula": "(C16H40N6)x. (C3H5ClO)y",
    "efficacy": "Antihyperphosphatemic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2190",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Bixalomer"
  },
  {
    "kegg_id": "D01607",
    "name_en": "Dimorpholamine (JP18)",
    "name_ja": "",
    "names_alt": [
      "Theraptique (TN)"
    ],
    "formula": "C20H38N4O4",
    "efficacy": "Respiratory stimulant",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2213",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Dimorpholamine"
  },
  {
    "kegg_id": "D02238",
    "name_en": "Levallorphan tartrate (JP18)",
    "name_ja": "",
    "names_alt": [
      "Lorfan (TN)"
    ],
    "formula": "C19H25NO. C4H6O6",
    "efficacy": "Narcotic antagonist, Respiratory stimulant, Opioid receptor agonist/antagonist",
    "target": "OPRM1 [HSA:4988] [KO:K04215]\nOPRK1 [HSA:4986] [KO:K04214]\nOPRD1 [HSA:4985] [KO:K04213]\nPATHWAY   hsa04080(4985+4986+4988)  Neuroactive ligand-receptor interaction",
    "metabolism": "",
    "therapeutic_category": "2213",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Levallorphan tartrate"
  },
  {
    "kegg_id": "D01340",
    "name_en": "Naloxone hydrochloride (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Evzio (TN)",
      "Narcan (TN)"
    ],
    "formula": "C19H21NO4. HCl",
    "efficacy": "Respiratory stimulant, Opioid receptor antagonist",
    "target": "OPRM1 [HSA:4988] [KO:K04215]\nOPRK1 [HSA:4986] [KO:K04214]\nOPRD1 [HSA:4985] [KO:K04213]\nPATHWAY   hsa04080(4985+4986+4988)  Neuroactive ligand-receptor interaction\nhsa05032(4988)  Morphine addiction",
    "metabolism": "",
    "therapeutic_category": "2219",
    "atc_code": "A06AH04",
    "drug_class": [
      "Analgesic",
      "Opioid receptor antagonist"
    ],
    "cyp_enzymes": [],
    "search_name": "Naloxone hydrochloride"
  },
  {
    "kegg_id": "D01872",
    "name_en": "Doxapram hydrochloride (USP)",
    "name_ja": "",
    "names_alt": [
      "Doxapram hydrochloride hydrate (JP18)",
      "Dopram (TN)"
    ],
    "formula": "C24H30N2O2. HCl. H2O",
    "efficacy": "Respiratory stimulant",
    "target": "",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576], CYP3A5 [HSA:1577]",
    "therapeutic_category": "2219",
    "atc_code": "R07AB01",
    "drug_class": [
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "CYP3A5 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4",
      "CYP3A5"
    ],
    "search_name": "Doxapram hydrochloride"
  },
  {
    "kegg_id": "D00697",
    "name_en": "Flumazenil (JAN/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Romazicon (TN)"
    ],
    "formula": "C15H14FN3O3",
    "efficacy": "Antidote (benzodiazepines), Respiratory stimulant",
    "target": "GABR [HSA:2554 2555 2556 2557 2558 2559 2560 2561 2562 2563 2564 2565 2566 2567 2568 55879] [KO:K05175 K05181 K05184 K05185 K05186 K05189 K05192]\nPATHWAY   hsa04080(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879)  Neuroactive ligand-receptor interaction\nhsa04727(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879)  GABAergic synapse",
    "metabolism": "",
    "therapeutic_category": "2219",
    "atc_code": "V03AB25",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Flumazenil"
  },
  {
    "kegg_id": "D04289",
    "name_en": "Lung-surfactant",
    "name_ja": "",
    "names_alt": [
      "Surfacten (TN)"
    ],
    "formula": "",
    "efficacy": "Respiratory stimulant",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2219",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Lung-surfactant"
  },
  {
    "kegg_id": "D02109",
    "name_en": "dl-Methylephedrine hydrochloride (JP18)",
    "name_ja": "",
    "names_alt": [
      "Methy-F (TN)"
    ],
    "formula": "C11H17NO. HCl",
    "efficacy": "Antitussive, Bronchodilator, Adrenergic receptor agonist",
    "target": "ADRA1 [HSA:148 147 146] [KO:K04135 K04136 K04137]\nADRA2 [HSA:150 151 152] [KO:K04138 K04139 K04140]\nADRB [HSA:153 154 155] [KO:K04141 K04142 K04143]\nPATHWAY   hsa04020(146+147+148+153+154+155)  Calcium signaling pathway\nhsa04080(146+147+148+150+151+152+153+154+155)  Neuroactive ligand-receptor interaction\nhsa04261(146+147+148+153+154)  Adrenergic signaling in cardiomyocytes\nhsa04270(146+147+148)  Vascular smooth muscle contraction\nhsa04970(146+147+148+153+154+155)  Salivary secretion",
    "metabolism": "",
    "therapeutic_category": "2221",
    "atc_code": "",
    "drug_class": [
      "Cardiovascular agent",
      "Adrenergic receptor agonist",
      "Respiratory system agent",
      "Ephedrine-containing preparation"
    ],
    "cyp_enzymes": [],
    "search_name": "dl-Methylephedrine hydrochloride"
  },
  {
    "kegg_id": "D00848",
    "name_en": "Dextromethorphan hydrobromide (USP)",
    "name_ja": "",
    "names_alt": [
      "Dextromethorphan hydrobromide hydrate (JP18)",
      "Benylin DM (TN)"
    ],
    "formula": "C18H25NO. HBr. H2O",
    "efficacy": "Antitussive",
    "target": "SIGMAR1 [HSA:10280] [KO:K20719]\nGRIN (NMDAR) [HSA:2902 2903 2904 2905 2906] [KO:K05208 K05209 K05210 K05211 K05212]\nPATHWAY   hsa04080(2902+2903+2904+2905+2906)  Neuroactive ligand-receptor interaction\nhsa04724(2902+2903+2904+2905+2906)  Glutamatergic synapse",
    "metabolism": "Enzyme: CYP2D6 [HSA:1565]",
    "therapeutic_category": "2223",
    "atc_code": "R05DA09",
    "drug_class": [
      "Neuropsychiatric agent",
      "NMDA receptor antagonist",
      "Metabolizing enzyme substrate",
      "CYP2D6 substrate"
    ],
    "cyp_enzymes": [
      "CYP2D6"
    ],
    "search_name": "Dextromethorphan hydrobromide"
  },
  {
    "kegg_id": "D01260",
    "name_en": "Pentoxyverine citrate (JP18)",
    "name_ja": "",
    "names_alt": [
      "Carbetapentane citrate",
      "Astomatop (TN)"
    ],
    "formula": "C20H31NO3. C6H8O7",
    "efficacy": "Antitussive",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2224",
    "atc_code": "R05DB05",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Pentoxyverine citrate"
  },
  {
    "kegg_id": "D08695",
    "name_en": "dl-Methylephedrine hydrochloride, dihydrocodeine phosphate, diprophylline, diphenhydramine salicylate, acetaminophen and bromovalerylurea",
    "name_ja": "",
    "names_alt": [
      "Coughcode N (TN)"
    ],
    "formula": "",
    "efficacy": "Analgesic, Antipyretic, Antitussive",
    "target": "",
    "metabolism": "Enzyme: UGT2B7 [HSA:7364], UGT2B4 [HSA:7363]; CYP3A4 [HSA:1576], CYP2D6 [HSA:1565]",
    "therapeutic_category": "2229",
    "atc_code": "N02AA58",
    "drug_class": [
      "Respiratory system agent",
      "Ephedrine-containing preparation",
      "Metabolizing enzyme substrate",
      "CYP2D6 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "UGT substrate",
      "UGT2B4 substrate",
      "UGT2B7 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4",
      "CYP2D6"
    ],
    "search_name": "dl-Methylephedrine hydrochloride, dihydrocodeine phosphate, diprophylline, diphenhydramine salicylate, acetaminophen and bromovalerylurea"
  },
  {
    "kegg_id": "D01506",
    "name_en": "Dimemorfan phosphate (JP18)",
    "name_ja": "",
    "names_alt": [
      "Astomin (TN)"
    ],
    "formula": "C18H25N. H3PO4",
    "efficacy": "Antitussive",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2229",
    "atc_code": "R05DA11",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Dimemorfan phosphate"
  },
  {
    "kegg_id": "D01389",
    "name_en": "Chlophedianol hydrochloride (USAN)",
    "name_ja": "",
    "names_alt": [
      "Clofedanol hydrochloride (JP18)",
      "Coldrin (TN)"
    ],
    "formula": "C17H20ClNO. HCl",
    "efficacy": "Antitussive",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2229",
    "atc_code": "R05DB10",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Chlophedianol hydrochloride"
  },
  {
    "kegg_id": "D01569",
    "name_en": "Cloperastine fendizoate (JP18)",
    "name_ja": "",
    "names_alt": [
      "Hustazol (TN)"
    ],
    "formula": "C20H24ClNO. C20H14O4",
    "efficacy": "Antitussive",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2229",
    "atc_code": "R05DB21",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Cloperastine fendizoate"
  },
  {
    "kegg_id": "D01609",
    "name_en": "Cloperastine Hydrochloride (JP18)",
    "name_ja": "",
    "names_alt": [
      "Hustazol (TN)"
    ],
    "formula": "C20H24ClNO. HCl",
    "efficacy": "Antitussive",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2229",
    "atc_code": "R05DB21",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Cloperastine Hydrochloride"
  },
  {
    "kegg_id": "D04313",
    "name_en": "Dihydrocodeine phosphate, dl-methylephedrine hydrochloride and Chlorpheniramine maleate",
    "name_ja": "",
    "names_alt": [
      "Huscode (TN)"
    ],
    "formula": "",
    "efficacy": "Antitussive",
    "target": "",
    "metabolism": "Enzyme: UGT2B7 [HSA:7364], UGT2B4 [HSA:7363]; CYP3A4 [HSA:1576], CYP2D6 [HSA:1565]",
    "therapeutic_category": "2229",
    "atc_code": "R06AB54",
    "drug_class": [
      "Metabolizing enzyme substrate",
      "CYP2D6 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "UGT substrate",
      "UGT2B4 substrate",
      "UGT2B7 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4",
      "CYP2D6"
    ],
    "search_name": "Dihydrocodeine phosphate, dl-methylephedrine hydrochloride and Chlorpheniramine maleate"
  },
  {
    "kegg_id": "D04326",
    "name_en": "Senega syrup (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Expectorant",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2231",
    "atc_code": "R05CA06",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Senega syrup"
  },
  {
    "kegg_id": "D00221",
    "name_en": "Acetylcysteine (JP18/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Mucomyst (TN)"
    ],
    "formula": "C5H9NO3S",
    "efficacy": "Antidote (acetaminophen), Mucolytic, Expectorant\nDISEASE   Chronic emphysema [DS:H01714]\nCystic fibrosis [DS:H00218]",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2233",
    "atc_code": "R05CB01",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Acetylcysteine"
  },
  {
    "kegg_id": "D00175",
    "name_en": "L-Carbocisteine (JP18)",
    "name_ja": "",
    "names_alt": [
      "Mucodyne (TN)"
    ],
    "formula": "C5H9NO4S",
    "efficacy": "Mucolytic, Expectorant",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2233",
    "atc_code": "R05CB03",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "L-Carbocisteine"
  },
  {
    "kegg_id": "D01559",
    "name_en": "Ethyl L-cysteine hydrochloride (JP18)",
    "name_ja": "",
    "names_alt": [
      "L-Cysteine, ethyl ester, hydrochloride",
      "Daiace (TN)"
    ],
    "formula": "C5H11NO2S. HCl",
    "efficacy": "Expectorant",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2233",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Ethyl L-cysteine hydrochloride"
  },
  {
    "kegg_id": "D01845",
    "name_en": "Fudosteine (JP18/INN)",
    "name_ja": "",
    "names_alt": [
      "Cleanal (TN)"
    ],
    "formula": "C6H13NO3S",
    "efficacy": "Mucolytic, Expectorant",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2233",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Fudosteine"
  },
  {
    "kegg_id": "D01778",
    "name_en": "Bromhexine hydrochloride (JP18/USAN)",
    "name_ja": "",
    "names_alt": [
      "Bisolvon (TN)"
    ],
    "formula": "C14H20Br2N2. HCl",
    "efficacy": "Expectorant, Mucolytic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2234",
    "atc_code": "R05CB02",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Bromhexine hydrochloride"
  },
  {
    "kegg_id": "D01479",
    "name_en": "Ambroxol hydrochloride (JAN)",
    "name_ja": "",
    "names_alt": [
      "Hustless (TN)"
    ],
    "formula": "C13H18Br2N2O. HCl",
    "efficacy": "Expectorant, Mucolytic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2239",
    "atc_code": "R02AD05",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Ambroxol hydrochloride"
  },
  {
    "kegg_id": "D04331",
    "name_en": "Apricot kernel water (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Antitussive, Expectorant",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2241",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Apricot kernel water"
  },
  {
    "kegg_id": "D04335",
    "name_en": "Cherry bark extract",
    "name_ja": "",
    "names_alt": [
      "Brocin (TN)"
    ],
    "formula": "",
    "efficacy": "Antitussive, Expectorant",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2241",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Cherry bark extract"
  },
  {
    "kegg_id": "D01481",
    "name_en": "Dihydrocodeine phosphate (JP18)",
    "name_ja": "",
    "names_alt": [
      "Dihydro (TN)"
    ],
    "formula": "C18H23NO3. H3PO4",
    "efficacy": "Antitussive, Narcotic, Opioid receptor agonist",
    "target": "OPRM1 [HSA:4988] [KO:K04215]\nPATHWAY   hsa04080(4988)  Neuroactive ligand-receptor interaction",
    "metabolism": "Enzyme: UGT2B7 [HSA:7364], UGT2B4 [HSA:7363]; CYP3A4 [HSA:1576], CYP2D6 [HSA:1565]",
    "therapeutic_category": "2242",
    "atc_code": "N02AA08",
    "drug_class": [
      "Neuropsychiatric agent",
      "Opioid receptor agonist",
      "mu-Opioid receptor agonist",
      "Analgesic",
      "Opioid analgesics",
      "Metabolizing enzyme substrate",
      "CYP2D6 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "UGT substrate",
      "UGT2B4 substrate",
      "UGT2B7 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4",
      "CYP2D6"
    ],
    "search_name": "Dihydrocodeine phosphate"
  },
  {
    "kegg_id": "D02101",
    "name_en": "Codeine phosphate (USP)",
    "name_ja": "コデイン",
    "names_alt": [
      "Codeine phosphate hydrate (JP18)"
    ],
    "formula": "(C18H21NO3)2. 2H3PO4. H2O",
    "efficacy": "Analgesic (narcotic), Antitussive, Opioid receptor agonist",
    "target": "OPRM1 [HSA:4988] [KO:K04215]\nPATHWAY   hsa04080(4988)  Neuroactive ligand-receptor interaction",
    "metabolism": "Enzyme: UGT2B7 [HSA:7364], UGT2B4 [HSA:7363]; CYP3A4 [HSA:1576], CYP2D6 [HSA:1565]",
    "therapeutic_category": "2242",
    "atc_code": "R05DA04",
    "drug_class": [
      "Neuropsychiatric agent",
      "Opioid receptor agonist",
      "mu-Opioid receptor agonist",
      "Analgesic",
      "Opioid analgesics",
      "Metabolizing enzyme substrate",
      "CYP2D6 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "UGT substrate",
      "UGT2B4 substrate",
      "UGT2B7 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4",
      "CYP2D6"
    ],
    "search_name": "Codeine phosphate"
  },
  {
    "kegg_id": "D01106",
    "name_en": "Eprazinone hydrochloride (JAN)",
    "name_ja": "",
    "names_alt": [
      "Resplen (TN)"
    ],
    "formula": "C24H32N2O2. 2HCl",
    "efficacy": "Antitussive, Mucolytic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2249",
    "atc_code": "R05CB04",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Eprazinone hydrochloride"
  },
  {
    "kegg_id": "D01495",
    "name_en": "Tipepidine hibenzate (JP18)",
    "name_ja": "",
    "names_alt": [
      "Asverin (TN)"
    ],
    "formula": "C15H17NS2. C14H10O4",
    "efficacy": "Antitussive, Expectorant",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2249",
    "atc_code": "R05DB24",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Tipepidine hibenzate"
  },
  {
    "kegg_id": "D04340",
    "name_en": "Dextromethorphan hydrobromide and potassium cresolsulfonate",
    "name_ja": "",
    "names_alt": [
      "Medicon (TN)"
    ],
    "formula": "",
    "efficacy": "Antitussive, Expectorant",
    "target": "",
    "metabolism": "Enzyme: CYP2D6 [HSA:1565], CYP3A4 [HSA:1576]",
    "therapeutic_category": "2249",
    "atc_code": "R05FA02",
    "drug_class": [
      "Metabolizing enzyme substrate",
      "CYP2D6 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4",
      "CYP2D6"
    ],
    "search_name": "Dextromethorphan hydrobromide and potassium cresolsulfonate"
  },
  {
    "kegg_id": "D00371",
    "name_en": "Theophylline (JP18)",
    "name_ja": "テオフィリン",
    "names_alt": [
      "Elixophyllin (TN)",
      "Quibron-t (TN)",
      "Theo-24 (TN)",
      "Theodur G (TN)",
      "Theolair (TN)",
      "Uniphyl (TN)"
    ],
    "formula": "C7H8N4O2",
    "efficacy": "Bronchodilator, Phosphodiesterase inhibitor\nDISEASE   Chronic asthma [DS:H00079]",
    "target": "ADORA1 [HSA:134] [KO:K04265]\nADORA2B [HSA:136] [KO:K04267]\nPDE [HSA:10846 27115 50940 5136 5137 5138 5139 5140 5141 5142 5143 5144 5150 5151 5153 8622] [KO:K18438 K18436 K13298 K13755 K18283 K19021 K13296 K13293 K18437]\nPATHWAY   hsa04020(136+5136+5137+5153)  Calcium signaling pathway\nhsa04022(134+5138+5139+5140)  cGMP-PKG signaling pathway\nhsa04024(10846+134+5139+5140+5141+5142+5143+5144)  cAMP signaling pathway\nhsa04080(134+136)  Neuroactive ligand-receptor interaction\nhsa04270(136)  Vascular smooth muscle contraction",
    "metabolism": "Enzyme: CYP1A2 [HSA:1544]",
    "therapeutic_category": "2251",
    "atc_code": "R03DA04",
    "drug_class": [
      "Respiratory system agent",
      "Xanthine derivative",
      "Xanthine-type bronchodilator",
      "Metabolizing enzyme substrate",
      "CYP1A2 substrate"
    ],
    "cyp_enzymes": [
      "CYP1A2"
    ],
    "search_name": "Theophylline"
  },
  {
    "kegg_id": "D01428",
    "name_en": "Fenoterol hydrobromide (JAN)",
    "name_ja": "",
    "names_alt": [
      "Berotec (TN)"
    ],
    "formula": "C17H21NO4. HBr",
    "efficacy": "Bronchodilator, beta2-Adrenergic receptor agonist",
    "target": "ADRB2 [HSA:154] [KO:K04142]\nPATHWAY   hsa04020(154)  Calcium signaling pathway\nhsa04024(154)  cAMP signaling pathway\nhsa04080(154)  Neuroactive ligand-receptor interaction",
    "metabolism": "",
    "therapeutic_category": "2252",
    "atc_code": "G02CA03",
    "drug_class": [
      "Cardiovascular agent",
      "Adrenergic receptor agonist",
      "beta-Adrenergic receptor agonist",
      "beta2-Adrenergic receptor agonist"
    ],
    "cyp_enzymes": [],
    "search_name": "Fenoterol hydrobromide"
  },
  {
    "kegg_id": "D00688",
    "name_en": "Terbutaline sulfate (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Brethine (TN)"
    ],
    "formula": "(C12H19NO3)2. H2SO4",
    "efficacy": "Bronchodilator, beta2-Adrenergic receptor agonist\nDISEASE   Asthma [DS:H00079]\nEmphysema [DS:H01714]",
    "target": "ADRB2 [HSA:154] [KO:K04142]\nPATHWAY   hsa04020(154)  Calcium signaling pathway\nhsa04024(154)  cAMP signaling pathway\nhsa04080(154)  Neuroactive ligand-receptor interaction",
    "metabolism": "",
    "therapeutic_category": "2252",
    "atc_code": "R03AC03",
    "drug_class": [
      "Cardiovascular agent",
      "Adrenergic receptor agonist",
      "beta-Adrenergic receptor agonist",
      "beta2-Adrenergic receptor agonist"
    ],
    "cyp_enzymes": [],
    "search_name": "Terbutaline sulfate"
  },
  {
    "kegg_id": "D00683",
    "name_en": "Albuterol sulfate (USP)",
    "name_ja": "",
    "names_alt": [
      "Salbutamol sulfate (JP18)",
      "Accuneb (TN)",
      "Proventil (TN)",
      "Ventolin (TN)"
    ],
    "formula": "(C13H21NO3)2. H2SO4",
    "efficacy": "Bronchodilator, beta2-Adrenergic receptor agonist",
    "target": "ADRB2 [HSA:154] [KO:K04142]\nPATHWAY   hsa04020(154)  Calcium signaling pathway\nhsa04024(154)  cAMP signaling pathway\nhsa04080(154)  Neuroactive ligand-receptor interaction",
    "metabolism": "",
    "therapeutic_category": "2254",
    "atc_code": "R03AC02",
    "drug_class": [
      "Cardiovascular agent",
      "Adrenergic receptor agonist",
      "beta-Adrenergic receptor agonist",
      "beta2-Adrenergic receptor agonist"
    ],
    "cyp_enzymes": [],
    "search_name": "Albuterol sulfate"
  },
  {
    "kegg_id": "D00540",
    "name_en": "Glycopyrrolate (USP)",
    "name_ja": "",
    "names_alt": [
      "Glycopyrronium bromide (JAN/INN)",
      "Cuvposa (TN)",
      "Robinul (TN)",
      "Seebri breezhaler (TN)"
    ],
    "formula": "C19H28NO3. Br",
    "efficacy": "Anti-ulcerative, Bronchodilator, Muscarinic acetylcholine receptor antagonist\nDISEASE   Peptic ulcer [DS:H01634]\nChronic obstructive pulmonary disease [DS:H01714]",
    "target": "CHRM3 [HSA:1131] [KO:K04131]\nPATHWAY   hsa04020(1131)  Calcium signaling pathway\nhsa04080(1131)  Neuroactive ligand-receptor interaction\nhsa04725(1131)  Cholinergic synapse\nhsa04971(1131)  Gastric acid secretion",
    "metabolism": "",
    "therapeutic_category": "2259",
    "atc_code": "A03AB02",
    "drug_class": [
      "Neuropsychiatric agent",
      "Muscarinic cholinergic receptor antagonist"
    ],
    "cyp_enzymes": [],
    "search_name": "Glycopyrrolate"
  },
  {
    "kegg_id": "D02212",
    "name_en": "Ipratropium bromide (USP)",
    "name_ja": "",
    "names_alt": [
      "Ipratropium bromide hydrate (JP18)",
      "Atrovent (TN)"
    ],
    "formula": "C20H30NO3. Br. H2O",
    "efficacy": "Bronchodilator, Muscarinic acetylcholine receptor antagonist\nDISEASE   Chronic obstructive pulmonary disease [DS:H01714]\nEmphysema [DS:H01714]",
    "target": "CHRM [HSA:1128 1129 1131 1132 1133] [KO:K04129 K04130 K04131 K04132 K04133]\nPATHWAY   hsa04024(1128+1129)  cAMP signaling pathway\nhsa04080(1128+1129+1131+1132+1133)  Neuroactive ligand-receptor interaction\nhsa04725(1128+1129+1131+1132+1133)  Cholinergic synapse",
    "metabolism": "",
    "therapeutic_category": "2259",
    "atc_code": "R01AX03",
    "drug_class": [
      "Neuropsychiatric agent",
      "Muscarinic cholinergic receptor antagonist"
    ],
    "cyp_enzymes": [],
    "search_name": "Ipratropium bromide"
  },
  {
    "kegg_id": "D05037",
    "name_en": "Trimetoquinol hydrochloride hydrate (JP18)",
    "name_ja": "",
    "names_alt": [
      "Tretoquinol hydrate",
      "Caluyon (TN)"
    ],
    "formula": "C19H23NO5. HCl. H2O",
    "efficacy": "Bronchodilator, beta2-Adrenergic receptor agonist",
    "target": "ADRB2 [HSA:154] [KO:K04142]\nPATHWAY   hsa04020(154)  Calcium signaling pathway\nhsa04024(154)  cAMP signaling pathway\nhsa04080(154)  Neuroactive ligand-receptor interaction",
    "metabolism": "",
    "therapeutic_category": "2259",
    "atc_code": "R03AC09",
    "drug_class": [
      "Cardiovascular agent",
      "Adrenergic receptor agonist",
      "beta-Adrenergic receptor agonist",
      "beta2-Adrenergic receptor agonist"
    ],
    "cyp_enzymes": [],
    "search_name": "Trimetoquinol hydrochloride hydrate"
  },
  {
    "kegg_id": "D01362",
    "name_en": "Tulobuterol hydrochloride (JP18)",
    "name_ja": "",
    "names_alt": [
      "Hokunalin (TN)",
      "Respacal (TN)"
    ],
    "formula": "C12H18ClNO. HCl",
    "efficacy": "Bronchodilator, beta2-Adrenergic receptor agonist",
    "target": "ADRB2 [HSA:154] [KO:K04142]\nPATHWAY   hsa04020(154)  Calcium signaling pathway\nhsa04024(154)  cAMP signaling pathway\nhsa04080(154)  Neuroactive ligand-receptor interaction",
    "metabolism": "",
    "therapeutic_category": "2259",
    "atc_code": "R03AC11",
    "drug_class": [
      "Cardiovascular agent",
      "Adrenergic receptor agonist",
      "beta-Adrenergic receptor agonist",
      "beta2-Adrenergic receptor agonist"
    ],
    "cyp_enzymes": [],
    "search_name": "Tulobuterol hydrochloride"
  },
  {
    "kegg_id": "D02151",
    "name_en": "Tulobuterol (JP18/INN)",
    "name_ja": "",
    "names_alt": [
      "Atenos (TN)",
      "Hokunalin (TN)"
    ],
    "formula": "C12H18ClNO",
    "efficacy": "Bronchodilator, beta2-Adrenergic receptor agonist",
    "target": "ADRB2 [HSA:154] [KO:K04142]\nPATHWAY   hsa04020(154)  Calcium signaling pathway\nhsa04024(154)  cAMP signaling pathway\nhsa04080(154)  Neuroactive ligand-receptor interaction",
    "metabolism": "",
    "therapeutic_category": "2259",
    "atc_code": "R03AC11",
    "drug_class": [
      "Cardiovascular agent",
      "Adrenergic receptor agonist",
      "beta-Adrenergic receptor agonist",
      "beta2-Adrenergic receptor agonist"
    ],
    "cyp_enzymes": [],
    "search_name": "Tulobuterol"
  },
  {
    "kegg_id": "D00687",
    "name_en": "Salmeterol xinafoate (JAN/USP)",
    "name_ja": "",
    "names_alt": [
      "Serevent (TN)"
    ],
    "formula": "C25H37NO4. C11H8O3",
    "efficacy": "Bronchodilator, beta2-Adrenergic receptor agonist\nDISEASE   Asthma [DS:H00079]\nChronic obstructive pulmonary disease [DS:H01714]",
    "target": "ADRB2 [HSA:154] [KO:K04142]\nPATHWAY   hsa04020(154)  Calcium signaling pathway\nhsa04024(154)  cAMP signaling pathway\nhsa04080(154)  Neuroactive ligand-receptor interaction",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "2259",
    "atc_code": "R03AC12",
    "drug_class": [
      "Cardiovascular agent",
      "Adrenergic receptor agonist",
      "beta-Adrenergic receptor agonist",
      "beta2-Adrenergic receptor agonist",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Salmeterol xinafoate"
  },
  {
    "kegg_id": "D05277",
    "name_en": "Formoterol fumarate hydrate (JP18)",
    "name_ja": "",
    "names_alt": [
      "Formoterol fumarate dihydrate",
      "Atock (TN)",
      "Foradil (TN)"
    ],
    "formula": "(C19H24N2O4)2. C4H4O4. 2H2O",
    "efficacy": "Bronchodilator, beta2-Adrenergic receptor agonist\nDISEASE   Chronic obstructive pulmonary disease [DS:H01714]",
    "target": "ADRB2 [HSA:154] [KO:K04142]\nPATHWAY   hsa04020(154)  Calcium signaling pathway\nhsa04024(154)  cAMP signaling pathway\nhsa04080(154)  Neuroactive ligand-receptor interaction",
    "metabolism": "Enzyme: UGT [KO:K00699]",
    "therapeutic_category": "2259",
    "atc_code": "R03AC13",
    "drug_class": [
      "Cardiovascular agent",
      "Adrenergic receptor agonist",
      "beta-Adrenergic receptor agonist",
      "beta2-Adrenergic receptor agonist",
      "Metabolizing enzyme substrate",
      "UGT substrate"
    ],
    "cyp_enzymes": [],
    "search_name": "Formoterol fumarate hydrate"
  },
  {
    "kegg_id": "D01360",
    "name_en": "Clenbuterol hydrochloride (JAN/USP)",
    "name_ja": "",
    "names_alt": [
      "Spiropent (TN)"
    ],
    "formula": "C12H18Cl2N2O. HCl",
    "efficacy": "Bronchodilator, Overactive bladder agent, beta2-Adrenergic receptor agonist",
    "target": "ADRB2 [HSA:154] [KO:K04142]\nPATHWAY   hsa04020(154)  Calcium signaling pathway\nhsa04024(154)  cAMP signaling pathway\nhsa04080(154)  Neuroactive ligand-receptor interaction",
    "metabolism": "",
    "therapeutic_category": "2259",
    "atc_code": "R03AC14",
    "drug_class": [
      "Cardiovascular agent",
      "Adrenergic receptor agonist",
      "beta-Adrenergic receptor agonist",
      "beta2-Adrenergic receptor agonist"
    ],
    "cyp_enzymes": [],
    "search_name": "Clenbuterol hydrochloride"
  },
  {
    "kegg_id": "D05366",
    "name_en": "Procaterol hydrochloride hydrate (JP18)",
    "name_ja": "",
    "names_alt": [
      "Meptin (TN)"
    ],
    "formula": "(C16H22N2O3)2. 2HCl. H2O",
    "efficacy": "Bronchodilator, beta2-Adrenergic receptor agonist",
    "target": "ADRB2 [HSA:154] [KO:K04142]\nPATHWAY   hsa04020(154)  Calcium signaling pathway\nhsa04024(154)  cAMP signaling pathway\nhsa04080(154)  Neuroactive ligand-receptor interaction",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "2259",
    "atc_code": "R03AC16",
    "drug_class": [
      "Cardiovascular agent",
      "Adrenergic receptor agonist",
      "beta-Adrenergic receptor agonist",
      "beta2-Adrenergic receptor agonist",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Procaterol hydrochloride hydrate"
  },
  {
    "kegg_id": "D09319",
    "name_en": "Indacaterol maleate (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Arcapta (TN)"
    ],
    "formula": "C24H28N2O3. C4H4O4",
    "efficacy": "Bronchodilator, beta2-Adrenergic receptor agonist\nDISEASE   Chronic obstructive pulmonary disease [DS:H01714]",
    "target": "ADRB2 [HSA:154] [KO:K04142]\nPATHWAY   hsa04020(154)  Calcium signaling pathway\nhsa04024(154)  cAMP signaling pathway\nhsa04080(154)  Neuroactive ligand-receptor interaction",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]\nTransporter: ABCB1 [HSA:5243]",
    "therapeutic_category": "2259",
    "atc_code": "R03AC18",
    "drug_class": [
      "Cardiovascular agent",
      "Adrenergic receptor agonist",
      "beta-Adrenergic receptor agonist",
      "beta2-Adrenergic receptor agonist",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "Transporter substrate",
      "ABCB1 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Indacaterol maleate"
  },
  {
    "kegg_id": "D10533",
    "name_en": "Umeclidinium bromide and vilanterol",
    "name_ja": "",
    "names_alt": [
      "Anoro (TN)"
    ],
    "formula": "",
    "efficacy": "Bronchodilator\nDISEASE   Chronic obstructive pulmonary disease [DS:H01714]",
    "target": "",
    "metabolism": "Enzyme: CYP2D6 [HSA:1565], CYP3A4 [HSA:1576]",
    "therapeutic_category": "2259",
    "atc_code": "R03AL03",
    "drug_class": [
      "Cardiovascular agent",
      "Adrenergic receptor agonist",
      "beta-Adrenergic receptor agonist",
      "beta3-Adrenergic receptor agonist",
      "Metabolizing enzyme substrate",
      "CYP2D6 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4",
      "CYP2D6"
    ],
    "search_name": "Umeclidinium bromide and vilanterol"
  },
  {
    "kegg_id": "D10505",
    "name_en": "Glycopyrronium bromide and indacaterol maleate",
    "name_ja": "",
    "names_alt": [
      "Ultibro (TN)"
    ],
    "formula": "",
    "efficacy": "Bronchodilator\nDISEASE   Chronic obstructive pulmonary disease [DS:H01714]",
    "target": "",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]\nTransporter: ABCB1 [HSA:5243]",
    "therapeutic_category": "2259",
    "atc_code": "R03AL04",
    "drug_class": [
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "Transporter substrate",
      "ABCB1 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Glycopyrronium bromide and indacaterol maleate"
  },
  {
    "kegg_id": "D10744",
    "name_en": "Tiotropium and olodaterol",
    "name_ja": "",
    "names_alt": [
      "Spiolto (TN)"
    ],
    "formula": "",
    "efficacy": "Bronchodilator\nDISEASE   Chronic obstructive pulmonary disease [DS:H01714]",
    "target": "",
    "metabolism": "Enzyme: UGT [KO:K00699]",
    "therapeutic_category": "2259",
    "atc_code": "R03AL06",
    "drug_class": [
      "Metabolizing enzyme substrate",
      "UGT substrate"
    ],
    "cyp_enzymes": [],
    "search_name": "Tiotropium and olodaterol"
  },
  {
    "kegg_id": "D11036",
    "name_en": "Glycopyrrolate and formoterol",
    "name_ja": "",
    "names_alt": [
      "Bevespi (TN)"
    ],
    "formula": "",
    "efficacy": "Bronchodilator\nDISEASE   Chronic obstructive pulmonary disease [DS:H01714]",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2259",
    "atc_code": "R03AL07",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Glycopyrrolate and formoterol"
  },
  {
    "kegg_id": "D01929",
    "name_en": "Tiotropium bromide hydrate (JAN)",
    "name_ja": "",
    "names_alt": [
      "Tiotropium bromide monohydrate",
      "Spiriva (TN)"
    ],
    "formula": "C19H22NO4S2. Br. H2O",
    "efficacy": "Bronchodilator, Muscarinic acetylcholine receptor antagonist\nDISEASE   Chronic obstructive pulmonary disease [DS:H01714]\nAsthma [DS:H00079]",
    "target": "CHRM3 [HSA:1131] [KO:K04131]\nPATHWAY   hsa04020(1131)  Calcium signaling pathway\nhsa04080(1131)  Neuroactive ligand-receptor interaction\nhsa04725(1131)  Cholinergic synapse",
    "metabolism": "",
    "therapeutic_category": "2259",
    "atc_code": "R03BB04",
    "drug_class": [
      "Neuropsychiatric agent",
      "Muscarinic cholinergic receptor antagonist"
    ],
    "cyp_enzymes": [],
    "search_name": "Tiotropium bromide hydrate"
  },
  {
    "kegg_id": "D08837",
    "name_en": "Aclidinium bromide (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Tudorza (TN)",
      "Eklira (TN)"
    ],
    "formula": "C26H30NO4S2. Br",
    "efficacy": "Bronchodilator, Muscarinic acetylcholine receptor antagonist\nDISEASE   Chronic obstructive pulmonary disease [DS:H01714]",
    "target": "CHRM [HSA:1128 1129 1131 1132 1133] [KO:K04129 K04130 K04131 K04132 K04133]\nPATHWAY   hsa04020(1128+1129+1131+1133)  Calcium signaling pathway\nhsa04080(1128+1129+1131+1132+1133)  Neuroactive ligand-receptor interaction\nhsa04725(1128+1129+1131+1132+1133)  Cholinergic synapse",
    "metabolism": "Enzyme: BCHE [HSA:590]",
    "therapeutic_category": "2259",
    "atc_code": "R03BB05",
    "drug_class": [
      "Neuropsychiatric agent",
      "Muscarinic cholinergic receptor antagonist",
      "Metabolizing enzyme substrate",
      "BCHE substrate",
      "Metabolizing enzyme inhibitor",
      "CYP2D6 inhibitor",
      "CYP3A/CYP3A4 inhibitor",
      "CYP3A4 inhibitor",
      "CYP3A5 inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Aclidinium bromide"
  },
  {
    "kegg_id": "D10181",
    "name_en": "Umeclidinium bromide (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Incruse ellipta (TN)"
    ],
    "formula": "C29H34NO2. Br",
    "efficacy": "Bronchodilator, Muscarinic acetylcholine receptor antagonist\nDISEASE   Chronic obstructive pulmonary disease [DS:H01714]",
    "target": "CHRM [HSA:1128 1129 1131 1132 1133] [KO:K04129 K04130 K04131 K04132 K04133]\nPATHWAY   hsa04020(1128+1129+1131+1133)  Calcium signaling pathway\nhsa04080(1128+1129+1131+1132+1133)  Neuroactive ligand-receptor interaction\nhsa04725(1128+1129+1131+1132+1133)  Cholinergic synapse",
    "metabolism": "Enzyme: CYP2D6 [HSA:1565]",
    "therapeutic_category": "2259",
    "atc_code": "R03BB07",
    "drug_class": [
      "Neuropsychiatric agent",
      "Muscarinic cholinergic receptor antagonist",
      "Metabolizing enzyme substrate",
      "CYP2D6 substrate"
    ],
    "cyp_enzymes": [
      "CYP2D6"
    ],
    "search_name": "Umeclidinium bromide"
  },
  {
    "kegg_id": "D04342",
    "name_en": "dl-Methylephedrine hydrochloride and diprophylline",
    "name_ja": "",
    "names_alt": [
      "Anysumer F (TN)"
    ],
    "formula": "",
    "efficacy": "Antiasthmatic, Antitussive",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2259",
    "atc_code": "R03DA51",
    "drug_class": [
      "Respiratory system agent",
      "Ephedrine-containing preparation"
    ],
    "cyp_enzymes": [],
    "search_name": "dl-Methylephedrine hydrochloride and diprophylline"
  },
  {
    "kegg_id": "D00863",
    "name_en": "Povidone-iodine (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Betadine (TN)"
    ],
    "formula": "xI2. (C6H9NO)n",
    "efficacy": "Disinfectant",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2260",
    "atc_code": "D08AG02",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Povidone-iodine"
  },
  {
    "kegg_id": "D04344",
    "name_en": "Azulene sulfonate sodium and sodium bicarbonate",
    "name_ja": "",
    "names_alt": [
      "Hachiazule (TN)"
    ],
    "formula": "",
    "efficacy": "Anti-inflammatory",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2260",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Azulene sulfonate sodium and sodium bicarbonate"
  },
  {
    "kegg_id": "D00246",
    "name_en": "Budesonide (JP18/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Entocort EC (TN)",
      "Pulmicort (TN)",
      "Rhinocort (TN)",
      "Uceris (TN)"
    ],
    "formula": "C25H34O6",
    "efficacy": "Antiasthmatic, Anti-inflammatory, Glucocorticoid receptor agonist\nDISEASE   Asthma [DS:H00079]\nCrohn's disease [DS:H00286]\nPerennial allergic rhinitis [DS:H01360]\nDistal ulcerative colitis [DS:H01466]",
    "target": "NR3C1 (GR) [HSA:2908] [KO:K05771]\nPATHWAY   hsa04080(2908)  Neuroactive ligand-receptor interaction",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "2290",
    "atc_code": "A07EA06",
    "drug_class": [
      "Anti-inflammatory",
      "Corticosteroid",
      "Glucocorticoid",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Budesonide"
  },
  {
    "kegg_id": "D00690",
    "name_en": "Mometasone furoate (JAN/USP)",
    "name_ja": "",
    "names_alt": [
      "Asmanex (TN)",
      "Elocon (TN)"
    ],
    "formula": "C27H30Cl2O6",
    "efficacy": "Antiasthmatic, Anti-inflammatory, Glucocorticoid receptor agonist\nDISEASE   Asthma [DS:H00079]\nSeasonal allergic rhinitis [DS:H01360]",
    "target": "NR3C1 (GR) [HSA:2908] [KO:K05771]\nPATHWAY   hsa04080(2908)  Neuroactive ligand-receptor interaction",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "2290",
    "atc_code": "D07AC13",
    "drug_class": [
      "Anti-inflammatory",
      "Corticosteroid",
      "Glucocorticoid",
      "Dermatological agent",
      "Atopic dermatitis agent",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Mometasone furoate"
  },
  {
    "kegg_id": "D05803",
    "name_en": "Sargramostim (USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Sargramostim (genetical recombination) (JAN)",
      "Leukine (TN)",
      "Sargmalin (TN)"
    ],
    "formula": "",
    "efficacy": "Antineutropenic, Hematopoietic stimulant, Granulocyte-macrophage colony stimulating factor (GM-CSF)\nDISEASE   Acute myelogenous leukemia [DS:H00003]",
    "target": "CSF2RA (GMCSFR, CD116) [HSA:1438] [KO:K05066]\nPATHWAY   hsa04060(1438)  Cytokine-cytokine receptor interaction\nhsa04630(1438)  JAK-STAT signaling pathway\nhsa04640(1438)  Hematopoietic cell lineage\nhsa05200(1438)  Pathways in cancer",
    "metabolism": "",
    "therapeutic_category": "2290",
    "atc_code": "L03AA09",
    "drug_class": [
      "Immunological agent",
      "Colony stimulating factor",
      "Granulocyte macrophage colony-stimulating factors (GM-CSF)"
    ],
    "cyp_enzymes": [],
    "search_name": "Sargramostim"
  },
  {
    "kegg_id": "D01703",
    "name_en": "Ciclesonide (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Alvesco (TN)",
      "Omnaris (TN)",
      "Zetonna (TN)"
    ],
    "formula": "C32H44O7",
    "efficacy": "Antiasthmatic, Anti-inflammatory, Glucocorticoid receptor agonist\nDISEASE   Allergic rhinitis [DS:H01360]\nAsthma [DS:H00079]",
    "target": "NR3C1 (GR) [HSA:2908] [KO:K05771]\nPATHWAY   hsa04080(2908)  Neuroactive ligand-receptor interaction",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "2290",
    "atc_code": "R01AD13",
    "drug_class": [
      "Anti-inflammatory",
      "Corticosteroid",
      "Glucocorticoid",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Ciclesonide"
  },
  {
    "kegg_id": "D08699",
    "name_en": "Salmeterol xinafoate and fluticasone propionate",
    "name_ja": "",
    "names_alt": [
      "Adoair diskus (TN)",
      "Aerivio Spiromax (TN)"
    ],
    "formula": "",
    "efficacy": "Antiasthmatic\nDISEASE   Asthma [DS:H00079]\nChronic obstructive pulmonary disease [DS:H01714]",
    "target": "",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "2290",
    "atc_code": "R01AD58",
    "drug_class": [
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Salmeterol xinafoate and fluticasone propionate"
  },
  {
    "kegg_id": "D09595",
    "name_en": "Budesonide and formoterol fumarate dihydrate",
    "name_ja": "",
    "names_alt": [
      "Symbicort (TN)",
      "Budeforu (TN)"
    ],
    "formula": "",
    "efficacy": "Antiasthmatic\nDISEASE   Asthma [DS:H00079]\nChronic obstructive pulmonary disease [DS:H01714]",
    "target": "",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576], UGT [KO:K00699]",
    "therapeutic_category": "2290",
    "atc_code": "R03AK07",
    "drug_class": [
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "UGT substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Budesonide and formoterol fumarate dihydrate"
  },
  {
    "kegg_id": "D10501",
    "name_en": "Fluticasone furoate and vilanterol trifenatate",
    "name_ja": "",
    "names_alt": [
      "Breo ellipta (TN)",
      "Relvar ellipita (TN)"
    ],
    "formula": "",
    "efficacy": "Antiasthmatic\nDISEASE   Chronic obstructive pulmonary disease [DS:H01714]\nAsthma [DS:H00079]",
    "target": "",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "2290",
    "atc_code": "R03AK10",
    "drug_class": [
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Fluticasone furoate and vilanterol trifenatate"
  },
  {
    "kegg_id": "D10506",
    "name_en": "Fluticasone propionate and formoterol fumarate hydrate",
    "name_ja": "",
    "names_alt": [
      "Flutiform (TN)"
    ],
    "formula": "",
    "efficacy": "Antiasthmatic",
    "target": "",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576], UGT [KO:K00699]",
    "therapeutic_category": "2290",
    "atc_code": "R03AK11",
    "drug_class": [
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "UGT substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Fluticasone propionate and formoterol fumarate hydrate"
  },
  {
    "kegg_id": "D11862",
    "name_en": "Indacaterol and mometasone furoate",
    "name_ja": "",
    "names_alt": [
      "Atectura (TN)"
    ],
    "formula": "",
    "efficacy": "Antiasthmatic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2290",
    "atc_code": "R03AK14",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Indacaterol and mometasone furoate"
  },
  {
    "kegg_id": "D11035",
    "name_en": "Fluticasone furoate, umeclidinium bromide and vilanterol",
    "name_ja": "",
    "names_alt": [
      "Trelegy ellipta (TN)"
    ],
    "formula": "",
    "efficacy": "Bronchodilator\nDISEASE   Chronic obstructive pulmonary disease [DS:H01714]",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2290",
    "atc_code": "R03AL08",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Fluticasone furoate, umeclidinium bromide and vilanterol"
  },
  {
    "kegg_id": "D11584",
    "name_en": "Budesonide, glycopyrronium bromide and formoterol fumarate",
    "name_ja": "",
    "names_alt": [
      "Budesonide, glycopyrrolate and formoterol fumarate",
      "Breztri (TN)"
    ],
    "formula": "",
    "efficacy": "Bronchodilator",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2290",
    "atc_code": "R03AL11",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Budesonide, glycopyrronium bromide and formoterol fumarate"
  },
  {
    "kegg_id": "D11861",
    "name_en": "Indacaterol acetate, glycopyrronium bromide and mometasone furoate",
    "name_ja": "",
    "names_alt": [
      "Enerzair (TN)"
    ],
    "formula": "",
    "efficacy": "Antiasthmatic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2290",
    "atc_code": "R03AL12",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Indacaterol acetate, glycopyrronium bromide and mometasone furoate"
  },
  {
    "kegg_id": "D05251",
    "name_en": "Omalizumab (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Omalizumab (genetical recombination) (JAN)",
      "Xolair (TN)"
    ],
    "formula": "",
    "efficacy": "Antiasthmatic, Urticaria therapeutic agent, Mediator release inhibitor, Anti-IgE antibody\nDISEASE   Asthma [DS:H00079]\nTYPE      Monoclonal antibody",
    "target": "FCER1A [HSA:2205] [KO:K08089]\nPATHWAY   hsa04664(2205)  Fc epsilon RI signaling pathway\nhsa05310(2205)  Asthma",
    "metabolism": "",
    "therapeutic_category": "2290",
    "atc_code": "R03DX05",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Omalizumab"
  },
  {
    "kegg_id": "D04923",
    "name_en": "Mepolizumab (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Mepolizumab (genetical recombination) (JAN)",
      "Nucala (TN)"
    ],
    "formula": "",
    "efficacy": "Antiasthmatic, Anti-IL-5 antibody\nDISEASE   Asthma, eosinophilic phenotype [DS:H00079]\nTYPE      Monoclonal antibody",
    "target": "IL5 [HSA:3567] [KO:K05428]\nPATHWAY   hsa04060(3567)  Cytokine-cytokine receptor interaction\nhsa04630(3567)  JAK-STAT signaling pathway\nhsa04640(3567)  Hematopoietic cell lineage\nhsa04657(3567)  IL-17 signaling pathway\nhsa04658(3567)  Th1 and Th2 cell differentiation\nhsa04660(3567)  T cell receptor signaling pathway\nhsa05310(3567)  Asthma",
    "metabolism": "",
    "therapeutic_category": "2290",
    "atc_code": "R03DX09",
    "drug_class": [
      "Immunological agent",
      "Interleukin inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Mepolizumab"
  },
  {
    "kegg_id": "D09874",
    "name_en": "Benralizumab (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Benralizumab (genetical recombination) (JAN)",
      "Fasenra (TN)"
    ],
    "formula": "C6492H10060N1724O2028S42",
    "efficacy": "Antiasthmatic, Anti-IL-5 receptor alpha antibody\nDISEASE   Asthma, eosinophilic phenotype [DS:H00079]\nTYPE      Monoclonal antibody",
    "target": "IL5RA (CD125) [HSA:3568] [KO:K05067]\nPATHWAY   hsa04060(3568)  Cytokine-cytokine receptor interaction",
    "metabolism": "",
    "therapeutic_category": "2290",
    "atc_code": "R03DX10",
    "drug_class": [
      "Immunological agent",
      "Interleukin inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Benralizumab"
  },
  {
    "kegg_id": "D11771",
    "name_en": "Tezepelumab (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Tezepelumab (genetical recombination) (JAN)",
      "Tezepelumab-ekko",
      "Tezspire (TN)"
    ],
    "formula": "C6400H9844N1732O1992S52",
    "efficacy": "Anti-inflammatory, Anti thymic stromal lymphopoietin antibody\nDISEASE   Asthma [DS:H00079]\nTYPE      Monoclonal antibody",
    "target": "TSLP [HSA:85480] [KO:K05436]\nPATHWAY   hsa04060(85480)  Cytokine-cytokine receptor interaction\nhsa04630(85480)  JAK-STAT signaling pathway",
    "metabolism": "",
    "therapeutic_category": "2290",
    "atc_code": "R03DX11",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Tezepelumab"
  },
  {
    "kegg_id": "D12169",
    "name_en": "Depemokimab (USAN)",
    "name_ja": "",
    "names_alt": [
      "Depemokimab (genetical recombination) (JAN)",
      "Depemokimab-ulaa",
      "Exdensur (TN)"
    ],
    "formula": "C6474H10108N1734O2025S44",
    "efficacy": "Antiasthmatic, Anti-IL-5 antibody\nDISEASE   Severe asthma [DS:H00079]\nTYPE      Monoclonal antibody",
    "target": "IL5 [HSA:3567] [KO:K05428]\nPATHWAY   hsa04060(3567)  Cytokine-cytokine receptor interaction\nhsa04630(3567)  JAK-STAT signaling pathway",
    "metabolism": "",
    "therapeutic_category": "2290",
    "atc_code": "R03DX12",
    "drug_class": [
      "Immunological agent",
      "Interleukin inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Depemokimab"
  },
  {
    "kegg_id": "D03261",
    "name_en": "Tyloxapol (JAN/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Alevaire (TN)"
    ],
    "formula": "",
    "efficacy": "Expectorant, Surfactant",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2290",
    "atc_code": "R05CA01",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Tyloxapol"
  },
  {
    "kegg_id": "D03896",
    "name_en": "Dornase alfa (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Dornase alfa (genetical recombination) (JAN)",
      "Pulmozyme (TN)"
    ],
    "formula": "C1321H1995N339O396S9",
    "efficacy": "Mucolytic\nDISEASE   Cystic fibrosis [DS:H00218]",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2290",
    "atc_code": "R05CB13",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Dornase alfa"
  },
  {
    "kegg_id": "D11693",
    "name_en": "Gefapixant citrate (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Lyfnua (TN)"
    ],
    "formula": "C14H19N5O4S. C6H8O7",
    "efficacy": "Analgesic, Anti-inflammatory, Antitussive, P2X3 receptor antagonist",
    "target": "P2RX3 [HSA:5024] [KO:K05217]\nPATHWAY   hsa04080(5024)  Neuroactive ligand-receptor interaction",
    "metabolism": "",
    "therapeutic_category": "2290",
    "atc_code": "R05DB29",
    "drug_class": [
      "Respiratory system agent",
      "Purinergic receptor P2X 3 antagonist"
    ],
    "cyp_enzymes": [],
    "search_name": "Gefapixant citrate"
  },
  {
    "kegg_id": "D03339",
    "name_en": "Albumin tannate (JP18)",
    "name_ja": "",
    "names_alt": [
      "Tannalbin (TN)"
    ],
    "formula": "",
    "efficacy": "Antidiarrheal",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2312",
    "atc_code": "A07XA01",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Albumin tannate"
  },
  {
    "kegg_id": "D03293",
    "name_en": "Berberine sulfate hydrate (JAN)",
    "name_ja": "",
    "names_alt": [
      "Erben (TN)"
    ],
    "formula": "(C20H18NO4)2. SO4. xH2O",
    "efficacy": "Antidiarrheal",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2314",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Berberine sulfate hydrate"
  },
  {
    "kegg_id": "D01642",
    "name_en": "Bismuth subnitrate (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Mammol (TN)"
    ],
    "formula": "BiN3H2O9",
    "efficacy": "Antidiarrheal",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2315",
    "atc_code": "A02BX12",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Bismuth subnitrate"
  },
  {
    "kegg_id": "D01398",
    "name_en": "Bismuth subgallate (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Dermatol (TN)"
    ],
    "formula": "C7H5BiO6",
    "efficacy": "Antidiarrheal, Astringent",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2315",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Bismuth subgallate"
  },
  {
    "kegg_id": "D04345",
    "name_en": "Antibiotics-resistant lactic acid bacteriae",
    "name_ja": "",
    "names_alt": [
      "Antibiophilus (TN)",
      "Biofermin R (TN)"
    ],
    "formula": "",
    "efficacy": "Intestinal regulator",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2316",
    "atc_code": "A07FA01",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Antibiotics-resistant lactic acid bacteriae"
  },
  {
    "kegg_id": "D04346",
    "name_en": "Bifidobacterium",
    "name_ja": "",
    "names_alt": [
      "Lac B (TN)"
    ],
    "formula": "",
    "efficacy": "Intestinal regulator",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2316",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Bifidobacterium"
  },
  {
    "kegg_id": "D04347",
    "name_en": "Clostridium butyricum",
    "name_ja": "",
    "names_alt": [
      "Miya BM (TN)"
    ],
    "formula": "",
    "efficacy": "Intestinal regulator",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2316",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Clostridium butyricum"
  },
  {
    "kegg_id": "D04349",
    "name_en": "Lactomin (JAN)",
    "name_ja": "",
    "names_alt": [
      "Lactobacillus acidophilus",
      "Biolact (TN)"
    ],
    "formula": "",
    "efficacy": "Intestinal regulator",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2316",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Lactomin"
  },
  {
    "kegg_id": "D08700",
    "name_en": "Bifidobacterium and lactomin",
    "name_ja": "",
    "names_alt": [
      "Biosmin (TN)"
    ],
    "formula": "",
    "efficacy": "Intestinal regulator",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2316",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Bifidobacterium and lactomin"
  },
  {
    "kegg_id": "D08701",
    "name_en": "Lactomin and amylolytic bacillus",
    "name_ja": "",
    "names_alt": [
      "Biofermin (TN)"
    ],
    "formula": "",
    "efficacy": "Intestinal regulator",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2316",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Lactomin and amylolytic bacillus"
  },
  {
    "kegg_id": "D08702",
    "name_en": "Lactomin, amylolytic bacillus and clostridium butyricum",
    "name_ja": "",
    "names_alt": [
      "Bio three (TN)"
    ],
    "formula": "",
    "efficacy": "Intestinal regulator",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2316",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Lactomin, amylolytic bacillus and clostridium butyricum"
  },
  {
    "kegg_id": "D01540",
    "name_en": "Dimeticone (JAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Dimethicone (NF)",
      "Dimethylpolysiloxane"
    ],
    "formula": "C4H12Si(C2H6OSi)n",
    "efficacy": "Antiflatulent, Lubricant, Hydrophobing",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2318",
    "atc_code": "P03AX05",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Dimeticone"
  },
  {
    "kegg_id": "D03251",
    "name_en": "Charcoal, activated (USP)",
    "name_ja": "",
    "names_alt": [
      "Medicinal carbon (JP18)"
    ],
    "formula": "",
    "efficacy": "Antidiarrheal, Antidote, Pharmaceutic aid (adsorbent)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2319",
    "atc_code": "A07BA01",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Charcoal, activated"
  },
  {
    "kegg_id": "D00729",
    "name_en": "Loperamide hydrochloride (JAN/USP)",
    "name_ja": "",
    "names_alt": [
      "Imodium (TN)"
    ],
    "formula": "C29H33ClN2O2. HCl",
    "efficacy": "Antidiarrheal, Antiperistaltic, Opioid receptor agonist",
    "target": "OPRM1 [HSA:4988] [KO:K04215]\nOPRD1 [HSA:4985] [KO:K04213]\nOPRK1 [HSA:4986] [KO:K04214]\nPATHWAY   hsa04080(4985+4986+4988)  Neuroactive ligand-receptor interaction",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576], CYP2C8 [HSA:1558]\nTransporter: ABCB1 [HSA:5243]",
    "therapeutic_category": "2319",
    "atc_code": "A07DA03",
    "drug_class": [
      "Neuropsychiatric agent",
      "Opioid receptor agonist",
      "Metabolizing enzyme substrate",
      "CYP2C8 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "Transporter substrate",
      "ABCB1 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C8",
      "CYP3A4"
    ],
    "search_name": "Loperamide hydrochloride"
  },
  {
    "kegg_id": "D04362",
    "name_en": "Berberine chloride and geranium herb extract",
    "name_ja": "",
    "names_alt": [
      "Phelloberin A (TN)"
    ],
    "formula": "",
    "efficacy": "Antidiarrheal",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2319",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Berberine chloride and geranium herb extract"
  },
  {
    "kegg_id": "D00177",
    "name_en": "Methylmethionine sulfonium chloride (JAN)",
    "name_ja": "",
    "names_alt": [
      "L-Methylmethionine sulfonium chloride",
      "Cabagin U (TN)"
    ],
    "formula": "C6H14NO2S. Cl",
    "efficacy": "Anti-ulcerative",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2321",
    "atc_code": "A02BX04",
    "drug_class": [
      "Gastrointestinal agent",
      "Agents for peptic ulcer",
      "Gastric mucosal protectant"
    ],
    "cyp_enzymes": [],
    "search_name": "Methylmethionine sulfonium chloride"
  },
  {
    "kegg_id": "D03366",
    "name_en": "Egualen sodium hydrate (JAN)",
    "name_ja": "",
    "names_alt": [
      "Egualen sodium",
      "Azuloxa (TN)"
    ],
    "formula": "(C15H17O3S. Na)3. H2O",
    "efficacy": "Anti-ulcerative",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2323",
    "atc_code": "",
    "drug_class": [
      "Gastrointestinal agent",
      "Agents for peptic ulcer",
      "Gastric mucosal protectant"
    ],
    "cyp_enzymes": [],
    "search_name": "Egualen sodium hydrate"
  },
  {
    "kegg_id": "D00295",
    "name_en": "Cimetidine (JP18/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Tagamet (TN)"
    ],
    "formula": "C10H16N6S",
    "efficacy": "Anti-ulcerative, H2 receptor antagonist\nDISEASE   Duodenal ulcer [DS:H01634]\nGastric ulcer [DS:H01634]\nGastroesophageal reflux disease [DS:H01602]\nZollinger-Ellison syndrome [DS:H01522]",
    "target": "HRH2 [HSA:3274] [KO:K04150]\nPATHWAY   hsa04020(3274)  Calcium signaling pathway\nhsa04080(3274)  Neuroactive ligand-receptor interaction\nhsa04971(3274)  Gastric acid secretion",
    "metabolism": "",
    "therapeutic_category": "2325",
    "atc_code": "A02BA01",
    "drug_class": [
      "Gastrointestinal agent",
      "Agents for peptic ulcer",
      "Histamine receptor H2 antagonist",
      "Metabolizing enzyme inhibitor",
      "CYP2D6 inhibitor",
      "CYP3A/CYP3A4 inhibitor",
      "CYP3A4 inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Cimetidine"
  },
  {
    "kegg_id": "D00318",
    "name_en": "Famotidine (JP18/USP/INN)",
    "name_ja": "ファモチジン",
    "names_alt": [
      "Fluxid (TN)",
      "Pepcid (TN)"
    ],
    "formula": "C8H15N7O2S3",
    "efficacy": "Anti-ulcerative, H2 receptor antagonist\nDISEASE   Duodenal ulcer [DS:H01634]\nGastric ulcer [DS:H01634]\nGastroesophageal reflux disease [DS:H01602]\nZollinger-Ellison syndrome [DS:H01522]",
    "target": "HRH2 [HSA:3274] [KO:K04150]\nPATHWAY   hsa04020(3274)  Calcium signaling pathway\nhsa04080(3274)  Neuroactive ligand-receptor interaction\nhsa04971(3274)  Gastric acid secretion",
    "metabolism": "Transporter: SLC22A2 [HSA:6582], SLC22A8 [HSA:9376]",
    "therapeutic_category": "2325",
    "atc_code": "A02BA03",
    "drug_class": [
      "Gastrointestinal agent",
      "Agents for peptic ulcer",
      "Histamine receptor H2 antagonist",
      "Metabolizing enzyme inhibitor",
      "CYP1A2 inhibitor",
      "Transporter substrate",
      "SLC22A2 substrate",
      "SLC22A8 substrate",
      "Transporter inhibitor",
      "SLC22A2 inhibitor",
      "SLC22A3 inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Famotidine"
  },
  {
    "kegg_id": "D00440",
    "name_en": "Nizatidine (JP18/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Acinon (TN)",
      "Axid (TN)"
    ],
    "formula": "C12H21N5O2S2",
    "efficacy": "Anti-ulcerative, H2 receptor antagonist\nDISEASE   Duodenal ulcer [DS:H01634]\nGERD [DS:H01602]\nGastric ulcer [DS:H01634]",
    "target": "HRH2 [HSA:3274] [KO:K04150]\nPATHWAY   hsa04020(3274)  Calcium signaling pathway\nhsa04080(3274)  Neuroactive ligand-receptor interaction\nhsa04971(3274)  Gastric acid secretion",
    "metabolism": "",
    "therapeutic_category": "2325",
    "atc_code": "A02BA04",
    "drug_class": [
      "Gastrointestinal agent",
      "Agents for peptic ulcer",
      "Histamine receptor H2 antagonist"
    ],
    "cyp_enzymes": [],
    "search_name": "Nizatidine"
  },
  {
    "kegg_id": "D01467",
    "name_en": "Roxatidine acetate hydrochloride (JP18/USAN)",
    "name_ja": "",
    "names_alt": [
      "Altat (TN)"
    ],
    "formula": "C19H28N2O4. HCl",
    "efficacy": "Anti-ulcerative, H2 receptor antagonist",
    "target": "HRH2 [HSA:3274] [KO:K04150]\nPATHWAY   hsa04020(3274)  Calcium signaling pathway\nhsa04080(3274)  Neuroactive ligand-receptor interaction\nhsa04971(3274)  Gastric acid secretion",
    "metabolism": "",
    "therapeutic_category": "2325",
    "atc_code": "A02BA06",
    "drug_class": [
      "Gastrointestinal agent",
      "Agents for peptic ulcer",
      "Histamine receptor H2 antagonist"
    ],
    "cyp_enzymes": [],
    "search_name": "Roxatidine acetate hydrochloride"
  },
  {
    "kegg_id": "D01131",
    "name_en": "Lafutidine (JP18/INN)",
    "name_ja": "",
    "names_alt": [
      "Protecadin (TN)"
    ],
    "formula": "C22H29N3O4S",
    "efficacy": "Anti-ulcerative, H2 receptor antagonist",
    "target": "HRH2 [HSA:3274] [KO:K04150]\nPATHWAY   hsa04020(3274)  Calcium signaling pathway\nhsa04080(3274)  Neuroactive ligand-receptor interaction\nhsa04971(3274)  Gastric acid secretion",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576], CYP2D6 [HSA:1565]",
    "therapeutic_category": "2325",
    "atc_code": "A02BA08",
    "drug_class": [
      "Gastrointestinal agent",
      "Agents for peptic ulcer",
      "Histamine receptor H2 antagonist",
      "Metabolizing enzyme substrate",
      "CYP2D6 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4",
      "CYP2D6"
    ],
    "search_name": "Lafutidine"
  },
  {
    "kegg_id": "D00419",
    "name_en": "Misoprostol (JAN/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Cytotec (TN)"
    ],
    "formula": "C22H38O5",
    "efficacy": "Anti-ulcerative, Prostaglandin E receptor agonist\nDISEASE   Gastric ulcers [DS:H01634]",
    "target": "PTGER2 [HSA:5732] [KO:K04259]\nPTGER3 [HSA:5733] [KO:K04260]\nPTGER4 [HSA:5734] [KO:K04261]\nPATHWAY   hsa04024(5732+5733)  cAMP signaling pathway\nhsa04080(5732+5733+5734)  Neuroactive ligand-receptor interaction\nhsa04750(5732+5734)  Inflammatory mediator regulation of TRP channels",
    "metabolism": "",
    "therapeutic_category": "2329",
    "atc_code": "A02BB01",
    "drug_class": [
      "Hormonal agent",
      "Prostaglandin derivative",
      "Prostaglandin E1 derivative",
      "Gastrointestinal agent",
      "Agents for peptic ulcer"
    ],
    "cyp_enzymes": [],
    "search_name": "Misoprostol"
  },
  {
    "kegg_id": "D00455",
    "name_en": "Omeprazole (JP18/USP/INN)",
    "name_ja": "オメプラゾール",
    "names_alt": [
      "Prilosec (TN)"
    ],
    "formula": "C17H19N3O3S",
    "efficacy": "Antisecretory (gastric acid), Anti-ulcerative, Proton pump inhibitor\nDISEASE   Duodenal ulcer [DS:H01634]\nGastric ulcer [DS:H01634]\nGastroesophageal reflux disease [DS:H01602]\nZollinger-Ellison syndrome [DS:H01522]\nMultiple endocrine adenomas [DS:H01102]",
    "target": "ATP4 [HSA:495 496] [KO:K01542 K01543]\nPATHWAY   hsa04966(495+496)  Collecting duct acid secretion\nhsa04971(495+496)  Gastric acid secretion",
    "metabolism": "Enzyme: CYP2C19 [HSA:1557]; CYP3A4 [HSA:1576]",
    "therapeutic_category": "2329",
    "atc_code": "A02BC01",
    "drug_class": [
      "Gastrointestinal agent",
      "Agents for peptic ulcer",
      "Proton pump inhibitor (PPI)",
      "Metabolizing enzyme substrate",
      "CYP2C19 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C19",
      "CYP3A4"
    ],
    "search_name": "Omeprazole"
  },
  {
    "kegg_id": "D05261",
    "name_en": "Omeprazole sodium injection (JAN)",
    "name_ja": "オメプラゾール",
    "names_alt": [
      "Omeprazole sodium hydrate",
      "Omepral (TN)"
    ],
    "formula": "C17H18N3O3S. Na. H2O",
    "efficacy": "Antisecretory (gastric acid), Anti-ulcerative, Proton pump inhibitor",
    "target": "ATP4 [HSA:495 496] [KO:K01542 K01543]\nPATHWAY   hsa04966(495+496)  Collecting duct acid secretion\nhsa04971(495+496)  Gastric acid secretion",
    "metabolism": "Enzyme: CYP2C19 [HSA:1557]; CYP3A4 [HSA:1576]",
    "therapeutic_category": "2329",
    "atc_code": "A02BC01",
    "drug_class": [
      "Gastrointestinal agent",
      "Agents for peptic ulcer",
      "Proton pump inhibitor (PPI)",
      "Metabolizing enzyme substrate",
      "CYP2C19 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C19",
      "CYP3A4"
    ],
    "search_name": "Omeprazole sodium injection"
  },
  {
    "kegg_id": "D00355",
    "name_en": "Lansoprazole (JP18/USP/INN)",
    "name_ja": "ランソプラゾール",
    "names_alt": [
      "Prevacid (TN)"
    ],
    "formula": "C16H14F3N3O2S",
    "efficacy": "Anti-ulcerative, Proton pump inhibitor\nDISEASE   Duodenal ulcer [DS:H01634]\nH. pylori eradication [DS:H00320]\nGastric ulcer [DS:H01634]\nGastroesophageal reflux disease [DS:H01602]\nZollinger-Ellison syndrome [DS:H01522]",
    "target": "ATP4 [HSA:495 496] [KO:K01542 K01543]\nPATHWAY   hsa04966(495+496)  Collecting duct acid secretion\nhsa04971(495+496)  Gastric acid secretion",
    "metabolism": "Enzyme: CYP2C19 [HSA:1557], CYP3A4 [HSA:1576]",
    "therapeutic_category": "2329",
    "atc_code": "A02BC03",
    "drug_class": [
      "Gastrointestinal agent",
      "Agents for peptic ulcer",
      "Proton pump inhibitor (PPI)",
      "Metabolizing enzyme substrate",
      "CYP2C19 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "Metabolizing enzyme inhibitor",
      "CYP2C19 inhibitor",
      "Transporter inhibitor",
      "ABCC2 inhibitor"
    ],
    "cyp_enzymes": [
      "CYP2C19",
      "CYP3A4"
    ],
    "search_name": "Lansoprazole"
  },
  {
    "kegg_id": "D00724",
    "name_en": "Rabeprazole sodium (JP18/USP)",
    "name_ja": "ラベプラゾール",
    "names_alt": [
      "Aciphex (TN)",
      "Pariet (TN)"
    ],
    "formula": "C18H20N3O3S. Na",
    "efficacy": "Antisecretory (gastric acid), Anti-ulcerative, Proton pump inhibitor\nDISEASE   Erosive or ulcerative GERD [DS:H01602]\nDuodenal ulcer [DS:H01634]\nHelicobacter pylori eradication [DS:H00320]\nZollinger-Ellison syndrome [DS:H01522]",
    "target": "ATP4 [HSA:495 496] [KO:K01542 K01543]\nPATHWAY   hsa04966(495+496)  Collecting duct acid secretion\nhsa04971(495+496)  Gastric acid secretion",
    "metabolism": "Enzyme: CYP2C19 [HSA:1557], CYP3A4 [HSA:1576]",
    "therapeutic_category": "2329",
    "atc_code": "A02BC04",
    "drug_class": [
      "Gastrointestinal agent",
      "Agents for peptic ulcer",
      "Proton pump inhibitor (PPI)",
      "Metabolizing enzyme substrate",
      "CYP2C19 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C19",
      "CYP3A4"
    ],
    "search_name": "Rabeprazole sodium"
  },
  {
    "kegg_id": "D01984",
    "name_en": "Esomeprazole magnesium (USP)",
    "name_ja": "エソメプラゾール",
    "names_alt": [
      "Esomeprazole magnesium hydrate (JAN)",
      "Esomeprazole magnesium trihydrate",
      "Nexium (TN)"
    ],
    "formula": "(C17H18N3O3S)2. 3H2O. Mg",
    "efficacy": "Antisecretory (gastric acid), Anti-ulcerative, Proton pump inhibitor\nDISEASE   Gastroesophageal reflux disease [DS:H01602]\nGastric ulcer [DS:H01634]\nH. pylori eradication [DS:H00320]\nZollinger-Ellison syndrome [DS:H01522]",
    "target": "ATP4 [HSA:495 496] [KO:K01542 K01543]\nPATHWAY   hsa04966(495+496)  Collecting duct acid secretion\nhsa04971(495+496)  Gastric acid secretion",
    "metabolism": "Enzyme: CYP2C19 [HSA:1557]; CYP3A4 [HSA:1576]",
    "therapeutic_category": "2329",
    "atc_code": "A02BC05",
    "drug_class": [
      "Gastrointestinal agent",
      "Agents for peptic ulcer",
      "Proton pump inhibitor (PPI)",
      "Metabolizing enzyme substrate",
      "CYP2C19 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C19",
      "CYP3A4"
    ],
    "search_name": "Esomeprazole magnesium"
  },
  {
    "kegg_id": "D10466",
    "name_en": "Vonoprazan fumarate (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Takecab (TN)",
      "Voquezna (TN)"
    ],
    "formula": "C17H16FN3O2S. C4H4O4",
    "efficacy": "Anti-ulcerative, Proton pump inhibitor\nDISEASE   Erosive esophagitis [DS:H01602]\nHelicobacter pylori infection [DS:H00320]",
    "target": "ATP4 [HSA:495 496] [KO:K01542 K01543]\nPATHWAY   hsa04966(495+496)  Collecting duct acid secretion\nhsa04971(495+496)  Gastric acid secretion",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]; CYP2B6 [HSA:1555], CYP2C19 [HSA:1557], CYP2D6 [HSA:1565]",
    "therapeutic_category": "2329",
    "atc_code": "A02BC08",
    "drug_class": [
      "Gastrointestinal agent",
      "Agents for peptic ulcer",
      "Proton pump inhibitor (PPI)",
      "Metabolizing enzyme substrate",
      "CYP2B6 substrate",
      "CYP2C19 substrate",
      "CYP2D6 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C19",
      "CYP3A4",
      "CYP2B6",
      "CYP2D6"
    ],
    "search_name": "Vonoprazan fumarate"
  },
  {
    "kegg_id": "D00446",
    "name_en": "Sucralfate (USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Sucralfate hydrate (JP18)",
      "Carafate (TN)"
    ],
    "formula": "C12H14O11R8. xAlH3O3. yH2O",
    "efficacy": "Anti-ulcerative, Antipepcin\nDISEASE   Duodenal ulcer [DS:H01634]",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2329",
    "atc_code": "A02BX02",
    "drug_class": [
      "Gastrointestinal agent",
      "Agents for peptic ulcer",
      "Gastric mucosal protectant"
    ],
    "cyp_enzymes": [],
    "search_name": "Sucralfate"
  },
  {
    "kegg_id": "D05276",
    "name_en": "Pirenzepine hydrochloride hydrate (JP18)",
    "name_ja": "",
    "names_alt": [
      "Gastrozepin (TN)"
    ],
    "formula": "C19H21N5O2. 2HCl. H2O",
    "efficacy": "Antisecretory (gastric acid), Anti-ulcerative, Muscarinic acetylcholine receptor antagonist",
    "target": "CHRM [HSA:1128 1129 1131 1132 1133] [KO:K04129 K04130 K04131 K04132 K04133]\nPATHWAY   hsa04020(1128+1129+1131+1133)  Calcium signaling pathway\nhsa04080(1128+1129+1131+1132+1133)  Neuroactive ligand-receptor interaction\nhsa04725(1128+1129+1131+1132+1133)  Cholinergic synapse\nhsa04971(1131)  Gastric acid secretion\nhsa04972(1131)  Pancreatic secretion",
    "metabolism": "",
    "therapeutic_category": "2329",
    "atc_code": "A02BX03",
    "drug_class": [
      "Neuropsychiatric agent",
      "Muscarinic cholinergic receptor antagonist",
      "Gastrointestinal agent",
      "Agents for peptic ulcer"
    ],
    "cyp_enzymes": [],
    "search_name": "Pirenzepine hydrochloride hydrate"
  },
  {
    "kegg_id": "D01306",
    "name_en": "Troxipide (JP18/INN)",
    "name_ja": "",
    "names_alt": [
      "Aplace (TN)"
    ],
    "formula": "C15H22N2O4",
    "efficacy": "Anti-ulcerative",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2329",
    "atc_code": "A02BX11",
    "drug_class": [
      "Gastrointestinal agent",
      "Agents for peptic ulcer",
      "Gastric mucosal protectant"
    ],
    "cyp_enzymes": [],
    "search_name": "Troxipide"
  },
  {
    "kegg_id": "D03336",
    "name_en": "Sodium alginate (JAN/NF)",
    "name_ja": "",
    "names_alt": [
      "Ascophyllum",
      "Arcrane (TN)"
    ],
    "formula": "",
    "efficacy": "Anti-ulcerative, Hemostatic (local), Pharmaceutic aid (suspending)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2329",
    "atc_code": "A02BX13",
    "drug_class": [
      "Gastrointestinal agent",
      "Agents for peptic ulcer",
      "Gastric mucosal protectant"
    ],
    "cyp_enzymes": [],
    "search_name": "Sodium alginate"
  },
  {
    "kegg_id": "D01827",
    "name_en": "Teprenone (JP18/INN)",
    "name_ja": "",
    "names_alt": [
      "Selbex (TN)"
    ],
    "formula": "C23H38O",
    "efficacy": "Anti-ulcerative, Mucosal protectant",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2329",
    "atc_code": "A02BX15",
    "drug_class": [
      "Gastrointestinal agent",
      "Agents for peptic ulcer",
      "Gastric mucosal protectant"
    ],
    "cyp_enzymes": [],
    "search_name": "Teprenone"
  },
  {
    "kegg_id": "D01658",
    "name_en": "Irsogladine maleate (JP18)",
    "name_ja": "",
    "names_alt": [
      "Gaslon N (TN)"
    ],
    "formula": "C9H7Cl2N5. C4H4O4",
    "efficacy": "Anti-ulcerative",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2329",
    "atc_code": "A02BX16",
    "drug_class": [
      "Gastrointestinal agent",
      "Agents for peptic ulcer",
      "Gastric mucosal protectant"
    ],
    "cyp_enzymes": [],
    "search_name": "Irsogladine maleate"
  },
  {
    "kegg_id": "D01611",
    "name_en": "Polaprezinc (JP18/INN)",
    "name_ja": "",
    "names_alt": [
      "Promac (TN)"
    ],
    "formula": "C9H12N4O3. Zn",
    "efficacy": "Anti-ulcerative",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2329",
    "atc_code": "",
    "drug_class": [
      "Gastrointestinal agent",
      "Agents for peptic ulcer",
      "Gastric mucosal protectant"
    ],
    "cyp_enzymes": [],
    "search_name": "Polaprezinc"
  },
  {
    "kegg_id": "D01956",
    "name_en": "Sofalcone (JAN)",
    "name_ja": "",
    "names_alt": [
      "Solon (TN)"
    ],
    "formula": "C27H30O6",
    "efficacy": "Anti-ulcerative, Mucosal protectant",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2329",
    "atc_code": "",
    "drug_class": [
      "Gastrointestinal agent",
      "Agents for peptic ulcer",
      "Gastric mucosal protectant"
    ],
    "cyp_enzymes": [],
    "search_name": "Sofalcone"
  },
  {
    "kegg_id": "D01991",
    "name_en": "Ecabet sodium hydrate (JP18)",
    "name_ja": "",
    "names_alt": [
      "Ecabet sodium",
      "Gastrom (TN)"
    ],
    "formula": "C20H27O5S. 5H2O. Na",
    "efficacy": "Anti-ulcerative",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2329",
    "atc_code": "",
    "drug_class": [
      "Gastrointestinal agent",
      "Agents for peptic ulcer",
      "Gastric mucosal protectant"
    ],
    "cyp_enzymes": [],
    "search_name": "Ecabet sodium hydrate"
  },
  {
    "kegg_id": "D02033",
    "name_en": "Aldioxa (JP18/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Dihydroxyaluminum allantoinate",
      "Ascomp (TN)",
      "Isalon (TN)"
    ],
    "formula": "C4H7AlN4O5",
    "efficacy": "Anti-ulcerative, Astringent, Keratolytic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2329",
    "atc_code": "",
    "drug_class": [
      "Gastrointestinal agent",
      "Agents for peptic ulcer",
      "Gastric mucosal protectant"
    ],
    "cyp_enzymes": [],
    "search_name": "Aldioxa"
  },
  {
    "kegg_id": "D02266",
    "name_en": "Cetraxate hydrochloride (JP18/USAN)",
    "name_ja": "",
    "names_alt": [
      "Neuer (TN)"
    ],
    "formula": "C17H23NO4. HCl",
    "efficacy": "Anti-ulcerative",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2329",
    "atc_code": "",
    "drug_class": [
      "Gastrointestinal agent",
      "Agents for peptic ulcer",
      "Gastric mucosal protectant"
    ],
    "cyp_enzymes": [],
    "search_name": "Cetraxate hydrochloride"
  },
  {
    "kegg_id": "D02452",
    "name_en": "Benexate hydrochloride betadex (JAN)",
    "name_ja": "",
    "names_alt": [
      "Ulgut (TN)"
    ],
    "formula": "C42H70O35. C23H27N3O4. HCl",
    "efficacy": "Anti-ulcerative",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2329",
    "atc_code": "",
    "drug_class": [
      "Gastrointestinal agent",
      "Agents for peptic ulcer",
      "Gastric mucosal protectant"
    ],
    "cyp_enzymes": [],
    "search_name": "Benexate hydrochloride betadex"
  },
  {
    "kegg_id": "D04363",
    "name_en": "Azulene sulfonate sodium and L-glutamine",
    "name_ja": "",
    "names_alt": [
      "Marzulene-S (TN)"
    ],
    "formula": "",
    "efficacy": "Anti-ulcerative",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2329",
    "atc_code": "",
    "drug_class": [
      "Gastrointestinal agent",
      "Agents for peptic ulcer",
      "Gastric mucosal protectant"
    ],
    "cyp_enzymes": [],
    "search_name": "Azulene sulfonate sodium and L-glutamine"
  },
  {
    "kegg_id": "D04364",
    "name_en": "Dicyclomine hydrochloride, aluminium hydroxide, dried and magnesium oxide",
    "name_ja": "",
    "names_alt": [
      "Kolantyl (TN)"
    ],
    "formula": "",
    "efficacy": "Anti-ulcerative",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2329",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Dicyclomine hydrochloride, aluminium hydroxide, dried and magnesium oxide"
  },
  {
    "kegg_id": "D08704",
    "name_en": "Magnesium aluminometasilicate, methylmethionine sulfonium chloride, magnesium carbonate and precipitated calcium carbonate",
    "name_ja": "",
    "names_alt": [
      "Cabagin-U (TN)"
    ],
    "formula": "",
    "efficacy": "Anti-ulcerative",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2329",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Magnesium aluminometasilicate, methylmethionine sulfonium chloride, magnesium carbonate and precipitated calcium carbonate"
  },
  {
    "kegg_id": "D03329",
    "name_en": "Diastase (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Digestant (enzyme)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2331",
    "atc_code": "A09AA01",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Diastase"
  },
  {
    "kegg_id": "D03322",
    "name_en": "Pancreatin (JP18/USP)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Digestant (enzyme)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2331",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Pancreatin"
  },
  {
    "kegg_id": "D03345",
    "name_en": "beta-Galactosidase (Aspergillus) (JP18)",
    "name_ja": "",
    "names_alt": [
      "Oryzatym (TN)"
    ],
    "formula": "",
    "efficacy": "Digestant adjunct (enzyme)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2331",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "beta-Galactosidase"
  },
  {
    "kegg_id": "D05349",
    "name_en": "Pancrelipase (JAN/USP)",
    "name_ja": "",
    "names_alt": [
      "Cotazym (TN)",
      "Creon (TN)",
      "Pancrease (TN)",
      "Zenpep (TN)"
    ],
    "formula": "",
    "efficacy": "Digestant adjunct (enzyme)\nDISEASE   Cystic fibrosis [DS:H00218]\nChronic pancreatitis [DS:H01680]",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2331",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Pancrelipase"
  },
  {
    "kegg_id": "D08832",
    "name_en": "Digestive enzyme preparation",
    "name_ja": "",
    "names_alt": [
      "Berizym (TN)"
    ],
    "formula": "",
    "efficacy": "Digestant (enzyme)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2331",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Digestive enzyme preparation"
  },
  {
    "kegg_id": "D04380",
    "name_en": "Dried yeast (JP18)",
    "name_ja": "",
    "names_alt": [
      "Yeast, dried",
      "Ebios (TN)"
    ],
    "formula": "",
    "efficacy": "Supplement (nutrient)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2332",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Dried yeast"
  },
  {
    "kegg_id": "D04383",
    "name_en": "Condurango fluidextract (JP18)",
    "name_ja": "",
    "names_alt": [
      "Condurango extract"
    ],
    "formula": "",
    "efficacy": "Gastric secretion accelerator",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2333",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Condurango fluidextract"
  },
  {
    "kegg_id": "D04389",
    "name_en": "Bitter tincture (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Stomachic, Pharmaceutic aid (flavor)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2333",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Bitter tincture"
  },
  {
    "kegg_id": "D04391",
    "name_en": "Swertia and sodium bicarbonate (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Stomachic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2333",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Swertia and sodium bicarbonate"
  },
  {
    "kegg_id": "D06494",
    "name_en": "Nux vomica tincture (JP18)",
    "name_ja": "",
    "names_alt": [
      "Strychnos extract tincture (TN)"
    ],
    "formula": "",
    "efficacy": "Gastric secretion accelerator",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2333",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Nux vomica tincture"
  },
  {
    "kegg_id": "D06500",
    "name_en": "Orange peel tincture (JP18)",
    "name_ja": "",
    "names_alt": [
      "Orange peel tincture, sweet (NF)",
      "Osbeck (TN)"
    ],
    "formula": "",
    "efficacy": "Pharmaceutic aid (flavor)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2333",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Orange peel tincture"
  },
  {
    "kegg_id": "D06501",
    "name_en": "Orange peel syrup (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Pharmaceutic aid (flavor)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2333",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Orange peel syrup"
  },
  {
    "kegg_id": "D06873",
    "name_en": "Nux vomica extract (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Gastric secretion accelerator",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2333",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Nux vomica extract"
  },
  {
    "kegg_id": "D04390",
    "name_en": "Dilute hydrochloric acid (JP18)",
    "name_ja": "",
    "names_alt": [
      "Hydrochloric acid lemonade (JP18)"
    ],
    "formula": "",
    "efficacy": "Digestant, Stomachic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2335",
    "atc_code": "A09AB03",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Dilute hydrochloric acid"
  },
  {
    "kegg_id": "D03346",
    "name_en": "beta-Galactosidase (Penicillium) (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Digestant adjunct (enzyme)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2339",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "beta-Galactosidase"
  },
  {
    "kegg_id": "D08708",
    "name_en": "Licase (alpha Amylase), aluminum hydroxide, dried, magnesium carbonate, sodium bicarbonate and precipitated calcium carbonate",
    "name_ja": "",
    "names_alt": [
      "AM (TN)",
      "NS (TN)"
    ],
    "formula": "",
    "efficacy": "Stomachic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2339",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Licase"
  },
  {
    "kegg_id": "D08709",
    "name_en": "Picrasma wood and sodium bicarbonate",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Stomachic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2339",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Picrasma wood and sodium bicarbonate"
  },
  {
    "kegg_id": "D08834",
    "name_en": "Stomachic and digestive",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Digestant, Stomachic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2339",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Stomachic and digestive"
  },
  {
    "kegg_id": "D02416",
    "name_en": "Aluminum hydroxide (USP)",
    "name_ja": "",
    "names_alt": [
      "Aluminum hydroxide, dried (USP)",
      "Dried aluminum hydroxide gel (JP18)",
      "ALterna GEL (TN)",
      "Dialume (TN)"
    ],
    "formula": "AlH3O3",
    "efficacy": "Antacid",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2343",
    "atc_code": "A02AB01",
    "drug_class": [
      "Gastrointestinal agent",
      "Agents for peptic ulcer",
      "Antacid",
      "Aluminum compounds antacid"
    ],
    "cyp_enzymes": [],
    "search_name": "Aluminum hydroxide"
  },
  {
    "kegg_id": "D03237",
    "name_en": "Natural aluminum silicate (JP18)",
    "name_ja": "",
    "names_alt": [
      "Aluminum silicate, natural",
      "Adsorbin (TN)"
    ],
    "formula": "",
    "efficacy": "Antidiarrheal",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2343",
    "atc_code": "",
    "drug_class": [
      "Gastrointestinal agent",
      "Agents for peptic ulcer",
      "Antacid",
      "Aluminum compounds antacid"
    ],
    "cyp_enzymes": [],
    "search_name": "Natural aluminum silicate"
  },
  {
    "kegg_id": "D01446",
    "name_en": "Magnesium carbonate (JP18/USP)",
    "name_ja": "",
    "names_alt": [],
    "formula": "CO3. Mg. xH2O",
    "efficacy": "Antacid, Laxative",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2344",
    "atc_code": "A02AA01",
    "drug_class": [
      "Gastrointestinal agent",
      "Agents for peptic ulcer",
      "Antacid",
      "Laxative",
      "Magnesium containing preparation"
    ],
    "cyp_enzymes": [],
    "search_name": "Magnesium carbonate"
  },
  {
    "kegg_id": "D01167",
    "name_en": "Magnesium oxide (JP18/USP)",
    "name_ja": "酸化マグネシウム",
    "names_alt": [
      "Magmitt (TN)"
    ],
    "formula": "MgO",
    "efficacy": "Antacid, Laxative, Pharmaceutic aid (sorbent)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2344",
    "atc_code": "A02AA02",
    "drug_class": [
      "Gastrointestinal agent",
      "Agents for peptic ulcer",
      "Antacid",
      "Laxative",
      "Magnesium containing preparation"
    ],
    "cyp_enzymes": [],
    "search_name": "Magnesium oxide"
  },
  {
    "kegg_id": "D00731",
    "name_en": "Magnesium hydroxide (JAN/USP)",
    "name_ja": "",
    "names_alt": [
      "Magnesia, (Milk of) (USP)",
      "Milmag (TN)",
      "Mint-o-mag (TN)"
    ],
    "formula": "MgH2O2",
    "efficacy": "Antacid, Laxative",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2344",
    "atc_code": "A02AA04",
    "drug_class": [
      "Gastrointestinal agent",
      "Agents for peptic ulcer",
      "Antacid",
      "Magnesium containing preparation"
    ],
    "cyp_enzymes": [],
    "search_name": "Magnesium hydroxide"
  },
  {
    "kegg_id": "D01203",
    "name_en": "Sodium bicarbonate (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Meylon (TN)",
      "Neut (TN)"
    ],
    "formula": "HCO3. Na",
    "efficacy": "Antacid, Alkalizer, Antidote, Replenisher (electrolyte)\nDISEASE   Metabolic acidosis [DS:H00241 H00243 H00428 H00429]",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2344",
    "atc_code": "B05CB04",
    "drug_class": [
      "Gastrointestinal agent",
      "Agents for peptic ulcer",
      "Antacid"
    ],
    "cyp_enzymes": [],
    "search_name": "Sodium bicarbonate"
  },
  {
    "kegg_id": "D04393",
    "name_en": "Aluminum hydroxide and magnesium hydroxide",
    "name_ja": "",
    "names_alt": [
      "Aluminum hydroxide and magnesium hydroxide",
      "Maalox (TN)",
      "Sakloft (TN)"
    ],
    "formula": "",
    "efficacy": "Antacid, Anti-ulcerative",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2349",
    "atc_code": "",
    "drug_class": [
      "Gastrointestinal agent",
      "Agents for peptic ulcer",
      "Antacid",
      "Aluminum compounds antacid"
    ],
    "cyp_enzymes": [],
    "search_name": "Aluminum hydroxide and magnesium hydroxide"
  },
  {
    "kegg_id": "D02171",
    "name_en": "Sennosides (USP)",
    "name_ja": "",
    "names_alt": [
      "Pursennid (TN)"
    ],
    "formula": "C42H38O20",
    "efficacy": "Laxative",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2354",
    "atc_code": "A06AB06",
    "drug_class": [
      "Gastrointestinal agent",
      "Laxative"
    ],
    "cyp_enzymes": [],
    "search_name": "Sennosides"
  },
  {
    "kegg_id": "D04396",
    "name_en": "Cascara sagrada (USP)",
    "name_ja": "",
    "names_alt": [
      "Cascara sagrada fluidextract"
    ],
    "formula": "",
    "efficacy": "Laxative",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2354",
    "atc_code": "A06AB07",
    "drug_class": [
      "Gastrointestinal agent",
      "Laxative"
    ],
    "cyp_enzymes": [],
    "search_name": "Cascara sagrada"
  },
  {
    "kegg_id": "D04395",
    "name_en": "Senna (USP)",
    "name_ja": "",
    "names_alt": [
      "Senna extract",
      "Senokot (TN)"
    ],
    "formula": "",
    "efficacy": "Laxative",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2354",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Senna"
  },
  {
    "kegg_id": "D04408",
    "name_en": "Carlsbad salt",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Laxative",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2355",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Carlsbad salt"
  },
  {
    "kegg_id": "D03418",
    "name_en": "Aromatic castor oil (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Laxative",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2356",
    "atc_code": "A06AB05",
    "drug_class": [
      "Gastrointestinal agent",
      "Laxative"
    ],
    "cyp_enzymes": [],
    "search_name": "Aromatic castor oil"
  },
  {
    "kegg_id": "D06462",
    "name_en": "Castor oil (JP18/USP)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Laxative",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2356",
    "atc_code": "A06AB05",
    "drug_class": [
      "Gastrointestinal agent",
      "Laxative"
    ],
    "cyp_enzymes": [],
    "search_name": "Castor oil"
  },
  {
    "kegg_id": "D00028",
    "name_en": "Glycerin (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Concentrated glycerin (JP18)",
      "Glycerol (INN)",
      "Glycerin, concentrated"
    ],
    "formula": "C3H8O3",
    "efficacy": "Enema, Pharmaceutic aid (humectant, solvent)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2357",
    "atc_code": "A06AG04",
    "drug_class": [
      "Gastrointestinal agent",
      "Laxative"
    ],
    "cyp_enzymes": [],
    "search_name": "Glycerin"
  },
  {
    "kegg_id": "D00245",
    "name_en": "Bisacodyl (JP18/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Dulcolax (TN)"
    ],
    "formula": "C22H19NO4",
    "efficacy": "Laxative (suppository)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2359",
    "atc_code": "A06AB02",
    "drug_class": [
      "Gastrointestinal agent",
      "Laxative"
    ],
    "cyp_enzymes": [],
    "search_name": "Bisacodyl"
  },
  {
    "kegg_id": "D01612",
    "name_en": "Sodium picosulfate hydrate (JP18)",
    "name_ja": "",
    "names_alt": [
      "Laxoberal (TN)",
      "Laxoberon (TN)"
    ],
    "formula": "C18H13NO8S2. 2Na. H2O",
    "efficacy": "Laxative",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2359",
    "atc_code": "A06AB08",
    "drug_class": [
      "Gastrointestinal agent",
      "Laxative"
    ],
    "cyp_enzymes": [],
    "search_name": "Sodium picosulfate hydrate"
  },
  {
    "kegg_id": "D00352",
    "name_en": "Lactulose (JP18/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Cephulac (TN)",
      "Chronulac (TN)"
    ],
    "formula": "C12H22O11",
    "efficacy": "Antihyperammonemic, Laxative",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2359",
    "atc_code": "A06AD11",
    "drug_class": [
      "Gastrointestinal agent",
      "Laxative"
    ],
    "cyp_enzymes": [],
    "search_name": "Lactulose"
  },
  {
    "kegg_id": "D10478",
    "name_en": "Naldemedine tosylate (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Naldemedine tosilate",
      "Symproic (TN)"
    ],
    "formula": "C32H34N4O6. C7H8O3S",
    "efficacy": "Anti-emetic, Laxative, Opioid receptor antagonist",
    "target": "OPRM1 [HSA:4988] [KO:K04215]\nPATHWAY   hsa04080(4988)  Neuroactive ligand-receptor interaction\nhsa05032(4988)  Morphine addiction",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "2359",
    "atc_code": "A06AH05",
    "drug_class": [
      "Analgesic",
      "Opioid receptor antagonist",
      "Gastrointestinal agent",
      "Laxative",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Naldemedine tosylate"
  },
  {
    "kegg_id": "D04790",
    "name_en": "Lubiprostone (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Amitiza (TN)"
    ],
    "formula": "C20H32F2O5",
    "efficacy": "Peristaltic accelerator, Softener, Clc chloride channel inhibitor\nDISEASE   Irritable bowel syndrome with constipation [DS:H01615]",
    "target": "CLCN2 [HSA:1181] [KO:K05011]\nPATHWAY   hsa04978(1181)  Mineral absorption",
    "metabolism": "",
    "therapeutic_category": "2359",
    "atc_code": "A06AX03",
    "drug_class": [
      "Gastrointestinal agent",
      "Laxative"
    ],
    "cyp_enzymes": [],
    "search_name": "Lubiprostone"
  },
  {
    "kegg_id": "D10795",
    "name_en": "Elobixibat hydrate (JAN)",
    "name_ja": "",
    "names_alt": [
      "Goofice (TN)"
    ],
    "formula": "C36H45N3O7S2. H2O",
    "efficacy": "Laxative, Bile acid transporter (ASBT/IBAT) inhibitor",
    "target": "SLC10A2 (ASBT, IBAT) [HSA:6555] [KO:K14342]\nPATHWAY   hsa04976(6555)  Bile secretion",
    "metabolism": "",
    "therapeutic_category": "2359",
    "atc_code": "A06AX09",
    "drug_class": [
      "Transporter inhibitor",
      "ABCB1 inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Elobixibat hydrate"
  },
  {
    "kegg_id": "D01544",
    "name_en": "Carboxymethylcellulose sodium (USP)",
    "name_ja": "",
    "names_alt": [
      "Carmellose sodium (JP18)",
      "C.M.C. (TN)",
      "Celluvisc (TN)"
    ],
    "formula": "C6H12O6. C2H3O2. Na",
    "efficacy": "Laxative, Pharmaceutic aid (suspending, tablet excipient, viscosity-increasing)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2359",
    "atc_code": "",
    "drug_class": [
      "Gastrointestinal agent",
      "Laxative"
    ],
    "cyp_enzymes": [],
    "search_name": "Carboxymethylcellulose sodium"
  },
  {
    "kegg_id": "D04402",
    "name_en": "Sodium bicarbonate and anhydrous monobasic sodium phosphate",
    "name_ja": "",
    "names_alt": [
      "New Lecicarbon (TN)"
    ],
    "formula": "",
    "efficacy": "Laxative (suppository)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2359",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Sodium bicarbonate and anhydrous monobasic sodium phosphate"
  },
  {
    "kegg_id": "D04406",
    "name_en": "Dioctyl sodium sulfosuccinate and casanthranol",
    "name_ja": "",
    "names_alt": [
      "Vemas S (TN)"
    ],
    "formula": "",
    "efficacy": "Laxative, Softener",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2359",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Dioctyl sodium sulfosuccinate and casanthranol"
  },
  {
    "kegg_id": "D08710",
    "name_en": "Sulfur, fennel, glycyrrhiza and senna leaf",
    "name_ja": "",
    "names_alt": [
      "Compound glycyrrhiza (TN)"
    ],
    "formula": "",
    "efficacy": "Laxative",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2359",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Sulfur, fennel, glycyrrhiza and senna leaf"
  },
  {
    "kegg_id": "D08711",
    "name_en": "Coptis rhizome, senna leaf, rhubarb, magnesium oxide and magnesium sulfate hydrate",
    "name_ja": "",
    "names_alt": [
      "Cetilo (TN)"
    ],
    "formula": "",
    "efficacy": "Laxative",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2359",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Coptis rhizome, senna leaf, rhubarb, magnesium oxide and magnesium sulfate hydrate"
  },
  {
    "kegg_id": "D11174",
    "name_en": "Macrogol 4000, sodium chloride, sodium bicarbonate and potassium chloride",
    "name_ja": "",
    "names_alt": [
      "Movicol (TN)"
    ],
    "formula": "",
    "efficacy": "Laxative",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2359",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Macrogol 4000, sodium chloride, sodium bicarbonate and potassium chloride"
  },
  {
    "kegg_id": "D00163",
    "name_en": "Chenodiol (USAN)",
    "name_ja": "",
    "names_alt": [
      "Chenodeoxycholic acid (JP18/INN)",
      "Chenix (TN)"
    ],
    "formula": "C24H40O4",
    "efficacy": "Anticholelithogenic\nDISEASE   Radiolucent stones in well-opacifying gallbladders [DS:H01213]",
    "target": "NR1H4 (FXR) [HSA:9971] [KO:K08537]\nPATHWAY   hsa04976(9971)  Bile secretion",
    "metabolism": "",
    "therapeutic_category": "2362",
    "atc_code": "A05AA01",
    "drug_class": [
      "Gastrointestinal agent",
      "Bile acid preparation"
    ],
    "cyp_enzymes": [],
    "search_name": "Chenodiol"
  },
  {
    "kegg_id": "D00734",
    "name_en": "Ursodiol (USP)",
    "name_ja": "",
    "names_alt": [
      "Ursodeoxycholic acid (JP18/INN)",
      "Actigall (TN)",
      "Urso (TN)"
    ],
    "formula": "C24H40O4",
    "efficacy": "Anticholelithogenic, Choleretic\nDISEASE   Primary biliary cirrhosis [DS:H01467]",
    "target": "NR1H4 (FXR) [HSA:9971] [KO:K08537]\nPATHWAY   hsa04976(9971)  Bile secretion",
    "metabolism": "",
    "therapeutic_category": "2362",
    "atc_code": "A05AA02",
    "drug_class": [
      "Gastrointestinal agent",
      "Bile acid preparation"
    ],
    "cyp_enzymes": [],
    "search_name": "Ursodiol"
  },
  {
    "kegg_id": "D01693",
    "name_en": "Dehydrocholic acid (JP18/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Purified dehydrocholic acid (JP18)",
      "Decholin (TN)"
    ],
    "formula": "C24H34O5",
    "efficacy": "Choleretic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2362",
    "atc_code": "",
    "drug_class": [
      "Gastrointestinal agent",
      "Bile acid preparation"
    ],
    "cyp_enzymes": [],
    "search_name": "Dehydrocholic acid"
  },
  {
    "kegg_id": "D01365",
    "name_en": "Trepibutone (JP18/INN)",
    "name_ja": "",
    "names_alt": [
      "Supacal (TN)"
    ],
    "formula": "C16H22O6",
    "efficacy": "Choleretic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2369",
    "atc_code": "A03AX09",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Trepibutone"
  },
  {
    "kegg_id": "D00678",
    "name_en": "Ondansetron hydrochloride hydrate (JAN/USP)",
    "name_ja": "",
    "names_alt": [
      "Ondansetron hydrochloride",
      "Ondansetron hydrochloride dihydrate",
      "Zofran (TN)"
    ],
    "formula": "C18H19N3O. 2H2O. HCl",
    "efficacy": "Anti-emetic, Serotonin 5-HT3 receptor antagonist",
    "target": "HTR3 [HSA:3359 9177 170572 200909 285242] [KO:K04819]\nPATHWAY   hsa04726(170572+200909+285242+3359+9177)  Serotonergic synapse",
    "metabolism": "Enzyme: CYP1A2 [HSA:1544], CYP2D6 [HSA:1565], CYP3A4 [HSA:1576]",
    "therapeutic_category": "2391",
    "atc_code": "A04AA01",
    "drug_class": [
      "Gastrointestinal agent",
      "5-HT3-receptor antagonist",
      "Antiemetic",
      "Metabolizing enzyme substrate",
      "CYP1A2 substrate",
      "CYP2D6 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4",
      "CYP1A2",
      "CYP2D6"
    ],
    "search_name": "Ondansetron hydrochloride hydrate"
  },
  {
    "kegg_id": "D00677",
    "name_en": "Granisetron hydrochloride (JAN/USP)",
    "name_ja": "",
    "names_alt": [
      "Kytril (TN)"
    ],
    "formula": "C18H24N4O. HCl",
    "efficacy": "Anti-emetic, Serotonin 5-HT3 receptor antagonist",
    "target": "HTR3B [HSA:9177] [KO:K04819]\nPATHWAY   hsa04726(9177)  Serotonergic synapse",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576], CYP1A1 [HSA:1543]",
    "therapeutic_category": "2391",
    "atc_code": "A04AA02",
    "drug_class": [
      "Gastrointestinal agent",
      "5-HT3-receptor antagonist",
      "Antiemetic",
      "Metabolizing enzyme substrate",
      "CYP1A1 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP1A1",
      "CYP3A4"
    ],
    "search_name": "Granisetron hydrochloride"
  },
  {
    "kegg_id": "D05343",
    "name_en": "Palonosetron hydrochloride (JAN/USP)",
    "name_ja": "",
    "names_alt": [
      "Aloxi (TN)"
    ],
    "formula": "C19H24N2O. HCl",
    "efficacy": "Anti-emetic, Serotonin 5-HT3 receptor antagonist",
    "target": "HTR3 [HSA:3359 9177 170572 200909 285242] [KO:K04819]\nPATHWAY   hsa04726(170572+200909+285242+3359+9177)  Serotonergic synapse",
    "metabolism": "Enzyme: CYP1A2 [HSA:1544], CYP2D6 [HSA:1565], CYP3A4 [HSA:1576]",
    "therapeutic_category": "2391",
    "atc_code": "A04AA05",
    "drug_class": [
      "Gastrointestinal agent",
      "5-HT3-receptor antagonist",
      "Antiemetic",
      "Metabolizing enzyme substrate",
      "CYP1A2 substrate",
      "CYP2D6 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4",
      "CYP1A2",
      "CYP2D6"
    ],
    "search_name": "Palonosetron hydrochloride"
  },
  {
    "kegg_id": "D02968",
    "name_en": "Aprepitant (JAN/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Aponvie (TN)",
      "Emend (TN)",
      "Cinvanti (TN)"
    ],
    "formula": "C23H21F7N4O3",
    "efficacy": "Anti-emetic, Antidepressant, Antipsychotic, Neurokinin NK1 antagonist",
    "target": "TACR1 (NK1R) [HSA:6869] [KO:K04222]\nPATHWAY   hsa04080(6869)  Neuroactive ligand-receptor interaction",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "2391",
    "atc_code": "A04AD12",
    "drug_class": [
      "Gastrointestinal agent",
      "Antiemetic",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "Metabolizing enzyme inhibitor",
      "CYP3A/CYP3A4 inhibitor",
      "CYP3A4 inhibitor",
      "Metabolizing enzyme inducer",
      "CYP2C9 inducer",
      "CYP3A/CYP3A4 inducer",
      "CYP3A4 inducer"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Aprepitant"
  },
  {
    "kegg_id": "D06597",
    "name_en": "Fosaprepitant dimeglumine (USAN)",
    "name_ja": "",
    "names_alt": [
      "Fosaprepitant meglumine (JAN)",
      "Proemend (TN)"
    ],
    "formula": "C23H22F7N4O6P. (C7H17NO5)2",
    "efficacy": "Anti-emetic, Neurokinin NK1 antagonist",
    "target": "TACR1 (NK1R) [HSA:6869] [KO:K04222]\nPATHWAY   hsa04080(6869)  Neuroactive ligand-receptor interaction",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "2391",
    "atc_code": "A04AD12",
    "drug_class": [
      "Gastrointestinal agent",
      "Antiemetic",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "Metabolizing enzyme inhibitor",
      "CYP3A/CYP3A4 inhibitor",
      "CYP3A4 inhibitor",
      "Metabolizing enzyme inducer",
      "CYP2C9 inducer",
      "CYP3A/CYP3A4 inducer",
      "CYP3A4 inducer"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Fosaprepitant dimeglumine"
  },
  {
    "kegg_id": "D02016",
    "name_en": "Ramosetron hydrochloride (JAN)",
    "name_ja": "",
    "names_alt": [
      "YM 060",
      "Nasea (TN)",
      "Irribow (TN)"
    ],
    "formula": "C17H17N3O. HCl",
    "efficacy": "Anti-emetic, Serotonin 5-HT3 receptor antagonist",
    "target": "HTR3 [HSA:3359 9177 170572 200909 285242] [KO:K04819]\nPATHWAY   hsa04726(170572+200909+285242+3359+9177)  Serotonergic synapse",
    "metabolism": "Enzyme: CYP1A2 [HSA:1544], CYP2D6 [HSA:1565]",
    "therapeutic_category": "2391",
    "atc_code": "",
    "drug_class": [
      "Gastrointestinal agent",
      "5-HT3-receptor antagonist",
      "Antiemetic",
      "Metabolizing enzyme substrate",
      "CYP1A2 substrate",
      "CYP2D6 substrate"
    ],
    "cyp_enzymes": [
      "CYP1A2",
      "CYP2D6"
    ],
    "search_name": "Ramosetron hydrochloride"
  },
  {
    "kegg_id": "D11370",
    "name_en": "Fosnetupitant chloride hydrochloride (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Arokaris (TN)"
    ],
    "formula": "C31H36F6N4O5P. HCl. Cl",
    "efficacy": "Anti-emetic, Neurokinin NK1 antagonist",
    "target": "TACR1 (NK1R) [HSA:6869] [KO:K04222]\nPATHWAY   hsa04080(6869)  Neuroactive ligand-receptor interaction",
    "metabolism": "",
    "therapeutic_category": "2391",
    "atc_code": "",
    "drug_class": [
      "Gastrointestinal agent",
      "Antiemetic"
    ],
    "cyp_enzymes": [],
    "search_name": "Fosnetupitant chloride hydrochloride"
  },
  {
    "kegg_id": "D01588",
    "name_en": "Domiphen bromide (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Oradol (TN)"
    ],
    "formula": "C22H40NO. Br",
    "efficacy": "Anti-infective (dental)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2399",
    "atc_code": "A01AB06",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Domiphen bromide"
  },
  {
    "kegg_id": "D02122",
    "name_en": "Tetracycline hydrochloride (JP18/USP)",
    "name_ja": "テトラサイクリン",
    "names_alt": [
      "Bristacycline (TN)"
    ],
    "formula": "C22H24N2O8. HCl",
    "efficacy": "Antibacterial, Amebicide, Antirickettsial, Protein biosynthesis inhibitor\nDISEASE   Rocky Mountain spotted fever [DS:H00323]\nTyphus group infections [DS:H00322]\nQ fever [DS:H00310]\nPsittacosis [DS:H00350]\nTrachoma [DS:H00349]\nLymphogranuloma venereum [DS:H00348]\nGranuloma inguinale [DS:H01415]\nRelapsing fever [DS:H00427]\nBartonellosis [DS:H00326]\nChancroid [DS:H00305]\nTularemia [DS:H00312]\nPlague [DS:H00297]\nCholera [DS:H00110]\nBrucellosis [DS:H00325]\nInfections due to Campylobacter fetus [DS:H00321]\nAmebiasis [DS:H00360]\nSevere acne [DS:H01445]\nSyphilis [DS:H00354]\nYaws [DS:H01318]\nVincent's infection [DS:H01440]\nAnthrax [DS:H00328]\nActinomycosis [DS:H01325]",
    "target": "30S ribosomal subunit\nPATHWAY   ko03010(K01977)  Ribosome",
    "metabolism": "",
    "therapeutic_category": "2399",
    "atc_code": "A01AB13",
    "drug_class": [
      "Antibacterial",
      "Tetracycline antibiotic"
    ],
    "cyp_enzymes": [],
    "search_name": "Tetracycline hydrochloride"
  },
  {
    "kegg_id": "D01500",
    "name_en": "Trimebutine maleate (JP18)",
    "name_ja": "",
    "names_alt": [
      "Cerekinon (TN)"
    ],
    "formula": "C22H29NO5. C4H4O4",
    "efficacy": "Antispasmodic",
    "target": "OPRM1 [HSA:4988] [KO:K04215]\nOPRK1 [HSA:4986] [KO:K04214]\nPATHWAY   hsa04080(4986+4988)  Neuroactive ligand-receptor interaction",
    "metabolism": "",
    "therapeutic_category": "2399",
    "atc_code": "A03AA05",
    "drug_class": [
      "Analgesic",
      "Opioid receptor agonist/antagonist"
    ],
    "cyp_enzymes": [],
    "search_name": "Trimebutine maleate"
  },
  {
    "kegg_id": "D00726",
    "name_en": "Metoclopramide (JP18/INN)",
    "name_ja": "",
    "names_alt": [
      "Elieten (TN)",
      "Terperan (TN)"
    ],
    "formula": "C14H22ClN3O2",
    "efficacy": "Anti-emetic, Prokinetic, Dopamine D2 receptor antagonist",
    "target": "DRD2 [HSA:1813] [KO:K04145]\nPATHWAY   hsa04080(1813)  Neuroactive ligand-receptor interaction\nhsa04728(1813)  Dopaminergic synapse",
    "metabolism": "Enzyme: CYP2D6 [HSA:1565]",
    "therapeutic_category": "2399",
    "atc_code": "A03FA01",
    "drug_class": [
      "Neuropsychiatric agent",
      "Dopamine antagonist",
      "Dopamine D2-receptor antagonist",
      "Gastrointestinal agent",
      "Propulsive",
      "5-HT3-receptor antagonist",
      "Antiemetic",
      "Benzamide type antiemetic",
      "Metabolizing enzyme substrate",
      "CYP2D6 substrate",
      "Metabolizing enzyme inhibitor",
      "CYP2D6 inhibitor"
    ],
    "cyp_enzymes": [
      "CYP2D6"
    ],
    "search_name": "Metoclopramide"
  },
  {
    "kegg_id": "D02213",
    "name_en": "Metoclopramide hydrochloride (JAN)",
    "name_ja": "",
    "names_alt": [
      "Metoclopramide dihydrochloride monohydrate",
      "Primperan (TN)",
      "Reglan (TN)"
    ],
    "formula": "C14H22ClN3O2. 2HCl. H2O",
    "efficacy": "Anti-emetic, Prokinetic, Dopamine D2 receptor antagonist",
    "target": "DRD2 [HSA:1813] [KO:K04145]\nPATHWAY   hsa04080(1813)  Neuroactive ligand-receptor interaction\nhsa04728(1813)  Dopaminergic synapse",
    "metabolism": "Enzyme: CYP2D6 [HSA:1565]",
    "therapeutic_category": "2399",
    "atc_code": "A03FA01",
    "drug_class": [
      "Neuropsychiatric agent",
      "Dopamine antagonist",
      "Dopamine D2-receptor antagonist",
      "Gastrointestinal agent",
      "Propulsive",
      "5-HT3-receptor antagonist",
      "Antiemetic",
      "Benzamide type antiemetic",
      "Metabolizing enzyme substrate",
      "CYP2D6 substrate",
      "Metabolizing enzyme inhibitor",
      "CYP2D6 inhibitor"
    ],
    "cyp_enzymes": [
      "CYP2D6"
    ],
    "search_name": "Metoclopramide hydrochloride"
  },
  {
    "kegg_id": "D01745",
    "name_en": "Domperidone (JP18/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Motilium (TN)"
    ],
    "formula": "C22H24ClN5O2",
    "efficacy": "Anti-emetic, Prokinetic, Dopamine D2 receptor antagonist",
    "target": "DRD2 [HSA:1813] [KO:K04145]\nPATHWAY   hsa04080(1813)  Neuroactive ligand-receptor interaction\nhsa04728(1813)  Dopaminergic synapse",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "2399",
    "atc_code": "A03FA03",
    "drug_class": [
      "Neuropsychiatric agent",
      "Dopamine antagonist",
      "Dopamine D2-receptor antagonist",
      "Gastrointestinal agent",
      "Propulsive",
      "Antiemetic",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Domperidone"
  },
  {
    "kegg_id": "D02729",
    "name_en": "Itopride hydrochloride (JAN)",
    "name_ja": "",
    "names_alt": [
      "Ganaton (TN)"
    ],
    "formula": "C20H26N2O4. HCl",
    "efficacy": "Prokinetic, Dopamine receptor antagonist",
    "target": "DRD2 [HSA:1813] [KO:K04145]\nACHE [HSA:43] [KO:K01049]\nPATHWAY   hsa04080(1813)  Neuroactive ligand-receptor interaction\nhsa04725(43)  Cholinergic synapse\nhsa04728(1813)  Dopaminergic synapse",
    "metabolism": "Enzyme: FMO1 [HSA:2326], FMO3 [HSA:2328]",
    "therapeutic_category": "2399",
    "atc_code": "A03FA07",
    "drug_class": [
      "Neuropsychiatric agent",
      "Cholinesterase inhibitor",
      "Acetylcholinesterase inhibitor",
      "Butyrylcholinesterase inhibitor",
      "Gastrointestinal agent",
      "Propulsive",
      "Metabolizing enzyme substrate",
      "FMO substrate",
      "FMO1 substrate",
      "FMO3 substrate"
    ],
    "cyp_enzymes": [],
    "search_name": "Itopride hydrochloride"
  },
  {
    "kegg_id": "D01994",
    "name_en": "Mosapride citrate hydrate (JP18)",
    "name_ja": "",
    "names_alt": [
      "Mosapride citrate dihydrate",
      "Gasmotin (TN)"
    ],
    "formula": "C21H25ClFN3O3. C6H8O7. 2H2O",
    "efficacy": "Prokinetic, Serotonin receptor agonist",
    "target": "HTR4 [HSA:3360] [KO:K04160]\nPATHWAY   hsa04080(3360)  Neuroactive ligand-receptor interaction\nhsa04726(3360)  Serotonergic synapse",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "2399",
    "atc_code": "A03FA09",
    "drug_class": [
      "Gastrointestinal agent",
      "Propulsive",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Mosapride citrate hydrate"
  },
  {
    "kegg_id": "D08838",
    "name_en": "Acotiamide hydrochloride (USAN)",
    "name_ja": "",
    "names_alt": [
      "Acotiamide hydrochloride hydrate (JAN)"
    ],
    "formula": "C21H30N4O5S. 3H2O. HCl",
    "efficacy": "Prokinetic, Acetylcholinesterase inhibitor",
    "target": "ACHE [HSA:43] [KO:K01049]\nPATHWAY   hsa04725(43)  Cholinergic synapse",
    "metabolism": "",
    "therapeutic_category": "2399",
    "atc_code": "A03FA10",
    "drug_class": [
      "Neuropsychiatric agent",
      "Muscarinic cholinergic receptor antagonist",
      "Cholinesterase inhibitor",
      "Acetylcholinesterase inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Acotiamide hydrochloride"
  },
  {
    "kegg_id": "D03306",
    "name_en": "Calcium polycarbophil (USP)",
    "name_ja": "",
    "names_alt": [
      "Polycarbophil calcium (JAN)",
      "Mitrolan (TN)"
    ],
    "formula": "",
    "efficacy": "Laxative",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2399",
    "atc_code": "A06AC08",
    "drug_class": [
      "Gastrointestinal agent",
      "Laxative",
      "Calcium"
    ],
    "cyp_enzymes": [],
    "search_name": "Calcium polycarbophil"
  },
  {
    "kegg_id": "D09355",
    "name_en": "Linaclotide (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Linzess (TN)",
      "Constella (TN)"
    ],
    "formula": "C59H79N15O21S6",
    "efficacy": "Peristaltic accelerator, Enterotoxin receptor agonist\nDISEASE   Irritable bowel syndrome [DS:H01615]",
    "target": "GUCY2C [HSA:2984] [KO:K12320]",
    "metabolism": "",
    "therapeutic_category": "2399",
    "atc_code": "A06AX04",
    "drug_class": [
      "Gastrointestinal agent",
      "Laxative"
    ],
    "cyp_enzymes": [],
    "search_name": "Linaclotide"
  },
  {
    "kegg_id": "D00377",
    "name_en": "Mesalamine (USP)",
    "name_ja": "",
    "names_alt": [
      "Mesalazine (JP18/INN)",
      "Apriso (TN)",
      "Asacol (TN)",
      "Canasa (TN)",
      "Delzicol (TN)",
      "Lialda (TN)",
      "Mesalamine (TN)",
      "Pentasa (TN)",
      "Rowasa (TN)",
      "Sfrowasa (TN)"
    ],
    "formula": "C7H7NO3",
    "efficacy": "Anti-inflammatory\nDISEASE   Ulcerative colitis [DS:H01466]",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2399",
    "atc_code": "A07EC02",
    "drug_class": [
      "Anti-inflammatory",
      "Nonsteroidal anti-inflammatory drug (NSAID)",
      "Anti-inflammatory drug, salicylic acid derivatives"
    ],
    "cyp_enzymes": [],
    "search_name": "Mesalamine"
  },
  {
    "kegg_id": "D01062",
    "name_en": "Cetylpyridinium chloride (USP)",
    "name_ja": "",
    "names_alt": [
      "Cetylpyridinium chloride hydrate (JAN)",
      "Sprol (TN)"
    ],
    "formula": "C21H38N. Cl. H2O",
    "efficacy": "Disinfectant (oral), Pharmaceutic aid (preservative)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2399",
    "atc_code": "B05CA01",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Cetylpyridinium chloride"
  },
  {
    "kegg_id": "D01575",
    "name_en": "Dequalinium chloride (JAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Nordman (TN)"
    ],
    "formula": "C30H40N4. 2Cl",
    "efficacy": "Antiseptic, Disinfectant",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2399",
    "atc_code": "D08AH01",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Dequalinium chloride"
  },
  {
    "kegg_id": "D02598",
    "name_en": "Infliximab (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Infliximab (genetical recombination) (JAN)",
      "Infliximab (genetical recombination) [Infliximab biosimilar 1] (JAN)",
      "Infliximab (genetical recombination) [Infliximab biosimilar 2] (JAN)",
      "Infliximab (genetical recombination) [Infliximab biosimilar 3] (JAN)",
      "Infliximab-dyyb",
      "Infliximab-abda",
      "Infliximab-axxq",
      "Remicade (TN)",
      "Inflectra (TN)",
      "Renflexis (TN)",
      "Avsola (TN)",
      "Zymfentra (TN)"
    ],
    "formula": "",
    "efficacy": "Anti-inflammatory, Antirheumatic, Anti-TNF-alpha antibody\nDISEASE   Crohn's disease [DS:H00286]\nUlcerative colitis [DS:H01466]\nRheumatoid arthritis [DS:H00630]\nAnkylosing spondylitis [DS:H01674]\nPsoriatic arthritis [DS:H01507]\nPlaque psoriasis [DS:H01656]\nTYPE      Monoclonal antibody",
    "target": "TNF (TNFA, TNFSF2) [HSA:7124] [KO:K03156]\nPATHWAY   hsa04010(7124)  MAPK signaling pathway\nhsa04060(7124)  Cytokine-cytokine receptor interaction\nhsa04210(7124)  Apoptosis\nhsa04350(7124)  TGF-beta signaling pathway\nhsa04380(7124)  Osteoclast differentiation\nhsa04612(7124)  Antigen processing and presentation\nhsa04920(7124)  Adipocytokine signaling pathway\nhsa05321(7124)  Inflammatory bowel disease\nhsa05323(7124)  Rheumatoid arthritis",
    "metabolism": "",
    "therapeutic_category": "2399",
    "atc_code": "L04AB02",
    "drug_class": [
      "Anti-inflammatory",
      "Disease modifying anti-rheumatic drug (DMARD)",
      "TNF inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Infliximab"
  },
  {
    "kegg_id": "D11123",
    "name_en": "Mirikizumab (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Mirikizumab (genetical recombination) (JAN)",
      "Mirikizumab-mrkz",
      "Omvoh (TN)"
    ],
    "formula": "C6380H9842N1686O2004S48",
    "efficacy": "Anti-inflammatory, Antipsoriatic, Anti-IL-23 antibody\nDISEASE   Ulcerative colitis [DS:H01466]\nTYPE      Monoclonal antibody",
    "target": "IL23A [HSA:51561] [KO:K05426]\nPATHWAY   hsa04060(51561)  Cytokine-cytokine receptor interaction\nhsa04630(51561)  JAK-STAT signaling pathway",
    "metabolism": "",
    "therapeutic_category": "2399",
    "atc_code": "L04AC24",
    "drug_class": [
      "Immunological agent",
      "Interleukin inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Mirikizumab"
  },
  {
    "kegg_id": "D10967",
    "name_en": "Ozanimod hydrochloride (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Zeposia (TN)"
    ],
    "formula": "C23H24N4O3. HCl",
    "efficacy": "Anti-ulcerative, Sphingosine-1-phosphate receptor modulator\nDISEASE   Multiple sclerosis [DS:H01490]\nUlcerative colitis [DS:H01466]",
    "target": "S1PR [HSA:1901 9294 1903 8698 53637] [KO:K04288 K04292 K04290 K04293 K04295]\nPATHWAY   hsa04071(1901+1903+53637+8698+9294)  Sphingolipid signaling pathway\nhsa04080(1901+1903+53637+8698+9294)  Neuroactive ligand-receptor interaction",
    "metabolism": "",
    "therapeutic_category": "2399",
    "atc_code": "L04AE02",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Ozanimod hydrochloride"
  },
  {
    "kegg_id": "D10931",
    "name_en": "Etrasimod arginine (USAN)",
    "name_ja": "",
    "names_alt": [
      "Etrasimod L-arginine (JAN)",
      "Velsipity (TN)"
    ],
    "formula": "C26H26F3NO3. C6H14N4O2",
    "efficacy": "Anti-inflammatory disease, Sphingosine-1-phosphate receptor modulator\nDISEASE   Ulcerative colitis [DS:H01466]",
    "target": "S1PR1 [HSA:1901] [KO:K04288]\nS1PR4 [HSA:8698] [KO:K04293]\nS1PR5 [HSA:53637] [KO:K04295]\nPATHWAY   hsa04071(1901+53637+8698)  Sphingolipid signaling pathway\nhsa04080(1901+53637+8698)  Neuroactive ligand-receptor interaction\nhsa04148(1901)  Efferocytosis",
    "metabolism": "Enzyme: CYP2C8 [HSA:1558], CYP2C9 [HSA:1559], CYP3A4 [HSA:1576], UGT [KO:K00699]; CYP2C19 [HSA:1557], CYP2J2 [HSA:1573]",
    "therapeutic_category": "2399",
    "atc_code": "L04AE05",
    "drug_class": [
      "Metabolizing enzyme substrate",
      "CYP2C8 substrate",
      "CYP2C9 substrate",
      "CYP2C19 substrate",
      "CYP2J2 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "UGT substrate"
    ],
    "cyp_enzymes": [
      "CYP2C19",
      "CYP3A4",
      "CYP2C9",
      "CYP2J2",
      "CYP2C8"
    ],
    "search_name": "Etrasimod arginine"
  },
  {
    "kegg_id": "D08083",
    "name_en": "Vedolizumab (USAN)",
    "name_ja": "",
    "names_alt": [
      "Vedolizumab (genetical recombination) (JAN)",
      "Entyvio (TN)"
    ],
    "formula": "C6428H10072N1732O2042S42",
    "efficacy": "Anti-inflammatory, Integrin receptor antagonist, Anti-alpha4/beta7 integrin antibody\nDISEASE   Ulcerative colitis [DS:H01466]\nCrohn's disease [DS:H00286]\nTYPE      Monoclonal antibody",
    "target": "ITGA4/ITGB7 [HSA:3676 3695] [KO:K06483 K06590]\nPATHWAY   hsa04512(3676+3695)  ECM-receptor interaction\nhsa04514(3676+3695)  Cell adhesion molecule (CAM) interaction",
    "metabolism": "",
    "therapeutic_category": "2399",
    "atc_code": "L04AG05",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Vedolizumab"
  },
  {
    "kegg_id": "D00661",
    "name_en": "Cevimeline hydrochloride (USAN)",
    "name_ja": "",
    "names_alt": [
      "Cevimeline hydrochloride hydrate (JAN)",
      "Evoxac (TN)",
      "Saligren (TN)"
    ],
    "formula": "(C10H17NOS)2. 2HCl. H2O",
    "efficacy": "Salivation accelaletor, Muscarinic acetylcholine receptor agonist\nDISEASE   Sjögren's Syndrome [DS:H01502]",
    "target": "CHRM3 [HSA:1131] [KO:K04131]\nPATHWAY   hsa04080(1131)  Neuroactive ligand-receptor interaction\nhsa04725(1131)  Cholinergic synapse\nhsa04970(1131)  Salivary secretion",
    "metabolism": "Enzyme: CYP2D6 [HSA:1565], CYP3A4 [HSA:1576]",
    "therapeutic_category": "2399",
    "atc_code": "N07AX03",
    "drug_class": [
      "Neuropsychiatric agent",
      "Muscarinic cholinergic receptor agonist",
      "Parasympathomimetic agent",
      "Metabolizing enzyme substrate",
      "CYP2D6 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4",
      "CYP2D6"
    ],
    "search_name": "Cevimeline hydrochloride"
  },
  {
    "kegg_id": "D04424",
    "name_en": "Potassium phosphate, dibasic, potassium chloride, calcium chloride hydrate, sodium chloride and magnesium chloride",
    "name_ja": "",
    "names_alt": [
      "Saliveht (TN)"
    ],
    "formula": "",
    "efficacy": "Artificial saliva",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2399",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Potassium phosphate, dibasic, potassium chloride, calcium chloride hydrate, sodium chloride and magnesium chloride"
  },
  {
    "kegg_id": "D04425",
    "name_en": "Diphenhydramine salicylate, hydrocortisone acetate, benzalkonium chloride and chlorhexidine hydrochloride",
    "name_ja": "",
    "names_alt": [
      "Despa (TN)"
    ],
    "formula": "",
    "efficacy": "Antistomatitis",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2399",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Diphenhydramine salicylate, hydrocortisone acetate, benzalkonium chloride and chlorhexidine hydrochloride"
  },
  {
    "kegg_id": "D09799",
    "name_en": "Carotegrast methyl (JAN)",
    "name_ja": "",
    "names_alt": [
      "Carogra (TN)"
    ],
    "formula": "C28H26Cl2N4O5",
    "efficacy": "Antiasthmatic, Integrin alpha 4 inhibitor",
    "target": "ITGA4/ITGB1 [HSA:3676 3688] [KO:K06483 K05719]\nITGA4/ITGB7 [HSA:3676 3695] [KO:K06483 K06590]\nPATHWAY   hsa04514(3676+3676+3688+3695)  Cell adhesion molecule (CAM) interaction\nhsa04670(3676+3676+3688)  Leukocyte transendothelial migration\nhsa04672(3676+3676+3695)  Intestinal immune network for IgA production",
    "metabolism": "Transporter: SLCO1B1 [HSA:10599], SLCO1B3 [HSA:28234]",
    "therapeutic_category": "2399",
    "atc_code": "",
    "drug_class": [
      "Metabolizing enzyme inhibitor",
      "CYP3A/CYP3A4 inhibitor",
      "CYP3A4 inhibitor",
      "Transporter substrate",
      "SLCO1B1 substrate",
      "SLCO1B3 substrate"
    ],
    "cyp_enzymes": [],
    "search_name": "Carotegrast methyl"
  },
  {
    "kegg_id": "D02105",
    "name_en": "Tetracosactide acetate (JAN)",
    "name_ja": "",
    "names_alt": [
      "Cortrosyn (TN)"
    ],
    "formula": "C136H210N40O31S. (C2H4O2)x",
    "efficacy": "Diagnostic (adrenocortical function), Melanocortin 2 receptor agonist",
    "target": "MC2R [HSA:4158] [KO:K04200]\nPATHWAY   hsa04080(4158)  Neuroactive ligand-receptor interaction\nhsa04925(4158)  Aldosterone synthesis and secretion\nhsa04927(4158)  Cortisol synthesis and secretion",
    "metabolism": "",
    "therapeutic_category": "2411",
    "atc_code": "H01AA02",
    "drug_class": [
      "Hormonal agent",
      "Adrenocorticotropic hormone (ACTH)"
    ],
    "cyp_enzymes": [],
    "search_name": "Tetracosactide acetate"
  },
  {
    "kegg_id": "D02691",
    "name_en": "Somatropin (USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Somatropin (genetical recombination) (JAN)",
      "Human growth hormone (JAN)",
      "Asellacrin (TN)",
      "Humatrope (TN)",
      "Nutropin (TN)",
      "Omnitrope (TN)"
    ],
    "formula": "C990H1528N262O300S7",
    "efficacy": "Growth hormone (GH) receptor agonist\nDISEASE   HIV patient [DS:H01563]\nGrowth hormone deficiency [DS:H00254]",
    "target": "GHR [HSA:2690] [KO:K05080]\nPATHWAY   hsa04060(2690)  Cytokine-cytokine receptor interaction\nhsa04080(2690)  Neuroactive ligand-receptor interaction\nhsa04935(2690)  Growth hormone synthesis, secretion and action\nNETWORK   nt06324  GHRH-GH-IGF signaling",
    "metabolism": "",
    "therapeutic_category": "2412",
    "atc_code": "H01AC01",
    "drug_class": [
      "Hormonal agent",
      "Growth hormone receptor agonist",
      "Metabolizing enzyme inhibitor",
      "CYP2C19 inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Somatropin"
  },
  {
    "kegg_id": "D11194",
    "name_en": "Somapacitan (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Somapacitan (genetical recombination) (JAN)",
      "Somapacitan-beco",
      "Sogroya (TN)"
    ],
    "formula": "C1038H1609N273O319S9",
    "efficacy": "Growth hormone (GH) receptor agonist\nDISEASE   Growth hormone deficiency [DS:H00254]",
    "target": "GHR [HSA:2690] [KO:K05080]\nPATHWAY   hsa04080(2690)  Neuroactive ligand-receptor interaction\nhsa04935(2690)  Growth hormone synthesis, secretion and action\nNETWORK   nt06324  GHRH-GH-IGF signaling",
    "metabolism": "",
    "therapeutic_category": "2412",
    "atc_code": "H01AC07",
    "drug_class": [
      "Hormonal agent",
      "Growth hormone receptor agonist"
    ],
    "cyp_enzymes": [],
    "search_name": "Somapacitan"
  },
  {
    "kegg_id": "D10990",
    "name_en": "Somatrogon (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Somatrogon (genetical recombination) (JAN)",
      "Somatrogon-ghla",
      "Ngenla (TN)"
    ],
    "formula": "",
    "efficacy": "Replenisher (somatotoropin)\nDISEASE   Growth hormone deficiency [DS:H00254]",
    "target": "GHR [HSA:2690] [KO:K05080]\nPATHWAY   hsa04080(2690)  Neuroactive ligand-receptor interaction\nhsa04935(2690)  Growth hormone synthesis, secretion and action\nNETWORK   nt06324  GHRH-GH-IGF signaling",
    "metabolism": "",
    "therapeutic_category": "2412",
    "atc_code": "H01AC08",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Somatrogon"
  },
  {
    "kegg_id": "D06457",
    "name_en": "Gonadotropin, chorionic (USP)",
    "name_ja": "",
    "names_alt": [
      "Human chorionic gonadotrophin (JP18)",
      "HCG (TN)",
      "A.P.L. (TN)",
      "Pregnyl (TN)"
    ],
    "formula": "",
    "efficacy": "Ovulation inducing agent, Luteinizing hormone/choriogonadotropin receptor agonist, Follicle stimulating hormone receptor agonist",
    "target": "LHCGR [HSA:3973] [KO:K04248]\nFSHR [HSA:2492] [KO:K04247]\nPATHWAY   hsa04080(2492+3973)  Neuroactive ligand-receptor interaction\nhsa04913(2492+3973)  Ovarian steroidogenesis\nNETWORK   nt06323  KISS1-GnRH-LH/FSH-E2 signaling",
    "metabolism": "",
    "therapeutic_category": "2413",
    "atc_code": "G03GA01",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Gonadotropin, chorionic"
  },
  {
    "kegg_id": "D02692",
    "name_en": "Menotropins (USAN)",
    "name_ja": "",
    "names_alt": [
      "Human menopausal gonadotrophin (JP18)",
      "Gonadoryl (JAN)",
      "Humegon (TN)"
    ],
    "formula": "",
    "efficacy": "Ovulation inducing agent, Luteinizing hormone/choriogonadotropin receptor agonist, Follicle stimulating hormone receptor agonist",
    "target": "LHCGR [HSA:3973] [KO:K04248]\nFSHR [HSA:2492] [KO:K04247]\nPATHWAY   hsa04080(2492+3973)  Neuroactive ligand-receptor interaction\nhsa04913(2492+3973)  Ovarian steroidogenesis",
    "metabolism": "",
    "therapeutic_category": "2413",
    "atc_code": "G03GA02",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Menotropins"
  },
  {
    "kegg_id": "D06459",
    "name_en": "Purified human menopausal gonadotrophin (JAN)",
    "name_ja": "",
    "names_alt": [
      "Human menopausal gonadotrophin, purified"
    ],
    "formula": "",
    "efficacy": "Ovulation inducing agent, Luteinizing hormone/choriogonadotropin receptor agonist, Follicle stimulating hormone receptor agonist",
    "target": "LHCGR [HSA:3973] [KO:K04248]\nFSHR [HSA:2492] [KO:K04247]\nPATHWAY   hsa04080(2492+3973)  Neuroactive ligand-receptor interaction\nhsa04913(2492+3973)  Ovarian steroidogenesis",
    "metabolism": "",
    "therapeutic_category": "2413",
    "atc_code": "G03GA02",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Purified human menopausal gonadotrophin"
  },
  {
    "kegg_id": "D04429",
    "name_en": "Follitropin alfa (genetical recombination) (JAN)",
    "name_ja": "",
    "names_alt": [
      "Follitropin alfa",
      "Gonale-F (TN)"
    ],
    "formula": "C437H682N122O134S13",
    "efficacy": "Ovulation inducing agent, Follicle stimulating hormone receptor agonist",
    "target": "FSHR [HSA:2492] [KO:K04247]\nPATHWAY   hsa04080(2492)  Neuroactive ligand-receptor interaction\nhsa04913(2492)  Ovarian steroidogenesis",
    "metabolism": "",
    "therapeutic_category": "2413",
    "atc_code": "G03GA05",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Follitropin alfa"
  },
  {
    "kegg_id": "D04430",
    "name_en": "Follitropin beta (genetical recombination) (JAN)",
    "name_ja": "",
    "names_alt": [
      "Follistim (TN)",
      "Puregon (TN)"
    ],
    "formula": "C538H833N145O171S13",
    "efficacy": "Ovulation inducing agent, Follicle stimulating hormone receptor agonist",
    "target": "FSHR [HSA:2492] [KO:K04247]\nPATHWAY   hsa04080(2492)  Neuroactive ligand-receptor interaction\nhsa04913(2492)  Ovarian steroidogenesis",
    "metabolism": "",
    "therapeutic_category": "2413",
    "atc_code": "G03GA06",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Follitropin beta"
  },
  {
    "kegg_id": "D03478",
    "name_en": "Choriogonadotropin alfa (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Choriogonadotropin alfa (genetical recombination) (JAN)",
      "Ovidrel (TN)"
    ],
    "formula": "",
    "efficacy": "Ovulation inducing agent, Luteinizing hormone/choriogonadotropin receptor agonist\nDISEASE   Hypogonadotropic hypogonadism [DS:H00255]",
    "target": "LHCGR [HSA:3973] [KO:K04248]\nPATHWAY   hsa04020(3973)  Calcium signaling pathway\nhsa04080(3973)  Neuroactive ligand-receptor interaction\nNETWORK   nt06323  KISS1-GnRH-LH/FSH-E2 signaling",
    "metabolism": "",
    "therapeutic_category": "2413",
    "atc_code": "G03GA08",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Choriogonadotropin alfa"
  },
  {
    "kegg_id": "D06400",
    "name_en": "Follitropin delta (USAN)",
    "name_ja": "",
    "names_alt": [
      "Follitropin delta (genetical recombination) (JAN)",
      "Follitropin alfa/beta",
      "Follistim (TN)",
      "Gonal-F (TN)"
    ],
    "formula": "",
    "efficacy": "Ovulation inducing agent, Follicle stimulating hormone receptor agonist",
    "target": "FSHR [HSA:2492] [KO:K04247]\nPATHWAY   hsa04080(2492)  Neuroactive ligand-receptor interaction\nhsa04913(2492)  Ovarian steroidogenesis",
    "metabolism": "",
    "therapeutic_category": "2413",
    "atc_code": "G03GA10",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Follitropin delta"
  },
  {
    "kegg_id": "D00101",
    "name_en": "Vasopressin (JP18/USP)",
    "name_ja": "バソプレシン",
    "names_alt": [
      "Pitressin (TN)",
      "Vasostrict (TN)"
    ],
    "formula": "C46H65N15O12S2",
    "efficacy": "Antidiuretic, Antihypotensive, Arginine vasopressin receptor agonist",
    "target": "AVPR1 [HSA:552 553] [KO:K04226 K04227]\nAVPR2 [HSA:554] [KO:K04228]\nPATHWAY   hsa04020(552+553)  Calcium signaling pathway\nhsa04080(552+553+554)  Neuroactive ligand-receptor interaction\nhsa04270(552+553)  Vascular smooth muscle contraction\nhsa04962(554)  Vasopressin-regulated water reabsorption\nNETWORK   nt06325  Hormone/cytokine signaling",
    "metabolism": "",
    "therapeutic_category": "2414",
    "atc_code": "H01BA01",
    "drug_class": [
      "Cardiovascular agent",
      "Vasopressin analog"
    ],
    "cyp_enzymes": [],
    "search_name": "Vasopressin"
  },
  {
    "kegg_id": "D00089",
    "name_en": "Oxytocin (JP18/USP/INN)",
    "name_ja": "オキシトシン",
    "names_alt": [
      "Oxytocin (TN)",
      "Pitocin (TN)",
      "Syntocinon (TN)"
    ],
    "formula": "C43H66N12O12S2",
    "efficacy": "Oxytocic, Oxytocin receptor agonist",
    "target": "OXTR [HSA:5021] [KO:K04229]\nPATHWAY   hsa04080(5021)  Neuroactive ligand-receptor interaction\nhsa04921(5021)  Oxytocin signaling pathway",
    "metabolism": "",
    "therapeutic_category": "2414",
    "atc_code": "H01BB02",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Oxytocin"
  },
  {
    "kegg_id": "D02235",
    "name_en": "Desmopressin acetate (USP)",
    "name_ja": "",
    "names_alt": [
      "Desmopressin acetate hydrate (JAN)",
      "Desmopressin acetate trihydrate",
      "DDAVP (TN)",
      "Minirinmelt (TN)",
      "Stimate (TN)"
    ],
    "formula": "C46H64N14O12S2. C2H4O2. 3H2O",
    "efficacy": "Antidiuretic, Arginine vasopressin receptor agonist\nDISEASE   Hemophilia A [DS:H00219]\nvon Willebrand's disease type 1 [DS:H02092]\nCentral diabetes insipidus [DS:H00253]",
    "target": "AVPR2 [HSA:554] [KO:K04228]\nF8 [HSA:2157] [KO:K03899]\nPATHWAY   hsa04080(554)  Neuroactive ligand-receptor interaction\nhsa04081(554)  Hormone signaling\nhsa04610(2157)  Complement and coagulation cascades\nhsa04962(554)  Vasopressin-regulated water reabsorption\nNETWORK   nt06325  Hormone/cytokine signaling\nnt06514  Coagulation cascade",
    "metabolism": "",
    "therapeutic_category": "2419",
    "atc_code": "H01BA02",
    "drug_class": [
      "Cardiovascular agent",
      "Vasopressin analog"
    ],
    "cyp_enzymes": [],
    "search_name": "Desmopressin acetate"
  },
  {
    "kegg_id": "D01010",
    "name_en": "Levothyroxine sodium (USP)",
    "name_ja": "レボチロキシン",
    "names_alt": [
      "Levothyroxine sodium hydrate (JP18)",
      "Levothroid (TN)",
      "Levoxyl (TN)",
      "Synthroid (TN)"
    ],
    "formula": "C15H10I4NO4. Na. xH2O",
    "efficacy": "Replenisher (thyroid hormone)\nDISEASE   Hypothyroidism [DS:H00250]\nHashimoto's thyroiditis [DS:H00081]",
    "target": "NR1A (THR) [HSA:7067 7068] [KO:K05547 K08362]\nPATHWAY   hsa04080(7067+7068)  Neuroactive ligand-receptor interaction\nhsa04919(7067+7068)  Thyroid hormone signaling pathway\nNETWORK   nt06322  TRH-TSH-TH signaling",
    "metabolism": "",
    "therapeutic_category": "2431",
    "atc_code": "H03AA01",
    "drug_class": [
      "Hormonal agent",
      "Thyroid preparation",
      "Thyroid hormone replenisher"
    ],
    "cyp_enzymes": [],
    "search_name": "Levothyroxine sodium"
  },
  {
    "kegg_id": "D01011",
    "name_en": "Liothyronine sodium (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Cytomel (TN)",
      "Triostat (TN)"
    ],
    "formula": "C15H11I3NO4. Na",
    "efficacy": "Replenisher (thyroid hormone)\nDISEASE   Hypothyroidism [DS:H00081 H00250 H00251]",
    "target": "NR1A (THR) [HSA:7067 7068] [KO:K05547 K08362]\nPATHWAY   hsa04080(7067+7068)  Neuroactive ligand-receptor interaction\nhsa04919(7067+7068)  Thyroid hormone signaling pathway\nNETWORK   nt06322  TRH-TSH-TH signaling",
    "metabolism": "",
    "therapeutic_category": "2431",
    "atc_code": "H03AA02",
    "drug_class": [
      "Hormonal agent",
      "Thyroid preparation",
      "Thyroid hormone replenisher"
    ],
    "cyp_enzymes": [],
    "search_name": "Liothyronine sodium"
  },
  {
    "kegg_id": "D00562",
    "name_en": "Propylthiouracil (JP18/USP/INN)",
    "name_ja": "",
    "names_alt": [],
    "formula": "C7H10N2OS",
    "efficacy": "Antithyroid, Thyroid hormone synthesis inhibitor\nDISEASE   Graves' disease [DS:H00082]\nHyperthyroidism [DS:H01645]",
    "target": "TPO [HSA:7173] [KO:K00431]\nDIO1 [HSA:1733] [KO:K01562]\nDIO2 [HSA:1734] [KO:K17904]\nPATHWAY   hsa04918(7173)  Thyroid hormone synthesis\nhsa04919(1733+1734)  Thyroid hormone signaling pathway\nhsa05320(7173)  Autoimmune thyroid disease\nNETWORK   nt06322  TRH-TSH-TH signaling",
    "metabolism": "",
    "therapeutic_category": "2432",
    "atc_code": "H03BA02",
    "drug_class": [
      "Hormonal agent",
      "Antithyroid agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Propylthiouracil"
  },
  {
    "kegg_id": "D00401",
    "name_en": "Methimazole (USP)",
    "name_ja": "",
    "names_alt": [
      "Thiamazole (JP18/INN)",
      "Tapazole (TN)"
    ],
    "formula": "C4H6N2S",
    "efficacy": "Antithyroid, Thyroid hormone synthesis inhibitor\nDISEASE   Graves' disease [DS:H00082]\nHyperthyroidism [DS:H01645]",
    "target": "TPO [HSA:7173] [KO:K00431]\nPATHWAY   hsa04918(7173)  Thyroid hormone synthesis\nNETWORK   nt06322  TRH-TSH-TH signaling",
    "metabolism": "",
    "therapeutic_category": "2432",
    "atc_code": "H03BB02",
    "drug_class": [
      "Hormonal agent",
      "Antithyroid agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Methimazole"
  },
  {
    "kegg_id": "D03358",
    "name_en": "Teriparatide acetate (JAN)",
    "name_ja": "",
    "names_alt": [
      "Human PHT (TN)"
    ],
    "formula": "C181H291N55O51S2. (C2H4O2)5",
    "efficacy": "Diagnostic (parathyroid function), Osteoporosis agent, Parathyroid hormone receptor agonist",
    "target": "PTH1R [HSA:5745] [KO:K04585]\nPATHWAY   hsa04080(5745)  Neuroactive ligand-receptor interaction\nhsa04081(5745)  Hormone signaling\nhsa04928(5745)  Parathyroid hormone synthesis, secretion and action\nhsa04961(5745)  Endocrine and other factor-regulated calcium reabsorption\nNETWORK   nt06318  CaSR-PTH signaling",
    "metabolism": "",
    "therapeutic_category": "2439",
    "atc_code": "H05AA02",
    "drug_class": [
      "Hormonal agent",
      "Parathyroid hormone and parathyroid hormone-related protein analog",
      "Musculo-skeletal system agent",
      "Osteoporosis agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Teriparatide acetate"
  },
  {
    "kegg_id": "D06078",
    "name_en": "Teriparatide (USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Teriparatide (genetical recombination) (JAN)",
      "Teriparatide (genetical recombination) [Teriparatide biosimilar 1] (JAN)",
      "Forteo (TN)"
    ],
    "formula": "C181H291N55O51S2",
    "efficacy": "Antiresorptive, Osteoporosis agent, Parathyroid hormone receptor agonist\nDISEASE   Osteoporosis [DS:H01593]",
    "target": "PTH1R [HSA:5745] [KO:K04585]\nPATHWAY   hsa04080(5745)  Neuroactive ligand-receptor interaction\nhsa04928(5745)  Parathyroid hormone synthesis, secretion and action\nhsa04961(5745)  Endocrine and other factor-regulated calcium reabsorption\nNETWORK   nt06318  CaSR-PTH signaling",
    "metabolism": "",
    "therapeutic_category": "2439",
    "atc_code": "H05AA02",
    "drug_class": [
      "Hormonal agent",
      "Parathyroid hormone and parathyroid hormone-related protein analog",
      "Musculo-skeletal system agent",
      "Osteoporosis agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Teriparatide"
  },
  {
    "kegg_id": "D11563",
    "name_en": "Abaloparatide acetate (JAN)",
    "name_ja": "",
    "names_alt": [
      "Ostabalo (TN)"
    ],
    "formula": "C174H300N56O49. (C2H4O2)x",
    "efficacy": "Osteoporosis agent, Osteogenesis stimulant, Parathyroid hormone receptor 1 agonist\nTYPE      Modified peptide",
    "target": "PTH1R [HSA:5745] [KO:K04585]\nPATHWAY   hsa04928(5745)  Parathyroid hormone synthesis, secretion and action\nhsa04961(5745)  Endocrine and other factor-regulated calcium reabsorption",
    "metabolism": "",
    "therapeutic_category": "2439",
    "atc_code": "H05AA04",
    "drug_class": [
      "Hormonal agent",
      "Parathyroid hormone and parathyroid hormone-related protein analog",
      "Musculo-skeletal system agent",
      "Osteoporosis agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Abaloparatide acetate"
  },
  {
    "kegg_id": "D12395",
    "name_en": "Palopegteriparatide (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Yorvipath (TN)"
    ],
    "formula": "",
    "efficacy": "Parathyroid hormone receptor agonist\nDISEASE   Hypoparathyroidism [DS:H01862]\nTYPE      Modified peptide",
    "target": "PTH1R [HSA:5745] [KO:K04585]\nPATHWAY   hsa04080(5745)  Neuroactive ligand-receptor interaction\nhsa04928(5745)  Parathyroid hormone synthesis, secretion and action\nhsa04961(5745)  Endocrine and other factor-regulated calcium reabsorption\nNETWORK   nt06318  CaSR-PTH signaling",
    "metabolism": "",
    "therapeutic_category": "2439",
    "atc_code": "H05AA05",
    "drug_class": [
      "Hormonal agent",
      "Parathyroid hormone and parathyroid hormone-related protein analog"
    ],
    "cyp_enzymes": [],
    "search_name": "Palopegteriparatide"
  },
  {
    "kegg_id": "D01375",
    "name_en": "Methenolone acetate (USAN)",
    "name_ja": "",
    "names_alt": [
      "Metenolone acetate (JP18)",
      "Primobolan (TN)"
    ],
    "formula": "C22H32O3",
    "efficacy": "Anabolic, Androgen receptor agonist",
    "target": "NR3C4 (AR) [HSA:367] [KO:K08557]",
    "metabolism": "",
    "therapeutic_category": "2449",
    "atc_code": "A14AA04",
    "drug_class": [
      "Hormonal agent",
      "Androgen receptor agonist",
      "Anabolic steroid",
      "Musculo-skeletal system agent",
      "Osteoporosis agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Methenolone acetate"
  },
  {
    "kegg_id": "D00095",
    "name_en": "Epinephrine (USP/INN)",
    "name_ja": "エピネフリン",
    "names_alt": [
      "Adrenaline (JP18)",
      "Auvi-q (TN)",
      "Epipen (TN)"
    ],
    "formula": "C9H13NO3",
    "efficacy": "Bronchodilator, Vasoconstrictor, Adrenergic receptor agonist\nDISEASE   Anaphylaxis [DS:H01359]",
    "target": "ADRA1 [HSA:148 147 146] [KO:K04135 K04136 K04137]\nADRA2 [HSA:150 151 152] [KO:K04138 K04139 K04140]\nADRB [HSA:153 154 155] [KO:K04141 K04142 K04143]\nPATHWAY   hsa04020(146+147+148+153+154+155)  Calcium signaling pathway\nhsa04022(146+147+148+150+151+152+153+154+155)  cGMP-PKG signaling pathway\nhsa04024(153+154)  cAMP signaling pathway\nhsa04080(146+147+148+150+151+152+153+154+155)  Neuroactive ligand-receptor interaction\nhsa04261(146+147+148+153+154)  Adrenergic signaling in cardiomyocytes\nhsa04270(146+147+148)  Vascular smooth muscle contraction\nhsa04970(146+147+148+153+154+155)  Salivary secretion",
    "metabolism": "Enzyme: COMT [HSA:1312], MAO [HSA:4128 4129]",
    "therapeutic_category": "2451",
    "atc_code": "A01AD01",
    "drug_class": [
      "Cardiovascular agent",
      "Cardiotonic",
      "Catecholamine cardiotonic",
      "Adrenergic receptor agonist",
      "Catecholamine adrenergic receptor agonist",
      "Metabolizing enzyme substrate",
      "COMT substrate",
      "MAO substrate"
    ],
    "cyp_enzymes": [],
    "search_name": "Epinephrine"
  },
  {
    "kegg_id": "D00076",
    "name_en": "Noradrenaline (JP18)",
    "name_ja": "",
    "names_alt": [
      "Norepinephrine (INN)"
    ],
    "formula": "C8H11NO3",
    "efficacy": "Antihypotensive, Vasoconstrictor, Adrenergic receptor agonist",
    "target": "ADRA1 [HSA:148 147 146] [KO:K04135 K04136 K04137]\nADRA2 [HSA:150 151 152] [KO:K04138 K04139 K04140]\nADRB [HSA:153 154 155] [KO:K04141 K04142 K04143]\nPATHWAY   hsa04020(146+147+148+153+154+155)  Calcium signaling pathway\nhsa04080(146+147+148+150+151+152+153+154+155)  Neuroactive ligand-receptor interaction\nhsa04261(146+147+148+153+154)  Adrenergic signaling in cardiomyocytes\nhsa04270(146+147+148)  Vascular smooth muscle contraction",
    "metabolism": "Enzyme: COMT [HSA:1312], MAO [HSA:4128 4129]",
    "therapeutic_category": "2451",
    "atc_code": "C01CA03",
    "drug_class": [
      "Cardiovascular agent",
      "Cardiotonic",
      "Catecholamine cardiotonic",
      "Adrenergic receptor agonist",
      "Catecholamine adrenergic receptor agonist",
      "Metabolizing enzyme substrate",
      "COMT substrate",
      "MAO substrate"
    ],
    "cyp_enzymes": [],
    "search_name": "Noradrenaline"
  },
  {
    "kegg_id": "D00088",
    "name_en": "Hydrocortisone (JP18/USP/INN)",
    "name_ja": "ヒドロコルチゾン",
    "names_alt": [
      "HC",
      "Acticort (TN)",
      "Anusol HC (TN)",
      "Colocort (TN)",
      "Cortef (TN)",
      "Hytone (TN)",
      "Plenadren (TN)"
    ],
    "formula": "C21H30O5",
    "efficacy": "Anti-inflammatory, Glucocorticoid receptor agonist\nDISEASE   Ulcerative colitis [DS:H01466]\nPrimary or secondary adrenocortical insufficiency [DS:H01598]\nPsoriatic arthritis [DS:H01507]\nRheumatoid arthritis [DS:H00630]\nJuvenile rheumatoid arthritis [DS:H01672]\nAnkylosing spondylitis [DS:H01674]\nAcute gouty arthritis [DS:H01532]\nSystemic lupus erythematosus [DS:H00080]\nPemphigus [DS:H01648]\nSevere erythema multiforme [DS:H01695]\nStevens-Johnson syndrome [DS:H01694]\nMycosis fungoides [DS:H01463]\nPsoriasis [DS:H01656]\nSeborrheic dermatitis [DS:H01652]\nSeasonal or perennial allergic rhinitis [DS:H01360]\nBronchial asthma [DS:H00079]\nContact dermatitis [DS:H01357]\nAtopic dermatitis [DS:H01358]\nHerpes zoster ophthalmicus [DS:H00366]\nOptic neuritis [DS:H01717]\nPulmonary tuberculosis [DS:H00342]\nAcquired (autoimmune) hemolytic anemia [DS:H01585]\nNephrotic syndrome [DS:H01657]\nUlcerative colitis [DS:H01466]\nMultiple sclerosis [DS:H01490]",
    "target": "NR3C1 (GR) [HSA:2908] [KO:K05771]\nPATHWAY   hsa04080(2908)  Neuroactive ligand-receptor interaction",
    "metabolism": "Enzyme: CYP3A [HSA:1576 1577 1551]",
    "therapeutic_category": "2452",
    "atc_code": "A01AC03",
    "drug_class": [
      "Anti-inflammatory",
      "Corticosteroid",
      "Glucocorticoid",
      "Dermatological agent",
      "Atopic dermatitis agent",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A"
    ],
    "search_name": "Hydrocortisone"
  },
  {
    "kegg_id": "D00977",
    "name_en": "Hydrocortisone sodium phosphate (JP18/USP)",
    "name_ja": "ヒドロコルチゾン",
    "names_alt": [
      "Hydrocortone phosphate (TN)"
    ],
    "formula": "C21H29O8P. 2Na",
    "efficacy": "Anti-inflammatory, Glucocorticoid receptor agonist",
    "target": "NR3C1 (GR) [HSA:2908] [KO:K05771]\nPATHWAY   hsa04080(2908)  Neuroactive ligand-receptor interaction",
    "metabolism": "Enzyme: CYP3A [HSA:1576 1577 1551]",
    "therapeutic_category": "2452",
    "atc_code": "A01AC03",
    "drug_class": [
      "Anti-inflammatory",
      "Corticosteroid",
      "Glucocorticoid",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A"
    ],
    "search_name": "Hydrocortisone sodium phosphate"
  },
  {
    "kegg_id": "D00978",
    "name_en": "Hydrocortisone sodium succinate (JP18/USP)",
    "name_ja": "ヒドロコルチゾン",
    "names_alt": [
      "A-hydrocort (TN)",
      "Solu-cortef (TN)"
    ],
    "formula": "C25H33O8. Na",
    "efficacy": "Anti-inflammatory, Glucocorticoid receptor agonist\nDISEASE   Asthma [DS:H00079]\nAtopic dermatitis [DS:H01358]\nContact dermatitis [DS:H01357]\nPerennial or seasonal allergic rhinitis [DS:H01360]\nBullous dermatitis herpetiformis [DS:H01362]\nMycosis fungoides [DS:H01463]\nPemphigus [DS:H01648]\nSevere erythema multiforme [DS:H01695]\nStevens-Johnson syndrome [DS:H01694]\nUlcerative colitis [DS:H01466]\nAcquired (autoimmune) hemolytic anemia [DS:H01585]\nDiamond-Blackfan anemia [DS:H00237]\nPure red cell aplasia [DS:H01586]\nMultiple sclerosis [DS:H01490]\nNephrotic syndrome [DS:H01657]\nPulmonary tuberculosis [DS:H00342]\nAnkylosing spondylitis [DS:H01674]\nPsoriatic arthritis [DS:H01507]\nRheumatoid arthritis [DS:H00630]\nJuvenile rheumatoid arthritis [DS:H01672]\nDermatomyositis [DS:H01604]\nTemporal arteritis [DS:H01698]\nPolymyositis [DS:H01604]\nSystemic lupus erythematosus [DS:H00080]",
    "target": "NR3C1 (GR) [HSA:2908] [KO:K05771]\nPATHWAY   hsa04080(2908)  Neuroactive ligand-receptor interaction",
    "metabolism": "Enzyme: CYP3A [HSA:1576 1577 1551]",
    "therapeutic_category": "2452",
    "atc_code": "A01AC03",
    "drug_class": [
      "Anti-inflammatory",
      "Corticosteroid",
      "Glucocorticoid",
      "Dermatological agent",
      "Atopic dermatitis agent",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A"
    ],
    "search_name": "Hydrocortisone sodium succinate"
  },
  {
    "kegg_id": "D00973",
    "name_en": "Cortisone acetate (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Cortone acetate (TN)"
    ],
    "formula": "C23H30O6",
    "efficacy": "Anti-inflammatory, Glucocorticoid receptor agonist\nDISEASE   Congenital adrenal hyperplasia [DS:H00216]\nPsoriatic arthritis [DS:H01507]\nRheumatoid arthritis [DS:H00630]\nJuvenile rheumatoid arthritis [DS:H01672]\nAnkylosing spondylitis [DS:H01674]\nGouty arthritis [DS:H01532]\nSystemic lupus erythematosus [DS:H00080]\nDermatomyositis and polymyositis [DS:H01604]\nUlcerative colitis [DS:H01466]\nPemphigus [DS:H01648]\nBullous dermatitis herpetiformis [DS:H01362]\nErythema multiforme [DS:H01695]\nStevens-Johnson syndrome [DS:H01694]\nMycosis fungoides [DS:H01463]\nSevere psoriasis [DS:H01656]\nSevere seborrheic dermatitis [DS:H01652]\nSeasonal or perennial allergic rhinitis [DS:H01360]\nBronchial asthma [DS:H00079]\nContact dermatitis [DS:H01357]\nAtopic dermatitis [DS:H01358]\nHerpes zoster ophthalmicus [DS:H00366]\nOptic neuritis [DS:H01717]\nAcquired (autoimmune) hemolytic anemia [DS:H01585]\nPulmonary tuberculosis [DS:H00342]",
    "target": "NR3C1 (GR) [HSA:2908] [KO:K05771]\nPATHWAY   hsa04080(2908)  Neuroactive ligand-receptor interaction",
    "metabolism": "",
    "therapeutic_category": "2452",
    "atc_code": "H02AB10",
    "drug_class": [
      "Anti-inflammatory",
      "Corticosteroid",
      "Glucocorticoid",
      "Dermatological agent",
      "Atopic dermatitis agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Cortisone acetate"
  },
  {
    "kegg_id": "D00385",
    "name_en": "Triamcinolone (JP18/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Aristocort (TN)",
      "Kenacort (TN)"
    ],
    "formula": "C21H27FO6",
    "efficacy": "Antiasthmatic, Anti-inflammatory, Antirheumatic, Glucocorticoid receptor agonist",
    "target": "NR3C1 (GR) [HSA:2908] [KO:K05771]\nPATHWAY   hsa04080(2908)  Neuroactive ligand-receptor interaction",
    "metabolism": "",
    "therapeutic_category": "2454",
    "atc_code": "A01AC01",
    "drug_class": [
      "Anti-inflammatory",
      "Corticosteroid",
      "Glucocorticoid",
      "Dermatological agent",
      "Atopic dermatitis agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Triamcinolone"
  },
  {
    "kegg_id": "D01615",
    "name_en": "Dexamethasone palmitate (JAN)",
    "name_ja": "デキサメタゾン",
    "names_alt": [
      "Dexamethasone 21-palmitate",
      "Limethason (TN)"
    ],
    "formula": "C38H59FO6",
    "efficacy": "Anti-inflammatory, Antirheumatic, Glucocorticoid receptor agonist",
    "target": "NR3C1 (GR) [HSA:2908] [KO:K05771]\nPATHWAY   hsa04080(2908)  Neuroactive ligand-receptor interaction",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "2454",
    "atc_code": "A01AC02",
    "drug_class": [
      "Anti-inflammatory",
      "Corticosteroid",
      "Glucocorticoid",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "Metabolizing enzyme inducer",
      "CYP3A/CYP3A4 inducer",
      "CYP3A4 inducer"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Dexamethasone palmitate"
  },
  {
    "kegg_id": "D00244",
    "name_en": "Betamethasone (JP18/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Celestone (TN)",
      "Rinderon (TN)"
    ],
    "formula": "C22H29FO5",
    "efficacy": "Anti-inflammatory, Antirheumatic, Glucocorticoid receptor agonist",
    "target": "NR3C1 (GR) [HSA:2908] [KO:K05771]\nPATHWAY   hsa04080(2908)  Neuroactive ligand-receptor interaction",
    "metabolism": "",
    "therapeutic_category": "2454",
    "atc_code": "A07EA04",
    "drug_class": [
      "Anti-inflammatory",
      "Corticosteroid",
      "Glucocorticoid",
      "Dermatological agent",
      "Atopic dermatitis agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Betamethasone"
  },
  {
    "kegg_id": "D04446",
    "name_en": "Betamethasone acetate and betamethasone sodium phosphate",
    "name_ja": "",
    "names_alt": [
      "Celestone soluspan (TN)",
      "Rinderon (TN)"
    ],
    "formula": "",
    "efficacy": "Anti-inflammatory",
    "target": "",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "2454",
    "atc_code": "",
    "drug_class": [
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Betamethasone acetate and betamethasone sodium phosphate"
  },
  {
    "kegg_id": "D00472",
    "name_en": "Prednisolone (JP18/USP/INN)",
    "name_ja": "プレドニゾロン",
    "names_alt": [
      "Delta-cortef (TN)"
    ],
    "formula": "C21H28O5",
    "efficacy": "Anti-inflammatory, Antirheumatic, Glucocorticoid receptor agonist\nDISEASE   Congenital adrenal hyperplasia [DS:H00216]\nPsoriatic arthritis [DS:H01507]\nRheumatoid arthritis [DS:H00630]\nJuvenile rheumatoid arthritis [DS:H01672]\nAnkylosing spondylitis [DS:H01674]\nSystemic lupus erythematosus [DS:H00080]\nPemphigus [DS:H01648]\nBullous dermatitis herpetiformis [DS:H01362]\nErythema multiforme [DS:H01695]\nStevens-Johnson syndrome [DS:H01694]\nMycosis fungoides [DS:H01463]\nPsoriasis [DS:H01656]\nSeborrheic dermatitis [DS:H01652]\nAllergic rhinitis [DS:H01360]\nBronchial asthma [DS:H00079]\nContact dermatitis [DS:H01357]\nAtopic dermatitis [DS:H01358]\nOptic neuritis [DS:H01717]\nPulmonary tuberculosis [DS:H00342]\nAcquired (autoimmune) hemolytic anemia [DS:H01585]\nNephrotic syndrome [DS:H01657]\nUlcerative colitis [DS:H01466]",
    "target": "NR3C1 (GR) [HSA:2908] [KO:K05771]\nPATHWAY   hsa04080(2908)  Neuroactive ligand-receptor interaction",
    "metabolism": "Enzyme: CYP3A [HSA:1576 1577 1551]",
    "therapeutic_category": "2456",
    "atc_code": "A01AC04",
    "drug_class": [
      "Anti-inflammatory",
      "Corticosteroid",
      "Glucocorticoid",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A"
    ],
    "search_name": "Prednisolone"
  },
  {
    "kegg_id": "D00981",
    "name_en": "Prednisolone sodium phosphate (JP18/USP)",
    "name_ja": "プレドニゾロン",
    "names_alt": [
      "Pediapred (TN)"
    ],
    "formula": "C21H27O8P. 2Na",
    "efficacy": "Anti-inflammatory, Glucocorticoid receptor agonist\nDISEASE   Atopic dermatitis [DS:H01358]\nAllergic rhinitis [DS:H01360]\nBullous dermatitis herpetiformis [DS:H01362]\nContact dermatitis [DS:H01357]\nMycosis fungoides [DS:H01463]\nPemphigus [DS:H01648]\nSevere erythema multiforme [DS:H01695]\nStevens-Johnson syndrome [DS:H01694]\nCongenital adrenal hyperplasia [DS:H00216]\nPrimary or secondary adrenocortical insufficiency [DS:H01598]\nCrohn's disease [DS:H00286]\nUlcerative colitis [DS:H01466]\nAcquired (autoimmune) hemolytic anemia [DS:H01585]\nDiamond-Blackfan anemia [DS:H00237]\nPure red cell aplasia [DS:H01586]\nMultiple sclerosis [DS:H01490]\nAcute or chronic solid organ rejection [DS:H00083]\nChronic obstructive pulmonary disease [DS:H01714]\nAllergic bronchopulmonary aspergillosis [DS:H01328]\nAsthma [DS:H00079]\nPulmonary tuberculosis [DS:H00342]\nHypersensitivity pneumonitis [DS:H00346]\nIdiopathic bronchiolitis obliterans [DS:H01873]\nIdiopathic pulmonary fibrosis [DS:H01299]\nPneumocystis carinii pneumonia [DS:H01521]\nNephrotic syndrome [DS:H01657]\nAnkylosing spondylitis [DS:H01674]\nDermatomyositis and polymyositis [DS:H01604]\nPolymyalgia rheumatica [DS:H01606]\nTemporal arteritis [DS:H01698]\nPsoriatic arthritis [DS:H01507]\nRelapsing polychondritis [DS:H01758]\nRheumatoid arthritis [DS:H00630]\nJuvenile rheumatoid arthritis [DS:H01672]\nSjogren's Syndrome [DS:H01502]\nSystemic lupus erythematosus [DS:H00080]\nTrichinosis with neurologic or myocardial involvement [DS:H01099]",
    "target": "NR3C1 (GR) [HSA:2908] [KO:K05771]\nPATHWAY   hsa04080(2908)  Neuroactive ligand-receptor interaction",
    "metabolism": "",
    "therapeutic_category": "2456",
    "atc_code": "A01AC04",
    "drug_class": [
      "Anti-inflammatory",
      "Corticosteroid",
      "Glucocorticoid"
    ],
    "cyp_enzymes": [],
    "search_name": "Prednisolone sodium phosphate"
  },
  {
    "kegg_id": "D01239",
    "name_en": "Prednisolone sodium succinate (JP18/USP)",
    "name_ja": "プレドニゾロン",
    "names_alt": [
      "Kohakusanin (TN)"
    ],
    "formula": "C25H31O8. Na",
    "efficacy": "Anti-inflammatory, Antirheumatic, Glucocorticoid receptor agonist",
    "target": "NR3C1 (GR) [HSA:2908] [KO:K05771]\nPATHWAY   hsa04080(2908)  Neuroactive ligand-receptor interaction",
    "metabolism": "",
    "therapeutic_category": "2456",
    "atc_code": "A01AC04",
    "drug_class": [
      "Anti-inflammatory",
      "Corticosteroid",
      "Glucocorticoid",
      "Dermatological agent",
      "Atopic dermatitis agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Prednisolone sodium succinate"
  },
  {
    "kegg_id": "D00407",
    "name_en": "Methylprednisolone (JP18/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Medrol (TN)"
    ],
    "formula": "C22H30O5",
    "efficacy": "Antiallergic, Anti-inflammatory, Glucocorticoid receptor agonist\nDISEASE   Congenital adrenal hyperplasia [DS:H00216]\nRheumatoid arthritis [DS:H00630]\nJuvenile rheumatoid arthritis [DS:H01672]\nAnkylosing spondylitis [DS:H01674]\nPsoriatic arthritis [DS:H01507]\nSystemic lupus erythematosus [DS:H00080]\nSystemic dermatomyositis and polymyositis [DS:H01604]\nBullous dermatitis herpetiformis [DS:H01362]\nErythema multiforme [DS:H01695]\nStevens-Johnson syndrome [DS:H01694]\nSeborrheic dermatitis [DS:H01652]\nMycosis fungoides [DS:H01463]\nPemphigus [DS:H01648]\nSevere psoriasis [DS:H01656]\nSeasonal or perennial allergic rhinitis [DS:H01360]\nContact dermatitis [DS:H01357]\nBronchial asthma [DS:H00079]\nAtopic dermatitis [DS:H01358]\nOptic neuritis [DS:H01717]\nPulmonary tuberculosis [DS:H00342]\nAcquired (autoimmune) hemolytic anemia [DS:H01585]\nNephrotic syndrome [DS:H01657]\nUlcerative colitis [DS:H01466]\nMultiple sclerosis [DS:H01490]",
    "target": "NR3C1 (GR) [HSA:2908] [KO:K05771]\nPATHWAY   hsa04080(2908)  Neuroactive ligand-receptor interaction",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "2456",
    "atc_code": "D07AA01",
    "drug_class": [
      "Anti-inflammatory",
      "Corticosteroid",
      "Glucocorticoid",
      "Dermatological agent",
      "Atopic dermatitis agent",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Methylprednisolone"
  },
  {
    "kegg_id": "D00751",
    "name_en": "Methylprednisolone sodium succinate (JAN/USP)",
    "name_ja": "",
    "names_alt": [
      "A-methapred (TN)",
      "Solu-medrol (TN)"
    ],
    "formula": "C26H33O8. Na",
    "efficacy": "Anti-inflammatory, Immunosuppressant, Glucocorticoid receptor agonist\nDISEASE   Asthma [DS:H00079]\nAtopic dermatitis [DS:H01358]\nContact dermatitis [DS:H01357]\nAllergic rhinitis [DS:H01360]\nDermatitis herpetiformis [DS:H01362]\nMycosis fungoides [DS:H01463]\nPemphigus [DS:H01648]\nErythema multiforme [DS:H01695]\nStevens-Johnson syndrome [DS:H01694]\nCongenital adrenal hyperplasia [DS:H00216]\nUlcerative colitis [DS:H01466]\nAcquired (autoimmune) hemolytic anemia [DS:H01585]\nCongenital (erythroid) hypoplastic anemia; Diamond-Blackfan anemia [DS:H00237]\nIdiopathic thrombocytopenic purpura [DS:H01240]\nPure red cell aplasia [DS:H01586]\nMultiple sclerosis [DS:H01490]\nAnkylosing spondylitis [DS:H01674]\nPsoriatic arthritis [DS:H01507]\nRheumatoid arthritis [DS:H00630]\nJuvenile idiopathic arthritis [DS:H01672]\nDermatomyositis [DS:H01604]\nTemporal arteritis [DS:H01698]\nPolymyositis [DS:H01604]\nSystemic lupus erythematosus [DS:H00080]",
    "target": "NR3C1 (GR) [HSA:2908] [KO:K05771]\nPATHWAY   hsa04080(2908)  Neuroactive ligand-receptor interaction",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "2456",
    "atc_code": "D07AA01",
    "drug_class": [
      "Anti-inflammatory",
      "Corticosteroid",
      "Glucocorticoid",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Methylprednisolone sodium succinate"
  },
  {
    "kegg_id": "D00979",
    "name_en": "Methylprednisolone acetate (JAN/USP)",
    "name_ja": "",
    "names_alt": [
      "Depo-medrol (TN)"
    ],
    "formula": "C24H32O6",
    "efficacy": "Anti-inflammatory, Glucocorticoid receptor agonist\nDISEASE   Asthma [DS:H00079]\nAtopic dermatitis [DS:H01358]\nContact dermatitis [DS:H01357]\nSeasonal or perennial allergic rhinitis [DS:H01360]\nBullous dermatitis herpetiformis [DS:H01362]\nMcosis fungoides [DS:H01463]\nPemphigus [DS:H01648]\nStevens-Johnson syndrome [DS:H01694]\nCongenital adrenal hyperplasia [DS:H00216]\nUlcerative colitis [DS:H01466]\nAcquired (autoimmune) hemolytic anemia [DS:H01585]\nDiamond blackfan anemia [DS:H00237]\nMultiple sclerosis [DS:H01490]\nTemporal arteritis [DS:H01698]\nPulmonary tuberculosis [DS:H00342]\nAnkylosing spondylitis [DS:H01674]\nPsoriatic arthritis [DS:H01507]\nRheumatoid arthritis [DS:H00630]\nJuvenile rheumatoid arthritis [DS:H01672]\nDermatomyositis and polymyositis [DS:H01604]\nSystemic lupus erythematosus [DS:H00080]\nDiscoid lupus erythematosus [DS:H01595]\nLichen planus [DS:H01654]",
    "target": "NR3C1 (GR) [HSA:2908] [KO:K05771]\nPATHWAY   hsa04080(2908)  Neuroactive ligand-receptor interaction",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "2456",
    "atc_code": "D07AA01",
    "drug_class": [
      "Anti-inflammatory",
      "Corticosteroid",
      "Glucocorticoid",
      "Dermatological agent",
      "Atopic dermatitis agent",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Methylprednisolone acetate"
  },
  {
    "kegg_id": "D00986",
    "name_en": "Fludrocortisone acetate (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Florinef acetate (TN)"
    ],
    "formula": "C23H31FO6",
    "efficacy": "Salts metabolic regulator, Replenisher (glucocorticoid), Mineralocorticoid receptor agonist\nDISEASE   Addison's disease [DS:H01598]",
    "target": "NR3C2 (MR) [HSA:4306] [KO:K08555]\nPATHWAY   hsa04960(4306)  Aldosterone-regulated sodium reabsorption",
    "metabolism": "",
    "therapeutic_category": "2459",
    "atc_code": "H02AA02",
    "drug_class": [
      "Anti-inflammatory",
      "Corticosteroid"
    ],
    "cyp_enzymes": [],
    "search_name": "Fludrocortisone acetate"
  },
  {
    "kegg_id": "D04447",
    "name_en": "Betamethasone and d-chlorpheniramine maleate",
    "name_ja": "",
    "names_alt": [
      "Celestamine (TN)"
    ],
    "formula": "",
    "efficacy": "Anti-inflammatory",
    "target": "",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "2459",
    "atc_code": "R06AB54",
    "drug_class": [
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Betamethasone and d-chlorpheniramine maleate"
  },
  {
    "kegg_id": "D00958",
    "name_en": "Testosterone enanthate (JP18/USP)",
    "name_ja": "テストステロン",
    "names_alt": [
      "Delatestryl (TN)"
    ],
    "formula": "C26H40O3",
    "efficacy": "Replenisher (androgen), Androgen receptor agonist\nDISEASE   Hypogonadotropic hypogonadism [DS:H00255]\nMmmary cancer [DS:H00031]",
    "target": "NR3C4 (AR) [HSA:367] [KO:K08557]\nPATHWAY   hsa04114(367)  Oocyte meiosis\nhsa05200(367)  Pathways in cancer",
    "metabolism": "",
    "therapeutic_category": "2461",
    "atc_code": "G03BA03",
    "drug_class": [
      "Hormonal agent",
      "Androgen receptor agonist",
      "Testosterone"
    ],
    "cyp_enzymes": [],
    "search_name": "Testosterone enanthate"
  },
  {
    "kegg_id": "D00105",
    "name_en": "Estradiol (JAN/USP/INN)",
    "name_ja": "エストラジオール",
    "names_alt": [
      "Climara (TN)",
      "Divigel (TN)",
      "Estrace (TN)",
      "Estraderm (TN)",
      "Estrasorb (TN)",
      "Estring (TN)",
      "Estrogel (TN)",
      "Innofem (TN)",
      "Vagifem (TN)",
      "Vivelle (TN)"
    ],
    "formula": "C18H24O2",
    "efficacy": "Menstruation disorder agent, Estrogen receptor agonist\nDISEASE   Postmenopausal osteoporosis [DS:H01593]\nPrimary ovarian failure [DS:H00627]",
    "target": "NR3A (ESR) [HSA:2099 2100] [KO:K08550 K08551]\nPATHWAY   hsa04915(2099+2100)  Estrogen signaling pathway\nhsa04961(2099)  Endocrine and other factor-regulated calcium reabsorption",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "2473",
    "atc_code": "G03CA03",
    "drug_class": [
      "Hormonal agent",
      "Estrogen",
      "Estrogen receptor agonist",
      "Musculo-skeletal system agent",
      "Osteoporosis agent",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Estradiol"
  },
  {
    "kegg_id": "D01413",
    "name_en": "Estradiol valerate (JAN/USP/INN)",
    "name_ja": "エストラジオール",
    "names_alt": [
      "Deladumone (TN)"
    ],
    "formula": "C23H32O3",
    "efficacy": "Menstruation disorder agent, Estrogen receptor agonist\nDISEASE   Advanced androgen-dependent carcinoma of the prostate [DS:H00024]",
    "target": "NR3A (ESR) [HSA:2099 2100] [KO:K08550 K08551]\nPATHWAY   hsa04915(2099+2100)  Estrogen signaling pathway",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "2473",
    "atc_code": "G03CA03",
    "drug_class": [
      "Hormonal agent",
      "Estrogen",
      "Estrogen receptor agonist",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Estradiol valerate"
  },
  {
    "kegg_id": "D00554",
    "name_en": "Ethinyl estradiol (USP)",
    "name_ja": "",
    "names_alt": [
      "Ethinylestradiol (JP18/INN)",
      "Estinyl (TN)"
    ],
    "formula": "C20H24O2",
    "efficacy": "Antineoplastic, Menstruation disorder agent, Estrogen receptor agonist",
    "target": "NR3A1 (ESR1) [HSA:2099] [KO:K08550]\nPATHWAY   hsa04915(2099)  Estrogen signaling pathway\nhsa05200(2099)  Pathways in cancer\nhsa05224(2099)  Breast cancer\nNETWORK   nt06270  Breast cancer",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "2474",
    "atc_code": "G03CA01",
    "drug_class": [
      "Hormonal agent",
      "Estrogen",
      "Estrogen receptor agonist",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "Metabolizing enzyme inhibitor",
      "CYP3A/CYP3A4 inhibitor",
      "CYP3A4 inhibitor"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Ethinyl estradiol"
  },
  {
    "kegg_id": "D00185",
    "name_en": "Estriol (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Estriel (TN)"
    ],
    "formula": "C18H24O3",
    "efficacy": "Menstruation disorder agent, Estrogen receptor agonist",
    "target": "NR3A (ESR) [HSA:2099 2100] [KO:K08550 K08551]\nPATHWAY   hsa04915(2099+2100)  Estrogen signaling pathway\nhsa04961(2099)  Endocrine and other factor-regulated calcium reabsorption",
    "metabolism": "",
    "therapeutic_category": "2475",
    "atc_code": "G03CA04",
    "drug_class": [
      "Hormonal agent",
      "Estrogen",
      "Estrogen receptor agonist",
      "Musculo-skeletal system agent",
      "Osteoporosis agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Estriol"
  },
  {
    "kegg_id": "D00949",
    "name_en": "Hydroxyprogesterone caproate (JAN/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Delalutin (TN)",
      "Hylutin (TN)",
      "Makena (TN)"
    ],
    "formula": "C27H40O4",
    "efficacy": "Menstruation disorder agent, Progesterone receptor agonist",
    "target": "NR3C3 (PGR) [HSA:5241] [KO:K08556]\nPATHWAY   hsa04114(5241)  Oocyte meiosis\nhsa04914(5241)  Progesterone-mediated oocyte maturation\nhsa04915(5241)  Estrogen signaling pathway",
    "metabolism": "",
    "therapeutic_category": "2477",
    "atc_code": "G03DA03",
    "drug_class": [
      "Hormonal agent",
      "Progesterone",
      "Progesterone receptor agonist"
    ],
    "cyp_enzymes": [],
    "search_name": "Hydroxyprogesterone caproate"
  },
  {
    "kegg_id": "D00066",
    "name_en": "Progesterone (JP18/USP/INN)",
    "name_ja": "プロゲステロン",
    "names_alt": [
      "Crinone (TN)",
      "Prometrium (TN)"
    ],
    "formula": "C21H30O2",
    "efficacy": "Menstruation disorder agent, Luteal replacement, Progesterone receptor agonist",
    "target": "NR3C3 (PGR) [HSA:5241] [KO:K08556]\nPATHWAY   hsa04114(5241)  Oocyte meiosis\nhsa04914(5241)  Progesterone-mediated oocyte maturation\nhsa04915(5241)  Estrogen signaling pathway",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576], CYP2C19 [HSA:1557]",
    "therapeutic_category": "2477",
    "atc_code": "G03DA04",
    "drug_class": [
      "Hormonal agent",
      "Progesterone",
      "Progesterone receptor agonist",
      "Metabolizing enzyme substrate",
      "CYP2C19 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C19",
      "CYP3A4"
    ],
    "search_name": "Progesterone"
  },
  {
    "kegg_id": "D00951",
    "name_en": "Medroxyprogesterone acetate (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Depo-provera (TN)",
      "Depo-subq provera 104 (TN)",
      "Provera (TN)"
    ],
    "formula": "C24H34O4",
    "efficacy": "Antineoplastic, Contraceptive, Progesterone receptor agonist\nDISEASE   Endometriosis [DS:H01639]\nEndometrial carcinoma [DS:H00026]\nRenal carcinoma [DS:H00021]",
    "target": "NR3C3 (PGR) [HSA:5241] [KO:K08556]\nPATHWAY   hsa04114(5241)  Oocyte meiosis\nhsa04914(5241)  Progesterone-mediated oocyte maturation\nhsa04915(5241)  Estrogen signaling pathway\nhsa05224(5241)  Breast cancer\nNETWORK   nt06270  Breast cancer",
    "metabolism": "",
    "therapeutic_category": "2478",
    "atc_code": "G03AC06",
    "drug_class": [
      "Hormonal agent",
      "Progesterone",
      "Progesterone receptor agonist"
    ],
    "cyp_enzymes": [],
    "search_name": "Medroxyprogesterone acetate"
  },
  {
    "kegg_id": "D01217",
    "name_en": "Dydrogesterone (JP18/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Duphaston (TN)",
      "Gynorest (TN)"
    ],
    "formula": "C21H28O2",
    "efficacy": "Menstruation disorder agent, Progesterone receptor agonist",
    "target": "NR3C3 (PGR) [HSA:5241] [KO:K08556]\nPATHWAY   hsa04114(5241)  Oocyte meiosis\nhsa04914(5241)  Progesterone-mediated oocyte maturation\nhsa04915(5241)  Estrogen signaling pathway",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "2478",
    "atc_code": "G03DB01",
    "drug_class": [
      "Hormonal agent",
      "Progesterone",
      "Progesterone receptor agonist",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Dydrogesterone"
  },
  {
    "kegg_id": "D01299",
    "name_en": "Chlormadinone acetate (JP18/USAN)",
    "name_ja": "",
    "names_alt": [
      "Lutoral (TN)"
    ],
    "formula": "C23H29ClO4",
    "efficacy": "Menstruation disorder agent, Prostatic hyperplasia treatment, Progesterone receptor agonist, Androgen receptor antagonist",
    "target": "NR3C3 (PGR) [HSA:5241] [KO:K08556]\nNR3C4 (AR) [HSA:367] [KO:K08557]\nPATHWAY   hsa04114(367+5241)  Oocyte meiosis\nhsa04914(5241)  Progesterone-mediated oocyte maturation\nhsa04915(5241)  Estrogen signaling pathway\nhsa05215(367)  Prostate cancer",
    "metabolism": "",
    "therapeutic_category": "2478",
    "atc_code": "G03DB06",
    "drug_class": [
      "Antineoplastic",
      "Androgen receptor antagonist",
      "Hormonal agent",
      "Progesterone",
      "Progesterone receptor agonist"
    ],
    "cyp_enzymes": [],
    "search_name": "Chlormadinone acetate"
  },
  {
    "kegg_id": "D00182",
    "name_en": "Norethindrone (USP)",
    "name_ja": "",
    "names_alt": [
      "Norethisterone (JP18)",
      "Camila (TN)",
      "Micronor (TN)",
      "Primolut-N (TN)"
    ],
    "formula": "C20H26O2",
    "efficacy": "Contraceptive, Progesterone receptor agonist",
    "target": "NR3C3 (PGR) [HSA:5241] [KO:K08556]\nPATHWAY   hsa04114(5241)  Oocyte meiosis\nhsa04914(5241)  Progesterone-mediated oocyte maturation\nhsa04915(5241)  Estrogen signaling pathway",
    "metabolism": "",
    "therapeutic_category": "2479",
    "atc_code": "G03AC01",
    "drug_class": [
      "Hormonal agent",
      "Progesterone",
      "Progesterone receptor agonist"
    ],
    "cyp_enzymes": [],
    "search_name": "Norethindrone"
  },
  {
    "kegg_id": "D04070",
    "name_en": "Estrogens, conjugated (JAN/USP)",
    "name_ja": "",
    "names_alt": [
      "Conjugated estrogens",
      "Premarin (TN)"
    ],
    "formula": "",
    "efficacy": "Replenisher (estrogen), Estrogen receptor agonist",
    "target": "",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "2479",
    "atc_code": "G03CA57",
    "drug_class": [
      "Hormonal agent",
      "Estrogen",
      "Estrogen receptor agonist",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "Transporter inhibitor",
      "ABCB11 inhibitor"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Estrogens, conjugated"
  },
  {
    "kegg_id": "D01159",
    "name_en": "Gestonorone caproate (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Depostat (TN)"
    ],
    "formula": "C26H38O4",
    "efficacy": "Prostatic hyperplasia treatment, Progesterone receptor agonist",
    "target": "NR3C3 (PGR) [HSA:5241] [KO:K08556]\nPATHWAY   hsa04114(5241)  Oocyte meiosis\nhsa04914(5241)  Progesterone-mediated oocyte maturation\nhsa04915(5241)  Estrogen signaling pathway",
    "metabolism": "",
    "therapeutic_category": "2479",
    "atc_code": "G03DA01",
    "drug_class": [
      "Hormonal agent",
      "Progesterone",
      "Progesterone receptor agonist"
    ],
    "cyp_enzymes": [],
    "search_name": "Gestonorone caproate"
  },
  {
    "kegg_id": "D04454",
    "name_en": "Testosterone enanthate and estradiol valerate",
    "name_ja": "テストステロン",
    "names_alt": [
      "Primodian (TN)"
    ],
    "formula": "",
    "efficacy": "Replenisher (hormone)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2481",
    "atc_code": "G03EA02",
    "drug_class": [
      "Musculo-skeletal system agent",
      "Osteoporosis agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Testosterone enanthate and estradiol valerate"
  },
  {
    "kegg_id": "D04483",
    "name_en": "Ethinylestradiol and norethisterone",
    "name_ja": "",
    "names_alt": [
      "Norethindrone and ethinyl estradiol",
      "Synphase T28 (TN)"
    ],
    "formula": "",
    "efficacy": "Contraceptive, Menstruation disorder agent",
    "target": "",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "2482",
    "atc_code": "G03AA05",
    "drug_class": [
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Ethinylestradiol and norethisterone"
  },
  {
    "kegg_id": "D04463",
    "name_en": "Norgestrel and ethinylestradiol tablets (JP18)",
    "name_ja": "",
    "names_alt": [
      "Low-ogestrel (TN)",
      "Planovar (TN)"
    ],
    "formula": "",
    "efficacy": "Contraceptive, Menstruation disorder agent",
    "target": "",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576], CYP2C9 [HSA:1559], CYP2C19 [HSA:1557]",
    "therapeutic_category": "2482",
    "atc_code": "G03AA06",
    "drug_class": [
      "Metabolizing enzyme substrate",
      "CYP2C9 substrate",
      "CYP2C19 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C19",
      "CYP2C9",
      "CYP3A4"
    ],
    "search_name": "Norgestrel and ethinylestradiol tablets"
  },
  {
    "kegg_id": "D04482",
    "name_en": "Ethinylestradiol and levonorgestrel",
    "name_ja": "",
    "names_alt": [
      "Ange (TN)",
      "Levora (TN)",
      "Lo/ovral (TN)",
      "Seasonique (TN)",
      "Triphasil-21 (TN)",
      "Trivora (TN)"
    ],
    "formula": "",
    "efficacy": "Contraceptive, Menstruation disorder agent",
    "target": "",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "2482",
    "atc_code": "G03AA07",
    "drug_class": [
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Ethinylestradiol and levonorgestrel"
  },
  {
    "kegg_id": "D09741",
    "name_en": "Drospirenone and ethinylestradiol",
    "name_ja": "",
    "names_alt": [
      "Drospirenone and ethinylestradiol betadex",
      "Angeliq (TN)",
      "Yaz (TN)",
      "Flexyess (TN)"
    ],
    "formula": "",
    "efficacy": "Menstruation disorder agent",
    "target": "",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "2482",
    "atc_code": "G03AA12",
    "drug_class": [
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Drospirenone and ethinylestradiol"
  },
  {
    "kegg_id": "D12047",
    "name_en": "Drospirenone and estetrol",
    "name_ja": "",
    "names_alt": [
      "Nextstellis (TN)",
      "Drovelis (TN)",
      "Lydisilka (TN)",
      "Alyssa (TN)"
    ],
    "formula": "",
    "efficacy": "Contraceptive",
    "target": "",
    "metabolism": "Enzyme: UGT2B7 [HSA:7364]",
    "therapeutic_category": "2482",
    "atc_code": "G03AA18",
    "drug_class": [
      "Metabolizing enzyme substrate",
      "UGT substrate",
      "UGT2B7 substrate"
    ],
    "cyp_enzymes": [],
    "search_name": "Drospirenone and estetrol"
  },
  {
    "kegg_id": "D09188",
    "name_en": "Estradiol and norethindrone",
    "name_ja": "エストラジオール",
    "names_alt": [
      "Menoaid (TN)",
      "Activella (TN)",
      "Combipatch (TN)"
    ],
    "formula": "",
    "efficacy": "Replenisher (hormone)",
    "target": "",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "2482",
    "atc_code": "G03FA01",
    "drug_class": [
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Estradiol and norethindrone"
  },
  {
    "kegg_id": "D04465",
    "name_en": "Hydroxyprogesterone caproate and estradiol benzoate",
    "name_ja": "",
    "names_alt": [
      "Lutes (TN)"
    ],
    "formula": "",
    "efficacy": "Replenisher (hormone)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2482",
    "atc_code": "G03FA02",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Hydroxyprogesterone caproate and estradiol benzoate"
  },
  {
    "kegg_id": "D09187",
    "name_en": "Estradiol and levonorgestrel",
    "name_ja": "エストラジオール",
    "names_alt": [
      "Wellnara (TN)",
      "Climara pro (TN)"
    ],
    "formula": "",
    "efficacy": "Osteoporosis agent, Replenisher (hormone)\nDISEASE   Osteoporosis [DS:H01593]",
    "target": "",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "2482",
    "atc_code": "G03FA11",
    "drug_class": [
      "Musculo-skeletal system agent",
      "Osteoporosis agent",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Estradiol and levonorgestrel"
  },
  {
    "kegg_id": "D03330",
    "name_en": "Kallidinogenase (JP18/INN)",
    "name_ja": "",
    "names_alt": [
      "Cacelmin A (TN)"
    ],
    "formula": "",
    "efficacy": "Vasodilator, Bradykinin releaser",
    "target": "KNG1 [HSA:3827] [KO:K03898]\nPATHWAY   hsa04610(3827)  Complement and coagulation cascades",
    "metabolism": "",
    "therapeutic_category": "2491",
    "atc_code": "C04AF01",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Kallidinogenase"
  },
  {
    "kegg_id": "D03230",
    "name_en": "Insulin human (USP/INN)",
    "name_ja": "インスリン",
    "names_alt": [
      "Insulin human (genetical recombination) (JP18)",
      "Insulin human (biosynthesis) (JAN)",
      "Insulin human (synthesis) (JAN)",
      "Humulin (TN)"
    ],
    "formula": "C257H383N65O77S6",
    "efficacy": "Antidiabetic, Insulin receptor agonist\nDISEASE   Diabetes mellitus [DS:H00408 H00409]",
    "target": "INSR (CD220) [HSA:3643] [KO:K04527]\nPATHWAY   hsa04910(3643)  Insulin signaling pathway\nhsa04930(3643)  Type II diabetes mellitus",
    "metabolism": "",
    "therapeutic_category": "2492",
    "atc_code": "A10AB01",
    "drug_class": [
      "Antidiabetic agent",
      "Insulin preparation",
      "Human insulin",
      "Metabolizing enzyme inducer",
      "CYP1A2 inducer"
    ],
    "cyp_enzymes": [],
    "search_name": "Insulin human"
  },
  {
    "kegg_id": "D04477",
    "name_en": "Insulin lispro (USP/INN)",
    "name_ja": "インスリン",
    "names_alt": [
      "Insulin lispro (genetical recombination) (JAN)",
      "Insulin lispro (genetical recombination) [Insulin lispro Biosimilar 1] (JAN)",
      "Insulin lispro-aabc",
      "Humalog (TN)",
      "Lyumjev (TN)"
    ],
    "formula": "C257H383N65O77S6",
    "efficacy": "Antidiabetic, Insulin receptor agonist\nDISEASE   Diabetes mellitus [DS:H00408 H00409]",
    "target": "INSR (CD220) [HSA:3643] [KO:K04527]\nPATHWAY   hsa04910(3643)  Insulin signaling pathway\nhsa04930(3643)  Type II diabetes mellitus",
    "metabolism": "",
    "therapeutic_category": "2492",
    "atc_code": "A10AB04",
    "drug_class": [
      "Antidiabetic agent",
      "Insulin preparation",
      "Insulin analog, fast-acting",
      "Metabolizing enzyme inducer",
      "CYP1A2 inducer"
    ],
    "cyp_enzymes": [],
    "search_name": "Insulin lispro"
  },
  {
    "kegg_id": "D04475",
    "name_en": "Insulin aspart (USP/INN)",
    "name_ja": "インスリン",
    "names_alt": [
      "Insulin aspart (genetical recombination) (JP18)",
      "Insulin aspart (genetical recombination) [Insulin aspart biosimilar 1] (JAN)",
      "Insulin X 14",
      "Insulin aspart-szjj",
      "nsulin aspart-xjhz",
      "Merilog (TN)",
      "NovoRapid (TN)",
      "Novolog (TN)",
      "Kirsty (TN)"
    ],
    "formula": "C256H381N65O79S6",
    "efficacy": "Antidiabetic, Insulin receptor agonist\nDISEASE   Diabetes mellitus [DS:H00408 H00409]",
    "target": "INSR (CD220) [HSA:3643] [KO:K04527]\nPATHWAY   hsa04910(3643)  Insulin signaling pathway\nhsa04930(3643)  Type II diabetes mellitus",
    "metabolism": "",
    "therapeutic_category": "2492",
    "atc_code": "A10AB05",
    "drug_class": [
      "Antidiabetic agent",
      "Insulin preparation",
      "Insulin analog, fast-acting",
      "Metabolizing enzyme inducer",
      "CYP1A2 inducer"
    ],
    "cyp_enzymes": [],
    "search_name": "Insulin aspart"
  },
  {
    "kegg_id": "D04540",
    "name_en": "Insulin glulisine (USAN/INN)",
    "name_ja": "インスリン",
    "names_alt": [
      "Insulin glulisine (genetical recombination) (JAN)",
      "Apidra (TN)"
    ],
    "formula": "C258H384N64O78S6",
    "efficacy": "Antidiabetic, Insulin receptor agonist\nDISEASE   Diabetes mellitus [DS:H00408 H00409]",
    "target": "INSR (CD220) [HSA:3643] [KO:K04527]\nPATHWAY   hsa04910(3643)  Insulin signaling pathway\nhsa04930(3643)  Type II diabetes mellitus",
    "metabolism": "",
    "therapeutic_category": "2492",
    "atc_code": "A10AB06",
    "drug_class": [
      "Antidiabetic agent",
      "Insulin preparation",
      "Insulin analog, fast-acting",
      "Metabolizing enzyme inducer",
      "CYP1A2 inducer"
    ],
    "cyp_enzymes": [],
    "search_name": "Insulin glulisine"
  },
  {
    "kegg_id": "D10570",
    "name_en": "Insulin degludec (genetical recombination) and insulin aspart (genetical recombination)",
    "name_ja": "インスリン",
    "names_alt": [
      "Ryzodeg (TN)"
    ],
    "formula": "",
    "efficacy": "Antidiabetic, Insulin receptor agonist",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2492",
    "atc_code": "A10AD06",
    "drug_class": [
      "Antidiabetic agent",
      "Insulin preparation"
    ],
    "cyp_enzymes": [],
    "search_name": "Insulin degludec"
  },
  {
    "kegg_id": "D03250",
    "name_en": "Insulin glargine (USAN/INN)",
    "name_ja": "インスリン",
    "names_alt": [
      "Insulin glargine (genetical recombination) (JP18)",
      "Insulin glargine (genetical recombination) [Insulin glargin biosimilar 1] (JAN)",
      "Insulin glargine (genetical recombination) [Insulin glargin biosimilar 2] (JAN)",
      "Insulin glargine-yfgn",
      "Lantus (TN)"
    ],
    "formula": "C267H404N72O78S6",
    "efficacy": "Antidiabetic, Insulin receptor agonist\nDISEASE   Diabetes mellitus [DS:H00408 H00409]",
    "target": "INSR (CD220) [HSA:3643] [KO:K04527]\nPATHWAY   hsa04910(3643)  Insulin signaling pathway\nhsa04930(3643)  Type II diabetes mellitus",
    "metabolism": "",
    "therapeutic_category": "2492",
    "atc_code": "A10AE04",
    "drug_class": [
      "Antidiabetic agent",
      "Insulin preparation",
      "Insulin analog, long-acting",
      "Metabolizing enzyme inducer",
      "CYP1A2 inducer"
    ],
    "cyp_enzymes": [],
    "search_name": "Insulin glargine"
  },
  {
    "kegg_id": "D04539",
    "name_en": "Insulin detemir (USAN/INN)",
    "name_ja": "インスリン",
    "names_alt": [
      "Insulin detemir (genetical recombination) (JAN)",
      "Levemir (TN)"
    ],
    "formula": "C267H402N64O76S6",
    "efficacy": "Antidiabetic, Insulin receptor agonist\nDISEASE   Diabetes mellitus [DS:H00408 H00409]",
    "target": "INSR (CD220) [HSA:3643] [KO:K04527]\nPATHWAY   hsa04910(3643)  Insulin signaling pathway\nhsa04930(3643)  Type II diabetes mellitus",
    "metabolism": "",
    "therapeutic_category": "2492",
    "atc_code": "A10AE05",
    "drug_class": [
      "Antidiabetic agent",
      "Insulin preparation",
      "Insulin analog, long-acting",
      "Metabolizing enzyme inducer",
      "CYP1A2 inducer"
    ],
    "cyp_enzymes": [],
    "search_name": "Insulin detemir"
  },
  {
    "kegg_id": "D09727",
    "name_en": "Insulin degludec (USAN/INN)",
    "name_ja": "インスリン",
    "names_alt": [
      "Insulin degludec (genetical recombination) (JAN)",
      "Tresiba (TN)"
    ],
    "formula": "C274H411N65O81S6",
    "efficacy": "Antidiabetic, Insulin receptor agonist\nDISEASE   Diabetes mellitus [DS:H00408 H00409]",
    "target": "INSR (CD220) [HSA:3643] [KO:K04527]\nPATHWAY   hsa04910(3643)  Insulin signaling pathway\nhsa04930(3643)  Type II diabetes mellitus",
    "metabolism": "",
    "therapeutic_category": "2492",
    "atc_code": "A10AE06",
    "drug_class": [
      "Antidiabetic agent",
      "Insulin preparation",
      "Insulin analog, long-acting"
    ],
    "cyp_enzymes": [],
    "search_name": "Insulin degludec"
  },
  {
    "kegg_id": "D12358",
    "name_en": "Insulin icodec (USAN/INN)",
    "name_ja": "インスリン",
    "names_alt": [
      "Insulin icodec (genetical recombination) (JAN)",
      "Awiqli (TN)"
    ],
    "formula": "C280H435N71O87S6",
    "efficacy": "Antidiabetic, Insulin receptor agonist",
    "target": "INSR (CD220) [HSA:3643] [KO:K04527]\nPATHWAY   hsa04910(3643)  Insulin signaling pathway\nNETWORK   nt06325  Hormone/cytokine signaling",
    "metabolism": "",
    "therapeutic_category": "2492",
    "atc_code": "A10AE07",
    "drug_class": [
      "Antidiabetic agent",
      "Insulin preparation",
      "Insulin analog, long-acting"
    ],
    "cyp_enzymes": [],
    "search_name": "Insulin icodec"
  },
  {
    "kegg_id": "D00116",
    "name_en": "Glucagon (USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Glucagon (genetical recombination) (JP18)"
    ],
    "formula": "C153H225N43O49S",
    "efficacy": "Antidiabetic, Diagnostic, Glucagon receptor agonist",
    "target": "GCGR [HSA:2642] [KO:K04583]\nPATHWAY   hsa04080(2642)  Neuroactive ligand-receptor interaction\nhsa04922(2642)  Glucagon signaling pathway",
    "metabolism": "",
    "therapeutic_category": "2492",
    "atc_code": "H04AA01",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Glucagon"
  },
  {
    "kegg_id": "D04547",
    "name_en": "Insulin, isophane (USP)",
    "name_ja": "インスリン",
    "names_alt": [
      "Isophane insulin (aqueous suspension) (JAN)",
      "Humalog PEN (TN)"
    ],
    "formula": "",
    "efficacy": "Antidiabetic, Insulin receptor agonist",
    "target": "INSR (CD220) [HSA:3643] [KO:K04527]\nPATHWAY   hsa04910(3643)  Insulin signaling pathway",
    "metabolism": "",
    "therapeutic_category": "2492",
    "atc_code": "",
    "drug_class": [
      "Antidiabetic agent",
      "Insulin preparation",
      "Human insulin",
      "Metabolizing enzyme inducer",
      "CYP1A2 inducer"
    ],
    "cyp_enzymes": [],
    "search_name": "Insulin, isophane"
  },
  {
    "kegg_id": "D08080",
    "name_en": "Insulin injection, biphasic isophane (BAN)",
    "name_ja": "インスリン",
    "names_alt": [
      "Biphasic isophane insuline human (genetical recombination) injectable aqueous suspension (JP18)",
      "Insulin Humacart (TN)"
    ],
    "formula": "",
    "efficacy": "Antidiabetic, Insulin receptor agonist",
    "target": "INSR (CD220) [HSA:3643] [KO:K04527]\nPATHWAY   hsa04910(3643)  Insulin signaling pathway",
    "metabolism": "",
    "therapeutic_category": "2492",
    "atc_code": "",
    "drug_class": [
      "Antidiabetic agent",
      "Insulin preparation",
      "Human insulin",
      "Metabolizing enzyme inducer",
      "CYP1A2 inducer"
    ],
    "cyp_enzymes": [],
    "search_name": "Insulin injection, biphasic isophane"
  },
  {
    "kegg_id": "D04121",
    "name_en": "Exenatide (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Byetta (TN)"
    ],
    "formula": "C184H282N50O60S",
    "efficacy": "Antidiabetic, Glucagon-like peptide 1 (GLP-1) receptor agonist\nDISEASE   Type 2 diabetes mellitus [DS:H00409]",
    "target": "GLP1R [HSA:2740] [KO:K04581]\nPATHWAY   hsa04080(2740)  Neuroactive ligand-receptor interaction\nhsa04911(2740)  Insulin secretion",
    "metabolism": "",
    "therapeutic_category": "2499",
    "atc_code": "A10BJ01",
    "drug_class": [
      "Antidiabetic agent",
      "Hypoglycemic agent",
      "GLP-1 receptor agonist"
    ],
    "cyp_enzymes": [],
    "search_name": "Exenatide"
  },
  {
    "kegg_id": "D06404",
    "name_en": "Liraglutide (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Liraglutide (genetical recombination) (JAN)",
      "Victoza (TN)"
    ],
    "formula": "C172H265N43O51",
    "efficacy": "Antidiabetic, Glucagon-like peptide 1 (GLP-1) receptor agonist\nDISEASE   Type 2 diabetes mellitus [DS:H00409]\nTYPE      Modified peptide",
    "target": "GLP1R [HSA:2740] [KO:K04581]\nPATHWAY   hsa04080(2740)  Neuroactive ligand-receptor interaction\nhsa04911(2740)  Insulin secretion",
    "metabolism": "",
    "therapeutic_category": "2499",
    "atc_code": "A10BJ02",
    "drug_class": [
      "Antidiabetic agent",
      "Hypoglycemic agent",
      "GLP-1 receptor agonist"
    ],
    "cyp_enzymes": [],
    "search_name": "Liraglutide"
  },
  {
    "kegg_id": "D09889",
    "name_en": "Dulaglutide (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Dulaglutide (genetical recombination) (JAN)",
      "Trulicity (TN)"
    ],
    "formula": "C2646H4044N704O836S18",
    "efficacy": "Antidiabetic, Glucagon-like peptide 1 (GLP-1) receptor agonist\nDISEASE   Type 2 diabetes mellitus [DS:H00409]\nTYPE      Modified peptide",
    "target": "GLP1R [HSA:2740] [KO:K04581]\nPATHWAY   hsa04080(2740)  Neuroactive ligand-receptor interaction\nhsa04911(2740)  Insulin secretion",
    "metabolism": "",
    "therapeutic_category": "2499",
    "atc_code": "A10BJ05",
    "drug_class": [
      "Antidiabetic agent",
      "Hypoglycemic agent",
      "GLP-1 receptor agonist"
    ],
    "cyp_enzymes": [],
    "search_name": "Dulaglutide"
  },
  {
    "kegg_id": "D10025",
    "name_en": "Semaglutide (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Semaglutide (genetical recombination) (JAN)",
      "Ozempic (TN)"
    ],
    "formula": "C187H291N45O59",
    "efficacy": "Antidiabetic, Glucagon-like peptide 1 (GLP-1) receptor agonist\nDISEASE   Type 2 diabetes mellitus [DS:H00409]\nTYPE      Modified peptide",
    "target": "GLP1R [HSA:2740] [KO:K04581]\nPATHWAY   hsa04080(2740)  Neuroactive ligand-receptor interaction\nhsa04911(2740)  Insulin secretion",
    "metabolism": "",
    "therapeutic_category": "2499",
    "atc_code": "A10BJ06",
    "drug_class": [
      "Antidiabetic agent",
      "Hypoglycemic agent",
      "GLP-1 receptor agonist"
    ],
    "cyp_enzymes": [],
    "search_name": "Semaglutide"
  },
  {
    "kegg_id": "D11360",
    "name_en": "Tirzepatide (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Mounjaro (TN)",
      "Zepbound (TN)"
    ],
    "formula": "C225H348N48O68",
    "efficacy": "Antidiabetic, Gastric inhibitory polypeptide receptor agonist, Glucagon-like peptide 1 (GLP-1) receptor agonist\nDISEASE   Type 2 diabetes mellitus [DS:H00409]\nTYPE      Modified peptide",
    "target": "GIPR [HSA:2696] [KO:K04580]\nGLP1R [HSA:2740] [KO:K04581]\nPATHWAY   hsa04024(2696+2740)  cAMP signaling pathway\nhsa04080(2696+2740)  Neuroactive ligand-receptor interaction\nhsa04911(2740)  Insulin secretion",
    "metabolism": "",
    "therapeutic_category": "2499",
    "atc_code": "A10BX16",
    "drug_class": [
      "Antidiabetic agent",
      "Hypoglycemic agent",
      "GLP-1 receptor agonist"
    ],
    "cyp_enzymes": [],
    "search_name": "Tirzepatide"
  },
  {
    "kegg_id": "D05014",
    "name_en": "Metreleptin (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Mettreleptin (genetical recombination) (JAN)",
      "Metreleptin (TN)",
      "Myalept (TN)"
    ],
    "formula": "C714H1167N191O221S6",
    "efficacy": "Metabolic homeostasis regulator, Leptin receptor agonist\nDISEASE   Lipodystrophy [DS:H01475]",
    "target": "LEPR (CD295) [HSA:3953] [KO:K05062]\nPATHWAY   hsa04060(3953)  Cytokine-cytokine receptor interaction\nhsa04080(3953)  Neuroactive ligand-receptor interaction\nhsa04920(3953)  Adipocytokine signaling pathway",
    "metabolism": "",
    "therapeutic_category": "2499",
    "atc_code": "A16AA07",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Metreleptin"
  },
  {
    "kegg_id": "D06053",
    "name_en": "Teduglutide (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Teduglutide (genetical recombination) (JAN)",
      "Gattex (TN)",
      "Revestive (TN)"
    ],
    "formula": "C164H252N44O55S",
    "efficacy": "Mucosal growth promotor, Glucagon-like peptide 2 receptor agonist\nDISEASE   Short bowel syndrome [DS:H01469]",
    "target": "GLP2R [HSA:9340] [KO:K04582]",
    "metabolism": "",
    "therapeutic_category": "2499",
    "atc_code": "A16AX08",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Teduglutide"
  },
  {
    "kegg_id": "D00321",
    "name_en": "Finasteride (JAN/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Propecia (TN)",
      "Proscar (TN)"
    ],
    "formula": "C23H36N2O2",
    "efficacy": "Antiandrogen, 5alpha-Reductase inhibitor",
    "target": "SRD5A2 [HSA:6716] [KO:K12344]\nPATHWAY   hsa00140(6716)  Steroid hormone biosynthesis",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "2499",
    "atc_code": "D11AX10",
    "drug_class": [
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Finasteride"
  },
  {
    "kegg_id": "D00081",
    "name_en": "Dinoprost (JP18/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Prosmon (TN)"
    ],
    "formula": "C20H34O5",
    "efficacy": "Oxytocic, Prostaglandin F receptor agonist",
    "target": "PTGFR [HSA:5737] [KO:K04262]\nPATHWAY   hsa04020(5737)  Calcium signaling pathway\nhsa04080(5737)  Neuroactive ligand-receptor interaction",
    "metabolism": "",
    "therapeutic_category": "2499",
    "atc_code": "G02AD01",
    "drug_class": [
      "Hormonal agent",
      "Prostaglandin derivative",
      "Prostaglandin F derivative"
    ],
    "cyp_enzymes": [],
    "search_name": "Dinoprost"
  },
  {
    "kegg_id": "D00079",
    "name_en": "Dinoprostone (JAN/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Cervidil (TN)",
      "Prepidil (TN)",
      "Prostin E2 (TN)"
    ],
    "formula": "C20H32O5",
    "efficacy": "Oxytocic, Prostaglandin E2 receptor agonist",
    "target": "PTGER2 [HSA:5732] [KO:K04259]\nPATHWAY   hsa04080(5732)  Neuroactive ligand-receptor interaction",
    "metabolism": "",
    "therapeutic_category": "2499",
    "atc_code": "G02AD02",
    "drug_class": [
      "Hormonal agent",
      "Prostaglandin derivative",
      "Prostaglandin E2 derivative"
    ],
    "cyp_enzymes": [],
    "search_name": "Dinoprostone"
  },
  {
    "kegg_id": "D02073",
    "name_en": "Gemeprost (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Preglandin (TN)"
    ],
    "formula": "C23H38O5",
    "efficacy": "Oxytocic, Prostaglandin E1 receptor agonist",
    "target": "PTGER1 [HSA:5731] [KO:K04258]\nPATHWAY   hsa04020(5731)  Calcium signaling pathway\nhsa04080(5731)  Neuroactive ligand-receptor interaction",
    "metabolism": "",
    "therapeutic_category": "2499",
    "atc_code": "G02AD03",
    "drug_class": [
      "Hormonal agent",
      "Prostaglandin derivative",
      "Prostaglandin E1 derivative"
    ],
    "cyp_enzymes": [],
    "search_name": "Gemeprost"
  },
  {
    "kegg_id": "D03799",
    "name_en": "Dienogest (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Endometrion (TN)"
    ],
    "formula": "C20H25NO2",
    "efficacy": "Anti-endometriosis, Contraceptive, Replenisher (progesterone), Progesterone receptor agonist",
    "target": "NR3C3 (PGR) [HSA:5241] [KO:K08556]\nPATHWAY   hsa04114(5241)  Oocyte meiosis\nhsa04914(5241)  Progesterone-mediated oocyte maturation\nhsa04915(5241)  Estrogen signaling pathway",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "2499",
    "atc_code": "G03DB08",
    "drug_class": [
      "Hormonal agent",
      "Progesterone",
      "Progesterone receptor agonist",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Dienogest"
  },
  {
    "kegg_id": "D01281",
    "name_en": "Cyclofenil (JAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Sexovid (TN)"
    ],
    "formula": "C23H24O4",
    "efficacy": "Ovulation inducing agent, Gonadotropin stimulant",
    "target": "LHCGR [HSA:3973] [KO:K04248]\nFSHR [HSA:2492] [KO:K04247]\nPATHWAY   hsa04080(2492+3973)  Neuroactive ligand-receptor interaction\nhsa04913(2492+3973)  Ovarian steroidogenesis\nhsa04917(3973)  Prolactin signaling pathway",
    "metabolism": "",
    "therapeutic_category": "2499",
    "atc_code": "G03GB01",
    "drug_class": [
      "Hormonal agent",
      "Estrogen receptor antagonist/modulator"
    ],
    "cyp_enzymes": [],
    "search_name": "Cyclofenil"
  },
  {
    "kegg_id": "D00962",
    "name_en": "Clomiphene citrate (USP)",
    "name_ja": "",
    "names_alt": [
      "Clomifene citrate (JP18)",
      "Clomid (TN)",
      "Serophene (TN)"
    ],
    "formula": "C26H28ClNO. C6H8O7",
    "efficacy": "Ovulation inducing agent, Gonadotropin stimulant, Estrogen receptor agonist/antagonist",
    "target": "NR3A (ESR) [HSA:2099 2100] [KO:K08550 K08551]\nPATHWAY   hsa04915(2099+2100)  Estrogen signaling pathway",
    "metabolism": "",
    "therapeutic_category": "2499",
    "atc_code": "G03GB02",
    "drug_class": [
      "Hormonal agent",
      "Estrogen receptor antagonist/modulator"
    ],
    "cyp_enzymes": [],
    "search_name": "Clomiphene citrate"
  },
  {
    "kegg_id": "D00289",
    "name_en": "Danazol (JP18/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Danocrine (TN)"
    ],
    "formula": "C22H27NO2",
    "efficacy": "Anti-endometriosis, Anterior pituitary suppressant\nDISEASE   Endometriosis [DS:H01639]\nHereditary angioedema [DS:H01006]",
    "target": "NR3C4 (AR) [HSA:367] [KO:K08557]\nNR3C3 (PGR) [HSA:5241] [KO:K08556]\nNR3A1 (ESR1) [HSA:2099] [KO:K08550]\nPATHWAY   hsa04114(367+5241)  Oocyte meiosis\nhsa04914(5241)  Progesterone-mediated oocyte maturation\nhsa04915(2099+5241)  Estrogen signaling pathway",
    "metabolism": "",
    "therapeutic_category": "2499",
    "atc_code": "G03XA01",
    "drug_class": [
      "Hormonal agent",
      "Androgen receptor agonist",
      "Progesterone receptor agonist"
    ],
    "cyp_enzymes": [],
    "search_name": "Danazol"
  },
  {
    "kegg_id": "D12586",
    "name_en": "Mifepristone and misoprostol",
    "name_ja": "",
    "names_alt": [
      "Mefeego (TN)"
    ],
    "formula": "",
    "efficacy": "Abortifacient",
    "target": "",
    "metabolism": "Enzyme: CYP3A [HSA:1576 1577 1551]",
    "therapeutic_category": "2499",
    "atc_code": "G03XB51",
    "drug_class": [
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "Metabolizing enzyme inhibitor",
      "CYP3A/CYP3A4 inhibitor"
    ],
    "cyp_enzymes": [
      "CYP3A"
    ],
    "search_name": "Mifepristone and misoprostol"
  },
  {
    "kegg_id": "D03820",
    "name_en": "Dutasteride (JAN/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Avodart (TN)"
    ],
    "formula": "C27H30F6N2O2",
    "efficacy": "Prostatic hyperplasia treatment, Antiandrogen, 5alpha-Reductase inhibitor",
    "target": "SRD5A1 [HSA:6715] [KO:K12343]\nSRD5A2 [HSA:6716] [KO:K12344]\nPATHWAY   hsa00140(6715+6716)  Steroid hormone biosynthesis",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576], CYP3A5 [HSA:1577]",
    "therapeutic_category": "2499",
    "atc_code": "G04CB02",
    "drug_class": [
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "CYP3A5 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4",
      "CYP3A5"
    ],
    "search_name": "Dutasteride"
  },
  {
    "kegg_id": "D03297",
    "name_en": "Mecasermin (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Mecasermin (genetical recombination) (JAN)",
      "Increlex (TN)",
      "Myotrophin (TN)"
    ],
    "formula": "C331H512N94O101S7",
    "efficacy": "Antidiabetic, Insulin-like growth factor receptor agonist\nDISEASE   Primary IGF-1 deficiency [DS:H02040]",
    "target": "IGF1R (CD221) [HSA:3480] [KO:K05087]\nGHR [HSA:2690] [KO:K05080]\nPATHWAY   hsa04151(2690+3480)  PI3K-Akt signaling pathway\nhsa04935(2690)  Growth hormone synthesis, secretion and action\nNETWORK   nt06324  GHRH-GH-IGF signaling\nnt06518  JAK-STAT signaling",
    "metabolism": "",
    "therapeutic_category": "2499",
    "atc_code": "H01AC03",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Mecasermin"
  },
  {
    "kegg_id": "D05394",
    "name_en": "Pegvisomant (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Pegvisomant (genetical recombination) (JAN)",
      "Somavert (TN)"
    ],
    "formula": "",
    "efficacy": "Growth hormone receptor antagonist\nDISEASE   Acromegaly [DS:H01483]",
    "target": "GHR [HSA:2690] [KO:K05080]\nPATHWAY   hsa04060(2690)  Cytokine-cytokine receptor interaction\nhsa04080(2690)  Neuroactive ligand-receptor interaction\nhsa04935(2690)  Growth hormone synthesis, secretion and action\nNETWORK   nt06324  GHRH-GH-IGF signaling",
    "metabolism": "",
    "therapeutic_category": "2499",
    "atc_code": "H01AX01",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Pegvisomant"
  },
  {
    "kegg_id": "D03267",
    "name_en": "Gonadorelin diacetate (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "C55H75N17O13. (C2H4O2)2",
    "efficacy": "Diagnostic (pituitary function determination), Gonadotropin-releasing hormone receptor agonist",
    "target": "GNRHR [HSA:2798] [KO:K04280]\nPATHWAY   hsa04080(2798)  Neuroactive ligand-receptor interaction\nhsa04912(2798)  GnRH signaling pathway\nNETWORK   nt06323  KISS1-GnRH-LH/FSH-E2 signaling",
    "metabolism": "",
    "therapeutic_category": "2499",
    "atc_code": "H01CA01",
    "drug_class": [
      "Hormonal agent",
      "Gonadotropin-releasing hormone receptor agonist"
    ],
    "cyp_enzymes": [],
    "search_name": "Gonadorelin diacetate"
  },
  {
    "kegg_id": "D00990",
    "name_en": "Nafarelin acetate (USAN)",
    "name_ja": "",
    "names_alt": [
      "Nafarelin acetate hydrate (JAN)",
      "Synarel (TN)"
    ],
    "formula": "C66H83N17O13. (C2H4O2)x. yH2O",
    "efficacy": "Anti-endometriosis, Gonadotropin-releasing hormone receptor agonist\nDISEASE   Central precocious puberty [DS:H02018]\nEndometriosis [DS:H01639]",
    "target": "GNRHR [HSA:2798] [KO:K04280]\nPATHWAY   hsa04080(2798)  Neuroactive ligand-receptor interaction\nhsa04912(2798)  GnRH signaling pathway\nNETWORK   nt06323  KISS1-GnRH-LH/FSH-E2 signaling",
    "metabolism": "",
    "therapeutic_category": "2499",
    "atc_code": "H01CA02",
    "drug_class": [
      "Hormonal agent",
      "Gonadotropin-releasing hormone receptor agonist"
    ],
    "cyp_enzymes": [],
    "search_name": "Nafarelin acetate"
  },
  {
    "kegg_id": "D02250",
    "name_en": "Octreotide acetate (JAN)",
    "name_ja": "",
    "names_alt": [
      "Octreotide diacetate",
      "Sandostatin (TN)"
    ],
    "formula": "C49H66N10O10S2. (C2H4O2)2",
    "efficacy": "Antineoplastic, Antisecretory (hormone), Somatostatin receptor agonist",
    "target": "SSTR2 [HSA:6752] [KO:K04218]\nPATHWAY   hsa04024(6752)  cAMP signaling pathway\nhsa04080(6752)  Neuroactive ligand-receptor interaction\nhsa04935(6752)  Growth hormone synthesis, secretion and action\nhsa04971(6752)  Gastric acid secretion",
    "metabolism": "",
    "therapeutic_category": "2499",
    "atc_code": "H01CB02",
    "drug_class": [
      "Hormonal agent",
      "Somatostatin receptor agonist"
    ],
    "cyp_enzymes": [],
    "search_name": "Octreotide acetate"
  },
  {
    "kegg_id": "D04666",
    "name_en": "Lanreotide acetate (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Somatuline (TN)"
    ],
    "formula": "C54H69N11O10S2. (C2H4O2)x",
    "efficacy": "Antineoplastic, Antisecretory (hormone), Somatostatin receptor agonist\nDISEASE   Acromegaly [DS:H01483]\nGastroenteropancreatic neuroendocrine tumors [DS:H00045]",
    "target": "SSTR2 [HSA:6752] [KO:K04218]\nSSTR5 [HSA:6755] [KO:K04221]\nPATHWAY   hsa04024(6752+6755)  cAMP signaling pathway\nhsa04080(6752+6755)  Neuroactive ligand-receptor interaction\nhsa04935(6752+6755)  Growth hormone synthesis, secretion and action\nhsa04971(6752)  Gastric acid secretion",
    "metabolism": "",
    "therapeutic_category": "2499",
    "atc_code": "H01CB03",
    "drug_class": [
      "Hormonal agent",
      "Somatostatin receptor agonist"
    ],
    "cyp_enzymes": [],
    "search_name": "Lanreotide acetate"
  },
  {
    "kegg_id": "D10566",
    "name_en": "Pasireotide pamoate (JAN)",
    "name_ja": "",
    "names_alt": [
      "Signifor lar (TN)"
    ],
    "formula": "C58H66N10O9. C23H16O6",
    "efficacy": "Antisecretory, Somatostatin receptor agonist\nDISEASE   Acromegaly [DS:H01483]\nCushing’s disease [DS:H01431]",
    "target": "SSTR1 [HSA:6751] [KO:K04217]\nSSTR2 [HSA:6752] [KO:K04218]\nSSTR3 [HSA:6753] [KO:K04219]\nSSTR5 [HSA:6755] [KO:K04221]\nPATHWAY   hsa04024(6751+6752+6755)  cAMP signaling pathway\nhsa04080(6751+6752+6753+6755)  Neuroactive ligand-receptor interaction\nhsa04935(6751+6752+6753+6755)  Growth hormone synthesis, secretion and action\nhsa04971(6752)  Gastric acid secretion",
    "metabolism": "",
    "therapeutic_category": "2499",
    "atc_code": "H01CB05",
    "drug_class": [
      "Hormonal agent",
      "Somatostatin receptor agonist"
    ],
    "cyp_enzymes": [],
    "search_name": "Pasireotide pamoate"
  },
  {
    "kegg_id": "D04302",
    "name_en": "Ganirelix acetate (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Ganirest (TN)"
    ],
    "formula": "C80H113ClN18O13. (C2H4O2)2",
    "efficacy": "Gonadotropin-releasing hormone receptor antagonist",
    "target": "GNRHR [HSA:2798] [KO:K04280]\nPATHWAY   hsa04080(2798)  Neuroactive ligand-receptor interaction\nhsa04912(2798)  GnRH signaling pathway",
    "metabolism": "",
    "therapeutic_category": "2499",
    "atc_code": "H01CC01",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Ganirelix acetate"
  },
  {
    "kegg_id": "D01685",
    "name_en": "Cetrorelix acetate (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Cetrotide (TN)"
    ],
    "formula": "C70H92ClN17O14. (C2H4O2)x",
    "efficacy": "Antineoplastic, Gonadotropin-releasing hormone receptor antagonist",
    "target": "GNRHR [HSA:2798] [KO:K04280]\nPATHWAY   hsa04080(2798)  Neuroactive ligand-receptor interaction\nhsa04912(2798)  GnRH signaling pathway",
    "metabolism": "",
    "therapeutic_category": "2499",
    "atc_code": "H01CC02",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Cetrorelix acetate"
  },
  {
    "kegg_id": "D11609",
    "name_en": "Linzagolix choline (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Yselty (TN)"
    ],
    "formula": "C22H14F3N2O7S. C5H14NO",
    "efficacy": "Anti-endometriosis, Gonadotropin-releasing hormone receptor antagonist",
    "target": "GNRHR [HSA:2798] [KO:K04280]\nPATHWAY   hsa04080(2798)  Neuroactive ligand-receptor interaction\nhsa04081(2798)  Hormone signaling\nhsa04912(2798)  GnRH signaling pathway",
    "metabolism": "",
    "therapeutic_category": "2499",
    "atc_code": "H01CC04",
    "drug_class": [
      "Metabolizing enzyme inhibitor",
      "CYP2C8 inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Linzagolix choline"
  },
  {
    "kegg_id": "D01180",
    "name_en": "Trilostane (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Desopan (TN)",
      "Modrenal (TN)"
    ],
    "formula": "C20H27NO3",
    "efficacy": "Antisecretory (hormone), Adrenocortical hormone biosynthesis inhibitor",
    "target": "HSD3B [HSA:3283 3284] [KO:K00070]\nPATHWAY   hsa00140(3283+3284)  Steroid hormone biosynthesis\nhsa04925(3283+3284)  Aldosterone synthesis and secretion\nhsa04934(3283+3284)  Cushing syndrome\nNETWORK   nt06019  Steroid hormone biosynthesis",
    "metabolism": "",
    "therapeutic_category": "2499",
    "atc_code": "H02CA01",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Trilostane"
  },
  {
    "kegg_id": "D11062",
    "name_en": "Osilodrostat phosphate (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Isturisa (TN)"
    ],
    "formula": "C13H10FN3. H3PO4",
    "efficacy": "Antihypertensive, Steroid 11-beta-hydroxylase inhibitor\nDISEASE   Cushing's disease [DS:H01431]",
    "target": "CYP11B2 [HSA:1585] [KO:K07433]\nPATHWAY   hsa00140(1585)  Steroid hormone biosynthesis\nhsa04925(1585)  Aldosterone synthesis and secretion\nNETWORK   nt06019  Steroid hormone biosynthesis\nnt06310  CRH-ACTH-cortisol signaling",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576], CYP2B6 [HSA:1555], CYP2D6 [HSA:1565], UGT [KO:K00699]",
    "therapeutic_category": "2499",
    "atc_code": "H02CA02",
    "drug_class": [
      "Metabolizing enzyme substrate",
      "CYP2B6 substrate",
      "CYP2D6 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "UGT substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4",
      "CYP2B6",
      "CYP2D6"
    ],
    "search_name": "Osilodrostat phosphate"
  },
  {
    "kegg_id": "D00420",
    "name_en": "Mitotane (JAN/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Lysodren (TN)"
    ],
    "formula": "C14H10Cl4",
    "efficacy": "Antineoplastic, Steroid biosynthesis inhibitor\nDISEASE   Adrenal cortical carcinoma [DS:H00033]",
    "target": "CYP17A1 [HSA:1586] [KO:K00512]\nPATHWAY   hsa00140(1586)  Steroid hormone biosynthesis\nhsa04934(1586)  Cushing syndrome\nNETWORK   nt06310  CRH-ACTH-cortisol signaling",
    "metabolism": "",
    "therapeutic_category": "2499",
    "atc_code": "L01XX23",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Mitotane"
  },
  {
    "kegg_id": "D01831",
    "name_en": "Buserelin acetate (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Suprecur (TN)"
    ],
    "formula": "C60H86N16O13. C2H4O2",
    "efficacy": "Anti-endometriosis, Gonadotropin-releasing hormone receptor agonist",
    "target": "GNRHR [HSA:2798] [KO:K04280]\nPATHWAY   hsa04080(2798)  Neuroactive ligand-receptor interaction\nhsa04912(2798)  GnRH signaling pathway",
    "metabolism": "",
    "therapeutic_category": "2499",
    "atc_code": "L02AE01",
    "drug_class": [
      "Hormonal agent",
      "Gonadotropin-releasing hormone receptor agonist"
    ],
    "cyp_enzymes": [],
    "search_name": "Buserelin acetate"
  },
  {
    "kegg_id": "D00989",
    "name_en": "Leuprolide acetate (USP)",
    "name_ja": "",
    "names_alt": [
      "Leuprorelin acetate (JP18)",
      "Lupron (TN)",
      "Lutrate (TN)",
      "Eligard (TN)",
      "Fensolvi (TN)"
    ],
    "formula": "C59H84N16O12. C2H4O2",
    "efficacy": "Antineoplastic, Gonadotropin-releasing hormone receptor agonist\nDISEASE   Endometriosis [DS:H01639]\nUterine leiomyomata [DS:H01640]\nCentral precocious puberty [DS:H02018]\nProstate cancer [DS:H00024]",
    "target": "GNRHR [HSA:2798] [KO:K04280]\nPATHWAY   hsa04080(2798)  Neuroactive ligand-receptor interaction\nhsa04912(2798)  GnRH signaling pathway",
    "metabolism": "",
    "therapeutic_category": "2499",
    "atc_code": "L02AE02",
    "drug_class": [
      "Hormonal agent",
      "Gonadotropin-releasing hormone receptor agonist"
    ],
    "cyp_enzymes": [],
    "search_name": "Leuprolide acetate"
  },
  {
    "kegg_id": "D00573",
    "name_en": "Goserelin acetate (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Zoladex (TN)"
    ],
    "formula": "C59H84N18O14. (C2H4O2)x",
    "efficacy": "Antineoplastic, Gonadotropin-releasing hormone receptor agonist\nDISEASE   Prostatic carcinoma [DS:H00024]\nEndometriosis [DS:H01639]\nBreast cancer [DS:H00031]",
    "target": "GNRHR [HSA:2798] [KO:K04280]\nPATHWAY   hsa04080(2798)  Neuroactive ligand-receptor interaction\nhsa04912(2798)  GnRH signaling pathway",
    "metabolism": "",
    "therapeutic_category": "2499",
    "atc_code": "L02AE03",
    "drug_class": [
      "Hormonal agent",
      "Gonadotropin-releasing hormone receptor agonist"
    ],
    "cyp_enzymes": [],
    "search_name": "Goserelin acetate"
  },
  {
    "kegg_id": "D09400",
    "name_en": "Degarelix acetate (JAN)",
    "name_ja": "",
    "names_alt": [
      "Firmagon (TN)"
    ],
    "formula": "C82H103ClN18O16. (C2H4O2)x",
    "efficacy": "Antineoplastic, Gonadotropin-releasing hormone receptor antagonist\nDISEASE   Prostate cancer [DS:H00024]",
    "target": "GNRHR [HSA:2798] [KO:K04280]\nPATHWAY   hsa04080(2798)  Neuroactive ligand-receptor interaction\nhsa04912(2798)  GnRH signaling pathway",
    "metabolism": "",
    "therapeutic_category": "2499",
    "atc_code": "L02BX02",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Degarelix acetate"
  },
  {
    "kegg_id": "D10888",
    "name_en": "Relugolix (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Orgovyx (TN)"
    ],
    "formula": "C29H27F2N7O5S",
    "efficacy": "Anti-endometriosis, Antineoplastic, Gonadotropin-releasing hormone receptor antagonist\nDISEASE   prostate cancer [DS:H00024]",
    "target": "GNRHR [HSA:2798] [KO:K04280]\nPATHWAY   hsa04080(2798)  Neuroactive ligand-receptor interaction\nhsa04912(2798)  GnRH signaling pathway",
    "metabolism": "Transporter: ABCB1 [HSA:5243]",
    "therapeutic_category": "2499",
    "atc_code": "L02BX04",
    "drug_class": [
      "Transporter substrate",
      "ABCB1 substrate"
    ],
    "cyp_enzymes": [],
    "search_name": "Relugolix"
  },
  {
    "kegg_id": "D00410",
    "name_en": "Metyrapone (JP18/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Metopirone (TN)"
    ],
    "formula": "C14H14N2O",
    "efficacy": "Diagnostic aid (pituitary function determination)",
    "target": "CYP11B1 [HSA:1584] [KO:K00497]\nPATHWAY   hsa00140(1584)  Steroid hormone biosynthesis\nNETWORK   nt06310  CRH-ACTH-cortisol signaling\nnt06360  Cushing syndrome",
    "metabolism": "",
    "therapeutic_category": "2499",
    "atc_code": "V04CD01",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Metyrapone"
  },
  {
    "kegg_id": "D00393",
    "name_en": "Methenamine (USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Hexamine (JAN)",
      "Hexamine (TN)"
    ],
    "formula": "C6H12N4",
    "efficacy": "Antibacterial, Antiseptic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2511",
    "atc_code": "J01XX05",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Methenamine"
  },
  {
    "kegg_id": "D00096",
    "name_en": "Sorbitol solution (USP)",
    "name_ja": "",
    "names_alt": [
      "D-Sorbitol (JP18)",
      "Sorbitol (NF)"
    ],
    "formula": "C6H14O6",
    "efficacy": "Diagnostic aid (contrast adjunct), Laxative, Perfusate, Pharmaceutic aid (tablet excipient), Supplement (nutrient)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2519",
    "atc_code": "A06AD18",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Sorbitol solution"
  },
  {
    "kegg_id": "D00882",
    "name_en": "Miconazole nitrate (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Micatin (TN)",
      "Monistat (TN)"
    ],
    "formula": "C18H14Cl4N2O. HNO3",
    "efficacy": "Antifungal, Ergosterol biosynthesis inhibitor\nDISEASE   Vulvovaginal candidiasis [DS:H00363]",
    "target": "sterol 14alpha-demethylase [KO:K05917]\nPATHWAY   ko00100(K05917)  Steroid biosynthesis",
    "metabolism": "",
    "therapeutic_category": "2529",
    "atc_code": "A01AB09",
    "drug_class": [
      "Antifungal",
      "Imidazole antifungal",
      "Metabolizing enzyme inhibitor",
      "CYP2C9 inhibitor",
      "CYP3A/CYP3A4 inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Miconazole nitrate"
  },
  {
    "kegg_id": "D00409",
    "name_en": "Metronidazole (JP18/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Flagyl (TN)",
      "Noritate (TN)",
      "Nuvessa (TN)",
      "Vandazole (TN)"
    ],
    "formula": "C6H9N3O3",
    "efficacy": "Antibacterial, Antiprotozoal, DNA synthesis inhibitor\nDISEASE   Bacterial vaginosis [DS:H01380]\nTrichomoniasis [DS:H00812]\nIntestinal amebiasis; amebic dysentery [DS:H00360]\nBacterial endocarditis [DS:H00334]\nAnaerobic bacterial infections [DS:H01410]",
    "target": "DNA",
    "metabolism": "Enzyme: CYP2A6 [HSA:1548]",
    "therapeutic_category": "2529",
    "atc_code": "A01AB17",
    "drug_class": [
      "Antiparasitic",
      "Imidazole antiprotozoal",
      "Metabolizing enzyme substrate",
      "CYP2A6 substrate",
      "Metabolizing enzyme inhibitor",
      "CYP2C9 inhibitor"
    ],
    "cyp_enzymes": [
      "CYP2A6"
    ],
    "search_name": "Metronidazole"
  },
  {
    "kegg_id": "D00282",
    "name_en": "Clotrimazole (JP18/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Lotrimin (TN)",
      "Mycelex (TN)\nABBR      CLT"
    ],
    "formula": "C22H17ClN2",
    "efficacy": "Antifungal, Ergosterol biosynthesis inhibitor\nDISEASE   Candidiasis [DS:H00363]",
    "target": "sterol 14alpha-demethylase [KO:K05917]\nPATHWAY   ko00100(K05917)  Steroid biosynthesis",
    "metabolism": "",
    "therapeutic_category": "2529",
    "atc_code": "A01AB18",
    "drug_class": [
      "Antifungal",
      "Imidazole antifungal",
      "Metabolizing enzyme inhibitor",
      "CYP3A/CYP3A4 inhibitor",
      "CYP3A4 inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Clotrimazole"
  },
  {
    "kegg_id": "D01480",
    "name_en": "Isoconazole nitrate (JAN)",
    "name_ja": "",
    "names_alt": [
      "Adestan-G (TN)"
    ],
    "formula": "C18H14Cl4N2O. HNO3",
    "efficacy": "Antifungal, Ergosterol biosynthesis inhibitor",
    "target": "sterol 14alpha-demethylase [KO:K05917]\nPATHWAY   ko00100(K05917)  Steroid biosynthesis",
    "metabolism": "",
    "therapeutic_category": "2529",
    "atc_code": "D01AC05",
    "drug_class": [
      "Antifungal",
      "Imidazole antifungal"
    ],
    "cyp_enzymes": [],
    "search_name": "Isoconazole nitrate"
  },
  {
    "kegg_id": "D00885",
    "name_en": "Oxiconazole nitrate (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Oxistat (TN)"
    ],
    "formula": "C18H13Cl4N3O. HNO3",
    "efficacy": "Antifungal, Ergosterol biosynthesis inhibitor\nDISEASE   Tinea pedis [DS:H01316]\nTinea (pityriasis) versicolor [DS:H01334]",
    "target": "sterol 14alpha-demethylase [KO:K05917]\nPATHWAY   ko00100(K05917)  Steroid biosynthesis",
    "metabolism": "",
    "therapeutic_category": "2529",
    "atc_code": "D01AC11",
    "drug_class": [
      "Antifungal",
      "Imidazole antifungal"
    ],
    "cyp_enzymes": [],
    "search_name": "Oxiconazole nitrate"
  },
  {
    "kegg_id": "D01426",
    "name_en": "Tinidazole (JP18/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Haisigyn (TN)",
      "Tindamax (TN)"
    ],
    "formula": "C8H13N3O4S",
    "efficacy": "Antiprotozoal\nDISEASE   Trichomoniasis [DS:H00812]\nGiardiasis [DS:H00362]\nAmebiasis [DS:H00360]\nBacterial vaginosis [DS:H01380]",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2529",
    "atc_code": "G01AF21",
    "drug_class": [
      "Antiparasitic",
      "Imidazole antiprotozoal"
    ],
    "cyp_enzymes": [],
    "search_name": "Tinidazole"
  },
  {
    "kegg_id": "D00950",
    "name_en": "Levonorgestrel (JAN/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Mirena (TN)",
      "Norplant (TN)",
      "Skyla (TN)"
    ],
    "formula": "C21H28O2",
    "efficacy": "Contraceptive, Progesterone receptor agonist",
    "target": "NR3C3 (PGR) [HSA:5241] [KO:K08556]\nPATHWAY   hsa04114(5241)  Oocyte meiosis\nhsa04914(5241)  Progesterone-mediated oocyte maturation\nhsa04915(5241)  Estrogen signaling pathway",
    "metabolism": "",
    "therapeutic_category": "2529",
    "atc_code": "G03AC03",
    "drug_class": [
      "Hormonal agent",
      "Progesterone",
      "Progesterone receptor agonist"
    ],
    "cyp_enzymes": [],
    "search_name": "Levonorgestrel"
  },
  {
    "kegg_id": "D00964",
    "name_en": "Letrozole (JAN/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Femara (TN)"
    ],
    "formula": "C17H11N5",
    "efficacy": "Antineoplastic, Estrogen biosynthesis inhibitor\nDISEASE   Breast cancer, postmenopausal (HR positive) [DS:H00031]",
    "target": "CYP19A1 (ARO) [HSA:1588] [KO:K07434]\nPATHWAY   hsa00140(1588)  Steroid hormone biosynthesis",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576], CYP2A6 [HSA:1548]",
    "therapeutic_category": "2529",
    "atc_code": "L02BG04",
    "drug_class": [
      "Antineoplastic",
      "Aromatase inhibitor",
      "Triazole antineoplastic",
      "Metabolizing enzyme substrate",
      "CYP2A6 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "Metabolizing enzyme inhibitor",
      "CYP2A6 inhibitor"
    ],
    "cyp_enzymes": [
      "CYP3A4",
      "CYP2A6"
    ],
    "search_name": "Letrozole"
  },
  {
    "kegg_id": "D00680",
    "name_en": "Methylergonovine maleate (USP)",
    "name_ja": "",
    "names_alt": [
      "Methylergometrine maleate (JP18)",
      "Methergine (TN)"
    ],
    "formula": "C20H25N3O2. C4H4O4",
    "efficacy": "Hemostatic, Oxytocic",
    "target": "ADRA1 [HSA:148 147 146] [KO:K04135 K04136 K04137]\nADRA2 [HSA:150 151 152] [KO:K04138 K04139 K04140]\nPATHWAY   hsa04020(146+147+148)  Calcium signaling pathway\nhsa04022(146+147+148+150+151+152)  cGMP-PKG signaling pathway\nhsa04080(146+147+148+150+151+152)  Neuroactive ligand-receptor interaction\nhsa04270(146+147+148)  Vascular smooth muscle contraction",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "2531",
    "atc_code": "G02AB01",
    "drug_class": [
      "Neuropsychiatric agent",
      "Ergot alkaloid",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Methylergonovine maleate"
  },
  {
    "kegg_id": "D04484",
    "name_en": "Desogestrel and ethinylestradiol",
    "name_ja": "",
    "names_alt": [
      "Marvelon21 (TN)",
      "Ortho-cept (TN)"
    ],
    "formula": "",
    "efficacy": "Contraceptive",
    "target": "",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576], CYP2C9 [HSA:1559], CYP2C19 [HSA:1557]",
    "therapeutic_category": "2549",
    "atc_code": "G03AA09",
    "drug_class": [
      "Metabolizing enzyme substrate",
      "CYP2C9 substrate",
      "CYP2C19 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C19",
      "CYP2C9",
      "CYP3A4"
    ],
    "search_name": "Desogestrel and ethinylestradiol"
  },
  {
    "kegg_id": "D03917",
    "name_en": "Drospirenone (JAN/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Slynd (TN)",
      "Slinda (TN)"
    ],
    "formula": "C24H30O3",
    "efficacy": "Contraceptive, Aldosterone antagonist",
    "target": "NR3C2 (MR) [HSA:4306] [KO:K08555]\nNR3C3 (PGR) [HSA:5241] [KO:K08556]\nPATHWAY   hsa04114(5241)  Oocyte meiosis\nhsa04914(5241)  Progesterone-mediated oocyte maturation\nhsa04915(5241)  Estrogen signaling pathway",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "2549",
    "atc_code": "G03AC10",
    "drug_class": [
      "Cardiovascular agent",
      "Antihypertensive",
      "Aldosterone antagonist",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Drospirenone"
  },
  {
    "kegg_id": "D01095",
    "name_en": "Tribenoside (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Hemocuron (TN)"
    ],
    "formula": "C29H34O6",
    "efficacy": "Hemorrhoid agent (sclerosing)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2559",
    "atc_code": "C05AX05",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Tribenoside"
  },
  {
    "kegg_id": "D00033",
    "name_en": "Phenol (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Liquefied phenol (JP18)",
      "Phenol for disinfection (JP18)",
      "Phenol, liquefied",
      "Paoscle (TN)"
    ],
    "formula": "C6H6O",
    "efficacy": "Analgesic, Anesthetic (oral), Antipruritic, Disinfectant, Hemorrhoid agent (sclerosing), Pharmaceutic aid (preservative)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2559",
    "atc_code": "C05BB05",
    "drug_class": [
      "Neuropsychiatric agent",
      "Anesthetics",
      "Local anesthetic"
    ],
    "cyp_enzymes": [],
    "search_name": "Phenol"
  },
  {
    "kegg_id": "D04684",
    "name_en": "Aluminum potassium sulfate hydrate and tannic acid",
    "name_ja": "",
    "names_alt": [
      "Zione (TN)"
    ],
    "formula": "",
    "efficacy": "Hemorrhoid agent (sclerosing)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2559",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Aluminum potassium sulfate hydrate and tannic acid"
  },
  {
    "kegg_id": "D04688",
    "name_en": "Tribenoside and lidocaine",
    "name_ja": "",
    "names_alt": [
      "Borraza-G (TN)"
    ],
    "formula": "",
    "efficacy": "Hemorrhoid agent",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2559",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Tribenoside and lidocaine"
  },
  {
    "kegg_id": "D04692",
    "name_en": "Diflucortolone valerate and lidocaine",
    "name_ja": "",
    "names_alt": [
      "Neriproct (TN)"
    ],
    "formula": "",
    "efficacy": "Hemorrhoid agent",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2559",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Diflucortolone valerate and lidocaine"
  },
  {
    "kegg_id": "D04699",
    "name_en": "Hydrocortisone, fradiomycin sulfate, dibucaine hydrochloride and esculoside",
    "name_ja": "ヒドロコルチゾン",
    "names_alt": [
      "Proctosedyl (TN)"
    ],
    "formula": "",
    "efficacy": "Anti-inflammatory, Hemorrhoid agent",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2559",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Hydrocortisone, fradiomycin sulfate, dibucaine hydrochloride and esculoside"
  },
  {
    "kegg_id": "D04702",
    "name_en": "Bromelain and tocopherol acetate",
    "name_ja": "",
    "names_alt": [
      "Hemonase (TN)"
    ],
    "formula": "",
    "efficacy": "Hemorrhoid agent",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2559",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Bromelain and tocopherol acetate"
  },
  {
    "kegg_id": "D07742",
    "name_en": "Ethyl aminobenzoate, lidocaine and bismuth subgallate",
    "name_ja": "",
    "names_alt": [
      "Helmitin S (TN)"
    ],
    "formula": "",
    "efficacy": "Hemorrhoid agent",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2559",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Ethyl aminobenzoate, lidocaine and bismuth subgallate"
  },
  {
    "kegg_id": "D08825",
    "name_en": "Hemolingual",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Hemorrhoid agent",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2559",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Hemolingual"
  },
  {
    "kegg_id": "D08827",
    "name_en": "Hydrocortisone and killed escherichia coli suspension",
    "name_ja": "ヒドロコルチゾン",
    "names_alt": [
      "Posterisan forte (TN)"
    ],
    "formula": "",
    "efficacy": "Hemorrhoid agent",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2559",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Hydrocortisone and killed escherichia coli suspension"
  },
  {
    "kegg_id": "D01263",
    "name_en": "Ritodrine hydrochloride (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Yutopar (TN)"
    ],
    "formula": "C17H21NO3. HCl",
    "efficacy": "Tocolytic, beta2-Adrenergic receptor agonist",
    "target": "ADRB2 [HSA:154] [KO:K04142]\nPATHWAY   hsa04020(154)  Calcium signaling pathway\nhsa04024(154)  cAMP signaling pathway\nhsa04080(154)  Neuroactive ligand-receptor interaction",
    "metabolism": "",
    "therapeutic_category": "2590",
    "atc_code": "G02CA01",
    "drug_class": [
      "Cardiovascular agent",
      "Adrenergic receptor agonist",
      "beta-Adrenergic receptor agonist",
      "beta2-Adrenergic receptor agonist"
    ],
    "cyp_enzymes": [],
    "search_name": "Ritodrine hydrochloride"
  },
  {
    "kegg_id": "D00718",
    "name_en": "Flavoxate hydrochloride (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Urispas (TN)"
    ],
    "formula": "C24H25NO4. HCl",
    "efficacy": "Antipollakisuria, Phosphodiesterase inhibitor",
    "target": "PDE [HSA:10846 27115 50940 5136 5137 5138 5139 5140 5141 5142 5143 5144 5150 5151 5153 8622] [KO:K18438 K18436 K13298 K13755 K18283 K19021 K13296 K13293 K18437]\nPATHWAY   hsa04024(10846+5139+5140+5141+5142+5143+5144)  cAMP signaling pathway",
    "metabolism": "",
    "therapeutic_category": "2590",
    "atc_code": "G04BD02",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Flavoxate hydrochloride"
  },
  {
    "kegg_id": "D01007",
    "name_en": "Propiverine hydrochloride (JP18)",
    "name_ja": "",
    "names_alt": [
      "Bup-4 (TN)",
      "Mictonorm (TN)"
    ],
    "formula": "C23H29NO3. HCl",
    "efficacy": "Antipollakisuria, Overactive bladder agent, Muscarinic acetylcholine receptor antagonist",
    "target": "CHRM [HSA:1128 1129 1131 1132 1133] [KO:K04129 K04130 K04131 K04132 K04133]\nCACNA1-L [HSA:775 776 778 779] [KO:K04850 K04851 K04853 K04857]\nPATHWAY   hsa04020(1128+1129+1131+1133+775+776+778+779)  Calcium signaling pathway\nhsa04080(1128+1129+1131+1132+1133)  Neuroactive ligand-receptor interaction\nhsa04725(1128+1129+1131+1132+1133+775+776+778+779)  Cholinergic synapse",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "2590",
    "atc_code": "G04BD06",
    "drug_class": [
      "Neuropsychiatric agent",
      "Muscarinic cholinergic receptor antagonist",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Propiverine hydrochloride"
  },
  {
    "kegg_id": "D01269",
    "name_en": "Solifenacin succinate (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Vesicare (TN)"
    ],
    "formula": "C23H26N2O2. C4H6O4",
    "efficacy": "Overactive bladder agent, Muscarinic acetylcholine receptor antagonist",
    "target": "CHRM3 [HSA:1131] [KO:K04131]\nPATHWAY   hsa04020(1131)  Calcium signaling pathway\nhsa04080(1131)  Neuroactive ligand-receptor interaction\nhsa04725(1131)  Cholinergic synapse",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "2590",
    "atc_code": "G04BD08",
    "drug_class": [
      "Neuropsychiatric agent",
      "Muscarinic cholinergic receptor antagonist",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Solifenacin succinate"
  },
  {
    "kegg_id": "D08923",
    "name_en": "Fesoterodine fumarate (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Toviaz (TN)"
    ],
    "formula": "C26H37NO3. C4H4O4",
    "efficacy": "Overactive bladder agent, Muscarinic acetylcholine receptor antagonist",
    "target": "CHRM3 [HSA:1131] [KO:K04131]\nCHRM2 [HSA:1129] [KO:K04130]\nPATHWAY   hsa04020(1129+1131)  Calcium signaling pathway\nhsa04080(1129+1131)  Neuroactive ligand-receptor interaction\nhsa04725(1129+1131)  Cholinergic synapse",
    "metabolism": "Enzyme: CYP2D6 [HSA:1565], CYP3A4 [HSA:1576]",
    "therapeutic_category": "2590",
    "atc_code": "G04BD11",
    "drug_class": [
      "Neuropsychiatric agent",
      "Muscarinic cholinergic receptor antagonist",
      "Metabolizing enzyme substrate",
      "CYP2D6 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4",
      "CYP2D6"
    ],
    "search_name": "Fesoterodine fumarate"
  },
  {
    "kegg_id": "D09535",
    "name_en": "Mirabegron (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Myrbetriq (TN)"
    ],
    "formula": "C21H24N4O2S",
    "efficacy": "Overactive bladder agent, beta3-Adrenergic receptor agonist",
    "target": "ADRB3 [HSA:155] [KO:K04143]\nPATHWAY   hsa04020(155)  Calcium signaling pathway\nhsa04080(155)  Neuroactive ligand-receptor interaction",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "2590",
    "atc_code": "G04BD12",
    "drug_class": [
      "Cardiovascular agent",
      "Adrenergic receptor agonist",
      "beta-Adrenergic receptor agonist",
      "beta3-Adrenergic receptor agonist",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "Metabolizing enzyme inhibitor",
      "CYP2D6 inhibitor",
      "Transporter inhibitor",
      "ABCB1 inhibitor"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Mirabegron"
  },
  {
    "kegg_id": "D06273",
    "name_en": "Imidafenacin (JAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Uritos (TN)",
      "Staybla (TN)"
    ],
    "formula": "C20H21N3O",
    "efficacy": "Overactive bladder agent, Muscarinic acetylcholine receptor antagonist",
    "target": "CHRM1 [HSA:1128] [KO:K04129]\nCHRM3 [HSA:1131] [KO:K04131]\nPATHWAY   hsa04080(1128+1131)  Neuroactive ligand-receptor interaction\nhsa04725(1128+1131)  Cholinergic synapse",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576], UGT1A4 [HSA:54657]",
    "therapeutic_category": "2590",
    "atc_code": "G04BD14",
    "drug_class": [
      "Neuropsychiatric agent",
      "Muscarinic cholinergic receptor antagonist",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "UGT substrate",
      "UGT1A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Imidafenacin"
  },
  {
    "kegg_id": "D10433",
    "name_en": "Vibegron (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Beova (TN)",
      "Gemtesa (TN)"
    ],
    "formula": "C26H28N4O3",
    "efficacy": "Antidysuria, beta3-Adrenergic receptor agonist",
    "target": "ADRB3 [HSA:155] [KO:K04143]\nPATHWAY   hsa04080(155)  Neuroactive ligand-receptor interaction",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]\nTransporter: ABCB1 [HSA:5243]",
    "therapeutic_category": "2590",
    "atc_code": "G04BD15",
    "drug_class": [
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "Transporter substrate",
      "ABCB1 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Vibegron"
  },
  {
    "kegg_id": "D03260",
    "name_en": "Vardenafil hydrochloride hydrate (JAN)",
    "name_ja": "",
    "names_alt": [
      "Vardenafil monohydrochloride trihydrate",
      "Levitra (TN)",
      "Staxyn (TN)"
    ],
    "formula": "C23H32N6O4S. 3H2O. HCl",
    "efficacy": "Vasodilator, Impotence therapy, Phosphodiesterase V inhibitor",
    "target": "PDE5 [HSA:8654] [KO:K13762]\nPATHWAY   hsa04022(8654)  cGMP-PKG signaling pathway",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "2590",
    "atc_code": "G04BE09",
    "drug_class": [
      "Cardiovascular agent",
      "Phosphodiesterase V inhibitor",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Vardenafil hydrochloride hydrate"
  },
  {
    "kegg_id": "D01043",
    "name_en": "Dimethyl sulfoxide (JAN/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Rimso-50 (TN)",
      "Zymso (TN)"
    ],
    "formula": "C2H6OS",
    "efficacy": "Anti-inflammatory (topical)\nDISEASE   Interstitial cystitis [DS:H01551]",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2590",
    "atc_code": "G04BX13",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Dimethyl sulfoxide"
  },
  {
    "kegg_id": "D01024",
    "name_en": "Tamsulosin hydrochloride (JP18/USP)",
    "name_ja": "タムスロシン",
    "names_alt": [
      "Flomax (TN)",
      "Harnal (TN)"
    ],
    "formula": "C20H28N2O5S. HCl",
    "efficacy": "Antidysuria, alpha1-Adrenergic receptor antagonist",
    "target": "ADRA1 [HSA:148 147 146] [KO:K04135 K04136 K04137]\nPATHWAY   hsa04022(146+147+148)  cGMP-PKG signaling pathway\nhsa04080(146+147+148)  Neuroactive ligand-receptor interaction\nhsa04270(146+147+148)  Vascular smooth muscle contraction",
    "metabolism": "",
    "therapeutic_category": "2590",
    "atc_code": "G04CA02",
    "drug_class": [
      "Cardiovascular agent",
      "Adrenergic receptor antagonist",
      "alpha-Adrenergic receptor antagonist",
      "alpha1-Adrenergic receptor antagonist"
    ],
    "cyp_enzymes": [],
    "search_name": "Tamsulosin hydrochloride"
  },
  {
    "kegg_id": "D01965",
    "name_en": "Silodosin (JP18/INN)",
    "name_ja": "",
    "names_alt": [
      "KMD 3213",
      "Rapaflo (TN)",
      "Urief (TN)"
    ],
    "formula": "C25H32F3N3O4",
    "efficacy": "Antidysuria, alpha1-Adrenergic receptor antagonist",
    "target": "ADRA1A [HSA:148] [KO:K04135]\nPATHWAY   hsa04022(148)  cGMP-PKG signaling pathway\nhsa04080(148)  Neuroactive ligand-receptor interaction\nhsa04270(148)  Vascular smooth muscle contraction",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576], UGT [KO:K00699]",
    "therapeutic_category": "2590",
    "atc_code": "G04CA04",
    "drug_class": [
      "Cardiovascular agent",
      "Adrenergic receptor antagonist",
      "alpha-Adrenergic receptor antagonist",
      "alpha1-Adrenergic receptor antagonist",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "UGT substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Silodosin"
  },
  {
    "kegg_id": "D01674",
    "name_en": "Naftopidil (JP18/INN)",
    "name_ja": "",
    "names_alt": [
      "Flivas (TN)"
    ],
    "formula": "C24H28N2O3",
    "efficacy": "Antidysuria, alpha1-Adrenergic receptor antagonist",
    "target": "ADRA1 [HSA:148 147 146] [KO:K04135 K04136 K04137]\nPATHWAY   hsa04020(146+147+148)  Calcium signaling pathway\nhsa04080(146+147+148)  Neuroactive ligand-receptor interaction\nhsa04270(146+147+148)  Vascular smooth muscle contraction\nhsa04970(146+147+148)  Salivary secretion",
    "metabolism": "",
    "therapeutic_category": "2590",
    "atc_code": "",
    "drug_class": [
      "Cardiovascular agent",
      "Adrenergic receptor antagonist",
      "alpha-Adrenergic receptor antagonist",
      "alpha1-Adrenergic receptor antagonist"
    ],
    "cyp_enzymes": [],
    "search_name": "Naftopidil"
  },
  {
    "kegg_id": "D04711",
    "name_en": "Cernitin pollen extract (JAN)",
    "name_ja": "",
    "names_alt": [
      "Cernilton (TN)"
    ],
    "formula": "",
    "efficacy": "Antidysuria, Prostate diseases agent",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2590",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Cernitin pollen extract"
  },
  {
    "kegg_id": "D04712",
    "name_en": "Quercus salicina extract (Non-JPS)",
    "name_ja": "",
    "names_alt": [
      "Urocalun (TN)"
    ],
    "formula": "",
    "efficacy": "Urological agent",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2590",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Quercus salicina extract"
  },
  {
    "kegg_id": "D08712",
    "name_en": "Chimaphila umbellata, populus tremula, pulsatilla pratensis mill, equisetum arvense and wheat germ oil",
    "name_ja": "",
    "names_alt": [
      "Nerset (TN)"
    ],
    "formula": "",
    "efficacy": "Antipollakisuria, Overactive bladder agent",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2590",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Chimaphila umbellata, populus tremula, pulsatilla pratensis mill, equisetum arvense and wheat germ oil"
  },
  {
    "kegg_id": "D01711",
    "name_en": "Sodium hypochlorite (JAN/USP)",
    "name_ja": "",
    "names_alt": [
      "Texant (TN)"
    ],
    "formula": "OCl. Na",
    "efficacy": "Disinfectant",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2611",
    "atc_code": "D08AX07",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Sodium hypochlorite"
  },
  {
    "kegg_id": "D00108",
    "name_en": "Iodine (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Cadex (TN)"
    ],
    "formula": "I2",
    "efficacy": "Anti-ulcerative (skin), Disinfectant (topical), Pharmaceutic aid",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2612",
    "atc_code": "D08AG03",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Iodine"
  },
  {
    "kegg_id": "D04470",
    "name_en": "Dilute iodine tincture (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Disinfectant (topical)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2612",
    "atc_code": "D08AG03",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Dilute iodine tincture"
  },
  {
    "kegg_id": "D04723",
    "name_en": "Iodine tincture (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Disinfectant (topical)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2612",
    "atc_code": "D08AG03",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Iodine tincture"
  },
  {
    "kegg_id": "D01910",
    "name_en": "Iodoform (JP18/USP)",
    "name_ja": "",
    "names_alt": [],
    "formula": "CHI3",
    "efficacy": "Disinfectant (topical)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2612",
    "atc_code": "D09AA13",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Iodoform"
  },
  {
    "kegg_id": "D00008",
    "name_en": "Hydrogen peroxide (USP)",
    "name_ja": "",
    "names_alt": [
      "Oxydol (JP18)",
      "Oxyfull (TN)"
    ],
    "formula": "H2O2",
    "efficacy": "Disinfectant (topical)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2614",
    "atc_code": "A01AB02",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Hydrogen peroxide"
  },
  {
    "kegg_id": "D02053",
    "name_en": "Potassium permanganate (JP18/USP)",
    "name_ja": "",
    "names_alt": [],
    "formula": "MnO4. K",
    "efficacy": "Disinfectant (topical)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2614",
    "atc_code": "D08AX06",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Potassium permanganate"
  },
  {
    "kegg_id": "D00137",
    "name_en": "Isopropyl alcohol (USP)",
    "name_ja": "",
    "names_alt": [
      "Isopropanol (JP18)",
      "Isopro (TN)"
    ],
    "formula": "C3H8O",
    "efficacy": "Disinfectant (topical), Pharmaceutic aid (solvent)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2615",
    "atc_code": "D08AX05",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Isopropyl alcohol"
  },
  {
    "kegg_id": "D00068",
    "name_en": "Alcohol (USP)",
    "name_ja": "",
    "names_alt": [
      "Anhydrous ethanol (JP18)",
      "Dehydrated alcohol",
      "Dehydrated ethanol",
      "Ethyl alcohol"
    ],
    "formula": "C2H6O",
    "efficacy": "Antineoplastic, Disinfectant (topical), Pharmaceutic aid (solvent)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2615",
    "atc_code": "D08AX08",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Alcohol"
  },
  {
    "kegg_id": "D04855",
    "name_en": "Ethanol for disinfection (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Disinfectant (topical)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2615",
    "atc_code": "D08AX08",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Ethanol for disinfection"
  },
  {
    "kegg_id": "D06542",
    "name_en": "Ethanol (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Disinfectant (topical)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2615",
    "atc_code": "D08AX08",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Ethanol"
  },
  {
    "kegg_id": "D04732",
    "name_en": "Isopropanol and methylated alcohol",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Disinfectant (topical)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2615",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Isopropanol and methylated alcohol"
  },
  {
    "kegg_id": "D00857",
    "name_en": "Benzalkonium chloride (JP18/NF/INN)",
    "name_ja": "",
    "names_alt": [
      "Zephiran chloride (TN)"
    ],
    "formula": "C9H13NR. Cl",
    "efficacy": "Disinfectant, Pharmaceutic aid (preservative)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2616",
    "atc_code": "D08AJ01",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Benzalkonium chloride"
  },
  {
    "kegg_id": "D01140",
    "name_en": "Benzethonium chloride (JP18/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Hyamine (TN)",
      "Microklenz (TN)",
      "Neostelin green (TN)"
    ],
    "formula": "C27H42NO2. Cl",
    "efficacy": "Anti-infective (topical), Pharmaceutic aid (preservative)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2616",
    "atc_code": "D08AJ08",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Benzethonium chloride"
  },
  {
    "kegg_id": "D06417",
    "name_en": "Saponated cresol solution (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Disinfectant",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2616",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Saponated cresol solution"
  },
  {
    "kegg_id": "D00858",
    "name_en": "Chlorhexidine gluconate (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Hibiclens (TN)",
      "Peridex (TN)",
      "Periogard (TN)"
    ],
    "formula": "C22H30Cl2N10. (C6H12O7)2",
    "efficacy": "Antibacterial, Disinfectant, Cell membrane function inhibitor",
    "target": "Lipopolysaccharide\nLipoteichoic acid",
    "metabolism": "",
    "therapeutic_category": "2619",
    "atc_code": "A01AB03",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Chlorhexidine gluconate"
  },
  {
    "kegg_id": "D06534",
    "name_en": "Phenolated water (JP18)",
    "name_ja": "",
    "names_alt": [
      "Phenolated water for disinfection (JP18)",
      "Phenol hydrate"
    ],
    "formula": "C6H6O. H2O",
    "efficacy": "Disinfectant (topical)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2619",
    "atc_code": "C05BB05",
    "drug_class": [
      "Neuropsychiatric agent",
      "Anesthetics",
      "Local anesthetic"
    ],
    "cyp_enzymes": [],
    "search_name": "Phenolated water"
  },
  {
    "kegg_id": "D10301",
    "name_en": "Chlorhexidine gluconate and alcohol",
    "name_ja": "",
    "names_alt": [
      "Prevantics (TN)"
    ],
    "formula": "",
    "efficacy": "Antiseptic, Disinfectant (topical)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2619",
    "atc_code": "D08AC52",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Chlorhexidine gluconate and alcohol"
  },
  {
    "kegg_id": "D00133",
    "name_en": "Resorcinol (USP)",
    "name_ja": "",
    "names_alt": [
      "Resorcin (JAN)",
      "Resorcin (TN)"
    ],
    "formula": "C6H6O2",
    "efficacy": "Anti-acne, Disinfectant (topical), Keratolytic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2619",
    "atc_code": "D10AX02",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Resorcinol"
  },
  {
    "kegg_id": "D03318",
    "name_en": "Wood creosote (JP18)",
    "name_ja": "",
    "names_alt": [
      "Creosote (TN)"
    ],
    "formula": "",
    "efficacy": "Disinfectant",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2619",
    "atc_code": "R05CA08",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Wood creosote"
  },
  {
    "kegg_id": "D00017",
    "name_en": "Formaldehyde (USP)",
    "name_ja": "",
    "names_alt": [
      "Formalin (JP18)"
    ],
    "formula": "CH2O",
    "efficacy": "Disinfectant",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2619",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Formaldehyde"
  },
  {
    "kegg_id": "D04734",
    "name_en": "Alkyldiaminoethylglycine hydrochloride (JAN)",
    "name_ja": "",
    "names_alt": [
      "Alkylpolyaminoethylglycine hydrochloride",
      "Tego (TN)"
    ],
    "formula": "C6H14N3O2R. HCl",
    "efficacy": "Disinfectant (topical)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2619",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Alkyldiaminoethylglycine hydrochloride"
  },
  {
    "kegg_id": "D04744",
    "name_en": "Sodium thiosulfate and ethanol",
    "name_ja": "",
    "names_alt": [
      "Hypoethanol (TN)"
    ],
    "formula": "",
    "efficacy": "Disinfectant (topical)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2619",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Sodium thiosulfate and ethanol"
  },
  {
    "kegg_id": "D10451",
    "name_en": "Olanexidine gluconate (JAN)",
    "name_ja": "",
    "names_alt": [],
    "formula": "C17H27Cl2N5. C6H12O7",
    "efficacy": "Disinfectant (topical)",
    "target": "lipopolysaccharide\nlipoteichoic acid",
    "metabolism": "",
    "therapeutic_category": "2619",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Olanexidine gluconate"
  },
  {
    "kegg_id": "D04797",
    "name_en": "Zinc oxide starch powder (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Astringent, Protectant (topical)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2621",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Zinc oxide starch powder"
  },
  {
    "kegg_id": "D00433",
    "name_en": "Sulfadiazine, silver (USP)",
    "name_ja": "",
    "names_alt": [
      "Sulfadiazine silver (JP18)",
      "Silvadene (TN)"
    ],
    "formula": "C10H9N4O2S. Ag",
    "efficacy": "Antibacterial (topical), Folic acid biosynthesis inhibitor",
    "target": "dihydropteroate synthase [KO:K00796]\nPATHWAY   ko00790(K00796)  Folate biosynthesis",
    "metabolism": "",
    "therapeutic_category": "2633",
    "atc_code": "D06BA01",
    "drug_class": [
      "Antibacterial",
      "Sulfonamide antibacterial",
      "Intermediate-acting sulfonamide"
    ],
    "cyp_enzymes": [],
    "search_name": "Sulfadiazine, silver"
  },
  {
    "kegg_id": "D01618",
    "name_en": "Neomycin sulfate (USP)",
    "name_ja": "",
    "names_alt": [
      "Fradiomycin sulfate (JP18)",
      "Mycifradin (TN)",
      "Neo-fradin (TN)",
      "Sofratulle (TN)"
    ],
    "formula": "",
    "efficacy": "Antibacterial, Protein biosynthesis inhibitor",
    "target": "30S ribosomal subunit\nPATHWAY   ko03010(K01977)  Ribosome",
    "metabolism": "",
    "therapeutic_category": "2634",
    "atc_code": "A01AB08",
    "drug_class": [
      "Antibacterial",
      "Aminoglycoside antibiotic"
    ],
    "cyp_enzymes": [],
    "search_name": "Neomycin sulfate"
  },
  {
    "kegg_id": "D01066",
    "name_en": "Polymyxin B sulfate (USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Polymixin B sulfate (JP18)",
      "Aerosporin (TN)"
    ],
    "formula": "C55H95N16O13R. xH2SO4",
    "efficacy": "Antibacterial, Cell membrane function inhibitor",
    "target": "Lipopolysaccharide",
    "metabolism": "",
    "therapeutic_category": "2634",
    "atc_code": "A07AA05",
    "drug_class": [
      "Antibacterial",
      "Polypeptide antibiotic"
    ],
    "cyp_enzymes": [],
    "search_name": "Polymyxin B sulfate"
  },
  {
    "kegg_id": "D00213",
    "name_en": "Fusidate sodium (USAN)",
    "name_ja": "",
    "names_alt": [
      "Sodium fusidate (JP18)",
      "Fucidin leo (TN)"
    ],
    "formula": "C31H47O6. Na",
    "efficacy": "Antibacterial, Protein biosynthesis inhibitor",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2634",
    "atc_code": "D06AX01",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Fusidate sodium"
  },
  {
    "kegg_id": "D01073",
    "name_en": "Clindamycin phosphate (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Cleocin (TN)",
      "Dalacin-S (TN)",
      "Evoclin (TN)"
    ],
    "formula": "C18H34ClN2O8PS",
    "efficacy": "Antibacterial, Protein biosynthesis inhibitor\nDISEASE   Infections due to susceptible strains of Streptococci [DS:H00333]\nAcne vulgaris [DS:H01445]",
    "target": "50S ribosomal subunit\nPATHWAY   ko03010(K01980)  Ribosome",
    "metabolism": "",
    "therapeutic_category": "2634",
    "atc_code": "D10AF01",
    "drug_class": [
      "Antibacterial",
      "Lincosamide antibiotic"
    ],
    "cyp_enzymes": [],
    "search_name": "Clindamycin phosphate"
  },
  {
    "kegg_id": "D09544",
    "name_en": "Ozenoxacin (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Xepi (TN)"
    ],
    "formula": "C21H21N3O3",
    "efficacy": "Antibacterial, Nucleic acid biosynthesis inhibitor",
    "target": "DNA gyrase [KO:K02469 K02470]\ntopoisomerase IV [KO:K02621 K02622]",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "2639",
    "atc_code": "D06AX14",
    "drug_class": [
      "Antibacterial",
      "Quinolone",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Ozenoxacin"
  },
  {
    "kegg_id": "D04753",
    "name_en": "Chloramphenicol, fradiomycin sulfate and prednisolone",
    "name_ja": "クロラムフェニコール",
    "names_alt": [
      "Chlomy-P (TN)"
    ],
    "formula": "",
    "efficacy": "Antibacterial, Anti-inflammatory",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2639",
    "atc_code": "D07CA03",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Chloramphenicol, fradiomycin sulfate and prednisolone"
  },
  {
    "kegg_id": "D01147",
    "name_en": "Nadifloxacin (JAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Acuatim (TN)"
    ],
    "formula": "C19H21FN2O4",
    "efficacy": "Antibacterial, Nucleic acid biosynthesis inhibitor",
    "target": "DNA gyrase [KO:K02469 K02470]",
    "metabolism": "",
    "therapeutic_category": "2639",
    "atc_code": "D10AF05",
    "drug_class": [
      "Antibacterial",
      "Quinolone",
      "Fluoroquinolone"
    ],
    "cyp_enzymes": [],
    "search_name": "Nadifloxacin"
  },
  {
    "kegg_id": "D02144",
    "name_en": "Oxytetracycline hydrochloride and polymixin B sulfate",
    "name_ja": "",
    "names_alt": [
      "Terramycin ophthalmic (TN)"
    ],
    "formula": "",
    "efficacy": "Antibacterial",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2639",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Oxytetracycline hydrochloride and polymixin B sulfate"
  },
  {
    "kegg_id": "D04755",
    "name_en": "Bacitracin and fradiomycin sulfate",
    "name_ja": "",
    "names_alt": [
      "Baramycin (TN)"
    ],
    "formula": "",
    "efficacy": "Antibacterial",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2639",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Bacitracin and fradiomycin sulfate"
  },
  {
    "kegg_id": "D01087",
    "name_en": "Methyl salicylate (JP18/NF)",
    "name_ja": "",
    "names_alt": [],
    "formula": "C8H8O3",
    "efficacy": "Analgesic, Anti-inflammatory",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2641",
    "atc_code": "",
    "drug_class": [
      "Anti-inflammatory",
      "Nonsteroidal anti-inflammatory drug (NSAID)",
      "Anti-inflammatory drug, salicylic acid derivatives"
    ],
    "cyp_enzymes": [],
    "search_name": "Methyl salicylate"
  },
  {
    "kegg_id": "D00300",
    "name_en": "Diphenhydramine (JP18/INN)",
    "name_ja": "",
    "names_alt": [
      "Restamin (TN)"
    ],
    "formula": "C17H21NO",
    "efficacy": "Antiallergic, H1 receptor antagonist",
    "target": "HRH1 [HSA:3269] [KO:K04149]\nPATHWAY   hsa04020(3269)  Calcium signaling pathway\nhsa04080(3269)  Neuroactive ligand-receptor interaction",
    "metabolism": "",
    "therapeutic_category": "2642",
    "atc_code": "D04AA32",
    "drug_class": [
      "Anti-allergic agent",
      "Histamine receptor antagonist",
      "Histamine receptor H1 antagonist"
    ],
    "cyp_enzymes": [],
    "search_name": "Diphenhydramine"
  },
  {
    "kegg_id": "D04594",
    "name_en": "Ammonia water (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "NH4. OH",
    "efficacy": "Antipruritic, Expectorant",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2643",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Ammonia water"
  },
  {
    "kegg_id": "D01945",
    "name_en": "Lead acetate (JAN)",
    "name_ja": "",
    "names_alt": [
      "Lead acetate trihydrate"
    ],
    "formula": "(C2H3O2)2. 3H2O. Pb",
    "efficacy": "Astringent",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2644",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Lead acetate"
  },
  {
    "kegg_id": "D00098",
    "name_en": "Camphor (USP)",
    "name_ja": "",
    "names_alt": [
      "dl-Camphor (JP18)"
    ],
    "formula": "C10H16O",
    "efficacy": "Analgesic, Anti-inflammatory, Antipruritic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2645",
    "atc_code": "C01EB02",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Camphor"
  },
  {
    "kegg_id": "D06620",
    "name_en": "dl-Camphor and ethanol",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Analgesic, Anti-inflammatory, Antipruritic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2645",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "dl-Camphor and ethanol"
  },
  {
    "kegg_id": "D01632",
    "name_en": "Dexamethasone dipropionate (USAN)",
    "name_ja": "デキサメタゾン",
    "names_alt": [
      "Dexamethasone propionate (JAN)",
      "Hifmeta (TN)"
    ],
    "formula": "C28H37FO7",
    "efficacy": "Anti-inflammatory, Glucocorticoid receptor agonist",
    "target": "NR3C1 (GR) [HSA:2908] [KO:K05771]\nPATHWAY   hsa04080(2908)  Neuroactive ligand-receptor interaction",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "2646",
    "atc_code": "A01AC02",
    "drug_class": [
      "Anti-inflammatory",
      "Corticosteroid",
      "Glucocorticoid",
      "Dermatological agent",
      "Atopic dermatitis agent",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "Metabolizing enzyme inducer",
      "CYP3A/CYP3A4 inducer",
      "CYP3A4 inducer"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Dexamethasone dipropionate"
  },
  {
    "kegg_id": "D01948",
    "name_en": "Dexamethasone valerate (JAN)",
    "name_ja": "デキサメタゾン",
    "names_alt": [
      "Dexamethasone 17-valerate",
      "DV-17",
      "Voalla ointment (TN)"
    ],
    "formula": "C27H37FO6",
    "efficacy": "Anti-inflammatory, Glucocorticoid receptor agonist",
    "target": "NR3C1 (GR) [HSA:2908] [KO:K05771]\nPATHWAY   hsa04080(2908)  Neuroactive ligand-receptor interaction",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "2646",
    "atc_code": "A01AC02",
    "drug_class": [
      "Anti-inflammatory",
      "Corticosteroid",
      "Glucocorticoid",
      "Dermatological agent",
      "Atopic dermatitis agent",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "Metabolizing enzyme inducer",
      "CYP3A/CYP3A4 inducer",
      "CYP3A4 inducer"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Dexamethasone valerate"
  },
  {
    "kegg_id": "D01619",
    "name_en": "Hydrocortisone butyrate (JP18/USP)",
    "name_ja": "ヒドロコルチゾン",
    "names_alt": [
      "Locoid (TN)"
    ],
    "formula": "C25H36O6",
    "efficacy": "Anti-inflammatory, Glucocorticoid receptor agonist\nDISEASE   Atopic dermatitis [DS:H01358]\nSeborrheic dermatitis [DS:H01652]",
    "target": "NR3C1 (GR) [HSA:2908] [KO:K05771]\nPATHWAY   hsa04080(2908)  Neuroactive ligand-receptor interaction",
    "metabolism": "Enzyme: CYP3A [HSA:1576 1577 1551]",
    "therapeutic_category": "2646",
    "atc_code": "A01AC03",
    "drug_class": [
      "Anti-inflammatory",
      "Corticosteroid",
      "Glucocorticoid",
      "Dermatological agent",
      "Atopic dermatitis agent",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A"
    ],
    "search_name": "Hydrocortisone butyrate"
  },
  {
    "kegg_id": "D01886",
    "name_en": "Hydrocortisone probutate (USAN)",
    "name_ja": "ヒドロコルチゾン",
    "names_alt": [
      "Hydrocortisone butyrate propionate (JAN)",
      "Hydrocortisone buteprate",
      "Pandel (TN)"
    ],
    "formula": "C28H40O7",
    "efficacy": "Anti-inflammatory, Glucocorticoid receptor agonist",
    "target": "NR3C1 (GR) [HSA:2908] [KO:K05771]\nPATHWAY   hsa04080(2908)  Neuroactive ligand-receptor interaction",
    "metabolism": "Enzyme: CYP3A [HSA:1576 1577 1551]",
    "therapeutic_category": "2646",
    "atc_code": "A01AC03",
    "drug_class": [
      "Anti-inflammatory",
      "Corticosteroid",
      "Glucocorticoid",
      "Dermatological agent",
      "Atopic dermatitis agent",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A"
    ],
    "search_name": "Hydrocortisone probutate"
  },
  {
    "kegg_id": "D03301",
    "name_en": "Prednisolone valerate acetate (JAN)",
    "name_ja": "プレドニゾロン",
    "names_alt": [
      "PDL",
      "Spirazon (TN)"
    ],
    "formula": "C28H38O7",
    "efficacy": "Anti-inflammatory, Glucocorticoid receptor agonist",
    "target": "NR3C1 (GR) [HSA:2908] [KO:K05771]\nPATHWAY   hsa04080(2908)  Neuroactive ligand-receptor interaction",
    "metabolism": "",
    "therapeutic_category": "2646",
    "atc_code": "A01AC04",
    "drug_class": [
      "Anti-inflammatory",
      "Corticosteroid",
      "Glucocorticoid",
      "Dermatological agent",
      "Atopic dermatitis agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Prednisolone valerate acetate"
  },
  {
    "kegg_id": "D01357",
    "name_en": "Betamethasone valerate (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Beta-Val (TN)",
      "Luxiq (TN)",
      "Rinderon-V (TN)"
    ],
    "formula": "C27H37FO6",
    "efficacy": "Anti-inflammatory, Glucocorticoid receptor agonist",
    "target": "NR3C1 (GR) [HSA:2908] [KO:K05771]\nPATHWAY   hsa04080(2908)  Neuroactive ligand-receptor interaction",
    "metabolism": "",
    "therapeutic_category": "2646",
    "atc_code": "A07EA04",
    "drug_class": [
      "Anti-inflammatory",
      "Corticosteroid",
      "Glucocorticoid",
      "Dermatological agent",
      "Atopic dermatitis agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Betamethasone valerate"
  },
  {
    "kegg_id": "D01637",
    "name_en": "Betamethasone dipropionate (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Diprolene (TN)",
      "Rinderon-DP (TN)",
      "Sernivo (TN)"
    ],
    "formula": "C28H37FO7",
    "efficacy": "Anti-inflammatory, Antipruritic, Glucocorticoid receptor agonist\nDISEASE   Plaque psoriasis [DS:H01656]",
    "target": "NR3C1 (GR) [HSA:2908] [KO:K05771]\nPATHWAY   hsa04080(2908)  Neuroactive ligand-receptor interaction",
    "metabolism": "",
    "therapeutic_category": "2646",
    "atc_code": "A07EA04",
    "drug_class": [
      "Anti-inflammatory",
      "Corticosteroid",
      "Glucocorticoid",
      "Dermatological agent",
      "Atopic dermatitis agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Betamethasone dipropionate"
  },
  {
    "kegg_id": "D02032",
    "name_en": "Betamethasone butyrate propionate (JAN)",
    "name_ja": "",
    "names_alt": [
      "Antebate (TN)"
    ],
    "formula": "C29H39FO7",
    "efficacy": "Anti-inflammatory, Glucocorticoid receptor agonist",
    "target": "NR3C1 (GR) [HSA:2908] [KO:K05771]\nPATHWAY   hsa04080(2908)  Neuroactive ligand-receptor interaction",
    "metabolism": "",
    "therapeutic_category": "2646",
    "atc_code": "A07EA04",
    "drug_class": [
      "Anti-inflammatory",
      "Corticosteroid",
      "Glucocorticoid",
      "Dermatological agent",
      "Atopic dermatitis agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Betamethasone butyrate propionate"
  },
  {
    "kegg_id": "D01825",
    "name_en": "Fluocinolone acetonide (JP18/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Fluocet (TN)",
      "Retisert (TN)",
      "Synalar (TN)"
    ],
    "formula": "C24H30F2O6",
    "efficacy": "Anti-inflammatory, Glucocorticoid receptor agonist",
    "target": "NR3C1 (GR) [HSA:2908] [KO:K05771]\nPATHWAY   hsa04080(2908)  Neuroactive ligand-receptor interaction",
    "metabolism": "",
    "therapeutic_category": "2646",
    "atc_code": "C05AA10",
    "drug_class": [
      "Anti-inflammatory",
      "Corticosteroid",
      "Glucocorticoid",
      "Dermatological agent",
      "Atopic dermatitis agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Fluocinolone acetonide"
  },
  {
    "kegg_id": "D00325",
    "name_en": "Fluocinonide (JP18/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Lidex (TN)",
      "Vanos (TN)"
    ],
    "formula": "C26H32F2O7",
    "efficacy": "Anti-inflammatory, Glucocorticoid receptor agonist",
    "target": "NR3C1 (GR) [HSA:2908] [KO:K05771]\nPATHWAY   hsa04080(2908)  Neuroactive ligand-receptor interaction",
    "metabolism": "",
    "therapeutic_category": "2646",
    "atc_code": "C05AA11",
    "drug_class": [
      "Anti-inflammatory",
      "Corticosteroid",
      "Glucocorticoid",
      "Dermatological agent",
      "Atopic dermatitis agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Fluocinonide"
  },
  {
    "kegg_id": "D01273",
    "name_en": "Clobetasone butyrate (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Kindavate (TN)"
    ],
    "formula": "C26H32ClFO5",
    "efficacy": "Anti-inflammatory, Glucocorticoid receptor agonist",
    "target": "NR3C1 (GR) [HSA:2908] [KO:K05771]\nPATHWAY   hsa04080(2908)  Neuroactive ligand-receptor interaction",
    "metabolism": "",
    "therapeutic_category": "2646",
    "atc_code": "D07AB01",
    "drug_class": [
      "Anti-inflammatory",
      "Corticosteroid",
      "Glucocorticoid",
      "Dermatological agent",
      "Atopic dermatitis agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Clobetasone butyrate"
  },
  {
    "kegg_id": "D01820",
    "name_en": "Alclometasone dipropionate (JAN/USP)",
    "name_ja": "",
    "names_alt": [
      "Aclovate (TN)"
    ],
    "formula": "C28H37ClO7",
    "efficacy": "Anti-inflammatory, Glucocorticoid receptor agonist",
    "target": "NR3C1 (GR) [HSA:2908] [KO:K05771]\nPATHWAY   hsa04080(2908)  Neuroactive ligand-receptor interaction",
    "metabolism": "",
    "therapeutic_category": "2646",
    "atc_code": "D07AB10",
    "drug_class": [
      "Anti-inflammatory",
      "Corticosteroid",
      "Glucocorticoid",
      "Dermatological agent",
      "Atopic dermatitis agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Alclometasone dipropionate"
  },
  {
    "kegg_id": "D01764",
    "name_en": "Diflucortolone valerate (JP18)",
    "name_ja": "",
    "names_alt": [
      "Afusona (TN)"
    ],
    "formula": "C27H36F2O5",
    "efficacy": "Anti-inflammatory, Glucocorticoid receptor agonist",
    "target": "NR3C1 (GR) [HSA:2908] [KO:K05771]\nPATHWAY   hsa04080(2908)  Neuroactive ligand-receptor interaction",
    "metabolism": "",
    "therapeutic_category": "2646",
    "atc_code": "D07AC06",
    "drug_class": [
      "Anti-inflammatory",
      "Corticosteroid",
      "Glucocorticoid",
      "Dermatological agent",
      "Atopic dermatitis agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Diflucortolone valerate"
  },
  {
    "kegg_id": "D01327",
    "name_en": "Diflorasone diacetate (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Florone (TN)",
      "Psorcon (TN)"
    ],
    "formula": "C26H32F2O7",
    "efficacy": "Anti-inflammatory, Glucocorticoid receptor agonist",
    "target": "NR3C1 (GR) [HSA:2908] [KO:K05771]\nPATHWAY   hsa04080(2908)  Neuroactive ligand-receptor interaction",
    "metabolism": "",
    "therapeutic_category": "2646",
    "atc_code": "D07AC10",
    "drug_class": [
      "Anti-inflammatory",
      "Corticosteroid",
      "Glucocorticoid",
      "Dermatological agent",
      "Atopic dermatitis agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Diflorasone diacetate"
  },
  {
    "kegg_id": "D01387",
    "name_en": "Amcinonide (JAN/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Cyclocort (TN)"
    ],
    "formula": "C28H35FO7",
    "efficacy": "Anti-inflammatory, Glucocorticoid receptor agonist",
    "target": "NR3C1 (GR) [HSA:2908] [KO:K05771]\nPATHWAY   hsa04080(2908)  Neuroactive ligand-receptor interaction",
    "metabolism": "",
    "therapeutic_category": "2646",
    "atc_code": "D07AC11",
    "drug_class": [
      "Anti-inflammatory",
      "Corticosteroid",
      "Glucocorticoid",
      "Dermatological agent",
      "Atopic dermatitis agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Amcinonide"
  },
  {
    "kegg_id": "D01266",
    "name_en": "Difluprednate (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Durezol (TN)"
    ],
    "formula": "C27H34F2O7",
    "efficacy": "Anti-inflammatory, Glucocorticoid receptor agonist",
    "target": "NR3C1 (GR) [HSA:2908] [KO:K05771]\nPATHWAY   hsa04080(2908)  Neuroactive ligand-receptor interaction",
    "metabolism": "",
    "therapeutic_category": "2646",
    "atc_code": "D07AC19",
    "drug_class": [
      "Anti-inflammatory",
      "Corticosteroid",
      "Glucocorticoid",
      "Dermatological agent",
      "Atopic dermatitis agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Difluprednate"
  },
  {
    "kegg_id": "D01272",
    "name_en": "Clobetasol propionate (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Clobex (TN)",
      "Cormax (TN)",
      "Olux (TN)"
    ],
    "formula": "C25H32ClFO5",
    "efficacy": "Anti-inflammatory, Glucocorticoid receptor agonist\nDISEASE   Plaque psoriasis [DS:H01656]\nPsoriasis [DS:H01656]",
    "target": "NR3C1 (GR) [HSA:2908] [KO:K05771]\nPATHWAY   hsa04080(2908)  Neuroactive ligand-receptor interaction",
    "metabolism": "",
    "therapeutic_category": "2646",
    "atc_code": "D07AD01",
    "drug_class": [
      "Anti-inflammatory",
      "Corticosteroid",
      "Glucocorticoid",
      "Dermatological agent",
      "Atopic dermatitis agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Clobetasol propionate"
  },
  {
    "kegg_id": "D01434",
    "name_en": "Deprodone propionate (JAN)",
    "name_ja": "",
    "names_alt": [
      "Allomidon (TN)"
    ],
    "formula": "C24H32O5",
    "efficacy": "Anti-inflammatory",
    "target": "NR3C1 (GR) [HSA:2908] [KO:K05771]\nPATHWAY   hsa04080(2908)  Neuroactive ligand-receptor interaction",
    "metabolism": "",
    "therapeutic_category": "2646",
    "atc_code": "",
    "drug_class": [
      "Anti-inflammatory",
      "Corticosteroid",
      "Glucocorticoid",
      "Dermatological agent",
      "Atopic dermatitis agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Deprodone propionate"
  },
  {
    "kegg_id": "D04773",
    "name_en": "Betamethasone valerate and gentamicin sulfate (JP18)",
    "name_ja": "",
    "names_alt": [
      "Rinderon-VG (TN)"
    ],
    "formula": "",
    "efficacy": "Antibacterial, Anti-inflammatory",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2647",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Betamethasone valerate and gentamicin sulfate"
  },
  {
    "kegg_id": "D04776",
    "name_en": "Oxytetracycline hydrochloride and hydrocortisone",
    "name_ja": "",
    "names_alt": [
      "Terra Cortril (TN)"
    ],
    "formula": "",
    "efficacy": "Antibacterial, Anti-inflammatory",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2647",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Oxytetracycline hydrochloride and hydrocortisone"
  },
  {
    "kegg_id": "D04795",
    "name_en": "Fradiomycin sulfate and fluocinolone acetonide",
    "name_ja": "",
    "names_alt": [
      "Neomycin sulfate and fluocinolone acetonide",
      "Flucort F (TN)",
      "Neo-synalar (TN)"
    ],
    "formula": "",
    "efficacy": "Antibacterial, Anti-inflammatory",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2647",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Fradiomycin sulfate and fluocinolone acetonide"
  },
  {
    "kegg_id": "D04796",
    "name_en": "Fradiomycin sulfate and betamethasone valerate",
    "name_ja": "",
    "names_alt": [
      "Betnevate N (TN)"
    ],
    "formula": "",
    "efficacy": "Antibacterial, Anti-inflammatory",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2647",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Fradiomycin sulfate and betamethasone valerate"
  },
  {
    "kegg_id": "D01122",
    "name_en": "Ibuprofen piconol (JP18/USAN)",
    "name_ja": "イブプロフェン",
    "names_alt": [
      "Staderm (TN)"
    ],
    "formula": "C19H23NO2",
    "efficacy": "Analgesic, Anti-inflammatory, COX inhibitor",
    "target": "PTGS1 (COX1) [HSA:5742] [KO:K00509]\nPTGS2 (COX2) [HSA:5743] [KO:K11987]\nPATHWAY   hsa00590(5742+5743)  Arachidonic acid metabolism",
    "metabolism": "Enzyme: CYP2C9 [HSA:1559]",
    "therapeutic_category": "2649",
    "atc_code": "C01EB16",
    "drug_class": [
      "Anti-inflammatory",
      "Nonsteroidal anti-inflammatory drug (NSAID)",
      "Anti-inflammatory drug, propionic acid derivative",
      "Dermatological agent",
      "Atopic dermatitis agent",
      "Metabolizing enzyme substrate",
      "CYP2C9 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C9"
    ],
    "search_name": "Ibuprofen piconol"
  },
  {
    "kegg_id": "D00156",
    "name_en": "Glycyrrhetinic acid (JAN)",
    "name_ja": "",
    "names_alt": [
      "Enoxolone (INN)",
      "Hidermart (TN)"
    ],
    "formula": "C30H46O4",
    "efficacy": "Anti-inflammatory, Antipruritic",
    "target": "HSD11B1 [HSA:3290] [KO:K15680]\nPATHWAY   hsa00140(3290)  Steroid hormone biosynthesis",
    "metabolism": "",
    "therapeutic_category": "2649",
    "atc_code": "D03AX10",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Glycyrrhetinic acid"
  },
  {
    "kegg_id": "D00010",
    "name_en": "Acetic acid, glacial (USP)",
    "name_ja": "",
    "names_alt": [
      "Acetic acid (JP18/NF)",
      "Glacial acetic acid (JP18)",
      "Acetasol (TN)"
    ],
    "formula": "C2H4O2",
    "efficacy": "Antibacterial, Antifungal, Emollient, Pharmaceutic aid (acidifying, flavor, lavage)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2649",
    "atc_code": "G01AD02",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Acetic acid, glacial"
  },
  {
    "kegg_id": "D01823",
    "name_en": "Ufenamate (JAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Flufenamic acid butyl ester",
      "Combec (TN)"
    ],
    "formula": "C18H18F3NO2",
    "efficacy": "Analgesic, Anti-inflammatory (topical), COX inhibitor",
    "target": "PTGS1 (COX1) [HSA:5742] [KO:K00509]\nPTGS2 (COX2) [HSA:5743] [KO:K11987]\nPATHWAY   hsa00590(5742+5743)  Arachidonic acid metabolism",
    "metabolism": "",
    "therapeutic_category": "2649",
    "atc_code": "M01AG03",
    "drug_class": [
      "Anti-inflammatory",
      "Nonsteroidal anti-inflammatory drug (NSAID)",
      "Anti-inflammatory drug, fenamic acid derivatives",
      "Dermatological agent",
      "Atopic dermatitis agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Ufenamate"
  },
  {
    "kegg_id": "D01675",
    "name_en": "Felbinac (JP18/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Dolinac (TN)"
    ],
    "formula": "C14H12O2",
    "efficacy": "Analgesic, Anti-inflammatory, COX inhibitor",
    "target": "PTGS1 (COX1) [HSA:5742] [KO:K00509]\nPTGS2 (COX2) [HSA:5743] [KO:K11987]\nPATHWAY   hsa00590(5742+5743)  Arachidonic acid metabolism",
    "metabolism": "",
    "therapeutic_category": "2649",
    "atc_code": "M02AA08",
    "drug_class": [
      "Anti-inflammatory",
      "Nonsteroidal anti-inflammatory drug (NSAID)",
      "Anti-inflammatory drug, acetic acid derivatives",
      "Anti-inflammatory drug, phenylacetic acid derivative"
    ],
    "cyp_enzymes": [],
    "search_name": "Felbinac"
  },
  {
    "kegg_id": "D01594",
    "name_en": "Bendazac (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Iwazac (TN)"
    ],
    "formula": "C16H14N2O3",
    "efficacy": "Anti-inflammatory",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2649",
    "atc_code": "M02AA11",
    "drug_class": [
      "Anti-inflammatory",
      "Nonsteroidal anti-inflammatory drug (NSAID)",
      "Anti-inflammatory drug, acetic acid derivatives",
      "Dermatological agent",
      "Atopic dermatitis agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Bendazac"
  },
  {
    "kegg_id": "D01037",
    "name_en": "1,4-Dimethyl-7-isopropylazulene (JAN)",
    "name_ja": "",
    "names_alt": [
      "Guaiazulene",
      "Azunol (TN)"
    ],
    "formula": "C15H18",
    "efficacy": "Anti-inflammatory",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2649",
    "atc_code": "S01XA01",
    "drug_class": [
      "Anti-inflammatory",
      "Nonsteroidal anti-inflammatory drug (NSAID)",
      "Gastrointestinal agent",
      "Agents for peptic ulcer"
    ],
    "cyp_enzymes": [],
    "search_name": "1,4-Dimethyl-7-isopropylazulene"
  },
  {
    "kegg_id": "D01724",
    "name_en": "Alum, potassium (USP)",
    "name_ja": "",
    "names_alt": [
      "Aluminum potassium sulfate hydrate (JP18)"
    ],
    "formula": "2SO4. 12H2O. K. Al",
    "efficacy": "Astringent",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2649",
    "atc_code": "S01XA07",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Alum, potassium"
  },
  {
    "kegg_id": "D00069",
    "name_en": "Vitamin A oil (JP18)",
    "name_ja": "",
    "names_alt": [
      "Chocola A (TN)"
    ],
    "formula": "",
    "efficacy": "Supplement (vitamin A)",
    "target": "",
    "metabolism": "Enzyme: CYP2C8 [HSA:1558]",
    "therapeutic_category": "2649",
    "atc_code": "",
    "drug_class": [
      "Metabolizing enzyme substrate",
      "CYP2C8 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C8"
    ],
    "search_name": "Vitamin A oil"
  },
  {
    "kegg_id": "D01083",
    "name_en": "Calcium hydroxide (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Calkyl (TN)"
    ],
    "formula": "CaH2O2",
    "efficacy": "Astringent",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2649",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Calcium hydroxide"
  },
  {
    "kegg_id": "D01170",
    "name_en": "Zinc oxide (JP18/USP)",
    "name_ja": "",
    "names_alt": [],
    "formula": "ZnO",
    "efficacy": "Astringent, Protectant (topical)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2649",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Zinc oxide"
  },
  {
    "kegg_id": "D01381",
    "name_en": "Crotamiton (JAN/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Eurax (TN)"
    ],
    "formula": "C13H17NO",
    "efficacy": "Antipruritic, Scabicide\nDISEASE   Scabies [DS:H01519]",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2649",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Crotamiton"
  },
  {
    "kegg_id": "D04798",
    "name_en": "Zinc oxide oil (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Astringent, Protectant (topical)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2649",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Zinc oxide oil"
  },
  {
    "kegg_id": "D04799",
    "name_en": "Heparinoid (JAN)",
    "name_ja": "ヘパリン",
    "names_alt": [
      "Hirudoid (TN)"
    ],
    "formula": "",
    "efficacy": "Anticoagulant, Anti-inflammatory",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2649",
    "atc_code": "",
    "drug_class": [
      "Blood modifier agent",
      "Antithrombotic agent",
      "Heparin anticoagulant"
    ],
    "cyp_enzymes": [],
    "search_name": "Heparinoid"
  },
  {
    "kegg_id": "D04800",
    "name_en": "Heparinoid, adrenal extract and salicylic acid",
    "name_ja": "ヘパリン",
    "names_alt": [
      "Amel S (TN)"
    ],
    "formula": "",
    "efficacy": "Anti-inflammatory",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2649",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Heparinoid, adrenal extract and salicylic acid"
  },
  {
    "kegg_id": "D04801",
    "name_en": "Hydrocortisone and crotamiton",
    "name_ja": "ヒドロコルチゾン",
    "names_alt": [
      "Eurax H (TN)"
    ],
    "formula": "",
    "efficacy": "Anti-inflammatory, Antipruritic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2649",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Hydrocortisone and crotamiton"
  },
  {
    "kegg_id": "D04802",
    "name_en": "Phenol and zinc oxide liniment (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Anti-inflammatory, Antipruritic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2649",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Phenol and zinc oxide liniment"
  },
  {
    "kegg_id": "D04803",
    "name_en": "Calamine and zinc oxide",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Astringent, Protectant (topical)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2649",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Calamine and zinc oxide"
  },
  {
    "kegg_id": "D04804",
    "name_en": "Cantharides tincture (JAN)",
    "name_ja": "",
    "names_alt": [
      "Cantharides"
    ],
    "formula": "",
    "efficacy": "Hair growth stimulant, Skin irritant",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2649",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Cantharides tincture"
  },
  {
    "kegg_id": "D04805",
    "name_en": "Tocopherol and vitamin A",
    "name_ja": "",
    "names_alt": [
      "Juvela (TN)"
    ],
    "formula": "",
    "efficacy": "Supplement (vitamin A, D)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2649",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Tocopherol and vitamin A"
  },
  {
    "kegg_id": "D04806",
    "name_en": "Hydrocortisone acetate, diphenhydramine hydrochloride and fradiomycin sulfate",
    "name_ja": "ヒドロコルチゾン",
    "names_alt": [
      "Strong restamin cortisone (TN)"
    ],
    "formula": "",
    "efficacy": "Antiallergic, Anti-inflammatory",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2649",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Hydrocortisone acetate, diphenhydramine hydrochloride and fradiomycin sulfate"
  },
  {
    "kegg_id": "D06455",
    "name_en": "Capsicum tincture (JP18)",
    "name_ja": "",
    "names_alt": [
      "Capsicum extract"
    ],
    "formula": "",
    "efficacy": "Skin irritant",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2649",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Capsicum tincture"
  },
  {
    "kegg_id": "D08716",
    "name_en": "dl-Camphor, l-menthol, glycyrrhetinic acid and methyl salicylate",
    "name_ja": "",
    "names_alt": [
      "Stick zenol A (TN)"
    ],
    "formula": "",
    "efficacy": "Analgesic, Anti-inflammatory",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2649",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "dl-Camphor, l-menthol, glycyrrhetinic acid and methyl salicylate"
  },
  {
    "kegg_id": "D08718",
    "name_en": "dl-Camphor, l-menthol and methyl salicylate",
    "name_ja": "",
    "names_alt": [
      "Mirusart (TN)"
    ],
    "formula": "",
    "efficacy": "Analgesic, Anti-inflammatory",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2649",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "dl-Camphor, l-menthol and methyl salicylate"
  },
  {
    "kegg_id": "D08723",
    "name_en": "dl-Camphor, capsicum extract and methyl salicylate",
    "name_ja": "",
    "names_alt": [
      "Rakool (TN)"
    ],
    "formula": "",
    "efficacy": "Analgesic, Anti-inflammatory",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2649",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "dl-Camphor, capsicum extract and methyl salicylate"
  },
  {
    "kegg_id": "D08733",
    "name_en": "Dexamethasone and glyteer",
    "name_ja": "デキサメタゾン",
    "names_alt": [
      "Dexamethasone and dry distillation tar of defatting soybean",
      "Glymesason (TN)"
    ],
    "formula": "",
    "efficacy": "Anti-inflammatory, Antipruritic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2649",
    "atc_code": "",
    "drug_class": [
      "Dermatological agent",
      "Atopic dermatitis agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Dexamethasone and glyteer"
  },
  {
    "kegg_id": "D08734",
    "name_en": "Dry distillation tar of defatting soybean",
    "name_ja": "",
    "names_alt": [
      "Glyteer (TN)"
    ],
    "formula": "",
    "efficacy": "Anti-inflammatory, Antipruritic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2649",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Dry distillation tar of defatting soybean"
  },
  {
    "kegg_id": "D08828",
    "name_en": "Eksalb",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Anti-inflammatory",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2649",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Eksalb"
  },
  {
    "kegg_id": "D10746",
    "name_en": "Esflurbiprofen and mentha oil",
    "name_ja": "",
    "names_alt": [
      "Loqoa (TN)"
    ],
    "formula": "",
    "efficacy": "Analgesic, Anti-inflammatory",
    "target": "",
    "metabolism": "Enzyme: CYP2C9 [HSA:1559]",
    "therapeutic_category": "2649",
    "atc_code": "",
    "drug_class": [
      "Metabolizing enzyme substrate",
      "CYP2C9 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C9"
    ],
    "search_name": "Esflurbiprofen and mentha oil"
  },
  {
    "kegg_id": "D11745",
    "name_en": "Cantharidin (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Ycanth (TN)"
    ],
    "formula": "C10H12O4",
    "efficacy": "Skin irritant, Wart removal\nDISEASE   Molluscum contagiosum [DS:H01052]",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2649",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Cantharidin"
  },
  {
    "kegg_id": "D00097",
    "name_en": "Salicylic acid (JP18/USP)",
    "name_ja": "",
    "names_alt": [],
    "formula": "C7H6O3",
    "efficacy": "Antifungal, Keratolytic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2652",
    "atc_code": "D01AE12",
    "drug_class": [
      "Transporter inhibitor",
      "SLC22A7 inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Salicylic acid"
  },
  {
    "kegg_id": "D00351",
    "name_en": "Ketoconazole (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Nizoral (TN)",
      "Xolegel (TN)\nABBR      KTC"
    ],
    "formula": "C26H28Cl2N4O4",
    "efficacy": "Antifungal, Ergosterol biosynthesis inhibitor\nDISEASE   Seborrheic dermatitis [DS:H01652]\nTinea (pityriasis) versicolor [DS:H01334]\nTinea pedis [DS:H01316]\nBlastomycosis [DS:H01501]\nCoccidioidomycosis [DS:H01319]\nHistoplasmosis [DS:H01062]\nChromomycosis [DS:H01520]\nParacoccidioidomycosis [DS:H01329]",
    "target": "sterol 14alpha-demethylase [KO:K05917]\nPATHWAY   hsa00140(1586)  Steroid hormone biosynthesis\nko00100(K05917)  Steroid biosynthesis",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "2655",
    "atc_code": "D01AC08",
    "drug_class": [
      "Antifungal",
      "Imidazole antifungal",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "Metabolizing enzyme inhibitor",
      "CYP3A/CYP3A4 inhibitor",
      "CYP3A4 inhibitor",
      "Transporter inhibitor",
      "ABCB1 inhibitor"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Ketoconazole"
  },
  {
    "kegg_id": "D00886",
    "name_en": "Sulconazole nitrate (JAN/USP)",
    "name_ja": "",
    "names_alt": [
      "Exelderm (TN)"
    ],
    "formula": "C18H15Cl3N2S. HNO3",
    "efficacy": "Antifungal, Ergosterol biosynthesis inhibitor\nDISEASE   Tinea pedis [DS:H01316]\nTinea versicolor [DS:H01334]",
    "target": "sterol 14alpha-demethylase [KO:K05917]\nPATHWAY   ko00100(K05917)  Steroid biosynthesis",
    "metabolism": "",
    "therapeutic_category": "2655",
    "atc_code": "D01AC09",
    "drug_class": [
      "Antifungal",
      "Imidazole antifungal"
    ],
    "cyp_enzymes": [],
    "search_name": "Sulconazole nitrate"
  },
  {
    "kegg_id": "D01775",
    "name_en": "Bifonazole (JP18/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Mycospor (TN)"
    ],
    "formula": "C22H18N2",
    "efficacy": "Antifungal, Ergosterol biosynthesis inhibitor",
    "target": "sterol 14alpha-demethylase [KO:K05917]\nPATHWAY   ko00100(K05917)  Steroid biosynthesis",
    "metabolism": "",
    "therapeutic_category": "2655",
    "atc_code": "D01AC10",
    "drug_class": [
      "Antifungal",
      "Imidazole antifungal"
    ],
    "cyp_enzymes": [],
    "search_name": "Bifonazole"
  },
  {
    "kegg_id": "D01980",
    "name_en": "Luliconazole (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Lulicon (TN)",
      "Luzu (TN)"
    ],
    "formula": "C14H9Cl2N3S2",
    "efficacy": "Antifungal\nDISEASE   Interdigital tinea pedis [DS:H01316]\nTinea cruris [DS:H01316]\nTinea corporis [DS:H01316]",
    "target": "sterol 14alpha-demethylase [KO:K05917]",
    "metabolism": "",
    "therapeutic_category": "2655",
    "atc_code": "D01AC18",
    "drug_class": [
      "Antifungal",
      "Imidazole antifungal",
      "Metabolizing enzyme inhibitor",
      "CYP2B6 inhibitor",
      "CYP2C8 inhibitor",
      "CYP2C19 inhibitor",
      "CYP3A/CYP3A4 inhibitor",
      "CYP3A4 inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Luliconazole"
  },
  {
    "kegg_id": "D01620",
    "name_en": "Neticonazole hydrochloride (JAN)",
    "name_ja": "",
    "names_alt": [
      "Atolant (TN)"
    ],
    "formula": "C17H22N2OS. HCl",
    "efficacy": "Antifungal, Ergosterol biosynthesis inhibitor",
    "target": "sterol 14alpha-demethylase [KO:K05917]\nPATHWAY   ko00100(K05917)  Steroid biosynthesis",
    "metabolism": "",
    "therapeutic_category": "2655",
    "atc_code": "D01AC21",
    "drug_class": [
      "Antifungal",
      "Imidazole antifungal"
    ],
    "cyp_enzymes": [],
    "search_name": "Neticonazole hydrochloride"
  },
  {
    "kegg_id": "D01092",
    "name_en": "Lanoconazole (JP18/INN)",
    "name_ja": "",
    "names_alt": [
      "Latoconazole",
      "Astat (TN)"
    ],
    "formula": "C14H10ClN3S2",
    "efficacy": "Antifungal, Ergosterol biosynthesis inhibitor",
    "target": "sterol 14alpha-demethylase [KO:K05917]\nPATHWAY   ko00100(K05917)  Steroid biosynthesis",
    "metabolism": "",
    "therapeutic_category": "2655",
    "atc_code": "D01AC22",
    "drug_class": [
      "Antifungal",
      "Imidazole antifungal",
      "Metabolizing enzyme inhibitor",
      "CYP2C9 inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Lanoconazole"
  },
  {
    "kegg_id": "D02219",
    "name_en": "Terbinafine hydrochloride (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Lamisil (TN)"
    ],
    "formula": "C21H25N. HCl",
    "efficacy": "Antifungal, Ergosterol biosynthesis inhibitor\nDISEASE   Onychomycosis [DS:H01316]\nTinea unguium [DS:H01316]\nTinea capitis [DS:H01316]",
    "target": "squalene epoxidase [KO:K00511]\nPATHWAY   ko00100(K00511)  Steroid biosynthesis",
    "metabolism": "Enzyme: CYP2C9 [HSA:1559], CYP1A2 [HSA:1544], CYP3A4 [HSA:1576], CYP2C8 [HSA:1558], CYP2C19 [HSA:1557]",
    "therapeutic_category": "2659",
    "atc_code": "D01AE15",
    "drug_class": [
      "Metabolizing enzyme substrate",
      "CYP1A2 substrate",
      "CYP2C8 substrate",
      "CYP2C9 substrate",
      "CYP2C19 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "Metabolizing enzyme inhibitor",
      "CYP2D6 inhibitor"
    ],
    "cyp_enzymes": [
      "CYP2C19",
      "CYP3A4",
      "CYP1A2",
      "CYP2C9",
      "CYP2C8"
    ],
    "search_name": "Terbinafine hydrochloride"
  },
  {
    "kegg_id": "D01720",
    "name_en": "Amorolfine hydrochloride (JAN)",
    "name_ja": "",
    "names_alt": [
      "Pekiron (TN)"
    ],
    "formula": "C21H35NO. HCl",
    "efficacy": "Antifungal, Ergosterol biosynthesis inhibitor",
    "target": "squalene epoxidase [KO:K00511]\nPATHWAY   ko00100(K00511)  Steroid biosynthesis",
    "metabolism": "",
    "therapeutic_category": "2659",
    "atc_code": "D01AE16",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Amorolfine hydrochloride"
  },
  {
    "kegg_id": "D00381",
    "name_en": "Tolnaftate (JP18/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Separin (TN)",
      "Tinactin (TN)"
    ],
    "formula": "C19H17NOS",
    "efficacy": "Antifungal, Ergosterol biosynthesis inhibitor",
    "target": "squalene epoxidase [KO:K00511]\nPATHWAY   ko00100(K00511)  Steroid biosynthesis",
    "metabolism": "",
    "therapeutic_category": "2659",
    "atc_code": "D01AE18",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Tolnaftate"
  },
  {
    "kegg_id": "D01093",
    "name_en": "Butenafine hydrochloride (JP18/USAN)",
    "name_ja": "",
    "names_alt": [
      "Mentax (TN)",
      "Volley (TN)"
    ],
    "formula": "C23H27N. HCl",
    "efficacy": "Antifungal, Ergosterol biosynthesis inhibitor\nDISEASE   Tinea (pityriasis) versicolor [DS:H01334]",
    "target": "squalene epoxidase [KO:K00511]\nPATHWAY   ko00100(K00511)  Steroid biosynthesis",
    "metabolism": "",
    "therapeutic_category": "2659",
    "atc_code": "D01AE23",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Butenafine hydrochloride"
  },
  {
    "kegg_id": "D01550",
    "name_en": "Liranaftate (JAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Zefnart (TN)"
    ],
    "formula": "C18H20N2O2S",
    "efficacy": "Antifungal, Ergosterol biosynthesis inhibitor",
    "target": "squalene epoxidase [KO:K00511]\nPATHWAY   ko00100(K00511)  Steroid biosynthesis",
    "metabolism": "",
    "therapeutic_category": "2659",
    "atc_code": "D01AE25",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Liranaftate"
  },
  {
    "kegg_id": "D00024",
    "name_en": "Sulfur, precipitated (USP)",
    "name_ja": "",
    "names_alt": [
      "Sulfur, sublimed (USP)",
      "Sulfur (JP18)",
      "Bensulfoid (TN)",
      "Sastid (TN)"
    ],
    "formula": "S",
    "efficacy": "Antifungal, Scabicide",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2659",
    "atc_code": "D10AB02",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Sulfur, precipitated"
  },
  {
    "kegg_id": "D04809",
    "name_en": "Glycerin and potash solution (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Emollient",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2662",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Glycerin and potash solution"
  },
  {
    "kegg_id": "D04810",
    "name_en": "Potash soap (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Emollient, Pharmaceutic aid (enema, lavage)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2662",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Potash soap"
  },
  {
    "kegg_id": "D00023",
    "name_en": "Urea (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Carbamide",
      "Pastaron (TN)"
    ],
    "formula": "CH4N2O",
    "efficacy": "Diuretic, Emollient, Keratolytic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2669",
    "atc_code": "B05BC02",
    "drug_class": [
      "Dermatological agent",
      "Atopic dermatitis agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Urea"
  },
  {
    "kegg_id": "D04811",
    "name_en": "Sulfur and camphor (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Emollient",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2669",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Sulfur and camphor"
  },
  {
    "kegg_id": "D01175",
    "name_en": "Carpronium chloride (JAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Actinamin (TN)"
    ],
    "formula": "C8H18NO2. Cl",
    "efficacy": "Hair growth stimulant, Muscarinic acetylcholine receptor agonist",
    "target": "CHRM [HSA:1128 1129 1131 1132 1133] [KO:K04129 K04130 K04131 K04132 K04133]\nPATHWAY   hsa04020(1128+1129+1131+1133)  Calcium signaling pathway\nhsa04080(1128+1129+1131+1132+1133)  Neuroactive ligand-receptor interaction\nhsa04725(1128+1129+1131+1132+1133)  Cholinergic synapse\nhsa04810(1128+1129+1131+1132+1133)  Regulation of actin cytoskeleton",
    "metabolism": "",
    "therapeutic_category": "2679",
    "atc_code": "",
    "drug_class": [
      "Neuropsychiatric agent",
      "Muscarinic cholinergic receptor agonist"
    ],
    "cyp_enzymes": [],
    "search_name": "Carpronium chloride"
  },
  {
    "kegg_id": "D09752",
    "name_en": "Carpronium chloride hydrate (JAN)",
    "name_ja": "",
    "names_alt": [
      "Furozin (TN)"
    ],
    "formula": "C8H18NO2. Cl. H2O",
    "efficacy": "Hair growth stimulant, Muscarinic acetylcholine receptor agonist",
    "target": "CHRM [HSA:1128 1129 1131 1132 1133] [KO:K04129 K04130 K04131 K04132 K04133]\nPATHWAY   hsa04020(1128+1129+1131+1133)  Calcium signaling pathway\nhsa04080(1128+1129+1131+1132+1133)  Neuroactive ligand-receptor interaction\nhsa04725(1128+1129+1131+1132+1133)  Cholinergic synapse\nhsa04810(1128+1129+1131+1132+1133)  Regulation of actin cytoskeleton",
    "metabolism": "",
    "therapeutic_category": "2679",
    "atc_code": "",
    "drug_class": [
      "Neuropsychiatric agent",
      "Muscarinic cholinergic receptor agonist"
    ],
    "cyp_enzymes": [],
    "search_name": "Carpronium chloride hydrate"
  },
  {
    "kegg_id": "D01125",
    "name_en": "Calcipotriene (USP)",
    "name_ja": "",
    "names_alt": [
      "Calcipotriol (JAN)",
      "Dovonex (TN)"
    ],
    "formula": "C27H40O3",
    "efficacy": "Antipsoriatic, Vitamin D receptor agonist\nDISEASE   Plaque psoriasis [DS:H01656]",
    "target": "NR1I1 (VDR) [HSA:7421] [KO:K08539]\nPATHWAY   hsa04961(7421)  Endocrine and other factor-regulated calcium reabsorption\nhsa04978(7421)  Mineral absorption",
    "metabolism": "",
    "therapeutic_category": "2691",
    "atc_code": "D05AX02",
    "drug_class": [
      "Gastrointestinal agent",
      "Vitamin D derivatives",
      "Activated vitamin D3"
    ],
    "cyp_enzymes": [],
    "search_name": "Calcipotriene"
  },
  {
    "kegg_id": "D01472",
    "name_en": "Tacalcitol hydrate (JP18)",
    "name_ja": "",
    "names_alt": [
      "Bonalfa high (TN)",
      "Curatoderm (TN)"
    ],
    "formula": "C27H44O3. H2O",
    "efficacy": "Antipsoriatic, Vitamin D receptor agonist",
    "target": "NR1I1 (VDR) [HSA:7421] [KO:K08539]\nPATHWAY   hsa04961(7421)  Endocrine and other factor-regulated calcium reabsorption\nhsa04978(7421)  Mineral absorption",
    "metabolism": "",
    "therapeutic_category": "2691",
    "atc_code": "D05AX04",
    "drug_class": [
      "Gastrointestinal agent",
      "Vitamin D derivatives",
      "Activated vitamin D3"
    ],
    "cyp_enzymes": [],
    "search_name": "Tacalcitol hydrate"
  },
  {
    "kegg_id": "D01098",
    "name_en": "Maxacalcitol (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Oxarol (TN)",
      "Prezios (TN)"
    ],
    "formula": "C26H42O4",
    "efficacy": "Antipsoriatic, Vitamin D receptor agonist",
    "target": "NR1I1 (VDR) [HSA:7421] [KO:K08539]\nPATHWAY   hsa04961(7421)  Endocrine and other factor-regulated calcium reabsorption\nhsa04978(7421)  Mineral absorption",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "2691",
    "atc_code": "",
    "drug_class": [
      "Gastrointestinal agent",
      "Vitamin D derivatives",
      "Activated vitamin D3",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Maxacalcitol"
  },
  {
    "kegg_id": "D03283",
    "name_en": "Cadexomer iodine (USAN)",
    "name_ja": "",
    "names_alt": [
      "Iodine and cadexomer",
      "Iodosorb (TN)"
    ],
    "formula": "",
    "efficacy": "Antiseptic, Anti-ulcerative (skin)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2699",
    "atc_code": "D03AX01",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Cadexomer iodine"
  },
  {
    "kegg_id": "D12495",
    "name_en": "Anacaulase",
    "name_ja": "",
    "names_alt": [
      "Purified pineapple stem juice",
      "Anacaulase-bcdb",
      "Nexobrid (TN)"
    ],
    "formula": "",
    "efficacy": "Debridement",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2699",
    "atc_code": "D03BA03",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Anacaulase"
  },
  {
    "kegg_id": "D00139",
    "name_en": "Methoxsalen (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Oxsoralen (TN)",
      "UVADEX (TN)"
    ],
    "formula": "C12H8O4",
    "efficacy": "Antivitiligo, Pigmentation agent\nDISEASE   Psoriasis [DS:H01656]",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2699",
    "atc_code": "D05AD02",
    "drug_class": [
      "Metabolizing enzyme inhibitor",
      "CYP2A6 inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Methoxsalen"
  },
  {
    "kegg_id": "D11365",
    "name_en": "Tapinarof (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Vtama (TN)"
    ],
    "formula": "C17H18O2",
    "efficacy": "Anti-inflammatory, Aryl hydrocarbon receptor agonist\nDISEASE   Plaque psoriasis [DS:H01656]",
    "target": "AHR [HSA:196] [KO:K09093]\nPATHWAY   hsa04659(196)  Th17 cell differentiation",
    "metabolism": "",
    "therapeutic_category": "2699",
    "atc_code": "D05AX07",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Tapinarof"
  },
  {
    "kegg_id": "D10534",
    "name_en": "Calcipotriene and betamethasone dipropionate",
    "name_ja": "",
    "names_alt": [
      "Calcipotriol and betamethasone dipropionate",
      "Dovobet (TN)",
      "Enstilar (TN)",
      "Taclonex (TN)"
    ],
    "formula": "",
    "efficacy": "Antipsoriatic\nDISEASE   Plaque psoriasis [DS:H01656]",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2699",
    "atc_code": "D05AX52",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Calcipotriene and betamethasone dipropionate"
  },
  {
    "kegg_id": "D01516",
    "name_en": "Tretinoin tocoferil (JAN)",
    "name_ja": "",
    "names_alt": [
      "Tocoretinate"
    ],
    "formula": "C49H76O3",
    "efficacy": "Anti-ulcerative (skin), Retinoic acid receptor (RAR) agonist",
    "target": "NR1B (RAR) [HSA:5914 5915 5916] [KO:K08527 K08528 K08529]\nPATHWAY   hsa04659(5914)  Th17 cell differentiation",
    "metabolism": "",
    "therapeutic_category": "2699",
    "atc_code": "D10AD01",
    "drug_class": [
      "Vitamin and mineral",
      "Retinol derivative"
    ],
    "cyp_enzymes": [],
    "search_name": "Tretinoin tocoferil"
  },
  {
    "kegg_id": "D01112",
    "name_en": "Adapalene (JAN/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Differin (TN)"
    ],
    "formula": "C28H28O3",
    "efficacy": "Anti-acne, Retinoic acid receptor (RAR) agonist\nDISEASE   Acne vulgaris [DS:H01445]",
    "target": "NR1B3 (RARG) [HSA:5916] [KO:K08529]\nNR1B2 (RARB) [HSA:5915] [KO:K08528]\nNR2B3 (RXRG) [HSA:6258] [KO:K08526]\nNR2B2 (RXRB) [HSA:6257] [KO:K08525]\nPATHWAY   hsa04659(6257+6258)  Th17 cell differentiation",
    "metabolism": "",
    "therapeutic_category": "2699",
    "atc_code": "D10AD03",
    "drug_class": [
      "Vitamin and mineral",
      "Retinol derivative"
    ],
    "cyp_enzymes": [],
    "search_name": "Adapalene"
  },
  {
    "kegg_id": "D10792",
    "name_en": "Adapalene and benzoyl peroxide",
    "name_ja": "",
    "names_alt": [
      "Epiduo (TN)"
    ],
    "formula": "",
    "efficacy": "Anti-acne\nDISEASE   Acne vulgaris [DS:H01445]",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2699",
    "atc_code": "D10AD53",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Adapalene and benzoyl peroxide"
  },
  {
    "kegg_id": "D03093",
    "name_en": "Benzoyl peroxide (JAN/USP)",
    "name_ja": "",
    "names_alt": [
      "Bepio (TN)"
    ],
    "formula": "C14H10O4",
    "efficacy": "Anti-acne, Keratolytic\nDISEASE   Acne vulgaris [DS:H01445]",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2699",
    "atc_code": "D10AE01",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Benzoyl peroxide"
  },
  {
    "kegg_id": "D10602",
    "name_en": "Clindamycin phosphate and benzoyl peroxide",
    "name_ja": "",
    "names_alt": [
      "Duac (TN)",
      "Onexton (TN)"
    ],
    "formula": "",
    "efficacy": "Anti-acne\nDISEASE   Acne vulgaris [DS:H01445]",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2699",
    "atc_code": "D10AE51",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Clindamycin phosphate and benzoyl peroxide"
  },
  {
    "kegg_id": "D00592",
    "name_en": "Dapsone (USP)",
    "name_ja": "",
    "names_alt": [
      "Diaphenylsulfone (JAN)",
      "Aczone (TN)"
    ],
    "formula": "C12H12N2O2S",
    "efficacy": "Antibacterial (leprostatic)\nDISEASE   Acne vulgaris [DS:H01445]\nDermatitis herpetiformis [DS:H01362]\nLeprosy [DS:H00344]",
    "target": "dihydropteroate synthase [KO:K00796]\nPATHWAY   ko00790(K00796)  Folate biosynthesis",
    "metabolism": "Enzyme: CYP2E1 [HSA:1571], CYP3A4 [HSA:1576]",
    "therapeutic_category": "2699",
    "atc_code": "D10AX05",
    "drug_class": [
      "Metabolizing enzyme substrate",
      "CYP2E1 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP2E1",
      "CYP3A4"
    ],
    "search_name": "Dapsone"
  },
  {
    "kegg_id": "D11046",
    "name_en": "Delgocitinib (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Corectim (TN)",
      "Anzupgo (TN)"
    ],
    "formula": "C16H18N6O",
    "efficacy": "Anti-inflammatory, Antipsoriatic, Janus kinase (JAK) inhibitor",
    "target": "JAK1 [HSA:3716] [KO:K11217]\nJAK2 [HSA:3717] [KO:K04447]\nJAK3 [HSA:3718] [KO:K11218]\nTYK2 [HSA:7297] [KO:K11219]\nPATHWAY   hsa04062(3717+3718)  Chemokine signaling pathway\nhsa04217(3716+3717+3718+7297)  Necroptosis\nhsa04630(3716+3717+3718+7297)  JAK-STAT signaling pathway\nhsa04658(3716+3717+3718+7297)  Th1 and Th2 cell differentiation\nhsa04659(3716+3717+3718+7297)  Th17 cell differentiation",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576], CYP3A5 [HSA:1577]",
    "therapeutic_category": "2699",
    "atc_code": "D11AH11",
    "drug_class": [
      "Anti-inflammatory",
      "Disease modifying anti-rheumatic drug (DMARD)",
      "JAK inhibitor",
      "Dermatological agent",
      "Atopic dermatitis agent",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "CYP3A5 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4",
      "CYP3A5"
    ],
    "search_name": "Delgocitinib"
  },
  {
    "kegg_id": "D04812",
    "name_en": "Sucrose and povidone iodine",
    "name_ja": "",
    "names_alt": [
      "Sorenurse (TN)"
    ],
    "formula": "",
    "efficacy": "Anti-ulcerative (skin)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2699",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Sucrose and povidone iodine"
  },
  {
    "kegg_id": "D10788",
    "name_en": "Maxacalcitol and betamethasone butyrate propionate",
    "name_ja": "",
    "names_alt": [
      "Marduox (TN)"
    ],
    "formula": "",
    "efficacy": "Antipsoriatic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2699",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Maxacalcitol and betamethasone butyrate propionate"
  },
  {
    "kegg_id": "D11314",
    "name_en": "Difamilast (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Adquey (TN)",
      "Moizerto (TN)"
    ],
    "formula": "C23H24F2N2O5",
    "efficacy": "Anti-inflammatory, Phosphodiesterase IV inhibitor\nDISEASE   Atopic dermatitis [DS:H01358]",
    "target": "PDE4 [HSA:5141 5142 5143 5144] [KO:K13293]\nPATHWAY   hsa00230(5141+5142+5143+5144)  Purine metabolism\nhsa04024(5141+5142+5143+5144)  cAMP signaling pathway",
    "metabolism": "",
    "therapeutic_category": "2699",
    "atc_code": "",
    "drug_class": [
      "Dermatological agent",
      "Atopic dermatitis agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Difamilast"
  },
  {
    "kegg_id": "D00552",
    "name_en": "Benzocaine (USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Ethyl aminobenzoate (JP18)",
      "Parathesin (TN)"
    ],
    "formula": "C9H11NO2",
    "efficacy": "Analgesic, Anesthetic (topical), Antipruritic",
    "target": "SCN1A [HSA:6323] [KO:K04833]\nSCN2A [HSA:6326] [KO:K04834]\nSCN3A [HSA:6328] [KO:K04836]\nSCN4A [HSA:6329] [KO:K04837]\nSCN5A [HSA:6331] [KO:K04838]\nSCN8A [HSA:6334] [KO:K04840]\nSCN9A [HSA:6335] [KO:K04841]\nSCN10A [HSA:6336] [KO:K04842]\nSCN11A [HSA:11280] [KO:K04843]\nPATHWAY   hsa04728(6323)  Dopaminergic synapse",
    "metabolism": "",
    "therapeutic_category": "2710",
    "atc_code": "C05AD03",
    "drug_class": [
      "Neuropsychiatric agent",
      "Anesthetics",
      "Local anesthetic",
      "Esterified local anesthetic"
    ],
    "cyp_enzymes": [],
    "search_name": "Benzocaine"
  },
  {
    "kegg_id": "D04816",
    "name_en": "Ethyl aminobenzoate, tetracaine hydrochloride, dibucaine hydrochloride and homosulfamine",
    "name_ja": "",
    "names_alt": [
      "Prones-pasta aroma (TN)"
    ],
    "formula": "",
    "efficacy": "Anesthetic (topical, dental)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2710",
    "atc_code": "N01BA53",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Ethyl aminobenzoate, tetracaine hydrochloride, dibucaine hydrochloride and homosulfamine"
  },
  {
    "kegg_id": "D11290",
    "name_en": "Articaine hydrochloride and epinephrine",
    "name_ja": "",
    "names_alt": [
      "Articaine hydrochloride and adrenaline",
      "Orabloc (TN)",
      "Septocaine (TN)",
      "Ultacan (TN)"
    ],
    "formula": "",
    "efficacy": "Anesthetic (local, topical, dental)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2710",
    "atc_code": "N01BB58",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Articaine hydrochloride and epinephrine"
  },
  {
    "kegg_id": "D04813",
    "name_en": "Lidocaine hydrochloride and epinephrine bitartrate",
    "name_ja": "リドカイン",
    "names_alt": [
      "Lidocaine hydrochloride and adrenaline bitartrate",
      "Ora (TN)",
      "Lidosite (TN)"
    ],
    "formula": "",
    "efficacy": "Anesthetic (topical, dental)",
    "target": "",
    "metabolism": "Enzyme: CYP1A2 [HSA:1544], CYP3A4 [HSA:1576]",
    "therapeutic_category": "2710",
    "atc_code": "",
    "drug_class": [
      "Metabolizing enzyme substrate",
      "CYP1A2 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4",
      "CYP1A2"
    ],
    "search_name": "Lidocaine hydrochloride and epinephrine bitartrate"
  },
  {
    "kegg_id": "D04814",
    "name_en": "Ethyl aminobenzoate and p-butylaminobenzoyldiethylaminoethyl hydrochloride",
    "name_ja": "",
    "names_alt": [
      "Neozalocaine (TN)"
    ],
    "formula": "",
    "efficacy": "Anesthetic (topical, dental)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2710",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Ethyl aminobenzoate and p-butylaminobenzoyldiethylaminoethyl hydrochloride"
  },
  {
    "kegg_id": "D04817",
    "name_en": "Propitocaine hydrochloride and felypressin",
    "name_ja": "",
    "names_alt": [
      "Citanest octapressin (TN)"
    ],
    "formula": "",
    "efficacy": "Anesthetic (local, dental)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2710",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Propitocaine hydrochloride and felypressin"
  },
  {
    "kegg_id": "D00117",
    "name_en": "Guaiacol (JAN)",
    "name_ja": "",
    "names_alt": [
      "Creodon (TN)"
    ],
    "formula": "C7H8O2",
    "efficacy": "Analgesic, Disinfectant",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2730",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Guaiacol"
  },
  {
    "kegg_id": "D04840",
    "name_en": "Dental phenol with camphor (JP18)",
    "name_ja": "",
    "names_alt": [
      "Phenol and camphor",
      "Camphenic (TN)"
    ],
    "formula": "",
    "efficacy": "Analgesic, Disinfectant",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2730",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Dental phenol with camphor"
  },
  {
    "kegg_id": "D04842",
    "name_en": "Formalin and cresol",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Disinfectant",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2730",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Formalin and cresol"
  },
  {
    "kegg_id": "D04844",
    "name_en": "Paraformaldehyde and dibucaine hydrochloride",
    "name_ja": "",
    "names_alt": [
      "Periodon (TN)"
    ],
    "formula": "",
    "efficacy": "Disinfectant",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2730",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Paraformaldehyde and dibucaine hydrochloride"
  },
  {
    "kegg_id": "D04846",
    "name_en": "Formalin and guaiacol",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Disinfectant",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2730",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Formalin and guaiacol"
  },
  {
    "kegg_id": "D04847",
    "name_en": "Guaiacol and parachlorophenol",
    "name_ja": "",
    "names_alt": [
      "Methocol (TN)"
    ],
    "formula": "",
    "efficacy": "Analgesic, Disinfectant",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2730",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Guaiacol and parachlorophenol"
  },
  {
    "kegg_id": "D04880",
    "name_en": "Dental iodine glycerin (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Disinfectant",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2730",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Dental iodine glycerin"
  },
  {
    "kegg_id": "D04856",
    "name_en": "Sulfathiazole, diethylaminoethyl p-butylaminobenzoate hydrochloride, iodoform and calcium hydroxide",
    "name_ja": "",
    "names_alt": [
      "Calvital (TN)"
    ],
    "formula": "",
    "efficacy": "Pulp capping agent",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2750",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Sulfathiazole, diethylaminoethyl p-butylaminobenzoate hydrochloride, iodoform and calcium hydroxide"
  },
  {
    "kegg_id": "D04857",
    "name_en": "Zinc oxide and eugenol",
    "name_ja": "",
    "names_alt": [
      "Neodyne (TN)"
    ],
    "formula": "",
    "efficacy": "Pulp capping agent",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2750",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Zinc oxide and eugenol"
  },
  {
    "kegg_id": "D00850",
    "name_en": "Minocycline hydrochloride (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Arestin (TN)",
      "Dynacin (TN)",
      "Minocin (TN)",
      "Solodyn (TN)"
    ],
    "formula": "C23H27N3O7. HCl",
    "efficacy": "Antibacterial, Protein biosynthesis inhibitor\nDISEASE   Rocky Mountain spotted fever [DS:H00323]\nTyphus fever [DS:H00322]\nQ fever [DS:H00310]\nLymphogranuloma venereum [DS:H00348]\nPsittacosis [DS:H00350]\nTrachoma [DS:H00349]\nRelapsing fever [DS:H00427]\nChancroid [DS:H00305]\nPlague [DS:H00297]\nTularemia [DS:H00312]\nCholera [DS:H00110]\nCampylobacter fetus infections [DS:H00321]\nBrucellosis [DS:H00325]\nBartonellosis [DS:H00326]\nGranuloma inguinale [DS:H01415]\nSyphilis [DS:H00354]\nYaws [DS:H01318]\nListeriosis [DS:H00332]\nAnthrax [DS:H00328]\nVincent's infection [DS:H01440]\nActinomycosis [DS:H01325]\nAcute intestinal amebiasis [DS:H00360]\nAcne vulgaris [DS:H01445]",
    "target": "30S ribosomal subunit\nPATHWAY   ko03010(K01977)  Ribosome",
    "metabolism": "",
    "therapeutic_category": "2760",
    "atc_code": "A01AB23",
    "drug_class": [
      "Antibacterial",
      "Tetracycline antibiotic"
    ],
    "cyp_enzymes": [],
    "search_name": "Minocycline hydrochloride"
  },
  {
    "kegg_id": "D01596",
    "name_en": "Oxytetracycline hydrochloride (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Terramycin (TN)"
    ],
    "formula": "C22H24N2O9. HCl",
    "efficacy": "Antibacterial, Antirickettsial, Protein biosynthesis inhibitor",
    "target": "30S ribosomal subunit\nPATHWAY   ko03010(K01977)  Ribosome",
    "metabolism": "",
    "therapeutic_category": "2760",
    "atc_code": "A01AB25",
    "drug_class": [
      "Antibacterial",
      "Tetracycline antibiotic"
    ],
    "cyp_enzymes": [],
    "search_name": "Oxytetracycline hydrochloride"
  },
  {
    "kegg_id": "D04865",
    "name_en": "Tetracycline hydrochloride and Epidihydrocholesterin",
    "name_ja": "テトラサイクリン",
    "names_alt": [
      "Tetracycline presteron (TN)"
    ],
    "formula": "",
    "efficacy": "Antibacterial",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2760",
    "atc_code": "J01AA20",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Tetracycline hydrochloride and Epidihydrocholesterin"
  },
  {
    "kegg_id": "D00943",
    "name_en": "Sodium fluoride (JAN/USP)",
    "name_ja": "",
    "names_alt": [
      "Fluorinse (TN)"
    ],
    "formula": "Na. F",
    "efficacy": "Dental caries prophylactic\nDISEASE   Dental caries [DS:H01331]",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2790",
    "atc_code": "A01AA01",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Sodium fluoride"
  },
  {
    "kegg_id": "D01502",
    "name_en": "Silver diammine fluoride (JAN)",
    "name_ja": "",
    "names_alt": [
      "Saforide (TN)"
    ],
    "formula": "Ag. F. 2NH3",
    "efficacy": "Analgesic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2790",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Silver diammine fluoride"
  },
  {
    "kegg_id": "D04412",
    "name_en": "Compound iodine glycerin (JP18)",
    "name_ja": "",
    "names_alt": [
      "Lugol (TN)"
    ],
    "formula": "",
    "efficacy": "Antiseptic, Disinfectant",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2790",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Compound iodine glycerin"
  },
  {
    "kegg_id": "D04873",
    "name_en": "Zinc oxide and clove oil",
    "name_ja": "",
    "names_alt": [
      "Surgicalpack (TN)"
    ],
    "formula": "",
    "efficacy": "Intraoral bandage",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2790",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Zinc oxide and clove oil"
  },
  {
    "kegg_id": "D04875",
    "name_en": "Zinc sulfate, iodine, sodium iodine and glycerin",
    "name_ja": "",
    "names_alt": [
      "Neoglycerol (TN)"
    ],
    "formula": "",
    "efficacy": "Disinfectant",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2790",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Zinc sulfate, iodine, sodium iodine and glycerin"
  },
  {
    "kegg_id": "D04879",
    "name_en": "Hydrocortisone acetate, hinokitiol and ethyl aminobenzoate",
    "name_ja": "ヒドロコルチゾン",
    "names_alt": [
      "Hinoporon (TN)"
    ],
    "formula": "",
    "efficacy": "Anti-inflammatory",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2790",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Hydrocortisone acetate, hinokitiol and ethyl aminobenzoate"
  },
  {
    "kegg_id": "D04881",
    "name_en": "Aluminum chloride, cetylpyridinium chloride and Lidocaine",
    "name_ja": "",
    "names_alt": [
      "Dental TDZ (TN)"
    ],
    "formula": "",
    "efficacy": "Hemostatic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2790",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Aluminum chloride, cetylpyridinium chloride and Lidocaine"
  },
  {
    "kegg_id": "D01035",
    "name_en": "Cepharanthine (JAN)",
    "name_ja": "",
    "names_alt": [],
    "formula": "C37H38N2O6",
    "efficacy": "Antiallergic, Blood circulation promotor",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "2900",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Cepharanthine"
  },
  {
    "kegg_id": "D00164",
    "name_en": "Retinol palmitate (JP18)",
    "name_ja": "",
    "names_alt": [
      "Aquasol A (TN)"
    ],
    "formula": "C36H60O2",
    "efficacy": "Supplement (vitamin A), Retinoic acid receptor (RAR) agonist",
    "target": "NR1B (RAR) [HSA:5914 5915 5916] [KO:K08527 K08528 K08529]",
    "metabolism": "Enzyme: CYP2C8 [HSA:1558]",
    "therapeutic_category": "3111",
    "atc_code": "A11CA01",
    "drug_class": [
      "Vitamin and mineral",
      "Retinol derivative",
      "Metabolizing enzyme substrate",
      "CYP2C8 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C8"
    ],
    "search_name": "Retinol palmitate"
  },
  {
    "kegg_id": "D06543",
    "name_en": "Vitamin A (USP)",
    "name_ja": "",
    "names_alt": [
      "Retinol",
      "Vitamin A1",
      "Aquasol A (TN)"
    ],
    "formula": "C20H30O",
    "efficacy": "Supplement (vitamin A), Retinoic acid receptor (RAR) agonist",
    "target": "NR1B (RAR) [HSA:5914 5915 5916] [KO:K08527 K08528 K08529]",
    "metabolism": "Enzyme: CYP2C8 [HSA:1558]",
    "therapeutic_category": "3111",
    "atc_code": "A11CA01",
    "drug_class": [
      "Vitamin and mineral",
      "Retinol derivative",
      "Metabolizing enzyme substrate",
      "CYP2C8 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C8"
    ],
    "search_name": "Vitamin A"
  },
  {
    "kegg_id": "D01518",
    "name_en": "Alfacalcidol (JAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Alsiodol (TN)"
    ],
    "formula": "C27H44O2",
    "efficacy": "Osteoporosis agent, Vitamin D receptor agonist",
    "target": "NR1I1 (VDR) [HSA:7421] [KO:K08539]\nPATHWAY   hsa04961(7421)  Endocrine and other factor-regulated calcium reabsorption\nhsa04978(7421)  Mineral absorption",
    "metabolism": "",
    "therapeutic_category": "3112",
    "atc_code": "A11CC03",
    "drug_class": [
      "Gastrointestinal agent",
      "Vitamin D derivatives",
      "Activated vitamin D3",
      "Musculo-skeletal system agent",
      "Osteoporosis agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Alfacalcidol"
  },
  {
    "kegg_id": "D00129",
    "name_en": "Calcitriol (JAN/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Rocaltrol (TN)"
    ],
    "formula": "C27H44O3",
    "efficacy": "Osteoporosis agent, Vitamin D receptor agonist\nDISEASE   Hypoparathyroidism [DS:H01862]\nPlaque psoriasis [DS:H01656]",
    "target": "NR1I1 (VDR) [HSA:7421] [KO:K08539]\nPATHWAY   hsa04961(7421)  Endocrine and other factor-regulated calcium reabsorption\nhsa04978(7421)  Mineral absorption",
    "metabolism": "",
    "therapeutic_category": "3112",
    "atc_code": "A11CC04",
    "drug_class": [
      "Gastrointestinal agent",
      "Vitamin D derivatives",
      "Activated vitamin D3",
      "Musculo-skeletal system agent",
      "Osteoporosis agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Calcitriol"
  },
  {
    "kegg_id": "D01662",
    "name_en": "Falecalcitriol (JAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Hornel (TN)"
    ],
    "formula": "C27H38F6O3",
    "efficacy": "Antirachitic, Vitamin D receptor agonist",
    "target": "NR1I1 (VDR) [HSA:7421] [KO:K08539]\nPATHWAY   hsa04961(7421)  Endocrine and other factor-regulated calcium reabsorption\nhsa04978(7421)  Mineral absorption",
    "metabolism": "",
    "therapeutic_category": "3112",
    "atc_code": "",
    "drug_class": [
      "Gastrointestinal agent",
      "Vitamin D derivatives",
      "Activated vitamin D3"
    ],
    "cyp_enzymes": [],
    "search_name": "Falecalcitriol"
  },
  {
    "kegg_id": "D07578",
    "name_en": "Eldecalcitol (JAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Edirol (TN)"
    ],
    "formula": "C30H50O5",
    "efficacy": "Antipsoriatic, Osteoporosis agent, Vitamin D receptor agonist",
    "target": "NR1I1 (VDR) [HSA:7421] [KO:K08539]\nPATHWAY   hsa04961(7421)  Endocrine and other factor-regulated calcium reabsorption\nhsa04978(7421)  Mineral absorption",
    "metabolism": "",
    "therapeutic_category": "3112",
    "atc_code": "",
    "drug_class": [
      "Gastrointestinal agent",
      "Vitamin D derivatives",
      "Activated vitamin D3",
      "Musculo-skeletal system agent",
      "Osteoporosis agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Eldecalcitol"
  },
  {
    "kegg_id": "D00316",
    "name_en": "Etretinate (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Tegison (TN)"
    ],
    "formula": "C23H30O3",
    "efficacy": "Antipsoriatic, Retinoic acid receptor agonist",
    "target": "NR1B (RAR) [HSA:5914 5915 5916] [KO:K08527 K08528 K08529]\nNR2B (RXR) [HSA:6256 6257 6258] [KO:K08524 K08525 K08526]\nPATHWAY   hsa04659(5914+6256+6257+6258)  Th17 cell differentiation",
    "metabolism": "",
    "therapeutic_category": "3119",
    "atc_code": "D05BB01",
    "drug_class": [
      "Vitamin and mineral",
      "Retinol derivative"
    ],
    "cyp_enzymes": [],
    "search_name": "Etretinate"
  },
  {
    "kegg_id": "D02094",
    "name_en": "Thiamine hydrochloride (USP)",
    "name_ja": "",
    "names_alt": [
      "Thiamine chloride hydrochloride (JP18)"
    ],
    "formula": "C12H17N4OS. HCl. Cl",
    "efficacy": "Supplement (vitamin B1)\nDISEASE   Beriberi [DS:H01566]\nWernicke's encephalopathy [DS:H01565]",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3121",
    "atc_code": "A11DA01",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Thiamine hydrochloride"
  },
  {
    "kegg_id": "D01255",
    "name_en": "Benfotiamine (JAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Biotamin (TN)"
    ],
    "formula": "C19H23N4O6PS",
    "efficacy": "Supplement (vitamin B1)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3122",
    "atc_code": "A11DA03",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Benfotiamine"
  },
  {
    "kegg_id": "D01284",
    "name_en": "Bisbentiamine (JAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Beston (TN)"
    ],
    "formula": "C38H42N8O6S2",
    "efficacy": "Supplement (vitamin B1)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3122",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Bisbentiamine"
  },
  {
    "kegg_id": "D03286",
    "name_en": "Prosultiamine (JAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Alinamin (TN)"
    ],
    "formula": "C15H24N4O2S2",
    "efficacy": "Supplement (vitamin B1)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3122",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Prosultiamine"
  },
  {
    "kegg_id": "D03292",
    "name_en": "Cetotiamine hydrochloride hydrate (JP18)",
    "name_ja": "",
    "names_alt": [
      "Dicethiamine hydrochloride hydrate",
      "Dicetamin (TN)"
    ],
    "formula": "C18H26N4O6S. HCl. H2O",
    "efficacy": "Supplement (vitamin B1)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3122",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Cetotiamine hydrochloride hydrate"
  },
  {
    "kegg_id": "D03299",
    "name_en": "Thiamine disulfide (JAN)",
    "name_ja": "",
    "names_alt": [
      "Allynate F (TN)"
    ],
    "formula": "C24H34N8O4S2",
    "efficacy": "Supplement (vitamin B1)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3122",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Thiamine disulfide"
  },
  {
    "kegg_id": "D03319",
    "name_en": "Fursultiamine (JAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Aliaron F (TN)"
    ],
    "formula": "C17H26N4O3S2",
    "efficacy": "Supplement (vitamin B1)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3122",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Fursultiamine"
  },
  {
    "kegg_id": "D03321",
    "name_en": "Fursultiamine hydrochloride (JP18)",
    "name_ja": "",
    "names_alt": [
      "Thiamine tetrahydrofurfuryl disulfide hydrochloride",
      "Alinaxin (TN)"
    ],
    "formula": "C17H26N4O3S2. HCl",
    "efficacy": "Supplement (vitamin B1)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3122",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Fursultiamine hydrochloride"
  },
  {
    "kegg_id": "D01622",
    "name_en": "Riboflavin sodium phosphate (JP18)",
    "name_ja": "",
    "names_alt": [
      "Infuvite (TN)"
    ],
    "formula": "C17H20N4O9P. Na",
    "efficacy": "Supplement (vitamin B2)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3131",
    "atc_code": "A11HA04",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Riboflavin sodium phosphate"
  },
  {
    "kegg_id": "D01913",
    "name_en": "Riboflavin butyrate (JP18)",
    "name_ja": "",
    "names_alt": [
      "Riboflavin tetrabutyrate",
      "Hibon (TN)"
    ],
    "formula": "C33H44N4O10",
    "efficacy": "Supplement (vitamin B2)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3131",
    "atc_code": "A11HA04",
    "drug_class": [
      "Hypolipidemic agent",
      "Hypolipidemic agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Riboflavin butyrate"
  },
  {
    "kegg_id": "D00036",
    "name_en": "Niacinamide (USP)",
    "name_ja": "",
    "names_alt": [
      "Nicotinamide (JP18/INN)"
    ],
    "formula": "C6H6N2O",
    "efficacy": "Supplement (nicotinic acid)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3132",
    "atc_code": "A11HA01",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Niacinamide"
  },
  {
    "kegg_id": "D00193",
    "name_en": "Dexpanthenol (USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Panthenol (JAN)",
      "Ilopan (TN)"
    ],
    "formula": "C9H19NO4",
    "efficacy": "Supplement (pantothenic acid), Muscarinic acetylcholine receptor agonist",
    "target": "CHRM3 [HSA:1131] [KO:K04131]\nPATHWAY   hsa04020(1131)  Calcium signaling pathway\nhsa04080(1131)  Neuroactive ligand-receptor interaction\nhsa04725(1131)  Cholinergic synapse",
    "metabolism": "",
    "therapeutic_category": "3133",
    "atc_code": "A11HA30",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Dexpanthenol"
  },
  {
    "kegg_id": "D01234",
    "name_en": "Pantethine (JP18)",
    "name_ja": "",
    "names_alt": [
      "Pantosin (TN)"
    ],
    "formula": "C22H42N4O8S2",
    "efficacy": "Supplement (pantothenic acid)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3133",
    "atc_code": "A11HA32",
    "drug_class": [
      "Hypolipidemic agent",
      "Hypolipidemic agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Pantethine"
  },
  {
    "kegg_id": "D02179",
    "name_en": "Pyridoxine hydrochloride (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Hexa-betalin (TN)"
    ],
    "formula": "C8H11NO3. HCl",
    "efficacy": "Supplement (vitamin B6)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3134",
    "atc_code": "A11HA02",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Pyridoxine hydrochloride"
  },
  {
    "kegg_id": "D00006",
    "name_en": "Pyridoxal phosphate hydrate (JP18)",
    "name_ja": "",
    "names_alt": [
      "Pyridoxal phosphate monohydrate",
      "Hipyridoxin (TN)"
    ],
    "formula": "C8H10NO6P. H2O",
    "efficacy": "Supplement (vitamin B6)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3134",
    "atc_code": "A11HA06",
    "drug_class": [
      "Dermatological agent",
      "Atopic dermatitis agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Pyridoxal phosphate hydrate"
  },
  {
    "kegg_id": "D00070",
    "name_en": "Folic acid (JP18/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Folicet (TN)"
    ],
    "formula": "C19H19N7O6",
    "efficacy": "Anti-anemic, Hematopoietic, Supplement (folic acid)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3135",
    "atc_code": "B03BB01",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Folic acid"
  },
  {
    "kegg_id": "D02707",
    "name_en": "Hydroxocobalamin acetate (JP18)",
    "name_ja": "",
    "names_alt": [
      "Docelan (TN)"
    ],
    "formula": "C64H91CoN13O16P",
    "efficacy": "Anti-anemic, Hematopoietic, Supplement (vitamin B12)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3136",
    "atc_code": "B03BA03",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Hydroxocobalamin acetate"
  },
  {
    "kegg_id": "D00042",
    "name_en": "Cobamamide (JAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Calomide (TN)"
    ],
    "formula": "C72H100CoN18O17P",
    "efficacy": "Anti-anemic, Supplement (vitamin B12)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3136",
    "atc_code": "B03BA04",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Cobamamide"
  },
  {
    "kegg_id": "D00018",
    "name_en": "Ascorbic acid (JP18/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Ascoltin (TN)",
      "Ascorbicap (TN)",
      "ASCOR (TN)"
    ],
    "formula": "C6H8O6",
    "efficacy": "Antiscorbutic, Supplement (vitamin C)\nDISEASE   Scurvy [DS:H01580]",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3140",
    "atc_code": "A11GA01",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Ascorbic acid"
  },
  {
    "kegg_id": "D08739",
    "name_en": "L-Cysteine and ascorbic acid",
    "name_ja": "",
    "names_alt": [
      "Crystfan (TN)"
    ],
    "formula": "",
    "efficacy": "Supplement (vitamin complex)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3140",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "L-Cysteine and ascorbic acid"
  },
  {
    "kegg_id": "D01735",
    "name_en": "Tocopherol acetate (JP18)",
    "name_ja": "",
    "names_alt": [
      "Vectan (TN)"
    ],
    "formula": "C31H52O3",
    "efficacy": "Supplement (vitamin E)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3150",
    "atc_code": "A11HA03",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Tocopherol acetate"
  },
  {
    "kegg_id": "D00148",
    "name_en": "Phytonadione (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Phytomenadione (INN)",
      "Mephyton (TN)",
      "Vitamin K1 (TN)"
    ],
    "formula": "C31H46O2",
    "efficacy": "Antihypoprothrombinemia, Hemostatic, Supplement (vitamin K1)\nDISEASE   Coagulation disorders which are due to faulty formation of factors II,VII, IX and X when caused by vitamin K deficiency or interference with vitamin K activity [DS:H00995]",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3160",
    "atc_code": "B02BA01",
    "drug_class": [
      "Blood modifier agent",
      "Hemostatics",
      "Blood coagulation accelerant",
      "Vitamin K"
    ],
    "cyp_enzymes": [],
    "search_name": "Phytonadione"
  },
  {
    "kegg_id": "D00100",
    "name_en": "Menatetrenone (JP18/INN)",
    "name_ja": "",
    "names_alt": [
      "Vitamin K2 (TN)"
    ],
    "formula": "C31H40O2",
    "efficacy": "Hemostatic, Osteoporosis agent",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3160",
    "atc_code": "M05BX08",
    "drug_class": [
      "Blood modifier agent",
      "Hemostatics",
      "Blood coagulation accelerant",
      "Vitamin K",
      "Musculo-skeletal system agent",
      "Osteoporosis agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Menatetrenone"
  },
  {
    "kegg_id": "D04899",
    "name_en": "Thiamine chloride hydrochloride, riboflavin sodium phosphate and ascorbic acid",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Supplement (vitamin B, C)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3172",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Thiamine chloride hydrochloride, riboflavin sodium phosphate and ascorbic acid"
  },
  {
    "kegg_id": "D04909",
    "name_en": "Ascorbic acid and calcium pantothenate (JP18)",
    "name_ja": "",
    "names_alt": [
      "Cinal (TN)"
    ],
    "formula": "",
    "efficacy": "Supplement (vitamin complex)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3179",
    "atc_code": "A11GB01",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Ascorbic acid and calcium pantothenate"
  },
  {
    "kegg_id": "D04901",
    "name_en": "Thiamine disulfide, pyridoxine hydrochloride and cyanocobalamin",
    "name_ja": "",
    "names_alt": [
      "Alithia N (TN)"
    ],
    "formula": "",
    "efficacy": "Supplement (B vitamin complex)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3179",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Thiamine disulfide, pyridoxine hydrochloride and cyanocobalamin"
  },
  {
    "kegg_id": "D04904",
    "name_en": "Thiamine disulfide, pyridoxine hydrochloride and hydroxocobalamin acetate",
    "name_ja": "",
    "names_alt": [
      "Dai medine (TN)"
    ],
    "formula": "",
    "efficacy": "Supplement (B vitamin complex)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3179",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Thiamine disulfide, pyridoxine hydrochloride and hydroxocobalamin acetate"
  },
  {
    "kegg_id": "D04911",
    "name_en": "Benfotiamine, pyridoxine hydrochloride and cyanocobalamin",
    "name_ja": "",
    "names_alt": [
      "Vitamedin (TN)"
    ],
    "formula": "",
    "efficacy": "Supplement (B vitamin complex)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3179",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Benfotiamine, pyridoxine hydrochloride and cyanocobalamin"
  },
  {
    "kegg_id": "D04913",
    "name_en": "Thiamine chloride hydrochloride, pyridoxine hydrochloride and cyanocobalamin",
    "name_ja": "",
    "names_alt": [
      "Daivitamix (TN)"
    ],
    "formula": "",
    "efficacy": "Supplement (B vitamin complex)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3179",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Thiamine chloride hydrochloride, pyridoxine hydrochloride and cyanocobalamin"
  },
  {
    "kegg_id": "D04917",
    "name_en": "Octotiamine, riboflavin, pyridoxine hydrochloride and cyanocobalamin",
    "name_ja": "",
    "names_alt": [
      "Neurovitan (TN)"
    ],
    "formula": "",
    "efficacy": "Supplement (B vitamin complex)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3179",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Octotiamine, riboflavin, pyridoxine hydrochloride and cyanocobalamin"
  },
  {
    "kegg_id": "D04919",
    "name_en": "Pyridoxal phosphate, fursultiamine hydrochloride, riboflavin and hydroxocobalamin acetate",
    "name_ja": "",
    "names_alt": [
      "Vitadan (TN)"
    ],
    "formula": "",
    "efficacy": "Supplement (B vitamin complex)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3179",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Pyridoxal phosphate, fursultiamine hydrochloride, riboflavin and hydroxocobalamin acetate"
  },
  {
    "kegg_id": "D04935",
    "name_en": "Thiamine disulfide phosphate, pyridoxine hydrochloride and cyanocobalamin",
    "name_ja": "",
    "names_alt": [
      "Vitamedin (TN)"
    ],
    "formula": "",
    "efficacy": "Supplement (B vitamin complex)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3179",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Thiamine disulfide phosphate, pyridoxine hydrochloride and cyanocobalamin"
  },
  {
    "kegg_id": "D04937",
    "name_en": "Riboflavin and pyridoxine hydrochloride",
    "name_ja": "",
    "names_alt": [
      "Bifuroxin (TN)"
    ],
    "formula": "",
    "efficacy": "Anti-inflammatory, Supplement (vitamin B2, B6)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3179",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Riboflavin and pyridoxine hydrochloride"
  },
  {
    "kegg_id": "D07851",
    "name_en": "Ascorbic acid, thiamine chloride hydrochloride, pyridoxine hydrochloride, riboflavin sodium phosphate, nicotinamide and panthenol",
    "name_ja": "",
    "names_alt": [
      "C para (TN)"
    ],
    "formula": "",
    "efficacy": "Supplement (vitamin complex)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3179",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Ascorbic acid, thiamine chloride hydrochloride, pyridoxine hydrochloride, riboflavin sodium phosphate, nicotinamide and panthenol"
  },
  {
    "kegg_id": "D08829",
    "name_en": "Hydroxocobalamin acetate, pyridoxal phosphate hydrate, fursultiamine hydrochloride and riboflavin",
    "name_ja": "",
    "names_alt": [
      "Vitaneurin (TN)"
    ],
    "formula": "",
    "efficacy": "Supplement (B vitamin complex)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3179",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Hydroxocobalamin acetate, pyridoxal phosphate hydrate, fursultiamine hydrochloride and riboflavin"
  },
  {
    "kegg_id": "D08830",
    "name_en": "Retinol palmitate, thiamine nitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, ascorbic acid, ergocalciferol, tocopherol acetate, calcium pantothenate, nicotinamide and folic acid",
    "name_ja": "",
    "names_alt": [
      "Panvitan (TN)"
    ],
    "formula": "",
    "efficacy": "Supplement (vitamin complex)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3179",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Retinol palmitate, thiamine nitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, ascorbic acid, ergocalciferol, tocopherol acetate, calcium pantothenate, nicotinamide and folic acid"
  },
  {
    "kegg_id": "D00029",
    "name_en": "Biotin (JP18/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Bioepiderm (TN)"
    ],
    "formula": "C10H16N2O3S",
    "efficacy": "Anti-inflammatory, Supplement (biotin)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3190",
    "atc_code": "A11HA05",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Biotin"
  },
  {
    "kegg_id": "D02254",
    "name_en": "Calcium lactate hydrate (JP18)",
    "name_ja": "",
    "names_alt": [
      "Calcium lactate pentahydrate"
    ],
    "formula": "(C3H5O3)2. 5H2O. Ca",
    "efficacy": "Antihypocalcemia, Supplement (calcium)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3211",
    "atc_code": "A12AA05",
    "drug_class": [
      "Gastrointestinal agent",
      "Calcium"
    ],
    "cyp_enzymes": [],
    "search_name": "Calcium lactate hydrate"
  },
  {
    "kegg_id": "D05463",
    "name_en": "Calcium gluconate hydrate (JP18)",
    "name_ja": "",
    "names_alt": [
      "Calcicol (TN)"
    ],
    "formula": "(C6H11O7)2. Ca. H2O",
    "efficacy": "Antihypocalcemia, Supplement (calcium)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3213",
    "atc_code": "A12AA03",
    "drug_class": [
      "Gastrointestinal agent",
      "Calcium"
    ],
    "cyp_enzymes": [],
    "search_name": "Calcium gluconate hydrate"
  },
  {
    "kegg_id": "D01598",
    "name_en": "Calcium L-aspartate hydrate (JAN)",
    "name_ja": "",
    "names_alt": [
      "Calcium L-aspartate",
      "Aspara-CA (TN)"
    ],
    "formula": "(C4H6NO4)2. 3H2O. Ca",
    "efficacy": "Antihypocalcemia, Supplement (calcium)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3214",
    "atc_code": "",
    "drug_class": [
      "Gastrointestinal agent",
      "Calcium",
      "Musculo-skeletal system agent",
      "Osteoporosis agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Calcium L-aspartate hydrate"
  },
  {
    "kegg_id": "D02256",
    "name_en": "Calcium chloride (USP)",
    "name_ja": "",
    "names_alt": [
      "Calcium chloride hydrate (JP18)",
      "Calcium chloride dihydrate",
      "Conclyte-Ca (TN)"
    ],
    "formula": "CaCl2. 2H2O",
    "efficacy": "Antihypocalcemia, Supplement (calcium)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3215",
    "atc_code": "A12AA07",
    "drug_class": [
      "Gastrointestinal agent",
      "Calcium"
    ],
    "cyp_enzymes": [],
    "search_name": "Calcium chloride"
  },
  {
    "kegg_id": "D00937",
    "name_en": "Calcium phosphate, dihydrate, dibasic (USP)",
    "name_ja": "",
    "names_alt": [
      "Dibasic calcium phosphate hydrate (JP18)",
      "Calster (TN)"
    ],
    "formula": "HPO4. 2H2O. Ca",
    "efficacy": "Supplement (calcium), Pharmaceutic aid (tablet base)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3216",
    "atc_code": "A12AA01",
    "drug_class": [
      "Gastrointestinal agent",
      "Calcium",
      "Musculo-skeletal system agent",
      "Osteoporosis agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Calcium phosphate, dihydrate, dibasic"
  },
  {
    "kegg_id": "D12590",
    "name_en": "Calcium carbonate, cholecalciferol and magnesium carbonate",
    "name_ja": "�ite酸カルシウム",
    "names_alt": [
      "Denotas (TN)"
    ],
    "formula": "",
    "efficacy": "Supplement (calcium)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3219",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Calcium carbonate, cholecalciferol and magnesium carbonate"
  },
  {
    "kegg_id": "D01016",
    "name_en": "Potassium iodide (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Thyroblock (TN)"
    ],
    "formula": "I. K",
    "efficacy": "Antifungal, Expectorant, Supplement (iodine)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3221",
    "atc_code": "R05CA02",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Potassium iodide"
  },
  {
    "kegg_id": "D04944",
    "name_en": "Iodolecithine (JAN)",
    "name_ja": "",
    "names_alt": [
      "Jolethin (TN)"
    ],
    "formula": "",
    "efficacy": "Supplement (iodine)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3221",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Iodolecithine"
  },
  {
    "kegg_id": "D04172",
    "name_en": "Ferrous sulfate, dried (USP)",
    "name_ja": "",
    "names_alt": [
      "Ferrous sulfate hydrate",
      "Fero-gradumet (TN)",
      "Tetucur (TN)"
    ],
    "formula": "SO4. Fe. xH2O",
    "efficacy": "Anti-anemic, Hematinic, Supplement (iron)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3222",
    "atc_code": "B03AA07",
    "drug_class": [
      "Blood modifier agent",
      "Iron preparation"
    ],
    "cyp_enzymes": [],
    "search_name": "Ferrous sulfate, dried"
  },
  {
    "kegg_id": "D03275",
    "name_en": "Sodium ferrous citrate (JAN)",
    "name_ja": "",
    "names_alt": [
      "Iromia (TN)"
    ],
    "formula": "",
    "efficacy": "Anti-anemic, Hematinic, Supplement (iron)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3222",
    "atc_code": "B03AA12",
    "drug_class": [
      "Blood modifier agent",
      "Iron preparation"
    ],
    "cyp_enzymes": [],
    "search_name": "Sodium ferrous citrate"
  },
  {
    "kegg_id": "D04946",
    "name_en": "Ferric pyrophosphate, soluble (JAN)",
    "name_ja": "",
    "names_alt": [
      "Incremin (TN)"
    ],
    "formula": "(C6H4O7. Fe. Na). (P2H4O7. Fe)x",
    "efficacy": "Anti-anemic, Hematinic, Supplement (iron)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3222",
    "atc_code": "",
    "drug_class": [
      "Blood modifier agent",
      "Iron preparation"
    ],
    "cyp_enzymes": [],
    "search_name": "Ferric pyrophosphate, soluble"
  },
  {
    "kegg_id": "D08920",
    "name_en": "Ferric carboxymaltose (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Injectafer (TN)",
      "Ferinject (TN)"
    ],
    "formula": "",
    "efficacy": "Hematinic, Supplement (iron)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3222",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Ferric carboxymaltose"
  },
  {
    "kegg_id": "D11808",
    "name_en": "Ferric derisomaltose (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Monoferric (TN)",
      "Monover (TN)"
    ],
    "formula": "(C6H11O5[C6H10O5]aC6H13O5)y. xFe",
    "efficacy": "Anti-anemic, Hematinic, Supplement (iron)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3222",
    "atc_code": "",
    "drug_class": [
      "Blood modifier agent",
      "Iron preparation"
    ],
    "cyp_enzymes": [],
    "search_name": "Ferric derisomaltose"
  },
  {
    "kegg_id": "D02060",
    "name_en": "Potassium chloride (JP18/USP)",
    "name_ja": "塩化カリウム",
    "names_alt": [
      "K-dur (TN)",
      "KCL (TN)",
      "Kaon-Cl (TN)",
      "Klor-con (TN)",
      "Klotrix (TN)"
    ],
    "formula": "K. Cl",
    "efficacy": "Supplement (potassium), Replenisher (electrolyte)\nDISEASE   Hypokalemic familial periodic paralysis [DS:H00746]",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3229",
    "atc_code": "A12BA01",
    "drug_class": [
      "Gastrointestinal agent",
      "Potassium"
    ],
    "cyp_enzymes": [],
    "search_name": "Potassium chloride"
  },
  {
    "kegg_id": "D01298",
    "name_en": "Potassium gluconate (JAN/USP)",
    "name_ja": "",
    "names_alt": [
      "Gluconsan-K (TN)"
    ],
    "formula": "C6H11O7. K",
    "efficacy": "Supplement (potassium)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3229",
    "atc_code": "A12BA05",
    "drug_class": [
      "Gastrointestinal agent",
      "Potassium"
    ],
    "cyp_enzymes": [],
    "search_name": "Potassium gluconate"
  },
  {
    "kegg_id": "D10530",
    "name_en": "Sodium selenite (JAN)",
    "name_ja": "",
    "names_alt": [
      "Aselend (TN)"
    ],
    "formula": "Na2SeO3",
    "efficacy": "Supplement (selenium)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3229",
    "atc_code": "A12CE02",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Sodium selenite"
  },
  {
    "kegg_id": "D01154",
    "name_en": "Potassium acetate (JAN/USP)",
    "name_ja": "",
    "names_alt": [],
    "formula": "C2H3O2. K",
    "efficacy": "Supplement (potassium)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3229",
    "atc_code": "B05XA17",
    "drug_class": [
      "Gastrointestinal agent",
      "Potassium"
    ],
    "cyp_enzymes": [],
    "search_name": "Potassium acetate"
  },
  {
    "kegg_id": "D04948",
    "name_en": "Potassium L-aspartate (JAN)",
    "name_ja": "",
    "names_alt": [
      "Potassium aspartate",
      "L-Aspartate potassium",
      "Aspara K (TN)"
    ],
    "formula": "C4H6NO4. K",
    "efficacy": "Supplement (potassium)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3229",
    "atc_code": "",
    "drug_class": [
      "Gastrointestinal agent",
      "Potassium"
    ],
    "cyp_enzymes": [],
    "search_name": "Potassium L-aspartate"
  },
  {
    "kegg_id": "D04952",
    "name_en": "Potassium aspartate and magnesium aspartate (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Aspara (TN)"
    ],
    "formula": "",
    "efficacy": "Supplement (potassium, magnesium)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3229",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Potassium aspartate and magnesium aspartate"
  },
  {
    "kegg_id": "D04956",
    "name_en": "Ferric chloride, manganese chloride, zinc sulfate, cupric sulfate and potassium iodide",
    "name_ja": "",
    "names_alt": [
      "Elemenmic (TN)"
    ],
    "formula": "",
    "efficacy": "Supplement (mineral)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3229",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Ferric chloride, manganese chloride, zinc sulfate, cupric sulfate and potassium iodide"
  },
  {
    "kegg_id": "D08815",
    "name_en": "Monobasic sodium phosphate monohydrate and dibasic sodium phosphate anhydrous",
    "name_ja": "",
    "names_alt": [
      "Z-521",
      "Visiclear (TN)"
    ],
    "formula": "",
    "efficacy": "Antihypophosphatemia, Laxative",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3229",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Monobasic sodium phosphate monohydrate and dibasic sodium phosphate anhydrous"
  },
  {
    "kegg_id": "D12440",
    "name_en": "Zinc histidine hydrate (JAN)",
    "name_ja": "",
    "names_alt": [
      "Zintus (TN)"
    ],
    "formula": "(C6H8N3O2)2. Zn. 2H2O",
    "efficacy": "Supplement (zinc)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3229",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Zinc histidine hydrate"
  },
  {
    "kegg_id": "D00009",
    "name_en": "Glucose (JP18)",
    "name_ja": "ブドウ糖",
    "names_alt": [
      "Purified glucose (JP18)",
      "D-Glucose"
    ],
    "formula": "C6H12O6",
    "efficacy": "Supplement (nutrient)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3231",
    "atc_code": "B05CX01",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Glucose"
  },
  {
    "kegg_id": "D00114",
    "name_en": "Fructose (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "D-Fructose",
      "Fructon (TN)"
    ],
    "formula": "C6H12O6",
    "efficacy": "Supplement (nutrient)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3232",
    "atc_code": "V06DC02",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Fructose"
  },
  {
    "kegg_id": "D05373",
    "name_en": "Maltose hydrate (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "C12H22O11. H2O",
    "efficacy": "Supplement (nutrient)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3233",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Maltose hydrate"
  },
  {
    "kegg_id": "D00061",
    "name_en": "Xylitol (JP18/NF)",
    "name_ja": "",
    "names_alt": [
      "Klinit (TN)"
    ],
    "formula": "C5H12O5",
    "efficacy": "Pharmaceutic aid (vehicle, sweetener), Supplement (nutrient)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3234",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Xylitol"
  },
  {
    "kegg_id": "D04271",
    "name_en": "D-Mannitol and D-sorbitol",
    "name_ja": "",
    "names_alt": [
      "Mannitol S (TN)"
    ],
    "formula": "",
    "efficacy": "Diuretic, Hypotensive (intracranial)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3239",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "D-Mannitol and D-sorbitol"
  },
  {
    "kegg_id": "D04958",
    "name_en": "L-Isoleucine, L-leucine and L-valine (JP18)",
    "name_ja": "",
    "names_alt": [
      "L-Isoleucine, L-leucine and L-valine",
      "Branched chain amino acids",
      "Livact (TN)"
    ],
    "formula": "",
    "efficacy": "Antihypoalbuminemic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3253",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "L-Isoleucine, L-leucine and L-valine"
  },
  {
    "kegg_id": "D08252",
    "name_en": "Placenta hydrolysate",
    "name_ja": "",
    "names_alt": [
      "Laennec (TN)"
    ],
    "formula": "",
    "efficacy": "Liver function improving agent",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3259",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Placenta hydrolysate"
  },
  {
    "kegg_id": "D08823",
    "name_en": "Placenta extract",
    "name_ja": "",
    "names_alt": [
      "Melsmon (TN)"
    ],
    "formula": "",
    "efficacy": "Tissue therapy agent",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3259",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Placenta extract"
  },
  {
    "kegg_id": "D12136",
    "name_en": "L-Lysine hydrochlroide and L-arginine hydrochloride",
    "name_ja": "",
    "names_alt": [
      "Lysakare (TN)"
    ],
    "formula": "",
    "efficacy": "Reabsorption inhibitor",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3259",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "L-Lysine hydrochlroide and L-arginine hydrochloride"
  },
  {
    "kegg_id": "D04960",
    "name_en": "Malt extract (JAN)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Laxative, Supplement (nutrient)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3272",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Malt extract"
  },
  {
    "kegg_id": "D08831",
    "name_en": "Special powdered milk",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Maple syrup urine disease agent, Phenylketoniuria agent",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3279",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Special powdered milk"
  },
  {
    "kegg_id": "D04961",
    "name_en": "Wine (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Analeptic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3291",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Wine"
  },
  {
    "kegg_id": "D04962",
    "name_en": "Soybean oil (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Intrafat (TN)",
      "Intralipid (TN)"
    ],
    "formula": "",
    "efficacy": "Supplement (nutrient), Pharmaceutic aid (ointment base)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3299",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Soybean oil"
  },
  {
    "kegg_id": "D02056",
    "name_en": "Sodium chloride (JP18/USP)",
    "name_ja": "塩化ナトリウム",
    "names_alt": [
      "Adsorbanac (TN)"
    ],
    "formula": "Cl. Na",
    "efficacy": "Pharmaceutic aid (tonicity agent), Replenisher (electrolyte), Supplement (sodium chloride)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3311",
    "atc_code": "A12CA01",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Sodium chloride"
  },
  {
    "kegg_id": "D05352",
    "name_en": "Isotonic sodium chloride solution (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Physiological saline",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3311",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Isotonic sodium chloride solution"
  },
  {
    "kegg_id": "D03335",
    "name_en": "Hetastarch (USAN)",
    "name_ja": "",
    "names_alt": [
      "Hydroxyethyl starch (USAN)",
      "Hydroxyethylated starch (JAN)",
      "Hydroxyethylstarch",
      "Hespan (TN)"
    ],
    "formula": "",
    "efficacy": "Plasma volume extender",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3319",
    "atc_code": "B05AA07",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Hetastarch"
  },
  {
    "kegg_id": "D01139",
    "name_en": "Ammonium chloride (JAN/USP)",
    "name_ja": "",
    "names_alt": [
      "Conclyte-A (TN)"
    ],
    "formula": "Cl. NH4",
    "efficacy": "Replenisher (electrolyte)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3319",
    "atc_code": "B05XA04",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Ammonium chloride"
  },
  {
    "kegg_id": "D02183",
    "name_en": "Sodium lactate (JAN/USP)",
    "name_ja": "",
    "names_alt": [
      "Mediject L (TN)"
    ],
    "formula": "C3H5O3. Na",
    "efficacy": "Replenisher (electrolyte)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3319",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Sodium lactate"
  },
  {
    "kegg_id": "D02403",
    "name_en": "Potassium phosphate, dibasic (JAN/USP)",
    "name_ja": "",
    "names_alt": [
      "Mediject P (TN)"
    ],
    "formula": "HPO4. 2K",
    "efficacy": "Replenisher (electrolyte)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3319",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Potassium phosphate, dibasic"
  },
  {
    "kegg_id": "D04963",
    "name_en": "Dextran 40 and glucose",
    "name_ja": "",
    "names_alt": [
      "Dextron (TN)"
    ],
    "formula": "",
    "efficacy": "Extracorporeal circulation perfusate",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3319",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Dextran 40 and glucose"
  },
  {
    "kegg_id": "D05329",
    "name_en": "Ringer's injection (USP)",
    "name_ja": "",
    "names_alt": [
      "Ringer's solution (JP18)"
    ],
    "formula": "",
    "efficacy": "Replenisher (fluid), Replenisher (electrolyte)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3319",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Ringer's injection"
  },
  {
    "kegg_id": "D01525",
    "name_en": "Carbazochrome sodium sulfonate hydrate (JP18)",
    "name_ja": "",
    "names_alt": [
      "Auzei (TN)"
    ],
    "formula": "C10H11N4O5S. 3H2O. Na",
    "efficacy": "Hemostatic, Vascular reinforcement",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3321",
    "atc_code": "B02BX02",
    "drug_class": [
      "Blood modifier agent",
      "Hemostatics"
    ],
    "cyp_enzymes": [],
    "search_name": "Carbazochrome sodium sulfonate hydrate"
  },
  {
    "kegg_id": "D00115",
    "name_en": "Gelatin (JP18/NF)",
    "name_ja": "",
    "names_alt": [
      "Gelfilm (TN)"
    ],
    "formula": "",
    "efficacy": "Hemostatic (local), Pharmaceutic aid (encapsulating, suspending, tablet binder, tablet coating)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3322",
    "atc_code": "B05AA06",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Gelatin"
  },
  {
    "kegg_id": "D00090",
    "name_en": "Thrombin (JP18/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Factor IIa",
      "Thrombostat (TN)"
    ],
    "formula": "",
    "efficacy": "Blood coagulation factor (enzyme), Hemostatic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3323",
    "atc_code": "B02BC06",
    "drug_class": [
      "Blood modifier agent",
      "Hemostatics",
      "Blood coagulation accelerant"
    ],
    "cyp_enzymes": [],
    "search_name": "Thrombin"
  },
  {
    "kegg_id": "D01136",
    "name_en": "Tranexamic acid (JP18/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Cyklokapron (TN)",
      "Rikavarin (TN)",
      "Transamin (TN)"
    ],
    "formula": "C8H15NO2",
    "efficacy": "Antifibrinolytic, Anti-inflammatory, Plasmin inhibitor\nDISEASE   Hemophilia [DS:H00219]",
    "target": "Plasmin [CPD:C00471] [HSA:5340] [KO:K01315]\nPATHWAY   hsa04610(5340+C00471)  Complement and coagulation cascades\nNETWORK   nt06513  Complement cascade\nnt06514  Coagulation cascade",
    "metabolism": "",
    "therapeutic_category": "3327",
    "atc_code": "B02AA02",
    "drug_class": [
      "Blood modifier agent",
      "Hemostatics",
      "Antifibrinolytic",
      "Plasmin inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Tranexamic acid"
  },
  {
    "kegg_id": "D02276",
    "name_en": "Ethanolamine oleate (USAN)",
    "name_ja": "",
    "names_alt": [
      "Monoethanolamine oleate (JAN)",
      "Ethamolin (TN)",
      "Oldamin (TN)"
    ],
    "formula": "C18H34O2. C2H7NO",
    "efficacy": "Antivaricose, Hemostatic, Sclerosing agent",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3329",
    "atc_code": "C05BB01",
    "drug_class": [
      "Blood modifier agent",
      "Hemostatics"
    ],
    "cyp_enzymes": [],
    "search_name": "Ethanolamine oleate"
  },
  {
    "kegg_id": "D01993",
    "name_en": "Polidocanol (JAN)",
    "name_ja": "",
    "names_alt": [
      "Asclera (TN)",
      "Aethoxysklerol (TN)",
      "Varithena (TN)"
    ],
    "formula": "C12H26O(C2H4O)n",
    "efficacy": "Antivaricose, Hemostatic, Sclerosing agent",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3329",
    "atc_code": "C05BB02",
    "drug_class": [
      "Blood modifier agent",
      "Hemostatics"
    ],
    "cyp_enzymes": [],
    "search_name": "Polidocanol"
  },
  {
    "kegg_id": "D03331",
    "name_en": "Hemocoagulase (JAN)",
    "name_ja": "",
    "names_alt": [
      "Reptilase S (TN)"
    ],
    "formula": "",
    "efficacy": "Blood coagulation factor (enzyme), Hemostatic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3329",
    "atc_code": "",
    "drug_class": [
      "Blood modifier agent",
      "Hemostatics",
      "Blood coagulation accelerant"
    ],
    "cyp_enzymes": [],
    "search_name": "Hemocoagulase"
  },
  {
    "kegg_id": "D04968",
    "name_en": "Yellow beewax (JP18)",
    "name_ja": "",
    "names_alt": [
      "Wax, Yellow (NF)"
    ],
    "formula": "",
    "efficacy": "Hemostatic, Pharmaceutic aid (stiffening)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3329",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Yellow beewax"
  },
  {
    "kegg_id": "D08740",
    "name_en": "Yellow beewax, almond oil and salicylic acid",
    "name_ja": "",
    "names_alt": [
      "Bone wax (TN)"
    ],
    "formula": "",
    "efficacy": "Hemostatic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3329",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Yellow beewax, almond oil and salicylic acid"
  },
  {
    "kegg_id": "D01781",
    "name_en": "Sodium citrate hydrate (JP18)",
    "name_ja": "",
    "names_alt": [
      "Trisodium citrate dihydrate",
      "Tricitrasol (TN)"
    ],
    "formula": "C6H5O7. 2H2O. 3Na",
    "efficacy": "Anticoagulant, Pharmaceutic aid (buffering agent, flavor)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3331",
    "atc_code": "B05CB02",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Sodium citrate hydrate"
  },
  {
    "kegg_id": "D01280",
    "name_en": "Warfarin potassium (JP18)",
    "name_ja": "ワルファリン",
    "names_alt": [
      "Athrombin-K (TN)"
    ],
    "formula": "C19H15O4. K",
    "efficacy": "Anticoagulant, Vitamin K antagonist",
    "target": "VKORC1 [HSA:79001] [KO:K05357]\nNQO1 [HSA:1728] [KO:K00355]\nPATHWAY   hsa00130(1728+79001)  Ubiquinone and other terpenoid-quinone biosynthesis",
    "metabolism": "Enzyme: CYP2C9 [HSA:1559]",
    "therapeutic_category": "3332",
    "atc_code": "B01AA03",
    "drug_class": [
      "Blood modifier agent",
      "Antithrombotic agent",
      "Coumarin anticoagulant",
      "Warfarin and analog",
      "Metabolizing enzyme substrate",
      "CYP2C9 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C9"
    ],
    "search_name": "Warfarin potassium"
  },
  {
    "kegg_id": "D04427",
    "name_en": "Heparin calcium (JP18)",
    "name_ja": "ヘパリン",
    "names_alt": [
      "Nadroparin calcium (INN)",
      "Calciparin",
      "Calciparine (TN)"
    ],
    "formula": "",
    "efficacy": "Anticoagulant, Antithrombin III activator, Platelet aggregation inhibitor",
    "target": "SERPINC1 (AT3) [HSA:462] [KO:K03911]\nPATHWAY   hsa04610(462)  Complement and coagulation cascades",
    "metabolism": "",
    "therapeutic_category": "3334",
    "atc_code": "B01AB01",
    "drug_class": [
      "Blood modifier agent",
      "Antithrombotic agent",
      "Heparin anticoagulant"
    ],
    "cyp_enzymes": [],
    "search_name": "Heparin calcium"
  },
  {
    "kegg_id": "D02112",
    "name_en": "Heparin sodium (JP18/USP/INN)",
    "name_ja": "ヘパリン",
    "names_alt": [
      "Parnaparin sodium (INN)",
      "Liquemin sodium (TN)"
    ],
    "formula": "",
    "efficacy": "Anticoagulant, Antithrombin III activator\nDISEASE   Disseminated intravascular coagulation [DS:H01587]",
    "target": "SERPINC1 (AT3) [HSA:462] [KO:K03911]\nPATHWAY   hsa04610(462)  Complement and coagulation cascades",
    "metabolism": "",
    "therapeutic_category": "3334",
    "atc_code": "B01AB01",
    "drug_class": [
      "Blood modifier agent",
      "Antithrombotic agent",
      "Heparin anticoagulant"
    ],
    "cyp_enzymes": [],
    "search_name": "Heparin sodium"
  },
  {
    "kegg_id": "D03353",
    "name_en": "Dalteparin sodium (JAN/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Ardeparin sodium",
      "Fragmin (TN)"
    ],
    "formula": "",
    "efficacy": "Anticoagulant, Antithrombin III activator\nDISEASE   Deep vein thrombosis [DS:H01723]",
    "target": "SERPINC1 (AT3) [HSA:462] [KO:K03911]\nPATHWAY   hsa04610(462)  Complement and coagulation cascades",
    "metabolism": "",
    "therapeutic_category": "3334",
    "atc_code": "B01AB04",
    "drug_class": [
      "Blood modifier agent",
      "Antithrombotic agent",
      "Heparin anticoagulant"
    ],
    "cyp_enzymes": [],
    "search_name": "Dalteparin sodium"
  },
  {
    "kegg_id": "D04977",
    "name_en": "Parnaparin sodium (JP18)",
    "name_ja": "",
    "names_alt": [
      "Lowhepa (TN)"
    ],
    "formula": "",
    "efficacy": "Anticoagulant, Antithrombin III activator",
    "target": "SERPINC1 (AT3) [HSA:462] [KO:K03911]\nPATHWAY   hsa04610(462)  Complement and coagulation cascades",
    "metabolism": "",
    "therapeutic_category": "3334",
    "atc_code": "B01AB07",
    "drug_class": [
      "Blood modifier agent",
      "Antithrombotic agent",
      "Heparin anticoagulant"
    ],
    "cyp_enzymes": [],
    "search_name": "Parnaparin sodium"
  },
  {
    "kegg_id": "D03674",
    "name_en": "Enoxaparin sodium (JAN/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Lovenox (TN)"
    ],
    "formula": "",
    "efficacy": "Anticoagulant, Antithrombin III activator",
    "target": "SERPINC1 (AT3) [HSA:462] [KO:K03911]\nPATHWAY   hsa04610(462)  Complement and coagulation cascades",
    "metabolism": "",
    "therapeutic_category": "3339",
    "atc_code": "B01AB05",
    "drug_class": [
      "Blood modifier agent",
      "Antithrombotic agent",
      "Heparin anticoagulant"
    ],
    "cyp_enzymes": [],
    "search_name": "Enoxaparin sodium"
  },
  {
    "kegg_id": "D07082",
    "name_en": "Dabigatran etexilate mesylate (USAN)",
    "name_ja": "ダビガトラン",
    "names_alt": [
      "Dabigatran etexilate methanesulfonate (JAN)",
      "Dabigatran etexilate mesilate",
      "Pradaxa (TN)"
    ],
    "formula": "C34H41N7O5. CH4SO3",
    "efficacy": "Anticoagulant, Thrombin inhibitor",
    "target": "F2a [CPD:C00752] [HSA:2147] [KO:K01313]\nPATHWAY   hsa04610(2147+C00752)  Complement and coagulation cascades\nhsa04611(2147)  Platelet activation\nNETWORK   nt06514  Coagulation cascade",
    "metabolism": "Transporter: ABCB1 [HSA:5243]",
    "therapeutic_category": "3339",
    "atc_code": "B01AE07",
    "drug_class": [
      "Blood modifier agent",
      "Antithrombotic agent",
      "Thrombin inhibitor",
      "Direct oral anticoagulant (DOAC)",
      "Transporter substrate",
      "ABCB1 substrate"
    ],
    "cyp_enzymes": [],
    "search_name": "Dabigatran etexilate mesylate"
  },
  {
    "kegg_id": "D07086",
    "name_en": "Rivaroxaban (JAN/USAN/INN)",
    "name_ja": "リバーロキサバン",
    "names_alt": [
      "Xarelto (TN)"
    ],
    "formula": "C19H18ClN3O5S",
    "efficacy": "Antithrombotic, Factor Xa inhibitor",
    "target": "F10a [CPD:C01065] [HSA:2159] [KO:K01314]\nPATHWAY   hsa04610(2159+C01065)  Complement and coagulation cascades\nNETWORK   nt06514  Coagulation cascade",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576], CYP2J2 [HSA:1573]\nTransporter: ABCB1 [HSA:5243], ABCG2 [HSA:9429]",
    "therapeutic_category": "3339",
    "atc_code": "B01AF01",
    "drug_class": [
      "Blood modifier agent",
      "Antithrombotic agent",
      "Factor Xa inhibitor",
      "Direct oral anticoagulant (DOAC)",
      "Metabolizing enzyme substrate",
      "CYP2J2 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "Transporter substrate",
      "ABCB1 substrate",
      "ABCG2 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4",
      "CYP2J2"
    ],
    "search_name": "Rivaroxaban"
  },
  {
    "kegg_id": "D03213",
    "name_en": "Apixaban (JAN/USAN/INN)",
    "name_ja": "アピキサバン",
    "names_alt": [
      "Eliquis (TN)"
    ],
    "formula": "C25H25N5O4",
    "efficacy": "Anticoagulant, Antithrombotic, Factor Xa inhibitor\nDISEASE   Deep vein thrombosis [DS:H01723]",
    "target": "F10a [CPD:C01065] [HSA:2159] [KO:K01314]\nPATHWAY   hsa04610(2159+C01065)  Complement and coagulation cascades\nNETWORK   nt06514  Coagulation cascade",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576], CYP3A5 [HSA:1577]\nTransporter: ABCB1 [HSA:5243], ABCG2 [HSA:9429]",
    "therapeutic_category": "3339",
    "atc_code": "B01AF02",
    "drug_class": [
      "Blood modifier agent",
      "Antithrombotic agent",
      "Factor Xa inhibitor",
      "Direct oral anticoagulant (DOAC)",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "CYP3A5 substrate",
      "Transporter substrate",
      "ABCB1 substrate",
      "ABCG2 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4",
      "CYP3A5"
    ],
    "search_name": "Apixaban"
  },
  {
    "kegg_id": "D09546",
    "name_en": "Edoxaban tosilate hydrate (JAN)",
    "name_ja": "エドキサバン",
    "names_alt": [
      "Edoxaban tosylate monohydrate",
      "Lixiana (TN)",
      "Savaysa (TN)"
    ],
    "formula": "C24H30ClN7O4S. C7H8O3S. H2O",
    "efficacy": "Antithrombotic, Factor Xa inhibitor",
    "target": "F10a [CPD:C01065] [HSA:2159] [KO:K01314]\nPATHWAY   hsa04610(2159+C01065)  Complement and coagulation cascades\nNETWORK   nt06514  Coagulation cascade",
    "metabolism": "Transporter: ABCB1 [HSA:5243]",
    "therapeutic_category": "3339",
    "atc_code": "B01AF03",
    "drug_class": [
      "Blood modifier agent",
      "Antithrombotic agent",
      "Factor Xa inhibitor",
      "Direct oral anticoagulant (DOAC)",
      "Transporter substrate",
      "ABCB1 substrate"
    ],
    "cyp_enzymes": [],
    "search_name": "Edoxaban tosilate hydrate"
  },
  {
    "kegg_id": "D01844",
    "name_en": "Fondaparinux sodium (JAN/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Arixtra (TN)"
    ],
    "formula": "C31H43N3O49S8. 10Na",
    "efficacy": "Antithrombotic, Factor Xa inhibitor",
    "target": "SERPINC1 (AT3) [HSA:462] [KO:K03911]\nF10a [CPD:C01065] [HSA:2159] [KO:K01314]\nPATHWAY   hsa04610(2159+462+C01065)  Complement and coagulation cascades\nNETWORK   nt06514  Coagulation cascade",
    "metabolism": "",
    "therapeutic_category": "3339",
    "atc_code": "B01AX05",
    "drug_class": [
      "Blood modifier agent",
      "Antithrombotic agent",
      "Factor Xa inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Fondaparinux sodium"
  },
  {
    "kegg_id": "D04978",
    "name_en": "Sodium citrate hydrate, citric acid hydrate and glucose",
    "name_ja": "",
    "names_alt": [
      "Acid -Citrate -Dextrose solution",
      "ACD-A solution",
      "ACD-A (TN)"
    ],
    "formula": "",
    "efficacy": "Blood preservation",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3339",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Sodium citrate hydrate, citric acid hydrate and glucose"
  },
  {
    "kegg_id": "D06410",
    "name_en": "Thrombomodulin alfa (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Thrombomodulin alfa (genetical recombination) (JAN)"
    ],
    "formula": "C2230H3357N633O718S50",
    "efficacy": "Anticoagulant, Anti-inflammatory",
    "target": "F2a [CPD:C00752] [HSA:2147] [KO:K01313]\nPATHWAY   hsa04610(2147+C00752)  Complement and coagulation cascades\nhsa04611(2147)  Platelet activation",
    "metabolism": "",
    "therapeutic_category": "3339",
    "atc_code": "",
    "drug_class": [
      "Blood modifier agent",
      "Antithrombotic agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Thrombomodulin alfa"
  },
  {
    "kegg_id": "D08741",
    "name_en": "Adenine, sodium citrate hydrate, citric acid hydrate, glucose and potassium phosphate, monobasic",
    "name_ja": "",
    "names_alt": [
      "CPDA solution",
      "Karmi CA (TN)"
    ],
    "formula": "",
    "efficacy": "Blood preservation",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3339",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Adenine, sodium citrate hydrate, citric acid hydrate, glucose and potassium phosphate, monobasic"
  },
  {
    "kegg_id": "D08744",
    "name_en": "ACD-A solution and MAP solution",
    "name_ja": "",
    "names_alt": [
      "Karmi AMAP (TN)"
    ],
    "formula": "",
    "efficacy": "Blood preservation",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3339",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "ACD-A solution and MAP solution"
  },
  {
    "kegg_id": "D08745",
    "name_en": "CPD solution and MAP solution",
    "name_ja": "",
    "names_alt": [
      "Sepacell Integra C-MAP (TN)"
    ],
    "formula": "",
    "efficacy": "Blood preservation",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3339",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "CPD solution and MAP solution"
  },
  {
    "kegg_id": "D02224",
    "name_en": "Protamine sulfate (JP18/USP/INN)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Neutralizer (heparin)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3391",
    "atc_code": "V03AB14",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Protamine sulfate"
  },
  {
    "kegg_id": "D00769",
    "name_en": "Clopidogrel bisulfate (USP)",
    "name_ja": "クロピドグレル",
    "names_alt": [
      "Clopidogrel sulfate (JP18)",
      "Clopidogrel sulfate tablets (JP18)",
      "Clopidogrel hydrogen sulphate",
      "Isocover (TN)",
      "Plavix (TN)"
    ],
    "formula": "C16H16ClNO2S. H2SO4",
    "efficacy": "Anticoagulant, Platelet aggregation inhibitor, Purinergic receptor P2Y12 antagonist\nDISEASE   Myocardial infarction [DS:H01730]",
    "target": "P2RY12 [HSA:64805] [KO:K04298]\nPATHWAY   hsa04611(64805)  Platelet activation",
    "metabolism": "Enzyme: CYP2C19 [HSA:1557]; CYP3A4 [HSA:1576], CYP1A2 [HSA:1544], CYP2B6 [HSA:1555]",
    "therapeutic_category": "3399",
    "atc_code": "B01AC04",
    "drug_class": [
      "Blood modifier agent",
      "Antithrombotic agent",
      "Antiplatelet agent",
      "Thienopyridine",
      "P2Y12 receptor antagonist",
      "Thienopyridine",
      "Metabolizing enzyme substrate",
      "CYP1A2 substrate",
      "CYP2B6 substrate",
      "CYP2C19 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "Metabolizing enzyme inhibitor",
      "CYP2C8 inhibitor"
    ],
    "cyp_enzymes": [
      "CYP2B6",
      "CYP2C19",
      "CYP3A4",
      "CYP1A2"
    ],
    "search_name": "Clopidogrel bisulfate"
  },
  {
    "kegg_id": "D01028",
    "name_en": "Ticlopidine hydrochloride (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Ticlid (TN)"
    ],
    "formula": "C14H14ClNS. HCl",
    "efficacy": "Anticoagulant, Platelet aggregation inhibitor, Purinergic receptor P2Y12 antagonist\nDISEASE   Thrombotic thrombocytopenic purpura [DS:H00225]\nAplastic anemia [DS:H01132]",
    "target": "P2RY12 [HSA:64805] [KO:K04298]\nPATHWAY   hsa04611(64805)  Platelet activation",
    "metabolism": "",
    "therapeutic_category": "3399",
    "atc_code": "B01AC05",
    "drug_class": [
      "Blood modifier agent",
      "Antithrombotic agent",
      "Antiplatelet agent",
      "Thienopyridine",
      "P2Y12 receptor antagonist",
      "Thienopyridine",
      "Metabolizing enzyme inhibitor",
      "CYP1A2 inhibitor",
      "CYP2B6 inhibitor",
      "CYP2C19 inhibitor",
      "CYP2D6 inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Ticlopidine hydrochloride"
  },
  {
    "kegg_id": "D05597",
    "name_en": "Prasugrel hydrochloride (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Effient (TN)"
    ],
    "formula": "C20H20FNO3S. HCl",
    "efficacy": "Platelet aggregation inhibitor, Purinergic receptor P2Y12 antagonist\nDISEASE   Unstable angina [DS:H01632]\nMyocardial infarction [DS:H01730]",
    "target": "P2RY12 [HSA:64805] [KO:K04298]\nPATHWAY   hsa04611(64805)  Platelet activation",
    "metabolism": "",
    "therapeutic_category": "3399",
    "atc_code": "B01AC22",
    "drug_class": [
      "Blood modifier agent",
      "Antithrombotic agent",
      "Antiplatelet agent",
      "Thienopyridine",
      "P2Y12 receptor antagonist",
      "Thienopyridine"
    ],
    "cyp_enzymes": [],
    "search_name": "Prasugrel hydrochloride"
  },
  {
    "kegg_id": "D01896",
    "name_en": "Cilostazol (JP18/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Pletal (TN)"
    ],
    "formula": "C20H27N5O2",
    "efficacy": "Vasodilator, Platelet aggregation inhibitor, Phosphodiesterase inhibitor",
    "target": "PDE3 [HSA:5139 5140] [KO:K19021 K13296]\nTBXA2R [HSA:6915] [KO:K04264]\nPATHWAY   hsa00230(5139+5140)  Purine metabolism\nhsa04022(5139+5140)  cGMP-PKG signaling pathway\nhsa04024(5139+5140)  cAMP signaling pathway\nhsa04611(6915)  Platelet activation\nhsa04910(5140)  Insulin signaling pathway\nhsa04922(5140)  Glucagon signaling pathway",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]; CYP2D6 [HSA:1565], CYP2C19 [HSA:1557]",
    "therapeutic_category": "3399",
    "atc_code": "B01AC23",
    "drug_class": [
      "Cardiovascular agent",
      "Phosphodiesterase III inhibitor",
      "Blood modifier agent",
      "Antithrombotic agent",
      "Antiplatelet agent",
      "Metabolizing enzyme substrate",
      "CYP2C19 substrate",
      "CYP2D6 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C19",
      "CYP3A4",
      "CYP2D6"
    ],
    "search_name": "Cilostazol"
  },
  {
    "kegg_id": "D09017",
    "name_en": "Ticagrelor (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Brilinta (TN)"
    ],
    "formula": "C23H28F2N6O4S",
    "efficacy": "Platelet aggregation inhibitor, Purinergic receptor P2Y12 antagonist\nDISEASE   Myocardial infarction [DS:H01730]",
    "target": "P2RY12 [HSA:64805] [KO:K04298]\nPATHWAY   hsa04611(64805)  Platelet activation",
    "metabolism": "Enzyme: CYP3A [HSA:1576 1577 1551]\nTransporter: ABCB1 [HSA:5243]",
    "therapeutic_category": "3399",
    "atc_code": "B01AC24",
    "drug_class": [
      "Blood modifier agent",
      "Antithrombotic agent",
      "Antiplatelet agent",
      "P2Y12 receptor antagonist",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "Metabolizing enzyme inhibitor",
      "CYP3A/CYP3A4 inhibitor",
      "Transporter substrate",
      "ABCB1 substrate",
      "Transporter inhibitor",
      "ABCB1 inhibitor"
    ],
    "cyp_enzymes": [
      "CYP3A"
    ],
    "search_name": "Ticagrelor"
  },
  {
    "kegg_id": "D10513",
    "name_en": "Clopidogrel sulfate and aspirin",
    "name_ja": "クロピドグレル",
    "names_alt": [
      "Clopidogrel and acetylsalicyclic acid",
      "Complavin (TN)"
    ],
    "formula": "",
    "efficacy": "Antiplatelet",
    "target": "",
    "metabolism": "Enzyme: CYP2C19 [HSA:1557]; CYP1A2 [HSA:1544], CYP2B6 [HSA:1555], CYP3A4 [HSA:1576]",
    "therapeutic_category": "3399",
    "atc_code": "B01AC30",
    "drug_class": [
      "Metabolizing enzyme substrate",
      "CYP1A2 substrate",
      "CYP2B6 substrate",
      "CYP2C19 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "Metabolizing enzyme inhibitor",
      "CYP2C8 inhibitor"
    ],
    "cyp_enzymes": [
      "CYP2B6",
      "CYP3A4",
      "CYP2C19",
      "CYP1A2"
    ],
    "search_name": "Clopidogrel sulfate and aspirin"
  },
  {
    "kegg_id": "D10527",
    "name_en": "Acetylsalicylic acid and lansoprazole",
    "name_ja": "",
    "names_alt": [
      "Acetylsalicylic acid and lansoprazole",
      "Takelda (TN)"
    ],
    "formula": "",
    "efficacy": "Antithrombotic",
    "target": "",
    "metabolism": "Enzyme: CYP2C19 [HSA:1557], CYP3A4 [HSA:1576]",
    "therapeutic_category": "3399",
    "atc_code": "B01AC56",
    "drug_class": [
      "Metabolizing enzyme substrate",
      "CYP2C19 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C19",
      "CYP3A4"
    ],
    "search_name": "Acetylsalicylic acid and lansoprazole"
  },
  {
    "kegg_id": "D12835",
    "name_en": "Apadamtase alfa and cinaxadamtase alfa",
    "name_ja": "",
    "names_alt": [
      "Recombinant ADAMTS13",
      "Apadamtase alfa (genetical recombination) and cinaxadamtase alfa (genetical recombination)",
      "ADAMTS13, recombinant-krhn",
      "Adzynma (TN)"
    ],
    "formula": "",
    "efficacy": "Antithrombotic\nDISEASE   Congenital thrombotic thrombocytopenic purpura [DS:H00225]\nTYPE      Enzyme replacement therapy product",
    "target": "ADAMTS13 [HSA:11093] [KO:K08627]\nPATHWAY   hsa04611(11093)  Platelet activation\nNETWORK   nt06514  Coagulation cascade",
    "metabolism": "",
    "therapeutic_category": "3399",
    "atc_code": "B01AD13",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Apadamtase alfa and cinaxadamtase alfa"
  },
  {
    "kegg_id": "D11160",
    "name_en": "Caplacizumab (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Caplacizumab (genetical recombination) (JAN)",
      "Caplacizumab-yhdp",
      "Cablivi (TN)"
    ],
    "formula": "C1213H1891N357O380S10",
    "efficacy": "Platelet aggregation inhibitor, Anti-vWF antibody\nDISEASE   Acquired thrombotic thrombocytopenic purpura [DS:H00225]\nTYPE      Monoclonal antibody",
    "target": "VWF [HSA:7450] [KO:K03900]\nPATHWAY   hsa04610(7450)  Complement and coagulation cascades\nhsa04611(7450)  Platelet activation",
    "metabolism": "",
    "therapeutic_category": "3399",
    "atc_code": "B01AX07",
    "drug_class": [
      "Blood modifier agent",
      "Antithrombotic agent",
      "Antiplatelet agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Caplacizumab"
  },
  {
    "kegg_id": "D10476",
    "name_en": "Lusutrombopag (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Mulpleta (TN)"
    ],
    "formula": "C29H32Cl2N2O5S",
    "efficacy": "Antithrombocytopenia, Thrombopoietin receptor agonist\nDISEASE   Thrombocytopenia [DS:H00978]",
    "target": "MPL (TPOR, CD110) [HSA:4352] [KO:K05082]\nPATHWAY   hsa04060(4352)  Cytokine-cytokine receptor interaction\nhsa04630(4352)  JAK-STAT signaling pathway",
    "metabolism": "Enzyme: CYP4A11 [HSA:1579]",
    "therapeutic_category": "3399",
    "atc_code": "B02BX07",
    "drug_class": [
      "Metabolizing enzyme substrate",
      "CYP4A11 substrate"
    ],
    "cyp_enzymes": [
      "CYP4A11"
    ],
    "search_name": "Lusutrombopag"
  },
  {
    "kegg_id": "D10307",
    "name_en": "Avatrombopag maleate (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Doptelet (TN)"
    ],
    "formula": "C29H34Cl2N6O3S2. C4H4O4",
    "efficacy": "Antithrombocytopenia, Thrombopoietin receptor agonist\nDISEASE   Thrombocytopenia [DS:H00978]",
    "target": "MPL (TPOR, CD110) [HSA:4352] [KO:K05082]\nPATHWAY   hsa04060(4352)  Cytokine-cytokine receptor interaction\nhsa04630(4352)  JAK-STAT signaling pathway",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576], CYP2C9 [HSA:1559]",
    "therapeutic_category": "3399",
    "atc_code": "B02BX08",
    "drug_class": [
      "Metabolizing enzyme substrate",
      "CYP2C9 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C9",
      "CYP3A4"
    ],
    "search_name": "Avatrombopag maleate"
  },
  {
    "kegg_id": "D11701",
    "name_en": "Luspatercept (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Luspatercept (genetical recombination) (JAN)",
      "Luspatercept-aamt",
      "Reblozyl (TN)"
    ],
    "formula": "C3350H5070N906O1044S38",
    "efficacy": "Anti-anemic, Erythroid maturation agent\nDISEASE   beta Thalassemia [DS:H00228]",
    "target": "ACVR2B [HSA:93] [KO:K13596]\nPATHWAY   hsa04060(93)  Cytokine-cytokine receptor interaction\nhsa04350(93)  TGF-beta signaling pathway\nhsa04550(93)  Signaling pathways regulating pluripotency of stem cells",
    "metabolism": "",
    "therapeutic_category": "3399",
    "atc_code": "B03XA06",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Luspatercept"
  },
  {
    "kegg_id": "D03235",
    "name_en": "Filgrastim (USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Filgrastim (genetical recombination) (JP18)",
      "Filgrastim (genetical recombination) [Filgrastim biosimilar 1] (JAN)",
      "Tbo-filgrastim",
      "Filgrastim (genetical recombination) [Filgrastim biosimilar 2] (JAN)",
      "Filgrastim (genetical recombination) [Filgrastim biosimilar 3] (JAN)",
      "Filgrastim-sndz",
      "Filgrastim-aafi",
      "Filgrastim-txid",
      "Neupogen (TN)",
      "Nivestym (TN)",
      "Grastofil (TN)",
      "Zarxio (TN)"
    ],
    "formula": "C845H1339N223O243S9",
    "efficacy": "Antineutropenic, Hematopoietic stimulant, Antineoplastic (enhancer), Granulocyte colony stimulating factor (G-CSF)\nDISEASE   Neutropenia [DS:H00100]",
    "target": "CSF3R (GCSFR, CD114) [HSA:1441] [KO:K05061]\nPATHWAY   hsa04060(1441)  Cytokine-cytokine receptor interaction\nhsa04151(1441)  PI3K-Akt signaling pathway\nhsa04630(1441)  JAK-STAT signaling pathway\nhsa04640(1441)  Hematopoietic cell lineage\nhsa05200(1441)  Pathways in cancer",
    "metabolism": "",
    "therapeutic_category": "3399",
    "atc_code": "L03AA02",
    "drug_class": [
      "Immunological agent",
      "Colony stimulating factor",
      "Granulocyte colony stimulating factor (G-CSF)"
    ],
    "cyp_enzymes": [],
    "search_name": "Filgrastim"
  },
  {
    "kegg_id": "D03247",
    "name_en": "Lenograstim (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Lenograstim (genetical recombination) (JP18)",
      "Neutrogin (TN)"
    ],
    "formula": "",
    "efficacy": "Antineutropenic, Hematopoietic stimulant, Granulocyte colony stimulating factor (G-CSF)",
    "target": "CSF3R (GCSFR, CD114) [HSA:1441] [KO:K05061]\nPATHWAY   hsa04060(1441)  Cytokine-cytokine receptor interaction\nhsa04151(1441)  PI3K-Akt signaling pathway\nhsa04630(1441)  JAK-STAT signaling pathway\nhsa04640(1441)  Hematopoietic cell lineage\nhsa05200(1441)  Pathways in cancer",
    "metabolism": "",
    "therapeutic_category": "3399",
    "atc_code": "L03AA10",
    "drug_class": [
      "Immunological agent",
      "Colony stimulating factor",
      "Granulocyte colony stimulating factor (G-CSF)"
    ],
    "cyp_enzymes": [],
    "search_name": "Lenograstim"
  },
  {
    "kegg_id": "D06889",
    "name_en": "Pegfilgrastim (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Pegfilgrastim (genetical recombination) (JAN)",
      "Pegfilgrastim (genetical recombination) [Pegfilgrastim biosimilar 1] (JAN)",
      "Pegfilgrastim-cbqv",
      "Pegfilgrastim-bmez",
      "Pegfilgrastim-fpgk",
      "Neulasta (TN)",
      "G-lasta (TN)",
      "Stimufend (TN)",
      "Udenyca (TN)"
    ],
    "formula": "C849H1347N223O244S9. (C2H4O)n",
    "efficacy": "Antineutropenic, Hematopoietic stimulant, Granulocyte colony stimulating factor (G-CSF)\nDISEASE   Febrile neutropenia [DS:H00100]",
    "target": "CSF3R (GCSFR, CD114) [HSA:1441] [KO:K05061]\nPATHWAY   hsa04060(1441)  Cytokine-cytokine receptor interaction\nhsa04151(1441)  PI3K-Akt signaling pathway\nhsa04630(1441)  JAK-STAT signaling pathway\nhsa04640(1441)  Hematopoietic cell lineage\nhsa05200(1441)  Pathways in cancer",
    "metabolism": "",
    "therapeutic_category": "3399",
    "atc_code": "L03AA13",
    "drug_class": [
      "Immunological agent",
      "Colony stimulating factor",
      "Granulocyte colony stimulating factor (G-CSF)"
    ],
    "cyp_enzymes": [],
    "search_name": "Pegfilgrastim"
  },
  {
    "kegg_id": "D08971",
    "name_en": "Plerixafor (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Mozobil (TN)"
    ],
    "formula": "C28H54N8",
    "efficacy": "Antineoplastic, Chemokine receptor type 4 (CXCR4) antagonist\nDISEASE   Non-Hodgkin's lymphoma [DS:H02418]\nMultiple myeloma [DS:H00010]",
    "target": "CXCR4 (CD184) [HSA:7852] [KO:K04189]\nPATHWAY   hsa04060(7852)  Cytokine-cytokine receptor interaction\nhsa04062(7852)  Chemokine signaling pathway\nhsa05200(7852)  Pathways in cancer",
    "metabolism": "",
    "therapeutic_category": "3399",
    "atc_code": "L03AX16",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Plerixafor"
  },
  {
    "kegg_id": "D03960",
    "name_en": "Aspirin and dialuminate",
    "name_ja": "アスピリン",
    "names_alt": [
      "Aspirin, aluminum glycinate and magnesium carbonate",
      "Bufferin (TN)"
    ],
    "formula": "",
    "efficacy": "Analgesic, Anti-inflammatory, Antipyretic, Antiplatelet",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3399",
    "atc_code": "N02BA51",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Aspirin and dialuminate"
  },
  {
    "kegg_id": "D10741",
    "name_en": "Idarucizumab (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Idarucizumab (genetical recombination) (JAN)",
      "Praxbind (TN)"
    ],
    "formula": "",
    "efficacy": "Neutralizer (dabigatran)\nTYPE      Monoclonal antibody",
    "target": "Dabigatran [DR:D07082] [DG:DG00164]",
    "metabolism": "",
    "therapeutic_category": "3399",
    "atc_code": "V03AB37",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Idarucizumab"
  },
  {
    "kegg_id": "D11029",
    "name_en": "Andexanet alfa (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Andexanet alfa (genetical recombination) (JAN)",
      "Andexxa (TN)",
      "Ondexxya (TN)"
    ],
    "formula": "",
    "efficacy": "Anticoagulant reversal (factor Xa inhibitors)",
    "target": "F10a [CPD:C01065] [HSA:2159] [KO:K01314]\nPATHWAY   hsa04610(2159+C01065)  Complement and coagulation cascades",
    "metabolism": "",
    "therapeutic_category": "3399",
    "atc_code": "V03AB38",
    "drug_class": [
      "Blood modifier agent",
      "Antithrombotic agent",
      "Factor Xa inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Andexanet alfa"
  },
  {
    "kegg_id": "D01624",
    "name_en": "Sarpogrelate hydrochloride (JP18)",
    "name_ja": "",
    "names_alt": [
      "Anplag (TN)"
    ],
    "formula": "C24H31NO6. HCl",
    "efficacy": "Anticoagulant, Platelet aggregation inhibitor, Serotonin 5-HT2 receptor antagonist",
    "target": "HTR2A [HSA:3356] [KO:K04157]\nPATHWAY   hsa04080(3356)  Neuroactive ligand-receptor interaction\nhsa04726(3356)  Serotonergic synapse",
    "metabolism": "Enzyme: CYP1A2 [HSA:1544], CYP2B6 [HSA:1555], CYP2C9 [HSA:1559], CYP2C19 [HSA:1557], CYP2D6 [HSA:1565], CYP3A4 [HSA:1576]",
    "therapeutic_category": "3399",
    "atc_code": "",
    "drug_class": [
      "Blood modifier agent",
      "Antithrombotic agent",
      "Antiplatelet agent",
      "Metabolizing enzyme substrate",
      "CYP1A2 substrate",
      "CYP2B6 substrate",
      "CYP2C9 substrate",
      "CYP2C19 substrate",
      "CYP2D6 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C19",
      "CYP2B6",
      "CYP1A2",
      "CYP3A4",
      "CYP2C9",
      "CYP2D6"
    ],
    "search_name": "Sarpogrelate hydrochloride"
  },
  {
    "kegg_id": "D04981",
    "name_en": "Tromethamol, sodium chloride and potassium chloride",
    "name_ja": "",
    "names_alt": [
      "Tham Set (TN)"
    ],
    "formula": "",
    "efficacy": "Anti-acidosis",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3399",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Tromethamol, sodium chloride and potassium chloride"
  },
  {
    "kegg_id": "D08746",
    "name_en": "Hot water extract of Mycobacterium tuberculosis",
    "name_ja": "",
    "names_alt": [
      "Ancer (TN)"
    ],
    "formula": "",
    "efficacy": "Antileukopenic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3399",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Hot water extract of Mycobacterium tuberculosis"
  },
  {
    "kegg_id": "D11804",
    "name_en": "Aspirin and vonoprazan",
    "name_ja": "アスピリン",
    "names_alt": [
      "Cabpirin (TN)"
    ],
    "formula": "",
    "efficacy": "Antithrombotic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3399",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Aspirin and vonoprazan"
  },
  {
    "kegg_id": "D10952",
    "name_en": "Maralixibat chloride (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Livmarli (TN)"
    ],
    "formula": "C40H56N3O4S. Cl",
    "efficacy": "Hepatoprotectants, Bile acid transporter (ASBT/IBAT) inhibitor\nDISEASE   Alagille syndrome [DS:H00551]\nProgressive familial intrahepatic cholestasis [DS:H00624]",
    "target": "SLC10A2 (ASBT, IBAT) [HSA:6555] [KO:K14342]\nPATHWAY   hsa04976(6555)  Bile secretion",
    "metabolism": "",
    "therapeutic_category": "3919",
    "atc_code": "A05AX04",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Maralixibat chloride"
  },
  {
    "kegg_id": "D13092",
    "name_en": "Odevixibat hydrate (JAN)",
    "name_ja": "",
    "names_alt": [
      "Odevixibat sesquihydrate",
      "Bylvay (TN)"
    ],
    "formula": "(C37H48N4O8S2)2. 3H2O",
    "efficacy": "Hepatoprotectants, Bile acid transporter (ASBT/IBAT) inhibitor\nDISEASE   Progressive familial intrahepatic cholestasis [DS:H00624]\nAlagille syndrome [DS:H00551]",
    "target": "SLC10A2 (ASBT, IBAT) [HSA:6555] [KO:K14342]\nPATHWAY   hsa04976(6555)  Bile secretion",
    "metabolism": "Transporter: ABCB1 [HSA:5243]",
    "therapeutic_category": "3919",
    "atc_code": "A05AX05",
    "drug_class": [
      "Transporter substrate",
      "ABCB1 substrate"
    ],
    "cyp_enzymes": [],
    "search_name": "Odevixibat hydrate"
  },
  {
    "kegg_id": "D07423",
    "name_en": "Defibrotide sodium (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Defitelio (TN)"
    ],
    "formula": "",
    "efficacy": "Antithrombotic, Thrombogenesis factor regulator",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3919",
    "atc_code": "B01AX01",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Defibrotide sodium"
  },
  {
    "kegg_id": "D01430",
    "name_en": "Tiopronin (JAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Thiola (TN)"
    ],
    "formula": "C5H9NO3S",
    "efficacy": "Antidote (mercury), Liver function improving agent\nDISEASE   Cystinuria [DS:H00901]",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3919",
    "atc_code": "G04BX16",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Tiopronin"
  },
  {
    "kegg_id": "D01626",
    "name_en": "Propagermanium (JAN)",
    "name_ja": "",
    "names_alt": [
      "Serocion (TN)"
    ],
    "formula": "(C6H10Ge2O7)n",
    "efficacy": "Antiviral, Immunostimulant",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3919",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Propagermanium"
  },
  {
    "kegg_id": "D01816",
    "name_en": "Diisopropylamine dichloroacetate (JAN)",
    "name_ja": "",
    "names_alt": [
      "Liverall (TN)"
    ],
    "formula": "C2H2Cl2O2. C6H15N",
    "efficacy": "Liver function improving agent",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3919",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Diisopropylamine dichloroacetate"
  },
  {
    "kegg_id": "D04990",
    "name_en": "Monoammonium glycyrrhizinate, glycine and L-cysteine hydrochloride",
    "name_ja": "",
    "names_alt": [
      "Stronger neo minophagen C (TN)"
    ],
    "formula": "",
    "efficacy": "Antiallergic, Liver function improving agent",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3919",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Monoammonium glycyrrhizinate, glycine and L-cysteine hydrochloride"
  },
  {
    "kegg_id": "D04993",
    "name_en": "Monoammonium glycyrrhizinate, glycine and DL-methionine",
    "name_ja": "",
    "names_alt": [
      "Glycyron (TN)"
    ],
    "formula": "",
    "efficacy": "Antiallergic, Liver function improving agent",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3919",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Monoammonium glycyrrhizinate, glycine and DL-methionine"
  },
  {
    "kegg_id": "D03943",
    "name_en": "Edetate calcium disodium (USP)",
    "name_ja": "",
    "names_alt": [
      "Calcium sodium edetate hydrate (JP18)",
      "Sodium calcium edetate (INN)",
      "Calcium disodium edetate hydrate",
      "Edetate calcium disodium"
    ],
    "formula": "C10H12N2O8. 2Na. Ca. xH2O",
    "efficacy": "Antidote (lead), Chelating agent (metal)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3921",
    "atc_code": "V03AB03",
    "drug_class": [
      "Vitamin and mineral",
      "Chelator"
    ],
    "cyp_enzymes": [],
    "search_name": "Edetate calcium disodium"
  },
  {
    "kegg_id": "D00014",
    "name_en": "Glutathione (JP18)",
    "name_ja": "",
    "names_alt": [
      "Glutathione (reduced type)",
      "Tathion (TN)"
    ],
    "formula": "C10H17N3O6S",
    "efficacy": "Antidote",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3922",
    "atc_code": "V03AB32",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Glutathione"
  },
  {
    "kegg_id": "D00167",
    "name_en": "Dimercaprol (JP18/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "BAL (TN)"
    ],
    "formula": "C3H8OS2",
    "efficacy": "Antidote",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3923",
    "atc_code": "V03AB09",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Dimercaprol"
  },
  {
    "kegg_id": "D01091",
    "name_en": "Sodium thiosulfate (USP)",
    "name_ja": "",
    "names_alt": [
      "Sodium thiosulfate hydrate (JP18)",
      "Detoxol (TN)",
      "Pedmark (TN)",
      "Sulfactol (TN)",
      "Pedmarqsi (TN)"
    ],
    "formula": "S2O3. 5H2O. 2Na",
    "efficacy": "Antidote (cyanide), Antidote (cisplatin)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3925",
    "atc_code": "V03AB06",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Sodium thiosulfate"
  },
  {
    "kegg_id": "D10468",
    "name_en": "Cysteamine bitartrate (JAN)",
    "name_ja": "",
    "names_alt": [
      "Mercaptamine bitartrate",
      "Cystagon (TN)",
      "Procysbi (TN)"
    ],
    "formula": "C4H6O6. C2H7NS",
    "efficacy": "Cystine concentration-lowering agent\nDISEASE   Nephropathic cystinosis [DS:H00275]",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3929",
    "atc_code": "A16AA04",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Cysteamine bitartrate"
  },
  {
    "kegg_id": "D06408",
    "name_en": "Zinc acetate (USP)",
    "name_ja": "",
    "names_alt": [
      "Zinc acetate hydrate (JAN)",
      "Zinc acetate dihydrate",
      "Galzin (TN)"
    ],
    "formula": "(C2H3O2)2. 2H2O. Zn",
    "efficacy": "Antidote (copper)\nDISEASE   Wilson disease [DS:H00210]",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3929",
    "atc_code": "A16AX05",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Zinc acetate"
  },
  {
    "kegg_id": "D00736",
    "name_en": "Trientine hydrochloride (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Trientine dihydrochloride",
      "Syprine (TN)"
    ],
    "formula": "C6H18N4. 2HCl",
    "efficacy": "Chelating agent\nDISEASE   Wilson's disease [DS:H00210]",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3929",
    "atc_code": "A16AX12",
    "drug_class": [
      "Vitamin and mineral",
      "Chelator"
    ],
    "cyp_enzymes": [],
    "search_name": "Trientine hydrochloride"
  },
  {
    "kegg_id": "D00496",
    "name_en": "Penicillamine (JAN/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Cuprimine (TN)",
      "Depen (TN)"
    ],
    "formula": "C5H11NO2S",
    "efficacy": "Antidote, Antirheumatic, Chelating agent\nDISEASE   Wilson's disease [DS:H00210]",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3929",
    "atc_code": "M01CC01",
    "drug_class": [
      "Anti-inflammatory",
      "Disease modifying anti-rheumatic drug (DMARD)",
      "Vitamin and mineral",
      "Chelator"
    ],
    "cyp_enzymes": [],
    "search_name": "Penicillamine"
  },
  {
    "kegg_id": "D01459",
    "name_en": "Mesna (JAN/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Mesnex (TN)",
      "Uromitexan (TN)"
    ],
    "formula": "C2H5O3S2. Na",
    "efficacy": "Antidote",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3929",
    "atc_code": "R05CB05",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Mesna"
  },
  {
    "kegg_id": "D01572",
    "name_en": "Pralidoxime iodide (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Pam (TN)"
    ],
    "formula": "C7H9N2O. I",
    "efficacy": "Antidote (organicphosphorus compound), Acetylcholinesterase (AChE) reactivator",
    "target": "ACHE [HSA:43] [KO:K01049]\nPATHWAY   hsa00564(43)  Glycerophospholipid metabolism\nhsa04725(43)  Cholinergic synapse",
    "metabolism": "",
    "therapeutic_category": "3929",
    "atc_code": "V03AB04",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Pralidoxime iodide"
  },
  {
    "kegg_id": "D10537",
    "name_en": "Methylthioninium chloride hydrate (JAN)",
    "name_ja": "",
    "names_alt": [
      "Methylene blue (TN)"
    ],
    "formula": "C16H18N3S. Cl. xH2O",
    "efficacy": "Antimethemoglobinemic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3929",
    "atc_code": "V03AB17",
    "drug_class": [
      "Metabolizing enzyme inhibitor",
      "CYP1A2 inhibitor",
      "CYP2B6 inhibitor",
      "CYP2C9 inhibitor",
      "CYP2C19 inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Methylthioninium chloride hydrate"
  },
  {
    "kegg_id": "D00707",
    "name_en": "Fomepizole (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Antizol (TN)"
    ],
    "formula": "C4H6N2",
    "efficacy": "Antidote (ethyleneglycol, methanol), Alcohol dehydrogenase inhibitor",
    "target": "ADH [HSA:124 125 126] [KO:K13951]\nPATHWAY   hsa00980(124+125+126)  Metabolism of xenobiotics by cytochrome P450",
    "metabolism": "",
    "therapeutic_category": "3929",
    "atc_code": "V03AB34",
    "drug_class": [
      "Metabolizing enzyme inhibitor",
      "CYP1A2 inhibitor",
      "CYP2A6 inhibitor",
      "CYP2C9 inhibitor",
      "CYP2D6 inhibitor",
      "CYP2E1 inhibitor",
      "CYP3A/CYP3A4 inhibitor",
      "CYP3A4 inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Fomepizole"
  },
  {
    "kegg_id": "D05940",
    "name_en": "Sugammadex sodium (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Bridion (TN)"
    ],
    "formula": "C72H104O48S8. 8Na",
    "efficacy": "Antidote (muscle relaxants)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3929",
    "atc_code": "V03AB35",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Sugammadex sodium"
  },
  {
    "kegg_id": "D01186",
    "name_en": "Deferoxamine mesylate (USP)",
    "name_ja": "",
    "names_alt": [
      "Deferoxamine mesilate (JP18)",
      "Desferal (TN)"
    ],
    "formula": "C25H48N6O8. CH4SO3",
    "efficacy": "Antidote (iron), Chelating agent",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3929",
    "atc_code": "V03AC01",
    "drug_class": [
      "Vitamin and mineral",
      "Chelator",
      "Iron chelator"
    ],
    "cyp_enzymes": [],
    "search_name": "Deferoxamine mesylate"
  },
  {
    "kegg_id": "D03669",
    "name_en": "Deferasirox (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Exjade (TN)",
      "Jadenu (TN)"
    ],
    "formula": "C21H15N3O4",
    "efficacy": "Antidote (iron), Chelating agent",
    "target": "",
    "metabolism": "Enzyme: UGT1A1 [HSA:54658], UGT1A3 [HSA:54659]",
    "therapeutic_category": "3929",
    "atc_code": "V03AC03",
    "drug_class": [
      "Vitamin and mineral",
      "Chelator",
      "Iron chelator",
      "Metabolizing enzyme substrate",
      "UGT substrate",
      "UGT1A1 substrate",
      "UGT1A3 substrate",
      "Metabolizing enzyme inhibitor",
      "CYP1A2 inhibitor",
      "CYP2C8 inhibitor",
      "Metabolizing enzyme inducer",
      "CYP3A/CYP3A4 inducer",
      "CYP3A4 inducer"
    ],
    "cyp_enzymes": [],
    "search_name": "Deferasirox"
  },
  {
    "kegg_id": "D03730",
    "name_en": "Dexrazoxane (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [],
    "formula": "C11H16N4O4",
    "efficacy": "Antidote, Chelating agent",
    "target": "TOP2 [HSA:7153 7155] [KO:K03164]",
    "metabolism": "",
    "therapeutic_category": "3929",
    "atc_code": "V03AF02",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Dexrazoxane"
  },
  {
    "kegg_id": "D01211",
    "name_en": "Leucovorin calcium (USP)",
    "name_ja": "",
    "names_alt": [
      "Calcium folinate (JP18)",
      "Uzel (TN)",
      "Wellcovorin (TN)"
    ],
    "formula": "C20H21N7O7. Ca. xH2O",
    "efficacy": "Anti-anemic (folate deficiency), Antidote (antifolate), Antineoplastic (enhancer), Supplement (folic acid)\nDISEASE   Osteosarcoma [DS:H00036]\nColorectal cancer [DS:H00020]",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3929",
    "atc_code": "V03AF03",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Leucovorin calcium"
  },
  {
    "kegg_id": "D11555",
    "name_en": "Calcium levofolinate hydrate (JP18)",
    "name_ja": "",
    "names_alt": [
      "Levoleucovorin calcium pentahydrate",
      "Calcium levofolinate pentahydrate",
      "Isovorin (TN)"
    ],
    "formula": "C20H21N7O7. 5H2O. Ca",
    "efficacy": "Antidote (antifolate), Antineoplastic (enhancer)\nDISEASE   Osteosarcoma [DS:H00036]\nColorectal cancer [DS:H00020]",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3929",
    "atc_code": "V03AF04",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Calcium levofolinate hydrate"
  },
  {
    "kegg_id": "D10260",
    "name_en": "Glucarpidase (INN)",
    "name_ja": "",
    "names_alt": [
      "Glucarpidase (genetical recombination) (JAN)",
      "Voraxaze (TN)",
      "Megludase (TN)"
    ],
    "formula": "C3670H5926N10114O1140S12",
    "efficacy": "Antidote (methotrexate concentrations)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3929",
    "atc_code": "V03AF09",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Glucarpidase"
  },
  {
    "kegg_id": "D05419",
    "name_en": "Pentetate calcium trisodium (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Calcium trisodium pentetate (INN)"
    ],
    "formula": "C14H18N3O10. Ca. 3Na",
    "efficacy": "Antidote (plutonium, americium, curium), Chelating agent",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3929",
    "atc_code": "",
    "drug_class": [
      "Vitamin and mineral",
      "Chelator"
    ],
    "cyp_enzymes": [],
    "search_name": "Pentetate calcium trisodium"
  },
  {
    "kegg_id": "D08749",
    "name_en": "Hydroxocobalamin and isotonic sodium chloride solution",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Antidote (cyanide)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3929",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Hydroxocobalamin and isotonic sodium chloride solution"
  },
  {
    "kegg_id": "D08750",
    "name_en": "Spherical carbonaceous adsorbent",
    "name_ja": "",
    "names_alt": [
      "Kremezin",
      "Merckmezin (TN)"
    ],
    "formula": "",
    "efficacy": "Antidote",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3929",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Spherical carbonaceous adsorbent"
  },
  {
    "kegg_id": "D09736",
    "name_en": "Iron (III) hexacyanoferrate (II)",
    "name_ja": "",
    "names_alt": [
      "Radiogardase (TN)"
    ],
    "formula": "(Fe. (CN)6)3. 4Fe. xH2O",
    "efficacy": "Antidote",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3929",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Iron"
  },
  {
    "kegg_id": "D09762",
    "name_en": "Pentetate zinc trisodium (JAN)",
    "name_ja": "",
    "names_alt": [],
    "formula": "C14H18N3O10. Zn. 3Na",
    "efficacy": "Antidote (plutonium, americium, curium), Chelating agent",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3929",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Pentetate zinc trisodium"
  },
  {
    "kegg_id": "D00123",
    "name_en": "Cyanamide (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "CH2N2",
    "efficacy": "Antialcohol dependence, Aldehyde dehydrogenase inhibitor",
    "target": "ALDH [HSA:217 219 224] [KO:K00128]\nPATHWAY   hsa00010(217+219+224)  Glycolysis / Gluconeogenesis\nhsa00071(217+219+224)  Fatty acid degradation\nhsa00620(217+219+224)  Pyruvate metabolism",
    "metabolism": "",
    "therapeutic_category": "3932",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Cyanamide"
  },
  {
    "kegg_id": "D00131",
    "name_en": "Disulfiram (JP18/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Antabuse (TN)"
    ],
    "formula": "C10H20N2S4",
    "efficacy": "Antialcohol dependence, Aldehyde dehydrogenase inhibitor\nDISEASE   Management of selected chronic alcohol patients [DS:H01611]",
    "target": "ALDH [HSA:217 219 224] [KO:K00128]\nPATHWAY   hsa00010(217+219+224)  Glycolysis / Gluconeogenesis\nhsa00071(217+219+224)  Fatty acid degradation\nhsa00620(217+219+224)  Pyruvate metabolism",
    "metabolism": "",
    "therapeutic_category": "3939",
    "atc_code": "N07BB01",
    "drug_class": [
      "Metabolizing enzyme inhibitor",
      "CYP1A2 inhibitor",
      "CYP2E1 inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Disulfiram"
  },
  {
    "kegg_id": "D00570",
    "name_en": "Colchicine (JP18/USP)",
    "name_ja": "コルヒチン",
    "names_alt": [],
    "formula": "C22H25NO6",
    "efficacy": "Gout suppressant, Leukocyte (neutrophil) migration inhibitor, Tubulin polymerization inhibitor\nDISEASE   Gout flares [DS:H01532]\nFamilial mediterranean fever [DS:H00288]",
    "target": "TUBB [HSA:10381 10382 10383 203068 347688 347733 7280 81027 84617] [KO:K07375]\nPATHWAY   hsa04145(10381+10382+10383+203068+347688+347733+7280+81027+84617)  Phagosome\nhsa04540(10381+10382+10383+203068+347688+347733+7280+81027+84617)  Gap junction",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]\nTransporter: ABCB1 [HSA:5243]",
    "therapeutic_category": "3941",
    "atc_code": "M04AC01",
    "drug_class": [
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "Transporter substrate",
      "ABCB1 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Colchicine"
  },
  {
    "kegg_id": "D00475",
    "name_en": "Probenecid (JP18/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Benemid (TN)"
    ],
    "formula": "C13H19NO4S",
    "efficacy": "Gout suppressant, Uricosuric\nDISEASE   Gout and gouty arthritis [DS:H01532]",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3942",
    "atc_code": "M04AB01",
    "drug_class": [
      "Musculo-skeletal system agent",
      "Uricosurics"
    ],
    "cyp_enzymes": [],
    "search_name": "Probenecid"
  },
  {
    "kegg_id": "D00224",
    "name_en": "Allopurinol (JP18/USP/INN)",
    "name_ja": "アロプリノール",
    "names_alt": [
      "Zyloprim (TN)"
    ],
    "formula": "C5H4N4O",
    "efficacy": "Gout suppressant, Uric acid biosynthesis inhibitor, Xanthine oxidase inhibitor\nDISEASE   Primary or secondary gout [DS:H01532]",
    "target": "XDH [HSA:7498] [KO:K00106]\nPATHWAY   hsa00230(7498)  Purine metabolism\nhsa04146(7498)  Peroxisome",
    "metabolism": "",
    "therapeutic_category": "3943",
    "atc_code": "M04AA01",
    "drug_class": [
      "Cardiovascular agent",
      "Xanthine dehydrogenase inhibitor",
      "Musculo-skeletal system agent",
      "Xanthin oxidase inhibitor",
      "Metabolizing enzyme inhibitor",
      "CYP1A2 inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Allopurinol"
  },
  {
    "kegg_id": "D01206",
    "name_en": "Febuxostat (JP18/USAN/INN)",
    "name_ja": "フェブキソスタット",
    "names_alt": [
      "Uloric (TN)",
      "Feburic (TN)"
    ],
    "formula": "C16H16N2O3S",
    "efficacy": "Gout suppressant, Uric acid biosynthesis inhibitor, Xanthine oxidase inhibitor\nDISEASE   Gout [DS:H01532]",
    "target": "XDH [HSA:7498] [KO:K00106]\nPATHWAY   hsa00230(7498)  Purine metabolism\nhsa04146(7498)  Peroxisome",
    "metabolism": "",
    "therapeutic_category": "3949",
    "atc_code": "M04AA03",
    "drug_class": [
      "Cardiovascular agent",
      "Xanthine dehydrogenase inhibitor",
      "Musculo-skeletal system agent",
      "Xanthin oxidase inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Febuxostat"
  },
  {
    "kegg_id": "D11081",
    "name_en": "Febuxostat hydrate (JAN)",
    "name_ja": "フェブキソスタット",
    "names_alt": [
      "Febuxostat hemihydrate"
    ],
    "formula": "(C16H16N2O3S)2. H2O",
    "efficacy": "Gout suppressant, Uric acid biosynthesis inhibitor, Xanthine oxidase inhibitor",
    "target": "XDH [HSA:7498] [KO:K00106]\nPATHWAY   hsa00230(7498)  Purine metabolism\nhsa04146(7498)  Peroxisome",
    "metabolism": "",
    "therapeutic_category": "3949",
    "atc_code": "M04AA03",
    "drug_class": [
      "Cardiovascular agent",
      "Xanthine dehydrogenase inhibitor",
      "Musculo-skeletal system agent",
      "Xanthin oxidase inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Febuxostat hydrate"
  },
  {
    "kegg_id": "D01056",
    "name_en": "Benzbromarone (JP18/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Uroleap (TN)"
    ],
    "formula": "C17H12Br2O3",
    "efficacy": "Gout suppressant, Uricosuric",
    "target": "SLC22A12 (URAT1) [HSA:116085] [KO:K08208]",
    "metabolism": "Enzyme: CYP2C9 [HSA:1559]",
    "therapeutic_category": "3949",
    "atc_code": "M04AB03",
    "drug_class": [
      "Musculo-skeletal system agent",
      "Uricosurics",
      "Urate transporter inhibitor",
      "Metabolizing enzyme substrate",
      "CYP2C9 substrate",
      "Metabolizing enzyme inhibitor",
      "CYP2C9 inhibitor"
    ],
    "cyp_enzymes": [
      "CYP2C9"
    ],
    "search_name": "Benzbromarone"
  },
  {
    "kegg_id": "D11071",
    "name_en": "Dotinurad (JAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Urece (TN)"
    ],
    "formula": "C14H9Cl2NO4S",
    "efficacy": "Antihyperuricemic, Urate transporter inhibitor",
    "target": "SLC22A12 (URAT1) [HSA:116085] [KO:K08208]",
    "metabolism": "",
    "therapeutic_category": "3949",
    "atc_code": "M04AB06",
    "drug_class": [
      "Musculo-skeletal system agent",
      "Urate transporter inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Dotinurad"
  },
  {
    "kegg_id": "D05624",
    "name_en": "Potassium citrate and sodium citrate hydrate",
    "name_ja": "",
    "names_alt": [
      "Uralyt (TN)"
    ],
    "formula": "",
    "efficacy": "Gout suppressant, Alkalizer",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3949",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Potassium citrate and sodium citrate hydrate"
  },
  {
    "kegg_id": "D09786",
    "name_en": "Topiroxostat (JAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Uriadec (TN)"
    ],
    "formula": "C13H8N6",
    "efficacy": "Gout suppressant, Uric acid biosynthesis inhibitor, Xanthine oxidase inhibitor",
    "target": "XDH [HSA:7498] [KO:K00106]\nPATHWAY   hsa00230(7498)  Purine metabolism\nhsa00232(7498)  Caffeine metabolism",
    "metabolism": "",
    "therapeutic_category": "3949",
    "atc_code": "",
    "drug_class": [
      "Cardiovascular agent",
      "Xanthine dehydrogenase inhibitor",
      "Musculo-skeletal system agent",
      "Xanthin oxidase inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Topiroxostat"
  },
  {
    "kegg_id": "D03341",
    "name_en": "Urokinase (JP18/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Abbokinase (TN)"
    ],
    "formula": "",
    "efficacy": "Thrombolytic, Fibrinolytic, Urokinase plasminogen activator (u-PA)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3954",
    "atc_code": "B01AD04",
    "drug_class": [
      "Blood modifier agent",
      "Antithrombotic agent",
      "Fibrinolytic",
      "Urokinase-type plasminogen activator"
    ],
    "cyp_enzymes": [],
    "search_name": "Urokinase"
  },
  {
    "kegg_id": "D03020",
    "name_en": "Imiglucerase (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Imiglucerase (genetical recombination) (JAN)",
      "Cerezyme (TN)"
    ],
    "formula": "C2532H3843N671O711S16",
    "efficacy": "Lysosomal storage disease treatment, Enzyme replacement (glucocerebrosidase)\nDISEASE   Gaucher disease [DS:H00126]\nTYPE      Enzyme replacement therapy product",
    "target": "GBA* [HSA_VAR:2629v1] [HSA:2629] [KO:K01201]\nPATHWAY   hsa00511(2629)  Other glycan degradation\nhsa00600(2629)  Sphingolipid metabolism\nhsa04142(2629)  Lysosome\nNETWORK   nt06014  Sphingolipid degradation",
    "metabolism": "",
    "therapeutic_category": "3959",
    "atc_code": "A16AB02",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Imiglucerase"
  },
  {
    "kegg_id": "D02784",
    "name_en": "Agalsidase alfa (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Agalsidase alfa (genetical recombination) (JAN)"
    ],
    "formula": "",
    "efficacy": "Lysosomal storage disease treatment, Enzyme replacement (alpha-galactosidase)\nDISEASE   Fabry disease [DS:H00125]\nTYPE      Enzyme replacement therapy product",
    "target": "GLA* [HSA_VAR:2717v1] [HSA:2717] [KO:K01189]\nPATHWAY   hsa00600(2717)  Sphingolipid metabolism\nhsa04142(2717)  Lysosome\nNETWORK   nt06014  Sphingolipid degradation",
    "metabolism": "",
    "therapeutic_category": "3959",
    "atc_code": "A16AB03",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Agalsidase alfa"
  },
  {
    "kegg_id": "D03228",
    "name_en": "Agalsidase beta (INN)",
    "name_ja": "",
    "names_alt": [
      "Agalsidase beta (genetical recombination) (JAN)",
      "Agalsidase beta (genetical recombination) [Agalsidase beta biosimilar 1] (JAN)",
      "Fabrazyme (TN)"
    ],
    "formula": "",
    "efficacy": "Lysosomal storage disease treatment, Enzyme replacement (alpha-galactosidase)\nDISEASE   Fabry disease [DS:H00125]\nTYPE      Enzyme replacement therapy product",
    "target": "GLA* [HSA_VAR:2717v1] [HSA:2717] [KO:K01189]\nPATHWAY   hsa00600(2717)  Sphingolipid metabolism\nhsa04142(2717)  Lysosome\nNETWORK   nt06014  Sphingolipid degradation",
    "metabolism": "",
    "therapeutic_category": "3959",
    "atc_code": "A16AB04",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Agalsidase beta"
  },
  {
    "kegg_id": "D04670",
    "name_en": "Laronidase (USAN)",
    "name_ja": "",
    "names_alt": [
      "Laronidase (genetical recombination) (JAN)",
      "Aldurazyme (TN)"
    ],
    "formula": "C3567H5645N921O1261S12P4",
    "efficacy": "Lysosomal storage disease treatment, Enzyme replacement (L-iduronidase)\nDISEASE   Mucopolysaccharidosis I [DS:H00128]\nTYPE      Enzyme replacement therapy product",
    "target": "IDUA* [HSA_VAR:3425v1] [HSA:3425] [KO:K01217]\nPATHWAY   hsa00531(3425)  Glycosaminoglycan degradation\nhsa04142(3425)  Lysosome\nNETWORK   nt06012  Glycosaminoglycan degradation",
    "metabolism": "",
    "therapeutic_category": "3959",
    "atc_code": "A16AB05",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Laronidase"
  },
  {
    "kegg_id": "D03207",
    "name_en": "Alglucosidase alfa (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Alglucosidase alfa (genetical recombination) (JAN)",
      "Lumizyme (TN)",
      "Myozyme (TN)"
    ],
    "formula": "C4758H7262N1274O1369S35",
    "efficacy": "Lysosomal storage disease treatment, Enzyme replacement (alpha-glucosidase)\nDISEASE   Pompe disease [DS:H01940]\nTYPE      Enzyme replacement therapy product",
    "target": "GAA* [HSA_VAR:2548v1] [HSA:2548] [KO:K12316]\nPATHWAY   hsa00052(2548)  Galactose metabolism\nhsa00500(2548)  Starch and sucrose metabolism\nhsa04142(2548)  Lysosome\nNETWORK   nt06017  Glycogen metabolism",
    "metabolism": "",
    "therapeutic_category": "3959",
    "atc_code": "A16AB07",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Alglucosidase alfa"
  },
  {
    "kegg_id": "D06565",
    "name_en": "Galsulfase (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Galsulfase (genetical recombination) (JAN)",
      "Aryplase (TN)"
    ],
    "formula": "C2529H3843N689O716S16",
    "efficacy": "Lysosomal storage disease treatment, Enzyme replacement (arylsulfatase B)\nDISEASE   Mucopolysaccharidosis VI; Maroteaux-Lamy syndrome [DS:H00131]\nTYPE      Enzyme replacement therapy product",
    "target": "ARSB* [HSA_VAR:411v1] [HSA:411] [KO:K01135]\nPATHWAY   hsa00531(411)  Glycosaminoglycan degradation\nhsa04142(411)  Lysosome\nNETWORK   nt06012  Glycosaminoglycan degradation",
    "metabolism": "",
    "therapeutic_category": "3959",
    "atc_code": "A16AB08",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Galsulfase"
  },
  {
    "kegg_id": "D04499",
    "name_en": "Idursulfase (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Idursulfase (genetical recombination) (JAN)",
      "Elaprase (TN)"
    ],
    "formula": "",
    "efficacy": "Lysosomal storage disease treatment, Enzyme replacement (iduronate-2-sulfatase)\nDISEASE   Hunter syndrome [DS:H00129]\nTYPE      Enzyme replacement therapy product",
    "target": "IDS* [HSA_VAR:3423v1] [HSA:3423] [KO:K01136]\nPATHWAY   hsa00531(3423)  Glycosaminoglycan degradation\nhsa04142(3423)  Lysosome\nNETWORK   nt06012  Glycosaminoglycan degradation",
    "metabolism": "",
    "therapeutic_category": "3959",
    "atc_code": "A16AB09",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Idursulfase"
  },
  {
    "kegg_id": "D09029",
    "name_en": "Velaglucerase alfa (USAN)",
    "name_ja": "",
    "names_alt": [
      "Velaglucerase alfa (genetical recombination) (JAN)",
      "Vpriv (TN)"
    ],
    "formula": "C2532H3854N672O711S16",
    "efficacy": "Lysosomal storage disease treatment, Enzyme replacement (glucocerebrosidase)\nDISEASE   Type 1 Gaucher disease [DS:H00126]\nTYPE      Enzyme replacement therapy product",
    "target": "GBA* [HSA_VAR:2629v1] [HSA:2629] [KO:K01201]\nPATHWAY   hsa00511(2629)  Other glycan degradation\nhsa00600(2629)  Sphingolipid metabolism\nhsa04142(2629)  Lysosome\nNETWORK   nt06014  Sphingolipid degradation",
    "metabolism": "",
    "therapeutic_category": "3959",
    "atc_code": "A16AB10",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Velaglucerase alfa"
  },
  {
    "kegg_id": "D10333",
    "name_en": "Elosulfase alfa (USAN)",
    "name_ja": "",
    "names_alt": [
      "Elosulfase alfa (genetical recombination) (JAN)",
      "Vimizim (TN)"
    ],
    "formula": "C5020H7572N1364O1420S32",
    "efficacy": "Lysosomal storage disease treatment, Enzyme replacement (N-acetylgalactosamine-6-sulfatase)\nDISEASE   Mucopolysaccharidosis type IVA [DS:H00123]\nTYPE      Enzyme replacement therapy product",
    "target": "GALNS* [HSA_VAR:2588v1] [HSA:2588] [KO:K01132]\nPATHWAY   hsa00531(2588)  Glycosaminoglycan degradation\nhsa04142(2588)  Lysosome\nNETWORK   nt06012  Glycosaminoglycan degradation",
    "metabolism": "",
    "therapeutic_category": "3959",
    "atc_code": "A16AB12",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Elosulfase alfa"
  },
  {
    "kegg_id": "D10595",
    "name_en": "Asfotase alfa (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Asfotase alfa (genetical recombination) (JAN)",
      "Strensiq (TN)"
    ],
    "formula": "C7108H11008N1968O2206S56 ",
    "efficacy": "Enzyme replacement (akaline phosphatase)\nDISEASE   Hypophosphatasia [DS:H00213]\nTYPE      Enzyme replacement therapy product",
    "target": "ALPL* [HSA_VAR:249v1] [HSA:249] [KO:K01077]\nPATHWAY   hsa00730(249)  Thiamine metabolism\nhsa00790(249)  Folate biosynthesis",
    "metabolism": "",
    "therapeutic_category": "3959",
    "atc_code": "A16AB13",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Asfotase alfa"
  },
  {
    "kegg_id": "D10377",
    "name_en": "Sebelipase alfa (USAN)",
    "name_ja": "",
    "names_alt": [
      "Sebelipase alfa (genetical recombination) (JAN)",
      "Kanuma (TN)"
    ],
    "formula": "C1968H2945N507O551S15",
    "efficacy": "Lysosomal storage disease treatment, Enzyme replacement (lysosomal acid lipase)\nDISEASE   Lysosomal acid lipase deficiency [DS:H00148]\nTYPE      Enzyme replacement therapy product",
    "target": "LIPA* [HSA_VAR:3988v1] [HSA:3988] [KO:K01052]\nPATHWAY   hsa00100(3988)  Steroid biosynthesis\nhsa04142(3988)  Lysosome\nhsa04979(3988)  Cholesterol metabolism\nNETWORK   nt06535  Efferocytosis",
    "metabolism": "",
    "therapeutic_category": "3959",
    "atc_code": "A16AB14",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Sebelipase alfa"
  },
  {
    "kegg_id": "D11025",
    "name_en": "Idursulfase beta (INN)",
    "name_ja": "",
    "names_alt": [
      "Idursulfase beta (genetical recombination) (JAN)",
      "Hunterase (TN)"
    ],
    "formula": "C2689H4051N699O793S13",
    "efficacy": "Lysosomal storage disease treatment, Enzyme replacement (iduronate-2-sulfatase)\nTYPE      Enzyme replacement therapy product",
    "target": "IDS* [HSA_VAR:3423v1] [HSA:3423] [KO:K01136]\nPATHWAY   hsa00531(3423)  Glycosaminoglycan degradation\nhsa04142(3423)  Lysosome\nNETWORK   nt06012  Glycosaminoglycan degradation",
    "metabolism": "",
    "therapeutic_category": "3959",
    "atc_code": "A16AB16",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Idursulfase beta"
  },
  {
    "kegg_id": "D10813",
    "name_en": "Cerliponase alfa (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Cerliponase alfa (genetical recombination) (JAN)",
      "Brineura (TN)"
    ],
    "formula": "",
    "efficacy": "Lysosomal storage disease treatment, Enzyme replacement (tripeptidyl peptidase)\nDISEASE   Neuronal ceroid lipofuscinosis type 2 [DS:H00149]\nTYPE      Enzyme replacement therapy product",
    "target": "TPP1* [HSA_VAR:1200v1] [HSA:1200] [KO:K01279]\nPATHWAY   hsa04142(1200)  Lysosome",
    "metabolism": "",
    "therapeutic_category": "3959",
    "atc_code": "A16AB17",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Cerliponase alfa"
  },
  {
    "kegg_id": "D11004",
    "name_en": "Vestronidase alfa (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Vestronidase alfa (genetical recombination) (JAN)",
      "Vestronidase alfa-vjbk",
      "MepseVII (TN)"
    ],
    "formula": "",
    "efficacy": "Lysosomal storage disease treatment, Enzyme replacement (beta-glucuronidase)\nDISEASE   Mucopolysaccharidosis VII; Sly syndrome [DS:H00132]\nTYPE      Enzyme replacement therapy product",
    "target": "GUSB* [HSA_VAR:2990v1] [HSA:2990] [KO:K01195]\nPATHWAY   hsa04142(2990)  Lysosome\nNETWORK   nt06012  Glycosaminoglycan degradation",
    "metabolism": "",
    "therapeutic_category": "3959",
    "atc_code": "A16AB18",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Vestronidase alfa"
  },
  {
    "kegg_id": "D11744",
    "name_en": "Avalglucosidase alfa (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Avalglucosidase alfa (genetical recombination) (JAN)",
      "Avalglucosidase alfa-ngpt",
      "Nexviazyme (TN)"
    ],
    "formula": "C4490H6818N1197O1299S32",
    "efficacy": "Enzyme replacement (alpha-glucosidase)\nDISEASE   Pompe disease [DS:H01940]\nTYPE      Enzyme replacement therapy product",
    "target": "GAA* [HSA_VAR:2548v1] [HSA:2548] [KO:K12316]\nPATHWAY   hsa00052(2548)  Galactose metabolism\nhsa00500(2548)  Starch and sucrose metabolism\nhsa04142(2548)  Lysosome\nNETWORK   nt06017  Glycogen metabolism",
    "metabolism": "",
    "therapeutic_category": "3959",
    "atc_code": "A16AB22",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Avalglucosidase alfa"
  },
  {
    "kegg_id": "D11798",
    "name_en": "Cipaglucosidase alfa (USAN)",
    "name_ja": "",
    "names_alt": [
      "Cipaglucosidase alfa (genetical recombination) (JAN)",
      "Cipaglucosidase alfa-atga",
      "Pombiliti (TN)"
    ],
    "formula": "C4489H6817N1197O1298S32",
    "efficacy": "Enzyme replacement (alpha-glucosidase)\nDISEASE   Pompe disease [DS:H01940]\nTYPE      Enzyme replacement therapy product",
    "target": "GAA* [HSA_VAR:2548v1] [HSA:2548] [KO:K12316]\nPATHWAY   hsa00052(2548)  Galactose metabolism\nhsa00500(2548)  Starch and sucrose metabolism\nhsa04142(2548)  Lysosome\nNETWORK   nt06017  Glycogen metabolism",
    "metabolism": "",
    "therapeutic_category": "3959",
    "atc_code": "A16AB23",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Cipaglucosidase alfa"
  },
  {
    "kegg_id": "D10820",
    "name_en": "Olipudase alfa (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Olipudase alfa (genetical recombination) (JAN)",
      "Olipudase alfa-rpcp",
      "Xenpozyme (TN)"
    ],
    "formula": "C2900H4373N783O791S24",
    "efficacy": "Lysosomal storage disease treatment, Enzyme replacement (acid sphingomyelinase)\nDISEASE   Acid sphingomyelinase deficiency [DS:H00137]\nTYPE      Enzyme replacement therapy product",
    "target": "SMPD1* [HSA_VAR:6609v1] [HSA:6609] [KO:K12350]\nPATHWAY   hsa00600(6609)  Sphingolipid metabolism\nhsa04071(6609)  Sphingolipid signaling pathway\nhsa04142(6609)  Lysosome\nNETWORK   nt06014  Sphingolipid degradation",
    "metabolism": "",
    "therapeutic_category": "3959",
    "atc_code": "A16AB25",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Olipudase alfa"
  },
  {
    "kegg_id": "D11812",
    "name_en": "Pabinafusp alfa (genetical recombination) (JAN)",
    "name_ja": "",
    "names_alt": [
      "Pabinafusp alfa (INN)",
      "Izcargo (TN)"
    ],
    "formula": "",
    "efficacy": "Inherited metabolic disorder therapeutic agent",
    "target": "IDS* [HSA_VAR:3423v1] [HSA:3423] [KO:K01136]\nTFRC (CD71) [HSA:7037] [KO:K06503]\nPATHWAY   hsa00531(3423)  Glycosaminoglycan degradation\nhsa04066(7037)  HIF-1 signaling pathway\nhsa04142(3423)  Lysosome\nhsa04144(7037)  Endocytosis\nhsa04145(7037)  Phagosome\nhsa04216(7037)  Ferroptosis\nhsa04640(7037)  Hematopoietic cell lineage\nNETWORK   nt06012  Glycosaminoglycan degradation",
    "metabolism": "",
    "therapeutic_category": "3959",
    "atc_code": "A16AB27",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Pabinafusp alfa"
  },
  {
    "kegg_id": "D02837",
    "name_en": "Alteplase (USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Alteplase (genetical recombination) (JAN)",
      "Activase (TN)",
      "Cathflo activase (TN)"
    ],
    "formula": "C2569H3894N746O781S40",
    "efficacy": "Thrombolytic, Tissue plasminogen activator (t-PA)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3959",
    "atc_code": "B01AD02",
    "drug_class": [
      "Blood modifier agent",
      "Antithrombotic agent",
      "Fibrinolytic",
      "Tissue plasminogen activator (t-PA)"
    ],
    "cyp_enzymes": [],
    "search_name": "Alteplase"
  },
  {
    "kegg_id": "D03352",
    "name_en": "Batroxobin (JAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Defibrase (TN)"
    ],
    "formula": "",
    "efficacy": "Antithrombotic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3959",
    "atc_code": "B02BX03",
    "drug_class": [
      "Blood modifier agent",
      "Antithrombotic agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Batroxobin"
  },
  {
    "kegg_id": "D03162",
    "name_en": "Bromelains (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Bromelain (JAN)",
      "Edemase D (TN)"
    ],
    "formula": "",
    "efficacy": "Anti-inflammatory",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3959",
    "atc_code": "D03BA03",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Bromelains"
  },
  {
    "kegg_id": "D11017",
    "name_en": "Elapegademase (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Elapegademase (genetical recombination) (JAN)",
      "Elapegademase-lvlr",
      "Revcovi (TN)"
    ],
    "formula": "",
    "efficacy": "Enzyme replacement (adenosine deaminase)\nDISEASE   Adenosine deaminase severe combined immune deficiency [DS:H02309]\nTYPE      Enzyme replacement therapy product",
    "target": "ADA* [HSA_VAR:100v1] [HSA:100] [KO:K01488]\nPATHWAY   hsa00230(100)  Purine metabolism\nhsa05340(100)  Primary immunodeficiency",
    "metabolism": "",
    "therapeutic_category": "3959",
    "atc_code": "L03AX21",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Elapegademase"
  },
  {
    "kegg_id": "D05704",
    "name_en": "Rasburicase (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Rasburicase (genetical recombination) (JAN)",
      "Elitek (TN)"
    ],
    "formula": "",
    "efficacy": "Uricolytic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3959",
    "atc_code": "V03AF07",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Rasburicase"
  },
  {
    "kegg_id": "D05412",
    "name_en": "Monteplase (INN)",
    "name_ja": "",
    "names_alt": [
      "Monteplase (genetical recombination) (JAN)",
      "Cleactor (TN)"
    ],
    "formula": "C2569H3896N746O783S39",
    "efficacy": "Thrombolytic, Tissue plasminogen activator (t-PA)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3959",
    "atc_code": "",
    "drug_class": [
      "Blood modifier agent",
      "Antithrombotic agent",
      "Fibrinolytic",
      "Tissue plasminogen activator (t-PA)"
    ],
    "cyp_enzymes": [],
    "search_name": "Monteplase"
  },
  {
    "kegg_id": "D00336",
    "name_en": "Glyburide (USP)",
    "name_ja": "",
    "names_alt": [
      "Glibenclamide (JP18/INN)",
      "Diabeta (TN)",
      "Glynase (TN)",
      "Micronase (TN)"
    ],
    "formula": "C23H28ClN3O5S",
    "efficacy": "Antidiabetic, Hypoglycemic\nDISEASE   Type 2 diabetes mellitus [DS:H00409]",
    "target": "ABCC8(SUR1)/KCNJ11(KIR6.2) [HSA:6833 3767] [KO:K05032 K05004]\nPATHWAY   hsa02010(6833)  ABC transporters\nhsa04911(3767+6833)  Insulin secretion\nhsa04930(3767+6833)  Type II diabetes mellitus",
    "metabolism": "Enzyme: CYP2C9 [HSA:1559], CYP3A4 [HSA:1576]",
    "therapeutic_category": "3961",
    "atc_code": "A10BB01",
    "drug_class": [
      "Antidiabetic agent",
      "Sulfonylurea receptor agonist",
      "Sulfonylurea",
      "Hypoglycemic agent",
      "Sulfonylurea",
      "Metabolizing enzyme substrate",
      "CYP2C9 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C9",
      "CYP3A4"
    ],
    "search_name": "Glyburide"
  },
  {
    "kegg_id": "D01599",
    "name_en": "Gliclazide (JP18/INN)",
    "name_ja": "",
    "names_alt": [
      "Glimicron (TN)"
    ],
    "formula": "C15H21N3O3S",
    "efficacy": "Antidiabetic, Hypoglycemic, Sulfonylurea receptor agonist",
    "target": "ABCC8 (SUR1) [HSA:6833] [KO:K05032]\nPATHWAY   hsa02010(6833)  ABC transporters\nhsa04911(6833)  Insulin secretion\nhsa04930(6833)  Type II diabetes mellitus",
    "metabolism": "",
    "therapeutic_category": "3961",
    "atc_code": "A10BB09",
    "drug_class": [
      "Antidiabetic agent",
      "Sulfonylurea receptor agonist",
      "Sulfonylurea",
      "Hypoglycemic agent",
      "Sulfonylurea"
    ],
    "cyp_enzymes": [],
    "search_name": "Gliclazide"
  },
  {
    "kegg_id": "D00593",
    "name_en": "Glimepiride (JP18/USP/INN)",
    "name_ja": "グリメピリド",
    "names_alt": [
      "Amaryl (TN)"
    ],
    "formula": "C24H34N4O5S",
    "efficacy": "Antidiabetic, Hypoglycemic, Sulfonylurea receptor agonist\nDISEASE   Type 2 diabetes mellitus [DS:H00409]",
    "target": "ABCC8 (SUR1) [HSA:6833] [KO:K05032]\nPATHWAY   hsa02010(6833)  ABC transporters\nhsa04911(6833)  Insulin secretion\nhsa04930(6833)  Type II diabetes mellitus",
    "metabolism": "Enzyme: CYP2C9 [HSA:1559]",
    "therapeutic_category": "3961",
    "atc_code": "A10BB12",
    "drug_class": [
      "Antidiabetic agent",
      "Sulfonylurea receptor agonist",
      "Sulfonylurea",
      "Hypoglycemic agent",
      "Sulfonylurea",
      "Metabolizing enzyme substrate",
      "CYP2C9 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C9"
    ],
    "search_name": "Glimepiride"
  },
  {
    "kegg_id": "D00219",
    "name_en": "Acetohexamide (JP18/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Dymelor (TN)"
    ],
    "formula": "C15H20N2O4S",
    "efficacy": "Antidiabetic, Hypoglycemic, Sulfonylurea receptor agonist",
    "target": "ABCC8 (SUR1) [HSA:6833] [KO:K05032]\nPATHWAY   hsa02010(6833)  ABC transporters\nhsa04911(6833)  Insulin secretion\nhsa04930(6833)  Type II diabetes mellitus",
    "metabolism": "",
    "therapeutic_category": "3961",
    "atc_code": "A10BB31",
    "drug_class": [
      "Antidiabetic agent",
      "Sulfonylurea receptor agonist",
      "Sulfonylurea",
      "Hypoglycemic agent",
      "Sulfonylurea"
    ],
    "cyp_enzymes": [],
    "search_name": "Acetohexamide"
  },
  {
    "kegg_id": "D01799",
    "name_en": "Glyclopyramide (JAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Deamelin-S (TN)"
    ],
    "formula": "C11H14ClN3O3S",
    "efficacy": "Antidiabetic, Hypoglycemic, Sulfonylurea receptor agonist",
    "target": "ABCC8 (SUR1) [HSA:6833] [KO:K05032]\nPATHWAY   hsa02010(6833)  ABC transporters\nhsa04911(6833)  Insulin secretion\nhsa04930(6833)  Type II diabetes mellitus",
    "metabolism": "",
    "therapeutic_category": "3961",
    "atc_code": "",
    "drug_class": [
      "Antidiabetic agent",
      "Sulfonylurea receptor agonist",
      "Sulfonylurea",
      "Hypoglycemic agent",
      "Sulfonylurea"
    ],
    "cyp_enzymes": [],
    "search_name": "Glyclopyramide"
  },
  {
    "kegg_id": "D00944",
    "name_en": "Metformin hydrochloride (JP18/USP)",
    "name_ja": "メトホルミン",
    "names_alt": [
      "Glucophage (TN)"
    ],
    "formula": "C4H11N5. HCl",
    "efficacy": "Antidiabetic, Hypoglycemic, AMP kinase activator\nDISEASE   Type 2 diabetes mellitus [DS:H00409]",
    "target": "AMPK (PRKAA) [HSA:5562 5563] [KO:K07198]\nPATHWAY   hsa04152(5562+5563)  AMPK signaling pathway\nhsa04910(5562+5563)  Insulin signaling pathway\nhsa04920(5562+5563)  Adipocytokine signaling pathway",
    "metabolism": "",
    "therapeutic_category": "3962",
    "atc_code": "A10BA02",
    "drug_class": [
      "Antidiabetic agent",
      "Insulin sensitizer",
      "Biguanide antidiabetic",
      "Hypoglycemic agent",
      "Biguanide antidiabetic"
    ],
    "cyp_enzymes": [],
    "search_name": "Metformin hydrochloride"
  },
  {
    "kegg_id": "D02206",
    "name_en": "Buformin hydrochloride (JP18)",
    "name_ja": "",
    "names_alt": [
      "Dibetos-B (TN)"
    ],
    "formula": "C6H15N5. HCl",
    "efficacy": "Antidiabetic, Hypoglycemic",
    "target": "AMPK (PRKAA) [HSA:5562 5563] [KO:K07198]\nPATHWAY   hsa04152(5562+5563)  AMPK signaling pathway\nhsa04910(5562+5563)  Insulin signaling pathway\nhsa04920(5562+5563)  Adipocytokine signaling pathway",
    "metabolism": "",
    "therapeutic_category": "3962",
    "atc_code": "A10BA03",
    "drug_class": [
      "Antidiabetic agent",
      "Insulin sensitizer",
      "Biguanide antidiabetic",
      "Hypoglycemic agent",
      "Biguanide antidiabetic"
    ],
    "cyp_enzymes": [],
    "search_name": "Buformin hydrochloride"
  },
  {
    "kegg_id": "D11034",
    "name_en": "Insulin glargine and lixisenatide",
    "name_ja": "インスリン",
    "names_alt": [
      "Insulin glargine (genetical recombination) and lixisenatide",
      "Soliqua (TN)"
    ],
    "formula": "",
    "efficacy": "Antidiabetic\nDISEASE   Type 2 diabetes mellitus [DS:H00409]",
    "target": "INSR (CD220) [HSA:3643] [KO:K04527]\nGLP1R [HSA:2740] [KO:K04581]\nPATHWAY   hsa04910(3643)  Insulin signaling pathway\nhsa04911(2740)  Insulin secretion\nhsa04930(3643)  Type II diabetes mellitus\nhsa04931(3643)  Insulin resistance",
    "metabolism": "",
    "therapeutic_category": "3969",
    "atc_code": "A10AE54",
    "drug_class": [
      "Antidiabetic agent",
      "Insulin preparation",
      "Combination of insulin analog and GLP-1 receptor agonist"
    ],
    "cyp_enzymes": [],
    "search_name": "Insulin glargine and lixisenatide"
  },
  {
    "kegg_id": "D11567",
    "name_en": "Insulin degludec and liraglutide",
    "name_ja": "インスリン",
    "names_alt": [
      "Xultophy (TN)"
    ],
    "formula": "",
    "efficacy": "Antidiabetic\nDISEASE   Type 2 diabetes mellitus [DS:H00409]",
    "target": "INSR (CD220) [HSA:3643] [KO:K04527]\nGLP1R [HSA:2740] [KO:K04581]\nPATHWAY   hsa04910(3643)  Insulin signaling pathway\nhsa04911(2740)  Insulin secretion\nhsa04930(3643)  Type II diabetes mellitus\nhsa04931(3643)  Insulin resistance",
    "metabolism": "",
    "therapeutic_category": "3969",
    "atc_code": "A10AE56",
    "drug_class": [
      "Antidiabetic agent",
      "Insulin preparation",
      "Combination of insulin analog and GLP-1 receptor agonist"
    ],
    "cyp_enzymes": [],
    "search_name": "Insulin degludec and liraglutide"
  },
  {
    "kegg_id": "D09744",
    "name_en": "Pioglitazone hydrochloride and metformin hydrochloride (JP18)",
    "name_ja": "ピオグリタゾン",
    "names_alt": [
      "Pioglitazone and metformin",
      "Metact (TN)"
    ],
    "formula": "",
    "efficacy": "Antidiabetic\nDISEASE   Type 2 diabetes mellitus [DS:H00409]",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3969",
    "atc_code": "A10BD05",
    "drug_class": [
      "Antidiabetic agent",
      "Hypoglycemic agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Pioglitazone hydrochloride and metformin hydrochloride"
  },
  {
    "kegg_id": "D09848",
    "name_en": "Pioglitazone hydrochloride and glimepiride tablets (JP18)",
    "name_ja": "ピオグリタゾン",
    "names_alt": [
      "Pioglitazone and glimepiride",
      "Duetact (TN)",
      "Sonias (TN)"
    ],
    "formula": "",
    "efficacy": "Antidiabetic\nDISEASE   Type 2 diabetes mellitus [DS:H00409]",
    "target": "",
    "metabolism": "Enzyme: CYP2C8 [HSA:1558], CYP2C9 [HSA:1559]",
    "therapeutic_category": "3969",
    "atc_code": "A10BD06",
    "drug_class": [
      "Antidiabetic agent",
      "Hypoglycemic agent",
      "Metabolizing enzyme substrate",
      "CYP2C8 substrate",
      "CYP2C9 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C9",
      "CYP2C8"
    ],
    "search_name": "Pioglitazone hydrochloride and glimepiride tablets"
  },
  {
    "kegg_id": "D10743",
    "name_en": "Vildagliptin and metformin hydrochloride",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Antidiabetic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3969",
    "atc_code": "A10BD08",
    "drug_class": [
      "Antidiabetic agent",
      "Hypoglycemic agent",
      "Combination of metformin and DPP-4 inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Vildagliptin and metformin hydrochloride"
  },
  {
    "kegg_id": "D10159",
    "name_en": "Alogliptin benzoate and pioglitazone hydrochloride",
    "name_ja": "",
    "names_alt": [
      "Liovel (TN)",
      "Oseni (TN)",
      "Incresync (TN)"
    ],
    "formula": "",
    "efficacy": "Antidiabetic\nDISEASE   Type 2 diabetes mellitus [DS:H00409]",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3969",
    "atc_code": "A10BD09",
    "drug_class": [
      "Antidiabetic agent",
      "Hypoglycemic agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Alogliptin benzoate and pioglitazone hydrochloride"
  },
  {
    "kegg_id": "D10253",
    "name_en": "Alogliptin benzoate and metformin hydrochloride",
    "name_ja": "",
    "names_alt": [
      "Kazano (TN)",
      "Vipdomet (TN)"
    ],
    "formula": "",
    "efficacy": "Antidiabetic\nDISEASE   Type 2 diabetes mellitus [DS:H00409]",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3969",
    "atc_code": "A10BD13",
    "drug_class": [
      "Antidiabetic agent",
      "Hypoglycemic agent",
      "Combination of metformin and DPP-4 inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Alogliptin benzoate and metformin hydrochloride"
  },
  {
    "kegg_id": "D10588",
    "name_en": "Empagliflozin and linagliptin",
    "name_ja": "",
    "names_alt": [
      "Glyxambi (TN)"
    ],
    "formula": "",
    "efficacy": "Antidiabetic\nDISEASE   Type 2 diabetes mellitus [DS:H00409]",
    "target": "",
    "metabolism": "Transporter: ABCB1 [HSA:5243], ABCG2 [HSA:9429]",
    "therapeutic_category": "3969",
    "atc_code": "A10BD19",
    "drug_class": [
      "Antidiabetic agent",
      "Hypoglycemic agent",
      "Combination of DPP-4 inhibitor and SGLT2 inhibitor",
      "Transporter substrate",
      "ABCB1 substrate",
      "ABCG2 substrate"
    ],
    "cyp_enzymes": [],
    "search_name": "Empagliflozin and linagliptin"
  },
  {
    "kegg_id": "D00216",
    "name_en": "Acarbose (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Precose (TN)"
    ],
    "formula": "C25H43NO18",
    "efficacy": "Antidiabetic, alpha-Glucosidase inhibitor\nDISEASE   Type 2 diabetes mellitus [DS:H00409]",
    "target": "GAA [HSA:2548] [KO:K12316]\nGANC [HSA:2595] [KO:K12317]\nMGAM [HSA:8972] [KO:K12047]\nAMY [HSA:279 280] [KO:K01176]\nPATHWAY   hsa00052(2548+2595+8972)  Galactose metabolism\nhsa00500(2548+2595+279+280+8972)  Starch and sucrose metabolism\nhsa04972(279+280)  Pancreatic secretion\nhsa04973(279+280+8972)  Carbohydrate digestion and absorption",
    "metabolism": "",
    "therapeutic_category": "3969",
    "atc_code": "A10BF01",
    "drug_class": [
      "Antidiabetic agent",
      "Hypoglycemic agent",
      "alpha-Glucosidase inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Acarbose"
  },
  {
    "kegg_id": "D00625",
    "name_en": "Miglitol (JP18/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Glyset (TN)"
    ],
    "formula": "C8H17NO5",
    "efficacy": "Antidiabetic, alpha-Glucosidase inhibitor\nDISEASE   Type 2 diabetes mellitus [DS:H00409]",
    "target": "GAA [HSA:2548] [KO:K12316]\nGANC [HSA:2595] [KO:K12317]\nMGAM [HSA:8972] [KO:K12047]\nPATHWAY   hsa00052(2548+2595+8972)  Galactose metabolism\nhsa00500(2548+2595+8972)  Starch and sucrose metabolism\nhsa04973(8972)  Carbohydrate digestion and absorption",
    "metabolism": "",
    "therapeutic_category": "3969",
    "atc_code": "A10BF02",
    "drug_class": [
      "Antidiabetic agent",
      "Hypoglycemic agent",
      "alpha-Glucosidase inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Miglitol"
  },
  {
    "kegg_id": "D01665",
    "name_en": "Voglibose (JP18/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Basen (TN)"
    ],
    "formula": "C10H21NO7",
    "efficacy": "Antidiabetic, alpha-Glucosidase inhibitor",
    "target": "GAA [HSA:2548] [KO:K12316]\nGANC [HSA:2595] [KO:K12317]\nMGAM [HSA:8972] [KO:K12047]\nPATHWAY   hsa00052(2548+2595+8972)  Galactose metabolism\nhsa00500(2548+2595+8972)  Starch and sucrose metabolism\nhsa04973(8972)  Carbohydrate digestion and absorption",
    "metabolism": "",
    "therapeutic_category": "3969",
    "atc_code": "A10BF03",
    "drug_class": [
      "Antidiabetic agent",
      "Hypoglycemic agent",
      "alpha-Glucosidase inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Voglibose"
  },
  {
    "kegg_id": "D00945",
    "name_en": "Pioglitazone hydrochloride (JP18/USP)",
    "name_ja": "ピオグリタゾン",
    "names_alt": [
      "Actos (TN)"
    ],
    "formula": "C19H20N2O3S. HCl",
    "efficacy": "Antidiabetic, Peroxisome proliferator-activated receptor (PPAR) gamma agonist\nDISEASE   Type 2 diabetes mellitus [DS:H00409]",
    "target": "NR1C3 (PPARG) [HSA:5468] [KO:K08530]\nPATHWAY   hsa03320(5468)  PPAR signaling pathway\nhsa04152(5468)  AMPK signaling pathway",
    "metabolism": "Enzyme: CYP2C8 [HSA:1558]",
    "therapeutic_category": "3969",
    "atc_code": "A10BG03",
    "drug_class": [
      "Antidiabetic agent",
      "Insulin sensitizer",
      "PPAR gamma agonist",
      "Thiazolidinedione type PPAR agonist",
      "Hypoglycemic agent",
      "Thiazolidinedione type PPAR agonist",
      "Metabolizing enzyme substrate",
      "CYP2C8 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C8"
    ],
    "search_name": "Pioglitazone hydrochloride"
  },
  {
    "kegg_id": "D06645",
    "name_en": "Sitagliptin phosphate (USAN)",
    "name_ja": "シタグリプチン",
    "names_alt": [
      "Sitagliptin phosphate hydrate (JP18)",
      "Sitagliptin phosphate monohydrate",
      "Januvia (TN)"
    ],
    "formula": "C16H15F6N5O. H3PO4. H2O",
    "efficacy": "Antidiabetic, Dipeptidyl peptidase-4 (DPP-4) inhibitor\nDISEASE   Type 2 diabetes mellitus [DS:H00409]",
    "target": "DPP4 (CD26) [HSA:1803] [KO:K01278]\nPATHWAY   hsa04974(1803)  Protein digestion and absorption",
    "metabolism": "",
    "therapeutic_category": "3969",
    "atc_code": "A10BH01",
    "drug_class": [
      "Antidiabetic agent",
      "Hypoglycemic agent",
      "DPP-4 inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Sitagliptin phosphate"
  },
  {
    "kegg_id": "D07080",
    "name_en": "Vildagliptin (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Equa (TN)",
      "Galvus (TN)"
    ],
    "formula": "C17H25N3O2",
    "efficacy": "Antidiabetic, Dipeptidyl peptidase-4 (DPP-4) inhibitor",
    "target": "DPP4 (CD26) [HSA:1803] [KO:K01278]\nPATHWAY   hsa04974(1803)  Protein digestion and absorption",
    "metabolism": "",
    "therapeutic_category": "3969",
    "atc_code": "A10BH02",
    "drug_class": [
      "Antidiabetic agent",
      "Hypoglycemic agent",
      "DPP-4 inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Vildagliptin"
  },
  {
    "kegg_id": "D09753",
    "name_en": "Saxagliptin hydrate (JAN)",
    "name_ja": "",
    "names_alt": [
      "Onglyza (TN)"
    ],
    "formula": "C18H25N3O2. H2O",
    "efficacy": "Antidiabetic, Dipeptidyl peptidase-4 (DPP-4) inhibitor",
    "target": "DPP4 (CD26) [HSA:1803] [KO:K01278]\nPATHWAY   hsa04974(1803)  Protein digestion and absorption",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576], CYP3A5 [HSA:1577]",
    "therapeutic_category": "3969",
    "atc_code": "A10BH03",
    "drug_class": [
      "Antidiabetic agent",
      "Hypoglycemic agent",
      "DPP-4 inhibitor",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "CYP3A5 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4",
      "CYP3A5"
    ],
    "search_name": "Saxagliptin hydrate"
  },
  {
    "kegg_id": "D06553",
    "name_en": "Alogliptin benzoate (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Vipidia (TN)",
      "Nesina (TN)"
    ],
    "formula": "C18H21N5O2. C7H6O2",
    "efficacy": "Antidiabetic, Dipeptidyl peptidase-4 (DPP-4) inhibitor\nDISEASE   Type 2 diabetes mellitus [DS:H00409]",
    "target": "DPP4 (CD26) [HSA:1803] [KO:K01278]\nPATHWAY   hsa04974(1803)  Protein digestion and absorption",
    "metabolism": "",
    "therapeutic_category": "3969",
    "atc_code": "A10BH04",
    "drug_class": [
      "Antidiabetic agent",
      "Hypoglycemic agent",
      "DPP-4 inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Alogliptin benzoate"
  },
  {
    "kegg_id": "D09566",
    "name_en": "Linagliptin (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Tradjenta (TN)"
    ],
    "formula": "C25H28N8O2",
    "efficacy": "Antidiabetic, Dipeptidyl peptidase-4 (DPP-4) inhibitor\nDISEASE   Type 2 diabetes mellitus [DS:H00409]",
    "target": "DPP4 (CD26) [HSA:1803] [KO:K01278]\nPATHWAY   hsa04974(1803)  Protein digestion and absorption",
    "metabolism": "",
    "therapeutic_category": "3969",
    "atc_code": "A10BH05",
    "drug_class": [
      "Antidiabetic agent",
      "Hypoglycemic agent",
      "DPP-4 inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Linagliptin"
  },
  {
    "kegg_id": "D09756",
    "name_en": "Teneligliptin hydrobromide hydrate (JAN)",
    "name_ja": "",
    "names_alt": [],
    "formula": "(C22H30N6OS)2. 5HBr. xH2O",
    "efficacy": "Antidiabetic, Dipeptidyl peptidase-4 (DPP-4) inhibitor\nDISEASE   Type 2 diabetes mellitus [DS:H00409]",
    "target": "DPP4 (CD26) [HSA:1803] [KO:K01278]\nPATHWAY   hsa04974(1803)  Protein digestion and absorption",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576], FMO1 [HSA:2326], FMO3 [HSA:2328]",
    "therapeutic_category": "3969",
    "atc_code": "A10BH08",
    "drug_class": [
      "Antidiabetic agent",
      "Hypoglycemic agent",
      "DPP-4 inhibitor",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "FMO substrate",
      "FMO1 substrate",
      "FMO3 substrate",
      "Metabolizing enzyme inhibitor",
      "CYP2D6 inhibitor",
      "CYP3A/CYP3A4 inhibitor",
      "CYP3A4 inhibitor",
      "FMO inhibitor"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Teneligliptin hydrobromide hydrate"
  },
  {
    "kegg_id": "D08897",
    "name_en": "Dapagliflozin (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Forxiga (TN)"
    ],
    "formula": "C21H25ClO6",
    "efficacy": "Antidiabetic, SGLT-2 inhibitor",
    "target": "SLC5A2 (SGLT2) [HSA:6524] [KO:K14382]",
    "metabolism": "Enzyme: UGT1A9 [HSA:54600]",
    "therapeutic_category": "3969",
    "atc_code": "A10BK01",
    "drug_class": [
      "Antidiabetic agent",
      "Hypoglycemic agent",
      "SGLT2 inhibitor",
      "Metabolizing enzyme substrate",
      "UGT substrate",
      "UGT1A9 substrate"
    ],
    "cyp_enzymes": [],
    "search_name": "Dapagliflozin"
  },
  {
    "kegg_id": "D09592",
    "name_en": "Canagliflozin (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Canagliflozin hydrate (JAN)",
      "Invokana (TN)"
    ],
    "formula": "(C24H25FO5S)2. H2O",
    "efficacy": "Antidiabetic, SGLT-2 inhibitor\nDISEASE   Type 2 diabetes mellitus [DS:H00409]",
    "target": "SLC5A2 (SGLT2) [HSA:6524] [KO:K14382]",
    "metabolism": "Enzyme: UGT1A9 [HSA:54600], UGT2B4 [HSA:7363]\nTransporter: ABCB1 [HSA:5243]",
    "therapeutic_category": "3969",
    "atc_code": "A10BK02",
    "drug_class": [
      "Antidiabetic agent",
      "Hypoglycemic agent",
      "SGLT2 inhibitor",
      "Metabolizing enzyme substrate",
      "UGT substrate",
      "UGT1A9 substrate",
      "UGT2B4 substrate",
      "Transporter substrate",
      "ABCB1 substrate",
      "Transporter inhibitor",
      "ABCB1 inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Canagliflozin"
  },
  {
    "kegg_id": "D10200",
    "name_en": "Ipragliflozin L-proline (JAN)",
    "name_ja": "",
    "names_alt": [
      "Suglat (TN)"
    ],
    "formula": "C21H21FO5S. C5H9NO2",
    "efficacy": "Antidiabetic, SGLT-2 inhibitor",
    "target": "SLC5A2 (SGLT2) [HSA:6524] [KO:K14382]",
    "metabolism": "Enzyme: UGT2B7 [HSA:7364]",
    "therapeutic_category": "3969",
    "atc_code": "A10BK05",
    "drug_class": [
      "Antidiabetic agent",
      "Hypoglycemic agent",
      "SGLT2 inhibitor",
      "Metabolizing enzyme substrate",
      "UGT substrate",
      "UGT2B7 substrate"
    ],
    "cyp_enzymes": [],
    "search_name": "Ipragliflozin L-proline"
  },
  {
    "kegg_id": "D10195",
    "name_en": "Luseogliflozin hydrate (JAN)",
    "name_ja": "",
    "names_alt": [
      "Lusefi (TN)"
    ],
    "formula": "C23H30O6S. xH2O",
    "efficacy": "Antidiabetic, SGLT-2 inhibitor",
    "target": "SLC5A2 (SGLT2) [HSA:6524] [KO:K14382]",
    "metabolism": "",
    "therapeutic_category": "3969",
    "atc_code": "A10BK07",
    "drug_class": [
      "Antidiabetic agent",
      "Hypoglycemic agent",
      "SGLT2 inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Luseogliflozin hydrate"
  },
  {
    "kegg_id": "D00594",
    "name_en": "Repaglinide (JAN/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Prandin (TN)",
      "Surepost (TN)"
    ],
    "formula": "C27H36N2O4",
    "efficacy": "Antidiabetic, Hypoglycemic, Sulfonylurea receptor agonist\nDISEASE   Type 2 diabetes mellitus [DS:H00409]",
    "target": "ABCC8(SUR1)/KCNJ11(KIR6.2) [HSA:6833 3767] [KO:K05032 K05004]\nPATHWAY   hsa02010(6833)  ABC transporters\nhsa04911(3767+6833)  Insulin secretion\nhsa04930(3767+6833)  Type II diabetes mellitus",
    "metabolism": "Enzyme: CYP2C8 [HSA:1558]; CYP3A4 [HSA:1576]",
    "therapeutic_category": "3969",
    "atc_code": "A10BX02",
    "drug_class": [
      "Antidiabetic agent",
      "Sulfonylurea receptor agonist",
      "Glinide",
      "Hypoglycemic agent",
      "Glinide",
      "Metabolizing enzyme substrate",
      "CYP2C8 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C8",
      "CYP3A4"
    ],
    "search_name": "Repaglinide"
  },
  {
    "kegg_id": "D01111",
    "name_en": "Nateglinide (JP18/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Starsis (TN)"
    ],
    "formula": "C19H27NO3",
    "efficacy": "Antidiabetic, Hypoglycemic, Sulfonylurea receptor agonist\nDISEASE   Type 2 diabetes mellitus [DS:H00409]",
    "target": "ABCC8(SUR1)/KCNJ11(KIR6.2) [HSA:6833 3767] [KO:K05032 K05004]\nPATHWAY   hsa02010(6833)  ABC transporters\nhsa04911(3767+6833)  Insulin secretion\nhsa04930(3767+6833)  Type II diabetes mellitus",
    "metabolism": "Enzyme: CYP2C9 [HSA:1559]",
    "therapeutic_category": "3969",
    "atc_code": "A10BX03",
    "drug_class": [
      "Antidiabetic agent",
      "Sulfonylurea receptor agonist",
      "Glinide",
      "Hypoglycemic agent",
      "Glinide",
      "Metabolizing enzyme substrate",
      "CYP2C9 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C9"
    ],
    "search_name": "Nateglinide"
  },
  {
    "kegg_id": "D01854",
    "name_en": "Mitiglinide calcium hydrate (JP18)",
    "name_ja": "",
    "names_alt": [
      "Mitiglinide calcium dihydrate",
      "Glufast (TN)"
    ],
    "formula": "(C19H24NO3)2. 2H2O. Ca",
    "efficacy": "Antidiabetic, Hypoglycemic, Sulfonylurea receptor agonist",
    "target": "ABCC8(SUR1)/KCNJ11(KIR6.2) [HSA:6833 3767] [KO:K05032 K05004]\nPATHWAY   hsa02010(6833)  ABC transporters\nhsa04911(3767+6833)  Insulin secretion\nhsa04930(3767+6833)  Type II diabetes mellitus",
    "metabolism": "Enzyme: UGT [KO:K00699]",
    "therapeutic_category": "3969",
    "atc_code": "A10BX08",
    "drug_class": [
      "Antidiabetic agent",
      "Sulfonylurea receptor agonist",
      "Glinide",
      "Hypoglycemic agent",
      "Glinide",
      "Metabolizing enzyme substrate",
      "UGT substrate"
    ],
    "cyp_enzymes": [],
    "search_name": "Mitiglinide calcium hydrate"
  },
  {
    "kegg_id": "D11807",
    "name_en": "Imeglimin hydrochloride (JAN)",
    "name_ja": "",
    "names_alt": [
      "Twymeeg (TN)"
    ],
    "formula": "C6H13N5. HCl",
    "efficacy": "Antidiabetic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3969",
    "atc_code": "A10BX15",
    "drug_class": [
      "Antidiabetic agent",
      "Hypoglycemic agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Imeglimin hydrochloride"
  },
  {
    "kegg_id": "D09780",
    "name_en": "Anagliptin (JAN/INN)",
    "name_ja": "",
    "names_alt": [],
    "formula": "C19H25N7O2",
    "efficacy": "Antidiabetic, Dipeptidyl peptidase-4 (DPP-4) inhibitor\nDISEASE   Type 2 diabetes mellitus [DS:H00409]",
    "target": "DPP4 (CD26) [HSA:1803] [KO:K01278]\nPATHWAY   hsa04974(1803)  Protein digestion and absorption",
    "metabolism": "",
    "therapeutic_category": "3969",
    "atc_code": "",
    "drug_class": [
      "Antidiabetic agent",
      "Hypoglycemic agent",
      "DPP-4 inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Anagliptin"
  },
  {
    "kegg_id": "D09978",
    "name_en": "Tofogliflozin (USAN)",
    "name_ja": "",
    "names_alt": [
      "Tofogliflozin hydrate (JAN)",
      "Apleway (TN)",
      "Deberza (TN)"
    ],
    "formula": "C22H26O6. H2O",
    "efficacy": "Antidiabetic, SGLT-2 inhibitor",
    "target": "SLC5A2 (SGLT2) [HSA:6524] [KO:K14382]",
    "metabolism": "Enzyme: CYP2C18 [HSA:1562], CYP4A11 [HSA:1579], CYP4F3 [HSA:4051]",
    "therapeutic_category": "3969",
    "atc_code": "",
    "drug_class": [
      "Antidiabetic agent",
      "Hypoglycemic agent",
      "SGLT2 inhibitor",
      "Metabolizing enzyme substrate",
      "CYP2C18 substrate",
      "CYP4A11 substrate",
      "CYP4F3 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C18",
      "CYP4A11",
      "CYP4F3"
    ],
    "search_name": "Tofogliflozin"
  },
  {
    "kegg_id": "D10160",
    "name_en": "Mitiglinide calcium hydrate and voglibose",
    "name_ja": "",
    "names_alt": [
      "Glubes (TN)"
    ],
    "formula": "",
    "efficacy": "Antidiabetic\nDISEASE   Type 2 diabetes mellitus [DS:H00409]",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3969",
    "atc_code": "",
    "drug_class": [
      "Antidiabetic agent",
      "Hypoglycemic agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Mitiglinide calcium hydrate and voglibose"
  },
  {
    "kegg_id": "D10179",
    "name_en": "Trelagliptin succinate (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Zafatek (TN)"
    ],
    "formula": "C18H20FN5O2. C4H6O4",
    "efficacy": "Antidiabetic, Dipeptidyl peptidase-4 (DPP-4) inhibitor\nDISEASE   Type 2 diabetes mellitus [DS:H00409]",
    "target": "DPP4 (CD26) [HSA:1803] [KO:K01278]\nPATHWAY   hsa04974(1803)  Protein digestion and absorption",
    "metabolism": "Enzyme: CYP2D6 [HSA:1565]",
    "therapeutic_category": "3969",
    "atc_code": "",
    "drug_class": [
      "Antidiabetic agent",
      "Hypoglycemic agent",
      "DPP-4 inhibitor",
      "Metabolizing enzyme substrate",
      "CYP2D6 substrate"
    ],
    "cyp_enzymes": [
      "CYP2D6"
    ],
    "search_name": "Trelagliptin succinate"
  },
  {
    "kegg_id": "D10317",
    "name_en": "Omarigliptin (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [],
    "formula": "C17H20F2N4O3S",
    "efficacy": "Antidiabetic, Dipeptidyl peptidase-4 (DPP-4) inhibitor\nDISEASE   Type 2 diabetes mellitus [DS:H00409]",
    "target": "DPP4 (CD26) [HSA:1803] [KO:K01278]\nPATHWAY   hsa04974(1803)  Protein digestion and absorption",
    "metabolism": "",
    "therapeutic_category": "3969",
    "atc_code": "",
    "drug_class": [
      "Antidiabetic agent",
      "Hypoglycemic agent",
      "DPP-4 inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Omarigliptin"
  },
  {
    "kegg_id": "D10897",
    "name_en": "Teneligliptin and canagliflozin",
    "name_ja": "",
    "names_alt": [
      "Teneligliptin and canagliflozin",
      "Canalia (TN)"
    ],
    "formula": "",
    "efficacy": "Antidiabetic",
    "target": "",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576], FMO1 [HSA:2326], FMO3 [HSA:2328], UGT1A9 [HSA:54600], UGT2B4 [HSA:7363]\nTransporter: ABCB1 [HSA:5243]",
    "therapeutic_category": "3969",
    "atc_code": "",
    "drug_class": [
      "Antidiabetic agent",
      "Hypoglycemic agent",
      "Combination of DPP-4 inhibitor and SGLT2 inhibitor",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "FMO substrate",
      "FMO1 substrate",
      "FMO3 substrate",
      "UGT substrate",
      "UGT1A9 substrate",
      "UGT2B4 substrate",
      "Transporter substrate",
      "ABCB1 substrate",
      "Transporter inhibitor",
      "ABCB1 inhibitor"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Teneligliptin and canagliflozin"
  },
  {
    "kegg_id": "D11064",
    "name_en": "Sitagliptin and ipragliflozin",
    "name_ja": "シタグリプチン",
    "names_alt": [
      "Sujanu (TN)"
    ],
    "formula": "",
    "efficacy": "Antidiabetic",
    "target": "",
    "metabolism": "Enzyme: UGT2B7 [HSA:7364]",
    "therapeutic_category": "3969",
    "atc_code": "",
    "drug_class": [
      "Antidiabetic agent",
      "Hypoglycemic agent",
      "Combination of DPP-4 inhibitor and SGLT2 inhibitor",
      "Metabolizing enzyme substrate",
      "UGT substrate",
      "UGT2B7 substrate"
    ],
    "cyp_enzymes": [],
    "search_name": "Sitagliptin and ipragliflozin"
  },
  {
    "kegg_id": "D11109",
    "name_en": "Anagliptin and Metformin hydrochloride",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Antidiabetic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3969",
    "atc_code": "",
    "drug_class": [
      "Antidiabetic agent",
      "Hypoglycemic agent",
      "Combination of metformin and DPP-4 inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Anagliptin and Metformin hydrochloride"
  },
  {
    "kegg_id": "D02300",
    "name_en": "Adenosine triphosphate disodium hydrate (JAN)",
    "name_ja": "",
    "names_alt": [
      "Adenosine triphosphate disodium trihydrate",
      "Adenosine 5'-triphosphate disodium",
      "ATP (TN)"
    ],
    "formula": "C10H14N5Na2O13P3. 3H2O",
    "efficacy": "Antivertigo, Metabolic enhancer",
    "target": "ADORA [HSA:134 135 136 140] [KO:K04265 K04266 K04267 K04268]\nPATHWAY   hsa04080(134+135+136+140)  Neuroactive ligand-receptor interaction",
    "metabolism": "",
    "therapeutic_category": "3992",
    "atc_code": "C01EB10",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Adenosine triphosphate disodium hydrate"
  },
  {
    "kegg_id": "D10699",
    "name_en": "Cholic acid (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Cholbam (TN)"
    ],
    "formula": "C24H40O5",
    "efficacy": "Choleretic, Supplement (bile acid)\nDISEASE   Peroxisomal Disorders [DS:H00205]\nZellweger spectrum disorder [DS:H01342]",
    "target": "NR1H4 (FXR) [HSA:9971] [KO:K08537]\nPATHWAY   hsa04976(9971)  Bile secretion",
    "metabolism": "",
    "therapeutic_category": "3999",
    "atc_code": "A05AA03",
    "drug_class": [
      "Gastrointestinal agent",
      "Bile acid preparation"
    ],
    "cyp_enzymes": [],
    "search_name": "Cholic acid"
  },
  {
    "kegg_id": "D02397",
    "name_en": "Arginine glutamate (USAN)",
    "name_ja": "",
    "names_alt": [
      "Modumate (TN)"
    ],
    "formula": "C6H14N4O2. C5H9NO4",
    "efficacy": "Antihyperammonemic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3999",
    "atc_code": "A05BA01",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Arginine glutamate"
  },
  {
    "kegg_id": "D02039",
    "name_en": "Lactitol hydrate (JAN)",
    "name_ja": "",
    "names_alt": [
      "Lactitol monohydrate",
      "Portolac (TN)"
    ],
    "formula": "C12H24O11. H2O",
    "efficacy": "Antihyperammonemic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3999",
    "atc_code": "A06AD12",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Lactitol hydrate"
  },
  {
    "kegg_id": "D02176",
    "name_en": "Levocarnitine (JAN/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "L-Carnitine",
      "Carnitor (TN)"
    ],
    "formula": "C7H15NO3",
    "efficacy": "Replenisher (carnitine)\nDISEASE   Primary systemic carnitine deficiency [DS:H01589]",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3999",
    "atc_code": "A16AA01",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Levocarnitine"
  },
  {
    "kegg_id": "D07130",
    "name_en": "Carglumic acid (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Carbaglu (TN)"
    ],
    "formula": "C6H10N2O5",
    "efficacy": "Antihyperammonemic, CPS1 activator\nDISEASE   NAGS deficiency [DS:H01032]",
    "target": "CPS1 [HSA:1373] [KO:K01948]\nPATHWAY   hsa00220(1373)  Arginine biosynthesis\nhsa00250(1373)  Alanine, aspartate and glutamate metabolism\nhsa00910(1373)  Nitrogen metabolism\nNETWORK   nt06010  Urea cycle",
    "metabolism": "",
    "therapeutic_category": "3999",
    "atc_code": "A16AA05",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Carglumic acid"
  },
  {
    "kegg_id": "D07523",
    "name_en": "Betaine (JAN)",
    "name_ja": "",
    "names_alt": [
      "Cystadane (TN)"
    ],
    "formula": "C5H11NO2",
    "efficacy": "Antihomocystinuria\nDISEASE   Homocystinuria [DS:H00183]",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3999",
    "atc_code": "A16AA06",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Betaine"
  },
  {
    "kegg_id": "D11077",
    "name_en": "Pegvaliase (INN)",
    "name_ja": "",
    "names_alt": [
      "Pegvaliase (genetical recombination) (JAN)",
      "Pegvaliase-pqpz",
      "Palynziq (TN)"
    ],
    "formula": "",
    "efficacy": "Antihyperphenylalaninemia\nDISEASE   Phenylketonuria [DS:H00167]",
    "target": "PAH* [HSA_VAR:5053v1] [HSA:5053] [KO:K00500]\nPATHWAY   hsa00360(5053)  Phenylalanine metabolism\nhsa00400(5053)  Phenylalanine, tyrosine and tryptophan biosynthesis\nhsa00790(5053)  Folate biosynthesis\nNETWORK   nt06016  Phenylalanine and tyrosine metabolism",
    "metabolism": "",
    "therapeutic_category": "3999",
    "atc_code": "A16AB19",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Pegvaliase"
  },
  {
    "kegg_id": "D00086",
    "name_en": "Thioctic acid (JAN)",
    "name_ja": "",
    "names_alt": [
      "Thiotomin (TN)"
    ],
    "formula": "C8H14O2S2",
    "efficacy": "Supplement (thioctic acid)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3999",
    "atc_code": "A16AX01",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Thioctic acid"
  },
  {
    "kegg_id": "D05868",
    "name_en": "Sodium phenylbutyrate (JAN/USP)",
    "name_ja": "",
    "names_alt": [
      "Buphenyl (TN)"
    ],
    "formula": "C10H11O2. Na",
    "efficacy": "Antihyperammonemic, Nitrogen binding agent\nDISEASE   Deficiency of carbamylphosphate synthetase [DS:H00164]\nDeficiency of ornithine transcarbamylase [DS:H00187]\nDeficiency of argininosuccinic acid synthetase [DS:H00185]\nUrea cycle disorders [DS:H01398]",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3999",
    "atc_code": "A16AX03",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Sodium phenylbutyrate"
  },
  {
    "kegg_id": "D05177",
    "name_en": "Nitisinone (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Orfadin (TN)"
    ],
    "formula": "C14H10F3NO5",
    "efficacy": "Antityrosinemia\nDISEASE   Hereditary tyrosinemia type 1 [DS:H00165]",
    "target": "HPD [HSA:3242] [KO:K00457]\nPATHWAY   hsa00130(3242)  Ubiquinone and other terpenoid-quinone biosynthesis\nhsa00350(3242)  Tyrosine metabolism\nhsa00360(3242)  Phenylalanine metabolism\nNETWORK   nt06016  Phenylalanine and tyrosine metabolism",
    "metabolism": "",
    "therapeutic_category": "3999",
    "atc_code": "A16AX04",
    "drug_class": [
      "Metabolizing enzyme inhibitor",
      "CYP2C9 inhibitor",
      "Transporter inhibitor",
      "SLC22A6 inhibitor",
      "SLC22A8 inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Nitisinone"
  },
  {
    "kegg_id": "D05032",
    "name_en": "Miglustat (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Brazaves (TN)",
      "Zavesca (TN)",
      "Opfolda (TN)"
    ],
    "formula": "C10H21NO4",
    "efficacy": "Lysosomal storage disease treatment, Glucosylceramide synthase inhibitor\nDISEASE   Type 1 Gaucher disease [DS:H00126]\nPompe disease [DS:H01940]",
    "target": "UGCG [HSA:7357] [KO:K00720]\nPATHWAY   hsa00600(7357)  Sphingolipid metabolism\nNETWORK   nt06014  Sphingolipid degradation",
    "metabolism": "",
    "therapeutic_category": "3999",
    "atc_code": "A16AX06",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Miglustat"
  },
  {
    "kegg_id": "D01798",
    "name_en": "Sapropterin dihydrochloride (USAN)",
    "name_ja": "",
    "names_alt": [
      "Sapropterin hydrochloride (JAN)",
      "Biopten (TN)",
      "Kuvan (TN)"
    ],
    "formula": "C9H15N5O3. 2HCl",
    "efficacy": "Antihyperphenylalaninemia, Cofactor replacement (tetrahydrobiopterin)\nDISEASE   Phenylketonuria, BH4-responsive [DS:H00167]",
    "target": "Tetrahydrobiopterin [CPD:C00272]\nNETWORK   nt06016  Phenylalanine and tyrosine metabolism",
    "metabolism": "",
    "therapeutic_category": "3999",
    "atc_code": "A16AX07",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Sapropterin dihydrochloride"
  },
  {
    "kegg_id": "D10127",
    "name_en": "Glycerol phenylbutyrate (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Ravicti (TN)"
    ],
    "formula": "C33H38O6",
    "efficacy": "Urea cycle disorder agent, Nitrogen binding agent\nDISEASE   Urea cycle disorders [DS:H01398]",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3999",
    "atc_code": "A16AX09",
    "drug_class": [
      "Metabolizing enzyme inducer",
      "CYP3A/CYP3A4 inducer"
    ],
    "cyp_enzymes": [],
    "search_name": "Glycerol phenylbutyrate"
  },
  {
    "kegg_id": "D09894",
    "name_en": "Eliglustat tartrate (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Eliglustat hemitartrate",
      "Cerdelga (TN)"
    ],
    "formula": "(C23H36N2O4)2. C4H6O6",
    "efficacy": "Lysosomal storage disease treatment, Glucosylceramide synthase inhibitor\nDISEASE   Gaucher disease type 1 [DS:H00126]",
    "target": "UGCG [HSA:7357] [KO:K00720]\nPATHWAY   hsa00600(7357)  Sphingolipid metabolism\nNETWORK   nt06014  Sphingolipid degradation",
    "metabolism": "Enzyme: CYP2D6 [HSA:1565]; CYP3A4 [HSA:1576]\nTransporter: ABCB1 [HSA:5243]",
    "therapeutic_category": "3999",
    "atc_code": "A16AX10",
    "drug_class": [
      "Metabolizing enzyme substrate",
      "CYP2D6 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "Transporter substrate",
      "ABCB1 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4",
      "CYP2D6"
    ],
    "search_name": "Eliglustat tartrate"
  },
  {
    "kegg_id": "D05031",
    "name_en": "Migalastat hydrochloride (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Galafold (TN)"
    ],
    "formula": "C6H13NO4. HCl",
    "efficacy": "Lysosomal storage disease treatment, Pharmacological chaperone\nDISEASE   Fabry disease (GLA variant) [DS:H00125]",
    "target": "GLA* [HSA_VAR:2717v2] [HSA:2717] [KO:K01189]\nPATHWAY   hsa00600(2717)  Sphingolipid metabolism\nhsa04142(2717)  Lysosome\nNETWORK   nt06014  Sphingolipid degradation",
    "metabolism": "",
    "therapeutic_category": "3999",
    "atc_code": "A16AX14",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Migalastat hydrochloride"
  },
  {
    "kegg_id": "D11708",
    "name_en": "Givosiran sodium (JAN)",
    "name_ja": "",
    "names_alt": [
      "Givlaari (TN)"
    ],
    "formula": "C524H694F16N173O316P43S6.43Na",
    "efficacy": "Accumulation reduction (neurotoxic intermediates)\nDISEASE   Acute hepatic porphyria [DS:H00202]\nTYPE      RNA interference (RNAi) drug",
    "target": "ALAS1 [HSA:211] [KO:K00643] (mRNA)\nPATHWAY   hsa00860(211)  Porphyrin metabolism",
    "metabolism": "",
    "therapeutic_category": "3999",
    "atc_code": "A16AX16",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Givosiran sodium"
  },
  {
    "kegg_id": "D04768",
    "name_en": "Lonafarnib (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Zokinvy (TN)"
    ],
    "formula": "C27H31Br2ClN4O2",
    "efficacy": "Antineoplastic, Farnesyltransferase inhibitor\nDISEASE   Hutchinson-Gilford progeria syndrome [DS:H00601]\nProgeroid laminopathy (LMNA mutation, ZMPSTE24 mutation) [DS:H02677]",
    "target": "FNT [HSA:2339 2342] [KO:K05955 K05954]\nPATHWAY   hsa00900(2339+2342)  Terpenoid backbone biosynthesis",
    "metabolism": "Enzyme: CYP3A [HSA:1576 1577 1551]\nTransporter: ABCB1 [HSA:5243]",
    "therapeutic_category": "3999",
    "atc_code": "A16AX20",
    "drug_class": [
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "Metabolizing enzyme inhibitor",
      "CYP2C19 inhibitor",
      "CYP3A/CYP3A4 inhibitor",
      "Transporter substrate",
      "ABCB1 substrate",
      "Transporter inhibitor",
      "ABCB1 inhibitor",
      "SLC47A1 inhibitor"
    ],
    "cyp_enzymes": [
      "CYP3A"
    ],
    "search_name": "Lonafarnib"
  },
  {
    "kegg_id": "D12286",
    "name_en": "Sepiapterin (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Sephience (TN)"
    ],
    "formula": "C9H11N5O3",
    "efficacy": "Antihyperphenylalaninemia\nDISEASE   Hyperphenylalaninemia [DS:H00167]",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3999",
    "atc_code": "A16AX28",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Sepiapterin"
  },
  {
    "kegg_id": "D01766",
    "name_en": "Camostat mesilate (JP18)",
    "name_ja": "",
    "names_alt": [
      "Camostat mesylate",
      "Camostat monomethanesulfonate",
      "Foipan (TN)"
    ],
    "formula": "C20H22N4O5. CH4SO3",
    "efficacy": "Anti-inflammatory, Serine protease inhibitor",
    "target": "serine proteases",
    "metabolism": "",
    "therapeutic_category": "3999",
    "atc_code": "B02AB04",
    "drug_class": [
      "Blood modifier agent",
      "Hemostatics",
      "Antifibrinolytic",
      "Serine protease inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Camostat mesilate"
  },
  {
    "kegg_id": "D05183",
    "name_en": "Ulinastatin (JP18)",
    "name_ja": "",
    "names_alt": [
      "Miraclid (TN)"
    ],
    "formula": "",
    "efficacy": "Trypsin inhibitor",
    "target": "PRSS [HSA:5644 5645 5646] [KO:K01312]\nCTRB [HSA:1504 440387] [KO:K01310]\nELANE [HSA:1991] [KO:K01327]\nPATHWAY   hsa04972(1504+5644+5645+5646)  Pancreatic secretion\nhsa04974(1504+5644+5645+5646)  Protein digestion and absorption",
    "metabolism": "",
    "therapeutic_category": "3999",
    "atc_code": "B02AB05",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Ulinastatin"
  },
  {
    "kegg_id": "D08990",
    "name_en": "Romiplostim (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Romiplostim (genetical recombination) (JAN)",
      "Nplate (TN)",
      "Romiplate (TN)"
    ],
    "formula": "C1317H2043N361O395S9",
    "efficacy": "Antithrombocytopenia, Thrombopoietin receptor agonist\nDISEASE   Chronic immune thrombocytopenia [DS:H01240]",
    "target": "MPL (TPOR, CD110) [HSA:4352] [KO:K05082]\nPATHWAY   hsa04060(4352)  Cytokine-cytokine receptor interaction\nhsa04630(4352)  JAK-STAT signaling pathway",
    "metabolism": "",
    "therapeutic_category": "3999",
    "atc_code": "B02BX04",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Romiplostim"
  },
  {
    "kegg_id": "D03978",
    "name_en": "Eltrombopag olamine (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Promacta (TN)"
    ],
    "formula": "C25H22N4O4. (C2H7NO)2",
    "efficacy": "Antithrombocytopenia, Thrombopoietin receptor agonist\nDISEASE   Chronic immune thrombocytopenia [DS:H01240]\nAplastic anemia [DS:H01132]",
    "target": "MPL (TPOR, CD110) [HSA:4352] [KO:K05082]\nPATHWAY   hsa04060(4352)  Cytokine-cytokine receptor interaction\nhsa04630(4352)  JAK-STAT signaling pathway",
    "metabolism": "",
    "therapeutic_category": "3999",
    "atc_code": "B02BX05",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Eltrombopag olamine"
  },
  {
    "kegg_id": "D09348",
    "name_en": "Fostamatinib disodium (USAN)",
    "name_ja": "",
    "names_alt": [
      "Fostamatinib sodium hydrate (JAN)",
      "Fostamatinib disodium hexahydrate",
      "Tavalisse (TN)"
    ],
    "formula": "C23H24FN6O9P. 6H2O. 2Na",
    "efficacy": "Antineoplastic, Immunomodulator, Tyrosin kinase inhibitor\nDISEASE   Immune thrombocytopenia [DS:H01240]",
    "target": "SYK [HSA:6850] [KO:K05855]\nPATHWAY   hsa04064(6850)  NF-kappa B signaling pathway\nhsa04611(6850)  Platelet activation\nhsa04662(6850)  B cell receptor signaling pathway",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "3999",
    "atc_code": "B02BX09",
    "drug_class": [
      "Antineoplastic",
      "Tyrosine kinase inhibitor",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "Metabolizing enzyme inhibitor",
      "CYP3A/CYP3A4 inhibitor",
      "Transporter inhibitor",
      "ABCB1 inhibitor",
      "ABCG2 inhibitor"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Fostamatinib disodium"
  },
  {
    "kegg_id": "D03231",
    "name_en": "Epoetin alfa (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Epoetin kappa (INN)",
      "Epoetin alfa (genetical recombination) (JP18)",
      "Epoetin kappa (genetical recombination) [Epoetin alfa biosimilar 1] (JAN)",
      "Epoetin alfa-epbx",
      "Epogen (TN)",
      "Epoetin alfa BS (TN)"
    ],
    "formula": "C809H1301N229O240S5",
    "efficacy": "Anti-anemic, Hematinic, Erythropoietin receptor agonist\nDISEASE   Anemia due to chronic kidney disease [DS:H01642]",
    "target": "EPOR [HSA:2057] [KO:K05079]\nPATHWAY   hsa04060(2057)  Cytokine-cytokine receptor interaction\nhsa04630(2057)  JAK-STAT signaling pathway\nhsa04640(2057)  Hematopoietic cell lineage",
    "metabolism": "",
    "therapeutic_category": "3999",
    "atc_code": "B03XA01",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Epoetin alfa"
  },
  {
    "kegg_id": "D03232",
    "name_en": "Epoetin beta (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Epoetin beta (genetical recombination) (JP18)",
      "Marogen (TN)"
    ],
    "formula": "C809H1301N229O240S5",
    "efficacy": "Anti-anemic, Hematinic, Erythropoietin receptor agonist",
    "target": "EPOR [HSA:2057] [KO:K05079]\nPATHWAY   hsa04060(2057)  Cytokine-cytokine receptor interaction\nhsa04630(2057)  JAK-STAT signaling pathway\nhsa04640(2057)  Hematopoietic cell lineage",
    "metabolism": "",
    "therapeutic_category": "3999",
    "atc_code": "B03XA01",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Epoetin beta"
  },
  {
    "kegg_id": "D03651",
    "name_en": "Darbepoetin alfa (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Darbepoetin alfa (genetical recombination) (JAN)",
      "Darbepoetin alfa (genetical recombination) [Darbepoetin alfa biosimilar 1] (JAN)",
      "Darbepoetin alfa (genetical recombination) [Darbepoetin alfa biosimilar 2] (JAN)",
      "Darbepoetin alfa (genetical recombination) [Darbepoetin alfa biosimilar 3] (JAN)",
      "Aranesp (TN)"
    ],
    "formula": "C800H1300N228O24S5",
    "efficacy": "Anti-anemic, Erythropoietin receptor agonist\nDISEASE   Anemia due to chronic kidney disease [DS:H01642]",
    "target": "EPOR [HSA:2057] [KO:K05079]\nPATHWAY   hsa04060(2057)  Cytokine-cytokine receptor interaction\nhsa04630(2057)  JAK-STAT signaling pathway\nhsa04640(2057)  Hematopoietic cell lineage",
    "metabolism": "",
    "therapeutic_category": "3999",
    "atc_code": "B03XA02",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Darbepoetin alfa"
  },
  {
    "kegg_id": "D09998",
    "name_en": "Epoetin beta pegol (genetical recombination) (JAN)",
    "name_ja": "",
    "names_alt": [
      "Methoxy polyethylene glycol - epoetin beta",
      "Mircera (TN)"
    ],
    "formula": "C809H1301N229O240S5",
    "efficacy": "Anti-anemic, Erythropoietin receptor agonist\nDISEASE   Anemia due to chronic kidney disease [DS:H01642]",
    "target": "EPOR [HSA:2057] [KO:K05079]\nPATHWAY   hsa04060(2057)  Cytokine-cytokine receptor interaction\nhsa04630(2057)  JAK-STAT signaling pathway",
    "metabolism": "",
    "therapeutic_category": "3999",
    "atc_code": "B03XA03",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Epoetin beta pegol"
  },
  {
    "kegg_id": "D10593",
    "name_en": "Roxadustat (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Evrenzo (TN)"
    ],
    "formula": "C19H16N2O5",
    "efficacy": "Anti-anemic, Prolyl hydroxylase inhibitor",
    "target": "EGLN (HPH) [HSA:54583 112398 112399] [KO:K09592]\nPATHWAY   hsa04066(112398+112399+54583)  HIF-1 signaling pathway",
    "metabolism": "Enzyme: CYP2C8 [HSA:1558], UGT1A9 [HSA:54600]\nTransporter: ABCG2 [HSA:9429], SLCO1B1 [HSA:10599], SLC22A6 [HSA:9356], SLC22A8 [HSA:9376]",
    "therapeutic_category": "3999",
    "atc_code": "B03XA05",
    "drug_class": [
      "Metabolizing enzyme substrate",
      "CYP2C8 substrate",
      "UGT substrate",
      "UGT1A9 substrate",
      "Transporter substrate",
      "ABCG2 substrate",
      "SLC22A6 substrate",
      "SLC22A8 substrate",
      "SLCO1B1 substrate",
      "Transporter inhibitor",
      "ABCG2 inhibitor",
      "SLCO1B1 inhibitor"
    ],
    "cyp_enzymes": [
      "CYP2C8"
    ],
    "search_name": "Roxadustat"
  },
  {
    "kegg_id": "D10874",
    "name_en": "Daprodustat (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Duvroq (TN)",
      "Jesduvroq (TN)"
    ],
    "formula": "C19H27N3O6",
    "efficacy": "Anti-anemic, Prolyl hydroxylase inhibitor\nDISEASE   Anemia due to chronic kidney disease [DS:H01642]",
    "target": "EGLN (HPH) [HSA:54583 112398 112399] [KO:K09592]\nPATHWAY   hsa04066(112398+112399+54583)  HIF-1 signaling pathway",
    "metabolism": "",
    "therapeutic_category": "3999",
    "atc_code": "B03XA07",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Daprodustat"
  },
  {
    "kegg_id": "D11078",
    "name_en": "Vadadustat (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Vafseo (TN)"
    ],
    "formula": "C14H11ClN2O4",
    "efficacy": "Anti-anemic, Prolyl hydroxylase inhibitor\nDISEASE   Anemia due to chronic kidney disease [DS:H01642]",
    "target": "EGLN (HPH) [HSA:54583 112398 112399] [KO:K09592]\nPATHWAY   hsa04066(112398+112399+54583)  HIF-1 signaling pathway",
    "metabolism": "",
    "therapeutic_category": "3999",
    "atc_code": "B03XA08",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Vadadustat"
  },
  {
    "kegg_id": "D11273",
    "name_en": "Molidustat sodium (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Musredo (TN)"
    ],
    "formula": "C13H13N8O2. Na",
    "efficacy": "Anti-anemic, Hypoxia inducible factor-prolyl hydroxylase (HIF-PH) inhibitor",
    "target": "EGLN (HPH) [HSA:54583 112398 112399] [KO:K09592]\nPATHWAY   hsa04066(112398+112399+54583)  HIF-1 signaling pathway",
    "metabolism": "",
    "therapeutic_category": "3999",
    "atc_code": "B03XA09",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Molidustat sodium"
  },
  {
    "kegg_id": "D01126",
    "name_en": "Arginine hydrochloride (USP)",
    "name_ja": "",
    "names_alt": [
      "L-Arginine hydrochloride (JP18)",
      "R-gene (TN)"
    ],
    "formula": "C6H14N4O2. HCl",
    "efficacy": "Antihyperammonemic, Diagnostic agent",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3999",
    "atc_code": "B05XB01",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Arginine hydrochloride"
  },
  {
    "kegg_id": "D00294",
    "name_en": "Diazoxide (JAN/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Hyperstat (TN)",
      "Proglycem (TN)"
    ],
    "formula": "C8H7ClN2O2S",
    "efficacy": "Antihypoglycemia, Antihypertensive, ATP-sensitive potassium channel opener\nDISEASE   Hypoglycemia due to hyperinsulinism [DS:H01267]",
    "target": "ABCC8(SUR1)/KCNJ11(KIR6.2) [HSA:6833 3767] [KO:K05032 K05004]\nPATHWAY   hsa04911(3767+6833)  Insulin secretion",
    "metabolism": "Enzyme: CYP1A2 [HSA:1544]",
    "therapeutic_category": "3999",
    "atc_code": "C02DA01",
    "drug_class": [
      "Cardiovascular agent",
      "ATP-sensitive potassium channel opener",
      "Metabolizing enzyme substrate",
      "CYP1A2 substrate"
    ],
    "cyp_enzymes": [
      "CYP1A2"
    ],
    "search_name": "Diazoxide"
  },
  {
    "kegg_id": "D09960",
    "name_en": "Ruxolitinib phosphate (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Jakafi (TN)",
      "Jakavi (TN)",
      "Opzelura (TN)"
    ],
    "formula": "C17H18N6. H3PO4",
    "efficacy": "Antineoplastic, Janus kinase (JAK) inhibitor\nDISEASE   Myelofibrosis [DS:H01605]\nPolycythemia vera [DS:H00012]\nAcute graft-versus-host disease [DS:H00084]\nChronic graft-versus-host disease [DS:H00084]\nAtopic dermatitis [DS:H01358]\nNonsegmental vitiligo [DS:H01372]",
    "target": "JAK1 [HSA:3716] [KO:K11217]\nJAK2 [HSA:3717] [KO:K04447]\nPATHWAY   hsa04062(3717)  Chemokine signaling pathway\nhsa04630(3716+3717)  JAK-STAT signaling pathway\nhsa05200(3716+3717)  Pathways in cancer",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]; CYP2C9 [HSA:1559]",
    "therapeutic_category": "3999",
    "atc_code": "D11AH09",
    "drug_class": [
      "Anti-inflammatory",
      "Disease modifying anti-rheumatic drug (DMARD)",
      "JAK inhibitor",
      "Metabolizing enzyme substrate",
      "CYP2C9 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C9",
      "CYP3A4"
    ],
    "search_name": "Ruxolitinib phosphate"
  },
  {
    "kegg_id": "D02217",
    "name_en": "Raloxifene hydrochloride (JAN/USP)",
    "name_ja": "",
    "names_alt": [
      "LY 156758",
      "Evista (TN)"
    ],
    "formula": "C28H27NO4S. HCl",
    "efficacy": "Osteoporosis agent, Selective estrogen receptor modulator (SERM)\nDISEASE   Osteoporosis [DS:H01593]",
    "target": "NR3A (ESR) [HSA:2099 2100] [KO:K08550 K08551]\nPATHWAY   hsa04915(2099+2100)  Estrogen signaling pathway\nhsa04961(2099)  Endocrine and other factor-regulated calcium reabsorption",
    "metabolism": "",
    "therapeutic_category": "3999",
    "atc_code": "G03XC01",
    "drug_class": [
      "Hormonal agent",
      "Estrogen receptor antagonist/modulator",
      "Selective estrogen receptor modulator",
      "Musculo-skeletal system agent",
      "Osteoporosis agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Raloxifene hydrochloride"
  },
  {
    "kegg_id": "D10606",
    "name_en": "Raloxifene hydrochloride hydrate (JAN)",
    "name_ja": "",
    "names_alt": [],
    "formula": "C28H27NO4S. HCl. H2O",
    "efficacy": "Osteoporosis agent, Selective estrogen receptor modulator (SERM)",
    "target": "NR3A (ESR) [HSA:2099 2100] [KO:K08550 K08551]\nPATHWAY   hsa04915(2099+2100)  Estrogen signaling pathway\nhsa04961(2099)  Endocrine and other factor-regulated calcium reabsorption",
    "metabolism": "",
    "therapeutic_category": "3999",
    "atc_code": "G03XC01",
    "drug_class": [
      "Hormonal agent",
      "Estrogen receptor antagonist/modulator",
      "Selective estrogen receptor modulator",
      "Musculo-skeletal system agent",
      "Osteoporosis agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Raloxifene hydrochloride hydrate"
  },
  {
    "kegg_id": "D03062",
    "name_en": "Bazedoxifene acetate (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Viviant (TN)"
    ],
    "formula": "C30H34N2O3. C2H4O2",
    "efficacy": "Osteoporosis agent, Selective estrogen receptor modulator (SERM)",
    "target": "NR3A (ESR) [HSA:2099 2100] [KO:K08550 K08551]\nPATHWAY   hsa04915(2099+2100)  Estrogen signaling pathway\nhsa04961(2099)  Endocrine and other factor-regulated calcium reabsorption",
    "metabolism": "",
    "therapeutic_category": "3999",
    "atc_code": "G03XC02",
    "drug_class": [
      "Hormonal agent",
      "Estrogen receptor antagonist/modulator",
      "Selective estrogen receptor modulator",
      "Musculo-skeletal system agent",
      "Osteoporosis agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Bazedoxifene acetate"
  },
  {
    "kegg_id": "D03287",
    "name_en": "Elcatonin (JP18/INN)",
    "name_ja": "",
    "names_alt": [
      "Adevirock (TN)"
    ],
    "formula": "C148H244N42O47",
    "efficacy": "Antiresorptive, Regulator (calcium)",
    "target": "CALCR [HSA:799] [KO:K04576]\nPATHWAY   hsa04080(799)  Neuroactive ligand-receptor interaction\nhsa04380(799)  Osteoclast differentiation",
    "metabolism": "",
    "therapeutic_category": "3999",
    "atc_code": "H05BA04",
    "drug_class": [
      "Musculo-skeletal system agent",
      "Osteoporosis agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Elcatonin"
  },
  {
    "kegg_id": "D03505",
    "name_en": "Cinacalcet hydrochloride (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Sensipar (TN)",
      "Mimpara (TN)"
    ],
    "formula": "C22H22F3N. HCl",
    "efficacy": "Antihypercalcemia, Antihyperparathyroidism, Calcium sensing receptor allosteric modulator\nDISEASE   Secondary hyperparathyroidism [DS:H01669]\nParathyroid carcinoma [DS:H01558]\nPrimary Hyperparathyroidism [DS:H00246]",
    "target": "CASR [HSA:846] [KO:K04612]\nPATHWAY   hsa04621(846)  NOD-like receptor signaling pathway\nhsa04928(846)  Parathyroid hormone synthesis, secretion and action\nNETWORK   nt06318  CaSR-PTH signaling",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "3999",
    "atc_code": "H05BX01",
    "drug_class": [
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "Metabolizing enzyme inhibitor",
      "CYP2D6 inhibitor"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Cinacalcet hydrochloride"
  },
  {
    "kegg_id": "D10677",
    "name_en": "Etelcalcetide hydrochloride (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Velcalcetide hydrochloride (USAN)",
      "Parsabiv (TN)"
    ],
    "formula": "C38H73N21O10S2. xHCl",
    "efficacy": "Antihyperparathyroidism, Calcium-sensing receptor agonist\nDISEASE   Secondary hyperparathyroidism [DS:H01669]",
    "target": "CASR [HSA:846] [KO:K04612]\nPATHWAY   hsa04621(846)  NOD-like receptor signaling pathway\nhsa04928(846)  Parathyroid hormone synthesis, secretion and action\nNETWORK   nt06318  CaSR-PTH signaling",
    "metabolism": "",
    "therapeutic_category": "3999",
    "atc_code": "H05BX04",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Etelcalcetide hydrochloride"
  },
  {
    "kegg_id": "D11063",
    "name_en": "Evocalcet (JAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Orkedia (TN)"
    ],
    "formula": "C24H26N2O2",
    "efficacy": "Antihyperparathyroidism, Calcium-sensing receptor agonist",
    "target": "CASR [HSA:846] [KO:K04612]\nPATHWAY   hsa04621(846)  NOD-like receptor signaling pathway\nhsa04928(846)  Parathyroid hormone synthesis, secretion and action\nNETWORK   nt06318  CaSR-PTH signaling",
    "metabolism": "",
    "therapeutic_category": "3999",
    "atc_code": "H05BX06",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Evocalcet"
  },
  {
    "kegg_id": "D00142",
    "name_en": "Methotrexate (JP18/USP/INN)",
    "name_ja": "メトトレキサート",
    "names_alt": [
      "Otrexup (TN)",
      "Xatmep (TN)"
    ],
    "formula": "C20H22N8O5",
    "efficacy": "Antineoplastic, Antimetabolite\nDISEASE   Rheumatoid arthritis [DS:H00630]\nJuvenile idiopathic arthritis [DS:H01672]\nPsoriasis [DS:H01656]\nLymphoblastic leukemia [DS:H00001 H00002]",
    "target": "DHFR [HSA:1719 200895] [KO:K00287]\nPATHWAY   hsa00670(1719+200895)  One carbon pool by folate\nhsa00790(1719+200895)  Folate biosynthesis",
    "metabolism": "",
    "therapeutic_category": "3999",
    "atc_code": "L01BA01",
    "drug_class": [
      "Antineoplastic",
      "Antimetabolite",
      "Folic acid analog",
      "Dihydrofolate reductase inhibitor",
      "Anti-inflammatory",
      "Disease modifying anti-rheumatic drug (DMARD)"
    ],
    "cyp_enzymes": [],
    "search_name": "Methotrexate"
  },
  {
    "kegg_id": "D02714",
    "name_en": "Everolimus (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Afinitor (TN)",
      "Votubia (TN)",
      "Zortress (TN)"
    ],
    "formula": "C53H83NO14",
    "efficacy": "Antineoplastic, Immunosuppressant, mTOR inhibitor\nDISEASE   Breast cancer (HR positive, HER2 negative) [DS:H00031]\nPancreatic neuroendocrine tumor [DS:H00045]\nRenal cell carcinoma [DS:H00021]\nTuberous sclerosis complex-associated renal angiomyolipoma [DS:H01691]\nTuberous sclerosis complex-associated subependymal giant cell astrocytoma [DS:H01692]\nOrgan rejection in kidney transplantation [DS:H00083]\nOrgan rejection in liver transplantation [DS:H00083]",
    "target": "MTOR [HSA:2475] [KO:K07203]\nPATHWAY   hsa04012(2475)  ErbB signaling pathway\nhsa04150(2475)  mTOR signaling pathway\nhsa05200(2475)  Pathways in cancer\nhsa05224(2475)  Breast cancer\nNETWORK   nt06270  Breast cancer",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]\nTransporter: ABCB1 [HSA:5243]",
    "therapeutic_category": "3999",
    "atc_code": "L01EG02",
    "drug_class": [
      "Antineoplastic",
      "mTOR inhibitor",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "Transporter substrate",
      "ABCB1 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Everolimus"
  },
  {
    "kegg_id": "D10396",
    "name_en": "Nintedanib esylate (USAN)",
    "name_ja": "",
    "names_alt": [
      "Nintedanib ethanesulfonate (JAN)",
      "Ofev (TN)"
    ],
    "formula": "C31H33N5O4. C2H6O3S",
    "efficacy": "Antifibrosis, Tyrosine kinase inhibitor\nDISEASE   Idiopathic pulmonary fibrosis [DS:H01299]",
    "target": "VEGFR1 (FLT1) [HSA:2321] [KO:K05096]\nVEGFR2 (KDR) [HSA:3791] [KO:K05098]\nVEGFR3 (FLT4) [HSA:2324] [KO:K05097]\nPDGFR [HSA:5156 5159] [KO:K04363 K05089]\nFGFR1 (CD331) [HSA:2260] [KO:K04362]\nFGFR2 (CD332) [HSA:2263] [KO:K05093]\nFGFR3 (CD333) [HSA:2261] [KO:K05094]\nPATHWAY   hsa04010(2260+2261+2263+2321+2324+3791+5156+5159)  MAPK signaling pathway\nhsa04370(3791)  VEGF signaling pathway\nhsa05200(2260+2261+2263+2324+5156+5159)  Pathways in cancer",
    "metabolism": "Enzyme: UGT [KO:K00699]\nTransporter: ABCB1 [HSA:5243]",
    "therapeutic_category": "3999",
    "atc_code": "L01EX09",
    "drug_class": [
      "Antineoplastic",
      "Tyrosine kinase inhibitor",
      "Metabolizing enzyme substrate",
      "UGT substrate",
      "Transporter substrate",
      "ABCB1 substrate"
    ],
    "cyp_enzymes": [],
    "search_name": "Nintedanib esylate"
  },
  {
    "kegg_id": "D04318",
    "name_en": "Glatiramer acetate (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Copaxone (TN)"
    ],
    "formula": "(C5H9NO4. C3H7NO2. C6H14N2O2. C9H11NO3)x. (C2H4O2)y",
    "efficacy": "Immunomodulator, T cell receptor antagonist\nDISEASE   Multiple sclerosis [DS:H01490]",
    "target": "MHC1 [HSA:3105 3106 3107 3133 3134 3135] [KO:K06751]\nMHC2 [HSA:3108 3109 3111 3112 3113 3115 3117 3118 3119 3122 3123 3125 3126 3127] [KO:K06752]\nPATHWAY   hsa04612(3105+3106+3107+3108+3109+3111+3112+3113+3115+3117+3118+3119+3122+3123+3125+3126+3127+3133+3134+3135)  Antigen processing and presentation",
    "metabolism": "",
    "therapeutic_category": "3999",
    "atc_code": "L03AX13",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Glatiramer acetate"
  },
  {
    "kegg_id": "D00752",
    "name_en": "Mycophenolate mofetil (JAN/USP)",
    "name_ja": "",
    "names_alt": [
      "Cellcept (TN)"
    ],
    "formula": "C23H31NO7",
    "efficacy": "Immunosuppressant, Inosine monophosphate dehydrogenase inhibitor\nDISEASE   Prophylaxis of organ rejection [DS:H00083]",
    "target": "IMPDH [HSA:3614 3615] [KO:K00088]\nPATHWAY   hsa00230(3614+3615)  Purine metabolism",
    "metabolism": "",
    "therapeutic_category": "3999",
    "atc_code": "L04AA06",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Mycophenolate mofetil"
  },
  {
    "kegg_id": "D01566",
    "name_en": "Gusperimus trihydrochloride (USAN)",
    "name_ja": "",
    "names_alt": [
      "Gusperimus hydrochloride (JAN)",
      "Spanidin (TN)"
    ],
    "formula": "C17H37N7O3. 3HCl",
    "efficacy": "Immunosuppressant",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3999",
    "atc_code": "L04AA19",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Gusperimus trihydrochloride"
  },
  {
    "kegg_id": "D03203",
    "name_en": "Abatacept (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Abatacept (genetical recombination) (JAN)",
      "Orencia (TN)"
    ],
    "formula": "",
    "efficacy": "Antirheumatic\nDISEASE   Rheumatoid arthritis [DS:H00630]\nJuvenile idiopathic arthritis [DS:H01672]\nPsoriatic arthritis [DS:H01507]\nAcute graft versus host disease [DS:H00084]",
    "target": "CD80 [HSA:941] [KO:K05412]\nCD86 [HSA:942] [KO:K05413]\nPATHWAY   hsa04514(941+942)  Cell adhesion molecule (CAM) interaction\nhsa04672(941+942)  Intestinal immune network for IgA production\nhsa05323(941+942)  Rheumatoid arthritis",
    "metabolism": "",
    "therapeutic_category": "3999",
    "atc_code": "L04AA24",
    "drug_class": [
      "Anti-inflammatory",
      "Disease modifying anti-rheumatic drug (DMARD)"
    ],
    "cyp_enzymes": [],
    "search_name": "Abatacept"
  },
  {
    "kegg_id": "D08860",
    "name_en": "Apremilast (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Otezla (TN)"
    ],
    "formula": "C22H24N2O7S",
    "efficacy": "Anti-inflammatory, Phosphodiesterase IV inhibitor\nDISEASE   Psoriatic arthritis [DS:H01507]\nPsoriasis [DS:H01656]\nPlaque Psoriasis [DS:H01656]\nBehçet’s disease [DS:H01476]",
    "target": "PDE4 [HSA:5141 5142 5143 5144] [KO:K13293]\nPATHWAY   hsa00230(5141+5142+5143+5144)  Purine metabolism\nhsa04024(5141+5142+5143+5144)  cAMP signaling pathway",
    "metabolism": "",
    "therapeutic_category": "3999",
    "atc_code": "L04AA32",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Apremilast"
  },
  {
    "kegg_id": "D11816",
    "name_en": "Belumosudil mesylate (USAN)",
    "name_ja": "",
    "names_alt": [
      "Belumosudil mesilate (JAN)",
      "Rezurock (TN)"
    ],
    "formula": "C26H24N6O2. CH4SO3",
    "efficacy": "Autoimmune disease treatment, Rho-associated kinase inhibitor\nDISEASE   Chronic graft-versus-host disease [DS:H00084]",
    "target": "ROCK2 [HSA:9475] [KO:K17388]\nPATHWAY   hsa04062(9475)  Chemokine signaling pathway",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "3999",
    "atc_code": "L04AA48",
    "drug_class": [
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "Metabolizing enzyme inhibitor",
      "CYP3A/CYP3A4 inhibitor",
      "Transporter inhibitor",
      "ABCB1 inhibitor",
      "ABCG2 inhibitor",
      "SLCO1B1 inhibitor"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Belumosudil mesylate"
  },
  {
    "kegg_id": "D00742",
    "name_en": "Etanercept (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Etanercept (genetical recombination) (JAN)",
      "Etanercept (genetical recombination) [Etanercept biosimilar 1] (JAN)",
      "Etanercept (genetical recombination) [Etanercept biosimilar 2] (JAN)",
      "Enbrel (TN)"
    ],
    "formula": "",
    "efficacy": "Antirheumatic, TNF receptor antagonist\nDISEASE   Rheumatoid arthritis [DS:H00630]\nPolyarticular juvenile idiopathic arthritis [DS:H01672]\nPsoriatic arthritis [DS:H01507]\nAnkylosing spondylitis [DS:H01674]\nPlaque psoriasis [DS:H01656]",
    "target": "TNF (TNFA, TNFSF2) [HSA:7124] [KO:K03156]\nLTA (TNFB, TNFSF1) [HSA:4049] [KO:K05468]\nPATHWAY   hsa04010(7124)  MAPK signaling pathway\nhsa04060(4049+7124)  Cytokine-cytokine receptor interaction\nhsa04064(4049+7124)  NF-kappa B signaling pathway\nhsa04210(7124)  Apoptosis\nhsa04350(7124)  TGF-beta signaling pathway\nhsa04380(7124)  Osteoclast differentiation\nhsa04612(7124)  Antigen processing and presentation\nhsa04920(7124)  Adipocytokine signaling pathway\nhsa05323(7124)  Rheumatoid arthritis",
    "metabolism": "",
    "therapeutic_category": "3999",
    "atc_code": "L04AB01",
    "drug_class": [
      "Anti-inflammatory",
      "Disease modifying anti-rheumatic drug (DMARD)",
      "TNF inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Etanercept"
  },
  {
    "kegg_id": "D02597",
    "name_en": "Adalimumab (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Adalimumab (genetical recombination) (JAN)",
      "Adalimumab (genetical recombination) [Adalimumab biosimilar 1] (JAN)",
      "Adalimumab (genetical recombination) [Adalimumab biosimilar 2] (JAN)",
      "Adalimumab (genetical recombination) [Adalimumab biosimilar 3] (JAN)",
      "Adalimumab (genetical recombination) [Adalimumab biosimilar 4] (JAN)",
      "Adalimumab-adaz",
      "Adalimumab-adbm",
      "Adalimumab-afzb",
      "Adalimumab-atto",
      "Adalimumab-bwwd",
      "Adalimumab-fkjp",
      "Adalimumab-aaty",
      "Adalimumab-aacf",
      "Adalimumab-aqvh",
      "Adalimumab-ryvk",
      "Humira (TN)",
      "Abrilada (TN)",
      "Amjevita (TN)",
      "Cyltezo (TN)",
      "Hadlima (TN)",
      "Hyrimoz (TN)"
    ],
    "formula": "",
    "efficacy": "Anti-inflammatory, Antirheumatic, Anti-TNF-alpha antibody\nDISEASE   Rheumatoid arthritis [DS:H00630]\nJuvenile idiopathic arthritis [DS:H01672]\nPsoriatic arthritis [DS:H01507]\nAnkylosing spondylitis [DS:H01674]\nAdult Crohn's disease [DS:H00286]\nPediatric Crohn's disease [DS:H00286]\nUlcerative colitis [DS:H01466]\nPlaque psoriasis [DS:H01656]\nHidradenitis suppurativa [DS:H00681]\nTYPE      Monoclonal antibody",
    "target": "TNF (TNFA, TNFSF2) [HSA:7124] [KO:K03156]\nPATHWAY   hsa04010(7124)  MAPK signaling pathway\nhsa04060(7124)  Cytokine-cytokine receptor interaction\nhsa04210(7124)  Apoptosis\nhsa04350(7124)  TGF-beta signaling pathway\nhsa04380(7124)  Osteoclast differentiation\nhsa04612(7124)  Antigen processing and presentation\nhsa04650(7124)  Natural killer cell mediated cytotoxicity\nhsa05321(7124)  Inflammatory bowel disease\nhsa05323(7124)  Rheumatoid arthritis",
    "metabolism": "",
    "therapeutic_category": "3999",
    "atc_code": "L04AB04",
    "drug_class": [
      "Anti-inflammatory",
      "Disease modifying anti-rheumatic drug (DMARD)",
      "TNF inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Adalimumab"
  },
  {
    "kegg_id": "D03441",
    "name_en": "Certolizumab pegol (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Certolizumab pegol (genetical recombination) (JAN)",
      "Cimzia (TN)"
    ],
    "formula": "C2115H3252N556O673S16",
    "efficacy": "Anti-inflammatory, Antirheumatic, Anti-TNF-alpha antibody\nDISEASE   Crohn's disease [DS:H00286]\nRheumatoid arthritis [DS:H00630]\nPsoriatic arthritis [DS:H01507]\nAnkylosing spondylitis [DS:H01674]\nTYPE      Monoclonal antibody",
    "target": "TNF (TNFA, TNFSF2) [HSA:7124] [KO:K03156]\nPATHWAY   hsa04010(7124)  MAPK signaling pathway\nhsa04060(7124)  Cytokine-cytokine receptor interaction\nhsa04210(7124)  Apoptosis\nhsa04350(7124)  TGF-beta signaling pathway\nhsa04380(7124)  Osteoclast differentiation\nhsa04612(7124)  Antigen processing and presentation\nhsa04620(7124)  Toll-like receptor signaling pathway\nhsa04650(7124)  Natural killer cell mediated cytotoxicity\nhsa04920(7124)  Adipocytokine signaling pathway\nhsa05323(7124)  Rheumatoid arthritis",
    "metabolism": "",
    "therapeutic_category": "3999",
    "atc_code": "L04AB05",
    "drug_class": [
      "Anti-inflammatory",
      "Disease modifying anti-rheumatic drug (DMARD)",
      "TNF inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Certolizumab pegol"
  },
  {
    "kegg_id": "D04358",
    "name_en": "Golimumab (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Golimumab (genetical recombination) (JAN)",
      "Golimumab (genetical recombination) [Golimumab biosimilar 1] (JAN)",
      "Simponi (TN)"
    ],
    "formula": "C6530H10068N1752O2026S44",
    "efficacy": "Anti-inflammatory, Antirheumatic, Anti-TNF-alpha antibody\nDISEASE   Rheumatoid arthritis [DS:H00630]\nPsoriatic arthritis [DS:H01507]\nAnkylosing spondylitis [DS:H01674]\nUlcerative colitis [DS:H01466]\nTYPE      Monoclonal antibody",
    "target": "TNF (TNFA, TNFSF2) [HSA:7124] [KO:K03156]\nPATHWAY   hsa04010(7124)  MAPK signaling pathway\nhsa04060(7124)  Cytokine-cytokine receptor interaction\nhsa04210(7124)  Apoptosis\nhsa04350(7124)  TGF-beta signaling pathway\nhsa04380(7124)  Osteoclast differentiation\nhsa04664(7124)  Fc epsilon RI signaling pathway\nhsa04920(7124)  Adipocytokine signaling pathway\nhsa05321(7124)  Inflammatory bowel disease\nhsa05323(7124)  Rheumatoid arthritis",
    "metabolism": "",
    "therapeutic_category": "3999",
    "atc_code": "L04AB06",
    "drug_class": [
      "Anti-inflammatory",
      "Disease modifying anti-rheumatic drug (DMARD)",
      "TNF inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Golimumab"
  },
  {
    "kegg_id": "D09214",
    "name_en": "Ustekinumab (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Ustekinumab (genetical recombination) (JAN)",
      "Ustekinumab (genetical recombination) [Ustekinumab biosimilar 1] (JAN)",
      "Ustekinumab (genetical recombination) [Ustekinumab biosimilar 2] (JAN)",
      "Ustekinumab (genetical recombination) [Ustekinumab biosimilar 3] (JAN)",
      "Ustekinumab (genetical recombination) [Ustekinumab biosimilar 4] (JAN)",
      "Ustekinumab-aauz",
      "Ustekinumab-auub",
      "Ustekinumab-ttwe",
      "Ustekinumab-aekn",
      "Ustekinumab-srlf",
      "Stelara (TN)",
      "Otulfi (TN)",
      "Pyzchiva (TN)",
      "Wezlana (TN)"
    ],
    "formula": "C6482H10004N1712O2016S46",
    "efficacy": "Antipsoriatic, Anti-IL12/IL23 antibody\nDISEASE   Psoriasis [DS:H01656]\nPsoriatic arthritis [DS:H01507]\nCrohn's disease [DS:H00286]\nUlcerative colitis [DS:H01466]\nTYPE      Bispecific antibody",
    "target": "IL12 [HSA:3592 3593] [KO:K05406 K05425]\nIL23A [HSA:51561] [KO:K05426]\nPATHWAY   hsa04060(3592+3593+51561)  Cytokine-cytokine receptor interaction\nhsa04630(3592+3593+51561)  JAK-STAT signaling pathway",
    "metabolism": "",
    "therapeutic_category": "3999",
    "atc_code": "L04AC05",
    "drug_class": [
      "Immunological agent",
      "Interleukin inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Ustekinumab"
  },
  {
    "kegg_id": "D09315",
    "name_en": "Canakinumab (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Canakinumab (genetical recombination) (JAN)",
      "Ilaris (TN)"
    ],
    "formula": "C6452H9958N1722O2010S42",
    "efficacy": "Anti-inflammatory disease, Anti-IL-1 beta antibody\nDISEASE   Cryopyrin-associated periodic syndromes [DS:H00282]\nTumor necrosis factor receptor associated periodic syndrome [DS:H00912]\nHyperimmunoglobulin D syndrome /Mevalonate kinase deficiency [DS:H00206]\nFamilial mediterranean fever [DS:H00288]\nSystemic juvenile idiopathic arthritis [DS:H01672]\nTYPE      Monoclonal antibody",
    "target": "IL1B [HSA:3553] [KO:K04519]\nPATHWAY   hsa04010(3553)  MAPK signaling pathway\nhsa04060(3553)  Cytokine-cytokine receptor interaction\nhsa04621(3553)  NOD-like receptor signaling pathway",
    "metabolism": "",
    "therapeutic_category": "3999",
    "atc_code": "L04AC08",
    "drug_class": [
      "Immunological agent",
      "Interleukin inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Canakinumab"
  },
  {
    "kegg_id": "D09967",
    "name_en": "Secukinumab (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Secukinumab (genetical recombination) (JAN)",
      "Cosentyx (TN)"
    ],
    "formula": "C6584H10134N1754O2042S44",
    "efficacy": "Antipsoriatic, Anti-IL-17A antibody\nDISEASE   Plaque psoriasis [DS:H01656]\nPsoriatic arthritis [DS:H01507]\nAnkylosing spondylitis [DS:H01674]\nTYPE      Monoclonal antibody",
    "target": "IL17A [HSA:3605] [KO:K05489]\nPATHWAY   hsa04060(3605)  Cytokine-cytokine receptor interaction\nhsa05323(3605)  Rheumatoid arthritis",
    "metabolism": "",
    "therapeutic_category": "3999",
    "atc_code": "L04AC10",
    "drug_class": [
      "Immunological agent",
      "Interleukin inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Secukinumab"
  },
  {
    "kegg_id": "D10061",
    "name_en": "Brodalumab (USAN)",
    "name_ja": "",
    "names_alt": [
      "Brodalumab (genetical recombination) (JAN)",
      "Siliq (TN)"
    ],
    "formula": "C6372H9840N1712O1988S52",
    "efficacy": "Antipsoriatic, Anti-IL-17A receptor antibody\nDISEASE   Plaque psoriasis [DS:H01656]\nTYPE      Monoclonal antibody",
    "target": "IL17RA (CD217) [HSA:23765] [KO:K05164]\nPATHWAY   hsa04060(23765)  Cytokine-cytokine receptor interaction\nhsa04657(23765)  IL-17 signaling pathway",
    "metabolism": "",
    "therapeutic_category": "3999",
    "atc_code": "L04AC12",
    "drug_class": [
      "Immunological agent",
      "Interleukin inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Brodalumab"
  },
  {
    "kegg_id": "D10071",
    "name_en": "Ixekizumab (USAN)",
    "name_ja": "",
    "names_alt": [
      "Ixekizumab (genetical recombination) (JAN)",
      "Taltz (TN)"
    ],
    "formula": "",
    "efficacy": "Antipsoriatic, Anti-IL-17A antibody\nDISEASE   Plaque psoriasis [DS:H01656]\nPsoriatic arthritis [DS:H01656]\nTYPE      Monoclonal antibody",
    "target": "IL17A [HSA:3605] [KO:K05489]\nPATHWAY   hsa04060(3605)  Cytokine-cytokine receptor interaction\nhsa04657(3605)  IL-17 signaling pathway",
    "metabolism": "",
    "therapeutic_category": "3999",
    "atc_code": "L04AC13",
    "drug_class": [
      "Immunological agent",
      "Interleukin inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Ixekizumab"
  },
  {
    "kegg_id": "D10161",
    "name_en": "Sarilumab (USAN)",
    "name_ja": "",
    "names_alt": [
      "Sarilumab (genetical receombination) (JAN)",
      "Kevzara (TN)"
    ],
    "formula": "C6388H9918N1718O1998S44",
    "efficacy": "Anti-inflammatory, Antirheumatic, Anti-IL-6 receptor antibody\nDISEASE   Rheumatoid arthritis [DS:H00630]\nTYPE      Monoclonal antibody",
    "target": "IL6R (CD126) [HSA:3570] [KO:K05055]\nPATHWAY   hsa04060(3570)  Cytokine-cytokine receptor interaction\nhsa04630(3570)  JAK-STAT signaling pathway",
    "metabolism": "",
    "therapeutic_category": "3999",
    "atc_code": "L04AC14",
    "drug_class": [
      "Immunological agent",
      "Interleukin inhibitor",
      "Anti-inflammatory",
      "Disease modifying anti-rheumatic drug (DMARD)"
    ],
    "cyp_enzymes": [],
    "search_name": "Sarilumab"
  },
  {
    "kegg_id": "D10438",
    "name_en": "Guselkumab (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Guselkumab (genetical recombination) (JAN)",
      "Tremfya (TN)"
    ],
    "formula": "C6402H9864N1676O1994S42",
    "efficacy": "Antipsoriatic, Anti-IL-23 antibody\nDISEASE   Plaque psoriasis [DS:H01656]\nTYPE      Monoclonal antibody",
    "target": "IL23A [HSA:51561] [KO:K05426]\nPATHWAY   hsa04060(51561)  Cytokine-cytokine receptor interaction\nhsa04630(51561)  JAK-STAT signaling pathway",
    "metabolism": "",
    "therapeutic_category": "3999",
    "atc_code": "L04AC16",
    "drug_class": [
      "Immunological agent",
      "Interleukin inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Guselkumab"
  },
  {
    "kegg_id": "D10400",
    "name_en": "Tildrakizumab (USAN)",
    "name_ja": "",
    "names_alt": [
      "Tildrakizumab (genetical recombination) (JAN)",
      "Tildrakizumab-asmn",
      "Ilumya (TN)"
    ],
    "formula": "C6426H9918N1698O2000S46",
    "efficacy": "Antipsoriatic, Immunosuppressant, Anti-IL-23 antibody\nDISEASE   Plaque psoriasis [DS:H01656]\nTYPE      Monoclonal antibody",
    "target": "IL23A [HSA:51561] [KO:K05426]\nPATHWAY   hsa04060(51561)  Cytokine-cytokine receptor interaction",
    "metabolism": "",
    "therapeutic_category": "3999",
    "atc_code": "L04AC17",
    "drug_class": [
      "Immunological agent",
      "Interleukin inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Tildrakizumab"
  },
  {
    "kegg_id": "D11052",
    "name_en": "Risankizumab (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Risankizumab (genetical recombination) (JAN)",
      "Risankizumab-rzaa",
      "Skyrizi (TN)"
    ],
    "formula": "C6476H9992N1720O2016S44",
    "efficacy": "Anti-inflammatory disease, Anti-IL-23 alpha antibody\nDISEASE   Plaque psoriasis [DS:H01656]\nPsoriatic arthritis [DS:H01507]\nCrohn's disease [DS:H00286]\nUlcerative colitis [DS:H01466]\nTYPE      Monoclonal antibody",
    "target": "IL23A [HSA:51561] [KO:K05426]\nPATHWAY   hsa04060(51561)  Cytokine-cytokine receptor interaction\nhsa04630(51561)  JAK-STAT signaling pathway\nhsa04659(51561)  Th17 cell differentiation",
    "metabolism": "",
    "therapeutic_category": "3999",
    "atc_code": "L04AC18",
    "drug_class": [
      "Immunological agent",
      "Interleukin inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Risankizumab"
  },
  {
    "kegg_id": "D11550",
    "name_en": "Bimekizumab (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Bimekizumab (genetical recombination) (JAN)",
      "Bimzelx (TN)"
    ],
    "formula": "C6552H10132N1750O2029S42",
    "efficacy": "Antipsoriatic, Anti-IL-17A/IL-17F antibody\nDISEASE   Plaque psoriasis [DS:H01656]\nTYPE      Monoclonal antibody",
    "target": "IL17A [HSA:3605] [KO:K05489]\nIL17F [HSA:112744] [KO:K05494]\nPATHWAY   hsa04060(112744+3605)  Cytokine-cytokine receptor interaction\nhsa04657(112744+3605)  IL-17 signaling pathway",
    "metabolism": "",
    "therapeutic_category": "3999",
    "atc_code": "L04AC21",
    "drug_class": [
      "Immunological agent",
      "Interleukin inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Bimekizumab"
  },
  {
    "kegg_id": "D12066",
    "name_en": "Spesolimab (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Spesolimab (genetical recombination) (JAN)",
      "Spesolimab-sbzo",
      "Spevigo (TN)"
    ],
    "formula": "C6480H9988N1736O2012S46",
    "efficacy": "Antipsoriatic, Anti-IL-36 receptor antagonist\nDISEASE   Generalized pustular psoriasis [DS:H01663]\nTYPE      Monoclonal antibody",
    "target": "IL1RL2 (IL-36R) [HSA:8808] [KO:K05172]\nPATHWAY   hsa04060(8808)  Cytokine-cytokine receptor interaction",
    "metabolism": "",
    "therapeutic_category": "3999",
    "atc_code": "L04AC22",
    "drug_class": [
      "Immunological agent",
      "Interleukin inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Spesolimab"
  },
  {
    "kegg_id": "D09033",
    "name_en": "Voclosporin (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Lupkynis (TN)"
    ],
    "formula": "C63H111N11O12",
    "efficacy": "Immunosuppressant, Calcineurin inhibitor\nDISEASE   Lupus nephritis [DS:H01500]",
    "target": "PPP3C/PPP3R/CHP [HSA:5530 5532 5533 5534 5535 11261 63928] [KO:K04348 K06268 K17610 K17611]\nPATHWAY   hsa04010(5530+5532+5533+5534+5535)  MAPK signaling pathway\nhsa04218(5530+5532+5533+5534+5535)  Cellular senescence\nhsa04380(5530+5532+5533+5534+5535)  Osteoclast differentiation\nhsa04650(5530+5532+5533+5534+5535)  Natural killer cell mediated cytotoxicity\nhsa04658(5530+5532+5533+5534+5535)  Th1 and Th2 cell differentiation\nhsa04659(5530+5532+5533+5534+5535)  Th17 cell differentiation\nhsa04660(5530+5532+5533+5534+5535)  T cell receptor signaling pathway",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "3999",
    "atc_code": "L04AD03",
    "drug_class": [
      "Immunological agent",
      "Calcineurin inhibitor",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Voclosporin"
  },
  {
    "kegg_id": "D04187",
    "name_en": "Fingolimod hydrochloride (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Gilenya (TN)"
    ],
    "formula": "C19H33NO2. HCl",
    "efficacy": "Immunosuppressant, Sphingosine-1-phosphate receptor agonist\nDISEASE   Multiple sclerosis [DS:H01490]",
    "target": "S1PR1 [HSA:1901] [KO:K04288]\nPATHWAY   hsa04071(1901)  Sphingolipid signaling pathway\nhsa04080(1901)  Neuroactive ligand-receptor interaction",
    "metabolism": "Enzyme: CYP4F2 [HSA:8529]",
    "therapeutic_category": "3999",
    "atc_code": "L04AE01",
    "drug_class": [
      "Metabolizing enzyme substrate",
      "CYP4F2 substrate"
    ],
    "cyp_enzymes": [
      "CYP4F2"
    ],
    "search_name": "Fingolimod hydrochloride"
  },
  {
    "kegg_id": "D11072",
    "name_en": "Siponimod fumarate (USAN)",
    "name_ja": "",
    "names_alt": [
      "Siponimod fumaric acid (JAN)",
      "Mayzent (TN)"
    ],
    "formula": "(C29H35F3N2O3)2. C4H4O4",
    "efficacy": "Immunomodulator, Sphingosine 1-phosphate receptor agonist\nDISEASE   Multiple sclerosis [DS:H01490]",
    "target": "S1PR1 [HSA:1901] [KO:K04288]\nS1PR5 [HSA:53637] [KO:K04295]\nPATHWAY   hsa04071(1901+53637)  Sphingolipid signaling pathway\nhsa04080(1901+53637)  Neuroactive ligand-receptor interaction",
    "metabolism": "Enzyme: CYP2C9 [HSA:1559]; CYP3A4 [HSA:1576]",
    "therapeutic_category": "3999",
    "atc_code": "L04AE03",
    "drug_class": [
      "Metabolizing enzyme substrate",
      "CYP2C9 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C9",
      "CYP3A4"
    ],
    "search_name": "Siponimod fumarate"
  },
  {
    "kegg_id": "D09783",
    "name_en": "Tofacitinib citrate (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Tasocitinib citrate",
      "Xeljanz (TN)"
    ],
    "formula": "C16H20N6O. C6H8O7",
    "efficacy": "Antirheumatic, Janus kinase (JAK) inhibitor\nDISEASE   Rheumatoid arthritis [DS:H00630]\nPsoriatic arthritis [DS:H01656]\nAnkylosing spondylitis [DS:H01674]\nUlcerative colitis [DS:H01466]\nJuvenile idiopathic arthritis [DS:H01672]",
    "target": "JAK1 [HSA:3716] [KO:K11217]\nJAK2 [HSA:3717] [KO:K04447]\nJAK3 [HSA:3718] [KO:K11218]\nTYK2 [HSA:7297] [KO:K11219]\nPATHWAY   hsa04062(3717+3718)  Chemokine signaling pathway\nhsa04630(3716+3717+3718+7297)  JAK-STAT signaling pathway",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]; CYP2C19 [HSA:1557]",
    "therapeutic_category": "3999",
    "atc_code": "L04AF01",
    "drug_class": [
      "Anti-inflammatory",
      "Disease modifying anti-rheumatic drug (DMARD)",
      "JAK inhibitor",
      "Metabolizing enzyme substrate",
      "CYP2C19 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C19",
      "CYP3A4"
    ],
    "search_name": "Tofacitinib citrate"
  },
  {
    "kegg_id": "D10308",
    "name_en": "Baricitinib (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Olumiant (TN)"
    ],
    "formula": "C16H17N7O2S",
    "efficacy": "Anti-inflammatory, Antirheumatic, Immunosuppressant, Janus kinase (JAK) inhibitor\nDISEASE   Rheumatoid arthritis [DS:H00630]\nCoronavirus disease 2019 [DS:H02398]\nAlopecia areata [DS:H01158]",
    "target": "JAK1 [HSA:3716] [KO:K11217]\nJAK2 [HSA:3717] [KO:K04447]\nPATHWAY   hsa04062(3717)  Chemokine signaling pathway\nhsa04380(3716)  Osteoclast differentiation\nhsa04630(3716+3717)  JAK-STAT signaling pathway\nhsa05171(3716)  Coronavirus disease - COVID-19",
    "metabolism": "Transporter: ABCB1 [HSA:5243], ABCG2 [HSA:9429], SLC22A8 [HSA:9376], SLC47A2 [HSA:146802]",
    "therapeutic_category": "3999",
    "atc_code": "L04AF02",
    "drug_class": [
      "Anti-inflammatory",
      "Disease modifying anti-rheumatic drug (DMARD)",
      "JAK inhibitor",
      "Dermatological agent",
      "Atopic dermatitis agent",
      "Transporter substrate",
      "ABCB1 substrate",
      "ABCG2 substrate",
      "SLC22A8 substrate",
      "SLC47A2 substrate"
    ],
    "cyp_enzymes": [],
    "search_name": "Baricitinib"
  },
  {
    "kegg_id": "D11048",
    "name_en": "Upadacitinib hydrate (JAN)",
    "name_ja": "",
    "names_alt": [
      "Upadacitinib hemihydrate",
      "Rinvoq (TN)"
    ],
    "formula": "(C17H19F3N6O)2. H2O",
    "efficacy": "Antirheumatic, Janus kinase (JAK) inhibitor\nDISEASE   Rheumatoid arthritis [DS:H00630]\nPsoriatic arthritis [DS:H01507]\nAtopic dermatitis [DS:H01358]\nUlcerative colitis [DS:H01466]\nAnkylosing spondylitis [DS:H01674]",
    "target": "JAK1 [HSA:3716] [KO:K11217]\nPATHWAY   hsa04630(3716)  JAK-STAT signaling pathway",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]; CYP2D6 [HSA:1565]",
    "therapeutic_category": "3999",
    "atc_code": "L04AF03",
    "drug_class": [
      "Anti-inflammatory",
      "Disease modifying anti-rheumatic drug (DMARD)",
      "JAK inhibitor",
      "Dermatological agent",
      "Atopic dermatitis agent",
      "Metabolizing enzyme substrate",
      "CYP2D6 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4",
      "CYP2D6"
    ],
    "search_name": "Upadacitinib hydrate"
  },
  {
    "kegg_id": "D11106",
    "name_en": "Filgotinib maleate (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Jyseleca (TN)"
    ],
    "formula": "C21H23N5O3S. C4H4O4",
    "efficacy": "Anti-inflammatory, Janus kinase (JAK) inhibitor",
    "target": "JAK1 [HSA:3716] [KO:K11217]\nJAK2 [HSA:3717] [KO:K04447]\nJAK3 [HSA:3718] [KO:K11218]\nTYK2 [HSA:7297] [KO:K11219]\nPATHWAY   hsa04630(3716+3717+3718+7297)  JAK-STAT signaling pathway\nhsa04658(3716+3717+3718+7297)  Th1 and Th2 cell differentiation\nhsa04659(3716+3717+3718+7297)  Th17 cell differentiation",
    "metabolism": "Enzyme: CES1 [HSA:1066], CES2 [HSA:8824]",
    "therapeutic_category": "3999",
    "atc_code": "L04AF04",
    "drug_class": [
      "Anti-inflammatory",
      "Disease modifying anti-rheumatic drug (DMARD)",
      "JAK inhibitor",
      "Metabolizing enzyme substrate",
      "CES substrate",
      "CES1 substrate",
      "CES2 substrate"
    ],
    "cyp_enzymes": [],
    "search_name": "Filgotinib maleate"
  },
  {
    "kegg_id": "D10721",
    "name_en": "Peficitinib hydrobromide (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Smyraf (TN)"
    ],
    "formula": "C18H22N4O2. HBr",
    "efficacy": "Antirheumatic, Immunosuppressant, Janus kinase (JAK) inhibitor",
    "target": "JAK1 [HSA:3716] [KO:K11217]\nJAK2 [HSA:3717] [KO:K04447]\nJAK3 [HSA:3718] [KO:K11218]",
    "metabolism": "",
    "therapeutic_category": "3999",
    "atc_code": "L04AF06",
    "drug_class": [
      "Anti-inflammatory",
      "Disease modifying anti-rheumatic drug (DMARD)",
      "JAK inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Peficitinib hydrobromide"
  },
  {
    "kegg_id": "D11817",
    "name_en": "Deucravacitinib (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Sotyktu (TN)"
    ],
    "formula": "C20H22N8O3",
    "efficacy": "Anti-inflammatory, Tyrosine kinase 2 inhibitor\nDISEASE   Plaque psoriasis [DS:H01656]",
    "target": "TYK2 [HSA:7297] [KO:K11219]\nPATHWAY   hsa04217(7297)  Necroptosis\nhsa04380(7297)  Osteoclast differentiation\nhsa04621(7297)  NOD-like receptor signaling pathway\nhsa04630(7297)  JAK-STAT signaling pathway\nhsa04658(7297)  Th1 and Th2 cell differentiation\nhsa04659(7297)  Th17 cell differentiation",
    "metabolism": "Enzyme: CYP1A2 [HSA:1544]; CYP2B6 [HSA:1555], CYP2D6 [HSA:1565], CES2 [HSA:8824], UGT1A9 [HSA:54600]",
    "therapeutic_category": "3999",
    "atc_code": "L04AF07",
    "drug_class": [
      "Metabolizing enzyme substrate",
      "CYP1A2 substrate",
      "CYP2B6 substrate",
      "CYP2D6 substrate",
      "CES substrate",
      "CES2 substrate",
      "UGT substrate",
      "UGT1A9 substrate"
    ],
    "cyp_enzymes": [
      "CYP2B6",
      "CYP1A2",
      "CYP2D6"
    ],
    "search_name": "Deucravacitinib"
  },
  {
    "kegg_id": "D11970",
    "name_en": "Ritlecitinib tosylate (USAN)",
    "name_ja": "",
    "names_alt": [
      "Ritlecitinib tosilate (JAN)",
      "Litfulo (TN)"
    ],
    "formula": "C15H19N5O. C7H8O3S",
    "efficacy": "Antirheumatic, Janus kinase (JAK) inhibitor\nDISEASE   Alopecia areata [DS:H01158]",
    "target": "JAK3 [HSA:3718] [KO:K11218]\nPATHWAY   hsa04062(3718)  Chemokine signaling pathway\nhsa04630(3718)  JAK-STAT signaling pathway",
    "metabolism": "",
    "therapeutic_category": "3999",
    "atc_code": "L04AF08",
    "drug_class": [
      "Anti-inflammatory",
      "Disease modifying anti-rheumatic drug (DMARD)",
      "JAK inhibitor",
      "Metabolizing enzyme inhibitor",
      "CYP1A2 inhibitor",
      "CYP3A/CYP3A4 inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Ritlecitinib tosylate"
  },
  {
    "kegg_id": "D03068",
    "name_en": "Belimumab (USAN)",
    "name_ja": "",
    "names_alt": [
      "Belimumab (genetical recombination) (JAN)",
      "Benlysta (TN)",
      "LymphoStat-B (TN)"
    ],
    "formula": "C6714H10428N1816O2102S52",
    "efficacy": "Immunosuppressant, Anti-BLyS antibody\nDISEASE   Systemic lupus erythematosus [DS:H00080]\nTYPE      Monoclonal antibody",
    "target": "TNFSF13B (BAFF, CD257) [HSA:10673] [KO:K05476]\nPATHWAY   hsa04060(10673)  Cytokine-cytokine receptor interaction\nhsa04064(10673)  NF-kappa B signaling pathway",
    "metabolism": "",
    "therapeutic_category": "3999",
    "atc_code": "L04AG04",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Belimumab"
  },
  {
    "kegg_id": "D11082",
    "name_en": "Anifrolumab (USAN)",
    "name_ja": "",
    "names_alt": [
      "Anifrolumab (genetical recombination) (JAN)",
      "Anifrolumab-fnia",
      "Saphnelo (TN)"
    ],
    "formula": "C6444H9964N1712O2018S44",
    "efficacy": "Immunomodulator, Anti-IFN-type 1 receptor antibody\nDISEASE   Systemic lupus erythematosus [DS:H00080]\nTYPE      Monoclonal antibody",
    "target": "IFNAR1 [HSA:3454] [KO:K05130]\nIFNAR2 [HSA:3455] [KO:K05131]\nPATHWAY   hsa04060(3454+3455)  Cytokine-cytokine receptor interaction",
    "metabolism": "",
    "therapeutic_category": "3999",
    "atc_code": "L04AG11",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Anifrolumab"
  },
  {
    "kegg_id": "D11613",
    "name_en": "Pegcetacoplan (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Empaveli (TN)"
    ],
    "formula": "C170H248N50O47S4. (C2H4O)n",
    "efficacy": "Complement inhibitor\nDISEASE   Paroxysmal nocturnal hemoglobinuria [DS:H01053]",
    "target": "C3 (C3b) [HSA:718] [KO:K03990]\nPATHWAY   hsa04610(718)  Complement and coagulation cascades",
    "metabolism": "",
    "therapeutic_category": "3999",
    "atc_code": "L04AJ03",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Pegcetacoplan"
  },
  {
    "kegg_id": "D11093",
    "name_en": "Avacopan (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Tavneos (TN)"
    ],
    "formula": "C33H35F4N3O2",
    "efficacy": "Anti-inflammatory, Complement C5a receptor antagonist",
    "target": "C5AR1 (CD88) [HSA:728] [KO:K04010]\nPATHWAY   hsa04080(728)  Neuroactive ligand-receptor interaction\nhsa04610(728)  Complement and coagulation cascades",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "3999",
    "atc_code": "L04AJ05",
    "drug_class": [
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Avacopan"
  },
  {
    "kegg_id": "D12356",
    "name_en": "Zilucoplan sodium (JAN)",
    "name_ja": "",
    "names_alt": [
      "Zilbrysq (TN)"
    ],
    "formula": "C172H274N24O55. 4Na",
    "efficacy": "Autoimmune disease treatment, Complement C5 inhibitor\nDISEASE   Generalized myasthenia gravis (antiacetylcholine receptor antibody positive) [DS:H01594]",
    "target": "C5 [HSA:727] [KO:K03994]\nPATHWAY   hsa04080(727)  Neuroactive ligand-receptor interaction\nhsa04610(727)  Complement and coagulation cascades\nhsa04613(727)  Neutrophil extracellular trap formation",
    "metabolism": "Enzyme: CYP4F2 [HSA:8529]",
    "therapeutic_category": "3999",
    "atc_code": "L04AJ06",
    "drug_class": [
      "Metabolizing enzyme substrate",
      "CYP4F2 substrate"
    ],
    "cyp_enzymes": [
      "CYP4F2"
    ],
    "search_name": "Zilucoplan sodium"
  },
  {
    "kegg_id": "D12252",
    "name_en": "Iptacopan hydrochloride (USAN)",
    "name_ja": "",
    "names_alt": [
      "Iptacopan hydrochloride hydrate (JAN)",
      "Iptacopan hydrochloride monohydrate",
      "Fabhalta (TN)"
    ],
    "formula": "C25H30N2O4. HCl. H2O",
    "efficacy": "Complement factor B inhibitor\nDISEASE   Paroxysmal nocturnal hemoglobinuria [DS:H01053]",
    "target": "CFB [HSA:629] [KO:K01335]\nPATHWAY   hsa04610(629)  Complement and coagulation cascades\nNETWORK   nt06513  Complement cascade",
    "metabolism": "Enzyme: CYP2C8 [HSA:1558]\nTransporter: SLCO1B1 [HSA:10599], SLCO1B3 [HSA:28234]",
    "therapeutic_category": "3999",
    "atc_code": "L04AJ08",
    "drug_class": [
      "Metabolizing enzyme substrate",
      "CYP2C8 substrate",
      "Metabolizing enzyme inhibitor",
      "CYP2C8 inhibitor",
      "Metabolizing enzyme inducer",
      "CYP3A/CYP3A4 inducer",
      "CYP3A4 inducer",
      "Transporter substrate",
      "SLCO1B1 substrate",
      "SLCO1B3 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C8"
    ],
    "search_name": "Iptacopan hydrochloride"
  },
  {
    "kegg_id": "D11641",
    "name_en": "Danicopan (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Voydeya (TN)"
    ],
    "formula": "C26H23BrFN7O3",
    "efficacy": "Complement factor D inhibitor\nDISEASE   Paroxysmal nocturnal hemoglobinuria [DS:H01053]",
    "target": "CFD [HSA:1675] [KO:K01334]\nPATHWAY   hsa04610(1675)  Complement and coagulation cascades",
    "metabolism": "",
    "therapeutic_category": "3999",
    "atc_code": "L04AJ09",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Danicopan"
  },
  {
    "kegg_id": "D00749",
    "name_en": "Leflunomide (JAN/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Arava (TN)"
    ],
    "formula": "C12H9F3N2O2",
    "efficacy": "Antirheumatic, Dihydroorotate dehydrogenase inhibitor\nDISEASE   Active rheumatoid arthritis [DS:H00630]",
    "target": "DHODH [HSA:1723] [KO:K00254]\nPATHWAY   hsa00240(1723)  Pyrimidine metabolism",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "3999",
    "atc_code": "L04AK01",
    "drug_class": [
      "Anti-inflammatory",
      "Disease modifying anti-rheumatic drug (DMARD)",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "Metabolizing enzyme inhibitor",
      "CYP2C9 inhibitor"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Leflunomide"
  },
  {
    "kegg_id": "D00238",
    "name_en": "Azathioprine (JP18/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Azasan (TN)",
      "Imuran (TN)",
      "Jayempi (TN)"
    ],
    "formula": "C9H7N7O2S",
    "efficacy": "Immunosuppressant, Nucleic acid biosynthesis inhibitor\nDISEASE   Prevention of rejection in renal homotransplantation [DS:H00083]\nRheumatoid arthritis [DS:H00630]",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3999",
    "atc_code": "L04AX01",
    "drug_class": [
      "Anti-inflammatory",
      "Disease modifying anti-rheumatic drug (DMARD)"
    ],
    "cyp_enzymes": [],
    "search_name": "Azathioprine"
  },
  {
    "kegg_id": "D01583",
    "name_en": "Pirfenidone (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Esbriet (TN)"
    ],
    "formula": "C12H11NO",
    "efficacy": "Analgesic, Antifibrotic, Anti-inflammatory, Antipyretic\nDISEASE   Idiopathic pulmonary fibrosis [DS:H01299]",
    "target": "TNF (TNFA, TNFSF2) [HSA:7124] [KO:K03156]\nIL1 [HSA:3552 3553] [KO:K04383 K04519]\nIL6 [HSA:3569] [KO:K05405]\nCCL2 [HSA:6347] [KO:K14624]\nIL10 [HSA:3586] [KO:K05443]\nPATHWAY   hsa04060(3552+3553+3569+3586+6347+7124)  Cytokine-cytokine receptor interaction\nhsa04218(3552+3569)  Cellular senescence\nhsa04350(7124)  TGF-beta signaling pathway\nhsa04640(3552+3553+3569+7124)  Hematopoietic cell lineage\nhsa04668(3553+3569+6347+7124)  TNF signaling pathway",
    "metabolism": "Enzyme: CYP1A2 [HSA:1544]; CYP2C9 [HSA:1559], CYP2C19 [HSA:1557], CYP2D6 [HSA:1565], CYP2E1 [HSA:1571]",
    "therapeutic_category": "3999",
    "atc_code": "L04AX05",
    "drug_class": [
      "Immunological agent",
      "Interleukin inhibitor",
      "Metabolizing enzyme substrate",
      "CYP1A2 substrate",
      "CYP2C9 substrate",
      "CYP2C19 substrate",
      "CYP2D6 substrate",
      "CYP2E1 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C19",
      "CYP1A2",
      "CYP2C9",
      "CYP2D6",
      "CYP2E1"
    ],
    "search_name": "Pirfenidone"
  },
  {
    "kegg_id": "D00314",
    "name_en": "Etidronate disodium (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Didronel (TN)"
    ],
    "formula": "C2H6O7P2. 2Na",
    "efficacy": "Antiresorptive, Osteoporosis agent\nDISEASE   Paget's disease of bone [DS:H00437]",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3999",
    "atc_code": "M05BA01",
    "drug_class": [
      "Musculo-skeletal system agent",
      "Osteoporosis agent",
      "Bisphosphonate"
    ],
    "cyp_enzymes": [],
    "search_name": "Etidronate disodium"
  },
  {
    "kegg_id": "D00941",
    "name_en": "Pamidronate disodium (USP)",
    "name_ja": "",
    "names_alt": [
      "Pamidronate disodium hydrate (JAN)",
      "Pamidronate disodium pentahydrate",
      "Aredia (TN)"
    ],
    "formula": "C3H9NO7P2. 5H2O. 2Na",
    "efficacy": "Antihypercalcemia, Antiresorptive, Farnesylpyrophosphate synthetase inhibitor\nDISEASE   Paget's disease of bone [DS:H00437]",
    "target": "FDPS [HSA:2224] [KO:K00787]\nPATHWAY   hsa00900(2224)  Terpenoid backbone biosynthesis",
    "metabolism": "",
    "therapeutic_category": "3999",
    "atc_code": "M05BA03",
    "drug_class": [
      "Musculo-skeletal system agent",
      "Osteoporosis agent",
      "Bisphosphonate"
    ],
    "cyp_enzymes": [],
    "search_name": "Pamidronate disodium"
  },
  {
    "kegg_id": "D00939",
    "name_en": "Alendronate sodium (USP)",
    "name_ja": "アレンドロン酸",
    "names_alt": [
      "Alendronate sodium hydrate (JP18)",
      "Binosto (TN)",
      "Fosamax (TN)"
    ],
    "formula": "C4H12NO7P2. 3H2O. Na",
    "efficacy": "Antiresorptive, Osteoporosis agent, Farnesylpyrophosphate synthetase inhibitor\nDISEASE   Osteoporosis [DS:H01593]\nGlucocorticoid-induced osteoporosis [DS:H01709]\nPaget's disease of bone [DS:H00437]",
    "target": "FDPS [HSA:2224] [KO:K00787]\nPATHWAY   hsa00900(2224)  Terpenoid backbone biosynthesis",
    "metabolism": "",
    "therapeutic_category": "3999",
    "atc_code": "M05BA04",
    "drug_class": [
      "Musculo-skeletal system agent",
      "Osteoporosis agent",
      "Bisphosphonate"
    ],
    "cyp_enzymes": [],
    "search_name": "Alendronate sodium"
  },
  {
    "kegg_id": "D04486",
    "name_en": "Ibandronate sodium (USAN)",
    "name_ja": "",
    "names_alt": [
      "Ibandronate sodium hydrate (JAN)",
      "Ibandronate sodium monohydrate",
      "Bondronat (TN)",
      "Boniva (TN)",
      "Bonviva (TN)"
    ],
    "formula": "C9H22NO7P2. Na. H2O",
    "efficacy": "Antiresorptive, Osteoporosis agent, Farnesylpyrophosphate synthetase inhibitor\nDISEASE   Osteoporosis [DS:H01593]",
    "target": "FDPS [HSA:2224] [KO:K00787]\nPATHWAY   hsa00900(2224)  Terpenoid backbone biosynthesis",
    "metabolism": "",
    "therapeutic_category": "3999",
    "atc_code": "M05BA06",
    "drug_class": [
      "Musculo-skeletal system agent",
      "Osteoporosis agent",
      "Bisphosphonate"
    ],
    "cyp_enzymes": [],
    "search_name": "Ibandronate sodium"
  },
  {
    "kegg_id": "D03234",
    "name_en": "Sodium risedronate hydrate (JP18)",
    "name_ja": "",
    "names_alt": [
      "Sodium risedronate hemipentahydrate",
      "Actonel (TN)"
    ],
    "formula": "(C7H10NO7P2. Na)2. 5H2O",
    "efficacy": "Antiresorptive, Osteoporosis agent, Farnesylpyrophosphate synthetase inhibitor\nDISEASE   Osteoporosis [DS:H01593]\nGlucocorticoid-induced osteoporosis [DS:H01709]\nPaget's disease of bone [DS:H00437]",
    "target": "FDPS [HSA:2224] [KO:K00787]\nPATHWAY   hsa00900(2224)  Terpenoid backbone biosynthesis",
    "metabolism": "",
    "therapeutic_category": "3999",
    "atc_code": "M05BA07",
    "drug_class": [
      "Musculo-skeletal system agent",
      "Osteoporosis agent",
      "Bisphosphonate"
    ],
    "cyp_enzymes": [],
    "search_name": "Sodium risedronate hydrate"
  },
  {
    "kegg_id": "D01968",
    "name_en": "Zoledronic acid (USAN)",
    "name_ja": "",
    "names_alt": [
      "Zoledronic acid hydrate (JAN)",
      "Zometa (TN)",
      "Reclast (TN)"
    ],
    "formula": "C5H10N2O7P2. H2O",
    "efficacy": "Antihypercalcemia, Antiresorptive, Farnesylpyrophosphate synthetase inhibitor\nDISEASE   Osteoporosis [DS:H01593]\nGlucocorticoid-induced osteoporosis [DS:H01709]\nPaget's disease of bone [DS:H00437]\nMultiple myeloma [DS:H00010]",
    "target": "FDPS [HSA:2224] [KO:K00787]\nPATHWAY   hsa00900(2224)  Terpenoid backbone biosynthesis",
    "metabolism": "",
    "therapeutic_category": "3999",
    "atc_code": "M05BA08",
    "drug_class": [
      "Musculo-skeletal system agent",
      "Osteoporosis agent",
      "Bisphosphonate"
    ],
    "cyp_enzymes": [],
    "search_name": "Zoledronic acid"
  },
  {
    "kegg_id": "D03684",
    "name_en": "Denosumab (USAN)",
    "name_ja": "",
    "names_alt": [
      "Denosumab (genetical recombination) (JAN)",
      "Denosumab (genetical recombination) [Denosumab biosimilar 1] (JAN)",
      "Denosumab-dssb",
      "Denosumab-bmwo",
      "Ospomyv (TN)",
      "Prolia (TN)",
      "Ranmark (TN)",
      "Xbryk (TN)",
      "Xgeva (TN)"
    ],
    "formula": "C6404H9912N1724O2004S50",
    "efficacy": "Osteoporosis agent, Anti-RANKL antibody\nDISEASE   Osteoporosis [DS:H01593]\nMultiple myeloma [DS:H00010]\nGiant cell tumor of bone [DS:H01470]\nTYPE      Monoclonal antibody",
    "target": "TNFSF11 (RANKL, CD254) [HSA:8600] [KO:K05473]\nPATHWAY   hsa04060(8600)  Cytokine-cytokine receptor interaction\nhsa04380(8600)  Osteoclast differentiation",
    "metabolism": "",
    "therapeutic_category": "3999",
    "atc_code": "M05BX04",
    "drug_class": [
      "Anti-inflammatory",
      "Disease modifying anti-rheumatic drug (DMARD)",
      "Musculo-skeletal system agent",
      "Osteoporosis agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Denosumab"
  },
  {
    "kegg_id": "D10913",
    "name_en": "Burosumab (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Burosumab (genetical recombination) (JAN)",
      "Burosumab-twza",
      "Crysvita (TN)"
    ],
    "formula": "",
    "efficacy": "Antifibroblast growth factor antibody\nDISEASE   X-linked hypophosphatemia [DS:H02143]\nTYPE      Monoclonal antibody",
    "target": "FGF23 [HSA:8074] [KO:K22428]\nPATHWAY   hsa04010(8074)  MAPK signaling pathway",
    "metabolism": "",
    "therapeutic_category": "3999",
    "atc_code": "M05BX05",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Burosumab"
  },
  {
    "kegg_id": "D10156",
    "name_en": "Romosozumab (USAN)",
    "name_ja": "",
    "names_alt": [
      "Romosozumab (genetical recombination) (JAN)",
      "Romosozumab-aqqg",
      "Evenity (TN)"
    ],
    "formula": "C6452H9926N1714O2040S54",
    "efficacy": "Osteoporosis agent, Anti-Sclerostin monoclonal antibody\nDISEASE   Osteoporosis [DS:H01593]\nTYPE      Monoclonal antibody",
    "target": "SOST [HSA:50964] [KO:K16834]\nPATHWAY   hsa04310(50964)  Wnt signaling pathway",
    "metabolism": "",
    "therapeutic_category": "3999",
    "atc_code": "M05BX06",
    "drug_class": [
      "Musculo-skeletal system agent",
      "Osteoporosis agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Romosozumab"
  },
  {
    "kegg_id": "D11190",
    "name_en": "Vosoritide (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Vosoritide (genetical recombination) (JAN)",
      "Voxzogo (TN)"
    ],
    "formula": "C176H290N56O51S3",
    "efficacy": "Achondroplasia therapeutic agent\nDISEASE   Achondroplasia [DS:H01749]",
    "target": "NPR2 [HSA:4882] [KO:K12324]\nPATHWAY   hsa04022(4882)  cGMP-PKG signaling pathway\nhsa04270(4882)  Vascular smooth muscle contraction\nhsa04921(4882)  Oxytocin signaling pathway",
    "metabolism": "",
    "therapeutic_category": "3999",
    "atc_code": "M05BX07",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Vosoritide"
  },
  {
    "kegg_id": "D02114",
    "name_en": "Hydroxychloroquine sulfate (JAN/USP)",
    "name_ja": "",
    "names_alt": [
      "Plaquenil (TN)"
    ],
    "formula": "C18H26ClN3O. H2SO4",
    "efficacy": "Antimalarial\nDISEASE   Malaria [DS:H00361]\nDiscoid lupus erythematosus [DS:H01595]\nSystemic lupus erythematosus [DS:H00080]\nRheumatoid arthritis [DS:H00630]",
    "target": "",
    "metabolism": "Enzyme: CYP2C8 [HSA:1558], CYP3A4 [HSA:1576]",
    "therapeutic_category": "3999",
    "atc_code": "P01BA02",
    "drug_class": [
      "Metabolizing enzyme substrate",
      "CYP2C8 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C8",
      "CYP3A4"
    ],
    "search_name": "Hydroxychloroquine sulfate"
  },
  {
    "kegg_id": "D00026",
    "name_en": "L-Cysteine (JP18)",
    "name_ja": "",
    "names_alt": [
      "Ecolan (TN)"
    ],
    "formula": "C3H7NO2S",
    "efficacy": "Sulfhydryl enzyme activator",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3999",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "L-Cysteine"
  },
  {
    "kegg_id": "D01146",
    "name_en": "Iguratimod (JAN/INN)",
    "name_ja": "",
    "names_alt": [],
    "formula": "C17H14N2O6S",
    "efficacy": "Antirheumatic, NF-kappa B inhibitor",
    "target": "NFKB1 [HSA:4790] [KO:K02580]\nPATHWAY   hsa04064(4790)  NF-kappa B signaling pathway\nhsa04380(4790)  Osteoclast differentiation",
    "metabolism": "Enzyme: NAT [HSA:9 10]",
    "therapeutic_category": "3999",
    "atc_code": "",
    "drug_class": [
      "Anti-inflammatory",
      "Disease modifying anti-rheumatic drug (DMARD)",
      "Metabolizing enzyme substrate",
      "NAT substrate"
    ],
    "cyp_enzymes": [],
    "search_name": "Iguratimod"
  },
  {
    "kegg_id": "D01392",
    "name_en": "Mizoribine (JP18/INN)",
    "name_ja": "",
    "names_alt": [
      "Bredinin (TN)"
    ],
    "formula": "C9H13N3O6",
    "efficacy": "Immunosuppressant, Inosine monophosphate synthetase inhibitor",
    "target": "IMPDH [HSA:3614 3615] [KO:K00088]\nPATHWAY   hsa00230(3614+3615)  Purine metabolism\nhsa01100(3614+3615)  Metabolic pathways",
    "metabolism": "",
    "therapeutic_category": "3999",
    "atc_code": "",
    "drug_class": [
      "Anti-inflammatory",
      "Disease modifying anti-rheumatic drug (DMARD)"
    ],
    "cyp_enzymes": [],
    "search_name": "Mizoribine"
  },
  {
    "kegg_id": "D01670",
    "name_en": "Nafamostat mesylate (USAN)",
    "name_ja": "",
    "names_alt": [
      "Nafamostat mesilate (JP18)",
      "Ronastat (TN)"
    ],
    "formula": "C19H17N5O2. (CH4SO3)2",
    "efficacy": "Anticoagulant, Antifibrinolytic, Serine protease inhibitor",
    "target": "serine proteases",
    "metabolism": "",
    "therapeutic_category": "3999",
    "atc_code": "",
    "drug_class": [
      "Blood modifier agent",
      "Antithrombotic agent",
      "Hemostatics",
      "Antifibrinolytic",
      "Serine protease inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Nafamostat mesylate"
  },
  {
    "kegg_id": "D01672",
    "name_en": "Gabexate mesilate (JP18)",
    "name_ja": "",
    "names_alt": [
      "Gabexate mesylate",
      "Arodate (TN)"
    ],
    "formula": "C16H23N3O4. CH4SO3",
    "efficacy": "Anticoagulant, Proteolytic enzyme inhibitor",
    "target": "KLKB1 [HSA:3818] [KO:K01324]\nKLK [HSA:3816 3817] [KO:K01325]\nPATHWAY   hsa04610(3818)  Complement and coagulation cascades",
    "metabolism": "",
    "therapeutic_category": "3999",
    "atc_code": "",
    "drug_class": [
      "Blood modifier agent",
      "Antithrombotic agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Gabexate mesilate"
  },
  {
    "kegg_id": "D01688",
    "name_en": "Epalrestat (JP18/INN)",
    "name_ja": "",
    "names_alt": [
      "Kinedak (TN)"
    ],
    "formula": "C15H13NO3S2",
    "efficacy": "Hypoglycemic, Aldose reductase inhibitor",
    "target": "AKR1B1 [HSA:231] [KO:K00011]\nPATHWAY   hsa00051(231)  Fructose and mannose metabolism\nhsa00052(231)  Galactose metabolism",
    "metabolism": "",
    "therapeutic_category": "3999",
    "atc_code": "",
    "drug_class": [
      "Antidiabetic agent",
      "Aldose reductase inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Epalrestat"
  },
  {
    "kegg_id": "D01918",
    "name_en": "Sivelestat sodium (USAN)",
    "name_ja": "",
    "names_alt": [
      "Sivelestat sodium hydrate (JP18)",
      "Sivelestat sodium for injection (JP18)",
      "Elaspol (TN)"
    ],
    "formula": "C20H21N2O7S. 4H2O. Na",
    "efficacy": "Anti-inflammatory disease, Elastase inhibitor",
    "target": "ELANE [HSA:1991] [KO:K01327]",
    "metabolism": "",
    "therapeutic_category": "3999",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Sivelestat sodium"
  },
  {
    "kegg_id": "D08754",
    "name_en": "L-Arginine and L-arginine hydrochloride",
    "name_ja": "",
    "names_alt": [
      "Argi-U (TN)"
    ],
    "formula": "",
    "efficacy": "Antihyperammonemic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3999",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "L-Arginine and L-arginine hydrochloride"
  },
  {
    "kegg_id": "D08856",
    "name_en": "Anamorelin hydrochloride (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Adlumiz (TN)"
    ],
    "formula": "C31H42N6O3. HCl",
    "efficacy": "Antineoplastic, Growth hormone secretagogue receptor (GHSR) agonist",
    "target": "GHSR [HSA:2693] [KO:K04284]\nPATHWAY   hsa04080(2693)  Neuroactive ligand-receptor interaction",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "3999",
    "atc_code": "",
    "drug_class": [
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Anamorelin hydrochloride"
  },
  {
    "kegg_id": "D09198",
    "name_en": "Minodronic acid hydrate (JAN)",
    "name_ja": "",
    "names_alt": [
      "Bonoteo (TN)",
      "Recalbon (TN)"
    ],
    "formula": "C9H12N2O7P2. H2O",
    "efficacy": "Antiresorptive, Osteoporosis agent, Farnesylpyrophosphate synthetase inhibitor",
    "target": "FDPS [HSA:2224] [KO:K00787]\nPATHWAY   hsa00900(2224)  Terpenoid backbone biosynthesis",
    "metabolism": "",
    "therapeutic_category": "3999",
    "atc_code": "",
    "drug_class": [
      "Musculo-skeletal system agent",
      "Osteoporosis agent",
      "Bisphosphonate"
    ],
    "cyp_enzymes": [],
    "search_name": "Minodronic acid hydrate"
  },
  {
    "kegg_id": "D09800",
    "name_en": "Condoliase (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Chondroitinase ABC",
      "Hernicore (TN)"
    ],
    "formula": "C5039H7770N1360O1525S22",
    "efficacy": "Lumbar disc herniation treatment, Proteoglycan modulator",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3999",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Condoliase"
  },
  {
    "kegg_id": "D09944",
    "name_en": "Ozoralizumab (USAN)",
    "name_ja": "",
    "names_alt": [
      "Ozoralizumab (genetical recombination) (JAN)",
      "Nanozora (TN)"
    ],
    "formula": "C1682H2608N472O538S12",
    "efficacy": "Anti-inflammatory, Anti-TNF-alpha antibody\nTYPE      Monoclonal antibody",
    "target": "TNF (TNFA, TNFSF2) [HSA:7124] [KO:K03156]\nPATHWAY   hsa04010(7124)  MAPK signaling pathway\nhsa04060(7124)  Cytokine-cytokine receptor interaction\nhsa04350(7124)  TGF-beta signaling pathway",
    "metabolism": "",
    "therapeutic_category": "3999",
    "atc_code": "",
    "drug_class": [
      "Anti-inflammatory",
      "Disease modifying anti-rheumatic drug (DMARD)",
      "TNF inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Ozoralizumab"
  },
  {
    "kegg_id": "D10573",
    "name_en": "Sodium hyaluronate crosslinked polymer (JAN)",
    "name_ja": "",
    "names_alt": [
      "Synvisc (TN)"
    ],
    "formula": "",
    "efficacy": "Joint function improving agent, Pain relief",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "3999",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Sodium hyaluronate crosslinked polymer"
  },
  {
    "kegg_id": "D11020",
    "name_en": "Diclofenac etalhyaluronate sodium (JAN)",
    "name_ja": "ジクロフェナク",
    "names_alt": [
      "Joycle (TN)"
    ],
    "formula": "",
    "efficacy": "Anti-inflammatory, Joint function improving agent",
    "target": "PTGS2 (COX2) [HSA:5743] [KO:K11987]\nMMP1 [HSA:4312] [KO:K01388]\nPATHWAY   hsa05323(4312)  Rheumatoid arthritis",
    "metabolism": "",
    "therapeutic_category": "3999",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Diclofenac etalhyaluronate sodium"
  },
  {
    "kegg_id": "D11523",
    "name_en": "Enarodustat (JAN)",
    "name_ja": "",
    "names_alt": [
      "Enaroy (TN)"
    ],
    "formula": "C17H16N4O4",
    "efficacy": "Anti-anemic, Hypoxia inducible factor-prolyl hydroxylase (HIF-PH) inhibitor",
    "target": "EGLN (HPH) [HSA:54583 112398 112399] [KO:K09592]\nPATHWAY   hsa04066(112398+112399+54583)  HIF-1 signaling pathway",
    "metabolism": "",
    "therapeutic_category": "3999",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Enarodustat"
  },
  {
    "kegg_id": "D11564",
    "name_en": "Upacicalcet sodium hydrate (JAN)",
    "name_ja": "",
    "names_alt": [
      "Upasita (TN)"
    ],
    "formula": "C11H13ClN3O6S. Na. xH2O",
    "efficacy": "Calcium sensing receptor agonist",
    "target": "CASR [HSA:846] [KO:K04612]\nPATHWAY   hsa04621(846)  NOD-like receptor signaling pathway\nhsa04928(846)  Parathyroid hormone synthesis, secretion and action\nNETWORK   nt06318  CaSR-PTH signaling",
    "metabolism": "",
    "therapeutic_category": "3999",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Upacicalcet sodium hydrate"
  },
  {
    "kegg_id": "D00034",
    "name_en": "Adenine (JAN/USP)",
    "name_ja": "",
    "names_alt": [
      "Leucon (TN)"
    ],
    "formula": "C5H5N5",
    "efficacy": "Cell activator",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "4191",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Adenine"
  },
  {
    "kegg_id": "D00287",
    "name_en": "Cyclophosphamide (USP)",
    "name_ja": "シクロホスファミド",
    "names_alt": [
      "Cyclophosphamide hydrate (JP18)",
      "Cytoxan (TN)",
      "Neosar (TN)"
    ],
    "formula": "C7H15Cl2N2O2P. H2O",
    "efficacy": "Antineoplastic, Alkylating agent, Immunosuppressant\nDISEASE   Hodgkin's disease [DS:H00007]\nBurkitt lymphoma [DS:H00008]\nMultiple myeloma [DS:H00010]\nChronic lymphocytic leukemia [DS:H00005]\nAcute myelogenous leukemia [DS:H00003]\nAcute lymphoblastic (stem-cell) leukemia [DS:H00001 H00002]\nMycosis fungoides [DS:H01463]\nNeuroblastoma [DS:H00043]\nAdenocarcinoma of the ovary [DS:H00027]\nRetinoblastoma [DS:H01513]\nCarcinoma of the breast [DS:H00031]\nNephrotic syndrome [DS:H01657]",
    "target": "DNA",
    "metabolism": "Enzyme: CYP2B6 [HSA:1555]; CYP2A6 [HSA:1548], CYP2C8 [HSA:1558], CYP2C9 [HSA:1559], CYP3A4 [HSA:1576]",
    "therapeutic_category": "4211",
    "atc_code": "L01AA01",
    "drug_class": [
      "Antineoplastic",
      "Alkylating agent",
      "Nitrogen mustard analog",
      "Isophosphoramide mustard analog",
      "Metabolizing enzyme substrate",
      "CYP2A6 substrate",
      "CYP2B6 substrate",
      "CYP2C8 substrate",
      "CYP2C9 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4",
      "CYP2B6",
      "CYP2A6",
      "CYP2C9",
      "CYP2C8"
    ],
    "search_name": "Cyclophosphamide"
  },
  {
    "kegg_id": "D00343",
    "name_en": "Ifosfamide (JAN/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Ifex (TN)"
    ],
    "formula": "C7H15Cl2N2O2P",
    "efficacy": "Antineoplastic, Alkylating agent\nDISEASE   Testicular cancer [DS:H00023]",
    "target": "DNA",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "4211",
    "atc_code": "L01AA06",
    "drug_class": [
      "Antineoplastic",
      "Alkylating agent",
      "Nitrogen mustard analog",
      "Isophosphoramide mustard analog",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Ifosfamide"
  },
  {
    "kegg_id": "D00583",
    "name_en": "Thiotepa (JAN/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Thioplex (TN)",
      "Tepadina (TN)",
      "Rethio (TN)"
    ],
    "formula": "C6H12N3PS",
    "efficacy": "Antineoplastic, Alkylating agent\nDISEASE   Beta-Thalassemia [DS:H00228]\nGraft rejection [DS:H00083]\nAdenocarcinoma of the breast or ovary [DS:H00031 H00027]\nPapillary carcinoma of the urinary bladder [DS:H00022]",
    "target": "DNA",
    "metabolism": "",
    "therapeutic_category": "4212",
    "atc_code": "L01AC01",
    "drug_class": [
      "Antineoplastic",
      "Alkylating agent",
      "Ethylene imine",
      "Thiotepa type ethylene imine"
    ],
    "cyp_enzymes": [],
    "search_name": "Thiotepa"
  },
  {
    "kegg_id": "D00248",
    "name_en": "Busulfan (JP18/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Myleran (TN)"
    ],
    "formula": "C6H14O6S2",
    "efficacy": "Antineoplastic, Alkylating agent, Immunosuppressant\nDISEASE   Chronic myelogenous (myeloid, myelocytic, granulocytic) leukemia [DS:H00004]",
    "target": "DNA",
    "metabolism": "",
    "therapeutic_category": "4213",
    "atc_code": "L01AB01",
    "drug_class": [
      "Antineoplastic",
      "Alkylating agent",
      "Methanesulfonate derivative"
    ],
    "cyp_enzymes": [],
    "search_name": "Busulfan"
  },
  {
    "kegg_id": "D00369",
    "name_en": "Melphalan (JP18/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Alkeran (TN)"
    ],
    "formula": "C13H18Cl2N2O2",
    "efficacy": "Antineoplastic, Alkylating agent\nDISEASE   Multiple myeloma [DS:H00010]\nCarcinoma of the ovary [DS:H00027]",
    "target": "DNA",
    "metabolism": "",
    "therapeutic_category": "4219",
    "atc_code": "L01AA03",
    "drug_class": [
      "Antineoplastic",
      "Alkylating agent",
      "Nitrogen mustard analog"
    ],
    "cyp_enzymes": [],
    "search_name": "Melphalan"
  },
  {
    "kegg_id": "D07085",
    "name_en": "Bendamustine hydrochloride (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Treanda (TN)",
      "Ribomustin (TN)"
    ],
    "formula": "C16H21Cl2N3O2. HCl",
    "efficacy": "Antineoplastic, Alkylating agent\nDISEASE   Chronic lymphocytic leukemia [DS:H00005]\nNon-Hodgkin lymphoma [DS:H02418]",
    "target": "DNA",
    "metabolism": "",
    "therapeutic_category": "4219",
    "atc_code": "L01AA09",
    "drug_class": [
      "Antineoplastic",
      "Alkylating agent",
      "Nitrogen mustard analog"
    ],
    "cyp_enzymes": [],
    "search_name": "Bendamustine hydrochloride"
  },
  {
    "kegg_id": "D11661",
    "name_en": "Bendamustine hydrochloride hydrate (JAN)",
    "name_ja": "",
    "names_alt": [
      "Bendamustine hydrochloride monohydrate",
      "Treakisym (TN)"
    ],
    "formula": "C16H21Cl2N3O2. HCl. H2O",
    "efficacy": "Antineoplastic, Alkylating agent",
    "target": "DNA",
    "metabolism": "",
    "therapeutic_category": "4219",
    "atc_code": "L01AA09",
    "drug_class": [
      "Antineoplastic",
      "Alkylating agent",
      "Nitrogen mustard analog"
    ],
    "cyp_enzymes": [],
    "search_name": "Bendamustine hydrochloride hydrate"
  },
  {
    "kegg_id": "D00254",
    "name_en": "Carmustine (JAN/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Bicnu (TN)",
      "Gliadel (TN)"
    ],
    "formula": "C5H9Cl2N3O2",
    "efficacy": "Antineoplastic, Alkylating agent\nDISEASE   Glioma [DS:H00042]\nGlioblastoma [DS:H00042]\nMedulloblastoma [DS:H01667]\nAstrocytoma [DS:H00042]\nEpendymoma [DS:H00042]\nMultiple myeloma [DS:H00010]\nHodgkin's lymphoma [DS:H00007]\nNon-Hodgkin's lymphomas [DS:H02418]",
    "target": "DNA",
    "metabolism": "",
    "therapeutic_category": "4219",
    "atc_code": "L01AD01",
    "drug_class": [
      "Antineoplastic",
      "Alkylating agent",
      "Nitrosourea"
    ],
    "cyp_enzymes": [],
    "search_name": "Carmustine"
  },
  {
    "kegg_id": "D05932",
    "name_en": "Streptozocin (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Streptozotocin",
      "Zanosar (TN)"
    ],
    "formula": "C8H15N3O7",
    "efficacy": "Antineoplastic, Alkylating agent\nDISEASE   Islet cell carcinoma of the pancreas [DS:H00045]",
    "target": "DNA",
    "metabolism": "",
    "therapeutic_category": "4219",
    "atc_code": "L01AD04",
    "drug_class": [
      "Antineoplastic",
      "Alkylating agent",
      "Nitrosourea"
    ],
    "cyp_enzymes": [],
    "search_name": "Streptozocin"
  },
  {
    "kegg_id": "D01059",
    "name_en": "Nimustine hydrochloride (JAN)",
    "name_ja": "",
    "names_alt": [
      "Nidran (TN)"
    ],
    "formula": "C9H13ClN6O2. HCl",
    "efficacy": "Antineoplastic, Alkylating agent",
    "target": "DNA",
    "metabolism": "",
    "therapeutic_category": "4219",
    "atc_code": "L01AD06",
    "drug_class": [
      "Antineoplastic",
      "Alkylating agent",
      "Nitrosourea"
    ],
    "cyp_enzymes": [],
    "search_name": "Nimustine hydrochloride"
  },
  {
    "kegg_id": "D01760",
    "name_en": "Ranimustine (JAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Cymerin (TN)"
    ],
    "formula": "C10H18ClN3O7",
    "efficacy": "Antineoplastic, Alkylating agent",
    "target": "DNA\nRNA",
    "metabolism": "",
    "therapeutic_category": "4219",
    "atc_code": "L01AD07",
    "drug_class": [
      "Antineoplastic",
      "Alkylating agent",
      "Nitrosourea"
    ],
    "cyp_enzymes": [],
    "search_name": "Ranimustine"
  },
  {
    "kegg_id": "D06067",
    "name_en": "Temozolomide (JP18/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Temodal (TN)",
      "Temodar (TN)"
    ],
    "formula": "C6H6N6O2",
    "efficacy": "Antineoplastic, Alkylating agent\nDISEASE   Glioblastoma [DS:H00042]\nAnaplastic astrocytoma [DS:H00042]",
    "target": "DNA",
    "metabolism": "",
    "therapeutic_category": "4219",
    "atc_code": "L01AX03",
    "drug_class": [
      "Antineoplastic",
      "Alkylating agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Temozolomide"
  },
  {
    "kegg_id": "D00288",
    "name_en": "Dacarbazine (JAN/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "DTIC-Dome (TN)"
    ],
    "formula": "C6H10N6O",
    "efficacy": "Antineoplastic, Alkylating agent\nDISEASE   Malignant melanoma [DS:H00038]\nHodgkin's disease [DS:H00007]",
    "target": "DNA\nRNA",
    "metabolism": "",
    "therapeutic_category": "4219",
    "atc_code": "L01AX04",
    "drug_class": [
      "Antineoplastic",
      "Alkylating agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Dacarbazine"
  },
  {
    "kegg_id": "D06397",
    "name_en": "Estramustine phosphate sodium hydrate (JAN)",
    "name_ja": "",
    "names_alt": [
      "Estramustine phosphate sodium monohydrate",
      "Estracyt (TN)",
      "Emcyt (TN)"
    ],
    "formula": "C23H30Cl2NO6P. 2Na. H2O",
    "efficacy": "Antineoplastic, Alkylating agent\nDISEASE   Carcinoma of the prostate [DS:H00024]",
    "target": "TUBB [HSA:10381 10382 10383 203068 347688 347733 7280 81027 84617] [KO:K07375]\nSRD5A2 [HSA:6716] [KO:K12344]",
    "metabolism": "",
    "therapeutic_category": "4219",
    "atc_code": "L01XX11",
    "drug_class": [
      "Antineoplastic",
      "Alkylating agent",
      "Nitrogen mustard analog"
    ],
    "cyp_enzymes": [],
    "search_name": "Estramustine phosphate sodium hydrate"
  },
  {
    "kegg_id": "D00161",
    "name_en": "Mercaptopurine (USP)",
    "name_ja": "",
    "names_alt": [
      "Mercaptopurine hydrate (JP18)",
      "Purinethol (TN)",
      "Purixan (TN)"
    ],
    "formula": "C5H4N4S. H2O",
    "efficacy": "Antineoplastic, Antimetabolite\nDISEASE   Acute lymphoblastic leukemia [DS:H00001 H00002]",
    "target": "HPRT1 [HSA:3251] [KO:K00760]\nPATHWAY   hsa00230(3251)  Purine metabolism",
    "metabolism": "",
    "therapeutic_category": "4221",
    "atc_code": "L01BB02",
    "drug_class": [
      "Antineoplastic",
      "Antimetabolite",
      "Nucleic acid derivative, antineoplastic"
    ],
    "cyp_enzymes": [],
    "search_name": "Mercaptopurine"
  },
  {
    "kegg_id": "D00584",
    "name_en": "Fluorouracil (JP18/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "5-FU (TN)",
      "Adrucil (TN)",
      "Carac (TN)",
      "Fluoroplex (TN)"
    ],
    "formula": "C4H3FN2O2",
    "efficacy": "Antineoplastic, Antimetabolite\nDISEASE   Superficial basal cell carcinomas [DS:H00039]",
    "target": "TYMS [HSA:7298] [KO:K00560]\nPATHWAY   hsa00240(7298)  Pyrimidine metabolism\nhsa00670(7298)  One carbon pool by folate",
    "metabolism": "Enzyme: DPYD [HSA:1806]",
    "therapeutic_category": "4223",
    "atc_code": "L01BC02",
    "drug_class": [
      "Antineoplastic",
      "Antimetabolite",
      "Nucleic acid derivative, antineoplastic",
      "Fluoropyrimidine antineoplastic",
      "Metabolizing enzyme substrate",
      "DPYD substrate"
    ],
    "cyp_enzymes": [],
    "search_name": "Fluorouracil"
  },
  {
    "kegg_id": "D01223",
    "name_en": "Capecitabine (JAN/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Xeloda (TN)"
    ],
    "formula": "C15H22FN3O6",
    "efficacy": "Antineoplastic, Antimetabolite\nDISEASE   Colorectal cancer [DS:H00020]\nBreast cancer [DS:H00031]\nGastric cancer [DS:H00018]\nEsophageal cancer [DS:H00017]\nPancreatic cancer [DS:H00019]",
    "target": "TYMS [HSA:7298] [KO:K00560]\nPATHWAY   hsa00240(7298)  Pyrimidine metabolism\nhsa00670(7298)  One carbon pool by folate",
    "metabolism": "Enzyme: CYP2C9 [HSA:1559]",
    "therapeutic_category": "4223",
    "atc_code": "L01BC06",
    "drug_class": [
      "Antineoplastic",
      "Antimetabolite",
      "Nucleic acid derivative, antineoplastic",
      "Fluoropyrimidine antineoplastic",
      "Metabolizing enzyme substrate",
      "CYP2C9 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C9"
    ],
    "search_name": "Capecitabine"
  },
  {
    "kegg_id": "D01309",
    "name_en": "Doxifluridine (JP18/INN)",
    "name_ja": "",
    "names_alt": [
      "Furtulon (TN)"
    ],
    "formula": "C9H11FN2O5",
    "efficacy": "Antineoplastic, Antimetabolite",
    "target": "TYMS [HSA:7298] [KO:K00560]\nPATHWAY   hsa00240(7298)  Pyrimidine metabolism\nhsa00670(7298)  One carbon pool by folate",
    "metabolism": "",
    "therapeutic_category": "4223",
    "atc_code": "",
    "drug_class": [
      "Antineoplastic",
      "Antimetabolite",
      "Nucleic acid derivative, antineoplastic",
      "Fluoropyrimidine antineoplastic"
    ],
    "cyp_enzymes": [],
    "search_name": "Doxifluridine"
  },
  {
    "kegg_id": "D00168",
    "name_en": "Cytarabine (JP18/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "ARA-C",
      "Depocyt (TN)"
    ],
    "formula": "C9H13N3O5",
    "efficacy": "Antineoplastic, Antimetabolite, DNA polymerase inhibitor\nDISEASE   Lymphomatous meningitis [DS:H01668]\nAcute myeloid leukemia [DS:H00003]\nChronic myelocytic leukemia [DS:H00004]",
    "target": "DNA polymerase",
    "metabolism": "",
    "therapeutic_category": "4224",
    "atc_code": "L01BC01",
    "drug_class": [
      "Antineoplastic",
      "Antimetabolite",
      "Nucleic acid derivative, antineoplastic",
      "Arabinofuranosyl type antineoplastic"
    ],
    "cyp_enzymes": [],
    "search_name": "Cytarabine"
  },
  {
    "kegg_id": "D03046",
    "name_en": "Cytarabine ocfosfate hydrate (JAN)",
    "name_ja": "",
    "names_alt": [
      "Cytarabine ocfosphate hydrate",
      "Fosteabine sodium monohydrate",
      "Starasid (TN)"
    ],
    "formula": "C27H49N3O8P. Na. H2O",
    "efficacy": "Antineoplastic, Antimetabolite",
    "target": "DNA polymerase",
    "metabolism": "",
    "therapeutic_category": "4224",
    "atc_code": "L01BC01",
    "drug_class": [
      "Antineoplastic",
      "Antimetabolite",
      "Nucleic acid derivative, antineoplastic",
      "Arabinofuranosyl type antineoplastic"
    ],
    "cyp_enzymes": [],
    "search_name": "Cytarabine ocfosfate hydrate"
  },
  {
    "kegg_id": "D01155",
    "name_en": "Gemcitabine hydrochloride (JAN/USP)",
    "name_ja": "",
    "names_alt": [
      "Gemzar (TN)"
    ],
    "formula": "C9H11F2N3O4. HCl",
    "efficacy": "Antineoplastic, Antimetabolite\nDISEASE   Ovarian cancer [DS:H00027]\nBreast cancer [DS:H00031]\nNon-small cell lung cancer [DS:H00014]\nPancreatic cancer [DS:H00019]",
    "target": "RRM1 [HSA:6240] [KO:K10807]\nPATHWAY   hsa00230(6240)  Purine metabolism\nhsa00240(6240)  Pyrimidine metabolism",
    "metabolism": "",
    "therapeutic_category": "4224",
    "atc_code": "L01BC05",
    "drug_class": [
      "Antineoplastic",
      "Antimetabolite",
      "Nucleic acid derivative, antineoplastic",
      "Arabinofuranosyl type antineoplastic"
    ],
    "cyp_enzymes": [],
    "search_name": "Gemcitabine hydrochloride"
  },
  {
    "kegg_id": "D01633",
    "name_en": "Enocitabine (JAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Sunrabin (TN)"
    ],
    "formula": "C31H55N3O6",
    "efficacy": "Antineoplastic, Antimetabolite\nDISEASE   Acute leukemia [DS:H00003 H00001 H00002]",
    "target": "DNA polymerase",
    "metabolism": "",
    "therapeutic_category": "4224",
    "atc_code": "",
    "drug_class": [
      "Antineoplastic",
      "Antimetabolite",
      "Nucleic acid derivative, antineoplastic",
      "Arabinofuranosyl type antineoplastic"
    ],
    "cyp_enzymes": [],
    "search_name": "Enocitabine"
  },
  {
    "kegg_id": "D06503",
    "name_en": "Pemetrexed sodium hydrate (JAN)",
    "name_ja": "",
    "names_alt": [
      "Pemetrexed disodium heptahydrate",
      "Alimta (TN)"
    ],
    "formula": "C20H19N5O6. 7H2O. 2Na",
    "efficacy": "Antineoplastic, Antimetabolite\nDISEASE   Non-small cell lung cancer [DS:H00014]\nMesothelioma [DS:H00015]",
    "target": "TYMS [HSA:7298] [KO:K00560]\nDHFR [HSA:1719 200895] [KO:K00287]\nGART [HSA:2618] [KO:K11787]\nPATHWAY   hsa00230(2618)  Purine metabolism\nhsa00670(1719+200895+2618+7298)  One carbon pool by folate\nhsa00790(1719+200895)  Folate biosynthesis",
    "metabolism": "",
    "therapeutic_category": "4229",
    "atc_code": "L01BA04",
    "drug_class": [
      "Antineoplastic",
      "Antimetabolite",
      "Folic acid analog"
    ],
    "cyp_enzymes": [],
    "search_name": "Pemetrexed sodium hydrate"
  },
  {
    "kegg_id": "D10596",
    "name_en": "Pemetrexed sodium hemipentahydrate (JAN)",
    "name_ja": "",
    "names_alt": [
      "Pemetrexed disodium hemipentahydrate"
    ],
    "formula": "(C20H19N5O6. 2Na)2. 5H2O",
    "efficacy": "Antineoplastic, Antimetabolite",
    "target": "TYMS [HSA:7298] [KO:K00560]\nDHFR [HSA:1719 200895] [KO:K00287]\nGART [HSA:2618] [KO:K11787]\nPATHWAY   hsa00230(2618)  Purine metabolism\nhsa00670(1719+200895+2618+7298)  One carbon pool by folate\nhsa00790(1719+200895)  Folate biosynthesis",
    "metabolism": "",
    "therapeutic_category": "4229",
    "atc_code": "L01BA04",
    "drug_class": [
      "Antineoplastic",
      "Antimetabolite",
      "Folic acid analog"
    ],
    "cyp_enzymes": [],
    "search_name": "Pemetrexed sodium hemipentahydrate"
  },
  {
    "kegg_id": "D05589",
    "name_en": "Pralatrexate (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "10-Propargyl-10-deazaaminopterin",
      "Folotyn (TN)"
    ],
    "formula": "C23H23N7O5",
    "efficacy": "Antineoplastic, Antimetabolite\nDISEASE   Peripheral T-cell lymphoma [DS:H01892]",
    "target": "DHFR [HSA:1719 200895] [KO:K00287]\nPATHWAY   hsa00670(1719+200895)  One carbon pool by folate\nhsa00790(1719+200895)  Folate biosynthesis",
    "metabolism": "",
    "therapeutic_category": "4229",
    "atc_code": "L01BA05",
    "drug_class": [
      "Antineoplastic",
      "Antimetabolite",
      "Folic acid analog",
      "Dihydrofolate reductase inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Pralatrexate"
  },
  {
    "kegg_id": "D01907",
    "name_en": "Fludarabine phosphate (JAN/USP)",
    "name_ja": "",
    "names_alt": [
      "Fludara (TN)"
    ],
    "formula": "C10H13FN5O7P",
    "efficacy": "Antineoplastic, Antimetabolite\nDISEASE   B-cell chronic lymphocytic leukemia [DS:H00005]",
    "target": "RRM1 [HSA:6240] [KO:K10807]\nDNA polymerase\nRNA polymerase\nPATHWAY   hsa00230(6240)  Purine metabolism\nhsa00240(6240)  Pyrimidine metabolism",
    "metabolism": "",
    "therapeutic_category": "4229",
    "atc_code": "L01BB05",
    "drug_class": [
      "Antineoplastic",
      "Antimetabolite",
      "Nucleic acid derivative, antineoplastic",
      "Arabinofuranosyl type antineoplastic"
    ],
    "cyp_enzymes": [],
    "search_name": "Fludarabine phosphate"
  },
  {
    "kegg_id": "D03546",
    "name_en": "Clofarabine (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Clolar (TN)"
    ],
    "formula": "C10H11ClFN5O3",
    "efficacy": "Antineoplastic, Antimetabolite\nDISEASE   Acute lymphoblastic leukemia [DS:H00001 H00002]",
    "target": "RRM1 [HSA:6240] [KO:K10807]\nPOLA [HSA:5422 23649] [KO:K02320 K02321]\nPATHWAY   hsa00230(6240)  Purine metabolism\nhsa00240(6240)  Pyrimidine metabolism\nhsa03030(23649+5422)  DNA replication",
    "metabolism": "",
    "therapeutic_category": "4229",
    "atc_code": "L01BB06",
    "drug_class": [
      "Antineoplastic",
      "Antimetabolite",
      "Nucleic acid derivative, antineoplastic",
      "Arabinofuranosyl type antineoplastic"
    ],
    "cyp_enzymes": [],
    "search_name": "Clofarabine"
  },
  {
    "kegg_id": "D05134",
    "name_en": "Nelarabine (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Nelzarabine (USAN)",
      "Arranon (TN)"
    ],
    "formula": "C11H15N5O5",
    "efficacy": "Antineoplastic, Antimetabolite\nDISEASE   T-cell acute lymphoblastic leukemia [DS:H00002]\nT-cell lymphoblastic lymphoma [DS:H00002]",
    "target": "DNA polymerase",
    "metabolism": "Enzyme: ADA [HSA:100]",
    "therapeutic_category": "4229",
    "atc_code": "L01BB07",
    "drug_class": [
      "Antineoplastic",
      "Antimetabolite",
      "Nucleic acid derivative, antineoplastic",
      "Arabinofuranosyl type antineoplastic",
      "Metabolizing enzyme substrate",
      "ADA substrate"
    ],
    "cyp_enzymes": [],
    "search_name": "Nelarabine"
  },
  {
    "kegg_id": "D02131",
    "name_en": "Tegafur and uracil",
    "name_ja": "",
    "names_alt": [
      "Uftoral (TN)"
    ],
    "formula": "C8H9FN2O3. C4H4N2O2",
    "efficacy": "Antineoplastic, Antimetabolite",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "4229",
    "atc_code": "L01BC53",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Tegafur and uracil"
  },
  {
    "kegg_id": "D06399",
    "name_en": "Tegafur, gimeracil and oteracil potassium",
    "name_ja": "",
    "names_alt": [
      "Ts-1 (TN)",
      "Teysuno (TN)"
    ],
    "formula": "",
    "efficacy": "Antineoplastic, Antimetabolite",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "4229",
    "atc_code": "L01BC53",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Tegafur, gimeracil and oteracil potassium"
  },
  {
    "kegg_id": "D00341",
    "name_en": "Hydroxyurea (USP)",
    "name_ja": "",
    "names_alt": [
      "Hydroxycarbamide (JAN/INN)",
      "Droxia (TN)",
      "Hydrea (TN)",
      "Siklos (TN)"
    ],
    "formula": "CH4N2O2",
    "efficacy": "Antineoplastic, Antimetabolite\nDISEASE   Chronic myeloid leukemia [DS:H00004]\nSquamous cell carcinomas of the head and neck [DS:H02420]\nSickle cell anemia [DS:H00229]",
    "target": "RRM2 [HSA:6241] [KO:K10808]\nPATHWAY   hsa00230(6241)  Purine metabolism\nhsa00240(6241)  Pyrimidine metabolism\nhsa00480(6241)  Glutathione metabolism\nhsa04115(6241)  p53 signaling pathway",
    "metabolism": "",
    "therapeutic_category": "4229",
    "atc_code": "L01XX05",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Hydroxyurea"
  },
  {
    "kegg_id": "D00214",
    "name_en": "Dactinomycin (USP)",
    "name_ja": "",
    "names_alt": [
      "Actinomycin D (JP18)",
      "Cosmegen (TN)"
    ],
    "formula": "C62H86N12O16",
    "efficacy": "Antineoplastic\nDISEASE   Wilms tumor [DS:H02301]\nRhabdomyosarcoma [DS:H00037]\nEwings sarcoma [DS:H00035]\nTesticular cancer [DS:H00023]\nSolid malignancies [DS:H02421]",
    "target": "RNA polymerase",
    "metabolism": "",
    "therapeutic_category": "4233",
    "atc_code": "L01DA01",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Dactinomycin"
  },
  {
    "kegg_id": "D02177",
    "name_en": "Bleomycin sulfate (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Blenoxane (TN)"
    ],
    "formula": "C50H71N16O21S2R. xH2SO4",
    "efficacy": "Antibiotic, Antineoplastic\nDISEASE   Squamous cell carcinoma [DS:H00040]\nHodgkin's disease [DS:H00007]\nNon-Hodgkin's lymphoma [DS:H02418]\nTesticular carcinoma [DS:H00023]\nChoriocarcinoma [DS:H00028]",
    "target": "DNA",
    "metabolism": "",
    "therapeutic_category": "4234",
    "atc_code": "L01DC01",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Bleomycin sulfate"
  },
  {
    "kegg_id": "D03229",
    "name_en": "Bleomycin hydrochloride (JP18)",
    "name_ja": "",
    "names_alt": [
      "BLM",
      "Bleo (TN)"
    ],
    "formula": "C50H71N16O21S2R. xHCl",
    "efficacy": "Antibiotic, Antineoplastic",
    "target": "DNA",
    "metabolism": "",
    "therapeutic_category": "4234",
    "atc_code": "L01DC01",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Bleomycin hydrochloride"
  },
  {
    "kegg_id": "D01275",
    "name_en": "Doxorubicin hydrochloride (JP18/USP)",
    "name_ja": "ドキソルビシン",
    "names_alt": [
      "Adriacin (TN)",
      "Adriamycin (TN)",
      "Doxil (TN)",
      "Rubex (TN)"
    ],
    "formula": "C27H29NO11. HCl",
    "efficacy": "Antineoplastic, Topoisomerase II inhibitor\nDISEASE   Ovarian cancer [DS:H00027]\nAIDS-related Kaposi's sarcoma [DS:H00041]\nMultiple myeloma [DS:H00010]\nAcute lymphoblastic leukemia [DS:H00001 H00002]\nAcute myeloblastic leukemia [DS:H00003]\nHodgkin lymphoma [DS:H00007]\nNon-Hodgkin lymphoma [DS:H02418]\nBreast cancer [DS:H00031]\nWilms' tumor [DS:H02301]\nNeuroblastoma [DS:H00043]\nSoft tissue sarcoma [DS:H02427]\nOvarian carcinoma [DS:H00027]\nTransitional cell bladder carcinoma [DS:H00022]\nThyroid carcinoma [DS:H00032]\nGastric carcinoma [DS:H00018]",
    "target": "TOP2 [HSA:7153 7155] [KO:K03164]",
    "metabolism": "",
    "therapeutic_category": "4235",
    "atc_code": "L01DB01",
    "drug_class": [
      "Antineoplastic",
      "Anthracycline antineoplastic",
      "Topoisomerase inhibitor",
      "Topoisomerase II inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Doxorubicin hydrochloride"
  },
  {
    "kegg_id": "D01264",
    "name_en": "Daunorubicin hydrochloride (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Cerubidine (TN)"
    ],
    "formula": "C27H29NO10. HCl",
    "efficacy": "Antineoplastic, Topoisomerase II inhibitor\nDISEASE   Acute nonlymphocytic leukemia, myelogenous [DS:H00003]\nAcute lymphocytic leukemia [DS:H00001 H00002]",
    "target": "TOP2 [HSA:7153 7155] [KO:K03164]",
    "metabolism": "",
    "therapeutic_category": "4235",
    "atc_code": "L01DB02",
    "drug_class": [
      "Antineoplastic",
      "Anthracycline antineoplastic",
      "Topoisomerase inhibitor",
      "Topoisomerase II inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Daunorubicin hydrochloride"
  },
  {
    "kegg_id": "D02214",
    "name_en": "Epirubicin hydrochloride (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "EPI",
      "Ellence (TN)"
    ],
    "formula": "C27H29NO11. HCl",
    "efficacy": "Antineoplastic, Topoisomerase II inhibitor\nDISEASE   Breast cancer [DS:H00031]",
    "target": "TOP2 [HSA:7153 7155] [KO:K03164]",
    "metabolism": "",
    "therapeutic_category": "4235",
    "atc_code": "L01DB03",
    "drug_class": [
      "Antineoplastic",
      "Anthracycline antineoplastic",
      "Topoisomerase inhibitor",
      "Topoisomerase II inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Epirubicin hydrochloride"
  },
  {
    "kegg_id": "D01911",
    "name_en": "Aclarubicin hydrochloride (JP18)",
    "name_ja": "",
    "names_alt": [
      "Aclacinon (TN)"
    ],
    "formula": "C42H53NO15. HCl",
    "efficacy": "Antineoplastic, Topoisomerase inhibitor",
    "target": "TOP1 [HSA:7150] [KO:K03163]\nTOP2 [HSA:7153 7155] [KO:K03164]",
    "metabolism": "",
    "therapeutic_category": "4235",
    "atc_code": "L01DB04",
    "drug_class": [
      "Antineoplastic",
      "Anthracycline antineoplastic",
      "Topoisomerase inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Aclarubicin hydrochloride"
  },
  {
    "kegg_id": "D01747",
    "name_en": "Idarubicin hydrochloride (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Idamycin (TN)"
    ],
    "formula": "C26H27NO9. HCl",
    "efficacy": "Antineoplastic, Topoisomerase II inhibitor\nDISEASE   Acute myeloid leukemia [DS:H00003]",
    "target": "TOP2 [HSA:7153 7155] [KO:K03164]",
    "metabolism": "",
    "therapeutic_category": "4235",
    "atc_code": "L01DB06",
    "drug_class": [
      "Antineoplastic",
      "Anthracycline antineoplastic",
      "Topoisomerase inhibitor",
      "Topoisomerase II inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Idarubicin hydrochloride"
  },
  {
    "kegg_id": "D08386",
    "name_en": "Pirarubicin hydrochloride",
    "name_ja": "",
    "names_alt": [
      "Pinorubin (TN)",
      "Therarubicin (TN)"
    ],
    "formula": "C32H37NO12. HCl",
    "efficacy": "Antibiotic, Antineoplastic, Topoisomerase II inhibitor",
    "target": "TOP2 [HSA:7153 7155] [KO:K03164]",
    "metabolism": "",
    "therapeutic_category": "4235",
    "atc_code": "L01DB08",
    "drug_class": [
      "Antineoplastic",
      "Anthracycline antineoplastic",
      "Topoisomerase inhibitor",
      "Topoisomerase II inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Pirarubicin hydrochloride"
  },
  {
    "kegg_id": "D07100",
    "name_en": "Amrubicin hydrochloride (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Calsed (TN)"
    ],
    "formula": "C25H25NO9. HCl",
    "efficacy": "Antineoplastic, Topoisomerase II inhibitor",
    "target": "TOP2 [HSA:7153 7155] [KO:K03164]",
    "metabolism": "",
    "therapeutic_category": "4235",
    "atc_code": "L01DB10",
    "drug_class": [
      "Antineoplastic",
      "Anthracycline antineoplastic",
      "Topoisomerase inhibitor",
      "Topoisomerase II inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Amrubicin hydrochloride"
  },
  {
    "kegg_id": "D08933",
    "name_en": "Inotuzumab ozogamicin (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Inotuzumab ozogamicin (genetical recombination) (JAN)",
      "Besponsa (TN)"
    ],
    "formula": "C6518H10002N1738O2036S42",
    "efficacy": "Antineoplastic, DNA synthesis inhibitor, Anti-CD22 antibody\nDISEASE   B-cell precursor acute lymphoblastic leukemia [DS:H00001]\nTYPE      Antibody-drug conjugate",
    "target": "CD22 (SIGLEC2) [HSA:933] [KO:K06467]\nPATHWAY   hsa04514(933)  Cell adhesion molecule (CAM) interaction\nhsa04640(933)  Hematopoietic cell lineage\nhsa04662(933)  B cell receptor signaling pathway",
    "metabolism": "",
    "therapeutic_category": "4239",
    "atc_code": "L01FB01",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Inotuzumab ozogamicin"
  },
  {
    "kegg_id": "D03259",
    "name_en": "Gemtuzumab ozogamicin (USAN)",
    "name_ja": "",
    "names_alt": [
      "Gemtuzumab ozogamicin (genetical recombination) (JAN)",
      "Gemtuzumab (INN)",
      "Mylotarg (TN)"
    ],
    "formula": "",
    "efficacy": "Antineoplastic, Anti-CD33 antibody\nDISEASE   Acute myeloid leukemia (CD33 positive) [DS:H00003]\nTYPE      Antibody-drug conjugate",
    "target": "CD33 (SIGLEC3) [HSA:945] [KO:K06473]\nPATHWAY   hsa04640(945)  Hematopoietic cell lineage",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "4239",
    "atc_code": "L01FX02",
    "drug_class": [
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Gemtuzumab ozogamicin"
  },
  {
    "kegg_id": "D01068",
    "name_en": "Vinblastine sulfate (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Exal (TN)",
      "Velban (TN)"
    ],
    "formula": "C46H58N4O9. H2SO4",
    "efficacy": "Antineoplastic, Tubulin polymerization inhibitor\nDISEASE   Hodgkin's disease [DS:H00007]\nMycosis fungoides [DS:H01463]\nCarcinoma of the testis [DS:H00023]\nKaposi's sarcoma [DS:H00041]\nLetterer-Siwe disease [DS:H01512]\nChoriocarcinoma [DS:H00028]\nCarcinoma of the breast [DS:H00031]",
    "target": "TUBB [HSA:10381 10382 10383 203068 347688 347733 7280 81027 84617] [KO:K07375]\nPATHWAY   hsa04540(10381+10382+10383+203068+347688+347733+7280+81027+84617)  Gap junction",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "4240",
    "atc_code": "L01CA01",
    "drug_class": [
      "Antineoplastic",
      "Vinca alkaloid antineoplastic",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Vinblastine sulfate"
  },
  {
    "kegg_id": "D02197",
    "name_en": "Vincristine sulfate (JP18/USP)",
    "name_ja": "ビンクリスチン",
    "names_alt": [
      "VCR",
      "Marqibo (TN)",
      "Oncovin (TN)",
      "Vincasar (TN)",
      "Vincrex (TN)"
    ],
    "formula": "C46H56N4O10. H2SO4",
    "efficacy": "Antineoplastic, Tubulin polymerization inhibitor\nDISEASE   Acute lymphoblastic leukemia (Philadelphia chromosome negative) [DS:H00001 H00002]\nHodgkin's disease [DS:H00007]\nNon–Hodgkin's malignant lymphomas [DS:H02418]\nRhabdomyosarcoma [DS:H00037]\nNeuroblastoma [DS:H00043]\nWilms' tumor [DS:H02301]",
    "target": "TUBB [HSA:10381 10382 10383 203068 347688 347733 7280 81027 84617] [KO:K07375]\nPATHWAY   hsa04540(10381+10382+10383+203068+347688+347733+7280+81027+84617)  Gap junction",
    "metabolism": "Enzyme: CYP3A [HSA:1576 1577 1551]",
    "therapeutic_category": "4240",
    "atc_code": "L01CA02",
    "drug_class": [
      "Antineoplastic",
      "Vinca alkaloid antineoplastic",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A"
    ],
    "search_name": "Vincristine sulfate"
  },
  {
    "kegg_id": "D01769",
    "name_en": "Vindesine sulfate (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Fildesin (TN)"
    ],
    "formula": "C43H55N5O7. H2SO4",
    "efficacy": "Antineoplastic, Tubulin polymerization inhibitor",
    "target": "TUBB [HSA:10381 10382 10383 203068 347688 347733 7280 81027 84617] [KO:K07375]\nPATHWAY   hsa04540(10381+10382+10383+203068+347688+347733+7280+81027+84617)  Gap junction",
    "metabolism": "Enzyme: CYP3A [HSA:1576 1577 1551]",
    "therapeutic_category": "4240",
    "atc_code": "L01CA03",
    "drug_class": [
      "Antineoplastic",
      "Vinca alkaloid antineoplastic",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A"
    ],
    "search_name": "Vindesine sulfate"
  },
  {
    "kegg_id": "D01935",
    "name_en": "Vinorelbine tartrate (USP)",
    "name_ja": "",
    "names_alt": [
      "Vinorelbine ditartrate (JAN)",
      "KW 2307",
      "Navelbine (TN)"
    ],
    "formula": "C45H54N4O8. (C4H6O6)2",
    "efficacy": "Antineoplastic, Tubulin polymerization inhibitor\nDISEASE   Non-small cell lung cancer [DS:H00014]",
    "target": "TUBB [HSA:10381 10382 10383 203068 347688 347733 7280 81027 84617] [KO:K07375]\nPATHWAY   hsa04540(10381+10382+10383+203068+347688+347733+7280+81027+84617)  Gap junction",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "4240",
    "atc_code": "L01CA04",
    "drug_class": [
      "Antineoplastic",
      "Vinca alkaloid antineoplastic",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Vinorelbine tartrate"
  },
  {
    "kegg_id": "D00125",
    "name_en": "Etoposide (JP18/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Vepesid (TN)"
    ],
    "formula": "C29H32O13",
    "efficacy": "Antineoplastic, Topoisomerase II inhibitor\nDISEASE   Testicular tumors [DS:H00023]\nSmall cell lung cancer [DS:H00013]",
    "target": "TOP2 [HSA:7153 7155] [KO:K03164]",
    "metabolism": "",
    "therapeutic_category": "4240",
    "atc_code": "L01CB01",
    "drug_class": [
      "Antineoplastic",
      "Topoisomerase inhibitor",
      "Topoisomerase II inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Etoposide"
  },
  {
    "kegg_id": "D00491",
    "name_en": "Paclitaxel (JAN/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Abraxane (TN)",
      "Taxol (TN)"
    ],
    "formula": "C47H51NO14",
    "efficacy": "Antineoplastic, Tubulin depolymerization inhibitor\nDISEASE   Breast cancer [DS:H00031]\nNon-small cell lung cancer [DS:H00014]\nAdenocarcinoma of the pancreas [DS:H00019]\nCarcinoma of the ovary [DS:H00027]\nAIDS-related Kaposi's sarcoma [DS:H00041]",
    "target": "TUBB [HSA:10381 10382 10383 203068 347688 347733 7280 81027 84617] [KO:K07375]\nPATHWAY   hsa04540(10381+10382+10383+203068+347688+347733+7280+81027+84617)  Gap junction",
    "metabolism": "Enzyme: CYP2C8 [HSA:1558], CYP3A4 [HSA:1576]",
    "therapeutic_category": "4240",
    "atc_code": "L01CD01",
    "drug_class": [
      "Metabolizing enzyme substrate",
      "CYP2C8 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C8",
      "CYP3A4"
    ],
    "search_name": "Paclitaxel"
  },
  {
    "kegg_id": "D02165",
    "name_en": "Docetaxel (USP)",
    "name_ja": "",
    "names_alt": [
      "Docetaxel hydrate (JP18)",
      "Docetaxel trihydrate",
      "Taxotere (TN)"
    ],
    "formula": "C43H53NO14. 3H2O",
    "efficacy": "Antineoplastic, Tubulin depolymerization inhibitor\nDISEASE   Breast cancer [DS:H00031]\nNon-small cell lung cancer [DS:H00014]\nProstate cancer [DS:H00024]\nGastric adenocarcinoma [DS:H00018]\nHead and neck cancer [DS:H02420]",
    "target": "TUBB [HSA:10381 10382 10383 203068 347688 347733 7280 81027 84617] [KO:K07375]\nPATHWAY   hsa04540(10381+10382+10383+203068+347688+347733+7280+81027+84617)  Gap junction",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "4240",
    "atc_code": "L01CD02",
    "drug_class": [
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Docetaxel"
  },
  {
    "kegg_id": "D07866",
    "name_en": "Docetaxel (JAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Taxotere (TN)"
    ],
    "formula": "C43H53NO14",
    "efficacy": "Antineoplastic, Tubulin depolymerization inhibitor\nDISEASE   Breast cancer [DS:H00031]\nNon-small cell lung cancer [DS:H00014]\nProstate cancer [DS:H00024]\nGastric adenocarcinoma [DS:H00018]\nHead and neck cancer [DS:H02420]",
    "target": "TUBB [HSA:10381 10382 10383 203068 347688 347733 7280 81027 84617] [KO:K07375]\nPATHWAY   hsa04540(10381+10382+10383+203068+347688+347733+7280+81027+84617)  Gap junction",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "4240",
    "atc_code": "L01CD02",
    "drug_class": [
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Docetaxel"
  },
  {
    "kegg_id": "D10452",
    "name_en": "Cabazitaxel acetonate (JAN)",
    "name_ja": "",
    "names_alt": [
      "Cabazitaxel acetone",
      "Jevtana (TN)"
    ],
    "formula": "C45H57NO14. C3H6O",
    "efficacy": "Antineoplastic, Tubulin depolymerization inhibitor\nDISEASE   Prostate cancer [DS:H00024]",
    "target": "TUBB [HSA:10381 10382 10383 203068 347688 347733 7280 81027 84617] [KO:K07375]\nPATHWAY   hsa04540(10381+10382+10383+203068+347688+347733+7280+81027+84617)  Gap junction",
    "metabolism": "Enzyme: CYP3A [HSA:1576 1577 1551]",
    "therapeutic_category": "4240",
    "atc_code": "L01CD04",
    "drug_class": [
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A"
    ],
    "search_name": "Cabazitaxel acetonate"
  },
  {
    "kegg_id": "D02168",
    "name_en": "Topotecan hydrochloride (USAN)",
    "name_ja": "",
    "names_alt": [
      "Nogitecan hydrochloride (JAN)",
      "Hycamtin (TN)",
      "Potactasol (TN)"
    ],
    "formula": "C23H23N3O5. HCl",
    "efficacy": "Antineoplastic, Topoisomerase I inhibitor\nDISEASE   Small cell lung cancer [DS:H00013]\nOvarian cancer [DS:H00027]\nCervical cancer [DS:H00030]",
    "target": "TOP1 [HSA:7150] [KO:K03163]",
    "metabolism": "Transporter: ABCB1 [HSA:5243], ABCG2 [HSA:9429], ABCC4 [HSA:10257]",
    "therapeutic_category": "4240",
    "atc_code": "L01CE01",
    "drug_class": [
      "Antineoplastic",
      "Topoisomerase inhibitor",
      "Topoisomerase I inhibitor",
      "Transporter substrate",
      "ABCB1 substrate",
      "ABCC4 substrate",
      "ABCG2 substrate"
    ],
    "cyp_enzymes": [],
    "search_name": "Topotecan hydrochloride"
  },
  {
    "kegg_id": "D01061",
    "name_en": "Irinotecan hydrochloride (USP)",
    "name_ja": "",
    "names_alt": [
      "Irinotecan hydrochloride hydrate (JP18)",
      "Irinotecan hydrochloride trihydrate",
      "CPT 11",
      "CPT-11",
      "Campto (TN)",
      "Camptosar (TN)",
      "Onivyde (TN)"
    ],
    "formula": "C33H38N4O6. 3H2O. HCl",
    "efficacy": "Antineoplastic, Topoisomerase I inhibitor\nDISEASE   Adenocarcinoma of the pancreas [DS:H00019]\nCarcinoma of the colon or rectum [DS:H00020]",
    "target": "TOP1 [HSA:7150] [KO:K03163]",
    "metabolism": "Enzyme: CES [HSA:1066 221223 23491 8824]; CYP3A4 [HSA:1576], UGT1A1 [HSA:54658]",
    "therapeutic_category": "4240",
    "atc_code": "L01CE02",
    "drug_class": [
      "Antineoplastic",
      "Topoisomerase inhibitor",
      "Topoisomerase I inhibitor",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "CES substrate",
      "UGT substrate",
      "UGT1A1 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Irinotecan hydrochloride"
  },
  {
    "kegg_id": "D00094",
    "name_en": "Tretinoin (JAN/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Avita (TN)",
      "Renova (TN)",
      "Retin A (TN)"
    ],
    "formula": "C20H28O2",
    "efficacy": "Antineoplastic, Keratolytic, Retinoic acid receptor (RAR) agonist\nDISEASE   Acne vulgaris [DS:H01445]",
    "target": "PML-RARA [HSA:5371 5914] [KO:K10054 K08527]\nNR1B (RAR) [HSA:5914 5915 5916] [KO:K08527 K08528 K08529]\nPATHWAY   hsa04659(5914)  Th17 cell differentiation\nhsa05200(5371+5914+5915)  Pathways in cancer\nhsa05202(5371+5914)  Transcriptional misregulation in cancer\nhsa05221(5371+5914)  Acute myeloid leukemia",
    "metabolism": "",
    "therapeutic_category": "4291",
    "atc_code": "D10AD01",
    "drug_class": [
      "Vitamin and mineral",
      "Retinol derivative"
    ],
    "cyp_enzymes": [],
    "search_name": "Tretinoin"
  },
  {
    "kegg_id": "D01370",
    "name_en": "Cladribine (JAN/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Leustatin (TN)",
      "Mavenclad (TN)"
    ],
    "formula": "C10H12ClN5O3",
    "efficacy": "Antineoplastic, Antimetabolite\nDISEASE   Hairy-cell leukemia [DS:H00006]\nMultiple sclerosis [DS:H01490]",
    "target": "RRM1 [HSA:6240] [KO:K10807]\nDNA polymerase\nPATHWAY   hsa00230(6240)  Purine metabolism\nhsa00240(6240)  Pyrimidine metabolism",
    "metabolism": "",
    "therapeutic_category": "4291",
    "atc_code": "L01BB04",
    "drug_class": [
      "Antineoplastic",
      "Antimetabolite",
      "Nucleic acid derivative, antineoplastic"
    ],
    "cyp_enzymes": [],
    "search_name": "Cladribine"
  },
  {
    "kegg_id": "D03021",
    "name_en": "Azacitidine (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Vidaza (TN)"
    ],
    "formula": "C8H12N4O5",
    "efficacy": "Antineoplastic, Antimetabolite\nDISEASE   Myelodysplastic syndrome [DS:H01481]",
    "target": "DNMT [HSA:1786 1788 1789] [KO:K00558 K17398 K17399]\nPATHWAY   hsa00270(1786+1788+1789)  Cysteine and methionine metabolism\nhsa05206(1786+1788+1789)  MicroRNAs in cancer",
    "metabolism": "",
    "therapeutic_category": "4291",
    "atc_code": "L01BC07",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Azacitidine"
  },
  {
    "kegg_id": "D06199",
    "name_en": "Trabectedin (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Yondelis (TN)"
    ],
    "formula": "C39H43N3O11S",
    "efficacy": "Antineoplastic, Alkylating agent\nDISEASE   Liposarcoma [DS:H02427]\nLeiomyosarcoma [DS:H02427]",
    "target": "DNA",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "4291",
    "atc_code": "L01CX01",
    "drug_class": [
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Trabectedin"
  },
  {
    "kegg_id": "D02166",
    "name_en": "Mitoxantrone hydrochloride (JAN/USP)",
    "name_ja": "",
    "names_alt": [
      "Novantron (TN)"
    ],
    "formula": "C22H28N4O6. 2HCl",
    "efficacy": "Antineoplastic, Topoisomerase II inhibitor\nDISEASE   Multiple sclerosis [DS:H01490]\nProstate cancer [DS:H00024]\nAcute leukemia [DS:H00003 H00001 H00002]",
    "target": "TOP2 [HSA:7153 7155] [KO:K03164]",
    "metabolism": "Transporter: ABCG2 [HSA:9429], ABCC2 [HSA:1244]",
    "therapeutic_category": "4291",
    "atc_code": "L01DB07",
    "drug_class": [
      "Antineoplastic",
      "Anthraquinone antineoplastic",
      "Topoisomerase inhibitor",
      "Topoisomerase II inhibitor",
      "Transporter substrate",
      "ABCC2 substrate",
      "ABCG2 substrate"
    ],
    "cyp_enzymes": [],
    "search_name": "Mitoxantrone hydrochloride"
  },
  {
    "kegg_id": "D01441",
    "name_en": "Imatinib mesylate (USAN)",
    "name_ja": "",
    "names_alt": [
      "Imatinib mesilate (JAN)",
      "Gleevec (TN)",
      "Glivec (TN)"
    ],
    "formula": "C29H31N7O. CH4SO3",
    "efficacy": "Antineoplastic, Tyrosine kinase inhibitor\nDISEASE   Chronic myeloid leukemia (Philadelphia chromosome positive) [DS:H00004]\nAcute lymphoblastic leukemia (Philadelphia chromosome positive) [DS:H00001]\nMyelodysplastic/myeloproliferative diseases [DS:H02410]\nMastocytosis [DS:H01511]\nHypereosinophilic syndrome (FIP1L1-PDGFRA positive) [DS:H01599]\nChronic eosinophilic leukemia (FIP1L1-PDGFRA positive) [DS:H01590]\nGastrointestinal stromal tumors (KIT positive) [DS:H01591]",
    "target": "BCR-ABL [HSA_VAR:25v1] [HSA:25] [KO:K06619]\nFIP1L1-PDGFRA [HSA:5156] [KO:K04363]\nKIT (CD117) [HSA:3815] [KO:K05091]\nPATHWAY   hsa04010(3815+5156)  MAPK signaling pathway\nhsa05200(25+3815+5156)  Pathways in cancer\nhsa05220(25)  Chronic myeloid leukemia\nNETWORK   nt06276  Chronic myeloid leukemia",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "4291",
    "atc_code": "L01EA01",
    "drug_class": [
      "Antineoplastic",
      "Tyrosine kinase inhibitor",
      "BCR-ABL inhibitor",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Imatinib mesylate"
  },
  {
    "kegg_id": "D03658",
    "name_en": "Dasatinib (JAN/INN)",
    "name_ja": "",
    "names_alt": [],
    "formula": "C22H26ClN7O2S",
    "efficacy": "Antineoplastic, Tyrosine kinase inhibitor",
    "target": "BCR-ABL [HSA_VAR:25v1] [HSA:25] [KO:K06619]\nKIT (CD117) [HSA:3815] [KO:K05091]\nSRC [HSA:6714] [KO:K05704]\nLCK [HSA:3932] [KO:K05856]\nYES1 [HSA:7525] [KO:K05705]\nFYN [HSA:2534] [KO:K05703]\nEPHA2 [HSA:1969] [KO:K05103]\nPDGFRB [HSA:5159] [KO:K05089]\nPATHWAY   hsa04010(1969+3815+5159)  MAPK signaling pathway\nhsa04012(25+6714)  ErbB signaling pathway\nhsa04370(6714)  VEGF signaling pathway\nhsa05200(25+3815+5159)  Pathways in cancer\nhsa05220(25)  Chronic myeloid leukemia",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576], FMO3 [HSA:2328], UGT [KO:K00699]",
    "therapeutic_category": "4291",
    "atc_code": "L01EA02",
    "drug_class": [
      "Antineoplastic",
      "Tyrosine kinase inhibitor",
      "BCR-ABL inhibitor",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "FMO substrate",
      "FMO3 substrate",
      "UGT substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Dasatinib"
  },
  {
    "kegg_id": "D06414",
    "name_en": "Dasatinib (USAN)",
    "name_ja": "",
    "names_alt": [
      "Dasatinib hydrate (JAN)",
      "Sprycel (TN)"
    ],
    "formula": "C22H26ClN7O2S. H2O",
    "efficacy": "Antineoplastic, Tyrosine kinase inhibitor\nDISEASE   Chronic myeloid leukemia (Philadelphia chromosome positive) [DS:H00004]\nAcute lymphoblastic leukemia (Philadelphia chromosome positive) [DS:H00001]",
    "target": "BCR-ABL [HSA_VAR:25v1] [HSA:25] [KO:K06619]\nKIT (CD117) [HSA:3815] [KO:K05091]\nSRC [HSA:6714] [KO:K05704]\nLCK [HSA:3932] [KO:K05856]\nYES1 [HSA:7525] [KO:K05705]\nFYN [HSA:2534] [KO:K05703]\nEPHA2 [HSA:1969] [KO:K05103]\nPDGFRB [HSA:5159] [KO:K05089]\nPATHWAY   hsa04010(1969+3815+5159)  MAPK signaling pathway\nhsa04012(25+6714)  ErbB signaling pathway\nhsa04370(6714)  VEGF signaling pathway\nhsa05200(25+3815+5159)  Pathways in cancer\nhsa05220(25)  Chronic myeloid leukemia\nNETWORK   nt06276  Chronic myeloid leukemia",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576], FMO3 [HSA:2328], UGT [KO:K00699]",
    "therapeutic_category": "4291",
    "atc_code": "L01EA02",
    "drug_class": [
      "Antineoplastic",
      "Tyrosine kinase inhibitor",
      "BCR-ABL inhibitor",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "FMO substrate",
      "FMO3 substrate",
      "UGT substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Dasatinib"
  },
  {
    "kegg_id": "D06413",
    "name_en": "Nilotinib hydrochloride hydrate (JAN)",
    "name_ja": "",
    "names_alt": [
      "Nilotinib monohydrochloride monohydrate",
      "Tasigna (TN)"
    ],
    "formula": "C28H22F3N7O. HCl. H2O",
    "efficacy": "Antineoplastic, Tyrosine kinase inhibitor\nDISEASE   Chronic myeloid leukemia (Philadelphia chromosome positive) [DS:H00004]\nChronic myelogenous leukemia (Philadelphia chromosome positive) [DS:H00004]",
    "target": "BCR-ABL [HSA_VAR:25v1] [HSA:25] [KO:K06619]\nPDGFR [HSA:5156 5159] [KO:K04363 K05089]\nKIT (CD117) [HSA:3815] [KO:K05091]\nPATHWAY   hsa04010(3815+5156+5159)  MAPK signaling pathway\nhsa04012(25)  ErbB signaling pathway\nhsa05200(25+3815+5156+5159)  Pathways in cancer\nhsa05220(25)  Chronic myeloid leukemia\nNETWORK   nt06276  Chronic myeloid leukemia",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]; CYP2C8 [HSA:1558]\nTransporter: ABCB1 [HSA:5243]",
    "therapeutic_category": "4291",
    "atc_code": "L01EA03",
    "drug_class": [
      "Antineoplastic",
      "Tyrosine kinase inhibitor",
      "BCR-ABL inhibitor",
      "Metabolizing enzyme substrate",
      "CYP2C8 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "Transporter substrate",
      "ABCB1 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C8",
      "CYP3A4"
    ],
    "search_name": "Nilotinib hydrochloride hydrate"
  },
  {
    "kegg_id": "D12444",
    "name_en": "Nilotinib hydrochloride dihydrate (JAN)",
    "name_ja": "",
    "names_alt": [],
    "formula": "C28H22F3N7O. HCl. 2H2O",
    "efficacy": "Antineoplastic, Tyrosine kinase inhibitor",
    "target": "BCR-ABL [HSA_VAR:25v1] [HSA:25] [KO:K06619]\nPDGFR [HSA:5156 5159] [KO:K04363 K05089]\nKIT (CD117) [HSA:3815] [KO:K05091]\nPATHWAY   hsa04012(25)  ErbB signaling pathway\nhsa04014(25+3815+5156+5159)  Ras signaling pathway\nhsa05200(25+3815+5156+5159)  Pathways in cancer\nNETWORK   nt06276  Chronic myeloid leukemia",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]; CYP2C8 [HSA:1558]\nTransporter: ABCB1 [HSA:5243]",
    "therapeutic_category": "4291",
    "atc_code": "L01EA03",
    "drug_class": [
      "Antineoplastic",
      "Tyrosine kinase inhibitor",
      "BCR-ABL inhibitor",
      "Metabolizing enzyme substrate",
      "CYP2C8 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "Transporter substrate",
      "ABCB1 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C8",
      "CYP3A4"
    ],
    "search_name": "Nilotinib hydrochloride dihydrate"
  },
  {
    "kegg_id": "D09728",
    "name_en": "Bosutinib hydrate (JAN)",
    "name_ja": "",
    "names_alt": [
      "Bosutinib monohydrate",
      "Bosulif (TN)"
    ],
    "formula": "C26H29Cl2N5O3. H2O",
    "efficacy": "Antineoplastic, Tyrosine kinase inhibitor\nDISEASE   Chronic myeloid leukemia (Philadelphia chromosome positive) [DS:H00004]",
    "target": "BCR-ABL [HSA_VAR:25v1] [HSA:25] [KO:K06619]\nSRC [HSA:6714] [KO:K05704]\nPATHWAY   hsa04012(25+6714)  ErbB signaling pathway\nhsa05200(25)  Pathways in cancer\nhsa05220(25)  Chronic myeloid leukemia\nNETWORK   nt06276  Chronic myeloid leukemia",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "4291",
    "atc_code": "L01EA04",
    "drug_class": [
      "Antineoplastic",
      "Tyrosine kinase inhibitor",
      "BCR-ABL inhibitor",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Bosutinib hydrate"
  },
  {
    "kegg_id": "D09951",
    "name_en": "Ponatinib hydrochloride (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Iclusig (TN)"
    ],
    "formula": "C29H27F3N6O. HCl",
    "efficacy": "Antineoplastic, Tyrosine kinase inhibitor\nDISEASE   Chronic myeloid leukemia [DS:H00004]\nChronic myeloid leukemia (Philadelphia chromosome positive) [DS:H00004]\nChronic myeloid leukemia (T315I positive) [DS:H00004]\nAcute lymphoblastic leukemia (T315I positive, Philadelphia chromosome positive) [DS:H00001]",
    "target": "BCR-ABL [HSA_VAR:25v1] [HSA:25] [KO:K06619]\nPATHWAY   hsa05200(25)  Pathways in cancer\nhsa05220(25)  Chronic myeloid leukemia\nNETWORK   nt06276  Chronic myeloid leukemia",
    "metabolism": "Enzyme: CYP3A [HSA:1576 1577 1551]",
    "therapeutic_category": "4291",
    "atc_code": "L01EA05",
    "drug_class": [
      "Antineoplastic",
      "Tyrosine kinase inhibitor",
      "BCR-ABL inhibitor",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A"
    ],
    "search_name": "Ponatinib hydrochloride"
  },
  {
    "kegg_id": "D11404",
    "name_en": "Asciminib hydrochloride (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Scemblix (TN)"
    ],
    "formula": "C20H18ClF2N5O3. HCl",
    "efficacy": "Antineoplastic, Tyrosine kinase inhibitor\nDISEASE   Chronic myeloid leukemia (Philadelphia chromosome positive) [DS:H00004]\nChronic myeloid leukemia (mutation positive) [DS:H00004]",
    "target": "BCR-ABL [HSA_VAR:25v1] [HSA:25] [KO:K06619]\nPATHWAY   hsa05200(25)  Pathways in cancer\nhsa05220(25)  Chronic myeloid leukemia\nNETWORK   nt06276  Chronic myeloid leukemia",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576], UGT2B7 [HSA:7364], UGT2B17 [HSA:7367]",
    "therapeutic_category": "4291",
    "atc_code": "L01EA06",
    "drug_class": [
      "Antineoplastic",
      "Tyrosine kinase inhibitor",
      "BCR-ABL inhibitor",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "UGT substrate",
      "UGT2B7 substrate",
      "UGT2B17 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Asciminib hydrochloride"
  },
  {
    "kegg_id": "D01977",
    "name_en": "Gefitinib (JP18/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Iressa (TN)"
    ],
    "formula": "C22H24ClFN4O3",
    "efficacy": "Antineoplastic, Receptor tyrosine kinase inhibitor\nDISEASE   Non-small cell lung cancer (EGFR mutation positive) [DS:H00014]",
    "target": "EGFR* [HSA_VAR:1956v2] [HSA:1956] [KO:K04361]\nPATHWAY   hsa04010(1956)  MAPK signaling pathway\nhsa04012(1956)  ErbB signaling pathway\nhsa05200(1956)  Pathways in cancer\nhsa05223(1956)  Non-small cell lung cancer\nNETWORK   nt06266  Non-small cell lung cancer",
    "metabolism": "",
    "therapeutic_category": "4291",
    "atc_code": "L01EB01",
    "drug_class": [
      "Antineoplastic",
      "Tyrosine kinase inhibitor",
      "Receptor tyrosine kinase inhibitor",
      "EGFR inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Gefitinib"
  },
  {
    "kegg_id": "D04023",
    "name_en": "Erlotinib hydrochloride (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Tarceva (TN)"
    ],
    "formula": "C22H23N3O4. HCl",
    "efficacy": "Antineoplastic, Receptor tyrosine kinase inhibitor\nDISEASE   Non-small cell lung cancer (EGFR mutation positive) [DS:H00014]\nPancreatic cancer [DS:H00019]",
    "target": "EGFR* [HSA_VAR:1956v2] [HSA:1956] [KO:K04361]\nPATHWAY   hsa04010(1956)  MAPK signaling pathway\nhsa04012(1956)  ErbB signaling pathway\nhsa05200(1956)  Pathways in cancer\nhsa05212(1956)  Pancreatic cancer\nhsa05223(1956)  Non-small cell lung cancer\nNETWORK   nt06266  Non-small cell lung cancer",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576], CYP1A2 [HSA:1544]",
    "therapeutic_category": "4291",
    "atc_code": "L01EB02",
    "drug_class": [
      "Antineoplastic",
      "Tyrosine kinase inhibitor",
      "Receptor tyrosine kinase inhibitor",
      "EGFR inhibitor",
      "Metabolizing enzyme substrate",
      "CYP1A2 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4",
      "CYP1A2"
    ],
    "search_name": "Erlotinib hydrochloride"
  },
  {
    "kegg_id": "D09733",
    "name_en": "Afatinib dimaleate (USAN)",
    "name_ja": "",
    "names_alt": [
      "Afatinib maleate (JAN)",
      "Gilotrif (TN)",
      "Giotrif (TN)"
    ],
    "formula": "C24H25ClFN5O3. (C4H4O4)2",
    "efficacy": "Antineoplastic, Receptor tyrosine kinase inhibitor\nDISEASE   Non-small cell lung cancer (EGFR mutation positive) [DS:H00014]",
    "target": "EGFR* [HSA_VAR:1956v2] [HSA:1956] [KO:K04361]\nERBB2 (HER2, CD340) [HSA:2064] [KO:K05083]\nERBB4 (HER4) [HSA:2066] [KO:K05085]\nPATHWAY   hsa04010(1956+2064+2066)  MAPK signaling pathway\nhsa04012(1956+2064+2066)  ErbB signaling pathway\nhsa05200(1956+2064)  Pathways in cancer\nhsa05223(1956+2064)  Non-small cell lung cancer\nNETWORK   nt06266  Non-small cell lung cancer",
    "metabolism": "Transporter: ABCB1 [HSA:5243]",
    "therapeutic_category": "4291",
    "atc_code": "L01EB03",
    "drug_class": [
      "Antineoplastic",
      "Tyrosine kinase inhibitor",
      "Receptor tyrosine kinase inhibitor",
      "EGFR inhibitor",
      "Transporter substrate",
      "ABCB1 substrate"
    ],
    "cyp_enzymes": [],
    "search_name": "Afatinib dimaleate"
  },
  {
    "kegg_id": "D10766",
    "name_en": "Osimertinib mesylate (USAN)",
    "name_ja": "",
    "names_alt": [
      "Osimertinib mesilate (JAN)",
      "Tagrisso (TN)"
    ],
    "formula": "C28H33N7O2. CH4SO3",
    "efficacy": "Antineoplastic, Receptor tyrosine kinase inhibitor\nDISEASE   Non-small cell lung cancer (EGFR mutation positive) [DS:H00014]",
    "target": "EGFR* [HSA_VAR:1956v2] [HSA:1956] [KO:K04361]\nPATHWAY   hsa01521(1956)  EGFR tyrosine kinase inhibitor resistance\nhsa04010(1956)  MAPK signaling pathway\nhsa04012(1956)  ErbB signaling pathway\nhsa05200(1956)  Pathways in cancer\nhsa05223(1956)  Non-small cell lung cancer\nNETWORK   nt06266  Non-small cell lung cancer",
    "metabolism": "Enzyme: CYP3A [HSA:1576 1577 1551]",
    "therapeutic_category": "4291",
    "atc_code": "L01EB04",
    "drug_class": [
      "Antineoplastic",
      "Tyrosine kinase inhibitor",
      "Receptor tyrosine kinase inhibitor",
      "EGFR inhibitor",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "Transporter inhibitor",
      "ABCG2 inhibitor"
    ],
    "cyp_enzymes": [
      "CYP3A"
    ],
    "search_name": "Osimertinib mesylate"
  },
  {
    "kegg_id": "D10514",
    "name_en": "Dacomitinib (USAN)",
    "name_ja": "",
    "names_alt": [
      "Dacomitinib hydrate (JAN)",
      "Vizimpro (TN)"
    ],
    "formula": "C24H25ClFN5O2. H2O",
    "efficacy": "Antineoplastic, Receptor tyrosine kinase inhibitor\nDISEASE   Non-small cell lung cancer (EGFR mutation positive) [DS:H00014]",
    "target": "EGFR* [HSA_VAR:1956v2] [HSA:1956] [KO:K04361]\nERBB2 (HER2, CD340) [HSA:2064] [KO:K05083]\nERBB4 (HER4) [HSA:2066] [KO:K05085]\nPATHWAY   hsa04012(1956+2064+2066)  ErbB signaling pathway\nhsa04020(1956+2064+2066)  Calcium signaling pathway\nhsa05205(1956+2064+2066)  Proteoglycans in cancer\nhsa05223(1956+2064)  Non-small cell lung cancer\nNETWORK   nt06266  Non-small cell lung cancer",
    "metabolism": "",
    "therapeutic_category": "4291",
    "atc_code": "L01EB07",
    "drug_class": [
      "Antineoplastic",
      "Tyrosine kinase inhibitor",
      "Receptor tyrosine kinase inhibitor",
      "EGFR inhibitor",
      "Metabolizing enzyme inhibitor",
      "CYP2D6 inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Dacomitinib"
  },
  {
    "kegg_id": "D12245",
    "name_en": "Lazertinib mesylate (USAN)",
    "name_ja": "",
    "names_alt": [
      "Lazertinib mesilate hydrate (JAN)",
      "Lazcluze (TN)"
    ],
    "formula": "C30H34N8O3. CH4SO3. H2O",
    "efficacy": "Antineoplastic, Receptor tyrosine kinase inhibitor\nDISEASE   Non-small cell lung cancer (EGFR exon 19 deletions or exon 21 (L858R) substitution mutated) [DS:H00014]",
    "target": "EGFR* [HSA_VAR:1956v2] [HSA:1956] [KO:K04361]\nPATHWAY   hsa01521(1956)  EGFR tyrosine kinase inhibitor resistance\nhsa04010(1956)  MAPK signaling pathway\nhsa04012(1956)  ErbB signaling pathway\nhsa05200(1956)  Pathways in cancer\nNETWORK   nt06266  Non-small cell lung cancer",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "4291",
    "atc_code": "L01EB09",
    "drug_class": [
      "Antineoplastic",
      "Tyrosine kinase inhibitor",
      "Receptor tyrosine kinase inhibitor",
      "EGFR inhibitor",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Lazertinib mesylate"
  },
  {
    "kegg_id": "D09996",
    "name_en": "Vemurafenib (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Zelboraf (TN)"
    ],
    "formula": "C23H18ClF2N3O3S",
    "efficacy": "Antineoplastic, BRAF kinase inhibitor\nDISEASE   Melanoma (BRAF mutation positive) [DS:H00038]\nErdheim-Chester disease (BRAF mutation positive) [DS:H02425]",
    "target": "BRAF* [HSA_VAR:673v1] [HSA:673] [KO:K04365]\nPATHWAY   hsa04010(673)  MAPK signaling pathway\nhsa04012(673)  ErbB signaling pathway\nhsa05200(673)  Pathways in cancer\nhsa05218(673)  Melanoma\nNETWORK   nt06268  Melanoma",
    "metabolism": "",
    "therapeutic_category": "4291",
    "atc_code": "L01EC01",
    "drug_class": [
      "Antineoplastic",
      "BRAF inhibitor",
      "Metabolizing enzyme inhibitor",
      "CYP1A2 inhibitor",
      "CYP2C9 inhibitor",
      "Metabolizing enzyme inducer",
      "CYP3A/CYP3A4 inducer",
      "CYP3A4 inducer",
      "Transporter inhibitor",
      "ABCB1 inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Vemurafenib"
  },
  {
    "kegg_id": "D10104",
    "name_en": "Dabrafenib mesylate (USAN)",
    "name_ja": "",
    "names_alt": [
      "Dabrafenib mesilate (JAN)",
      "Tafinlar (TN)"
    ],
    "formula": "C23H20F3N5O2S2. CH4SO3",
    "efficacy": "Antineoplastic, BRAF kinase inhibitor\nDISEASE   Melanoma (BRAF mutation positive) [DS:H00038]\nNon-small cell lung cancer (BRAF mutation positive) [DS:H00014]\nAnaplastic thyroid cancer (BRAF mutation positive) [DS:H00032]",
    "target": "BRAF* [HSA_VAR:673v1] [HSA:673] [KO:K04365]\nPATHWAY   hsa04010(673)  MAPK signaling pathway\nhsa04012(673)  ErbB signaling pathway\nhsa05200(673)  Pathways in cancer\nhsa05218(673)  Melanoma\nNETWORK   nt06268  Melanoma\nnt06274  Thyroid cancer",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576], CYP2C8 [HSA:1558]",
    "therapeutic_category": "4291",
    "atc_code": "L01EC02",
    "drug_class": [
      "Antineoplastic",
      "BRAF inhibitor",
      "Metabolizing enzyme substrate",
      "CYP2C8 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "Metabolizing enzyme inducer",
      "CYP2C9 inducer",
      "CYP3A/CYP3A4 inducer",
      "CYP3A4 inducer"
    ],
    "cyp_enzymes": [
      "CYP2C8",
      "CYP3A4"
    ],
    "search_name": "Dabrafenib mesylate"
  },
  {
    "kegg_id": "D11053",
    "name_en": "Encorafenib (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Braftovi (TN)"
    ],
    "formula": "C22H27ClFN7O4S",
    "efficacy": "Antineoplastic, BRAF kinase inhibitor\nDISEASE   Melanoma (BRAF mutation positive) [DS:H00038]\nColorectal cancer (BRAF mutation positive) [DS:H00020]",
    "target": "BRAF* [HSA_VAR:673v1] [HSA:673] [KO:K04365]\nPATHWAY   hsa04010(673)  MAPK signaling pathway\nhsa04012(673)  ErbB signaling pathway\nhsa05200(673)  Pathways in cancer\nhsa05210(673)  Colorectal cancer\nhsa05216(673)  Thyroid cancer\nhsa05218(673)  Melanoma\nNETWORK   nt06268  Melanoma\nnt06274  Thyroid cancer",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "4291",
    "atc_code": "L01EC03",
    "drug_class": [
      "Antineoplastic",
      "BRAF inhibitor",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Encorafenib"
  },
  {
    "kegg_id": "D09731",
    "name_en": "Crizotinib (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Xalkori (TN)"
    ],
    "formula": "C21H22Cl2FN5O",
    "efficacy": "Antineoplastic, Tyrosine kinase inhibitor\nDISEASE   Non-small cell lung cancer (ALK or ROS1 positive) [DS:H00014]\nAnaplastic large cell lymphoma (ALK positive) [DS:H01601]\nInflammatory myofibroblastic tumor (ALK positive)",
    "target": "EML4-ALK [HSA_VAR:238v1] [HSA:238] [KO:K05119]\nROS1* [HSA_VAR:6098v1] [HSA:6098] [KO:K05088]\nPATHWAY   hsa05200(238)  Pathways in cancer\nhsa05223(238)  Non-small cell lung cancer\nNETWORK   nt06266  Non-small cell lung cancer",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576], CYP3A5 [HSA:1577]",
    "therapeutic_category": "4291",
    "atc_code": "L01ED01",
    "drug_class": [
      "Antineoplastic",
      "Tyrosine kinase inhibitor",
      "ALK inhibitor",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "CYP3A5 substrate",
      "Metabolizing enzyme inhibitor",
      "CYP2B6 inhibitor",
      "CYP3A/CYP3A4 inhibitor",
      "Transporter inhibitor",
      "ABCB1 inhibitor",
      "SLC22A1 inhibitor",
      "SLC22A2 inhibitor"
    ],
    "cyp_enzymes": [
      "CYP3A4",
      "CYP3A5"
    ],
    "search_name": "Crizotinib"
  },
  {
    "kegg_id": "D10551",
    "name_en": "Ceritinib (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Zykadia (TN)"
    ],
    "formula": "C28H36ClN5O3S",
    "efficacy": "Antineoplastic, Anaplastic lymphoma kinase (ALK) inhibitor\nDISEASE   Non-small cell lung cancer (ALK positive) [DS:H00014]",
    "target": "EML4-ALK [HSA_VAR:238v1] [HSA:238] [KO:K05119]\nPATHWAY   hsa05200(238)  Pathways in cancer\nhsa05223(238)  Non-small cell lung cancer\nNETWORK   nt06266  Non-small cell lung cancer",
    "metabolism": "Enzyme: CYP3A [HSA:1576 1577 1551]",
    "therapeutic_category": "4291",
    "atc_code": "L01ED02",
    "drug_class": [
      "Antineoplastic",
      "Tyrosine kinase inhibitor",
      "ALK inhibitor",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "Metabolizing enzyme inhibitor",
      "CYP2C9 inhibitor",
      "CYP3A/CYP3A4 inhibitor"
    ],
    "cyp_enzymes": [
      "CYP3A"
    ],
    "search_name": "Ceritinib"
  },
  {
    "kegg_id": "D10450",
    "name_en": "Alectinib hydrochloride (JAN)",
    "name_ja": "",
    "names_alt": [
      "Alecensa (TN)"
    ],
    "formula": "C30H34N4O2. HCl",
    "efficacy": "Antineoplastic, Anaplastic lymphoma kinase (ALK) inhibitor\nDISEASE   Non-small cell lung cancer (ALK positive) [DS:H00014]",
    "target": "EML4-ALK [HSA_VAR:238v1] [HSA:238] [KO:K05119]\nPATHWAY   hsa05200(238)  Pathways in cancer\nhsa05223(238)  Non-small cell lung cancer\nNETWORK   nt06266  Non-small cell lung cancer",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "4291",
    "atc_code": "L01ED03",
    "drug_class": [
      "Antineoplastic",
      "Tyrosine kinase inhibitor",
      "ALK inhibitor",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Alectinib hydrochloride"
  },
  {
    "kegg_id": "D10866",
    "name_en": "Brigatinib (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Alunbrig (TN)"
    ],
    "formula": "C29H39ClN7O2P",
    "efficacy": "Antineoplastic, Anaplastic lymphoma kinase (ALK) inhibitor\nDISEASE   Non-small cell lung cancer (ALK positive) [DS:H00014]",
    "target": "EML4-ALK [HSA_VAR:238v1] [HSA:238] [KO:K05119]\nPATHWAY   hsa05200(238)  Pathways in cancer\nhsa05223(238)  Non-small cell lung cancer",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "4291",
    "atc_code": "L01ED04",
    "drug_class": [
      "Antineoplastic",
      "Tyrosine kinase inhibitor",
      "ALK inhibitor",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Brigatinib"
  },
  {
    "kegg_id": "D11012",
    "name_en": "Lorlatinib (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Lorbrena (TN)"
    ],
    "formula": "C21H19FN6O2",
    "efficacy": "Antineoplastic, Tyrosine kinase inhibitor\nDISEASE   Non-small cell lung cancer (ALK positive) [DS:H00014]",
    "target": "EML4-ALK [HSA_VAR:238v1] [HSA:238] [KO:K05119]\nALK (CD246) [HSA:238] [KO:K05119]\nROS1 [HSA:6098] [KO:K05088]\nPATHWAY   hsa05200(238)  Pathways in cancer\nhsa05223(238)  Non-small cell lung cancer\nNETWORK   nt06266  Non-small cell lung cancer",
    "metabolism": "Enzyme: CYP3A [HSA:1576 1577 1551]",
    "therapeutic_category": "4291",
    "atc_code": "L01ED05",
    "drug_class": [
      "Antineoplastic",
      "Tyrosine kinase inhibitor",
      "ALK inhibitor",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "Metabolizing enzyme inducer",
      "CYP3A/CYP3A4 inducer",
      "Transporter inducer",
      "ABCB1 inducer"
    ],
    "cyp_enzymes": [
      "CYP3A"
    ],
    "search_name": "Lorlatinib"
  },
  {
    "kegg_id": "D10176",
    "name_en": "Trametinib dimethyl sulfoxide (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Mekinist (TN)",
      "Spexotras (TN)"
    ],
    "formula": "C26H23FIN5O4. C2H6OS",
    "efficacy": "Antineoplastic, Mitogen-activated extracellular signal-regulated kinase (MEK) inhibitor\nDISEASE   Melanoma (BRAF mutation positive) [DS:H00038]\nNon-small cell lung cancer (BRAF mutation positive) [DS:H00014]\nAnaplastic thyroid cancer (BRAF mutation positive) [DS:H00032]",
    "target": "MAP2K (MEK) [HSA:5604 5605] [KO:K04368 K04369]\nPATHWAY   hsa04010(5604+5605)  MAPK signaling pathway\nhsa04012(5604+5605)  ErbB signaling pathway\nhsa04014(5604+5605)  Ras signaling pathway\nhsa05200(5604+5605)  Pathways in cancer\nhsa05216(5604+5605)  Thyroid cancer\nhsa05218(5604+5605)  Melanoma\nhsa05220(5604+5605)  Chronic myeloid leukemia\nhsa05221(5604+5605)  Acute myeloid leukemia\nhsa05223(5604+5605)  Non-small cell lung cancer\nNETWORK   nt06266  Non-small cell lung cancer\nnt06268  Melanoma\nnt06274  Thyroid cancer",
    "metabolism": "",
    "therapeutic_category": "4291",
    "atc_code": "L01EE01",
    "drug_class": [
      "Antineoplastic",
      "MEK inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Trametinib dimethyl sulfoxide"
  },
  {
    "kegg_id": "D10604",
    "name_en": "Binimetinib (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Mektovi (TN)"
    ],
    "formula": "C17H15BrF2N4O3",
    "efficacy": "Antineoplastic, Mitogen-activated extracellular signal-regulated kinase (MEK) inhibitor\nDISEASE   Melanoma (BRAF mutation positive) [DS:H00038]",
    "target": "MAP2K (MEK) [HSA:5604 5605] [KO:K04368 K04369]\nPATHWAY   hsa04010(5604+5605)  MAPK signaling pathway\nhsa04919(5604+5605)  Thyroid hormone signaling pathway\nhsa05200(5604+5605)  Pathways in cancer\nhsa05210(5604+5605)  Colorectal cancer\nhsa05216(5604+5605)  Thyroid cancer\nhsa05218(5604+5605)  Melanoma\nNETWORK   nt06260  Colorectal cancer\nnt06268  Melanoma\nnt06274  Thyroid cancer",
    "metabolism": "",
    "therapeutic_category": "4291",
    "atc_code": "L01EE03",
    "drug_class": [
      "Antineoplastic",
      "MEK inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Binimetinib"
  },
  {
    "kegg_id": "D10372",
    "name_en": "Palbociclib (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Ibrance (TN)"
    ],
    "formula": "C24H29N7O2",
    "efficacy": "Antineoplastic, Cyclin-dependent kinase (CDK) inhibitor\nDISEASE   Breast cancer (HR positive, HER2 negative) [DS:H00031]",
    "target": "CDK4/6 [HSA:1019 1021] [KO:K02089 K02091]\nPATHWAY   hsa04110(1019+1021)  Cell cycle\nhsa04151(1019+1021)  PI3K-Akt signaling pathway\nhsa05200(1019+1021)  Pathways in cancer\nhsa05224(1019+1021)  Breast cancer\nNETWORK   nt06270  Breast cancer",
    "metabolism": "",
    "therapeutic_category": "4291",
    "atc_code": "L01EF01",
    "drug_class": [
      "Antineoplastic",
      "CDK inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Palbociclib"
  },
  {
    "kegg_id": "D10688",
    "name_en": "Abemaciclib (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Verzenio (TN)"
    ],
    "formula": "C27H32F2N8",
    "efficacy": "Antineoplastic, Cyclin-dependent kinase (CDK) inhibitor\nDISEASE   Breast cancer (HR positive, HER2 negative) [DS:H00031]",
    "target": "CDK4/6 [HSA:1019 1021] [KO:K02089 K02091]\nPATHWAY   hsa04110(1019+1021)  Cell cycle\nhsa04151(1019+1021)  PI3K-Akt signaling pathway\nhsa05200(1019+1021)  Pathways in cancer\nhsa05224(1019+1021)  Breast cancer\nNETWORK   nt06270  Breast cancer",
    "metabolism": "Enzyme: CYP3A [HSA:1576 1577 1551]",
    "therapeutic_category": "4291",
    "atc_code": "L01EF03",
    "drug_class": [
      "Antineoplastic",
      "CDK inhibitor",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A"
    ],
    "search_name": "Abemaciclib"
  },
  {
    "kegg_id": "D06068",
    "name_en": "Temsirolimus (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Torisel (TN)"
    ],
    "formula": "C56H87NO16",
    "efficacy": "Antineoplastic, mTOR inhibitor\nDISEASE   Renal cell carcinoma [DS:H00021]",
    "target": "MTOR [HSA:2475] [KO:K07203]\nPATHWAY   hsa04012(2475)  ErbB signaling pathway\nhsa04150(2475)  mTOR signaling pathway\nhsa05200(2475)  Pathways in cancer",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "4291",
    "atc_code": "L01EG01",
    "drug_class": [
      "Antineoplastic",
      "mTOR inhibitor",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Temsirolimus"
  },
  {
    "kegg_id": "D00753",
    "name_en": "Sirolimus (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Rapamune (TN)",
      "Rapamycin (TN)"
    ],
    "formula": "C51H79NO13",
    "efficacy": "Antineoplastic, Immunosuppressant, mTOR inhibitor\nDISEASE   Organ rejection in renal transplantation [DS:H00083]\nLymphangioleiomyomatosis [DS:H00896]",
    "target": "MTOR [HSA:2475] [KO:K07203]\nPATHWAY   hsa04150(2475)  mTOR signaling pathway\nhsa05200(2475)  Pathways in cancer",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]\nTransporter: ABCB1 [HSA:5243]",
    "therapeutic_category": "4291",
    "atc_code": "L01EG04",
    "drug_class": [
      "Antineoplastic",
      "mTOR inhibitor",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "Metabolizing enzyme inhibitor",
      "CYP3A/CYP3A4 inhibitor",
      "CYP3A4 inhibitor",
      "Transporter substrate",
      "ABCB1 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Sirolimus"
  },
  {
    "kegg_id": "D04024",
    "name_en": "Lapatinib ditosylate (USAN)",
    "name_ja": "",
    "names_alt": [
      "Lapatinib tosilate hydrate (JAN)",
      "Lapatinib ditosylate monohydrate",
      "Tykerb (TN)",
      "Tyverb (TN)"
    ],
    "formula": "C29H26ClFN4O4S. (C7H8O3S)2. H2O",
    "efficacy": "Antineoplastic, Receptor tyrosine kinase inhibitor\nDISEASE   Breast cancer (HER2 overexpressing) [DS:H00031]",
    "target": "EGFR [HSA:1956] [KO:K04361]\nERBB2* (HER2, CD340) [HSA_VAR:2064v1] [HSA:2064] [KO:K05083]\nPATHWAY   hsa04010(1956+2064)  MAPK signaling pathway\nhsa04012(1956+2064)  ErbB signaling pathway\nhsa05200(1956+2064)  Pathways in cancer\nhsa05224(1956+2064)  Breast cancer\nNETWORK   nt06270  Breast cancer",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576], CYP3A5 [HSA:1577]; CYP2C19 [HSA:1557], CYP2C8 [HSA:1558]\nTransporter: ABCB1 [HSA:5243], ABCG2 [HSA:9429]",
    "therapeutic_category": "4291",
    "atc_code": "L01EH01",
    "drug_class": [
      "Antineoplastic",
      "Tyrosine kinase inhibitor",
      "Receptor tyrosine kinase inhibitor",
      "HER2 inhibitor",
      "Metabolizing enzyme substrate",
      "CYP2C8 substrate",
      "CYP2C19 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "CYP3A5 substrate",
      "Transporter substrate",
      "ABCB1 substrate",
      "ABCG2 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C19",
      "CYP2C8",
      "CYP3A4",
      "CYP3A5"
    ],
    "search_name": "Lapatinib ditosylate"
  },
  {
    "kegg_id": "D12879",
    "name_en": "Zongertinib (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Hernexeos (TN)"
    ],
    "formula": "C29H29N9O2",
    "efficacy": "Antineoplastic, Receptor tyrosine kinase inhibitor\nDISEASE   Non-squamous non-small cell lung cancer (HER2 activating mutation) [DS:H00014]",
    "target": "ERBB2 (HER2, CD340) [HSA:2064] [KO:K05083]\nPATHWAY   hsa01521(2064)  EGFR tyrosine kinase inhibitor resistance\nhsa04012(2064)  ErbB signaling pathway\nhsa05200(2064)  Pathways in cancer\nhsa05223(2064)  Non-small cell lung cancer\nNETWORK   nt06210  ERK signaling (cancer)\nnt06266  Non-small cell lung cancer",
    "metabolism": "",
    "therapeutic_category": "4291",
    "atc_code": "L01EH04",
    "drug_class": [
      "Antineoplastic",
      "Tyrosine kinase inhibitor",
      "Receptor tyrosine kinase inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Zongertinib"
  },
  {
    "kegg_id": "D11296",
    "name_en": "Fedratinib hydrochloride (USAN)",
    "name_ja": "",
    "names_alt": [
      "Fedratinib hydrochloride hydrate (JAN)",
      "Fedratinib dihydrochloride monohydrate",
      "Inrebic (TN)"
    ],
    "formula": "C27H36N6O3S. 2HCl. H2O",
    "efficacy": "Antineoplastic, Janus kinase (JAK) inhibitor\nDISEASE   Myelofibrosis [DS:H01605]",
    "target": "JAK2 [HSA:3717] [KO:K04447]\nPATHWAY   hsa04630(3717)  JAK-STAT signaling pathway\nhsa05200(3717)  Pathways in cancer",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576], CYP2C19 [HSA:1557], FMO3 [HSA:2328]",
    "therapeutic_category": "4291",
    "atc_code": "L01EJ02",
    "drug_class": [
      "Anti-inflammatory",
      "Disease modifying anti-rheumatic drug (DMARD)",
      "JAK inhibitor",
      "Metabolizing enzyme substrate",
      "CYP2C19 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "FMO substrate",
      "FMO3 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C19",
      "CYP3A4"
    ],
    "search_name": "Fedratinib hydrochloride"
  },
  {
    "kegg_id": "D10889",
    "name_en": "Momelotinib hydrochloride hydrate (JAN)",
    "name_ja": "",
    "names_alt": [
      "Momelotinib dihydrochloride monohydrate",
      "Ojjaara (TN)",
      "Omjjara (TN)"
    ],
    "formula": "C23H22N6O2. 2HCl. H2O",
    "efficacy": "Antineoplastic, Janus kinase (JAK) inhibitor\nDISEASE   Myelofibrosis [DS:H01605]",
    "target": "JAK1 [HSA:3716] [KO:K11217]\nJAK2 [HSA:3717] [KO:K04447]\nJAK2* [HSA_VAR:3717v1] [HSA:3717] [KO:K04447]\nACVR1 (ALK2) [HSA:90] [KO:K04675]\nPATHWAY   hsa04060(90)  Cytokine-cytokine receptor interaction\nhsa04550(3716+3717+3717+90)  Signaling pathways regulating pluripotency of stem cells\nhsa04630(3716+3717+3717)  JAK-STAT signaling pathway",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576], CYP2C8 [HSA:1558], CYP2C9 [HSA:1559], CYP2C19 [HSA:1557], CYP1A2 [HSA:1544]",
    "therapeutic_category": "4291",
    "atc_code": "L01EJ04",
    "drug_class": [
      "Anti-inflammatory",
      "Disease modifying anti-rheumatic drug (DMARD)",
      "JAK inhibitor",
      "Metabolizing enzyme substrate",
      "CYP1A2 substrate",
      "CYP2C8 substrate",
      "CYP2C9 substrate",
      "CYP2C19 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C19",
      "CYP3A4",
      "CYP1A2",
      "CYP2C9",
      "CYP2C8"
    ],
    "search_name": "Momelotinib hydrochloride hydrate"
  },
  {
    "kegg_id": "D03218",
    "name_en": "Axitinib (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Inlyta (TN)"
    ],
    "formula": "C22H18N4OS",
    "efficacy": "Antineoplastic, Receptor tyrosine kinase inhibitor\nDISEASE   Renal cell carcinoma [DS:H00021]",
    "target": "VEGFR1 (FLT1) [HSA:2321] [KO:K05096]\nVEGFR2 (KDR) [HSA:3791] [KO:K05098]\nVEGFR3 (FLT4) [HSA:2324] [KO:K05097]\nPATHWAY   hsa04010(2321+2324+3791)  MAPK signaling pathway\nhsa04370(3791)  VEGF signaling pathway\nhsa05200(2324)  Pathways in cancer",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576], CYP3A5 [HSA:1577]",
    "therapeutic_category": "4291",
    "atc_code": "L01EK01",
    "drug_class": [
      "Antineoplastic",
      "Tyrosine kinase inhibitor",
      "Receptor tyrosine kinase inhibitor",
      "VEGFR inhibitor",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "CYP3A5 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4",
      "CYP3A5"
    ],
    "search_name": "Axitinib"
  },
  {
    "kegg_id": "D11977",
    "name_en": "Fruquintinib (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Fruzaqla (TN)"
    ],
    "formula": "C21H19N3O5",
    "efficacy": "Antineoplastic, Receptor tyrosine kinase inhibitor\nDISEASE   Colorectal cancer [DS:H00020]",
    "target": "VEGFR1 (FLT1) [HSA:2321] [KO:K05096]\nVEGFR2 (KDR) [HSA:3791] [KO:K05098]\nVEGFR3 (FLT4) [HSA:2324] [KO:K05097]\nPATHWAY   hsa04010(2321+2324+3791)  MAPK signaling pathway\nhsa04151(2321+2324+3791)  PI3K-Akt signaling pathway\nhsa04510(2321+2324+3791)  Focal adhesion",
    "metabolism": "Enzyme: CYP3A [HSA:1576 1577 1551]; CYP2C8 [HSA:1558], CYP2C9 [HSA:1559], CYP2C19 [HSA:1557]",
    "therapeutic_category": "4291",
    "atc_code": "L01EK04",
    "drug_class": [
      "Antineoplastic",
      "Tyrosine kinase inhibitor",
      "Receptor tyrosine kinase inhibitor",
      "Metabolizing enzyme substrate",
      "CYP2C8 substrate",
      "CYP2C9 substrate",
      "CYP2C19 substrate",
      "CYP3A/CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C9",
      "CYP2C8",
      "CYP3A",
      "CYP2C19"
    ],
    "search_name": "Fruquintinib"
  },
  {
    "kegg_id": "D10223",
    "name_en": "Ibrutinib (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Imbruvica (TN)"
    ],
    "formula": "C25H24N6O2",
    "efficacy": "Antineoplastic, Bruton's tyrosine kinase inhibitor\nDISEASE   Mantle cell lymphoma [DS:H01464]\nChronic lymphocytic leukemia [DS:H00005]\nChronic lymphocytic leukemia (chromosome 17p deletion) [DS:H00005]\nWaldenström's macroglobulinemia [DS:H00011]\nChronic graft versus host disease [DS:H00084]",
    "target": "BTK [HSA:695] [KO:K07370]\nPATHWAY   hsa04662(695)  B cell receptor signaling pathway",
    "metabolism": "Enzyme: CYP3A [HSA:1576 1577 1551]",
    "therapeutic_category": "4291",
    "atc_code": "L01EL01",
    "drug_class": [
      "Antineoplastic",
      "Tyrosine kinase inhibitor",
      "BTK inhibitor",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A"
    ],
    "search_name": "Ibrutinib"
  },
  {
    "kegg_id": "D10893",
    "name_en": "Acalabrutinib (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Calquence (TN)"
    ],
    "formula": "C26H23N7O2",
    "efficacy": "Antineoplastic, Bruton's tyrosine kinase inhibitor\nDISEASE   Mantle cell lymphoma [DS:H01464]\nChronic lymphocytic leukemia [DS:H00005]",
    "target": "BTK [HSA:695] [KO:K07370]\nPATHWAY   hsa04611(695)  Platelet activation\nhsa04662(695)  B cell receptor signaling pathway",
    "metabolism": "Enzyme: CYP3A [HSA:1576 1577 1551]",
    "therapeutic_category": "4291",
    "atc_code": "L01EL02",
    "drug_class": [
      "Antineoplastic",
      "Tyrosine kinase inhibitor",
      "BTK inhibitor",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A"
    ],
    "search_name": "Acalabrutinib"
  },
  {
    "kegg_id": "D12704",
    "name_en": "Acalabrutinib maleate hydrate (JAN)",
    "name_ja": "",
    "names_alt": [
      "Acalabrutinib maleate monohydrate",
      "Calquence (TN)"
    ],
    "formula": "C26H23N7O2. C4H4O4. H2O",
    "efficacy": "Antineoplastic, Bruton's tyrosine kinase inhibitor",
    "target": "BTK [HSA:695] [KO:K07370]\nPATHWAY   hsa04611(695)  Platelet activation\nhsa04662(695)  B cell receptor signaling pathway",
    "metabolism": "Enzyme: CYP3A [HSA:1576 1577 1551]",
    "therapeutic_category": "4291",
    "atc_code": "L01EL02",
    "drug_class": [
      "Antineoplastic",
      "Tyrosine kinase inhibitor",
      "BTK inhibitor",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A"
    ],
    "search_name": "Acalabrutinib maleate hydrate"
  },
  {
    "kegg_id": "D11422",
    "name_en": "Zanubrutinib (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Brukinsa (TN)"
    ],
    "formula": "C27H29N5O3",
    "efficacy": "Antineoplastic, Bruton's tyrosine kinase inhibitor\nDISEASE   Mantle cell lymphoma [DS:H01464]",
    "target": "BTK [HSA:695] [KO:K07370]\nPATHWAY   hsa04662(695)  B cell receptor signaling pathway",
    "metabolism": "Enzyme: CYP3A [HSA:1576 1577 1551]",
    "therapeutic_category": "4291",
    "atc_code": "L01EL03",
    "drug_class": [
      "Antineoplastic",
      "Tyrosine kinase inhibitor",
      "BTK inhibitor",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A"
    ],
    "search_name": "Zanubrutinib"
  },
  {
    "kegg_id": "D12050",
    "name_en": "Pirtobrutinib (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Jaypirca (TN)"
    ],
    "formula": "C22H21F4N5O3",
    "efficacy": "Antineoplastic, Bruton's tyrosine kinase inhibitor\nDISEASE   Mantle cell lymphoma [DS:H01464]\nChronic lymphocytic leukemia/ small lymphocytic lymphoma [DS:H00005]",
    "target": "BTK [HSA:695] [KO:K07370]\nPATHWAY   hsa04611(695)  Platelet activation\nhsa04662(695)  B cell receptor signaling pathway",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "4291",
    "atc_code": "L01EL05",
    "drug_class": [
      "Antineoplastic",
      "Tyrosine kinase inhibitor",
      "BTK inhibitor",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "Metabolizing enzyme inhibitor",
      "CYP2C8 inhibitor",
      "CYP2C19 inhibitor",
      "CYP3A/CYP3A4 inhibitor",
      "Transporter inhibitor",
      "ABCB1 inhibitor",
      "ABCG2 inhibitor"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Pirtobrutinib"
  },
  {
    "kegg_id": "D11070",
    "name_en": "Tirabrutinib hydrochloride (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Velexbru (TN)"
    ],
    "formula": "C25H22N6O3. HCl",
    "efficacy": "Antineoplastic, Bruton's tyrosine kinase inhibitor",
    "target": "BTK [HSA:695] [KO:K07370]\nPATHWAY   hsa04611(695)  Platelet activation\nhsa04662(695)  B cell receptor signaling pathway\nhsa04664(695)  Fc epsilon RI signaling pathway",
    "metabolism": "",
    "therapeutic_category": "4291",
    "atc_code": "L01EL06",
    "drug_class": [
      "Antineoplastic",
      "Tyrosine kinase inhibitor",
      "BTK inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Tirabrutinib hydrochloride"
  },
  {
    "kegg_id": "D10927",
    "name_en": "Erdafitinib (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Balversa (TN)"
    ],
    "formula": "C25H30N6O2",
    "efficacy": "Antineoplastic, Receptor tyrosine kinase inhibitor\nDISEASE   Urothelial carcinoma (FGFR3 or FGFR2 genetic alterations) [DS:H00022]",
    "target": "FGFR3* (CD333) [HSA_VAR:2261v2] [HSA:2261] [KO:K05094]\nFGFR2* (CD332) [HSA_VAR:2263v2] [HSA:2263] [KO:K05093]\nPATHWAY   hsa04151(2260+2261+2263+2264)  PI3K-Akt signaling pathway\nhsa05200(2260+2261+2263+2264)  Pathways in cancer\nhsa05219(2261)  Bladder cancer\nNETWORK   nt06265  Bladder cancer",
    "metabolism": "Enzyme: CYP2C9 [HSA:1559], CYP3A4 [HSA:1576]\nTransporter: ABCB1 [HSA:5243]",
    "therapeutic_category": "4291",
    "atc_code": "L01EN01",
    "drug_class": [
      "Antineoplastic",
      "Tyrosine kinase inhibitor",
      "Receptor tyrosine kinase inhibitor",
      "FGFR inhibitor",
      "Metabolizing enzyme substrate",
      "CYP2C9 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "Transporter substrate",
      "ABCB1 substrate",
      "Transporter inhibitor",
      "ABCB1 inhibitor",
      "SLC22A2 inhibitor"
    ],
    "cyp_enzymes": [
      "CYP2C9",
      "CYP3A4"
    ],
    "search_name": "Erdafitinib"
  },
  {
    "kegg_id": "D11417",
    "name_en": "Pemigatinib (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Pemazyre (TN)"
    ],
    "formula": "C24H27F2N5O4",
    "efficacy": "Antineoplastic, Receptor tyrosine kinase inhibitor\nDISEASE   Cholangiocarcinoma (FGFR2 fusion positive) [DS:H00046]\nMyeloid-lymphoid neoplasms (FGFR1 rearrangement) [DS:H01605 H01612 H02410 H00007 H00011 H01613 H01463 H00005 H01464 H01613 H01892 H00008 H00001 H00002]",
    "target": "FGFR2* (CD332) [HSA_VAR:2263v2] [HSA:2263] [KO:K05093]\nFGFR1 (CD331) [HSA:2260] [KO:K04362]\nFGFR3 (CD333) [HSA:2261] [KO:K05094]\nPATHWAY   hsa01521(2261+2263)  EGFR tyrosine kinase inhibitor resistance\nhsa04151(2260+2261+2263)  PI3K-Akt signaling pathway\nhsa05200(2260+2261+2263)  Pathways in cancer",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "4291",
    "atc_code": "L01EN02",
    "drug_class": [
      "Antineoplastic",
      "Tyrosine kinase inhibitor",
      "Receptor tyrosine kinase inhibitor",
      "FGFR inhibitor",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Pemigatinib"
  },
  {
    "kegg_id": "D11725",
    "name_en": "Futibatinib (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Lytgobi (TN)"
    ],
    "formula": "C22H22N6O3",
    "efficacy": "Antineoplastic, Receptor tyrosine kinase inhibitor\nDISEASE   Cholangiocarcinoma (FGFR2 gene fusion) [DS:H00046]",
    "target": "FGFR2* (CD332) [HSA_VAR:2263v2] [HSA:2263] [KO:K05093]\nPATHWAY   hsa01521(2263)  EGFR tyrosine kinase inhibitor resistance\nhsa04010(2263)  MAPK signaling pathway\nhsa05200(2263)  Pathways in cancer",
    "metabolism": "",
    "therapeutic_category": "4291",
    "atc_code": "L01EN04",
    "drug_class": [
      "Antineoplastic",
      "Tyrosine kinase inhibitor",
      "Receptor tyrosine kinase inhibitor",
      "FGFR inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Futibatinib"
  },
  {
    "kegg_id": "D10891",
    "name_en": "Capmatinib hydrochloride (USAN)",
    "name_ja": "",
    "names_alt": [
      "Capmatinib hydrochloride hydrate (JAN)",
      "Tabrecta (TN)"
    ],
    "formula": "C23H17FN6O. 2HCl. H2O",
    "efficacy": "Antineoplastic, Receptor tyrosine kinase inhibitor\nDISEASE   Non-small cell lung cancer (MET exon 14 skipping positive) [DS:H00014]",
    "target": "MET* [HSA_VAR:4233v4] [HSA:4233] [KO:K05099]\nPATHWAY   hsa04014(4233)  Ras signaling pathway\nhsa04151(4233)  PI3K-Akt signaling pathway\nhsa05200(4233)  Pathways in cancer\nhsa05202(4233)  Transcriptional misregulation in cancer\nhsa05223(4233)  Non-small cell lung cancer\nNETWORK   nt06266  Non-small cell lung cancer",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576], AOX1 [HSA:316]",
    "therapeutic_category": "4291",
    "atc_code": "L01EP01",
    "drug_class": [
      "Antineoplastic",
      "Tyrosine kinase inhibitor",
      "Receptor tyrosine kinase inhibitor",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "AOX1 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Capmatinib hydrochloride"
  },
  {
    "kegg_id": "D11073",
    "name_en": "Tepotinib hydrochloride (USAN)",
    "name_ja": "",
    "names_alt": [
      "Tepotinib hydrochloride hydrate (JAN)",
      "Tepmetko (TN)"
    ],
    "formula": "C29H28N6O2. HCl. H2O",
    "efficacy": "Antineoplastic, Receptor tyrosine kinase inhibitor\nDISEASE   Non-small cell lung cancer (MET exon 14 skipping) [DS:H00014]",
    "target": "MET* [HSA_VAR:4233v4] [HSA:4233] [KO:K05099]\nPATHWAY   hsa04014(4233)  Ras signaling pathway\nhsa04151(4233)  PI3K-Akt signaling pathway\nhsa05200(4233)  Pathways in cancer\nhsa05202(4233)  Transcriptional misregulation in cancer\nhsa05223(4233)  Non-small cell lung cancer\nNETWORK   nt06266  Non-small cell lung cancer",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576], CYP2C8 [HSA:1558]",
    "therapeutic_category": "4291",
    "atc_code": "L01EP02",
    "drug_class": [
      "Antineoplastic",
      "Tyrosine kinase inhibitor",
      "Receptor tyrosine kinase inhibitor",
      "Metabolizing enzyme substrate",
      "CYP2C8 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C8",
      "CYP3A4"
    ],
    "search_name": "Tepotinib hydrochloride"
  },
  {
    "kegg_id": "D06402",
    "name_en": "Sunitinib malate (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Sutent (TN)"
    ],
    "formula": "C22H27FN4O2. C4H6O5",
    "efficacy": "Antineoplastic, Angiogenesis inhibitor, Receptor tyrosine kinase inhibitor\nDISEASE   Gastrotintestinal stromal tumor [DS:H01591]\nRenal cell carcinoma [DS:H00021]\nPancreatic neuroendocrine tumor [DS:H00045]",
    "target": "CSF1R (FMS, CD115) [HSA:1436] [KO:K05090]\nFLT3 (CD135) [HSA:2322] [KO:K05092]\nPDGFR [HSA:5156 5159] [KO:K04363 K05089]\nRET [HSA:5979] [KO:K05126]\nVEGFR1 (FLT1) [HSA:2321] [KO:K05096]\nVEGFR2 (KDR) [HSA:3791] [KO:K05098]\nVEGFR3 (FLT4) [HSA:2324] [KO:K05097]\nKIT (CD117) [HSA:3815] [KO:K05091]\nPATHWAY   hsa04010(1436+2321+2322+2324+3791+3815+5156+5159)  MAPK signaling pathway\nhsa04014(1436+2321+2322+2324+3791+3815+5156+5159)  Ras signaling pathway\nhsa04151(1436+2321+2322+2324+3791+3815+5156+5159)  PI3K-Akt signaling pathway\nhsa04370(3791)  VEGF signaling pathway\nhsa05200(1436+2322+2324+3815+5156+5159+5979)  Pathways in cancer",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "4291",
    "atc_code": "L01EX01",
    "drug_class": [
      "Antineoplastic",
      "Tyrosine kinase inhibitor",
      "Receptor tyrosine kinase inhibitor",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Sunitinib malate"
  },
  {
    "kegg_id": "D06272",
    "name_en": "Sorafenib tosylate (USAN)",
    "name_ja": "",
    "names_alt": [
      "Sorafenib tosilate (JAN)",
      "Nexavar (TN)"
    ],
    "formula": "C21H16ClF3N4O3. C7H8O3S",
    "efficacy": "Antineoplastic, Tyrosine kinase inhibitor\nDISEASE   Hepatocellular carcinoma [DS:H00048]\nRenal cell carcinoma [DS:H00021]\nThyroid carcinoma [DS:H00032]",
    "target": "RAF1 [HSA:5894] [KO:K04366]\nBRAF [HSA:673] [KO:K04365]\nFLT3 (CD135) [HSA:2322] [KO:K05092]\nPDGFRB [HSA:5159] [KO:K05089]\nVEGFR2 (KDR) [HSA:3791] [KO:K05098]\nVEGFR3 (FLT4) [HSA:2324] [KO:K05097]\nKIT (CD117) [HSA:3815] [KO:K05091]\nRET [HSA:5979] [KO:K05126]\nPATHWAY   hsa04010(2322+2324+3791+3815+5159+5894+673)  MAPK signaling pathway\nhsa04012(5894+673)  ErbB signaling pathway\nhsa04370(3791+5894)  VEGF signaling pathway\nhsa05200(2322+2324+3815+5159+5894+5979+673)  Pathways in cancer\nhsa05211(5894+673)  Renal cell carcinoma\nhsa05216(5979+673)  Thyroid cancer\nhsa05225(5894+673)  Hepatocellular carcinoma",
    "metabolism": "",
    "therapeutic_category": "4291",
    "atc_code": "L01EX02",
    "drug_class": [
      "Antineoplastic",
      "Tyrosine kinase inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Sorafenib tosylate"
  },
  {
    "kegg_id": "D05380",
    "name_en": "Pazopanib hydrochloride (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Votrient (TN)"
    ],
    "formula": "C21H23N7O2S. HCl",
    "efficacy": "Antineoplastic, Receptor tyrosine kinase inhibitor\nDISEASE   Renal cell carcinoma [DS:H00021]\nSoft tissue sarcoma [DS:H02427]",
    "target": "PDGFR [HSA:5156 5159] [KO:K04363 K05089]\nVEGFR1 (FLT1) [HSA:2321] [KO:K05096]\nVEGFR2 (KDR) [HSA:3791] [KO:K05098]\nVEGFR3 (FLT4) [HSA:2324] [KO:K05097]\nKIT (CD117) [HSA:3815] [KO:K05091]\nPATHWAY   hsa04010(2321+2324+3791+3815+5156+5159)  MAPK signaling pathway\nhsa05200(2324+3815+5156+5159)  Pathways in cancer",
    "metabolism": "",
    "therapeutic_category": "4291",
    "atc_code": "L01EX03",
    "drug_class": [
      "Antineoplastic",
      "Tyrosine kinase inhibitor",
      "Receptor tyrosine kinase inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Pazopanib hydrochloride"
  },
  {
    "kegg_id": "D06407",
    "name_en": "Vandetanib (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Caprelsa (TN)"
    ],
    "formula": "C22H24BrFN4O2",
    "efficacy": "Antineoplastic, Receptor tyrosine kinase inhibitor\nDISEASE   Medullary thyroid cancer [DS:H01592]",
    "target": "EGFR [HSA:1956] [KO:K04361]\nVEGFR2 (KDR) [HSA:3791] [KO:K05098]\nRET [HSA:5979] [KO:K05126]\nPATHWAY   hsa04010(1956+3791)  MAPK signaling pathway\nhsa04012(1956)  ErbB signaling pathway\nhsa04370(3791)  VEGF signaling pathway\nhsa05200(1956+5979)  Pathways in cancer\nhsa05216(5979)  Thyroid cancer",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "4291",
    "atc_code": "L01EX04",
    "drug_class": [
      "Antineoplastic",
      "Tyrosine kinase inhibitor",
      "Receptor tyrosine kinase inhibitor",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "Transporter inhibitor",
      "ABCB1 inhibitor",
      "SLC22A2 inhibitor"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Vandetanib"
  },
  {
    "kegg_id": "D10137",
    "name_en": "Regorafenib hydrate (JAN)",
    "name_ja": "",
    "names_alt": [
      "Stivarga (TN)"
    ],
    "formula": "C21H15ClF4N4O3. H2O",
    "efficacy": "Antineoplastic, Receptor tyrosine kinase inhibitor\nDISEASE   Colorectal cancer [DS:H00020]\nGastrotintestinal stromal tumor [DS:H01591]\nHepatocellular carcinoma [DS:H00048]",
    "target": "VEGFR1 (FLT1) [HSA:2321] [KO:K05096]\nVEGFR2 (KDR) [HSA:3791] [KO:K05098]\nVEGFR3 (FLT4) [HSA:2324] [KO:K05097]\nTEK (TIE2, CD202) [HSA:7010] [KO:K05121]\nPDGFRB [HSA:5159] [KO:K05089]\nFGFR1 (CD331) [HSA:2260] [KO:K04362]\nKIT (CD117) [HSA:3815] [KO:K05091]\nRET [HSA:5979] [KO:K05126]\nRAF1 [HSA:5894] [KO:K04366]\nBRAF [HSA:673] [KO:K04365]\nPATHWAY   hsa04010(2260+2321+2324+3791+3815+5159+5894+673+7010)  MAPK signaling pathway\nhsa04370(3791+5894)  VEGF signaling pathway\nhsa05200(2260+2324+3815+5159+5894+5979+673)  Pathways in cancer\nhsa05210(5894+673)  Colorectal cancer\nhsa05225(5894+673)  Hepatocellular carcinoma",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576], UGT1A9 [HSA:54600]\nTransporter: ABCB1 [HSA:5243], ABCG2 [HSA:9429]",
    "therapeutic_category": "4291",
    "atc_code": "L01EX05",
    "drug_class": [
      "Antineoplastic",
      "Tyrosine kinase inhibitor",
      "Receptor tyrosine kinase inhibitor",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "UGT substrate",
      "UGT1A9 substrate",
      "Transporter substrate",
      "ABCB1 substrate",
      "ABCG2 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Regorafenib hydrate"
  },
  {
    "kegg_id": "D10095",
    "name_en": "Cabozantinib s-malate (USAN)",
    "name_ja": "",
    "names_alt": [
      "Cabozantinib malate (JAN)",
      "Cometriq (TN)",
      "Cabometyx (TN)"
    ],
    "formula": "C28H24FN3O5. C4H6O5",
    "efficacy": "Antineoplastic, Receptor tyrosine kinase inhibitor\nDISEASE   Medullary thyroid cancer [DS:H01592]\nRenal cell carcinoma [DS:H00021]\nHepatocellular carcinoma [DS:H00048]\nDifferentiated thyroid cancer [DS:H00032]",
    "target": "VEGFR2 (KDR) [HSA:3791] [KO:K05098]\nMET [HSA:4233] [KO:K05099]\nAXL [HSA:558] [KO:K05115]\nPATHWAY   hsa04010(3791+4233)  MAPK signaling pathway\nhsa04014(3791+4233)  Ras signaling pathway\nhsa04151(3791+4233)  PI3K-Akt signaling pathway\nhsa04370(3791)  VEGF signaling pathway\nhsa05200(4233)  Pathways in cancer\nhsa05211(4233)  Renal cell carcinoma",
    "metabolism": "",
    "therapeutic_category": "4291",
    "atc_code": "L01EX07",
    "drug_class": [
      "Antineoplastic",
      "Tyrosine kinase inhibitor",
      "Receptor tyrosine kinase inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Cabozantinib s-malate"
  },
  {
    "kegg_id": "D09920",
    "name_en": "Lenvatinib mesylate (USAN)",
    "name_ja": "",
    "names_alt": [
      "Lenvatinib mesilate (JAN)",
      "Lenvima (TN)"
    ],
    "formula": "C21H19ClN4O4. CH4SO3",
    "efficacy": "Antineoplastic, Receptor tyrosine kinase inhibitor\nDISEASE   Thyroid cancer [DS:H00032]\nRenal cell carcinoma [DS:H00021]\nHepatocellular carcinoma [DS:H00048]\nEndometrial cancer [DS:H00026]",
    "target": "VEGFR1 (FLT1) [HSA:2321] [KO:K05096]\nVEGFR2 (KDR) [HSA:3791] [KO:K05098]\nVEGFR3 (FLT4) [HSA:2324] [KO:K05097]\nFGFR [HSA:2260 2263 2261 2264] [KO:K04362 K05093 K05094 K05095]\nRET [HSA:5979] [KO:K05126]\nPATHWAY   hsa04010(2260+2261+2263+2264+2321+2324+3791)  MAPK signaling pathway\nhsa04370(3791)  VEGF signaling pathway\nhsa05200(2260+2261+2263+2264+2324+5979)  Pathways in cancer\nhsa05216(5979)  Thyroid cancer",
    "metabolism": "Enzyme: CYP3A [HSA:1576 1577 1551]\nTransporter: ABCB1 [HSA:5243]",
    "therapeutic_category": "4291",
    "atc_code": "L01EX08",
    "drug_class": [
      "Antineoplastic",
      "Tyrosine kinase inhibitor",
      "Receptor tyrosine kinase inhibitor",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "Transporter substrate",
      "ABCB1 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A"
    ],
    "search_name": "Lenvatinib mesylate"
  },
  {
    "kegg_id": "D09956",
    "name_en": "Quizartinib dihydrochloride (USAN)",
    "name_ja": "",
    "names_alt": [
      "Quizartinib hydrochloride (JAN)",
      "Vanflyta (TN)"
    ],
    "formula": "C29H32N6O4S. 2HCl",
    "efficacy": "Antineoplastic, Receptor tyrosine kinase inhibitor\nDISEASE   Acute myeloid leukemia (FLT3 internal tandem duplication) [DS:H00003]",
    "target": "FLT3* (CD135) [HSA_VAR:2322v2] [HSA:2322] [KO:K05092]\nPATHWAY   hsa04640(2322)  Hematopoietic cell lineage\nhsa05200(2322)  Pathways in cancer\nNETWORK   nt06275  Acute myeloid leukemia",
    "metabolism": "Enzyme: CYP3A [HSA:1576 1577 1551]",
    "therapeutic_category": "4291",
    "atc_code": "L01EX11",
    "drug_class": [
      "Antineoplastic",
      "Tyrosine kinase inhibitor",
      "Receptor tyrosine kinase inhibitor",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A"
    ],
    "search_name": "Quizartinib dihydrochloride"
  },
  {
    "kegg_id": "D11138",
    "name_en": "Larotrectinib sulfate (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Vitrakvi (TN)"
    ],
    "formula": "C21H22F2N6O2. H2SO4",
    "efficacy": "Antineoplastic, Tropomyosin receptor kinase inhibitor\nDISEASE   Solid tumors (NTRK gene fusion positive) [DS:H02421]",
    "target": "NTRK [HSA:4914 4915 4916] [KO:K03176 K04360 K05101]\nPATHWAY   hsa04722(4914+4915+4916)  Neurotrophin signaling pathway\nhsa05200(4914)  Pathways in cancer\nNETWORK   nt06210  ERK signaling (cancer)",
    "metabolism": "Enzyme: CYP3A [HSA:1576 1577 1551]",
    "therapeutic_category": "4291",
    "atc_code": "L01EX12",
    "drug_class": [
      "Antineoplastic",
      "Tyrosine kinase inhibitor",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A"
    ],
    "search_name": "Larotrectinib sulfate"
  },
  {
    "kegg_id": "D10800",
    "name_en": "Gilteritinib fumarate (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Xospata (TN)"
    ],
    "formula": "(C29H44N8O3)2. C4H4O4",
    "efficacy": "Antineoplastic, Tyrosine kinase inhibitor\nDISEASE   Acute myeloid leukemia (FLT3 mutation positive) [DS:H00003]",
    "target": "FLT3* (CD135) [HSA_VAR:2322v1 2322v2] [HSA:2322] [KO:K05092]\nPATHWAY   hsa04014(2322)  Ras signaling pathway\nhsa04640(2322)  Hematopoietic cell lineage\nhsa05200(2322)  Pathways in cancer\nhsa05221(2322)  Acute myeloid leukemia\nNETWORK   nt06275  Acute myeloid leukemia",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]\nTransporter: ABCB1 [HSA:5243]",
    "therapeutic_category": "4291",
    "atc_code": "L01EX13",
    "drug_class": [
      "Antineoplastic",
      "Tyrosine kinase inhibitor",
      "Receptor tyrosine kinase inhibitor",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "Transporter substrate",
      "ABCB1 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Gilteritinib fumarate"
  },
  {
    "kegg_id": "D10926",
    "name_en": "Entrectinib (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Rozlytrek (TN)"
    ],
    "formula": "C31H34F2N6O2",
    "efficacy": "Antineoplastic, Tyrosine kinase inhibitor\nDISEASE   Non-small cell lung cancer (ROS1 positive) [DS:H00014]\nSolid tumors (NTRK gene fusion positive) [DS:H02421]",
    "target": "NTRK1* (TRKA) [HSA_VAR:4914v1] [HSA:4914] [KO:K03176]\nROS1* [HSA_VAR:6098v1] [HSA:6098] [KO:K05088]\nNTRK2 (TRKB) [HSA:4915] [KO:K04360]\nNTRK3 (TRKC) [HSA:4916] [KO:K05101]\nALK (CD246) [HSA:238] [KO:K05119]\nPATHWAY   hsa04151(4914+4915)  PI3K-Akt signaling pathway\nhsa05200(238+4914)  Pathways in cancer\nNETWORK   nt06210  ERK signaling (cancer)\nnt06266  Non-small cell lung cancer",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "4291",
    "atc_code": "L01EX14",
    "drug_class": [
      "Antineoplastic",
      "Tyrosine kinase inhibitor",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "Metabolizing enzyme inhibitor",
      "CYP3A/CYP3A4 inhibitor"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Entrectinib"
  },
  {
    "kegg_id": "D11713",
    "name_en": "Selpercatinib (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Retevmo (TN)"
    ],
    "formula": "C29H31N7O3",
    "efficacy": "Antineoplastic, Tyrosine kinase inhibitor\nDISEASE   Non-small cell lung cancer (RET fusion positive) [DS:H00014]\nMedullary thyroid cancer (RET mutant) [DS:H01592]\nThyroid cancer (RET fusion positive) [DS:H00032]",
    "target": "RET* [HSA_VAR:5979v1 5979v2] [HSA:5979] [KO:K05126]\nVEGFR1 (FLT1) [HSA:2321] [KO:K05096]\nVEGFR3 (FLT4) [HSA:2324] [KO:K05097]\nPATHWAY   hsa05200(2324+5979)  Pathways in cancer\nhsa05216(5979)  Thyroid cancer\nhsa05223(5979)  Non-small cell lung cancer\nhsa05230(5979)  Central carbon metabolism in cancer\nNETWORK   nt06266  Non-small cell lung cancer\nnt06274  Thyroid cancer",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "4291",
    "atc_code": "L01EX22",
    "drug_class": [
      "Antineoplastic",
      "Tyrosine kinase inhibitor",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Selpercatinib"
  },
  {
    "kegg_id": "D11371",
    "name_en": "Capivasertib (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Truqap (TN)"
    ],
    "formula": "C21H25ClN6O2",
    "efficacy": "Antineoplastic, AKT serine/threonine kinase inhibitor\nDISEASE   Breast cancer (HR positive, HER2 negative, PIK3CA/AKT1/PTEN mutated) [DS:H00031]",
    "target": "AKT (PKB) [HSA:207 208 10000] [KO:K04456]\nPATHWAY   hsa04151(10000+207+208)  PI3K-Akt signaling pathway\nhsa05200(10000+207+208)  Pathways in cancer\nNETWORK   nt06270  Breast cancer",
    "metabolism": "Enzyme: CYP3A [HSA:1576 1577 1551]",
    "therapeutic_category": "4291",
    "atc_code": "L01EX27",
    "drug_class": [
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "Metabolizing enzyme inhibitor",
      "CYP3A/CYP3A4 inhibitor",
      "Transporter inhibitor",
      "SLC22A2 inhibitor",
      "SLC47A1 inhibitor",
      "SLC47A2 inhibitor"
    ],
    "cyp_enzymes": [
      "CYP3A"
    ],
    "search_name": "Capivasertib"
  },
  {
    "kegg_id": "D11454",
    "name_en": "Repotrectinib (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Augtyro (TN)"
    ],
    "formula": "C18H18FN5O2",
    "efficacy": "Antineoplastic, Receptor tyrosine kinase inhibitor\nDISEASE   Non-small cell lung cancer (ROS1 positive) [DS:H00014]",
    "target": "ROS1* [HSA_VAR:6098v1] [HSA:6098] [KO:K05088]\nNTRK1 (TRKA) [HSA:4914] [KO:K03176]\nNTRK2 (TRKB) [HSA:4915] [KO:K04360]\nNTRK3 (TRKC) [HSA:4916] [KO:K05101]\nPATHWAY   hsa04722(4914+4915+4916)  Neurotrophin signaling pathway\nhsa05200(4914)  Pathways in cancer\nNETWORK   nt06210  ERK signaling (cancer)\nnt06240  Transcription (cancer)",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "4291",
    "atc_code": "L01EX28",
    "drug_class": [
      "Antineoplastic",
      "Tyrosine kinase inhibitor",
      "Receptor tyrosine kinase inhibitor",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Repotrectinib"
  },
  {
    "kegg_id": "D02994",
    "name_en": "Rituximab (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Rituximab (genetical recombination) (JAN)",
      "Rituximab (genetical recombination) [Rituximab biosimilar 1] (JAN)",
      "Rituximab (genetical recombination) [Rituximab biosimilar 2] (JAN)",
      "Rituximab-abbs",
      "Rituximab-pvvr",
      "Rituximab-arrx",
      "Rituxan (TN)",
      "Riabni (TN)",
      "Truximab (TN)"
    ],
    "formula": "",
    "efficacy": "Antineoplastic, Anti-CD20 antibody\nDISEASE   Non-Hodgkin's lymphoma (CD20 positive) [DS:H02418]\nChronic lymphocytic leukemia (CD20 positive) [DS:H00005]\nRheumatoid arthritis [DS:H00630]\nGranulomatosis with polyangiitis; Wegener's granulomatosis [DS:H01655]\nMicroscopic polyangiitis [DS:H01658]\nPemphigus vulgaris [DS:H01648]\nTYPE      Monoclonal antibody",
    "target": "CD20 [HSA:931] [KO:K06466]\nPATHWAY   hsa04640(931)  Hematopoietic cell lineage",
    "metabolism": "",
    "therapeutic_category": "4291",
    "atc_code": "L01FA01",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Rituximab"
  },
  {
    "kegg_id": "D09321",
    "name_en": "Obinutuzumab (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Obinutuzumab (genetical recombination) (JAN)",
      "Gazyva (TN)"
    ],
    "formula": "C6512H10060N1712O2020S44",
    "efficacy": "Antineoplastic, Anti-CD20 antibody\nDISEASE   Chronic lymphocytic leukemia [DS:H00005]\nFollicular lymphoma [DS:H01613]\nTYPE      Monoclonal antibody",
    "target": "CD20 [HSA:931] [KO:K06466]\nPATHWAY   hsa04640(931)  Hematopoietic cell lineage",
    "metabolism": "",
    "therapeutic_category": "4291",
    "atc_code": "L01FA03",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Obinutuzumab"
  },
  {
    "kegg_id": "D10777",
    "name_en": "Daratumumab (USAN)",
    "name_ja": "",
    "names_alt": [
      "Daratumumab (genetical recombination) (JAN)",
      "Darzalex (TN)"
    ],
    "formula": "C6466H9996N1724O2010S42",
    "efficacy": "Antineoplastic, Anti-CD38 antibody\nDISEASE   Multiple myeloma [DS:H00010]\nTYPE      Monoclonal antibody",
    "target": "CD38 [HSA:952] [KO:K01242]\nPATHWAY   hsa04640(952)  Hematopoietic cell lineage",
    "metabolism": "",
    "therapeutic_category": "4291",
    "atc_code": "L01FC01",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Daratumumab"
  },
  {
    "kegg_id": "D11967",
    "name_en": "Daratumumab and hyaluronidase",
    "name_ja": "",
    "names_alt": [
      "Daratumumab (genetical recombination) and vorhyaluronidase alfa (genetical recombination)",
      "Daratumumab and hyaluronidase-fihj",
      "Darzalex faspro (TN)",
      "Darzquro (TN)"
    ],
    "formula": "",
    "efficacy": "Antineoplastic\nDISEASE   Multiple myeloma [DS:H00010]\nLight chain amyloidosis [DS:H02499]\nTYPE      Monoclonal antibody combination",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "4291",
    "atc_code": "L01FC01",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Daratumumab and hyaluronidase"
  },
  {
    "kegg_id": "D11050",
    "name_en": "Isatuximab (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Isatuximab (genetical recombination) (JAN)",
      "Isatuximab-irfc",
      "Sarclisa (TN)"
    ],
    "formula": "",
    "efficacy": "Antineoplastic, Anti-CD38 antibody\nDISEASE   Multiple myeloma [DS:H00010]\nTYPE      Monoclonal antibody",
    "target": "CD38 [HSA:952] [KO:K01242]\nPATHWAY   hsa04640(952)  Hematopoietic cell lineage",
    "metabolism": "",
    "therapeutic_category": "4291",
    "atc_code": "L01FC02",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Isatuximab"
  },
  {
    "kegg_id": "D03257",
    "name_en": "Trastuzumab (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Trastuzumab (genetical recombination) (JAN)",
      "Trastuzumab (genetical recombination) [Trastuzumab biosimilar 1] (JAN)",
      "Trastuzumab (genetical recombination) [Trastuzumab biosimilar 2] (JAN)",
      "Trastuzumab (genetical recombination) [Trastuzumab biosimilar 3] (JAN)",
      "Trastuzumab-pkrb",
      "Trastuzumab-anns",
      "Trastuzumab-dkst",
      "Trastuzumab-dttb",
      "Trastuzumab-qyyp",
      "Trastuzumab-anns",
      "Trastuzumab-strf",
      "Herceptin (TN)",
      "Hercessi (TN)",
      "Herzuma (TN)",
      "Kanjinti (TN)",
      "Ogivri (TN)",
      "Ontruzant (TN)"
    ],
    "formula": "",
    "efficacy": "Antineoplastic, Receptor tyrosine kinase inhibitor, Anti-HER2 antibody\nDISEASE   Breast cancer (HER2 overexpressing) [DS:H00031]\nBreast cancer (ER/ PR negative) [DS:H00031]\nGastric cancer (HER2 overexpressing) [DS:H00018]\nTYPE      Monoclonal antibody",
    "target": "ERBB2* (HER2, CD340) [HSA_VAR:2064v1] [HSA:2064] [KO:K05083]\nPATHWAY   hsa04012(2064)  ErbB signaling pathway\nhsa05200(2064)  Pathways in cancer\nhsa05224(2064)  Breast cancer\nhsa05226(2064)  Gastric cancer\nNETWORK   nt06270  Breast cancer",
    "metabolism": "",
    "therapeutic_category": "4291",
    "atc_code": "L01FD01",
    "drug_class": [
      "Antineoplastic",
      "Tyrosine kinase inhibitor",
      "Receptor tyrosine kinase inhibitor",
      "HER2 inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Trastuzumab"
  },
  {
    "kegg_id": "D05446",
    "name_en": "Pertuzumab (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Pertuzumab (genetical recombination) (JAN)",
      "Perjeta (TN)"
    ],
    "formula": "",
    "efficacy": "Antineoplastic, Receptor tyrosine kinase inhibitor, Anti-HER2 antibody\nDISEASE   Breast cancer (HER2 positive) [DS:H00031]\nTYPE      Monoclonal antibody",
    "target": "ERBB2* (HER2, CD340) [HSA_VAR:2064v1 2064v3] [HSA:2064] [KO:K05083]\nPATHWAY   hsa04012(2064)  ErbB signaling pathway\nhsa05200(2064)  Pathways in cancer\nhsa05224(2064)  Breast cancer\nNETWORK   nt06270  Breast cancer",
    "metabolism": "",
    "therapeutic_category": "4291",
    "atc_code": "L01FD02",
    "drug_class": [
      "Antineoplastic",
      "Tyrosine kinase inhibitor",
      "Receptor tyrosine kinase inhibitor",
      "HER2 inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Pertuzumab"
  },
  {
    "kegg_id": "D09980",
    "name_en": "Trastuzumab emtansine (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Trastuzumab emtansine (genetical recombination) (JAN)",
      "Ado-trastuzumab emtansine",
      "Kadcyla (TN)"
    ],
    "formula": "C6448H9948N1720O2012S44",
    "efficacy": "Antineoplastic, Tubulin polymerization inhibitor, Receptor tyrosine kinase inhibitor, Anti-HER2 antibody\nDISEASE   Breast cancer (HER2 positive) [DS:H00031]\nTYPE      Antibody-drug conjugate",
    "target": "ERBB2* (HER2, CD340) [HSA_VAR:2064v1 2064v3] [HSA:2064] [KO:K05083]\nTUBB [HSA:10381 10382 10383 203068 347688 347733 7280 81027 84617] [KO:K07375]\nPATHWAY   hsa04012(2064)  ErbB signaling pathway\nhsa05200(2064)  Pathways in cancer\nhsa05224(2064)  Breast cancer\nNETWORK   nt06270  Breast cancer",
    "metabolism": "",
    "therapeutic_category": "4291",
    "atc_code": "L01FD03",
    "drug_class": [
      "Antineoplastic",
      "Tyrosine kinase inhibitor",
      "Receptor tyrosine kinase inhibitor",
      "HER2 inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Trastuzumab emtansine"
  },
  {
    "kegg_id": "D11529",
    "name_en": "Trastuzumab deruxtecan (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Trastuzumab deruxtecan (genetical recombination) (JAN)",
      "Fam-trastuzumab deruxtecan-nxki",
      "Enhertu (TN)"
    ],
    "formula": "C6460H9972N1724O2014S44. (C52H57FN9O13)8",
    "efficacy": "Antineoplastic\nDISEASE   Breast cancer (HER2 positive) [DS:H00031]\nBreast cancer (HER2 low) [DS:H00031]\nNon-small cell lung cancer (HER2 mutant) [DS:H00014]\nGastric cancer (HER2 positive) [DS:H00018]\nSolid tumor (HER2 positive IHC 3+) [DS:H02421]\nTYPE      Antibody-drug conjugate",
    "target": "ERBB2* (HER2, CD340) [HSA_VAR:2064v1] [HSA:2064] [KO:K05083]\nTOP1 [HSA:7150] [KO:K03163]\nPATHWAY   hsa01521(2064)  EGFR tyrosine kinase inhibitor resistance\nhsa04012(2064)  ErbB signaling pathway\nhsa05200(2064)  Pathways in cancer\nNETWORK   nt06266  Non-small cell lung cancer\nnt06270  Breast cancer",
    "metabolism": "",
    "therapeutic_category": "4291",
    "atc_code": "L01FD04",
    "drug_class": [
      "Antineoplastic",
      "Tyrosine kinase inhibitor",
      "Receptor tyrosine kinase inhibitor",
      "HER2 inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Trastuzumab deruxtecan"
  },
  {
    "kegg_id": "D03455",
    "name_en": "Cetuximab (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Cetuximab (genetical recombination) (JAN)",
      "Erbitux (TN)"
    ],
    "formula": "",
    "efficacy": "Antineoplastic, Anti-epidermal growth factor receptor antibody\nDISEASE   Squamous cell carcinoma of the head and neck [DS:H02420]\nColorectal cancer (K-Ras wild type, EGFR-expressing) [DS:H00020]\nColorectal cancer (BRAF mutation positive) [DS:H00020]\nTYPE      Monoclonal antibody",
    "target": "EGFR [HSA:1956] [KO:K04361]\nPATHWAY   hsa04010(1956)  MAPK signaling pathway\nhsa04012(1956)  ErbB signaling pathway\nhsa05200(1956)  Pathways in cancer\nNETWORK   nt06260  Colorectal cancer",
    "metabolism": "",
    "therapeutic_category": "4291",
    "atc_code": "L01FE01",
    "drug_class": [
      "Antineoplastic",
      "Tyrosine kinase inhibitor",
      "Receptor tyrosine kinase inhibitor",
      "EGFR inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Cetuximab"
  },
  {
    "kegg_id": "D05350",
    "name_en": "Panitumumab (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Panitumumab (genetical recombination) (JAN)",
      "Vectibix (TN)"
    ],
    "formula": "",
    "efficacy": "Antineoplastic, Anti-epidermal growth factor receptor antibody\nDISEASE   Colorectal cancer (KRAS and NRAS wild type) [DS:H00020]\nTYPE      Monoclonal antibody",
    "target": "EGFR [HSA:1956] [KO:K04361]\nPATHWAY   hsa04010(1956)  MAPK signaling pathway\nhsa04012(1956)  ErbB signaling pathway\nhsa05200(1956)  Pathways in cancer\nNETWORK   nt06260  Colorectal cancer",
    "metabolism": "",
    "therapeutic_category": "4291",
    "atc_code": "L01FE02",
    "drug_class": [
      "Antineoplastic",
      "Tyrosine kinase inhibitor",
      "Receptor tyrosine kinase inhibitor",
      "EGFR inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Panitumumab"
  },
  {
    "kegg_id": "D10018",
    "name_en": "Necitumumab (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Necitumumab (genetical recombination) (JAN)",
      "Portrazza (TN)"
    ],
    "formula": "",
    "efficacy": "Antineoplastic, Receptor tyrosine kinase inhibitor, Anti-epidermal growth factor receptor antibody\nDISEASE   Squamous non-small cell lung cancer [DS:H00014]\nTYPE      Monoclonal antibody",
    "target": "EGFR [HSA:1956] [KO:K04361]\nPATHWAY   hsa04010(1956)  MAPK signaling pathway\nhsa04012(1956)  ErbB signaling pathway\nhsa05223(1956)  Non-small cell lung cancer",
    "metabolism": "",
    "therapeutic_category": "4291",
    "atc_code": "L01FE03",
    "drug_class": [
      "Antineoplastic",
      "Tyrosine kinase inhibitor",
      "Receptor tyrosine kinase inhibitor",
      "EGFR inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Necitumumab"
  },
  {
    "kegg_id": "D10316",
    "name_en": "Nivolumab (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Nivolumab (genetical recombination) (JAN)",
      "Opdivo (TN)"
    ],
    "formula": "C6362H9862N1712O1995S42",
    "efficacy": "Antineoplastic, Immune checkpoint inhibitor, Anti-PD-1 antibody\nDISEASE   Melanoma [DS:H00038]\nNon-small cell lung cancer [DS:H00014]\nSmall cell lung cancer [DS:H00013]\nMalignant pleural mesothelioma [DS:H00015]\nRenal cell carcinoma [DS:H00021]\nHodgkin lymphoma [DS:H00007]\nSquamous cell carcinoma of the head and neck [DS:H02420]\nUrothelial carcinoma [DS:H00022]\nColorectal cancer (MSI-H or dMMR) [DS:H00020]\nHepatocellular carcinoma [DS:H00048]\nEsophageal squamous cell carcinoma [DS:H00017]\nGastric cancer [DS:H00018]\nEsophageal adenocarcinoma [DS:H00017]\nTYPE      Monoclonal antibody",
    "target": "PDCD1 (PD1, CD279) [HSA:5133] [KO:K06744]\nPATHWAY   hsa04514(5133)  Cell adhesion molecule (CAM) interaction\nhsa04660(5133)  T cell receptor signaling pathway\nhsa05235(5133)  PD-L1 expression and PD-1 checkpoint pathway in cancer",
    "metabolism": "",
    "therapeutic_category": "4291",
    "atc_code": "L01FF01",
    "drug_class": [
      "Antineoplastic",
      "Immune checkpoint inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Nivolumab"
  },
  {
    "kegg_id": "D10574",
    "name_en": "Pembrolizumab (USAN)",
    "name_ja": "",
    "names_alt": [
      "Pembrolizumab (genetical recombination) (JAN)",
      "Keytruda (TN)"
    ],
    "formula": "C6504H10004N1716O2036S46",
    "efficacy": "Antineoplastic, Immune checkpoint inhibitor, Anti-PD-1 antibody\nDISEASE   Melanoma [DS:H00038]\nNon-small cell lung cancer (PD-L1 expressed) [DS:H00014]\nHead and neck squamous cell carcinoma (PD-L1 expressed) [DS:H02420]\nHead and neck squamous cell carcinoma [DS:H02420]\nHodgkin lymphoma [DS:H00007]\nMediastinal large B-cell lymphoma [DS:H02434]\nUrothelial carcinoma [DS:H00022]\nSolid tumor (MSI-H or dMMR) [DS:H02421]\nColorectal cancer (MSI-H) [DS:H00020]\nGastric cancer (HER2 positive) [DS:H00018]\nEsophageal cancer (PD-L1 expressed) [DS:H00017]\nCervical cancer (PD-L1 expressed) [DS:H00030]\nHepatocellular carcinoma [DS:H00048]\nMerkel cell carcinoma [DS:H01555]\nRenal cell carcinoma [DS:H00021]\nEndometrial carcinoma (MSI-H or dMMR) [DS:H00026]\nSolid tumor (TMB-H) [DS:H02421]\nCutaneous squamous cell carcinoma [DS:H00040]\nBreast cancer (triple negative, PD-L1 expressed) [DS:H00031]\nTYPE      Monoclonal antibody",
    "target": "PDCD1 (PD1, CD279) [HSA:5133] [KO:K06744]\nPATHWAY   hsa04514(5133)  Cell adhesion molecule (CAM) interaction\nhsa04660(5133)  T cell receptor signaling pathway\nhsa05235(5133)  PD-L1 expression and PD-1 checkpoint pathway in cancer",
    "metabolism": "",
    "therapeutic_category": "4291",
    "atc_code": "L01FF02",
    "drug_class": [
      "Antineoplastic",
      "Immune checkpoint inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Pembrolizumab"
  },
  {
    "kegg_id": "D10808",
    "name_en": "Durvalumab (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Durvalumab (genetical recombination) (JAN)",
      "Imfinzi (TN)"
    ],
    "formula": "",
    "efficacy": "Antineoplastic, Anti-PD-L1 antibody\nDISEASE   Non-small cell lung cancer [DS:H00014]\nSmall cell lung cancer [DS:H00013]\nBiliary tract cancers [DS:H00046 H00047]\nHepatocellular carcinoma [DS:H00048]\nTYPE      Monoclonal antibody",
    "target": "PDL1 (CD274) [HSA:29126] [KO:K06745]\nPATHWAY   hsa04514(29126)  Cell adhesion molecule (CAM) interaction\nhsa05235(29126)  PD-L1 expression and PD-1 checkpoint pathway in cancer",
    "metabolism": "",
    "therapeutic_category": "4291",
    "atc_code": "L01FF03",
    "drug_class": [
      "Antineoplastic",
      "Immune checkpoint inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Durvalumab"
  },
  {
    "kegg_id": "D10817",
    "name_en": "Avelumab (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Avelumab (genetical recombination) (JAN)",
      "Bavencio (TN)"
    ],
    "formula": "",
    "efficacy": "Antineoplastic, Immunomodulator, Anti-PD-L1 antibody\nDISEASE   Merkel cell carcinoma [DS:H01555]\nUrothelial carcinoma [DS:H00022]\nRenal cell carcinoma [DS:H00021]\nTYPE      Monoclonal antibody",
    "target": "PDL1 (CD274) [HSA:29126] [KO:K06745]\nPATHWAY   hsa04514(29126)  Cell adhesion molecule (CAM) interaction\nhsa05235(29126)  PD-L1 expression and PD-1 checkpoint pathway in cancer",
    "metabolism": "",
    "therapeutic_category": "4291",
    "atc_code": "L01FF04",
    "drug_class": [
      "Antineoplastic",
      "Immune checkpoint inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Avelumab"
  },
  {
    "kegg_id": "D10773",
    "name_en": "Atezolizumab (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Atezolizumab (genetical recombination) (JAN)",
      "Tecentriq (TN)"
    ],
    "formula": "C6446H9902N1706O1998S42",
    "efficacy": "Antineoplastic, Immune checkpoint inhibitor, Anti-PD-L1 antibody\nDISEASE   Urothelial carcinoma [DS:H00022]\nUrothelial carcinoma (PD-L1 expressed) [DS:H00022]\nNon-small cell lung cancer [DS:H00014]\nBreast cancer (PD-L1 expressed, HR negative, HER2 negative) [DS:H00031]\nSmall cell lung cancer [DS:H00013]\nHepatocellular carcinoma [DS:H00048]\nTYPE      Monoclonal antibody",
    "target": "PDL1 (CD274) [HSA:29126] [KO:K06745]\nPATHWAY   hsa04514(29126)  Cell adhesion molecule (CAM) interaction\nhsa05235(29126)  PD-L1 expression and PD-1 checkpoint pathway in cancer",
    "metabolism": "",
    "therapeutic_category": "4291",
    "atc_code": "L01FF05",
    "drug_class": [
      "Antineoplastic",
      "Immune checkpoint inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Atezolizumab"
  },
  {
    "kegg_id": "D11108",
    "name_en": "Cemiplimab (USAN)",
    "name_ja": "",
    "names_alt": [
      "Cemiplimab (genetical recombination) (JAN)",
      "Cemiplimab-rwlc",
      "Libtayo (TN)"
    ],
    "formula": "",
    "efficacy": "Antineoplastic, Immune checkpoint inhibitor, Anti-PD-1 antibody\nDISEASE   Squamous cell carcinoma [DS:H00040]\nBasal cell carcinoma [DS:H00039]\nNon-small cell lung cance [DS:H00014]\nTYPE      Monoclonal antibody",
    "target": "PDCD1 (PD1, CD279) [HSA:5133] [KO:K06744]\nPATHWAY   hsa04514(5133)  Cell adhesion molecule (CAM) interaction\nhsa04660(5133)  T cell receptor signaling pathway\nhsa05235(5133)  PD-L1 expression and PD-1 checkpoint pathway in cancer",
    "metabolism": "",
    "therapeutic_category": "4291",
    "atc_code": "L01FF06",
    "drug_class": [
      "Antineoplastic",
      "Immune checkpoint inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Cemiplimab"
  },
  {
    "kegg_id": "D11487",
    "name_en": "Tislelizumab (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Tislelizumab (genetical recombination) (JAN)",
      "Tislelizumab-jsgr",
      "Tevimbra (TN)"
    ],
    "formula": "C6410H9916N1686O2009S40",
    "efficacy": "Antineoplastic, Anti-PD-1 antibody\nDISEASE   Esophageal squamous cell carcinoma [DS:H00017]\nTYPE      Monoclonal antibody",
    "target": "PDCD1 (PD1, CD279) [HSA:5133] [KO:K06744]\nPATHWAY   hsa04514(5133)  Cell adhesion molecule (CAM) interaction\nhsa04660(5133)  T cell receptor signaling pathway\nhsa05235(5133)  PD-L1 expression and PD-1 checkpoint pathway in cancer",
    "metabolism": "",
    "therapeutic_category": "4291",
    "atc_code": "L01FF09",
    "drug_class": [
      "Antineoplastic",
      "Immune checkpoint inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Tislelizumab"
  },
  {
    "kegg_id": "D11827",
    "name_en": "Retifanlimab (USAN)",
    "name_ja": "",
    "names_alt": [
      "Retifanlimab (genetical recombination) (JAN)",
      "Retifanlimab-dlwr",
      "Zynyz (TN)"
    ],
    "formula": "C6456H9934N1702O2032S46",
    "efficacy": "Antineoplastic, Immune checkpoint inhibitor, Anti-PD-1 antibody\nDISEASE   Squamous cell carcinoma of the anal canal [DS:H00044]\nMerkel cell carcinoma [DS:H01555]\nTYPE      Monoclonal antibody",
    "target": "PDCD1 (PD1, CD279) [HSA:5133] [KO:K06744]\nPATHWAY   hsa04514(5133)  Cell adhesion molecule (CAM) interaction\nhsa04660(5133)  T cell receptor signaling pathway\nhsa05235(5133)  PD-L1 expression and PD-1 checkpoint pathway in cancer",
    "metabolism": "",
    "therapeutic_category": "4291",
    "atc_code": "L01FF10",
    "drug_class": [
      "Antineoplastic",
      "Immune checkpoint inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Retifanlimab"
  },
  {
    "kegg_id": "D06409",
    "name_en": "Bevacizumab (USAN)",
    "name_ja": "",
    "names_alt": [
      "Bevacizumab (genetical recombination) (JAN)",
      "Bevacizumab (genetical recombination) [Bevacizumab biosimilar 1] (JAN)",
      "Bevacizumab (genetical recombination) [Bevacizumab biosimilar 2] (JAN)",
      "Bevacizumab (genetical recombination) [Bevacizumab biosimilar 3] (JAN)",
      "Bevacizumab (genetical recombination) [Bevacizumab biosimilar 4] (JAN)",
      "Bevacizumab-awwb",
      "Bevacizumab-bvzr",
      "Bevacizumab-maly",
      "Bevacizumab-adcd",
      "Bevacizumab-tnjn",
      "Bevacizumab-nwgd",
      "Avastin (TN)",
      "Alymsys (TN)",
      "Mvasi (TN)",
      "Vegzelma (TN)",
      "Zirabev (TN)"
    ],
    "formula": "C6638H10160N1720O2108S44",
    "efficacy": "Antineoplastic, Angiogenesis inhibitor, Anti-VEGF antibody\nDISEASE   Colorectal cancer [DS:H00020]\nNon-squamous non-small cell lung cancer [DS:H00014]\nGlioblastoma [DS:H00042]\nRenal cell carcinoma [DS:H00021]\nCervical cancer [DS:H00030]\nEpithelial ovarian cancer [DS:H00027]\nFallopian tube cancer [DS:H01554]\nPrimary peritoneal cancer [DS:H01665]\nHepatocellular carcinoma [DS:H00048]\nTYPE      Monoclonal antibody",
    "target": "VEGFA [HSA:7422] [KO:K05448]\nPATHWAY   hsa04370(7422)  VEGF signaling pathway\nhsa05200(7422)  Pathways in cancer\nhsa05211(7422)  Renal cell carcinoma",
    "metabolism": "",
    "therapeutic_category": "4291",
    "atc_code": "L01FG01",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Bevacizumab"
  },
  {
    "kegg_id": "D09371",
    "name_en": "Ramucirumab (USAN)",
    "name_ja": "",
    "names_alt": [
      "Ramucirumab (genetical recombination) (JAN)",
      "Cyramza (TN)"
    ],
    "formula": "C6374H9864N1692O1996S46",
    "efficacy": "Antineoplastic, Anti-VEGF receptor 2 antibody\nDISEASE   Gastric cancer [DS:H00018]\nNon-small cell lung cancer (EGFR exon 19 deletions or exon 21 (L858R) substitution mutated) [DS:H00014]\nColorectal cancer [DS:H00020]\nHepatocellular carcinoma [DS:H00048]\nTYPE      Monoclonal antibody",
    "target": "VEGFR2 (KDR) [HSA:3791] [KO:K05098]\nPATHWAY   hsa01521(3791)  EGFR tyrosine kinase inhibitor resistance\nhsa04014(3791)  Ras signaling pathway\nhsa04370(3791)  VEGF signaling pathway",
    "metabolism": "",
    "therapeutic_category": "4291",
    "atc_code": "L01FG02",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Ramucirumab"
  },
  {
    "kegg_id": "D04603",
    "name_en": "Ipilimumab (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Ipilimumab (genetical recombination) (JAN)",
      "Yervoy (TN)"
    ],
    "formula": "C6472H9972N1732O2004S40",
    "efficacy": "Antineoplastic, Immune checkpoint inhibitor, Anti-CTLA4 antibody\nDISEASE   Melanoma [DS:H00038]\nRenal cell carcinoma [DS:H00021]\nColorectal cancer (MSI-H or dMMR) [DS:H00020]\nHepatocellular carcinoma [DS:H00048]\nTYPE      Monoclonal antibody",
    "target": "CTLA4 (CD152) [HSA:1493] [KO:K06538]\nPATHWAY   hsa04660(1493)  T cell receptor signaling pathway",
    "metabolism": "",
    "therapeutic_category": "4291",
    "atc_code": "L01FX04",
    "drug_class": [
      "Antineoplastic",
      "Immune checkpoint inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Ipilimumab"
  },
  {
    "kegg_id": "D09587",
    "name_en": "Brentuximab vedotin (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Brentuximab vedotin (genetical recombination) (JAN)",
      "Adcetris (TN)"
    ],
    "formula": "C6476H9930N1690O2030S40. (C68H105N11O15)n",
    "efficacy": "Antineoplastic, Tubulin polymerization inhibitor, Anti-CD30 antibody\nDISEASE   Hodgkin lymphoma [DS:H00007]\nAnaplastic large cell lymphoma [DS:H01601]\nPeripheral T-cell lymphoma (CD30 expressing) [DS:H01892]\nMycosis fungoides (CD30 expressing) [DS:H01463]\nTYPE      Antibody-drug conjugate",
    "target": "TNFRSF8 (CD30) [HSA:943] [KO:K05145]\nTUBB [HSA:10381 10382 10383 203068 347688 347733 7280 81027 84617] [KO:K07375]\nPATHWAY   hsa04060(943)  Cytokine-cytokine receptor interaction",
    "metabolism": "",
    "therapeutic_category": "4291",
    "atc_code": "L01FX05",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Brentuximab vedotin"
  },
  {
    "kegg_id": "D10559",
    "name_en": "Dinutuximab (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Dinutuximab (genetical recombination) (JAN)",
      "Unituxin (TN)"
    ],
    "formula": "",
    "efficacy": "Antineoplastic, Immunomodulator, Anti-GD2 antibody\nDISEASE   Neuroblastoma [DS:H02301]\nTYPE      Monoclonal antibody",
    "target": "GD2 [GL:G00114]",
    "metabolism": "",
    "therapeutic_category": "4291",
    "atc_code": "L01FX06",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Dinutuximab"
  },
  {
    "kegg_id": "D09325",
    "name_en": "Blinatumomab (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Blinatumomab (genetical recombination) (JAN)",
      "Blincyto (TN)"
    ],
    "formula": "C2367H3577N649O772S19",
    "efficacy": "Antineoplastic, Anti-CD19 and CD3 antibody\nDISEASE   B-cell precursor acute lymphoblastic leukemia (Philadelphia chromosome negative) [DS:H00001]\nTYPE      Bispecific antibody",
    "target": "CD19 [HSA:930] [KO:K06465]\nCD3 [HSA:915 916 917] [KO:K06450 K06451 K06452]\nPATHWAY   hsa04660(915+916+917)  T cell receptor signaling pathway\nhsa04662(930)  B cell receptor signaling pathway",
    "metabolism": "",
    "therapeutic_category": "4291",
    "atc_code": "L01FX07",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Blinatumomab"
  },
  {
    "kegg_id": "D09337",
    "name_en": "Elotuzumab (USAN)",
    "name_ja": "",
    "names_alt": [
      "Elotuzumab (genetical recombination) (JAN)",
      "Empliciti (TN)"
    ],
    "formula": "C6476H9982N1714O2016S42",
    "efficacy": "Antineoplastic, Anti-SLAMF7 antibody\nDISEASE   Multiple myeloma [DS:H00010]\nTYPE      Monoclonal antibody",
    "target": "SLAMF7 (CD319) [HSA:57823] [KO:K06733]",
    "metabolism": "",
    "therapeutic_category": "4291",
    "atc_code": "L01FX08",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Elotuzumab"
  },
  {
    "kegg_id": "D09761",
    "name_en": "Mogamulizumab (USAN)",
    "name_ja": "",
    "names_alt": [
      "Mogamulizumab (genetical recombination) (JAN)",
      "Mogamulizumab-kpkc",
      "Poteligeo (TN)"
    ],
    "formula": "C6520H10072N1736O2020S42",
    "efficacy": "Antineoplastic, Anti-CCR4 antibody\nDISEASE   Mycosis fungoides (CCR4-directed) [DS:H01463]\nTYPE      Monoclonal antibody",
    "target": "CCR4 (CD194) [HSA:1233] [KO:K04179]\nPATHWAY   hsa04060(1233)  Cytokine-cytokine receptor interaction\nhsa04062(1233)  Chemokine signaling pathway",
    "metabolism": "",
    "therapeutic_category": "4291",
    "atc_code": "L01FX09",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Mogamulizumab"
  },
  {
    "kegg_id": "D11601",
    "name_en": "Tafasitamab (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Tafasitamab (genetical recombination) (JAN)",
      "Tafasitamab-cxix",
      "Monjuvi (TN)",
      "Minjuvi (TN)"
    ],
    "formula": "C6550H10092N1724O2048S52",
    "efficacy": "Antineoplastic, Anti-CD19 antibody\nDISEASE   Diffuse large B-cell lymphoma (CD19-directed) [DS:H02434]\nTYPE      Monoclonal antibody",
    "target": "CD19 [HSA:930] [KO:K06465]\nPATHWAY   hsa04151(930)  PI3K-Akt signaling pathway\nhsa04640(930)  Hematopoietic cell lineage\nhsa04662(930)  B cell receptor signaling pathway",
    "metabolism": "",
    "therapeutic_category": "4291",
    "atc_code": "L01FX12",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Tafasitamab"
  },
  {
    "kegg_id": "D11525",
    "name_en": "Enfortumab vedotin (USAN)",
    "name_ja": "",
    "names_alt": [
      "Enfortumab vedotin (genetical recombination) (JAN)",
      "Enfortumab vedotin-ejfv",
      "Padcev (TN)"
    ],
    "formula": "C6642H10284N1742O2063S46",
    "efficacy": "Antineoplastic, Nectin-4 antibody, Tubulin polymerization inhibitor\nDISEASE   Urothelial cancer [DS:H00022]\nTYPE      Antibody-drug conjugate",
    "target": "PVRL4 (NECTIN4) [HSA:81607] [KO:K06593]\nTUBB [HSA:10381 10382 10383 203068 347688 347733 7280 81027 84617] [KO:K07375]\nPATHWAY   hsa04145(10381+10382+10383+203068+347688+347733+7280+81027+84617)  Phagosome\nhsa04520(81607)  Adherens junction\nhsa04540(10381+10382+10383+203068+347688+347733+7280+81027+84617)  Gap junction",
    "metabolism": "",
    "therapeutic_category": "4291",
    "atc_code": "L01FX13",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Enfortumab vedotin"
  },
  {
    "kegg_id": "D10761",
    "name_en": "Polatuzumab vedotin (USAN)",
    "name_ja": "",
    "names_alt": [
      "Polatuzumab vedotin (genetical recombination) (JAN)",
      "Polatuzumab vedotin-piiq",
      "Polivy (TN)"
    ],
    "formula": "C6670H10317N1745O2087S40",
    "efficacy": "Antineoplastic\nDISEASE   Diffuse large B-cell lymphoma [DS:H02434]\nTYPE      Antibody-drug conjugate",
    "target": "CD79B [HSA:974] [KO:K06507]\nPATHWAY   hsa04662(974)  B cell receptor signaling pathway",
    "metabolism": "Enzyme: CYP3A [HSA:1576 1577 1551]",
    "therapeutic_category": "4291",
    "atc_code": "L01FX14",
    "drug_class": [
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A"
    ],
    "search_name": "Polatuzumab vedotin"
  },
  {
    "kegg_id": "D11595",
    "name_en": "Belantamab mafodotin (USAN)",
    "name_ja": "",
    "names_alt": [
      "Belantamab mafodotin (genetical recombination) (JAN)",
      "Belantamab mafodotin-blmf",
      "Blenrep (TN)"
    ],
    "formula": "C6484H10008N1728O2030S44. (C49H66N6O11)4",
    "efficacy": "Antineoplastic\nDISEASE   Multiple myeloma [DS:H00010]\nTYPE      Antibody-drug conjugate",
    "target": "TNFRSF17 (BCMA, CD269) [HSA:608] [KO:K05153]\nTUBB [HSA:10381 10382 10383 203068 347688 347733 7280 81027 84617] [KO:K07375]\nPATHWAY   hsa04060(608)  Cytokine-cytokine receptor interaction\nhsa04672(608)  Intestinal immune network for IgA production",
    "metabolism": "",
    "therapeutic_category": "4291",
    "atc_code": "L01FX15",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Belantamab mafodotin"
  },
  {
    "kegg_id": "D10985",
    "name_en": "Sacituzumab govitecan (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Sacituzumab govitecan (genetical recombination) (JAN)",
      "Sacituzumab govitecan-hziy",
      "Trodelvy (TN)"
    ],
    "formula": "",
    "efficacy": "Antineoplastic, Anti-TROP2 antibody, Topoisomerase I inhibitor\nDISEASE   Breast cancer (triple negative) [DS:H00031]\nTYPE      Antibody-drug conjugate",
    "target": "TACSTD2 (TROP2) [HSA:4070] [KO:K17288]\nTOP1 [HSA:7150] [KO:K03163]",
    "metabolism": "Enzyme: UGT1A1 [HSA:54658]",
    "therapeutic_category": "4291",
    "atc_code": "L01FX17",
    "drug_class": [
      "Metabolizing enzyme substrate",
      "UGT substrate",
      "UGT1A1 substrate"
    ],
    "cyp_enzymes": [],
    "search_name": "Sacituzumab govitecan"
  },
  {
    "kegg_id": "D11894",
    "name_en": "Amivantamab (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Amivantamab (genetical recombination) (JAN)",
      "Amivantamab-vmjw",
      "Rybrevant (TN)"
    ],
    "formula": "C6472H10014N1730O2023S46",
    "efficacy": "Antineoplastic\nDISEASE   Non-small cell lung cancer (EGFR exon 20 insertion) [DS:H00014]\nTYPE      Bispecific antibody",
    "target": "EGFR* [HSA_VAR:1956v2] [HSA:1956] [KO:K04361]\nMET [HSA:4233] [KO:K05099]\nPATHWAY   hsa04010(1956+1956+4233)  MAPK signaling pathway\nhsa04014(1956+1956+4233)  Ras signaling pathway\nhsa04015(1956+1956+4233)  Rap1 signaling pathway\nhsa04151(1956+1956+4233)  PI3K-Akt signaling pathway\nhsa04510(1956+1956+4233)  Focal adhesion\nhsa04520(1956+1956+4233)  Adherens junction\nhsa05200(1956+1956+4233)  Pathways in cancer\nhsa05223(1956+1956+4233)  Non-small cell lung cancer\nNETWORK   nt06266  Non-small cell lung cancer",
    "metabolism": "",
    "therapeutic_category": "4291",
    "atc_code": "L01FX18",
    "drug_class": [
      "Antineoplastic",
      "Tyrosine kinase inhibitor",
      "Receptor tyrosine kinase inhibitor",
      "EGFR inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Amivantamab"
  },
  {
    "kegg_id": "D13229",
    "name_en": "Amivantamab (genetical recombination) and vorhyaluronidase alfa (genetical recombination)",
    "name_ja": "",
    "names_alt": [
      "Rybrofaz (TN)"
    ],
    "formula": "",
    "efficacy": "Antineoplastic",
    "target": "EGFR* [HSA_VAR:1956v2] [HSA:1956] [KO:K04361]\nMET [HSA:4233] [KO:K05099]\nPATHWAY   hsa04010(1956+4233)  MAPK signaling pathway\nhsa04014(1956+4233)  Ras signaling pathway\nhsa04015(1956+4233)  Rap1 signaling pathway\nhsa04151(1956+4233)  PI3K-Akt signaling pathway\nhsa04510(1956+4233)  Focal adhesion\nhsa04520(1956+4233)  Adherens junction\nhsa05200(1956+4233)  Pathways in cancer\nhsa05223(1956+4233)  Non-small cell lung cancer",
    "metabolism": "",
    "therapeutic_category": "4291",
    "atc_code": "L01FX18",
    "drug_class": [
      "Antineoplastic",
      "Tyrosine kinase inhibitor",
      "Receptor tyrosine kinase inhibitor",
      "EGFR inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Amivantamab"
  },
  {
    "kegg_id": "D06657",
    "name_en": "Tremelimumab (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Tremelimumab (genetical recombination) (JAN)",
      "Tremelimumab-actl",
      "CP 675206",
      "Imjudo (TN)"
    ],
    "formula": "C6500H9974N1726O2026S52",
    "efficacy": "Antineoplastic, Immune checkpoint inhibitor, Anti-CTLA4 antibody\nDISEASE   Hepatocellular carcinoma [DS:H00048]\nNon-small cell lung cancer [DS:H00014]\nTYPE      Monoclonal antibody",
    "target": "CTLA4 (CD152) [HSA:1493] [KO:K06538]\nPATHWAY   hsa04514(1493)  Cell adhesion molecule (CAM) interaction\nhsa04660(1493)  T cell receptor signaling pathway",
    "metabolism": "",
    "therapeutic_category": "4291",
    "atc_code": "L01FX20",
    "drug_class": [
      "Antineoplastic",
      "Immune checkpoint inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Tremelimumab"
  },
  {
    "kegg_id": "D11814",
    "name_en": "Tisotumab vedotin (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Tisotumab vedotin (genetical recombination) (JAN)",
      "Tisotumab vedotin-tftv",
      "Tivdak (TN)"
    ],
    "formula": "C6418H9906N1710O2022S44.(C68H106N11O15)n",
    "efficacy": "Antineoplastic\nDISEASE   Cervical cancer [DS:H00030]\nTYPE      Antibody-drug conjugate",
    "target": "F3 (CD142, TF) [HSA:2152] [KO:K03901]\nTUBB [HSA:10381 10382 10383 203068 347688 347733 7280 81027 84617] [KO:K07375]\nPATHWAY   hsa04540(10381+10382+10383+203068+347688+347733+7280+81027+84617)  Gap junction\nhsa04610(2152)  Complement and coagulation cascades",
    "metabolism": "",
    "therapeutic_category": "4291",
    "atc_code": "L01FX23",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Tisotumab vedotin"
  },
  {
    "kegg_id": "D12177",
    "name_en": "Teclistamab (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Teclistamab (genetical recombination) (JAN)",
      "Teclistamab-cqyv",
      "Tecvayli (TN)"
    ],
    "formula": "C6383H9847N1695O2003S40",
    "efficacy": "Antineoplastic\nDISEASE   Multiple myeloma [DS:H00010]\nTYPE      Bispecific antibody",
    "target": "TNFRSF17 (BCMA, CD269) [HSA:608] [KO:K05153]\nCD3E [HSA:916] [KO:K06451]\nPATHWAY   hsa04060(608)  Cytokine-cytokine receptor interaction\nhsa04640(916)  Hematopoietic cell lineage",
    "metabolism": "",
    "therapeutic_category": "4291",
    "atc_code": "L01FX24",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Teclistamab"
  },
  {
    "kegg_id": "D11463",
    "name_en": "Mosunetuzumab (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Mosunetuzumab (genetical recombination) (JAN)",
      "Mosunetuzumab-axgb",
      "Lunsumio (TN)"
    ],
    "formula": "C6515H10031N1725O2025S43",
    "efficacy": "Antineoplastic\nDISEASE   Follicular lymphoma [DS:H01613]\nTYPE      Bispecific antibody",
    "target": "CD3E [HSA:916] [KO:K06451]\nCD20 [HSA:931] [KO:K06466]\nPATHWAY   hsa04640(916+931)  Hematopoietic cell lineage",
    "metabolism": "",
    "therapeutic_category": "4291",
    "atc_code": "L01FX25",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Mosunetuzumab"
  },
  {
    "kegg_id": "D12368",
    "name_en": "Epcoritamab (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Epcoritamab (genetical recombination) (JAN)",
      "Epcoritamab-bysp",
      "Epkinly (TN)",
      "Tepkinly (TN)"
    ],
    "formula": "C6471H9999N1735O2007S44",
    "efficacy": "Antineoplastic\nDISEASE   Diffuse large B-cell lymphoma, not otherwise specified [DS:H02434]\nHigh-grade B-cell lymphoma [DS:H00008]\nTYPE      Bispecific antibody",
    "target": "CD3E [HSA:916] [KO:K06451]\nCD20 [HSA:931] [KO:K06466]\nPATHWAY   hsa04640(916+931)  Hematopoietic cell lineage\nhsa04658(916)  Th1 and Th2 cell differentiation\nhsa04659(916)  Th17 cell differentiation\nhsa04660(916)  T cell receptor signaling pathway",
    "metabolism": "",
    "therapeutic_category": "4291",
    "atc_code": "L01FX27",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Epcoritamab"
  },
  {
    "kegg_id": "D12180",
    "name_en": "Talquetamab (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Talquetamab (genetical recombination) (JAN)",
      "Talquetamab-tgvs",
      "Talvey (TN)"
    ],
    "formula": "C6410H9938N1716O2006S45",
    "efficacy": "Antineoplastic\nDISEASE   Multiple myeloma [DS:H00010]\nTYPE      Bispecific antibody",
    "target": "GPRC5D [HSA:55507] [KO:K04621]\nCD3E [HSA:916] [KO:K06451]\nPATHWAY   hsa04640(916)  Hematopoietic cell lineage\nhsa04660(916)  T cell receptor signaling pathway",
    "metabolism": "",
    "therapeutic_category": "4291",
    "atc_code": "L01FX29",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Talquetamab"
  },
  {
    "kegg_id": "D11527",
    "name_en": "Zolbetuximab (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Zolbetuximab (genetical recombination) (JAN)",
      "Vyloy (TN)"
    ],
    "formula": "C6534H10066N1726O2056S44",
    "efficacy": "Antineoplastic, Anti-claudin 18.2 antibody\nDISEASE   Gastric or gastroesophageal junction adenocarcinoma (HER2 negative, claudin 18.2 positive) [DS:H00018]\nTYPE      Monoclonal antibody",
    "target": "CLDN18 [HSA:51208] [KO:K06087]\nPATHWAY   hsa04514(51208)  Cell adhesion molecule (CAM) interaction\nhsa04530(51208)  Tight junction\nhsa04670(51208)  Leukocyte transendothelial migration",
    "metabolism": "",
    "therapeutic_category": "4291",
    "atc_code": "L01FX31",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Zolbetuximab"
  },
  {
    "kegg_id": "D12058",
    "name_en": "Elranatamab (USAN)",
    "name_ja": "",
    "names_alt": [
      "Elranatamab (genetical recombination) (JAN)",
      "Elranatamab-bcmm",
      "Elrexfio (TN)"
    ],
    "formula": "C6440H9958N1738O2010S49",
    "efficacy": "Antineoplastic\nDISEASE   Multiple myeloma [DS:H00010]\nTYPE      Monoclonal antibody",
    "target": "CD3E [HSA:916] [KO:K06451]\nPATHWAY   hsa04640(916)  Hematopoietic cell lineage\nhsa04660(916)  T cell receptor signaling pathway",
    "metabolism": "",
    "therapeutic_category": "4291",
    "atc_code": "L01FX32",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Elranatamab"
  },
  {
    "kegg_id": "D12234",
    "name_en": "Tarlatamab (USAN)",
    "name_ja": "",
    "names_alt": [
      "Tarlatamab (genetical recombination) (JAN)",
      "Tarlatamab-dlle",
      "Imdelltra (TN)"
    ],
    "formula": "C4664H7139N1259O1454S34",
    "efficacy": "Antineoplastic\nDISEASE   Small cell lung cancer [DS:H00013]\nTYPE      Bispecific antibody",
    "target": "DLL3 [HSA:10683] [KO:K06051]\nCD3E [HSA:916] [KO:K06451]",
    "metabolism": "",
    "therapeutic_category": "4291",
    "atc_code": "L01FX33",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Tarlatamab"
  },
  {
    "kegg_id": "D12359",
    "name_en": "Datopotamab deruxtecan (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Datopotamab deruxtecan (genetical recombination) (JAN)",
      "Datopotamab deruxtecan-dlnk",
      "Datroway (TN)"
    ],
    "formula": "C6464H9984N1708O2016S44. (C52H57FN9O13)n",
    "efficacy": "Antineoplastic, Anti-TROP2 antibody, Topoisomerase I inhibitor\nDISEASE   Non-small cell lung cancer (EGFR-mutated) [DS:H00014]\nBreast cancer (HR positive, HER2 negative) [DS:H00031]\nTYPE      Antibody-drug conjugate",
    "target": "TACSTD2 (TROP2) [HSA:4070] [KO:K17288]\nTOP1 [HSA:7150] [KO:K03163]",
    "metabolism": "",
    "therapeutic_category": "4291",
    "atc_code": "L01FX35",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Datopotamab deruxtecan"
  },
  {
    "kegg_id": "D11934",
    "name_en": "Pertuzumab, trastuzumab and hyaluronidase",
    "name_ja": "",
    "names_alt": [
      "Pertuzumab (genetical recombination), trastuzumab (genetical recombination) and vorhyaluronidase alfa (genetical recombination)",
      "Pertuzumab, trastuzumab and hyaluronidase-zzxf",
      "Phesgo (TN)"
    ],
    "formula": "",
    "efficacy": "Antineoplastic\nDISEASE   Breast cancer [DS:H00031]\nTYPE      Monoclonal antibody combination",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "4291",
    "atc_code": "L01FY01",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Pertuzumab, trastuzumab and hyaluronidase"
  },
  {
    "kegg_id": "D00275",
    "name_en": "Cisplatin (JP18/USP/INN)",
    "name_ja": "シスプラチン",
    "names_alt": [
      "Platinol (TN)"
    ],
    "formula": "PtCl2. 2NH3",
    "efficacy": "Antineoplastic, Cell growth inhibitor\nDISEASE   Testicular tumors [DS:H00023]\nOvarian tumors [DS:H00027]\nBladder cancer [DS:H00022]",
    "target": "DNA",
    "metabolism": "Transporter: SLC22A2 [HSA:6582]",
    "therapeutic_category": "4291",
    "atc_code": "L01XA01",
    "drug_class": [
      "Antineoplastic",
      "Platinum compound",
      "Transporter substrate",
      "SLC22A2 substrate"
    ],
    "cyp_enzymes": [],
    "search_name": "Cisplatin"
  },
  {
    "kegg_id": "D01363",
    "name_en": "Carboplatin (JP18/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Paraplatin (TN)"
    ],
    "formula": "C6H6O4Pt. 2NH3",
    "efficacy": "Antineoplastic, Cell growth inhibitor\nDISEASE   Ovarian carcinoma [DS:H00027]",
    "target": "DNA",
    "metabolism": "",
    "therapeutic_category": "4291",
    "atc_code": "L01XA02",
    "drug_class": [
      "Antineoplastic",
      "Platinum compound"
    ],
    "cyp_enzymes": [],
    "search_name": "Carboplatin"
  },
  {
    "kegg_id": "D01790",
    "name_en": "Oxaliplatin (JP18/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Eloxatin (TN)"
    ],
    "formula": "Pt. C6H14N2. C2O4",
    "efficacy": "Antineoplastic, Cell growth inhibitor\nDISEASE   Colon cancer [DS:H00020]\nColorectal cancer [DS:H00020]",
    "target": "DNA",
    "metabolism": "Transporter: SLC22A2 [HSA:6582], SLC22A1 [HSA:6580]",
    "therapeutic_category": "4291",
    "atc_code": "L01XA03",
    "drug_class": [
      "Antineoplastic",
      "Platinum compound",
      "Transporter substrate",
      "SLC22A1 substrate",
      "SLC22A2 substrate"
    ],
    "cyp_enzymes": [],
    "search_name": "Oxaliplatin"
  },
  {
    "kegg_id": "D00478",
    "name_en": "Procarbazine hydrochloride (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Matulane (TN)"
    ],
    "formula": "C12H19N3O. HCl",
    "efficacy": "Antineoplastic\nDISEASE   Hodgkin's disease [DS:H00007]",
    "target": "DNA",
    "metabolism": "",
    "therapeutic_category": "4291",
    "atc_code": "L01XB01",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Procarbazine hydrochloride"
  },
  {
    "kegg_id": "D03106",
    "name_en": "Bexarotene (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Targretin (TN)"
    ],
    "formula": "C24H28O2",
    "efficacy": "Antineoplastic\nDISEASE   Cutaneous T-cell lymphoma [DS:H01463]",
    "target": "NR2B (RXR) [HSA:6256 6257 6258] [KO:K08524 K08525 K08526]\nPATHWAY   hsa03320(6256+6257+6258)  PPAR signaling pathway\nhsa04920(6256+6257+6258)  Adipocytokine signaling pathway\nhsa05200(6256+6257+6258)  Pathways in cancer",
    "metabolism": "",
    "therapeutic_category": "4291",
    "atc_code": "L01XF03",
    "drug_class": [
      "Vitamin and mineral",
      "Retinol derivative",
      "Metabolizing enzyme inducer",
      "CYP3A/CYP3A4 inducer"
    ],
    "cyp_enzymes": [],
    "search_name": "Bexarotene"
  },
  {
    "kegg_id": "D03150",
    "name_en": "Bortezomib (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Velcade (TN)"
    ],
    "formula": "C19H25BN4O4",
    "efficacy": "Antineoplastic, Proteasome inhibitor\nDISEASE   Multiple myeloma [DS:H00010]\nMantle cell lymphoma [DS:H01464]",
    "target": "PSMB5 [HSA:5693] [KO:K02737]\nPATHWAY   hsa03050(5693)  Proteasome",
    "metabolism": "",
    "therapeutic_category": "4291",
    "atc_code": "L01XG01",
    "drug_class": [
      "Antineoplastic",
      "Proteasome inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Bortezomib"
  },
  {
    "kegg_id": "D12311",
    "name_en": "Bortezomib hydrate (JAN)",
    "name_ja": "",
    "names_alt": [],
    "formula": "C19H25BN4O4. H2O",
    "efficacy": "Antineoplastic, Proteasome inhibitor",
    "target": "PSMB5 [HSA:5693] [KO:K02737]\nPATHWAY   hsa03050(5693)  Proteasome",
    "metabolism": "",
    "therapeutic_category": "4291",
    "atc_code": "L01XG01",
    "drug_class": [
      "Antineoplastic",
      "Proteasome inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Bortezomib hydrate"
  },
  {
    "kegg_id": "D08880",
    "name_en": "Carfilzomib (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Kyprolis (TN)"
    ],
    "formula": "C40H57N5O7",
    "efficacy": "Antineoplastic, Proteasome inhibitor\nDISEASE   Multiple myeloma [DS:H00010]",
    "target": "PSMB5 [HSA:5693] [KO:K02737]\nPATHWAY   hsa03050(5693)  Proteasome",
    "metabolism": "",
    "therapeutic_category": "4291",
    "atc_code": "L01XG02",
    "drug_class": [
      "Antineoplastic",
      "Proteasome inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Carfilzomib"
  },
  {
    "kegg_id": "D10131",
    "name_en": "Ixazomib citrate (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Ninlaro (TN)"
    ],
    "formula": "C20H23BCl2N2O9",
    "efficacy": "Antineoplastic, Proteasome inhibitor\nDISEASE   Multiple myeloma [DS:H00010]",
    "target": "PSMB5 [HSA:5693] [KO:K02737]\nPATHWAY   hsa03050(5693)  Proteasome",
    "metabolism": "",
    "therapeutic_category": "4291",
    "atc_code": "L01XG03",
    "drug_class": [
      "Antineoplastic",
      "Proteasome inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Ixazomib citrate"
  },
  {
    "kegg_id": "D06320",
    "name_en": "Vorinostat (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Zolinza (TN)"
    ],
    "formula": "C14H20N2O3",
    "efficacy": "Antineoplastic, Histone deacetylase inhibitor\nDISEASE   Cutaneous T-cell lymphoma [DS:H01463]",
    "target": "HDAC [HSA:3065 3066 8841 9759 10014 10013 51564 55869 9734 83933 79885] [KO:K06067 K11404 K11406 K11407 K11408 K11405 K11409 K18671 K11418]\nPATHWAY   hsa04110(3065+3066+55869)  Cell cycle\nhsa04330(3065+3066)  Notch signaling pathway\nhsa05200(3065+3066)  Pathways in cancer\nhsa05202(3065+3066)  Transcriptional misregulation in cancer\nhsa05220(3065+3066)  Chronic myeloid leukemia",
    "metabolism": "Enzyme: UGT [KO:K00699]",
    "therapeutic_category": "4291",
    "atc_code": "L01XH01",
    "drug_class": [
      "Antineoplastic",
      "Histone deacetylase inhibitor",
      "Metabolizing enzyme substrate",
      "UGT substrate"
    ],
    "cyp_enzymes": [],
    "search_name": "Vorinostat"
  },
  {
    "kegg_id": "D06637",
    "name_en": "Romidepsin (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Istodax (TN)"
    ],
    "formula": "C24H36N4O6S2",
    "efficacy": "Antineoplastic, Histone deacetylase inhibitor\nDISEASE   Peripheral T-cell lymphoma [DS:H01892]\nCutaneous T-Cell Lymphoma [DS:H01463]",
    "target": "HDAC [HSA:3065 3066 8841 9759 10014 10013 51564 55869 9734 83933 79885] [KO:K06067 K11404 K11406 K11407 K11408 K11405 K11409 K18671 K11418]\nPATHWAY   hsa04110(3065+3066)  Cell cycle\nhsa04330(3065+3066)  Notch signaling pathway\nhsa05200(3065+3066)  Pathways in cancer",
    "metabolism": "Enzyme: CYP3A [HSA:1576 1577 1551]",
    "therapeutic_category": "4291",
    "atc_code": "L01XH02",
    "drug_class": [
      "Antineoplastic",
      "Histone deacetylase inhibitor",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A"
    ],
    "search_name": "Romidepsin"
  },
  {
    "kegg_id": "D10993",
    "name_en": "Tucidinostat (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Hiyasta (TN)"
    ],
    "formula": "C22H19FN4O2",
    "efficacy": "Antineoplastic, Histone deacetylase inhibitor",
    "target": "CD244 [HSA:51744] [KO:K06582]\nCD8 [HSA:925 926] [KO:K06458 K06459]\nHDAC1 [HSA:3065] [KO:K06067]\nHDAC2 [HSA:3066] [KO:K06067]\nHDAC3 [HSA:8841] [KO:K11404]\nHDAC10 [HSA:83933] [KO:K18671]\nPATHWAY   hsa04110(3065+3066)  Cell cycle\nhsa04330(3065+3066)  Notch signaling pathway\nhsa04640(925+926)  Hematopoietic cell lineage\nhsa04650(51744)  Natural killer cell mediated cytotoxicity\nhsa04660(925+926)  T cell receptor signaling pathway\nhsa05200(3065+3066)  Pathways in cancer",
    "metabolism": "",
    "therapeutic_category": "4291",
    "atc_code": "L01XH06",
    "drug_class": [
      "Antineoplastic",
      "Histone deacetylase inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Tucidinostat"
  },
  {
    "kegg_id": "D09730",
    "name_en": "Olaparib (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Lynparza (TN)"
    ],
    "formula": "C24H23FN4O3",
    "efficacy": "Antineoplastic, PARP inhibitor\nDISEASE   Ovarian cancer [DS:H00027]\nOvarian cancer (BRCA mutated) [DS:H00027]\nOvarian cancer (HRD positive) [DS:H00027]\nBreast cancer (BRCA mutated, HER2 negative) [DS:H00031]\nPancreatic adenocarcinoma (BRCA mutated) [DS:H00019]\nProstate cancer, castration-resistant (HRR gene mutated) [DS:H00024]\nProstate cancer, castration-resistant (BRCA mutated) [DS:H00024]",
    "target": "PARP1 [HSA:142] [KO:K24070]\nPARP2 [HSA:10038] [KO:K28005]\nPATHWAY   hsa03410(10038+142)  Base excision repair\nhsa04064(142)  NF-kappa B signaling pathway\nhsa04210(10038+142)  Apoptosis\nhsa04217(142)  Necroptosis",
    "metabolism": "Enzyme: CYP3A [HSA:1576 1577 1551]",
    "therapeutic_category": "4291",
    "atc_code": "L01XK01",
    "drug_class": [
      "Antineoplastic",
      "PARP inhibitor",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A"
    ],
    "search_name": "Olaparib"
  },
  {
    "kegg_id": "D11895",
    "name_en": "Niraparib tosylate (USAN)",
    "name_ja": "",
    "names_alt": [
      "Niraparib tosilate hydrate (JAN)",
      "Niraparib tosylate monohydrate",
      "Zejula (TN)"
    ],
    "formula": "C19H20N4O. C7H8O3S. H2O",
    "efficacy": "Antineoplastic, PARP inhibitor\nDISEASE   Ovarian cancer [DS:H00027]\nFallopian tube cancer [DS:H01554]\nPrimary peritoneal cancer [DS:H01665]\nOvarian cancer (BRCA mutated) [DS:H00027]\nFallopian tube cancer (BRCA mutated) [DS:H01554]\nPrimary peritoneal cancer (BRCA mutated) [DS:H01665]",
    "target": "PARP1 [HSA:142] [KO:K24070]\nPARP2 [HSA:10038] [KO:K28005]\nPATHWAY   hsa04210(10038+142)  Apoptosis\nhsa04217(142)  Necroptosis",
    "metabolism": "",
    "therapeutic_category": "4291",
    "atc_code": "L01XK02",
    "drug_class": [
      "Antineoplastic",
      "PARP inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Niraparib tosylate"
  },
  {
    "kegg_id": "D10733",
    "name_en": "Talazoparib tosylate (USAN)",
    "name_ja": "",
    "names_alt": [
      "Talazoparib tosilate (JAN)",
      "Talzenna (TN)"
    ],
    "formula": "C19H14F2N6O. C7H8O3S",
    "efficacy": "Antineoplastic, PARP inhibitor\nDISEASE   Breast cancer (BRCA mutated, HER2 negative) [DS:H00031]\nProstate cancer, castration-resistant (HRR gene mutated) [DS:H00024]",
    "target": "PARP1 [HSA:142] [KO:K24070]\nPARP2 [HSA:10038] [KO:K28005]\nPATHWAY   hsa03410(10038+142)  Base excision repair\nhsa04064(142)  NF-kappa B signaling pathway\nhsa04210(10038+142)  Apoptosis\nhsa04217(142)  Necroptosis",
    "metabolism": "",
    "therapeutic_category": "4291",
    "atc_code": "L01XK04",
    "drug_class": [
      "Antineoplastic",
      "PARP inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Talazoparib tosylate"
  },
  {
    "kegg_id": "D11090",
    "name_en": "Ivosidenib (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Tibsovo (TN)"
    ],
    "formula": "C28H22ClF3N6O3",
    "efficacy": "Antineoplastic, Isocitrate dehydrogenase 1 inhibitor\nDISEASE   Acute myeloid leukemia (susceptible IDH1 mutation) [DS:H00003]\nmyelodysplastic syndrome (susceptible IDH1 mutation) [DS:H01481]\nCholangiocarcinoma (susceptible IDH1 mutation) [DS:H00046]",
    "target": "IDH1* [HSA_VAR:3417v1] [HSA:3417] [KO:K00031]\nPATHWAY   hsa00020(3417)  Citrate cycle (TCA cycle)\nhsa01210(3417)  2-Oxocarboxylic acid metabolism\nhsa04146(3417)  Peroxisome\nhsa05230(3417)  Central carbon metabolism in cancer",
    "metabolism": "",
    "therapeutic_category": "4291",
    "atc_code": "L01XM02",
    "drug_class": [
      "Antineoplastic",
      "Isocitrate dehydrogenase inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Ivosidenib"
  },
  {
    "kegg_id": "D11835",
    "name_en": "Vorasidenib citrate (USAN)",
    "name_ja": "",
    "names_alt": [
      "Vorasidenib citric acid hydrate (JAN)",
      "Voranigo (TN)"
    ],
    "formula": "(C14H13ClF6N6)2. C6H8O7. H2O",
    "efficacy": "Antineoplastic, Isocitrate dehydrogenase inhibitor\nDISEASE   Astrocytoma (susceptible IDH1 or IDH2 mutation) [DS:H00042]\nOligodendroglioma (susceptible IDH1 or IDH2 mutation) [DS:H00042]",
    "target": "IDH [HSA:3417 3418] [KO:K00031]\nPATHWAY   hsa00020(3417+3418)  Citrate cycle (TCA cycle)\nhsa04146(3417+3418)  Peroxisome",
    "metabolism": "Enzyme: CYP1A2 [HSA:1544]; CYP2B6 [HSA:1555], CYP2C8 [HSA:1558], CYP2C9 [HSA:1559], CYP2C19 [HSA:1557], CYP2D6 [HSA:1565], CYP3A [HSA:1576 1577 1551]",
    "therapeutic_category": "4291",
    "atc_code": "L01XM04",
    "drug_class": [
      "Antineoplastic",
      "Isocitrate dehydrogenase inhibitor",
      "Metabolizing enzyme substrate",
      "CYP1A2 substrate",
      "CYP2B6 substrate",
      "CYP2C8 substrate",
      "CYP2C9 substrate",
      "CYP2C19 substrate",
      "CYP2D6 substrate",
      "CYP3A/CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A",
      "CYP2C19",
      "CYP2B6",
      "CYP1A2",
      "CYP2C9",
      "CYP2D6",
      "CYP2C8"
    ],
    "search_name": "Vorasidenib citrate"
  },
  {
    "kegg_id": "D02997",
    "name_en": "Asparaginase (USAN)",
    "name_ja": "",
    "names_alt": [
      "L-Asparaginase (JAN)",
      "Asparaginase Erwinia chrysanthemi (USAN)",
      "Asparaginase erwinia chrysanthemi (recombinant)-rywn",
      "Elspar (TN)",
      "Erwinaze (TN)",
      "Rylaze (TN)"
    ],
    "formula": "",
    "efficacy": "Antineoplastic, Enzyme (L-asparaginase)\nDISEASE   Acute lymphoblastic leukemia [DS:H00001 H00002]",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "4291",
    "atc_code": "L01XX02",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Asparaginase"
  },
  {
    "kegg_id": "D10517",
    "name_en": "Crisantaspase (JAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Enrylaze (TN)",
      "Erwinase (TN)"
    ],
    "formula": "C1546H2510N432O476S9",
    "efficacy": "Antineoplastic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "4291",
    "atc_code": "L01XX02",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Crisantaspase"
  },
  {
    "kegg_id": "D02106",
    "name_en": "Arsenic trioxide (JP18/USAN)",
    "name_ja": "",
    "names_alt": [
      "Trisenox (TN)"
    ],
    "formula": "As2O3",
    "efficacy": "Antineoplastic\nDISEASE   Acute promyelocytic leukemia [DS:H02542]",
    "target": "PML-RARA [HSA:5371 5914] [KO:K10054 K08527]\nPATHWAY   hsa05200(5371+5914)  Pathways in cancer",
    "metabolism": "",
    "therapeutic_category": "4291",
    "atc_code": "L01XX27",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Arsenic trioxide"
  },
  {
    "kegg_id": "D03682",
    "name_en": "Denileukin diftitox (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Denileukin difitox (genetical recombination) (JAN)",
      "Denileukin diftitox-cxdl",
      "Ontak (TN)",
      "Remitoro (TN)",
      "Lymphir (TN)"
    ],
    "formula": "C2560H4036N678O799S17",
    "efficacy": "Antineoplastic, Biological response modifier\nDISEASE   Cutaneous T-cell lymphoma (CD25 express) [DS:H01463]",
    "target": "IL2RA (CD25) [HSA:3559] [KO:K05068]\nPATHWAY   hsa04060(3559)  Cytokine-cytokine receptor interaction\nhsa04144(3559)  Endocytosis\nhsa04630(3559)  JAK-STAT signaling pathway\nhsa05200(3559)  Pathways in cancer",
    "metabolism": "",
    "therapeutic_category": "4291",
    "atc_code": "L01XX29",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Denileukin diftitox"
  },
  {
    "kegg_id": "D08914",
    "name_en": "Eribulin mesylate (USAN)",
    "name_ja": "",
    "names_alt": [
      "Eribulin mesilate (JP18)",
      "Halaven (TN)"
    ],
    "formula": "C40H59NO11. CH4SO3",
    "efficacy": "Antineoplastic, Tubulin polymerization inhibitor\nDISEASE   Breast cancer [DS:H00031]\nLiposarcoma [DS:H02427]",
    "target": "TUBB [HSA:10381 10382 10383 203068 347688 347733 7280 81027 84617] [KO:K07375]\nPATHWAY   hsa04540(10381+10382+10383+203068+347688+347733+7280+81027+84617)  Gap junction",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "4291",
    "atc_code": "L01XX41",
    "drug_class": [
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Eribulin mesylate"
  },
  {
    "kegg_id": "D10679",
    "name_en": "Venetoclax (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Venclexta (TN)"
    ],
    "formula": "C45H50ClN7O7S",
    "efficacy": "Antineoplastic, Bcl-2 inhibitor\nDISEASE   Chronic lymphocytic leukemia [DS:H00005]\nChronic lymphocytic leukemia (chromosome 17p deletion) [DS:H00005]\nAcute myeloid leukemia [DS:H00003]",
    "target": "BCL2* [HSA_VAR:596v1] [HSA:596] [KO:K02161]\nPATHWAY   hsa04210(596)  Apoptosis\nhsa05200(596)  Pathways in cancer",
    "metabolism": "",
    "therapeutic_category": "4291",
    "atc_code": "L01XX52",
    "drug_class": [
      "Antineoplastic",
      "BCL-2 inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Venetoclax"
  },
  {
    "kegg_id": "D11358",
    "name_en": "Tagraxofusp (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Tagraxofusp (genetical recombination) (JAN)",
      "Tagraxofusp-erzs",
      "Elzonris (TN)"
    ],
    "formula": "C2553H4026N692O798S16",
    "efficacy": "Antineoplastic, Immunotoxin",
    "target": "IL3RA (CD123) [HSA:3563] [KO:K04737]\nPATHWAY   hsa04210(3563)  Apoptosis\nhsa04640(3563)  Hematopoietic cell lineage\nhsa05200(3563)  Pathways in cancer",
    "metabolism": "",
    "therapeutic_category": "4291",
    "atc_code": "L01XX67",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Tagraxofusp"
  },
  {
    "kegg_id": "D11485",
    "name_en": "Tazemetostat hydrobromide (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Tazverik (TN)"
    ],
    "formula": "C34H44N4O4. HBr",
    "efficacy": "Antineoplastic, Histone methyltransferase inhibitor\nDISEASE   Epithelioid sarcoma [DS:H02427]\nFollicular Lymphoma (EZH2 mutation positive) [DS:H01613]",
    "target": "EZH2* [HSA_VAR:2146v1] [HSA:2146] [KO:K11430]\nPATHWAY   hsa00310(2146)  Lysine degradation\nhsa05206(2146)  MicroRNAs in cancer",
    "metabolism": "Transporter: ABCB1 [HSA:5243]",
    "therapeutic_category": "4291",
    "atc_code": "L01XX72",
    "drug_class": [
      "Transporter substrate",
      "ABCB1 substrate",
      "Transporter inhibitor",
      "SLC47A1 inhibitor",
      "SLC47A2 inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Tazemetostat hydrobromide"
  },
  {
    "kegg_id": "D12055",
    "name_en": "Sotorasib (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Lumakras (TN)"
    ],
    "formula": "C30H30F2N6O3",
    "efficacy": "Antineoplastic\nDISEASE   Non-small cell lung cancer (KRAS G12C mutated) [DS:H00014]",
    "target": "KRAS* [HSA_VAR:3845v1] [HSA:3845] [KO:K07827]\nPATHWAY   hsa04014(3845)  Ras signaling pathway\nhsa04151(3845)  PI3K-Akt signaling pathway\nhsa05200(3845)  Pathways in cancer\nhsa05223(3845)  Non-small cell lung cancer\nNETWORK   nt06266  Non-small cell lung cancer",
    "metabolism": "Enzyme: CYP3A [HSA:1576 1577 1551]",
    "therapeutic_category": "4291",
    "atc_code": "L01XX73",
    "drug_class": [
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A"
    ],
    "search_name": "Sotorasib"
  },
  {
    "kegg_id": "D11954",
    "name_en": "Belzutifan (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Welireg (TN)"
    ],
    "formula": "C17H12F3NO4S",
    "efficacy": "Antineoplastic, Hypoxia-inducible factor-2 alpha inhibitor\nDISEASE   von Hippel-Lindau disease-associated tumors [DS:H00559]\nRenal cell carcinoma [DS:H00021]",
    "target": "HIF2A (EPAS1) [HSA:2034] [KO:K09095]\nPATHWAY   hsa04066(2034)  HIF-1 signaling pathway\nhsa05200(2034)  Pathways in cancer\nhsa05211(2034)  Renal cell carcinoma\nNETWORK   nt06542  HIF signaling",
    "metabolism": "Enzyme: UGT2B17 [HSA:7367], CYP2C19 [HSA:1557]",
    "therapeutic_category": "4291",
    "atc_code": "L01XX74",
    "drug_class": [
      "Antineoplastic",
      "Hypoxia-inducible factor-2 alpha inhibitor",
      "Metabolizing enzyme substrate",
      "CYP2C19 substrate",
      "UGT substrate",
      "UGT2B17 substrate",
      "Metabolizing enzyme inducer",
      "CYP3A/CYP3A4 inducer"
    ],
    "cyp_enzymes": [
      "CYP2C19"
    ],
    "search_name": "Belzutifan"
  },
  {
    "kegg_id": "D08898",
    "name_en": "Darinaparsin (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Darvias (TN)"
    ],
    "formula": "C12H22AsN3O6S",
    "efficacy": "Antineoplastic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "4291",
    "atc_code": "L01XX82",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Darinaparsin"
  },
  {
    "kegg_id": "D11390",
    "name_en": "Daunorubicin and cytarabine",
    "name_ja": "",
    "names_alt": [
      "Vyxeos (TN)"
    ],
    "formula": "",
    "efficacy": "Antineoplastic\nDISEASE   Acute myeloid leukemia [DS:H00003]",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "4291",
    "atc_code": "L01XY01",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Daunorubicin and cytarabine"
  },
  {
    "kegg_id": "D00966",
    "name_en": "Tamoxifen citrate (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Nolvadex (TN)",
      "Soltamox (TN)"
    ],
    "formula": "C26H29NO. C6H8O7",
    "efficacy": "Antineoplastic, Estrogen receptor agonist/antagonist\nDISEASE   Breast cancer (ER positive) [DS:H00031]",
    "target": "NR3A (ESR) [HSA:2099 2100] [KO:K08550 K08551]\nPATHWAY   hsa04915(2099+2100)  Estrogen signaling pathway\nhsa05200(2099+2100)  Pathways in cancer\nhsa05224(2099+2100)  Breast cancer\nNETWORK   nt06270  Breast cancer",
    "metabolism": "Enzyme: CYP2D6 [HSA:1565], CYP3A4 [HSA:1576]",
    "therapeutic_category": "4291",
    "atc_code": "L02BA01",
    "drug_class": [
      "Antineoplastic",
      "Estrogen receptor antagonist",
      "Tamoxifene-type antineoplastic",
      "Hormonal agent",
      "Estrogen receptor antagonist/modulator",
      "Metabolizing enzyme substrate",
      "CYP2D6 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4",
      "CYP2D6"
    ],
    "search_name": "Tamoxifen citrate"
  },
  {
    "kegg_id": "D00967",
    "name_en": "Toremifene citrate (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Fareston (TN)"
    ],
    "formula": "C26H28ClNO. C6H8O7",
    "efficacy": "Antineoplastic, Estrogen receptor antagonist\nDISEASE   Breast cancer, postmenopausal (ER positive) [DS:H00031]",
    "target": "NR3A (ESR) [HSA:2099 2100] [KO:K08550 K08551]\nIGF1 [HSA:3479] [KO:K05459]\nPATHWAY   hsa04014(3479)  Ras signaling pathway\nhsa04915(2099+2100)  Estrogen signaling pathway\nhsa05200(2099+2100+3479)  Pathways in cancer\nhsa05224(2099+2100+3479)  Breast cancer",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "4291",
    "atc_code": "L02BA02",
    "drug_class": [
      "Antineoplastic",
      "Estrogen receptor antagonist",
      "Tamoxifene-type antineoplastic",
      "Hormonal agent",
      "Estrogen receptor antagonist/modulator",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Toremifene citrate"
  },
  {
    "kegg_id": "D01161",
    "name_en": "Fulvestrant (JAN/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Faslodex (TN)"
    ],
    "formula": "C32H47F5O3S",
    "efficacy": "Antineoplastic, Estrogen receptor agonist/antagonist\nDISEASE   Breast cancer, postmenopausal (HR positive) [DS:H00031]\nBreast cancer, postmenopausal (HR positive, HER2 negative) [DS:H00031]",
    "target": "NR3A (ESR) [HSA:2099 2100] [KO:K08550 K08551]\nPATHWAY   hsa04915(2099+2100)  Estrogen signaling pathway\nhsa05200(2099+2100)  Pathways in cancer\nhsa05224(2099+2100)  Breast cancer\nNETWORK   nt06270  Breast cancer",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "4291",
    "atc_code": "L02BA03",
    "drug_class": [
      "Antineoplastic",
      "Estrogen receptor antagonist",
      "Hormonal agent",
      "Estrogen receptor antagonist/modulator",
      "Selective estrogen receptor modulator",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Fulvestrant"
  },
  {
    "kegg_id": "D00586",
    "name_en": "Flutamide (JP18/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Eulexin (TN)"
    ],
    "formula": "C11H11F3N2O3",
    "efficacy": "Antineoplastic, Androgen receptor antagonist\nDISEASE   Prostate Carcinoma [DS:H00024]",
    "target": "NR3C4 (AR) [HSA:367] [KO:K08557]\nPATHWAY   hsa05200(367)  Pathways in cancer\nhsa05215(367)  Prostate cancer\nNETWORK   nt06272  Prostate cancer",
    "metabolism": "",
    "therapeutic_category": "4291",
    "atc_code": "L02BB01",
    "drug_class": [
      "Antineoplastic",
      "Androgen receptor antagonist",
      "Flutamide-type antiandrogen"
    ],
    "cyp_enzymes": [],
    "search_name": "Flutamide"
  },
  {
    "kegg_id": "D00961",
    "name_en": "Bicalutamide (JP18/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Casodex (TN)"
    ],
    "formula": "C18H14F4N2O4S",
    "efficacy": "Antineoplastic, Androgen receptor antagonist\nDISEASE   Prostate cancer [DS:H00024]",
    "target": "NR3C4 (AR) [HSA:367] [KO:K08557]\nPATHWAY   hsa05200(367)  Pathways in cancer\nhsa05215(367)  Prostate cancer\nNETWORK   nt06272  Prostate cancer",
    "metabolism": "",
    "therapeutic_category": "4291",
    "atc_code": "L02BB03",
    "drug_class": [
      "Antineoplastic",
      "Androgen receptor antagonist",
      "Flutamide-type antiandrogen",
      "Metabolizing enzyme inhibitor",
      "CYP3A/CYP3A4 inhibitor",
      "CYP3A4 inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Bicalutamide"
  },
  {
    "kegg_id": "D10218",
    "name_en": "Enzalutamide (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Xtandi (TN)"
    ],
    "formula": "C21H16F4N4O2S",
    "efficacy": "Antineoplastic, Androgen receptor antagonist\nDISEASE   Prostate cancer, castration-resistant [DS:H00024]",
    "target": "NR3C4 (AR) [HSA:367] [KO:K08557]\nPATHWAY   hsa05200(367)  Pathways in cancer\nhsa05215(367)  Prostate cancer\nNETWORK   nt06272  Prostate cancer",
    "metabolism": "Enzyme: CYP2C8 [HSA:1558]; CYP3A4 [HSA:1576]",
    "therapeutic_category": "4291",
    "atc_code": "L02BB04",
    "drug_class": [
      "Antineoplastic",
      "Androgen receptor antagonist",
      "Flutamide-type antiandrogen",
      "Metabolizing enzyme substrate",
      "CYP2C8 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C8",
      "CYP3A4"
    ],
    "search_name": "Enzalutamide"
  },
  {
    "kegg_id": "D11040",
    "name_en": "Apalutamide (JAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Erleada (TN)"
    ],
    "formula": "C21H15F4N5O2S",
    "efficacy": "Antineoplastic, Androgen receptor antagonist\nDISEASE   Prostate cancer [DS:H00024]",
    "target": "NR3C4 (AR) [HSA:367] [KO:K08557]\nPATHWAY   hsa05200(367)  Pathways in cancer\nhsa05215(367)  Prostate cancer\nNETWORK   nt06272  Prostate cancer",
    "metabolism": "Enzyme: CYP2C8 [HSA:1558], CYP3A4 [HSA:1576]",
    "therapeutic_category": "4291",
    "atc_code": "L02BB05",
    "drug_class": [
      "Antineoplastic",
      "Androgen receptor antagonist",
      "Flutamide-type antiandrogen",
      "Metabolizing enzyme substrate",
      "CYP2C8 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "Metabolizing enzyme inducer",
      "CYP2C9 inducer",
      "CYP2C19 inducer",
      "CYP3A/CYP3A4 inducer",
      "CYP3A4 inducer",
      "Transporter inducer",
      "ABCB1 inducer",
      "ABCG2 inducer",
      "SLCO1B1 inducer"
    ],
    "cyp_enzymes": [
      "CYP2C8",
      "CYP3A4"
    ],
    "search_name": "Apalutamide"
  },
  {
    "kegg_id": "D11045",
    "name_en": "Darolutamide (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Nebeqa (TN)"
    ],
    "formula": "C19H19ClN6O2",
    "efficacy": "Antineoplastic, Androgen receptor antagonist\nDISEASE   Prostate cancer [DS:H00024]",
    "target": "NR3C4 (AR) [HSA:367] [KO:K08557]\nPATHWAY   hsa05200(367)  Pathways in cancer\nhsa05207(367)  Chemical carcinogenesis - receptor activation\nhsa05215(367)  Prostate cancer\nNETWORK   nt06272  Prostate cancer",
    "metabolism": "",
    "therapeutic_category": "4291",
    "atc_code": "L02BB06",
    "drug_class": [
      "Antineoplastic",
      "Androgen receptor antagonist",
      "Flutamide-type antiandrogen"
    ],
    "cyp_enzymes": [],
    "search_name": "Darolutamide"
  },
  {
    "kegg_id": "D00960",
    "name_en": "Anastrozole (JP18/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Arimidex (TN)"
    ],
    "formula": "C17H19N5",
    "efficacy": "Antineoplastic, Estrogen biosynthesis inhibitor\nDISEASE   Breast cancer, postmenopausal (HR positive or HR unknown) [DS:H00031]",
    "target": "CYP19A1 (ARO) [HSA:1588] [KO:K07434]\nPATHWAY   hsa00140(1588)  Steroid hormone biosynthesis",
    "metabolism": "",
    "therapeutic_category": "4291",
    "atc_code": "L02BG03",
    "drug_class": [
      "Antineoplastic",
      "Aromatase inhibitor",
      "Triazole antineoplastic",
      "Metabolizing enzyme inhibitor",
      "CYP1A2 inhibitor",
      "CYP2C9 inhibitor",
      "CYP3A/CYP3A4 inhibitor",
      "CYP3A4 inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Anastrozole"
  },
  {
    "kegg_id": "D00963",
    "name_en": "Exemestane (JAN/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Aromasin (TN)"
    ],
    "formula": "C20H24O2",
    "efficacy": "Antineoplastic, Estrogen biosynthesis inhibitor\nDISEASE   Breast cancer, postmenopausal (ER positive) [DS:H00031]",
    "target": "CYP19A1 (ARO) [HSA:1588] [KO:K07434]\nPATHWAY   hsa00140(1588)  Steroid hormone biosynthesis",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "4291",
    "atc_code": "L02BG06",
    "drug_class": [
      "Antineoplastic",
      "Aromatase inhibitor",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Exemestane"
  },
  {
    "kegg_id": "D09701",
    "name_en": "Abiraterone acetate (JAN/USP)",
    "name_ja": "",
    "names_alt": [
      "Zytiga (TN)"
    ],
    "formula": "C26H33NO2",
    "efficacy": "Antineoplastic, Androgen synthesis inhibitor\nDISEASE   Prostate cancer, castration-resistant [DS:H00024]\nProstate cancer, castration-sensitive [DS:H00024]",
    "target": "CYP17A1 [HSA:1586] [KO:K00512]\nPATHWAY   hsa00140(1586)  Steroid hormone biosynthesis",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "4291",
    "atc_code": "L02BX03",
    "drug_class": [
      "Antineoplastic",
      "Androgen receptor antagonist",
      "Steroid-type antiandrogen",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Abiraterone acetate"
  },
  {
    "kegg_id": "D11027",
    "name_en": "Ropeginterferon alfa-2b (INN)",
    "name_ja": "",
    "names_alt": [
      "Ropeginterferon alfa-2b (genetical recombination) (JAN)",
      "Ropeginterferon alfa-2b-njft",
      "Besremi (TN)"
    ],
    "formula": "",
    "efficacy": "Antineoplastic, Antiviral\nDISEASE   Polycythemia vera [DS:H00012]",
    "target": "IFNAR1 [HSA:3454] [KO:K05130]\nIFNAR2 [HSA:3455] [KO:K05131]\nPATHWAY   hsa04060(3454+3455)  Cytokine-cytokine receptor interaction\nhsa04620(3454+3455)  Toll-like receptor signaling pathway\nhsa04630(3454+3455)  JAK-STAT signaling pathway\nhsa04650(3454+3455)  Natural killer cell mediated cytotoxicity",
    "metabolism": "",
    "therapeutic_category": "4291",
    "atc_code": "L03AB15",
    "drug_class": [
      "Immunological agent",
      "Interferone"
    ],
    "cyp_enzymes": [],
    "search_name": "Ropeginterferon alfa-2b"
  },
  {
    "kegg_id": "D02802",
    "name_en": "Alemtuzumab (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Alemtuzumab (genetical recombination) (JAN)",
      "Campath (TN)",
      "Lemtrada (TN)"
    ],
    "formula": "",
    "efficacy": "Antineoplastic, Anti-CD52 antibody\nDISEASE   B-cell chronic lymphocytic leukemia [DS:H00005]\nMultiple sclerosis [DS:H01490]\nTYPE      Monoclonal antibody",
    "target": "CD52 [HSA:1043] [KO:K06488]",
    "metabolism": "",
    "therapeutic_category": "4291",
    "atc_code": "L04AG06",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Alemtuzumab"
  },
  {
    "kegg_id": "D04687",
    "name_en": "Lenalidomide (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Revlimid (TN)"
    ],
    "formula": "C13H13N3O3",
    "efficacy": "Antineoplastic, Immunomodulator, TNF-alpha inhibitor\nDISEASE   Multiple myeloma [DS:H00010]\nMyelodysplastic syndromes (chromosome 5q deletion) [DS:H01484]\nMantle cell lymphoma [DS:H01464]\nFollicular lymphoma [DS:H01613]",
    "target": "TNF (TNFA, TNFSF2) [HSA:7124] [KO:K03156]\nPATHWAY   hsa04060(7124)  Cytokine-cytokine receptor interaction\nhsa04064(7124)  NF-kappa B signaling pathway\nhsa04210(7124)  Apoptosis\nhsa04640(7124)  Hematopoietic cell lineage\nhsa04650(7124)  Natural killer cell mediated cytotoxicity\nhsa04668(7124)  TNF signaling pathway",
    "metabolism": "",
    "therapeutic_category": "4291",
    "atc_code": "L04AX04",
    "drug_class": [
      "Antineoplastic",
      "Thalidomide derivative",
      "Anti-inflammatory",
      "Disease modifying anti-rheumatic drug (DMARD)",
      "TNF inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Lenalidomide"
  },
  {
    "kegg_id": "D09813",
    "name_en": "Lenalidomide hydrate (JAN)",
    "name_ja": "",
    "names_alt": [
      "Revlimid (TN)"
    ],
    "formula": "(C13H13N3O3)2. H2O",
    "efficacy": "Antineoplastic, Immunomodulator, TNF-alpha inhibitor",
    "target": "TNF (TNFA, TNFSF2) [HSA:7124] [KO:K03156]\nPATHWAY   hsa04060(7124)  Cytokine-cytokine receptor interaction\nhsa04064(7124)  NF-kappa B signaling pathway\nhsa04210(7124)  Apoptosis\nhsa04640(7124)  Hematopoietic cell lineage\nhsa04650(7124)  Natural killer cell mediated cytotoxicity\nhsa04668(7124)  TNF signaling pathway",
    "metabolism": "",
    "therapeutic_category": "4291",
    "atc_code": "L04AX04",
    "drug_class": [
      "Antineoplastic",
      "Thalidomide derivative",
      "Anti-inflammatory",
      "Disease modifying anti-rheumatic drug (DMARD)",
      "TNF inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Lenalidomide hydrate"
  },
  {
    "kegg_id": "D08976",
    "name_en": "Pomalidomide (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Pomalyst (TN)"
    ],
    "formula": "C13H11N3O4",
    "efficacy": "Antineoplastic, Immunomodulator\nDISEASE   Multiple myeloma [DS:H00010]",
    "target": "TNF (TNFA, TNFSF2) [HSA:7124] [KO:K03156]\nIL6 [HSA:3569] [KO:K05405]\nPATHWAY   hsa04060(3569+7124)  Cytokine-cytokine receptor interaction\nhsa04210(7124)  Apoptosis\nhsa04640(3569+7124)  Hematopoietic cell lineage\nhsa04650(7124)  Natural killer cell mediated cytotoxicity\nhsa04660(7124)  T cell receptor signaling pathway\nhsa04668(3569+7124)  TNF signaling pathway",
    "metabolism": "Enzyme: CYP1A2 [HSA:1544], CYP3A4 [HSA:1576]",
    "therapeutic_category": "4291",
    "atc_code": "L04AX06",
    "drug_class": [
      "Antineoplastic",
      "Thalidomide derivative",
      "Metabolizing enzyme substrate",
      "CYP1A2 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4",
      "CYP1A2"
    ],
    "search_name": "Pomalidomide"
  },
  {
    "kegg_id": "D03308",
    "name_en": "Iobenguane I 131 (USP)",
    "name_ja": "",
    "names_alt": [
      "3-Iodobenzylguanidine (131I) (JAN)",
      "131I-m-Iodobenzylguanidine",
      "Azedra (TN)",
      "PheoMIBG-I 131 (TN)",
      "Raiatt MIBG-I 131 (TN)"
    ],
    "formula": "C8H10IN3",
    "efficacy": "Antineoplastic, Diagnostic aid, Radioactive agent",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "4291",
    "atc_code": "V09IX02",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Iobenguane I 131"
  },
  {
    "kegg_id": "D10398",
    "name_en": "Radium Ra 223 dichloride (USAN)",
    "name_ja": "",
    "names_alt": [
      "Xofigo (TN)"
    ],
    "formula": "RaCl2",
    "efficacy": "Antineoplastic, Radioactive agent\nDISEASE   Prostate cancer, castration-resistant [DS:H00024]",
    "target": "DNA",
    "metabolism": "",
    "therapeutic_category": "4291",
    "atc_code": "V10XX03",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Radium Ra 223 dichloride"
  },
  {
    "kegg_id": "D11033",
    "name_en": "Lutetium (177Lu) oxodotreotide (INN)",
    "name_ja": "",
    "names_alt": [
      "Lutetium (177Lu) dotatate",
      "Lutathera (TN)"
    ],
    "formula": "C65H86N14O19S2. Lu. H",
    "efficacy": "Antineoplastic\nDISEASE   Gastroenteropancreatic neuroendocrine tumors (somatostatin receptor positive) [DS:H00045]",
    "target": "SSTR2 [HSA:6752] [KO:K04218]\nPATHWAY   hsa04024(6752)  cAMP signaling pathway\nhsa04080(6752)  Neuroactive ligand-receptor interaction\nhsa04935(6752)  Growth hormone synthesis, secretion and action\nhsa04971(6752)  Gastric acid secretion",
    "metabolism": "",
    "therapeutic_category": "4291",
    "atc_code": "V10XX04",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Lutetium"
  },
  {
    "kegg_id": "D12335",
    "name_en": "Lutetium Lu 177 vipivotide tetraxetan (USAN)",
    "name_ja": "",
    "names_alt": [
      "Pluvicto (TN)"
    ],
    "formula": "C49H65N9O16. Lu. 3H",
    "efficacy": "Antineoplastic, Radioactive agent\nDISEASE   Prostate cancer (PSMA positive) [DS:H00024]",
    "target": "FOLH1 (PSMA) [HSA:2346] [KO:K14592]\nPATHWAY   hsa04981(2346)  Folate transport and metabolism\nhsa05215(2346)  Prostate cancer",
    "metabolism": "",
    "therapeutic_category": "4291",
    "atc_code": "V10XX05",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Lutetium Lu 177 vipivotide tetraxetan"
  },
  {
    "kegg_id": "D01404",
    "name_en": "Sobuzoxane (JAN)",
    "name_ja": "",
    "names_alt": [
      "Perazolin (TN)"
    ],
    "formula": "C22H34N4O10",
    "efficacy": "Antineoplastic, Topoisomerase II inhibitor",
    "target": "TOP2 [HSA:7153 7155] [KO:K03164]",
    "metabolism": "",
    "therapeutic_category": "4291",
    "atc_code": "",
    "drug_class": [
      "Antineoplastic",
      "Topoisomerase inhibitor",
      "Topoisomerase II inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Sobuzoxane"
  },
  {
    "kegg_id": "D01416",
    "name_en": "Nedaplatin (JAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Aqupla (TN)"
    ],
    "formula": "C2H8N2O3Pt",
    "efficacy": "Antineoplastic, Cell growth inhibitor",
    "target": "DNA",
    "metabolism": "",
    "therapeutic_category": "4291",
    "atc_code": "",
    "drug_class": [
      "Antineoplastic",
      "Platinum compound"
    ],
    "cyp_enzymes": [],
    "search_name": "Nedaplatin"
  },
  {
    "kegg_id": "D01418",
    "name_en": "Tamibarotene (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Am 80",
      "Amnoid (TN)"
    ],
    "formula": "C22H25NO3",
    "efficacy": "Antineoplastic, Retinoic acid receptor (RAR) agonist",
    "target": "NR1B1 (RARA) [HSA:5914] [KO:K08527]",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "4291",
    "atc_code": "",
    "drug_class": [
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Tamibarotene"
  },
  {
    "kegg_id": "D04245",
    "name_en": "Forodesine hydrochloride (JAN/USAN)",
    "name_ja": "",
    "names_alt": [],
    "formula": "C11H14N4O4. HCl",
    "efficacy": "Antineoplastic, Purine nucleoside phosphorylase (PNP) inhibitor",
    "target": "PNP [HSA:4860] [KO:K03783]\nPATHWAY   hsa00230(4860)  Purine metabolism\nhsa00240(4860)  Pyrimidine metabolism\nhsa00760(4860)  Nicotinate and nicotinamide metabolism",
    "metabolism": "",
    "therapeutic_category": "4291",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Forodesine hydrochloride"
  },
  {
    "kegg_id": "D06294",
    "name_en": "Miriplatin hydrate (JAN)",
    "name_ja": "",
    "names_alt": [
      "Miripla (TN)"
    ],
    "formula": "(C14H27O2)2. Pt. C6H14N2. H2O",
    "efficacy": "Antineoplastic, Cell growth inhibitor",
    "target": "DNA",
    "metabolism": "",
    "therapeutic_category": "4291",
    "atc_code": "",
    "drug_class": [
      "Antineoplastic",
      "Platinum compound"
    ],
    "cyp_enzymes": [],
    "search_name": "Miriplatin hydrate"
  },
  {
    "kegg_id": "D10819",
    "name_en": "Aflibercept beta (genetical recombination) (JAN)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Antineoplastic, Angiogenesis inhibitor, VEGF inhibitor",
    "target": "VEGFA [HSA:7422] [KO:K05448]\nVEGFB [HSA:7423] [KO:K16858]\nPGF [HSA:5228] [KO:K16859]",
    "metabolism": "",
    "therapeutic_category": "4291",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Aflibercept beta"
  },
  {
    "kegg_id": "D11272",
    "name_en": "Borofalan (10B) (JAN)",
    "name_ja": "",
    "names_alt": [
      "Boronophenylalanine B-10"
    ],
    "formula": "C9H12BNO4",
    "efficacy": "Antineoplastic, Diagnostic aid, Radioactive agent",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "4291",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Borofalan"
  },
  {
    "kegg_id": "D11662",
    "name_en": "Valemetostat tosilate (JAN)",
    "name_ja": "",
    "names_alt": [
      "Valemetostat tosylate",
      "Ezharmia (TN)"
    ],
    "formula": "C26H34ClN3O4. C7H8O3S",
    "efficacy": "Antineoplastic, histone methyltransferase inhibitor",
    "target": "EZH [HSA:2145 2146] [KO:K17451 K11430]\nPATHWAY   hsa00310(2145+2146)  Lysine degradation\nhsa05206(2146)  MicroRNAs in cancer",
    "metabolism": "",
    "therapeutic_category": "4291",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Valemetostat tosilate"
  },
  {
    "kegg_id": "D11920",
    "name_en": "Pimitespib (JAN)",
    "name_ja": "",
    "names_alt": [
      "Jeselhy (TN)"
    ],
    "formula": "C25H26N8O",
    "efficacy": "Antineoplastic, Hsp 90 inhibitor",
    "target": "HSP90 [HSA:3320 3326 7184] [KO:K04079 K09487]\nPATHWAY   hsa04151(3320+3326+7184)  PI3K-Akt signaling pathway\nhsa04915(3320+3326+7184)  Estrogen signaling pathway",
    "metabolism": "",
    "therapeutic_category": "4291",
    "atc_code": "",
    "drug_class": [
      "Metabolizing enzyme inhibitor",
      "CYP3A/CYP3A4 inhibitor",
      "Transporter inhibitor",
      "SLC47A1 inhibitor",
      "SLC47A2 inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Pimitespib"
  },
  {
    "kegg_id": "D12217",
    "name_en": "Imlunestrant tosylate (USAN)",
    "name_ja": "",
    "names_alt": [
      "Imlunestrant tosilate (JAN)",
      "Inluriyo (TN)"
    ],
    "formula": "C29H24F4N2O3. C7H8O3S",
    "efficacy": "Antineoplastic, Estrogen receptor antagonist\nDISEASE   Breast cancer (ER positive, HER2 negative, ESR1 mutated) [DS:H00031]",
    "target": "NR3A1 (ESR1) [HSA:2099] [KO:K08550]\nPATHWAY   hsa04081(2099)  Hormone signaling\nhsa04915(2099)  Estrogen signaling pathway\nhsa05200(2099)  Pathways in cancer\nhsa05224(2099)  Breast cancer\nNETWORK   nt06210  ERK signaling (cancer)\nnt06214  PI3K signaling (cancer)\nnt06227  Nuclear receptor signaling (cancer)\nnt06270  Breast cancer",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576], UGT1A1 [HSA:54658], UGT1A3 [HSA:54659], UGT1A8 [HSA:54576], UGT1A9 [HSA:54600], UGT1A10 [HSA:54575]",
    "therapeutic_category": "4291",
    "atc_code": "",
    "drug_class": [
      "Antineoplastic",
      "Estrogen receptor antagonist",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "UGT substrate",
      "UGT1A1 substrate",
      "UGT1A3 substrate",
      "UGT1A8 substrate",
      "UGT1A9 substrate",
      "Unclassified",
      "UGT1A10 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Imlunestrant tosylate"
  },
  {
    "kegg_id": "D12364",
    "name_en": "Taletrectinib adipate (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Ibtrozi (TN)"
    ],
    "formula": "C23H24FN5O. C6H10O4",
    "efficacy": "Antineoplastic, Tyrosine kinase inhibitor\nDISEASE   Non-small cell lung cancer (ROS1 positive) [DS:H00014]",
    "target": "ROS1 [HSA:6098] [KO:K05088]\nNTRK [HSA:4914 4915 4916] [KO:K03176 K04360 K05101]\nPATHWAY   hsa04151(4914+4915)  PI3K-Akt signaling pathway\nhsa04722(4914+4915+4916)  Neurotrophin signaling pathway\nhsa05200(4914)  Pathways in cancer",
    "metabolism": "Enzyme: CYP3A [HSA:1576 1577 1551]; CYP2C8 [HSA:1558], CYP2C9 [HSA:1559]",
    "therapeutic_category": "4291",
    "atc_code": "",
    "drug_class": [
      "Antineoplastic",
      "Tyrosine kinase inhibitor",
      "Metabolizing enzyme substrate",
      "CYP2C8 substrate",
      "CYP2C9 substrate",
      "CYP3A/CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C9",
      "CYP2C8",
      "CYP3A"
    ],
    "search_name": "Taletrectinib adipate"
  },
  {
    "kegg_id": "D12405",
    "name_en": "Tasurgratinib succinate (JAN)",
    "name_ja": "",
    "names_alt": [
      "Tasfygo (TN)"
    ],
    "formula": "(C32H37N5O6)2. (C4H6O4)3",
    "efficacy": "Antineoplastic, Receptor tyrosine kinase inhibitor",
    "target": "FGFR2* (CD332) [HSA_VAR:2263v2] [HSA:2263] [KO:K05093]\nFGFR1 (CD331) [HSA:2260] [KO:K04362]\nFGFR3 (CD333) [HSA:2261] [KO:K05094]\nPATHWAY   hsa04014(2260+2261+2263)  Ras signaling pathway\nhsa04151(2260+2261+2263)  PI3K-Akt signaling pathway\nhsa05200(2260+2261+2263)  Pathways in cancer",
    "metabolism": "",
    "therapeutic_category": "4291",
    "atc_code": "",
    "drug_class": [
      "Antineoplastic",
      "Tyrosine kinase inhibitor",
      "Receptor tyrosine kinase inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Tasurgratinib succinate"
  },
  {
    "kegg_id": "D12705",
    "name_en": "Gumarontinib hydrate (JAN)",
    "name_ja": "",
    "names_alt": [
      "Haiyitan (TN)"
    ],
    "formula": "C21H17N9O2S. H2O",
    "efficacy": "Antineoplastic, Receptor tyrosine kinase inhibitor",
    "target": "MET* [HSA_VAR:4233v4] [HSA:4233] [KO:K05099]\nPATHWAY   hsa04014(4233)  Ras signaling pathway\nhsa04151(4233)  PI3K-Akt signaling pathway\nhsa05200(4233)  Pathways in cancer\nhsa05202(4233)  Transcriptional misregulation in cancer\nhsa05223(4233)  Non-small cell lung cancer\nNETWORK   nt06266  Non-small cell lung cancer",
    "metabolism": "",
    "therapeutic_category": "4291",
    "atc_code": "",
    "drug_class": [
      "Antineoplastic",
      "Tyrosine kinase inhibitor",
      "Receptor tyrosine kinase inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Gumarontinib hydrate"
  },
  {
    "kegg_id": "D10526",
    "name_en": "Trifluridine and tipiracil hydrochloride",
    "name_ja": "",
    "names_alt": [
      "Lonsurf (TN)"
    ],
    "formula": "",
    "efficacy": "Antineoplastic\nDISEASE   Colorectal cancer [DS:H00020]\nGastric cancer [DS:H00018]",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "4299",
    "atc_code": "L01BC59",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Trifluridine and tipiracil hydrochloride"
  },
  {
    "kegg_id": "D10024",
    "name_en": "Selumetinib sulfate (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Koselugo (TN)"
    ],
    "formula": "C17H15BrClFN4O3. H2SO4",
    "efficacy": "Antineoplastic, Mitogen-activated extracellular signal-regulated kinase (MEK) inhibitor\nDISEASE   Neurofibromatosis type 1 [DS:H01437]",
    "target": "MAP2K (MEK) [HSA:5604 5605] [KO:K04368 K04369]\nPATHWAY   hsa04010(5604+5605)  MAPK signaling pathway\nhsa04012(5604+5605)  ErbB signaling pathway\nhsa04014(5604+5605)  Ras signaling pathway\nhsa05214(5604+5605)  Glioma\nNETWORK   nt06273  Glioma",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576], UGT1A1 [HSA:54658], UGT1A3 [HSA:54659]; CYP2C19 [HSA:1557], CYP1A2 [HSA:1544], CYP2C9 [HSA:1559], CYP2E1 [HSA:1571], CYP3A5 [HSA:1577]",
    "therapeutic_category": "4299",
    "atc_code": "L01EE04",
    "drug_class": [
      "Antineoplastic",
      "MEK inhibitor",
      "Metabolizing enzyme substrate",
      "CYP1A2 substrate",
      "CYP2C9 substrate",
      "CYP2C19 substrate",
      "CYP2E1 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "CYP3A5 substrate",
      "UGT substrate",
      "UGT1A1 substrate",
      "UGT1A3 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C19",
      "CYP3A4",
      "CYP1A2",
      "CYP3A5",
      "CYP2C9",
      "CYP2E1"
    ],
    "search_name": "Selumetinib sulfate"
  },
  {
    "kegg_id": "D05387",
    "name_en": "Pegaspargase (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Oncaspar (TN)"
    ],
    "formula": "",
    "efficacy": "Antineoplastic\nDISEASE   Acute lymphoblastic leukemia [DS:H00001 H00002]",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "4299",
    "atc_code": "L01XX24",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Pegaspargase"
  },
  {
    "kegg_id": "D10255",
    "name_en": "Anagrelide hydrochloride hydrate (JAN)",
    "name_ja": "",
    "names_alt": [
      "Anagrelide hydrochloride monohydrate",
      "Agrylin (TN)"
    ],
    "formula": "C10H7Cl2N3O. HCl. H2O",
    "efficacy": "Thrombocythemia treatment, Platelet aggregation inhibitor, Phosphodiesterase inhibitor",
    "target": "PDE3 [HSA:5139 5140] [KO:K19021 K13296]\nPATHWAY   hsa00230(5139+5140)  Purine metabolism",
    "metabolism": "Enzyme: CYP1A1 [HSA:1543], CYP1A2 [HSA:1544]",
    "therapeutic_category": "4299",
    "atc_code": "L01XX35",
    "drug_class": [
      "Cardiovascular agent",
      "Phosphodiesterase III inhibitor",
      "Metabolizing enzyme substrate",
      "CYP1A1 substrate",
      "CYP1A2 substrate"
    ],
    "cyp_enzymes": [
      "CYP1A1",
      "CYP1A2"
    ],
    "search_name": "Anagrelide hydrochloride hydrate"
  },
  {
    "kegg_id": "D00087",
    "name_en": "Ubenimex (JP18/INN)",
    "name_ja": "",
    "names_alt": [
      "Bestatin (TN)"
    ],
    "formula": "C16H24N2O4",
    "efficacy": "Antineoplastic, Immunomodulator",
    "target": "ANPEP (CD13) [HSA:290] [KO:K11140]",
    "metabolism": "",
    "therapeutic_category": "4299",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Ubenimex"
  },
  {
    "kegg_id": "D01084",
    "name_en": "Talc (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Sclerosol (TN)"
    ],
    "formula": "",
    "efficacy": "Dusting powder, Pharmaceutic aid (tablet and capsule lubricant)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "4299",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Talc"
  },
  {
    "kegg_id": "D01985",
    "name_en": "Talaporfin sodium (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Laserphyrin (TN)"
    ],
    "formula": "C38H37N5O9. 4Na",
    "efficacy": "Antineoplastic, Photosensitizer",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "4299",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Talaporfin sodium"
  },
  {
    "kegg_id": "D08756",
    "name_en": "Picibanil",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Antineoplastic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "4299",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Picibanil"
  },
  {
    "kegg_id": "D11805",
    "name_en": "Cetuximab sarotalocan sodium (genetical recombination) (JAN)",
    "name_ja": "",
    "names_alt": [
      "Akalux (TN)"
    ],
    "formula": "",
    "efficacy": "Antineoplastic\nTYPE      Antibody-drug conjugate",
    "target": "EGFR [HSA:1956] [KO:K04361]\nPATHWAY   hsa04010(1956)  MAPK signaling pathway\nhsa04012(1956)  ErbB signaling pathway\nhsa05200(1956)  Pathways in cancer",
    "metabolism": "",
    "therapeutic_category": "4299",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Cetuximab sarotalocan sodium"
  },
  {
    "kegg_id": "D02284",
    "name_en": "Technetium Tc 99m exametazime (USP)",
    "name_ja": "",
    "names_alt": [
      "Ceretec (TN)"
    ],
    "formula": "C13H25N4O2. TcO",
    "efficacy": "Diagnostic aid, Radioactive agent",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "4300",
    "atc_code": "V09AA01",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Technetium Tc 99m exametazime"
  },
  {
    "kegg_id": "D01570",
    "name_en": "Iofetamine hydrochloride I 123 (USAN)",
    "name_ja": "",
    "names_alt": [
      "N-Isopropyl-p-iodoamphetamine (123I) hydrochloride (JAN)",
      "Spectamine (TN)"
    ],
    "formula": "C12H18IN. HCl",
    "efficacy": "Diagnostic aid, Radioactive agent",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "4300",
    "atc_code": "V09AB01",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Iofetamine hydrochloride I 123"
  },
  {
    "kegg_id": "D10014",
    "name_en": "Ioflupane I 123 (USAN)",
    "name_ja": "",
    "names_alt": [
      "Datscan (TN)"
    ],
    "formula": "C18H23FINO2",
    "efficacy": "Diagnostic (SPECT imaging)",
    "target": "SLC6A3 (DAT1) [HSA:6531] [KO:K05036]\nPATHWAY   hsa04728(6531)  Dopaminergic synapse\nhsa05012(6531)  Parkinson disease",
    "metabolism": "",
    "therapeutic_category": "4300",
    "atc_code": "V09AB03",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Ioflupane I 123"
  },
  {
    "kegg_id": "D04527",
    "name_en": "Indium In 111 pentetate (USP)",
    "name_ja": "",
    "names_alt": [
      "Indium (111In) diethylenetriamine pentaacetate injection (JAN)"
    ],
    "formula": "",
    "efficacy": "Diagnostic aid, Radioactive agent",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "4300",
    "atc_code": "V09AX01",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Indium In 111 pentetate"
  },
  {
    "kegg_id": "D10231",
    "name_en": "Flutemetamol F 18 (USAN)",
    "name_ja": "",
    "names_alt": [
      "Vizamyl (TN)"
    ],
    "formula": "C14H11FN2OS",
    "efficacy": "Diagnostic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "4300",
    "atc_code": "V09AX04",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Flutemetamol F 18"
  },
  {
    "kegg_id": "D09617",
    "name_en": "Florbetapir F-18 (USAN)",
    "name_ja": "",
    "names_alt": [
      "Amyvid (TN)"
    ],
    "formula": "C20H25FN2O3",
    "efficacy": "Diagnostic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "4300",
    "atc_code": "V09AX05",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Florbetapir F-18"
  },
  {
    "kegg_id": "D11210",
    "name_en": "Flortaucipir F 18 (USAN)",
    "name_ja": "",
    "names_alt": [
      "Flortaucipir (18F) (INN)",
      "Tauvid (TN)"
    ],
    "formula": "C16H10FN3",
    "efficacy": "Diagnostic aid (PET imaging)",
    "target": "MAPT (TAU) [HSA:4137] [KO:K04380]\nPATHWAY   hsa04010(4137)  MAPK signaling pathway\nhsa05010(4137)  Alzheimer disease",
    "metabolism": "",
    "therapeutic_category": "4300",
    "atc_code": "V09AX07",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Flortaucipir F 18"
  },
  {
    "kegg_id": "D02029",
    "name_en": "Technetium Tc 99m medronate (USP)",
    "name_ja": "",
    "names_alt": [
      "Technetium (99mTc) methylenediphosphonate",
      "Tc-99m Mdp",
      "AN-MDP (TN)"
    ],
    "formula": "CH6O6P2. xTc",
    "efficacy": "Diagnostic aid, Radioactive agent",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "4300",
    "atc_code": "V09BA02",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Technetium Tc 99m medronate"
  },
  {
    "kegg_id": "D08765",
    "name_en": "Sodium pyrophosphate and technetium (99mTc) pyrophosphate",
    "name_ja": "",
    "names_alt": [
      "Techne pyrophosphate (TN)"
    ],
    "formula": "",
    "efficacy": "Diagnostic (cardiac disorder, bone disorder), Radioactive agent",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "4300",
    "atc_code": "V09BA03",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Sodium pyrophosphate and technetium"
  },
  {
    "kegg_id": "D02025",
    "name_en": "Technetium Tc 99m succimer (USP)",
    "name_ja": "",
    "names_alt": [
      "Technetium (99mTc) dimercaptosuccinic acid (injeciton)",
      "DMSA kidney reagent (TN)",
      "Nephroscan (TN)"
    ],
    "formula": "C4H6O4S2. xTc",
    "efficacy": "Diagnostic aid, Radioactive agent",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "4300",
    "atc_code": "V09CA02",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Technetium Tc 99m succimer"
  },
  {
    "kegg_id": "D08766",
    "name_en": "Phytate sodium hydrate and technetium (99mTc) phytic acid",
    "name_ja": "",
    "names_alt": [
      "Phytate sodium hydrate and technetium (99mTc) phytic acid",
      "Techne phytate (TN)"
    ],
    "formula": "",
    "efficacy": "Diagnostic (hepatosplenic disorders), Radioactive agent",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "4300",
    "atc_code": "V09DB07",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Phytate sodium hydrate and technetium"
  },
  {
    "kegg_id": "D04656",
    "name_en": "Krypton Kr 81m (USP)",
    "name_ja": "",
    "names_alt": [
      "Krypton (81mKr)",
      "MPI krypton 81m gas generator (TN)"
    ],
    "formula": "Kr",
    "efficacy": "Diagnostic aid, Radioactive agent",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "4300",
    "atc_code": "V09EX01",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Krypton Kr 81m"
  },
  {
    "kegg_id": "D05189",
    "name_en": "Sodium pertechnetate Tc 99m (USP)",
    "name_ja": "",
    "names_alt": [
      "Sodium pertechnetate (99mTc) (JP18)",
      "Meditec (TN)",
      "Radiogenix (TN)",
      "Technelite (TN)",
      "Ultra-technekow (TN)"
    ],
    "formula": "TcO4. Na",
    "efficacy": "Diagnostic aid, Radioactive agent",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "4300",
    "atc_code": "V09FX01",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Sodium pertechnetate Tc 99m"
  },
  {
    "kegg_id": "D05328",
    "name_en": "Sodium iodide I 123 (USP)",
    "name_ja": "",
    "names_alt": [
      "Sodium iodide (123I) (JP18)",
      "Iodocapsule 123 (TN)"
    ],
    "formula": "NaI",
    "efficacy": "Diagnostic aid, Radioactive agent",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "4300",
    "atc_code": "V09FX02",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Sodium iodide I 123"
  },
  {
    "kegg_id": "D02259",
    "name_en": "Sodium iodide I 131 (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Iodotope (TN)",
      "Hicon (TN)"
    ],
    "formula": "NaI",
    "efficacy": "Antineoplastic, Diagnostic aid, Radioactive agent\nDISEASE   Hyperthyroidism [DS:H01645]\nThyroid carcinoma [DS:H00032]",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "4300",
    "atc_code": "V09FX03",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Sodium iodide I 131"
  },
  {
    "kegg_id": "D06050",
    "name_en": "Technetium Tc 99m tetrofosmin (USP)",
    "name_ja": "",
    "names_alt": [
      "Technetium (99mTc) tetrofosmin",
      "Tetrofosmin 99mTc-complex"
    ],
    "formula": "",
    "efficacy": "Diagnostic aid, Radioactive agent",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "4300",
    "atc_code": "V09GA02",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Technetium Tc 99m tetrofosmin"
  },
  {
    "kegg_id": "D06042",
    "name_en": "Technetium Tc 99m pentetate (USP)",
    "name_ja": "",
    "names_alt": [
      "Human serum albumin diethylenetriamine pentaacetic acid technetium (99mTc)"
    ],
    "formula": "C14H18N3O10. Tc. Na",
    "efficacy": "Diagnostic aid, Radioactive agent",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "4300",
    "atc_code": "V09GA04",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Technetium Tc 99m pentetate"
  },
  {
    "kegg_id": "D08759",
    "name_en": "Galactosyl human serum albumin diethylenetriamine pentaacetic acid technetium (99mTc)",
    "name_ja": "",
    "names_alt": [
      "Asialoscinti (TN)"
    ],
    "formula": "",
    "efficacy": "Diagnostic aid, Radioactive agent",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "4300",
    "atc_code": "V09GA04",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Galactosyl human serum albumin diethylenetriamine pentaacetic acid technetium"
  },
  {
    "kegg_id": "D08762",
    "name_en": "Technetium (99mTc) labelled macroaggregated human serum albumin",
    "name_ja": "",
    "names_alt": [
      "Lungscinti (TN)"
    ],
    "formula": "",
    "efficacy": "Diagnostic, Radioactive agent",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "4300",
    "atc_code": "V09GA04",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Technetium"
  },
  {
    "kegg_id": "D08761",
    "name_en": "Sodium pertechnetate (99mTc) and stannous chloride, anhydrous",
    "name_ja": "",
    "names_alt": [
      "Tin colloid Tc-99m (TN)"
    ],
    "formula": "",
    "efficacy": "Diagnostic (hepatosplenic disorders), Radioactive agent",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "4300",
    "atc_code": "V09GA06",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Sodium pertechnetate"
  },
  {
    "kegg_id": "D02402",
    "name_en": "Thallous chloride Tl 201 (USP)",
    "name_ja": "",
    "names_alt": [
      "Thallium (201Tl) chloride injection (JP18)",
      "Thallous chloride Tl 201 (TN)"
    ],
    "formula": "Tl. Cl",
    "efficacy": "Diagnostic aid, Radioactive agent",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "4300",
    "atc_code": "V09GX01",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Thallous chloride Tl 201"
  },
  {
    "kegg_id": "D01936",
    "name_en": "Gallium citrate Ga 67 (USP)",
    "name_ja": "",
    "names_alt": [
      "Gallium (67Ga) citrate (INN)",
      "Gallium (67Ga) citrate injection (JP18)",
      "Neoscan (TN)"
    ],
    "formula": "C6H5O7. Ga",
    "efficacy": "Diagnostic aid (tumor, inflammaotry), Radioactive agent",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "4300",
    "atc_code": "V09HX01",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Gallium citrate Ga 67"
  },
  {
    "kegg_id": "D02108",
    "name_en": "Indium In 111 pentetreotide (USP)",
    "name_ja": "",
    "names_alt": [
      "OctreoScan (TN)"
    ],
    "formula": "C63H83N13O19S2. In. H",
    "efficacy": "Diagnostic aid, Radioactive agent",
    "target": "SSTR2 [HSA:6752] [KO:K04218]\nSSTR3 [HSA:6753] [KO:K04219]\nSSTR5 [HSA:6755] [KO:K04221]\nPATHWAY   hsa04080(6752+6753+6755)  Neuroactive ligand-receptor interaction\nhsa04971(6752)  Gastric acid secretion",
    "metabolism": "",
    "therapeutic_category": "4300",
    "atc_code": "V09IB01",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Indium In 111 pentetreotide"
  },
  {
    "kegg_id": "D01729",
    "name_en": "3-Iodobenzylguanidine (123I) (JAN)",
    "name_ja": "",
    "names_alt": [
      "m-Iodobenzylguanidine-123I",
      "MyoMIBG-I 123 (TN)"
    ],
    "formula": "C8H10IN3",
    "efficacy": "Diagnostic aid, Radioactive agent",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "4300",
    "atc_code": "V09IX01",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "3-Iodobenzylguanidine"
  },
  {
    "kegg_id": "D01843",
    "name_en": "Fludeoxyglucose F 18 (USP)",
    "name_ja": "",
    "names_alt": [
      "Fludeoxyglucose (18F) (JAN/INN)",
      "18DG"
    ],
    "formula": "C6H11FO5",
    "efficacy": "Diagnostic aid, Radioactive agent",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "4300",
    "atc_code": "V09IX04",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Fludeoxyglucose F 18"
  },
  {
    "kegg_id": "D10860",
    "name_en": "Fluciclovine F-18 (USAN)",
    "name_ja": "",
    "names_alt": [
      "Fluciclovine (18F) (INN)",
      "Axumin (TN)"
    ],
    "formula": "C5H8FNO2",
    "efficacy": "Diagnostic, Radioactive agent",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "4300",
    "atc_code": "V09IX12",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Fluciclovine F-18"
  },
  {
    "kegg_id": "D02043",
    "name_en": "Norcholestenol iodomethyl (131I) (JAN)",
    "name_ja": "",
    "names_alt": [
      "Adosterol (TN)"
    ],
    "formula": "C27H45IO",
    "efficacy": "Diagnostic aid, Radioactive agent",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "4300",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Norcholestenol iodomethyl"
  },
  {
    "kegg_id": "D02107",
    "name_en": "Indium In 111 chloride (USP)",
    "name_ja": "",
    "names_alt": [
      "Indium (111In) chloride injection (JP18)",
      "Indiclor (TN)"
    ],
    "formula": "InCl3",
    "efficacy": "Diagnostic aid, Radioactive agent",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "4300",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Indium In 111 chloride"
  },
  {
    "kegg_id": "D02283",
    "name_en": "Iomazenil (123I) (JAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Benzodine (TN)"
    ],
    "formula": "C15H14IN3O3",
    "efficacy": "Diagnostic aid, Radioactive agent",
    "target": "GABR [HSA:2554 2555 2556 2557 2558 2559 2560 2561 2562 2563 2564 2565 2566 2567 2568 55879] [KO:K05175 K05181 K05184 K05185 K05186 K05189 K05192]\nPATHWAY   hsa04080(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879)  Neuroactive ligand-receptor interaction\nhsa04727(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879)  GABAergic synapse",
    "metabolism": "",
    "therapeutic_category": "4300",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Iomazenil"
  },
  {
    "kegg_id": "D06608",
    "name_en": "Iodofiltic acid I 123 (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "15-(4-Iodophenyl)-3(R,S)-methylpentadecanoic acid (123I)",
      "15-(p-Iodophenyl)-3-methylpentadecanoic acid (123I)",
      "Zemiva (TN)"
    ],
    "formula": "C22H35IO2",
    "efficacy": "Diagnostic aid, Radioactive agent",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "4300",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Iodofiltic acid I 123"
  },
  {
    "kegg_id": "D08757",
    "name_en": "[N,N'-ethylenedi-L-cysteinate (3-)] oxotechnetium (99mTc) diethylester",
    "name_ja": "",
    "names_alt": [
      "Neurolite (TN)"
    ],
    "formula": "C12H21N2O5S2. Tc.",
    "efficacy": "Diagnostic aid, Radioactive agent",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "4300",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "[N,N'-ethylenedi-L-cysteinate"
  },
  {
    "kegg_id": "D08758",
    "name_en": "Technetium (99mTc) N-pyridoxyl-5-methyltryptophan",
    "name_ja": "",
    "names_alt": [
      "Hepatimage (TN)"
    ],
    "formula": "",
    "efficacy": "Diagnostic aid, Radioactive agent",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "4300",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Technetium"
  },
  {
    "kegg_id": "D08760",
    "name_en": "Diethylenetriamine pentaacetic acid and diethylenetriamine pentaacetic acid technetium (99mTc)",
    "name_ja": "",
    "names_alt": [
      "Techne DTPA (TN)"
    ],
    "formula": "",
    "efficacy": "Diagnostic (renal disease), Radioactive agent",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "4300",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Diethylenetriamine pentaacetic acid and diethylenetriamine pentaacetic acid technetium"
  },
  {
    "kegg_id": "D08763",
    "name_en": "99mTc-MIBI and tetrakis (2-methosyisobutykisonitrile) copper (I) tetrafluoroboric acid",
    "name_ja": "",
    "names_alt": [
      "99mTc-MIBI and tetrakis (2-methosyisobutykisonitrile) copper (I) tetrafluoroboric acid",
      "Cardiolite (TN)"
    ],
    "formula": "",
    "efficacy": "Diagnostic, Radioactive agent",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "4300",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "99mTc-MIBI and tetrakis"
  },
  {
    "kegg_id": "D08764",
    "name_en": "Technetium (99mTc) hydroxymethylene diphosphonate",
    "name_ja": "",
    "names_alt": [
      "Clear bone (TN)"
    ],
    "formula": "",
    "efficacy": "Diagnostic (bone disorder), Radioactive agent",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "4300",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Technetium"
  },
  {
    "kegg_id": "D08767",
    "name_en": "Benzoylmercaptoacetylglycylglycylglycine and mercaptoacetylglycylglycylglycine technetium (99mTc)",
    "name_ja": "",
    "names_alt": [
      "Techne MAG3 (TN)"
    ],
    "formula": "",
    "efficacy": "Diagnostic (renal disease, urinary tract disease), Radioactive agent",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "4300",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Benzoylmercaptoacetylglycylglycylglycine and mercaptoacetylglycylglycylglycine technetium"
  },
  {
    "kegg_id": "D00669",
    "name_en": "Diphenhydramine hydrochloride (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Benadryl (TN)"
    ],
    "formula": "C17H21NO. HCl",
    "efficacy": "Antiallergic, H1 receptor antagonist\nDISEASE   Parkinsonism [DS:H01600]\nNighttime sleep-aid [DS:H01609]",
    "target": "HRH1 [HSA:3269] [KO:K04149]\nPATHWAY   hsa04020(3269)  Calcium signaling pathway\nhsa04080(3269)  Neuroactive ligand-receptor interaction",
    "metabolism": "",
    "therapeutic_category": "4411",
    "atc_code": "D04AA32",
    "drug_class": [
      "Anti-allergic agent",
      "Histamine receptor antagonist",
      "Histamine receptor H1 antagonist"
    ],
    "cyp_enzymes": [],
    "search_name": "Diphenhydramine hydrochloride"
  },
  {
    "kegg_id": "D00480",
    "name_en": "Promethazine hydrochloride (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Phenergan (TN)",
      "Promethegan (TN)"
    ],
    "formula": "C17H20N2S. HCl",
    "efficacy": "Antiallergic, Anti-emetic, Antiparkinsonian, H1 receptor antagonist\nDISEASE   Perennial and seasonal allergic rhinitis [DS:H01360]",
    "target": "HRH1 [HSA:3269] [KO:K04149]\nPATHWAY   hsa04020(3269)  Calcium signaling pathway\nhsa04080(3269)  Neuroactive ligand-receptor interaction\nhsa04750(3269)  Inflammatory mediator regulation of TRP channels",
    "metabolism": "Enzyme: CYP2D6 [HSA:1565]",
    "therapeutic_category": "4413",
    "atc_code": "D04AA10",
    "drug_class": [
      "Anti-allergic agent",
      "Histamine receptor antagonist",
      "Histamine receptor H1 antagonist",
      "Metabolizing enzyme substrate",
      "CYP2D6 substrate"
    ],
    "cyp_enzymes": [
      "CYP2D6"
    ],
    "search_name": "Promethazine hydrochloride"
  },
  {
    "kegg_id": "D08768",
    "name_en": "Promethazine hibenzate",
    "name_ja": "",
    "names_alt": [
      "Hiberna (TN)"
    ],
    "formula": "C17H20N2S. C14H10O4",
    "efficacy": "Antiallergic, Antiparkinsonian, H1 receptor antagonist",
    "target": "HRH1 [HSA:3269] [KO:K04149]\nPATHWAY   hsa04020(3269)  Calcium signaling pathway\nhsa04080(3269)  Neuroactive ligand-receptor interaction\nhsa04750(3269)  Inflammatory mediator regulation of TRP channels",
    "metabolism": "Enzyme: CYP2D6 [HSA:1565]",
    "therapeutic_category": "4413",
    "atc_code": "D04AA10",
    "drug_class": [
      "Anti-allergic agent",
      "Histamine receptor antagonist",
      "Histamine receptor H1 antagonist",
      "Metabolizing enzyme substrate",
      "CYP2D6 substrate"
    ],
    "cyp_enzymes": [
      "CYP2D6"
    ],
    "search_name": "Promethazine hibenzate"
  },
  {
    "kegg_id": "D02245",
    "name_en": "Trimeprazine tartrate (USP)",
    "name_ja": "",
    "names_alt": [
      "Alimemazine tartrate (JP18)",
      "Alimezine (TN)"
    ],
    "formula": "(C18H22N2S)2. C4H6O6",
    "efficacy": "Antiallergic, Antipruritic, H1 receptor antagonist",
    "target": "HRH1 [HSA:3269] [KO:K04149]\nPATHWAY   hsa04080(3269)  Neuroactive ligand-receptor interaction\nhsa04750(3269)  Inflammatory mediator regulation of TRP channels",
    "metabolism": "",
    "therapeutic_category": "4413",
    "atc_code": "R06AD01",
    "drug_class": [
      "Anti-allergic agent",
      "Histamine receptor antagonist",
      "Histamine receptor H1 antagonist"
    ],
    "cyp_enzymes": [],
    "search_name": "Trimeprazine tartrate"
  },
  {
    "kegg_id": "D01324",
    "name_en": "Mequitazine (JP18/INN)",
    "name_ja": "",
    "names_alt": [
      "Kitazemin (TN)"
    ],
    "formula": "C20H22N2S",
    "efficacy": "Antiallergic, Antiasthmatic, H1 receptor antagonist",
    "target": "HRH1 [HSA:3269] [KO:K04149]\nPATHWAY   hsa04020(3269)  Calcium signaling pathway\nhsa04080(3269)  Neuroactive ligand-receptor interaction",
    "metabolism": "Enzyme: CYP2D6 [HSA:1565]",
    "therapeutic_category": "4413",
    "atc_code": "R06AD07",
    "drug_class": [
      "Anti-allergic agent",
      "Histamine receptor antagonist",
      "Histamine receptor H1 antagonist",
      "Dermatological agent",
      "Atopic dermatitis agent",
      "Metabolizing enzyme substrate",
      "CYP2D6 substrate"
    ],
    "cyp_enzymes": [
      "CYP2D6"
    ],
    "search_name": "Mequitazine"
  },
  {
    "kegg_id": "D00666",
    "name_en": "Clemastine fumarate (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Tavist (TN)"
    ],
    "formula": "C21H26ClNO. C4H4O4",
    "efficacy": "Antiallergic, H1 receptor antagonist\nDISEASE   Allergic rhinitis [DS:H01360]",
    "target": "HRH1 [HSA:3269] [KO:K04149]\nPATHWAY   hsa04020(3269)  Calcium signaling pathway\nhsa04080(3269)  Neuroactive ligand-receptor interaction",
    "metabolism": "",
    "therapeutic_category": "4419",
    "atc_code": "D04AA14",
    "drug_class": [
      "Anti-allergic agent",
      "Histamine receptor antagonist",
      "Histamine receptor H1 antagonist",
      "Metabolizing enzyme inhibitor",
      "CYP2D6 inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Clemastine fumarate"
  },
  {
    "kegg_id": "D00668",
    "name_en": "Dexchlorpheniramine maleate (USP)",
    "name_ja": "",
    "names_alt": [
      "d-Chlorpheniramine maleate (JP18)",
      "Mylaramine (TN)",
      "Polaramine (TN)"
    ],
    "formula": "C16H19ClN2. C4H4O4",
    "efficacy": "Antiallergic, Antipruritic, H1 receptor antagonist\nDISEASE   Perennial and seasonal allergic rhinitis [DS:H01360]",
    "target": "HRH1 [HSA:3269] [KO:K04149]\nPATHWAY   hsa04080(3269)  Neuroactive ligand-receptor interaction\nhsa04750(3269)  Inflammatory mediator regulation of TRP channels",
    "metabolism": "Enzyme: CYP2D6 [HSA:1565], CYP3A [HSA:1576 1577 1551]",
    "therapeutic_category": "4419",
    "atc_code": "R06AB02",
    "drug_class": [
      "Anti-allergic agent",
      "Histamine receptor antagonist",
      "Histamine receptor H1 antagonist",
      "Metabolizing enzyme substrate",
      "CYP2D6 substrate",
      "CYP3A/CYP3A4 substrate",
      "Metabolizing enzyme inhibitor",
      "CYP2D6 inhibitor"
    ],
    "cyp_enzymes": [
      "CYP3A",
      "CYP2D6"
    ],
    "search_name": "Dexchlorpheniramine maleate"
  },
  {
    "kegg_id": "D00665",
    "name_en": "Chlorpheniramine maleate (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Chlor-trimeton (TN)",
      "Teldrin (TN)"
    ],
    "formula": "C16H19ClN2. C4H4O4",
    "efficacy": "Antiallergic, H1 receptor antagonist",
    "target": "HRH1 [HSA:3269] [KO:K04149]\nPATHWAY   hsa04080(3269)  Neuroactive ligand-receptor interaction\nhsa04750(3269)  Inflammatory mediator regulation of TRP channels",
    "metabolism": "",
    "therapeutic_category": "4419",
    "atc_code": "R06AB04",
    "drug_class": [
      "Anti-allergic agent",
      "Histamine receptor antagonist",
      "Histamine receptor H1 antagonist"
    ],
    "cyp_enzymes": [],
    "search_name": "Chlorpheniramine maleate"
  },
  {
    "kegg_id": "D02234",
    "name_en": "Cyproheptadine hydrochloride (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Cyproheptadine hydrochloride sesquihydrate",
      "Periactin (TN)"
    ],
    "formula": "(C21H21N)2. 2HCl. 3H2O",
    "efficacy": "Antiallergic, Antipruritic, H1 receptor antagonist, Serotonin receptor antagonist\nDISEASE   Perennial and seasonal allergic rhinitis [DS:H01360]",
    "target": "HRH1 [HSA:3269] [KO:K04149]\nHTR2 [HSA:3356 3357 3358] [KO:K04157]\nHTR1 [HSA:3350 3351 3352 3354 3355] [KO:K04153]\nPATHWAY   hsa04080(3269+3350+3351+3352+3354+3355+3356+3357+3358)  Neuroactive ligand-receptor interaction\nhsa04726(3350+3351+3352+3354+3355+3356+3357+3358)  Serotonergic synapse\nhsa04750(3269+3356+3357+3358)  Inflammatory mediator regulation of TRP channels",
    "metabolism": "",
    "therapeutic_category": "4419",
    "atc_code": "R06AX02",
    "drug_class": [
      "Anti-allergic agent",
      "Histamine receptor antagonist",
      "Histamine receptor H1 antagonist"
    ],
    "cyp_enzymes": [],
    "search_name": "Cyproheptadine hydrochloride"
  },
  {
    "kegg_id": "D08769",
    "name_en": "Diphenhydramine hydrochloride and calcium bromide",
    "name_ja": "",
    "names_alt": [
      "Rescalmin (TN)"
    ],
    "formula": "",
    "efficacy": "Antiallergic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "4419",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Diphenhydramine hydrochloride and calcium bromide"
  },
  {
    "kegg_id": "D00992",
    "name_en": "Gold sodium thiomalate (USP)",
    "name_ja": "",
    "names_alt": [
      "Sodium aurothiomalate (JP18)",
      "Myochrysine (TN)"
    ],
    "formula": "C4H3AuO4S. xNa. (2-x)H",
    "efficacy": "Antirheumatic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "4420",
    "atc_code": "M01CB01",
    "drug_class": [
      "Anti-inflammatory",
      "Disease modifying anti-rheumatic drug (DMARD)",
      "Gold preparations"
    ],
    "cyp_enzymes": [],
    "search_name": "Gold sodium thiomalate"
  },
  {
    "kegg_id": "D01809",
    "name_en": "Bucillamine (JP18/INN)",
    "name_ja": "",
    "names_alt": [
      "Bucilant (TN)"
    ],
    "formula": "C7H13NO3S2",
    "efficacy": "Antirheumatic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "4420",
    "atc_code": "M01CC02",
    "drug_class": [
      "Anti-inflammatory",
      "Disease modifying anti-rheumatic drug (DMARD)"
    ],
    "cyp_enzymes": [],
    "search_name": "Bucillamine"
  },
  {
    "kegg_id": "D04492",
    "name_en": "Icatibant acetate (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Firazyr (TN)"
    ],
    "formula": "C59H89N19O13S. (C2H4O2)x",
    "efficacy": "Antiangioedema, Bradykinin receptor antagonist\nDISEASE   Hereditary angioedema [DS:H01006]",
    "target": "BDKRB2 [HSA:624] [KO:K03916]\nPATHWAY   hsa04080(624)  Neuroactive ligand-receptor interaction\nhsa04610(624)  Complement and coagulation cascades\nhsa04750(624)  Inflammatory mediator regulation of TRP channels\nhsa04810(624)  Regulation of actin cytoskeleton\nhsa04961(624)  Endocrine and other factor-regulated calcium reabsorption",
    "metabolism": "",
    "therapeutic_category": "4490",
    "atc_code": "B06AC02",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Icatibant acetate"
  },
  {
    "kegg_id": "D11094",
    "name_en": "Lanadelumab (USAN)",
    "name_ja": "",
    "names_alt": [
      "Lanadelumab (genetical recombination) (JAN)",
      "Lanadelumab-flyo",
      "Takhzyro (TN)"
    ],
    "formula": "C6468H10016N1728O2012S48",
    "efficacy": "Immunomodulator, Plasma kallikrein inhibitor\nDISEASE   Hereditary angioedema [DS:H01006]\nTYPE      Monoclonal antibody",
    "target": "KLKB1 [HSA:3818] [KO:K01324]\nPATHWAY   hsa04610(3818)  Complement and coagulation cascades\nNETWORK   nt06514  Coagulation cascade",
    "metabolism": "",
    "therapeutic_category": "4490",
    "atc_code": "B06AC05",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Lanadelumab"
  },
  {
    "kegg_id": "D11674",
    "name_en": "Berotralstat hydrochloride (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Orladeyo (TN)"
    ],
    "formula": "C30H26F4N6O. 2HCl",
    "efficacy": "Antiangioedema, Plasma kallikrein inhibitor\nDISEASE   Hereditary angioedema [DS:H01006]",
    "target": "KLKB1 [HSA:3818] [KO:K01324]\nPATHWAY   hsa04610(3818)  Complement and coagulation cascades\nNETWORK   nt06514  Coagulation cascade",
    "metabolism": "Transporter: ABCB1 [HSA:5243], ABCG2 [HSA:9429]",
    "therapeutic_category": "4490",
    "atc_code": "B06AC06",
    "drug_class": [
      "Metabolizing enzyme inhibitor",
      "CYP2D6 inhibitor",
      "CYP3A/CYP3A4 inhibitor",
      "CYP3A4 inhibitor",
      "Transporter substrate",
      "ABCB1 substrate",
      "ABCG2 substrate"
    ],
    "cyp_enzymes": [],
    "search_name": "Berotralstat hydrochloride"
  },
  {
    "kegg_id": "D12613",
    "name_en": "Garadacimab (INN)",
    "name_ja": "",
    "names_alt": [
      "Garadacimab (genetical recombination) (JAN)",
      "Andembry (TN)"
    ],
    "formula": "C6470H10004N1724O2022S42",
    "efficacy": "Bleeding suppressant, Anti-F12a antibody\nDISEASE   Hereditary angioedema [DS:H01006]\nTYPE      Monoclonal antibody",
    "target": "F12a [CPD:C03379] [HSA:2161] [KO:K01328]\nPATHWAY   hsa04610(2161+C03379)  Complement and coagulation cascades\nNETWORK   nt06514  Coagulation cascade",
    "metabolism": "",
    "therapeutic_category": "4490",
    "atc_code": "B06AC07",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Garadacimab"
  },
  {
    "kegg_id": "D12396",
    "name_en": "Sebetralstat (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Ekterly (TN)"
    ],
    "formula": "C26H26FN5O4",
    "efficacy": "Antiangioedema, Plasma kallikrein inhibitor\nDISEASE   Hereditary angioedema [DS:H01006]",
    "target": "KLKB1 [HSA:3818] [KO:K01324]\nPATHWAY   hsa04610(3818)  Complement and coagulation cascades",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]; CYP2C8 [HSA:1558]",
    "therapeutic_category": "4490",
    "atc_code": "B06AC08",
    "drug_class": [
      "Metabolizing enzyme substrate",
      "CYP2C8 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C8",
      "CYP3A4"
    ],
    "search_name": "Sebetralstat"
  },
  {
    "kegg_id": "D10354",
    "name_en": "Dupilumab (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Dupilumab (genetical recombination) (JAN)",
      "Dupixent (TN)"
    ],
    "formula": "C6512H10066N1730O2052S46",
    "efficacy": "Anti-inflammatory, Anti-IL-4/IL-13 antibody\nDISEASE   Atopic dermatitis [DS:H01358]\nAsthma [DS:H00079]\nTYPE      Monoclonal antibody",
    "target": "IL4R (CD124) [HSA:3566] [KO:K05071]\nPATHWAY   hsa04060(3566)  Cytokine-cytokine receptor interaction\nhsa04151(3566)  PI3K-Akt signaling pathway\nhsa04630(3566)  JAK-STAT signaling pathway\nhsa04640(3566)  Hematopoietic cell lineage",
    "metabolism": "",
    "therapeutic_category": "4490",
    "atc_code": "D11AH05",
    "drug_class": [
      "Immunological agent",
      "Interleukin inhibitor",
      "Dermatological agent",
      "Atopic dermatitis agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Dupilumab"
  },
  {
    "kegg_id": "D09979",
    "name_en": "Tralokinumab (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Tralokinumab (genetical recombination) (JAN)",
      "Tralokinumab-ldrm",
      "Adbry (TN)",
      "Adtralza (TN)"
    ],
    "formula": "C6374H9822N1698O2014S44",
    "efficacy": "Antiasthmatic, Anti-inflammatory, Anti-IL-13 antibody\nDISEASE   Atopic dermatitis [DS:H01358]\nTYPE      Monoclonal antibody",
    "target": "IL13 [HSA:3596] [KO:K05435]\nPATHWAY   hsa04060(3596)  Cytokine-cytokine receptor interaction\nhsa04630(3596)  JAK-STAT signaling pathway",
    "metabolism": "",
    "therapeutic_category": "4490",
    "atc_code": "D11AH07",
    "drug_class": [
      "Immunological agent",
      "Interleukin inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Tralokinumab"
  },
  {
    "kegg_id": "D11400",
    "name_en": "Abrocitinib (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Cibinqo (TN)"
    ],
    "formula": "C14H21N5O2S",
    "efficacy": "Anti-inflammatory, Janus kinase (JAK) inhibitor\nDISEASE   Atopic dermatitis [DS:H01358]",
    "target": "JAK1 [HSA:3716] [KO:K11217]\nPATHWAY   hsa04630(3716)  JAK-STAT signaling pathway\nhsa04658(3716)  Th1 and Th2 cell differentiation",
    "metabolism": "Enzyme: CYP2C19 [HSA:1557], CYP2C9 [HSA:1559]",
    "therapeutic_category": "4490",
    "atc_code": "D11AH08",
    "drug_class": [
      "Anti-inflammatory",
      "Disease modifying anti-rheumatic drug (DMARD)",
      "JAK inhibitor",
      "Dermatological agent",
      "Atopic dermatitis agent",
      "Metabolizing enzyme substrate",
      "CYP2C9 substrate",
      "CYP2C19 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C9",
      "CYP2C19"
    ],
    "search_name": "Abrocitinib"
  },
  {
    "kegg_id": "D09633",
    "name_en": "Lebrikizumab (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Lebrikizumab (genetical recombination) (JAN)",
      "Lebrikizumab-lbkz",
      "Ebglyss (TN)"
    ],
    "formula": "C6434H9972N1700O2034S50",
    "efficacy": "Anti-inflammatory, Anti-IL-13 antibody\nDISEASE   Atopic dermatitis [DS:H01358]\nTYPE      Monoclonal antibody",
    "target": "IL13 [HSA:3596] [KO:K05435]\nPATHWAY   hsa04060(3596)  Cytokine-cytokine receptor interaction\nhsa04630(3596)  JAK-STAT signaling pathway",
    "metabolism": "",
    "therapeutic_category": "4490",
    "atc_code": "D11AH10",
    "drug_class": [
      "Immunological agent",
      "Interleukin inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Lebrikizumab"
  },
  {
    "kegg_id": "D11080",
    "name_en": "Nemolizumab (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Nemolizumab (genetical recombination) (JAN)",
      "Nemolizumab-ilto",
      "Nemluvio (TN)",
      "Mitchga (TN)"
    ],
    "formula": "C6384H9814N1678O2034S48",
    "efficacy": "Anti-inflammatory, Antipruritic, Anti-IL-31 receptor antibody\nTYPE      Monoclonal antibody",
    "target": "IL31RA [HSA:133396] [KO:K22630]\nPATHWAY   hsa04060(133396)  Cytokine-cytokine receptor interaction",
    "metabolism": "",
    "therapeutic_category": "4490",
    "atc_code": "D11AH12",
    "drug_class": [
      "Immunological agent",
      "Interleukin inhibitor",
      "Dermatological agent",
      "Atopic dermatitis agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Nemolizumab"
  },
  {
    "kegg_id": "D00659",
    "name_en": "Azelastine hydrochloride (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Astelin (TN)"
    ],
    "formula": "C22H24ClN3O. HCl",
    "efficacy": "Antiallergic, Antiasthmatic, H1 receptor antagonist\nDISEASE   Allergic rhinitis [DS:H01360]",
    "target": "HRH1 [HSA:3269] [KO:K04149]\nPATHWAY   hsa04020(3269)  Calcium signaling pathway\nhsa04080(3269)  Neuroactive ligand-receptor interaction",
    "metabolism": "",
    "therapeutic_category": "4490",
    "atc_code": "R01AC03",
    "drug_class": [
      "Anti-allergic agent",
      "Histamine receptor antagonist",
      "Histamine receptor H1 antagonist",
      "Dermatological agent",
      "Atopic dermatitis agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Azelastine hydrochloride"
  },
  {
    "kegg_id": "D10252",
    "name_en": "Fexofenadine hydrochloride and pseudoephedrine hydrochloride",
    "name_ja": "フェキソフェナジン",
    "names_alt": [
      "Allegra-d (TN)"
    ],
    "formula": "",
    "efficacy": "Antiallergic\nDISEASE   Allergic rhinitis [DS:H01360]",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "4490",
    "atc_code": "R01BA52",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Fexofenadine hydrochloride and pseudoephedrine hydrochloride"
  },
  {
    "kegg_id": "D02732",
    "name_en": "Pranlukast hydrate (JP18)",
    "name_ja": "",
    "names_alt": [
      "Onon (TN)"
    ],
    "formula": "(C27H23N5O4)2. H2O",
    "efficacy": "Antiallergic, Antiasthmatic, Anti-inflammatory, Leukotriene receptor antagonist",
    "target": "CYSLTR1 [HSA:10800] [KO:K04322]\nPATHWAY   hsa04020(10800)  Calcium signaling pathway\nhsa04080(10800)  Neuroactive ligand-receptor interaction",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "4490",
    "atc_code": "R03DC02",
    "drug_class": [
      "Anti-allergic agent",
      "Cysteinyl leukotriene receptor antagonist",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Pranlukast hydrate"
  },
  {
    "kegg_id": "D00529",
    "name_en": "Montelukast sodium (JP18/USP)",
    "name_ja": "モンテルカスト",
    "names_alt": [
      "Singulair (TN)"
    ],
    "formula": "C35H35ClNO3S. Na",
    "efficacy": "Antiallergic, Antiasthmatic, Leukotriene receptor antagonist\nDISEASE   Asthma [DS:H00079]\nAllergic rhinitis [DS:H01360]",
    "target": "CYSLTR1 [HSA:10800] [KO:K04322]\nPATHWAY   hsa04020(10800)  Calcium signaling pathway\nhsa04080(10800)  Neuroactive ligand-receptor interaction",
    "metabolism": "Enzyme: CYP2C8 [HSA:1558], CYP2C9 [HSA:1559], CYP3A4 [HSA:1576]",
    "therapeutic_category": "4490",
    "atc_code": "R03DC03",
    "drug_class": [
      "Anti-allergic agent",
      "Cysteinyl leukotriene receptor antagonist",
      "Metabolizing enzyme substrate",
      "CYP2C8 substrate",
      "CYP2C9 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C9",
      "CYP2C8",
      "CYP3A4"
    ],
    "search_name": "Montelukast sodium"
  },
  {
    "kegg_id": "D01773",
    "name_en": "Oxatomide (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Celtect (TN)"
    ],
    "formula": "C27H30N4O",
    "efficacy": "Antiallergic, Antiasthmatic",
    "target": "ALOX5 [HSA:240] [KO:K00461]\nPATHWAY   hsa00590(240)  Arachidonic acid metabolism",
    "metabolism": "",
    "therapeutic_category": "4490",
    "atc_code": "R06AE06",
    "drug_class": [
      "Anti-allergic agent",
      "Histamine receptor antagonist",
      "Histamine receptor H1 antagonist",
      "Dermatological agent",
      "Atopic dermatitis agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Oxatomide"
  },
  {
    "kegg_id": "D00664",
    "name_en": "Cetirizine hydrochloride (JP18/USP)",
    "name_ja": "セチリジン",
    "names_alt": [
      "Zyrtec (TN)"
    ],
    "formula": "C21H25ClN2O3. 2HCl",
    "efficacy": "Antiallergic, H1 receptor antagonist",
    "target": "HRH1 [HSA:3269] [KO:K04149]\nPATHWAY   hsa04080(3269)  Neuroactive ligand-receptor interaction\nhsa04750(3269)  Inflammatory mediator regulation of TRP channels",
    "metabolism": "Transporter: ABCB1 [HSA:5243], SLC22A2 [HSA:6582]",
    "therapeutic_category": "4490",
    "atc_code": "R06AE07",
    "drug_class": [
      "Anti-allergic agent",
      "Histamine receptor antagonist",
      "Histamine receptor H1 antagonist",
      "Dermatological agent",
      "Atopic dermatitis agent",
      "Transporter substrate",
      "ABCB1 substrate",
      "SLC22A2 substrate",
      "Transporter inhibitor",
      "SLC22A2 inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Cetirizine hydrochloride"
  },
  {
    "kegg_id": "D08118",
    "name_en": "Levocetirizine dihydrochloride (USP)",
    "name_ja": "",
    "names_alt": [
      "Levocetirizine hydrochloride (JAN)",
      "Xyzal (TN)"
    ],
    "formula": "C21H25ClN2O3. 2HCl",
    "efficacy": "Antiallergic, H1 receptor antagonist\nDISEASE   Allergic rhinitis [DS:H01360]",
    "target": "HRH1 [HSA:3269] [KO:K04149]\nPATHWAY   hsa04080(3269)  Neuroactive ligand-receptor interaction\nhsa04750(3269)  Inflammatory mediator regulation of TRP channels",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "4490",
    "atc_code": "R06AE09",
    "drug_class": [
      "Anti-allergic agent",
      "Histamine receptor antagonist",
      "Histamine receptor H1 antagonist",
      "Dermatological agent",
      "Atopic dermatitis agent",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Levocetirizine dihydrochloride"
  },
  {
    "kegg_id": "D00364",
    "name_en": "Loratadine (JAN/USP/INN)",
    "name_ja": "ロラタジン",
    "names_alt": [
      "Claritin (TN)"
    ],
    "formula": "C22H23ClN2O2",
    "efficacy": "Antiallergic, H1 receptor antagonist",
    "target": "HRH1 [HSA:3269] [KO:K04149]\nPATHWAY   hsa04080(3269)  Neuroactive ligand-receptor interaction\nhsa04750(3269)  Inflammatory mediator regulation of TRP channels",
    "metabolism": "Enzyme: CYP2D6 [HSA:1565], CYP3A4 [HSA:1576]",
    "therapeutic_category": "4490",
    "atc_code": "R06AX13",
    "drug_class": [
      "Anti-allergic agent",
      "Histamine receptor antagonist",
      "Histamine receptor H1 antagonist",
      "Dermatological agent",
      "Atopic dermatitis agent",
      "Metabolizing enzyme substrate",
      "CYP2D6 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4",
      "CYP2D6"
    ],
    "search_name": "Loratadine"
  },
  {
    "kegg_id": "D01478",
    "name_en": "Ebastine (JP18/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Kestine (TN)"
    ],
    "formula": "C32H39NO2",
    "efficacy": "Antiallergic, Antipruritic, H1 receptor antagonist",
    "target": "HRH1 [HSA:3269] [KO:K04149]\nPATHWAY   hsa04080(3269)  Neuroactive ligand-receptor interaction\nhsa04750(3269)  Inflammatory mediator regulation of TRP channels",
    "metabolism": "Enzyme: CYP2J2 [HSA:1573], CYP3A4 [HSA:1576]",
    "therapeutic_category": "4490",
    "atc_code": "R06AX22",
    "drug_class": [
      "Anti-allergic agent",
      "Histamine receptor antagonist",
      "Histamine receptor H1 antagonist",
      "Dermatological agent",
      "Atopic dermatitis agent",
      "Metabolizing enzyme substrate",
      "CYP2J2 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4",
      "CYP2J2"
    ],
    "search_name": "Ebastine"
  },
  {
    "kegg_id": "D00671",
    "name_en": "Fexofenadine hydrochloride (JP18/USP)",
    "name_ja": "フェキソフェナジン",
    "names_alt": [
      "Allegra (TN)"
    ],
    "formula": "C32H39NO4. HCl",
    "efficacy": "Antiallergic, H1 receptor antagonist\nDISEASE   Seasonal allergic rhinitis [DS:H01360]",
    "target": "HRH1 [HSA:3269] [KO:K04149]\nPATHWAY   hsa04080(3269)  Neuroactive ligand-receptor interaction\nhsa04750(3269)  Inflammatory mediator regulation of TRP channels",
    "metabolism": "",
    "therapeutic_category": "4490",
    "atc_code": "R06AX26",
    "drug_class": [
      "Anti-allergic agent",
      "Histamine receptor antagonist",
      "Histamine receptor H1 antagonist",
      "Dermatological agent",
      "Atopic dermatitis agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Fexofenadine hydrochloride"
  },
  {
    "kegg_id": "D03693",
    "name_en": "Desloratadine (JAN/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Clarinex (TN)"
    ],
    "formula": "C19H19ClN2",
    "efficacy": "Antiallergic, Antipruritic, H1 receptor antagonist\nDISEASE   Allergic rhinitis [DS:H01360]",
    "target": "HRH1 [HSA:3269] [KO:K04149]\nPATHWAY   hsa04080(3269)  Neuroactive ligand-receptor interaction\nhsa04750(3269)  Inflammatory mediator regulation of TRP channels",
    "metabolism": "",
    "therapeutic_category": "4490",
    "atc_code": "R06AX27",
    "drug_class": [
      "Anti-allergic agent",
      "Histamine receptor antagonist",
      "Histamine receptor H1 antagonist",
      "Dermatological agent",
      "Atopic dermatitis agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Desloratadine"
  },
  {
    "kegg_id": "D08497",
    "name_en": "Rupatadine fumarate (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Rinialer (TN)",
      "Rupafin (TN)"
    ],
    "formula": "C26H26ClN3. C4H4O4",
    "efficacy": "Antiallergic, H1 receptor antagonist, Platelet activating factor (PAF) antagonist",
    "target": "HRH1 [HSA:3269] [KO:K04149]\nPTAFR [HSA:5724] [KO:K04279]\nPATHWAY   hsa04080(3269+5724)  Neuroactive ligand-receptor interaction\nhsa04750(3269)  Inflammatory mediator regulation of TRP channels",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "4490",
    "atc_code": "R06AX28",
    "drug_class": [
      "Anti-allergic agent",
      "Histamine receptor antagonist",
      "Histamine receptor H1 antagonist",
      "Dermatological agent",
      "Atopic dermatitis agent",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Rupatadine fumarate"
  },
  {
    "kegg_id": "D09570",
    "name_en": "Bilastine (JAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Bilanoa (TN)"
    ],
    "formula": "C28H37N3O3",
    "efficacy": "Antiallergic, Antipruritic, H1 receptor antagonist",
    "target": "HRH1 [HSA:3269] [KO:K04149]\nPATHWAY   hsa04080(3269)  Neuroactive ligand-receptor interaction\nhsa04750(3269)  Inflammatory mediator regulation of TRP channels",
    "metabolism": "",
    "therapeutic_category": "4490",
    "atc_code": "R06AX29",
    "drug_class": [
      "Anti-allergic agent",
      "Histamine receptor antagonist",
      "Histamine receptor H1 antagonist",
      "Dermatological agent",
      "Atopic dermatitis agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Bilastine"
  },
  {
    "kegg_id": "D02249",
    "name_en": "Emedastine difumarate (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Daren (TN)",
      "Emadine (TN)"
    ],
    "formula": "C17H26N4O. (C4H4O4)2",
    "efficacy": "Antiallergic, Antiasthmatic, H1 receptor antagonist",
    "target": "HRH1 [HSA:3269] [KO:K04149]\nPATHWAY   hsa04080(3269)  Neuroactive ligand-receptor interaction\nhsa04750(3269)  Inflammatory mediator regulation of TRP channels",
    "metabolism": "",
    "therapeutic_category": "4490",
    "atc_code": "S01GX06",
    "drug_class": [
      "Anti-allergic agent",
      "Histamine receptor antagonist",
      "Histamine receptor H1 antagonist",
      "Dermatological agent",
      "Atopic dermatitis agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Emedastine difumarate"
  },
  {
    "kegg_id": "D10603",
    "name_en": "Mite allergen extract",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Antiallergic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "4490",
    "atc_code": "V01AA03",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Mite allergen extract"
  },
  {
    "kegg_id": "D10536",
    "name_en": "Japanese cedar pollen extract",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Antiallergic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "4490",
    "atc_code": "V01AA05",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Japanese cedar pollen extract"
  },
  {
    "kegg_id": "D08770",
    "name_en": "Allergen extract (therapeutic)",
    "name_ja": "",
    "names_alt": [
      "Allergen extract (diagnostic)"
    ],
    "formula": "",
    "efficacy": "Antiallergic, Diagnostic (allergen)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "4490",
    "atc_code": "V01AA20",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Allergen extract"
  },
  {
    "kegg_id": "D01128",
    "name_en": "Ramatroban (JAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Baynas (TN)"
    ],
    "formula": "C21H21FN2O4S",
    "efficacy": "Antiallergic, Antiasthmatic, Anti-inflammatory, Thromboxane A2 (TXA2) receptor antagonist, Prostaglandin D receptor antagonist",
    "target": "TBXA2R [HSA:6915] [KO:K04264]\nPTGDR [HSA:5729] [KO:K04332]\nPATHWAY   hsa04020(6915)  Calcium signaling pathway\nhsa04080(6915+5729)  Neuroactive ligand-receptor interaction",
    "metabolism": "",
    "therapeutic_category": "4490",
    "atc_code": "",
    "drug_class": [
      "Anti-allergic agent",
      "Thromboxane A2 receptor antagonist"
    ],
    "cyp_enzymes": [],
    "search_name": "Ramatroban"
  },
  {
    "kegg_id": "D01423",
    "name_en": "Suplatast tosilate (JAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Suplatast tosylate",
      "IPD (TN)"
    ],
    "formula": "C16H26NO4S. C7H7O3S",
    "efficacy": "Antiallergic, Antiasthmatic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "4490",
    "atc_code": "",
    "drug_class": [
      "Dermatological agent",
      "Atopic dermatitis agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Suplatast tosilate"
  },
  {
    "kegg_id": "D01654",
    "name_en": "Bepotastine besylate (USAN)",
    "name_ja": "",
    "names_alt": [
      "Bepotastine besilate (JP18)",
      "Bepreve (TN)",
      "Talion (TN)"
    ],
    "formula": "C21H25ClN2O3. C6H6O3S",
    "efficacy": "Antiallergic, Antipruritic, H1 receptor antagonist",
    "target": "HRH1 [HSA:3269] [KO:K04149]\nPATHWAY   hsa04020(3269)  Calcium signaling pathway\nhsa04080(3269)  Neuroactive ligand-receptor interaction",
    "metabolism": "",
    "therapeutic_category": "4490",
    "atc_code": "",
    "drug_class": [
      "Anti-allergic agent",
      "Histamine receptor antagonist",
      "Histamine receptor H1 antagonist",
      "Dermatological agent",
      "Atopic dermatitis agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Bepotastine besylate"
  },
  {
    "kegg_id": "D01683",
    "name_en": "Ozagrel hydrochloride hydrate (JAN)",
    "name_ja": "",
    "names_alt": [
      "Ozagrel hydrochloride",
      "Domenan (TN)"
    ],
    "formula": "C13H12N2O2. HCl. H2O",
    "efficacy": "Antiasthmatic, Airway hyperreactivity inhibitor, Thromboxane A2 (TXA2) synthase inhibitor",
    "target": "TBXAS1 (CYP5A1) [HSA:6916] [KO:K01832]\nPATHWAY   hsa00590(6916)  Arachidonic acid metabolism\nhsa04611(6916)  Platelet activation",
    "metabolism": "",
    "therapeutic_category": "4490",
    "atc_code": "",
    "drug_class": [
      "Blood modifier agent",
      "Antithrombotic agent",
      "Antiplatelet agent",
      "Thromboxane A2 synthase inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Ozagrel hydrochloride hydrate"
  },
  {
    "kegg_id": "D11559",
    "name_en": "Onasemnogene abeparvovec (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Onasemnogene abeparvovec-xioi",
      "Onasemnogene abeparvovec-brve",
      "Zolgensma (TN)",
      "Itvisma (TN)"
    ],
    "formula": "",
    "efficacy": "Spinal muscular atrophy treatment\nDISEASE   Spinal muscular atrophy (bi-allelic SMN1 mutations) [DS:H00455]\nTYPE      Gene therapy product",
    "target": "SMN1 [HSA:6606] [KO:K13129]",
    "metabolism": "",
    "therapeutic_category": "4900",
    "atc_code": "M09AX09",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Onasemnogene abeparvovec"
  },
  {
    "kegg_id": "D12587",
    "name_en": "Human (allogeneic) bone marrow-derived mesenchymal stem cell",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Immunomodulator",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "4900",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Human"
  },
  {
    "kegg_id": "D12588",
    "name_en": "Human (autologous) bone marrow-derived mesenchymal stem cell",
    "name_ja": "",
    "names_alt": [
      "Stemirac (TN)"
    ],
    "formula": "",
    "efficacy": "Neuroprotectant",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "4900",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Human"
  },
  {
    "kegg_id": "D05525",
    "name_en": "Plantago seed (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Ispaghula"
    ],
    "formula": "",
    "efficacy": "Antitussive, Expectorant, Hypoglycemic, Laxative",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "A06AC01",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Plantago seed"
  },
  {
    "kegg_id": "D06745",
    "name_en": "Cimicifuga rhizome (JP18)",
    "name_ja": "",
    "names_alt": [
      "Cimicifugae rhizoma"
    ],
    "formula": "",
    "efficacy": "Antiedemic, Antipyretic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "G02CX04",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Cimicifuga rhizome"
  },
  {
    "kegg_id": "D06699",
    "name_en": "Japanese valerian (JP18)",
    "name_ja": "",
    "names_alt": [
      "Powdered japanese valerian (JP18)"
    ],
    "formula": "",
    "efficacy": "Natural tranquilizer, Sedative",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "N05CM09",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Japanese valerian"
  },
  {
    "kegg_id": "D06771",
    "name_en": "Picrasma wood (JP18)",
    "name_ja": "",
    "names_alt": [
      "Powdered picrasma wood (JP18)"
    ],
    "formula": "",
    "efficacy": "Insecticide, Stomachic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "P03AX04",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Picrasma wood"
  },
  {
    "kegg_id": "D03868",
    "name_en": "Ipecac (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Powdered lpecac (JP18)",
      "Ipsatol (TN)"
    ],
    "formula": "",
    "efficacy": "Emetic, Expectorant",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "R05CA04",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Ipecac"
  },
  {
    "kegg_id": "D06747",
    "name_en": "Senega (JP18)",
    "name_ja": "",
    "names_alt": [
      "Powdered senega (JP18)"
    ],
    "formula": "",
    "efficacy": "Expectorant",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "R05CA06",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Senega"
  },
  {
    "kegg_id": "D00092",
    "name_en": "Coptis rhizome (JP18)",
    "name_ja": "",
    "names_alt": [
      "Powdered coptis rhizome (JP18)"
    ],
    "formula": "",
    "efficacy": "Antibacterial, Antispasmodic, Choleretic, Stomachic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Coptis rhizome"
  },
  {
    "kegg_id": "D00173",
    "name_en": "Evodia fruit (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Analgesic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Evodia fruit"
  },
  {
    "kegg_id": "D01030",
    "name_en": "Saffron (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Analgesic, Emmenagogue, Sedative",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Saffron"
  },
  {
    "kegg_id": "D01032",
    "name_en": "Agar (JP18/NF)",
    "name_ja": "",
    "names_alt": [
      "Powdered agar (JP18)"
    ],
    "formula": "",
    "efficacy": "Laxative, Pharmaceutic aid (demulcent, suspending)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Agar"
  },
  {
    "kegg_id": "D01728",
    "name_en": "Gypsum (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Anti-inflammatory, Antipyretic, Sedative, Pharmaceutic aid (tablet and capsule diluent)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Gypsum"
  },
  {
    "kegg_id": "D03374",
    "name_en": "Capsicum (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Powdered capsicum (JP18)"
    ],
    "formula": "",
    "efficacy": "Carminative, Counterirritant, Stomachic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Capsicum"
  },
  {
    "kegg_id": "D03404",
    "name_en": "Cardamon (JP18)",
    "name_ja": "",
    "names_alt": [
      "Cardamom seed (NF)"
    ],
    "formula": "",
    "efficacy": "Stomachic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Cardamon"
  },
  {
    "kegg_id": "D03570",
    "name_en": "Clove (JP18)",
    "name_ja": "",
    "names_alt": [
      "Powdered clove (JP18)"
    ],
    "formula": "",
    "efficacy": "Analgesic, Anesthetic (local), Antiviral",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Clove"
  },
  {
    "kegg_id": "D04360",
    "name_en": "Geranium herb (JP18)",
    "name_ja": "",
    "names_alt": [
      "Powdered geranium herb (JP18)"
    ],
    "formula": "",
    "efficacy": "Antidiarrheal, Intestinal regulator",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Geranium herb"
  },
  {
    "kegg_id": "D04365",
    "name_en": "Glycyrrhiza (JP18)",
    "name_ja": "",
    "names_alt": [
      "Powdered glycyrrhiza (JP18)",
      "Prepared glycyrrhiza (JP18)",
      "Licorice (NF)",
      "Liquorice",
      "Glycyrrhizae radix",
      "Glycyrrhizae radix praeparata"
    ],
    "formula": "",
    "efficacy": "Antitussive, Anti-ulcerative, Expectorant",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Glycyrrhiza"
  },
  {
    "kegg_id": "D04385",
    "name_en": "Swertia herb (JP18)",
    "name_ja": "",
    "names_alt": [
      "Powdered swertia herb (JP18)"
    ],
    "formula": "",
    "efficacy": "Stomachic, Gastric secretion accelerator",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Swertia herb"
  },
  {
    "kegg_id": "D04388",
    "name_en": "Bitter orange peel (JP18)",
    "name_ja": "",
    "names_alt": [
      "Powdered bitter orange peel (Non-JPS)",
      "Orange peel, bitter"
    ],
    "formula": "",
    "efficacy": "Stomachic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Bitter orange peel"
  },
  {
    "kegg_id": "D04674",
    "name_en": "Forsythia fruit (JP18)",
    "name_ja": "",
    "names_alt": [
      "Powdered forsythia fruit (Non-JPS)"
    ],
    "formula": "",
    "efficacy": "Antibacterial, Anti-inflammatory",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Forsythia fruit"
  },
  {
    "kegg_id": "D04705",
    "name_en": "Lithospermum root (JP18)",
    "name_ja": "",
    "names_alt": [
      "Macrotomiae radix"
    ],
    "formula": "",
    "efficacy": "Wound healing",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Lithospermum root"
  },
  {
    "kegg_id": "D05431",
    "name_en": "Mentha herb (JP18)",
    "name_ja": "",
    "names_alt": [
      "Peppermint (NF)"
    ],
    "formula": "",
    "efficacy": "Antiseptic, Choleretic, Pharmaceutic aid (perfume)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Mentha herb"
  },
  {
    "kegg_id": "D06679",
    "name_en": "Gambir (JP18)",
    "name_ja": "",
    "names_alt": [
      "Powdered gambir (JP18)"
    ],
    "formula": "",
    "efficacy": "Antidiarrheal",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Gambir"
  },
  {
    "kegg_id": "D06680",
    "name_en": "Sweet hydrangea leaf (JP18)",
    "name_ja": "",
    "names_alt": [
      "Powdered sweet hydrangea leaf (JP18)"
    ],
    "formula": "",
    "efficacy": "Antibacterial, Antioxidant",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Sweet hydrangea leaf"
  },
  {
    "kegg_id": "D06681",
    "name_en": "Aloe (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Powdered aloe (JP18)"
    ],
    "formula": "",
    "efficacy": "Analeptic, Laxative, Stomachic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Aloe"
  },
  {
    "kegg_id": "D06682",
    "name_en": "Artemisia capillaris flower (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Anti-inflammatory, Antipyretic, Choleretic, Diuretic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Artemisia capillaris flower"
  },
  {
    "kegg_id": "D06683",
    "name_en": "Fennel (JP18)",
    "name_ja": "",
    "names_alt": [
      "Powdered fennel (JP18)"
    ],
    "formula": "",
    "efficacy": "Expectorant, Stomachic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Fennel"
  },
  {
    "kegg_id": "D06684",
    "name_en": "Bearberry leaf (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Disinfectant, Diuretic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Bearberry leaf"
  },
  {
    "kegg_id": "D06685",
    "name_en": "Rose fruit (JP18)",
    "name_ja": "",
    "names_alt": [
      "Powdered rose fruit (JP18)"
    ],
    "formula": "",
    "efficacy": "Laxative (cathartic)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Rose fruit"
  },
  {
    "kegg_id": "D06686",
    "name_en": "Corydalis tuber (JP18)",
    "name_ja": "",
    "names_alt": [
      "Powdered corydalis tuber (JP18)"
    ],
    "formula": "",
    "efficacy": "Analgesic, Antispasmodic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Corydalis tuber"
  },
  {
    "kegg_id": "D06687",
    "name_en": "Astragalus root (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Antihypertensive, Diuretic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Astragalus root"
  },
  {
    "kegg_id": "D06688",
    "name_en": "Scutellaria root (JP18)",
    "name_ja": "",
    "names_alt": [
      "Powdered scutellaria root (JP18)"
    ],
    "formula": "",
    "efficacy": "Diuretic, Laxative",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Scutellaria root"
  },
  {
    "kegg_id": "D06689",
    "name_en": "Phellodendron bark (JP18)",
    "name_ja": "",
    "names_alt": [
      "Powdered phellodendron bark (JP18)"
    ],
    "formula": "",
    "efficacy": "Anti-inflammatory, Stomachic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Phellodendron bark"
  },
  {
    "kegg_id": "D06690",
    "name_en": "Polygala root (JP18)",
    "name_ja": "",
    "names_alt": [
      "Powdered polygala root (JP18)"
    ],
    "formula": "",
    "efficacy": "Central nervous system depressant, Expectorant",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Polygala root"
  },
  {
    "kegg_id": "D06691",
    "name_en": "Prunella spike (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Anti-inflammatory, Diuretic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Prunella spike"
  },
  {
    "kegg_id": "D06692",
    "name_en": "Zedoary (JP18)",
    "name_ja": "",
    "names_alt": [
      "Powdered curcuma rhizome (Non-JPS)"
    ],
    "formula": "",
    "efficacy": "Stomachic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Zedoary"
  },
  {
    "kegg_id": "D06693",
    "name_en": "Pueraria root (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Antipyretic, Antispasmodic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Pueraria root"
  },
  {
    "kegg_id": "D06694",
    "name_en": "Clematis root (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Antibacterial, Hypoglycemic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Clematis root"
  },
  {
    "kegg_id": "D06695",
    "name_en": "Termeric (JP18)",
    "name_ja": "",
    "names_alt": [
      "Powdered termeric (JP18)",
      "Turmeric rhizome"
    ],
    "formula": "",
    "efficacy": "Choleretic, Hepatoprotectant",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Termeric"
  },
  {
    "kegg_id": "D06696",
    "name_en": "Lindera root (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Intestinal regulator",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Lindera root"
  },
  {
    "kegg_id": "D06697",
    "name_en": "Polygonum root (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Analeptic, Antidote",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Polygonum root"
  },
  {
    "kegg_id": "D06701",
    "name_en": "Trichosanthes root (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Hypoglycemic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Trichosanthes root"
  },
  {
    "kegg_id": "D06702",
    "name_en": "Processed ginger (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Analgesic, Anti-inflammatory, Antipyretic, Antitussive",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Processed ginger"
  },
  {
    "kegg_id": "D06703",
    "name_en": "Platycodon root (JP18)",
    "name_ja": "",
    "names_alt": [
      "Powdered platycodon root (JP18)"
    ],
    "formula": "",
    "efficacy": "Antitussive, Expectorant",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Platycodon root"
  },
  {
    "kegg_id": "D06704",
    "name_en": "Chrysanthemum flower (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Antidote, Anti-inflammatory, Antipyretic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Chrysanthemum flower"
  },
  {
    "kegg_id": "D06705",
    "name_en": "Catalpa fruit (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Diuretic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Catalpa fruit"
  },
  {
    "kegg_id": "D06706",
    "name_en": "Immature orange (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Stomachic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Immature orange"
  },
  {
    "kegg_id": "D06707",
    "name_en": "Notopterygium rhizome (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Analgesic, Anti-inflammatory",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Notopterygium rhizome"
  },
  {
    "kegg_id": "D06708",
    "name_en": "Apricot kernel (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Antitussive",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Apricot kernel"
  },
  {
    "kegg_id": "D06709",
    "name_en": "Lycium fruit (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Analeptic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Lycium fruit"
  },
  {
    "kegg_id": "D06710",
    "name_en": "Sophora root (JP18)",
    "name_ja": "",
    "names_alt": [
      "Powdered sophora root (JP18)"
    ],
    "formula": "",
    "efficacy": "Anti-inflammatory, Anti-ulcerative",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Sophora root"
  },
  {
    "kegg_id": "D06711",
    "name_en": "Schizonepeta spike (JP18)",
    "name_ja": "",
    "names_alt": [
      "Powdered schizonepeta spike (Non-JPS)"
    ],
    "formula": "",
    "efficacy": "Analgesic, Antibacterial",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Schizonepeta spike"
  },
  {
    "kegg_id": "D06712",
    "name_en": "Cinnamon bark (JP18)",
    "name_ja": "",
    "names_alt": [
      "Powdered cinnamon bark (JP18)"
    ],
    "formula": "",
    "efficacy": "Analgesic, Antipyretic, Sweating",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Cinnamon bark"
  },
  {
    "kegg_id": "D06714",
    "name_en": "Cassia seed (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Laxative",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Cassia seed"
  },
  {
    "kegg_id": "D06715",
    "name_en": "Pharbitis seed (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Laxative",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Pharbitis seed"
  },
  {
    "kegg_id": "D06716",
    "name_en": "Gentian (JP18)",
    "name_ja": "",
    "names_alt": [
      "Powdered gentian (JP18)"
    ],
    "formula": "",
    "efficacy": "Bitter stomachic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Gentian"
  },
  {
    "kegg_id": "D06717",
    "name_en": "Safflower (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Emmenagogue",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Safflower"
  },
  {
    "kegg_id": "D06718",
    "name_en": "Red ginseng (JP18)",
    "name_ja": "",
    "names_alt": [
      "Powdered red ginseng (Non-JPS)"
    ],
    "formula": "",
    "efficacy": "Analeptic, Hypoglycemic, Sedative",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Red ginseng"
  },
  {
    "kegg_id": "D06719",
    "name_en": "Cyperus rhizome (JP18)",
    "name_ja": "",
    "names_alt": [
      "Powdered cyperus rhizome (JP18)",
      "Xianghu (TN)"
    ],
    "formula": "",
    "efficacy": "Analgesic, Choleretic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Cyperus rhizome"
  },
  {
    "kegg_id": "D06720",
    "name_en": "Magnolia bark (JP18)",
    "name_ja": "",
    "names_alt": [
      "Powdered magnolia bark (JP18)"
    ],
    "formula": "",
    "efficacy": "Analgesic, Antispasmodic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Magnolia bark"
  },
  {
    "kegg_id": "D06721",
    "name_en": "Oriental bezoar (JP18)",
    "name_ja": "",
    "names_alt": [
      "Powdered oriental bezoar (Non-JPS)"
    ],
    "formula": "",
    "efficacy": "Antipyretic, Antispasmodic, Cardiotonic, Choleretic, Sedative",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Oriental bezoar"
  },
  {
    "kegg_id": "D06722",
    "name_en": "Achyranthes root (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Antiallergic, Antitumor",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Achyranthes root"
  },
  {
    "kegg_id": "D06723",
    "name_en": "Burdock fruit (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Antitumor, Diuretic, Sweating",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Burdock fruit"
  },
  {
    "kegg_id": "D06724",
    "name_en": "Schisandra fruit (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Analgesic, Anti-ulcerative",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Schisandra fruit"
  },
  {
    "kegg_id": "D06725",
    "name_en": "Calumba (JP18)",
    "name_ja": "",
    "names_alt": [
      "Powdered calumba (JP18)"
    ],
    "formula": "",
    "efficacy": "Intestinal regulator, Stomachic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Calumba"
  },
  {
    "kegg_id": "D06726",
    "name_en": "Condurango (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Antitumor",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Condurango"
  },
  {
    "kegg_id": "D06727",
    "name_en": "Bupleurum root (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Anti-inflammatory, Antipyretic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Bupleurum root"
  },
  {
    "kegg_id": "D06728",
    "name_en": "Asiasarum root (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Analgesic, Antipyretic, Antitussive, Expectorant",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Asiasarum root"
  },
  {
    "kegg_id": "D06730",
    "name_en": "Smilax rhizome (JP18)",
    "name_ja": "",
    "names_alt": [
      "Powdered smilax rhizome (JP18)"
    ],
    "formula": "",
    "efficacy": "Antidote",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Smilax rhizome"
  },
  {
    "kegg_id": "D06731",
    "name_en": "Gardenia fruit (JP18)",
    "name_ja": "",
    "names_alt": [
      "Powdered gardenia fruit (JP18)"
    ],
    "formula": "",
    "efficacy": "Choleretic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Gardenia fruit"
  },
  {
    "kegg_id": "D06732",
    "name_en": "Cornus fruit (JP18)",
    "name_ja": "",
    "names_alt": [
      "Powdered cornus fruit (Non-JPS)",
      "Corni fructus pulveratus"
    ],
    "formula": "",
    "efficacy": "Analeptic, Anhidrotic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Cornus fruit"
  },
  {
    "kegg_id": "D06733",
    "name_en": "Zanthoxylum fruit (JP18)",
    "name_ja": "",
    "names_alt": [
      "Powdered zanthoxylum fruit (JP18)"
    ],
    "formula": "",
    "efficacy": "Analgesic, Anthelmintic, Antibacterial",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Zanthoxylum fruit"
  },
  {
    "kegg_id": "D06734",
    "name_en": "Jujube seed (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Sedative",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Jujube seed"
  },
  {
    "kegg_id": "D06735",
    "name_en": "Dioscorea rhizome (JP18)",
    "name_ja": "",
    "names_alt": [
      "Powdered dioscorea rhizome (JP18)"
    ],
    "formula": "",
    "efficacy": "Analeptic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Dioscorea rhizome"
  },
  {
    "kegg_id": "D06736",
    "name_en": "Rehmannia root (JP18)",
    "name_ja": "",
    "names_alt": [
      "Powdered rehmannia root (Non-JPS)",
      "Rehmanniae radix",
      "Rehmanniae radix pulverata"
    ],
    "formula": "",
    "efficacy": "Antidiarrheal, Diuretic, Laxative",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Rehmannia root"
  },
  {
    "kegg_id": "D06737",
    "name_en": "Lycium bark (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Antihypertensive, Antipyretic, Hypoglycemic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Lycium bark"
  },
  {
    "kegg_id": "D06738",
    "name_en": "Tribulus fruit (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Sedative",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Tribulus fruit"
  },
  {
    "kegg_id": "D06739",
    "name_en": "Peony root (JP18)",
    "name_ja": "",
    "names_alt": [
      "Powdered peony root (JP18)"
    ],
    "formula": "",
    "efficacy": "Analgesic, Antispasmodic, Astringent",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Peony root"
  },
  {
    "kegg_id": "D06740",
    "name_en": "Cnidium monnieri fruit (JP18)",
    "name_ja": "",
    "names_alt": [
      "Cnidium monnieri fructus"
    ],
    "formula": "",
    "efficacy": "Antibacterial, Antipruritic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Cnidium monnieri fruit"
  },
  {
    "kegg_id": "D06741",
    "name_en": "Plantago herb (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Antitussive, Diuretic, Expectorant",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Plantago herb"
  },
  {
    "kegg_id": "D06742",
    "name_en": "Houttuynia herb (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Antibacterial, Diuretic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Houttuynia herb"
  },
  {
    "kegg_id": "D06743",
    "name_en": "Amomum seed (JP18)",
    "name_ja": "",
    "names_alt": [
      "Powdered amomum seed (JP18)"
    ],
    "formula": "",
    "efficacy": "Intestinal regulator, Stomachic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Amomum seed"
  },
  {
    "kegg_id": "D06744",
    "name_en": "Ginger (JP18)",
    "name_ja": "",
    "names_alt": [
      "Powdered ginger (JP18)",
      "Ginger extract (Non-JPS)"
    ],
    "formula": "",
    "efficacy": "Flavor, Stomachic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Ginger"
  },
  {
    "kegg_id": "D06746",
    "name_en": "Magnolia flower (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Analgesic, Sedative",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Magnolia flower"
  },
  {
    "kegg_id": "D06748",
    "name_en": "Cnidium rhizome (JP18)",
    "name_ja": "",
    "names_alt": [
      "Powdered cnidium rhizome (JP18)"
    ],
    "formula": "",
    "efficacy": "Analeptic, Blood replenishment",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Cnidium rhizome"
  },
  {
    "kegg_id": "D06749",
    "name_en": "Nuphar rhizome (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Diuretic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Nuphar rhizome"
  },
  {
    "kegg_id": "D06751",
    "name_en": "Senna leaf (JP18)",
    "name_ja": "",
    "names_alt": [
      "Powdered senna leaf (JP18)"
    ],
    "formula": "",
    "efficacy": "Laxative (cathartic)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Senna leaf"
  },
  {
    "kegg_id": "D06752",
    "name_en": "Atractylodes lancea rhizome (JP18)",
    "name_ja": "",
    "names_alt": [
      "Powdered atractylodes lancea rhizome (JP18)"
    ],
    "formula": "",
    "efficacy": "Diuretic, Intestinal regulator, Stomachic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Atractylodes lancea rhizome"
  },
  {
    "kegg_id": "D06753",
    "name_en": "Mulberry bark (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Hypoglycemic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Mulberry bark"
  },
  {
    "kegg_id": "D06754",
    "name_en": "Sappan wood (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Analgesic, Anti-inflammatory, Antipyretic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Sappan wood"
  },
  {
    "kegg_id": "D06755",
    "name_en": "Perilla herb (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Antibacterial",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Perilla herb"
  },
  {
    "kegg_id": "D06756",
    "name_en": "Rhubarb (JP18)",
    "name_ja": "",
    "names_alt": [
      "Powdered rhubarb (JP18)"
    ],
    "formula": "",
    "efficacy": "Laxative",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Rhubarb"
  },
  {
    "kegg_id": "D06758",
    "name_en": "Jujube (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Anticomplement",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Jujube"
  },
  {
    "kegg_id": "D06759",
    "name_en": "Alisma rhizome (JP18)",
    "name_ja": "",
    "names_alt": [
      "Powdered alisma rhizome (JP18)"
    ],
    "formula": "",
    "efficacy": "Diuretic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Alisma rhizome"
  },
  {
    "kegg_id": "D06760",
    "name_en": "Panax rhizome (JP18)",
    "name_ja": "",
    "names_alt": [
      "Powdered panax rhizome (JP18)"
    ],
    "formula": "",
    "efficacy": "Analeptic, Expectorant, Stomachic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Panax rhizome"
  },
  {
    "kegg_id": "D06761",
    "name_en": "Anemarrhena rhizome (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Antipyretic, Anti-ulcerative, Hypoglycemic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Anemarrhena rhizome"
  },
  {
    "kegg_id": "D06762",
    "name_en": "Uncaria hook (JP18)",
    "name_ja": "",
    "names_alt": [
      "Uncaria hook extract (Non-JPS)"
    ],
    "formula": "",
    "efficacy": "Antihypertensive",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Uncaria hook"
  },
  {
    "kegg_id": "D06763",
    "name_en": "Polyporus sclerotium (JP18)",
    "name_ja": "",
    "names_alt": [
      "Powdered polyporus sclerotium (JP18)"
    ],
    "formula": "",
    "efficacy": "Diuretic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Polyporus sclerotium"
  },
  {
    "kegg_id": "D06764",
    "name_en": "Citrus unshiu peel (JP18)",
    "name_ja": "",
    "names_alt": [
      "Powdered citrus unshiu peel (Non-JPS)"
    ],
    "formula": "",
    "efficacy": "Antitussive, Bitter stomachic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Citrus unshiu peel"
  },
  {
    "kegg_id": "D06765",
    "name_en": "Gastrodia tuber (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Analgesic, Antispasmodic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Gastrodia tuber"
  },
  {
    "kegg_id": "D06766",
    "name_en": "Asparagus tuber (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Analeptic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Asparagus tuber"
  },
  {
    "kegg_id": "D06767",
    "name_en": "Benincasa seed (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Antiedemic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Benincasa seed"
  },
  {
    "kegg_id": "D06768",
    "name_en": "Japanese angelica root (JP18)",
    "name_ja": "",
    "names_alt": [
      "Powdered japanese angelica root (JP18)"
    ],
    "formula": "",
    "efficacy": "Analeptic, Analgesic, Blood replenishment, Sedative",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Japanese angelica root"
  },
  {
    "kegg_id": "D06769",
    "name_en": "Peach kernel (JP18)",
    "name_ja": "",
    "names_alt": [
      "Powdered peach kernel (JP18)"
    ],
    "formula": "",
    "efficacy": "Antibacterial, Anti-inflammatory",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Peach kernel"
  },
  {
    "kegg_id": "D06770",
    "name_en": "Eucommia bark (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Analeptic, Analgesic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Eucommia bark"
  },
  {
    "kegg_id": "D06772",
    "name_en": "Ginseng (JP18)",
    "name_ja": "",
    "names_alt": [
      "Powdered ginseng (JP18)"
    ],
    "formula": "",
    "efficacy": "Analeptic, Stomachic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Ginseng"
  },
  {
    "kegg_id": "D06773",
    "name_en": "Lonicera leaf and stem (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Antidote, Anti-inflammatory",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Lonicera leaf and stem"
  },
  {
    "kegg_id": "D06774",
    "name_en": "Fritillaria bulb (JP18)",
    "name_ja": "",
    "names_alt": [
      "Powdered fritillaria bulb (Non-JPS)"
    ],
    "formula": "",
    "efficacy": "Antitussive, Expectorant",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Fritillaria bulb"
  },
  {
    "kegg_id": "D06775",
    "name_en": "Ophiopogon tuber (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Antitussive, Expectorant",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Ophiopogon tuber"
  },
  {
    "kegg_id": "D06777",
    "name_en": "Glehnia root (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Analgesic, Antipyretic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Glehnia root"
  },
  {
    "kegg_id": "D06778",
    "name_en": "Pinellia tuber (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Anti-emetic, Antitussive, Expectorant, Sedative",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Pinellia tuber"
  },
  {
    "kegg_id": "D06779",
    "name_en": "Angelica dahurica root (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Analgesic, Antidote, Antipyretic, Pus discharge",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Angelica dahurica root"
  },
  {
    "kegg_id": "D06780",
    "name_en": "Atractylodes rhizome (JP18)",
    "name_ja": "",
    "names_alt": [
      "Powdered atractylodes rhizome (JP18)"
    ],
    "formula": "",
    "efficacy": "Anhidrotic, Diuretic, Intestinal regulator, Stomachic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Atractylodes rhizome"
  },
  {
    "kegg_id": "D06781",
    "name_en": "Loquat leaf (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Anti-emetic, Anti-inflammatory",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Loquat leaf"
  },
  {
    "kegg_id": "D06782",
    "name_en": "Areca (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Anthelmintic, Antihypertensive, Miotic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Areca"
  },
  {
    "kegg_id": "D06783",
    "name_en": "Poria sclerotium (JP18)",
    "name_ja": "",
    "names_alt": [
      "Powdered poria sclerotium (JP18)",
      "Hoelen (TN)"
    ],
    "formula": "",
    "efficacy": "Diuretic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Poria sclerotium"
  },
  {
    "kegg_id": "D06784",
    "name_en": "Processed aconite root (JP18)",
    "name_ja": "",
    "names_alt": [
      "Powdered processed aconite root (JP18)",
      "Processed aconite root (fibrous root)",
      "Powdered processed aconite root (fibrous root)"
    ],
    "formula": "",
    "efficacy": "Analgesic, Cardiotonic, Diuretic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Processed aconite root"
  },
  {
    "kegg_id": "D06785",
    "name_en": "Sinomenium stem (JP18)",
    "name_ja": "",
    "names_alt": [
      "Powdered sinomenium stem and rhizome (Non-JPS)",
      "Fangji (TN)"
    ],
    "formula": "",
    "efficacy": "Analgesic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Sinomenium stem"
  },
  {
    "kegg_id": "D06786",
    "name_en": "Imperata rhizome (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Anti-inflammatory, Diuretic, Hemostatic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Imperata rhizome"
  },
  {
    "kegg_id": "D06787",
    "name_en": "Saposhnikovia root (JP18)",
    "name_ja": "",
    "names_alt": [
      "Fangfeng (TN)"
    ],
    "formula": "",
    "efficacy": "Analgesic, Antipyretic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Saposhnikovia root"
  },
  {
    "kegg_id": "D06788",
    "name_en": "Moutan bark (JP18)",
    "name_ja": "",
    "names_alt": [
      "Powdered moutan bark (JP18)",
      "Mudanpi (TN)"
    ],
    "formula": "",
    "efficacy": "Antibacterial, Emmenagogue",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Moutan bark"
  },
  {
    "kegg_id": "D06790",
    "name_en": "Oyster shell (JP18)",
    "name_ja": "",
    "names_alt": [
      "Powdered oyster shell (JP18)"
    ],
    "formula": "",
    "efficacy": "Antacid, Diuretic, Sedative",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Oyster shell"
  },
  {
    "kegg_id": "D06791",
    "name_en": "Ephedra herb (JP18)",
    "name_ja": "",
    "names_alt": [
      "Powdered ephedra herb (Non-JPS)"
    ],
    "formula": "",
    "efficacy": "Anti-inflammatory, Antipyretic, Antitussive, Expectorant, Sweating",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [
      "Respiratory system agent",
      "Ephedrine-containing preparation"
    ],
    "cyp_enzymes": [],
    "search_name": "Ephedra herb"
  },
  {
    "kegg_id": "D06793",
    "name_en": "Hemp fruit (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Laxative (cathartic)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Hemp fruit"
  },
  {
    "kegg_id": "D06794",
    "name_en": "Akebia stem (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Anti-inflammatory, Diuretic, Emmenagogue",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Akebia stem"
  },
  {
    "kegg_id": "D06795",
    "name_en": "Saussurea root (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Stomachic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Saussurea root"
  },
  {
    "kegg_id": "D06796",
    "name_en": "Bitter cardamon (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Intestinal regulator, Stomachic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Bitter cardamon"
  },
  {
    "kegg_id": "D06798",
    "name_en": "Coix seed (JP18)",
    "name_ja": "",
    "names_alt": [
      "Coix extract",
      "Powdered coix seed (JP18)"
    ],
    "formula": "",
    "efficacy": "Analeptic, Wart removal",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Coix seed"
  },
  {
    "kegg_id": "D06799",
    "name_en": "Longgu (JP18)",
    "name_ja": "",
    "names_alt": [
      "Powdered longgu (JP18)"
    ],
    "formula": "",
    "efficacy": "Central nervous system depressant",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Longgu"
  },
  {
    "kegg_id": "D06800",
    "name_en": "Japanese gentian (JP18)",
    "name_ja": "",
    "names_alt": [
      "Powdered japanese gentian (JP18)"
    ],
    "formula": "",
    "efficacy": "Bitter stomachic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Japanese gentian"
  },
  {
    "kegg_id": "D06801",
    "name_en": "Alpinia offcinarum rhizome (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Analgesic, Stomachic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Alpinia offcinarum rhizome"
  },
  {
    "kegg_id": "D06803",
    "name_en": "Nelumbo seed (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Analeptic, Sedative",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Nelumbo seed"
  },
  {
    "kegg_id": "D06805",
    "name_en": "Scopolia rhizome (JP18)",
    "name_ja": "",
    "names_alt": [
      "Scoolia (TN)"
    ],
    "formula": "",
    "efficacy": "Analgesic, Antispasmodic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Scopolia rhizome"
  },
  {
    "kegg_id": "D06892",
    "name_en": "Donkey glue (Non-JPS)",
    "name_ja": "",
    "names_alt": [
      "Ass hide glue",
      "Asini corii collas",
      "Akyo"
    ],
    "formula": "",
    "efficacy": "Blood replenishment",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Donkey glue"
  },
  {
    "kegg_id": "D06893",
    "name_en": "Cherry bark (JP18)",
    "name_ja": "",
    "names_alt": [
      "Pruni jamasakura cortex",
      "Ohi"
    ],
    "formula": "",
    "efficacy": "Antidote, Antitussive, Expectorant",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Cherry bark"
  },
  {
    "kegg_id": "D06894",
    "name_en": "Artemisia leaf (JP18)",
    "name_ja": "",
    "names_alt": [
      "Artemisiae folium",
      "Gaiyo"
    ],
    "formula": "",
    "efficacy": "Hemostatic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Artemisia leaf"
  },
  {
    "kegg_id": "D06895",
    "name_en": "Aluminum silicate hydrate with silicon dioxide (JP18)",
    "name_ja": "",
    "names_alt": [
      "Hydrated halloysite",
      "Talcum crystallinum",
      "Kasseki"
    ],
    "formula": "",
    "efficacy": "Diuretic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Aluminum silicate hydrate with silicon dioxide"
  },
  {
    "kegg_id": "D06896",
    "name_en": "Trichosanthes seed (Non-JPS)",
    "name_ja": "",
    "names_alt": [
      "Trichosanthis semen",
      "Karonin"
    ],
    "formula": "",
    "efficacy": "Analgesic, Antibacterial, Anti-inflammatory, Antipyretic, Expectorant",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Trichosanthes seed"
  },
  {
    "kegg_id": "D06897",
    "name_en": "Citrus peel (Non-JPS)",
    "name_ja": "",
    "names_alt": [
      "Kippi"
    ],
    "formula": "",
    "efficacy": "Stomachic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Citrus peel"
  },
  {
    "kegg_id": "D06899",
    "name_en": "Koi (JP18)",
    "name_ja": "",
    "names_alt": [
      "Saccharum granorum",
      "Malt extract"
    ],
    "formula": "",
    "efficacy": "Analeptic, Analgesic, Antitussive, Sedative",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Koi"
  },
  {
    "kegg_id": "D06900",
    "name_en": "Brown rice (JP18)",
    "name_ja": "",
    "names_alt": [
      "Kobei"
    ],
    "formula": "",
    "efficacy": "Stomachic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Brown rice"
  },
  {
    "kegg_id": "D06901",
    "name_en": "Sesame (JP18)",
    "name_ja": "",
    "names_alt": [
      "Sesami semen",
      "Goma"
    ],
    "formula": "",
    "efficacy": "Analeptic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Sesame"
  },
  {
    "kegg_id": "D06902",
    "name_en": "Wheat (Non-JPS)",
    "name_ja": "",
    "names_alt": [
      "Tritici fructus",
      "Shobaku"
    ],
    "formula": "",
    "efficacy": "Sedative",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Wheat"
  },
  {
    "kegg_id": "D06903",
    "name_en": "Green tea leaf (Non-JPS)",
    "name_ja": "",
    "names_alt": [
      "Cameliae sinesis folium",
      "Theae folium",
      "Chayo",
      "Saicha"
    ],
    "formula": "",
    "efficacy": "Diuretic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Green tea leaf"
  },
  {
    "kegg_id": "D06904",
    "name_en": "Crataegus fruit (JP18)",
    "name_ja": "",
    "names_alt": [
      "Crataegi fructus",
      "Sanzashi"
    ],
    "formula": "",
    "efficacy": "Antidiarrheal, Stomachic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Crataegus fruit"
  },
  {
    "kegg_id": "D06905",
    "name_en": "Peucedanum root (JP18)",
    "name_ja": "",
    "names_alt": [
      "Peucedani radix",
      "Zenko"
    ],
    "formula": "",
    "efficacy": "Analgesic, Antipyretic, Antitussive, Expectorant",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Peucedanum root"
  },
  {
    "kegg_id": "D06906",
    "name_en": "Cicada slough (Non-JPS)",
    "name_ja": "",
    "names_alt": [
      "Cicada larva exuvia",
      "Cicadae periostracum",
      "Zentai"
    ],
    "formula": "",
    "efficacy": "Antipyretic, Antispasmodic, Sedative",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Cicada slough"
  },
  {
    "kegg_id": "D06907",
    "name_en": "Bamboo culm (Non-JPS)",
    "name_ja": "",
    "names_alt": [
      "Bambusae caulis",
      "Tikujyo"
    ],
    "formula": "",
    "efficacy": "Anti-emetic, Antipyretic, Antitussive",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Bamboo culm"
  },
  {
    "kegg_id": "D06908",
    "name_en": "Arisaema tuber (Non-JPS)",
    "name_ja": "",
    "names_alt": [
      "Arisaematis tuber",
      "Tennansho"
    ],
    "formula": "",
    "efficacy": "Anti-inflammatory, Antitumor, Antitussive, Expectorant, Sedative",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Arisaema tuber"
  },
  {
    "kegg_id": "D06909",
    "name_en": "Aralia rhizome (JP18)",
    "name_ja": "",
    "names_alt": [
      "Dokkatsu"
    ],
    "formula": "",
    "efficacy": "Analgesic, Anti-inflammatory, Antispasmodic, Sedative, Sweating",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Aralia rhizome"
  },
  {
    "kegg_id": "D06910",
    "name_en": "Malt (JP18)",
    "name_ja": "",
    "names_alt": [
      "Hordei fructus germinatus",
      "Germinated barley",
      "Bakuga"
    ],
    "formula": "",
    "efficacy": "Stomachic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Malt"
  },
  {
    "kegg_id": "D06911",
    "name_en": "Lilium bulb (JP18)",
    "name_ja": "",
    "names_alt": [
      "Lily bulb",
      "Byakugo"
    ],
    "formula": "",
    "efficacy": "Analeptic, Antitussive, Diuretic, Expectorant",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Lilium bulb"
  },
  {
    "kegg_id": "D06912",
    "name_en": "Quercus bark (JP18)",
    "name_ja": "",
    "names_alt": [
      "Quercus acutissima bark",
      "Quercus cortex",
      "Bokusoku",
      "Oak bark"
    ],
    "formula": "",
    "efficacy": "Astringent, Disinfectant",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Quercus bark"
  },
  {
    "kegg_id": "D06913",
    "name_en": "Leonurus herb (JP18)",
    "name_ja": "",
    "names_alt": [
      "Leonuri herba",
      "Yakumoso"
    ],
    "formula": "",
    "efficacy": "Analeptic, Emmenagogue, Hemostatic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Leonurus herb"
  },
  {
    "kegg_id": "D06914",
    "name_en": "Longan aril (JP18)",
    "name_ja": "",
    "names_alt": [
      "Longan arillus",
      "Ryuganniku"
    ],
    "formula": "",
    "efficacy": "Analeptic, Sedative, Stomachic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Longan aril"
  },
  {
    "kegg_id": "D07152",
    "name_en": "Processed aconite root",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Analgesic, Cardiotonic, Diuretic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Processed aconite root"
  },
  {
    "kegg_id": "D07154",
    "name_en": "Persimmon calyx (Non-JPS)",
    "name_ja": "",
    "names_alt": [
      "Kaki calyx",
      "Persimmon calyx"
    ],
    "formula": "",
    "efficacy": "Anti-emetic, Antitussive",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Persimmon calyx"
  },
  {
    "kegg_id": "D09125",
    "name_en": "Pogostemon herb (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Antidiarrheal, Antipyretic, Gastric secretion accelarator",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Pogostemon herb"
  },
  {
    "kegg_id": "D09127",
    "name_en": "Scrophularia root (Non-JPS)",
    "name_ja": "",
    "names_alt": [
      "Scroplulariae radix",
      "Ningpo figwort root"
    ],
    "formula": "",
    "efficacy": "Anti-inflammatory, Antipyretic, Sedative",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Scrophularia root"
  },
  {
    "kegg_id": "D09138",
    "name_en": "Aster root (Non-JPS)",
    "name_ja": "",
    "names_alt": [
      "Aster root and rhizome",
      "Asteris radix"
    ],
    "formula": "",
    "efficacy": "Antitussive, Diuretic, Expectorant",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Aster root"
  },
  {
    "kegg_id": "D09139",
    "name_en": "Myrobalan fruit (Non-JPS)",
    "name_ja": "",
    "names_alt": [
      "Myrobalan",
      "Chebulae fructus"
    ],
    "formula": "",
    "efficacy": "Antidiarrheal, Astringent, Sedative",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Myrobalan fruit"
  },
  {
    "kegg_id": "D09140",
    "name_en": "Lonicera flower (Non-JPS)",
    "name_ja": "",
    "names_alt": [
      "Lonicera flower bud",
      "Lonicerae flos"
    ],
    "formula": "",
    "efficacy": "Antibacterial, Antidote, Anti-inflammatory, Diuretic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Lonicera flower"
  },
  {
    "kegg_id": "D09144",
    "name_en": "Adenophora root (Non-JPS)",
    "name_ja": "",
    "names_alt": [
      "Adenophrae radix"
    ],
    "formula": "",
    "efficacy": "Analeptic, Antitussive, Expectorant",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Adenophora root"
  },
  {
    "kegg_id": "D09146",
    "name_en": "Medicated leaven",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Digestant, Stomachic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Medicated leaven"
  },
  {
    "kegg_id": "D09158",
    "name_en": "Salvia miltiorrhiza root (JP18)",
    "name_ja": "",
    "names_alt": [
      "Salvia miltiorrhizae radix"
    ],
    "formula": "",
    "efficacy": "Analgesic, Antihypertensive, Sedative, Vasodilator",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Salvia miltiorrhiza root"
  },
  {
    "kegg_id": "D09166",
    "name_en": "Codonopsis root (JP18)",
    "name_ja": "",
    "names_alt": [
      "Codonopsis radix"
    ],
    "formula": "",
    "efficacy": "Analeptic, Stomachic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Codonopsis root"
  },
  {
    "kegg_id": "D09184",
    "name_en": "Areca pericarp (Non-JPS)",
    "name_ja": "",
    "names_alt": [
      "Areca fruit peel",
      "Arecae pericarpium"
    ],
    "formula": "",
    "efficacy": "Diuretic, Intestinal regulator, Stomachic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Areca pericarp"
  },
  {
    "kegg_id": "D09191",
    "name_en": "Shrub chaste tree fruit (Non-JPS)",
    "name_ja": "",
    "names_alt": [
      "Vitex fruit",
      "Viticis fructus"
    ],
    "formula": "",
    "efficacy": "Analgesic, Anti-inflammatory, Sedative",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Shrub chaste tree fruit"
  },
  {
    "kegg_id": "D09192",
    "name_en": "Chaenomeles fruit (Non-JPS)",
    "name_ja": "",
    "names_alt": [
      "Chaenomelis fructus",
      "Chaenomeles speciosa fruit"
    ],
    "formula": "",
    "efficacy": "Analeptic, Antispasmodic, Antitussive, Diuretic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Chaenomeles fruit"
  },
  {
    "kegg_id": "D09220",
    "name_en": "Isodon herb (Non-JPS)",
    "name_ja": "",
    "names_alt": [
      "Powdered isodon herb (Non-JPS)",
      "Rabdosia herb",
      "Plectranthi herba"
    ],
    "formula": "",
    "efficacy": "Bitter stomachic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Isodon herb"
  },
  {
    "kegg_id": "D09228",
    "name_en": "Nandina fruit (Non-JPS)",
    "name_ja": "",
    "names_alt": [
      "Nandinae fructus"
    ],
    "formula": "",
    "efficacy": "Antitussive",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Nandina fruit"
  },
  {
    "kegg_id": "D09233",
    "name_en": "Processed mume (Non-JPS)",
    "name_ja": "",
    "names_alt": [
      "Prunus mume fruit",
      "Mume fructus"
    ],
    "formula": "",
    "efficacy": "Anthelmintic, Antidiarrheal, Anti-emetic, Antipyretic, Astringent, Expectorant",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Processed mume"
  },
  {
    "kegg_id": "D09244",
    "name_en": "Nutmeg (JP18)",
    "name_ja": "",
    "names_alt": [
      "Powdered nutmeg (Non-JPS)",
      "Myristicae semen"
    ],
    "formula": "",
    "efficacy": "Antidiarrheal, Astringent, Intestinal regulator, Stomachic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Nutmeg"
  },
  {
    "kegg_id": "D09246",
    "name_en": "Water chestnut (Non-JPS)",
    "name_ja": "精製水",
    "names_alt": [
      "Trapae fructus"
    ],
    "formula": "",
    "efficacy": "Analeptic, Stomachic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Water chestnut"
  },
  {
    "kegg_id": "D09255",
    "name_en": "Sophora japoinca flower (Non-JPS)",
    "name_ja": "",
    "names_alt": [
      "Sophora japonica flower bud",
      "Sophorae flos"
    ],
    "formula": "",
    "efficacy": "Hemostatic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Sophora japoinca flower"
  },
  {
    "kegg_id": "D09296",
    "name_en": "Sophora subprostrata root (Non-JPS)",
    "name_ja": "",
    "names_alt": [
      "Sophorae subprostratae radix"
    ],
    "formula": "",
    "efficacy": "Anti-inflammatory",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Sophora subprostrata root"
  },
  {
    "kegg_id": "D09297",
    "name_en": "Ligusticum sinese rhizome (Non-JPS)",
    "name_ja": "",
    "names_alt": [
      "Ligusticum root and rhizome",
      "Ligustici rhizoma"
    ],
    "formula": "",
    "efficacy": "Analgesic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Ligusticum sinese rhizome"
  },
  {
    "kegg_id": "D09447",
    "name_en": "Perilla fruit (Non-JPS)",
    "name_ja": "",
    "names_alt": [
      "Perilla frutescens fruit",
      "Perillae fructus"
    ],
    "formula": "",
    "efficacy": "Antipyretic, Antitussive, Diuretic, Stomachic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Perilla fruit"
  },
  {
    "kegg_id": "D09520",
    "name_en": "Soft shell turtle carapace (Non-JPS)",
    "name_ja": "",
    "names_alt": [
      "Amyda carapace",
      "Amydae testudo"
    ],
    "formula": "",
    "efficacy": "Analeptic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Soft shell turtle carapace"
  },
  {
    "kegg_id": "D09550",
    "name_en": "Angelica pubescens root (Non-JPS)",
    "name_ja": "",
    "names_alt": [
      "Angelicae pubescentis radix"
    ],
    "formula": "",
    "efficacy": "Analgesic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Angelica pubescens root"
  },
  {
    "kegg_id": "D10232",
    "name_en": "Cinnamon twig (Non-JPS)",
    "name_ja": "",
    "names_alt": [
      "Cinamomi ramulus",
      "Cinnamon branch",
      "Keishi"
    ],
    "formula": "",
    "efficacy": "Analgesic, Antibacterial, Antipyretic, Stomachic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Cinnamon twig"
  },
  {
    "kegg_id": "D10240",
    "name_en": "Aralia root (Non-JPS)",
    "name_ja": "",
    "names_alt": [
      "Wakyoukatsu",
      "Araliae cordatae radix"
    ],
    "formula": "",
    "efficacy": "Analgesic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Aralia root"
  },
  {
    "kegg_id": "D10782",
    "name_en": "Hedysarum root (JP18)",
    "name_ja": "",
    "names_alt": [
      "Hedysari radix"
    ],
    "formula": "",
    "efficacy": "Analeptic, Anhidrotic, Diuretic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5100",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Hedysarum root"
  },
  {
    "kegg_id": "D06698",
    "name_en": "Kakkonto extract (JP18)",
    "name_ja": "",
    "names_alt": [
      "Kakkonto"
    ],
    "formula": "",
    "efficacy": "Anti-inflammatory, Antipyretic, Antispasmodic, Antitussive, Expectorant, Sweating",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Kakkonto extract"
  },
  {
    "kegg_id": "D06700",
    "name_en": "Kamishoyosan extract (JP18)",
    "name_ja": "",
    "names_alt": [
      "Kamishoyosan"
    ],
    "formula": "",
    "efficacy": "Analgesic, Emmenagogue, Sedative",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Kamishoyosan extract"
  },
  {
    "kegg_id": "D06729",
    "name_en": "Saireito extract (JP18)",
    "name_ja": "",
    "names_alt": [
      "Saireito"
    ],
    "formula": "",
    "efficacy": "Antidiarrheal, Antiedemic, Anti-emetic, Diuretic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Saireito extract"
  },
  {
    "kegg_id": "D06757",
    "name_en": "Daiokanzoto extract (JP18)",
    "name_ja": "",
    "names_alt": [
      "Daiokanzoto"
    ],
    "formula": "",
    "efficacy": "Laxative",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Daiokanzoto extract"
  },
  {
    "kegg_id": "D06789",
    "name_en": "Hochuekkito extract (JP18)",
    "name_ja": "",
    "names_alt": [
      "Hochuekkito"
    ],
    "formula": "",
    "efficacy": "Analeptic, Anhidrotic, Blood replenishment, Stomachic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Hochuekkito extract"
  },
  {
    "kegg_id": "D06802",
    "name_en": "Ryokeijutsukanto extract (JP18)",
    "name_ja": "",
    "names_alt": [
      "Ryokeijutsukanto"
    ],
    "formula": "",
    "efficacy": "Analgesic, Antivertigo, Sedative",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Ryokeijutsukanto extract"
  },
  {
    "kegg_id": "D06915",
    "name_en": "Anchusan",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Analgesic, Anti-emetic, Anti-inflammatory, Anti-ulcerative",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Anchusan"
  },
  {
    "kegg_id": "D06916",
    "name_en": "Ireito",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Analgesic, Antidiarrheal, Anti-emetic, Anti-inflammatory, Diuretic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Ireito"
  },
  {
    "kegg_id": "D06917",
    "name_en": "Inchinkoto",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Anti-inflammatory, Choleretic, Diuretic, Laxative",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Inchinkoto"
  },
  {
    "kegg_id": "D06918",
    "name_en": "Inchingoreisan",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Antiedemic, Anti-emetic, Anti-inflammatory",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Inchingoreisan"
  },
  {
    "kegg_id": "D06919",
    "name_en": "Unkeito",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Analgesic, Anti-inflammatory, Emmenagogue, Sedative-hypnotic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Unkeito"
  },
  {
    "kegg_id": "D06920",
    "name_en": "Unseiin extract (JP18)",
    "name_ja": "",
    "names_alt": [
      "Unseiin"
    ],
    "formula": "",
    "efficacy": "Antipyretic, Emmenagogue, Sedative",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Unseiin extract"
  },
  {
    "kegg_id": "D06921",
    "name_en": "Eppikajutsuto",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Antiedemic, Anti-inflammatory, Antirheumatic, Diuretic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Eppikajutsuto"
  },
  {
    "kegg_id": "D06922",
    "name_en": "Ogikenchuto",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Analeptic, Anhidrotic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Ogikenchuto"
  },
  {
    "kegg_id": "D06923",
    "name_en": "Ogonto",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Antidiarrheal, Anti-emetic, Anti-inflammatory, Digestant",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Ogonto"
  },
  {
    "kegg_id": "D06924",
    "name_en": "Orengedokuto extract (JP18)",
    "name_ja": "",
    "names_alt": [
      "Orengedokuto"
    ],
    "formula": "",
    "efficacy": "Antihypertensive, Anti-inflammatory, Antipruritic, Antipyretic, Antivertigo, Emmenagogue, Hemostatic, Sedative-hypnotic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Orengedokuto extract"
  },
  {
    "kegg_id": "D06925",
    "name_en": "Orento",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Anti-emetic, Anti-inflammatory, Choleretic, Stomachic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Orento"
  },
  {
    "kegg_id": "D06926",
    "name_en": "Otsujito extract (JP18)",
    "name_ja": "",
    "names_alt": [
      "Otsujito"
    ],
    "formula": "",
    "efficacy": "Hemorrhoid, Hemostatic, Laxative",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Otsujito extract"
  },
  {
    "kegg_id": "D06927",
    "name_en": "Kakkontokajutsubuto",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Analgesic, Anti-inflammatory, Antipyretic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Kakkontokajutsubuto"
  },
  {
    "kegg_id": "D06928",
    "name_en": "Kakkontokasenkyushin'i extract (JP18)",
    "name_ja": "",
    "names_alt": [
      "Kakkontokasenkyushin'i"
    ],
    "formula": "",
    "efficacy": "Anti-inflammatory, Pus discharge",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Kakkontokasenkyushin'i extract"
  },
  {
    "kegg_id": "D06929",
    "name_en": "Kamikihito extract (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Blood replenishment, Sedative-hypnotic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Kamikihito extract"
  },
  {
    "kegg_id": "D06930",
    "name_en": "Kanzoto",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Analgesic, Antitussive",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Kanzoto"
  },
  {
    "kegg_id": "D06931",
    "name_en": "Kambakutaisoto",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Antispasmodic, Sedative-hypnotic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Kambakutaisoto"
  },
  {
    "kegg_id": "D06932",
    "name_en": "Kikyousekko",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Antitussive, Pus discharge",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Kikyousekko"
  },
  {
    "kegg_id": "D06933",
    "name_en": "Kikyoto",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Anti-inflammatory",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Kikyoto"
  },
  {
    "kegg_id": "D06934",
    "name_en": "Kihito",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Blood replenishment, Hypnotic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Kihito"
  },
  {
    "kegg_id": "D06935",
    "name_en": "Kyukikyogaito",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Hemorrhoid, Hemostatic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Kyukikyogaito"
  },
  {
    "kegg_id": "D06936",
    "name_en": "Kyukichoketsuin",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Emmenagogue, Sedative",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Kyukichoketsuin"
  },
  {
    "kegg_id": "D06937",
    "name_en": "Kumibinroto",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Analgesic, Antihypertensive, Laxative",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Kumibinroto"
  },
  {
    "kegg_id": "D06938",
    "name_en": "Keigairengyoto",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Anti-acne, Anti-inflammatory, Pus discharge",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Keigairengyoto"
  },
  {
    "kegg_id": "D06939",
    "name_en": "Keishikaogito",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Anhidrotic, Antipyretic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Keishikaogito"
  },
  {
    "kegg_id": "D06940",
    "name_en": "Keishikakakkonto",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Analgesic, Antipyretic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Keishikakakkonto"
  },
  {
    "kegg_id": "D06941",
    "name_en": "Keishikakobokukyoninto",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Antitussive",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Keishikakobokukyoninto"
  },
  {
    "kegg_id": "D06942",
    "name_en": "Keishikashakuyakudaioto",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Laxative",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Keishikashakuyakudaioto"
  },
  {
    "kegg_id": "D06943",
    "name_en": "Keishikashakuyakuto",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Intestinal regulator",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Keishikashakuyakuto"
  },
  {
    "kegg_id": "D06944",
    "name_en": "Keishikajutsubuto",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Analgesic, Anti-inflammatory, Diuretic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Keishikajutsubuto"
  },
  {
    "kegg_id": "D06945",
    "name_en": "Keishikaryukotsuboreito",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Sedative",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Keishikaryukotsuboreito"
  },
  {
    "kegg_id": "D06946",
    "name_en": "Keishikaryojutsubuto",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Analgesic, Anti-inflammatory",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Keishikaryojutsubuto"
  },
  {
    "kegg_id": "D06947",
    "name_en": "Keishito",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Analgesic, Anti-inflammatory, Antipyretic, Sedative, Cold remedy",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Keishito"
  },
  {
    "kegg_id": "D06948",
    "name_en": "Keishininjinto",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Analgesic, Anti-inflammatory",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Keishininjinto"
  },
  {
    "kegg_id": "D06949",
    "name_en": "Keishibukuryogan extract (JP18)",
    "name_ja": "",
    "names_alt": [
      "Keishibukuryogan"
    ],
    "formula": "",
    "efficacy": "Analgesic, Anti-inflammatory, Antipyretic, Antivertigo, Emmenagogue",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Keishibukuryogan extract"
  },
  {
    "kegg_id": "D06950",
    "name_en": "Keishibukuryogankayokuinin",
    "name_ja": "",
    "names_alt": [
      "Keishibukuryoganyokuinin"
    ],
    "formula": "",
    "efficacy": "Analgesic, Anti-inflammatory, Antivertigo, Emmenagogue, Pus discharge",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Keishibukuryogankayokuinin"
  },
  {
    "kegg_id": "D06951",
    "name_en": "Keishakuchimoto",
    "name_ja": "",
    "names_alt": [
      "Keishishakuyakuchimoto"
    ],
    "formula": "",
    "efficacy": "Analgesic, Antirheumatic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Keishakuchimoto"
  },
  {
    "kegg_id": "D06952",
    "name_en": "Keihito",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Antidiarrheal, Anti-inflammatory, Digestant, Stomachic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Keihito"
  },
  {
    "kegg_id": "D06953",
    "name_en": "Keimakakuhanto",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Antipruritic, Antitussive, Cold remedy",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Keimakakuhanto"
  },
  {
    "kegg_id": "D06954",
    "name_en": "Kososan",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Analgesic, Anti-inflammatory, Emmenagogue, Sedative, Stomachic, Cold remedy",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Kososan"
  },
  {
    "kegg_id": "D06955",
    "name_en": "Gokoto",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Antiasthmatic, Antitussive",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Gokoto"
  },
  {
    "kegg_id": "D06956",
    "name_en": "Goshakusan",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Analgesic, Anti-inflammatory, Cold remedy",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [
      "Respiratory system agent",
      "Ephedrine-containing preparation"
    ],
    "cyp_enzymes": [],
    "search_name": "Goshakusan"
  },
  {
    "kegg_id": "D06957",
    "name_en": "Goshajinkigan extract (JP18)",
    "name_ja": "",
    "names_alt": [
      "Goshajinkigan"
    ],
    "formula": "",
    "efficacy": "Analgesic, Antidysuria, Antiedemic, Antipruritic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Goshajinkigan extract"
  },
  {
    "kegg_id": "D06958",
    "name_en": "Goshuyuto extract (JP18)",
    "name_ja": "",
    "names_alt": [
      "Goshuyuto"
    ],
    "formula": "",
    "efficacy": "Analgesic, Anti-emetic, Antimigraine, Hiccup stopper",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Goshuyuto extract"
  },
  {
    "kegg_id": "D06959",
    "name_en": "Gorinsan",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Antidysuria",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Gorinsan"
  },
  {
    "kegg_id": "D06960",
    "name_en": "Goreisan extract (JP18)",
    "name_ja": "",
    "names_alt": [
      "Goreisan"
    ],
    "formula": "",
    "efficacy": "Analgesic, Antidiarrheal, Antiedemic, Anti-emetic, Anti-inflammatory, Antivertigo, Diuretic, Hypoglycemic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Goreisan extract"
  },
  {
    "kegg_id": "D06961",
    "name_en": "Saikanto",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Analgesic, Antitussive",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Saikanto"
  },
  {
    "kegg_id": "D06962",
    "name_en": "Saikokaryukotsuboreito",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Antihypertensive, Sedative-hypnotic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Saikokaryukotsuboreito"
  },
  {
    "kegg_id": "D06963",
    "name_en": "Saikokeishikankyoto extract (JP18)",
    "name_ja": "",
    "names_alt": [
      "Saikokeishikankyoto"
    ],
    "formula": "",
    "efficacy": "Analeptic, Anhidrotic, Antipyretic, Antitussive, Blood replenishment, Emmenagogue, Sedative-hypnotic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Saikokeishikankyoto extract"
  },
  {
    "kegg_id": "D06964",
    "name_en": "Saikokeishito extract (JP18)",
    "name_ja": "",
    "names_alt": [
      "Saikokeishito"
    ],
    "formula": "",
    "efficacy": "Analgesic, Anti-emetic, Anti-inflammatory, Antipyretic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Saikokeishito extract"
  },
  {
    "kegg_id": "D06965",
    "name_en": "Saikoseikanto",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Anti-inflammatory, Blood replenishment, Sedative",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Saikoseikanto"
  },
  {
    "kegg_id": "D06966",
    "name_en": "Saibokuto extract (JP18)",
    "name_ja": "",
    "names_alt": [
      "Saibokuto"
    ],
    "formula": "",
    "efficacy": "Antiasthmatic, Anti-inflammatory, Antitussive, Sedative",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Saibokuto extract"
  },
  {
    "kegg_id": "D06967",
    "name_en": "San'oshashinto",
    "name_ja": "",
    "names_alt": [
      "San'osan"
    ],
    "formula": "",
    "efficacy": "Antihypertensive, Emmenagogue, Hemorrhoid, Hemostatic, Laxative",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "San'oshashinto"
  },
  {
    "kegg_id": "D06968",
    "name_en": "Sansoninto",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Sedative-hypnotic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Sansoninto"
  },
  {
    "kegg_id": "D06969",
    "name_en": "Sammotsuogonto",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Antipyretic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Sammotsuogonto"
  },
  {
    "kegg_id": "D06970",
    "name_en": "Jiinkokato",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Antitussive",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Jiinkokato"
  },
  {
    "kegg_id": "D06971",
    "name_en": "Jiinshihoto",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Antitussive, Expectorant",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Jiinshihoto"
  },
  {
    "kegg_id": "D06972",
    "name_en": "Shiunkou",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Wound healing",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Shiunkou"
  },
  {
    "kegg_id": "D06973",
    "name_en": "Shigyakusan",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Anti-inflammatory, Antisecretory (gastric acid), Sedative",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Shigyakusan"
  },
  {
    "kegg_id": "D06974",
    "name_en": "Shikunshito",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Antidiarrheal, Anti-emetic, Anti-inflammatory, Stomachic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Shikunshito"
  },
  {
    "kegg_id": "D06975",
    "name_en": "Shishihakuhito",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Antipruritic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Shishihakuhito"
  },
  {
    "kegg_id": "D06976",
    "name_en": "Shichimotsukokato",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Antihypertensive",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Shichimotsukokato"
  },
  {
    "kegg_id": "D06977",
    "name_en": "Shimotsuto",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Analeptic, Antihypertensive, Blood replenishment, Emmenagogue, Laxative",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Shimotsuto"
  },
  {
    "kegg_id": "D06978",
    "name_en": "Shakanzoto",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Analeptic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Shakanzoto"
  },
  {
    "kegg_id": "D06979",
    "name_en": "Shakuyakukanzoto extract (JP18)",
    "name_ja": "",
    "names_alt": [
      "Shakuyakukanzoto"
    ],
    "formula": "",
    "efficacy": "Analgesic, Anticonvulsant, Hiccup stopper",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Shakuyakukanzoto extract"
  },
  {
    "kegg_id": "D06980",
    "name_en": "Shakuyakukanzobushito",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Analgesic, Anti-inflammatory, Antirheumatic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Shakuyakukanzobushito"
  },
  {
    "kegg_id": "D06981",
    "name_en": "Juzentaihoto extract (JP18)",
    "name_ja": "",
    "names_alt": [
      "Juzentaihoto"
    ],
    "formula": "",
    "efficacy": "Analeptic, Blood replenishment, Hemostatic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Juzentaihoto extract"
  },
  {
    "kegg_id": "D06982",
    "name_en": "Jumihaidokuto",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Anti-acne, Anti-inflammatory, Pus discharge, Antifungal",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Jumihaidokuto"
  },
  {
    "kegg_id": "D06983",
    "name_en": "Junchoto",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Laxative",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Junchoto"
  },
  {
    "kegg_id": "D06984",
    "name_en": "Shokenchuto",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Analgesic, Antidiarrheal, Anti-inflammatory, Antipyretic, Blood replenishment, Diuretic, Laxative, Sedative",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Shokenchuto"
  },
  {
    "kegg_id": "D06985",
    "name_en": "Shosaikoto extract (JP18)",
    "name_ja": "",
    "names_alt": [
      "Shosaikoto"
    ],
    "formula": "",
    "efficacy": "Antiasthmatic, Anti-emetic, Anti-inflammatory, Antipyretic, Liver function improving, Stomachic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Shosaikoto extract"
  },
  {
    "kegg_id": "D06986",
    "name_en": "Shosaikotokakikyosekko",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Analgesic, Anti-inflammatory",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Shosaikotokakikyosekko"
  },
  {
    "kegg_id": "D06987",
    "name_en": "Shoseiryuto extract (JP18)",
    "name_ja": "",
    "names_alt": [
      "Shoseiryuto"
    ],
    "formula": "",
    "efficacy": "Antiallergic, Antiasthmatic, Anti-inflammatory",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Shoseiryuto extract"
  },
  {
    "kegg_id": "D06988",
    "name_en": "Shohangekabukuryoto",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Anti-emetic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Shohangekabukuryoto"
  },
  {
    "kegg_id": "D06989",
    "name_en": "Shofusan",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Anti-inflammatory, Antipruritic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Shofusan"
  },
  {
    "kegg_id": "D06990",
    "name_en": "Shomakakkonto",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Anti-inflammatory",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Shomakakkonto"
  },
  {
    "kegg_id": "D06991",
    "name_en": "Shireito",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Analgesic, Antiedemic, Anti-emetic, Anti-inflammatory, Diuretic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Shireito"
  },
  {
    "kegg_id": "D06992",
    "name_en": "Shin'iseihaito extract (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Anti-inflammatory, Pus discharge",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Shin'iseihaito extract"
  },
  {
    "kegg_id": "D06993",
    "name_en": "Jinsoin",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Antitussive",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Jinsoin"
  },
  {
    "kegg_id": "D06994",
    "name_en": "Shimpito",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Antiasthmatic, Anti-inflammatory, Antitussive, Expectorant",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Shimpito"
  },
  {
    "kegg_id": "D06995",
    "name_en": "Shimbuto extract (JP18)",
    "name_ja": "",
    "names_alt": [
      "Shimbuto"
    ],
    "formula": "",
    "efficacy": "Antidiarrheal, Antihypertensive, Anti-inflammatory, Antipruritic, Stomachic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Shimbuto extract"
  },
  {
    "kegg_id": "D06996",
    "name_en": "Seijobofuto",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Anti-acne",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Seijobofuto"
  },
  {
    "kegg_id": "D06997",
    "name_en": "Seishoekkito",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Analeptic, Antidiarrheal, Digestant",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Seishoekkito"
  },
  {
    "kegg_id": "D06998",
    "name_en": "Seishinrenshiin",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Analgesic, Antidysuria",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Seishinrenshiin"
  },
  {
    "kegg_id": "D06999",
    "name_en": "Seihaito",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Antitussive, Expectorant",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Seihaito"
  },
  {
    "kegg_id": "D07000",
    "name_en": "Senkyuchachosan",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Analgesic, Emmenagogue",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Senkyuchachosan"
  },
  {
    "kegg_id": "D07001",
    "name_en": "Sokeikakketsuto",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Analgesic, Anti-inflammatory",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Sokeikakketsuto"
  },
  {
    "kegg_id": "D07002",
    "name_en": "Daiobotampito",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Anti-inflammatory (dermal), Emmenagogue, Hemorrhoid, Laxative",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Daiobotampito"
  },
  {
    "kegg_id": "D07003",
    "name_en": "Daikenchuto",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Analgesic, Antidiarrheal, Anti-emetic, Anti-inflammatory, Antiperistaltic, Laxative",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Daikenchuto"
  },
  {
    "kegg_id": "D07004",
    "name_en": "Daisaikoto extract (JP18)",
    "name_ja": "",
    "names_alt": [
      "Daisaiko"
    ],
    "formula": "",
    "efficacy": "Antihypertensive",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Daisaikoto extract"
  },
  {
    "kegg_id": "D07005",
    "name_en": "Daisaikotokyodaio",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Analgesic, Antiasthmatic, Antihypertensive, Anti-inflammatory, Sedative-hypnotic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Daisaikotokyodaio"
  },
  {
    "kegg_id": "D07006",
    "name_en": "Daijokito",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Antihypertensive, Laxative, Sedative",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Daijokito"
  },
  {
    "kegg_id": "D07007",
    "name_en": "Daibofuto",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Analgesic, Anti-inflammatory, Antirheumatic, Gout suppressant",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Daibofuto"
  },
  {
    "kegg_id": "D07008",
    "name_en": "Chikujountanto",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Antipyretic, Antitussive, Expectorant, Sedative",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Chikujountanto"
  },
  {
    "kegg_id": "D07009",
    "name_en": "Jidabokuippo",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Analgesic, Anti-inflammatory",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Jidabokuippo"
  },
  {
    "kegg_id": "D07010",
    "name_en": "Jizusoippo",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Anti-inflammatory",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Jizusoippo"
  },
  {
    "kegg_id": "D07011",
    "name_en": "Choijokito",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Laxative",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Choijokito"
  },
  {
    "kegg_id": "D07012",
    "name_en": "Chotosan extract (JP18)",
    "name_ja": "",
    "names_alt": [
      "Chotosan"
    ],
    "formula": "",
    "efficacy": "Antihypertensive",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Chotosan extract"
  },
  {
    "kegg_id": "D07013",
    "name_en": "Choyoto",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Analgesic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Choyoto"
  },
  {
    "kegg_id": "D07014",
    "name_en": "Choreito",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Analgesic, Antidiarrheal, Antidysuria, Antiedemic, Anti-inflammatory, Diuretic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Choreito"
  },
  {
    "kegg_id": "D07015",
    "name_en": "Choreitogoshimotsuto",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Analgesic, Antidysuria",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Choreitogoshimotsuto"
  },
  {
    "kegg_id": "D07016",
    "name_en": "Tsudosan",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Analgesic, Antihypertensive, Emmenagogue, Laxative",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Tsudosan"
  },
  {
    "kegg_id": "D07017",
    "name_en": "Tokakujokito extract (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Antihypertensive, Emmenagogue, Laxative",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Tokakujokito extract"
  },
  {
    "kegg_id": "D07018",
    "name_en": "Tokiinshi",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Anti-inflammatory, Antipruritic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Tokiinshi"
  },
  {
    "kegg_id": "D07019",
    "name_en": "Tokikenchuto",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Analgesic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Tokikenchuto"
  },
  {
    "kegg_id": "D07020",
    "name_en": "Tokishigyakukagoshuyushokyoto",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Analgesic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Tokishigyakukagoshuyushokyoto"
  },
  {
    "kegg_id": "D07021",
    "name_en": "Tokishakuyakusan extract (JP18)",
    "name_ja": "",
    "names_alt": [
      "Tokishakuyakusan"
    ],
    "formula": "",
    "efficacy": "Analeptic, Analgesic, Anti-inflammatory, Blood replenishment, Diuretic, Emmenagogue",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Tokishakuyakusan extract"
  },
  {
    "kegg_id": "D07022",
    "name_en": "Tokishakuyakusankabushi",
    "name_ja": "",
    "names_alt": [
      "Tokishakuyakukabushi"
    ],
    "formula": "",
    "efficacy": "Analeptic, Analgesic, Anti-inflammatory, Blood replenishment, Emmenagogue",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Tokishakuyakusankabushi"
  },
  {
    "kegg_id": "D07023",
    "name_en": "Tokito",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Analgesic, Antipyretic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Tokito"
  },
  {
    "kegg_id": "D07024",
    "name_en": "Nijutsuto",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Analgesic, Anti-inflammatory",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Nijutsuto"
  },
  {
    "kegg_id": "D07025",
    "name_en": "Nichinto",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Anti-emetic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Nichinto"
  },
  {
    "kegg_id": "D07026",
    "name_en": "Nyoshinsan",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Blood replenishment, Emmenagogue, Sedative",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Nyoshinsan"
  },
  {
    "kegg_id": "D07027",
    "name_en": "Ninjinto",
    "name_ja": "",
    "names_alt": [
      "Richugan"
    ],
    "formula": "",
    "efficacy": "Analgesic, Antidiarrheal, Anti-emetic, Stomachic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Ninjinto"
  },
  {
    "kegg_id": "D07028",
    "name_en": "Ninjinyoeito",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Analeptic, Anhidrotic, Antipyretic, Blood replenishment, Laxative, Sedative-hypnotic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Ninjinyoeito"
  },
  {
    "kegg_id": "D07029",
    "name_en": "Hainosankyuto",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Anti-inflammatory, Pus discharge",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Hainosankyuto"
  },
  {
    "kegg_id": "D07030",
    "name_en": "Bakumondoto extract (JP18)",
    "name_ja": "",
    "names_alt": [
      "Bakumondoto"
    ],
    "formula": "",
    "efficacy": "Antiasthmatic, Anti-inflammatory, Antitussive, Expectorant",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Bakumondoto extract"
  },
  {
    "kegg_id": "D07031",
    "name_en": "Hachimijiogan extract (JP18)",
    "name_ja": "",
    "names_alt": [
      "Hachimijiogan",
      "Hachimigan"
    ],
    "formula": "",
    "efficacy": "Analgesic, Antidiabetic, Antiedemic, Antihypertensive, Anti-inflammatory, Antipruritic, Diuretic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Hachimijiogan extract"
  },
  {
    "kegg_id": "D07032",
    "name_en": "Hangekobokuto extract (JP18)",
    "name_ja": "",
    "names_alt": [
      "Hangekobokuto"
    ],
    "formula": "",
    "efficacy": "Analgesic, Antiasthmatic, Antiedemic, Anti-emetic, Anti-inflammatory, Antitussive, Sedative-hypnotic, Stomachic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Hangekobokuto extract"
  },
  {
    "kegg_id": "D07033",
    "name_en": "Hangeshashinto extract (JP18)",
    "name_ja": "",
    "names_alt": [
      "Hangeshashinto"
    ],
    "formula": "",
    "efficacy": "Anti-inflammatory, Digestant, Sedative, Stomachic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Hangeshashinto extract"
  },
  {
    "kegg_id": "D07034",
    "name_en": "Hangebyakujutsutemmato",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Analgesic, Anti-emetic, Antivertigo, Sedative, Stomachic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Hangebyakujutsutemmato"
  },
  {
    "kegg_id": "D07035",
    "name_en": "Byakkokaninjinto extract (JP18)",
    "name_ja": "",
    "names_alt": [
      "Byakkokaninjinto"
    ],
    "formula": "",
    "efficacy": "Anti-inflammatory, Antipruritic, Antipyretic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Byakkokaninjinto extract"
  },
  {
    "kegg_id": "D07036",
    "name_en": "Bukuryoin",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Anti-inflammatory, Digestant, Stomachic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Bukuryoin"
  },
  {
    "kegg_id": "D07037",
    "name_en": "Bukuryoingohangekobokuto",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Anti-emetic, Anti-inflammatory, Sedative",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Bukuryoingohangekobokuto"
  },
  {
    "kegg_id": "D07038",
    "name_en": "Bushirichuto",
    "name_ja": "",
    "names_alt": [
      "Bushininjinto"
    ],
    "formula": "",
    "efficacy": "Stomachic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Bushirichuto"
  },
  {
    "kegg_id": "D07039",
    "name_en": "Heiisan",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Digestant, Stomachic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Heiisan"
  },
  {
    "kegg_id": "D07040",
    "name_en": "Boiogito extract (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Anhidrotic, Antiedemic, Anti-inflammatory, Diuretic, Emmenagogue",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Boiogito extract"
  },
  {
    "kegg_id": "D07041",
    "name_en": "Bofutsushosan extract (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Antihypertensive",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Bofutsushosan extract"
  },
  {
    "kegg_id": "D07042",
    "name_en": "Maoto extract (JP18)",
    "name_ja": "",
    "names_alt": [
      "Maoto"
    ],
    "formula": "",
    "efficacy": "Analgesic, Antiasthmatic, Antipyretic, Antirheumatic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [
      "Respiratory system agent",
      "Ephedrine-containing preparation"
    ],
    "cyp_enzymes": [],
    "search_name": "Maoto extract"
  },
  {
    "kegg_id": "D07043",
    "name_en": "Maobushisaishinto",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Anti-inflammatory, Antipyretic, Antitussive",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Maobushisaishinto"
  },
  {
    "kegg_id": "D07044",
    "name_en": "Makyokansekito",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Antiasthmatic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Makyokansekito"
  },
  {
    "kegg_id": "D07045",
    "name_en": "Makyoyokukanto",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Analgesic, Anti-inflammatory, Antirheumatic, Wart removal",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Makyoyokukanto"
  },
  {
    "kegg_id": "D07046",
    "name_en": "Mashiningan",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Laxative, Hemorrhoid",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Mashiningan"
  },
  {
    "kegg_id": "D07047",
    "name_en": "Mokuboito",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Antiasthmatic, Antiedemic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Mokuboito"
  },
  {
    "kegg_id": "D07048",
    "name_en": "Yokuininto",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Analgesic, Anti-inflammatory",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Yokuininto"
  },
  {
    "kegg_id": "D07049",
    "name_en": "Yokukansan extract (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Sedative-hypnotic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Yokukansan extract"
  },
  {
    "kegg_id": "D07050",
    "name_en": "Yokukansankachimpihange extract (JP18)",
    "name_ja": "",
    "names_alt": [
      "Yokukansankachimpihange"
    ],
    "formula": "",
    "efficacy": "Sedative-hypnotic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Yokukansankachimpihange extract"
  },
  {
    "kegg_id": "D07051",
    "name_en": "Rikkunshito extract (JP18)",
    "name_ja": "",
    "names_alt": [
      "Rikkunshito"
    ],
    "formula": "",
    "efficacy": "Analgesic, Anti-emetic, Anti-inflammatory, Digestant, Stomachic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Rikkunshito extract"
  },
  {
    "kegg_id": "D07052",
    "name_en": "Rikkosan",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Analgesic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Rikkosan"
  },
  {
    "kegg_id": "D07053",
    "name_en": "Ryutanshakanto",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Analgesic, Anti-inflammatory, Antipruritic, Diuretic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Ryutanshakanto"
  },
  {
    "kegg_id": "D07054",
    "name_en": "Ryokankyomishingeninto",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Antiasthmatic, Antitussive, Expectorant",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Ryokankyomishingeninto"
  },
  {
    "kegg_id": "D07055",
    "name_en": "Ryokyojutsukanto",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Analgesic, Diuretic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Ryokyojutsukanto"
  },
  {
    "kegg_id": "D07056",
    "name_en": "Rokumigan",
    "name_ja": "",
    "names_alt": [
      "Rokumijiogan"
    ],
    "formula": "",
    "efficacy": "Antidysuria, Antiedemic, Antipruritic, Diuretic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "5200",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Rokumigan"
  },
  {
    "kegg_id": "D02157",
    "name_en": "Penicillin G benzathine (USP)",
    "name_ja": "ペニシリン",
    "names_alt": [
      "Benzylpenicillin benzathine hydrate (JP18)",
      "Bicillin L-A (TN)",
      "Permapen (TN)",
      "Wycillin (TN)",
      "Stelues (TN)"
    ],
    "formula": "(C16H18N2O4S)2. C16H20N2. 4H2O",
    "efficacy": "Antibacterial, Cell wall biosynthesis inhibitor\nDISEASE   Syphilis [DS:H00354]\nYaws [DS:H01318]\nBejel [DS:H01531]\nPinta [DS:H01530]",
    "target": "penicillin binding protein\nPATHWAY   ko00550  Peptidoglycan biosynthesis",
    "metabolism": "",
    "therapeutic_category": "6111",
    "atc_code": "J01CE01",
    "drug_class": [
      "Antibacterial",
      "beta-Lactam antibiotic",
      "Penicillin skeleton group",
      "Penicillin",
      "beta-Lactamase sensitive penicillin"
    ],
    "cyp_enzymes": [],
    "search_name": "Penicillin G benzathine"
  },
  {
    "kegg_id": "D01053",
    "name_en": "Penicillin G potassium (USP)",
    "name_ja": "ペニシリン",
    "names_alt": [
      "Benzylpenicillin potassium (JP18)",
      "Pfizerpen (TN)"
    ],
    "formula": "C16H17N2O4S. K",
    "efficacy": "Antibacterial, Cell wall biosynthesis inhibitor\nDISEASE   Pneumonia due to Streptococcus pneumoniae [DS:H01321]\nEndocarditis [DS:H00334]\nAnthrax [DS:H00328]\nActinomycosis [DS:H01325]\nBotulism [DS:H00339]\nGas gangrene [DS:H00336]\nTetanus [DS:H00337]\nDiphtheria [DS:H00343]\nListeria infections [DS:H00332]\nPasteurella infections [DS:H00306]\nHaverhill fever [DS:H01314]\nRat bite fever [DS:H01314]\nGonococcal infections [DS:H00315]\nSyphilis [DS:H00354]\nMeningococcal meningitis [DS:H00314]",
    "target": "penicillin binding protein\nPATHWAY   ko00550  Peptidoglycan biosynthesis",
    "metabolism": "Transporter: SLC22A8 [HSA:9376]",
    "therapeutic_category": "6111",
    "atc_code": "J01CE01",
    "drug_class": [
      "Antibacterial",
      "beta-Lactam antibiotic",
      "Penicillin skeleton group",
      "Penicillin",
      "beta-Lactamase sensitive penicillin",
      "Transporter substrate",
      "SLC22A8 substrate"
    ],
    "cyp_enzymes": [],
    "search_name": "Penicillin G potassium"
  },
  {
    "kegg_id": "D02132",
    "name_en": "Clindamycin hydrochloride (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Cleocin hydrochloride (TN)",
      "Dalacin (TN)"
    ],
    "formula": "C18H33ClN2O5S. HCl",
    "efficacy": "Antibacterial, Protein biosynthesis inhibitor\nDISEASE   Infections due to susceptible strains of streptococci [DS:H00333]\nInfections due to susceptible strains of staphylococci [DS:H01175]",
    "target": "50S ribosomal subunit\nPATHWAY   ko03010(K01980)  Ribosome",
    "metabolism": "",
    "therapeutic_category": "6112",
    "atc_code": "D10AF01",
    "drug_class": [
      "Antibacterial",
      "Lincosamide antibiotic"
    ],
    "cyp_enzymes": [],
    "search_name": "Clindamycin hydrochloride"
  },
  {
    "kegg_id": "D02346",
    "name_en": "Lincomycin hydrochloride hydrate (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "LCM",
      "Lincocin (TN)"
    ],
    "formula": "C18H34N2O6S. HCl. H2O",
    "efficacy": "Antibacterial, Protein biosynthesis inhibitor",
    "target": "50S ribosomal subunit\nPATHWAY   ko03010(K01980)  Ribosome",
    "metabolism": "",
    "therapeutic_category": "6112",
    "atc_code": "J01FF02",
    "drug_class": [
      "Antibacterial",
      "Lincosamide antibiotic"
    ],
    "cyp_enzymes": [],
    "search_name": "Lincomycin hydrochloride hydrate"
  },
  {
    "kegg_id": "D00926",
    "name_en": "Vancomycin hydrochloride (JP18/USP)",
    "name_ja": "バンコマイシン",
    "names_alt": [
      "Vancoled (TN)",
      "Vancocin (TN)"
    ],
    "formula": "C66H75Cl2N9O24. HCl",
    "efficacy": "Antibacterial, Cell wall biosynthesis inhibitor\nDISEASE   Infections caused by methicillin-resistant staphylococci [DS:H00330]\nStaphylococcal infection [DS:H01175]\nEndocarditis caused by enterococci [DS:H00334]",
    "target": "peptidoglycan (D-Ala-D-Ala)\nPATHWAY   ko00550  Peptidoglycan biosynthesis",
    "metabolism": "",
    "therapeutic_category": "6113",
    "atc_code": "A07AA09",
    "drug_class": [
      "Antibacterial",
      "Glycopeptide antibiotic"
    ],
    "cyp_enzymes": [],
    "search_name": "Vancomycin hydrochloride"
  },
  {
    "kegg_id": "D09394",
    "name_en": "Fidaxomicin (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Dificid (TN)",
      "Dificlir (TN)"
    ],
    "formula": "C52H74Cl2O18",
    "efficacy": "Antibacterial, Protein biosynthesis inhibitor\nDISEASE   Clostridium difficile-associated diarrhea [DS:H00338]",
    "target": "Clostridioides difficile DNA-directed RNA polymerase [KO:K03043 K03046]",
    "metabolism": "",
    "therapeutic_category": "6119",
    "atc_code": "A07AA12",
    "drug_class": [
      "Antibacterial",
      "Macrolide antibiotic",
      "Metabolizing enzyme inhibitor",
      "CYP2C9 inhibitor",
      "CYP2C19 inhibitor",
      "CYP3A/CYP3A4 inhibitor",
      "CYP3A4 inhibitor",
      "Transporter inhibitor",
      "ABCB1 inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Fidaxomicin"
  },
  {
    "kegg_id": "D02195",
    "name_en": "Mupirocin calcium (USP)",
    "name_ja": "",
    "names_alt": [
      "Mupirocin calcium hydrate (JP18)",
      "Mupirocin calcium dihydrate",
      "Bactroban (TN)"
    ],
    "formula": "(C26H43O9)2. 2H2O. Ca",
    "efficacy": "Antibacterial, tRNA Ligase inhibitor\nDISEASE   MRSA infection [DS:H00330]",
    "target": "isoleucine tRNA ligase [KO:K01870]\nPATHWAY   ko00970(K01870)  Aminoacyl-tRNA biosynthesis",
    "metabolism": "",
    "therapeutic_category": "6119",
    "atc_code": "D06AX09",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Mupirocin calcium"
  },
  {
    "kegg_id": "D01523",
    "name_en": "Arbekacin sulfate (JP18)",
    "name_ja": "",
    "names_alt": [
      "Habekacin (TN)"
    ],
    "formula": "C22H44N6O10. H2SO4",
    "efficacy": "Antibacterial, Protein biosynthesis inhibitor",
    "target": "30S ribosomal subunit\nPATHWAY   ko03010(K01977)  Ribosome",
    "metabolism": "",
    "therapeutic_category": "6119",
    "atc_code": "J01GB12",
    "drug_class": [
      "Antibacterial",
      "Aminoglycoside antibiotic"
    ],
    "cyp_enzymes": [],
    "search_name": "Arbekacin sulfate"
  },
  {
    "kegg_id": "D02142",
    "name_en": "Teicoplanin (JP18/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Tagocid (TN)\nABBR      TEC"
    ],
    "formula": "C58H42Cl2N7O18(R1)(R2)(R3)",
    "efficacy": "Antibacterial, Cell wall biosynthesis inhibitor",
    "target": "peptidoglycan (D-Ala-D-Ala)",
    "metabolism": "",
    "therapeutic_category": "6119",
    "atc_code": "J01XA02",
    "drug_class": [
      "Antibacterial",
      "Glycopeptide antibiotic"
    ],
    "cyp_enzymes": [],
    "search_name": "Teicoplanin"
  },
  {
    "kegg_id": "D01080",
    "name_en": "Daptomycin (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Cubicin (TN)\nABBR      DAP"
    ],
    "formula": "C72H101N17O26",
    "efficacy": "Antibacterial, Cell membrane function inhibitor\nDISEASE   Infective endocarditis [DS:H00334]",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "6119",
    "atc_code": "J01XX09",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Daptomycin"
  },
  {
    "kegg_id": "D00240",
    "name_en": "Aztreonam (JP18/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Azactam (TN)"
    ],
    "formula": "C13H17N5O8S2",
    "efficacy": "Antibacterial, Cell wall biosynthesis inhibitor\nDISEASE   Urinary tract infections [DS:H01176]",
    "target": "penicillin binding protein\nPATHWAY   ko00550  Peptidoglycan biosynthesis",
    "metabolism": "",
    "therapeutic_category": "6122",
    "atc_code": "J01DF01",
    "drug_class": [
      "Antibacterial",
      "beta-Lactam antibiotic",
      "Monobactam",
      "Oxyimino beta-lactam"
    ],
    "cyp_enzymes": [],
    "search_name": "Aztreonam"
  },
  {
    "kegg_id": "D00866",
    "name_en": "Kanamycin sulfate (USP)",
    "name_ja": "",
    "names_alt": [
      "Kanamycin monosulfate (JP18)",
      "Kantrex (TN)"
    ],
    "formula": "C18H36N4O11. H2SO4",
    "efficacy": "Antibacterial, Protein biosynthesis inhibitor",
    "target": "30S ribosomal subunit\nPATHWAY   ko03010(K01977)  Ribosome",
    "metabolism": "",
    "therapeutic_category": "6123",
    "atc_code": "A07AA08",
    "drug_class": [
      "Antibacterial",
      "Aminoglycoside antibiotic",
      "Antitubercular"
    ],
    "cyp_enzymes": [],
    "search_name": "Kanamycin sulfate"
  },
  {
    "kegg_id": "D00865",
    "name_en": "Amikacin sulfate (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Amikin (TN)"
    ],
    "formula": "C22H43N5O13. 2H2SO4",
    "efficacy": "Antibacterial, Protein biosynthesis inhibitor",
    "target": "30S ribosomal subunit\nPATHWAY   ko03010(K01977)  Ribosome",
    "metabolism": "",
    "therapeutic_category": "6123",
    "atc_code": "D06AX12",
    "drug_class": [
      "Antibacterial",
      "Aminoglycoside antibiotic"
    ],
    "cyp_enzymes": [],
    "search_name": "Amikacin sulfate"
  },
  {
    "kegg_id": "D01826",
    "name_en": "Isepamicin sulfate (JP18)",
    "name_ja": "",
    "names_alt": [
      "Isepacin (TN)"
    ],
    "formula": "C22H43N5O12. xH2SO4",
    "efficacy": "Antibacterial, Protein biosynthesis inhibitor",
    "target": "30S ribosomal subunit\nPATHWAY   ko03010(K01977)  Ribosome",
    "metabolism": "",
    "therapeutic_category": "6123",
    "atc_code": "J01GB11",
    "drug_class": [
      "Antibacterial",
      "Aminoglycoside antibiotic"
    ],
    "cyp_enzymes": [],
    "search_name": "Isepamicin sulfate"
  },
  {
    "kegg_id": "D02049",
    "name_en": "Colistimethate sodium (USP)",
    "name_ja": "",
    "names_alt": [
      "Colistin sodium methanesulfonate (JP18)",
      "Coly-Mycin M (TN)",
      "Methacolimycin (TN)"
    ],
    "formula": "C49H88N16O27S5R. 5Na",
    "efficacy": "Antibacterial, Cell membrane function inhibitor",
    "target": "Lipopolysaccharide",
    "metabolism": "",
    "therapeutic_category": "6125",
    "atc_code": "A07AA10",
    "drug_class": [
      "Antibacterial",
      "Polypeptide antibiotic"
    ],
    "cyp_enzymes": [],
    "search_name": "Colistimethate sodium"
  },
  {
    "kegg_id": "D01079",
    "name_en": "Tigecycline (JAN/USP)",
    "name_ja": "",
    "names_alt": [
      "Tygacil (TN)\nABBR      TGC"
    ],
    "formula": "C29H39N5O8",
    "efficacy": "Antibacterial, Protein biosynthesis inhibitor",
    "target": "30S ribosomal subunit\nPATHWAY   ko03010(K01977)  Ribosome",
    "metabolism": "",
    "therapeutic_category": "6129",
    "atc_code": "J01AA12",
    "drug_class": [
      "Antibacterial",
      "Tetracycline antibiotic"
    ],
    "cyp_enzymes": [],
    "search_name": "Tigecycline"
  },
  {
    "kegg_id": "D11621",
    "name_en": "Imipenem, cilastatin and relebactam",
    "name_ja": "",
    "names_alt": [
      "Relebactam hydrate, imipenem hydrate and cilastatin sodium",
      "Recarbrio (TN)"
    ],
    "formula": "",
    "efficacy": "Antibacterial\nDISEASE   Uncomplicated urinary tract infection [DS:H01176]",
    "target": "penicillin binding protein\nbeta-lactamases",
    "metabolism": "",
    "therapeutic_category": "6129",
    "atc_code": "J01DH56",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Imipenem, cilastatin and relebactam"
  },
  {
    "kegg_id": "D11013",
    "name_en": "Cefiderocol sulfate tosylate (USAN)",
    "name_ja": "",
    "names_alt": [
      "Cefiderocol tosilate sulfate hydrate (JAN)",
      "Cefiderocol sulfate tosilate",
      "Fetroja (TN)",
      "Fetcroja (TN)"
    ],
    "formula": "(C30H34ClN7O10S2)3. (C7H8O3S)4. H2SO4. xH2O",
    "efficacy": "Antibacterial, Cell wall biosynthesis inhibitor",
    "target": "penicillin binding protein",
    "metabolism": "",
    "therapeutic_category": "6129",
    "atc_code": "J01DI04",
    "drug_class": [
      "Antibacterial",
      "beta-Lactam antibiotic",
      "Cephalosporin skeleton group",
      "Cephem"
    ],
    "cyp_enzymes": [],
    "search_name": "Cefiderocol sulfate tosylate"
  },
  {
    "kegg_id": "D00869",
    "name_en": "Spectinomycin hydrochloride (USP)",
    "name_ja": "",
    "names_alt": [
      "Spectinomycin hydrochloride hydrate (JP18)",
      "Trobicin (TN)"
    ],
    "formula": "C14H24N2O7. 2HCl. 5H2O",
    "efficacy": "Antibacterial, Protein biosynthesis inhibitor",
    "target": "30S ribosomal subunit\nPATHWAY   ko03010(K01977)  Ribosome",
    "metabolism": "",
    "therapeutic_category": "6129",
    "atc_code": "J01XX04",
    "drug_class": [
      "Antibacterial",
      "Aminoglycoside antibiotic"
    ],
    "cyp_enzymes": [],
    "search_name": "Spectinomycin hydrochloride"
  },
  {
    "kegg_id": "D01251",
    "name_en": "Ampicillin hydrate (JP18)",
    "name_ja": "アンピシリン",
    "names_alt": [
      "Ampicillin trihydrate",
      "Amcill (TN)"
    ],
    "formula": "C16H19N3O4S. 3H2O",
    "efficacy": "Antibacterial, Cell wall biosynthesis inhibitor\nDISEASE   Gonorrhea [DS:H00315]",
    "target": "penicillin binding protein\nPATHWAY   ko00550  Peptidoglycan biosynthesis",
    "metabolism": "",
    "therapeutic_category": "6131",
    "atc_code": "J01CA01",
    "drug_class": [
      "Antibacterial",
      "beta-Lactam antibiotic",
      "Penicillin skeleton group",
      "Penicillin",
      "Extended spectrum penicillin"
    ],
    "cyp_enzymes": [],
    "search_name": "Ampicillin hydrate"
  },
  {
    "kegg_id": "D02119",
    "name_en": "Ampicillin sodium (JP18/USP)",
    "name_ja": "アンピシリン",
    "names_alt": [
      "Omnipen-N (TN)",
      "Viccillin (TN)"
    ],
    "formula": "C16H18N3O4S. Na",
    "efficacy": "Antibacterial, Cell wall biosynthesis inhibitor\nDISEASE   Bacterial endocarditis [DS:H00334]",
    "target": "penicillin binding protein\nPATHWAY   ko00550  Peptidoglycan biosynthesis",
    "metabolism": "",
    "therapeutic_category": "6131",
    "atc_code": "J01CA01",
    "drug_class": [
      "Antibacterial",
      "beta-Lactam antibiotic",
      "Penicillin skeleton group",
      "Penicillin",
      "Extended spectrum penicillin"
    ],
    "cyp_enzymes": [],
    "search_name": "Ampicillin sodium"
  },
  {
    "kegg_id": "D00229",
    "name_en": "Amoxicillin (USP)",
    "name_ja": "アモキシシリン",
    "names_alt": [
      "Amoxicillin hydrate (JP18)",
      "Amoxicilline (INN)",
      "Amoxicillin trihydrate",
      "Amoxil (TN)",
      "Dispermox (TN)",
      "Pasetocin (TN)"
    ],
    "formula": "C16H19N3O5S. 3H2O",
    "efficacy": "Antibacterial, Cell wall biosynthesis inhibitor\nDISEASE   Gonorrhea [DS:H00315]\nHelicobacter pylori infection [DS:H00320]",
    "target": "penicillin binding protein\nPATHWAY   ko00550  Peptidoglycan biosynthesis",
    "metabolism": "",
    "therapeutic_category": "6131",
    "atc_code": "J01CA04",
    "drug_class": [
      "Antibacterial",
      "beta-Lactam antibiotic",
      "Penicillin skeleton group",
      "Penicillin",
      "Extended spectrum penicillin"
    ],
    "cyp_enzymes": [],
    "search_name": "Amoxicillin"
  },
  {
    "kegg_id": "D00927",
    "name_en": "Bacampicillin hydrochloride (JP18/USAN)",
    "name_ja": "",
    "names_alt": [
      "Spectrobid (TN)"
    ],
    "formula": "C21H27N3O7S. HCl",
    "efficacy": "Antibacterial, Cell wall biosynthesis inhibitor",
    "target": "penicillin binding protein\nPATHWAY   ko00550  Peptidoglycan biosynthesis",
    "metabolism": "",
    "therapeutic_category": "6131",
    "atc_code": "J01CA06",
    "drug_class": [
      "Antibacterial",
      "beta-Lactam antibiotic",
      "Penicillin skeleton group",
      "Penicillin",
      "Extended spectrum penicillin"
    ],
    "cyp_enzymes": [],
    "search_name": "Bacampicillin hydrochloride"
  },
  {
    "kegg_id": "D00466",
    "name_en": "Piperacillin sodium (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Pentcillin (TN)",
      "Pipracil (TN)"
    ],
    "formula": "C23H26N5O7S. Na",
    "efficacy": "Antibacterial, Cell wall biosynthesis inhibitor",
    "target": "penicillin binding protein\nPATHWAY   ko00550  Peptidoglycan biosynthesis",
    "metabolism": "",
    "therapeutic_category": "6131",
    "atc_code": "J01CA12",
    "drug_class": [
      "Antibacterial",
      "beta-Lactam antibiotic",
      "Penicillin skeleton group",
      "Penicillin",
      "Extended spectrum penicillin"
    ],
    "cyp_enzymes": [],
    "search_name": "Piperacillin sodium"
  },
  {
    "kegg_id": "D01668",
    "name_en": "Sultamicillin tosilate hydrate (JP18)",
    "name_ja": "",
    "names_alt": [
      "Sultamicillin tosylate dihydrate",
      "Unasyn (TN)"
    ],
    "formula": "C25H30N4O9S2. C7H8O3S. 2H2O",
    "efficacy": "Antibacterial, Cell wall biosynthesis inhibitor, beta-Lactamase inhibitor",
    "target": "penicillin binding protein\nbeta-lactamases\nPATHWAY   ko00550  Peptidoglycan biosynthesis",
    "metabolism": "",
    "therapeutic_category": "6131",
    "atc_code": "J01CR04",
    "drug_class": [
      "Antibacterial",
      "beta-Lactam antibiotic",
      "Penicillin skeleton group",
      "Penicillin",
      "beta-Lactamase inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Sultamicillin tosilate hydrate"
  },
  {
    "kegg_id": "D00263",
    "name_en": "Cefalexin (JP18)",
    "name_ja": "",
    "names_alt": [
      "Cephalexin",
      "Keflex (TN)"
    ],
    "formula": "C16H17N3O4S",
    "efficacy": "Antibacterial, Cell wall biosynthesis inhibitor",
    "target": "penicillin binding protein\nPATHWAY   ko00550  Peptidoglycan biosynthesis",
    "metabolism": "",
    "therapeutic_category": "6132",
    "atc_code": "J01DB01",
    "drug_class": [
      "Antibacterial",
      "beta-Lactam antibiotic",
      "Cephalosporin skeleton group",
      "Cephem",
      "First-generation cephalosporin"
    ],
    "cyp_enzymes": [],
    "search_name": "Cefalexin"
  },
  {
    "kegg_id": "D00907",
    "name_en": "Cephalothin sodium (USP)",
    "name_ja": "",
    "names_alt": [
      "Cefalotin sodium (JP18)",
      "Keflin (TN)"
    ],
    "formula": "C16H15N2O6S2. Na",
    "efficacy": "Antibacterial, Cell wall biosynthesis inhibitor",
    "target": "penicillin binding protein\nPATHWAY   ko00550  Peptidoglycan biosynthesis",
    "metabolism": "",
    "therapeutic_category": "6132",
    "atc_code": "J01DB03",
    "drug_class": [
      "Antibacterial",
      "beta-Lactam antibiotic",
      "Cephalosporin skeleton group",
      "Cephem",
      "First-generation cephalosporin"
    ],
    "cyp_enzymes": [],
    "search_name": "Cephalothin sodium"
  },
  {
    "kegg_id": "D00905",
    "name_en": "Cefazolin sodium (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Ancef (TN)"
    ],
    "formula": "C14H13N8O4S3. Na",
    "efficacy": "Antibacterial, Cell wall biosynthesis inhibitor\nDISEASE   Bacterial endocarditis [DS:H00334]",
    "target": "penicillin binding protein\nPATHWAY   ko00550  Peptidoglycan biosynthesis",
    "metabolism": "",
    "therapeutic_category": "6132",
    "atc_code": "J01DB04",
    "drug_class": [
      "Antibacterial",
      "beta-Lactam antibiotic",
      "Cephalosporin skeleton group",
      "Cephem",
      "First-generation cephalosporin"
    ],
    "cyp_enzymes": [],
    "search_name": "Cefazolin sodium"
  },
  {
    "kegg_id": "D02226",
    "name_en": "Cefazolin sodium hydrate (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "C14H13N8O4S3. 5H2O. Na",
    "efficacy": "Antibacterial, Cell wall biosynthesis inhibitor",
    "target": "penicillin binding protein\nPATHWAY   ko00550  Peptidoglycan biosynthesis",
    "metabolism": "",
    "therapeutic_category": "6132",
    "atc_code": "J01DB04",
    "drug_class": [
      "Antibacterial",
      "beta-Lactam antibiotic",
      "Cephalosporin skeleton group",
      "Cephem",
      "First-generation cephalosporin"
    ],
    "cyp_enzymes": [],
    "search_name": "Cefazolin sodium hydrate"
  },
  {
    "kegg_id": "D05026",
    "name_en": "Cefroxadine hydrate (JP18)",
    "name_ja": "",
    "names_alt": [
      "Oraspor (TN)"
    ],
    "formula": "C16H19N3O5S. 2H2O",
    "efficacy": "Antibacterial, Cell wall biosynthesis inhibitor",
    "target": "penicillin binding protein\nPATHWAY   ko00550  Peptidoglycan biosynthesis",
    "metabolism": "",
    "therapeutic_category": "6132",
    "atc_code": "J01DB11",
    "drug_class": [
      "Antibacterial",
      "beta-Lactam antibiotic",
      "Cephalosporin skeleton group",
      "Cephem",
      "First-generation cephalosporin"
    ],
    "cyp_enzymes": [],
    "search_name": "Cefroxadine hydrate"
  },
  {
    "kegg_id": "D00914",
    "name_en": "Cefuroxime axetil (JP18/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Ceftin (TN)"
    ],
    "formula": "C20H22N4O10S",
    "efficacy": "Antibacterial, Cell wall biosynthesis inhibitor\nDISEASE   Uncomplicated urinary tract infections [DS:H01176]\nGonorrhea [DS:H00315]\nLyme disease [DS:H00353]",
    "target": "penicillin binding protein\nPATHWAY   ko00550  Peptidoglycan biosynthesis",
    "metabolism": "",
    "therapeutic_category": "6132",
    "atc_code": "J01DC02",
    "drug_class": [
      "Antibacterial",
      "beta-Lactam antibiotic",
      "Cephalosporin skeleton group",
      "Cephem",
      "Second-generation cephalosporin",
      "Oxyimino beta-lactam"
    ],
    "cyp_enzymes": [],
    "search_name": "Cefuroxime axetil"
  },
  {
    "kegg_id": "D00256",
    "name_en": "Cefaclor (JP18)",
    "name_ja": "",
    "names_alt": [
      "Cefaclor anhydrous",
      "Alenfral (TN)"
    ],
    "formula": "C15H14ClN3O4S",
    "efficacy": "Antibacterial, Cell wall biosynthesis inhibitor",
    "target": "penicillin binding protein\nPATHWAY   ko00550  Peptidoglycan biosynthesis",
    "metabolism": "",
    "therapeutic_category": "6132",
    "atc_code": "J01DC04",
    "drug_class": [
      "Antibacterial",
      "beta-Lactam antibiotic",
      "Cephalosporin skeleton group",
      "Cephem",
      "Second-generation cephalosporin"
    ],
    "cyp_enzymes": [],
    "search_name": "Cefaclor"
  },
  {
    "kegg_id": "D01819",
    "name_en": "Cefotiam hydrochloride (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Ceradon (TN)",
      "Pansporin (TN)"
    ],
    "formula": "C18H23N9O4S3. 2HCl",
    "efficacy": "Antibacterial, Cell wall biosynthesis inhibitor",
    "target": "penicillin binding protein\nPATHWAY   ko00550  Peptidoglycan biosynthesis",
    "metabolism": "",
    "therapeutic_category": "6132",
    "atc_code": "J01DC07",
    "drug_class": [
      "Antibacterial",
      "beta-Lactam antibiotic",
      "Cephalosporin skeleton group",
      "Cephem",
      "Second-generation cephalosporin"
    ],
    "cyp_enzymes": [],
    "search_name": "Cefotiam hydrochloride"
  },
  {
    "kegg_id": "D00911",
    "name_en": "Cefmetazole sodium (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Zefazone (TN)"
    ],
    "formula": "C15H16N7O5S3. Na",
    "efficacy": "Antibacterial, Cell wall biosynthesis inhibitor",
    "target": "penicillin binding protein\nPATHWAY   ko00550  Peptidoglycan biosynthesis",
    "metabolism": "",
    "therapeutic_category": "6132",
    "atc_code": "J01DC09",
    "drug_class": [
      "Antibacterial",
      "beta-Lactam antibiotic",
      "Cephalosporin skeleton group",
      "Cephem",
      "Second-generation cephalosporin"
    ],
    "cyp_enzymes": [],
    "search_name": "Cefmetazole sodium"
  },
  {
    "kegg_id": "D01909",
    "name_en": "Cefminox sodium hydrate (JP18)",
    "name_ja": "",
    "names_alt": [
      "Meicelin (TN)"
    ],
    "formula": "C16H20N7O7S3. 7H2O. Na",
    "efficacy": "Antibacterial, Cell wall biosynthesis inhibitor",
    "target": "penicillin binding protein\nPATHWAY   ko00550  Peptidoglycan biosynthesis",
    "metabolism": "",
    "therapeutic_category": "6132",
    "atc_code": "J01DC12",
    "drug_class": [
      "Antibacterial",
      "beta-Lactam antibiotic",
      "Cephalosporin skeleton group",
      "Cephem",
      "Second-generation cephalosporin"
    ],
    "cyp_enzymes": [],
    "search_name": "Cefminox sodium hydrate"
  },
  {
    "kegg_id": "D00919",
    "name_en": "Cefotaxime sodium (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Claforan (TN)"
    ],
    "formula": "C16H16N5O7S2. Na",
    "efficacy": "Antibacterial, Cell wall biosynthesis inhibitor",
    "target": "penicillin binding protein\nPATHWAY   ko00550  Peptidoglycan biosynthesis",
    "metabolism": "",
    "therapeutic_category": "6132",
    "atc_code": "J01DD01",
    "drug_class": [
      "Antibacterial",
      "beta-Lactam antibiotic",
      "Cephalosporin skeleton group",
      "Cephem",
      "Third-generation cephalosporin",
      "Oxyimino beta-lactam"
    ],
    "cyp_enzymes": [],
    "search_name": "Cefotaxime sodium"
  },
  {
    "kegg_id": "D00921",
    "name_en": "Ceftazidime (USP)",
    "name_ja": "",
    "names_alt": [
      "Ceftazidime hydrate (JP18)",
      "Ceftazidime pentahydrate",
      "Fortaz (TN)",
      "Tazicef (TN)"
    ],
    "formula": "C22H22N6O7S2. 5H2O",
    "efficacy": "Antibacterial, Cell wall biosynthesis inhibitor",
    "target": "penicillin binding protein\nPATHWAY   ko00550  Peptidoglycan biosynthesis",
    "metabolism": "",
    "therapeutic_category": "6132",
    "atc_code": "J01DD02",
    "drug_class": [
      "Antibacterial",
      "beta-Lactam antibiotic",
      "Cephalosporin skeleton group",
      "Cephem",
      "Third-generation cephalosporin",
      "Oxyimino beta-lactam"
    ],
    "cyp_enzymes": [],
    "search_name": "Ceftazidime"
  },
  {
    "kegg_id": "D00924",
    "name_en": "Ceftriaxone sodium (USP)",
    "name_ja": "",
    "names_alt": [
      "Ceftriaxone sodium hydrate (JP18)",
      "Rocephin (TN)"
    ],
    "formula": "(C18H16N8O7S3. 2Na)2. 7H2O",
    "efficacy": "Antibacterial, Cell wall biosynthesis inhibitor\nDISEASE   Uncomplicated urinary tract infections [DS:H01176]",
    "target": "penicillin binding protein\nPATHWAY   ko00550  Peptidoglycan biosynthesis",
    "metabolism": "",
    "therapeutic_category": "6132",
    "atc_code": "J01DD04",
    "drug_class": [
      "Antibacterial",
      "beta-Lactam antibiotic",
      "Cephalosporin skeleton group",
      "Cephem",
      "Third-generation cephalosporin",
      "Oxyimino beta-lactam"
    ],
    "cyp_enzymes": [],
    "search_name": "Ceftriaxone sodium"
  },
  {
    "kegg_id": "D00923",
    "name_en": "Ceftizoxime sodium (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Cefizox (TN)",
      "Epocelin (TN)"
    ],
    "formula": "C13H12N5O5S2. Na",
    "efficacy": "Antibacterial, Cell wall biosynthesis inhibitor",
    "target": "penicillin binding protein\nPATHWAY   ko00550  Peptidoglycan biosynthesis",
    "metabolism": "Transporter: SLC22A8 [HSA:9376]",
    "therapeutic_category": "6132",
    "atc_code": "J01DD07",
    "drug_class": [
      "Antibacterial",
      "beta-Lactam antibiotic",
      "Cephalosporin skeleton group",
      "Cephem",
      "Third-generation cephalosporin",
      "Oxyimino beta-lactam",
      "Transporter substrate",
      "SLC22A8 substrate"
    ],
    "cyp_enzymes": [],
    "search_name": "Ceftizoxime sodium"
  },
  {
    "kegg_id": "D07640",
    "name_en": "Cefixime (USP)",
    "name_ja": "",
    "names_alt": [
      "Cefixime hydrate (JP18)",
      "Cefixime trihydrate",
      "Oroken (TN)",
      "Suprax (TN)"
    ],
    "formula": "C16H15N5O7S2. 3H2O",
    "efficacy": "Antibacterial, Cell wall biosynthesis inhibitor\nDISEASE   Uncomplicated urinary tract infection [DS:H01176]\nUncomplicated gonorrhea [DS:H00315]",
    "target": "penicillin binding protein\nPATHWAY   ko00550  Peptidoglycan biosynthesis",
    "metabolism": "",
    "therapeutic_category": "6132",
    "atc_code": "J01DD08",
    "drug_class": [
      "Antibacterial",
      "beta-Lactam antibiotic",
      "Cephalosporin skeleton group",
      "Cephem",
      "Third-generation cephalosporin",
      "Oxyimino beta-lactam"
    ],
    "cyp_enzymes": [],
    "search_name": "Cefixime"
  },
  {
    "kegg_id": "D00920",
    "name_en": "Cefpodoxime proxetil (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Vantin (TN)"
    ],
    "formula": "C21H27N5O9S2",
    "efficacy": "Antibacterial, Cell wall biosynthesis inhibitor",
    "target": "penicillin binding protein\nPATHWAY   ko00550  Peptidoglycan biosynthesis",
    "metabolism": "",
    "therapeutic_category": "6132",
    "atc_code": "J01DD13",
    "drug_class": [
      "Antibacterial",
      "beta-Lactam antibiotic",
      "Cephalosporin skeleton group",
      "Cephem",
      "Third-generation cephalosporin",
      "Oxyimino beta-lactam"
    ],
    "cyp_enzymes": [],
    "search_name": "Cefpodoxime proxetil"
  },
  {
    "kegg_id": "D00917",
    "name_en": "Cefdinir (JP18/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Cefzon (TN)",
      "Omnicef (TN)"
    ],
    "formula": "C14H13N5O5S2",
    "efficacy": "Antibacterial, Cell wall biosynthesis inhibitor",
    "target": "penicillin binding protein\nPATHWAY   ko00550  Peptidoglycan biosynthesis",
    "metabolism": "",
    "therapeutic_category": "6132",
    "atc_code": "J01DD15",
    "drug_class": [
      "Antibacterial",
      "beta-Lactam antibiotic",
      "Cephalosporin skeleton group",
      "Cephem",
      "Third-generation cephalosporin",
      "Oxyimino beta-lactam"
    ],
    "cyp_enzymes": [],
    "search_name": "Cefdinir"
  },
  {
    "kegg_id": "D01628",
    "name_en": "Cefditoren pivoxil (JP18/USAN)",
    "name_ja": "",
    "names_alt": [
      "Meiact (TN)",
      "Spectracef (TN)"
    ],
    "formula": "C25H28N6O7S3",
    "efficacy": "Antibacterial, Cell wall biosynthesis inhibitor\nDISEASE   Pharyngitis/tonsillitis [DS:H01424]",
    "target": "penicillin binding protein\nPATHWAY   ko00550  Peptidoglycan biosynthesis",
    "metabolism": "",
    "therapeutic_category": "6132",
    "atc_code": "J01DD16",
    "drug_class": [
      "Antibacterial",
      "beta-Lactam antibiotic",
      "Cephalosporin skeleton group",
      "Cephem",
      "Third-generation cephalosporin",
      "Oxyimino beta-lactam"
    ],
    "cyp_enzymes": [],
    "search_name": "Cefditoren pivoxil"
  },
  {
    "kegg_id": "D01680",
    "name_en": "Cefcapene pivoxil hydrochloride hydrate (JP18)",
    "name_ja": "",
    "names_alt": [
      "S 1108",
      "Flomox (TN)"
    ],
    "formula": "C23H29N5O8S2. HCl. H2O",
    "efficacy": "Antibacterial, Cell wall biosynthesis inhibitor",
    "target": "penicillin binding protein\nPATHWAY   ko00550  Peptidoglycan biosynthesis",
    "metabolism": "",
    "therapeutic_category": "6132",
    "atc_code": "J01DD17",
    "drug_class": [
      "Antibacterial",
      "beta-Lactam antibiotic",
      "Cephalosporin skeleton group",
      "Cephem",
      "Third-generation cephalosporin"
    ],
    "cyp_enzymes": [],
    "search_name": "Cefcapene pivoxil hydrochloride hydrate"
  },
  {
    "kegg_id": "D01686",
    "name_en": "Cefteram pivoxil (JP18)",
    "name_ja": "",
    "names_alt": [
      "T 2588",
      "Tomiron (TN)"
    ],
    "formula": "C22H27N9O7S2",
    "efficacy": "Antibacterial, Cell wall biosynthesis inhibitor",
    "target": "penicillin binding protein\nPATHWAY   ko00550  Peptidoglycan biosynthesis",
    "metabolism": "",
    "therapeutic_category": "6132",
    "atc_code": "J01DD18",
    "drug_class": [
      "Antibacterial",
      "beta-Lactam antibiotic",
      "Cephalosporin skeleton group",
      "Cephem",
      "Oxyimino beta-lactam"
    ],
    "cyp_enzymes": [],
    "search_name": "Cefteram pivoxil"
  },
  {
    "kegg_id": "D01157",
    "name_en": "Cefepime hydrochloride (USP)",
    "name_ja": "",
    "names_alt": [
      "Cefepime dihydrochloride hydrate (JP18)",
      "Maxipime (TN)"
    ],
    "formula": "C19H25N6O5S2. HCl. Cl. H2O",
    "efficacy": "Antibacterial, Cell wall biosynthesis inhibitor\nDISEASE   Uncomplicated and complicated urinary tract infections [DS:H01176]",
    "target": "penicillin binding protein\nPATHWAY   ko00550  Peptidoglycan biosynthesis",
    "metabolism": "",
    "therapeutic_category": "6132",
    "atc_code": "J01DE01",
    "drug_class": [
      "Antibacterial",
      "beta-Lactam antibiotic",
      "Cephalosporin skeleton group",
      "Cephem",
      "Fourth-generation cephalosporin",
      "Oxyimino beta-lactam"
    ],
    "cyp_enzymes": [],
    "search_name": "Cefepime hydrochloride"
  },
  {
    "kegg_id": "D02233",
    "name_en": "Cefozopran hydrochloride (JP18)",
    "name_ja": "",
    "names_alt": [
      "Firstcin (TN)"
    ],
    "formula": "C19H18N9O5S2. Cl",
    "efficacy": "Antibacterial, Cell wall biosynthesis inhibitor",
    "target": "penicillin binding protein\nPATHWAY   ko00550  Peptidoglycan biosynthesis",
    "metabolism": "",
    "therapeutic_category": "6132",
    "atc_code": "J01DE03",
    "drug_class": [
      "Antibacterial",
      "beta-Lactam antibiotic",
      "Cephalosporin skeleton group",
      "Cephem",
      "Fourth-generation cephalosporin",
      "Oxyimino beta-lactam"
    ],
    "cyp_enzymes": [],
    "search_name": "Cefozopran hydrochloride"
  },
  {
    "kegg_id": "D01473",
    "name_en": "Flomoxef sodium (JP18)",
    "name_ja": "",
    "names_alt": [
      "S 6315",
      "Flumarin (TN)"
    ],
    "formula": "C16H18F2N5O7S2. Na",
    "efficacy": "Antibacterial, Cell wall biosynthesis inhibitor",
    "target": "penicillin binding protein\nPATHWAY   ko00550  Peptidoglycan biosynthesis",
    "metabolism": "",
    "therapeutic_category": "6133",
    "atc_code": "J01DC14",
    "drug_class": [
      "Antibacterial",
      "beta-Lactam antibiotic",
      "Cephalosporin skeleton group",
      "Oxacephem",
      "Second-generation cephalosporin"
    ],
    "cyp_enzymes": [],
    "search_name": "Flomoxef sodium"
  },
  {
    "kegg_id": "D02198",
    "name_en": "Moxalactam disodium (USAN)",
    "name_ja": "",
    "names_alt": [
      "Latamoxef sodium (JP18)",
      "Moxam (TN)",
      "Shiomarin (TN)"
    ],
    "formula": "C20H18N6O9S. 2Na",
    "efficacy": "Antibacterial, Cell wall biosynthesis inhibitor",
    "target": "penicillin binding protein\nPATHWAY   ko00550  Peptidoglycan biosynthesis",
    "metabolism": "",
    "therapeutic_category": "6133",
    "atc_code": "J01DD06",
    "drug_class": [
      "Antibacterial",
      "beta-Lactam antibiotic",
      "Cephalosporin skeleton group",
      "Oxacephem",
      "Third-generation cephalosporin"
    ],
    "cyp_enzymes": [],
    "search_name": "Moxalactam disodium"
  },
  {
    "kegg_id": "D02187",
    "name_en": "Fosfomycin calcium hydrate (JP18)",
    "name_ja": "",
    "names_alt": [
      "Fosmicin (TN)"
    ],
    "formula": "C3H5O4P. Ca. H2O",
    "efficacy": "Antibacterial, Cell wall biosynthesis inhibitor",
    "target": "UDP-N-acetylglucosamine 1-carboxyvinyltransferase [KO:K00790]\nPATHWAY   ko00550(K00790)  Peptidoglycan biosynthesis",
    "metabolism": "",
    "therapeutic_category": "6135",
    "atc_code": "J01XX01",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Fosfomycin calcium hydrate"
  },
  {
    "kegg_id": "D02065",
    "name_en": "Ampicillin sodium and sulbactam sodium (JP18)",
    "name_ja": "アンピシリン",
    "names_alt": [
      "Unasyn-S (TN)\nABBR      SAM"
    ],
    "formula": "",
    "efficacy": "Antibacterial",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "6139",
    "atc_code": "J01CA51",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Ampicillin sodium and sulbactam sodium"
  },
  {
    "kegg_id": "D06485",
    "name_en": "Amoxicillin hydrate and potassium clavulanate",
    "name_ja": "アモキシシリン",
    "names_alt": [
      "Augmentin (TN)\nABBR      AMC"
    ],
    "formula": "",
    "efficacy": "Antibacterial",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "6139",
    "atc_code": "J01CR02",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Amoxicillin hydrate and potassium clavulanate"
  },
  {
    "kegg_id": "D02505",
    "name_en": "Tazobactam and piperacillin (JP18)",
    "name_ja": "",
    "names_alt": [
      "Piperacillin sodium and tazobactam",
      "Tazocin (TN)",
      "Zosyn (TN)\nABBR      TZP"
    ],
    "formula": "C23H26N5O7S. C10H12N4O5S. Na",
    "efficacy": "Antibacterial",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "6139",
    "atc_code": "J01CR05",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Tazobactam and piperacillin"
  },
  {
    "kegg_id": "D10779",
    "name_en": "Ceftazidime and avibactam",
    "name_ja": "",
    "names_alt": [
      "Avycaz (TN)",
      "Zavicefta (TN)\nABBR      CZA"
    ],
    "formula": "",
    "efficacy": "Antibacterial",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "6139",
    "atc_code": "J01DD52",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Ceftazidime and avibactam"
  },
  {
    "kegg_id": "D08772",
    "name_en": "Cefoperazone sodium and sulbactam sodium (JP18)",
    "name_ja": "",
    "names_alt": [
      "Sulperazon (TN)"
    ],
    "formula": "",
    "efficacy": "Antibacterial",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "6139",
    "atc_code": "J01DD62",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Cefoperazone sodium and sulbactam sodium"
  },
  {
    "kegg_id": "D02222",
    "name_en": "Meropenem (USP)",
    "name_ja": "メロペネム",
    "names_alt": [
      "Meropenem hydrate (JP18)",
      "Meropenem trihydrate",
      "Merrem (TN)"
    ],
    "formula": "C17H25N3O5S. 3H2O",
    "efficacy": "Antibacterial, Cell wall biosynthesis inhibitor",
    "target": "penicillin binding protein\nPATHWAY   ko00550  Peptidoglycan biosynthesis",
    "metabolism": "",
    "therapeutic_category": "6139",
    "atc_code": "J01DH02",
    "drug_class": [
      "Antibacterial",
      "beta-Lactam antibiotic",
      "Penicillin skeleton group",
      "Carbapenem"
    ],
    "cyp_enzymes": [],
    "search_name": "Meropenem"
  },
  {
    "kegg_id": "D01836",
    "name_en": "Doripenem hydrate (JP18)",
    "name_ja": "",
    "names_alt": [
      "doripenem monohydrate",
      "Doribax (TN)"
    ],
    "formula": "C15H24N4O6S2. H2O",
    "efficacy": "Antibacterial, Cell wall biosynthesis inhibitor",
    "target": "penicillin binding protein\nPATHWAY   ko00550  Peptidoglycan biosynthesis",
    "metabolism": "",
    "therapeutic_category": "6139",
    "atc_code": "J01DH04",
    "drug_class": [
      "Antibacterial",
      "beta-Lactam antibiotic",
      "Penicillin skeleton group",
      "Carbapenem"
    ],
    "cyp_enzymes": [],
    "search_name": "Doripenem hydrate"
  },
  {
    "kegg_id": "D01057",
    "name_en": "Biapenem (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Omegacin (TN)"
    ],
    "formula": "C15H18N4O4S",
    "efficacy": "Antibacterial, Cell wall biosynthesis inhibitor",
    "target": "penicillin binding protein\nPATHWAY   ko00550  Peptidoglycan biosynthesis",
    "metabolism": "",
    "therapeutic_category": "6139",
    "atc_code": "J01DH05",
    "drug_class": [
      "Antibacterial",
      "beta-Lactam antibiotic",
      "Penicillin skeleton group",
      "Carbapenem"
    ],
    "cyp_enzymes": [],
    "search_name": "Biapenem"
  },
  {
    "kegg_id": "D09598",
    "name_en": "Tebipenem pivoxil (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Orapenem (TN)"
    ],
    "formula": "C22H31N3O6S2",
    "efficacy": "Antibacterial, Cell wall biosynthesis inhibitor",
    "target": "penicillin binding protein",
    "metabolism": "",
    "therapeutic_category": "6139",
    "atc_code": "J01DH06",
    "drug_class": [
      "Antibacterial",
      "beta-Lactam antibiotic",
      "Penicillin skeleton group",
      "Carbapenem"
    ],
    "cyp_enzymes": [],
    "search_name": "Tebipenem pivoxil"
  },
  {
    "kegg_id": "D00344",
    "name_en": "Imipenem and cilastatin sodium (JP18)",
    "name_ja": "",
    "names_alt": [
      "Primaxin (TN)"
    ],
    "formula": "",
    "efficacy": "Antibacterial\nDISEASE   Bacterial endocarditis [DS:H00334]",
    "target": "penicillin binding protein",
    "metabolism": "",
    "therapeutic_category": "6139",
    "atc_code": "J01DH51",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Imipenem and cilastatin sodium"
  },
  {
    "kegg_id": "D02509",
    "name_en": "Panipenem and betamipron (JP18)",
    "name_ja": "",
    "names_alt": [
      "Carbenin (TN)"
    ],
    "formula": "C15H21N3O4S. C10H11NO3",
    "efficacy": "Antibacterial",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "6139",
    "atc_code": "J01DH55",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Panipenem and betamipron"
  },
  {
    "kegg_id": "D01839",
    "name_en": "Faropenem sodium hydrate (JP18)",
    "name_ja": "",
    "names_alt": [
      "Farom (TN)"
    ],
    "formula": "(C12H14NO5S. Na)2. 5H2O",
    "efficacy": "Antibacterial, Cell wall biosynthesis inhibitor",
    "target": "penicillin binding protein\nPATHWAY   ko00550  Peptidoglycan biosynthesis",
    "metabolism": "",
    "therapeutic_category": "6139",
    "atc_code": "J01DI03",
    "drug_class": [
      "Antibacterial",
      "beta-Lactam antibiotic",
      "Penicillin skeleton group",
      "Penem"
    ],
    "cyp_enzymes": [],
    "search_name": "Faropenem sodium hydrate"
  },
  {
    "kegg_id": "D10577",
    "name_en": "Ceftolozane sulfate and tazobactam sodium",
    "name_ja": "",
    "names_alt": [
      "Zerbaxa (TN)\nABBR      C/T"
    ],
    "formula": "",
    "efficacy": "Antibacterial",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "6139",
    "atc_code": "J01DI54",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Ceftolozane sulfate and tazobactam sodium"
  },
  {
    "kegg_id": "D00140",
    "name_en": "Erythromycin (JP18/USP/INN)",
    "name_ja": "エリスロマイシン",
    "names_alt": [
      "Akne-mycin (TN)",
      "Eryc (TN)",
      "Erygel (TN)",
      "Pce (TN)",
      "Staticin (TN)",
      "T-stat (TN)"
    ],
    "formula": "C37H67NO13",
    "efficacy": "Antibacterial, Protein biosynthesis inhibitor\nDISEASE   Acne vulgaris [DS:H01445]\nListeriosis [DS:H00332]\nPertussis [DS:H00319]\nDiphtheria [DS:H00343]\nAmebiasis [DS:H00360]\nSyphilis [DS:H00354]\nLegionnaires' disease [DS:H00311]",
    "target": "50S ribosomal subunit\nPATHWAY   ko03010(K01980)  Ribosome",
    "metabolism": "Enzyme: CYP3A [HSA:1576 1577 1551]",
    "therapeutic_category": "6141",
    "atc_code": "D10AF02",
    "drug_class": [
      "Antibacterial",
      "Macrolide antibiotic",
      "14-membered ring macrolide antibiotic",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "Metabolizing enzyme inhibitor",
      "CYP3A/CYP3A4 inhibitor",
      "Transporter inhibitor",
      "ABCB1 inhibitor"
    ],
    "cyp_enzymes": [
      "CYP3A"
    ],
    "search_name": "Erythromycin"
  },
  {
    "kegg_id": "D01361",
    "name_en": "Erythromycin ethylsuccinate (JP18/USP)",
    "name_ja": "エリスロマイシン",
    "names_alt": [
      "E.E.S. (TN)",
      "Eryped (TN)",
      "Erythrocin W (TN)"
    ],
    "formula": "C43H75NO16",
    "efficacy": "Antibacterial, Protein biosynthesis inhibitor\nDISEASE   Listeriosis [DS:H00332]\nPertussis [DS:H00319]\nDiphtheria [DS:H00343]\nAmebiasis [DS:H00360]\nSyphilis [DS:H00354]\nLegionnaires' disease [DS:H00311]",
    "target": "50S ribosomal subunit\nPATHWAY   ko03010(K01980)  Ribosome",
    "metabolism": "Enzyme: CYP3A [HSA:1576 1577 1551]",
    "therapeutic_category": "6141",
    "atc_code": "D10AF02",
    "drug_class": [
      "Antibacterial",
      "Macrolide antibiotic",
      "14-membered ring macrolide antibiotic",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "Metabolizing enzyme inhibitor",
      "CYP3A/CYP3A4 inhibitor",
      "Transporter inhibitor",
      "ABCB1 inhibitor"
    ],
    "cyp_enzymes": [
      "CYP3A"
    ],
    "search_name": "Erythromycin ethylsuccinate"
  },
  {
    "kegg_id": "D02009",
    "name_en": "Erythromycin lactobionate (JP18/USP)",
    "name_ja": "エリスロマイシン",
    "names_alt": [
      "Erythrocin (TN)"
    ],
    "formula": "C37H67NO13. C12H22O12",
    "efficacy": "Antibacterial, Protein biosynthesis inhibitor\nDISEASE   Diphtheria [DS:H00343]\nGonorrhea [DS:H00315]\nLegionnaires' disease [DS:H00311]\nBacterial endocarditis [DS:H00334]",
    "target": "50S ribosomal subunit\nPATHWAY   ko03010(K01980)  Ribosome",
    "metabolism": "Enzyme: CYP3A [HSA:1576 1577 1551]",
    "therapeutic_category": "6141",
    "atc_code": "D10AF02",
    "drug_class": [
      "Antibacterial",
      "Macrolide antibiotic",
      "14-membered ring macrolide antibiotic",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "Metabolizing enzyme inhibitor",
      "CYP3A/CYP3A4 inhibitor",
      "Transporter inhibitor",
      "ABCB1 inhibitor"
    ],
    "cyp_enzymes": [
      "CYP3A"
    ],
    "search_name": "Erythromycin lactobionate"
  },
  {
    "kegg_id": "D02184",
    "name_en": "Erythromycin stearate (JP18/USP)",
    "name_ja": "エリスロマイシン",
    "names_alt": [
      "Bristamycin (TN)"
    ],
    "formula": "C37H67NO13. C18H36O2",
    "efficacy": "Antibacterial, Protein biosynthesis inhibitor\nDISEASE   Listeriosis [DS:H00332]\nPertussis [DS:H00319]\nDiphtheria [DS:H00343]\nAmebiasis [DS:H00360]\nSyphilis [DS:H00354]\nLegionnaires' disease [DS:H00311]",
    "target": "50S ribosomal subunit\nPATHWAY   ko03010(K01980)  Ribosome",
    "metabolism": "Enzyme: CYP3A [HSA:1576 1577 1551]",
    "therapeutic_category": "6141",
    "atc_code": "D10AF02",
    "drug_class": [
      "Antibacterial",
      "Macrolide antibiotic",
      "14-membered ring macrolide antibiotic",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "Metabolizing enzyme inhibitor",
      "CYP3A/CYP3A4 inhibitor",
      "Transporter inhibitor",
      "ABCB1 inhibitor"
    ],
    "cyp_enzymes": [
      "CYP3A"
    ],
    "search_name": "Erythromycin stearate"
  },
  {
    "kegg_id": "D02420",
    "name_en": "Acetylspiramycin (JP18)",
    "name_ja": "",
    "names_alt": [
      "Spiramycin II"
    ],
    "formula": "C45H76N2O15",
    "efficacy": "Antibiotic, Protein biosynthesis inhibitor",
    "target": "50S ribosomal subunit\nPATHWAY   ko03010(K01980)  Ribosome",
    "metabolism": "",
    "therapeutic_category": "6142",
    "atc_code": "J01FA02",
    "drug_class": [
      "Antibacterial",
      "Macrolide antibiotic",
      "16-Membered ring macrolide antibiotic"
    ],
    "cyp_enzymes": [],
    "search_name": "Acetylspiramycin"
  },
  {
    "kegg_id": "D01710",
    "name_en": "Roxithromycin (JP18/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Rulide (TN)"
    ],
    "formula": "C41H76N2O15",
    "efficacy": "Antibacterial, Protein biosynthesis inhibitor",
    "target": "50S ribosomal subunit\nPATHWAY   ko03010(K01980)  Ribosome",
    "metabolism": "Enzyme: CYP3A [HSA:1576 1577 1551]",
    "therapeutic_category": "6149",
    "atc_code": "J01FA06",
    "drug_class": [
      "Antibacterial",
      "Macrolide antibiotic",
      "14-membered ring macrolide antibiotic",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A"
    ],
    "search_name": "Roxithromycin"
  },
  {
    "kegg_id": "D00276",
    "name_en": "Clarithromycin (JP18/USP/INN)",
    "name_ja": "クラリスロマイシン",
    "names_alt": [
      "Biaxin (TN)"
    ],
    "formula": "C38H69NO13",
    "efficacy": "Antibacterial, Protein biosynthesis inhibitor\nDISEASE   Pharyngitis/tonsillitis [DS:H01424]\nHelicobacter pylori infection [DS:H00320]",
    "target": "50S ribosomal subunit\nPATHWAY   ko03010(K01980)  Ribosome",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "6149",
    "atc_code": "J01FA09",
    "drug_class": [
      "Antibacterial",
      "Macrolide antibiotic",
      "14-membered ring macrolide antibiotic",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "Metabolizing enzyme inhibitor",
      "CYP3A/CYP3A4 inhibitor",
      "CYP3A4 inhibitor",
      "Transporter inhibitor",
      "ABCB1 inhibitor"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Clarithromycin"
  },
  {
    "kegg_id": "D02185",
    "name_en": "Chloramphenicol sodium succinate (JP18/USP)",
    "name_ja": "クロラムフェニコール",
    "names_alt": [
      "Chloromycetin succinate (TN)"
    ],
    "formula": "C15H15Cl2N2O8. Na",
    "efficacy": "Antibacterial, Antirickettsial, Protein biosynthesis inhibitor\nDISEASE   Typhoid [DS:H00111]\nCystic fibrosis [DS:H00218]",
    "target": "50S ribosomal subunit\nPATHWAY   ko03010(K01980)  Ribosome",
    "metabolism": "",
    "therapeutic_category": "6151",
    "atc_code": "D06AX02",
    "drug_class": [
      "Antibacterial",
      "Amphenicol type antibacterial"
    ],
    "cyp_enzymes": [],
    "search_name": "Chloramphenicol sodium succinate"
  },
  {
    "kegg_id": "D02129",
    "name_en": "Doxycycline hyclate (USP)",
    "name_ja": "",
    "names_alt": [
      "Doxycycline hydrochloride hydrate (JP18)",
      "Doryx (TN)",
      "Lymepak (TN)",
      "Periostat (TN)",
      "Vibra-tabs (TN)"
    ],
    "formula": "(C22H24N2O8)2. 2HCl. C2H6O. H2O",
    "efficacy": "Antibacterial, Protein biosynthesis inhibitor\nDISEASE   Rocky Mountain spotted fever [DS:H00323]\nTyphus fever [DS:H00322]\nQ fever [DS:H00310]\nRickettsial pox [DS:H02379]\nLymphogranuloma venereum [DS:H00348]\nGranuloma inguinale [DS:H01415]\nGonorrhea [DS:H00315]\nChancroid [DS:H00305]\nPsittacosis [DS:H00350]\nRelapsing fever [DS:H00427]\nPlague [DS:H00297]\nTularemia [DS:H00312]\nCholera [DS:H00110]\nCampylobacter fetus infections [DS:H00321]\nBrucellosis [DS:H00325]\nBartonellosis [DS:H00326]\nTrachoma [DS:H00349]\nAnthrax [DS:H00328]\nSyphilis [DS:H00354]\nYaws [DS:H01318]\nListeriosis [DS:H00332]\nVincent's infection [DS:H01440]\nActinomycosis [DS:H01325]\nAmebiasis [DS:H00360]\nMalaria [DS:H00361]\nLyme disease [DS:H00353]",
    "target": "30S ribosomal subunit\nPATHWAY   ko03010(K01977)  Ribosome",
    "metabolism": "",
    "therapeutic_category": "6152",
    "atc_code": "A01AB22",
    "drug_class": [
      "Antibacterial",
      "Tetracycline antibiotic"
    ],
    "cyp_enzymes": [],
    "search_name": "Doxycycline hyclate"
  },
  {
    "kegg_id": "D00290",
    "name_en": "Demeclocycline hydrochloride (USP)",
    "name_ja": "",
    "names_alt": [
      "Demethylchlortetracycline hydrochloride (JP18)",
      "Declomycin (TN)"
    ],
    "formula": "C21H21ClN2O8. HCl",
    "efficacy": "Antibacterial, Protein biosynthesis inhibitor\nDISEASE   Rocky Mountain spotted fever [DS:H00323]\nTyphus fever [DS:H00322]\nQ fever [DS:H00310]\nLymphogranuloma venereum [DS:H00348]\nPsittacosis [DS:H00350]\nTrachoma [DS:H00349]\nRelapsing fever [DS:H00427]\nChancroid [DS:H00305]\nPlague [DS:H00297]\nTularemia [DS:H00312]\nCholera [DS:H00110]\nCampylobacter fetus infections [DS:H00321]\nBrucellosis [DS:H00325]\nBartonellosis [DS:H00326]\nGranuloma inguinale [DS:H01415]\nSyphilis [DS:H00354]\nYaws [DS:H01318]\nListeriosis [DS:H00332]\nAnthrax [DS:H00328]\nVincent's infection [DS:H01440]\nActinomycosis [DS:H01325]",
    "target": "30S ribosomal subunit\nPATHWAY   ko03010(K01977)  Ribosome",
    "metabolism": "",
    "therapeutic_category": "6152",
    "atc_code": "D06AA01",
    "drug_class": [
      "Antibacterial",
      "Tetracycline antibiotic"
    ],
    "cyp_enzymes": [],
    "search_name": "Demeclocycline hydrochloride"
  },
  {
    "kegg_id": "D01350",
    "name_en": "Streptomycin sulfate (JP18/USP)",
    "name_ja": "ストレプトマイシン",
    "names_alt": [],
    "formula": "(C21H39N7O12)2. 3H2SO4",
    "efficacy": "Antibacterial (tuberculostatic), Protein biosynthesis inhibitor\nDISEASE   Tuberculosis [DS:H00342]\nPlague [DS:H00297]\nTularemia [DS:H00312]\nBrucellosis [DS:H00325]\nDonovanosis, Granuloma inguinale [DS:H01415]\nChancroid [DS:H00305]\nEndocardial infection [DS:H00334]",
    "target": "30S ribosomal subunit\nPATHWAY   ko03010(K01977)  Ribosome",
    "metabolism": "",
    "therapeutic_category": "6161",
    "atc_code": "A07AA04",
    "drug_class": [
      "Antibacterial",
      "Aminoglycoside antibiotic",
      "Antitubercular"
    ],
    "cyp_enzymes": [],
    "search_name": "Streptomycin sulfate"
  },
  {
    "kegg_id": "D00877",
    "name_en": "Cycloserine (JP18/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Seromycin (TN)\nABBR      DCS"
    ],
    "formula": "C3H6N2O2",
    "efficacy": "Antibacterial (tuberculostatic), Cell wall biosynthesis inhibitor\nDISEASE   Tuberculosis [DS:H00342]",
    "target": "D-alanine-D-alanine ligase [KO:K01921]\nalanine racemase [KO:K01775]\nPATHWAY   ko00550(K01921)  Peptidoglycan biosynthesis",
    "metabolism": "",
    "therapeutic_category": "6162",
    "atc_code": "J04AB01",
    "drug_class": [
      "Antibacterial",
      "Antitubercular"
    ],
    "cyp_enzymes": [],
    "search_name": "Cycloserine"
  },
  {
    "kegg_id": "D00211",
    "name_en": "Rifampin (USP)",
    "name_ja": "",
    "names_alt": [
      "Rifampicin (JP18/INN)",
      "Rifadin (TN)",
      "Rimactane (TN)\nABBR      RIF"
    ],
    "formula": "C43H58N4O12",
    "efficacy": "Antibacterial, RNA polymerase inhibitor\nDISEASE   Tuberculosis [DS:H00342]",
    "target": "DNA-directed RNA polymerase subunit beta [KO:K03043 K03046]\nPATHWAY   ko03020(K03043+K03046)  RNA polymerase",
    "metabolism": "",
    "therapeutic_category": "6164",
    "atc_code": "J04AB02",
    "drug_class": [
      "Antibacterial",
      "Antitubercular",
      "Rifamycin antibiotic",
      "Metabolizing enzyme inducer",
      "CYP3A/CYP3A4 inducer",
      "CYP3A4 inducer",
      "UGT inducer",
      "Transporter inhibitor",
      "SLCO1B1 inhibitor",
      "SLCO1B3 inhibitor",
      "Transporter inducer",
      "ABCB1 inducer"
    ],
    "cyp_enzymes": [],
    "search_name": "Rifampin"
  },
  {
    "kegg_id": "D03262",
    "name_en": "Kanamycin sulfate (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "C18H36N4O11. xH2SO4",
    "efficacy": "Antibacterial, Protein biosynthesis inhibitor",
    "target": "30S ribosomal subunit\nPATHWAY   ko03010(K01977)  Ribosome",
    "metabolism": "",
    "therapeutic_category": "6169",
    "atc_code": "A07AA08",
    "drug_class": [
      "Antibacterial",
      "Aminoglycoside antibiotic",
      "Antitubercular"
    ],
    "cyp_enzymes": [],
    "search_name": "Kanamycin sulfate"
  },
  {
    "kegg_id": "D00424",
    "name_en": "Rifabutin (JAN/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Mycobutin (TN)\nABBR      RFB"
    ],
    "formula": "C46H62N4O11",
    "efficacy": "Antibacterial (antimycobacterial), RNA polymerase inhibitor",
    "target": "DNA-directed RNA polymerase [KO:K03040 K03043 K03046]\nPATHWAY   ko03020(K03040+K03043+K03046)  RNA polymerase",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "6169",
    "atc_code": "J04AB04",
    "drug_class": [
      "Antibacterial",
      "Antitubercular",
      "Rifamycin antibiotic",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "Metabolizing enzyme inducer",
      "CYP3A/CYP3A4 inducer"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Rifabutin"
  },
  {
    "kegg_id": "D00203",
    "name_en": "Amphotericin B (JP18/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Ambisome (TN)",
      "Amphotec (TN)",
      "Fungizone (TN)\nABBR      AMB"
    ],
    "formula": "C47H73NO17",
    "efficacy": "Antibiotic, Antifungal, Cell membrane function inhibitor\nDISEASE   Visceral leishmaniasis [DS:H00359]\nAspergillosis [DS:H01328]\nCryptococcosis [DS:H00364]\nNorth American blastomycosis [DS:H01501]\nSystemic candidiasis [DS:H00363]\nCoccidioidomycosis [DS:H01319]\nHistoplasmosis [DS:H01062]\nZygomycosis [DS:H01503]\nMucormycosis [DS:H02033]\nSporotrichosis [DS:H01499]",
    "target": "Ergosterol",
    "metabolism": "",
    "therapeutic_category": "6173",
    "atc_code": "A01AB04",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Amphotericin B"
  },
  {
    "kegg_id": "D00578",
    "name_en": "Voriconazole (JP18/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Vfend (TN)\nABBR      VRC"
    ],
    "formula": "C16H14F3N5O",
    "efficacy": "Antifungal, Ergosterol biosynthesis inhibitor\nDISEASE   Invasive aspergillosis [DS:H01328]\nEsophageal candidiasis [DS:H00363]\nScedosporiosis [DS:H02392]",
    "target": "sterol 14alpha-demethylase [KO:K05917]\nPATHWAY   ko00100(K05917)  Steroid biosynthesis",
    "metabolism": "",
    "therapeutic_category": "6179",
    "atc_code": "J02AC03",
    "drug_class": [
      "Antifungal",
      "Triazole antifungal",
      "Metabolizing enzyme inhibitor",
      "CYP3A/CYP3A4 inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Voriconazole"
  },
  {
    "kegg_id": "D02555",
    "name_en": "Posaconazole (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Noxafil (TN)\nABBR      POS"
    ],
    "formula": "C37H42F2N8O4",
    "efficacy": "Antifungal, Ergosterol biosynthesis inhibitor\nDISEASE   Invasive Aspergillus infection [DS:H01328]\nCandidiasis [DS:H00363]",
    "target": "sterol 14alpha-demethylase [KO:K05917]\nPATHWAY   ko00100(K05917)  Steroid biosynthesis",
    "metabolism": "Transporter: ABCB1 [HSA:5243]",
    "therapeutic_category": "6179",
    "atc_code": "J02AC04",
    "drug_class": [
      "Antifungal",
      "Triazole antifungal",
      "Metabolizing enzyme inhibitor",
      "CYP3A/CYP3A4 inhibitor",
      "CYP3A4 inhibitor",
      "Transporter substrate",
      "ABCB1 substrate"
    ],
    "cyp_enzymes": [],
    "search_name": "Posaconazole"
  },
  {
    "kegg_id": "D02501",
    "name_en": "Caspofungin acetate (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Cancidas (TN)"
    ],
    "formula": "C52H88N10O15. (C2H4O2)2",
    "efficacy": "Antifungal, Cell wall biosynthesis inhibitor\nDISEASE   Candidemia [DS:H00363]\nAspergillosis [DS:H01328]",
    "target": "beta-1,3-glucan synthase [KO:K00706]\nPATHWAY   ko00500(K00706)  Starch and sucrose metabolism",
    "metabolism": "",
    "therapeutic_category": "6179",
    "atc_code": "J02AX04",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Caspofungin acetate"
  },
  {
    "kegg_id": "D02465",
    "name_en": "Micafungin sodium (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Funguard (TN)",
      "Mycamine (TN)"
    ],
    "formula": "C56H70N9O23S. Na",
    "efficacy": "Antifungal, Cell wall biosynthesis inhibitor\nDISEASE   Candidiasis [DS:H00363]",
    "target": "beta-1,3-glucan synthase [KO:K00706]\nPATHWAY   ko00500(K00706)  Starch and sucrose metabolism",
    "metabolism": "",
    "therapeutic_category": "6179",
    "atc_code": "J02AX05",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Micafungin sodium"
  },
  {
    "kegg_id": "D11010",
    "name_en": "Micafungin sodium hydrate (JAN)",
    "name_ja": "",
    "names_alt": [],
    "formula": "C56H70N9O23S. Na. 2H2O",
    "efficacy": "Antifungal, Cell wall biosynthesis inhibitor",
    "target": "beta-1,3-glucan synthase [KO:K00706]\nPATHWAY   ko00500(K00706)  Starch and sucrose metabolism",
    "metabolism": "",
    "therapeutic_category": "6179",
    "atc_code": "J02AX05",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Micafungin sodium hydrate"
  },
  {
    "kegg_id": "D10643",
    "name_en": "Isavuconazonium sulfate (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Cresemba (TN)"
    ],
    "formula": "C35H35F2N8O5S. HSO4",
    "efficacy": "Antifungal\nDISEASE   Invasive aspergillosis [DS:H01328]\nInvasive mucormycosis [DS:H02033]",
    "target": "sterol 14alpha-demethylase [KO:K05917]",
    "metabolism": "Enzyme: CYP3A [HSA:1576 1577 1551]",
    "therapeutic_category": "6179",
    "atc_code": "",
    "drug_class": [
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "Metabolizing enzyme inhibitor",
      "CYP3A/CYP3A4 inhibitor",
      "UGT inhibitor",
      "Metabolizing enzyme inducer",
      "CYP2B6 inducer",
      "Transporter inhibitor",
      "ABCB1 inhibitor",
      "SLC22A2 inhibitor",
      "SLC47A1 inhibitor"
    ],
    "cyp_enzymes": [
      "CYP3A"
    ],
    "search_name": "Isavuconazonium sulfate"
  },
  {
    "kegg_id": "D02502",
    "name_en": "Ampicillin and cloxacillin",
    "name_ja": "アンピシリン",
    "names_alt": [
      "Viccillin S (TN)"
    ],
    "formula": "",
    "efficacy": "Antibacterial",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "6191",
    "atc_code": "J01CA51",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Ampicillin and cloxacillin"
  },
  {
    "kegg_id": "D10519",
    "name_en": "Rabeprazole, amoxicillin and clarithromycin",
    "name_ja": "ラベプラゾール",
    "names_alt": [
      "Rabecure (TN)"
    ],
    "formula": "",
    "efficacy": "Antibacterial",
    "target": "",
    "metabolism": "Enzyme: CYP2C19 [HSA:1557], CYP3A4 [HSA:1576]",
    "therapeutic_category": "6199",
    "atc_code": "A02BD12",
    "drug_class": [
      "Metabolizing enzyme substrate",
      "CYP2C19 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "Metabolizing enzyme inhibitor",
      "CYP3A/CYP3A4 inhibitor",
      "CYP3A4 inhibitor",
      "Transporter inhibitor",
      "ABCB1 inhibitor"
    ],
    "cyp_enzymes": [
      "CYP2C19",
      "CYP3A4"
    ],
    "search_name": "Rabeprazole, amoxicillin and clarithromycin"
  },
  {
    "kegg_id": "D10520",
    "name_en": "Rabeprazole, amoxicillin and metronidazole",
    "name_ja": "ラベプラゾール",
    "names_alt": [
      "Rabefine (TN)"
    ],
    "formula": "",
    "efficacy": "Antibacterial",
    "target": "",
    "metabolism": "Enzyme: CYP2C19 [HSA:1557], CYP3A4 [HSA:1576]",
    "therapeutic_category": "6199",
    "atc_code": "A02BD13",
    "drug_class": [
      "Metabolizing enzyme substrate",
      "CYP2C19 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C19",
      "CYP3A4"
    ],
    "search_name": "Rabeprazole, amoxicillin and metronidazole"
  },
  {
    "kegg_id": "D10775",
    "name_en": "Vonoprazan, amoxicillin and clarithromycin",
    "name_ja": "",
    "names_alt": [
      "Vonosap (TN)",
      "Voquenza (TN)"
    ],
    "formula": "",
    "efficacy": "Antibacterial\nDISEASE   Helicobacter pylori infection [DS:H00320]",
    "target": "",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]; CYP2B6 [HSA:1555], CYP2C19 [HSA:1557], CYP2D6 [HSA:1565]",
    "therapeutic_category": "6199",
    "atc_code": "A02BD14",
    "drug_class": [
      "Metabolizing enzyme substrate",
      "CYP2B6 substrate",
      "CYP2C19 substrate",
      "CYP2D6 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "Metabolizing enzyme inhibitor",
      "CYP3A/CYP3A4 inhibitor",
      "CYP3A4 inhibitor",
      "Transporter inhibitor",
      "ABCB1 inhibitor"
    ],
    "cyp_enzymes": [
      "CYP2C19",
      "CYP3A4",
      "CYP2B6",
      "CYP2D6"
    ],
    "search_name": "Vonoprazan, amoxicillin and clarithromycin"
  },
  {
    "kegg_id": "D10774",
    "name_en": "Vonoprazan, amoxicillin and metronidazole",
    "name_ja": "",
    "names_alt": [
      "Vonopion (TN)"
    ],
    "formula": "",
    "efficacy": "Antibacterial",
    "target": "",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]; CYP2B6 [HSA:1555], CYP2C19 [HSA:1557], CYP2D6 [HSA:1565]",
    "therapeutic_category": "6199",
    "atc_code": "A02BD15",
    "drug_class": [
      "Metabolizing enzyme substrate",
      "CYP2B6 substrate",
      "CYP2C19 substrate",
      "CYP2D6 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C19",
      "CYP3A4",
      "CYP2B6",
      "CYP2D6"
    ],
    "search_name": "Vonoprazan, amoxicillin and metronidazole"
  },
  {
    "kegg_id": "D02554",
    "name_en": "Rifaximin (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Xifaxan (TN)"
    ],
    "formula": "C43H51N3O11",
    "efficacy": "Antibacterial, Antihyperammonemic\nDISEASE   Hepatic encephalopathy [DS:H01506]",
    "target": "DNA-directed RNA polymerase subunit beta [KO:K03043]\nPATHWAY   ko03020(K03043)  RNA polymerase",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]\nTransporter: ABCB1 [HSA:5243], SLCO1A2 [HSA:6579], SLCO1B1 [HSA:10599], SLCO1B3 [HSA:28234]",
    "therapeutic_category": "6199",
    "atc_code": "A07AA11",
    "drug_class": [
      "Antibacterial",
      "Antitubercular",
      "Rifamycin antibiotic",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "Metabolizing enzyme inducer",
      "CYP3A/CYP3A4 inducer",
      "CYP3A4 inducer",
      "Transporter substrate",
      "ABCB1 substrate",
      "SLCO1A2 substrate",
      "SLCO1B1 substrate",
      "SLCO1B3 substrate",
      "Transporter inhibitor",
      "ABCB1 inhibitor",
      "SLCO1A2 inhibitor",
      "SLCO1B1 inhibitor",
      "SLCO1B3 inhibitor"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Rifaximin"
  },
  {
    "kegg_id": "D00448",
    "name_en": "Sulfasalazine (USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Salazosulfapyridine (JP18)",
      "Azulfidine (TN)"
    ],
    "formula": "C18H14N4O5S",
    "efficacy": "Anti-inflammatory disease, Antirheumatic\nDISEASE   Ulcerative colitis [DS:H01466]\nRheumatoid arthritis [DS:H00630]\nJuvenile rheumatoid arthritis [DS:H01672]",
    "target": "",
    "metabolism": "Transporter: ABCG2 [HSA:9429]",
    "therapeutic_category": "6219",
    "atc_code": "A07EC01",
    "drug_class": [
      "Anti-inflammatory",
      "Nonsteroidal anti-inflammatory drug (NSAID)",
      "Anti-inflammatory drug, salicylic acid derivatives",
      "Disease modifying anti-rheumatic drug (DMARD)",
      "Transporter substrate",
      "ABCG2 substrate"
    ],
    "cyp_enzymes": [],
    "search_name": "Sulfasalazine"
  },
  {
    "kegg_id": "D03368",
    "name_en": "Calcium para-aminosalicylate (JP18)",
    "name_ja": "",
    "names_alt": [
      "Nippas calcium (TN)"
    ],
    "formula": "(C7H5NO3. Ca)2. 7H2O",
    "efficacy": "Antibacterial (tuberculostatic)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "6221",
    "atc_code": "J04AA03",
    "drug_class": [
      "Antibacterial",
      "Antitubercular"
    ],
    "cyp_enzymes": [],
    "search_name": "Calcium para-aminosalicylate"
  },
  {
    "kegg_id": "D01643",
    "name_en": "Aluminoparaaminosalicylate calcium hydrate (JAN)",
    "name_ja": "",
    "names_alt": [
      "Aluminoparaaminosalicylate calcium pentahydrate",
      "Aluminoparaaminosalicylate calcium",
      "Alumino nippas calcium (TN)"
    ],
    "formula": "(C7H5NO3)2. Al. H2O. OH. 5H2O. Ca",
    "efficacy": "Antibacterial (tuberculostatic)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "6221",
    "atc_code": "",
    "drug_class": [
      "Antibacterial",
      "Antitubercular"
    ],
    "cyp_enzymes": [],
    "search_name": "Aluminoparaaminosalicylate calcium hydrate"
  },
  {
    "kegg_id": "D00346",
    "name_en": "Isoniazid (JP18/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Laniazid (TN)"
    ],
    "formula": "C6H7N3O",
    "efficacy": "Antibacterial (tuberculostatic)\nDISEASE   Tuberculosis [DS:H00342]",
    "target": "enoyl-[acyl-carrier-protein] reductase (NADH) [KO:K11611]",
    "metabolism": "",
    "therapeutic_category": "6222",
    "atc_code": "J04AC01",
    "drug_class": [
      "Antibacterial",
      "Antitubercular",
      "Neuropsychiatric agent",
      "MAO inhibitor",
      "Non-selective monoamine oxidase inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Isoniazid"
  },
  {
    "kegg_id": "D02002",
    "name_en": "Isoniazid sodium methanesulfonate hydrate (JAN)",
    "name_ja": "",
    "names_alt": [
      "Isoniazid sodium methanesulfonate monohydrate",
      "Isoniazid sodium methanesulfonate",
      "IHMS",
      "Neoiscotin (TN)"
    ],
    "formula": "C7H8N3O4S. Na. H2O",
    "efficacy": "Antibacterial (tuberculostatic)",
    "target": "enoyl-[acyl-carrier-protein] reductase (NADH) [KO:K11611]",
    "metabolism": "",
    "therapeutic_category": "6222",
    "atc_code": "J04AC01",
    "drug_class": [
      "Antibacterial",
      "Antitubercular",
      "Neuropsychiatric agent",
      "MAO inhibitor",
      "Non-selective monoamine oxidase inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Isoniazid sodium methanesulfonate hydrate"
  },
  {
    "kegg_id": "D09873",
    "name_en": "Bedaquiline fumarate (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Sirturo (TN)"
    ],
    "formula": "C32H31BrN2O2. C4H4O4",
    "efficacy": "Antibacterial (tuberculostatic), ATP synthase inhibitor\nDISEASE   Pulmonary multi-drug resistant tuberculosis [DS:H01472]",
    "target": "ATP synthase subunit C [KO:K02110]\nPATHWAY   ko00190(K02110)  Oxidative phosphorylation",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "6222",
    "atc_code": "J04AK05",
    "drug_class": [
      "Antibacterial",
      "Antitubercular",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Bedaquiline fumarate"
  },
  {
    "kegg_id": "D09785",
    "name_en": "Delamanid (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Deltyba (TN)\nABBR      DMD"
    ],
    "formula": "C25H25F3N4O6",
    "efficacy": "Antibacterial (tuberculostatic), Mycolic acid biosynthesis inhibitor",
    "target": "",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576], CYP1A1 [HSA:1543], CYP2D6 [HSA:1565], CYP2E1 [HSA:1571]",
    "therapeutic_category": "6222",
    "atc_code": "J04AK06",
    "drug_class": [
      "Antibacterial",
      "Antitubercular",
      "Metabolizing enzyme substrate",
      "CYP1A1 substrate",
      "CYP2D6 substrate",
      "CYP2E1 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP1A1",
      "CYP2E1",
      "CYP3A4",
      "CYP2D6"
    ],
    "search_name": "Delamanid"
  },
  {
    "kegg_id": "D00144",
    "name_en": "Pyrazinamide (JP18/USP/INN)\nABBR      PZA",
    "name_ja": "",
    "names_alt": [],
    "formula": "C5H5N3O",
    "efficacy": "Antibacterial (tuberculostatic)\nDISEASE   Tuberculosis [DS:H00342]",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "6223",
    "atc_code": "J04AK01",
    "drug_class": [
      "Antibacterial",
      "Antitubercular",
      "Pyrazinamide derivative"
    ],
    "cyp_enzymes": [],
    "search_name": "Pyrazinamide"
  },
  {
    "kegg_id": "D00591",
    "name_en": "Ethionamide (JP18/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Trecator (TN)\nABBR      ETO"
    ],
    "formula": "C8H10N2S",
    "efficacy": "Antibacterial (tuberculostatic)\nDISEASE   Tuberculosis [DS:H00342]",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "6224",
    "atc_code": "J04AD03",
    "drug_class": [
      "Antibacterial",
      "Antitubercular",
      "Thiocarbamide derivative"
    ],
    "cyp_enzymes": [],
    "search_name": "Ethionamide"
  },
  {
    "kegg_id": "D00878",
    "name_en": "Ethambutol hydrochloride (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Myambutol (TN)"
    ],
    "formula": "C10H24N2O2. 2HCl",
    "efficacy": "Antibacterial (tuberculostatic), Arabinosyltransferase inhibitor\nDISEASE   Pulmonary tuberculosis [DS:H00342]",
    "target": "arabinosyltransferase [KO:K11385 K11386 K11387]",
    "metabolism": "",
    "therapeutic_category": "6225",
    "atc_code": "J04AK02",
    "drug_class": [
      "Antibacterial",
      "Antitubercular"
    ],
    "cyp_enzymes": [],
    "search_name": "Ethambutol hydrochloride"
  },
  {
    "kegg_id": "D00278",
    "name_en": "Clofazimine (JAN/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Lamprene (TN)\nABBR      CLO"
    ],
    "formula": "C27H22Cl2N4",
    "efficacy": "Antibacterial (leprostatic)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "6239",
    "atc_code": "J04BA01",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Clofazimine"
  },
  {
    "kegg_id": "D00186",
    "name_en": "Ciprofloxacin (JP18/USP/INN)",
    "name_ja": "シプロフロキサシン",
    "names_alt": [
      "Cipro (TN)",
      "Otiprio (TN)"
    ],
    "formula": "C17H18FN3O3",
    "efficacy": "Antibacterial, Nucleic acid biosynthesis inhibitor\nDISEASE   Inhalational anthrax [DS:H00328]\nPlague [DS:H00297]",
    "target": "DNA gyrase [KO:K02469 K02470]",
    "metabolism": "",
    "therapeutic_category": "6241",
    "atc_code": "J01MA02",
    "drug_class": [
      "Antibacterial",
      "Quinolone",
      "Fluoroquinolone",
      "Metabolizing enzyme inhibitor",
      "CYP1A2 inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Ciprofloxacin"
  },
  {
    "kegg_id": "D02216",
    "name_en": "Ciprofloxacin hydrochloride (USP)",
    "name_ja": "シプロフロキサシン",
    "names_alt": [
      "Ciprofloxacin hydrochloride hydrate (JP18)",
      "Ciloxan (TN)",
      "Cipro (TN)",
      "Proquin XR (TN)"
    ],
    "formula": "C17H18FN3O3. HCl. H2O",
    "efficacy": "Antibacterial, Nucleic acid biosynthesis inhibitor\nDISEASE   Typhoid fever [DS:H00111]\nGonorrhea [DS:H00315]\nAnthrax [DS:H00328]\nPlague [DS:H00297]\nUncomplicated urinary tract infections [DS:H01176]",
    "target": "DNA gyrase [KO:K02469 K02470]",
    "metabolism": "",
    "therapeutic_category": "6241",
    "atc_code": "J01MA02",
    "drug_class": [
      "Antibacterial",
      "Quinolone",
      "Fluoroquinolone",
      "Metabolizing enzyme inhibitor",
      "CYP1A2 inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Ciprofloxacin hydrochloride"
  },
  {
    "kegg_id": "D01144",
    "name_en": "Prulifloxacin (JAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Sword (TN)"
    ],
    "formula": "C21H20FN3O6S",
    "efficacy": "Antibacterial, Nucleic acid biosynthesis inhibitor",
    "target": "DNA gyrase [KO:K02469 K02470]",
    "metabolism": "",
    "therapeutic_category": "6241",
    "atc_code": "J01MA17",
    "drug_class": [
      "Antibacterial",
      "Quinolone",
      "Fluoroquinolone"
    ],
    "cyp_enzymes": [],
    "search_name": "Prulifloxacin"
  },
  {
    "kegg_id": "D05382",
    "name_en": "Pazufloxacin mesilate (JP18)",
    "name_ja": "",
    "names_alt": [
      "Pazufloxacin methanesulfonate",
      "Pasil (TN)"
    ],
    "formula": "C16H15FN2O4. CH4SO3",
    "efficacy": "Antibacterial, Nucleic acid biosynthesis inhibitor",
    "target": "DNA gyrase [KO:K02469 K02470]\ntopoisomerase IV [KO:K02621 K02622]",
    "metabolism": "",
    "therapeutic_category": "6241",
    "atc_code": "J01MA18",
    "drug_class": [
      "Antibacterial",
      "Quinolone",
      "Fluoroquinolone",
      "Metabolizing enzyme inhibitor",
      "CYP1A2 inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Pazufloxacin mesilate"
  },
  {
    "kegg_id": "D02540",
    "name_en": "Garenoxacin mesylate (USAN)",
    "name_ja": "",
    "names_alt": [
      "Garenoxacin mesilate hydrate (JAN)"
    ],
    "formula": "C23H20F2N2O4. CH4SO3. H2O",
    "efficacy": "Antibacterial, Nucleic acid biosynthesis inhibitor",
    "target": "DNA gyrase [KO:K02469 K02470]\ntopoisomerase IV [KO:K02621 K02622]",
    "metabolism": "",
    "therapeutic_category": "6241",
    "atc_code": "J01MA19",
    "drug_class": [
      "Antibacterial",
      "Quinolone",
      "Fluoroquinolone"
    ],
    "cyp_enzymes": [],
    "search_name": "Garenoxacin mesylate"
  },
  {
    "kegg_id": "D02475",
    "name_en": "Sitafloxacin (USAN)",
    "name_ja": "",
    "names_alt": [
      "Sitafloxacin hydrate (JAN)"
    ],
    "formula": "(C19H18ClF2N3O3)2. 3H2O",
    "efficacy": "Antibacterial, Nucleic acid biosynthesis inhibitor",
    "target": "DNA gyrase [KO:K02469 K02470]\ntopoisomerase IV [KO:K02621 K02622]",
    "metabolism": "",
    "therapeutic_category": "6241",
    "atc_code": "J01MA21",
    "drug_class": [
      "Antibacterial",
      "Quinolone",
      "Fluoroquinolone"
    ],
    "cyp_enzymes": [],
    "search_name": "Sitafloxacin"
  },
  {
    "kegg_id": "D10772",
    "name_en": "Lascufloxacin hydrochloride (JAN)",
    "name_ja": "",
    "names_alt": [
      "Lasvic (TN)"
    ],
    "formula": "C21H24F3N3O4. HCl",
    "efficacy": "Antibacterial",
    "target": "DNA gyrase [KO:K02469 K02470]\ntopoisomerase IV [KO:K02621 K02622]",
    "metabolism": "",
    "therapeutic_category": "6241",
    "atc_code": "J01MA25",
    "drug_class": [
      "Antibacterial",
      "Quinolone",
      "Fluoroquinolone"
    ],
    "cyp_enzymes": [],
    "search_name": "Lascufloxacin hydrochloride"
  },
  {
    "kegg_id": "D00947",
    "name_en": "Linezolid (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Zyvox (TN)\nABBR      LZD"
    ],
    "formula": "C16H20FN3O4",
    "efficacy": "Antibacterial, Protein biosynthesis inhibitor\nDISEASE   Vancomycin-Resistant Enterococcus faecium infection [DS:H00340]",
    "target": "50S ribosomal subunit",
    "metabolism": "",
    "therapeutic_category": "6249",
    "atc_code": "J01XX08",
    "drug_class": [
      "Antibacterial",
      "Oxazolidinone antibiotic"
    ],
    "cyp_enzymes": [],
    "search_name": "Linezolid"
  },
  {
    "kegg_id": "D09686",
    "name_en": "Tedizolid phosphate (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Torezolid phosphate",
      "Sivextro (TN)"
    ],
    "formula": "C17H16FN6O6P",
    "efficacy": "Antibacterial, Protein biosynthesis inhibitor",
    "target": "50S ribosomal subunit",
    "metabolism": "",
    "therapeutic_category": "6249",
    "atc_code": "J01XX11",
    "drug_class": [
      "Antibacterial",
      "Oxazolidinone antibiotic"
    ],
    "cyp_enzymes": [],
    "search_name": "Tedizolid phosphate"
  },
  {
    "kegg_id": "D06298",
    "name_en": "Vidarabine (JAN)",
    "name_ja": "",
    "names_alt": [
      "Vidarabine anhydrous",
      "ARA-A",
      "Armes (TN)"
    ],
    "formula": "C10H13N5O4",
    "efficacy": "Antiviral, DNA polymerase inhibitor",
    "target": "Herpesvirus DNA polymerase [KO:K18964]\nPATHWAY   ko03240(K18964)  Viral replication",
    "metabolism": "",
    "therapeutic_category": "6250",
    "atc_code": "J05AB03",
    "drug_class": [
      "Antiviral",
      "Arabinofuranosyl type antiviral",
      "Anti-herpesvirus agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Vidarabine"
  },
  {
    "kegg_id": "D00333",
    "name_en": "Ganciclovir (JAN/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Cytovene (TN)",
      "Vitrasert (TN)",
      "Zirgan (TN)"
    ],
    "formula": "C9H13N5O4",
    "efficacy": "Antiviral, DNA polymerase inhibitor\nDISEASE   CMV retinitis, Prevention of CMV disease [DS:H00368]\nAcute herpetic keratitis [DS:H00365]",
    "target": "HCMV DNA polymerase [KO:K18964]\nHerpesvirus DNA polymerase [KO:K18964]\nPATHWAY   ko03240(K18964+K18964)  Viral replication",
    "metabolism": "",
    "therapeutic_category": "6250",
    "atc_code": "J05AB06",
    "drug_class": [
      "Antiviral",
      "Anti-herpesvirus agent",
      "Anti-cytomegalovirus agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Ganciclovir"
  },
  {
    "kegg_id": "D00317",
    "name_en": "Famciclovir (JAN/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Famvir (TN)\nABBR      FCV"
    ],
    "formula": "C14H19N5O4",
    "efficacy": "Antiviral, DNA polymerase inhibitor\nDISEASE   Herpes labialis, Genital herpes [DS:H00365]\nHerpes zoster [DS:H00366]",
    "target": "Herpesvirus DNA polymerase [KO:K18964]\nPATHWAY   ko03240(K18964)  Viral replication",
    "metabolism": "",
    "therapeutic_category": "6250",
    "atc_code": "J05AB09",
    "drug_class": [
      "Antiviral",
      "Anti-herpesvirus agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Famciclovir"
  },
  {
    "kegg_id": "D00398",
    "name_en": "Valacyclovir hydrochloride (USP)",
    "name_ja": "",
    "names_alt": [
      "Valaciclovir hydrochloride (JP18)",
      "Valtrex (TN)"
    ],
    "formula": "C13H20N6O4. HCl",
    "efficacy": "Antiviral, DNA polymerase inhibitor\nDISEASE   Herpes labialis [DS:H00365]\nGenital herpes [DS:H00365]\nHerpes zoster [DS:H00366]\nChickenpox [DS:H00366]",
    "target": "Herpesvirus DNA polymerase [KO:K18964]\nPATHWAY   ko03240(K18964)  Viral replication",
    "metabolism": "",
    "therapeutic_category": "6250",
    "atc_code": "J05AB11",
    "drug_class": [
      "Antiviral",
      "Anti-herpesvirus agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Valacyclovir hydrochloride"
  },
  {
    "kegg_id": "D10518",
    "name_en": "Valaciclovir hydrochloride hydrate (JAN)",
    "name_ja": "",
    "names_alt": [
      "Valacyclovir hydrochloride hydrate",
      "Valaciclovir (TN)"
    ],
    "formula": "C13H20N6O4. HCl. xH2O",
    "efficacy": "Antiviral, DNA polymerase inhibitor",
    "target": "Herpesvirus DNA polymerase [KO:K18964]\nPATHWAY   ko03240(K18964)  Viral replication",
    "metabolism": "",
    "therapeutic_category": "6250",
    "atc_code": "J05AB11",
    "drug_class": [
      "Antiviral",
      "Anti-herpesvirus agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Valaciclovir hydrochloride hydrate"
  },
  {
    "kegg_id": "D03256",
    "name_en": "Valganciclovir hydrochloride (JAN/USP)",
    "name_ja": "",
    "names_alt": [
      "Valcyte (TN)"
    ],
    "formula": "C14H22N6O5. HCl",
    "efficacy": "Antiviral, DNA polymerase inhibitor\nDISEASE   Cytomegalovirus (CMV) retinitis [DS:H00368]",
    "target": "HCMV DNA polymerase [KO:K18964]\nPATHWAY   ko03240(K18964)  Viral replication",
    "metabolism": "",
    "therapeutic_category": "6250",
    "atc_code": "J05AB14",
    "drug_class": [
      "Antiviral",
      "Anti-cytomegalovirus agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Valganciclovir hydrochloride"
  },
  {
    "kegg_id": "D11472",
    "name_en": "Remdesivir (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Veklury (TN)"
    ],
    "formula": "C27H35N6O8P",
    "efficacy": "Antiviral, RNA polymerase inhibitor\nDISEASE   Coronavirus disease 2019 [DS:H02398]",
    "target": "SARS coronavirus replicase [KO:K24149]\nPATHWAY   ko03230(K24149)  Viral genome structure\nko05171(K24149)  Coronavirus disease - COVID-19",
    "metabolism": "Transporter: SLCO1B1 [HSA:10599], SLCO1B3 [HSA:28234]",
    "therapeutic_category": "6250",
    "atc_code": "J05AB16",
    "drug_class": [
      "Antiviral",
      "Anti-SARS-CoV-2 agent",
      "Transporter substrate",
      "SLCO1B1 substrate",
      "SLCO1B3 substrate"
    ],
    "cyp_enzymes": [],
    "search_name": "Remdesivir"
  },
  {
    "kegg_id": "D11943",
    "name_en": "Molnupiravir (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Lagevrio (TN)"
    ],
    "formula": "C13H19N3O7",
    "efficacy": "Antiviral, RNA polymerase inhibitor\nDISEASE   Coronavirus disease 2019 [DS:H02398]",
    "target": "SARS coronavirus replicase [KO:K24149]\nPATHWAY   ko03230(K24149)  Viral genome structure\nko05171(K24149)  Coronavirus disease - COVID-19",
    "metabolism": "",
    "therapeutic_category": "6250",
    "atc_code": "J05AB18",
    "drug_class": [
      "Antiviral",
      "Anti-SARS-CoV-2 agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Molnupiravir"
  },
  {
    "kegg_id": "D02267",
    "name_en": "Foscarnet sodium hydrate (JAN)",
    "name_ja": "",
    "names_alt": [
      "Foscarnet sodium hexahydrate",
      "Trisodium phosphonoformate hexahydrate",
      "Foscavir (TN)"
    ],
    "formula": "CO5P. 6H2O. 3Na",
    "efficacy": "Antiviral, DNA polymerase inhibitor",
    "target": "HCMV DNA polymerase [KO:K18964]\nPATHWAY   ko03240(K18964)  Viral replication",
    "metabolism": "",
    "therapeutic_category": "6250",
    "atc_code": "J05AD01",
    "drug_class": [
      "Antiviral",
      "Anti-cytomegalovirus agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Foscarnet sodium hydrate"
  },
  {
    "kegg_id": "D00427",
    "name_en": "Ritonavir (JAN/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Norvir (TN)\nABBR      RTV, r"
    ],
    "formula": "C37H48N6O5S2",
    "efficacy": "Antiviral, HIV protease inhibitor\nDISEASE   HIV-1 infection [DS:H01563]",
    "target": "HIV protease [KO:K22599]\nPATHWAY   ko03230(K22599)  Viral genome structure\nko03250(K22599)  Viral life cycle - HIV-1\nko03260(K22599)  Virion - Human immunodeficiency virus",
    "metabolism": "Enzyme: CYP3A [HSA:1576 1577 1551], CYP2D6 [HSA:1565]",
    "therapeutic_category": "6250",
    "atc_code": "J05AE03",
    "drug_class": [
      "Antiviral",
      "Anti-HIV agent",
      "HIV protease inhibitor",
      "Metabolizing enzyme substrate",
      "CYP2D6 substrate",
      "CYP3A/CYP3A4 substrate",
      "Metabolizing enzyme inhibitor",
      "CYP3A/CYP3A4 inhibitor",
      "Metabolizing enzyme inducer",
      "CYP1A2 inducer",
      "CYP2C9 inducer",
      "CYP2C19 inducer"
    ],
    "cyp_enzymes": [
      "CYP3A",
      "CYP2D6"
    ],
    "search_name": "Ritonavir"
  },
  {
    "kegg_id": "D06478",
    "name_en": "Darunavir ethanolate (JAN)",
    "name_ja": "",
    "names_alt": [
      "Prezista (TN)"
    ],
    "formula": "C27H37N3O7S. C2H6O",
    "efficacy": "Antiviral, HIV protease inhibitor\nDISEASE   HIV-1 infection [DS:H01563]",
    "target": "HIV protease [KO:K22599]\nPATHWAY   ko03230(K22599)  Viral genome structure\nko03250(K22599)  Viral life cycle - HIV-1",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "6250",
    "atc_code": "J05AE10",
    "drug_class": [
      "Antiviral",
      "Anti-HIV agent",
      "HIV protease inhibitor",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "Metabolizing enzyme inhibitor",
      "CYP3A/CYP3A4 inhibitor",
      "CYP3A4 inhibitor"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Darunavir ethanolate"
  },
  {
    "kegg_id": "D12353",
    "name_en": "Ensitrelvir fumarate (USAN)",
    "name_ja": "",
    "names_alt": [
      "Ensitrelvir fumaric acid (JAN)",
      "Xocova (TN)"
    ],
    "formula": "C22H17ClF3N9O2. C4H4O4",
    "efficacy": "Antiviral",
    "target": "SARS coronavirus 3C-like proteinase [KO:K25015]\nPATHWAY   ko03230(K25015)  Viral genome structure\nko03262(K25015)  Virion - Coronavirus\nko05171(K25015)  Coronavirus disease - COVID-19",
    "metabolism": "Enzyme: CYP3A [HSA:1576 1577 1551]",
    "therapeutic_category": "6250",
    "atc_code": "J05AE16",
    "drug_class": [
      "Antiviral",
      "Anti-SARS-CoV-2 agent",
      "COVID 3CL protease inhibitor",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "Metabolizing enzyme inhibitor",
      "CYP3A/CYP3A4 inhibitor",
      "Transporter inhibitor",
      "ABCB1 inhibitor",
      "ABCG2 inhibitor",
      "SLCO1B1 inhibitor",
      "SLCO1B3 inhibitor"
    ],
    "cyp_enzymes": [
      "CYP3A"
    ],
    "search_name": "Ensitrelvir fumarate"
  },
  {
    "kegg_id": "D12269",
    "name_en": "Nirmatrelvir and ritonavir",
    "name_ja": "",
    "names_alt": [
      "Paxlovid (TN)"
    ],
    "formula": "",
    "efficacy": "Antiviral\nDISEASE   Coronavirus disease 2019 [DS:H02398]",
    "target": "",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "6250",
    "atc_code": "J05AE30",
    "drug_class": [
      "Antiviral",
      "Anti-SARS-CoV-2 agent",
      "COVID 3CL protease inhibitor",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "Metabolizing enzyme inhibitor",
      "CYP3A/CYP3A4 inhibitor"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Nirmatrelvir and ritonavir"
  },
  {
    "kegg_id": "D00413",
    "name_en": "Zidovudine (JP18/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Azidothymidine",
      "Retrovir (TN)\nABBR      AZT, ZDV"
    ],
    "formula": "C10H13N5O4",
    "efficacy": "Antiviral, Reverse transcriptase inhibitor\nDISEASE   HIV-1 infection [DS:H01563]",
    "target": "HIV-1 reverse transcriptase [KO:K24802]\nPATHWAY   ko03230(K24802)  Viral genome structure\nko03240(K24802)  Viral replication\nko03250(K24802)  Viral life cycle - HIV-1\nko03260(K24802)  Virion - Human immunodeficiency virus",
    "metabolism": "Transporter: SLC22A6 [HSA:9356], SLC22A8 [HSA:9376]",
    "therapeutic_category": "6250",
    "atc_code": "J05AF01",
    "drug_class": [
      "Antiviral",
      "Nucleoside reverse transcriptase inhibitor (NRTI)",
      "Zidovudine type antiviral",
      "Anti-HIV agent",
      "HIV reverse transcriptase inhibitor",
      "Transporter substrate",
      "SLC22A6 substrate",
      "SLC22A8 substrate"
    ],
    "cyp_enzymes": [],
    "search_name": "Zidovudine"
  },
  {
    "kegg_id": "D00353",
    "name_en": "Lamivudine (JAN/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Epivir (TN)\nABBR      3TC"
    ],
    "formula": "C8H11N3O3S",
    "efficacy": "Antiviral, Reverse transcriptase inhibitor\nDISEASE   HIV-1 infection [DS:H01563]\nHepatitis B [DS:H00412]",
    "target": "HBV reverse transcriptase [KO:K21037]\nHIV-1 reverse transcriptase [KO:K24802]\nPATHWAY   ko03230(K21037+K24802)  Viral genome structure\nko03240(K21037+K24802)  Viral replication\nko03250(K24802)  Viral life cycle - HIV-1\nko03260(K24802)  Virion - Human immunodeficiency virus\nko05161(K21037)  Hepatitis B",
    "metabolism": "Transporter: SLC22A6 [HSA:9356]",
    "therapeutic_category": "6250",
    "atc_code": "J05AF05",
    "drug_class": [
      "Antiviral",
      "Nucleoside reverse transcriptase inhibitor (NRTI)",
      "Zidovudine type antiviral",
      "Anti-HIV agent",
      "HIV reverse transcriptase inhibitor",
      "Transporter substrate",
      "SLC22A6 substrate"
    ],
    "cyp_enzymes": [],
    "search_name": "Lamivudine"
  },
  {
    "kegg_id": "D00891",
    "name_en": "Abacavir sulfate (JAN/USP)",
    "name_ja": "",
    "names_alt": [
      "Ziagen (TN)"
    ],
    "formula": "(C14H18N6O)2. H2SO4",
    "efficacy": "Antiviral, Reverse transcriptase inhibitor\nDISEASE   HIV-1 infection [DS:H01563]",
    "target": "HIV-1 reverse transcriptase [KO:K24802]\nPATHWAY   ko03230(K24802)  Viral genome structure\nko03240(K24802)  Viral replication\nko03250(K24802)  Viral life cycle - HIV-1\nko03260(K24802)  Virion - Human immunodeficiency virus",
    "metabolism": "",
    "therapeutic_category": "6250",
    "atc_code": "J05AF06",
    "drug_class": [
      "Antiviral",
      "Nucleoside reverse transcriptase inhibitor (NRTI)",
      "Anti-HIV agent",
      "HIV reverse transcriptase inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Abacavir sulfate"
  },
  {
    "kegg_id": "D01982",
    "name_en": "Tenofovir disoproxil fumarate (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Viread (TN)\nABBR      TDF"
    ],
    "formula": "C19H30N5O10P. C4H4O4",
    "efficacy": "Antiviral, Reverse transcriptase inhibitor\nDISEASE   HIV-1 infection [DS:H01563]\nChronic Hepatitis B [DS:H00412]",
    "target": "HBV reverse transcriptase [KO:K21037]\nHIV-1 reverse transcriptase [KO:K24802]\nPATHWAY   ko03230(K21037+K24802)  Viral genome structure\nko03240(K21037+K24802)  Viral replication\nko03250(K24802)  Viral life cycle - HIV-1\nko05161(K21037)  Hepatitis B",
    "metabolism": "",
    "therapeutic_category": "6250",
    "atc_code": "J05AF07",
    "drug_class": [
      "Antiviral",
      "Nucleoside reverse transcriptase inhibitor (NRTI)",
      "Anti-HIV agent",
      "HIV reverse transcriptase inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Tenofovir disoproxil fumarate"
  },
  {
    "kegg_id": "D04008",
    "name_en": "Entecavir (USP)",
    "name_ja": "",
    "names_alt": [
      "Entecavir hydrate (JAN)",
      "Baraclude (TN)"
    ],
    "formula": "C12H15N5O3. H2O",
    "efficacy": "Antiviral, Reverse transcriptase inhibitor\nDISEASE   Hepatitis B [DS:H00412]",
    "target": "HBV reverse transcriptase [KO:K21037]\nPATHWAY   ko03230(K21037)  Viral genome structure\nko03240(K21037)  Viral replication\nko05161(K21037)  Hepatitis B",
    "metabolism": "",
    "therapeutic_category": "6250",
    "atc_code": "J05AF10",
    "drug_class": [
      "Antiviral",
      "Nucleoside reverse transcriptase inhibitor (NRTI)"
    ],
    "cyp_enzymes": [],
    "search_name": "Entecavir"
  },
  {
    "kegg_id": "D10605",
    "name_en": "Tenofovir alafenamide fumarate (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Vemlidy (TN)\nABBR      TAF"
    ],
    "formula": "(C21H29N6O5P)2. C4H4O4",
    "efficacy": "Antiviral, Reverse transcriptase inhibitor\nDISEASE   Chronic hepatitis B virus infection [DS:H00412]",
    "target": "HBV reverse transcriptase [KO:K21037]\nPATHWAY   ko03230(K21037)  Viral genome structure\nko03240(K21037)  Viral replication\nko05161(K21037)  Hepatitis B",
    "metabolism": "Transporter: ABCB1 [HSA:5243], ABCG2 [HSA:9429]",
    "therapeutic_category": "6250",
    "atc_code": "J05AF13",
    "drug_class": [
      "Antiviral",
      "Nucleoside reverse transcriptase inhibitor (NRTI)",
      "Anti-HIV agent",
      "HIV reverse transcriptase inhibitor",
      "Transporter substrate",
      "ABCB1 substrate",
      "ABCG2 substrate"
    ],
    "cyp_enzymes": [],
    "search_name": "Tenofovir alafenamide fumarate"
  },
  {
    "kegg_id": "D00435",
    "name_en": "Nevirapine (JAN/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Viramune (TN)\nABBR      NVP"
    ],
    "formula": "C15H14N4O",
    "efficacy": "Antiviral, Reverse transcriptase inhibitor\nDISEASE   HIV-1 infection [DS:H01563]",
    "target": "HIV-1 reverse transcriptase [KO:K24802]\nPATHWAY   ko03230(K24802)  Viral genome structure\nko03240(K24802)  Viral replication\nko03250(K24802)  Viral life cycle - HIV-1\nko03260(K24802)  Virion - Human immunodeficiency virus",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576], CYP2B6 [HSA:1555], CYP2D6 [HSA:1565]",
    "therapeutic_category": "6250",
    "atc_code": "J05AG01",
    "drug_class": [
      "Antiviral",
      "Non-nucleoside reverse transcriptase inhibitor (NNRTI)",
      "Anti-HIV agent",
      "HIV reverse transcriptase inhibitor",
      "Metabolizing enzyme substrate",
      "CYP2B6 substrate",
      "CYP2D6 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4",
      "CYP2B6",
      "CYP2D6"
    ],
    "search_name": "Nevirapine"
  },
  {
    "kegg_id": "D09720",
    "name_en": "Rilpivirine (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Rekambys (TN)"
    ],
    "formula": "C22H18N6",
    "efficacy": "Antiviral, Reverse transcriptase inhibitor",
    "target": "HIV-1 reverse transcriptase [KO:K24802]\nPATHWAY   ko03230(K24802)  Viral genome structure\nko03240(K24802)  Viral replication\nko03250(K24802)  Viral life cycle - HIV-1",
    "metabolism": "Enzyme: CYP3A [HSA:1576 1577 1551]",
    "therapeutic_category": "6250",
    "atc_code": "J05AG05",
    "drug_class": [
      "Antiviral",
      "Non-nucleoside reverse transcriptase inhibitor (NNRTI)",
      "Anti-HIV agent",
      "HIV reverse transcriptase inhibitor",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A"
    ],
    "search_name": "Rilpivirine"
  },
  {
    "kegg_id": "D09958",
    "name_en": "Rilpivirine hydrochloride (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Edurant (TN)"
    ],
    "formula": "C22H18N6. HCl",
    "efficacy": "Antiviral, Reverse transcriptase inhibitor\nDISEASE   HIV-1 infection [DS:H01563]",
    "target": "HIV-1 reverse transcriptase [KO:K24802]\nPATHWAY   ko03230(K24802)  Viral genome structure\nko03240(K24802)  Viral replication\nko03250(K24802)  Viral life cycle - HIV-1",
    "metabolism": "Enzyme: CYP3A [HSA:1576 1577 1551]",
    "therapeutic_category": "6250",
    "atc_code": "J05AG05",
    "drug_class": [
      "Antiviral",
      "Non-nucleoside reverse transcriptase inhibitor (NNRTI)",
      "Anti-HIV agent",
      "HIV reverse transcriptase inhibitor",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A"
    ],
    "search_name": "Rilpivirine hydrochloride"
  },
  {
    "kegg_id": "D10624",
    "name_en": "Doravirine (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Pifeltro (TN)\nABBR      DOR"
    ],
    "formula": "C17H11ClF3N5O3",
    "efficacy": "Antiviral, Reverse transcriptase inhibitor\nDISEASE   HIV-1 infection [DS:H01563]",
    "target": "HIV-1 reverse transcriptase [KO:K24802]\nPATHWAY   ko03230(K24802)  Viral genome structure\nko03240(K24802)  Viral replication\nko03250(K24802)  Viral life cycle - HIV-1",
    "metabolism": "Enzyme: CYP3A [HSA:1576 1577 1551]",
    "therapeutic_category": "6250",
    "atc_code": "J05AG06",
    "drug_class": [
      "Antiviral",
      "Non-nucleoside reverse transcriptase inhibitor (NNRTI)",
      "Anti-HIV agent",
      "HIV reverse transcriptase inhibitor",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A"
    ],
    "search_name": "Doravirine"
  },
  {
    "kegg_id": "D01937",
    "name_en": "Zanamivir hydrate (JAN)",
    "name_ja": "",
    "names_alt": [
      "Relenza (TN)"
    ],
    "formula": "C12H20N4O7. xH2O",
    "efficacy": "Antiviral, Neuraminidase inhibitor",
    "target": "Influenza A/B virus neuraminidase [KO:K19392]\nPATHWAY   ko03230(K19392)  Viral genome structure\nko05164(K19392)  Influenza A",
    "metabolism": "",
    "therapeutic_category": "6250",
    "atc_code": "J05AH01",
    "drug_class": [
      "Antiviral",
      "Anti-influenza virus agent",
      "Neuraminidase inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Zanamivir hydrate"
  },
  {
    "kegg_id": "D00900",
    "name_en": "Oseltamivir phosphate (JAN/USP)",
    "name_ja": "オセルタミビル",
    "names_alt": [
      "Tamiflu (TN)",
      "Ebilfumin (TN)"
    ],
    "formula": "C16H28N2O4. H3PO4",
    "efficacy": "Antiviral, Neuraminidase inhibitor\nDISEASE   Influenza [DS:H00398]",
    "target": "Influenza A/B virus neuraminidase [KO:K19392]\nPATHWAY   ko03230(K19392)  Viral genome structure\nko05164(K19392)  Influenza A",
    "metabolism": "",
    "therapeutic_category": "6250",
    "atc_code": "J05AH02",
    "drug_class": [
      "Antiviral",
      "Anti-influenza virus agent",
      "Neuraminidase inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Oseltamivir phosphate"
  },
  {
    "kegg_id": "D03829",
    "name_en": "Peramivir (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Peramivir hydrate (JAN)",
      "Rapivab (TN)\nABBR      PRV"
    ],
    "formula": "C15H28N4O4. 3H2O",
    "efficacy": "Antiviral, Neuraminidase inhibitor\nDISEASE   Influenza [DS:H00398]",
    "target": "Influenza A/B virus neuraminidase [KO:K19392]\nPATHWAY   ko03230(K19392)  Viral genome structure\nko05164(K19392)  Influenza A",
    "metabolism": "",
    "therapeutic_category": "6250",
    "atc_code": "J05AH03",
    "drug_class": [
      "Antiviral",
      "Anti-influenza virus agent",
      "Neuraminidase inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Peramivir"
  },
  {
    "kegg_id": "D09547",
    "name_en": "Laninamivir octanoate hydrate (JAN)\nABBR      LO",
    "name_ja": "",
    "names_alt": [],
    "formula": "C21H36N4O8. H2O",
    "efficacy": "Antiviral, Neuraminidase inhibitor",
    "target": "Influenza A/B virus neuraminidase [KO:K19392]\nPATHWAY   ko03230(K19392)  Viral genome structure\nko05164(K19392)  Influenza A",
    "metabolism": "",
    "therapeutic_category": "6250",
    "atc_code": "J05AH04",
    "drug_class": [
      "Antiviral",
      "Anti-influenza virus agent",
      "Neuraminidase inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Laninamivir octanoate hydrate"
  },
  {
    "kegg_id": "D07133",
    "name_en": "Raltegravir potassium (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Isentress (TN)"
    ],
    "formula": "C20H20FN6O5. K",
    "efficacy": "Antiviral, HIV integrase inhibitor\nDISEASE   HIV-1 infection [DS:H01563]",
    "target": "HIV-1 integrase [KO:K24803]\nPATHWAY   ko03230(K24803)  Viral genome structure\nko03240(K24803)  Viral replication\nko03250(K24803)  Viral life cycle - HIV-1",
    "metabolism": "Enzyme: UGT1A1 [HSA:54658]",
    "therapeutic_category": "6250",
    "atc_code": "J05AJ01",
    "drug_class": [
      "Antiviral",
      "Anti-HIV agent",
      "HIV integrase inhibitor",
      "Metabolizing enzyme substrate",
      "UGT substrate",
      "UGT1A1 substrate"
    ],
    "cyp_enzymes": [],
    "search_name": "Raltegravir potassium"
  },
  {
    "kegg_id": "D10113",
    "name_en": "Dolutegravir sodium (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Tivicay (TN)"
    ],
    "formula": "C20H18F2N3O5. Na",
    "efficacy": "Antiviral, HIV integrase inhibitor\nDISEASE   HIV-1 infection [DS:H01563]",
    "target": "HIV-1 integrase [KO:K24803]\nPATHWAY   ko03230(K24803)  Viral genome structure\nko03240(K24803)  Viral replication\nko03250(K24803)  Viral life cycle - HIV-1",
    "metabolism": "Enzyme: UGT1A1 [HSA:54658]; CYP3A4 [HSA:1576]",
    "therapeutic_category": "6250",
    "atc_code": "J05AJ03",
    "drug_class": [
      "Antiviral",
      "Anti-HIV agent",
      "HIV integrase inhibitor",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "UGT substrate",
      "UGT1A1 substrate",
      "Transporter inhibitor",
      "SLC22A2 inhibitor",
      "SLC47A1 inhibitor"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Dolutegravir sodium"
  },
  {
    "kegg_id": "D10548",
    "name_en": "Cabotegravir (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Vocabria (TN)",
      "Apretude (TN)"
    ],
    "formula": "C19H17F2N3O5",
    "efficacy": "Antiviral, HIV integrase inhibitor",
    "target": "HIV-1 integrase [KO:K24803]\nPATHWAY   ko03230(K24803)  Viral genome structure\nko03240(K24803)  Viral replication\nko03250(K24803)  Viral life cycle - HIV-1",
    "metabolism": "Enzyme: UGT1A1 [HSA:54658]; UGT1A9 [HSA:54600]",
    "therapeutic_category": "6250",
    "atc_code": "J05AJ04",
    "drug_class": [
      "Antiviral",
      "Anti-HIV agent",
      "HIV integrase inhibitor",
      "Metabolizing enzyme substrate",
      "UGT substrate",
      "UGT1A1 substrate",
      "UGT1A9 substrate"
    ],
    "cyp_enzymes": [],
    "search_name": "Cabotegravir"
  },
  {
    "kegg_id": "D10549",
    "name_en": "Cabotegravir sodium (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Vocabria (TN)"
    ],
    "formula": "C19H16F2N3O5. Na",
    "efficacy": "Antiviral, HIV integrase inhibitor\nDISEASE   HIV-1 infection [DS:H01563]",
    "target": "HIV-1 integrase [KO:K24803]\nPATHWAY   ko03230(K24803)  Viral genome structure\nko03240(K24803)  Viral replication\nko03250(K24803)  Viral life cycle - HIV-1",
    "metabolism": "Enzyme: UGT1A1 [HSA:54658]; UGT1A9 [HSA:54600]",
    "therapeutic_category": "6250",
    "atc_code": "J05AJ04",
    "drug_class": [
      "Antiviral",
      "Anti-HIV agent",
      "HIV integrase inhibitor",
      "Metabolizing enzyme substrate",
      "UGT substrate",
      "UGT1A1 substrate",
      "UGT1A9 substrate"
    ],
    "cyp_enzymes": [],
    "search_name": "Cabotegravir sodium"
  },
  {
    "kegg_id": "D00423",
    "name_en": "Ribavirin (JP18/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Copegus (TN)",
      "Rebetol (TN)",
      "Ribasphere (TN)",
      "Virazole (TN)\nABBR      RBV"
    ],
    "formula": "C8H12N4O5",
    "efficacy": "Antiviral\nDISEASE   Chronic hepatitis C [DS:H00413]\nRSV infection [DS:H00401]",
    "target": "HCV NS5B polymerase [KO:K22472]\nPATHWAY   ko03230(K22472)  Viral genome structure\nko03240(K22472)  Viral replication\nko05160(K22472)  Hepatitis C",
    "metabolism": "",
    "therapeutic_category": "6250",
    "atc_code": "J05AP01",
    "drug_class": [
      "Antiviral",
      "Arabinofuranosyl type antiviral",
      "Anti-HCV agent",
      "HCV NS5B polymerase inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Ribavirin"
  },
  {
    "kegg_id": "D10578",
    "name_en": "Ledipasvir and sofosbuvir",
    "name_ja": "",
    "names_alt": [
      "Harvoni (TN)"
    ],
    "formula": "",
    "efficacy": "Antiviral\nDISEASE   Chronic hepatitis C virus infection [DS:H00413]",
    "target": "HCV NS5A [KO:K22275]\nHCV NS5B [KO:K22472]\nPATHWAY   ko03230(K22275+K22472)  Viral genome structure\nko03240(K22275+K22472)  Viral replication\nko05160(K22275+K22472)  Hepatitis C",
    "metabolism": "Transporter: ABCB1 [HSA:5243], ABCG2 [HSA:9429]",
    "therapeutic_category": "6250",
    "atc_code": "J05AP51",
    "drug_class": [
      "Antiviral",
      "Anti-HCV agent",
      "Transporter substrate",
      "ABCB1 substrate",
      "ABCG2 substrate"
    ],
    "cyp_enzymes": [],
    "search_name": "Ledipasvir and sofosbuvir"
  },
  {
    "kegg_id": "D10827",
    "name_en": "Sofosbuvir and velpatasvir",
    "name_ja": "",
    "names_alt": [
      "Epclusa (TN)"
    ],
    "formula": "",
    "efficacy": "Antiviral\nDISEASE   Hepatitis C virus infection [DS:H00413]",
    "target": "HCV NS5A [KO:K22275]\nHCV NS5B [KO:K22472]",
    "metabolism": "Enzyme: CYP2B6 [HSA:1555], CYP2C8 [HSA:1558], CYP3A4 [HSA:1576]\nTransporter: ABCB1 [HSA:5243], ABCG2 [HSA:9429]",
    "therapeutic_category": "6250",
    "atc_code": "J05AP55",
    "drug_class": [
      "Antiviral",
      "Anti-HCV agent",
      "Metabolizing enzyme substrate",
      "CYP2B6 substrate",
      "CYP2C8 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "Transporter substrate",
      "ABCB1 substrate",
      "ABCG2 substrate",
      "Transporter inhibitor",
      "ABCB1 inhibitor",
      "ABCG2 inhibitor",
      "SLCO1B1 inhibitor",
      "SLCO1B3 inhibitor"
    ],
    "cyp_enzymes": [
      "CYP2C8",
      "CYP3A4",
      "CYP2B6"
    ],
    "search_name": "Sofosbuvir and velpatasvir"
  },
  {
    "kegg_id": "D11014",
    "name_en": "Glecaprevir and pibrentasvir",
    "name_ja": "",
    "names_alt": [
      "Mavyret (TN)"
    ],
    "formula": "",
    "efficacy": "Antiviral\nDISEASE   Chronic hepatitis C virus infection [DS:H00413]",
    "target": "HCV NS3/4A protease [KO:K22273 K22274]\nHCV NS5A [KO:K22275]",
    "metabolism": "Transporter: ABCB1 [HSA:5243], ABCG2 [HSA:9429], SLCO1B1 [HSA:10599], SLCO1B3 [HSA:28234]",
    "therapeutic_category": "6250",
    "atc_code": "J05AP57",
    "drug_class": [
      "Antiviral",
      "Anti-HCV agent",
      "Transporter substrate",
      "ABCB1 substrate",
      "ABCG2 substrate",
      "SLCO1B1 substrate",
      "SLCO1B3 substrate",
      "Transporter inhibitor",
      "ABCB1 inhibitor",
      "ABCG2 inhibitor",
      "SLCO1B1 inhibitor",
      "SLCO1B3 inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Glecaprevir and pibrentasvir"
  },
  {
    "kegg_id": "D07507",
    "name_en": "Zidovudine and lamivudine",
    "name_ja": "",
    "names_alt": [
      "Combivir (TN)"
    ],
    "formula": "",
    "efficacy": "Antiviral\nDISEASE   HIV-1 infection [DS:H01563]",
    "target": "HIV-1 reverse transcriptase [KO:K24802]\nPATHWAY   ko03230(K24802)  Viral genome structure\nko03240(K24802)  Viral replication\nko03250(K24802)  Viral life cycle - HIV-1",
    "metabolism": "",
    "therapeutic_category": "6250",
    "atc_code": "J05AR01",
    "drug_class": [
      "Antiviral",
      "Nucleoside reverse transcriptase inhibitor (NRTI)",
      "Zidovudine type antiviral",
      "Anti-HIV agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Zidovudine and lamivudine"
  },
  {
    "kegg_id": "D08775",
    "name_en": "Abacavir sulfate and lamivudine",
    "name_ja": "",
    "names_alt": [
      "Epzicom (TN)"
    ],
    "formula": "",
    "efficacy": "Antiviral\nDISEASE   HIV-1 infection [DS:H01563]",
    "target": "HIV-1 reverse transcriptase [KO:K24802]\nPATHWAY   ko03230(K24802)  Viral genome structure\nko03240(K24802)  Viral replication\nko03250(K24802)  Viral life cycle - HIV-1",
    "metabolism": "",
    "therapeutic_category": "6250",
    "atc_code": "J05AR02",
    "drug_class": [
      "Antiviral",
      "Nucleoside reverse transcriptase inhibitor (NRTI)",
      "Anti-HIV agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Abacavir sulfate and lamivudine"
  },
  {
    "kegg_id": "D02297",
    "name_en": "Emtricitabine and tenofovir disoproxil",
    "name_ja": "",
    "names_alt": [
      "Truvada (TN)"
    ],
    "formula": "",
    "efficacy": "Antiviral\nDISEASE   HIV-1 infection [DS:H01563]",
    "target": "HIV-1 reverse transcriptase [KO:K24802]\nPATHWAY   ko03230(K24802)  Viral genome structure\nko03240(K24802)  Viral replication\nko03250(K24802)  Viral life cycle - HIV-1",
    "metabolism": "",
    "therapeutic_category": "6250",
    "atc_code": "J05AR03",
    "drug_class": [
      "Antiviral",
      "Nucleoside reverse transcriptase inhibitor (NRTI)",
      "Anti-HIV agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Emtricitabine and tenofovir disoproxil"
  },
  {
    "kegg_id": "D02498",
    "name_en": "Lopinavir and ritonavir",
    "name_ja": "",
    "names_alt": [
      "Kaletra (TN)\nABBR      LPV/r"
    ],
    "formula": "C37H48N6O5S2. C37H48N4O5",
    "efficacy": "Antiviral\nDISEASE   HIV-1 infection [DS:H01563]",
    "target": "HIV protease [KO:K22599]\nPATHWAY   ko03230(K22599)  Viral genome structure\nko03250(K22599)  Viral life cycle - HIV-1",
    "metabolism": "Enzyme: CYP3A [HSA:1576 1577 1551]",
    "therapeutic_category": "6250",
    "atc_code": "J05AR10",
    "drug_class": [
      "Antiviral",
      "Anti-HIV agent",
      "HIV protease inhibitor",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "Metabolizing enzyme inhibitor",
      "CYP3A/CYP3A4 inhibitor"
    ],
    "cyp_enzymes": [
      "CYP3A"
    ],
    "search_name": "Lopinavir and ritonavir"
  },
  {
    "kegg_id": "D10600",
    "name_en": "Dolutegravir, abacavir and lamivudine",
    "name_ja": "",
    "names_alt": [
      "Triumeq (TN)"
    ],
    "formula": "",
    "efficacy": "Antiviral\nDISEASE   HIV-1 infection [DS:H01563]",
    "target": "HIV-1 reverse transcriptase [KO:K24802]\nHIV-1 integrase [KO:K24803]\nPATHWAY   ko03230(K24802+K24803)  Viral genome structure\nko03240(K24802+K24803)  Viral replication\nko03250(K24802+K24803)  Viral life cycle - HIV-1",
    "metabolism": "Enzyme: UGT1A1 [HSA:54658]; CYP3A4 [HSA:1576]",
    "therapeutic_category": "6250",
    "atc_code": "J05AR13",
    "drug_class": [
      "Antiviral",
      "Anti-HIV agent",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "UGT substrate",
      "UGT1A1 substrate",
      "Transporter inhibitor",
      "SLC22A2 inhibitor",
      "SLC47A1 inhibitor"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Dolutegravir, abacavir and lamivudine"
  },
  {
    "kegg_id": "D10832",
    "name_en": "Darunavir and cobicistat",
    "name_ja": "",
    "names_alt": [
      "Prezcobix (TN)",
      "Rezolsta (TN)\nABBR      DRV/c"
    ],
    "formula": "",
    "efficacy": "Antiviral\nDISEASE   HIV-1 infection [DS:H01563]",
    "target": "HIV protease [KO:K22599]\nPATHWAY   ko03230(K22599)  Viral genome structure\nko03250(K22599)  Viral life cycle - HIV-1",
    "metabolism": "Enzyme: CYP3A [HSA:1576 1577 1551], CYP2D6 [HSA:1565]",
    "therapeutic_category": "6250",
    "atc_code": "J05AR14",
    "drug_class": [
      "Antiviral",
      "Anti-HIV agent",
      "Metabolizing enzyme substrate",
      "CYP2D6 substrate",
      "CYP3A/CYP3A4 substrate",
      "Metabolizing enzyme inhibitor",
      "CYP2D6 inhibitor",
      "CYP3A/CYP3A4 inhibitor",
      "Transporter inhibitor",
      "ABCB1 inhibitor",
      "ABCG2 inhibitor",
      "SLCO1B1 inhibitor",
      "SLCO1B3 inhibitor"
    ],
    "cyp_enzymes": [
      "CYP3A",
      "CYP2D6"
    ],
    "search_name": "Darunavir and cobicistat"
  },
  {
    "kegg_id": "D10835",
    "name_en": "Emtricitabine and tenofovir alafenamide",
    "name_ja": "",
    "names_alt": [
      "Descovy (TN)"
    ],
    "formula": "",
    "efficacy": "Antiviral\nDISEASE   HIV infection [DS:H01563]",
    "target": "HIV-1 reverse transcriptase [KO:K24802]\nPATHWAY   ko03230(K24802)  Viral genome structure\nko03240(K24802)  Viral replication\nko03250(K24802)  Viral life cycle - HIV-1",
    "metabolism": "Enzyme: CTSA [HSA:5476], CYP3A [HSA:1576 1577 1551]\nTransporter: ABCB1 [HSA:5243]",
    "therapeutic_category": "6250",
    "atc_code": "J05AR17",
    "drug_class": [
      "Antiviral",
      "Nucleoside reverse transcriptase inhibitor (NRTI)",
      "Anti-HIV agent",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "Transporter substrate",
      "ABCB1 substrate",
      "CTSA substrate"
    ],
    "cyp_enzymes": [
      "CYP3A"
    ],
    "search_name": "Emtricitabine and tenofovir alafenamide"
  },
  {
    "kegg_id": "D10755",
    "name_en": "Elvitegravir, cobicistat, emtricitabine and tenofovir alafenamide",
    "name_ja": "",
    "names_alt": [
      "Genvoya (TN)"
    ],
    "formula": "",
    "efficacy": "Antiviral\nDISEASE   HIV-1 infection [DS:H01563]",
    "target": "HIV-1 reverse transcriptase [KO:K24802]\nHIV-1 integrase [KO:K24803]\nPATHWAY   ko03230(K24802+K24803)  Viral genome structure\nko03240(K24802+K24803)  Viral replication\nko03250(K24802+K24803)  Viral life cycle - HIV-1",
    "metabolism": "Enzyme: CYP3A [HSA:1576 1577 1551], CYP2D6 [HSA:1565], CTSA [HSA:5476]\nTransporter: ABCB1 [HSA:5243], SLC22A2 [HSA:6582]",
    "therapeutic_category": "6250",
    "atc_code": "J05AR18",
    "drug_class": [
      "Antiviral",
      "Anti-HIV agent",
      "Metabolizing enzyme substrate",
      "CYP2D6 substrate",
      "CYP3A/CYP3A4 substrate",
      "Metabolizing enzyme inhibitor",
      "CYP2D6 inhibitor",
      "CYP3A/CYP3A4 inhibitor",
      "Transporter substrate",
      "ABCB1 substrate",
      "SLC22A2 substrate",
      "CTSA substrate",
      "Transporter inhibitor",
      "ABCB1 inhibitor"
    ],
    "cyp_enzymes": [
      "CYP3A",
      "CYP2D6"
    ],
    "search_name": "Elvitegravir, cobicistat, emtricitabine and tenofovir alafenamide"
  },
  {
    "kegg_id": "D10836",
    "name_en": "Emtricitabine, rilpivirine and tenofovir alafenamide",
    "name_ja": "",
    "names_alt": [
      "Odefsey (TN)"
    ],
    "formula": "",
    "efficacy": "Antiviral\nDISEASE   HIV-1 infection [DS:H01563]",
    "target": "HIV-1 reverse transcriptase [KO:K24802]",
    "metabolism": "Enzyme: CTSA [HSA:5476], CYP3A [HSA:1576 1577 1551]\nTransporter: ABCB1 [HSA:5243]",
    "therapeutic_category": "6250",
    "atc_code": "J05AR19",
    "drug_class": [
      "Antiviral",
      "Anti-HIV agent",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "Transporter substrate",
      "ABCB1 substrate",
      "CTSA substrate"
    ],
    "cyp_enzymes": [
      "CYP3A"
    ],
    "search_name": "Emtricitabine, rilpivirine and tenofovir alafenamide"
  },
  {
    "kegg_id": "D11039",
    "name_en": "Bictegravir, emtricitabine and tenofovir alafenamide",
    "name_ja": "",
    "names_alt": [
      "Biktarvy (TN)"
    ],
    "formula": "",
    "efficacy": "Antiviral\nDISEASE   HIV-1 infection [DS:H01563]",
    "target": "HIV-1 reverse transcriptase [KO:K24802]\nHIV-1 integrase [KO:K24803]\nPATHWAY   ko03230(K24802+K24803)  Viral genome structure\nko03240(K24802+K24803)  Viral replication\nko03250(K24802+K24803)  Viral life cycle - HIV-1",
    "metabolism": "",
    "therapeutic_category": "6250",
    "atc_code": "J05AR20",
    "drug_class": [
      "Antiviral",
      "Anti-HIV agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Bictegravir, emtricitabine and tenofovir alafenamide"
  },
  {
    "kegg_id": "D11282",
    "name_en": "Dolutegravir sodium and rilpivirine hydrochloride",
    "name_ja": "",
    "names_alt": [
      "Juluca (TN)"
    ],
    "formula": "",
    "efficacy": "Antiviral\nDISEASE   HIV-1 infection [DS:H01563]",
    "target": "HIV-1 reverse transcriptase [KO:K24802]\nHIV-1 integrase [KO:K24803]\nPATHWAY   ko03230(K24802+K24803)  Viral genome structure\nko03240(K24802+K24803)  Viral replication\nko03250(K24802+K24803)  Viral life cycle - HIV-1",
    "metabolism": "Enzyme: CYP3A [HSA:1576 1577 1551], UGT1A1 [HSA:54658]",
    "therapeutic_category": "6250",
    "atc_code": "J05AR21",
    "drug_class": [
      "Antiviral",
      "Anti-HIV agent",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "UGT substrate",
      "UGT1A1 substrate",
      "Transporter inhibitor",
      "SLC22A2 inhibitor",
      "SLC47A1 inhibitor"
    ],
    "cyp_enzymes": [
      "CYP3A"
    ],
    "search_name": "Dolutegravir sodium and rilpivirine hydrochloride"
  },
  {
    "kegg_id": "D11382",
    "name_en": "Darunavir, cobicistat, emtricitabine and tenofovir alafenamide",
    "name_ja": "",
    "names_alt": [
      "Symtuza (TN)"
    ],
    "formula": "",
    "efficacy": "Antiviral\nDISEASE   HIV-1 infection [DS:H01563]",
    "target": "HIV protease [KO:K22599]\nHIV-1 reverse transcriptase [KO:K24802]\nPATHWAY   ko03230(K22599+K24802)  Viral genome structure\nko03240(K24802)  Viral replication\nko03250(K22599+K24802)  Viral life cycle - HIV-1",
    "metabolism": "Enzyme: CYP3A [HSA:1576 1577 1551], CYP2D6 [HSA:1565], CTSA [HSA:5476]\nTransporter: ABCB1 [HSA:5243]",
    "therapeutic_category": "6250",
    "atc_code": "J05AR22",
    "drug_class": [
      "Antiviral",
      "Anti-HIV agent",
      "Metabolizing enzyme substrate",
      "CYP2D6 substrate",
      "CYP3A/CYP3A4 substrate",
      "Metabolizing enzyme inhibitor",
      "CYP2D6 inhibitor",
      "CYP3A/CYP3A4 inhibitor",
      "Transporter substrate",
      "ABCB1 substrate",
      "CTSA substrate",
      "Transporter inhibitor",
      "ABCB1 inhibitor",
      "ABCG2 inhibitor",
      "SLCO1B1 inhibitor",
      "SLCO1B3 inhibitor"
    ],
    "cyp_enzymes": [
      "CYP3A",
      "CYP2D6"
    ],
    "search_name": "Darunavir, cobicistat, emtricitabine and tenofovir alafenamide"
  },
  {
    "kegg_id": "D11522",
    "name_en": "Dolutegravir and lamivudine",
    "name_ja": "",
    "names_alt": [
      "Dovato (TN)"
    ],
    "formula": "",
    "efficacy": "Antiviral\nDISEASE   HIV-1 infection [DS:H01563]",
    "target": "HIV-1 reverse transcriptase [KO:K24802]\nHIV-1 integrase [KO:K24803]\nPATHWAY   ko03230(K24802+K24803)  Viral genome structure\nko03240(K24802+K24803)  Viral replication\nko03250(K24802+K24803)  Viral life cycle - HIV-1",
    "metabolism": "",
    "therapeutic_category": "6250",
    "atc_code": "J05AR25",
    "drug_class": [
      "Antiviral",
      "Anti-HIV agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Dolutegravir and lamivudine"
  },
  {
    "kegg_id": "D06670",
    "name_en": "Maraviroc (JAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Selzentry (TN)\nABBR      MVC"
    ],
    "formula": "C29H41F2N5O",
    "efficacy": "Antiviral, CCR5 antagonist\nDISEASE   HIV-1 infection (CCR5-tropic) [DS:H01563]",
    "target": "CCR5 (CD195) [HSA:1234] [KO:K04180]\nPATHWAY   hsa03250(1234)  Viral life cycle - HIV-1\nhsa04060(1234)  Cytokine-cytokine receptor interaction\nhsa04061(1234)  Viral protein interaction with cytokine and cytokine receptor\nhsa04062(1234)  Chemokine signaling pathway\nhsa04144(1234)  Endocytosis\nhsa05170(1234)  Human immunodeficiency virus 1 infection",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "6250",
    "atc_code": "J05AX09",
    "drug_class": [
      "Antiviral",
      "Anti-HIV agent",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Maraviroc"
  },
  {
    "kegg_id": "D04859",
    "name_en": "Maribavir (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Camvia (TN)",
      "Livtencity (TN)"
    ],
    "formula": "C15H19Cl2N3O4",
    "efficacy": "Antiviral, Protein kinase inhibitor\nDISEASE   Cytomegalovirus infection [DS:H00368]",
    "target": "HCMV tegument serine/threonine protein kinase [KO:K26102]",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]; CYP1A2 [HSA:1544]",
    "therapeutic_category": "6250",
    "atc_code": "J05AX10",
    "drug_class": [
      "Antiviral",
      "Anti-cytomegalovirus agent",
      "Metabolizing enzyme substrate",
      "CYP1A2 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4",
      "CYP1A2"
    ],
    "search_name": "Maribavir"
  },
  {
    "kegg_id": "D10801",
    "name_en": "Letermovir (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Prevymis (TN)"
    ],
    "formula": "C29H28F4N4O4",
    "efficacy": "Antiviral\nDISEASE   Cytomegalovirus infection [DS:H00368]",
    "target": "HCMV DNA terminase complex [KO:K26103 K26104 K26105]",
    "metabolism": "Transporter: SLCO1B1 [HSA:10599], SLCO1B3 [HSA:28234]",
    "therapeutic_category": "6250",
    "atc_code": "J05AX18",
    "drug_class": [
      "Antiviral",
      "Anti-cytomegalovirus agent",
      "Metabolizing enzyme inhibitor",
      "CYP3A/CYP3A4 inhibitor",
      "Metabolizing enzyme inducer",
      "CYP2C9 inducer",
      "CYP2C19 inducer",
      "Transporter substrate",
      "SLCO1B1 substrate",
      "SLCO1B3 substrate",
      "Transporter inhibitor",
      "ABCG2 inhibitor",
      "SLCO1B1 inhibitor",
      "SLCO1B3 inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Letermovir"
  },
  {
    "kegg_id": "D11557",
    "name_en": "Tecovirimat hydrate (JAN)",
    "name_ja": "",
    "names_alt": [
      "Tecovirimat monohydrate",
      "Tpoxx (TN)",
      "Tepoxx (TN)"
    ],
    "formula": "C19H15F3N2O3. H2O",
    "efficacy": "Antiviral\nDISEASE   Smallpox [DS:H00372]",
    "target": "orthopoxvirus VP37 protein",
    "metabolism": "Enzyme: UGT1A1 [HSA:54658], UGT1A4 [HSA:54657]",
    "therapeutic_category": "6250",
    "atc_code": "J05AX24",
    "drug_class": [
      "Metabolizing enzyme substrate",
      "UGT substrate",
      "UGT1A1 substrate",
      "UGT1A4 substrate"
    ],
    "cyp_enzymes": [],
    "search_name": "Tecovirimat hydrate"
  },
  {
    "kegg_id": "D11021",
    "name_en": "Baloxavir marboxil (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Xofluza (TN)"
    ],
    "formula": "C27H23F2N3O7S",
    "efficacy": "Antiviral, cap-dependent endonuclease inhibitor\nDISEASE   Influenza [DS:H00398]",
    "target": "Influenza A virus polymerase acidic protein [KO:K19390]\nPATHWAY   ko03230(K19390)  Viral genome structure\nko03240(K19390)  Viral replication\nko05164(K19390)  Influenza A",
    "metabolism": "",
    "therapeutic_category": "6250",
    "atc_code": "J05AX25",
    "drug_class": [
      "Antiviral",
      "Anti-influenza virus agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Baloxavir marboxil"
  },
  {
    "kegg_id": "D10564",
    "name_en": "Amenamevir (JAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Amenalief (TN)"
    ],
    "formula": "C24H26N4O5S",
    "efficacy": "Antiviral, Helicase-primase inhibitor",
    "target": "Herpesvirus helicase-primase complex [KO:K25235 K25236 K25237]\nPATHWAY   ko03240(K25235+K25236+K25237)  Viral replication",
    "metabolism": "Enzyme: CYP3A [HSA:1576 1577 1551]",
    "therapeutic_category": "6250",
    "atc_code": "J05AX26",
    "drug_class": [
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "Metabolizing enzyme inducer",
      "CYP2B6 inducer",
      "CYP3A/CYP3A4 inducer"
    ],
    "cyp_enzymes": [
      "CYP3A"
    ],
    "search_name": "Amenamevir"
  },
  {
    "kegg_id": "D09537",
    "name_en": "Favipiravir (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Avigan (TN)\nABBR      FPV"
    ],
    "formula": "C5H4FN3O2",
    "efficacy": "Antiviral, RNA polymerase inhibitor",
    "target": "Influenza A virus RNA-directed RNA polymerase [KO:K19389]\nPATHWAY   ko03230(K19389)  Viral genome structure\nko03240(K19389)  Viral replication\nko05164(K19389)  Influenza A",
    "metabolism": "Enzyme: AOX1 [HSA:316]; XDH [HSA:7498]",
    "therapeutic_category": "6250",
    "atc_code": "J05AX27",
    "drug_class": [
      "Antiviral",
      "Anti-influenza virus agent",
      "Metabolizing enzyme substrate",
      "AOX1 substrate",
      "XDH substrate",
      "Metabolizing enzyme inhibitor",
      "CYP2C8 inhibitor",
      "AOX1 inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Favipiravir"
  },
  {
    "kegg_id": "D12162",
    "name_en": "Lenacapavir sodium (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Sunlenca (TN)"
    ],
    "formula": "C39H31ClF10N7O5S2. Na",
    "efficacy": "Antiviral, HIV-1 capsid protein inhibitor\nDISEASE   HIV-1 infection [DS:H01563]",
    "target": "HIV-1 capsid protein [KO:K25306]\nPATHWAY   ko03230(K25306)  Viral genome structure\nko03250(K25306)  Viral life cycle - HIV-1\nko03260(K25306)  Virion - Human immunodeficiency virus",
    "metabolism": "Enzyme: UGT1A1 [HSA:54658], CYP3A [HSA:1576 1577 1551]\nTransporter: ABCB1 [HSA:5243]",
    "therapeutic_category": "6250",
    "atc_code": "J05AX31",
    "drug_class": [
      "Antiviral",
      "Anti-HIV agent",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "UGT substrate",
      "UGT1A1 substrate",
      "Transporter substrate",
      "ABCB1 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A"
    ],
    "search_name": "Lenacapavir sodium"
  },
  {
    "kegg_id": "D02737",
    "name_en": "Palivizumab (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Palivizumab (genetical recombination) (JAN)",
      "Synagis (TN)\nABBR      PZ"
    ],
    "formula": "",
    "efficacy": "Antiviral, Anti-RS virus humanized antibody\nDISEASE   Respiratory syncytial virus infection [DS:H00401]\nTYPE      Monoclonal antibody",
    "target": "RSV F protein [KO:K19261]",
    "metabolism": "",
    "therapeutic_category": "6250",
    "atc_code": "J06BD01",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Palivizumab"
  },
  {
    "kegg_id": "D12262",
    "name_en": "Tixagevimab and cilgavimab",
    "name_ja": "",
    "names_alt": [
      "Tixagevimab (genetical recombination) and cilgavimab (genetical recombination)",
      "Evusheld (TN)"
    ],
    "formula": "",
    "efficacy": "Antiviral\nDISEASE   Coronavirus disease 2019 [DS:H02398]\nTYPE      Monoclonal antibody combination",
    "target": "SARS-CoV-2 spike glycoprotein S1 [KO:K25001]\nPATHWAY   ko03230(K25001)  Viral genome structure\nko03262(K25001)  Virion - Coronavirus",
    "metabolism": "",
    "therapeutic_category": "6250",
    "atc_code": "J06BD03",
    "drug_class": [
      "Antiviral",
      "Anti-SARS-CoV-2 agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Tixagevimab and cilgavimab"
  },
  {
    "kegg_id": "D12014",
    "name_en": "Sotrovimab (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Sotrovimab (genetical recombination) (JAN)",
      "Xevudy (TN)"
    ],
    "formula": "C6492H10060N1744O2038S40",
    "efficacy": "Antiviral\nDISEASE   COVID-19 [DS:H02398]\nTYPE      Monoclonal antibody",
    "target": "SARS-CoV-2 spike glycoprotein [KO:K24152]\nPATHWAY   ko03230(K24152)  Viral genome structure\nko03262(K24152)  Virion - Coronavirus\nko05171(K24152)  Coronavirus disease - COVID-19\nNETWORK   nt06171  SARS coronavirus 2 (SARS-CoV-2)",
    "metabolism": "",
    "therapeutic_category": "6250",
    "atc_code": "J06BD05",
    "drug_class": [
      "Antiviral",
      "Anti-SARS-CoV-2 agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Sotrovimab"
  },
  {
    "kegg_id": "D12142",
    "name_en": "Casirivimab and imdevimab",
    "name_ja": "",
    "names_alt": [
      "Casirivimab (genetical recombination) and imdevimab (genetical recombination)",
      "Regen-cov (TN)",
      "Ronapreve (TN)"
    ],
    "formula": "",
    "efficacy": "Antiviral\nTYPE      Monoclonal antibody combination",
    "target": "SARS-CoV-2 spike glycoprotein [KO:K24152]\nPATHWAY   ko03230(K24152)  Viral genome structure\nko03262(K24152)  Virion - Coronavirus\nko05171(K24152)  Coronavirus disease - COVID-19\nNETWORK   nt06171  SARS coronavirus 2 (SARS-CoV-2)",
    "metabolism": "",
    "therapeutic_category": "6250",
    "atc_code": "J06BD07",
    "drug_class": [
      "Antiviral",
      "Anti-SARS-CoV-2 agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Casirivimab and imdevimab"
  },
  {
    "kegg_id": "D11380",
    "name_en": "Nirsevimab (USAN)",
    "name_ja": "",
    "names_alt": [
      "Nirsevimab (genetical recombination) (JAN)",
      "Nirsevimab-alip",
      "Beyfortus (TN)"
    ],
    "formula": "C6494H10060N1708O2050S46",
    "efficacy": "Antiviral\nDISEASE   RSV disease [DS:H00401]\nTYPE      Monoclonal antibody",
    "target": "RSV F protein [KO:K19261]",
    "metabolism": "",
    "therapeutic_category": "6250",
    "atc_code": "J06BD08",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Nirsevimab"
  },
  {
    "kegg_id": "D12974",
    "name_en": "Sipavibart (INN)",
    "name_ja": "",
    "names_alt": [
      "Sipavibart (genetical recombination) (JAN)",
      "Kavigale (TN)"
    ],
    "formula": "C6430H9880N1704O2022S40",
    "efficacy": "Antiviral\nTYPE      Monoclonal antibody",
    "target": "SARS-CoV-2 spike glycoprotein [KO:K24152]\nPATHWAY   ko03230(K24152)  Viral genome structure\nko03262(K24152)  Virion - Coronavirus\nko05171(K24152)  Coronavirus disease - COVID-19",
    "metabolism": "",
    "therapeutic_category": "6250",
    "atc_code": "J06BD09",
    "drug_class": [
      "Antiviral",
      "Anti-SARS-CoV-2 agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Sipavibart"
  },
  {
    "kegg_id": "D00416",
    "name_en": "Miconazole (JP18/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Monistat (TN)",
      "Oravig (TN)"
    ],
    "formula": "C18H14Cl4N2O",
    "efficacy": "Antifungal, Ergosterol biosynthesis inhibitor\nDISEASE   Oropharyngeal candidiasis [DS:H00363]",
    "target": "sterol 14alpha-demethylase [KO:K05917]\nPATHWAY   ko00100(K05917)  Steroid biosynthesis",
    "metabolism": "",
    "therapeutic_category": "6290",
    "atc_code": "A01AB09",
    "drug_class": [
      "Antifungal",
      "Imidazole antifungal",
      "Metabolizing enzyme inhibitor",
      "CYP2C9 inhibitor",
      "CYP3A/CYP3A4 inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Miconazole"
  },
  {
    "kegg_id": "D00322",
    "name_en": "Fluconazole (JP18/USP/INN)",
    "name_ja": "フルコナゾール",
    "names_alt": [
      "Diflucan (TN)"
    ],
    "formula": "C13H12F2N6O",
    "efficacy": "Antifungal, Ergosterol biosynthesis inhibitor\nDISEASE   Candidiasis [DS:H00363]\nCryptococcal meningitis [DS:H00364]",
    "target": "sterol 14alpha-demethylase [KO:K05917]\nPATHWAY   ko00100(K05917)  Steroid biosynthesis",
    "metabolism": "",
    "therapeutic_category": "6290",
    "atc_code": "D01AC15",
    "drug_class": [
      "Antifungal",
      "Triazole antifungal",
      "Metabolizing enzyme inhibitor",
      "CYP2C9 inhibitor",
      "CYP2C19 inhibitor",
      "CYP3A/CYP3A4 inhibitor",
      "CYP3A4 inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Fluconazole"
  },
  {
    "kegg_id": "D01429",
    "name_en": "Fosfluconazole (JAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Prodif (TN)"
    ],
    "formula": "C13H13F2N6O4P",
    "efficacy": "Antifungal, Ergosterol biosynthesis inhibitor",
    "target": "sterol 14alpha-demethylase [KO:K05917]\nPATHWAY   ko00100(K05917)  Steroid biosynthesis",
    "metabolism": "",
    "therapeutic_category": "6290",
    "atc_code": "D01AC15",
    "drug_class": [
      "Antifungal",
      "Triazole antifungal",
      "Metabolizing enzyme inhibitor",
      "CYP2C9 inhibitor",
      "CYP2C19 inhibitor",
      "CYP3A/CYP3A4 inhibitor",
      "CYP3A4 inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Fosfluconazole"
  },
  {
    "kegg_id": "D10021",
    "name_en": "Efinaconazole (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Clenafin (TN)",
      "Jublia (TN)"
    ],
    "formula": "C18H22F2N4O",
    "efficacy": "Antifungal, Ergosterol biosynthesis inhibitor\nDISEASE   Onychomycosis [DS:H01316]",
    "target": "sterol 14alpha-demethylase [KO:K05917]",
    "metabolism": "",
    "therapeutic_category": "6290",
    "atc_code": "D01AC19",
    "drug_class": [
      "Antifungal",
      "Triazole antifungal"
    ],
    "cyp_enzymes": [],
    "search_name": "Efinaconazole"
  },
  {
    "kegg_id": "D00323",
    "name_en": "Flucytosine (JP18/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Ancobon (TN)\nABBR      5FC"
    ],
    "formula": "C4H4FN3O",
    "efficacy": "Antifungal, Nucleic acid biosynthesis inhibitor\nDISEASE   Candidiasis [DS:H00363]\nCryptococcosis [DS:H00364]",
    "target": "TYMS [KO:K00560]\nPATHWAY   ko00240(K00560)  Pyrimidine metabolism",
    "metabolism": "",
    "therapeutic_category": "6290",
    "atc_code": "D01AE21",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Flucytosine"
  },
  {
    "kegg_id": "D10762",
    "name_en": "Fosravuconazole L-lysine ethanolate (JAN)",
    "name_ja": "",
    "names_alt": [],
    "formula": "C23H20F2N5O5PS. C6H14N2O2. C2H6O",
    "efficacy": "Antifungal, Ergosterol biosynthesis inhibitor",
    "target": "sterol 14alpha-demethylase [KO:K05917]",
    "metabolism": "",
    "therapeutic_category": "6290",
    "atc_code": "D01BA03",
    "drug_class": [
      "Antifungal",
      "Triazole antifungal",
      "Metabolizing enzyme inhibitor",
      "CYP3A/CYP3A4 inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Fosravuconazole L-lysine ethanolate"
  },
  {
    "kegg_id": "D01995",
    "name_en": "Inosine pranobex (JAN)",
    "name_ja": "",
    "names_alt": [
      "Isoprinosine (TN)"
    ],
    "formula": "(C9H9NO3. C5H13NO)3. C10H12N4O5",
    "efficacy": "Antiviral, Immunostimulant",
    "target": "Paramyxoviridae RNA-directed RNA polymerase L [KO:K19376]\nPATHWAY   ko03230(K19376)  Viral genome structure\nko03240(K19376)  Viral replication\nko05162(K19376)  Measles",
    "metabolism": "",
    "therapeutic_category": "6290",
    "atc_code": "D06BB05",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Inosine pranobex"
  },
  {
    "kegg_id": "D02500",
    "name_en": "Imiquimod (JAN/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Aldara (TN)",
      "Zyclara (TN)\nABBR      IQM"
    ],
    "formula": "C14H16N4",
    "efficacy": "Antiviral, Immunomodulator, Toll-like receptor agonist\nDISEASE   Actinic keratosis [DS:H02429]\nBasal cell carcinoma [DS:H00029]\nGenital warts [DS:H01418]",
    "target": "TLR7 [HSA:51284] [KO:K05404]\nPATHWAY   hsa04613(51284)  Neutrophil extracellular trap formation\nhsa04620(51284)  Toll-like receptor signaling pathway",
    "metabolism": "",
    "therapeutic_category": "6290",
    "atc_code": "D06BB10",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Imiquimod"
  },
  {
    "kegg_id": "D00285",
    "name_en": "Co-Trimoxazole (BAN)",
    "name_ja": "",
    "names_alt": [
      "Sulfamethoxazole and trimethoprim",
      "Bactrim (TN)",
      "Septra (TN)\nABBR      SXT"
    ],
    "formula": "C14H18N4O3. C10H11N3O3S",
    "efficacy": "Antibacterial\nDISEASE   Shigellosis [DS:H00299]\nPneumocystis jiroveci pneumonia [DS:H01521]",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "6290",
    "atc_code": "J01EE01",
    "drug_class": [
      "Metabolizing enzyme inhibitor",
      "CYP2C8 inhibitor",
      "CYP2C9 inhibitor",
      "Transporter inhibitor",
      "SLC22A2 inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Co-Trimoxazole"
  },
  {
    "kegg_id": "D00350",
    "name_en": "Itraconazole (JP18/USP)",
    "name_ja": "イトラコナゾール",
    "names_alt": [
      "Itrizole (TN)",
      "Sporanox (TN)\nABBR      ITC"
    ],
    "formula": "C35H38Cl2N8O4",
    "efficacy": "Antifungal, Ergosterol biosynthesis inhibitor\nDISEASE   Blastomycosis [DS:H01501]\nHistoplasmosis [DS:H01062]\nAspergillosis [DS:H01328]\nOnychomycosis of the toenail, fingernail [DS:H01316]",
    "target": "sterol 14alpha-demethylase [KO:K05917]\nPATHWAY   ko00100(K05917)  Steroid biosynthesis",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "6290",
    "atc_code": "J02AC02",
    "drug_class": [
      "Antifungal",
      "Triazole antifungal",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "Metabolizing enzyme inhibitor",
      "CYP3A/CYP3A4 inhibitor",
      "CYP3A4 inhibitor",
      "Transporter inhibitor",
      "ABCB1 inhibitor"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Itraconazole"
  },
  {
    "kegg_id": "D00236",
    "name_en": "Atovaquone (JAN/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Mepron (TN)"
    ],
    "formula": "C22H19ClO3",
    "efficacy": "Antifungal (pneumocystic)\nDISEASE   Pneumocystis jiroveci pneumonia [DS:H01521]",
    "target": "Cytochrome b [KO:K00412]",
    "metabolism": "",
    "therapeutic_category": "6290",
    "atc_code": "P01AX06",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Atovaquone"
  },
  {
    "kegg_id": "D09189",
    "name_en": "Haemophilus b conjugate vaccine (tetanus toxoid conjugate)",
    "name_ja": "",
    "names_alt": [
      "Haemophilus influenzae type b conjugate vaccine",
      "Acthib (TN)",
      "Hiberix (TN)"
    ],
    "formula": "",
    "efficacy": "Antiviral, Active immunization",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "6311",
    "atc_code": "J07AG51",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Haemophilus b conjugate vaccine"
  },
  {
    "kegg_id": "D12436",
    "name_en": "Tetravalent meningococcal vaccine (tetanus toxoid conjugate)",
    "name_ja": "",
    "names_alt": [
      "Menquadfi (TN)",
      "Penbraya (TN)"
    ],
    "formula": "",
    "efficacy": "Active immunization (pneumococcal)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "6311",
    "atc_code": "J07AH08",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Tetravalent meningococcal vaccine"
  },
  {
    "kegg_id": "D08776",
    "name_en": "Pneumococcal vaccine polyvalent",
    "name_ja": "",
    "names_alt": [
      "Pneumococcus vaccine",
      "Pneumovax 23 (TN)"
    ],
    "formula": "",
    "efficacy": "Active immunization (pneumococcal)\nDISEASE   Prevention of pneumococcal disease [DS:H01321]",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "6311",
    "atc_code": "J07AL01",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Pneumococcal vaccine polyvalent"
  },
  {
    "kegg_id": "D12205",
    "name_en": "Pneumococcal 15-valent conjugate vaccine",
    "name_ja": "",
    "names_alt": [
      "Vaxneuvance (TN)"
    ],
    "formula": "",
    "efficacy": "Active immunization (pneumococcal)\nDISEASE   Prevention of invasive disease caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 22F, 23F and 33F [DS:H01321]",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "6311",
    "atc_code": "J07AL02",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Pneumococcal 15-valent conjugate vaccine"
  },
  {
    "kegg_id": "D12207",
    "name_en": "Pneumococcal 20-valent conjugate vaccine",
    "name_ja": "",
    "names_alt": [
      "Prevnar 20 (TN)",
      "Apexxnar (TN)"
    ],
    "formula": "",
    "efficacy": "Active immunization (pneumococcal)\nDISEASE   Prevention of pneumonia and invasive disease caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 8, 9V, 10A, 11A, 12F, 14, 15B, 18C, 19A, 19F, 22F, 23F, and 33F [DS:H01321]",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "6311",
    "atc_code": "J07AL02",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Pneumococcal 20-valent conjugate vaccine"
  },
  {
    "kegg_id": "D13153",
    "name_en": "Pneumococcal 21-valent conjugate vaccine",
    "name_ja": "",
    "names_alt": [
      "Capvaxive (TN)"
    ],
    "formula": "",
    "efficacy": "Active immunization (pneumococcal)\nDISEASE   Prevention of invasive disease caused by Streptococcus pneumoniae serotypes 3, 6A, 7F, 8, 9N, 10A, 11A, 12F, 15A, 15B, 15C, 16F, 17F, 19A, 20A, 22F, 23A, 23B, 24F, 31, 33F, and 35B [DS:H01321]",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "6311",
    "atc_code": "J07AL02",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Pneumococcal 21-valent conjugate vaccine"
  },
  {
    "kegg_id": "D03063",
    "name_en": "BCG vaccine (USP)",
    "name_ja": "",
    "names_alt": [
      "Freeze-dried BCG vaccine (for percutaneous use) (JP18)"
    ],
    "formula": "",
    "efficacy": "Active immunization (tuberculosis)\nDISEASE   Prevention of tuberculosis [DS:H00342]",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "6311",
    "atc_code": "J07AN01",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "BCG vaccine"
  },
  {
    "kegg_id": "D12923",
    "name_en": "Purified Vi polysaccharide typhoid vaccine",
    "name_ja": "",
    "names_alt": [
      "Typhim Vi (TN)"
    ],
    "formula": "",
    "efficacy": "Active immunization (typhoid)\nDISEASE   Typhoid fever [DS:H00111]",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "6311",
    "atc_code": "J07AP03",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Purified Vi polysaccharide typhoid vaccine"
  },
  {
    "kegg_id": "D12206",
    "name_en": "Tick-borne encephalitis vaccine",
    "name_ja": "",
    "names_alt": [
      "Ticovac (TN)"
    ],
    "formula": "",
    "efficacy": "Active immunization (tick-borne encephalitis virus)\nDISEASE   Tick-borne encephalitis [DS:H00380]",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "6313",
    "atc_code": "J07BA01",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Tick-borne encephalitis vaccine"
  },
  {
    "kegg_id": "D05313",
    "name_en": "Japanese encephalitis vaccine (JAN)",
    "name_ja": "",
    "names_alt": [
      "Freeze-dried japanese encephalitis vaccine (JAN)",
      "Ixiaro (TN)"
    ],
    "formula": "",
    "efficacy": "Active immunization (Japanese encephalitis)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "6313",
    "atc_code": "J07BA02",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Japanese encephalitis vaccine"
  },
  {
    "kegg_id": "D05182",
    "name_en": "Influenza HA vaccine (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Active immunization (influenza virus)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "6313",
    "atc_code": "J07BB01",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Influenza HA vaccine"
  },
  {
    "kegg_id": "D12874",
    "name_en": "Influenza vaccine live, intranasal",
    "name_ja": "",
    "names_alt": [
      "Live attenuated influenza virus vaccine, intranasal",
      "Influenza vaccine (live attenuated, nasal)",
      "Flumist (TN)",
      "Fluenz (TN)"
    ],
    "formula": "",
    "efficacy": "Active immunization (influenza virus)\nDISEASE   Influenza disease [DS:H00398]",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "6313",
    "atc_code": "J07BB03",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Influenza vaccine live, intranasal"
  },
  {
    "kegg_id": "D06475",
    "name_en": "Adsorbed hepatitis B vaccine (JP18)",
    "name_ja": "",
    "names_alt": [
      "Bimmugen (TN)"
    ],
    "formula": "",
    "efficacy": "Active immunization (hepatitis B)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "6313",
    "atc_code": "J07BC01",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Adsorbed hepatitis B vaccine"
  },
  {
    "kegg_id": "D08778",
    "name_en": "Hepatitis A vaccine inactivated",
    "name_ja": "",
    "names_alt": [
      "Freeze-dried, inactivated hepatitis A vaccine (JAN)",
      "Freeze-dried inactivated tissue cluture hepatitis A vaccine",
      "Havrix (TN)",
      "Vaqta (TN)",
      "Aimmugen (TN)"
    ],
    "formula": "",
    "efficacy": "Active immunization (hepatitis A)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "6313",
    "atc_code": "J07BC02",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Hepatitis A vaccine inactivated"
  },
  {
    "kegg_id": "D04866",
    "name_en": "Freeze-dried live attenuated measles vaccine (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Active immunization (measles)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "6313",
    "atc_code": "J07BD01",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Freeze-dried live attenuated measles vaccine"
  },
  {
    "kegg_id": "D05089",
    "name_en": "Freeze-dried live attenuated mumps vaccine (JP18)",
    "name_ja": "",
    "names_alt": [
      "Freeze-dried live attenuated mumps vaccine (TN)"
    ],
    "formula": "",
    "efficacy": "Active immunization (mumps)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "6313",
    "atc_code": "J07BE01",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Freeze-dried live attenuated mumps vaccine"
  },
  {
    "kegg_id": "D10193",
    "name_en": "Live attenuated human rota virus vaccine, oral",
    "name_ja": "",
    "names_alt": [
      "Rotarix (TN)"
    ],
    "formula": "",
    "efficacy": "Active immunization (rotavirus)\nDISEASE   Prevention of rotavirus gastroenteritis [DS:H00975]",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "6313",
    "atc_code": "J07BH01",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Live attenuated human rota virus vaccine, oral"
  },
  {
    "kegg_id": "D10211",
    "name_en": "Rotavirus vaccine, live, oral, pentavalent",
    "name_ja": "",
    "names_alt": [
      "Rotateq (TN)"
    ],
    "formula": "",
    "efficacy": "Active immunization (rotavirus)\nDISEASE   Prevention of rotavirus gastroenteritis [DS:H00975]",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "6313",
    "atc_code": "J07BH02",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Rotavirus vaccine, live, oral, pentavalent"
  },
  {
    "kegg_id": "D06512",
    "name_en": "Freeze-dried live attenuated rubella vaccine (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Active immunization (rubella)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "6313",
    "atc_code": "J07BJ01",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Freeze-dried live attenuated rubella vaccine"
  },
  {
    "kegg_id": "D08777",
    "name_en": "Freeze-dried live attenuated varicella vaccine",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Active immunization (varicella)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "6313",
    "atc_code": "J07BK01",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Freeze-dried live attenuated varicella vaccine"
  },
  {
    "kegg_id": "D11562",
    "name_en": "Freeze-dried recombinant herpes zoster vaccine (prepared from Chinese hamster ovary cells)",
    "name_ja": "",
    "names_alt": [
      "Zoster vaccine recombinant, adjuvanted",
      "Shingrix (TN)"
    ],
    "formula": "",
    "efficacy": "Active immunization (herpes zoster)\nDISEASE   Herpes zoster [DS:H00366]",
    "target": "Varicella zoster virus surface glycoprotein E [KO:K24958]",
    "metabolism": "",
    "therapeutic_category": "6313",
    "atc_code": "J07BK03",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Freeze-dried recombinant herpes zoster vaccine"
  },
  {
    "kegg_id": "D06347",
    "name_en": "Yellow fever vaccine (USP)",
    "name_ja": "",
    "names_alt": [
      "YF-Vax (TN)"
    ],
    "formula": "",
    "efficacy": "Active immunization (yellow fever)\nDISEASE   Yellow fever [DS:H00384]",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "6313",
    "atc_code": "J07BL01",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Yellow fever vaccine"
  },
  {
    "kegg_id": "D10192",
    "name_en": "Recombinant adsorbed quadrivalent human papillomavirus virus-like particle vaccine (yeast origin)",
    "name_ja": "",
    "names_alt": [
      "Gardasil (TN)",
      "Silgard (TN)"
    ],
    "formula": "",
    "efficacy": "Active immunization (papillomavirus)\nDISEASE   Cervical cancer [DS:H00030]\nVulvar cancer [DS:H00029]\nGenital warts; Condyloma acuminata [DS:H01418]\nAnal cancer [DS:H00044]",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "6313",
    "atc_code": "J07BM01",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Recombinant adsorbed quadrivalent human papillomavirus virus-like particle vaccine"
  },
  {
    "kegg_id": "D10212",
    "name_en": "Recombinant adsorbed bivalent human papillomavirus-like particle vaccine (derived from Trichoplusia ni cells)",
    "name_ja": "",
    "names_alt": [
      "Cervarix (TN)"
    ],
    "formula": "",
    "efficacy": "Active immunization (papillomavirus)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "6313",
    "atc_code": "J07BM02",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Recombinant adsorbed bivalent human papillomavirus-like particle vaccine"
  },
  {
    "kegg_id": "D11863",
    "name_en": "Human papillomavirus 9-valent vaccine, recombinant",
    "name_ja": "",
    "names_alt": [
      "Recombinant adsorbed 9-valent human papillomavirus virus-like particle vaccine (yeast origin)",
      "Gardasil 9 (TN)",
      "Silgard 9 (TN)"
    ],
    "formula": "",
    "efficacy": "Active immunization (papillomavirus)\nDISEASE   Cervical cancer [DS:H00030]\nVulvar cancer [DS:H00029]\nOropharyngeal cancer [DS:H01559]\nAnal cancer [DS:H00044]\nHead and neck cancer [DS:H02420]\nGenital warts [DS:H01418]",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "6313",
    "atc_code": "J07BM03",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Human papillomavirus 9-valent vaccine, recombinant"
  },
  {
    "kegg_id": "D11971",
    "name_en": "Tozinameran (JAN)",
    "name_ja": "",
    "names_alt": [
      "COVID-19 mRNA vaccine (nucleoside-modified)",
      "Tozinameran and riltozinameran",
      "Tozinameran and famtozinameran",
      "Tozinameran and raxtozinameran",
      "Comirnaty (TN)"
    ],
    "formula": "",
    "efficacy": "Active immunization (SARS-CoV-2)\nDISEASE   Prevention of COVID-19 [DS:H02398]",
    "target": "SARS-CoV-2 spike glycoprotein [KO:K24152]\nPATHWAY   ko03230(K24152)  Viral genome structure\nko03262(K24152)  Virion - Coronavirus\nko05171(K24152)  Coronavirus disease - COVID-19\nNETWORK   nt06171  SARS coronavirus 2 (SARS-CoV-2)",
    "metabolism": "",
    "therapeutic_category": "6313",
    "atc_code": "J07BN01",
    "drug_class": [
      "Antiviral",
      "COVID-19 vaccine"
    ],
    "cyp_enzymes": [],
    "search_name": "Tozinameran"
  },
  {
    "kegg_id": "D12114",
    "name_en": "Elasomeran (JAN)",
    "name_ja": "",
    "names_alt": [
      "COVID-19 mRNA vaccine (nucleotide modified)",
      "Covid-19 vaccine",
      "CX-024414",
      "CX-034476",
      "Andusomeran (JAN)",
      "Elasomeran (JAN) and imelasomeran (JAN)",
      "Elasomeran (JAN) and davesomeran (JAN)",
      "Moderna Covid-19 vaccine (TN)",
      "Spikevax (TN)"
    ],
    "formula": "",
    "efficacy": "Active immunization (SARS-CoV-2)\nDISEASE   Prevention of COVID-19 [DS:H02398]",
    "target": "SARS-CoV-2 spike glycoprotein [KO:K24152]\nPATHWAY   ko03230(K24152)  Viral genome structure\nko03262(K24152)  Virion - Coronavirus\nko05171(K24152)  Coronavirus disease - COVID-19\nNETWORK   nt06171  SARS coronavirus 2 (SARS-CoV-2)",
    "metabolism": "",
    "therapeutic_category": "6313",
    "atc_code": "J07BN01",
    "drug_class": [
      "Antiviral",
      "COVID-19 vaccine"
    ],
    "cyp_enzymes": [],
    "search_name": "Elasomeran"
  },
  {
    "kegg_id": "D12610",
    "name_en": "Ufrenmeran (JAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Tegrenmeran (JAN)",
      "Bemremeran (JAN)",
      "MAFB-7256a",
      "Daichirona (TN)"
    ],
    "formula": "",
    "efficacy": "Active immunization (SARS-CoV-2)",
    "target": "SARS-CoV-2 spike glycoprotein [KO:K24152]\nPATHWAY   ko03230(K24152)  Viral genome structure\nko03262(K24152)  Virion - Coronavirus\nko05171(K24152)  Coronavirus disease - COVID-19\nNETWORK   nt06171  SARS coronavirus 2 (SARS-CoV-2)",
    "metabolism": "",
    "therapeutic_category": "6313",
    "atc_code": "J07BN01",
    "drug_class": [
      "Antiviral",
      "COVID-19 vaccine"
    ],
    "cyp_enzymes": [],
    "search_name": "Ufrenmeran"
  },
  {
    "kegg_id": "D12336",
    "name_en": "SARS-CoV-2 Spike glycoprotein vaccine antigen nvx-cov2373",
    "name_ja": "",
    "names_alt": [
      "SARS-CoV-2 rS",
      "Novavax Covid-19 vaccine (TN)",
      "Nuvaxovid (TN)"
    ],
    "formula": "",
    "efficacy": "Active immunization (SARS-CoV-2)\nDISEASE   Prevention of COVID-19 [DS:H02398]",
    "target": "SARS-CoV-2 spike glycoprotein [KO:K24152]\nPATHWAY   ko03230(K24152)  Viral genome structure\nko03262(K24152)  Virion - Coronavirus\nko05171(K24152)  Coronavirus disease - COVID-19\nNETWORK   nt06171  SARS coronavirus 2 (SARS-CoV-2)",
    "metabolism": "",
    "therapeutic_category": "6313",
    "atc_code": "J07BN04",
    "drug_class": [
      "Antiviral",
      "COVID-19 vaccine"
    ],
    "cyp_enzymes": [],
    "search_name": "SARS-CoV-2 Spike glycoprotein vaccine antigen nvx-cov2373"
  },
  {
    "kegg_id": "D06511",
    "name_en": "Freeze-dried smallpox vaccine prepared in cell culture (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Active immunization (smallpox)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "6313",
    "atc_code": "J07BX01",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Freeze-dried smallpox vaccine prepared in cell culture"
  },
  {
    "kegg_id": "D12607",
    "name_en": "Respiratory syncytial virus vaccine",
    "name_ja": "",
    "names_alt": [
      "Respiratory syncytial virus vaccine, adjuvanted",
      "Respiratory syncytial virus vaccine, nucleoside-modified mRNA",
      "Recombinant respiratory syncytial virus vaccine",
      "Arexvy (TN)",
      "Abrysvo (TN)",
      "mResvia (TN)"
    ],
    "formula": "",
    "efficacy": "Active immunization (RSV)\nDISEASE   Prevention of lower respiratory tract disease caused by respiratory syncytial virus [DS:H00401]",
    "target": "RSV F protein [KO:K19261]",
    "metabolism": "",
    "therapeutic_category": "6313",
    "atc_code": "J07BX05",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Respiratory syncytial virus vaccine"
  },
  {
    "kegg_id": "D05248",
    "name_en": "Freeze-dried inactivated tissue culture ravies vaccine (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Active immunization (rabies)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "6313",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Freeze-dried inactivated tissue culture ravies vaccine"
  },
  {
    "kegg_id": "D05543",
    "name_en": "Poliovirus vaccine inactivated (USP)",
    "name_ja": "",
    "names_alt": [
      "Ipol (TN)"
    ],
    "formula": "",
    "efficacy": "Active immunization (polio)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "6313",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Poliovirus vaccine inactivated"
  },
  {
    "kegg_id": "D12738",
    "name_en": "Zapomeran (JAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Kostaive (TN)"
    ],
    "formula": "",
    "efficacy": "Active immunization (SARS-CoV-2)",
    "target": "SARS-CoV-2 spike glycoprotein [KO:K24152]\nPATHWAY   ko03230(K24152)  Viral genome structure\nko03262(K24152)  Virion - Coronavirus\nko05171(K24152)  Coronavirus disease - COVID-19\nNETWORK   nt06171  SARS coronavirus 2 (SARS-CoV-2)",
    "metabolism": "",
    "therapeutic_category": "6313",
    "atc_code": "",
    "drug_class": [
      "Antiviral",
      "COVID-19 vaccine"
    ],
    "cyp_enzymes": [],
    "search_name": "Zapomeran"
  },
  {
    "kegg_id": "D05316",
    "name_en": "Tetanus toxoid adsorbed (USP)",
    "name_ja": "",
    "names_alt": [
      "Adsorbed tetanus toxoid (JP18)"
    ],
    "formula": "",
    "efficacy": "Toxoid",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "6322",
    "atc_code": "J07AM01",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Tetanus toxoid adsorbed"
  },
  {
    "kegg_id": "D03925",
    "name_en": "Freeze-dried diphtheria antitoxin, equine (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Antitoxin\nDISEASE   Diphtheria [DS:H00343]",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "6331",
    "atc_code": "J06AA01",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Freeze-dried diphtheria antitoxin, equine"
  },
  {
    "kegg_id": "D05187",
    "name_en": "Gas gangrene antitoxin, equine (JAN)",
    "name_ja": "",
    "names_alt": [
      "Gas gangrene antitoxin, pentavalent"
    ],
    "formula": "",
    "efficacy": "Antitoxin",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "6331",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Gas gangrene antitoxin, equine"
  },
  {
    "kegg_id": "D05317",
    "name_en": "Freeze-dried habu antivenom, equine (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Antitoxin",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "6331",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Freeze-dried habu antivenom, equine"
  },
  {
    "kegg_id": "D05368",
    "name_en": "Freeze-dried botulism antitoxin, equine (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Antitoxin",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "6331",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Freeze-dried botulism antitoxin, equine"
  },
  {
    "kegg_id": "D05372",
    "name_en": "Freeze-dried mamushi antivenom, equine (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Antitoxin",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "6331",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Freeze-dried mamushi antivenom, equine"
  },
  {
    "kegg_id": "D11173",
    "name_en": "Freeze-dried botulisum antitoxin, type E",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Antitoxin",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "6331",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Freeze-dried botulisum antitoxin, type E"
  },
  {
    "kegg_id": "D06467",
    "name_en": "Whole human blood (JP18)",
    "name_ja": "",
    "names_alt": [
      "Stored whole blood CPD (TN)"
    ],
    "formula": "",
    "efficacy": "Replenisher (blood)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "6341",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Whole human blood"
  },
  {
    "kegg_id": "D06498",
    "name_en": "Concentrated human blood platelet",
    "name_ja": "",
    "names_alt": [
      "Platelet concentrate HLA (TN)"
    ],
    "formula": "",
    "efficacy": "Replenisher (platelet)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "6342",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Concentrated human blood platelet"
  },
  {
    "kegg_id": "D08818",
    "name_en": "Concentrated frozen-thawed human red blood cells",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Replenisher (erythrocyte)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "6342",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Concentrated frozen-thawed human red blood cells"
  },
  {
    "kegg_id": "D08819",
    "name_en": "Synthetic blood",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Blood replenisher",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "6342",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Synthetic blood"
  },
  {
    "kegg_id": "D08820",
    "name_en": "Fresh-frozen human plasma",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Replenisher (plasma)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "6342",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Fresh-frozen human plasma"
  },
  {
    "kegg_id": "D08821",
    "name_en": "Human red blood cells",
    "name_ja": "",
    "names_alt": [
      "Concentrated human red blood cells"
    ],
    "formula": "",
    "efficacy": "Replenisher (erythrocyte)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "6342",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Human red blood cells"
  },
  {
    "kegg_id": "D08822",
    "name_en": "Washed human red blood cells",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Replenisher (erythrocyte)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "6342",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Washed human red blood cells"
  },
  {
    "kegg_id": "D08795",
    "name_en": "Human antithrombin III, freeze-dried concentrated",
    "name_ja": "",
    "names_alt": [
      "Neuart (TN)"
    ],
    "formula": "",
    "efficacy": "Anticoagulant",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "6343",
    "atc_code": "B01AB02",
    "drug_class": [
      "Blood modifier agent",
      "Antithrombotic agent",
      "Heparin anticoagulant",
      "Antithrombin"
    ],
    "cyp_enzymes": [],
    "search_name": "Human antithrombin III, freeze-dried concentrated"
  },
  {
    "kegg_id": "D08796",
    "name_en": "Human activated protein C, freeze-dried concentrated",
    "name_ja": "",
    "names_alt": [
      "Human protein C, freeze-dried concentrated",
      "Anact C (TN)",
      "Ceprotin (TN)"
    ],
    "formula": "",
    "efficacy": "Antithrombotic, Replenisher (protein C)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "6343",
    "atc_code": "B01AD12",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Human activated protein C, freeze-dried concentrated"
  },
  {
    "kegg_id": "D11965",
    "name_en": "alpha 1-Antitrypsin",
    "name_ja": "",
    "names_alt": [
      "Human alpha 1-Proteinase inibitor, freeze-dried concentrated",
      "Lynspad (TN)"
    ],
    "formula": "",
    "efficacy": "Elastase inhibitor",
    "target": "SERPINA1 [HSA:5265] [KO:K03984]\nPATHWAY   hsa04610(5265)  Complement and coagulation cascades",
    "metabolism": "",
    "therapeutic_category": "6343",
    "atc_code": "B02AB02",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "alpha 1-Antitrypsin"
  },
  {
    "kegg_id": "D08792",
    "name_en": "Freeze-dried human fibrinogen",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Hemostatic, Replenisher (fibrinogen)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "6343",
    "atc_code": "B02BB01",
    "drug_class": [
      "Blood modifier agent",
      "Hemostatics",
      "Blood coagulation accelerant",
      "Blood coagulation factor"
    ],
    "cyp_enzymes": [],
    "search_name": "Freeze-dried human fibrinogen"
  },
  {
    "kegg_id": "D08798",
    "name_en": "Freeze-dried human blood-coagulation factor VIII",
    "name_ja": "",
    "names_alt": [
      "Conco-eight-HT (TN)"
    ],
    "formula": "",
    "efficacy": "Bleeding suppressant, Replenisher (coagulation factor)",
    "target": "F8* [HSA_VAR:2157v1] [HSA:2157] [KO:K03899]\nVWF* [HSA_VAR:7450v1] [HSA:7450] [KO:K03900]\nPATHWAY   hsa04610(2157+7450)  Complement and coagulation cascades\nhsa04611(7450)  Platelet activation\nNETWORK   nt06514  Coagulation cascade",
    "metabolism": "",
    "therapeutic_category": "6343",
    "atc_code": "B02BD02",
    "drug_class": [
      "Blood modifier agent",
      "Hemostatics",
      "Blood coagulation accelerant",
      "Blood coagulation factor"
    ],
    "cyp_enzymes": [],
    "search_name": "Freeze-dried human blood-coagulation factor VIII"
  },
  {
    "kegg_id": "D10227",
    "name_en": "Turoctocog alfa (INN)",
    "name_ja": "",
    "names_alt": [
      "Turoctocog alfa (genetical recombination) (JAN)",
      "Novoeight (TN)"
    ],
    "formula": "C7480H11379N1999O2194S68",
    "efficacy": "Bleeding suppressant, Replenisher (coagulation factor)",
    "target": "F8* [HSA_VAR:2157v1] [HSA:2157] [KO:K03899]\nPATHWAY   hsa04610(2157)  Complement and coagulation cascades\nNETWORK   nt06514  Coagulation cascade",
    "metabolism": "",
    "therapeutic_category": "6343",
    "atc_code": "B02BD02",
    "drug_class": [
      "Blood modifier agent",
      "Hemostatics",
      "Blood coagulation accelerant",
      "Blood coagulation factor"
    ],
    "cyp_enzymes": [],
    "search_name": "Turoctocog alfa"
  },
  {
    "kegg_id": "D12421",
    "name_en": "Freeze-dried activated human blood coagulation factor VII concentrate containing factor X",
    "name_ja": "",
    "names_alt": [
      "Byclot (TN)"
    ],
    "formula": "",
    "efficacy": "Bleeding suppressant, Replenisher (coagulation factor)",
    "target": "F10 [HSA:2159] [KO:K01314]\nF7a [CPD:C03378] [HSA:2155] [KO:K01320]\nPATHWAY   hsa04610(2155+2159+C03378)  Complement and coagulation cascades\nNETWORK   nt06514  Coagulation cascade",
    "metabolism": "",
    "therapeutic_category": "6343",
    "atc_code": "B02BD03",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Freeze-dried activated human blood coagulation factor VII concentrate containing factor X"
  },
  {
    "kegg_id": "D05201",
    "name_en": "Nonacog alfa (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Nonacog alfa (genetical recombination) (JAN)",
      "Benefix (TN)"
    ],
    "formula": "",
    "efficacy": "Bleeding suppressant, Replenisher (coagulation factor)",
    "target": "F9* [HSA_VAR:2158v1] [HSA:2158] [KO:K01321]\nPATHWAY   hsa04610(2158)  Complement and coagulation cascades\nNETWORK   nt06514  Coagulation cascade",
    "metabolism": "",
    "therapeutic_category": "6343",
    "atc_code": "B02BD04",
    "drug_class": [
      "Blood modifier agent",
      "Hemostatics",
      "Blood coagulation accelerant",
      "Blood coagulation factor"
    ],
    "cyp_enzymes": [],
    "search_name": "Nonacog alfa"
  },
  {
    "kegg_id": "D08794",
    "name_en": "Human blood-coagulation factor IX complex, dried",
    "name_ja": "",
    "names_alt": [
      "PPSB-HT (TN)"
    ],
    "formula": "",
    "efficacy": "Bleeding suppressant, Replenisher (coagulation factor)",
    "target": "F9* [HSA_VAR:2158v1] [HSA:2158] [KO:K01321]\nPATHWAY   hsa04610(2158)  Complement and coagulation cascades\nNETWORK   nt06514  Coagulation cascade",
    "metabolism": "",
    "therapeutic_category": "6343",
    "atc_code": "B02BD04",
    "drug_class": [
      "Blood modifier agent",
      "Hemostatics",
      "Blood coagulation accelerant",
      "Blood coagulation factor"
    ],
    "cyp_enzymes": [],
    "search_name": "Human blood-coagulation factor IX complex, dried"
  },
  {
    "kegg_id": "D08797",
    "name_en": "Freeze-dried human blood-coagulation factor IX",
    "name_ja": "",
    "names_alt": [
      "Coagulation factor IX (recombinant)",
      "Novact M (TN)",
      "Rebinyn (TN)",
      "Rixubis (TN)"
    ],
    "formula": "",
    "efficacy": "Bleeding suppressant, Replenisher (coagulation factor)\nDISEASE   Hemophilia B [DS:H00219]",
    "target": "F9* [HSA_VAR:2158v1] [HSA:2158] [KO:K01321]\nPATHWAY   hsa04610(2158)  Complement and coagulation cascades\nNETWORK   nt06514  Coagulation cascade",
    "metabolism": "",
    "therapeutic_category": "6343",
    "atc_code": "B02BD04",
    "drug_class": [
      "Blood modifier agent",
      "Hemostatics",
      "Blood coagulation accelerant",
      "Blood coagulation factor"
    ],
    "cyp_enzymes": [],
    "search_name": "Freeze-dried human blood-coagulation factor IX"
  },
  {
    "kegg_id": "D10757",
    "name_en": "Nonacog beta pegol (INN)",
    "name_ja": "",
    "names_alt": [
      "Nonacog beta pegol (genetical recombination) (JAN)",
      "Refixia (TN)"
    ],
    "formula": "C2041H3114N558O641S25",
    "efficacy": "Bleeding suppressant, Replenisher (coagulation factor)",
    "target": "F9* [HSA_VAR:2158v1] [HSA:2158] [KO:K01321]\nPATHWAY   hsa04610(2158)  Complement and coagulation cascades\nNETWORK   nt06514  Coagulation cascade",
    "metabolism": "",
    "therapeutic_category": "6343",
    "atc_code": "B02BD04",
    "drug_class": [
      "Blood modifier agent",
      "Hemostatics",
      "Blood coagulation accelerant",
      "Blood coagulation factor"
    ],
    "cyp_enzymes": [],
    "search_name": "Nonacog beta pegol"
  },
  {
    "kegg_id": "D00172",
    "name_en": "Eptacog alfa (INN)",
    "name_ja": "",
    "names_alt": [
      "Eptacog alfa (activated) (genetical recombination) (JAN)",
      "Coagulation Factor VIIa",
      "Coagulation factor VIIa (recombinant)-jncw",
      "Novo- seven (TN)",
      "Sevenfact (TN)"
    ],
    "formula": "C1982H3054N560O618S28",
    "efficacy": "Bleeding suppressant, Replenisher (coagulation factor)",
    "target": "F7a [CPD:C03378] [HSA:2155] [KO:K01320]\nPATHWAY   hsa04610(2155z+C03378)  Complement and coagulation cascades\nNETWORK   nt06514  Coagulation cascade",
    "metabolism": "",
    "therapeutic_category": "6343",
    "atc_code": "B02BD05",
    "drug_class": [
      "Blood modifier agent",
      "Hemostatics",
      "Blood coagulation accelerant",
      "Blood coagulation factor"
    ],
    "cyp_enzymes": [],
    "search_name": "Eptacog alfa"
  },
  {
    "kegg_id": "D08802",
    "name_en": "Human blood-coagulation factor XIII fraction, dried",
    "name_ja": "",
    "names_alt": [
      "Fibrogammin P (TN)"
    ],
    "formula": "",
    "efficacy": "Bleeding suppressant, Replenisher (coagulation factor)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "6343",
    "atc_code": "B02BD07",
    "drug_class": [
      "Blood modifier agent",
      "Hemostatics",
      "Blood coagulation accelerant",
      "Blood coagulation factor"
    ],
    "cyp_enzymes": [],
    "search_name": "Human blood-coagulation factor XIII fraction, dried"
  },
  {
    "kegg_id": "D10532",
    "name_en": "Catridecacog (INN)",
    "name_ja": "",
    "names_alt": [
      "Catridecacog (genetical recombination) (JAN)",
      "NovoThirteen (TN)"
    ],
    "formula": "(C3708H5735N1013O1111S28)2",
    "efficacy": "Bleeding suppressant, Replenisher (coagulation factor)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "6343",
    "atc_code": "B02BD11",
    "drug_class": [
      "Blood modifier agent",
      "Hemostatics",
      "Blood coagulation accelerant",
      "Blood coagulation factor"
    ],
    "cyp_enzymes": [],
    "search_name": "Catridecacog"
  },
  {
    "kegg_id": "D05424",
    "name_en": "Human serum albumin (genetical recombination) (JAN)",
    "name_ja": "",
    "names_alt": [
      "Human serum albumin"
    ],
    "formula": "",
    "efficacy": "Replenisher (albumin)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "6343",
    "atc_code": "B05AA01",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Human serum albumin"
  },
  {
    "kegg_id": "D05526",
    "name_en": "Plasma protein fraction (USP)",
    "name_ja": "",
    "names_alt": [
      "Human plasma protein fraction",
      "Plasmanate"
    ],
    "formula": "",
    "efficacy": "Replenisher (albumin)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "6343",
    "atc_code": "B05AA02",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Plasma protein fraction"
  },
  {
    "kegg_id": "D08780",
    "name_en": "Human C1 inactivator, freeze-dried concentrated",
    "name_ja": "",
    "names_alt": [
      "Berinert P (TN)"
    ],
    "formula": "",
    "efficacy": "Coagulation inhibitor",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "6343",
    "atc_code": "B06AC01",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Human C1 inactivator, freeze-dried concentrated"
  },
  {
    "kegg_id": "D13027",
    "name_en": "pH4-Treated acidic normal human immunoglovulin and vorhyaluronidase alfa (genetical recombination)",
    "name_ja": "",
    "names_alt": [
      "Hyqvia (TN)"
    ],
    "formula": "",
    "efficacy": "Replenisher (gamma-globulin)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "6343",
    "atc_code": "J06BA01",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "pH4-Treated acidic normal human immunoglovulin and vorhyaluronidase alfa"
  },
  {
    "kegg_id": "D06458",
    "name_en": "Globulin, immune (USP)",
    "name_ja": "",
    "names_alt": [
      "Human normal immunoglobulin (JP18)",
      "Bay gam (TN)",
      "Hyqvia (TN)"
    ],
    "formula": "",
    "efficacy": "Immunizing agent (passive), Replenisher (gamma-globulin)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "6343",
    "atc_code": "J06BA01",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Globulin, immune"
  },
  {
    "kegg_id": "D08779",
    "name_en": "pH4 Treated human normal immunoglobulin",
    "name_ja": "",
    "names_alt": [
      "Polyglobin N (TN)",
      "Hizentra (TN)",
      "Privigen (TN)",
      "Cuvitru (TN)"
    ],
    "formula": "",
    "efficacy": "Replenisher (gamma-globulin)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "6343",
    "atc_code": "J06BA01",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "pH4 Treated human normal immunoglobulin"
  },
  {
    "kegg_id": "D08783",
    "name_en": "Polyethylene glycol treated human normal immunoglobulin",
    "name_ja": "",
    "names_alt": [
      "Venoglobulin-IH (TN)"
    ],
    "formula": "",
    "efficacy": "Replenisher (gamma-globulin)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "6343",
    "atc_code": "J06BA02",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Polyethylene glycol treated human normal immunoglobulin"
  },
  {
    "kegg_id": "D08785",
    "name_en": "Freeze-dried ion-exchange-resin treated human normal immunoglobulin",
    "name_ja": "",
    "names_alt": [
      "Gammagard (TN)"
    ],
    "formula": "",
    "efficacy": "Replenisher (gamma-globulin)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "6343",
    "atc_code": "J06BA02",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Freeze-dried ion-exchange-resin treated human normal immunoglobulin"
  },
  {
    "kegg_id": "D08786",
    "name_en": "Freeze-dried sulfonated human normal immunoglobulin",
    "name_ja": "",
    "names_alt": [
      "Venilon-I (TN)"
    ],
    "formula": "",
    "efficacy": "Replenisher (gamma-globulin)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "6343",
    "atc_code": "J06BA02",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Freeze-dried sulfonated human normal immunoglobulin"
  },
  {
    "kegg_id": "D08788",
    "name_en": "Freeze-dried polyethylene glycol treated human normal immunoglobulin",
    "name_ja": "",
    "names_alt": [
      "Glovenin-I (TN)"
    ],
    "formula": "",
    "efficacy": "Replenisher (gamma-globulin)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "6343",
    "atc_code": "J06BA02",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Freeze-dried polyethylene glycol treated human normal immunoglobulin"
  },
  {
    "kegg_id": "D08782",
    "name_en": "Polyethylene glycol treated human anti-tetanus immunoglobulin",
    "name_ja": "",
    "names_alt": [
      "Tetanobulin-IH (TN)"
    ],
    "formula": "",
    "efficacy": "Prophylactic (tetanus)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "6343",
    "atc_code": "J06BB02",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Polyethylene glycol treated human anti-tetanus immunoglobulin"
  },
  {
    "kegg_id": "D08791",
    "name_en": "Freeze-dried human anti-tetanus immunoglobulin",
    "name_ja": "",
    "names_alt": [
      "Tetanothera (TN)"
    ],
    "formula": "",
    "efficacy": "Prophylactic (tetanus)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "6343",
    "atc_code": "J06BB02",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Freeze-dried human anti-tetanus immunoglobulin"
  },
  {
    "kegg_id": "D08801",
    "name_en": "Human anti-tetanus immunoglobulin",
    "name_ja": "",
    "names_alt": [
      "Tetagam P (TN)"
    ],
    "formula": "",
    "efficacy": "Prophylactic (tetanus)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "6343",
    "atc_code": "J06BB02",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Human anti-tetanus immunoglobulin"
  },
  {
    "kegg_id": "D08781",
    "name_en": "Polyethylene glycol treated human anti-HBs immunoglobulin",
    "name_ja": "",
    "names_alt": [
      "Hebsbulin-IH (TN)"
    ],
    "formula": "",
    "efficacy": "Prophylactic (hepatitis B)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "6343",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Polyethylene glycol treated human anti-HBs immunoglobulin"
  },
  {
    "kegg_id": "D08789",
    "name_en": "Freeze-dried human anti-D (Rho) immunoglobulin",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Immunosuppressant",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "6343",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Freeze-dried human anti-D"
  },
  {
    "kegg_id": "D08790",
    "name_en": "Freeze-dried human anti-HBs immunoglobulin",
    "name_ja": "",
    "names_alt": [
      "Hebsbulin (TN)"
    ],
    "formula": "",
    "efficacy": "Prophylactic (hepatitis B)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "6343",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Freeze-dried human anti-HBs immunoglobulin"
  },
  {
    "kegg_id": "D08793",
    "name_en": "Human blood-coagulation factor eight inhibitor bypassing activity complex, dried",
    "name_ja": "",
    "names_alt": [
      "Anti-inhibitor coagulant complex",
      "Feiba (TN)"
    ],
    "formula": "",
    "efficacy": "Bleeding suppressant",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "6343",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Human blood-coagulation factor eight inhibitor bypassing activity complex, dried"
  },
  {
    "kegg_id": "D08799",
    "name_en": "Human anti-HBs immunoglobulin",
    "name_ja": "",
    "names_alt": [
      "Hepatothera (TN)"
    ],
    "formula": "",
    "efficacy": "Prophylactic (hepatitis B)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "6343",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Human anti-HBs immunoglobulin"
  },
  {
    "kegg_id": "D08800",
    "name_en": "Human haptoglobin",
    "name_ja": "",
    "names_alt": [
      "Haptoglobin (TN)"
    ],
    "formula": "",
    "efficacy": "Antihemoglobinemia",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "6343",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Human haptoglobin"
  },
  {
    "kegg_id": "D10884",
    "name_en": "Human prothrombin complex, freeze-dried concentrated",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Bleeding suppressant, Replenisher (coagulation factor)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "6343",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Human prothrombin complex, freeze-dried concentrated"
  },
  {
    "kegg_id": "D10684",
    "name_en": "Antithrombin gamma (INN)",
    "name_ja": "",
    "names_alt": [
      "Antithrombin gamma (genetical recombination) (JAN)",
      "Acoalan (TN)"
    ],
    "formula": "",
    "efficacy": "Anticoagulant",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "6349",
    "atc_code": "B01AB02",
    "drug_class": [
      "Blood modifier agent",
      "Antithrombotic agent",
      "Heparin anticoagulant",
      "Antithrombin"
    ],
    "cyp_enzymes": [],
    "search_name": "Antithrombin gamma"
  },
  {
    "kegg_id": "D05409",
    "name_en": "Rurioctocog alfa (genetical recombination) (JAN)",
    "name_ja": "",
    "names_alt": [
      "Advate (TN)"
    ],
    "formula": "",
    "efficacy": "Bleeding suppressant, Replenisher (coagulation factor)",
    "target": "F8* [HSA_VAR:2157v1] [HSA:2157] [KO:K03899]\nPATHWAY   hsa04610(2157)  Complement and coagulation cascades\nNETWORK   nt06514  Coagulation cascade",
    "metabolism": "",
    "therapeutic_category": "6349",
    "atc_code": "B02BD02",
    "drug_class": [
      "Blood modifier agent",
      "Hemostatics",
      "Blood coagulation accelerant",
      "Blood coagulation factor"
    ],
    "cyp_enzymes": [],
    "search_name": "Rurioctocog alfa"
  },
  {
    "kegg_id": "D10539",
    "name_en": "Efraloctocog alfa (genetical recombination) (JAN)",
    "name_ja": "",
    "names_alt": [
      "Eloctate (TN)"
    ],
    "formula": "",
    "efficacy": "Bleeding suppressant, Replenisher (coagulation factor)",
    "target": "F8* [HSA_VAR:2157v1] [HSA:2157] [KO:K03899]\nPATHWAY   hsa04610(2157)  Complement and coagulation cascades\nNETWORK   nt06514  Coagulation cascade",
    "metabolism": "",
    "therapeutic_category": "6349",
    "atc_code": "B02BD02",
    "drug_class": [
      "Blood modifier agent",
      "Hemostatics",
      "Blood coagulation accelerant",
      "Blood coagulation factor"
    ],
    "cyp_enzymes": [],
    "search_name": "Efraloctocog alfa"
  },
  {
    "kegg_id": "D10758",
    "name_en": "Turoctocog alfa pegol (genetical recombination) (JAN)",
    "name_ja": "",
    "names_alt": [
      "Esperoct (TN)"
    ],
    "formula": "C7480H11381N1999O2177S62",
    "efficacy": "Bleeding suppressant, Replenisher (coagulation factor)",
    "target": "F8* [HSA_VAR:2157v1] [HSA:2157] [KO:K03899]\nPATHWAY   hsa04610(2157)  Complement and coagulation cascades\nNETWORK   nt06514  Coagulation cascade",
    "metabolism": "",
    "therapeutic_category": "6349",
    "atc_code": "B02BD02",
    "drug_class": [
      "Blood modifier agent",
      "Hemostatics",
      "Blood coagulation accelerant",
      "Blood coagulation factor"
    ],
    "cyp_enzymes": [],
    "search_name": "Turoctocog alfa pegol"
  },
  {
    "kegg_id": "D10759",
    "name_en": "Damoctocog alfa pegol (INN)",
    "name_ja": "",
    "names_alt": [
      "Damoctocog alfa pegol (genetical recombination) (JAN)",
      "Jivi (TN)"
    ],
    "formula": "C7445H11318N1984O2184S69",
    "efficacy": "Bleeding suppressant, Replenisher (coagulation factor)",
    "target": "F8* [HSA_VAR:2157v1] [HSA:2157] [KO:K03899]\nPATHWAY   hsa04610(2157)  Complement and coagulation cascades\nNETWORK   nt06514  Coagulation cascade",
    "metabolism": "",
    "therapeutic_category": "6349",
    "atc_code": "B02BD02",
    "drug_class": [
      "Blood modifier agent",
      "Hemostatics",
      "Blood coagulation accelerant",
      "Blood coagulation factor"
    ],
    "cyp_enzymes": [],
    "search_name": "Damoctocog alfa pegol"
  },
  {
    "kegg_id": "D10760",
    "name_en": "Rurioctocog alfa pegol (genetical recombination) (JAN)",
    "name_ja": "",
    "names_alt": [],
    "formula": "C12257H17863N3220O3552S83",
    "efficacy": "Bleeding suppressant, Replenisher (coagulation factor), Blood coagulation factor X activator",
    "target": "F8* [HSA_VAR:2157v1] [HSA:2157] [KO:K03899]\nPATHWAY   hsa04610(2157)  Complement and coagulation cascades\nNETWORK   nt06514  Coagulation cascade",
    "metabolism": "",
    "therapeutic_category": "6349",
    "atc_code": "B02BD02",
    "drug_class": [
      "Blood modifier agent",
      "Hemostatics",
      "Blood coagulation accelerant",
      "Blood coagulation factor"
    ],
    "cyp_enzymes": [],
    "search_name": "Rurioctocog alfa pegol"
  },
  {
    "kegg_id": "D10771",
    "name_en": "Octocog beta (genetical recombination) (JAN)",
    "name_ja": "",
    "names_alt": [],
    "formula": "C11794H18294N3220O3572S89",
    "efficacy": "Bleeding suppressant, Replenisher (coagulation factor)",
    "target": "F8* [HSA_VAR:2157v1] [HSA:2157] [KO:K03899]\nPATHWAY   hsa04610(2157)  Complement and coagulation cascades\nNETWORK   nt06514  Coagulation cascade",
    "metabolism": "",
    "therapeutic_category": "6349",
    "atc_code": "B02BD02",
    "drug_class": [
      "Blood modifier agent",
      "Hemostatics",
      "Blood coagulation accelerant",
      "Blood coagulation factor"
    ],
    "cyp_enzymes": [],
    "search_name": "Octocog beta"
  },
  {
    "kegg_id": "D10818",
    "name_en": "Lonoctocog alfa (INN)",
    "name_ja": "",
    "names_alt": [
      "Lonoctocog alfa (genetical recombination) (JAN)",
      "Afstyla (TN)"
    ],
    "formula": "",
    "efficacy": "Bleeding suppressant, Replenisher (coagulation factor)",
    "target": "F8* [HSA_VAR:2157v1] [HSA:2157] [KO:K03899]\nPATHWAY   hsa04610(2157)  Complement and coagulation cascades\nNETWORK   nt06514  Coagulation cascade",
    "metabolism": "",
    "therapeutic_category": "6349",
    "atc_code": "B02BD02",
    "drug_class": [
      "Blood modifier agent",
      "Hemostatics",
      "Blood coagulation accelerant",
      "Blood coagulation factor"
    ],
    "cyp_enzymes": [],
    "search_name": "Lonoctocog alfa"
  },
  {
    "kegg_id": "D10831",
    "name_en": "Susoctocog alfa (INN)",
    "name_ja": "",
    "names_alt": [
      "Susoctocog alfa (genetical recombination) (JAN)",
      "Obizur (TN)"
    ],
    "formula": "",
    "efficacy": "Bleeding suppressant, Replenisher (coagulation factor)",
    "target": "F8* [HSA_VAR:2157v1] [HSA:2157] [KO:K03899]\nPATHWAY   hsa04610(2157)  Complement and coagulation cascades\nNETWORK   nt06514  Coagulation cascade",
    "metabolism": "",
    "therapeutic_category": "6349",
    "atc_code": "B02BD02",
    "drug_class": [
      "Blood modifier agent",
      "Hemostatics",
      "Blood coagulation accelerant",
      "Blood coagulation factor"
    ],
    "cyp_enzymes": [],
    "search_name": "Susoctocog alfa"
  },
  {
    "kegg_id": "D10842",
    "name_en": "Simoctocog alfa (INN)",
    "name_ja": "",
    "names_alt": [
      "Simoctocog alfa (genetical recombination) (JAN)",
      "Nuwiq (TN)"
    ],
    "formula": "",
    "efficacy": "Bleeding suppressant, Replenisher (coagulation factor)",
    "target": "F8* [HSA_VAR:2157v1] [HSA:2157] [KO:K03899]\nPATHWAY   hsa04610(2157)  Complement and coagulation cascades\nNETWORK   nt06514  Coagulation cascade",
    "metabolism": "",
    "therapeutic_category": "6349",
    "atc_code": "B02BD02",
    "drug_class": [
      "Blood modifier agent",
      "Hemostatics",
      "Blood coagulation accelerant",
      "Blood coagulation factor"
    ],
    "cyp_enzymes": [],
    "search_name": "Simoctocog alfa"
  },
  {
    "kegg_id": "D12441",
    "name_en": "Efanesoctocog alfa (INN)",
    "name_ja": "",
    "names_alt": [
      "Efanesoctocog alfa (genetical recombination) (JAN)",
      "Altuviiio (TN)",
      "Altuvoct (TN)"
    ],
    "formula": "C13690H20958N3682O4376S136",
    "efficacy": "Bleeding suppressant, Replenisher (coagulation factor)",
    "target": "F8* [HSA_VAR:2157v1] [HSA:2157] [KO:K03899]\nPATHWAY   hsa04610(2157)  Complement and coagulation cascades\nNETWORK   nt06514  Coagulation cascade",
    "metabolism": "",
    "therapeutic_category": "6349",
    "atc_code": "B02BD02",
    "drug_class": [
      "Blood modifier agent",
      "Hemostatics",
      "Blood coagulation accelerant",
      "Blood coagulation factor"
    ],
    "cyp_enzymes": [],
    "search_name": "Efanesoctocog alfa"
  },
  {
    "kegg_id": "D10522",
    "name_en": "Eftrenonacog alfa (INN)",
    "name_ja": "",
    "names_alt": [
      "Eftrenonacog alfa (genetical recombination) (JAN)",
      "Alprolix (TN)"
    ],
    "formula": "C4330H6648N1164O1331S41",
    "efficacy": "Bleeding suppressant, Replenisher (coagulation factor)",
    "target": "F9* [HSA_VAR:2158v1] [HSA:2158] [KO:K01321]\nPATHWAY   hsa04610(2158)  Complement and coagulation cascades\nNETWORK   nt06514  Coagulation cascade",
    "metabolism": "",
    "therapeutic_category": "6349",
    "atc_code": "B02BD04",
    "drug_class": [
      "Blood modifier agent",
      "Hemostatics",
      "Blood coagulation accelerant",
      "Blood coagulation factor"
    ],
    "cyp_enzymes": [],
    "search_name": "Eftrenonacog alfa"
  },
  {
    "kegg_id": "D10770",
    "name_en": "Albutrepenonacog alfa (INN)",
    "name_ja": "",
    "names_alt": [
      "Albutrepenonacog alfa (genetical recombination) (JAN)",
      "Idelvion (TN)"
    ],
    "formula": "",
    "efficacy": "Bleeding suppressant, Replenisher (coagulation factor)",
    "target": "F9* [HSA_VAR:2158v1] [HSA:2158] [KO:K01321]\nPATHWAY   hsa04610(2158)  Complement and coagulation cascades\nNETWORK   nt06514  Coagulation cascade",
    "metabolism": "",
    "therapeutic_category": "6349",
    "atc_code": "B02BD04",
    "drug_class": [
      "Blood modifier agent",
      "Hemostatics",
      "Blood coagulation accelerant",
      "Blood coagulation factor"
    ],
    "cyp_enzymes": [],
    "search_name": "Albutrepenonacog alfa"
  },
  {
    "kegg_id": "D08681",
    "name_en": "Vonicog alfa (USAN)",
    "name_ja": "",
    "names_alt": [
      "Vonicog alfa (genetical recombination) (JAN)",
      "Von willebrand factor",
      "Wilfactin (TN)",
      "Vonvendi (TN)"
    ],
    "formula": "C9712H15373N2737O3032S210",
    "efficacy": "Anticoagulant, Hemostatic, Replenisher (von Willebrand factor)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "6349",
    "atc_code": "B02BD10",
    "drug_class": [
      "Blood modifier agent",
      "Hemostatics",
      "Blood coagulation accelerant",
      "Blood coagulation factor"
    ],
    "cyp_enzymes": [],
    "search_name": "Vonicog alfa"
  },
  {
    "kegg_id": "D10821",
    "name_en": "Emicizumab (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Emicizumab (genetical recombination) (JAN)",
      "Hemlibra (TN)"
    ],
    "formula": "C2164H3334N572O690S18",
    "efficacy": "Bleeding suppressant, Factor VIII replacement\nDISEASE   Hemophilia A [DS:H00219]\nTYPE      Bispecific antibody",
    "target": "F9a [CPD:C03259] [HSA:2158] [KO:K01321]\nF10 [HSA:2159] [KO:K01314]\nPATHWAY   hsa04610(2158+2159)  Complement and coagulation cascades\nNETWORK   nt06514  Coagulation cascade",
    "metabolism": "",
    "therapeutic_category": "6349",
    "atc_code": "B02BX06",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Emicizumab"
  },
  {
    "kegg_id": "D11847",
    "name_en": "Concizumab (USAN)",
    "name_ja": "",
    "names_alt": [
      "Concizumab (genetical recombination) (JAN)",
      "Concizumab-mtci",
      "Alhemo (TN)"
    ],
    "formula": "C6462H10004N1712O2046S46",
    "efficacy": "Bleeding suppressant, Anti-tissue factor pathway inhibitor antibody\nDISEASE   Hemophilia A [DS:H00219]\nHemophilia B [DS:H00219]\nTYPE      Monoclonal antibody",
    "target": "TFPI [HSA:7035] [KO:K03909]\nPATHWAY   hsa04610(7035)  Complement and coagulation cascades",
    "metabolism": "",
    "therapeutic_category": "6349",
    "atc_code": "B02BX10",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Concizumab"
  },
  {
    "kegg_id": "D11261",
    "name_en": "Marstacimab (USAN)",
    "name_ja": "",
    "names_alt": [
      "Marstacimab (genetical recombination) (JAN)",
      "Marstacimab-hncq",
      "Hympavzi (TN)"
    ],
    "formula": "C6304H9766N1678O2006S44",
    "efficacy": "Bleeding suppressant, Anti-tissue factor pathway inhibitor antibody\nDISEASE   Hemophilia A [DS:H00219]\nHemophilia B [DS:H00219]\nTYPE      Monoclonal antibody",
    "target": "TFPI [HSA:7035] [KO:K03909]\nPATHWAY   hsa04610(7035)  Complement and coagulation cascades",
    "metabolism": "",
    "therapeutic_category": "6349",
    "atc_code": "B02BX11",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Marstacimab"
  },
  {
    "kegg_id": "D10003",
    "name_en": "Hemin (JAN)",
    "name_ja": "",
    "names_alt": [
      "Normosang (TN)",
      "Panhematin (TN)"
    ],
    "formula": "C34H30ClFeN4O4. 2H",
    "efficacy": "Accumulation reduction (porphyrin precursor), ALAS activity lowering agent\nDISEASE   Acute intermittent porphyria [DS:H01763]",
    "target": "ALAS [HSA:211 212] [KO:K00643]\nPATHWAY   hsa00860(211+212)  Porphyrin metabolism",
    "metabolism": "",
    "therapeutic_category": "6349",
    "atc_code": "B06AB01",
    "drug_class": [
      "Metabolizing enzyme inducer",
      "CYP2D6 inducer",
      "CYP3A/CYP3A4 inducer",
      "CYP3A4 inducer"
    ],
    "cyp_enzymes": [],
    "search_name": "Hemin"
  },
  {
    "kegg_id": "D08812",
    "name_en": "Factor XIII with fibrinogen",
    "name_ja": "",
    "names_alt": [
      "Aprotinin, thrombin, human blood-coagulation factor XIII fraction, calcium chloride hydrate and freeze-dried human fibrinogen",
      "Beriplast P combi-set (TN)"
    ],
    "formula": "",
    "efficacy": "Surgical aid (tissue adhesive)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "6349",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Factor XIII with fibrinogen"
  },
  {
    "kegg_id": "D12591",
    "name_en": "Fibrinogen and thrombin",
    "name_ja": "",
    "names_alt": [
      "Tachosil (TN)"
    ],
    "formula": "",
    "efficacy": "Surgical aid (tissue adhesive)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "6349",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Fibrinogen and thrombin"
  },
  {
    "kegg_id": "D08803",
    "name_en": "Varicella virus antigen",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Diagnostic (Varicella)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "6351",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Varicella virus antigen"
  },
  {
    "kegg_id": "D05257",
    "name_en": "Adsorbed diphtheria-tetanus combined toxoid (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Toxoid",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "6361",
    "atc_code": "J07AM51",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Adsorbed diphtheria-tetanus combined toxoid"
  },
  {
    "kegg_id": "D12585",
    "name_en": "Adsorbed diphtheria-purified pertussis-tetanus-inactivate polio-haemophilus type b conjugate combined vaccine",
    "name_ja": "",
    "names_alt": [
      "Gobik (TN)",
      "Pentacel (TN)",
      "Quintovac (TN)"
    ],
    "formula": "",
    "efficacy": "Active immunization",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "6361",
    "atc_code": "J07CA05",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Adsorbed diphtheria-purified pertussis-tetanus-inactivate polio-haemophilus type b conjugate combined vaccine"
  },
  {
    "kegg_id": "D05356",
    "name_en": "Adsorbed diphtheria-purified pertussis-tetanus combined vaccine (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Active immunization",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "6361",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Adsorbed diphtheria-purified pertussis-tetanus combined vaccine"
  },
  {
    "kegg_id": "D08804",
    "name_en": "Freeze-dried live attenuated measles-rubella combined vaccine",
    "name_ja": "",
    "names_alt": [
      "Mearubik (TN)"
    ],
    "formula": "",
    "efficacy": "Active immunization",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "6369",
    "atc_code": "J07BD53",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Freeze-dried live attenuated measles-rubella combined vaccine"
  },
  {
    "kegg_id": "D06466",
    "name_en": "Freeze-dried BCG for intravesical use",
    "name_ja": "",
    "names_alt": [
      "Immunobladder (TN)",
      "Tice BCG (TN)"
    ],
    "formula": "",
    "efficacy": "Antineoplastic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "6391",
    "atc_code": "L03AX03",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Freeze-dried BCG for intravesical use"
  },
  {
    "kegg_id": "D06256",
    "name_en": "Tuberculin (USP)",
    "name_ja": "",
    "names_alt": [
      "Purified tuberculin",
      "Freeze-dried tuberculin purified protein derivative",
      "Aplisol (TN)"
    ],
    "formula": "",
    "efficacy": "Diagnostic aid (tuberculosis)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "6393",
    "atc_code": "V04CF01",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Tuberculin"
  },
  {
    "kegg_id": "D03305",
    "name_en": "Interferon alfa (NAMALWA) (JP18)",
    "name_ja": "",
    "names_alt": [
      "Interferon alfa (BALL-1) (JAN)",
      "Interferon alfa (human leukocyte) (JAN)",
      "Interferon alfa (INN)",
      "OIF (TN)"
    ],
    "formula": "",
    "efficacy": "Antineoplastic, Antiviral, Biological response modifier",
    "target": "IFNAR1 [HSA:3454] [KO:K05130]\nIFNAR2 [HSA:3455] [KO:K05131]\nPATHWAY   hsa04060(3454+3455)  Cytokine-cytokine receptor interaction\nhsa04620(3454+3455)  Toll-like receptor signaling pathway\nhsa04630(3454+3455)  JAK-STAT signaling pathway\nhsa04650(3454+3455)  Natural killer cell mediated cytotoxicity\nhsa05160(3454+3455)  Hepatitis C\nhsa05161(3454)  Hepatitis B\nhsa05162(3454+3455)  Measles\nhsa05200(3454+3455)  Pathways in cancer",
    "metabolism": "",
    "therapeutic_category": "6399",
    "atc_code": "L03AB01",
    "drug_class": [
      "Immunological agent",
      "Interferone"
    ],
    "cyp_enzymes": [],
    "search_name": "Interferon alfa"
  },
  {
    "kegg_id": "D03357",
    "name_en": "Interferon gamma-1a (genetical recombination) (JAN)",
    "name_ja": "",
    "names_alt": [
      "Interferon gamma-1a",
      "Biogamma (TN)"
    ],
    "formula": "C761H1206N214O225S6",
    "efficacy": "Antineoplastic, Immunomodulator, Biological response modifier",
    "target": "IFNGR1 (CD119) [HSA:3459] [KO:K05132]\nIFNGR2 [HSA:3460] [KO:K05133]\nPATHWAY   hsa04060(3459+3460)  Cytokine-cytokine receptor interaction\nhsa04630(3459+3460)  JAK-STAT signaling pathway\nhsa04650(3459+3460)  Natural killer cell mediated cytotoxicity\nhsa05200(3459+3460)  Pathways in cancer",
    "metabolism": "",
    "therapeutic_category": "6399",
    "atc_code": "L03AB03",
    "drug_class": [
      "Immunological agent",
      "Interferone"
    ],
    "cyp_enzymes": [],
    "search_name": "Interferon gamma-1a"
  },
  {
    "kegg_id": "D04554",
    "name_en": "Interferon beta-1a (USAN)",
    "name_ja": "",
    "names_alt": [
      "Interferon beta-1a (genetical recombination) (JAN)",
      "Avonex (TN)",
      "Rebif (TN)"
    ],
    "formula": "C908H1406N246O252S7",
    "efficacy": "Antineoplastic, Biological response modifier\nDISEASE   Multiple sclerosis [DS:H01490]",
    "target": "IFNAR1 [HSA:3454] [KO:K05130]\nIFNAR2 [HSA:3455] [KO:K05131]\nPATHWAY   hsa04060(3454+3455)  Cytokine-cytokine receptor interaction\nhsa04620(3454+3455)  Toll-like receptor signaling pathway\nhsa04630(3454+3455)  JAK-STAT signaling pathway\nhsa04650(3454+3455)  Natural killer cell mediated cytotoxicity",
    "metabolism": "",
    "therapeutic_category": "6399",
    "atc_code": "L03AB07",
    "drug_class": [
      "Immunological agent",
      "Interferone"
    ],
    "cyp_enzymes": [],
    "search_name": "Interferon beta-1a"
  },
  {
    "kegg_id": "D00746",
    "name_en": "Interferon beta-1b (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Interferon beta-1b (genetical recombination) (JAN)",
      "Betaseron (TN)",
      "Extavia (TN)"
    ],
    "formula": "C903H1399N245O252S5",
    "efficacy": "Immunomodulator, Biological response modifier\nDISEASE   Multiple sclerosis [DS:H01490]",
    "target": "IFNAR1 [HSA:3454] [KO:K05130]\nIFNAR2 [HSA:3455] [KO:K05131]\nPATHWAY   hsa04060(3454+3455)  Cytokine-cytokine receptor interaction\nhsa04620(3454+3455)  Toll-like receptor signaling pathway\nhsa04630(3454+3455)  JAK-STAT signaling pathway\nhsa04650(3454+3455)  Natural killer cell mediated cytotoxicity",
    "metabolism": "",
    "therapeutic_category": "6399",
    "atc_code": "L03AB08",
    "drug_class": [
      "Immunological agent",
      "Interferone"
    ],
    "cyp_enzymes": [],
    "search_name": "Interferon beta-1b"
  },
  {
    "kegg_id": "D02747",
    "name_en": "Peginterferon alfa-2a (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Peginterferon alfa-2a (genetical recombination) (JAN)",
      "Pegasys (TN)"
    ],
    "formula": "C10H17N2O5R(C2H4O)n(C2H4O)n",
    "efficacy": "Antiviral, Biological response modifier\nDISEASE   Chronic hepatitis C [DS:H00413]\nChronic hepatitis B [DS:H00412]",
    "target": "IFNAR1 [HSA:3454] [KO:K05130]\nIFNAR2 [HSA:3455] [KO:K05131]\nPATHWAY   hsa04060(3454+3455)  Cytokine-cytokine receptor interaction\nhsa04620(3454+3455)  Toll-like receptor signaling pathway\nhsa04630(3454+3455)  JAK-STAT signaling pathway\nhsa04650(3454+3455)  Natural killer cell mediated cytotoxicity\nhsa05160(3454+3455)  Hepatitis C\nhsa05161(3454)  Hepatitis B",
    "metabolism": "",
    "therapeutic_category": "6399",
    "atc_code": "L03AB11",
    "drug_class": [
      "Immunological agent",
      "Interferone"
    ],
    "cyp_enzymes": [],
    "search_name": "Peginterferon alfa-2a"
  },
  {
    "kegg_id": "D09190",
    "name_en": "Anti-human thymocyte immunoglobulin, rabbit (JAN)",
    "name_ja": "",
    "names_alt": [
      "Thymoglobuline (TN)"
    ],
    "formula": "",
    "efficacy": "Immunosuppressant",
    "target": "CD2 [HSA:914] [KO:K06449]\nCD3 [HSA:915 916 917] [KO:K06450 K06451 K06452]\nCD4 [HSA:920] [KO:K06454]\nCD5 [HSA:921] [KO:K06455]\nCD7 [HSA:924] [KO:K06457]\nCD8 [HSA:925 926] [KO:K06458 K06459]\nIL2RA (CD25) [HSA:3559] [KO:K05068]\nITGAL (CD11A) [HSA:3683] [KO:K05718]\nPATHWAY   hsa04640(3559+914+915+916+917+920+921+924+925+926)  Hematopoietic cell lineage\nhsa04658(3559+915+916+917+920)  Th1 and Th2 cell differentiation\nhsa04659(3559+915+916+917+920)  Th17 cell differentiation\nhsa04660(915+916+917+920+925+926)  T cell receptor signaling pathway",
    "metabolism": "",
    "therapeutic_category": "6399",
    "atc_code": "L04AA04",
    "drug_class": [
      "Immunological agent",
      "Interleukin inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Anti-human thymocyte immunoglobulin, rabbit"
  },
  {
    "kegg_id": "D03058",
    "name_en": "Basiliximab (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Basiliximab (genetical recombination) (JAN)",
      "Simulect (TN)"
    ],
    "formula": "",
    "efficacy": "Immunosuppressant, Anti-CD25 antibody\nDISEASE   Prophylaxis of acute organ rejection [DS:H00083]\nTYPE      Monoclonal antibody",
    "target": "IL2RA (CD25) [HSA:3559] [KO:K05068]\nPATHWAY   hsa04060(3559)  Cytokine-cytokine receptor interaction\nhsa04144(3559)  Endocytosis\nhsa04630(3559)  JAK-STAT signaling pathway\nhsa04640(3559)  Hematopoietic cell lineage",
    "metabolism": "",
    "therapeutic_category": "6399",
    "atc_code": "L04AC02",
    "drug_class": [
      "Immunological agent",
      "Interleukin inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Basiliximab"
  },
  {
    "kegg_id": "D02596",
    "name_en": "Tocilizumab (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Tocilizumab (genetical recombination) (JAN)",
      "Tocilizumab (genetical recombination) [Tocilizumab biosimilar 1] (JAN)",
      "Tocilizumab-aazg",
      "Tocilizumab-bavi",
      "Tocilizumab-anoh",
      "Actemra (TN)",
      "Avtozma (TN)",
      "Tofidence (TN)",
      "Tyenne (TN)"
    ],
    "formula": "C6428H9976N1720O2018S42",
    "efficacy": "Anti-inflammatory, Antirheumatic, Immunosuppressant, Anti-IL-6 receptor antibody\nDISEASE   Rheumatoid arthritis [DS:H00630]\nGiant Cell Arteritis [DS:H01698]\nSystemic sclerosis-associated interstitial lung disease [DS:H01492]\nPolyarticular juvenile idiopathic arthritis [DS:H01672]\nSystemic juvenile idiopathic arthritis [DS:H01672]\nCoronavirus disease 2019 [DS:H02398]\nTYPE      Monoclonal antibody",
    "target": "IL6R (CD126) [HSA:3570] [KO:K05055]\nPATHWAY   hsa04060(3570)  Cytokine-cytokine receptor interaction\nhsa04630(3570)  JAK-STAT signaling pathway\nhsa04640(3570)  Hematopoietic cell lineage",
    "metabolism": "",
    "therapeutic_category": "6399",
    "atc_code": "L04AC07",
    "drug_class": [
      "Immunological agent",
      "Interleukin inhibitor",
      "Anti-inflammatory",
      "Disease modifying anti-rheumatic drug (DMARD)"
    ],
    "cyp_enzymes": [],
    "search_name": "Tocilizumab"
  },
  {
    "kegg_id": "D11079",
    "name_en": "Satralizumab (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Satralizumab (genetical recombination) (JAN)",
      "satralizumab-mwge",
      "Enspryng (TN)"
    ],
    "formula": "C6340H9776N1684O2022S46",
    "efficacy": "Anti-inflammatory, Immunosuppressant, Anti-IL-6 receptor antibody\nDISEASE   Neuromyelitis optica spectrum disorder (anti-AQP4 antibody positive) [DS:H01491]\nTYPE      Monoclonal antibody",
    "target": "IL6R (CD126) [HSA:3570] [KO:K05055]\nPATHWAY   hsa04060(3570)  Cytokine-cytokine receptor interaction\nhsa04630(3570)  JAK-STAT signaling pathway",
    "metabolism": "",
    "therapeutic_category": "6399",
    "atc_code": "L04AC19",
    "drug_class": [
      "Immunological agent",
      "Interleukin inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Satralizumab"
  },
  {
    "kegg_id": "D11757",
    "name_en": "Inebilizumab (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Inebilizumab (genetical recombination) (JAN)",
      "Inebilizumab-cdon",
      "Uplizna (TN)"
    ],
    "formula": "C6504H10080N1732O2044S44",
    "efficacy": "Antineoplastic, Anti-CD19 antibody\nDISEASE   Neuromyelitis optica spectrum disorder (AQP4 antibody positive) [DS:H01491]\nTYPE      Monoclonal antibody",
    "target": "CD19 [HSA:930] [KO:K06465]\nPATHWAY   hsa04151(930)  PI3K-Akt signaling pathway\nhsa04640(930)  Hematopoietic cell lineage\nhsa04662(930)  B cell receptor signaling pathway",
    "metabolism": "",
    "therapeutic_category": "6399",
    "atc_code": "L04AG10",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Inebilizumab"
  },
  {
    "kegg_id": "D03940",
    "name_en": "Eculizumab (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Eculizumab (genetical recombination) (JAN)",
      "Eculizumab-aagh",
      "Eculizumab-aeeb",
      "Soliris (TN)",
      "Bkemv (TN)",
      "Epysqli (TN)"
    ],
    "formula": "",
    "efficacy": "Immunosuppressant, Anti-complement C5 antibody\nDISEASE   Paroxysmal nocturnal hemoglobinuria [DS:H01053]\nAtypical hemolytic uremic syndrome [DS:H01434]\nGeneralized myasthenia gravis (AChR antibody positive) [DS:H01594]\nNeuromyelitis optica spectrum disorder (anti-AQP4 antibody positive) [DS:H01491]\nTYPE      Monoclonal antibody",
    "target": "C5 [HSA:727] [KO:K03994]\nPATHWAY   hsa04610(727)  Complement and coagulation cascades\nNETWORK   nt06513  Complement cascade",
    "metabolism": "",
    "therapeutic_category": "6399",
    "atc_code": "L04AJ01",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Eculizumab"
  },
  {
    "kegg_id": "D11054",
    "name_en": "Ravulizumab (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Ravulizumab (genetical recombination) (JAN)",
      "Ultomiris (TN)"
    ],
    "formula": "C6430H9888N1696O2028S48",
    "efficacy": "Immunomodulator, Anti-complement C5 antibody\nDISEASE   Paroxysmal nocturnal hemoglobinuria [DS:H01053]\nAtypical hemolytic uremic syndrome [DS:H01434]\nTYPE      Monoclonal antibody",
    "target": "C5 [HSA:727] [KO:K03994]\nPATHWAY   hsa04610(727)  Complement and coagulation cascades\nNETWORK   nt06513  Complement cascade",
    "metabolism": "",
    "therapeutic_category": "6399",
    "atc_code": "L04AJ02",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Ravulizumab"
  },
  {
    "kegg_id": "D11530",
    "name_en": "Sutimlimab (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Sutimlimab (genetical recombination) (JAN)",
      "Sutimlimab-jome",
      "Enjaymo (TN)"
    ],
    "formula": "C6436H9912N1700O2016S46",
    "efficacy": "Anti-anemic, Anti-complement C1s antibody\nDISEASE   Cold agglutinin disease [DS:H01585]\nTYPE      Monoclonal antibody",
    "target": "C1S [HSA:716] [KO:K01331]\nPATHWAY   hsa04610(716)  Complement and coagulation cascades",
    "metabolism": "",
    "therapeutic_category": "6399",
    "atc_code": "L04AJ04",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Sutimlimab"
  },
  {
    "kegg_id": "D11696",
    "name_en": "Crovalimab (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Crovalimab (genetical recombination) (JAN)",
      "Crovalimab-akkz",
      "Piasky (TN)"
    ],
    "formula": "C6430H9974N1726O2026S46",
    "efficacy": "Anti-complement C5 antibody\nDISEASE   Paroxysmal nocturnal hemoglobinuria [DS:H01053]\nTYPE      Monoclonal antibody",
    "target": "C5 [HSA:727] [KO:K03994]\nPATHWAY   hsa04080(727)  Neuroactive ligand-receptor interaction\nhsa04610(727)  Complement and coagulation cascades\nNETWORK   nt06513  Complement cascade",
    "metabolism": "",
    "therapeutic_category": "6399",
    "atc_code": "L04AJ07",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Crovalimab"
  },
  {
    "kegg_id": "D11876",
    "name_en": "Efgartigimod alfa (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Efgartigimod alfa (genetical recombination) (JAN)",
      "Efgartigimod alfa-fcab",
      "Vyvgart (TN)"
    ],
    "formula": "C2310H3554N602O692S14",
    "efficacy": "Autoimmune disease treatment\nDISEASE   Generalized myasthenia gravis (AChR antibody positive) [DS:H01594]",
    "target": "FCGRT [HSA:2217] [KO:K24019]",
    "metabolism": "",
    "therapeutic_category": "6399",
    "atc_code": "L04AL01",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Efgartigimod alfa"
  },
  {
    "kegg_id": "D12684",
    "name_en": "Efgartigimod alfa and hyaluronidase",
    "name_ja": "",
    "names_alt": [
      "Efgartigimod alfa (genetical recombination) and vorhyaluronidase alfa (genetical recombination)",
      "Efgartigimod alfa and hyaluronidase-qvfc",
      "Vyvgard hytrulo (TN)",
      "Vyvdura (TN)"
    ],
    "formula": "",
    "efficacy": "Autoimmune disease treatment\nDISEASE   Generalized myasthenia gravis (AChR antibody positive) [DS:H01594]",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "6399",
    "atc_code": "L04AL01",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Efgartigimod alfa and hyaluronidase"
  },
  {
    "kegg_id": "D12182",
    "name_en": "Rozanolixizumab (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Rozanolixizumab (genetical recombination) (JAN)",
      "rozanolixizumab-noli",
      "Rystiggo (TN)"
    ],
    "formula": "C6462H9984N1704O2016S44",
    "efficacy": "Autoimmune disease treatment, Anti-Fc receptor antibody\nDISEASE   Generalized myasthenia gravis (anti-acetylcholine receptor or anti-muscle specific tyrosine kinase antibody positive) [DS:H01594]\nTYPE      Monoclonal antibody",
    "target": "FCGRT [HSA:2217] [KO:K24019]",
    "metabolism": "",
    "therapeutic_category": "6399",
    "atc_code": "L04AL02",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Rozanolixizumab"
  },
  {
    "kegg_id": "D11666",
    "name_en": "Nipocalimab (USAN)",
    "name_ja": "",
    "names_alt": [
      "Nipocalimab (genetical recombination) (JAN)",
      "Nipocalimab-aahu",
      "Imaavy (TN)"
    ],
    "formula": "C6266H9722N1670O1992S46",
    "efficacy": "Autoimmune disease treatment, Anti-Fc receptor antibody\nDISEASE   Generalized myasthenia gravis (anti-acetylcholine receptor antibody positive) [DS:H01594]\nGeneralized myasthenia gravis (anti-muscle-specific tyrosine kinase antibody positive) [DS:H01594]\nTYPE      Monoclonal antibody",
    "target": "FCGRT [HSA:2217] [KO:K24019]",
    "metabolism": "",
    "therapeutic_category": "6399",
    "atc_code": "L04AL03",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Nipocalimab"
  },
  {
    "kegg_id": "D02749",
    "name_en": "Teceleukin (USAN)",
    "name_ja": "",
    "names_alt": [
      "Teceleukin (genetical recombination) (JP18)",
      "Imunace (TN)"
    ],
    "formula": "C698H1127N179O204S8",
    "efficacy": "Antineoplastic, Immunostimulant, Biological response modifier",
    "target": "IL2RA (CD25) [HSA:3559] [KO:K05068]\nIL2RB (CD122) [HSA:3560] [KO:K05069]\nIL2RG (CD132) [HSA:3561] [KO:K05070]\nPATHWAY   hsa04060(3559+3560+3561)  Cytokine-cytokine receptor interaction\nhsa04630(3559+3560+3561)  JAK-STAT signaling pathway",
    "metabolism": "",
    "therapeutic_category": "6399",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Teceleukin"
  },
  {
    "kegg_id": "D08806",
    "name_en": "Histamine dihydrochloride and human normal immunoglobulin",
    "name_ja": "",
    "names_alt": [
      "Histaglobin (TN)"
    ],
    "formula": "",
    "efficacy": "Antiallergic, Eosinophil infiltration inhibitor",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "6399",
    "atc_code": "",
    "drug_class": [
      "Dermatological agent",
      "Atopic dermatitis agent"
    ],
    "cyp_enzymes": [],
    "search_name": "Histamine dihydrochloride and human normal immunoglobulin"
  },
  {
    "kegg_id": "D08808",
    "name_en": "Anti-human thymocyte immunoglobulin, equine (JAN)",
    "name_ja": "",
    "names_alt": [
      "Atgam (TN)",
      "Lymphoglobuline (TN)"
    ],
    "formula": "",
    "efficacy": "Immunosuppressant",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "6399",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Anti-human thymocyte immunoglobulin, equine"
  },
  {
    "kegg_id": "D00868",
    "name_en": "Paromomycin sulfate (JAN/USP)",
    "name_ja": "",
    "names_alt": [
      "Humatin (TN)"
    ],
    "formula": "C23H45N5O14. xH2SO4",
    "efficacy": "Antibiotic, Amebicide, Protein biosynthesis inhibitor\nDISEASE   Intestinal amebiasis [DS:H00360]",
    "target": "30S ribosomal subunit\nPATHWAY   ko03010(K01977)  Ribosome",
    "metabolism": "",
    "therapeutic_category": "6419",
    "atc_code": "A07AA06",
    "drug_class": [
      "Antibacterial",
      "Aminoglycoside antibiotic"
    ],
    "cyp_enzymes": [],
    "search_name": "Paromomycin sulfate"
  },
  {
    "kegg_id": "D05908",
    "name_en": "Spiramycin (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Rovamycin (TN)"
    ],
    "formula": "C43H73N2O14R",
    "efficacy": "Antibiotic, Protein biosynthesis inhibitor",
    "target": "50S ribosomal subunit\nPATHWAY   ko03010(K01980)  Ribosome",
    "metabolism": "",
    "therapeutic_category": "6419",
    "atc_code": "J01FA02",
    "drug_class": [
      "Antibacterial",
      "Macrolide antibiotic",
      "16-Membered ring macrolide antibiotic"
    ],
    "cyp_enzymes": [],
    "search_name": "Spiramycin"
  },
  {
    "kegg_id": "D02126",
    "name_en": "Primaquine phosphate (JAN/USP)",
    "name_ja": "",
    "names_alt": [],
    "formula": "C15H21N3O. 2H3PO4",
    "efficacy": "Antimalarial\nDISEASE   Vivax malaria [DS:H00361]",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "6419",
    "atc_code": "P01BA03",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Primaquine phosphate"
  },
  {
    "kegg_id": "D02472",
    "name_en": "Atovaquone and proguanil hydrochloride",
    "name_ja": "",
    "names_alt": [
      "Malarone (TN)"
    ],
    "formula": "C22H19ClO3. C11H16ClN5. HCl",
    "efficacy": "Antimalarial\nDISEASE   Malaria [DS:H00361]",
    "target": "",
    "metabolism": "Enzyme: CYP2C19 [HSA:1557]",
    "therapeutic_category": "6419",
    "atc_code": "P01BB51",
    "drug_class": [
      "Metabolizing enzyme substrate",
      "CYP2C19 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C19"
    ],
    "search_name": "Atovaquone and proguanil hydrochloride"
  },
  {
    "kegg_id": "D00831",
    "name_en": "Mefloquine hydrochloride (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Lariam (TN)"
    ],
    "formula": "C17H16F6N2O. HCl",
    "efficacy": "Antimalarial\nDISEASE   Malaria [DS:H00361]",
    "target": "",
    "metabolism": "Enzyme: CYP3A [HSA:1576 1577 1551]",
    "therapeutic_category": "6419",
    "atc_code": "P01BC02",
    "drug_class": [
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A"
    ],
    "search_name": "Mefloquine hydrochloride"
  },
  {
    "kegg_id": "D02484",
    "name_en": "Artemether and lumefantrine",
    "name_ja": "",
    "names_alt": [
      "Coartem (TN)"
    ],
    "formula": "C30H32Cl3NO. C16H26O5",
    "efficacy": "Antimalarial\nDISEASE   Malaria infections [DS:H00361]",
    "target": "",
    "metabolism": "Enzyme: CYP3A [HSA:1576 1577 1551]",
    "therapeutic_category": "6419",
    "atc_code": "P01BF01",
    "drug_class": [
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A"
    ],
    "search_name": "Artemether and lumefantrine"
  },
  {
    "kegg_id": "D00834",
    "name_en": "Pentamidine isethionate (USP)",
    "name_ja": "",
    "names_alt": [
      "Pentamidine isetionate (JAN)",
      "Pentam 300 (TN)"
    ],
    "formula": "C19H24N4O2. (C2H6O4S)2",
    "efficacy": "Antifungal, Antiprotozoal\nDISEASE   Pneumocystis jiroveci pneumonia [DS:H01521]\nPneumonia due to Pneumocystis carinii [DS:H01521]",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "6419",
    "atc_code": "P01CX01",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Pentamidine isethionate"
  },
  {
    "kegg_id": "D00803",
    "name_en": "Diethylcarbamazine citrate (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Hetrazan (TN)"
    ],
    "formula": "C10H21N3O. C6H8O7",
    "efficacy": "Anthelmintic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "6428",
    "atc_code": "P02CB02",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Diethylcarbamazine citrate"
  },
  {
    "kegg_id": "D00804",
    "name_en": "Ivermectin (JAN/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Sklice (TN)",
      "Soolantra (TN)",
      "Stromectol (TN)"
    ],
    "formula": "C47H71O14R",
    "efficacy": "Antiparasitic\nDISEASE   Head lice infestation [DS:H01054]\nStrongyloidiasis of the intestinal tract [DS:H01100]\nOnchocerciasis [DS:H01043]",
    "target": "glutamate-gated chloride channel [KO:K05273]",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]\nTransporter: ABCB1 [HSA:5243]",
    "therapeutic_category": "6429",
    "atc_code": "D11AX22",
    "drug_class": [
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "Transporter substrate",
      "ABCB1 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Ivermectin"
  },
  {
    "kegg_id": "D00471",
    "name_en": "Praziquantel (JAN/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Biltricide (TN)"
    ],
    "formula": "C19H24N2O2",
    "efficacy": "Anthelmintic (veterinary)\nDISEASE   Infections due to schistosoma [DS:H01045]\nInfections due to liver flukes [DS:H01610 H01617 H01628]",
    "target": "",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "6429",
    "atc_code": "P02BA01",
    "drug_class": [
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Praziquantel"
  },
  {
    "kegg_id": "D00368",
    "name_en": "Mebendazole (JAN/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Vermox (TN)"
    ],
    "formula": "C16H13N3O3",
    "efficacy": "Anthelmintic\nDISEASE   Gastrointestinal infection, hookworm [DS:H01092]\nGastrointestinal infection, roundworm [DS:H01090]\nGastrointestinal infection, pinworm [DS:H01091]\nGastrointestinal infection, whipworm [DS:H01046]",
    "target": "tubulin alpha [KO:K07374]\ntubulin beta [KO:K07375]",
    "metabolism": "",
    "therapeutic_category": "6429",
    "atc_code": "P02CA01",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Mebendazole"
  },
  {
    "kegg_id": "D00134",
    "name_en": "Albendazole (JAN/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Albenza (TN)"
    ],
    "formula": "C12H15N3O2S",
    "efficacy": "Anthelmintic\nDISEASE   Neurocysticercosis [DS:H01047]\nHydatid disease [DS:H01153]",
    "target": "fumarate reductase",
    "metabolism": "",
    "therapeutic_category": "6429",
    "atc_code": "P02CA03",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Albendazole"
  },
  {
    "kegg_id": "D00486",
    "name_en": "Pyrantel pamoate (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Antiminth (TN)"
    ],
    "formula": "C23H16O6. C11H14N2S",
    "efficacy": "Anthelmintic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "6429",
    "atc_code": "P02CC01",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Pyrantel pamoate"
  },
  {
    "kegg_id": "D08357",
    "name_en": "Phenothrin (INN)",
    "name_ja": "",
    "names_alt": [
      "Hegor antipoux (TN)"
    ],
    "formula": "C23H26O3",
    "efficacy": "Insecticide\nDISEASE   Scabies [DS:H01519]",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "6429",
    "atc_code": "P03AC03",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Phenothrin"
  },
  {
    "kegg_id": "D03226",
    "name_en": "Lactose hydrate (JP18)",
    "name_ja": "",
    "names_alt": [
      "Lactose monohydrate (NF)"
    ],
    "formula": "C12H22O11. H2O",
    "efficacy": "Pharmaceutic aid (tablet and capsule diluent)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "7111",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Lactose hydrate"
  },
  {
    "kegg_id": "D05297",
    "name_en": "Corn starch (JP18)",
    "name_ja": "",
    "names_alt": [
      "Starch, corn (NF)"
    ],
    "formula": "",
    "efficacy": "Pharmaceutic aid (vehicle)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "7112",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Corn starch"
  },
  {
    "kegg_id": "D05318",
    "name_en": "Potato starch (JP18)",
    "name_ja": "",
    "names_alt": [
      "Starch, potato (NF)"
    ],
    "formula": "",
    "efficacy": "Pharmaceutic aid (vehicle)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "7112",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Potato starch"
  },
  {
    "kegg_id": "D02779",
    "name_en": "Acacia (JP18/NF)",
    "name_ja": "",
    "names_alt": [
      "Powdered acacia (JP18)"
    ],
    "formula": "",
    "efficacy": "Pharmaceutic aid (emulsifying, suspending, vehicle, viscosity-increasing)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "7119",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Acacia"
  },
  {
    "kegg_id": "D05042",
    "name_en": "Mineral oil (USP)",
    "name_ja": "",
    "names_alt": [
      "Liquid paraffin (JP18)",
      "Balneol (TN)"
    ],
    "formula": "",
    "efficacy": "Laxative, Pharmaceutic aid (solvent)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "7121",
    "atc_code": "A06AA01",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Mineral oil"
  },
  {
    "kegg_id": "D03311",
    "name_en": "Olive oil (JP18/NF)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Pharmaceutic aid (ointment base, oleaginous)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "7121",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Olive oil"
  },
  {
    "kegg_id": "D03314",
    "name_en": "Sesame oil (JP18/NF)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Pharmaceutic aid (ointment base, oleaginous, solvent, vehicle)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "7121",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Sesame oil"
  },
  {
    "kegg_id": "D04969",
    "name_en": "White beeswax (JP18)",
    "name_ja": "",
    "names_alt": [
      "Wax, white (NF)"
    ],
    "formula": "",
    "efficacy": "Pharmaceutic aid (ointment base, stiffening)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "7121",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "White beeswax"
  },
  {
    "kegg_id": "D05239",
    "name_en": "Ointment, white (USP)",
    "name_ja": "",
    "names_alt": [
      "White ointment (JP18)"
    ],
    "formula": "",
    "efficacy": "Pharmaceutic aid (ointment base, oleaginous)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "7121",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Ointment, white"
  },
  {
    "kegg_id": "D05287",
    "name_en": "Simple ointment (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Pharmaceutic aid (ointment base, oleaginous)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "7121",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Simple ointment"
  },
  {
    "kegg_id": "D05304",
    "name_en": "Petrolatum, white (USP)",
    "name_ja": "",
    "names_alt": [
      "White petrolatum (JP18)",
      "Moroline (TN)"
    ],
    "formula": "",
    "efficacy": "Pharmaceutic aid (ointment base, oleaginous), Protectant (topical)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "7121",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Petrolatum, white"
  },
  {
    "kegg_id": "D05331",
    "name_en": "Petrolatum (USP)",
    "name_ja": "",
    "names_alt": [
      "Yellow petrolatum (JP18)"
    ],
    "formula": "",
    "efficacy": "Pharmaceutic aid (ointment base)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "7121",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Petrolatum"
  },
  {
    "kegg_id": "D05332",
    "name_en": "Hydrophilic petrolatum (JP18)",
    "name_ja": "",
    "names_alt": [
      "Petrolatum, hydrophilic"
    ],
    "formula": "",
    "efficacy": "Pharmaceutic aid (ointment base), Protectant (topical)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "7121",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Hydrophilic petrolatum"
  },
  {
    "kegg_id": "D04662",
    "name_en": "Lanolin (USP)",
    "name_ja": "",
    "names_alt": [
      "Purified lanolin (JP18)"
    ],
    "formula": "",
    "efficacy": "Pharmaceutic aid (ointment base, absorbent)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "7122",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Lanolin"
  },
  {
    "kegg_id": "D05237",
    "name_en": "Ointment, hydrophilic (USP)",
    "name_ja": "",
    "names_alt": [
      "Hydrophilic cream (JP18)",
      "Hydrophilic ointment"
    ],
    "formula": "",
    "efficacy": "Pharmaceutic aid (ointment base, oil-in-water emulsion)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "7122",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Ointment, hydrophilic"
  },
  {
    "kegg_id": "D05354",
    "name_en": "Absorptive cream (JP18)",
    "name_ja": "",
    "names_alt": [
      "Absorptive ointment"
    ],
    "formula": "",
    "efficacy": "Pharmaceutic aid (ointment base, emulsion)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "7122",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Absorptive cream"
  },
  {
    "kegg_id": "D06418",
    "name_en": "Macrogol ointment (JP18)",
    "name_ja": "",
    "names_alt": [
      "Solbanon (TN)"
    ],
    "formula": "H2O(C2H4O)n",
    "efficacy": "Pharmaceutic aid (ointment base)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "7123",
    "atc_code": "A06AD15",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Macrogol ointment"
  },
  {
    "kegg_id": "D06419",
    "name_en": "Macrogol 400 (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "H2O(C2H4O)n",
    "efficacy": "Pharmaceutic aid (ointment base)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "7123",
    "atc_code": "A06AD15",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Macrogol 400"
  },
  {
    "kegg_id": "D06420",
    "name_en": "Macrogol 1500 (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "H2O(C2H4O)n",
    "efficacy": "Pharmaceutic aid (ointment base)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "7123",
    "atc_code": "A06AD15",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Macrogol 1500"
  },
  {
    "kegg_id": "D06421",
    "name_en": "Macrogol 4000 (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "H2O(C2H4O)n",
    "efficacy": "Pharmaceutic aid (ointment base)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "7123",
    "atc_code": "A06AD15",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Macrogol 4000"
  },
  {
    "kegg_id": "D09218",
    "name_en": "Liquid paraffin and polyethylene resin",
    "name_ja": "",
    "names_alt": [
      "Plastibase (TN)"
    ],
    "formula": "",
    "efficacy": "Pharmaceutic aid (ointment base)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "7129",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Liquid paraffin and polyethylene resin"
  },
  {
    "kegg_id": "D00001",
    "name_en": "Water (JP18/USP)",
    "name_ja": "精製水",
    "names_alt": [
      "Purified water (JP18)",
      "Purified water in containers (JP18)",
      "Water, purified (USP)",
      "Sterile purified water in containers (JP18)",
      "Water for injection (JP18)",
      "Water for injection in containers (JP18)"
    ],
    "formula": "H2O",
    "efficacy": "Pharmaceutic aid (solvent)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "7131",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Water"
  },
  {
    "kegg_id": "D00078",
    "name_en": "Propylene glycol (JP18/USP)",
    "name_ja": "",
    "names_alt": [],
    "formula": "C3H8O2",
    "efficacy": "Pharmaceutic aid (humectant, solvent, suspending)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "7139",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Propylene glycol"
  },
  {
    "kegg_id": "D05286",
    "name_en": "Simple syrup (JP18)",
    "name_ja": "",
    "names_alt": [
      "Syrup (NF)"
    ],
    "formula": "",
    "efficacy": "Pharmaceutic aid (flavor)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "7142",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Simple syrup"
  },
  {
    "kegg_id": "D04154",
    "name_en": "Fennel oil (JP18/NF)",
    "name_ja": "",
    "names_alt": [
      "Fennel oil, bitter"
    ],
    "formula": "",
    "efficacy": "Pharmaceutic aid (flavor)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "7143",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Fennel oil"
  },
  {
    "kegg_id": "D08809",
    "name_en": "Aromatic powder",
    "name_ja": "",
    "names_alt": [
      "Cinnamon bark, zanthoxylum fruit and ginger"
    ],
    "formula": "",
    "efficacy": "Stomachic, Pharmaceutic aid (perfume)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "7143",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Aromatic powder"
  },
  {
    "kegg_id": "D01222",
    "name_en": "Citric acid monohydrate (USP)",
    "name_ja": "",
    "names_alt": [
      "Citric acid hydrate (JP18)"
    ],
    "formula": "C6H8O7. H2O",
    "efficacy": "Pharmaceutic aid (buffering agent, flavor)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "7149",
    "atc_code": "A09AB04",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Citric acid monohydrate"
  },
  {
    "kegg_id": "D00111",
    "name_en": "Lactic acid (JP18/USP)",
    "name_ja": "",
    "names_alt": [],
    "formula": "C3H6O3",
    "efficacy": "Pharmaceutic aid (flavor)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "7149",
    "atc_code": "G01AD01",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Lactic acid"
  },
  {
    "kegg_id": "D00025",
    "name_en": "Sucrose (JP18/NF)",
    "name_ja": "",
    "names_alt": [
      "White soft sugar (JP18)",
      "Sugar, compressible (NF)",
      "Sugar, confectioner's (NF)",
      "Sugar spheres (NF)",
      "Sucrose, purified"
    ],
    "formula": "C12H22O11",
    "efficacy": "Pharmaceutic aid (flavor, tablet excipient, vehicle, solid carrier)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "7149",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Sucrose"
  },
  {
    "kegg_id": "D00064",
    "name_en": "l-Menthol (JP18)",
    "name_ja": "",
    "names_alt": [
      "Levomenthol"
    ],
    "formula": "C10H20O",
    "efficacy": "Antiperistaltic (gastric), Pharmaceutic aid (flavor)",
    "target": "TRPM8 [HSA:79054] [KO:K04983]\nTRPA1 [HSA:8989] [KO:K04984]",
    "metabolism": "",
    "therapeutic_category": "7149",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "l-Menthol"
  },
  {
    "kegg_id": "D00103",
    "name_en": "Tartaric acid (JP18/NF)",
    "name_ja": "",
    "names_alt": [],
    "formula": "C4H6O6",
    "efficacy": "Pharmaceutic aid (buffering agent, flavor)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "7149",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Tartaric acid"
  },
  {
    "kegg_id": "D02192",
    "name_en": "Saccharin sodium (USP)",
    "name_ja": "",
    "names_alt": [
      "Saccharin sodium hydrate (JP18)",
      "Sodium saccharin dihydrate",
      "Sucaryl (TN)"
    ],
    "formula": "C7H4NO3S. 2H2O. Na",
    "efficacy": "Pharmaceutic aid (flavor), Sweetener (non-nutritive)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "7149",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Saccharin sodium"
  },
  {
    "kegg_id": "D04410",
    "name_en": "Mentha water (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Pharmaceutic aid (flavor)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "7149",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Mentha water"
  },
  {
    "kegg_id": "D05764",
    "name_en": "Rose oil (NF)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Pharmaceutic aid (perfume)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "7149",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Rose oil"
  },
  {
    "kegg_id": "D06461",
    "name_en": "Mentha oil (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Pharmaceutic aid (flavor)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "7149",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Mentha oil"
  },
  {
    "kegg_id": "D06776",
    "name_en": "Honey (JP18)",
    "name_ja": "",
    "names_alt": [
      "Honey, purified (NF)"
    ],
    "formula": "",
    "efficacy": "Pharmaceutic aid (flavor)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "7149",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Honey"
  },
  {
    "kegg_id": "D03091",
    "name_en": "Benzoin (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Benzoin tincture",
      "Anxixang (TN)"
    ],
    "formula": "",
    "efficacy": "Antiseptic, Protectant (topical), Pharmaceutic aid (emulsifying)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "7150",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Benzoin"
  },
  {
    "kegg_id": "D02057",
    "name_en": "Hydrochloric acid (JP18/USP)",
    "name_ja": "",
    "names_alt": [],
    "formula": "HCl",
    "efficacy": "Pharmaceutic aid (acidifying agent)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "7190",
    "atc_code": "A09AB03",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Hydrochloric acid"
  },
  {
    "kegg_id": "D02277",
    "name_en": "Sodium benzoate (JP18/NF)",
    "name_ja": "",
    "names_alt": [],
    "formula": "C7H5O2. Na",
    "efficacy": "Antihyperammonemic, Pharmaceutic aid (antifungal)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "7190",
    "atc_code": "A16AX11",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Sodium benzoate"
  },
  {
    "kegg_id": "D00038",
    "name_en": "Benzoic acid (JP18/USP)",
    "name_ja": "",
    "names_alt": [],
    "formula": "C7H6O2",
    "efficacy": "Antifungal, Antiseptic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "7190",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Benzoic acid"
  },
  {
    "kegg_id": "D01168",
    "name_en": "Potassium hydroxide (JP18/NF)",
    "name_ja": "",
    "names_alt": [],
    "formula": "KOH",
    "efficacy": "Emollient, Pharmaceutic aid (alkalizing, caustic)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "7190",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Potassium hydroxide"
  },
  {
    "kegg_id": "D01169",
    "name_en": "Sodium hydroxide (JP18/NF)",
    "name_ja": "",
    "names_alt": [],
    "formula": "Na. OH",
    "efficacy": "Pharmaceutic aid (alkalizing, caustic)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "7190",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Sodium hydroxide"
  },
  {
    "kegg_id": "D04133",
    "name_en": "Fat, hard (NF)",
    "name_ja": "",
    "names_alt": [
      "Hard fat",
      "Vosco (TN)"
    ],
    "formula": "",
    "efficacy": "Pharmaceutic aid (suppository base)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "7190",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Fat, hard"
  },
  {
    "kegg_id": "D01940",
    "name_en": "Meglumine sodium amidotrizoate (JP18)",
    "name_ja": "",
    "names_alt": [
      "Meglumine diatrizoate and sodium diatrizoate",
      "Urovision",
      "Cystografin (TN)",
      "MD 50 (TN)"
    ],
    "formula": "C11H9I3N2O4. C7H17NO5. C11H8I3N2O4. Na",
    "efficacy": "Diagnostic aid (radiopaque contrast agent)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "7211",
    "atc_code": "V08AA01",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Meglumine sodium amidotrizoate"
  },
  {
    "kegg_id": "D03604",
    "name_en": "Iodine addition products of the ethylesters of the fatty acids obtained from poppyseed oil",
    "name_ja": "",
    "names_alt": [
      "Lipiodol ultra fluide (TN)"
    ],
    "formula": "",
    "efficacy": "Diagnostic aid (contrast medium), Pharmaceutic aid (suspending)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "7211",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Iodine addition products of the ethylesters of the fatty acids obtained from poppyseed oil"
  },
  {
    "kegg_id": "D02052",
    "name_en": "Barium sulfate (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Baricon (TN)"
    ],
    "formula": "Ba. SO4",
    "efficacy": "Diagnostic aid (radiopaque medium)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "7212",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Barium sulfate"
  },
  {
    "kegg_id": "D03265",
    "name_en": "Magnesium citrate (JAN/USP)",
    "name_ja": "",
    "names_alt": [
      "Tectlol (TN)"
    ],
    "formula": "(C6H5O7)2. 3Mg",
    "efficacy": "Laxative",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "7213",
    "atc_code": "A06AD19",
    "drug_class": [
      "Gastrointestinal agent",
      "Magnesium containing preparation"
    ],
    "cyp_enzymes": [],
    "search_name": "Magnesium citrate"
  },
  {
    "kegg_id": "D03901",
    "name_en": "Sodium bicarbonate and tartaric acid",
    "name_ja": "",
    "names_alt": [
      "Gastrast (TN)"
    ],
    "formula": "",
    "efficacy": "Diagnostic aid",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "7213",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Sodium bicarbonate and tartaric acid"
  },
  {
    "kegg_id": "D01817",
    "name_en": "Iohexol (JP18/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Omnipaque (TN)"
    ],
    "formula": "C19H26I3N3O9",
    "efficacy": "Diagnostic aid (radiopaque medium)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "7219",
    "atc_code": "V08AB02",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Iohexol"
  },
  {
    "kegg_id": "D01797",
    "name_en": "Iopamidol (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Iopamiron (TN)",
      "Isovue (TN)"
    ],
    "formula": "C17H22I3N3O8",
    "efficacy": "Diagnostic aid (radiopaque medium)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "7219",
    "atc_code": "V08AB04",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Iopamidol"
  },
  {
    "kegg_id": "D01893",
    "name_en": "Iopromide (JAN/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Proscope (TN)",
      "Ultravist (TN)"
    ],
    "formula": "C18H24I3N3O8",
    "efficacy": "Diagnostic aid (radiopaque medium)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "7219",
    "atc_code": "V08AB05",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Iopromide"
  },
  {
    "kegg_id": "D01714",
    "name_en": "Iotrolan (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Isovist 300 (TN)"
    ],
    "formula": "C37H48I6N6O18",
    "efficacy": "Diagnostic aid (radiopaque medium)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "7219",
    "atc_code": "V08AB06",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Iotrolan"
  },
  {
    "kegg_id": "D01555",
    "name_en": "Ioversol (JAN/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Optiray (TN)"
    ],
    "formula": "C18H24I3N3O9",
    "efficacy": "Diagnostic aid (radiopaque medium)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "7219",
    "atc_code": "V08AB07",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Ioversol"
  },
  {
    "kegg_id": "D01474",
    "name_en": "Iodixanol (JAN/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Visipaque (TN)"
    ],
    "formula": "C35H44I6N6O15",
    "efficacy": "Diagnostic aid (radiopaque medium)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "7219",
    "atc_code": "V08AB09",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Iodixanol"
  },
  {
    "kegg_id": "D01719",
    "name_en": "Iomeprol (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Iomervu (TN)",
      "Iomeron 300 (TN)"
    ],
    "formula": "C17H22I3N3O8",
    "efficacy": "Diagnostic aid (radiopaque medium)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "7219",
    "atc_code": "V08AB10",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Iomeprol"
  },
  {
    "kegg_id": "D03902",
    "name_en": "Iotroxate meglumine",
    "name_ja": "",
    "names_alt": [
      "Biliscopin DIC (TN)"
    ],
    "formula": "C22H18I6N2O9. C7H17NO5",
    "efficacy": "Diagnostic aid (contrast medium)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "7219",
    "atc_code": "V08AC02",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Iotroxate meglumine"
  },
  {
    "kegg_id": "D01342",
    "name_en": "Indocyanine green (JAN/USP)",
    "name_ja": "",
    "names_alt": [
      "IC-Green (TN)"
    ],
    "formula": "C43H47N2O6S2. Na",
    "efficacy": "Diagnostic aid (cardiac output determination, hepatic function determination, contrast media)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "7222",
    "atc_code": "V04CX01",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Indocyanine green"
  },
  {
    "kegg_id": "D03905",
    "name_en": "Corticorelin (human) (JAN)",
    "name_ja": "",
    "names_alt": [
      "Xerecept",
      "hCRH (TN)"
    ],
    "formula": "C208H344N60O63S2",
    "efficacy": "Diagnostic, Corticotropin releasing hormone receptor agonist",
    "target": "CRHR [HSA:1394 1395] [KO:K04578 K04579]\nPATHWAY   hsa04080(1394+1395)  Neuroactive ligand-receptor interaction",
    "metabolism": "",
    "therapeutic_category": "7223",
    "atc_code": "V04CD04",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Corticorelin"
  },
  {
    "kegg_id": "D00176",
    "name_en": "Protirelin (JP18/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Relefact TRH (TN)"
    ],
    "formula": "C16H22N6O4",
    "efficacy": "Diagnostic (pituitary function determination), Thyrotropin-releasing hormone receptor agonist",
    "target": "TRHR [HSA:7201] [KO:K04282]\nPATHWAY   hsa04020(7201)  Calcium signaling pathway\nhsa04080(7201)  Neuroactive ligand-receptor interaction",
    "metabolism": "",
    "therapeutic_category": "7223",
    "atc_code": "V04CJ02",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Protirelin"
  },
  {
    "kegg_id": "D02040",
    "name_en": "Pralmorelin dihydrochloride (USAN)",
    "name_ja": "",
    "names_alt": [
      "Pralmorelin hydrochloride (JAN)",
      "GHRP (TN)"
    ],
    "formula": "C45H55N9O6. 2HCl",
    "efficacy": "Diagnostic",
    "target": "GHSR [HSA:2693] [KO:K04284]\nPATHWAY   hsa04080(2693)  Neuroactive ligand-receptor interaction",
    "metabolism": "",
    "therapeutic_category": "7223",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Pralmorelin dihydrochloride"
  },
  {
    "kegg_id": "D01563",
    "name_en": "Indigotindisulfonate sodium (USP)",
    "name_ja": "",
    "names_alt": [
      "Indigocarmine (JP18)"
    ],
    "formula": "C16H8N2O8S2. 2Na",
    "efficacy": "Diagnostic aid (cystoscopy)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "7225",
    "atc_code": "V04CH02",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Indigotindisulfonate sodium"
  },
  {
    "kegg_id": "D01200",
    "name_en": "Phenolsulfonphthalein (JP18/NF)",
    "name_ja": "",
    "names_alt": [
      "Phenol red"
    ],
    "formula": "C19H14O5S",
    "efficacy": "Diagnostic aid (renal function determination)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "7225",
    "atc_code": "V04CH03",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Phenolsulfonphthalein"
  },
  {
    "kegg_id": "D01421",
    "name_en": "Aminohippurate sodium (USP)",
    "name_ja": "",
    "names_alt": [
      "Sodium p-aminophippurate (JAN)",
      "p-Aminohippurate sodium"
    ],
    "formula": "C9H9N2O3. Na",
    "efficacy": "Diagnostic aid (renal function determination)",
    "target": "",
    "metabolism": "Transporter: SLC22A6 [HSA:9356]",
    "therapeutic_category": "7225",
    "atc_code": "V04CH30",
    "drug_class": [
      "Transporter substrate",
      "SLC22A6 substrate"
    ],
    "cyp_enzymes": [],
    "search_name": "Aminohippurate sodium"
  },
  {
    "kegg_id": "D00171",
    "name_en": "Inulin (JAN/USP)",
    "name_ja": "",
    "names_alt": [],
    "formula": "(C12H20O10)n",
    "efficacy": "Diagnostic (renal function determination)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "7225",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Inulin"
  },
  {
    "kegg_id": "D01346",
    "name_en": "Bentiromide (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "PFD (TN)"
    ],
    "formula": "C23H20N2O5",
    "efficacy": "Diagnostic aid (pancreas function determination)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "7229",
    "atc_code": "V04CK03",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Bentiromide"
  },
  {
    "kegg_id": "D00994",
    "name_en": "Edrophonium chloride (JP18/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Enlon (TN)",
      "Tensilon (TN)"
    ],
    "formula": "C10H16NO. Cl",
    "efficacy": "Antidote (to curare principles), Diagnostic aid (myasthenia gravis)\nDISEASE   Myasthenia gravis (emergency treatment) [DS:H01594]",
    "target": "ACHE [HSA:43] [KO:K01049]\nPATHWAY   hsa04725(43)  Cholinergic synapse",
    "metabolism": "",
    "therapeutic_category": "7229",
    "atc_code": "V04CX07",
    "drug_class": [
      "Neuropsychiatric agent",
      "Cholinesterase inhibitor",
      "Acetylcholinesterase inhibitor"
    ],
    "cyp_enzymes": [],
    "search_name": "Edrophonium chloride"
  },
  {
    "kegg_id": "D08810",
    "name_en": "Quinine hydrochloride, sodium chloride, tartaric acid and sucrose",
    "name_ja": "キニーネ",
    "names_alt": [],
    "formula": "",
    "efficacy": "Diagnostic (taste)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "7229",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Quinine hydrochloride, sodium chloride, tartaric acid and sucrose"
  },
  {
    "kegg_id": "D02908",
    "name_en": "Aminolevulinic acid hydrochloride (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "5-Aminolevulinic acid hydrochloride",
      "Levulan (TN)",
      "Ameluz (TN)",
      "Gleolan (TN)"
    ],
    "formula": "C5H9NO3. HCl",
    "efficacy": "Diagnostic (malignant glioma), Photosensitizer\nDISEASE   Glioma [DS:H00042]\nActinic keratosis [DS:H02429]",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "7290",
    "atc_code": "L01XD04",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Aminolevulinic acid hydrochloride"
  },
  {
    "kegg_id": "D04444",
    "name_en": "Histamine dihydrochloride (USAN)",
    "name_ja": "",
    "names_alt": [
      "Ceplene (TN)"
    ],
    "formula": "C5H9N3. 2HCl",
    "efficacy": "Diagnostic aid (control)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "7290",
    "atc_code": "L03AX14",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Histamine dihydrochloride"
  },
  {
    "kegg_id": "D01901",
    "name_en": "Xenon (JAN)",
    "name_ja": "",
    "names_alt": [
      "Xenopure (TN)"
    ],
    "formula": "Xe",
    "efficacy": "Diagnostic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "7290",
    "atc_code": "N01AX15",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Xenon"
  },
  {
    "kegg_id": "D01261",
    "name_en": "Fluorescein (JAN/USP)",
    "name_ja": "",
    "names_alt": [
      "Fluorescite (TN)"
    ],
    "formula": "C20H12O5",
    "efficacy": "Diagnostic aid (corneal trauma indicator)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "7290",
    "atc_code": "S01JA01",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Fluorescein"
  },
  {
    "kegg_id": "D02024",
    "name_en": "Fluorescein sodium (JP18/USP)",
    "name_ja": "",
    "names_alt": [
      "Floures (TN)"
    ],
    "formula": "C20H10O5. 2Na",
    "efficacy": "Diagnostic aid (corneal trauma indicator)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "7290",
    "atc_code": "S01JA01",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Fluorescein sodium"
  },
  {
    "kegg_id": "D04970",
    "name_en": "Methacholine chloride (JAN/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Provocholine (TN)"
    ],
    "formula": "C8H18NO2. Cl",
    "efficacy": "Bronchoconstrictor, Diagnostic, Muscarinic acetylcholine receptor agonist",
    "target": "CHRM [HSA:1128 1129 1131 1132 1133] [KO:K04129 K04130 K04131 K04132 K04133]\nPATHWAY   hsa04020(1128+1129+1131+1133)  Calcium signaling pathway\nhsa04080(1128+1129+1131+1132+1133)  Neuroactive ligand-receptor interaction\nhsa04725(1128+1129+1131+1132+1133)  Cholinergic synapse\nhsa04970(1131)  Salivary secretion\nhsa04971(1131)  Gastric acid secretion\nhsa04972(1131)  Pancreatic secretion",
    "metabolism": "",
    "therapeutic_category": "7290",
    "atc_code": "V04CX03",
    "drug_class": [
      "Neuropsychiatric agent",
      "Muscarinic cholinergic receptor agonist"
    ],
    "cyp_enzymes": [],
    "search_name": "Methacholine chloride"
  },
  {
    "kegg_id": "D01749",
    "name_en": "Urea C13 (USP)",
    "name_ja": "",
    "names_alt": [
      "Urea (13C) (JAN)",
      "Helicosol (TN)"
    ],
    "formula": "CH4N2O",
    "efficacy": "Diagnostic (Helicobacter pylori infection)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "7290",
    "atc_code": "V04CX05",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Urea C13"
  },
  {
    "kegg_id": "D03355",
    "name_en": "Gadoterate meglumine (USAN)",
    "name_ja": "",
    "names_alt": [
      "Meglumine gadoterate (JAN)",
      "Meglumine gadopentate",
      "Dotarem (TN)",
      "Magnescope (TN)"
    ],
    "formula": "C16H25N4O8. C7H17NO5. Gd",
    "efficacy": "Diagnostic aid (contrast medium)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "7290",
    "atc_code": "V08CA02",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Gadoterate meglumine"
  },
  {
    "kegg_id": "D01137",
    "name_en": "Gadoteridol (JAN/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "ProHance (TN)"
    ],
    "formula": "C17H29N4O7. Gd",
    "efficacy": "Diagnostic aid (paramagnetic)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "7290",
    "atc_code": "V08CA04",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Gadoteridol"
  },
  {
    "kegg_id": "D01644",
    "name_en": "Ferric ammonium citrate (JAN/USP)",
    "name_ja": "",
    "names_alt": [
      "Ferriseltz (TN)"
    ],
    "formula": "C6H5O7. xFe. xNH3",
    "efficacy": "Diagnostic aid (contrast medium)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "7290",
    "atc_code": "V08CA07",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Ferric ammonium citrate"
  },
  {
    "kegg_id": "D07420",
    "name_en": "Gadobutrol (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Gadavist (TN)"
    ],
    "formula": "C18H31N4O9. Gd",
    "efficacy": "Diagnostic aid (contrast medium)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "7290",
    "atc_code": "V08CA09",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Gadobutrol"
  },
  {
    "kegg_id": "D04288",
    "name_en": "Gadoxetate disodium (USAN)",
    "name_ja": "",
    "names_alt": [
      "Gadoxetate sodium (JAN)",
      "Eovist (TN)"
    ],
    "formula": "C23H28N3O11. 2Na. Gd",
    "efficacy": "Diagnostic aid (contrast medium)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "7290",
    "atc_code": "V08CA10",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Gadoxetate disodium"
  },
  {
    "kegg_id": "D12257",
    "name_en": "Gallium Ga 68 gozetotide (USAN)",
    "name_ja": "",
    "names_alt": [
      "Gallium (69Ga) gozetotide (JAN)",
      "Gallium Ga-68 PSMA-11 (TN)",
      "Gozellix (TN)",
      "Illuccix (TN)",
      "Locametz (TN)"
    ],
    "formula": "C44H59N6O17. Ga",
    "efficacy": "Diagnostic aid (prostate cancer), Radioactive agent",
    "target": "FOLH1 (PSMA) [HSA:2346] [KO:K14592]\nPATHWAY   hsa04981(2346)  Folate transport and metabolism\nhsa05215(2346)  Prostate cancer",
    "metabolism": "",
    "therapeutic_category": "7290",
    "atc_code": "V09IX14",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Gallium Ga 68 gozetotide"
  },
  {
    "kegg_id": "D03928",
    "name_en": "Ferucarbotran (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Resovist (TN)"
    ],
    "formula": "",
    "efficacy": "Diagnostic aid (paramagnetic)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "7290",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Ferucarbotran"
  },
  {
    "kegg_id": "D04337",
    "name_en": "Glucose, liquid (JAN/NF)",
    "name_ja": "ブドウ糖",
    "names_alt": [
      "Liquid glucose",
      "Glucose-40 (TN)"
    ],
    "formula": "",
    "efficacy": "Diagnostic, Pharmaceutic aid (tablet binder, tablet coating)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "7290",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Glucose, liquid"
  },
  {
    "kegg_id": "D04852",
    "name_en": "Manganese chloride (USP)",
    "name_ja": "",
    "names_alt": [
      "Manganese chloride tetrahydrate (JAN)",
      "Lumenhance (TN)"
    ],
    "formula": "MnCl2. 4H2O",
    "efficacy": "Diagnostic aid (contrast medium), Supplement (trace mineral)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "7290",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Manganese chloride"
  },
  {
    "kegg_id": "D05440",
    "name_en": "Perflubutane (JAN/USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Sonazoid (TN)"
    ],
    "formula": "C4F10",
    "efficacy": "Diagnostic aid (contrast medium)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "7290",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Perflubutane"
  },
  {
    "kegg_id": "D01039",
    "name_en": "Thymol (JP18/NF)",
    "name_ja": "",
    "names_alt": [],
    "formula": "C10H14O",
    "efficacy": "Anthelmintic, Pharmaceutic aid (stabilizer)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "7319",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Thymol"
  },
  {
    "kegg_id": "D01120",
    "name_en": "Glutaral (JAN/USP/INN)",
    "name_ja": "",
    "names_alt": [
      "Sonacide (TN)",
      "Sterihyde L (TN)"
    ],
    "formula": "C5H8O2",
    "efficacy": "Disinfectant",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "7321",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Glutaral"
  },
  {
    "kegg_id": "D03467",
    "name_en": "Peracetic acid",
    "name_ja": "",
    "names_alt": [
      "Acecide (TN)"
    ],
    "formula": "C2H4O3",
    "efficacy": "Disinfectant",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "7321",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Peracetic acid"
  },
  {
    "kegg_id": "D03470",
    "name_en": "Phtharal (JAN)",
    "name_ja": "",
    "names_alt": [
      "o-Phthalaldehyde",
      "Disopa (TN)"
    ],
    "formula": "C8H6O2",
    "efficacy": "Disinfectant",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "7321",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Phtharal"
  },
  {
    "kegg_id": "D03474",
    "name_en": "Ethylene oxide",
    "name_ja": "",
    "names_alt": [],
    "formula": "C2H4O",
    "efficacy": "Disinfectant",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "7329",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Ethylene oxide"
  },
  {
    "kegg_id": "D10793",
    "name_en": "Sodium picosulfate hydrate, magnesium oxide and citric acid, anhydrous",
    "name_ja": "",
    "names_alt": [
      "Picoprep (TN)",
      "Prepopik (TN)",
      "Clenpiq (TN)"
    ],
    "formula": "",
    "efficacy": "Laxative",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "7990",
    "atc_code": "A06AB58",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Sodium picosulfate hydrate, magnesium oxide and citric acid, anhydrous"
  },
  {
    "kegg_id": "D00045",
    "name_en": "Adenosine (JAN/USP)",
    "name_ja": "",
    "names_alt": [
      "Adenocard (TN)",
      "Adenoscan (TN)"
    ],
    "formula": "C10H13N5O4",
    "efficacy": "Antiarrhythmic, Cardiac depressant, Diagnostic aid (cardiac stress test), Adenosine receptor agonist",
    "target": "ADORA [HSA:134 135 136 140] [KO:K04265 K04266 K04267 K04268]\nPATHWAY   hsa04080(134+135+136+140)  Neuroactive ligand-receptor interaction\nhsa04270(135+136)  Vascular smooth muscle contraction",
    "metabolism": "",
    "therapeutic_category": "7990",
    "atc_code": "C01EB10",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Adenosine"
  },
  {
    "kegg_id": "D06120",
    "name_en": "Thyrotropin alfa (USAN/INN)",
    "name_ja": "",
    "names_alt": [
      "Thyrotropin alfa (genetical recombination) (JAN)",
      "Thyrotropin human alfa (genetical recombination)",
      "Thyrogen (TN)"
    ],
    "formula": "",
    "efficacy": "Diagnostic aid, Thyrotropin-releasing hormone receptor agonist",
    "target": "TRHR [HSA:7201] [KO:K04282]\nPATHWAY   hsa04080(7201)  Neuroactive ligand-receptor interaction",
    "metabolism": "",
    "therapeutic_category": "7990",
    "atc_code": "H01AB01",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Thyrotropin alfa"
  },
  {
    "kegg_id": "D03365",
    "name_en": "Nicotine (USP)",
    "name_ja": "",
    "names_alt": [
      "Habitrol (TN)"
    ],
    "formula": "C10H14N2",
    "efficacy": "Smoking cessation adjunct",
    "target": "CHRN [HSA:1134 1135 1136 1137 1138 8973 1139 55584 57053 1140 1141 1142 1143 1144 1145 1146] [KO:K04803 K04804 K04805 K04806 K04807 K04808 K04809 K04810 K04811 K04812 K04813 K04814 K04815 K04816 K04817 K04818]\nPATHWAY   hsa04080(1134+1135+1136+1137+1138+1139+1140+1141+1142+1143+1144+1145+1146+55584+57053+8973)  Neuroactive ligand-receptor interaction\nhsa04725(1136+1137+1139+1141+1143+8973)  Cholinergic synapse\nhsa05033(1137+1139+1141+8973)  Nicotine addiction",
    "metabolism": "Enzyme: CYP2A6 [HSA:1548]",
    "therapeutic_category": "7990",
    "atc_code": "N07BA01",
    "drug_class": [
      "Neuropsychiatric agent",
      "Drugs for nicotine dependence",
      "Metabolizing enzyme substrate",
      "CYP2A6 substrate",
      "Metabolizing enzyme inducer",
      "CYP1A2 inducer"
    ],
    "cyp_enzymes": [
      "CYP2A6"
    ],
    "search_name": "Nicotine"
  },
  {
    "kegg_id": "D06282",
    "name_en": "Varenicline tartrate (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Chantix (TN)",
      "Champix (TN)",
      "Tyrvaya (TN)"
    ],
    "formula": "C13H13N3. C4H6O6",
    "efficacy": "Smoking cessation adjunct, Selective nicotinic acetylcholine receptor modulator\nDISEASE   Dry eye disease [DS:H01641]",
    "target": "CHRNA4/CHRNB2 [HSA:1137 1141] [KO:K04806 K04813]\nPATHWAY   hsa04080(1137+1141)  Neuroactive ligand-receptor interaction\nhsa04725(1137+1141)  Cholinergic synapse",
    "metabolism": "",
    "therapeutic_category": "7990",
    "atc_code": "N07BA03",
    "drug_class": [
      "Neuropsychiatric agent",
      "Nicotinic cholinergic receptor partial agonist",
      "Drugs for nicotine dependence"
    ],
    "cyp_enzymes": [],
    "search_name": "Varenicline tartrate"
  },
  {
    "kegg_id": "D00003",
    "name_en": "Oxygen (JP18/USP)",
    "name_ja": "酸素",
    "names_alt": [],
    "formula": "O2",
    "efficacy": "Medical gases",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "7990",
    "atc_code": "V03AN01",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Oxygen"
  },
  {
    "kegg_id": "D00004",
    "name_en": "Carbon dioxide (JP18/USP)",
    "name_ja": "二酸化炭素",
    "names_alt": [],
    "formula": "CO2",
    "efficacy": "Medical gases",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "7990",
    "atc_code": "V03AN02",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Carbon dioxide"
  },
  {
    "kegg_id": "D00083",
    "name_en": "Nitrogen (JP18/NF)",
    "name_ja": "",
    "names_alt": [],
    "formula": "N2",
    "efficacy": "Medical gases",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "7990",
    "atc_code": "V03AN04",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Nitrogen"
  },
  {
    "kegg_id": "D03457",
    "name_en": "Pronase (JAN)",
    "name_ja": "",
    "names_alt": [
      "Empynase-P (TN)"
    ],
    "formula": "",
    "efficacy": "Enzyme (proteolytic), Gastric mucus remover",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "7990",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Pronase"
  },
  {
    "kegg_id": "D08814",
    "name_en": "Potassium chloride, calcium chloride hydrate, sodium chloride, magnesium chloride and Sodium bicarbonate",
    "name_ja": "塩化カリウム",
    "names_alt": [
      "Miotecter (TN)"
    ],
    "formula": "",
    "efficacy": "Surgical aid (cardioplegic solution, cardioplegia)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "7990",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Potassium chloride, calcium chloride hydrate, sodium chloride, magnesium chloride and Sodium bicarbonate"
  },
  {
    "kegg_id": "D08816",
    "name_en": "Potassium chloride, sodium chloride, sodium bicarbonate and sodium sulfate, dried",
    "name_ja": "塩化カリウム",
    "names_alt": [
      "Niflec (TN)"
    ],
    "formula": "",
    "efficacy": "Laxative",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "7990",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Potassium chloride, sodium chloride, sodium bicarbonate and sodium sulfate, dried"
  },
  {
    "kegg_id": "D11985",
    "name_en": "Magnesium sulfate, anhydous sodium sulfate and potassium sulfate",
    "name_ja": "",
    "names_alt": [
      "Sulprep (TN)"
    ],
    "formula": "",
    "efficacy": "Laxative",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "7990",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Magnesium sulfate, anhydous sodium sulfate and potassium sulfate"
  },
  {
    "kegg_id": "D03444",
    "name_en": "Opium (USP)",
    "name_ja": "",
    "names_alt": [
      "Opium, powdered (JP18)",
      "Diluted opium powder (JP18)"
    ],
    "formula": "",
    "efficacy": "Analgesic, Antiperistaltic, Antispasmodic, Narcotic, Sedative",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "8112",
    "atc_code": "A07DA02",
    "drug_class": [
      "Analgesic",
      "Opioid analgesics"
    ],
    "cyp_enzymes": [],
    "search_name": "Opium"
  },
  {
    "kegg_id": "D06499",
    "name_en": "Opium tincture (JP18)",
    "name_ja": "",
    "names_alt": [],
    "formula": "",
    "efficacy": "Analgesic (narcotic)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "8113",
    "atc_code": "A07DA02",
    "drug_class": [
      "Analgesic",
      "Opioid analgesics"
    ],
    "cyp_enzymes": [],
    "search_name": "Opium tincture"
  },
  {
    "kegg_id": "D00842",
    "name_en": "Morphine sulfate (USP)",
    "name_ja": "モルヒネ",
    "names_alt": [
      "Morphine sulfate hydrate (JP18)",
      "Morphine sulfate pentahydrate",
      "Astramor PH (TN)",
      "Avinza (TN)",
      "Depodur (TN)",
      "Kadian (TN)",
      "MS contin (TN)"
    ],
    "formula": "(C17H19NO3)2. H2SO4. 5H2O",
    "efficacy": "Analgesic (narcotic), Opioid receptor agonist",
    "target": "OPRM1 [HSA:4988] [KO:K04215]\nPATHWAY   hsa04080(4988)  Neuroactive ligand-receptor interaction",
    "metabolism": "Enzyme: UGT [KO:K00699]",
    "therapeutic_category": "8114",
    "atc_code": "N02AA01",
    "drug_class": [
      "Neuropsychiatric agent",
      "Opioid receptor agonist",
      "mu-Opioid receptor agonist",
      "Analgesic",
      "Opioid analgesics",
      "Metabolizing enzyme substrate",
      "UGT substrate"
    ],
    "cyp_enzymes": [],
    "search_name": "Morphine sulfate"
  },
  {
    "kegg_id": "D02271",
    "name_en": "Morphine hydrochloride hydrate (JP18)",
    "name_ja": "モルヒネ",
    "names_alt": [
      "Morphine hydrochloride trihydrate",
      "Anpec (TN)"
    ],
    "formula": "C17H19NO3. 3H2O. HCl",
    "efficacy": "Analgesic (narcotic), Opioid receptor agonist",
    "target": "OPRM1 [HSA:4988] [KO:K04215]\nPATHWAY   hsa04080(4988)  Neuroactive ligand-receptor interaction",
    "metabolism": "Enzyme: UGT [KO:K00699]",
    "therapeutic_category": "8114",
    "atc_code": "N02AA01",
    "drug_class": [
      "Neuropsychiatric agent",
      "Opioid receptor agonist",
      "mu-Opioid receptor agonist",
      "Analgesic",
      "Opioid analgesics",
      "Metabolizing enzyme substrate",
      "UGT substrate"
    ],
    "cyp_enzymes": [],
    "search_name": "Morphine hydrochloride hydrate"
  },
  {
    "kegg_id": "D00839",
    "name_en": "Hydromorphone hydrochloride (JAN/USP)",
    "name_ja": "",
    "names_alt": [
      "Dilaudid (TN)",
      "Exalgo (TN)",
      "Palladone (TN)"
    ],
    "formula": "C17H19NO3. HCl",
    "efficacy": "Analgesic (narcotic), Opioid receptor agonist",
    "target": "OPRM1 [HSA:4988] [KO:K04215]\nPATHWAY   hsa04080(4988)  Neuroactive ligand-receptor interaction",
    "metabolism": "Enzyme: UGT [KO:K00699]",
    "therapeutic_category": "8119",
    "atc_code": "N02AA03",
    "drug_class": [
      "Neuropsychiatric agent",
      "Opioid receptor agonist",
      "mu-Opioid receptor agonist",
      "Analgesic",
      "Opioid analgesics",
      "Metabolizing enzyme substrate",
      "UGT substrate"
    ],
    "cyp_enzymes": [],
    "search_name": "Hydromorphone hydrochloride"
  },
  {
    "kegg_id": "D05462",
    "name_en": "Oxycodone hydrochloride hydrate (JP18)",
    "name_ja": "オキシコドン",
    "names_alt": [],
    "formula": "C18H21NO4. 3H2O. HCl",
    "efficacy": "Analgesic (narcotic), Opioid receptor agonist",
    "target": "OPRM1 [HSA:4988] [KO:K04215]\nOPRK1 [HSA:4986] [KO:K04214]\nOPRD1 [HSA:4985] [KO:K04213]\nPATHWAY   hsa04080(4985+4986+4988)  Neuroactive ligand-receptor interaction",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]; CYP2D6 [HSA:1565]",
    "therapeutic_category": "8119",
    "atc_code": "N02AA05",
    "drug_class": [
      "Neuropsychiatric agent",
      "Opioid receptor agonist",
      "Analgesic",
      "Opioid analgesics",
      "Metabolizing enzyme substrate",
      "CYP2D6 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4",
      "CYP2D6"
    ],
    "search_name": "Oxycodone hydrochloride hydrate"
  },
  {
    "kegg_id": "D01496",
    "name_en": "Oxymetebanol (JAN)",
    "name_ja": "",
    "names_alt": [
      "Drotebanol (INN)",
      "Metebanyl (TN)"
    ],
    "formula": "C19H27NO4",
    "efficacy": "Antitussive, Narcotic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "8119",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Oxymetebanol"
  },
  {
    "kegg_id": "D03445",
    "name_en": "Opium alkaloids hydrochlorides (JP18)",
    "name_ja": "",
    "names_alt": [
      "Pan opin (TN)"
    ],
    "formula": "",
    "efficacy": "Analgesic (narcotic)",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "8119",
    "atc_code": "",
    "drug_class": [
      "Analgesic",
      "Opioid analgesics"
    ],
    "cyp_enzymes": [],
    "search_name": "Opium alkaloids hydrochlorides"
  },
  {
    "kegg_id": "D03869",
    "name_en": "Opium ipecac (JP18)",
    "name_ja": "",
    "names_alt": [
      "Dover's powder (TN)"
    ],
    "formula": "",
    "efficacy": "Analgesic, Antitussive, Narcotic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "8119",
    "atc_code": "",
    "drug_class": [],
    "cyp_enzymes": [],
    "search_name": "Opium ipecac"
  },
  {
    "kegg_id": "D01383",
    "name_en": "Meperidine hydrochloride (USP)",
    "name_ja": "",
    "names_alt": [
      "Pethidine hydrochloride (JP18)",
      "Demerol (TN)"
    ],
    "formula": "C15H21NO2. HCl",
    "efficacy": "Analgesic (narcotic), Antispasmodic, Opioid receptor agonist",
    "target": "OPRM1 [HSA:4988] [KO:K04215]\nPATHWAY   hsa04080(4988)  Neuroactive ligand-receptor interaction\nhsa05032(4988)  Morphine addiction",
    "metabolism": "",
    "therapeutic_category": "8211",
    "atc_code": "N02AB02",
    "drug_class": [
      "Neuropsychiatric agent",
      "Opioid receptor agonist",
      "mu-Opioid receptor agonist",
      "Analgesic",
      "Opioid analgesics"
    ],
    "cyp_enzymes": [],
    "search_name": "Meperidine hydrochloride"
  },
  {
    "kegg_id": "D00320",
    "name_en": "Fentanyl (JAN/USP/INN)",
    "name_ja": "フェンタニル",
    "names_alt": [
      "Duragesic (TN)",
      "Subsys (TN)"
    ],
    "formula": "C22H28N2O",
    "efficacy": "Analgesic (narcotic), Opioid receptor agonist",
    "target": "OPRM1 [HSA:4988] [KO:K04215]\nPATHWAY   hsa04080(4988)  Neuroactive ligand-receptor interaction",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "8219",
    "atc_code": "N01AH01",
    "drug_class": [
      "Neuropsychiatric agent",
      "Anesthetics",
      "General anesthetics",
      "Opioid anesthetics",
      "Opioid receptor agonist",
      "mu-Opioid receptor agonist",
      "Analgesic",
      "Opioid analgesics",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Fentanyl"
  },
  {
    "kegg_id": "D01399",
    "name_en": "Fentanyl citrate (JP18/USP)",
    "name_ja": "フェンタニル",
    "names_alt": [
      "Abstral (TN)",
      "Fentora (TN)",
      "Lazanda (TN)",
      "Oralet (TN)"
    ],
    "formula": "C22H28N2O. C6H8O7",
    "efficacy": "Analgesic (narcotic), Opioid receptor agonist",
    "target": "OPRM1 [HSA:4988] [KO:K04215]\nPATHWAY   hsa04080(4988)  Neuroactive ligand-receptor interaction",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576]",
    "therapeutic_category": "8219",
    "atc_code": "N01AH01",
    "drug_class": [
      "Neuropsychiatric agent",
      "Anesthetics",
      "General anesthetics",
      "Opioid anesthetics",
      "Opioid receptor agonist",
      "mu-Opioid receptor agonist",
      "Analgesic",
      "Opioid analgesics",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "search_name": "Fentanyl citrate"
  },
  {
    "kegg_id": "D01177",
    "name_en": "Remifentanil hydrochloride (JAN/USAN)",
    "name_ja": "",
    "names_alt": [
      "Ultiva (TN)"
    ],
    "formula": "C20H28N2O5. HCl",
    "efficacy": "Analgesic, Opioid receptor agonist",
    "target": "OPRM1 [HSA:4988] [KO:K04215]\nPATHWAY   hsa04080(4988)  Neuroactive ligand-receptor interaction",
    "metabolism": "",
    "therapeutic_category": "8219",
    "atc_code": "N01AH06",
    "drug_class": [
      "Neuropsychiatric agent",
      "Anesthetics",
      "General anesthetics",
      "Opioid anesthetics",
      "Opioid receptor agonist",
      "mu-Opioid receptor agonist",
      "Analgesic",
      "Opioid analgesics"
    ],
    "cyp_enzymes": [],
    "search_name": "Remifentanil hydrochloride"
  },
  {
    "kegg_id": "D03855",
    "name_en": "Pethidine hydrochloride and levallorphan tartrate",
    "name_ja": "",
    "names_alt": [
      "Pethilorfan (TN)"
    ],
    "formula": "",
    "efficacy": "Analgesic",
    "target": "",
    "metabolism": "",
    "therapeutic_category": "8219",
    "atc_code": "N02AB52",
    "drug_class": [
      "Analgesic",
      "Opioid analgesics"
    ],
    "cyp_enzymes": [],
    "search_name": "Pethidine hydrochloride and levallorphan tartrate"
  },
  {
    "kegg_id": "D02102",
    "name_en": "Methadone hydrochloride (JAN/USP)",
    "name_ja": "",
    "names_alt": [
      "Dolophine hydrochloride (TN)"
    ],
    "formula": "C21H27NO. HCl",
    "efficacy": "Analgesic (narcotic), Opioid receptor agonist, NMDA receptor antagonist",
    "target": "OPRM1 [HSA:4988] [KO:K04215]\nGRIN (NMDAR) [HSA:2902 2903 2904 2905 2906] [KO:K05208 K05209 K05210 K05211 K05212]\nPATHWAY   hsa04080(2902+2903+2904+2905+2906+4988)  Neuroactive ligand-receptor interaction\nhsa04724(2902+2903+2904+2905+2906)  Glutamatergic synapse\nhsa04728(2903+2904)  Dopaminergic synapse",
    "metabolism": "Enzyme: CYP3A4 [HSA:1576], CYP2B6 [HSA:1555]; CYP2C8 [HSA:1558], CYP2C9 [HSA:1559], CYP2C19 [HSA:1557], CYP2D6 [HSA:1565]\nTransporter: ABCB1 [HSA:5243]",
    "therapeutic_category": "8219",
    "atc_code": "N07BC02",
    "drug_class": [
      "Neuropsychiatric agent",
      "NMDA receptor antagonist",
      "Opioid receptor agonist",
      "mu-Opioid receptor agonist",
      "Analgesic",
      "Opioid analgesics",
      "Metabolizing enzyme substrate",
      "CYP2B6 substrate",
      "CYP2C8 substrate",
      "CYP2C9 substrate",
      "CYP2C19 substrate",
      "CYP2D6 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "Metabolizing enzyme inducer",
      "CYP2B6 inducer",
      "CYP3A/CYP3A4 inducer",
      "CYP3A4 inducer",
      "Transporter substrate",
      "ABCB1 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C19",
      "CYP3A4",
      "CYP2B6",
      "CYP2C9",
      "CYP2D6",
      "CYP2C8"
    ],
    "search_name": "Methadone hydrochloride"
  }
]